Citrus Sinensis ID: 016588

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380------
Protein Sequence
MSVTLAAIFGAAAGAVALMGIIFFLSWFCLYRNRSVSRTSETGSSEPSVQRNICIIAGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPTVTLGSHLFRATK
Secondary Structure (PSIPRED)
ccccHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHcccccccccccccccccEEEEEccccEEEEEEccccccHHHHHHHHHHHcccccccccEEEEEccccEEEEEEEEccccccccccccccccccccccHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHccccccccccHHHHHHHHHHHcccccccccccccccHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHHccccccccccccEEEcccccccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccEcHHHHHHHHccccHHccccccccccEEEcEcccccEEEEEEcccccHHHHHHHHHHHHHHHHHHHHHEEEEEEccccEEEEEEEcccccHHHHHccccccccccccHHHHHHHHHHHHHHHHHHHHccccEEEEccHHHHEEccccccccHcHccHHEEcccccccEEEEEEEEccccccHHHHHcccEEEccHHHHHHHEHHHHHccccccccccccccHHHHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHHHccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
MSVTLAAIFGAAAGAVALMGIIFFLSWFCLyrnrsvsrtsetgssepsvqRNICIIAGRNVGIELSIREARRFQMEELSLATknfsdknligegkfgEVYKGLLQDGMLVAikkrpgaptqefIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEyipngsvsihlygpsqvsrqklEFKHRLSIALGAAKGLAhlhslsprvvhkdfktanvlVDEDFIAKVADAGLrnflgrtdvagpssqvtaDEIFLASEVKEFRrfseksdvySFGVFLLELVSgreassslspdssQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCldpsserrpsmsdVVTELDRTLDKEMNlttvmgegtptvtlgshlfratk
Flexible Loop (DISEMBL)
MSVTLAAIFGAAAGAVALMGIIFFLSWFCLYRNRSVsrtsetgssepsvqrniciiagrnvGIELSIREARRFQMEELSLAtknfsdknligeGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFlgrtdvagpssqvtadEIFLASEVKEFRrfseksdvYSFGVFLLELVSGREAssslspdssqDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLdpsserrpsmsdvVTELDRTLDKEMnlttvmgegtptvtlgshlfratk
Low Complexity Region (SEG)
MSVTLaaifgaaagavalmgiiFFLSWFCLYRNRSVSRTSETGSSEPSVQRNICIIAGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIalgaakglahlhslsPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAssslspdssqdlVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPTVTLGSHLFRATK
Disordered region (IsUnstruct)
**************************************************RNICIIAGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELV*******************LVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCL*************************************************
Disordered Region (DISOPRED)
**VTLAAIFGAAAGAVALMGIIFFLSWFC******************************************RFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRP*AP*QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAS******S**DLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT*****************************
Disordered Region (DISEMBL)
MSVTLAAIFGAAAGAVALMGIIFFLSWFCLYRNRS*************VQRNICIIAGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG**************LVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPTVTLGSHLFRATK
Disordered Region (DISPRO)
*SVTLAAIFGAAAGAVALMGIIFFLSWFCLYRNRS*********************************EARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK**************************
Transmembrane Helix (TMHMM)
iiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
oooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MSVTLAAIFGAAAGAVALMGIIFFLSWFCLYRNRSVSRTSETGSSEPSVQRNICIIAGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPTVTLGSHLFRATK
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	386	2.2.26 [Sep-21-2011]
Q8LKZ1	924	Nodulation receptor kinas	N/A	no	0.924	0.386	0.375	2e-58
Q8L4H4	925	Nodulation receptor kinas	N/A	no	0.922	0.384	0.372	2e-56
Q9LX66	830	Receptor-like protein kin	no	no	0.943	0.438	0.349	1e-51
Q9FFW5	681	Proline-rich receptor-lik	no	no	0.764	0.433	0.379	5e-51
C0LGV0	895	Probable LRR receptor-lik	no	no	0.725	0.312	0.406	5e-51
Q9SA72	849	Probable receptor-like pr	no	no	0.740	0.336	0.375	1e-50
Q9SR05	850	Receptor-like protein kin	no	no	0.873	0.396	0.343	5e-50
Q9CAL8	710	Proline-rich receptor-lik	no	no	0.735	0.4	0.385	7e-50
Q9FID9	880	Probable receptor-like pr	no	no	0.746	0.327	0.375	3e-49
Q9LK35	855	Receptor-like protein kin	no	no	0.927	0.418	0.338	3e-49

>sp|Q8LKZ1|NORK_PEA Nodulation receptor kinase OS=Pisum sativum GN=NORK PE=1 SV=1

 Score =  226 bits (576), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 137/365 (37%), Positives = 206/365 (56%), Gaps = 8/365 (2%)

Query: 8   IFGAAAGAVALMGIIFFLSWFCLYRNRSVSRTSETGSSEPSVQRNICIIAGRNVGIELSI 67
           + GA      L+ +   + +FC YR++S++     G + P     I  +  ++     S+
Sbjct: 521 MIGAITSGSILITLAVVILFFCRYRHKSITLEGFGGKTYPMATNIIFSLPSKDDFFIKSV 580

Query: 68  REARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFI 124
              + F +E + LAT+ +  K LIGEG FG VY+G L DG  VA+K R    TQ   EF 
Sbjct: 581 -SVKPFTLEYIELATEKY--KTLIGEGGFGSVYRGTLDDGQEVAVKVRSATSTQGTREFD 637

Query: 125 DEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRL 184
           +E+  L++IQH NLV LLGYC E + Q L+Y ++ NGS+   LYG     R+ L++  RL
Sbjct: 638 NELNLLSAIQHENLVPLLGYCNEYDQQILVYPFMSNGSLLDRLYG-EPAKRKILDWPTRL 696

Query: 185 SIALGAAKGLAHLHSLSPR-VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 243
           SIALGAA+GLA+LH+   R V+H+D K++N+L+D    AKVAD G   +  +   +  S 
Sbjct: 697 SIALGAARGLAYLHTFPGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSYVSL 756

Query: 244 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS 303
           +V     +L  E  + ++ SEKSDV+SFGV LLE+VSGRE  +   P     LVE  +  
Sbjct: 757 EVRGTAGYLDPEYYKTQQLSEKSDVFSFGVVLLEIVSGREPLNIKRPRVEWSLVEWAKPY 816

Query: 304 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 363
              S + +I+D  +   +  E +   +++ ++CL+P S  RP M D+V EL+  L  E N
Sbjct: 817 IRASKVDEIVDPGIKGGYHAEALWRVVEVALQCLEPYSTYRPCMVDIVRELEDALIIENN 876

Query: 364 LTTVM 368
            +  M
Sbjct: 877 ASEYM 881

Involved in the perception of symbiotic fungi and bacteria and required for the calcium spiking. Part of the perception/transduction system leading to nodulation or mycorrhizal infection.
Pisum sativum (taxid: 3888)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8L4H4|NORK_MEDTR Nodulation receptor kinase OS=Medicago truncatula GN=NORK PE=1 SV=2

 Score =  220 bits (560), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 136/365 (37%), Positives = 207/365 (56%), Gaps = 9/365 (2%)

Query: 8   IFGAAAGAVALMGIIFFLSWFCLYRNRSVSRTSETGSSEPSVQRNICIIAGRNVGIELSI 67
           + GA      L+ +   + +FC YR++S++     G + P     I  +  ++     S+
Sbjct: 523 VIGAITSGSLLITLAVGILFFCRYRHKSITLEG-FGKTYPMATNIIFSLPSKDDFFIKSV 581

Query: 68  REARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFI 124
              + F +E +  AT+ +  K LIGEG FG VY+G L DG  VA+K R    TQ   EF 
Sbjct: 582 -SVKPFTLEYIEQATEQY--KTLIGEGGFGSVYRGTLDDGQEVAVKVRSSTSTQGTREFD 638

Query: 125 DEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRL 184
           +E+  L++IQH NLV LLGYC E + Q L+Y ++ NGS+   LYG +   R+ L++  RL
Sbjct: 639 NELNLLSAIQHENLVPLLGYCNEYDQQILVYPFMSNGSLLDRLYGEAS-KRKILDWPTRL 697

Query: 185 SIALGAAKGLAHLHSLSPR-VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 243
           SIALGAA+GLA+LH+   R V+H+D K++N+L+D+   AKVAD G   +  +   +  S 
Sbjct: 698 SIALGAARGLAYLHTFPGRSVIHRDVKSSNILLDQSMCAKVADFGFSKYAPQEGDSYVSL 757

Query: 244 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS 303
           +V     +L  E  + ++ SEKSDV+SFGV LLE+VSGRE  +   P     LVE  +  
Sbjct: 758 EVRGTAGYLDPEYYKTQQLSEKSDVFSFGVVLLEIVSGREPLNIKRPRIEWSLVEWAKPY 817

Query: 304 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 363
              S + +I+D  +   +  E +   +++ ++CL+P S  RP M D+V EL+  L  E N
Sbjct: 818 IRASKVDEIVDPGIKGGYHAEALWRVVEVALQCLEPYSTYRPCMVDIVRELEDALIIENN 877

Query: 364 LTTVM 368
            +  M
Sbjct: 878 ASEYM 882

Involved in the perception of symbiotic fungi and bacteria. Part of the perception/transduction system leading to nodulation or mycorrhizal infection.

Medicago truncatula (taxid: 3880)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LX66|HERK_ARATH Receptor-like protein kinase HERK 1 OS=Arabidopsis thaliana GN=HERK1 PE=1 SV=1

 Score =  204 bits (518), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 136/389 (34%), Positives = 198/389 (50%), Gaps = 25/389 (6%)

Query: 5   LAAIFGAAAGAVALMGIIFFLSWFCLYRNRSVSRTSETGSSEPSVQRNICIIAGRNVGIE 64
           L  I G+A G+  L+ ++F  S F LY+ R   +   + +  P       + +  + G  
Sbjct: 404 LGLIVGSAIGS--LLAVVFLGSCFVLYKKRKRGQDGHSKTWMPFSINGTSMGSKYSNGTT 461

Query: 65  LS---IREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ 121
           L+        R     +  AT NF +   IG G FG+VYKG L DG  VA+K+  G P  
Sbjct: 462 LTSITTNANYRIPFAAVKDATNNFDESRNIGVGGFGKVYKGELNDGTKVAVKR--GNPKS 519

Query: 122 -----EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQ 176
                EF  E+  L+  +HR+LV+L+GYC ENN   LIYEY+ NG+V  HLYG    S  
Sbjct: 520 QQGLAEFRTEIEMLSQFRHRHLVSLIGYCDENNEMILIYEYMENGTVKSHLYGSGLPS-- 577

Query: 177 KLEFKHRLSIALGAAKGLAHLHSL-SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 235
            L +K RL I +GAA+GL +LH+  S  V+H+D K+AN+L+DE+F+AKVAD GL      
Sbjct: 578 -LTWKQRLEICIGAARGLHYLHTGDSKPVIHRDVKSANILLDENFMAKVADFGLSKTGPE 636

Query: 236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQD 295
            D    S+ V     +L  E    ++ ++KSDVYSFGV L E++  R       P    +
Sbjct: 637 LDQTHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARPVIDPTLPREMVN 696

Query: 296 LVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 355
           L E     +    L +I+D+ L      + + +F +   +CL      RPSM DV+  L+
Sbjct: 697 LAEWAMKWQKKGQLDQIIDQSLRGNIRPDSLRKFAETGEKCLADYGVDRPSMGDVLWNLE 756

Query: 356 RTL---------DKEMNLTTVMGEGTPTV 375
             L         + E N T ++GE  P +
Sbjct: 757 YALQLQEAVIDGEPEDNSTNMIGELPPQI 785

Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1

 Score =  202 bits (513), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 117/308 (37%), Positives = 179/308 (58%), Gaps = 13/308 (4%)

Query: 73  FQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFIDEVCF 129
           F  +ELS  T  FS+KNL+GEG FG VYKG+L DG  VA+K+     +Q   EF  EV  
Sbjct: 327 FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEI 386

Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG 189
           ++ + HR+LVTL+GYC     + L+Y+Y+PN ++  HL+ P    R  + ++ R+ +A G
Sbjct: 387 ISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAP---GRPVMTWETRVRVAAG 443

Query: 190 AAKGLAHLH-SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV-AGPSSQVTA 247
           AA+G+A+LH    PR++H+D K++N+L+D  F A VAD GL       D+    S++V  
Sbjct: 444 AARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMG 503

Query: 248 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVE----LVQNS 303
              ++A E     + SEK+DVYS+GV LLEL++GR+   +  P   + LVE    L+  +
Sbjct: 504 TFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQA 563

Query: 304 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 363
            +     +++D RL   F    M   ++    C+  S+ +RP MS VV  LD TL++  +
Sbjct: 564 IENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALD-TLEEATD 622

Query: 364 LTTVMGEG 371
           +T  M  G
Sbjct: 623 ITNGMRPG 630

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGV0|Y5487_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g48740 OS=Arabidopsis thaliana GN=At5g48740 PE=2 SV=1

 Score =  202 bits (513), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 118/290 (40%), Positives = 176/290 (60%), Gaps = 10/290 (3%)

Query: 70  ARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK---KRPGAPTQEFIDE 126
           +R F  +E+  AT+NF  K +IG G FG VY+G L DG  VA+K    R       FI+E
Sbjct: 593 SRIFSHKEIKSATRNF--KEVIGRGSFGAVYRGKLPDGKQVAVKVRFDRTQLGADSFINE 650

Query: 127 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 186
           V  L+ I+H+NLV+  G+C E   Q L+YEY+  GS++ HLYGP +  R  L +  RL +
Sbjct: 651 VHLLSQIRHQNLVSFEGFCYEPKRQILVYEYLSGGSLADHLYGP-RSKRHSLNWVSRLKV 709

Query: 187 ALGAAKGLAHLHSLS-PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 245
           A+ AAKGL +LH+ S PR++H+D K++N+L+D+D  AKV+D GL     + D +  ++ V
Sbjct: 710 AVDAAKGLDYLHNGSEPRIIHRDVKSSNILLDKDMNAKVSDFGLSKQFTKADASHITTVV 769

Query: 246 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA-SSSLSPDSSQDLVELVQNSR 304
                +L  E     + +EKSDVYSFGV LLEL+ GRE  S S SPDS   ++    N +
Sbjct: 770 KGTAGYLDPEYYSTLQLTEKSDVYSFGVVLLELICGREPLSHSGSPDSFNLVLWARPNLQ 829

Query: 305 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
             +   +I+D+ L  TF    M++   + +RC+   +  RPS+++V+T+L
Sbjct: 830 --AGAFEIVDDILKETFDPASMKKAASIAIRCVGRDASGRPSIAEVLTKL 877

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SA72|Y1357_ARATH Probable receptor-like protein kinase At1g30570 OS=Arabidopsis thaliana GN=At1g30570 PE=1 SV=1

 Score =  200 bits (509), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 110/293 (37%), Positives = 170/293 (58%), Gaps = 7/293 (2%)

Query: 70  ARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFIDE 126
            R+F + E+  ATKNF D   IG G FG+VY+G L+DG L+AIK+      Q   EF  E
Sbjct: 505 GRKFTLAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGTLIAIKRATPHSQQGLAEFETE 564

Query: 127 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 186
           +  L+ ++HR+LV+L+G+C E+N   L+YEY+ NG++  HL+G +      L +K RL  
Sbjct: 565 IVMLSRLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRSHLFGSN---LPPLSWKQRLEA 621

Query: 187 ALGAAKGLAHLHSLSPR-VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 245
            +G+A+GL +LH+ S R ++H+D KT N+L+DE+F+AK++D GL       D    S+ V
Sbjct: 622 CIGSARGLHYLHTGSERGIIHRDVKTTNILLDENFVAKMSDFGLSKAGPSMDHTHVSTAV 681

Query: 246 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD 305
                +L  E    ++ +EKSDVYSFGV L E V  R   +   P    +L E   + + 
Sbjct: 682 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINPTLPKDQINLAEWALSWQK 741

Query: 306 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
             NL  I+D  L   ++ E +E++ ++  +CL    + RP M +V+  L+  L
Sbjct: 742 QRNLESIIDSNLRGNYSPESLEKYGEIAEKCLADEGKNRPMMGEVLWSLEYVL 794

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9SR05|ANX1_ARATH Receptor-like protein kinase ANXUR1 OS=Arabidopsis thaliana GN=ANX1 PE=2 SV=1

 Score =  198 bits (504), Expect = 5e-50,   Method: Compositional matrix adjust.
 Identities = 130/378 (34%), Positives = 196/378 (51%), Gaps = 41/378 (10%)

Query: 6   AAIFGAAAGAVA-LMGIIFFL----------------SWFCLYRNRSVSRTSETGSSEPS 48
           A I G+A G +A L+G + F                 SW  +Y N + S T  T      
Sbjct: 430 AFIIGSAGGVLAVLIGALCFTAYKKKQGYQGGDSHTSSWLPIYGNSTTSGTKST------ 483

Query: 49  VQRNICIIAGR-NVGIELSIREA---RRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLL 104
                  I+G+ N G  LS   A   RRF + E+   T+NF D N+IG G FG+VYKG++
Sbjct: 484 -------ISGKSNNGSHLSNLAAGLCRRFSLPEIKHGTQNFDDSNVIGVGGFGKVYKGVI 536

Query: 105 QDGMLVAIKKRPGAPTQ---EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG 161
                VA+KK      Q   EF  E+  L+ ++H++LV+L+GYC E     L+Y+Y+  G
Sbjct: 537 DGTTKVAVKKSNPNSEQGLNEFETEIELLSRLRHKHLVSLIGYCDEGGEMCLVYDYMAFG 596

Query: 162 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP-RVVHKDFKTANVLVDEDF 220
           ++  HLY      + +L +K RL IA+GAA+GL +LH+ +   ++H+D KT N+LVDE++
Sbjct: 597 TLREHLY---NTKKPQLTWKRRLEIAIGAARGLHYLHTGAKYTIIHRDVKTTNILVDENW 653

Query: 221 IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
           +AKV+D GL       +    ++ V     +L  E    ++ +EKSDVYSFGV L E++ 
Sbjct: 654 VAKVSDFGLSKTGPNMNGGHVTTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC 713

Query: 281 GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPS 340
            R A +   P     L +   N +   NL  I+D  L      E +++F     +CL+ S
Sbjct: 714 ARPALNPSLPKEQVSLGDWAMNCKRKGNLEDIIDPNLKGKINAECLKKFADTAEKCLNDS 773

Query: 341 SERRPSMSDVVTELDRTL 358
              RP+M DV+  L+  L
Sbjct: 774 GLERPTMGDVLWNLEFAL 791

Receptor-like protein kinase that controls pollen tube behavior by directing rupture at proper timing to release the sperm cell.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1

 Score =  198 bits (503), Expect = 7e-50,   Method: Compositional matrix adjust.
 Identities = 114/296 (38%), Positives = 174/296 (58%), Gaps = 12/296 (4%)

Query: 72  RFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK---RPGAPTQEFIDEVC 128
            F  EEL+  T+ FS  N++GEG FG VYKG L DG LVA+K+     G   +EF  EV 
Sbjct: 340 HFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVE 399

Query: 129 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 188
            ++ + HR+LV+L+GYC  ++ + LIYEY+PN ++  HL+G     R  LE+  R+ IA+
Sbjct: 400 IISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHG---KGRPVLEWARRVRIAI 456

Query: 189 GAAKGLAHLH-SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 247
           G+AKGLA+LH    P+++H+D K+AN+L+D++F A+VAD GL      T     S++V  
Sbjct: 457 GSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTH-VSTRVMG 515

Query: 248 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVE----LVQNS 303
              +LA E  +  + +++SDV+SFGV LLEL++GR+      P   + LVE    L+  +
Sbjct: 516 TFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKA 575

Query: 304 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 359
            +  +  +++D RL   +    +   I+    C+  S  +RP M  VV  LD   D
Sbjct: 576 IETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGD 631

Regulates negatively root hairs elongation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FID9|Y5389_ARATH Probable receptor-like protein kinase At5g38990 OS=Arabidopsis thaliana GN=At5g38990 PE=2 SV=1

 Score =  196 bits (497), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 111/296 (37%), Positives = 174/296 (58%), Gaps = 8/296 (2%)

Query: 70  ARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDG-MLVAIKKRPGAPTQ---EFID 125
            RRF + E+  AT +F +K +IG G FG VYKG +  G  LVA+K+      Q   EF  
Sbjct: 510 CRRFSIYEIKSATNDFEEKLIIGVGGFGSVYKGRIDGGATLVAVKRLEITSNQGAKEFDT 569

Query: 126 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 185
           E+  L+ ++H +LV+L+GYC ++N   L+YEY+P+G++  HL+   + S   L +K RL 
Sbjct: 570 ELEMLSKLRHVHLVSLIGYCDDDNEMVLVYEYMPHGTLKDHLFRRDKASDPPLSWKRRLE 629

Query: 186 IALGAAKGLAHLHSLSP-RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ 244
           I +GAA+GL +LH+ +   ++H+D KT N+L+DE+F+AKV+D GL   +G T  +     
Sbjct: 630 ICIGAARGLQYLHTGAKYTIIHRDIKTTNILLDENFVAKVSDFGLSR-VGPTSASQTHVS 688

Query: 245 VTADEIFLASEVKEFRR--FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 302
                 F   + + +RR   +EKSDVYSFGV LLE++  R       P    DL+  V++
Sbjct: 689 TVVKGTFGYLDPEYYRRQILTEKSDVYSFGVVLLEVLCCRPIRMQSVPPEQADLIRWVKS 748

Query: 303 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
           + +   + +I+D  L +  T+  ME+F ++ +RC+      RP M+DVV  L+  L
Sbjct: 749 NFNKRTVDQIIDSDLTADITSTSMEKFCEIAIRCVQDRGMERPPMNDVVWALEFAL 804

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LK35|THE1_ARATH Receptor-like protein kinase THESEUS 1 OS=Arabidopsis thaliana GN=THE1 PE=1 SV=1

 Score =  196 bits (497), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 130/384 (33%), Positives = 196/384 (51%), Gaps = 26/384 (6%)

Query: 6   AAIFGAAAGAVALMGIIFFLSWFCLYRNRSVSRTS--ETGSSEPSVQRNICIIAGRNVGI 63
           A I G+  GAV L+ +I    + CL  +R    TS  E G+  P +   +  ++      
Sbjct: 416 AVIIGSLVGAVTLILLIAVCCYCCLVASRKQRSTSPQEGGNGHPWLPLPLYGLSQTLTKS 475

Query: 64  ELSIREA-------------RRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLV 110
             S + A             R F  +E+  AT  F + +L+G G FG VYKG L+DG  V
Sbjct: 476 TASHKSATASCISLASTHLGRCFMFQEIMDATNKFDESSLLGVGGFGRVYKGTLEDGTKV 535

Query: 111 AIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSI 165
           A+K+  G P       EF  E+  L+ ++HR+LV+L+GYC E +   L+YEY+ NG +  
Sbjct: 536 AVKR--GNPRSEQGMAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRS 593

Query: 166 HLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS-LSPRVVHKDFKTANVLVDEDFIAKV 224
           HLYG        L +K RL I +GAA+GL +LH+  S  ++H+D KT N+L+DE+ +AKV
Sbjct: 594 HLYG---ADLPPLSWKQRLEICIGAARGLHYLHTGASQSIIHRDVKTTNILLDENLVAKV 650

Query: 225 ADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 284
           AD GL       D    S+ V     +L  E    ++ +EKSDVYSFGV L+E++  R A
Sbjct: 651 ADFGLSKTGPSLDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCCRPA 710

Query: 285 SSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERR 344
            + + P    ++ E     +    L +I+D  L        +++F +   +CL      R
Sbjct: 711 LNPVLPREQVNIAEWAMAWQKKGLLDQIMDSNLTGKVNPASLKKFGETAEKCLAEYGVDR 770

Query: 345 PSMSDVVTELDRTLDKEMNLTTVM 368
           PSM DV+  L+  L  E   + +M
Sbjct: 771 PSMGDVLWNLEYALQLEETSSALM 794

Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Mediates the response of growing plant cells to the perturbation of cellulose synthesis and may act as a cell-wall-integrity sensor. Controls ectopic-lignin accumulation in cellulose-deficient mutant backgrounds.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	386
255543513	381	serine/threonine protein kinase, putativ	0.987	1.0	0.777	1e-173
224069640	378	predicted protein [Populus trichocarpa]	0.979	1.0	0.730	1e-161
351727579	379	protein kinase family protein [Glycine m	0.930	0.947	0.751	1e-156
356571643	379	PREDICTED: probable receptor-like protei	0.930	0.947	0.754	1e-156
225451635	381	PREDICTED: nodulation receptor kinase [V	0.932	0.944	0.732	1e-155
147805741	414	hypothetical protein VITISV_039777 [Viti	0.932	0.869	0.732	1e-155
388494484	380	unknown [Lotus japonicus]	0.930	0.944	0.737	1e-153
357508461	379	Nodulation receptor kinase [Medicago tru	0.930	0.947	0.710	1e-149
449452038	379	PREDICTED: nodulation receptor kinase-li	0.981	1.0	0.686	1e-148
30688460	380	protein kinase family protein [Arabidops	0.937	0.952	0.691	1e-145

>gi|255543513|ref|XP_002512819.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223547830|gb|EEF49322.1| serine/threonine protein kinase, putative [Ricinus communis]

 Score =  613 bits (1580), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 300/386 (77%), Positives = 338/386 (87%), Gaps = 5/386 (1%)

Query: 1   MSVTLAAIFGAAAGAVALMGIIFFLSWFCLYRNRSVSRTSETGSSEPSVQRNICIIAGRN 60
           MS TLAAI G AAG VAL+GI+ FL WFCL   +SVSRTSETGSS+PS+Q       GR+
Sbjct: 1   MSKTLAAILGGAAGVVALVGIVIFLIWFCLSHKKSVSRTSETGSSDPSIQ-----APGRH 55

Query: 61  VGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT 120
           VG+ELS+REARRF+M+ELS ATKNF DKNLIG GKFGEVYKGLL DGMLVAIKKR GA +
Sbjct: 56  VGVELSLREARRFEMDELSHATKNFVDKNLIGIGKFGEVYKGLLNDGMLVAIKKRSGASS 115

Query: 121 QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF 180
           QEF+DEV +L+ IQHRN+VTLLGYCQENNLQFL+YEYIP+GSVS HLYGPSQ S  KLEF
Sbjct: 116 QEFVDEVRYLSPIQHRNIVTLLGYCQENNLQFLVYEYIPSGSVSSHLYGPSQFSDGKLEF 175

Query: 181 KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 240
           KHRLSIALGAAKGLAHLHSLSPR+VHKDFKTANVLVDE+FIAKVADAGL NFLGR DVAG
Sbjct: 176 KHRLSIALGAAKGLAHLHSLSPRLVHKDFKTANVLVDENFIAKVADAGLPNFLGRVDVAG 235

Query: 241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV 300
           PSSQVTADEIF A EV+EFRRFS+K DV+SFGVFLLEL+SGREA+ S SPDSSQ+LVE V
Sbjct: 236 PSSQVTADEIFQAPEVREFRRFSDKGDVFSFGVFLLELLSGREATESPSPDSSQNLVEWV 295

Query: 301 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 360
           QN++D+S    ++D+RL + FT EGMEEFIQLI++CL+PSSERRPSMS VV ELDR L+K
Sbjct: 296 QNTQDYSAFSSVVDQRLGTRFTAEGMEEFIQLIIQCLEPSSERRPSMSYVVMELDRILEK 355

Query: 361 EMNLTTVMGEGTPTVTLGSHLFRATK 386
           EM LTTVMGEGTPTVTLGS LF+A+K
Sbjct: 356 EMTLTTVMGEGTPTVTLGSQLFKASK 381

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224069640|ref|XP_002303015.1| predicted protein [Populus trichocarpa] gi|222844741|gb|EEE82288.1| predicted protein [Populus trichocarpa]

 Score =  575 bits (1482), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 282/386 (73%), Positives = 332/386 (86%), Gaps = 8/386 (2%)

Query: 1   MSVTLAAIFGAAAGAVALMGIIFFLSWFCLYRNRSVSRTSETGSSEPSVQRNICIIAGRN 60
           MS TLAAI G AAG +AL G++ F+ W CLY  ++VSRTSETGSSE S+Q       GR+
Sbjct: 1   MSRTLAAILGGAAGVMALAGVVIFVLW-CLYHKKTVSRTSETGSSETSIQ------VGRH 53

Query: 61  VGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT 120
            GIELS +EARRF+MEEL LATK FS+KNLIG GKFGEVYKGLL +GM+VAIKKRPGAP+
Sbjct: 54  AGIELSSQEARRFEMEELGLATKGFSEKNLIGLGKFGEVYKGLLNNGMIVAIKKRPGAPS 113

Query: 121 QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF 180
            EF+DEV +L+SIQHRNLVTLLGYCQENNLQFL+YEYI +GSVS HLYG  Q    KLEF
Sbjct: 114 PEFVDEVRYLSSIQHRNLVTLLGYCQENNLQFLVYEYISSGSVSNHLYGVGQTLEGKLEF 173

Query: 181 KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 240
           K+RL IALGAAKGLAHLHS +PR++HK+FKTANVLVDE+FIAKVADAGLRNFLGR D+AG
Sbjct: 174 KNRLPIALGAAKGLAHLHSQTPRLLHKNFKTANVLVDENFIAKVADAGLRNFLGRVDIAG 233

Query: 241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV 300
           PS+QVTADEIFLA EV+EFR+FSEKSDV+SFGVFLLEL+SG+EA+   SP++SQ+LVE V
Sbjct: 234 PSTQVTADEIFLAPEVREFRQFSEKSDVFSFGVFLLELLSGKEATEP-SPETSQNLVEWV 292

Query: 301 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 360
           QN++D++N   I+D RL S+FT EGMEEFIQL+++C++PSS+RRP MS VV ELDR L+K
Sbjct: 293 QNTQDYTNFSSIVDHRLGSSFTAEGMEEFIQLMLQCVEPSSDRRPLMSYVVMELDRILEK 352

Query: 361 EMNLTTVMGEGTPTVTLGSHLFRATK 386
           E NLTTVMGEGTPTVTLGS LFRAT+
Sbjct: 353 ERNLTTVMGEGTPTVTLGSQLFRATR 378

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351727579|ref|NP_001235374.1| protein kinase family protein [Glycine max] gi|223452478|gb|ACM89566.1| protein kinase family protein [Glycine max]

 Score =  558 bits (1437), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 275/366 (75%), Positives = 311/366 (84%), Gaps = 7/366 (1%)

Query: 21  IIFFLSWFCLYRNRSVSRTSETGSSEPSVQRNICIIAGRNVGIELSIREARRFQMEELSL 80
           I   L WFCL R R+VSRTSETGSS+PS         GR+  +EL IR+ RRF+MEELSL
Sbjct: 21  IAIILIWFCLSRQRNVSRTSETGSSDPSQ-------VGRHGAMELPIRDTRRFEMEELSL 73

Query: 81  ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVT 140
           ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKR G  +QEF+DEV +L+SI HRNLV+
Sbjct: 74  ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRRGLASQEFVDEVRYLSSIHHRNLVS 133

Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 200
           LLGYCQENNLQFLIYEY+PNGSVS HLYG  Q  R+KLEFKHRL IA GAAKGLAHLHSL
Sbjct: 134 LLGYCQENNLQFLIYEYVPNGSVSSHLYGAGQQPREKLEFKHRLPIAQGAAKGLAHLHSL 193

Query: 201 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 260
           SPR+VHK+FKTANVLVDE+FIAKVADAGLRNFLGR D+AG SSQV  DEIFLASEV+EFR
Sbjct: 194 SPRLVHKNFKTANVLVDENFIAKVADAGLRNFLGRVDIAGSSSQVATDEIFLASEVREFR 253

Query: 261 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 320
           RFSEKSDVYSFGVFLLEL+SG++A+ S  PDS+Q+LVE V +++D   +  I+D RL S+
Sbjct: 254 RFSEKSDVYSFGVFLLELLSGKQATESPFPDSNQNLVEWVLSNQDRGMMSYIIDRRLESS 313

Query: 321 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPTVTLGSH 380
           FT EGMEE+I LI+RCLDPSSERRP+MS V  EL R LDKEMNLTT+MGEGTPTVTLGS 
Sbjct: 314 FTAEGMEEYIMLIIRCLDPSSERRPAMSYVEMELVRILDKEMNLTTIMGEGTPTVTLGSQ 373

Query: 381 LFRATK 386
           LF++TK
Sbjct: 374 LFKSTK 379

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356571643|ref|XP_003553985.1| PREDICTED: probable receptor-like protein kinase At1g30570-like [Glycine max]

 Score =  556 bits (1434), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 276/366 (75%), Positives = 310/366 (84%), Gaps = 7/366 (1%)

Query: 21  IIFFLSWFCLYRNRSVSRTSETGSSEPSVQRNICIIAGRNVGIELSIREARRFQMEELSL 80
           I   L WFCL R R+VSRTSETGSS+PS         GR+  IEL IR+ RRF+MEELSL
Sbjct: 21  IAIILIWFCLSRQRNVSRTSETGSSDPSQ-------VGRHGAIELPIRDTRRFEMEELSL 73

Query: 81  ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVT 140
           ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKR G  +QEF+DEV +L+SI HRNLV+
Sbjct: 74  ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRRGLASQEFVDEVHYLSSIHHRNLVS 133

Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 200
           LLGYCQENNLQFLIYEY+PNGSVS HLYG  Q  ++KLEFKHRLSIA GAAKGLAHLHSL
Sbjct: 134 LLGYCQENNLQFLIYEYVPNGSVSSHLYGAGQNPQEKLEFKHRLSIAQGAAKGLAHLHSL 193

Query: 201 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 260
           SPR+VHK+FKT NVLVDE+FIAKVADAGLRNFLGR D+AG SSQV  DEIFLASEV+EFR
Sbjct: 194 SPRLVHKNFKTTNVLVDENFIAKVADAGLRNFLGRVDIAGSSSQVATDEIFLASEVREFR 253

Query: 261 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 320
           RFSEKSDVYSFGVFLLEL+SG+EA     PDS+Q+LVE V +++D   +  I+D RL S+
Sbjct: 254 RFSEKSDVYSFGVFLLELLSGKEAIEPPFPDSNQNLVEWVLSNQDRGMMSYIIDRRLESS 313

Query: 321 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPTVTLGSH 380
           FT EGMEE+I LI+RCLDPSSERRP+MS V  ELDR L+KEMNLTTVMGEGTPTVTLGS 
Sbjct: 314 FTAEGMEEYILLIIRCLDPSSERRPAMSYVEMELDRILEKEMNLTTVMGEGTPTVTLGSQ 373

Query: 381 LFRATK 386
           LF++TK
Sbjct: 374 LFKSTK 379

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225451635|ref|XP_002277073.1| PREDICTED: nodulation receptor kinase [Vitis vinifera] gi|296082255|emb|CBI21260.3| unnamed protein product [Vitis vinifera]

 Score =  553 bits (1425), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 269/367 (73%), Positives = 318/367 (86%), Gaps = 7/367 (1%)

Query: 21  IIFFLSWFCLYRNRSVSRTSETGSSEPSVQRNICIIAGRNVGIELSIREARRFQMEELSL 80
           I+  + WFCL  NRSVSRTSETGSS+PSVQ       GRNVG+EL++REAR F+M ELSL
Sbjct: 21  IVILIIWFCLSHNRSVSRTSETGSSDPSVQ------VGRNVGVELALREARHFEMAELSL 74

Query: 81  ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVT 140
           ATKNFSD +LIGEGKFGEVYKGLL DGM VAIKKR G P+Q+F+DEV +L++I+HRNLVT
Sbjct: 75  ATKNFSDISLIGEGKFGEVYKGLLHDGMFVAIKKRFGGPSQDFVDEVRYLSAIEHRNLVT 134

Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLYG-PSQVSRQKLEFKHRLSIALGAAKGLAHLHS 199
           LLGYCQEN  QFLIYE+IP+GS+S +LYG  +QVS++KLEFK+RL IALGAAKGLAHLH+
Sbjct: 135 LLGYCQENGQQFLIYEHIPSGSISSYLYGTAAQVSQEKLEFKNRLQIALGAAKGLAHLHT 194

Query: 200 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 259
           LSPR+VHKDFKTANVLVDE+FI KVADAGLRNFLGR D+AGPSSQV ADEIFLA EV+EF
Sbjct: 195 LSPRLVHKDFKTANVLVDENFIPKVADAGLRNFLGRIDIAGPSSQVVADEIFLAPEVREF 254

Query: 260 RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS 319
           RRFS+KSDVYSFGVFLLEL+SG+EA++ LSPDS+ +LVE+VQN +D SN+  I+D+RL +
Sbjct: 255 RRFSDKSDVYSFGVFLLELLSGQEANTLLSPDSNLNLVEMVQNYQDHSNISTIIDQRLGN 314

Query: 320 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPTVTLGS 379
            FT EGMEEFIQLI+RC+D SSERRPSMS V+ ELDR L+KE  LTT++GEG P V LGS
Sbjct: 315 RFTAEGMEEFIQLIIRCVDTSSERRPSMSYVLMELDRILEKETTLTTLVGEGIPNVILGS 374

Query: 380 HLFRATK 386
            LF+A+K
Sbjct: 375 QLFKASK 381

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147805741|emb|CAN73905.1| hypothetical protein VITISV_039777 [Vitis vinifera]

 Score =  553 bits (1425), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 269/367 (73%), Positives = 318/367 (86%), Gaps = 7/367 (1%)

Query: 21  IIFFLSWFCLYRNRSVSRTSETGSSEPSVQRNICIIAGRNVGIELSIREARRFQMEELSL 80
           I+  + WFCL  NRSVSRTSETGSS+PSVQ       GRNVG+EL++REAR F+M ELSL
Sbjct: 54  IVILIIWFCLSHNRSVSRTSETGSSDPSVQ------VGRNVGVELALREARHFEMAELSL 107

Query: 81  ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVT 140
           ATKNFSD +LIGEGKFGEVYKGLL DGM VAIKKR G P+Q+F+DEV +L++I+HRNLVT
Sbjct: 108 ATKNFSDISLIGEGKFGEVYKGLLHDGMFVAIKKRFGGPSQDFVDEVRYLSAIEHRNLVT 167

Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLYG-PSQVSRQKLEFKHRLSIALGAAKGLAHLHS 199
           LLGYCQEN  QFLIYE+IP+GS+S +LYG  +QVS++KLEFK+RL IALGAAKGLAHLH+
Sbjct: 168 LLGYCQENGQQFLIYEHIPSGSISSYLYGTAAQVSQEKLEFKNRLQIALGAAKGLAHLHT 227

Query: 200 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 259
           LSPR+VHKDFKTANVLVDE+FI KVADAGLRNFLGR D+AGPSSQV ADEIFLA EV+EF
Sbjct: 228 LSPRLVHKDFKTANVLVDENFIPKVADAGLRNFLGRIDIAGPSSQVVADEIFLAPEVREF 287

Query: 260 RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS 319
           RRFS+KSDVYSFGVFLLEL+SG+EA++ LSPDS+ +LVE+VQN +D SN+  I+D+RL +
Sbjct: 288 RRFSDKSDVYSFGVFLLELLSGQEANTLLSPDSNLNLVEMVQNYQDHSNISTIIDQRLGN 347

Query: 320 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPTVTLGS 379
            FT EGMEEFIQLI+RC+D SSERRPSMS V+ ELDR L+KE  LTT++GEG P V LGS
Sbjct: 348 RFTAEGMEEFIQLIIRCVDTSSERRPSMSYVLMELDRILEKETTLTTLVGEGIPNVILGS 407

Query: 380 HLFRATK 386
            LF+A+K
Sbjct: 408 QLFKASK 414

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|388494484|gb|AFK35308.1| unknown [Lotus japonicus]

 Score =  546 bits (1408), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 270/366 (73%), Positives = 310/366 (84%), Gaps = 7/366 (1%)

Query: 21  IIFFLSWFCLYRNRSVSRTSETGSSEPSVQRNICIIAGRNVGIELSIREARRFQMEELSL 80
           I   L WFCL R RSVSRTSETGSS+PS         GR+  IEL IR+ RRF MEELSL
Sbjct: 22  ISIILLWFCLCRQRSVSRTSETGSSDPSQ-------VGRHGAIELQIRDTRRFAMEELSL 74

Query: 81  ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVT 140
           ATKNF+D NLIG+GKFGEVY GLLQDG+LVAIKKR G P+QEF+DEV +L+SIQHRN+VT
Sbjct: 75  ATKNFNDGNLIGQGKFGEVYNGLLQDGVLVAIKKRFGTPSQEFVDEVRYLSSIQHRNIVT 134

Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 200
           L+GYCQENNLQFLIYEY+PNGSVS HLYG  Q S++KLEFK RLSIA GAAKGLAH+HSL
Sbjct: 135 LIGYCQENNLQFLIYEYVPNGSVSSHLYGAGQQSQEKLEFKLRLSIAQGAAKGLAHIHSL 194

Query: 201 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 260
           SPR+VHKDFKTANVLVDE+FIAKVADAGL++FLGR D+ G SSQV ADEIFLA EV+EFR
Sbjct: 195 SPRLVHKDFKTANVLVDENFIAKVADAGLKHFLGRVDIVGSSSQVAADEIFLAPEVREFR 254

Query: 261 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 320
           RFSEKSDVYS+GVFLLEL+SG+EA+ S SPDS+ +LVE V  ++D   + KI+D RL S+
Sbjct: 255 RFSEKSDVYSYGVFLLELLSGKEATESPSPDSNLNLVEWVLRNQDRHLMSKIIDRRLESS 314

Query: 321 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPTVTLGSH 380
           FT EGME +I L++RCLD SSERRP+MS V TELDR L+KEMNLTT+MGEGTPTVTLGS 
Sbjct: 315 FTAEGMEAYILLVIRCLDLSSERRPAMSYVETELDRILEKEMNLTTIMGEGTPTVTLGSQ 374

Query: 381 LFRATK 386
           LF+ATK
Sbjct: 375 LFKATK 380

Source: Lotus japonicus

Species: Lotus japonicus

Genus: Lotus

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357508461|ref|XP_003624519.1| Nodulation receptor kinase [Medicago truncatula] gi|355499534|gb|AES80737.1| Nodulation receptor kinase [Medicago truncatula]

 Score =  534 bits (1375), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 260/366 (71%), Positives = 306/366 (83%), Gaps = 7/366 (1%)

Query: 21  IIFFLSWFCLYRNRSVSRTSETGSSEPSVQRNICIIAGRNVGIELSIREARRFQMEELSL 80
           I   L WF L+R  SVSRTSETGSS+PS         GR+ GIEL +R+ RRF MEELS 
Sbjct: 21  ISIILIWFYLFRQTSVSRTSETGSSDPSQ-------VGRHGGIELQMRDTRRFAMEELSH 73

Query: 81  ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVT 140
           ATKNF+DKNLIGEGKFGEVYKGLLQDGMLVAIKKR G  +QEF+DEV +L+SIQHRNLVT
Sbjct: 74  ATKNFNDKNLIGEGKFGEVYKGLLQDGMLVAIKKRRGVTSQEFVDEVRYLSSIQHRNLVT 133

Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 200
           L+GYCQENNLQFLIYEY+PNGSVS HLYG SQ  R+KLEFKHRLSIA GAAKGLAHLHSL
Sbjct: 134 LIGYCQENNLQFLIYEYVPNGSVSSHLYGASQQPREKLEFKHRLSIAQGAAKGLAHLHSL 193

Query: 201 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 260
           SPR+VHK+FKT+NVLVDE+FI+KVADAGLRNFL R ++ G SSQV  DEIFLA EV+EFR
Sbjct: 194 SPRLVHKNFKTSNVLVDENFISKVADAGLRNFLARVEIVGTSSQVATDEIFLAPEVREFR 253

Query: 261 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 320
           +FSEKSD YSFGVFLLEL+SG+EA+ S  P+++Q+LVE V ++++ S +  I+D+R+   
Sbjct: 254 QFSEKSDAYSFGVFLLELLSGKEATESPHPNTNQNLVESVLSNQNNSTMNTIIDQRMECR 313

Query: 321 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPTVTLGSH 380
           FT EGME +I L++RCLDPSSERRP+MS V  ELDR ++KEMNLTT+MGE TPTVTLGS 
Sbjct: 314 FTAEGMESYILLLIRCLDPSSERRPAMSYVEMELDRIIEKEMNLTTMMGERTPTVTLGSQ 373

Query: 381 LFRATK 386
           LF++ K
Sbjct: 374 LFKSNK 379

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449452038|ref|XP_004143767.1| PREDICTED: nodulation receptor kinase-like [Cucumis sativus] gi|449529349|ref|XP_004171662.1| PREDICTED: nodulation receptor kinase-like [Cucumis sativus]

 Score =  530 bits (1364), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 265/386 (68%), Positives = 321/386 (83%), Gaps = 7/386 (1%)

Query: 1   MSVTLAAIFGAAAGAVALMGIIFFLSWFCLYRNRSVSRTSETGSSEPSVQRNICIIAGRN 60
           MS  LAAI G +AGAVAL+G+I  L  F L R+R+ +RTSETGSS+PSVQ       GR+
Sbjct: 1   MSKVLAAILGGSAGAVALVGLIIILLRF-LARSRNTARTSETGSSDPSVQ------VGRH 53

Query: 61  VGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT 120
           VGIEL++R+ARRF+M EL LAT +FSDKNLIGEGKFGEVYKG+LQDGM VAIKKR GAP+
Sbjct: 54  VGIELTLRDARRFEMAELVLATNDFSDKNLIGEGKFGEVYKGMLQDGMFVAIKKRHGAPS 113

Query: 121 QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF 180
           Q+F+DEV +L+SIQHRNLVTLLGYCQENNLQFLI++YIPNGSVS H+YG  Q S +KLEF
Sbjct: 114 QDFVDEVHYLSSIQHRNLVTLLGYCQENNLQFLIFDYIPNGSVSSHIYGTEQRSAEKLEF 173

Query: 181 KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 240
           K RLSIALGAAKGL+HLHS+SPR+ H++FKT+NVLVDE+FIAKVADAGL N + R DV+ 
Sbjct: 174 KIRLSIALGAAKGLSHLHSMSPRLTHRNFKTSNVLVDENFIAKVADAGLHNVMRRFDVSE 233

Query: 241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV 300
            SS+ TADEIFLA EVKEFR+FSEKSDVYSFGVFLLELVSG++A+ +   + +  LV+ +
Sbjct: 234 SSSRATADEIFLAPEVKEFRQFSEKSDVYSFGVFLLELVSGQKATDAPVSNPNYTLVDWI 293

Query: 301 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 360
           QN++  S++  I D RL  +FT EGM E + LI++C++ SSERRP MS VVTEL+R L+K
Sbjct: 294 QNNQRKSDIGSITDPRLGKSFTEEGMGELMDLILQCVEYSSERRPVMSYVVTELERILEK 353

Query: 361 EMNLTTVMGEGTPTVTLGSHLFRATK 386
           EMNLTTVMGEG+PTVTLGS LF+ TK
Sbjct: 354 EMNLTTVMGEGSPTVTLGSQLFKTTK 379

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|30688460|ref|NP_189304.2| protein kinase family protein [Arabidopsis thaliana] gi|332643680|gb|AEE77201.1| protein kinase family protein [Arabidopsis thaliana]

 Score =  521 bits (1343), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 256/370 (69%), Positives = 315/370 (85%), Gaps = 8/370 (2%)

Query: 18  LMGIIFFLSWFCLYRNRSVSRTSETGSSEPSVQRNICIIAGRNVGIELSIREARRFQMEE 77
           L+ +  FL WFC++R +++SRTSETGSS+PS Q       GRNV IELS+REARRF+MEE
Sbjct: 18  LIALFVFLLWFCVFRRKNLSRTSETGSSDPSTQE------GRNVAIELSMREARRFEMEE 71

Query: 78  LSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRN 137
           L+ ATK+F++K+LIG GKFGEVYKGLLQDG+LVAIKKRPG PTQEF++EV +L+SI HRN
Sbjct: 72  LAQATKSFTNKSLIGIGKFGEVYKGLLQDGVLVAIKKRPGLPTQEFVNEVRYLSSIHHRN 131

Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPS-QVSRQKLEFKHRLSIALGAAKGLAH 196
           LVTLLG+CQE+N QFL+YEY+PNGSVS HLYG   +V   +LEF+HRL+I++GAAKGLAH
Sbjct: 132 LVTLLGFCQESNTQFLVYEYVPNGSVSSHLYGAGGKVPGNRLEFRHRLAISIGAAKGLAH 191

Query: 197 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV 256
           LHSLSPR++HKDFKTANVLVDE+FIAKVADAG+RNFLGR DV G SS + AD+IFL+ EV
Sbjct: 192 LHSLSPRLIHKDFKTANVLVDENFIAKVADAGVRNFLGREDV-GTSSHIVADQIFLSPEV 250

Query: 257 KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 316
           +EF+RFSEKSDVY+FGVFLLELVSGREAS      S+Q LV+ +QN  D++++  ++DER
Sbjct: 251 QEFKRFSEKSDVYAFGVFLLELVSGREASEPSPSSSTQTLVDWMQNLTDYADIPMMIDER 310

Query: 317 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPTVT 376
           L  T+T EG+EE I L +RC+D SSE+RP+MS VVTEL+R LDKE++LTTVMGEGTPTVT
Sbjct: 311 LGGTYTAEGVEELITLTLRCVDVSSEKRPTMSFVVTELERILDKEVSLTTVMGEGTPTVT 370

Query: 377 LGSHLFRATK 386
           LGS LF+ATK
Sbjct: 371 LGSQLFKATK 380

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	386
TAIR|locus:2090797	380	AT3G26700 [Arabidopsis thalian	0.981	0.997	0.622	7.2e-123
TAIR|locus:2156992	946	AT5G49770 [Arabidopsis thalian	0.772	0.315	0.355	1.8e-43
TAIR|locus:2019863	971	AT1G79620 [Arabidopsis thalian	0.836	0.332	0.328	1.1e-42
TAIR|locus:2157042	953	AT5G49760 [Arabidopsis thalian	0.738	0.299	0.353	1.3e-42
TAIR|locus:2091980	432	CDG1 "CONSTITUTIVE DIFFERENTIA	0.847	0.756	0.342	8.4e-42
TAIR|locus:2157002	857	AT5G49780 [Arabidopsis thalian	0.735	0.331	0.346	8.8e-42
TAIR|locus:2159873	681	PERK8 "proline-rich extensin-l	0.774	0.439	0.349	9.2e-42
TAIR|locus:2156549	895	AT5G48740 [Arabidopsis thalian	0.751	0.324	0.345	5.8e-41
UNIPROTKB|O24585	901	CR4 "Putative receptor protein	0.810	0.347	0.339	2.6e-40
TAIR|locus:2012325	466	AT1G09440 [Arabidopsis thalian	0.727	0.603	0.341	4.2e-40

TAIR|locus:2090797 AT3G26700 [Arabidopsis thaliana (taxid:3702)]

 Score = 1208 (430.3 bits), Expect = 7.2e-123, P = 7.2e-123
 Identities = 241/387 (62%), Positives = 295/387 (76%)

Query:     1 MSVTLXXXXXXXXXXXXXXXXXFFLSWFCLYRNRSVSRTSETGSSEPSVQRNICIIAGRN 60
             MS  L                  FL WFC++R +++SRTSETGSS+PS Q       GRN
Sbjct:     1 MSAILAAAIGGAVGALALIALFVFLLWFCVFRRKNLSRTSETGSSDPSTQE------GRN 54

Query:    61 VGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT 120
             V IELS+REARRF+MEEL+ ATK+F++K+LIG GKFGEVYKGLLQDG+LVAIKKRPG PT
Sbjct:    55 VAIELSMREARRFEMEELAQATKSFTNKSLIGIGKFGEVYKGLLQDGVLVAIKKRPGLPT 114

Query:   121 QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPS-QVSRQKLE 179
             QEF++EV +L+SI HRNLVTLLG+CQE+N QFL+YEY+PNGSVS HLYG   +V   +LE
Sbjct:   115 QEFVNEVRYLSSIHHRNLVTLLGFCQESNTQFLVYEYVPNGSVSSHLYGAGGKVPGNRLE 174

Query:   180 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 239
             F+HRL+I               PR++HKDFKTANVLVDE+FIAKVADAG+RNFLGR DV 
Sbjct:   175 FRHRLAISIGAAKGLAHLHSLSPRLIHKDFKTANVLVDENFIAKVADAGVRNFLGREDV- 233

Query:   240 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVEL 299
             G SS + AD+IFL+ EV+EF+RFSEKSDVY+FGVFLLELVSGREA            V+ 
Sbjct:   234 GTSSHIVADQIFLSPEVQEFKRFSEKSDVYAFGVFLLELVSGREASEPSPSSSTQTLVDW 293

Query:   300 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 359
             +QN  D++++  ++DERL  T+T EG+EE I L +RC+D SSE+RP+MS VVTEL+R LD
Sbjct:   294 MQNLTDYADIPMMIDERLGGTYTAEGVEELITLTLRCVDVSSEKRPTMSFVVTELERILD 353

Query:   360 KEMNLTTVMGEGTPTVTLGSHLFRATK 386
             KE++LTTVMGEGTPTVTLGS LF+ATK
Sbjct:   354 KEVSLTTVMGEGTPTVTLGSQLFKATK 380

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2156992 AT5G49770 [Arabidopsis thaliana (taxid:3702)]

 Score = 468 (169.8 bits), Expect = 1.8e-43, P = 1.8e-43
 Identities = 109/307 (35%), Positives = 167/307 (54%)

Query:    57 AGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRP 116
             AG+N      +   + F  EELS  T NFSD N +G G +G+VYKG L +G ++AIK+  
Sbjct:   606 AGKNEMDAPQLMGTKAFTFEELSKCTNNFSDANDVGGGGYGQVYKGTLPNGQVIAIKRAQ 665

Query:   117 GAPTQ---EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQV 173
                 Q   EF  E+  L+ + H+N+V LLG+C +   Q L+YEYIPNGS+   L G + V
Sbjct:   666 QGSMQGAFEFKTEIELLSRVHHKNVVKLLGFCFDQKEQMLVYEYIPNGSLRDGLSGKNGV 725

Query:   174 SRQKLEFKHRLSIXXXXXXXXXXXXXXX-PRVVHKDFKTANVLVDEDFIAKVADAGLRNF 232
                KL++  RL I                P ++H+D K+ N+L+DE   AKVAD GL   
Sbjct:   726 ---KLDWTRRLKIALGSGKGLAYLHELADPPIIHRDVKSNNILLDEHLTAKVADFGLSKL 782

Query:   233 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXX 292
             +G  + A  ++QV     +L  E     + +EKSDVY FGV +LEL++G+          
Sbjct:   783 VGDPEKAHVTTQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVVMLELLTGKSPIDRGSYVV 842

Query:   293 XXXXVELVQNSRDFSNLLKILDERLWSTFTN-EGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                  ++   SR+  +L ++LD  +     N +G E+++ + ++C++P    RP+MS+VV
Sbjct:   843 KEVKKKM-DKSRNLYDLQELLDTTIIQNSGNLKGFEKYVDVALQCVEPEGVNRPTMSEVV 901

Query:   352 TELDRTL 358
              EL+  L
Sbjct:   902 QELESIL 908

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019863 AT1G79620 [Arabidopsis thaliana (taxid:3702)]

 Score = 461 (167.3 bits), Expect = 1.1e-42, P = 1.1e-42
 Identities = 110/335 (32%), Positives = 179/335 (53%)

Query:    25 LSWFCLYRNRSVSRTSETGSSEPSVQRNICIIAGRNVGIELSIREARRFQMEELSLATKN 84
             L  + +++ R   +    G S P V       +G++ G    ++ AR F  EEL   T N
Sbjct:   583 LGIYAMWQKRRAEQA--IGLSRPFVS---WASSGKDSGGAPQLKGARWFSYEELKKITNN 637

Query:    85 FSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFIDEVCFLASIQHRNLVTL 141
             FS  + +G G +G+VYKG+LQDG +VAIK+     TQ   EF  E+  L+ + H+NLV L
Sbjct:   638 FSVSSELGYGGYGKVYKGMLQDGHMVAIKRAQQGSTQGGLEFKTEIELLSRVHHKNLVGL 697

Query:   142 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX 201
             +G+C E   Q L+YEY+ NGS+   L G S ++   L++K RL +               
Sbjct:   698 VGFCFEQGEQILVYEYMSNGSLKDSLTGRSGIT---LDWKRRLRVALGSARGLAYLHELA 754

Query:   202 -PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 260
              P ++H+D K+ N+L+DE+  AKVAD GL   +        S+QV     +L  E    +
Sbjct:   755 DPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDCTKGHVSTQVKGTLGYLDPEYYTTQ 814

Query:   261 RFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWST 320
             + +EKSDVYSFGV ++EL++ ++             + + ++  DF  L   +D  L   
Sbjct:   815 KLTEKSDVYSFGVVMMELITAKQPIEKGKYIVREIKLVMNKSDDDFYGLRDKMDRSLRDV 874

Query:   321 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 355
              T   +  +++L ++C+D +++ RP+MS+VV E++
Sbjct:   875 GTLPELGRYMELALKCVDETADERPTMSEVVKEIE 909

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0042546 "cell wall biogenesis" evidence=RCA

GO:0044036 "cell wall macromolecule metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2157042 AT5G49760 [Arabidopsis thaliana (taxid:3702)]

 Score = 460 (167.0 bits), Expect = 1.3e-42, P = 1.3e-42
 Identities = 104/294 (35%), Positives = 162/294 (55%)

Query:    70 ARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFIDE 126
             A+ F  EEL   T NFS+ N +G G +G+VY+G+L +G L+AIK+      Q   EF  E
Sbjct:   616 AKAFTFEELKKCTDNFSEANDVGGGGYGKVYRGILPNGQLIAIKRAQQGSLQGGLEFKTE 675

Query:   127 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 186
             +  L+ + H+N+V LLG+C + N Q L+YEYI NGS+   L G S +   +L++  RL I
Sbjct:   676 IELLSRVHHKNVVRLLGFCFDRNEQMLVYEYISNGSLKDSLSGKSGI---RLDWTRRLKI 732

Query:   187 XXXXXXXXXXXXXXX-PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 245
                             P ++H+D K+ N+L+DE+  AKVAD GL   +G  +    ++QV
Sbjct:   733 ALGSGKGLAYLHELADPPIIHRDIKSNNILLDENLTAKVADFGLSKLVGDPEKTHVTTQV 792

Query:   246 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRD 305
                  +L  E     + +EKSDVY FGV LLEL++GR               ++   SR 
Sbjct:   793 KGTMGYLDPEYYMTNQLTEKSDVYGFGVVLLELLTGRSPIERGKYVVREVKTKM-NKSRS 851

Query:   306 FSNLLKILDERLWSTFTN-EGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
               +L ++LD  + ++  N +G E+++ L +RC++     RPSM +VV E++  +
Sbjct:   852 LYDLQELLDTTIIASSGNLKGFEKYVDLALRCVEEEGVNRPSMGEVVKEIENIM 905

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005773 "vacuole" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006569 "tryptophan catabolic process" evidence=RCA

GO:0009684 "indoleacetic acid biosynthetic process" evidence=RCA

GO:0030003 "cellular cation homeostasis" evidence=RCA

GO:0044242 "cellular lipid catabolic process" evidence=RCA

GO:0070838 "divalent metal ion transport" evidence=RCA

TAIR|locus:2091980 CDG1 "CONSTITUTIVE DIFFERENTIAL GROWTH 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 443 (161.0 bits), Expect = 8.4e-42, P = 8.4e-42
 Identities = 117/342 (34%), Positives = 182/342 (53%)

Query:    34 RSVSRTSETGSSEPS-VQRNICIIAGRNVGIELSIREARRFQMEELSLATKNFSDKNLIG 92
             RS+   + + S++P+   + +   + + V  + S    + F   EL++AT +F +++LIG
Sbjct:    22 RSIRNQTSSSSAQPAGTAKEVDSSSSQTVVQDSSRYRCQIFSYRELAIATNSFRNESLIG 81

Query:    93 EGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFIDEVCFLASIQHRNLVTLLGYCQENN 149
              G FG VYKG L  G  +A+K    +  Q   EF+ EV  L+ + HRNLV L GYC E +
Sbjct:    82 RGGFGTVYKGRLSTGQNIAVKMLDQSGIQGDKEFLVEVLMLSLLHHRNLVHLFGYCAEGD 141

Query:   150 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX-PRVVHKD 208
              + ++YEY+P GSV  HLY  S+  ++ L++K R+ I                P V+++D
Sbjct:   142 QRLVVYEYMPLGSVEDHLYDLSE-GQEALDWKTRMKIALGAAKGLAFLHNEAQPPVIYRD 200

Query:   209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDV 268
              KT+N+L+D D+  K++D GL  F    D++  S++V     + A E     + + KSD+
Sbjct:   201 LKTSNILLDHDYKPKLSDFGLAKFGPSDDMSHVSTRVMGTHGYCAPEYANTGKLTLKSDI 260

Query:   269 YSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRD-FSN--LLKILDERLWST--FTN 323
             YSFGV LLEL+SGR+A              LV  +R  F N  + +I+D RL     F+N
Sbjct:   261 YSFGVVLLELISGRKALMPSSECVGNQSRYLVHWARPLFLNGRIRQIVDPRLARKGGFSN 320

Query:   324 EGMEEFIQLIVRCLDPSSERRPSMSDVVTEL----DRTLDKE 361
               +   I++   CL   +  RPS+S VV  L    D T+ KE
Sbjct:   321 ILLYRGIEVAFLCLAEEANARPSISQVVECLKYIIDHTIRKE 362

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0040007 "growth" evidence=IMP

GO:0004672 "protein kinase activity" evidence=IDA

GO:1900459 "positive regulation of brassinosteroid mediated signaling pathway" evidence=IMP

TAIR|locus:2157002 AT5G49780 [Arabidopsis thaliana (taxid:3702)]

 Score = 451 (163.8 bits), Expect = 8.8e-42, P = 8.8e-42
 Identities = 102/294 (34%), Positives = 163/294 (55%)

Query:    71 RRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGA--PTQEFIDEV 127
             + F  EE+     NFS  N +G G +G+VYKG+L  G L+AIK+ +PG+     EF  E+
Sbjct:   520 KAFTFEEMRKCANNFSVANDVGGGGYGQVYKGILPSGQLIAIKRAQPGSLQGALEFKTEI 579

Query:   128 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIX 187
               L+ + H+N+V LLG+C +   Q L+YEYIPNGS+   L G S +   +L++  RL I 
Sbjct:   580 ELLSRVHHKNVVKLLGFCFDRGEQMLVYEYIPNGSLRDSLSGKSGI---RLDWTRRLRIA 636

Query:   188 XXXXXXXXXXXXXX-PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 246
                            P ++H+D K++NVL+DE   AKVAD GL   +   + A  ++QV 
Sbjct:   637 LGSGKGLAYLHELADPPIIHRDVKSSNVLLDESLTAKVADFGLSQLVEDAEKANVTAQVK 696

Query:   247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 306
                 +L  E     + +EKSDVY FGV +LEL++G+              +++   S++ 
Sbjct:   697 GTMGYLDPEYYMTNQLTEKSDVYGFGVMMLELLTGKIPIENGKYVVKEMKMKM-NKSKNL 755

Query:   307 SNLLKILDERLWSTFTN--EGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
              +L   LD  + +T     +G E+++ + +RC+DP   +RPSM++VV E++  +
Sbjct:   756 YDLQDFLDTTISATSNRNLKGFEKYVDVALRCVDPEGVKRPSMNEVVKEIENIM 809

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 446 (162.1 bits), Expect = 9.2e-42, P = 9.2e-42
 Identities = 109/312 (34%), Positives = 166/312 (53%)

Query:    73 FQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQ-EFIDEVCF 129
             F  +ELS  T  FS+KNL+GEG FG VYKG+L DG  VA+K  K  G+  + EF  EV  
Sbjct:   327 FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEI 386

Query:   130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
             ++ + HR+LVTL+GYC     + L+Y+Y+PN ++  HL+ P    R  + ++ R+ +   
Sbjct:   387 ISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPG---RPVMTWETRVRVAAG 443

Query:   190 XXXXXXXXXXX-XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV-AGPSSQVTA 247
                          PR++H+D K++N+L+D  F A VAD GL       D+    S++V  
Sbjct:   444 AARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMG 503

Query:   248 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVE----LVQNS 303
                ++A E     + SEK+DVYS+GV LLEL++GR+             VE    L+  +
Sbjct:   504 TFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQA 563

Query:   304 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 363
              +     +++D RL   F    M   ++    C+  S+ +RP MS VV  LD TL++  +
Sbjct:   564 IENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALD-TLEEATD 622

Query:   364 LTTVMGEGTPTV 375
             +T  M  G   V
Sbjct:   623 ITNGMRPGQSQV 634

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005199 "structural constituent of cell wall" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2156549 AT5G48740 [Arabidopsis thaliana (taxid:3702)]

 Score = 444 (161.4 bits), Expect = 5.8e-41, P = 5.8e-41
 Identities = 103/298 (34%), Positives = 159/298 (53%)

Query:    70 ARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK---KRPGAPTQEFIDE 126
             +R F  +E+  AT+NF  K +IG G FG VY+G L DG  VA+K    R       FI+E
Sbjct:   593 SRIFSHKEIKSATRNF--KEVIGRGSFGAVYRGKLPDGKQVAVKVRFDRTQLGADSFINE 650

Query:   127 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 186
             V  L+ I+H+NLV+  G+C E   Q L+YEY+  GS++ HLYGP    R  L +  RL +
Sbjct:   651 VHLLSQIRHQNLVSFEGFCYEPKRQILVYEYLSGGSLADHLYGPRS-KRHSLNWVSRLKV 709

Query:   187 XXXXXXXXXXXXXXX-PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 245
                             PR++H+D K++N+L+D+D  AKV+D GL     + D +  ++ V
Sbjct:   710 AVDAAKGLDYLHNGSEPRIIHRDVKSSNILLDKDMNAKVSDFGLSKQFTKADASHITTVV 769

Query:   246 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRD 305
                  +L  E     + +EKSDVYSFGV LLEL+ GRE             V   + +  
Sbjct:   770 KGTAGYLDPEYYSTLQLTEKSDVYSFGVVLLELICGREPLSHSGSPDSFNLVLWARPNLQ 829

Query:   306 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 363
              +   +I+D+ L  TF    M++   + +RC+   +  RPS+++V+T+L      +++
Sbjct:   830 -AGAFEIVDDILKETFDPASMKKAASIAIRCVGRDASGRPSIAEVLTKLKEAYSLQLS 886

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

UNIPROTKB|O24585 CR4 "Putative receptor protein kinase CRINKLY4" [Zea mays (taxid:4577)]

 Score = 438 (159.2 bits), Expect = 2.6e-40, P = 2.6e-40
 Identities = 110/324 (33%), Positives = 173/324 (53%)

Query:    64 ELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP---- 119
             +L IR A+ F  EEL  AT  FS+ + +G+G F  V+KG+L+DG +VA+K+   A     
Sbjct:   484 DLKIRRAQEFSYEELEQATGGFSEDSQVGKGSFSCVFKGILRDGTVVAVKRAIKASDVKK 543

Query:   120 -TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL 178
              ++EF +E+  L+ + H +L+ LLGYC++ + + L+YE++ +GS+  HL+G     +++L
Sbjct:   544 SSKEFHNELDLLSRLNHAHLLNLLGYCEDGSERLLVYEFMAHGSLYQHLHGKDPNLKKRL 603

Query:   179 EFKHRLSIXXXXXXXXXXXXXXX-PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 237
              +  R++I                P V+H+D K++N+L+DED  A+VAD GL + LG  D
Sbjct:   604 NWARRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEDHNARVADFGL-SILGPAD 662

Query:   238 VAGPSSQVTADEI-FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXX 296
                P S++ A  + +L  E       + KSDVYSFGV LLE++SGR+A            
Sbjct:   663 SGTPLSELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVVLLEILSGRKAIDMQFEEGNI-- 720

Query:   297 VELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 356
             VE         ++  ILD  L      E +++   +  +C+    + RPSM  V T L+ 
Sbjct:   721 VEWAVPLIKAGDIFAILDPVLSPPSDLEALKKIASVACKCVRMRGKDRPSMDKVTTALEH 780

Query:   357 TLDKEMNLTTVMGEGTPT-VTLGS 379
              L   M    +     PT V LGS
Sbjct:   781 ALALLMGSPCIEQPILPTEVVLGS 804

GO:0042803 "protein homodimerization activity" evidence=IDA

TAIR|locus:2012325 AT1G09440 [Arabidopsis thaliana (taxid:3702)]

 Score = 427 (155.4 bits), Expect = 4.2e-40, P = 4.2e-40
 Identities = 98/287 (34%), Positives = 156/287 (54%)

Query:    73 FQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK---RPGAPTQEFIDEVCF 129
             F + +L +AT  FS +N+IGEG +G VY+G L +G LVA+KK     G   +EF  EV  
Sbjct:   145 FTLRDLEIATNRFSKENVIGEGGYGVVYRGELVNGSLVAVKKILNHLGQAEKEFRVEVDA 204

Query:   130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
             +  ++H+NLV LLGYC E   + L+YEY+ NG++   L+G  +     L ++ R+ +   
Sbjct:   205 IGHVRHKNLVRLLGYCIEGTNRILVYEYMNNGNLEEWLHGAMK-HHGYLTWEARMKVLTG 263

Query:   190 XXXXXXXXXXXX-PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 248
                          P+VVH+D K++N+L+D+ F AK++D GL   LG    +  +++V   
Sbjct:   264 TSKALAYLHEAIEPKVVHRDIKSSNILIDDRFNAKISDFGLAKLLG-DGKSHVTTRVMGT 322

Query:   249 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSN 308
               ++A E       +EKSDVYSFGV +LE ++GR+             VE ++       
Sbjct:   323 FGYVAPEYANTGLLNEKSDVYSFGVLVLEAITGRDPVDYARPANEVNLVEWLKMMVGSKR 382

Query:   309 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 355
             L +++D  +        ++  +   +RC+DP SE+RP MS VV  L+
Sbjct:   383 LEEVIDPNIAVRPATRALKRVLLTALRCIDPDSEKRPKMSQVVRMLE 429

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: estExt_fgenesh4_pm.C_LG_II1100 hypothetical protein (378 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	386
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-49
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-47
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-47
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-45
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-39
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-38
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-38
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-32
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-29
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-28
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-28
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-27
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-26
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-26
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-25
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-25
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-25
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-25
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-25
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-24
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-24
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-24
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	7e-24
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-23
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-23
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-23
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-23
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-23
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-22
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-22
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-22
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-22
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-22
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	6e-22
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-21
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-21
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	7e-21
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-20
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-20
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-20
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-20
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-20
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	6e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-20
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-19
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-19
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-19
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-19
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-19
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-19
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-19
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	6e-19
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	7e-19
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	8e-19
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	8e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-18
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-18
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-18
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-18
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-18
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-18
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-18
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-18
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-18
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-18
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	8e-18
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	9e-18
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-17
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-17
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-17
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-17
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-17
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-17
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-17
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-17
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-17
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	7e-17
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	8e-17
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-16
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-16
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-16
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-16
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-16
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	6e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	7e-16
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	8e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	8e-16
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	9e-16
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-15
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-15
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-15
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-15
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-15
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-15
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-15
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-15
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-15
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	6e-15
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	7e-15
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-14
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-14
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-14
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-14
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	6e-14
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	6e-14
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	6e-14
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	8e-14
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-13
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-13
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-13
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	7e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	7e-13
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	8e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	9e-13
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-12
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-12
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-12
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-12
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-12
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-12
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	8e-12
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-11
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-11
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-11
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-11
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-11
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-11
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	6e-11
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	7e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	7e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	9e-11
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-10
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-10
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-10
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-10
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-10
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	7e-10
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	7e-10
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	8e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	9e-10
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-09
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-09
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-09
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-09
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-09
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-09
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-09
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-09
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-09
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-09
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-08
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-08
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-08
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-08
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-08
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	9e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-07
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-07
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-07
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-07
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-07
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	7e-07
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	8e-07
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	9e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-06
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-06
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-06
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-06
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-06
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-06
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-06
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-06
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-06
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-06
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-06
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-06
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-06
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-06
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-06
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-06
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	6e-06
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-06
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	7e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	7e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	9e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	9e-06
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-05
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-05
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-05
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-05
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-05
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-05
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-05
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-05
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-05
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-05
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-05
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-05
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-05
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-05
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-05
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-05
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-05
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-05
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-05
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-05
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	5e-05
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-05
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	7e-05
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	8e-05
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	8e-05
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	8e-05
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	9e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-04
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-04
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-04
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-04
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-04
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-04
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-04
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-04
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-04
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-04
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-04
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	3e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-04
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-04
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	4e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-04
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-04
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	7e-04
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	8e-04
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	0.001
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	0.001
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	0.002
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	0.002
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.004
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.004
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	0.004
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	0.004

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  165 bits (421), Expect = 6e-49
 Identities = 82/275 (29%), Positives = 129/275 (46%), Gaps = 35/275 (12%)

Query: 91  IGEGKFGEVYKGLLQD-----GMLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTL 141
           +GEG FGEVYKG L+       + VA+K  +  A  Q   EF+ E   +  + H N+V L
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 201
           LG C E    +++ EY+  G +  +L    + +R KL     LS AL  A+G+ +L S  
Sbjct: 67  LGVCTEEEPLYIVMEYMEGGDLLSYL----RKNRPKLSLSDLLSFALQIARGMEYLESK- 121

Query: 202 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF-LASEVKEFR 260
              +H+D    N LV E+ + K++D GL   L   D      +     I  +A E  +  
Sbjct: 122 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY--RKRGGKLPIRWMAPESLKEG 178

Query: 261 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 320
           +F+ KSDV+SFGV L E+ +           S+++++E ++N             RL   
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTL--GEQPYPGMSNEEVLEYLKN-----------GYRLPQP 225

Query: 321 FTNEGM-EEFIQLIVRCLDPSSERRPSMSDVVTEL 354
                   E   L+++C     E RP+ S++V  L
Sbjct: 226 ---PNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  162 bits (412), Expect = 1e-47
 Identities = 81/279 (29%), Positives = 127/279 (45%), Gaps = 42/279 (15%)

Query: 91  IGEGKFGEVYKGLLQDG-----MLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTL 141
           +GEG FGEVYKG L+       + VA+K  +  A  Q   EF+ E   +  + H N+V L
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 201
           LG C E     ++ EY+P G +  +L    +   ++L     LS AL  A+G+ +L S  
Sbjct: 67  LGVCTEEEPLMIVMEYMPGGDLLDYL---RKNRPKELSLSDLLSFALQIARGMEYLESK- 122

Query: 202 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF----LASEVK 257
              +H+D    N LV E+ + K++D GL   L   D                  +A E  
Sbjct: 123 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-----YKVKGGKLPIRWMAPESL 176

Query: 258 EFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 316
           +  +F+ KSDV+SFGV L E+ + G E    +S     +++E ++              R
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN---AEVLEYLKK-----------GYR 222

Query: 317 LWSTFTNEGM-EEFIQLIVRCLDPSSERRPSMSDVVTEL 354
           L           E  +L+++C     E RP+ S++V  L
Sbjct: 223 LPKP---PNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  161 bits (411), Expect = 2e-47
 Identities = 81/278 (29%), Positives = 133/278 (47%), Gaps = 40/278 (14%)

Query: 91  IGEGKFGEVYKGLL-----QDGMLVAIKK-RPGAP---TQEFIDEVCFLASIQHRNLVTL 141
           +GEG FGEVYKG L          VA+K  + GA     +EF++E   +  + H N+V L
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 201
           LG C +    +++ EY+P G +   L    +   +KL  K  L +AL  AKG+ +L S  
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFL----RKHGEKLTLKDLLQMALQIAKGMEYLESK- 121

Query: 202 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF----LASEVK 257
              VH+D    N LV E+ + K++D GL   +   D      +           +A E  
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD----YYRKRGGGKLPIKWMAPESL 176

Query: 258 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 317
           +  +F+ KSDV+SFGV L E+ +           S+++++EL+++             RL
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTL--GEQPYPGMSNEEVLELLED-----------GYRL 223

Query: 318 WSTFTNEGMEEFI-QLIVRCLDPSSERRPSMSDVVTEL 354
                 E   + + +L+++C     E RP+ S++V +L
Sbjct: 224 ---PRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  157 bits (399), Expect = 1e-45
 Identities = 80/284 (28%), Positives = 124/284 (43%), Gaps = 39/284 (13%)

Query: 89  NLIGEGKFGEVYKGLLQDG----MLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVT 140
             +GEG FGEVYKG L+        VA+K  +  A  +   +F+ E   +  + H N+V 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 141 LLGYCQENNLQFLIYEYIPNGS----VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 196
           LLG C E    +L+ EY+  G     +           +  L  K  LS A+  AKG+ +
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 197 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF----L 252
           L S   + VH+D    N LV ED + K++D G    L R        +           +
Sbjct: 121 LASK--KFVHRDLAARNCLVGEDLVVKISDFG----LSRDVYDDDYYRKKTGGKLPIRWM 174

Query: 253 ASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK 311
           A E  +   F+ KSDV+SFGV L E+ + G      LS    ++++E ++          
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEYLRK--------- 222

Query: 312 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 355
               RL         +E  +L++ C     E RP+ S++V  L+
Sbjct: 223 --GYRL--PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  138 bits (350), Expect = 4e-39
 Identities = 72/268 (26%), Positives = 109/268 (40%), Gaps = 63/268 (23%)

Query: 91  IGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 145
           +GEG FG VY     + G  VAIK    +   +  +E + E+  L  + H N+V L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 146 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 205
           ++ N  +L+ EY   GS+   L    + +  KL     L I L   +GL +LHS    ++
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLL----KENEGKLSEDEILRILLQILEGLEYLHSN--GII 114

Query: 206 HKDFKTANVLVDED-FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR-FS 263
           H+D K  N+L+D D    K+AD GL   L        +   T    ++A EV   +  +S
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT--PAYMAPEVLLGKGYYS 172

Query: 264 EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN 323
           EKSD++S GV L E                                              
Sbjct: 173 EKSDIWSLGVILYE---------------------------------------------- 186

Query: 324 EGMEEFIQLIVRCLDPSSERRPSMSDVV 351
             + E   LI + L    E+RPS  +++
Sbjct: 187 --LPELKDLIRKMLQKDPEKRPSAKEIL 212

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  138 bits (350), Expect = 1e-38
 Identities = 69/273 (25%), Positives = 114/273 (41%), Gaps = 32/273 (11%)

Query: 85  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLV 139
           +     +GEG FG+VY     + G LVAIK     +     +  + E+  L  ++H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 199
            L    ++ +  +L+ EY   G +   L       R +L               L +LHS
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLL-----KKRGRLSEDEARFYLRQILSALEYLHS 115

Query: 200 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 259
               +VH+D K  N+L+DED   K+AD GL   L   +    +   T +  ++A EV   
Sbjct: 116 K--GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT-TFVGTPE--YMAPEVLLG 170

Query: 260 RRFSEKSDVYSFGVFLLELVSGREASSSLSP-DSSQDLVELVQNSRDFSNLLKILDERLW 318
           + + +  D++S GV L EL++G+       P      L+EL +         KI   +  
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGK------PPFPGDDQLLELFK---------KIGKPKPP 215

Query: 319 STFTNEGM-EEFIQLIVRCLDPSSERRPSMSDV 350
                  +  E   LI + L    E+R +  + 
Sbjct: 216 FPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  138 bits (349), Expect = 2e-38
 Identities = 73/268 (27%), Positives = 120/268 (44%), Gaps = 26/268 (9%)

Query: 91  IGEGKFGEVYKGLLQ-DGMLVAIK--KRPGAP---TQEFIDEVCFLASIQHRNLVTLLGY 144
           +G G FG VYK   +  G +VA+K  K+        Q    E+  L  + H N+V L+  
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 204
            ++ +  +L+ EY   G +  +L          L       IAL   +GL +LHS    +
Sbjct: 67  FEDKDHLYLVMEYCEGGDLFDYL-----SRGGPLSEDEAKKIALQILRGLEYLHSN--GI 119

Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV-KEFRRFS 263
           +H+D K  N+L+DE+ + K+AD GL   L ++      +       ++A EV      + 
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSS--SSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 264 EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN 323
            K DV+S GV L EL++G+      S ++  D     Q       L   L+        +
Sbjct: 178 PKVDVWSLGVILYELLTGK---PPFSGENILD-----QLQLIRRILGPPLEFDEP--KWS 227

Query: 324 EGMEEFIQLIVRCLDPSSERRPSMSDVV 351
            G EE   LI +CL+    +RP+  +++
Sbjct: 228 SGSEEAKDLIKKCLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  121 bits (306), Expect = 3e-32
 Identities = 67/203 (33%), Positives = 98/203 (48%), Gaps = 24/203 (11%)

Query: 88  KNLIGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 145
              IG+G+FG+V  G  + G  VA+K  K      Q F+ E   + +++H NLV LLG  
Sbjct: 11  GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69

Query: 146 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 205
            + N  +++ EY+  GS+  +L       R  +    +L  AL   +G+ +L       V
Sbjct: 70  LQGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLE--EKNFV 124

Query: 206 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-----ASEVKEFR 260
           H+D    NVLV ED +AKV+D GL             +    D   L     A E    +
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGL----------AKEASQGQDSGKLPVKWTAPEALREK 174

Query: 261 RFSEKSDVYSFGVFLLELVS-GR 282
           +FS KSDV+SFG+ L E+ S GR
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  115 bits (290), Expect = 1e-29
 Identities = 79/289 (27%), Positives = 129/289 (44%), Gaps = 37/289 (12%)

Query: 89  NLIGEGKFGEVYKGLL-----QDGMLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLV 139
             +GEG FG+V            G  VA+K            +F  E+  L ++ H N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 140 TLLGYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 196
              G C+     +L+ LI EY+P+GS+  +L    Q  R ++  K  L  +    KG+ +
Sbjct: 70  KYKGVCEKPGGRSLR-LIMEYLPSGSLRDYL----QRHRDQINLKRLLLFSSQICKGMDY 124

Query: 197 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF-LASE 255
           L S   R +H+D    N+LV+ + + K++D GL   L          +     IF  A E
Sbjct: 125 LGSQ--RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182

Query: 256 VKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 314
                +FS  SDV+SFGV L EL + G     S SP    + + ++  ++    + ++L 
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGD---PSQSP--PAEFLRMIGIAQGQMIVTRLL- 236

Query: 315 ERLWSTFTNEGM-------EEFIQLIVRCLDPSSERRPSMSDVVTELDR 356
           E L      E +       +E   L+  C +   + RPS +D++  +DR
Sbjct: 237 ELLKE---GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  111 bits (280), Expect = 1e-28
 Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 16/204 (7%)

Query: 83  KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQ-EFIDEVCFLASIQHRNLV 139
           + F+ +  +G G FGEV++GL ++ + VAIK  K      Q +F  EV  L  ++H++L+
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65

Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 199
           +L   C      ++I E +  GS+   L  P     Q L     + +A   A+G+A+L  
Sbjct: 66  SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEG---QVLPVASLIDMACQVAEGMAYLEE 122

Query: 200 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---FLASEV 256
                +H+D    N+LV ED + KVAD GL   + + DV   S +    +I   + A E 
Sbjct: 123 --QNSIHRDLAARNILVGEDLVCKVADFGLARLI-KEDVYLSSDK----KIPYKWTAPEA 175

Query: 257 KEFRRFSEKSDVYSFGVFLLELVS 280
                FS KSDV+SFG+ L E+ +
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  110 bits (277), Expect = 4e-28
 Identities = 85/267 (31%), Positives = 133/267 (49%), Gaps = 26/267 (9%)

Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           IG G+FG V+ G   +   VAIK  R GA ++E FI+E   +  + H  LV L G C E 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71

Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 208
           +   L++E++ +G +S +L    +  R K   +  L + L   +G+A+L S +  V+H+D
Sbjct: 72  SPICLVFEFMEHGCLSDYL----RAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRD 125

Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS-EVKEFRRFSEKSD 267
               N LV E+ + KV+D G+  F+   D    SS  T   +  +S EV  F ++S KSD
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFV--LDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183

Query: 268 VYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGME 327
           V+SFGV + E+ S  E  +     S+ ++VE        +   ++   RL S    E M+
Sbjct: 184 VWSFGVLMWEVFS--EGKTPYENRSNSEVVE------TINAGFRLYKPRLASQSVYELMQ 235

Query: 328 EFIQLIVRCLDPSSERRPSMSDVVTEL 354
                   C     E RPS S ++ +L
Sbjct: 236 H-------CWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  107 bits (269), Expect = 6e-27
 Identities = 71/280 (25%), Positives = 118/280 (42%), Gaps = 43/280 (15%)

Query: 85  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVT 140
           F     IG+G FGEVYK    + G  VAIK          ++ I+E+  L   +H N+V 
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS------IALGAAKGL 194
             G   + +  +++ E+   GS+         + +        L+      +     KGL
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLK-------DLLK---STNQTLTESQIAYVCKELLKGL 111

Query: 195 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 254
            +LHS    ++H+D K AN+L+  D   K+ D GL   L  T      + +     ++A 
Sbjct: 112 EYLHSN--GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT---KARNTMVGTPYWMAP 166

Query: 255 EVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 314
           EV   + +  K+D++S G+  +EL  G+   S L P  +  L ++  N      L     
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA--LFKIATN--GPPGLRNP-- 220

Query: 315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
              WS        EF   + +CL  + E+RP+      +L
Sbjct: 221 -EKWSD-------EFKDFLKKCLQKNPEKRPT----AEQL 248

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  105 bits (264), Expect = 3e-26
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 31/210 (14%)

Query: 89  NLIGEGKFGEVYKGLLQD-GMLVAIKK-RPGAPTQEFID----EVCFLASIQHRNLVTLL 142
            L+G G FG VY  L +D G L+A+K       ++E ++    E+  L+S+QH N+V   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 143 GYCQENNLQFL-IY-EYIPNGSVS--IHLYGP------SQVSRQKLEFKHRLSIALGAAK 192
           G  ++     L I+ EY+  GS+S  +  +G        + +RQ LE             
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILE------------- 112

Query: 193 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL 252
           GLA+LHS    +VH+D K AN+LVD D + K+AD G    LG  +    +  V     ++
Sbjct: 113 GLAYLHSN--GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170

Query: 253 ASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
           A EV     +   +D++S G  ++E+ +G+
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 5e-26
 Identities = 67/222 (30%), Positives = 106/222 (47%), Gaps = 40/222 (18%)

Query: 76  EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASI 133
           E L L  K       +G G+FGEV+ G       VA+K  +PG  + E F+ E   +  +
Sbjct: 6   ESLKLERK-------LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKL 58

Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 193
           +H  LV L   C E    +++ EY+  GS+   L        +KL     + +A   A+G
Sbjct: 59  RHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEG---KKLRLPQLVDMAAQIAEG 115

Query: 194 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 253
           +A+L S     +H+D    N+LV E+ + K+AD GL             +++  D+ + A
Sbjct: 116 MAYLESR--NYIHRDLAARNILVGENLVCKIADFGL-------------ARLIEDDEYTA 160

Query: 254 SE-----VK-------EFRRFSEKSDVYSFGVFLLELVS-GR 282
            E     +K        + RF+ KSDV+SFG+ L E+V+ GR
Sbjct: 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  106 bits (265), Expect = 1e-25
 Identities = 68/283 (24%), Positives = 111/283 (39%), Gaps = 25/283 (8%)

Query: 84  NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH-R 136
           ++     +GEG FGEVY    +D  LVA+K             + F+ E+  LAS+ H  
Sbjct: 1   SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 137 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 196
           N+V L  + Q+    +L+ EY+  GS+   L       +  L     L I       L +
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLL--KKIGRKGPLSESEALFILAQILSALEY 116

Query: 197 LHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRTDVAGPSSQVTADEI----F 251
           LHS    ++H+D K  N+L+D D  + K+ D GL   L           + +  +    +
Sbjct: 117 LHSK--GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174

Query: 252 LASEV---KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 308
           +A EV         S  SD++S G+ L EL++G          S+      +       +
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234

Query: 309 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
           L   L             +    L+ + L    + R S S  +
Sbjct: 235 LASPLSPS----NPELISKAASDLLKKLLAKDPKNRLSSSSDL 273

Length = 384

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  103 bits (259), Expect = 1e-25
 Identities = 76/273 (27%), Positives = 126/273 (46%), Gaps = 31/273 (11%)

Query: 90  LIGEGKFGEVYKGLLQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 145
            IG+G FG+VYKG+L+    VA+K      P    ++F+ E   L    H N+V L+G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 146 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 205
            +    +++ E +P GS+   L         +L  K  L ++L AA G+ +L S +   +
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKK----NRLTVKKLLQMSLDAAAGMEYLESKN--CI 115

Query: 206 HKDFKTANVLVDEDFIAKVADAGL--RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS 263
           H+D    N LV E+ + K++D G+      G   V+    Q+     + A E   + R++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK--WTAPEALNYGRYT 173

Query: 264 EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN 323
            +SDV+S+G+ L E  S      +  P  S       Q +R+         E  +     
Sbjct: 174 SESDVWSYGILLWETFSL---GDTPYPGMSN------QQTRERI-------ESGYRMPAP 217

Query: 324 EGM-EEFIQLIVRCLDPSSERRPSMSDVVTELD 355
           +   EE  +L+++C     E RPS S++  EL 
Sbjct: 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  104 bits (260), Expect = 2e-25
 Identities = 65/216 (30%), Positives = 101/216 (46%), Gaps = 35/216 (16%)

Query: 91  IGEGKFGEVYKGLL------QDGMLVAIK--KRPGAPT--QEFIDEVCFLASIQHRNLVT 140
           +GEG FG+V+ G         D  LVA+K  K   +    ++F  E   L + QH N+V 
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHL--YGPSQVS-------RQKLEFKHRLSIALGAA 191
             G C E +   +++EY+ +G ++  L  +GP             +L     L IA+  A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 192 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAG----PSSQ 244
            G+ +L S     VH+D  T N LV  D + K+ D G+   +  TD   V G    P   
Sbjct: 133 SGMVYLASQ--HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRW 190

Query: 245 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
           +  + I        +R+F+ +SDV+SFGV L E+ +
Sbjct: 191 MPPESIM-------YRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  103 bits (258), Expect = 2e-25
 Identities = 67/194 (34%), Positives = 103/194 (53%), Gaps = 11/194 (5%)

Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FG V+ G  +  + VAIK  R GA +++ FI+E   +  + H NLV L G C + 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71

Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 208
              F++ EY+ NG +  +L    +  + KL  +  L +     + + +L S     +H+D
Sbjct: 72  RPIFIVTEYMANGCLLNYL----RERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRD 125

Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS-EVKEFRRFSEKSD 267
               N LV ED + KV+D GL  ++   D    SSQ T   +  A  EV ++ RFS KSD
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYV--LDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183

Query: 268 VYSFGVFLLELVSG 281
           V+SFGV + E+ S 
Sbjct: 184 VWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  103 bits (258), Expect = 2e-25
 Identities = 71/213 (33%), Positives = 109/213 (51%), Gaps = 31/213 (14%)

Query: 84  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRN 137
           N+   +LIG G FG VYKGL L+ G  VAIK     K      +  + E+  L +++H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVS--IHLYGP---SQVSR---QKLEFKHRLSIALG 189
           +V  +G  + ++  ++I EY  NGS+   I  +GP   S V+    Q L+          
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQ---------- 110

Query: 190 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
              GLA+LH     V+H+D K AN+L  +D + K+AD G+   L   DV+   + V    
Sbjct: 111 ---GLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVGTP 163

Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
            ++A EV E    S  SD++S G  ++EL++G 
Sbjct: 164 YWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  100 bits (250), Expect = 2e-24
 Identities = 76/273 (27%), Positives = 130/273 (47%), Gaps = 34/273 (12%)

Query: 90  LIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTLLGYC 145
           L+G+G FGEV+KG L+D   VA+K  +   P +   +F+ E   L    H N+V L+G C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 146 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 205
            +    +++ E +P G     L    +  + +L+ K  +  AL AA G+A+L   S   +
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFL----RKKKDELKTKQLVKFALDAAAGMAYLE--SKNCI 115

Query: 206 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---FLASEVKEFRRF 262
           H+D    N LV E+ + K++D G    + R +  G  S     +I   + A E   + R+
Sbjct: 116 HRDLAARNCLVGENNVLKISDFG----MSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRY 171

Query: 263 SEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF 321
           S +SDV+S+G+ L E  S G      ++   +++ VE  +  R               + 
Sbjct: 172 SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE--KGYR--------------MSC 215

Query: 322 TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
             +  ++  +++ RC D   E RP  S++  EL
Sbjct: 216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 99.9 bits (250), Expect = 4e-24
 Identities = 66/281 (23%), Positives = 117/281 (41%), Gaps = 43/281 (15%)

Query: 84  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQEF-IDEVCFLASIQHRN 137
            +     IG+G FG+VY      DG L  +K+          +E  ++EV  L  + H N
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR-----LSIALGAAK 192
           ++      +E     ++ EY   G +S  +       +QK E K       L   +    
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKI------KKQKKEGKPFPEEQILDWFVQLCL 114

Query: 193 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL 252
            L +LHS   +++H+D K  N+ +  + + K+ D G+   L  T     +   T    +L
Sbjct: 115 ALKYLHS--RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTP--YYL 170

Query: 253 ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 312
           + E+ + + ++ KSD++S G  L EL + +       P   ++L+EL           KI
Sbjct: 171 SPELCQNKPYNYKSDIWSLGCVLYELCTLK------HPFEGENLLELAL---------KI 215

Query: 313 LD---ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
           L      + S ++     E   L+   L    E RPS++ +
Sbjct: 216 LKGQYPPIPSQYS----SELRNLVSSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  100 bits (250), Expect = 4e-24
 Identities = 85/305 (27%), Positives = 137/305 (44%), Gaps = 52/305 (17%)

Query: 77  ELSLATKNFSDKNLIGEGKFGEVYKG-LLQDG-----MLVAIK----KRPGAPTQEFIDE 126
           E+ L+   F ++  +GEG FG+VYKG L           VAIK           QEF  E
Sbjct: 1   EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58

Query: 127 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVS-----------R 175
              ++ +QH N+V LLG C +     +++EY+ +G +   L   S  S           +
Sbjct: 59  AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118

Query: 176 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 235
             L+    L IA+  A G+ +L   S   VH+D    N LV E    K++D GL   +  
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLS--SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYS 176

Query: 236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPD---S 292
            D     S+      ++  E   + +F+ +SD++SFGV L E+      S  L P    S
Sbjct: 177 ADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIF-----SYGLQPYYGFS 231

Query: 293 SQDLVELVQNSRDFSNLLKILDE---RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 349
           +Q+++E+++ SR    LL   ++   R+++            L++ C +    RRP   D
Sbjct: 232 NQEVIEMIR-SR---QLLPCPEDCPARVYA------------LMIECWNEIPARRPRFKD 275

Query: 350 VVTEL 354
           + T L
Sbjct: 276 IHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 99.5 bits (248), Expect = 7e-24
 Identities = 76/299 (25%), Positives = 119/299 (39%), Gaps = 59/299 (19%)

Query: 84  NFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIK---KRPGAPTQ-EFIDEVCFLASI 133
           N  +   +G G+FGEV+    +         LV +K   K      Q EF  E+     +
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL----YGPSQVSRQKLEFKHRLSIALG 189
            H+N+V LLG C+E    ++I EY   G +   L        ++    L  K ++++   
Sbjct: 66  SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125

Query: 190 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
            A G+ HL +   R VH+D    N LV      KV+   L            S  V   E
Sbjct: 126 IALGMDHLSNA--RFVHRDLAARNCLVSSQREVKVSLLSL------------SKDVYNSE 171

Query: 250 IF-----------LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVE 298
            +           LA E  +   FS KSDV+SFGV + E+ +  E      P       E
Sbjct: 172 YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGEL-----PFYGLSDEE 226

Query: 299 LVQNSRDFSNLLKILD---ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
           ++   +     L + +    RL+            +L+ RC   + + RPS S++V+ L
Sbjct: 227 VLNRLQAGKLELPVPEGCPSRLY------------KLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 98.8 bits (246), Expect = 1e-23
 Identities = 75/276 (27%), Positives = 133/276 (48%), Gaps = 34/276 (12%)

Query: 88  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 11  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 204
           C      ++I E++  G++  +L    + +RQ++     L +A   +  + +L   +   
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKKN--F 125

Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 263
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 183

Query: 264 EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN 323
            KSDV++FGV L E+     A+  +SP    DL          S + ++L++     +  
Sbjct: 184 IKSDVWAFGVLLWEI-----ATYGMSPYPGIDL----------SQVYELLEK----GYRM 224

Query: 324 EGME----EFIQLIVRCLDPSSERRPSMSDVVTELD 355
           E  E    +  +L+  C   +   RPS +++    +
Sbjct: 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 98.6 bits (246), Expect = 1e-23
 Identities = 72/281 (25%), Positives = 131/281 (46%), Gaps = 43/281 (15%)

Query: 91  IGEGKFGEVYKGL-LQDG----MLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLVTL 141
           +G G FG VYKG+ + +G    + VAIK    +      +E +DE   +AS+ H ++V L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 201
           LG C  + +Q LI + +P G +  ++       +  +  ++ L+  +  AKG+++L    
Sbjct: 75  LGICLSSQVQ-LITQLMPLGCLLDYVRNH----KDNIGSQYLLNWCVQIAKGMSYLEE-- 127

Query: 202 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE-----IFLASEV 256
            R+VH+D    NVLV      K+ D GL   L   +      +  A+       ++A E 
Sbjct: 128 KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE-----KEYHAEGGKVPIKWMALES 182

Query: 257 KEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 315
              R ++ KSDV+S+GV + EL++ G +    +              + +  +LL+   E
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI-------------PAVEIPDLLEK-GE 228

Query: 316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 356
           RL          +   ++V+C    +E RP+  +++ E  +
Sbjct: 229 RLPQPPICT--IDVYMVLVKCWMIDAESRPTFKELINEFSK 267

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 99.1 bits (247), Expect = 1e-23
 Identities = 82/279 (29%), Positives = 130/279 (46%), Gaps = 21/279 (7%)

Query: 90  LIGEGKFGEVYK---GLLQD--GMLVAIKK-RPGAPT--QEFIDEVCFLASIQHRNLVTL 141
            +G+G FG V       LQD  G +VA+KK +       ++F  E+  L S+QH N+V  
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70

Query: 142 LGYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 198
            G C      NL+ L+ EY+P GS+  +L    Q  R++L+ +  L  A    KG+ +L 
Sbjct: 71  KGVCYSAGRRNLR-LVMEYLPYGSLRDYL----QKHRERLDHRKLLLYASQICKGMEYLG 125

Query: 199 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF-LASEVK 257
           S   R VH+D  T N+LV+ +   K+ D GL   L +        +     IF  A E  
Sbjct: 126 SK--RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183

Query: 258 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 317
              +FS  SDV+SFGV L EL +  + S S   +  + +    Q      +L+++L    
Sbjct: 184 TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN- 242

Query: 318 WSTFTNEGM-EEFIQLIVRCLDPSSERRPSMSDVVTELD 355
                  G   E   ++  C +    +RPS S++  +++
Sbjct: 243 GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVE 281

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 97.8 bits (244), Expect = 2e-23
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 26/206 (12%)

Query: 89  NLIGEGKFGEVYKGLLQ----DGMLVAIKK-RPGAPTQEFIDEVCFL--ASI----QHRN 137
            +IG G+FGEV +G L+      + VAIK  + G+  ++ +D   FL  ASI     H N
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD---FLTEASIMGQFDHPN 66

Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 197
           ++ L G   ++    +I EY+ NGS    L    + +  K      + +  G A G+ +L
Sbjct: 67  IIRLEGVVTKSRPVMIITEYMENGS----LDKFLRENDGKFTVGQLVGMLRGIASGMKYL 122

Query: 198 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---FLAS 254
             ++   VH+D    N+LV+ + + KV+D GL   L  ++    +      +I   + A 
Sbjct: 123 SEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE---ATYTTKGGKIPIRWTAP 177

Query: 255 EVKEFRRFSEKSDVYSFGVFLLELVS 280
           E   +R+F+  SDV+SFG+ + E++S
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 96.2 bits (240), Expect = 6e-23
 Identities = 75/269 (27%), Positives = 124/269 (46%), Gaps = 28/269 (10%)

Query: 85  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP-GAPTQEFIDEVCFLASIQHRNLVTLL 142
           F     +GEG +G VYK +  + G +VAIK  P     QE I E+  L       +V   
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYY 64

Query: 143 G-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 201
           G Y +  +L +++ EY   GSVS  +    +++ + L  +   +I     KGL +LHS  
Sbjct: 65  GSYFKNTDL-WIVMEYCGAGSVSDIM----KITNKTLTEEEIAAILYQTLKGLEYLHSN- 118

Query: 202 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 261
            + +H+D K  N+L++E+  AK+AD G+   L  TD     + V     ++A EV +   
Sbjct: 119 -KKIHRDIKAGNILLNEEGQAKLADFGVSGQL--TDTMAKRNTVIGTPFWMAPEVIQEIG 175

Query: 262 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN-SRDFSNLLKILDERLWST 320
           ++ K+D++S G+  +E+  G+   S + P   + +  +        S+  K      WS 
Sbjct: 176 YNNKADIWSLGITAIEMAEGKPPYSDIHP--MRAIFMIPNKPPPTLSDPEK------WS- 226

Query: 321 FTNEGMEEFIQLIVRCLDPSSERRPSMSD 349
                  EF   + +CL    E RPS   
Sbjct: 227 ------PEFNDFVKKCLVKDPEERPSAIQ 249

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 95.0 bits (236), Expect = 2e-22
 Identities = 73/212 (34%), Positives = 111/212 (52%), Gaps = 18/212 (8%)

Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENN 149
           IGEG+FG V +G    G  VA+K  +     Q F++E   +  + H+NLV LLG    N 
Sbjct: 14  IGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG 72

Query: 150 LQFLIYEYIPNGSVSIHLY--GPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHK 207
           L +++ E +  G++   L   G + VS  +L     L  +L  A+G+ +L S   ++VH+
Sbjct: 73  L-YIVMELMSKGNLVNFLRTRGRALVSVIQL-----LQFSLDVAEGMEYLES--KKLVHR 124

Query: 208 DFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSD 267
           D    N+LV ED +AKV+D GL   +G   V      V     + A E  + ++FS KSD
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLPVK----WTAPEALKHKKFSSKSD 179

Query: 268 VYSFGVFLLELVS-GREASSSLSPDSSQDLVE 298
           V+S+GV L E+ S GR     +S    ++ VE
Sbjct: 180 VWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE 211

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 94.8 bits (236), Expect = 2e-22
 Identities = 62/195 (31%), Positives = 102/195 (52%), Gaps = 9/195 (4%)

Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPG-APTQEFIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FGEV++GL  +   VA+K  +PG    ++F+ E   +  ++H  L+ L   C   
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73

Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 208
              +++ E +  GS+  +L G +    + L+    + +A   A G+A+L + +   +H+D
Sbjct: 74  EPIYIVTELMKYGSLLEYLQGGAG---RALKLPQLIDMAAQVASGMAYLEAQN--YIHRD 128

Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDV 268
               NVLV E+ I KVAD GL   +   D+            + A E   + RFS KSDV
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKE-DIYEAREGAKFPIKWTAPEAALYNRFSIKSDV 187

Query: 269 YSFGVFLLELVS-GR 282
           +SFG+ L E+V+ GR
Sbjct: 188 WSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 94.7 bits (235), Expect = 2e-22
 Identities = 72/214 (33%), Positives = 107/214 (50%), Gaps = 23/214 (10%)

Query: 73  FQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK-KRPGAPTQEFIDEVCFLA 131
             M+EL L          IG+G+FG+V  G  + G  VA+K  +  A  Q F+ E   + 
Sbjct: 3   LNMKELKL-------LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMT 54

Query: 132 SIQHRNLVTLLGY-CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 190
            ++H NLV LLG   +E    +++ EY+  GS+  +L       R  L     L  +L  
Sbjct: 55  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDV 111

Query: 191 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT-DVAGPSSQVTADE 249
            + + +L + +   VH+D    NVLV ED +AKV+D GL      T D      + TA E
Sbjct: 112 CEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPE 169

Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GR 282
                 ++E ++FS KSDV+SFG+ L E+ S GR
Sbjct: 170 -----ALRE-KKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 94.7 bits (235), Expect = 3e-22
 Identities = 68/219 (31%), Positives = 109/219 (49%), Gaps = 22/219 (10%)

Query: 91  IGEGKFGEVY----KGLL--QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTL 141
           +GEG FG+V+      LL  QD MLVA+K    A     Q+F  E   L  +QH+++V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHL--YGP--------SQVSRQKLEFKHRLSIALGAA 191
            G C E     +++EY+ +G ++  L  +GP          V+  +L     L+IA   A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 192 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF 251
            G+ +L SL    VH+D  T N LV +  + K+ D G+   +  TD      +      +
Sbjct: 133 SGMVYLASL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 190

Query: 252 LASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS 289
           +  E   +R+F+ +SD++SFGV L E+ + G++    LS
Sbjct: 191 MPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS 229

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 94.3 bits (234), Expect = 5e-22
 Identities = 71/219 (32%), Positives = 116/219 (52%), Gaps = 17/219 (7%)

Query: 90  LIGEGKFGEVYKGL-LQDG----MLVAIK---KRPGAPT-QEFIDEVCFLASIQHRNLVT 140
           L+G G FG V+KG+ + +G    + VAIK    R G  T QE  D +  + S+ H  +V 
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 200
           LLG C   +LQ L+ +  P GS+  H+    +  R  L+ +  L+  +  AKG+ +L   
Sbjct: 74  LLGICPGASLQ-LVTQLSPLGSLLDHV----RQHRDSLDPQRLLNWCVQIAKGMYYLEE- 127

Query: 201 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 260
             R+VH++    N+L+  D I ++AD G+ + L   D     S+      ++A E   F 
Sbjct: 128 -HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186

Query: 261 RFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVE 298
           R++ +SDV+S+GV + E++S G E  + + P    DL+E
Sbjct: 187 RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE 225

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 94.1 bits (234), Expect = 6e-22
 Identities = 79/294 (26%), Positives = 123/294 (41%), Gaps = 46/294 (15%)

Query: 91  IGEGKFGEVYK----GLL--QDGMLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVT 140
           IG+G FG V++    GLL  +   +VA+K  +  A      +F  E   +A   H N+V 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHL-----YGPSQVSRQKLEFK------------HR 183
           LLG C       L++EY+  G ++  L          +S      +             +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 184 LSIALGAAKGLAHLHSLSPR-VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS 242
           L IA   A G+A+   LS R  VH+D  T N LV E+ + K+AD GL   +   D    S
Sbjct: 133 LCIAKQVAAGMAY---LSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 243 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 302
                   ++  E   + R++ +SDV+++GV L E+      S  + P       E++  
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF-----SYGMQPYYGMAHEEVIYY 244

Query: 303 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 356
            RD  N+L   D        N  +E +  L+  C       RPS + +   L R
Sbjct: 245 VRD-GNVLSCPD--------NCPLELY-NLMRLCWSKLPSDRPSFASINRILQR 288

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 92.7 bits (230), Expect = 2e-21
 Identities = 77/277 (27%), Positives = 124/277 (44%), Gaps = 23/277 (8%)

Query: 91  IGEGKFGEV----YKGLLQD-GMLVAIK--KRPGAP--TQEFIDEVCFLASIQHRNLVTL 141
           +GEG FG+V    Y       G +VA+K  KR      T  +  E+  L ++ H N+V  
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 142 LGYCQENNLQ--FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 199
            G C E   +   LI EY+P GS+  +L       + KL     L  A    +G+A+LHS
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYL------PKHKLNLAQLLLFAQQICEGMAYLHS 125

Query: 200 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF-LASEVKE 258
                +H+D    NVL+D D + K+ D GL   +          +     +F  A E  +
Sbjct: 126 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183

Query: 259 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS-QDLVELVQNSRDFSNLLKILDERL 317
             +FS  SDV+SFGV L EL++     S  SP    ++++   Q       L+++L+  +
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT--HCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM 241

Query: 318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
                    +E   L+  C +  ++ RP+   ++  L
Sbjct: 242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 93.2 bits (231), Expect = 2e-21
 Identities = 82/297 (27%), Positives = 134/297 (45%), Gaps = 41/297 (13%)

Query: 91  IGEGKFGEVYK----GLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 137
           +GEG FG+V      GL ++       VA+K      T+    + I E+  +  I +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 186
           ++ LLG C ++   ++I EY   G++  +L           Y P+QV  ++L FK  +S 
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 187 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 246
           A   A+G+ +L   S + +H+D    NVLV ED + K+AD GL   +   D    ++   
Sbjct: 146 AYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 203

Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 306
               ++A E    R ++ +SDV+SFGV L E+      +   SP     + E        
Sbjct: 204 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF-----TLGGSPYPGVPVEE-------- 250

Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 363
             L K+L E       +    E   ++  C      +RP+   +V +LDR L    N
Sbjct: 251 --LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSN 305

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 90.6 bits (225), Expect = 7e-21
 Identities = 73/277 (26%), Positives = 120/277 (43%), Gaps = 47/277 (16%)

Query: 84  NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRN 137
           +F   N IG+G FG V+K + + D  + A+K     K      +E IDE   LA +    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE---FKHRLSIALGAAKGL 194
           ++       +     ++ EY  NG +  H     Q  R   E   ++  + I LG    L
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDL--HKLLKMQRGRPLPEDQVWRFFIQILLG----L 114

Query: 195 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG------RTDVAGPSSQVTAD 248
           AHLHS   +++H+D K+ N+ +D     K+ D G+   L        T V  P       
Sbjct: 115 AHLHS--KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTP------- 165

Query: 249 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 308
             +L+ E+ E + ++EKSDV++ GV L E  +G+       P  + +   L+        
Sbjct: 166 -YYLSPELCEDKPYNEKSDVWALGVVLYECCTGKH------PFDANNQGALI-------- 210

Query: 309 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP 345
            LKI+    +   +    ++  QLI +CL     +RP
Sbjct: 211 -LKIIRGV-FPPVSQMYSQQLAQLIDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 90.6 bits (225), Expect = 1e-20
 Identities = 82/319 (25%), Positives = 131/319 (41%), Gaps = 68/319 (21%)

Query: 73  FQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQD------GMLVAIKK-RPGAPTQEFID 125
              + L+L          +GEG FG+V K              VA+K  +  A  ++  D
Sbjct: 9   LPRDRLTLG-------KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSD 61

Query: 126 ---EVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGP 170
              E+  +  I +H+N++ LLG C +    +++ EY  +G++   L              
Sbjct: 62  LVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDD 121

Query: 171 SQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 230
            +   + L  K  +S A   A+G+  L S   + +H+D    NVLV ED + K+AD GL 
Sbjct: 122 PRPPEETLTQKDLVSFAYQVARGMEFLAS--KKCIHRDLAARNVLVTEDHVMKIADFGLA 179

Query: 231 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS--GREASSSL 288
             +   D    ++       ++A E    R ++ +SDV+SFGV L E+ +  G       
Sbjct: 180 RDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG------- 232

Query: 289 SPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEG--ME-------EFIQLIVRCLDP 339
           SP     + EL +       LLK            EG  ME       E   L+  C   
Sbjct: 233 SPYPGIPVEELFK-------LLK------------EGYRMEKPQNCTQELYHLMRDCWHE 273

Query: 340 SSERRPSMSDVVTELDRTL 358
              +RP+   +V +LDR L
Sbjct: 274 VPSQRPTFKQLVEDLDRML 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 89.4 bits (222), Expect = 2e-20
 Identities = 63/279 (22%), Positives = 120/279 (43%), Gaps = 41/279 (14%)

Query: 84  NFSDKNLIGEGKFGEVYK-GLLQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRN 137
           +F     +G+G +G VYK   L D    A+K+           ++ ++E+  LAS+ H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRL--SIALGAAKGLA 195
           +++      + N   ++ EY P G +S      S+  +++     +    I +   +GL 
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLS---KAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117

Query: 196 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAGPSSQVTADEIF 251
            LH    +++H+D K+AN+L+  + + K+ D G    L+  + +T +  P         +
Sbjct: 118 ALHEQ--KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTP--------HY 167

Query: 252 LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 311
           +A EV + R +S KSD++S G  L E+ +           S QDL   VQ  +       
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFA---PPFEARSMQDLRYKVQRGK------- 217

Query: 312 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
                +   ++    ++    I   L    + RP+   +
Sbjct: 218 --YPPIPPIYS----QDLQNFIRSMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 89.5 bits (222), Expect = 2e-20
 Identities = 77/266 (28%), Positives = 121/266 (45%), Gaps = 40/266 (15%)

Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FGEV+ G       VAIK  + G+ + E F+ E   +  +QH  LV L     + 
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQE 73

Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 208
            + ++I EY+ NGS+   L  P  +   KL     + +A   A+G+A +   +   +H+D
Sbjct: 74  PI-YIITEYMENGSLVDFLKTPEGI---KLTINKLIDMAAQIAEGMAFIERKN--YIHRD 127

Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 262
            + AN+LV E    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 128 LRAANILVSETLCCKIADFGLARLI-------EDNEYTAREGAKFPIKWTAPEAINYGTF 180

Query: 263 SEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF 321
           + KSDV+SFG+ L E+V+ GR       P       E++QN            ER +   
Sbjct: 181 TIKSDVWSFGILLTEIVTYGR------IPYPGMTNPEVIQNL-----------ERGYRMP 223

Query: 322 TNEGM-EEFIQLIVRCLDPSSERRPS 346
             +   EE  +L+  C     E RP+
Sbjct: 224 RPDNCPEELYELMRLCWKEKPEERPT 249

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 89.6 bits (222), Expect = 2e-20
 Identities = 69/279 (24%), Positives = 124/279 (44%), Gaps = 50/279 (17%)

Query: 89  NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT---------QEFIDEVCFLASIQHRNLV 139
            ++G+G +G VY GL   G L+A+K+     +         ++  +EV  L S++H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 140 TLLGYCQENNLQFLIYEYIPNGSVS--IHLYGP------SQVSRQKLEFKHRLSIALGAA 191
             LG C ++N   +  E++P GS+S  ++ +GP       + ++Q L+            
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD------------ 113

Query: 192 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ----VTA 247
            G+A+LH+    VVH+D K  NV++  + I K+ D G    L    + G  S     +  
Sbjct: 114 -GVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170

Query: 248 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 307
              ++A EV     +  KSD++S G  + E+ +G+   +S+   ++   +  +   R   
Sbjct: 171 TPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA---MFYIGAHR--- 224

Query: 308 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 346
            L+  L +              I  +  CL      RPS
Sbjct: 225 GLMPRLPDSF--------SAAAIDFVTSCLTRDQHERPS 255

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 88.2 bits (219), Expect = 5e-20
 Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 18/202 (8%)

Query: 88  KNLIGEGKFGEVYKGLLQD----GMLVAIK--KRPGAP--TQEFIDEVCFLASIQHRNLV 139
              IGEG+FG+VY+G+        + VA+K  K   +P   ++F+ E   +    H ++V
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 199
            L+G   EN + +++ E  P G +  +L    QV++  L+    +  +   +  LA+L S
Sbjct: 71  KLIGVITENPV-WIVMELAPLGELRSYL----QVNKYSLDLASLILYSYQLSTALAYLES 125

Query: 200 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKE 258
              R VH+D    NVLV      K+ D GL  +L        S       I ++A E   
Sbjct: 126 K--RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKAS--KGKLPIKWMAPESIN 181

Query: 259 FRRFSEKSDVYSFGVFLLELVS 280
           FRRF+  SDV+ FGV + E++ 
Sbjct: 182 FRRFTSASDVWMFGVCMWEILM 203

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 88.5 bits (219), Expect = 6e-20
 Identities = 67/238 (28%), Positives = 115/238 (48%), Gaps = 26/238 (10%)

Query: 88  KNLIGEGKFGEVYKGL------LQDGMLVAIK--KRPG-APTQEFIDEVCFLASIQHRNL 138
           K  +GEG FG+V+          +D MLVA+K  K P  A  ++F  E   L ++QH ++
Sbjct: 10  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69

Query: 139 VTLLGYCQENNLQFLIYEYIPNGSVSIHL--YGPSQV---------SRQKLEFKHRLSIA 187
           V   G C + +   +++EY+ +G ++  L  +GP  +         ++ +L     L IA
Sbjct: 70  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 188 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 247
              A G+ +L   S   VH+D  T N LV  + + K+ D G+   +  TD          
Sbjct: 130 SQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187

Query: 248 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSR 304
              ++  E   +R+F+ +SDV+SFGV L E+ + G++    LS     +++E +   R
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN---TEVIECITQGR 242

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 88.1 bits (218), Expect = 7e-20
 Identities = 61/196 (31%), Positives = 104/196 (53%), Gaps = 12/196 (6%)

Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FGEV+ G       VA+K  +PG  + E F++E   +  ++H  LV L     E 
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE 73

Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 208
            + +++ EY+  GS+   L        + L+  + + +A   A G+A++  ++   +H+D
Sbjct: 74  PI-YIVTEYMSKGSLLDFL---KDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRD 127

Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 267
            ++AN+LV +  + K+AD GL   +   D    + Q     I + A E   + RF+ KSD
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 268 VYSFGVFLLELVS-GR 282
           V+SFG+ L ELV+ GR
Sbjct: 186 VWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 87.4 bits (216), Expect = 1e-19
 Identities = 68/239 (28%), Positives = 113/239 (47%), Gaps = 23/239 (9%)

Query: 84  NFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAPT---QEFIDEVCFLASIQ 134
           N   K  +GEG FG+V+          QD +LVA+K    A     ++F  E   L ++Q
Sbjct: 6   NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65

Query: 135 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL--YGPSQV------SRQKLEFKHRLSI 186
           H ++V   G C E +   +++EY+ +G ++  L  +GP  V         +L     L I
Sbjct: 66  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125

Query: 187 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 246
           A   A G+ +L   S   VH+D  T N LV E+ + K+ D G+   +  TD         
Sbjct: 126 AQQIAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 183

Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSR 304
               ++  E   +R+F+ +SDV+S GV L E+ + G++    L   S+ +++E +   R
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL---SNNEVIECITQGR 239

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 87.0 bits (215), Expect = 2e-19
 Identities = 75/290 (25%), Positives = 132/290 (45%), Gaps = 50/290 (17%)

Query: 88  KNLIGEGKFGEVYKGLLQ----DGMLVAIKK-RPG---APTQEFIDEVCFLASIQHRNLV 139
           + +IG G+FGEV++G+L+      + VAIK  +PG      Q+F+ E   +    H N++
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHL------YGPSQVSRQKLEFKHRLSIALGAAKG 193
            L G   +     +I EY+ NG++  +L      +   Q+          + +  G A G
Sbjct: 70  RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL----------VGMLRGIAAG 119

Query: 194 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--- 250
           + +L  ++   VH+D    N+LV+ +   KV+D GL   L   D    +   +  +I   
Sbjct: 120 MKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVL--EDDPEGTYTTSGGKIPIR 175

Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN-- 308
           + A E   +R+F+  SDV+SFG+ + E++S  E                 +   D SN  
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGE-----------------RPYWDMSNHE 218

Query: 309 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
           ++K +++        +      QL+++C      RRP   D+V  LD+ L
Sbjct: 219 VMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 87.0 bits (215), Expect = 2e-19
 Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 20/198 (10%)

Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FGEV+ G   +   VA+K  +PG    Q F++E   + ++QH  LV L     + 
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73

Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 208
              ++I EY+  GS+   L         K+     +  +   A+G+A++       +H+D
Sbjct: 74  EPIYIITEYMAKGSLLDFLKSDEG---GKVLLPKLIDFSAQIAEGMAYIER--KNYIHRD 128

Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 262
            + ANVLV E  + K+AD GL   +         ++ TA E       + A E   F  F
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVI-------EDNEYTAREGAKFPIKWTAPEAINFGSF 181

Query: 263 SEKSDVYSFGVFLLELVS 280
           + KSDV+SFG+ L E+V+
Sbjct: 182 TIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 86.8 bits (215), Expect = 2e-19
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 20/210 (9%)

Query: 89  NLIGEGKFGEVYKGLLQDGML-------VAIKK-RPGAPTQE---FIDEVCFLASIQHRN 137
           N +G G FGEVY+G   D +        VA+K  R GA  QE   F+ E   +++  H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK--LEFKHRLSIALGAAKGLA 195
           +V LLG C  N  Q++I E +  G +  +L            L  K  L I L  AKG  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 196 HLHSLSPRVVHKDFKTANVLVDE-----DFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 250
           +L  +    +H+D    N LV E     D + K+ D GL   + ++D      +      
Sbjct: 121 YLEQM--HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178

Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
           ++A E     +F+ +SDV+SFGV + E+++
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 87.0 bits (216), Expect = 2e-19
 Identities = 69/233 (29%), Positives = 109/233 (46%), Gaps = 42/233 (18%)

Query: 84  NFSDKNLIGEGKFGEVY------------KGLLQDGM-----LVAIKK-RPGAPT---QE 122
           NF +K  +GEG+FGEV+            K   ++       LVA+K  RP A     ++
Sbjct: 8   NFVEK--LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65

Query: 123 FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPS 171
           F+ EV  L+ +   N+  LLG C  +    +I EY+ NG ++  L               
Sbjct: 66  FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125

Query: 172 QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 231
            +S   L     L +A   A G+ +L SL+   VH+D  T N LV +++  K+AD G+  
Sbjct: 126 SLSFSTL-----LYMATQIASGMRYLESLN--FVHRDLATRNCLVGKNYTIKIADFGMSR 178

Query: 232 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GRE 283
            L  +D      +      ++A E     +F+ KSDV++FGV L E+++  RE
Sbjct: 179 NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 86.6 bits (214), Expect = 2e-19
 Identities = 65/196 (33%), Positives = 101/196 (51%), Gaps = 12/196 (6%)

Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 73

Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 208
            + +++ EY+  GS+   L G      + L     + +A   A G+A++  ++   VH+D
Sbjct: 74  PI-YIVTEYMSKGSLLDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVERMN--YVHRD 127

Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 267
            + AN+LV E+ + KVAD GL   +   D    + Q     I + A E   + RF+ KSD
Sbjct: 128 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 268 VYSFGVFLLELVS-GR 282
           V+SFG+ L EL + GR
Sbjct: 186 VWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 86.1 bits (214), Expect = 4e-19
 Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 29/207 (14%)

Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 143
           IGEG +G+VYK    + G LVA+KK      + G P    I E+  L  ++H N+V L  
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPIT-AIREIKLLQKLRHPNIVRLKE 65

Query: 144 Y---CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 200
                 + ++ ++++EY+ +    +      + +  ++  K          +GL +LHS 
Sbjct: 66  IVTSKGKGSI-YMVFEYMDHDLTGLLDSPEVKFTESQI--KC---YMKQLLEGLQYLHS- 118

Query: 201 SPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVT----ADEIFLASE 255
              ++H+D K +N+L++ D + K+AD GL R +  R      +  +T      E+ L + 
Sbjct: 119 -NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT 177

Query: 256 VKEFRRFSEKSDVYSFGVFLLELVSGR 282
                R+  + D++S G  L EL  G+
Sbjct: 178 -----RYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 85.8 bits (212), Expect = 6e-19
 Identities = 87/302 (28%), Positives = 131/302 (43%), Gaps = 46/302 (15%)

Query: 77  ELSLATKNFSDKNLIGEGKFGEVYKG-LLQDGM----LVAIK--KRPGAPTQ--EFIDEV 127
           EL L+   F ++  +GE  FG++YKG L   GM    LVAIK  K    P Q  EF  E 
Sbjct: 1   ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58

Query: 128 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVS------------R 175
             +A + H N+V LLG   +     +++EY+  G +   L   S  S            +
Sbjct: 59  SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118

Query: 176 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 235
             L+    L IA+  A G+ +L   S   VHKD    N+L+ E    K++D GL   +  
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLS--SHFFVHKDLAARNILIGEQLHVKISDLGLSREIYS 176

Query: 236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPD---S 292
            D      +      ++  E   + +FS  SD++SFGV L E+      S  L P    S
Sbjct: 177 ADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIF-----SFGLQPYYGFS 231

Query: 293 SQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT 352
           +Q+++E+V+  R      +    R++S            L+  C      RRP   D+ T
Sbjct: 232 NQEVIEMVRK-RQLLPCSEDCPPRMYS------------LMTECWQEGPSRRPRFKDIHT 278

Query: 353 EL 354
            L
Sbjct: 279 RL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 85.5 bits (212), Expect = 7e-19
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 21/209 (10%)

Query: 88  KNLIGEGKFGEVYKGLLQDG-------MLVAIKKRPGAPTQ--EFIDEVCFLASIQHRNL 138
            +L+ EG FG ++ G+L D        + V   K   +  Q    + E C L  + H+N+
Sbjct: 11  SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNI 70

Query: 139 VTLLGYCQEN-NLQFLIYEYIPNGSVSIHL----YGPSQVSRQKLEFKHRLSIALGAAKG 193
           + +L  C E+    F++Y Y+  G++ + L     G +    Q L  +  + +A+  A G
Sbjct: 71  LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNP-QALSTQQLVHMAIQIACG 129

Query: 194 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RN-FLGRTDVAGPSSQVTADEIF 251
           +++LH     V+HKD    N ++DE+   K+ D  L R+ F       G +       + 
Sbjct: 130 MSYLHKR--GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMA 187

Query: 252 LASEVKEFRRFSEKSDVYSFGVFLLELVS 280
           L S V +   +S  SDV+SFGV L EL++
Sbjct: 188 LESLVNKE--YSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 84.9 bits (210), Expect = 8e-19
 Identities = 58/193 (30%), Positives = 95/193 (49%), Gaps = 11/193 (5%)

Query: 91  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FG V  G  +    VAIK  K       EFI+E   +  + H  LV L G C + 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71

Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 208
              +++ EY+ NG +  +L    +   ++ +    L +     +G+A+L   S + +H+D
Sbjct: 72  RPIYIVTEYMSNGCLLNYL----REHGKRFQPSQLLEMCKDVCEGMAYLE--SKQFIHRD 125

Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 267
               N LVD+    KV+D GL  ++   D    SS  +   + +   EV  + +FS KSD
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSD 183

Query: 268 VYSFGVFLLELVS 280
           V++FGV + E+ S
Sbjct: 184 VWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 85.5 bits (211), Expect = 8e-19
 Identities = 84/302 (27%), Positives = 133/302 (44%), Gaps = 46/302 (15%)

Query: 77  ELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIK----KRPGAPTQEFIDE 126
           E++L+T  F ++  +GE +FG+VYKG L      +    VAIK    K  G   +EF  E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 127 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVS-----------R 175
               + +QH N+V LLG   +     +I+ Y  +  +   L   S  S           +
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 176 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 235
             LE    + I    A G+  L   S  VVHKD  T NVLV +    K++D GL   +  
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLS--SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176

Query: 236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---DS 292
            D             +++ E   + +FS  SD++S+GV L E+      S  L P    S
Sbjct: 177 ADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF-----SYGLQPYCGYS 231

Query: 293 SQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT 352
           +QD++E+++N +    +L   D+     +T         L++ C +    RRP   D+ +
Sbjct: 232 NQDVIEMIRNRQ----VLPCPDDCPAWVYT---------LMLECWNEFPSRRPRFKDIHS 278

Query: 353 EL 354
            L
Sbjct: 279 RL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 84.5 bits (209), Expect = 1e-18
 Identities = 72/281 (25%), Positives = 129/281 (45%), Gaps = 34/281 (12%)

Query: 90  LIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLVTL 141
           +IG G+FGEV +G L+      + VAIK      T+    +F+ E   +    H N++ L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 201
            G   ++    +I E++ NG++   L    + +  +      + +  G A G+ +L  ++
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFL----RQNDGQFTVIQLVGMLRGIAAGMKYLSEMN 126

Query: 202 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFL--GRTDVAGPSSQVTADEI-FLASEVKE 258
              VH+D    N+LV+ + + KV+D GL  FL    +D    SS      I + A E   
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184

Query: 259 FRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 317
           +R+F+  SDV+S+G+ + E++S G      +   S+QD++  ++            D RL
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERPYWDM---SNQDVINAIEQ-----------DYRL 230

Query: 318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
                 +      QL++ C       RP    +V+ LD+ +
Sbjct: 231 PPPM--DCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 83.9 bits (207), Expect = 2e-18
 Identities = 76/272 (27%), Positives = 120/272 (44%), Gaps = 32/272 (11%)

Query: 91  IGEGKFGEVYKGLLQ-DGMLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTLLGYC 145
           IG G FGEV+ G L+ D   VA+K  R   P     +F+ E   L    H N+V L+G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 146 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 205
            +    +++ E +  G     L    +    +L+ K  + +   AA G+ +L S     +
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFL----RTEGPRLKVKELIQMVENAAAGMEYLES--KHCI 116

Query: 206 HKDFKTANVLVDEDFIAKVADAGL--RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS 263
           H+D    N LV E  + K++D G+      G     G   Q+     + A E   + R+S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVK--WTAPEALNYGRYS 174

Query: 264 EKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFT 322
            +SDV+SFG+ L E  S G    ++LS   +++ +E  Q  R     L   +        
Sbjct: 175 SESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE--QGVR-----LPCPE-------- 219

Query: 323 NEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
               +   +L+ RC +    +RPS S V  EL
Sbjct: 220 -LCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 84.3 bits (208), Expect = 2e-18
 Identities = 77/300 (25%), Positives = 133/300 (44%), Gaps = 55/300 (18%)

Query: 88  KNLIGEGKFGEVYKGLL-QDG--MLVAIKKRPGAPTQE----FIDEVCFLASI-QHRNLV 139
           +++IGEG FG+V K  + +DG  M  AIK+     +++    F  E+  L  +  H N++
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSIAL 188
            LLG C+     +L  EY P+G++   L           +  +  +   L  +  L  A 
Sbjct: 72  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131

Query: 189 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL--------RNFLGRTDVAG 240
             A+G+ +L     + +H+D    N+LV E+++AK+AD GL        +  +GR  V  
Sbjct: 132 DVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR- 188

Query: 241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV 300
                     ++A E   +  ++  SDV+S+GV L E+V     S   +P       EL 
Sbjct: 189 ----------WMAIESLNYSVYTTNSDVWSYGVLLWEIV-----SLGGTPYCGMTCAELY 233

Query: 301 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 360
           +       L K L+            +E   L+ +C       RPS + ++  L+R L++
Sbjct: 234 EKLPQGYRLEKPLNCD----------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 83.3 bits (206), Expect = 3e-18
 Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 45/220 (20%)

Query: 90  LIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT-------------QEFIDEVCFLASIQH 135
           LIG+G +G VY  L +  G ++A+K+     T             +    E+  L  + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 136 RNLVTLLGYCQENNLQFLIYEYIPNGSVS--IHLYGP------SQVSRQKLEFKHRLSIA 187
            N+V  LG+        +  EY+P GS+   +  YG          + Q LE        
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLE-------- 119

Query: 188 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 247
                GLA+LHS    ++H+D K  N+LVD D I K++D G+     ++D    + Q  +
Sbjct: 120 -----GLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISK---KSDDIYDNDQNMS 169

Query: 248 --DEIF-LASEVKEFRR--FSEKSDVYSFGVFLLELVSGR 282
               +F +A EV       +S K D++S G  +LE+ +GR
Sbjct: 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 83.0 bits (205), Expect = 4e-18
 Identities = 74/270 (27%), Positives = 127/270 (47%), Gaps = 30/270 (11%)

Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FG V+ G  +  + VAIK    GA ++E FI+E   +  + H  LV L G C + 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71

Query: 149 NLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 205
              +++ E++ NG +  +L    G  ++S+  L     LS+     +G+ +L   S   +
Sbjct: 72  KPLYIVTEFMENGCLLNYLRQRQG--KLSKDML-----LSMCQDVCEGMEYLERNS--FI 122

Query: 206 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEK 265
           H+D    N LV    + KV+D G+  ++   D    SS       +   EV  F ++S K
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181

Query: 266 SDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEG 325
           SDV+SFGV + E+ +  E        S+ ++VE++  SR F    ++   +L S    E 
Sbjct: 182 SDVWSFGVLMWEVFT--EGKMPFEKKSNYEVVEMI--SRGF----RLYRPKLASMTVYEV 233

Query: 326 MEEFIQLIVRCLDPSSERRPSMSDVVTELD 355
           M         C     E RP+ ++++  + 
Sbjct: 234 M-------YSCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 83.9 bits (207), Expect = 4e-18
 Identities = 74/297 (24%), Positives = 130/297 (43%), Gaps = 41/297 (13%)

Query: 91  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 137
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 186
           ++ LLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 187 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 246
               A+G+ +L   S + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 143 TYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGR 200

Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 306
               ++A E    R ++ +SDV+SFGV + E+      +   SP     + E        
Sbjct: 201 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF-----TLGGSPYPGIPVEE-------- 247

Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 363
             L K+L E            E   ++  C       RP+   +V +LDR L    N
Sbjct: 248 --LFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 86.1 bits (213), Expect = 4e-18
 Identities = 77/307 (25%), Positives = 131/307 (42%), Gaps = 32/307 (10%)

Query: 68  REARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDG----MLVAIKKRPGAPTQEF 123
           + ++   + ++  + K   ++N+I  GK G  YKG         ++  I      P+ E 
Sbjct: 678 KVSKSITINDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEI 734

Query: 124 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR 183
            D    +  +QH N+V L+G C+     +LI+EYI   ++S  L   S   R+K      
Sbjct: 735 AD----MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRK------ 784

Query: 184 LSIALGAAKGLAHLH-SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS 242
             IA+G AK L  LH   SP VV  +     +++D      +    L   L        S
Sbjct: 785 --IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFIS 841

Query: 243 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 302
           S       ++A E +E +  +EKSD+Y FG+ L+EL++G+ + +         +VE  + 
Sbjct: 842 SA------YVAPETRETKDITEKSDIYGFGLILIELLTGK-SPADAEFGVHGSIVEWARY 894

Query: 303 SRDFSNLLKILDERLW---STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 359
                +L   +D  +    S   NE + E + L + C       RP  +DV+  L+    
Sbjct: 895 CYSDCHLDMWIDPSIRGDVSVNQNE-IVEVMNLALHCTATDPTARPCANDVLKTLESASR 953

Query: 360 KEMNLTT 366
              +  T
Sbjct: 954 SSSSCVT 960

Length = 968

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 83.3 bits (206), Expect = 5e-18
 Identities = 75/280 (26%), Positives = 124/280 (44%), Gaps = 38/280 (13%)

Query: 83  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKR--PGAPTQE----FIDEVCFLASIQH 135
           K F+D   IG G FG VY    ++   +VAIKK    G  + E     I EV FL  ++H
Sbjct: 15  KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74

Query: 136 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 195
            N +   G     +  +L+ EY   GS S  L    +V ++ L+     +I  GA +GLA
Sbjct: 75  PNTIEYKGCYLREHTAWLVMEYCL-GSASDIL----EVHKKPLQEVEIAAICHGALQGLA 129

Query: 196 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 255
           +LHS     +H+D K  N+L+ E    K+AD       G   +  P++       ++A E
Sbjct: 130 YLHSHE--RIHRDIKAGNILLTEPGTVKLAD------FGSASLVSPANSFVGTPYWMAPE 181

Query: 256 V---KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 312
           V    +  ++  K DV+S G+  +EL   +    +++  S+  L  + QN          
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQNDSP------- 232

Query: 313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT 352
                 +  +N+  + F   +  CL    + RPS  +++ 
Sbjct: 233 ------TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 82.4 bits (203), Expect = 6e-18
 Identities = 61/196 (31%), Positives = 102/196 (52%), Gaps = 12/196 (6%)

Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G+G FGEV+ G       VAIK  +PG    E F+ E   +  ++H  LV L     E 
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE 73

Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 208
            + +++ E++  GS+   L    +   + L+    + +A   A G+A++  ++   +H+D
Sbjct: 74  PI-YIVTEFMGKGSLLDFL---KEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRD 127

Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 267
            + AN+LV ++ + K+AD GL   +   D    + Q     I + A E   + RF+ KSD
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 268 VYSFGVFLLELVS-GR 282
           V+SFG+ L ELV+ GR
Sbjct: 186 VWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 82.7 bits (204), Expect = 6e-18
 Identities = 77/308 (25%), Positives = 126/308 (40%), Gaps = 64/308 (20%)

Query: 91  IGEGKFGEVYKGL------LQDGMLVAIKK-RPGAPTQEFID---EVCFLASIQHRNLVT 140
           +GEG+FG+V K              VA+K  +  A + E  D   E   L  + H +++ 
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHL-----YGPSQVSR--------------QKLEFK 181
           L G C ++    LI EY   GS+   L      GPS +                + L   
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 182 HRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP 241
             +S A   ++G+ +L  +   +VH+D    NVLV E    K++D GL   +   D    
Sbjct: 128 DLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVK 185

Query: 242 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELV 300
            S+      ++A E      ++ +SDV+SFGV L E+V+ G      ++P          
Sbjct: 186 RSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP---------- 235

Query: 301 QNSRDFSNLLKILDERLWSTF-TNEGM-------EEFIQLIVRCLDPSSERRPSMSDVVT 352
                         ERL++   T   M       EE   L++ C     ++RP+ +D+  
Sbjct: 236 --------------ERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281

Query: 353 ELDRTLDK 360
           EL++ + K
Sbjct: 282 ELEKMMVK 289

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 82.2 bits (203), Expect = 7e-18
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 32/214 (14%)

Query: 90  LIGEGKFGEVYKGL-LQDGMLVAIK------------KRPGAPTQEFIDEVCFLASIQHR 136
           LIG G FG VY G+    G L+A+K             R  +       E+  L  +QH 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 137 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHL--YGPSQVSRQKLEFKHRLSIALGAAKGL 194
           N+V  LG   + +   +  EY+P GSV+  L  YG  + +  +   +  L       KGL
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL-------KGL 119

Query: 195 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL------GRTDVAGPSSQVTAD 248
            +LH  +  ++H+D K AN+LVD     K++D G+   L       +T+ A PS Q +  
Sbjct: 120 NYLH--NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV- 176

Query: 249 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
             ++A EV +   ++ K+D++S G  ++E+++G+
Sbjct: 177 -FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 82.0 bits (203), Expect = 8e-18
 Identities = 77/268 (28%), Positives = 118/268 (44%), Gaps = 37/268 (13%)

Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLLGYCQ 146
           IG G +G+VYK   +  G LVAIK     P  +F     E+  L   +H N+V   G   
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 147 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL---GAAKGLAHLHSLSPR 203
             +  +++ EY   GS+   +Y   QV+R  L     L IA       KGLA+LH     
Sbjct: 71  RRDKLWIVMEYCGGGSLQ-DIY---QVTRGPLS---ELQIAYVCRETLKGLAYLHET--G 121

Query: 204 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV-----TADEIFLASEVKE 258
            +H+D K AN+L+ ED   K+AD G+   L  T +A   S +      A E+   + V+ 
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLTAT-IAKRKSFIGTPYWMAPEV---AAVER 177

Query: 259 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 318
              +  K D+++ G+  +EL   +     L P     +  L   S+      K+ D+  W
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPPMFDLHP-----MRALFLISKSNFPPPKLKDKEKW 232

Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPS 346
           S         F   I +CL    ++RP+
Sbjct: 233 SP-------VFHDFIKKCLTKDPKKRPT 253

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 81.9 bits (203), Expect = 9e-18
 Identities = 69/270 (25%), Positives = 116/270 (42%), Gaps = 31/270 (11%)

Query: 91  IGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEF----IDEVCFLASIQHRNLVTLLG-Y 144
           +G+G  G VYK   +  G + A+KK      +EF    + E+  L S +   +V   G +
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68

Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 204
            +E  +  ++ EY+  GS++  L    ++    L +     IA    KGL +LH+    +
Sbjct: 69  YKEGEI-SIVLEYMDGGSLADLLKKVGKIPEPVLAY-----IARQILKGLDYLHTKR-HI 121

Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSE 264
           +H+D K +N+L++     K+AD G+   L  T     +   T    +++ E  +   +S 
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTV--TYMSPERIQGESYSY 179

Query: 265 KSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNE 324
            +D++S G+ LLE   G+       P       EL+Q   D       L    +S     
Sbjct: 180 AADIWSLGLTLLECALGK---FPFLPPGQPSFFELMQAICDGPPPS--LPAEEFS----- 229

Query: 325 GMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
              EF   I  CL    ++RPS      EL
Sbjct: 230 --PEFRDFISACLQKDPKKRPS----AAEL 253

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 82.4 bits (203), Expect = 1e-17
 Identities = 80/296 (27%), Positives = 132/296 (44%), Gaps = 40/296 (13%)

Query: 83  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 135
           K FSD   IG G FG VY    +++  +VAIKK      +     Q+ I EV FL  ++H
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 136 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 195
            N +   G     +  +L+ EY   GS S  L    +V ++ L+     ++  GA +GLA
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCL-GSASDLL----EVHKKPLQEVEIAAVTHGALQGLA 129

Query: 196 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 255
           +LHS +  ++H+D K  N+L+ E  + K+ D       G   +  P++       ++A E
Sbjct: 130 YLHSHN--MIHRDVKAGNILLSEPGLVKLGD------FGSASIMAPANXFVGTPYWMAPE 181

Query: 256 V---KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 312
           V    +  ++  K DV+S G+  +EL          + ++   L  + QN          
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIAQNES------PA 233

Query: 313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVM 368
           L    WS       E F   +  CL    + RP+ S+V+ +  R + +E   T +M
Sbjct: 234 LQSGHWS-------EYFRNFVDSCLQKIPQDRPT-SEVLLK-HRFVLRERPPTVIM 280

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 82.3 bits (203), Expect = 2e-17
 Identities = 79/312 (25%), Positives = 138/312 (44%), Gaps = 45/312 (14%)

Query: 91  IGEGKFGEVYK----GLLQD----GMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 137
           +GEG FG+V +    G+ +      + VA+K      T     + I E+  +  I +H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLY-----GP------SQVSRQKLEFKHRLSI 186
           ++ LLG C +    ++I EY   G++   L      GP      ++V  ++L FK  +S 
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 187 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 246
           A   A+G+ +L S   R +H+D    NVLV ED + K+AD GL   +   D    +S   
Sbjct: 140 AYQVARGMEYLES--RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGR 197

Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 306
               ++A E    R ++ +SDV+SFG+ + E+ +   +     P                
Sbjct: 198 LPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP---------------V 242

Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL----DKEM 362
             L K+L E       +    E   L+  C      +RP+   +V  LD+ L    ++ +
Sbjct: 243 EELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYL 302

Query: 363 NLTTVMGEGTPT 374
           +L+    + +P+
Sbjct: 303 DLSMPFEQYSPS 314

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 29/206 (14%)

Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLG 143
           IGEG  G V+K    + G  VA+KK        G P Q  + E+  L + QH  +V LL 
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQ-ALREIKALQACQHPYVVKLLD 66

Query: 144 YCQENNLQFLIYEYIPNG--SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 201
                +   L+ EY+P+    V      P   ++ K   +  L       KG+A++H+  
Sbjct: 67  VFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLL-------KGVAYMHAN- 118

Query: 202 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT-----ADEIFLASEV 256
             ++H+D K AN+L+  D + K+AD GL       +    S QV      A E+   +  
Sbjct: 119 -GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA-- 175

Query: 257 KEFRRFSEKSDVYSFGVFLLELVSGR 282
              R++    D+++ G    EL++G 
Sbjct: 176 ---RKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 80.9 bits (200), Expect = 2e-17
 Identities = 74/286 (25%), Positives = 123/286 (43%), Gaps = 45/286 (15%)

Query: 82  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQ 134
             NF  +  IG+G+F  VYK + L DG +VA+KK            Q+ + E+  L  + 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 135 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 194
           H N++  L    ENN   ++ E    G +S  +    +  ++ +  +      +     L
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLS-RMIKHFKKQKRLIPERTIWKYFVQLCSAL 119

Query: 195 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA------D 248
            H+HS   R++H+D K ANV +    + K+ D GL  F         SS+ TA       
Sbjct: 120 EHMHS--KRIMHRDIKPANVFITATGVVKLGDLGLGRFF--------SSKTTAAHSLVGT 169

Query: 249 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP--DSSQDLVELVQN--SR 304
             +++ E      ++ KSD++S G  L E+ + +      SP      +L  L +     
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ------SPFYGDKMNLYSLCKKIEKC 223

Query: 305 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
           D+  L        +S       EE   L+ RC++P  E+RP +S V
Sbjct: 224 DYPPLPA----DHYS-------EELRDLVSRCINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 81.6 bits (201), Expect = 3e-17
 Identities = 75/317 (23%), Positives = 138/317 (43%), Gaps = 54/317 (17%)

Query: 91  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPT----------------QEFIDEVCFLASI- 133
           +GEG FG+V   ++ + + +  K +P  P                  + + E+  +  I 
Sbjct: 20  LGEGCFGQV---VMAEAIGID-KDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG 75

Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKH 182
           +H+N++ LLG C ++   +++ EY   G++  +L           +   ++  ++L FK 
Sbjct: 76  KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135

Query: 183 RLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS 242
            +S A   A+G+ +L   S + +H+D    NVLV ED + K+AD GL   +   D    +
Sbjct: 136 LVSCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193

Query: 243 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 302
           +       ++A E    R ++ +SDV+SFGV L E+      +   SP     + E    
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF-----TLGGSPYPGIPVEE---- 244

Query: 303 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL---- 358
                 L K+L E            E   ++  C      +RP+   +V +LDR L    
Sbjct: 245 ------LFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298

Query: 359 -DKEMNLTTVMGEGTPT 374
            D+ ++L+    + +P 
Sbjct: 299 TDEYLDLSVPFEQYSPG 315

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 80.6 bits (199), Expect = 3e-17
 Identities = 72/279 (25%), Positives = 130/279 (46%), Gaps = 37/279 (13%)

Query: 87  DKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQE---FIDEVCFLASIQHRNLVTLL 142
           ++ ++G+G +G VY    L   + +AIK+ P   ++      +E+   + ++HRN+V  L
Sbjct: 12  ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71

Query: 143 GYCQENNLQFLIY-EYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 198
           G   EN   F I+ E +P GS+S  L   +GP + + Q + F  +  +     +GL +LH
Sbjct: 72  GSDSENGF-FKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-----EGLKYLH 125

Query: 199 SLSPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV- 256
               ++VH+D K  NVLV+    + K++D G    L   +    +   T    ++A EV 
Sbjct: 126 DN--QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC--TETFTGTLQYMAPEVI 181

Query: 257 -KEFRRFSEKSDVYSFGVFLLELVSGREASSSL-SPDSSQDLVELVQNSRDFSNLLKILD 314
            K  R +   +D++S G  ++E+ +G+     L  P ++   V           + KI  
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV----------GMFKIHP 231

Query: 315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 353
           E            E    I+RC +P  ++R S  D++ +
Sbjct: 232 E-----IPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 80.9 bits (199), Expect = 4e-17
 Identities = 66/206 (32%), Positives = 105/206 (50%), Gaps = 28/206 (13%)

Query: 90  LIGEGKFGEVYKGL-LQDG----MLVAIK--KRPGAPTQ--EFIDEVCFLASIQHRNLVT 140
           ++G G FG VYKG+ + +G    + VAIK       P    EF+DE   +AS+ H +LV 
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLY-GPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 199
           LLG C    +Q L+ + +P+G +  +++     +  Q L     L+  +  AKG+ +L  
Sbjct: 74  LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLL-----LNWCVQIAKGMMYLE- 126

Query: 200 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE-----IFLAS 254
              R+VH+D    NVLV      K+ D GL   L      G   +  AD       ++A 
Sbjct: 127 -ERRLVHRDLAARNVLVKSPNHVKITDFGLARLL-----EGDEKEYNADGGKMPIKWMAL 180

Query: 255 EVKEFRRFSEKSDVYSFGVFLLELVS 280
           E   +R+F+ +SDV+S+GV + EL++
Sbjct: 181 ECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 80.4 bits (198), Expect = 4e-17
 Identities = 77/280 (27%), Positives = 136/280 (48%), Gaps = 39/280 (13%)

Query: 90  LIGEGKFGEVYKGL-LQDG----MLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLV 139
           ++G G FG VYKG+ + DG    + VAIK       P A  +E +DE   +A +    + 
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKA-NKEILDEAYVMAGVGSPYVC 72

Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 199
            LLG C  + +Q L+ + +P G +  ++    + ++ ++  +  L+  +  AKG+++L  
Sbjct: 73  RLLGICLTSTVQ-LVTQLMPYGCLLDYV----RENKDRIGSQDLLNWCVQIAKGMSYLEE 127

Query: 200 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG--RTDVAGPSSQVTADEIFLASEVK 257
           +  R+VH+D    NVLV      K+ D GL   L    T+      +V    + L S + 
Sbjct: 128 V--RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH 185

Query: 258 EFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 316
             RRF+ +SDV+S+GV + EL++ G +    +              +R+  +LL+   ER
Sbjct: 186 --RRFTHQSDVWSYGVTVWELMTFGAKPYDGIP-------------AREIPDLLE-KGER 229

Query: 317 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 356
           L        ++ ++ ++V+C    SE RP   ++V E  R
Sbjct: 230 L-PQPPICTIDVYM-IMVKCWMIDSECRPRFRELVDEFSR 267

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 80.4 bits (198), Expect = 5e-17
 Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 40/220 (18%)

Query: 88  KNLIGEGKFGEVYKGLLQ-DG--MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRNLV 139
           +++IGEG FG+V + +++ DG  M  AIK      ++    +F  E+  L  +  H N++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSIAL 188
            LLG C+     ++  EY P G++   L           +     +   L  +  L  A 
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 189 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL--------RNFLGRTDVAG 240
             A G+ +L     + +H+D    NVLV E+  +K+AD GL        +  +GR  V  
Sbjct: 127 DVATGMQYLSE--KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVR- 183

Query: 241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
                     ++A E   +  ++ KSDV+SFGV L E+VS
Sbjct: 184 ----------WMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 79.8 bits (197), Expect = 5e-17
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 36/211 (17%)

Query: 90  LIGEGKFGEVYKGL-LQDGMLVAIKKRP----GAPTQEFI----DEVCFLASIQHRNLVT 140
           L+G G FG VY+GL L DG   A+K+      G   QE +     E+  L+ +QH N+V 
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHL--YGP------SQVSRQKLEFKHRLSIALGAAK 192
            LG  +E +  ++  E +P GS++  L  YG          +RQ L              
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL-------------L 113

Query: 193 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL 252
           GL +LH      VH+D K AN+LVD + + K+AD G+   +     A           ++
Sbjct: 114 GLEYLHD--RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA---KSFKGSPYWM 168

Query: 253 ASEV-KEFRRFSEKSDVYSFGVFLLELVSGR 282
           A EV  +   +   +D++S G  +LE+ +G+
Sbjct: 169 APEVIAQQGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 79.5 bits (197), Expect = 7e-17
 Identities = 75/299 (25%), Positives = 119/299 (39%), Gaps = 58/299 (19%)

Query: 85  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQEF----IDEVCFLASIQHRNL 138
           +     +GEG +G VYK    + G +VA+KK R     +      + E+  L  ++H N+
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60

Query: 139 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 198
           V LL         +L++EY         L          L      SI     +GLA+ H
Sbjct: 61  VKLLDVIHTERKLYLVFEYCDM-----DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115

Query: 199 SLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFL--GRT---DVAGPSSQVT----AD 248
           S   R++H+D K  N+L++ D + K+AD GL R F    RT   +V      VT    A 
Sbjct: 116 S--HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV------VTLWYRAP 167

Query: 249 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE---ASSSLS-----------PDSSQ 294
           EI L S     + +S   D++S G    E+++G+      S +            P    
Sbjct: 168 EILLGS-----KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEES 222

Query: 295 --DLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCL--DPSSERRPSMSD 349
              + +L      F        E++      EG    I L+ + L  +P   +R S  +
Sbjct: 223 WPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEG----IDLLSKMLQYNP--AKRISAKE 275

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 79.2 bits (195), Expect = 8e-17
 Identities = 72/276 (26%), Positives = 116/276 (42%), Gaps = 31/276 (11%)

Query: 91  IGEGKFGEVYKGLLQDGMLVA---IKK-RPGAPTQE---FIDEVCFLASIQHRNLVTLLG 143
           IG G FG+V  G    GM  A   +K+ R  A   E   F+ EV     + H N++  LG
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 144 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 203
            C E+    L+ E+ P G +  +L     +  Q  +      +A   A GL  LH     
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-- 120

Query: 204 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR--- 260
            +H D    N  +  D   K+ D GL       D             +LA E+ E R   
Sbjct: 121 FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQD 180

Query: 261 ----RFSEKSDVYSFGVFLLELVSGREASSSLSPD-SSQDLVELVQNSRDFSNLLKILDE 315
                 ++KS+++S GV + EL     A+    PD S + +++ V   +D    +K+   
Sbjct: 181 LLPKDQTKKSNIWSLGVTMWELF---TAADQPYPDLSDEQVLKQVVREQD----IKLPKP 233

Query: 316 RLWSTFTNEGMEEFIQLIVRC-LDPSSERRPSMSDV 350
           +L   ++    + + +++  C LDP  E RP+  +V
Sbjct: 234 QLDLKYS----DRWYEVMQFCWLDP--ETRPTAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 69/267 (25%), Positives = 111/267 (41%), Gaps = 25/267 (9%)

Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 145
           IG G    VY  + L +   VAIK+    +      E   EV  ++   H N+V      
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 146 QENNLQFLIYEYIPNGSV-SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 204
              +  +L+  Y+  GS+  I         R  L+     ++     KGL +LHS     
Sbjct: 69  VVGDELWLVMPYLSGGSLLDIMKSS---YPRGGLDEAIIATVLKEVLKGLEYLHS--NGQ 123

Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFL--GRTDVAGPSSQVTADEIFLASEVKEFRR- 261
           +H+D K  N+L+ ED   K+AD G+   L  G                ++A EV E    
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183

Query: 262 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF 321
           +  K+D++SFG+  +EL +G    S   P   + L+  +QN  D  +L    D + +S  
Sbjct: 184 YDFKADIWSFGITAIELATGAAPYSKYPP--MKVLMLTLQN--DPPSLETGADYKKYS-- 237

Query: 322 TNEGMEEFIQLIVRCLDPSSERRPSMS 348
                + F ++I  CL     +RP+  
Sbjct: 238 -----KSFRKMISLCLQKDPSKRPTAE 259

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 78.4 bits (193), Expect = 2e-16
 Identities = 70/281 (24%), Positives = 124/281 (44%), Gaps = 40/281 (14%)

Query: 90  LIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLVTL 141
           +IG G+FGEV  G L+      + VAIK      T+    +F+ E   +    H N++ L
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFK--HRLSIALGAAKGLAHLHS 199
            G   ++    ++ EY+ NGS+   L       +   +F     + +  G A G+ +L  
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFL------RKHDGQFTVIQLVGMLRGIASGMKYLSD 124

Query: 200 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---FLASEV 256
           +    VH+D    N+LV+ + + KV+D GL   L   D    +      +I   + A E 
Sbjct: 125 MG--YVHRDLAARNILVNSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKIPIRWTAPEA 180

Query: 257 KEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 315
             +R+F+  SDV+S+G+ + E++S G      +   S+QD+++ ++              
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM---SNQDVIKAIEEGY----------- 226

Query: 316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 356
           RL +           QL++ C       RP    +V+ LD+
Sbjct: 227 RLPAPMDCPAA--LHQLMLDCWQKDRNERPKFEQIVSILDK 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 77.9 bits (192), Expect = 2e-16
 Identities = 75/280 (26%), Positives = 127/280 (45%), Gaps = 36/280 (12%)

Query: 89  NLIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVT 140
            +IG+G FG VY G L D     +  A+K           ++F+ E   +    H N+++
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 141 LLGYCQENN-LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 199
           LLG C  +     ++  Y+ +G +   +   +         K  +   L  AKG+ +L  
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETH----NPTVKDLIGFGLQVAKGMEYL-- 114

Query: 200 LSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRT-DVAGPSSQVTADEIFLASEVK 257
            S + VH+D    N ++DE F  KVAD GL R+   +        +       ++A E  
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174

Query: 258 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER- 316
           + ++F+ KSDV+SFGV L EL++ R A     PD          +S D +  L  L  R 
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMT-RGAPP--YPDV---------DSFDITVYL--LQGRR 220

Query: 317 -LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 355
            L   +  + + E   +++ C  P  E RP+ S++V+ ++
Sbjct: 221 LLQPEYCPDPLYE---VMLSCWHPKPEMRPTFSELVSRIE 257

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 77.4 bits (191), Expect = 3e-16
 Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 27/204 (13%)

Query: 91  IGEGKFGEVYKGLLQ--DG--MLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLVTLL 142
           +G G FG V KG+     G  + VA+K    +   A  +EF+ E   +A + H  +V L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 143 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 202
           G C+   L  L+ E  P G +  +L    ++    L       +A   A G+A+L S   
Sbjct: 63  GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDL-----KELAHQVAMGMAYLES--K 114

Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI------FLASEV 256
             VH+D    NVL+     AK++D G+   LG    AG S    A         + A E 
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALG----AG-SDYYRATTAGRWPLKWYAPEC 169

Query: 257 KEFRRFSEKSDVYSFGVFLLELVS 280
             + +FS KSDV+S+GV L E  S
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 78.2 bits (192), Expect = 3e-16
 Identities = 77/282 (27%), Positives = 127/282 (45%), Gaps = 38/282 (13%)

Query: 83  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 135
           K F+D   IG G FG VY    ++   +VAIKK      +     Q+ I EV FL  I+H
Sbjct: 25  KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84

Query: 136 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 195
            N +   G     +  +L+ EY   GS S  L    +V ++ L+     +I  GA +GLA
Sbjct: 85  PNSIEYKGCYLREHTAWLVMEYCL-GSASDLL----EVHKKPLQEVEIAAITHGALQGLA 139

Query: 196 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 255
           +LHS +  ++H+D K  N+L+ E    K+AD       G   +A P++       ++A E
Sbjct: 140 YLHSHN--MIHRDIKAGNILLTEPGQVKLAD------FGSASIASPANSFVGTPYWMAPE 191

Query: 256 V---KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 312
           V    +  ++  K DV+S G+  +EL   +    +++  S+  L  + QN          
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQNES------PT 243

Query: 313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
           L    WS +       F   +  CL    + RP+  +++  +
Sbjct: 244 LQSNEWSDY-------FRNFVDSCLQKIPQDRPTSEELLKHM 278

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 80/303 (26%), Positives = 136/303 (44%), Gaps = 71/303 (23%)

Query: 88  KNLIGEGKFGEVY----KGLL---------QDG--MLVAIKK-RPGAPT---QEFIDEVC 128
           K  +GEG+FGEV+    +GL           DG  +LVA+K  R         +F+ E+ 
Sbjct: 10  KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK 69

Query: 129 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG-------------PSQVSR 175
            ++ +++ N++ LLG C  ++   +I EY+ NG ++  L               PS VS 
Sbjct: 70  IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPS-VSI 128

Query: 176 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 235
             L     L +A+  A G+ +L SL+   VH+D  T N LV   +  K+AD G+   L  
Sbjct: 129 ANL-----LYMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHYTIKIADFGMSRNLYS 181

Query: 236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQ 294
            D      +      ++A E     +F+  SDV++FGV L E+ +  +E   SL  D   
Sbjct: 182 GDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-- 239

Query: 295 DLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFI-----------QLIVRCLDPSSER 343
              ++++N+ +F              F N+G + ++           +L++RC     + 
Sbjct: 240 ---QVIENTGEF--------------FRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKD 282

Query: 344 RPS 346
           RP+
Sbjct: 283 RPT 285

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 77.7 bits (191), Expect = 4e-16
 Identities = 77/276 (27%), Positives = 130/276 (47%), Gaps = 25/276 (9%)

Query: 91  IGEGKFGEVY------KGLLQDGMLVAIKK-RPGAPTQEFID---EVCFLASIQHRNLVT 140
           +GEG FG+V       +G    G  VA+K  +P +      D   E+  L ++ H N+V 
Sbjct: 12  LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70

Query: 141 LLGYCQEN--NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 198
             G C E+  N   LI E++P+GS+  +L  P   +  K+  K +L  A+   KG+ +L 
Sbjct: 71  YKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKN--KINLKQQLKYAVQICKGMDYLG 126

Query: 199 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE--IFLASEV 256
           S   + VH+D    NVLV+ +   K+ D GL   +  TD    + +   D    + A E 
Sbjct: 127 S--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYTVKDDLDSPVFWYAPEC 183

Query: 257 KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS-QDLVELVQNSRDFSNLLKILDE 315
               +F   SDV+SFGV L EL++  ++ S  SP +    ++         + L+++L+E
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLTYCDSES--SPMTLFLKMIGPTHGQMTVTRLVRVLEE 241

Query: 316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                      EE  QL+ +C +    +R +  +++
Sbjct: 242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLI 277

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 77.0 bits (189), Expect = 5e-16
 Identities = 62/219 (28%), Positives = 105/219 (47%), Gaps = 40/219 (18%)

Query: 89  NLIGEGKFGEVYKGLLQ-DG--MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRNLVT 140
           ++IGEG FG+V K  ++ DG  M  AIK+     ++    +F  E+  L  +  H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSIALG 189
           LLG C+     +L  EY P+G++   L           +  +  +   L  +  L  A  
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 190 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL--------RNFLGRTDVAGP 241
            A+G+ +L     + +H+D    N+LV E+++AK+AD GL        +  +GR  V   
Sbjct: 121 VARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR-- 176

Query: 242 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
                    ++A E   +  ++  SDV+S+GV L E+VS
Sbjct: 177 ---------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 76.7 bits (189), Expect = 6e-16
 Identities = 72/298 (24%), Positives = 122/298 (40%), Gaps = 46/298 (15%)

Query: 79  SLATKNFSDKNLIGEGKFGEVYKGLL--QDG----MLVAIKKRPGAPTQE----FIDEVC 128
            +   + +    +G G FGEVY+GL   +DG    + VA+K  P + +++    F+ E  
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61

Query: 129 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG--PSQVSRQKLEFKHRLSI 186
            ++   H+N+V L+G   E   +F++ E +  G +   L    P       L  K  L  
Sbjct: 62  IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121

Query: 187 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTDV----- 238
           A   AKG  +L       +H+D    N L+       +AK+AD G+   + R        
Sbjct: 122 ARDVAKGCKYLEEN--HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG 179

Query: 239 -AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDL 296
            A    +    E FL         F+ K+DV+SFGV L E+ S G          ++Q++
Sbjct: 180 RAMLPIKWMPPEAFLDG------IFTSKTDVWSFGVLLWEIFSLGYMPYPGR---TNQEV 230

Query: 297 VELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
           +E V               RL       G     +++  C   + E RP+ + ++  +
Sbjct: 231 MEFV-----------TGGGRLDPPKGCPG--PVYRIMTDCWQHTPEDRPNFATILERI 275

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 77.4 bits (190), Expect = 7e-16
 Identities = 75/277 (27%), Positives = 127/277 (45%), Gaps = 38/277 (13%)

Query: 85  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP--GAPT----QEFIDEVCFLASIQHRN 137
           F   + IG G FG VY         +VA+KK    G  T    Q+ I EV FL  ++H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 197
            +   G   + +  +L+ EY   GS S  L    +V ++ L+     +I  GA +GLA+L
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYCL-GSASDLL----EVHKKPLQEVEIAAITHGALQGLAYL 137

Query: 198 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV- 256
           HS +  ++H+D K  N+L+ E    K+AD       G    + P++       ++A EV 
Sbjct: 138 HSHN--MIHRDIKAGNILLTEPGQVKLAD------FGSASKSSPANSFVGTPYWMAPEVI 189

Query: 257 --KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 314
              +  ++  K DV+S G+  +EL   +    +++  S+  L  + QN    S  L+   
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQND---SPTLQ--- 241

Query: 315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                  +NE  + F   +  CL    + RP+ ++++
Sbjct: 242 -------SNEWTDSFRGFVDYCLQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 76.9 bits (189), Expect = 8e-16
 Identities = 78/316 (24%), Positives = 135/316 (42%), Gaps = 80/316 (25%)

Query: 88  KNLIGEGKFGEVY--------------------KGLLQDGMLVAIK-KRPGAPTQ---EF 123
           K  +GEG+FGEV+                    KG     +LVA+K  RP A      +F
Sbjct: 10  KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKG---RPLLVAVKILRPDANKNARNDF 66

Query: 124 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLY--------GPSQVSR 175
           + EV  L+ ++  N++ LLG C + +   +I EY+ NG ++  L              + 
Sbjct: 67  LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126

Query: 176 QK------LEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 229
                   + +   L +AL  A G+ +L SL+   VH+D  T N LV E+   K+AD G 
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENLTIKIADFG- 183

Query: 230 RNFLGRTDVAGPSSQVTADEI----FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAS 285
              + R   AG   ++    +    ++A E     +F+  SDV++FGV L E++   +  
Sbjct: 184 ---MSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE- 239

Query: 286 SSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFI-----------QLIV 334
               P       ++++N+ +F              F ++G + ++           +L++
Sbjct: 240 ---QPYGELTDEQVIENAGEF--------------FRDQGRQVYLFRPPPCPQGLYELML 282

Query: 335 RCLDPSSERRPSMSDV 350
           +C       RPS SD+
Sbjct: 283 QCWSRDCRERPSFSDI 298

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 77.0 bits (189), Expect = 8e-16
 Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 16/210 (7%)

Query: 80  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIK--KRPGAP--TQEFIDEVCFL 130
           L    F    ++G G FG VYKGL + +G    + VAIK  +   +P   +E +DE   +
Sbjct: 4   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 63

Query: 131 ASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 190
           AS+ + ++  LLG C  + +Q LI + +P G +  ++    +  +  +  ++ L+  +  
Sbjct: 64  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQI 118

Query: 191 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 250
           AKG+ +L     R+VH+D    NVLV      K+ D GL   LG  +    +        
Sbjct: 119 AKGMNYLE--ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK 176

Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
           ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 76.6 bits (189), Expect = 9e-16
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 26/204 (12%)

Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQEF----IDEVCFLASIQHRNLVTLLGY 144
           IGEG +G VYK      G +VAIKK +    ++      + E+  L  + H N++ LL  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 204
            +     +L++E++        LY   +  ++ L      S      +GLA  HS    +
Sbjct: 67  FRHKGDLYLVFEFM-----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS--HGI 119

Query: 205 VHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVT-----ADEIFLASEVKE 258
           +H+D K  N+L++ + + K+AD GL R+F   + V   +  V      A E+ L      
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSF--GSPVRPYTHYVVTRWYRAPELLLGD---- 173

Query: 259 FRRFSEKSDVYSFGVFLLELVSGR 282
            + +S   D++S G    EL+S R
Sbjct: 174 -KGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 70/278 (25%), Positives = 123/278 (44%), Gaps = 33/278 (11%)

Query: 84  NFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHR 136
           NF  +  IG G+F EVY+   L DG+ VA+KK             + I E+  L  + H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 137 NLVTLLGYCQENNLQFLIYEYIPNGSVS---IHLYGPSQVSRQKLEFKHRLSIALGAAKG 193
           N++       E+N   ++ E    G +S    H     ++  +K  +K+ + +       
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SA 118

Query: 194 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 253
           L H+HS   RV+H+D K ANV +    + K+ D GL  F      A  S  +     +++
Sbjct: 119 LEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMS 174

Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 313
            E      ++ KSD++S G  L E+ + +      SP           +  +  +L K +
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQ------SP--------FYGDKMNLYSLCKKI 220

Query: 314 DERLWSTF-TNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
           ++  +    ++   EE  QL+  C++P  E+RP ++ V
Sbjct: 221 EQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 75.8 bits (186), Expect = 1e-15
 Identities = 66/260 (25%), Positives = 119/260 (45%), Gaps = 28/260 (10%)

Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FGEV+         VA+K  +PG+ + E F+ E   + ++QH  LV L     + 
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 73

Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 208
            + ++I E++  GS+ +      + S+Q L     +  +   A+G+A +   +   +H+D
Sbjct: 74  PI-YIITEFMAKGSL-LDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN--YIHRD 127

Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTD-VAGPSSQVTADEIFLASEVKEFRRFSEKSD 267
            + AN+LV    + K+AD GL   +   +  A   ++      + A E   F  F+ KSD
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK--WTAPEAINFGSFTIKSD 185

Query: 268 VYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGM 326
           V+SFG+ L+E+V+ GR     +S                   +++ L+            
Sbjct: 186 VWSFGILLMEIVTYGRIPYPGMSN----------------PEVIRALERGYRMPRPENCP 229

Query: 327 EEFIQLIVRCLDPSSERRPS 346
           EE   +++RC     E RP+
Sbjct: 230 EELYNIMMRCWKNRPEERPT 249

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 76.1 bits (187), Expect = 1e-15
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 30/211 (14%)

Query: 90  LIGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQE-----FIDEVCFLASIQHRNLV 139
            +G G F   Y+   ++ G L+A+K+    R  +  QE        E+  +A + H +++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 140 TLLGYCQENNLQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSIA--LGAAKGLA 195
            +LG   E++   L  E++  GSVS  +  YG          FK  + I       +GL+
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA---------FKEAVIINYTEQLLRGLS 117

Query: 196 HLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRTDVAGP---SSQVTADEIF 251
           +LH    +++H+D K AN+L+D      ++AD G    L      G      Q+     F
Sbjct: 118 YLH--ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA-AKGTGAGEFQGQLLGTIAF 174

Query: 252 LASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
           +A EV    ++    DV+S G  ++E+ + +
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 75.9 bits (187), Expect = 1e-15
 Identities = 69/282 (24%), Positives = 113/282 (40%), Gaps = 45/282 (15%)

Query: 90  LIGEGKFGEVYKG----LLQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLVTL 141
            +G+G FG V +G         + VA+K     +      +F+ E   + S+ H NL+ L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 142 LGYCQENNLQFLIYEYIPNGSV--SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 199
            G    + L  ++ E  P GS+   +            L        A+  A G+ +L S
Sbjct: 62  YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTL-----CDYAVQIANGMRYLES 115

Query: 200 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAGPSSQVTADEIFLASEV 256
              R +H+D    N+L+  D   K+ D GL   L + +   V     +V     + A E 
Sbjct: 116 --KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPF--AWCAPES 171

Query: 257 KEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILD- 314
              R FS  SDV+ FGV L E+ + G E  + LS                 S +LK +D 
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG----------------SQILKKIDK 215

Query: 315 --ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
             ERL         ++   ++++C   +   RP+ + +   L
Sbjct: 216 EGERL--ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 76.1 bits (188), Expect = 1e-15
 Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 43/216 (19%)

Query: 89  NLIGEGKFGEVYKGL-LQDGMLVAIKK-RPGAP--TQEFID-----EVCFLASIQHRNLV 139
             +GEG +  VYK    + G +VAIKK + G     ++ I+     E+  L  ++H N++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 140 TLLG-YCQENNLQFLIYEY--------IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 190
            LL  +  ++N+  L++E+        I + S+   +  P+ +           S  L  
Sbjct: 66  GLLDVFGHKSNIN-LVFEFMETDLEKVIKDKSI---VLTPADIK----------SYMLMT 111

Query: 191 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---- 246
            +GL +LHS    ++H+D K  N+L+  D + K+AD GL    G  +       VT    
Sbjct: 112 LRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYR 169

Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
           A E+   +     R +    D++S G    EL+   
Sbjct: 170 APELLFGA-----RHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 27/210 (12%)

Query: 91  IGEGKFGEVYKGLLQD------GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVT 140
           +G+G FG VY+GL +          VAIK      +     EF++E   +      ++V 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLY----------GPSQVSRQKLEFKHRLSIALGA 190
           LLG         ++ E +  G +  +L           G    + QK      + +A   
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF-----IQMAAEI 128

Query: 191 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 250
           A G+A+L +   + VH+D    N +V ED   K+ D G+   +  TD      +      
Sbjct: 129 ADGMAYLAAK--KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
           ++A E  +   F+ KSDV+SFGV L E+ +
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 73/287 (25%), Positives = 125/287 (43%), Gaps = 39/287 (13%)

Query: 83  KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIK---KRPG-APTQEFIDEVCFLASIQHRN 137
           +   + + +GEG  G V K  L   GM+ A+K     P     ++ + E+    S +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 138 LVTLLGYC---QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 194
           +V   G       +++  +  EY   GS+   +Y   +    ++  K    IA    KGL
Sbjct: 61  IVKYYGAFLDESSSSIG-IAMEYCEGGSLD-SIYKKVKKRGGRIGEKVLGKIAESVLKGL 118

Query: 195 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 254
           ++LHS   +++H+D K +N+L+      K+ D G+   L    +AG     T    ++A 
Sbjct: 119 SYLHS--RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV-NSLAG---TFTGTSFYMAP 172

Query: 255 EVKEFRRFSEKSDVYSFGVFLLELVSGR-----EASSSLSPDSSQDLVELVQNSRDFSNL 309
           E  + + +S  SDV+S G+ LLE+   R     E    L P    +L+  + N  +    
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGP---IELLSYIVNMPNP--- 226

Query: 310 LKILDE----RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT 352
            ++ DE      WS       EEF   I +CL+    RRP+  D++ 
Sbjct: 227 -ELKDEPGNGIKWS-------EEFKDFIKQCLEKDPTRRPTPWDMLE 265

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 74.8 bits (184), Expect = 3e-15
 Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 37/217 (17%)

Query: 84  NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAP--------TQEFIDEVCFLASIQ 134
           N+    L+G+G FG VY     D G  +A+K+ P  P              E+  L ++Q
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62

Query: 135 HRNLVTLLGYCQENNLQFLIY-EYIPNGSVSIHL--YGP------SQVSRQKLEFKHRLS 185
           H  +V   G C  ++    I+ EY+P GSV   L  YG        + +RQ LE      
Sbjct: 63  HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE------ 115

Query: 186 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG--RTDVAGPSS 243
                  G+ +LH  S  +VH+D K AN+L D     K+ D G    L    +   G  S
Sbjct: 116 -------GVEYLH--SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS 166

Query: 244 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            VT    +++ EV     +  K+DV+S G  ++E+++
Sbjct: 167 -VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 75.1 bits (185), Expect = 3e-15
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 22/203 (10%)

Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 143
           IGEG +G VYKG   + G +VA+KK        G P+   I E+  L  +QH N+V L  
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTA-IREISLLKELQHPNIVCLQD 66

Query: 144 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 203
              + +  +LI+E++   S+ +  Y  S    Q ++ +   S      +G+   HS   R
Sbjct: 67  VLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS--RR 121

Query: 204 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----ADEIFLASEVKEF 259
           V+H+D K  N+L+D   + K+AD GL    G          VT    A E+ L S     
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSP---- 177

Query: 260 RRFSEKSDVYSFGVFLLELVSGR 282
            R+S   D++S G    E+ + +
Sbjct: 178 -RYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 74.6 bits (184), Expect = 3e-15
 Identities = 73/287 (25%), Positives = 123/287 (42%), Gaps = 42/287 (14%)

Query: 85  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ-------HR 136
           F    +IGEG +G+VYK    + G LVAIK       ++  +E+              H 
Sbjct: 8   FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD--IIEDEEEEI--KEEYNILRKYSNHP 63

Query: 137 NLVTLLG-------YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG 189
           N+ T  G          ++ L +L+ E    GSV   L    +   ++L+ +    I   
Sbjct: 64  NIATFYGAFIKKNPPGNDDQL-WLVMELCGGGSV-TDLVKGLRKKGKRLKEEWIAYILRE 121

Query: 190 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAGPSSQV 245
             +GLA+LH    +V+H+D K  N+L+ ++   K+ D G    L + LGR +    +   
Sbjct: 122 TLRGLAYLHE--NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYW 179

Query: 246 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD 305
            A E+    E  +   +  +SDV+S G+  +EL  G+     + P  +     L +  R+
Sbjct: 180 MAPEVIACDEQPD-ASYDARSDVWSLGITAIELADGKPPLCDMHPMRA-----LFKIPRN 233

Query: 306 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT 352
               LK      WS       ++F   I  CL  + E+RP M +++ 
Sbjct: 234 PPPTLK--SPENWS-------KKFNDFISECLIKNYEQRPFMEELLE 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 74.5 bits (183), Expect = 5e-15
 Identities = 84/298 (28%), Positives = 120/298 (40%), Gaps = 66/298 (22%)

Query: 84  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHR 136
           NF     IGEG +G VYK      G +VA+KK        G P+   I E+  L  + H 
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNHP 59

Query: 137 NLVTLLGYCQENNLQFLIYEYI-----------PNGSVSIHLYGPSQVSRQKLEFKHRLS 185
           N+V LL      N  +L++E++           P   + + L             K  L 
Sbjct: 60  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPL------------IKSYLF 107

Query: 186 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 245
             L   +GLA  H  S RV+H+D K  N+L++ +   K+AD GL    G          V
Sbjct: 108 QLL---QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 162

Query: 246 T----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ 301
           T    A EI L       + +S   D++S G    E+V+ R    +L P  S    E+ Q
Sbjct: 163 TLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR----ALFPGDS----EIDQ 209

Query: 302 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSER--RPSMSDVVTELDRT 357
             R F   L   DE +W   T+  + ++         PS  +  R   S VV  LD  
Sbjct: 210 LFRIF-RTLGTPDEVVWPGVTS--LPDY--------KPSFPKWARQDFSKVVPPLDED 256

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 74.0 bits (182), Expect = 6e-15
 Identities = 75/286 (26%), Positives = 115/286 (40%), Gaps = 65/286 (22%)

Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVTLL-GYC 145
           +G+G FG+VYK    + G+  A K          ++F+ E+  L+  +H N+V L   Y 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 146 QENNLQFLIYEYIPNGSV-SI-----HLYGPSQ---VSRQKLEFKHRLSIALGAAKGLAH 196
            EN L  LI E+   G++ SI           Q   V RQ LE              L  
Sbjct: 73  YENKLWILI-EFCDGGALDSIMLELERGLTEPQIRYVCRQMLE-------------ALNF 118

Query: 197 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----ADEIFL 252
           LHS   +V+H+D K  N+L+  D   K+AD G+      T     +   T    A E+ +
Sbjct: 119 LHS--HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEV-V 175

Query: 253 ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 312
           A E  +   +  K+D++S G+ L+EL         L+P                  LLKI
Sbjct: 176 ACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP---------------MRVLLKI 220

Query: 313 LDE--------RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
           L            WS+        F   +  CL    + RP+ +++
Sbjct: 221 LKSEPPTLDQPSKWSS-------SFNDFLKSCLVKDPDDRPTAAEL 259

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 73.8 bits (182), Expect = 7e-15
 Identities = 67/279 (24%), Positives = 118/279 (42%), Gaps = 47/279 (16%)

Query: 82  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNL 138
            + + +   IGEG  GEVYK      G  VAIKK R     +E  I+E+  +   +H N+
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI 77

Query: 139 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 198
           V         +  +++ EY+  GS++  +      +  ++       +     +GL +LH
Sbjct: 78  VDYYDSYLVGDELWVVMEYMDGGSLTDIITQ----NFVRMNEPQIAYVCREVLQGLEYLH 133

Query: 199 SLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----RNFLGRTDVAGPSSQVTADEIFLA 253
           S    V+H+D K+ N+L+ +D   K+AD G      +    R  V G     T    ++A
Sbjct: 134 SQ--NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVG-----TP--YWMA 184

Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPD------SSQDLVELVQNSRDFS 307
            EV + + +  K D++S G+  +E+  G        P       +++ +  L +N   +S
Sbjct: 185 PEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPL-KNPEKWS 243

Query: 308 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 346
              K                +F+    +CL    E+RPS
Sbjct: 244 PEFK----------------DFLN---KCLVKDPEKRPS 263

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 73.2 bits (179), Expect = 1e-14
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 15/211 (7%)

Query: 85  FSDKNLIGEGKFGEVYKGLL-QDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLV 139
           F+    IG+G FGEVYKG+  +   +VAIK    +      ++   E+  L+      + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 199
              G   +    ++I EY+  GS ++ L  P       LE  +  +I     KGL +LHS
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGS-ALDLLKPG-----PLEETYIATILREILKGLDYLHS 119

Query: 200 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 259
              R +H+D K ANVL+ E    K+AD G+   L  TD     +       ++A EV + 
Sbjct: 120 --ERKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQ 175

Query: 260 RRFSEKSDVYSFGVFLLELVSGREASSSLSP 290
             +  K+D++S G+  +EL  G   +S L P
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNSDLHP 206

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 72.1 bits (177), Expect = 2e-14
 Identities = 53/270 (19%), Positives = 122/270 (45%), Gaps = 35/270 (12%)

Query: 91  IGEGKFGE--VYKGLLQDGMLVAIK----KRPGAPTQEF-IDEVCFLASIQHRNLVTLLG 143
           +G+G FGE  +Y+   +D  LV  K     R     +   ++E+  L+ +QH N++    
Sbjct: 8   LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 144 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL--GAAKGLAHLHSLS 201
           +  ++N   +  EY   G++   +     V ++   F+  + +         ++++H   
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKI-----VRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG 121

Query: 202 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 261
             ++H+D KT N+ + +  + K+ D G+   LG ++ +   + V     +++ E+ +  +
Sbjct: 122 --ILHRDIKTLNIFLTKAGLIKLGDFGISKILG-SEYSMAET-VVGTPYYMSPELCQGVK 177

Query: 262 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF 321
           ++ KSD+++ G  L EL++ +    + +P                 NL+  + +  ++  
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTFDATNP----------------LNLVVKIVQGNYTPV 221

Query: 322 TNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
            +    E I L+   L    E+RP+  +V+
Sbjct: 222 VSVYSSELISLVHSLLQQDPEKRPTADEVL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 72.2 bits (177), Expect = 3e-14
 Identities = 60/232 (25%), Positives = 109/232 (46%), Gaps = 43/232 (18%)

Query: 83  KNFSDKNLIGEGKFGEVY----KGLLQ-------------DGMLVAIKK-RPGA---PTQ 121
           K  + K  +GEG+FGEV+    +G+ +               +LVA+K  R  A      
Sbjct: 5   KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64

Query: 122 EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLY------GPSQVSR 175
           +F+ E+  ++ ++  N++ LL  C  ++   +I EY+ NG ++  L          +   
Sbjct: 65  DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124

Query: 176 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 235
             + +   + +A   A G+ +L SL+   VH+D  T N LV +++  K+AD G+   L  
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182

Query: 236 TD---VAG----PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            D   + G    P   ++ + I L        +F+  SDV++FGV L E+++
Sbjct: 183 GDYYRIQGRAVLPIRWMSWESILLG-------KFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 71.1 bits (175), Expect = 5e-14
 Identities = 60/281 (21%), Positives = 108/281 (38%), Gaps = 52/281 (18%)

Query: 91  IGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           IG+G FG V K     DG ++  K            Q+ + EV  L  ++H N+V    Y
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV---RY 64

Query: 145 CQ-----ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 199
                   N   +++ EY   G ++  L    +  R+ +E +    I       L   H+
Sbjct: 65  YDRIIDRSNQTLYIVMEYCEGGDLA-QLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123

Query: 200 L---SPRVVHKDFKTANVLVDEDFIAKVADAGL------RNFLGRTDVAGPSSQVTADEI 250
                  V+H+D K AN+ +D +   K+ D GL       +   +T V  P         
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTP--------Y 175

Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD--FSN 308
           +++ E      + EKSD++S G  + EL +         P ++++ ++L    ++  F  
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALS------PPFTARNQLQLASKIKEGKFRR 229

Query: 309 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 349
           +       L              +I   L+   ++RPS  +
Sbjct: 230 IPYRYSSELNE------------VIKSMLNVDPDKRPSTEE 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 70.8 bits (174), Expect = 6e-14
 Identities = 72/275 (26%), Positives = 113/275 (41%), Gaps = 52/275 (18%)

Query: 91  IGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQE----FIDEVCFLASIQHRNLVTLLGYC 145
           +G G  G V K L +  G ++A+K       +      + E+  L       +V   G  
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 146 QENNLQFLIYEYIPNGSV-SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 204
             N    +  EY+  GS+  I      ++  + L       IA+   KGL +LH    ++
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK-----IAVAVLKGLTYLHE-KHKI 122

Query: 205 VHKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 260
           +H+D K +N+LV+     K+ D G    L N L +T V G SS       ++A E  +  
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-GTSS-------YMAPERIQGN 174

Query: 261 RFSEKSDVYSFGVFLLELVSGR--EASSSLSPDSSQDLVELVQNSRDFSNLLKILDE--- 315
            +S KSD++S G+ L+EL +GR      +  PD              F  L  I++E   
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG------------IFELLQYIVNEPPP 222

Query: 316 RL----WSTFTNEGMEEFIQLIVRCLDPSSERRPS 346
           RL    +S        +F   +  CL      RPS
Sbjct: 223 RLPSGKFS-------PDFQDFVNLCLIKDPRERPS 250

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 70.8 bits (173), Expect = 6e-14
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 20/207 (9%)

Query: 84  NFSDKNLIGEGKFGEVY--KGLLQDGMLV----AIKKRPGAPTQEFIDEVCFLASIQHRN 137
            +     IGEG FG++Y  K        V     + K P    +    EV  LA ++H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK---LEFKHRLSIALGAAKGL 194
           +VT     QEN   F++ EY   G +        +++RQ+         LS  +  + GL
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLM------KRINRQRGVLFSEDQILSWFVQISLGL 114

Query: 195 AHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 253
            H+H    +++H+D K+ N+ + ++  +AK+ D G+   L   D    +        +L+
Sbjct: 115 KHIH--DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL--NDSMELAYTCVGTPYYLS 170

Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVS 280
            E+ + R ++ K+D++S G  L EL +
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 70.7 bits (173), Expect = 6e-14
 Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 21/212 (9%)

Query: 80  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKK-RPGAPTQE---FIDEVCFLA 131
           L  K+   + ++G G+FGE+ +G L+      + VAI   R G   ++   F+ E   L 
Sbjct: 2   LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLG 61

Query: 132 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG-PSQVSRQKLEFKHRLSIALGA 190
              H N+V L G     N   ++ EY+ NG++   L     Q+   +L     + +  G 
Sbjct: 62  QFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQL-----MGMLPGL 116

Query: 191 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 250
           A G+ +L  +    VHK      VLV+ D + K++  G R  L         + ++    
Sbjct: 117 ASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKIS--GFRR-LQEDKSEAIYTTMSGKSP 171

Query: 251 FL--ASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            L  A E  ++  FS  SDV+SFG+ + E++S
Sbjct: 172 VLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 70.8 bits (174), Expect = 8e-14
 Identities = 56/228 (24%), Positives = 94/228 (41%), Gaps = 34/228 (14%)

Query: 90  LIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFID-----EVCFLASIQHRNLVTLLG 143
           ++GEG +G V K   +  G +VAIKK   +   E +      EV  L  ++H N+V L  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 144 YCQENNLQFLIYEYIPNGSVSIHLY---GPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 200
             +     +L++EY+     ++       P  +    +      S      + +A+ HS 
Sbjct: 68  AFRRKGRLYLVFEYVER---TLLELLEASPGGLPPDAVR-----SYIWQLLQAIAYCHSH 119

Query: 201 SPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVT----ADEIFLASE 255
              ++H+D K  N+LV E  + K+ D G  R    R          T    A E+ +   
Sbjct: 120 --NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177

Query: 256 VKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-DSSQDLVELVQN 302
                 + +  DV++ G  + EL+ G      L P DS  D + L+Q 
Sbjct: 178 -----NYGKPVDVWAIGCIMAELLDGE----PLFPGDSDIDQLYLIQK 216

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 70.1 bits (172), Expect = 1e-13
 Identities = 64/219 (29%), Positives = 96/219 (43%), Gaps = 46/219 (21%)

Query: 89  NLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFI-DEVCFLASIQHRNLVTLL 142
           N IG G FG+VY  + L  G L+A+K    +     T + I DE+  L  ++H NLV   
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 143 G-------------YCQENNL-QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 188
           G             YC    L + L +  I +  V I +Y     + Q LE         
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV-IRVY-----TLQLLE--------- 110

Query: 189 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR-TDVAGPSSQVTA 247
               GLA+LHS    +VH+D K AN+ +D + + K+ D G    L   T   G   Q  A
Sbjct: 111 ----GLAYLHS--HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA 164

Query: 248 -DEIFLASEVKEFRRFSEK---SDVYSFGVFLLELVSGR 282
               ++A EV    +       +D++S G  +LE+ +G+
Sbjct: 165 GTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGK 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 35/221 (15%)

Query: 85  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID----EVCFLASIQHRNLV 139
           F+    IG+G FGEVYK +  +   +VAIK       ++ I+    E+ FL+  +   + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 199
              G   + +  ++I EY   GS    L  P      KL+  +   I      GL +LH 
Sbjct: 63  KYYGSFLKGSKLWIIMEYCGGGSCL-DLLKPG-----KLDETYIAFILREVLLGLEYLHE 116

Query: 200 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--------- 250
                +H+D K AN+L+ E+   K+AD G         V+G   Q+T+            
Sbjct: 117 --EGKIHRDIKAANILLSEEGDVKLADFG---------VSG---QLTSTMSKRNTFVGTP 162

Query: 251 -FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP 290
            ++A EV +   + EK+D++S G+  +EL  G    S L P
Sbjct: 163 FWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP 203

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 70.1 bits (171), Expect = 1e-13
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 15/211 (7%)

Query: 85  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLV 139
           F+    IG+G FGEV+KG+  +   +VAIK    +      ++   E+  L+      + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 199
              G   ++   ++I EY+  GS ++ L  P  +   ++      +I     KGL +LHS
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGPLDETQIA-----TILREILKGLDYLHS 119

Query: 200 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 259
              + +H+D K ANVL+ E    K+AD G+   L  TD     +       ++A EV + 
Sbjct: 120 --EKKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQ 175

Query: 260 RRFSEKSDVYSFGVFLLELVSGREASSSLSP 290
             +  K+D++S G+  +EL  G    S L P
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPHSELHP 206

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 69.9 bits (172), Expect = 2e-13
 Identities = 53/233 (22%), Positives = 90/233 (38%), Gaps = 47/233 (20%)

Query: 83  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIK---KRPGAPTQE------FIDEVCFLAS 132
            +F    +IGEG F  V     +      AIK   KR     +E       I++      
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRL 58

Query: 133 IQHRNLVTLLGYCQ-ENNLQFLIYEYIPNGSV--SIHLYGPSQVSRQKLEFKHRLSIALG 189
             H  ++ L    Q E NL + + EY PNG +   I  YG        L+ K     A  
Sbjct: 59  NGHPGIIKLYYTFQDEENL-YFVLEYAPNGELLQYIRKYG-------SLDEKCTRFYAAE 110

Query: 190 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV---- 245
               L +LHS    ++H+D K  N+L+D+D   K+ D G    L        +       
Sbjct: 111 ILLALEYLHSK--GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168

Query: 246 ----------------TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                           TA+  +++ E+   +   + SD+++ G  + ++++G+
Sbjct: 169 DSQIEKNRRRFASFVGTAE--YVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 69.0 bits (169), Expect = 3e-13
 Identities = 65/271 (23%), Positives = 114/271 (42%), Gaps = 36/271 (13%)

Query: 90  LIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQH---RNLVTL 141
           LIG G +G VY+G  +  G +VA+K      P     +   EV  L+ ++     N+   
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 142 LG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 200
            G Y +   L ++I EY   GSV       + +    +  K+   I       L ++H +
Sbjct: 68  YGSYLKGPRL-WIIMEYAEGGSVR------TLMKAGPIAEKYISVIIREVLVALKYIHKV 120

Query: 201 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV-KEF 259
              V+H+D K AN+LV      K+ D G+   L     +   S       ++A EV  E 
Sbjct: 121 G--VIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGTPYWMAPEVITEG 176

Query: 260 RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS 319
           + +  K+D++S G+ + E+ +G    S +    +  L+   +  R        L++  +S
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPR--------LEDNGYS 228

Query: 320 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
                 + EF+     CLD   + R S  ++
Sbjct: 229 KL----LREFVAA---CLDEEPKERLSAEEL 252

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 70/277 (25%), Positives = 115/277 (41%), Gaps = 40/277 (14%)

Query: 91  IGEGKFGEVYK----GLLQDG--MLVAIKK-RPGA---PTQEFIDEVCFLASI-QHRNLV 139
           +G G FG+V +    GL +    M VA+K  +P A     +  + E+  ++ +  H N+V
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 199
            LLG C       +I EY   G +   L    +     L  +  LS +   AKG+A L S
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLR---RKRESFLTLEDLLSFSYQVAKGMAFLAS 159

Query: 200 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-----AS 254
            +   +H+D    NVL+    I K+ D GL       D+   S+ V      L     A 
Sbjct: 160 KN--CIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYVVKGNARLPVKWMAP 212

Query: 255 EVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 314
           E      ++ +SDV+S+G+ L E+ S     S+  P        +  +S+ F  L+K   
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFS---LGSNPYPG-------MPVDSK-FYKLIKEGY 261

Query: 315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                      + + ++    C D    +RP+   +V
Sbjct: 262 RMAQPEHAPAEIYDIMK---TCWDADPLKRPTFKQIV 295

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 68.5 bits (167), Expect = 4e-13
 Identities = 68/277 (24%), Positives = 117/277 (42%), Gaps = 31/277 (11%)

Query: 84  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHR 136
           NF  +  IG G+F EVY+   L D   VA+KK            Q+ + E+  L  + H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 137 NLVTLLGYCQENNLQFLIYEYIPNGSVS---IHLYGPSQVSRQKLEFKHRLSIALGAAKG 193
           N++  L    E+N   ++ E    G +S    +     ++  ++  +K+ + +       
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SA 118

Query: 194 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 253
           + H+HS   RV+H+D K ANV +    + K+ D GL  F      A  S  +     +++
Sbjct: 119 VEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMS 174

Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 313
            E      ++ KSD++S G  L E+       ++L      D + L      FS   KI 
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEM-------AALQSPFYGDKMNL------FSLCQKIE 221

Query: 314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
                   T    E+  +L+  C+ P  ++RP +  V
Sbjct: 222 QCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 68.5 bits (167), Expect = 6e-13
 Identities = 70/270 (25%), Positives = 129/270 (47%), Gaps = 31/270 (11%)

Query: 91  IGEGKFGEVYKGLLQD-GMLVA---IKKRPGAPTQEFIDEVCFLASIQHRNLVTLLG-YC 145
           +G+G FG+VYK   ++ G L A   I+ +     ++++ E+  LA+  H  +V LLG + 
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 146 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 205
            +  L  +I E+ P G+V   +    ++ R   E + ++ I     + L +LHS+  +++
Sbjct: 80  WDGKLWIMI-EFCPGGAVDAIML---ELDRGLTEPQIQV-ICRQMLEALQYLHSM--KII 132

Query: 206 HKDFKTANVLVDEDFIAKVADAGL--RNF--LGRTDVAGPSSQVTADEIFLASEVKEFRR 261
           H+D K  NVL+  D   K+AD G+  +N   L R D    +    A E+ +   +K+   
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD-TP 191

Query: 262 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF 321
           +  K+D++S G+ L+E+         L+P   + L+++ +     S    +     WS  
Sbjct: 192 YDYKADIWSLGITLIEMAQIEPPHHELNP--MRVLLKIAK-----SEPPTLSQPSKWSM- 243

Query: 322 TNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                 EF   +   LD   E RPS + ++
Sbjct: 244 ------EFRDFLKTALDKHPETRPSAAQLL 267

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 68.2 bits (166), Expect = 7e-13
 Identities = 70/273 (25%), Positives = 119/273 (43%), Gaps = 33/273 (12%)

Query: 85  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID----EVCFLASIQHRNLV 139
           F+    IG+G FGEV+KG+  +   +VAIK       ++ I+    E+  L+      + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 140 TLLGYCQENNLQFLIYEYIPNGS-VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 198
              G   +    ++I EY+  GS + +   GP    +     K  L       KGL +LH
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL-------KGLDYLH 118

Query: 199 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 258
           S   + +H+D K ANVL+ E    K+AD G+   L  TD     +       ++A EV +
Sbjct: 119 S--EKKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIQ 174

Query: 259 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 318
              +  K+D++S G+  +EL  G   +S + P                  +L ++ +   
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPNSDMHP----------------MRVLFLIPKNNP 218

Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
            T T E  + F + I  CL+     RP+  +++
Sbjct: 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 67.8 bits (165), Expect = 7e-13
 Identities = 73/277 (26%), Positives = 124/277 (44%), Gaps = 37/277 (13%)

Query: 90  LIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASI-QHRNLVTLLG-Y 144
           L+G G +G+VYKG  ++ G L AIK     G   +E   E+  L     HRN+ T  G +
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 145 CQEN-----NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 199
            ++N     +  +L+ E+   GSV+  L   ++ +  K E+   +   +   +GL+HLH 
Sbjct: 73  IKKNPPGMDDQLWLVMEFCGAGSVT-DLIKNTKGNTLKEEWIAYICREI--LRGLSHLHQ 129

Query: 200 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV--- 256
              +V+H+D K  NVL+ E+   K+ D G+   L RT   G  +       ++A EV   
Sbjct: 130 --HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIAC 185

Query: 257 --KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 314
                  +  KSD++S G+  +E+  G      + P  +  L+      R        L 
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR--------LK 237

Query: 315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
            + WS       ++F   I  CL  +  +RP+   ++
Sbjct: 238 SKKWS-------KKFQSFIESCLVKNHSQRPTTEQLM 267

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 67.7 bits (166), Expect = 8e-13
 Identities = 65/220 (29%), Positives = 97/220 (44%), Gaps = 57/220 (25%)

Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 143
           IGEG +G VYK      G +VA+KK        G P+   I E+  L  + H N+V LL 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA-IREISLLKELNHPNIVRLLD 65

Query: 144 YCQENNLQFLIYEY-----------IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK 192
                N  +L++E+            P   +      P  +      + ++L       +
Sbjct: 66  VVHSENKLYLVFEFLDLDLKKYMDSSPLTGL-----DPPLIKS----YLYQL------LQ 110

Query: 193 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG---RT---DVAGPSSQVT 246
           G+A+ H  S RV+H+D K  N+L+D +   K+AD GL    G   RT   +V      VT
Sbjct: 111 GIAYCH--SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEV------VT 162

Query: 247 ----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
               A EI L S     R++S   D++S G    E+V+ R
Sbjct: 163 LWYRAPEILLGS-----RQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 67.7 bits (165), Expect = 9e-13
 Identities = 70/255 (27%), Positives = 117/255 (45%), Gaps = 36/255 (14%)

Query: 91  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQE----FIDEVCFLASIQHRNLVTLL-GYC 145
           +G+G FG+VYK   ++  ++A  K     ++E    ++ E+  LAS  H N+V LL  + 
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 146 QENNLQFLIYEYIPNGSVS---IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 202
            ENNL  LI E+   G+V    + L  P    + ++  K  L       + L +LH    
Sbjct: 73  YENNLWILI-EFCAGGAVDAVMLELERPLTEPQIRVVCKQTL-------EALNYLHE--N 122

Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLR----NFLGRTDVAGPSSQVTADEIFLASEVKE 258
           +++H+D K  N+L   D   K+AD G+       + R D    +    A E+ +    K+
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182

Query: 259 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPD------SSQDLVELVQNSR---DFSNL 309
            R +  K+DV+S G+ L+E+         L+P       +  +   L Q SR   +F + 
Sbjct: 183 -RPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDF 241

Query: 310 LKILDER----LWST 320
           LK   E+     W+T
Sbjct: 242 LKKCLEKNVDARWTT 256

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 66/282 (23%), Positives = 120/282 (42%), Gaps = 49/282 (17%)

Query: 86  SDKNLIGEGKFGEVYKGLLQDGMLVAIK------KRPGAPTQEFIDEVCFLASIQHRNLV 139
           +D+N I +G F         +   V I+      K          +E+  L  I   N++
Sbjct: 31  NDQNSIYKGIF---------NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNIL 81

Query: 140 TLLGY----CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 195
            + G+      +     LI EY   G +   L        + L FK +L +A+   KGL 
Sbjct: 82  KIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD-----KEKDLSFKTKLDMAIDCCKGLY 136

Query: 196 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 255
           +L+  + +  +K+  + + LV E++  K+   GL   L     + P   V     F    
Sbjct: 137 NLYKYTNKP-YKNLTSVSFLVTENYKLKIICHGLEKILS----SPPFKNVNFMVYFSYKM 191

Query: 256 VKE-FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI-L 313
           + + F  ++ K D+YS GV L E+ +G+    +L   +++++ +L+ N    +N LK+ L
Sbjct: 192 LNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL---TTKEIYDLIINK---NNSLKLPL 245

Query: 314 DERLWSTFTNEGMEEFIQLIV-RCLDPSSERRPSMSDVVTEL 354
           D  L            I+ IV  C    S +RP++ +++  L
Sbjct: 246 DCPL-----------EIKCIVEACTSHDSIKRPNIKEILYNL 276

Length = 283

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 71/292 (24%), Positives = 126/292 (43%), Gaps = 47/292 (16%)

Query: 90  LIGEGKFGEVYKGLL--QDGML--VAIK--KRPG---APTQEFIDEVCFLASIQHRNLVT 140
           ++GEG+FG V +G L   DG    VA+K  K      +  +EF+ E   +    H N++ 
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 141 LLGYC-QENNLQ-----FLIYEYIPNGSVSIHLY------GPSQVSRQKLEFKHRLSIAL 188
           L+G C + ++LQ      +I  ++ +G +   L        P ++  Q L     L   +
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTL-----LKFMV 120

Query: 189 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV--AGPSSQVT 246
             A G+ +L +     +H+D    N ++ ED    VAD GL   +   D    G  +++ 
Sbjct: 121 DIALGMEYLSN--RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 178

Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 306
               ++A E    R ++ KSDV++FGV + E+     A+   +P         V+N   +
Sbjct: 179 VK--WIAIESLADRVYTSKSDVWAFGVTMWEI-----ATRGQTPYPG------VENHEIY 225

Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
             L      RL      + ++E   L+  C     + RP+ + +   L+  L
Sbjct: 226 DYLRH--GNRLKQ--PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 66.0 bits (162), Expect = 3e-12
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 46/214 (21%)

Query: 91  IGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFID--EVCFLASIQ-HRNLVTLLGY 144
           +G+G FG VY     + G LVAIK  K+     +E ++  EV  L  +  H N+V L   
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEV 66

Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRL-------SIALGAAKGLAHL 197
            +EN+  + ++EY     +  +LY   Q+ + +   K +        SI     +GLAH+
Sbjct: 67  FRENDELYFVFEY-----MEGNLY---QLMKDR---KGKPFSESVIRSIIYQILQGLAHI 115

Query: 198 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGL----RNFLGRTD-VAGPSSQVT----AD 248
           H       H+D K  N+LV    + K+AD GL    R+    TD V+      T    A 
Sbjct: 116 HKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVS------TRWYRAP 167

Query: 249 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
           EI L S       +S   D+++ G  + EL + R
Sbjct: 168 EILLRSTS-----YSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 46/164 (28%), Positives = 71/164 (43%), Gaps = 32/164 (19%)

Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 143
           +GEG FGEVYK   ++ G +VA+KK      + G P      E+  L  ++H N+V L+ 
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL-REIKILKKLKHPNVVPLID 74

Query: 144 YCQENNLQFLIYEYIPNGS---VSIHLYGPSQVS---------RQKLEFKHRLSIALGAA 191
                    +  E          S+++  P               KL         L   
Sbjct: 75  ---------MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL 125

Query: 192 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLG 234
           +G+ +LH     ++H+D K AN+L+D   I K+AD GL R + G
Sbjct: 126 EGINYLHE--NHILHRDIKAANILIDNQGILKIADFGLARPYDG 167

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 66.2 bits (162), Expect = 4e-12
 Identities = 69/258 (26%), Positives = 114/258 (44%), Gaps = 47/258 (18%)

Query: 83  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 135
             F   N IGEG +G VY+      G +VA+KK      R G P    + E+  L +++H
Sbjct: 7   TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS-LREITLLLNLRH 65

Query: 136 RNLVTLLGYCQENNLQ--FLIYEYIPN--GSVSIHLYGPSQVSRQKLEFKHRLSIALGAA 191
            N+V L       +L   FL+ EY      S+  ++  P   S+ K        + L   
Sbjct: 66  PNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVK-------CLMLQLL 118

Query: 192 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQ--VT-- 246
           +GL +LH     ++H+D K +N+L+ +    K+AD GL R +      A P +   VT  
Sbjct: 119 RGLQYLHE--NFIIHRDLKVSNLLLTDKGCLKIADFGLARTY---GLPAKPMTPKVVTLW 173

Query: 247 --ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ-DLVELVQNS 303
             A E+ L         ++   D+++ G  L EL++ +     L P  S+ + ++L+   
Sbjct: 174 YRAPELLLGCTT-----YTTAIDMWAVGCILAELLAHK----PLLPGKSEIEQLDLI--- 221

Query: 304 RDFSNLLKILDERLWSTF 321
                LL   +E +W  F
Sbjct: 222 ---IQLLGTPNESIWPGF 236

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 65.7 bits (161), Expect = 4e-12
 Identities = 49/168 (29%), Positives = 68/168 (40%), Gaps = 46/168 (27%)

Query: 89  NLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQ---HRNL 138
             IGEG +G VYK   L  G  VA+KK        G P    + E+  L  ++   H N+
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIP-LSTLREIALLKQLESFEHPNI 63

Query: 139 VTLLGYCQENNLQ-----FLIYEYIPNGSVSIHLY---------GPSQ---VSRQKLEFK 181
           V LL  C            L++E++      +  Y          P     + RQ L   
Sbjct: 64  VRLLDVCHGPRTDRELKLTLVFEHVDQ---DLATYLSKCPKPGLPPETIKDLMRQLL--- 117

Query: 182 HRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 229
                     +G+  LH  S R+VH+D K  N+LV  D   K+AD GL
Sbjct: 118 ----------RGVDFLH--SHRIVHRDLKPQNILVTSDGQVKIADFGL 153

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 65.8 bits (160), Expect = 4e-12
 Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 17/205 (8%)

Query: 91  IGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLVT 140
           +G+G FG VY    KG+++D     VAIK    A +     EF++E   +      ++V 
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLYG-----PSQVSRQKLEFKHRLSIALGAAKGLA 195
           LLG   +     +I E +  G +  +L        +   +     K  + +A   A G+A
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 196 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 255
           +L++   + VH+D    N +V EDF  K+ D G+   +  TD      +      +++ E
Sbjct: 134 YLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 191

Query: 256 VKEFRRFSEKSDVYSFGVFLLELVS 280
             +   F+  SDV+SFGV L E+ +
Sbjct: 192 SLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 64.7 bits (157), Expect = 8e-12
 Identities = 70/285 (24%), Positives = 120/285 (42%), Gaps = 36/285 (12%)

Query: 91  IGEGKFGEVYKGLL-QDG---------MLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVT 140
           +GEG+FG V +G L QD          M +AI  R  +  ++F+ E   +    H N++ 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTR--SEMEDFLSEAVCMKEFDHPNVMR 64

Query: 141 LLGYCQENNLQ------FLIYEYIPNGSV-SIHLYGPSQVSRQKLEFKHRLSIALGAAKG 193
           L+G C +           +I  ++ +G + S  LY       Q L  +  +      A G
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 194 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 253
           + +L S     +H+D    N +++E+    VAD GL   +   D             ++A
Sbjct: 125 MEYLSS--KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182

Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 313
            E    R ++ KSDV+SFGV + E+     A+   +P         V+NS  +  L +  
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEI-----ATRGQTPYPG------VENSEIYDYLRQ-- 229

Query: 314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
             RL      + ++    L+  C   + + RPS   +  EL++ L
Sbjct: 230 GNRLKQ--PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 29/205 (14%)

Query: 91  IGEGKFGEVYKG---LLQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLVTLLG 143
           +G G FG V KG   + +  + VAIK    +   +   E + E   +  + +  +V ++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 144 YCQENNLQFLIYEYIPNGSVSIHLYGPSQ--VSRQKLEFKHRLSIALGAAKGLAHLHSLS 201
            C+   L  L+ E    G ++  L G          +E  H++S+      G+ +L    
Sbjct: 63  VCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSM------GMKYLEG-- 113

Query: 202 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI------FLASE 255
              VH+D    NVL+     AK++D GL   LG  D     S   A         + A E
Sbjct: 114 KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD-----SYYKARSAGKWPLKWYAPE 168

Query: 256 VKEFRRFSEKSDVYSFGVFLLELVS 280
              FR+FS +SDV+S+G+ + E  S
Sbjct: 169 CINFRKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 62/206 (30%), Positives = 94/206 (45%), Gaps = 28/206 (13%)

Query: 91  IGEGKFGEVYKGLLQDGM---LVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTL 141
           IGEG +G VYK   +D +    +A+KK        G P+   I E+  L  +QH N+V L
Sbjct: 10  IGEGTYGVVYKA--RDRVTNETIALKKIRLEQEDEGVPSTA-IREISLLKEMQHGNIVRL 66

Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 201
                     +L++EY+ +  +  H+      ++     K  L   L   +G+A+ H  S
Sbjct: 67  QDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQIL---RGIAYCH--S 120

Query: 202 PRVVHKDFKTANVLVDEDFIA-KVADAGLRNFLGRTDVAGPSSQVT----ADEIFLASEV 256
            RV+H+D K  N+L+D    A K+AD GL    G          VT    A EI L S  
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGS-- 178

Query: 257 KEFRRFSEKSDVYSFGVFLLELVSGR 282
              R +S   D++S G    E+V+ +
Sbjct: 179 ---RHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 64.9 bits (159), Expect = 1e-11
 Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 38/213 (17%)

Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKKRPGA---PT--QEFIDEVCFLASI-QHRNLVTLLG 143
           +G+G +G V+K +  +   +VA+KK   A    T  Q    E+ FL  +  H N+V LL 
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLN 74

Query: 144 -YCQENNLQ-FLIYEYIPNGSVSIHLYGPSQVSRQK-LEFKHRLSIALGAAKGLAHLHSL 200
               EN+   +L++EY+      +H      V R   LE  H+  I     K L ++HS 
Sbjct: 75  VIKAENDKDIYLVFEYM---ETDLH-----AVIRANILEDVHKRYIMYQLLKALKYIHS- 125

Query: 201 SPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTAD----------E 249
              V+H+D K +N+L++ D   K+AD GL R+         P + V  D          E
Sbjct: 126 -GNVIHRDLKPSNILLNSDCRVKLADFGLARSL--SELEENPENPVLTDYVATRWYRAPE 182

Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
           I L S      R+++  D++S G  L E++ G+
Sbjct: 183 ILLGS-----TRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 63.3 bits (154), Expect = 2e-11
 Identities = 64/280 (22%), Positives = 120/280 (42%), Gaps = 37/280 (13%)

Query: 84  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP-----GAPTQEFIDEVCFLASIQHRN 137
            +    ++G G FG V+      D  LV IK+ P             +E   L  + H N
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 197
           ++       E+    ++ EY P G+++ ++    +     L+    L   +     L H+
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYI---QKRCNSLLDEDTILHFFVQILLALHHV 117

Query: 198 HSLSPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV 256
           H+    ++H+D KT N+L+D+   + K+ D G+   L     A     V     +++ E+
Sbjct: 118 HT--KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA---YTVVGTPCYISPEL 172

Query: 257 KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 316
            E + +++KSD+++ G  L EL S + A        + +L  LV         LKI+   
Sbjct: 173 CEGKPYNQKSDIWALGCVLYELASLKRAF------EAANLPALV---------LKIMS-- 215

Query: 317 LWSTF---TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 353
              TF   ++    +  QLI+  L+    +RP +S ++ +
Sbjct: 216 --GTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 23/210 (10%)

Query: 84  NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRN 137
           NF     +GEG +  VYKG  +  G +VA+K+       G P+   I E+  +  ++H N
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA-IREISLMKELKHEN 59

Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 197
           +V L       N   L++EY+      +  Y  +   R  L+     S      KG+A  
Sbjct: 60  IVRLHDVIHTENKLMLVFEYMDK---DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116

Query: 198 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT-----ADEIFL 252
           H    RV+H+D K  N+L+++    K+AD GL    G   V   S++V      A ++ L
Sbjct: 117 HE--NRVLHRDLKPQNLLINKRGELKLADFGLARAFG-IPVNTFSNEVVTLWYRAPDVLL 173

Query: 253 ASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
            S     R +S   D++S G  + E+++GR
Sbjct: 174 GS-----RTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 64.1 bits (157), Expect = 2e-11
 Identities = 57/223 (25%), Positives = 90/223 (40%), Gaps = 45/223 (20%)

Query: 85  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRN 137
           +     IG G +G V   +  + G  VAIKK       + ID      E+  L  ++H N
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKIS-NVFDDLIDAKRILREIKLLRHLRHEN 60

Query: 138 LVTLLGYCQENNLQFLIYEYIPN-GSVSI--HLYGP--SQV--SRQKLEFKHRLSIALGA 190
           ++ LL          L      +   V I   L      +V  S Q L   H        
Sbjct: 61  IIGLL--------DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQI 112

Query: 191 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ------ 244
            +GL +LHS +  V+H+D K +N+LV+ +   K+ D G    L R        +      
Sbjct: 113 LRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFG----LARGVDPDEDEKGFLTEY 166

Query: 245 -VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
            VT    A E+ L+S      R+++  D++S G    EL++ +
Sbjct: 167 VVTRWYRAPELLLSSS-----RYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 79/291 (27%), Positives = 126/291 (43%), Gaps = 33/291 (11%)

Query: 75  MEELSLATKNFSDKNLIGEGKFGEVYK-GLLQDGMLVAIK-KRPGAPTQEFID-EVCFLA 131
           +E L   T  +     IG+G +G+VYK    +DG L A+K   P +   E I+ E   L 
Sbjct: 14  LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQ 73

Query: 132 SI-QHRNLVTLLG------YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRL 184
           S+  H N+V   G            L +L+ E    GSV+  + G      Q+L+     
Sbjct: 74  SLPNHPNVVKFYGMFYKADKLVGGQL-WLVLELCNGGSVTELVKGLLICG-QRLDEAMIS 131

Query: 185 SIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ 244
            I  GA  GL HLH  + R++H+D K  N+L+  +   K+ D G+   L  T +   +S 
Sbjct: 132 YILYGALLGLQHLH--NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV 189

Query: 245 VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV 300
            T    A E+ +A E +    +  + DV+S G+  +EL  G      + P   + L ++ 
Sbjct: 190 GTPFWMAPEV-IACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP--VKTLFKIP 246

Query: 301 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
           +N         +L    W          F   I +CL    E RPS++ ++
Sbjct: 247 RNPPP-----TLLHPEKWC-------RSFNHFISQCLIKDFEARPSVTHLL 285

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 17/205 (8%)

Query: 91  IGEGKFGEVYKGLLQD------GMLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLVT 140
           +G+G FG VY+G  +D         VA+K    + +     EF++E   +      ++V 
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLY-----GPSQVSRQKLEFKHRLSIALGAAKGLA 195
           LLG   +     ++ E + +G +  +L        +   R     +  + +A   A G+A
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 196 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 255
           +L++   + VH+D    N +V  DF  K+ D G+   +  TD      +      ++A E
Sbjct: 134 YLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE 191

Query: 256 VKEFRRFSEKSDVYSFGVFLLELVS 280
             +   F+  SD++SFGV L E+ S
Sbjct: 192 SLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 61.9 bits (150), Expect = 7e-11
 Identities = 64/294 (21%), Positives = 124/294 (42%), Gaps = 47/294 (15%)

Query: 85  FSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPG-----APTQEFIDEVCFLASIQH 135
           F+   ++G+G+FG V +  L+        VA+K         +  +EF+ E   +    H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 136 RNLVTLLGYCQENNLQ------FLIYEYIPNGSVSIHLY------GPSQVSRQKLEFKHR 183
            N++ L+G    +  +       +I  ++ +G +   L        P  +  Q L     
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTL----- 115

Query: 184 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV--AGP 241
           +   +  A G+ +L S     +H+D    N +++E+    VAD GL   +   D    G 
Sbjct: 116 VRFMIDIASGMEYLSS--KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGC 173

Query: 242 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ 301
           +S++    + L S       ++  SDV++FGV + E+++             Q     V+
Sbjct: 174 ASKLPVKWLALESLADNV--YTTHSDVWAFGVTMWEIMT-----------RGQTPYAGVE 220

Query: 302 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 355
           NS  ++ L+K    RL      + +E+  +L+ +C  P  + RPS   +  +L+
Sbjct: 221 NSEIYNYLIK--GNRLKQPP--DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 61.9 bits (150), Expect = 7e-11
 Identities = 72/273 (26%), Positives = 120/273 (43%), Gaps = 39/273 (14%)

Query: 90  LIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYC 145
           ++G G +G+VYKG  ++ G L AIK         +E   E+  L     HRN+ T  G  
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82

Query: 146 -------QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 198
                   ++ L +L+ E+   GSV+  L   ++ +  K ++   +   +   +GLAHLH
Sbjct: 83  IKKSPPGHDDQL-WLVMEFCGAGSVT-DLVKNTKGNALKEDWIAYICREI--LRGLAHLH 138

Query: 199 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV-- 256
           +   +V+H+D K  NVL+ E+   K+ D G+   L RT   G  +       ++A EV  
Sbjct: 139 A--HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIA 194

Query: 257 ---KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 313
                   +  +SD++S G+  +E+  G      + P  +  L+          N    L
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP--------RNPPPKL 246

Query: 314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 346
             + WS       ++FI  I  CL  +   RPS
Sbjct: 247 KSKKWS-------KKFIDFIEGCLVKNYLSRPS 272

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 62.0 bits (151), Expect = 9e-11
 Identities = 49/166 (29%), Positives = 79/166 (47%), Gaps = 40/166 (24%)

Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 143
           IG+G FGEV+K    +   +VA+KK      + G P    + E+  L  ++H N+V L+ 
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITA-LREIKILQLLKHENVVNLIE 78

Query: 144 YC-----QENNLQ---FLIYEY--------IPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 187
            C       N  +   +L++E+        + N +V   L      S  K   K  L+  
Sbjct: 79  ICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTL------SEIKKVMKMLLN-- 130

Query: 188 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNF 232
                GL ++H    +++H+D K AN+L+ +D I K+AD GL R F
Sbjct: 131 -----GLYYIHR--NKILHRDMKAANILITKDGILKLADFGLARAF 169

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 61.1 bits (149), Expect = 2e-10
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 44/221 (19%)

Query: 84  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHR 136
            +   N I EG +G VY+    + G +VA+KK      + G P    + E+  L  +QH 
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITS-LREINILLKLQHP 64

Query: 137 NLVTLLGYCQE----NNLQ--FLIYEYIPNGSVSI--HLYGPSQVSRQKLEFKHRLSIAL 188
           N+VT+    +E    +NL   +++ EY+ +   S+   +  P   S  K      LS   
Sbjct: 65  NIVTV----KEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLS--- 117

Query: 189 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQ--V 245
               G+AHLH     ++H+D KT+N+L++   I K+ D GL R +        P +Q  V
Sbjct: 118 ----GVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREY---GSPLKPYTQLVV 168

Query: 246 T----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
           T    A E+ L +     + +S   D++S G    EL++ +
Sbjct: 169 TLWYRAPELLLGA-----KEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 61/216 (28%), Positives = 90/216 (41%), Gaps = 41/216 (18%)

Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRN-LVTLL 142
           IGEG +G+VYK      G LVA+KK        G P    + E+  L  +     +V LL
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTA-LREISLLQMLSESIYIVRLL 67

Query: 143 G--YCQENN---LQFLIYEYIPNGSVS-IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 196
              + +E N     +L++EY+ +     +   G      + L  K   S      KG+AH
Sbjct: 68  DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRG--PGRPLPAKTIKSFMYQLLKGVAH 125

Query: 197 LHSLSPRVVHKDFKTANVLVDED-FIAKVADAGL-RNFLGRTDVAGPSSQVT-------- 246
            H     V+H+D K  N+LVD+   + K+AD GL R F      + P    T        
Sbjct: 126 CHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF------SIPVKSYTHEIVTLWY 177

Query: 247 -ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
            A E+ L S       +S   D++S G    E+   
Sbjct: 178 RAPEVLLGS-----THYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 60.1 bits (145), Expect = 3e-10
 Identities = 59/230 (25%), Positives = 107/230 (46%), Gaps = 27/230 (11%)

Query: 70  ARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFI---D 125
           +RR   E+  L  +       IG G +G+VYK   +  G L AIK     P ++F     
Sbjct: 3   SRRNPQEDFELIQR-------IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ 55

Query: 126 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHR 183
           E+  +   +H N+V   G     +  ++  E+   GS+    H+ GP  +S  ++ +  R
Sbjct: 56  EIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP--LSESQIAYVSR 113

Query: 184 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 243
            ++     +GL +LHS     +H+D K AN+L+ ++   K+AD G+   +  T +A   S
Sbjct: 114 ETL-----QGLYYLHSKGK--MHRDIKGANILLTDNGHVKLADFGVSAQITAT-IAKRKS 165

Query: 244 QVTADEIFLASEVKEFRR---FSEKSDVYSFGVFLLELVSGREASSSLSP 290
            +     ++A EV    R   +++  D+++ G+  +EL   +     L P
Sbjct: 166 FI-GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 59.8 bits (145), Expect = 4e-10
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 23/203 (11%)

Query: 91  IGEGKFGEVYKGLLQD-GMLVA--------IKKRPGAPTQEFIDEVCFLASIQHRNLVTL 141
           +G+G FGEV    ++  G + A        +KKR G   Q  ++E   L  +  R +V+L
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKG--EQMALNEKKILEKVSSRFIVSL 58

Query: 142 LGYCQENNLQF-LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 200
             Y  E      L+   +  G +  H+Y    V          +  A     GL HLH  
Sbjct: 59  -AYAFETKDDLCLVMTLMNGGDLKYHIY---NVGEPGFPEARAIFYAAQIICGLEHLHQR 114

Query: 201 SPRVVHKDFKTANVLVDEDFIAKVADAGLR-NFLGRTDVAGPSSQVTADEIFLASEVKEF 259
             R+V++D K  NVL+D+    +++D GL     G   + G +        ++A EV + 
Sbjct: 115 --RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPG----YMAPEVLQG 168

Query: 260 RRFSEKSDVYSFGVFLLELVSGR 282
             +    D ++ G  L E+++GR
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 59.6 bits (144), Expect = 4e-10
 Identities = 60/207 (28%), Positives = 89/207 (42%), Gaps = 26/207 (12%)

Query: 91  IGEGKFGEVYKGLLQDGM---LVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVTLLG 143
           IG G FG+V  G +  G     V +K+ R  A  QE   F++E     S+QH NL+  LG
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 144 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 203
            C E     L+ E+ P G +  +L    +      +      +A   A GL HLH     
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--KNN 120

Query: 204 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF---------LAS 254
            +H D    N L+  D   K+ D GL +   + D       VT D+++         L  
Sbjct: 121 FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY-----YVTPDQLWVPLRWIAPELVD 175

Query: 255 EVKE---FRRFSEKSDVYSFGVFLLEL 278
           EV         +++S+V+S GV + EL
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 60.2 bits (146), Expect = 5e-10
 Identities = 51/233 (21%), Positives = 88/233 (37%), Gaps = 55/233 (23%)

Query: 89  NLIGEGKFGEVYKGL-LQDGMLVAIKK-------RPGAPTQEFIDEVCF----------L 130
             +GEG +G+V K      G +VAIKK             ++ +               +
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 131 ASIQHRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQV--SRQKLEFKHRLSIA 187
             I+H N++ L+  Y +         ++I N  + I      +V   + +L       I 
Sbjct: 75  NEIKHENIMGLVDVYVEG--------DFI-NLVMDIMASDLKKVVDRKIRLTESQVKCIL 125

Query: 188 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ--- 244
           L    GL  LH      +H+D   AN+ ++   I K+AD GL    G    +   S+   
Sbjct: 126 LQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDET 183

Query: 245 -----------VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                      VT    A E+ + +E     ++    D++S G    EL++G+
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAE-----KYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 58.8 bits (142), Expect = 6e-10
 Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 43/212 (20%)

Query: 91  IGEGKFGEVYKGLLQ---DGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLL 142
           +G G FG V KG+ +       VA+K         A   E + E   +  + +  +V ++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 143 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIALGAAKGLAHLHSLS 201
           G C+  +   L+ E    G ++  L     V+ + + E  H++S+      G+ +L   +
Sbjct: 63  GICEAESW-MLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM------GMKYLEETN 115

Query: 202 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL--------- 252
              VH+D    NVL+     AK++D GL            S  + ADE +          
Sbjct: 116 --FVHRDLAARNVLLVTQHYAKISDFGL------------SKALGADENYYKAKTHGKWP 161

Query: 253 ----ASEVKEFRRFSEKSDVYSFGVFLLELVS 280
               A E   + +FS KSDV+SFGV + E  S
Sbjct: 162 VKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 59.0 bits (143), Expect = 7e-10
 Identities = 44/150 (29%), Positives = 72/150 (48%), Gaps = 16/150 (10%)

Query: 91  IGEGKFGEVYKGLLQD-GMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 143
           IGEG +G V+K   ++   +VA+K+        G P+     E+C L  ++H+N+V L  
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-REICLLKELKHKNIVRLYD 66

Query: 144 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 203
               +    L++EY       +  Y  S      ++ +   S      KGLA  H  S  
Sbjct: 67  VLHSDKKLTLVFEYCDQ---DLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCH--SHN 119

Query: 204 VVHKDFKTANVLVDEDFIAKVADAGL-RNF 232
           V+H+D K  N+L++++   K+AD GL R F
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAF 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 59.0 bits (143), Expect = 7e-10
 Identities = 69/303 (22%), Positives = 119/303 (39%), Gaps = 70/303 (23%)

Query: 90  LIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFID-----EVCFLASIQHRNLVTLLG 143
           L+GEG +G V K   ++ G +VAIKK   +   + +      E+  L  ++H NLV L+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 144 YCQENNLQFLIYEYI-----------PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK 192
             +     +L++E++           PNG                L+            +
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPNG----------------LDESRVRKYLFQILR 111

Query: 193 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 249
           G+   HS +  ++H+D K  N+LV +  + K+ D G    L     A P    T   A  
Sbjct: 112 GIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTL-----AAPGEVYTDYVATR 164

Query: 250 IFLASE--VKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 307
            + A E  V +  ++    D+++ G  + E+++G      L P  S D+ +L    +   
Sbjct: 165 WYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTG----EPLFPGDS-DIDQLYHIIKCLG 218

Query: 308 NLLKILDE-----------RLWSTFTNEGME--------EFIQLIVRCLDPSSERRPSMS 348
           NL+    E           RL      E +E          + L  +CL    + RPS S
Sbjct: 219 NLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSS 278

Query: 349 DVV 351
            ++
Sbjct: 279 QLL 281

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 59.6 bits (145), Expect = 7e-10
 Identities = 72/296 (24%), Positives = 105/296 (35%), Gaps = 70/296 (23%)

Query: 90  LIGEGKFGEVYKGLL---QDGMLVAIK--------KRPGAPTQEFIDEVCFLASIQHRNL 138
           +IG G FGEV+  L+     G + A+K        KR          E   LA      +
Sbjct: 8   VIGRGAFGEVW--LVRDKDTGQVYAMKVLRKSDMIKRN--QIAHVRAERDILADADSPWI 63

Query: 139 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKH-RLSIA-LGAAKGLAH 196
           V L    Q+    +L+ EY+P G +   L     + +     +  R  IA L  A  L  
Sbjct: 64  VKLYYSFQDEEHLYLVMEYMPGGDLMNLL-----IRKDVFPEETARFYIAELVLA--LDS 116

Query: 197 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-------------------RNFLGRTD 237
           +H L    +H+D K  N+L+D D   K+AD GL                     F     
Sbjct: 117 VHKL--GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174

Query: 238 VAGPSSQV----------TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS 287
           V     +           T D  ++A EV     +  + D +S GV L E++ G      
Sbjct: 175 VRRRDHKQRRVRANSTVGTPD--YIAPEVLRGTPYGLECDWWSLGVILYEMLYGF----- 227

Query: 288 LSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSER 343
             P  S  L E      ++   L+   +   S        E I LI R L    +R
Sbjct: 228 -PPFYSDTLQETYNKIINWKESLRFPPDPPVS-------PEAIDLICRLLCDPEDR 275

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 58.9 bits (142), Expect = 8e-10
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 23/211 (10%)

Query: 84  NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAP-TQEFIDEV----C---FLASIQ 134
           N+    L+G G FGEVY     D G  +A+K+ P  P +QE   EV    C    L +++
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 135 HRNLVTLLGYC----QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 190
           H  +V   G C    +E  L   + EY+P GS+   L     ++ + +  ++   I    
Sbjct: 63  HDRIVQYYG-CLRDPEEKKLSIFV-EYMPGGSIKDQLKAYGALT-ENVTRRYTRQIL--- 116

Query: 191 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS-SQVTADE 249
            +G+++LHS    +VH+D K AN+L D     K+ D G    +    ++G     VT   
Sbjct: 117 -QGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173

Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            +++ EV     +  K+DV+S    ++E+++
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 58.5 bits (141), Expect = 9e-10
 Identities = 66/273 (24%), Positives = 120/273 (43%), Gaps = 32/273 (11%)

Query: 91  IGEGKFGEVYKGL-LQDGMLVA---IKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 146
           +G G +G+VYK   L  G L A   IK  PG        E+  +   +H N+V   G   
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 147 ENNLQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 204
                ++  EY   GS+    H+ GP  +S  ++ +  R ++     +GLA+LHS     
Sbjct: 77  SREKLWICMEYCGGGSLQDIYHVTGP--LSELQIAYVCRETL-----QGLAYLHSKGK-- 127

Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR--- 261
           +H+D K AN+L+ ++   K+AD G+   +  T              ++A EV    +   
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKI--TATIAKRKSFIGTPYWMAPEVAAVEKNGG 185

Query: 262 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF 321
           +++  D+++ G+  +EL   +     L P     +  L   S+      K+ D+  WS+ 
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHP-----MRALFLMSKSNFQPPKLKDKTKWSS- 239

Query: 322 TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
                  F+++    L  + ++RP+   ++T L
Sbjct: 240 ---TFHNFVKI---SLTKNPKKRPTAERLLTHL 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 35/216 (16%)

Query: 89  NLIGEGKFGEVYKGLLQD-GMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTL 141
             IGEG +G+VYK   +D G LVA+KK      + G P    I E+  L  + HRN+V L
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITA-IREIKILRQLNHRNIVNL 71

Query: 142 ----------LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA 191
                     L + ++    +L++EY+ +      L G  +         H  S      
Sbjct: 72  KEIVTDKQDALDFKKDKGAFYLVFEYMDH-----DLMGLLESGLVHFSEDHIKSFMKQLL 126

Query: 192 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA---- 247
           +GL + H  +   +H+D K +N+L++     K+AD GL       +    +++V      
Sbjct: 127 EGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYR 184

Query: 248 -DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
             E+ L  E     R+    DV+S G  L EL + +
Sbjct: 185 PPELLLGEE-----RYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 66/272 (24%), Positives = 116/272 (42%), Gaps = 44/272 (16%)

Query: 88  KNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEF----IDEVCFLASIQHRNLVTLL 142
           + ++G G  G VYK   L    ++A+K  P   T E     + E+  L       ++   
Sbjct: 6   QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65

Query: 143 G-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 201
           G +  EN +  +  E++  GS+ ++   P  V  +         IA+   KGL +L SL 
Sbjct: 66  GAFFVENRIS-ICTEFMDGGSLDVYRKIPEHVLGR---------IAVAVVKGLTYLWSL- 114

Query: 202 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 261
            +++H+D K +N+LV+     K+ D G+   L    V   +        ++A E     +
Sbjct: 115 -KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISGEQ 169

Query: 262 FSEKSDVYSFGVFLLELVSGR-------EASSSLSPDSSQDLVELVQNSRDFSNLLKILD 314
           +   SDV+S G+  +EL  GR       +   SL P      ++L+Q          I+D
Sbjct: 170 YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP------LQLLQC---------IVD 214

Query: 315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 346
           E        +  E+F+  I +C+    + RP+
Sbjct: 215 EDPPVLPVGQFSEKFVHFITQCMRKQPKERPA 246

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 57.9 bits (141), Expect = 1e-09
 Identities = 67/271 (24%), Positives = 104/271 (38%), Gaps = 53/271 (19%)

Query: 91  IGEGKFGEVYK-GLLQDGMLVAIK--------KRPGAPTQEFIDEVCFLASIQHRNLVTL 141
           +G+G FG+V        G L A+K        KR        + E   L+ I H  +V L
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEH--TLTERNILSRINHPFIVKL 58

Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK--------G 193
               Q     +L+ EY P G +  HL                   +   A+         
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGELFSHLS-------------KEGRFSEERARFYAAEIVLA 105

Query: 194 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 253
           L +LHSL   ++++D K  N+L+D D   K+ D GL   L        +   T +  +LA
Sbjct: 106 LEYLHSL--GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPE--YLA 161

Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 313
            EV   + + +  D +S GV L E+++G+       P  ++D  E+ +         KIL
Sbjct: 162 PEVLLGKGYGKAVDWWSLGVLLYEMLTGK------PPFYAEDRKEIYE---------KIL 206

Query: 314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERR 344
            + L   F      E   LI   L     +R
Sbjct: 207 KDPL--RFPEFLSPEARDLISGLLQKDPTKR 235

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 57.8 bits (139), Expect = 1e-09
 Identities = 69/254 (27%), Positives = 116/254 (45%), Gaps = 46/254 (18%)

Query: 84  NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKK---RPGAP-TQEFID----EVCFLASIQ 134
           N+    L+G+G FG VY     D G  +A K+    P +P T + +     E+  L ++Q
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 135 HRNLVTLLGYCQENNLQFL--IYEYIPNGSVSIHL--YGP------SQVSRQKLEFKHRL 184
           H  +V   G  ++   + L    EY+P GSV   L  YG        + +RQ LE     
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE----- 117

Query: 185 SIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS-S 243
                   G+++LHS    +VH+D K AN+L D     K+ D G    L    ++G    
Sbjct: 118 --------GMSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR 167

Query: 244 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR------EASSSL-----SPDS 292
            VT    +++ EV     +  K+DV+S G  ++E+++ +      EA +++      P +
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN 227

Query: 293 SQDLVELVQNSRDF 306
            Q    + +++RDF
Sbjct: 228 PQLPSHISEHARDF 241

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 37/212 (17%)

Query: 91  IGEGKFGEVYKGLL----QDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTL 141
           IGEG FG   K +L    +DG    IK     K      +E   EV  L++++H N+V  
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64

Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQV---SRQKLEFKHRLSIALGAAKGLAHLH 198
               +EN   +++ +Y   G +   +     V     Q L++  ++ +AL       H+H
Sbjct: 65  QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL------KHVH 118

Query: 199 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF------LGRTDVAGPSSQVTADEIFL 252
               +++H+D K+ N+ + +D   K+ D G+         L RT +  P         +L
Sbjct: 119 D--RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTP--------YYL 168

Query: 253 ASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 284
           + E+ E R ++ KSD+++ G  L E+ + + A
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYEMCTLKHA 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 58.2 bits (140), Expect = 2e-09
 Identities = 64/274 (23%), Positives = 122/274 (44%), Gaps = 30/274 (10%)

Query: 83  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKR--PGAPTQEFI-DEVCFLASIQHRNL 138
           K ++    IG+G  G VY  + +  G  VAIK+      P +E I +E+  +   ++ N+
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNI 78

Query: 139 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 198
           V  L      +  +++ EY+  GS++        V+   ++     ++     + L  LH
Sbjct: 79  VNYLDSYLVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALDFLH 132

Query: 199 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR-TDVAGPSSQVTADEIFLASEVK 257
           S   +V+H+D K+ N+L+  D   K+ D G   F  + T      S +     ++A EV 
Sbjct: 133 S--NQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSTMVGTPYWMAPEVV 187

Query: 258 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 317
             + +  K D++S G+  +E+V G     + +P  +  L+     + +  N      ERL
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQN-----PERL 241

Query: 318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
            + F +         + RCL+   +RR S  +++
Sbjct: 242 SAVFRD--------FLNRCLEMDVDRRGSAKELL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 64/274 (23%), Positives = 122/274 (44%), Gaps = 28/274 (10%)

Query: 83  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKR--PGAPTQEFI-DEVCFLASIQHRNL 138
           K ++    IG+G  G VY  + +  G  VAIK+      P +E I +E+  +   +H N+
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNI 78

Query: 139 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 198
           V  L      +  +++ EY+  GS++        V+   ++     ++     + L  LH
Sbjct: 79  VNYLDSYLVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALEFLH 132

Query: 199 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 258
           S   +V+H+D K+ N+L+  D   K+ D G    +  T      S +     ++A EV  
Sbjct: 133 S--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAPEVVT 188

Query: 259 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 318
            + +  K D++S G+  +E+V G     + +P  +  L+     + +  N      E+L 
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQN-----PEKLS 242

Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT 352
           + F      +F+    RCL+   E+R S  +++ 
Sbjct: 243 AIF-----RDFLN---RCLEMDVEKRGSAKELLQ 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 57.0 bits (137), Expect = 4e-09
 Identities = 61/273 (22%), Positives = 121/273 (44%), Gaps = 28/273 (10%)

Query: 83  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKR--PGAPTQEFI-DEVCFLASIQHRNL 138
           K ++    IG+G  G VY  + +  G  VAI++      P +E I +E+  +   ++ N+
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79

Query: 139 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 198
           V  L      +  +++ EY+  GS++        V+   ++     ++     + L  LH
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALEFLH 133

Query: 199 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 258
           S   +V+H+D K+ N+L+  D   K+ D G    +  T      S +     ++A EV  
Sbjct: 134 S--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAPEVVT 189

Query: 259 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 318
            + +  K D++S G+  +E++ G     + +P  +  L+     + +  N      E+L 
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-TNGTPELQN-----PEKLS 243

Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
           + F +         + RCLD   E+R S  +++
Sbjct: 244 AIFRD--------FLNRCLDMDVEKRGSAKELL 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 56.6 bits (136), Expect = 4e-09
 Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 37/220 (16%)

Query: 84  NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKK---RPGAP-TQEFID----EVCFLASIQ 134
           N+    L+G+G FG VY     D G  +A+K+    P +P T + ++    E+  L ++ 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 135 HRNLVTLLGYC---QENNLQFLIYEYIPNGSVSIHL--YGP------SQVSRQKLEFKHR 183
           H  +V   G      E  L   + E++P GS+   L  YG        + +RQ LE    
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFM-EHMPGGSIKDQLKSYGALTENVTRKYTRQILE---- 117

Query: 184 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS- 242
                    G+++LHS    +VH+D K AN+L D     K+ D G    L    ++G   
Sbjct: 118 ---------GVSYLHS--NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGM 166

Query: 243 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
             VT    +++ EV     +  K+D++S G  ++E+++ +
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 53/237 (22%), Positives = 107/237 (45%), Gaps = 21/237 (8%)

Query: 91  IGEGKFGEVYKGLLQD-GMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 146
           IGEG  G V    ++  G LVA+KK   R     +   +EV  +   QH N+V +     
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 147 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 206
             +  +++ E++  G+++        V+  ++  +   ++ L   K L+ LH+    V+H
Sbjct: 88  VGDELWVVMEFLEGGALT------DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG--VIH 139

Query: 207 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ-VTADEIFLASEVKEFRRFSEK 265
           +D K+ ++L+  D   K++D G   F  +     P  + +     ++A E+     +  +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPE 196

Query: 266 SDVYSFGVFLLELVSGREASSSLSPDSSQDLVE-----LVQNSRDFSNLLKILDERL 317
            D++S G+ ++E+V G     +  P  +  ++       ++N    S  LK   +RL
Sbjct: 197 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRL 253

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 71/268 (26%), Positives = 113/268 (42%), Gaps = 44/268 (16%)

Query: 90  LIGEGKFGEVY----KGLLQDGMLVAIKKRPGAPTQE----FIDEVCFLASIQHRNLVTL 141
           ++G+G FG+V+    KG  Q   + A+KK       +     +++     + +H  L  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 201
               Q     F + EY+  G +  H+      S  K +       A     GL  LHS  
Sbjct: 62  YCTFQTKENLFFVMEYLNGGDLMFHIQ-----SCHKFDLPRATFYAAEIICGLQFLHSKG 116

Query: 202 PRVVHKDFKTANVLVDEDFIAKVADAGL--RNFLG--RTDVAGPSSQVTADEIFLASEVK 257
             +V++D K  N+L+D D   K+AD G+   N LG  +T     +    A EI L     
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG---- 170

Query: 258 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 317
             ++++   D +SFGV L E++ G+      SP    D  EL Q+ R        +D   
Sbjct: 171 --QKYNTSVDWWSFGVLLYEMLIGQ------SPFHGHDEEELFQSIR--------MDNPC 214

Query: 318 WSTF-TNEGMEEFIQLIVRCLDPSSERR 344
           +  + T E  +  ++L VR      ERR
Sbjct: 215 YPRWLTREAKDILVKLFVR----EPERR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 71/282 (25%), Positives = 123/282 (43%), Gaps = 47/282 (16%)

Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEV-----CFLASIQHRNLVTLLGY 144
           IG+G +G+V+K L  ++G   A+K     P  +  +E+        A   H N+V   G 
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILD--PIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83

Query: 145 CQENNLQ-----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS------IALGAAKG 193
             + +++     +L+ E    GSV+        + +  L+   R+       I   A  G
Sbjct: 84  YYKKDVKNGDQLWLVLELCNGGSVT-------DLVKGFLKRGERMEEPIIAYILHEALMG 136

Query: 194 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----ADE 249
           L HLH    + +H+D K  N+L+  +   K+ D G+   L  T +   +S  T    A E
Sbjct: 137 LQHLHV--NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 194

Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL 309
           + +A E +    +  + DV+S G+  +EL  G    + L P   + L ++ +N       
Sbjct: 195 V-IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP--MRALFKIPRNPPP---- 247

Query: 310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
             +    LWS        EF   I +CL    E+RP++SD++
Sbjct: 248 -TLHQPELWSN-------EFNDFIRKCLTKDYEKRPTVSDLL 281

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 54.0 bits (129), Expect = 3e-08
 Identities = 62/273 (22%), Positives = 121/273 (44%), Gaps = 28/273 (10%)

Query: 83  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAPTQEFI-DEVCFLASIQHRNL 138
           K ++    IG+G  G V+  + +  G  VAIK+      P +E I +E+  +  +++ N+
Sbjct: 19  KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI 78

Query: 139 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 198
           V  L      +  F++ EY+  GS++        V+   ++     ++     + L  LH
Sbjct: 79  VNFLDSFLVGDELFVVMEYLAGGSLT------DVVTETCMDEAQIAAVCRECLQALEFLH 132

Query: 199 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 258
           +   +V+H+D K+ NVL+  D   K+ D G    +  T      S +     ++A EV  
Sbjct: 133 A--NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAPEVVT 188

Query: 259 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 318
            + +  K D++S G+  +E+V G     + +P  +  L+     + +  N      E+L 
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQN-----PEKLS 242

Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
             F +         + RCL+   E+R S  +++
Sbjct: 243 PIFRD--------FLNRCLEMDVEKRGSAKELL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 53.4 bits (129), Expect = 4e-08
 Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 34/211 (16%)

Query: 91  IGEGKFGEVY---KGLLQDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTL 141
           I +G +G V+   K    D  + AIK    A         + + E   L+  Q   +V L
Sbjct: 1   ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 142 L-GYCQENNLQFLIYEYIPNGSVS--IHLYG--PSQVSRQKLEFKHRLSIALGAAKGLAH 196
              +  + NL +L+ EY+P G ++  +   G     V+R  +       I L     L +
Sbjct: 59  YYSFQGKKNL-YLVMEYLPGGDLASLLENVGSLDEDVARIYIA-----EIVLA----LEY 108

Query: 197 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL------RNFLGRTDVAGPSSQVTADEI 250
           LHS    ++H+D K  N+L+D +   K+ D GL      R  +   D      ++     
Sbjct: 109 LHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166

Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
           ++A EV   +  S+  D +S G  L E + G
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 53.8 bits (130), Expect = 5e-08
 Identities = 49/169 (28%), Positives = 70/169 (41%), Gaps = 48/169 (28%)

Query: 91  IGEGKFGEVYKGLLQ---DGMLVAIKKRPGAPT------QEFIDEVCFLASIQHRNLVTL 141
           IG G +G VYK   +   DG   AIKK  G         Q    E+  L  ++H N+V+L
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 142 LGYCQENNLQ--FLIYEYIP------------NGSVSIHLYGPSQVSR---QKLEFKHRL 184
           +    E+  +  +L+++Y                 VSI    PS V     Q L      
Sbjct: 68  VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIP---PSMVKSLLWQILN----- 119

Query: 185 SIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGL 229
                   G+ +LH  S  V+H+D K AN+LV     E  + K+ D GL
Sbjct: 120 --------GVHYLH--SNWVLHRDLKPANILVMGEGPERGVVKIGDLGL 158

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 27/211 (12%)

Query: 85  FSDKNLIGEGKFGEVYKGLLQ-DGMLVA--------IKKRPGAPTQEFIDEVCFLASIQH 135
           F    ++G+G FGEV    ++  G + A        IKKR G      ++E   L  +  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNS 59

Query: 136 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 195
           R +V+L    +  +   L+   +  G +  H+Y    +     E    +  A     GL 
Sbjct: 60  RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY---HMGEAGFEEGRAVFYAAEICCGLE 116

Query: 196 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI----F 251
            LH    R+V++D K  N+L+D+    +++D GL        V  P  Q     +    +
Sbjct: 117 DLHQ--ERIVYRDLKPENILLDDHGHIRISDLGLA-------VHVPEGQTIKGRVGTVGY 167

Query: 252 LASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
           +A EV +  R++   D ++ G  L E+++G+
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 54.0 bits (130), Expect = 5e-08
 Identities = 57/214 (26%), Positives = 90/214 (42%), Gaps = 30/214 (14%)

Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGY 144
           IG G FG V+     +DG  VA+KK P         +    E+  L   +H N+++ L  
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67

Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 204
            Q  ++      Y+    +   L+    VS Q L   H         +GL +LHS    +
Sbjct: 68  LQPPHIDPFEEIYVVTELMQSDLH-KIIVSPQPLSSDHVKVFLYQILRGLKYLHS--AGI 124

Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---------ADEIFLASE 255
           +H+D K  N+LV+ + + K+ D G    L R +    S  +T         A EI + S 
Sbjct: 125 LHRDIKPGNLLVNSNCVLKICDFG----LARVEEPDESKHMTQEVVTQYYRAPEILMGS- 179

Query: 256 VKEFRRFSEKSDVYSFGVFLLELVSGR---EASS 286
               R ++   D++S G    EL+  R   +A S
Sbjct: 180 ----RHYTSAVDIWSVGCIFAELLGRRILFQAQS 209

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 53.7 bits (129), Expect = 6e-08
 Identities = 74/277 (26%), Positives = 117/277 (42%), Gaps = 39/277 (14%)

Query: 83  KNFSDKNLIGEGKFGEVYKGLLQD---GMLVAIK--KRPGAPTQE---FIDEVCFLASIQ 134
           K+F  K+L+G G FGEV   ++++   G + A+K  K+     QE   F +E   + SI 
Sbjct: 1   KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58

Query: 135 HRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 193
           +   +  L Y  Q+ +  +L+ EY P G +       S ++R + +F   ++    A   
Sbjct: 59  NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLL------SLLNRYEDQFDEDMAQFYLAELV 112

Query: 194 LAHLHSLSPR-VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL 252
           LA +HS+     VH+D K  NVL+D     K+AD G    L    +      V   + ++
Sbjct: 113 LA-IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPD-YI 170

Query: 253 ASEVKEFRRFSEKS------DVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 306
           A EV        K       D +S GV   E++ GR      SP       +   N  +F
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR------SPFHEGTSAKTYNNIMNF 224

Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSER 343
              LK  ++   S        +F+ LI   L    ER
Sbjct: 225 QRFLKFPEDPKVS-------SDFLDLIQSLLCGQKER 254

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 52.9 bits (127), Expect = 9e-08
 Identities = 45/178 (25%), Positives = 84/178 (47%), Gaps = 33/178 (18%)

Query: 186 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAGP 241
           IA+   +GL +L+++  R++H+D K +N+LV+     K+ D G    L N +  T V G 
Sbjct: 108 IAVAVVEGLTYLYNVH-RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-GT 165

Query: 242 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR-----EASSSLSPDSSQDL 296
           S+       +++ E  +  +++ KSDV+S G+ ++EL  G+             D    +
Sbjct: 166 ST-------YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI 218

Query: 297 VELVQNSRDFSNLLKILDE---RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
           ++L+Q         +I+ E   RL S+   E + +F+     CL      RP+   + 
Sbjct: 219 LDLLQ---------QIVQEPPPRLPSSDFPEDLRDFVD---ACLLKDPTERPTPQQLC 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 46/199 (23%), Positives = 85/199 (42%), Gaps = 30/199 (15%)

Query: 170 PSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 229
             ++ ++ L  +  +S +   A+G+  L S   + +H+D    N+L+ E+ + K+ D GL
Sbjct: 162 GDELYKEPLTLEDLISYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGL 219

Query: 230 R-------NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                   +++ + D   P   +  + IF        + ++ +SDV+SFGV L E+ S  
Sbjct: 220 ARDIYKDPDYVRKGDARLPLKWMAPESIF-------DKVYTTQSDVWSFGVLLWEIFS-- 270

Query: 283 EASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSE 342
              +S  P         VQ   +F   LK   E            E   +++ C   + E
Sbjct: 271 -LGASPYPG--------VQIDEEFCRRLK---EGTRMRAPEYATPEIYSIMLDCWHNNPE 318

Query: 343 RRPSMSDVVTELDRTLDKE 361
            RP+ S++V  L   L + 
Sbjct: 319 DRPTFSELVEILGDLLQEN 337

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 41/211 (19%)

Query: 91  IGEGKFGEVYKGL--LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLG 143
           +GEG +  VYKG   L D  LVA+K+       GAP    I EV  L  ++H N+VTL  
Sbjct: 14  LGEGTYATVYKGRSKLTDN-LVALKEIRLEHEEGAPCTA-IREVSLLKDLKHANIVTLHD 71

Query: 144 YCQENNLQFLIYEYIP--------NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 195
                    L++EY+         +   SI+++       Q L             +GL 
Sbjct: 72  IIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLL-------------RGLN 118

Query: 196 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----ADEIF 251
           + H    +V+H+D K  N+L++E    K+AD GL            +  VT      +I 
Sbjct: 119 YCHR--RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDIL 176

Query: 252 LASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
           L S       +S + D++  G    E+ +GR
Sbjct: 177 LGST-----DYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 27/204 (13%)

Query: 91  IGEGKFGEVYKGL--LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLG 143
           +GEG +  V+KG   L +  LVA+K+       GAP    I EV  L  ++H N+VTL  
Sbjct: 14  LGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTA-IREVSLLKDLKHANIVTLHD 71

Query: 144 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL-GAAKGLAHLHSLSP 202
               +    L++EY+      +  Y     +   +   H + I L    +GLA+ H    
Sbjct: 72  IVHTDKSLTLVFEYLDK---DLKQYMDDCGNIMSM---HNVKIFLYQILRGLAYCH--RR 123

Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----ADEIFLASEVKE 258
           +V+H+D K  N+L++E    K+AD GL            +  VT      ++ L S    
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSS--- 180

Query: 259 FRRFSEKSDVYSFGVFLLELVSGR 282
              +S + D++  G    E+ SGR
Sbjct: 181 --EYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 54/220 (24%), Positives = 95/220 (43%), Gaps = 37/220 (16%)

Query: 83  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEF----IDEVCFLASIQHRN 137
             + + + IGEG +G V        G+ VAIKK      Q F    + E+  L   +H N
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64

Query: 138 LVTLLGYCQENNLQ-----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK 192
           ++ +L   +  + +     +++ E +        LY    +  Q L   H         +
Sbjct: 65  IIGILDIIRPPSFESFNDVYIVQELMET-----DLY--KLIKTQHLSNDHIQYFLYQILR 117

Query: 193 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVT----- 246
           GL ++HS +  V+H+D K +N+L++ +   K+ D GL R      D    +  +T     
Sbjct: 118 GLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD---HTGFLTEYVAT 172

Query: 247 ----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
               A EI L S     + +++  D++S G  L E++S R
Sbjct: 173 RWYRAPEIMLNS-----KGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 51.4 bits (123), Expect = 3e-07
 Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 36/220 (16%)

Query: 81  ATKNFSD---KNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG----APTQEFIDEVCFLAS 132
           A K+ S+    N IG G  G VYK + +  G L A+K   G       ++   E+  L  
Sbjct: 69  AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRD 128

Query: 133 IQHRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQ----VSRQKLEFKHRLSIA 187
           + H N+V     +     +Q L+ E++  GS+        Q    V+RQ L         
Sbjct: 129 VNHPNVVKCHDMFDHNGEIQVLL-EFMDGGSLEGTHIADEQFLADVARQILS-------- 179

Query: 188 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT-----DVAGPS 242
                G+A+LH     +VH+D K +N+L++     K+AD G+   L +T        G  
Sbjct: 180 -----GIAYLHR--RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTI 232

Query: 243 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
           + ++ + I   +++          D++S GV +LE   GR
Sbjct: 233 AYMSPERI--NTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 51.6 bits (123), Expect = 4e-07
 Identities = 41/155 (26%), Positives = 73/155 (47%), Gaps = 3/155 (1%)

Query: 126 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 185
           E+  LA+  H  +V      + ++   LI EY   G ++  +    Q  ++ L F+    
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI---KQRLKEHLPFQEYEV 171

Query: 186 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 245
             L     LA     S +++H+D K+AN+ +    I K+ D G       +     +S  
Sbjct: 172 GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSF 231

Query: 246 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
                +LA E+ E +R+S+K+D++S GV L EL++
Sbjct: 232 CGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 50.6 bits (121), Expect = 4e-07
 Identities = 67/293 (22%), Positives = 120/293 (40%), Gaps = 65/293 (22%)

Query: 91  IGEGKFGEVYKGL---LQDG--------MLVAIKKRPGAPTQEFIDEVCFLASIQHRNLV 139
           +G+G F +++KG+   + D         +L  + K     ++ F +    ++ + H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH-LH 198
              G C   +   ++ EY+  GS+  +L        +K +    +S  L  AK LA  LH
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYL--------KKNKNLINISWKLEVAKQLAWALH 114

Query: 199 SLSPR-VVHKDFKTANVLV--DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL--- 252
            L  + + H +    NVL+  +ED        G   F+  +D  G S  V   EI L   
Sbjct: 115 FLEDKGLTHGNVCAKNVLLIREED-----RKTGNPPFIKLSD-PGISITVLPKEILLERI 168

Query: 253 ---ASE-VKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 308
                E ++  +  S  +D +SFG  L E+ SG                +   ++ D   
Sbjct: 169 PWVPPECIENPQNLSLAADKWSFGTTLWEIFSG---------------GDKPLSALDSQK 213

Query: 309 LLKILDERL------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 355
            L+  ++R       W+        E   LI +C+D   + RPS   ++ +L+
Sbjct: 214 KLQFYEDRHQLPAPKWT--------ELANLINQCMDYEPDFRPSFRAIIRDLN 258

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 50.5 bits (121), Expect = 4e-07
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 10/102 (9%)

Query: 186 IALGAAKGLAHLHS-LSPRVVHKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAG 240
           IA+   K L +LHS LS  V+H+D K +NVL++ +   K+ D G    L + + +T  AG
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAG 165

Query: 241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
               +  + I      K +     KSDV+S G+ ++EL +GR
Sbjct: 166 CKPYMAPERINPELNQKGY---DVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 64/273 (23%), Positives = 111/273 (40%), Gaps = 40/273 (14%)

Query: 91  IGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFIDEVC-------FLASIQHRNLVTLL 142
           +G+G +G+V+    +D G +VA+K R        ++EV         L + +   LV LL
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALK-RMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67

Query: 143 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF-KHRLSIALGAAKGLAHLHSLS 201
              Q++   +L  EY+P G     L     +S     F    +  A+ A      LH L 
Sbjct: 68  YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDA------LHELG 121

Query: 202 PRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEFR 260
              +H+D K  N L+D     K+ D GL +  +   +     S V + + ++A EV   +
Sbjct: 122 --YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYAN-----SVVGSPD-YMAPEVLRGK 173

Query: 261 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL---KILDERL 317
            +    D +S G  L E + G    S  +P+ +            + NL    + L   +
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET------------WENLKYWKETLQRPV 221

Query: 318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
           +        +E   LI + ++  S R  S+ D+
Sbjct: 222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDI 254

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 19/209 (9%)

Query: 83  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 134
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81

Query: 135 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 193
           H+N++ LL  +  + +L+     YI    +  +L    QV + +L+ +    +      G
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---CQVIQMELDHERMSYLLYQMLCG 138

Query: 194 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 253
           + HLHS    ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 139 IKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRA 193

Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
            EV     + E  D++S G  + E++ G 
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 50.0 bits (119), Expect = 8e-07
 Identities = 43/196 (21%), Positives = 91/196 (46%), Gaps = 16/196 (8%)

Query: 91  IGEGKFGEVYKGLLQ-DGMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 146
           IGEG  G V     +  G  VA+KK   R     +   +EV  +    H N+V +     
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 147 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 206
             +  +++ E++  G+++        V+  ++  +   ++ L   + L++LH+    V+H
Sbjct: 90  VGDELWVVMEFLEGGALT------DIVTHTRMNEEQIATVCLSVLRALSYLHNQG--VIH 141

Query: 207 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ-VTADEIFLASEVKEFRRFSEK 265
           +D K+ ++L+  D   K++D G   F  +     P  + +     ++A EV     +  +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFG---FCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTE 198

Query: 266 SDVYSFGVFLLELVSG 281
            D++S G+ ++E++ G
Sbjct: 199 VDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 49.4 bits (118), Expect = 9e-07
 Identities = 61/281 (21%), Positives = 119/281 (42%), Gaps = 44/281 (15%)

Query: 90  LIGEGKFGEVYKGLLQDG--MLVAIK-------------KRPGAPTQEFIDEVCFL-ASI 133
            +G G FG VYK   ++    L+A+K             +       + + EV  +   +
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 193
           +H N+V       EN+  +++ + I    +  H     +  +Q+   +   +I +     
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLA 125

Query: 194 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE---I 250
           L +LH    R+VH+D    N+++ ED    + D GL           P S++T+     +
Sbjct: 126 LRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGL------AKQKQPESKLTSVVGTIL 178

Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPD-SSQDLVELVQNSRDFSNL 309
           +   E+ +   + EK+DV++FG  L ++        +L P   S +++ L   ++    +
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMC-------TLQPPFYSTNMLSLA--TKIVEAV 229

Query: 310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
            + L E ++S       E+   +I  CL P +E RP +  V
Sbjct: 230 YEPLPEGMYS-------EDVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 51/217 (23%)

Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 143
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83

Query: 144 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIALGAAKGL 194
                   +E N  +L+           HL G    + V  QKL   H   +     +GL
Sbjct: 84  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 133

Query: 195 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---- 250
            ++HS    ++H+D K +N+ V+ED   K+ D GL             ++ T DE+    
Sbjct: 134 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGL-------------ARHTDDEMTGYV 178

Query: 251 ----FLASEVK-EFRRFSEKSDVYSFGVFLLELVSGR 282
               + A E+   +  +++  D++S G  + EL++GR
Sbjct: 179 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 56/243 (23%), Positives = 106/243 (43%), Gaps = 16/243 (6%)

Query: 91  IGEGKFGEVYKGLLQ-DGMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 146
           IGEG  G V     +  G  VA+K    R     +   +EV  +   QH+N+V +     
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 147 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 206
                +++ E++  G+++        VS+ +L  +   ++     + L +LHS    V+H
Sbjct: 89  VGEELWVLMEFLQGGALT------DIVSQTRLNEEQIATVCESVLQALCYLHSQG--VIH 140

Query: 207 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKS 266
           +D K+ ++L+  D   K++D G    + + DV    S V     ++A EV     +  + 
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISK-DVPKRKSLV-GTPYWMAPEVISRTPYGTEV 198

Query: 267 DVYSFGVFLLELVSGREASSSLSPDSSQDLV--ELVQNSRDFSNLLKILDERLWSTFTNE 324
           D++S G+ ++E+V G     S SP  +   +        ++   +  +L + L    T E
Sbjct: 199 DIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTRE 258

Query: 325 GME 327
             E
Sbjct: 259 PQE 261

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 64/279 (22%), Positives = 119/279 (42%), Gaps = 52/279 (18%)

Query: 91  IGEGKFGEVYKGLL---QDGMLVAIKK----------RPGAPTQEFIDEVCFLASIQHRN 137
           +G+G +GEV   L+    DG    IKK          R  A       E   L+ ++H N
Sbjct: 8   VGKGSYGEV--SLVRHRTDGKQYVIKKLNLRNASRRERKAAE-----QEAQLLSQLKHPN 60

Query: 138 LVTLLGYCQ-ENNLQFLIYEYIPNGSVSIHLY---GPSQVSRQKLEFKHRLSIALGAAKG 193
           +V      + E+ L +++  +   G +   L    G      Q +E+  ++++AL     
Sbjct: 61  IVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL----- 115

Query: 194 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFL 252
             +LH     ++H+D KT NV +    I KV D G+   L  + D+A   S +     ++
Sbjct: 116 -QYLHE--KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA---STLIGTPYYM 169

Query: 253 ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 312
           + E+   + ++ KSDV++ G  + E+ + + A                 N++D ++L+  
Sbjct: 170 SPELFSNKPYNYKSDVWALGCCVYEMATLKHAF----------------NAKDMNSLVYR 213

Query: 313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
           + E        +   E  +LI   L    E+RPS+  ++
Sbjct: 214 IIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 25/203 (12%)

Query: 91  IGEGKFGEVYKGLLQ-DGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           +GEG +  V+KG  +    LVA+K+       GAP    I EV  L +++H N+VTL   
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTA-IREVSLLKNLKHANIVTLHDI 71

Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL-GAAKGLAHLHSLSPR 203
                   L++EY+ +  +  +L          L   H + I +    +GL++ H    +
Sbjct: 72  IHTERCLTLVFEYLDS-DLKQYLDNCGN-----LMSMHNVKIFMFQLLRGLSYCH--KRK 123

Query: 204 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----ADEIFLASEVKEF 259
           ++H+D K  N+L++E    K+AD GL            +  VT      ++ L S     
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGST---- 179

Query: 260 RRFSEKSDVYSFGVFLLELVSGR 282
             +S   D++  G  L E+ +GR
Sbjct: 180 -EYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 49.7 bits (118), Expect = 1e-06
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 19/206 (9%)

Query: 83  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 134
           K + +   IG G  G V   Y  +L     VAIKK  RP       +    E+  +  + 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74

Query: 135 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 193
           H+N+++LL  +  + +L+     Y+    +  +L    QV + +L+ +    +      G
Sbjct: 75  HKNIISLLNVFTPQKSLEEFQDVYLVMELMDANL---CQVIQMELDHERMSYLLYQMLCG 131

Query: 194 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 253
           + HLHS    ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 132 IKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP---YVVTRYYRA 186

Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELV 279
            EV     + E  D++S G  + E+V
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 26/205 (12%)

Query: 90  LIGEGKFGEV----------YKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLV 139
           L+G+G FG+V          Y  +      V I K   A T   + E   L + +H  L 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHT---LTESRVLKNTRHPFLT 58

Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA--AKGLAHL 197
           +L    Q  +    + EY+  G +  HL      SR+++ F    +   GA     L +L
Sbjct: 59  SLKYSFQTKDRLCFVMEYVNGGELFFHL------SRERV-FSEDRTRFYGAEIVSALDYL 111

Query: 198 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK 257
           HS   ++V++D K  N+++D+D   K+ D GL    G TD A   +     E +LA EV 
Sbjct: 112 HS--GKIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPE-YLAPEVL 167

Query: 258 EFRRFSEKSDVYSFGVFLLELVSGR 282
           E   +    D +  GV + E++ GR
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 59/286 (20%), Positives = 105/286 (36%), Gaps = 67/286 (23%)

Query: 84  NFSDKNLIGEGKFGEVYKGLLQDGMLV----------AIKKRPGAPTQEFIDEVCFLASI 133
           +F    +IG+G FG+V     +D   +           ++K      +  ++E   L  +
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGS---VRNVLNERRILQEL 57

Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKH---RLSIALGA 190
            H  LV L    Q+    +L+ + +  G +  HL        QK++F     +  I    
Sbjct: 58  NHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL-------SQKVKFSEEQVKFWIC-EI 109

Query: 191 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 250
              L +LHS    ++H+D K  N+L+DE     + D  +            +++VT D +
Sbjct: 110 VLALEYLHS--KGIIHRDIKPDNILLDEQGHVHITDFNI------------ATKVTPDTL 155

Query: 251 ---------FLASEVKEFRRFSEKSDVYSFGVFLLELVSGR---EASSSLSPDSSQDLVE 298
                    ++A EV   + +S   D +S GV   E + G+      S       Q   +
Sbjct: 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI--RDQIRAK 213

Query: 299 LVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERR 344
                  +           WST       E I  I + L+   ++R
Sbjct: 214 QETADVLYPA--------TWST-------EAIDAINKLLERDPQKR 244

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 22/147 (14%)

Query: 204 VVHKDFKTANVLVDEDFIAKVADAGLRNFL----GRTDVAGPSSQVTADEIFLASEVKEF 259
           V+H+D K +N+L+D     K+ D G+   L     +T  AG ++ +  + I         
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERI---DPPDPN 192

Query: 260 RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS 319
            ++  ++DV+S G+ L+EL +G+       P              +F  L KIL E   S
Sbjct: 193 PKYDIRADVWSLGISLVELATGQ------FP--------YKNCKTEFEVLTKILQEEPPS 238

Query: 320 TFTNEGME-EFIQLIVRCLDPSSERRP 345
              NEG   +F   +  CL     +RP
Sbjct: 239 LPPNEGFSPDFCSFVDLCLTKDHRKRP 265

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 23/221 (10%)

Query: 90  LIGEGKFGEVYKGLLQ-DGMLVAIK---KRPGAPTQE----FIDEVCFLASIQHRNLVTL 141
           +IG+G FG+V     + +    A+K   K+     +E      +    L +++H  LV L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 201
               Q  +  + + +YI  G +  HL    Q  R  LE + R   A   A  L +LHSL+
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHL----QRERCFLEPRARF-YAAEIASALGYLHSLN 116

Query: 202 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 261
             +V++D K  N+L+D      + D GL       +  G +S       +LA EV   + 
Sbjct: 117 --IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172

Query: 262 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 302
           +    D +  G  L E++ G      L P  S++  E+  N
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG------LPPFYSRNTAEMYDN 207

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 20/202 (9%)

Query: 90  LIGEGKFGEVY---KGLLQD-GMLVAIKKRPGAPTQEFIDEV------CFLASIQHRNLV 139
           ++G+G FG+V+   K    D G L A+K    A T +  D V        LA + H  +V
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKA-TLKVRDRVRTKMERDILAEVNHPFIV 61

Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 199
            L    Q     +LI +++  G +   L      + + ++F +   +AL     L HLHS
Sbjct: 62  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-YLAELALA----LDHLHS 116

Query: 200 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 259
           L   ++++D K  N+L+DE+   K+ D GL       +    S   T +  ++A EV   
Sbjct: 117 LG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE--YMAPEVVNR 172

Query: 260 RRFSEKSDVYSFGVFLLELVSG 281
           R  ++ +D +SFGV + E+++G
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 47/222 (21%), Positives = 92/222 (41%), Gaps = 42/222 (18%)

Query: 110 VAIKKRPGAPTQEFID---------EVCFLASIQHRNLVTLLGYCQENNLQFLI------ 154
           V +  +PG P    +          E   L ++ H +++ +        +  ++      
Sbjct: 82  VFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS 141

Query: 155 --YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTA 212
             Y Y+   S  + +     + +Q LE             GL +LH+   R++H+D KT 
Sbjct: 142 DLYTYLTKRSRPLPIDQALIIEKQILE-------------GLRYLHAQ--RIIHRDVKTE 186

Query: 213 NVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKEFRRFSEKSDVYSF 271
           N+ +++     + D G   F     V  P+    A  +   A EV    +++ K+D++S 
Sbjct: 187 NIFINDVDQVCIGDLGAAQF----PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSA 242

Query: 272 GVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 313
           G+ L E+++     S++  D      E V++    S+LLKI+
Sbjct: 243 GIVLFEMLA---YPSTIFEDPPSTPEEYVKSCH--SHLLKII 279

Length = 357

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 24/205 (11%)

Query: 91  IGEGKFGEVYKGLLQ-DGMLVA--------IKKRPGAPTQEFIDEVCFLASIQHRNLVTL 141
           +G+G FGEV    ++  G L A        +KKR G   +  + E   LA +  R +V+L
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKG--YEGAMVEKRILAKVHSRFIVSL 58

Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA--KGLAHLHS 199
               Q      L+   +  G +  H+Y    V  +   F    +    A    GL HLH 
Sbjct: 59  AYAFQTKTDLCLVMTIMNGGDLRYHIY---NVDEENPGFPEPRACFYTAQIISGLEHLHQ 115

Query: 200 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL--GRTDVAGPSSQVTADEIFLASEVK 257
              R++++D K  NVL+D D   +++D GL   L  G++   G +        F+A E+ 
Sbjct: 116 --RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPG----FMAPELL 169

Query: 258 EFRRFSEKSDVYSFGVFLLELVSGR 282
           +   +    D ++ GV L E+++ R
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 46/203 (22%), Positives = 91/203 (44%), Gaps = 16/203 (7%)

Query: 84  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLV 139
              +   IGEG  G V        G  VA+KK   R     +   +EV  +   QH N+V
Sbjct: 20  YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79

Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 199
            +       +  +++ E++  G+++        V+  ++  +   ++ L   K L+ LH+
Sbjct: 80  EMYSSYLVGDELWVVMEFLEGGALT------DIVTHTRMNEEQIATVCLAVLKALSFLHA 133

Query: 200 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ-VTADEIFLASEVKE 258
               V+H+D K+ ++L+  D   K++D G   F  +     P  + +     ++A EV  
Sbjct: 134 --QGVIHRDIKSDSILLTSDGRVKLSDFG---FCAQVSKEVPRRKSLVGTPYWMAPEVIS 188

Query: 259 FRRFSEKSDVYSFGVFLLELVSG 281
              +  + D++S G+ ++E+V G
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 46/179 (25%), Positives = 80/179 (44%), Gaps = 42/179 (23%)

Query: 138 LVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFK--HRLSIALGAAKGL 194
            +T L  C Q  +  + + EY+  G +   +    QV R    FK  H +  A   A GL
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQI---QQVGR----FKEPHAVFYAAEIAIGL 114

Query: 195 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTDVAGPSS 243
             LHS    ++++D K  NV++D +   K+AD G+           + F G  D      
Sbjct: 115 FFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPD------ 166

Query: 244 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 302
                  ++A E+  ++ + +  D ++FGV L E+++G+      +P   +D  EL Q+
Sbjct: 167 -------YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ------APFEGEDEDELFQS 212

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 42/155 (27%), Positives = 61/155 (39%), Gaps = 27/155 (17%)

Query: 193 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIF 251
           G+  LH     ++H+D K  N+L+D+    K+ D GL RN L      G     T D  +
Sbjct: 109 GVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVG-----TPD--Y 159

Query: 252 LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 311
           LA E        + SD +S G  + E + G     + +PD+  D                
Sbjct: 160 LAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFD---------------N 204

Query: 312 ILDERL-WSTFTNEGME-EFIQLIVRCLDPSSERR 344
           IL  R+ W     E    E + LI R L     +R
Sbjct: 205 ILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKR 239

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 34/212 (16%)

Query: 91  IGEGKFGEVYKG--LLQDGMLVAIKK------RPGAPTQEFIDEVCFL---ASIQHRNLV 139
           IGEG +G+V+K   L   G  VA+K+        G P    I EV  L    + +H N+V
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST-IREVAVLRHLETFEHPNVV 67

Query: 140 TLLGYC------QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 193
            L   C      +E  L  L++E++ +  ++ +L    +V    +  +    +     +G
Sbjct: 68  RLFDVCTVSRTDRETKLT-LVFEHV-DQDLTTYL---DKVPEPGVPTETIKDMMFQLLRG 122

Query: 194 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR---NFLGRTDVAGPSSQVTADEI 250
           L  LHS   RVVH+D K  N+LV      K+AD GL    +F         +    A E+
Sbjct: 123 LDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 180

Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
            L S       ++   D++S G    E+   +
Sbjct: 181 LLQSS------YATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 49/214 (22%), Positives = 87/214 (40%), Gaps = 33/214 (15%)

Query: 85  FSDKNLIGEGKFGEVYKGLLQ-DGMLVA--------IKKRPGAPTQEFIDEVCFLASIQH 135
           F    ++G+G FGEV    ++  G + A        IKKR G      ++E   L  +  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNS 59

Query: 136 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 195
           + +V L    +  +   L+   +  G +  H+Y    +     E +  L  A     GL 
Sbjct: 60  QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIY---NMGNPGFEEERALFYAAEILCGLE 116

Query: 196 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNFLGRTDVAGPSSQVTAD 248
            LH      V++D K  N+L+D+    +++D GL        +  GR    G        
Sbjct: 117 DLHR--ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVG-------- 166

Query: 249 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
             ++A EV   +R++   D +  G  + E++ G+
Sbjct: 167 --YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 48.3 bits (115), Expect = 3e-06
 Identities = 51/207 (24%), Positives = 89/207 (42%), Gaps = 23/207 (11%)

Query: 84  NFSDKNLIGEGKFGEV----YKGLLQDGMLVAIKKRP---GAPTQEFIDEVCFLASIQHR 136
           +F     +G G FG V    +KG  +   +  +KKR        Q    E   L  + H 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78

Query: 137 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA- 195
            +V ++   Q+ N  + + E++  G +  HL       R+   F + ++    A   LA 
Sbjct: 79  FIVNMMCSFQDENRVYFLLEFVVGGELFTHL-------RKAGRFPNDVAKFYHAELVLAF 131

Query: 196 -HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 254
            +LHS    ++++D K  N+L+D     KV D G   F  +  V   +  +     +LA 
Sbjct: 132 EYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFG---FAKK--VPDRTFTLCGTPEYLAP 184

Query: 255 EVKEFRRFSEKSDVYSFGVFLLELVSG 281
           EV + +   +  D ++ GV L E ++G
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 48.3 bits (115), Expect = 3e-06
 Identities = 50/200 (25%), Positives = 85/200 (42%), Gaps = 36/200 (18%)

Query: 144 YC--QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA--KGLAHLHS 199
           +C  Q     F + EY+  G +  H+       +    F    +    A    GL  LH 
Sbjct: 62  FCTFQTKEHLFFVMEYLNGGDLMFHI-------QSSGRFDEARARFYAAEIICGLQFLHK 114

Query: 200 LSPRVVHKDFKTANVLVDEDFIAKVADAGL--RNFLGRTDVAGPSSQVTADEIFLASEVK 257
               ++++D K  NVL+D+D   K+AD G+   N  G     G +S       ++A E+ 
Sbjct: 115 KG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE----GKASTFCGTPDYIAPEIL 168

Query: 258 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 317
           + ++++E  D +SFGV L E++ G+      SP   +D  EL  +         IL++R 
Sbjct: 169 KGQKYNESVDWWSFGVLLYEMLIGQ------SPFHGEDEDELFDS---------ILNDRP 213

Query: 318 W--STFTNEGMEEFIQLIVR 335
                 + E  +   +L  R
Sbjct: 214 HFPRWISKEAKDCLSKLFER 233

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 67/240 (27%), Positives = 110/240 (45%), Gaps = 37/240 (15%)

Query: 81  ATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLV 139
             K++   N+IG G FG VY+ +  D    VAIKK    P Q    E+  + ++ H N++
Sbjct: 64  PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-QYKNRELLIMKNLNHINII 122

Query: 140 TLLGY----CQENNLQ--FL--IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL--- 188
            L  Y    C + N +  FL  + E+IP    ++H Y     +R      H L + L   
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQ---TVHKY-MKHYARN----NHALPLFLVKL 174

Query: 189 ---GAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAG-LRNFL-GRTDVAGPS 242
                 + LA++H  S  + H+D K  N+L+D +    K+ D G  +N L G+  V+   
Sbjct: 175 YSYQLCRALAYIH--SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC 232

Query: 243 SQV-TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ 301
           S+   A E+ L +       ++   D++S G  + E++ G    S  S  S   LV ++Q
Sbjct: 233 SRFYRAPELMLGAT-----NYTTHIDLWSLGCIIAEMILGYPIFSGQS--SVDQLVRIIQ 285

Length = 440

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 47.5 bits (113), Expect = 5e-06
 Identities = 68/293 (23%), Positives = 124/293 (42%), Gaps = 48/293 (16%)

Query: 47  PSVQRNICIIAGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY------ 100
           P++++N      +N+   LS  E    ++ +L +  ++F    +IG G FGEV       
Sbjct: 13  PALRKN------KNIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKS 66

Query: 101 -------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL 153
                  K L +  M+    KR  +    F +E   +A      +V L    Q++   ++
Sbjct: 67  SKQVYAMKLLSKFEMI----KRSDSAF--FWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120

Query: 154 IYEYIPNGSVSIHLYGPSQVSRQKLEF-KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTA 212
           + EY+P G + ++L     +  +   F    + +AL A      +HS+    +H+D K  
Sbjct: 121 VMEYMPGGDL-VNLMSNYDIPEKWARFYTAEVVLALDA------IHSMG--FIHRDVKPD 171

Query: 213 NVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV-TADEIFLASEVKEFRR----FSEKSD 267
           N+L+D+    K+AD G    +    +    + V T D  +++ EV + +     +  + D
Sbjct: 172 NMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPD--YISPEVLKSQGGDGYYGRECD 229

Query: 268 VYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 320
            +S GVFL E++ G       +P  +  LV       D  N L   D+   S 
Sbjct: 230 WWSVGVFLYEMLVGD------TPFYADSLVGTYSKIMDHKNSLTFPDDIEISK 276

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 46.9 bits (112), Expect = 6e-06
 Identities = 41/155 (26%), Positives = 67/155 (43%), Gaps = 34/155 (21%)

Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEF--IDEVCFLASIQ-------HRNLVT 140
           IGEG F EV K    + G   AIK       + F  +++V  L  IQ       H N++ 
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCM----KKHFKSLEQVNNLREIQALRRLSPHPNILR 62

Query: 141 LLGYCQENNLQFLIYEYIPNGSVS-------IHLYGPSQVSRQKLEFKHRLSIALGAAKG 193
           L+          ++++    G ++       ++LY   +  ++ L  K   S      K 
Sbjct: 63  LIE---------VLFD-RKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKS 112

Query: 194 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 228
           L H+H     + H+D K  N+L+ +D I K+AD G
Sbjct: 113 LDHMHRNG--IFHRDIKPENILIKDD-ILKLADFG 144

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 47.4 bits (113), Expect = 6e-06
 Identities = 59/209 (28%), Positives = 88/209 (42%), Gaps = 36/209 (17%)

Query: 91  IGEGKFGEV----YKGLLQDGMLVAIKKRPGAPTQEFI---DEV--------CFLA--SI 133
           +G G FG+V    YK     G L AIK    A  +  I   DEV         F    S 
Sbjct: 7   LGRGHFGKVLLAEYKK---TGELYAIK----ALKKGDIIARDEVESLMCEKRIFETANSE 59

Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 193
           +H  LV L    Q  +    + EY   G + +H++     S  +  F      A     G
Sbjct: 60  RHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH-TDVFSEPRAVF-----YAACVVLG 113

Query: 194 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFL 252
           L +LH    ++V++D K  N+L+D +   K+AD GL +  +G  D    +S       FL
Sbjct: 114 LQYLHE--NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR---TSTFCGTPEFL 168

Query: 253 ASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
           A EV     ++   D +  GV + E++ G
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 47.0 bits (112), Expect = 7e-06
 Identities = 48/160 (30%), Positives = 69/160 (43%), Gaps = 44/160 (27%)

Query: 91  IGEGKFGEVYKGLLQ-DGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           +GEG +  VYKG  +  G LVA+K+       GAP    I E   L  ++H N+VTL   
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTA-IREASLLKDLKHANIVTLHDI 71

Query: 145 CQENNLQFLIYEYI-----------PNG----SVSIHLYGPSQVSRQKLEFKHRLSIALG 189
                   L++EY+             G    +V + L+   Q+ R              
Sbjct: 72  IHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLF---QLLR-------------- 114

Query: 190 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 229
              GLA+ H    RV+H+D K  N+L+ E    K+AD GL
Sbjct: 115 ---GLAYCH--QRRVLHRDLKPQNLLISERGELKLADFGL 149

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 46.9 bits (111), Expect = 7e-06
 Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 30/207 (14%)

Query: 90  LIGEGKFGEVYKGLLQD---GMLVAIK---------KRPGAPTQEFIDEVCFLASIQHRN 137
           L+G+G FG+V   L+++   G   A+K         K   A T   + E   L + +H  
Sbjct: 2   LLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHT---VTESRVLQNTRHPF 56

Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA--AKGLA 195
           L  L    Q ++    + EY   G +  HL      SR+++ F    +   GA     L 
Sbjct: 57  LTALKYAFQTHDRLCFVMEYANGGELFFHL------SRERV-FTEERARFYGAEIVSALE 109

Query: 196 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 255
           +LHS    VV++D K  N+++D+D   K+ D GL    G +D A   +     E +LA E
Sbjct: 110 YLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPE-YLAPE 165

Query: 256 VKEFRRFSEKSDVYSFGVFLLELVSGR 282
           V E   +    D +  GV + E++ GR
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 46.9 bits (111), Expect = 9e-06
 Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 15/206 (7%)

Query: 83  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQHR 136
           K +     IG G  G V        G+ VA+KK  RP       +    E+  L  + H+
Sbjct: 21  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHK 80

Query: 137 NLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 195
           N+++LL  +  + +L+     Y+    +  +L    QV   +L+ +    +      G+ 
Sbjct: 81  NIISLLNVFTPQKSLEEFQDVYLVMELMDANL---CQVIHMELDHERMSYLLYQMLCGIK 137

Query: 196 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 255
           HLHS    ++H+D K +N++V  D   K+ D GL        +  P         + A E
Sbjct: 138 HLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTP---YVVTRYYRAPE 192

Query: 256 VKEFRRFSEKSDVYSFGVFLLELVSG 281
           V     + E  D++S G  + ELV G
Sbjct: 193 VILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 46.9 bits (111), Expect = 9e-06
 Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 25/222 (11%)

Query: 90  LIGEGKFGEVYKGLLQ-DGMLVAIK---KRPGAPTQE----FIDEVCFLASIQHRNLVTL 141
           +IG+G FG+V     + DG   A+K   K+     +E      +    L +++H  LV L
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 201
               Q     + + +++  G +  HL    Q  R   E + R   A   A  L +LHS+ 
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHL----QRERSFPEPRARFYAA-EIASALGYLHSI- 115

Query: 202 PRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEFR 260
             +V++D K  N+L+D      + D GL +  + ++D    ++       +LA EV   +
Sbjct: 116 -NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT---TTTFCGTPEYLAPEVIRKQ 171

Query: 261 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 302
            +    D +  G  L E++ G      L P   +D+ E+  N
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYG------LPPFYCRDVAEMYDN 207

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 63/252 (25%), Positives = 99/252 (39%), Gaps = 29/252 (11%)

Query: 90  LIGEGKFGEVYKGLLQD-GMLVAIK-------KRPGAPTQEFIDEVCF-LASIQHRNLVT 140
           +IG G FGEVY     D G + A+K       K     T    + +   L S      + 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 141 LLGYC--QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 198
            + Y     + L F I + +  G +  HL      S  ++ F +   I LG    L H+H
Sbjct: 61  CMSYAFHTPDKLSF-ILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEIILG----LEHMH 114

Query: 199 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV-K 257
           +    VV++D K AN+L+DE    +++D GL     +     P + V     ++A EV +
Sbjct: 115 NRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASV-GTHGYMAPEVLQ 168

Query: 258 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ--DLVELVQNSR---DFSNLLKI 312
           +   +   +D +S G  L +L+ G               D + L         FS  L+ 
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 228

Query: 313 LDERLWSTFTNE 324
           L E L     N 
Sbjct: 229 LLEGLLQRDVNR 240

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 49/204 (24%), Positives = 92/204 (45%), Gaps = 25/204 (12%)

Query: 91  IGEGKFGEVYKGLLQD-GMLVA--------IKKRPGAPTQEFIDEVCFLASIQHRNLVTL 141
           +G+G FGEV    +++ G + A        +KK+ G        E+  L  +    +V L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58

Query: 142 LGYCQENNLQF-LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 200
             Y  E+     L+   +  G +  H+Y    V  + LE +  +  +     G+ HLHS+
Sbjct: 59  -AYAFESKTHLCLVMSLMNGGDLKYHIY---NVGERGLEMERVIHYSAQITCGILHLHSM 114

Query: 201 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG--PSSQVTADEIFLASEVKE 258
              +V++D K  NVL+D+    +++D GL       ++      +Q      ++A E+ +
Sbjct: 115 --DIVYRDMKPENVLLDDQGNCRLSDLGL-----AVELKDGKTITQRAGTNGYMAPEILK 167

Query: 259 FRRFSEKSDVYSFGVFLLELVSGR 282
              +S   D ++ G  + E+V+GR
Sbjct: 168 EEPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 58/224 (25%), Positives = 95/224 (42%), Gaps = 29/224 (12%)

Query: 90  LIGEGKFGEVYKGLL----QDGMLVAIK---KRPGAPTQE----FIDEVCFLASIQHRNL 138
           +IG+G FG+V   LL     DG   A+K   K+     +E      +    L +++H  L
Sbjct: 2   VIGKGSFGKV---LLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFL 58

Query: 139 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 198
           V L    Q     + + +Y+  G +  HL    Q  R  LE + R   A   A  + +LH
Sbjct: 59  VGLHYSFQTAEKLYFVLDYVNGGELFFHL----QRERCFLEPRARF-YAAEVASAIGYLH 113

Query: 199 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 258
           SL+  ++++D K  N+L+D      + D GL       +    +S       +LA EV  
Sbjct: 114 SLN--IIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLR 169

Query: 259 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 302
              +    D +  G  L E++ G      L P  S+D+ ++  N
Sbjct: 170 KEPYDRTVDWWCLGAVLYEMLYG------LPPFYSRDVSQMYDN 207

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 54/204 (26%), Positives = 82/204 (40%), Gaps = 21/204 (10%)

Query: 91  IGEGKFGEVYKGLLQDGMLVA------IKKRPGAPTQ-EFIDEVCFLASIQHRNLVTLLG 143
           IG G FG+V    +     VA      +K    +  Q EF+ +      +QH N++  LG
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 144 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSR--QKLEFKHRLSIALGAAKGLAHLHSLS 201
            C E     L++EY   G +  +L       R  Q L  +    +A   A G+ H+H  +
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR---MACEIAAGVTHMHKHN 119

Query: 202 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE-VKEFR 260
              +H D    N  +  D   KV D G+     + D             +LA E V EF 
Sbjct: 120 --FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177

Query: 261 ------RFSEKSDVYSFGVFLLEL 278
                   ++ S+V++ GV L EL
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 39/146 (26%), Positives = 66/146 (45%), Gaps = 11/146 (7%)

Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 197
           LV L    Q  +  FL+ EY+  G +  H+       ++KL  +H    A      L  L
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQ-----RQRKLPEEHARFYAAEICIALNFL 112

Query: 198 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEV 256
           H     ++++D K  NVL+D D   K+ D G+ +  LG  D    +S       ++A E+
Sbjct: 113 HERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT---TSTFCGTPNYIAPEI 167

Query: 257 KEFRRFSEKSDVYSFGVFLLELVSGR 282
                +    D ++ GV + E+++GR
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 51/216 (23%), Positives = 89/216 (41%), Gaps = 37/216 (17%)

Query: 85  FSDKNLIGEGKFGEVYKGLLQ-DGMLVA--------IKKRPGAPTQEFIDEVCFLASIQH 135
           F    ++G+G FGEV    ++  G + A        IKKR G      ++E   L  +  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNS 59

Query: 136 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLY--GPSQVSRQKLEFKHRLSIALGAAKG 193
           R +V+L    +  +   L+   +  G +  H+Y  G      ++  F      A     G
Sbjct: 60  RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF-----YAAEITCG 114

Query: 194 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNFLGRTDVAGPSSQVT 246
           L  LH    R+V++D K  N+L+D+    +++D GL           GR    G      
Sbjct: 115 LEDLHR--ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVG------ 166

Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
               ++A EV +  R++   D +  G  + E++ G+
Sbjct: 167 ----YMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 28/95 (29%), Positives = 49/95 (51%), Gaps = 16/95 (16%)

Query: 194 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF--------LGRTDVAGPSSQV 245
           LA  H  S  ++H+D K+AN+L+  + + K+ D G            +GRT    P    
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP---- 209

Query: 246 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
                ++A E+   + +S+K+D++S GV L EL++
Sbjct: 210 ----YYVAPEIWRRKPYSKKADMFSLGVLLYELLT 240

Length = 496

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 46/198 (23%), Positives = 85/198 (42%), Gaps = 16/198 (8%)

Query: 90  LIGEGKFGE--VYKGLLQDGMLVAIKKR---PGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           ++GEG FG   + + +  D      + R     +  ++   E   LA ++H N+V     
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66

Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR--LSIALGAAKGLAHLHSLSP 202
            + +   +++ EY   G     L    ++ R KL F     L   +    G+ H+H    
Sbjct: 67  FEADGHLYIVMEYCDGGD----LMQKIKLQRGKL-FPEDTILQWFVQMCLGVQHIHE--K 119

Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
           RV+H+D K+ N+ + ++   K+ D G    L  T     +        ++  E+ E   +
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLL--TSPGAYACTYVGTPYYVPPEIWENMPY 177

Query: 263 SEKSDVYSFGVFLLELVS 280
           + KSD++S G  L EL +
Sbjct: 178 NNKSDIWSLGCILYELCT 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 27/211 (12%)

Query: 91  IGEGKFGEVYKGLLQ-DGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           +GEG +  VYKG+ + +G LVA+K        G P    I E   L  ++H N+V L   
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTA-IREASLLKGLKHANIVLLHDI 71

Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-FKHRLSIALGAAKGLAHLHSLSPR 203
                    ++EY+        +  P  +    +  F  +L       +GLA++H     
Sbjct: 72  IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQL------LRGLAYIHG--QH 123

Query: 204 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT-----ADEIFLASEVKE 258
           ++H+D K  N+L+      K+AD GL            S  VT      D +  A++   
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATD--- 180

Query: 259 FRRFSEKSDVYSFGVFLLELVSGREASSSLS 289
              +S   D++  G   +E++ G+ A   +S
Sbjct: 181 ---YSSALDIWGAGCIFIEMLQGQPAFPGVS 208

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 53/230 (23%), Positives = 106/230 (46%), Gaps = 27/230 (11%)

Query: 64  ELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRP 116
           E  +R+ R+ QM+      +++    +IG G FGEV        + +    +L   +   
Sbjct: 29  EKIVRKIRKLQMK-----AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIK 83

Query: 117 GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQ 176
            + +  F +E   +A      +V L    Q++   +++ EY+P G + ++L     V  +
Sbjct: 84  RSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDL-VNLMSNYDVPEK 142

Query: 177 KLEF-KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 235
             +F    + +AL A      +HS+   ++H+D K  N+L+D+    K+AD G    +  
Sbjct: 143 WAKFYTAEVVLALDA------IHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194

Query: 236 TDVAGPSSQVTADEIFLASEVKEFR----RFSEKSDVYSFGVFLLELVSG 281
           T +    + V   + +++ EV + +     +  + D +S GVFL E++ G
Sbjct: 195 TGMVRCDTAVGTPD-YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 51/209 (24%), Positives = 94/209 (44%), Gaps = 17/209 (8%)

Query: 80  LATKNFSDKNLIGEGKFGEVYK------GLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 133
           L   +F   + +G G  G V K      GL+    L+ ++ +P    Q  I E+  L   
Sbjct: 2   LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQ-IIRELQVLHEC 60

Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 193
               +V   G    +    +  E++  GS+   L    +  R   E   ++SIA+   +G
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KEAKRIPEEILGKVSIAV--LRG 115

Query: 194 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 253
           LA+L     +++H+D K +N+LV+     K+ D G+   L    +   ++       +++
Sbjct: 116 LAYLRE-KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMS 170

Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
            E  +   +S +SD++S G+ L+EL  GR
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 37/161 (22%), Positives = 65/161 (40%), Gaps = 29/161 (18%)

Query: 91  IGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFID-------------EVCFLASIQHR 136
           IGEG +G V+K   ++ G +VAIKK        F++             E+  L  ++H 
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKK--------FVESEDDPVIKKIALREIRMLKQLKHP 60

Query: 137 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 196
           NLV L+   +      L++EY  +  ++     P  V    ++      I     + +  
Sbjct: 61  NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK-----KIIWQTLQAVNF 115

Query: 197 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 237
            H  +   +H+D K  N+L+ +    K+ D G    L    
Sbjct: 116 CHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 65/284 (22%), Positives = 116/284 (40%), Gaps = 60/284 (21%)

Query: 82  TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK--RPGAPT---QEFIDEVCFLASIQH 135
           T  + D   +G G FG V     Q  G  VAIKK  +P +     +    E+  L  ++H
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 136 RNLVTLLG-YCQENNLQFLIYEYIPNGSVSIH-LYGPSQVSRQKLEFKHRLSIALGAAKG 193
            N+++L   +       + + E +      +H L     + +Q +++           +G
Sbjct: 69  ENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRPLEKQFIQY-----FLYQILRG 120

Query: 194 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT------- 246
           L ++HS    VVH+D K +N+L++E+   K+ D GL              Q+T       
Sbjct: 121 LKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARI--------QDPQMTGYVSTRY 170

Query: 247 --ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR 304
             A EI L      ++++  + D++S G    E++ G+     L P   +D V       
Sbjct: 171 YRAPEIMLT-----WQKYDVEVDIWSAGCIFAEMLEGK----PLFP--GKDHVN------ 213

Query: 305 DFSNLLKIL---DERLWSTFTNEGMEEFIQLIVRCLDPSSERRP 345
            FS +  +L    + + +T  +E    F+Q +     P  E  P
Sbjct: 214 QFSIITDLLGTPPDDVINTICSENTLRFVQSL-----PKREPVP 252

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 46/193 (23%), Positives = 85/193 (44%), Gaps = 26/193 (13%)

Query: 129 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 188
           F  +  H  LV L    Q  +  F + EY+  G +  H+       ++KL  +H    + 
Sbjct: 49  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-----RQRKLPEEHARFYSA 103

Query: 189 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTA 247
             +  L +LH     ++++D K  NVL+D +   K+ D G+ +  L   D    +S    
Sbjct: 104 EISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCG 158

Query: 248 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE----ASSSLSPDSSQDLVELVQNS 303
              ++A E+     +    D ++ GV + E+++GR       SS +PD         QN+
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD---------QNT 209

Query: 304 RDFSNLLKILDER 316
            D+  L +++ E+
Sbjct: 210 EDY--LFQVILEK 220

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 49/180 (27%), Positives = 76/180 (42%), Gaps = 31/180 (17%)

Query: 184 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 243
           LS     A+G+  L   S   VH+D    NVL+ +  I K+ D GL       D+   S+
Sbjct: 240 LSFTYQVARGMEFL--ASKNCVHRDLAARNVLLAQGKIVKICDFGLAR-----DIMHDSN 292

Query: 244 QVTADEIFL-----ASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLV 297
            V+    FL     A E      ++  SDV+S+G+ L E+ S G      +  DS+    
Sbjct: 293 YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST---- 348

Query: 298 ELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS---MSDVVTEL 354
                   F N +K           +   +E   ++V+C +   E+RPS   +SD+V  L
Sbjct: 349 --------FYNKIK---SGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 53/214 (24%), Positives = 99/214 (46%), Gaps = 33/214 (15%)

Query: 85  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAP---TQEFIDEVCFLASIQHRNL 138
           + D   +G G +G V   L  + G  VAIKK  RP       +    E+  L  ++H N+
Sbjct: 17  YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76

Query: 139 VTLLG-YCQENNLQ-----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK 192
           + LL  +  + +L      +L+  ++  G+    L    ++S  +++F     +     K
Sbjct: 77  IGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQF-----LVYQMLK 129

Query: 193 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----AD 248
           GL ++H+    ++H+D K  N+ V+ED   K+ D GL     +TD       VT    A 
Sbjct: 130 GLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVVTRWYRAP 184

Query: 249 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
           E+ L      +  +++  D++S G  + E+++G+
Sbjct: 185 EVIL-----NWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 29/223 (13%)

Query: 91  IGEGKFGEVYKGL-LQDGMLVAIK--------KRPGAPTQEFIDEVCFLASIQHRNLVTL 141
           IG+G FG+V       DG   A+K        K+         +    L +++H  LV L
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQ-KHIMAERNVLLKNVKHPFLVGL 61

Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 201
               Q  +  + + +Y+  G +  HL    Q  R   E + R   A   A  L +LHSL+
Sbjct: 62  HYSFQTADKLYFVLDYVNGGELFFHL----QRERSFPEPRARF-YAAEIASALGYLHSLN 116

Query: 202 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT--ADEIFLASEVKEF 259
             ++++D K  N+L+D      + D G    L +  +    +  T      +LA EV   
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFG----LCKEGIEHSKTTSTFCGTPEYLAPEVLRK 170

Query: 260 RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 302
           + +    D +  G  L E++ G      L P  S+D  E+  N
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYG------LPPFYSRDTAEMYDN 207

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 44.8 bits (106), Expect = 3e-05
 Identities = 66/290 (22%), Positives = 115/290 (39%), Gaps = 60/290 (20%)

Query: 91  IGEGKFGEVYKGLLQ-------------DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRN 137
           +G+G F  +YKG+L+               +++ +       +  F +    ++ + H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 138 LVTLLGYC--QENNLQFLIYEYIPNGSVSIHLY-GPSQVSRQKLEFKHRLSIALGAAKGL 194
           LV L G C   EN    ++ EY+  G + + L+   + VS         L   L  AK L
Sbjct: 63  LVKLYGVCVRDEN---IMVEEYVKFGPLDVFLHREKNNVS---------LHWKLDVAKQL 110

Query: 195 AH-LHSL-SPRVVHKDFKTANVLVDED--------FIAKVADAGLRNFLGRTDVAGPSSQ 244
           A  LH L   ++VH +    N+LV           FI K++D G+   +   +       
Sbjct: 111 ASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFI-KLSDPGIPITVLSREERVERIP 169

Query: 245 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR 304
             A E  + +        ++K   +SFG  LLE+ S  E      P S+    E  +  +
Sbjct: 170 WIAPE-CIRNGQASLTIAADK---WSFGTTLLEICSNGEE-----PLSTLSSSEKERFYQ 220

Query: 305 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
           D  + L + D    +   N        LI +C      +RPS   ++ +L
Sbjct: 221 D-QHRLPMPD---CAELAN--------LINQCWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 50/209 (23%), Positives = 95/209 (45%), Gaps = 17/209 (8%)

Query: 80  LATKNFSDKNLIGEGKFGEVYK------GLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 133
           L   +F   + +G G  G V+K      GL+    L+ ++ +P    Q  I E+  L   
Sbjct: 2   LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQ-IIRELQVLHEC 60

Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 193
               +V   G    +    +  E++  GS+   L    ++  Q L    ++SIA+   KG
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL---GKVSIAV--IKG 115

Query: 194 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 253
           L +L     +++H+D K +N+LV+     K+ D G+   L    +   ++       +++
Sbjct: 116 LTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMS 170

Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
            E  +   +S +SD++S G+ L+E+  GR
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 45.1 bits (106), Expect = 3e-05
 Identities = 38/145 (26%), Positives = 65/145 (44%), Gaps = 14/145 (9%)

Query: 91  IGEGKFGEVYKGLLQ-DGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           +GEG +  VYKG  + +G LVA+K     +  G P    I E   L  ++H N+V L   
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTA-IREASLLKGLKHANIVLLHDI 71

Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 204
                   L++EY+           P  +  + ++            +GL+++H     +
Sbjct: 72  IHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKL-----FLFQLLRGLSYIHQ--RYI 124

Query: 205 VHKDFKTANVLVDEDFIAKVADAGL 229
           +H+D K  N+L+ +    K+AD GL
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGL 149

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 44.8 bits (107), Expect = 3e-05
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 39/216 (18%)

Query: 83  KNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPT----QE--FIDEVCFLASIQH 135
            +F     +G G FG V     +  G   A+K    A      Q    ++E   L SI+H
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 136 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL--YG--PSQVSR----QKLEFKHRLSIA 187
             LV L G  Q+++  +L+ EY+P G +  HL   G  P  V+R    Q         + 
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ---------VV 111

Query: 188 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL-GRT-DVAGPSSQV 245
           L     L +LHSL   +V++D K  N+L+D D   K+ D G    + GRT  + G     
Sbjct: 112 L----ALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCG----- 160

Query: 246 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
           T +  +LA E+   + + +  D ++ G+ + E+++G
Sbjct: 161 TPE--YLAPEIILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 44.5 bits (105), Expect = 4e-05
 Identities = 43/165 (26%), Positives = 72/165 (43%), Gaps = 21/165 (12%)

Query: 144 YC--QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 201
           YC  Q     F + E++  G +  H+    +    +  F      A     GL  LHS  
Sbjct: 62  YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF-----YAAEIVCGLQFLHSKG 116

Query: 202 PRVVHKDFKTANVLVDEDFIAKVADAGL--RNFLGRTDVAGPSSQVTADEIFLASEVKEF 259
             ++++D K  NV++D D   K+AD G+   N  G       +S       ++A E+ + 
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR----ASTFCGTPDYIAPEILQG 170

Query: 260 RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR 304
            +++   D +SFGV L E++ G+      SP    D  EL ++ R
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQ------SPFHGDDEDELFESIR 209

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 44.1 bits (104), Expect = 5e-05
 Identities = 66/268 (24%), Positives = 116/268 (43%), Gaps = 33/268 (12%)

Query: 91  IGEGKFGEVYKGLLQ-DGMLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 145
           +G+G +G VYK L +  G+ +A+K+       +   + I E+  L       +V   G  
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 146 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 205
                 ++  EY+  GS+   LY     +    E   R  I     KGL  L      ++
Sbjct: 69  FIEGAVYMCMEYMDAGSLD-KLYAGGVATEGIPEDVLR-RITYAVVKGLKFLKE-EHNII 125

Query: 206 HKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 261
           H+D K  NVLV+ +   K+ D G    L   L +T++   S    A E   +    +   
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQS--YMAPERIKSGGPNQNPT 183

Query: 262 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD---ERLW 318
           ++ +SDV+S G+ +LE+  GR       P++  ++         F+ L  I+D     L 
Sbjct: 184 YTVQSDVWSLGLSILEMALGR---YPYPPETYANI---------FAQLSAIVDGDPPTLP 231

Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPS 346
           S ++++  ++F+     CL+    RRP+
Sbjct: 232 SGYSDDA-QDFVAK---CLNKIPNRRPT 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 43.8 bits (103), Expect = 7e-05
 Identities = 51/209 (24%), Positives = 87/209 (41%), Gaps = 25/209 (11%)

Query: 85  FSDKNLI---GEGKFGEVYKGLLQDGML--VAIKK--RPGAPTQEFIDEVC----FLASI 133
           + D N I   G G FG V     ++     VAIK+  +     Q+ +D V      L  I
Sbjct: 29  YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI 88

Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 193
            H   V L G  ++ +  +L+ E++  G     L       R+   F + +     A   
Sbjct: 89  NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-------RRNKRFPNDVGCFYAAQIV 141

Query: 194 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFL 252
           L   +  S  +V++D K  N+L+D+D   K+ D G    +  RT     + +  A EI L
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILL 201

Query: 253 ASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
                      + +D ++ G+F+ E++ G
Sbjct: 202 NVG------HGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 44.0 bits (104), Expect = 7e-05
 Identities = 38/144 (26%), Positives = 67/144 (46%), Gaps = 35/144 (24%)

Query: 152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFK--HRLSIALGAAKGLAHLHSLSPRVVHKDF 209
           + + EY+  G +  H+    QV +    FK  H +  A   A GL  LHS    ++++D 
Sbjct: 77  YFVMEYVNGGDLMYHI---QQVGK----FKEPHAVFYAAEIAIGLFFLHSKG--IIYRDL 127

Query: 210 KTANVLVDEDFIAKVADAGL-----------RNFLGRTDVAGPSSQVTADEIFLASEVKE 258
           K  NV++D +   K+AD G+           R F G  D             ++A E+  
Sbjct: 128 KLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPD-------------YIAPEIIA 174

Query: 259 FRRFSEKSDVYSFGVFLLELVSGR 282
           ++ + +  D ++FGV L E+++G+
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 43.8 bits (103), Expect = 8e-05
 Identities = 46/200 (23%), Positives = 88/200 (44%), Gaps = 16/200 (8%)

Query: 90  LIGEGKFGEVYKGLLQDGM-LVAIKKRPGAPTQEFIDEVCF-----LASIQHRNLVTLLG 143
           ++GEG +G V K   ++   +VAIKK   +   E + E        L +++  N+V L  
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 144 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 203
             +     +L++EY+    + +    P+ V  +K+      S      K +   H     
Sbjct: 68  AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVR-----SYIYQLIKAIHWCHK--ND 120

Query: 204 VVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
           +VH+D K  N+L+  + + K+ D G  RN    ++     ++  A   + + E+     +
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN--YTEYVATRWYRSPELLLGAPY 178

Query: 263 SEKSDVYSFGVFLLELVSGR 282
            +  D++S G  L EL  G+
Sbjct: 179 GKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 43.7 bits (103), Expect = 8e-05
 Identities = 57/250 (22%), Positives = 106/250 (42%), Gaps = 31/250 (12%)

Query: 90  LIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLA-----SIQHRN-LVTLL 142
           ++G+G FG+V    L + G L A+K        +  D  C +      S+   +  +T L
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 143 GYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 201
             C Q  +  F + E++  G +  H+    Q SR+  E + R   A      L  LH   
Sbjct: 62  YCCFQTPDRLFFVMEFVNGGDLMFHI----QKSRRFDEARARFYAA-EITSALMFLHDKG 116

Query: 202 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 261
             ++++D K  NVL+D +   K+AD G+            +   T D  ++A E+ +   
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPD--YIAPEILQEML 172

Query: 262 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF 321
           +    D ++ GV L E++ G    +    ++  DL E + N           DE ++ T+
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGH---APFEAENEDDLFEAILN-----------DEVVYPTW 218

Query: 322 TNEGMEEFIQ 331
            ++   + ++
Sbjct: 219 LSQDAVDILK 228

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 43.8 bits (104), Expect = 8e-05
 Identities = 55/223 (24%), Positives = 94/223 (42%), Gaps = 59/223 (26%)

Query: 89  NLIGEGKFGEVYKGLLQD-GMLVAIKK--RPGAPTQEFID------EVCFLASIQHRNLV 139
           + +G G +G+V        G  VAIKK  RP    Q  I       E+  L  + H N++
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP---FQSAIHAKRTYRELRLLKHMDHENVI 77

Query: 140 TLLGYCQENNLQFLIYEYIPNGSVS--------IHLYGP--SQVSR-QKLEFKHRLSIAL 188
            LL              + P  S+          HL G   + + + QKL   H   +  
Sbjct: 78  GLLDV------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVY 125

Query: 189 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 248
              +GL ++HS    ++H+D K +N+ V+ED   K+ D GL             ++ T D
Sbjct: 126 QILRGLKYIHS--AGIIHRDLKPSNIAVNEDCELKILDFGL-------------ARHTDD 170

Query: 249 EI--------FLASEVK-EFRRFSEKSDVYSFGVFLLELVSGR 282
           E+        + A E+   +  +++  D++S G  + EL++G+
Sbjct: 171 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 43.4 bits (102), Expect = 9e-05
 Identities = 56/240 (23%), Positives = 101/240 (42%), Gaps = 49/240 (20%)

Query: 84  NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVC------FLASIQHR 136
           +F+   ++G+G FG+V     +    L AIK        +  D  C       LA     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 137 NLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA--AKG 193
             +T L  C Q  +  + + EY+  G +  H+       +Q  +FK   ++   A  + G
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI-------QQVGKFKEPQAVFYAAEISVG 113

Query: 194 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTDVAGPS 242
           L  LH     ++++D K  NV++D +   K+AD G+           R F G  D     
Sbjct: 114 LFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPD----- 166

Query: 243 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 302
                   ++A E+  ++ + +  D +++GV L E+++G+       P   +D  EL Q+
Sbjct: 167 --------YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ------PPFDGEDEDELFQS 212

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 30/119 (25%), Positives = 56/119 (47%), Gaps = 16/119 (13%)

Query: 169 GPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 228
               + ++ L  +  +  +   AKG+  L   S + +H+D    N+L+ E+ + K+ D G
Sbjct: 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFG 224

Query: 229 LR-------NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
           L        +++ + D   P   +  + IF        R ++ +SDV+SFGV L E+ S
Sbjct: 225 LARDIYKDPDYVRKGDARLPLKWMAPETIF-------DRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 38/218 (17%)

Query: 83  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAPTQEFIDEVCFLASIQHRNLV 139
           + ++    +G G +G V   +  + G  VAIKK  RP      F  E+   A   +R L 
Sbjct: 15  ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRP------FQSEI--FAKRAYREL- 65

Query: 140 TLLGYCQENNLQFLIYEYIP----NGSVSIHLYGP-SQVSRQKLEFKHRLS------IAL 188
           TLL + Q  N+  L+  +      +     +L  P  Q   QK+   H LS      +  
Sbjct: 66  TLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKI-MGHPLSEDKVQYLVY 124

Query: 189 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT-- 246
               GL ++HS    ++H+D K  N+ V+ED   K+ D GL       D       VT  
Sbjct: 125 QMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVVTRW 179

Query: 247 --ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
             A E+ L      +  +++  D++S G  + E+++G+
Sbjct: 180 YRAPEVIL-----NWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 32/208 (15%)

Query: 90  LIGEGKFGEVYKGLLQD---GMLVAIKKRPGAPTQEFI---DEVC-------FLASIQHR 136
           L+G+G FG+V   L+++   G   A+K       +E I   DEV         L + +H 
Sbjct: 2   LLGKGTFGKVI--LVREKATGKYYAMK----ILKKEVIIAKDEVAHTLTESRVLQNTRHP 55

Query: 137 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA--AKGL 194
            L  L    Q ++    + EY   G +  HL      S  +  F        GA     L
Sbjct: 56  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-------YGAEIVSAL 108

Query: 195 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 254
            +LHS    VV++D K  N+++D+D   K+ D GL    G +D A   +     E +LA 
Sbjct: 109 GYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPE-YLAP 164

Query: 255 EVKEFRRFSEKSDVYSFGVFLLELVSGR 282
           EV E   +    D +  GV + E++ GR
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 24/204 (11%)

Query: 90  LIGEGKFGEVYKGLLQD-GMLVAI----KKRPGAPTQEF--IDEVCFLASIQHRN--LVT 140
           +IG G FGEVY     D G + A+    KKR      E   ++E   L+ +   +   + 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 141 LLGYC--QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 198
            + Y     + L F I + +  G +  HL      S +++ F +   I L    GL H+H
Sbjct: 61  CMTYAFHTPDKLCF-ILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIIL----GLEHMH 114

Query: 199 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV-K 257
           +    VV++D K AN+L+DE    +++D GL     +     P + V     ++A EV +
Sbjct: 115 NRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASV-GTHGYMAPEVLQ 168

Query: 258 EFRRFSEKSDVYSFGVFLLELVSG 281
           +   +   +D +S G  L +L+ G
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 52/218 (23%), Positives = 90/218 (41%), Gaps = 45/218 (20%)

Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKKRPGA---PT--QEFIDEVCFLASIQHRNLVTLLG- 143
           IG G +G V   +  + G  VAIKK P A   PT  +  + E+  L   +H N++ +   
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72

Query: 144 -----------YC----QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 188
                      Y      E++L  +I+                  S Q L  +H      
Sbjct: 73  LRPPGADFKDVYVVMDLMESDLHHIIH------------------SDQPLTEEHIRYFLY 114

Query: 189 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR--TDVAGPSSQVT 246
              +GL ++HS    V+H+D K +N+LV+ED   ++ D G+   L    T+     ++  
Sbjct: 115 QLLRGLKYIHS--ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172

Query: 247 ADEIFLASEVK-EFRRFSEKSDVYSFGVFLLELVSGRE 283
           A   + A E+      ++   D++S G    E++  R+
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ 210

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 39/217 (17%)

Query: 85  FSDKNLIGEGKFGEVYKGLLQ-DGMLVA--------IKKRPGAPTQEFIDEVCFLASIQH 135
           F    ++G+G FGEV    ++  G + A        IKKR G      ++E   L  +  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNS 59

Query: 136 RNLVTLLGYCQENNLQFLIYEYIPNG-SVSIHLY--GPSQVSRQKLEFKHRLSIALGAAK 192
           R +V+L  Y  E      +   I NG  +  H+Y  G      Q+  F      A     
Sbjct: 60  RFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIF-----YAAELCC 113

Query: 193 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNFLGRTDVAGPSSQV 245
           GL  L     R+V++D K  N+L+D+    +++D GL           GR    G     
Sbjct: 114 GLEDLQR--ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVG----- 166

Query: 246 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                ++A EV    +++   D +  G  + E++ G+
Sbjct: 167 -----YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 40/148 (27%), Positives = 66/148 (44%), Gaps = 14/148 (9%)

Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA-AKGLAH 196
           LVTL    Q +    LI +Y+  G +  HLY      R+    +  + + +      L H
Sbjct: 67  LVTLHYAFQTDTKLHLILDYVNGGELFTHLY-----QREHFT-ESEVRVYIAEIVLALDH 120

Query: 197 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASE 255
           LH L   ++++D K  N+L+D +    + D GL + FL   +    S   T +  ++A E
Sbjct: 121 LHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIE--YMAPE 176

Query: 256 V--KEFRRFSEKSDVYSFGVFLLELVSG 281
           V         +  D +S GV   EL++G
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 43/188 (22%), Positives = 76/188 (40%), Gaps = 30/188 (15%)

Query: 178 LEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-------R 230
           L+ +  LS +   AKG++ L   S   +H+D    N+L+    I K+ D GL        
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268

Query: 231 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP 290
           N++ + +   P   +  + IF          ++ +SDV+S+G+ L E+ S     SS  P
Sbjct: 269 NYVVKGNARLPVKWMAPESIFNCV-------YTFESDVWSYGILLWEIFS---LGSSPYP 318

Query: 291 DSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
               D           S   K++ E            E   ++  C D    +RP+   +
Sbjct: 319 GMPVD-----------SKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQI 367

Query: 351 VTELDRTL 358
           V  +++ L
Sbjct: 368 VQLIEQQL 375

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 39/165 (23%), Positives = 67/165 (40%), Gaps = 37/165 (22%)

Query: 152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKT 211
           F + EY+  G +  H+    Q S  + +       A     GL  LH     ++++D K 
Sbjct: 72  FFVMEYVNGGDLMFHI----QRSG-RFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKL 124

Query: 212 ANVLVDEDFIAKVADAGL-----------RNFLGRTDVAGPSSQVTADEIFLASEVKEFR 260
            NVL+D +   K+AD G+             F G  D             ++A E+  ++
Sbjct: 125 DNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPD-------------YIAPEILSYQ 171

Query: 261 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD 305
            +    D ++ GV L E+++G+      SP    D  EL Q+  +
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQ------SPFEGDDEDELFQSILE 210

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 36/112 (32%), Positives = 56/112 (50%), Gaps = 5/112 (4%)

Query: 174 SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNF 232
           S Q L   H  S       GL ++HS +  V+H+D K  N+LV+ D   K+ D GL R F
Sbjct: 98  SGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGF 155

Query: 233 -LGRTDVAGPSSQVTADEIFLASEVK-EFRRFSEKSDVYSFGVFLLELVSGR 282
                + AG  ++  A   + A E+   F+ +++  DV+S G  L EL+  +
Sbjct: 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 11/93 (11%)

Query: 193 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 249
           G+ HLHS    ++H+D K +N++V  D   K+ D G    L RT  AG S  +T      
Sbjct: 130 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFG----LART--AGTSFMMTPYVVTR 181

Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
            + A EV     + E  D++S G  + E++ G 
Sbjct: 182 YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 53/202 (26%), Positives = 80/202 (39%), Gaps = 36/202 (17%)

Query: 105 QDGMLVAIK-KRPGAPTQE-----FIDEVCFLASIQHRNLVTLL--GYCQENNLQFLIYE 156
             G  VAIK  R  AP +E     F  E    A + H N+V LL  G      L F ++E
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFE 59

Query: 157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA------LGAAKGLAHLHSLSPRVVHKDFK 210
           Y+P  ++           R+ L     L         L     LA  H+    +VH+D K
Sbjct: 60  YVPGRTL-----------REVLAADGALPAGETGRLMLQVLDALACAHNQG--IVHRDLK 106

Query: 211 TANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-----FLASEVKEFRRF 262
             N++V        AKV D G+   L     A  ++     E+     + A E       
Sbjct: 107 PQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV 166

Query: 263 SEKSDVYSFGVFLLELVSGREA 284
           +  SD+Y++G+  LE ++G+  
Sbjct: 167 TPNSDLYAWGLIFLECLTGQRV 188

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 36/154 (23%), Positives = 69/154 (44%), Gaps = 22/154 (14%)

Query: 127 VCFLAS-IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 185
           V F AS ++      +  YC+  +L   + E    G         +QV     E+  +L 
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKT----LSENQV----CEWFIQLL 116

Query: 186 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQ 244
           +      G+ ++H    R++H+D K  N+ +  + + K+ D G+   L G  D+A   + 
Sbjct: 117 L------GVHYMHQ--RRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLA---TT 164

Query: 245 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLEL 278
            T    +++ E  + + +  KSD++S G  L E+
Sbjct: 165 FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 49/221 (22%), Positives = 98/221 (44%), Gaps = 24/221 (10%)

Query: 74  QMEELSLATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDE 126
           ++ +L +  +++    +IG G FGEV        + +    +L   +    + +  F +E
Sbjct: 34  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 93

Query: 127 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF-KHRLS 185
              +A      +V L    Q++   +++ EY+P G + ++L     V  +   F    + 
Sbjct: 94  RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVV 152

Query: 186 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----RNFLGRTDVAG 240
           +AL A      +HS+    +H+D K  N+L+D+    K+AD G      +  + R D A 
Sbjct: 153 LALDA------IHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 204

Query: 241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
            +    + E+  +     +  +  + D +S GVFL E++ G
Sbjct: 205 GTPDYISPEVLKSQGGDGY--YGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 40.5 bits (95), Expect = 3e-04
 Identities = 32/146 (21%), Positives = 54/146 (36%), Gaps = 19/146 (13%)

Query: 86  SDKNLIGEGKFGEVYKGLLQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVT--L 141
           S   L+  G    VY  LL       +           +   EV  L  +  + L    +
Sbjct: 1   SSIKLLKGGLTNRVY--LLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKV 58

Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 201
           L   + +   +L+ E+I   ++             ++  + +  IA   A+ LA LH L 
Sbjct: 59  LASGESDGWSYLLMEWIEGETLD------------EVSEEEKEDIAEQLAELLAKLHQLP 106

Query: 202 PRVV-HKDFKTANVLVDEDFIAKVAD 226
             V+ H D    N+LVD+  I  + D
Sbjct: 107 LLVLCHGDLHPGNILVDDGKILGIID 132

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 42.0 bits (98), Expect = 3e-04
 Identities = 47/210 (22%), Positives = 92/210 (43%), Gaps = 27/210 (12%)

Query: 91  IGEGKFGEVYKGLLQDG---MLVAIKKRPGAP-TQEFIDEVCFLASIQHRNLVTL--LGY 144
           +G G +G VYK   +DG      A+K+  G   +     E+  L  ++H N++ L  +  
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 145 CQENNLQFLIYEYIPNGSVS-IHLYGPSQVSRQKLEFKHRL--SIALGAAKGLAHLHSLS 201
              +   +L+++Y  +     I  +  S+ +++ ++    +  S+      G+ +LH  +
Sbjct: 69  SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH--A 126

Query: 202 PRVVHKDFKTANVLV----DEDFIAKVADAGLRNF-------LGRTDVAGPSSQVTADEI 250
             V+H+D K AN+LV     E    K+AD G           L   D    +    A E+
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL 186

Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            L +     R +++  D+++ G    EL++
Sbjct: 187 LLGA-----RHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 41.9 bits (99), Expect = 3e-04
 Identities = 69/314 (21%), Positives = 113/314 (35%), Gaps = 61/314 (19%)

Query: 78  LSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-----RPGAPTQEFIDEVCFLAS 132
           L+L  K F D           + K       LVA+KK           +    E+     
Sbjct: 3   LTLIGKCFED------LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQ 55

Query: 133 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS---IAL- 188
           +QH N++  +     ++  +++   +  GS    L         K  F   L    IA  
Sbjct: 56  LQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL---------KTHFPEGLPELAIAFI 106

Query: 189 --GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG-------RTDVA 239
                  L ++HS     +H+  K +++L+  D   KV  +GLR  +        +  V 
Sbjct: 107 LKDVLNALDYIHSKG--FIHRSVKASHILLSGD--GKVVLSGLRYSVSMIKHGKRQRVVH 162

Query: 240 GPSSQVTADEIFLASEVKE--FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLV 297
                   +  +L+ EV +   + ++EKSD+YS G+   EL +G      +   ++Q L+
Sbjct: 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM--PATQMLL 220

Query: 298 E----LVQNSRDFSNLLKILDERLWSTFTNEG---------------MEEFIQLIVRCLD 338
           E     V    D S      D    S  +NE                 E F Q +  CL 
Sbjct: 221 EKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQ 280

Query: 339 PSSERRPSMSDVVT 352
              E RPS S ++ 
Sbjct: 281 RDPESRPSASQLLN 294

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 41.9 bits (98), Expect = 4e-04
 Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 11/146 (7%)

Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 197
           LVTL    Q      LI +Y+  G +  HLY     S  ++ F +   I L     L HL
Sbjct: 67  LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRF-YSGEIILA----LEHL 121

Query: 198 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEV 256
           H L   +V++D K  N+L+D +    + D GL + FL        S   T +  ++A E+
Sbjct: 122 HKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIE--YMAPEI 177

Query: 257 KEFRRFSEKS-DVYSFGVFLLELVSG 281
              +    K+ D +S G+ + EL++G
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 43/155 (27%), Positives = 68/155 (43%), Gaps = 24/155 (15%)

Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQ---HRNLVT 140
           IG G +G VYK      G  VA+K         G P    + EV  L  ++   H N+V 
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLST-VREVALLKRLEAFDHPNIVR 66

Query: 141 LLGYC------QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 194
           L+  C      +E  +  L++E++ +  +  +L    +V    L  +    +     +GL
Sbjct: 67  LMDVCATSRTDRETKVT-LVFEHV-DQDLRTYL---DKVPPPGLPAETIKDLMRQFLRGL 121

Query: 195 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 229
             LH+    +VH+D K  N+LV      K+AD GL
Sbjct: 122 DFLHA--NCIVHRDLKPENILVTSGGQVKLADFGL 154

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 46/186 (24%), Positives = 75/186 (40%), Gaps = 26/186 (13%)

Query: 178 LEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 237
           L +   +  +   A G+  L   S   VH+D    NVL+ E  + K+ D GL       D
Sbjct: 236 LSYMDLVGFSYQVANGMEFL--ASKNCVHRDLAARNVLICEGKLVKICDFGLAR-----D 288

Query: 238 VAGPSSQVTADEIFL-----ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS 292
           +   S+ ++    FL     A E      ++  SDV+SFG+ L E+ +      +  P  
Sbjct: 289 IMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT---LGGTPYP-- 343

Query: 293 SQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT 352
                EL  N + F N +K           ++ + E +Q   +C +   E RP  S +V 
Sbjct: 344 -----ELPMNEQ-FYNAIKRGYRMAKPAHASDEIYEIMQ---KCWEEKFEIRPDFSQLVH 394

Query: 353 ELDRTL 358
            +   L
Sbjct: 395 LVGDLL 400

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 41.6 bits (97), Expect = 4e-04
 Identities = 47/210 (22%), Positives = 93/210 (44%), Gaps = 27/210 (12%)

Query: 91  IGEGKFGEVYKGLLQDG---MLVAIKKRPGAP-TQEFIDEVCFLASIQHRNLVTL--LGY 144
           +G G +G VYK   +DG      A+K+  G   +     E+  L  ++H N+++L  +  
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 145 CQENNLQFLIYEYIPNGSVS-IHLYGPSQVSRQKLEFKHRL--SIALGAAKGLAHLHSLS 201
              +   +L+++Y  +     I  +  S+ +++ ++    +  S+      G+ +LH  +
Sbjct: 69  SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH--A 126

Query: 202 PRVVHKDFKTANVLV----DEDFIAKVADAGLRNF-------LGRTDVAGPSSQVTADEI 250
             V+H+D K AN+LV     E    K+AD G           L   D    +    A E+
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL 186

Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            L +     R +++  D+++ G    EL++
Sbjct: 187 LLGA-----RHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 54/207 (26%), Positives = 86/207 (41%), Gaps = 29/207 (14%)

Query: 90  LIGEGKFGEVY------------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRN 137
           L+G+G FG+V               +L+  ++VA  +     T+  +     L + +H  
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV-----LQNSRHPF 56

Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA--AKGLA 195
           L  L    Q ++    + EY   G +  HL      S  +  F        GA     L 
Sbjct: 57  LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-------YGAEIVSALD 109

Query: 196 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 255
           +LHS    VV++D K  N+++D+D   K+ D GL    G  D A   +     E +LA E
Sbjct: 110 YLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPE-YLAPE 166

Query: 256 VKEFRRFSEKSDVYSFGVFLLELVSGR 282
           V E   +    D +  GV + E++ GR
Sbjct: 167 VLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 41.3 bits (97), Expect = 5e-04
 Identities = 45/194 (23%), Positives = 83/194 (42%), Gaps = 28/194 (14%)

Query: 129 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQ-KLEFKHRLSIA 187
           F  +  H  LV L    Q  +  F + E++  G +  H+       RQ KL  +H    +
Sbjct: 49  FETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM------QRQRKLPEEHARFYS 102

Query: 188 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVT 246
              +  L  LH     ++++D K  NVL+D +   K+ D G+ +  +   D    +S   
Sbjct: 103 AEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT---TSTFC 157

Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE----ASSSLSPDSSQDLVELVQN 302
               ++A E+     +    D ++ GV + E+++GR        S +PD         QN
Sbjct: 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD---------QN 208

Query: 303 SRDFSNLLKILDER 316
           + D+  L +++ E+
Sbjct: 209 TEDY--LFQVILEK 220

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 41.1 bits (96), Expect = 6e-04
 Identities = 57/237 (24%), Positives = 100/237 (42%), Gaps = 54/237 (22%)

Query: 91  IGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLV--TLLGYC-- 145
           IG+G FG+VY+   +D   + A+K       +E + +     +I  RN++  TLL     
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKV---LSKKEIVAKKEVAHTIGERNILVRTLLDESPF 57

Query: 146 --------QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFK-HRLSIALGAAKGLAH 196
                   Q ++  +L+ +Y+  G +  HL    + S  + +F    L +AL       H
Sbjct: 58  IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLAL------EH 111

Query: 197 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTDVAGPSSQV 245
           LH     +V++D K  N+L+D      + D GL             F G T+   P  +V
Sbjct: 112 LHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAP--EV 167

Query: 246 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 302
             DE          + +++  D +S GV + E+  G       SP  ++D  ++ +N
Sbjct: 168 LLDE----------KGYTKHVDFWSLGVLVFEMCCG------WSPFYAEDTQQMYRN 208

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 41.3 bits (96), Expect = 7e-04
 Identities = 54/237 (22%), Positives = 96/237 (40%), Gaps = 62/237 (26%)

Query: 91  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEF-------------------IDEVCFLA 131
           IG G+FGEV+        LV  K+     TQEF                   + EV  + 
Sbjct: 21  IGNGRFGEVF--------LVKHKR-----TQEFFCWKAISYRGLKEREKSQLVIEVNVMR 67

Query: 132 SIQHRNLVTLLG--YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG 189
            ++H+N+V  +     + N   +++ E+   G +S ++    ++   K+E    + I   
Sbjct: 68  ELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMF-GKIEEHAIVDITRQ 126

Query: 190 AAKGLAHLHSLS-----PRVVHKDFKTANVLVDEDF-----------------IAKVADA 227
               LA+ H+L       RV+H+D K  N+ +                     IAK+ D 
Sbjct: 127 LLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDF 186

Query: 228 GLRNFLGRTDVAGPSSQVTADEIFLASEV--KEFRRFSEKSDVYSFGVFLLELVSGR 282
           GL   +G   +A           + + E+   E + + +KSD+++ G  + EL SG+
Sbjct: 187 GLSKNIGIESMA---HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Length = 1021

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 40.5 bits (95), Expect = 8e-04
 Identities = 46/205 (22%), Positives = 88/205 (42%), Gaps = 31/205 (15%)

Query: 90  LIGEGKFGEVYKGLLQD---GMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVT 140
            +G G FG V+  L++D       A+K             Q   +E   L  + H  ++ 
Sbjct: 8   TVGTGTFGRVH--LVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIR 65

Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA--AKGLAHLH 198
           L     +    +++ EY+P G +  +L       R    F +   +   +     L +LH
Sbjct: 66  LFWTEHDQRFLYMLMEYVPGGELFSYL-------RNSGRFSNSTGLFYASEIVCALEYLH 118

Query: 199 SLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRT-DVAGPSSQVTADEIFLASEV 256
           S    +V++D K  N+L+D++   K+ D G  +    RT  + G     T +  +LA EV
Sbjct: 119 SKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCG-----TPE--YLAPEV 169

Query: 257 KEFRRFSEKSDVYSFGVFLLELVSG 281
            + +  ++  D ++ G+ + E++ G
Sbjct: 170 IQSKGHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 50/189 (26%), Positives = 80/189 (42%), Gaps = 18/189 (9%)

Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFK-HRLSIALGA-AKGLA 195
           LVTL    Q +    LI +YI  G +  HL        Q+  FK   + I  G     L 
Sbjct: 67  LVTLHYAFQTDTKLHLILDYINGGELFTHL-------SQRERFKEQEVQIYSGEIVLALE 119

Query: 196 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 255
           HLH L   ++++D K  N+L+D +    + D GL       +V    S     E      
Sbjct: 120 HLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI 177

Query: 256 VKEFRRFSEKS-DVYSFGVFLLELVSGREASSSLSPDSSQ-DLVELVQNS-----RDFSN 308
           V+      +K+ D +S GV + EL++G    +     +SQ ++   +  S     ++ S 
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 237

Query: 309 LLKILDERL 317
           L K + +RL
Sbjct: 238 LAKDIIQRL 246

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 23/203 (11%)

Query: 91  IGEGKFGEV---YKGLLQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTL 141
           +G G +G V   Y   L+    VA+KK    P Q  I       E+  L  ++H N++ L
Sbjct: 23  VGSGAYGSVCSAYDTRLRQK--VAVKKL-SRPFQSLIHARRTYRELRLLKHMKHENVIGL 79

Query: 142 LG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 200
           L  +    +++     Y+    +   L   + V  QKL  +H   +     +GL ++HS 
Sbjct: 80  LDVFTPATSIENFNEVYLVTNLMGADL--NNIVKCQKLSDEHVQFLIYQLLRGLKYIHSA 137

Query: 201 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK-EF 259
              ++H+D K +NV V+ED   ++ D GL     + D     +   A   + A E+   +
Sbjct: 138 G--IIHRDLKPSNVAVNEDCELRILDFGLAR---QAD--DEMTGYVATRWYRAPEIMLNW 190

Query: 260 RRFSEKSDVYSFGVFLLELVSGR 282
             +++  D++S G  + EL+ G+
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 39.7 bits (93), Expect = 0.002
 Identities = 43/185 (23%), Positives = 72/185 (38%), Gaps = 48/185 (25%)

Query: 186 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-------DF---------IAKVADAGL 229
           IA+   K L +L     +++H+D K +N+L+D        DF         IAK  DAG 
Sbjct: 112 IAVATVKALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGC 170

Query: 230 RNFLG--RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS 287
           R ++   R D     S     ++              +SDV+S G+ L E+ +G+     
Sbjct: 171 RPYMAPERID----PSARDGYDV--------------RSDVWSLGITLYEVATGKFPYPK 212

Query: 288 LSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM 347
            +    Q L ++V+          IL       F+      F+  I  CL     +RP  
Sbjct: 213 WNSVFDQ-LTQVVKGDP------PILSNSEEREFS----PSFVNFINLCLIKDESKRPKY 261

Query: 348 SDVVT 352
            +++ 
Sbjct: 262 KELLE 266

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 39.7 bits (92), Expect = 0.002
 Identities = 59/232 (25%), Positives = 104/232 (44%), Gaps = 33/232 (14%)

Query: 83  KNFSDKNLIGEGKFGEVYKGLLQDG-MLVAIK--------KRPGAPTQEFIDEVCFLASI 133
           ++F    +IG G FGEV    L++   + A+K        KR  A T  F +E   L + 
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR--AETACFREERDVLVNG 58

Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA--LGAA 191
            ++ + TL    Q+ N  +L+ +Y   G +   L   S+   +  E   R  +A  + A 
Sbjct: 59  DNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYLAEMVIAI 115

Query: 192 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG-----LRNFLGRTDVAGPSSQVT 246
             +  LH      VH+D K  N+L+D +   ++AD G     + +   ++ VA  +    
Sbjct: 116 DSVHQLH-----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 170

Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVE 298
           + EI  A E  +  ++  + D +S GV + E++ G       +P  ++ LVE
Sbjct: 171 SPEILQAMEDGK-GKYGPECDWWSLGVCMYEMLYGE------TPFYAESLVE 215

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 29/92 (31%), Positives = 51/92 (55%), Gaps = 6/92 (6%)

Query: 191 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTD-VAGPSSQVTAD 248
           A+G+  L   S + +H+D    N+L+ E+ + K+ D GL R+     D V   S+++   
Sbjct: 184 ARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241

Query: 249 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
             ++A E    + ++ +SDV+SFGV L E+ S
Sbjct: 242 --WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 38.7 bits (90), Expect = 0.004
 Identities = 28/112 (25%), Positives = 51/112 (45%), Gaps = 16/112 (14%)

Query: 176 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL------ 229
             L+    L  +   A+G+  L S     +H+D    NVL+ +  +AK+ D GL      
Sbjct: 207 WPLDLDDLLRFSSQVAQGMDFLAS--KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264

Query: 230 -RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
             N++ + +   P   +  + IF          ++ +SDV+S+G+ L E+ S
Sbjct: 265 DSNYVVKGNARLPVKWMAPESIFDCV-------YTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 38.6 bits (90), Expect = 0.004
 Identities = 33/134 (24%), Positives = 64/134 (47%), Gaps = 24/134 (17%)

Query: 156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL---HSLSPRVVHKDFKTA 212
           E++  GS+   L    +  R       ++SIA+   +GL +L   H     ++H+D K +
Sbjct: 79  EHMDGGSLDQVL---KKAGRIPENILGKISIAV--LRGLTYLREKHK----IMHRDVKPS 129

Query: 213 NVLVDEDFIAKVADAG----LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDV 268
           N+LV+     K+ D G    L + +  + V   S        +++ E  +   ++ +SD+
Sbjct: 130 NILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS--------YMSPERLQGTHYTVQSDI 181

Query: 269 YSFGVFLLELVSGR 282
           +S G+ L+E+  GR
Sbjct: 182 WSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 38.4 bits (89), Expect = 0.004
 Identities = 50/242 (20%), Positives = 97/242 (40%), Gaps = 39/242 (16%)

Query: 123 FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKH 182
           F +    +  + H+++V L G C  +    ++ E++  G + + ++  S V     +FK 
Sbjct: 51  FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFK- 109

Query: 183 RLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP- 241
              +A   A  L++L      +VH +  T N+L+  + I    D     F+  +D   P 
Sbjct: 110 ---VAKQLASALSYLE--DKDLVHGNVCTKNILLAREGI----DGECGPFIKLSDPGIPI 160

Query: 242 ---SSQVTADEI-FLASE-VKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDL 296
              S Q   + I ++A E V++ +  S  +D +SFG  L E+    E      P   + L
Sbjct: 161 TVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEI-----PLKDKTL 215

Query: 297 VELVQNSRDFSNLLKILDERLWST---FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 353
            E                ER +           +E   L+  C++    +RP    ++ +
Sbjct: 216 AE---------------KERFYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260

Query: 354 LD 355
           ++
Sbjct: 261 IN 262

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	386
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.98
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.9
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.89
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.86
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.85
PRK12274	218	serine/threonine protein kinase; Provisional	99.85
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.83
PRK10345	210	hypothetical protein; Provisional	99.82
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.82
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.82
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.82
smart00090	237	RIO RIO-like kinase.	99.8
PRK14879	211	serine/threonine protein kinase; Provisional	99.77
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.76
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.75
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.75
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.74
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.66
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.66
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.64
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.63
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.57
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.55
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.5
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.41
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.38
KOG1243	690	consensus Protein kinase [General function predict	99.35
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.3
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.28
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.24
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.22
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.22
KOG3087	229	consensus Serine/threonine protein kinase [General	99.14
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.01
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.95
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.91
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.88
COG4248	637	Uncharacterized protein with protein kinase and he	98.88
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.82
PRK09902	216	hypothetical protein; Provisional	98.63
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.62
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.59
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.43
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.42
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.38
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.33
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.26
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.24
PLN02876	822	acyl-CoA dehydrogenase	98.18
PF01636	239	APH: Phosphotransferase enzyme family This family	98.14
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.02
PRK10593	297	hypothetical protein; Provisional	97.93
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.91
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.89
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.87
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.78
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.74
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.7
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.69
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.62
PRK05231	319	homoserine kinase; Provisional	97.61
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.59
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.5
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.36
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.22
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.08
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.06
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.0
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.86
PLN02756	418	S-methyl-5-thioribose kinase	96.47
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.43
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.35
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.32
KOG2270	520	consensus Serine/threonine protein kinase involved	96.31
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.19
PLN02236	344	choline kinase	96.07
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.04
PF01102	122	Glycophorin_A: Glycophorin A; InterPro: IPR001195	95.96
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.67
COG2334	331	Putative homoserine kinase type II (protein kinase	95.42
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	95.42
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.3
PF02439	38	Adeno_E3_CR2: Adenovirus E3 region protein CR2; In	95.27
PRK11768	325	serine/threonine protein kinase; Provisional	95.17
COG3231	266	Aph Aminoglycoside phosphotransferase [Translation	94.17
PRK06148	1013	hypothetical protein; Provisional	94.14
PRK12396	409	5-methylribose kinase; Reviewed	93.85

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-54  Score=403.20  Aligned_cols=286  Identities=44%  Similarity=0.731  Sum_probs=248.6

Q ss_pred             hhcccCHHHHHHHhcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCC---hhHHHHHHHHHHcCCCCcccccccce
Q 016588           69 EARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYC  145 (386)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~  145 (386)
                      ..+.|++.++..+|++|...+.||+|+||.||+|..+++..||||+.....   ..+|.+|++++.+++|||+++++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            456799999999999999999999999999999999988999999866544   46799999999999999999999999


Q ss_pred             eeCC-eEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCceecCCCCCCeeeCCCCceE
Q 016588          146 QENN-LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL-SPRVVHKDFKTANVLVDEDFIAK  223 (386)
Q Consensus       146 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~ivH~dlkp~Nill~~~~~~k  223 (386)
                      .+.+ ..+||+||+++|+|.++++.....   .++|..+++||.++|+||+|||.. .+.|+||||||+|||||+++++|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK  217 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK  217 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence            9988 599999999999999999865322   889999999999999999999984 34799999999999999999999


Q ss_pred             EcccccccccCCCCCCCCCccc-cCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHh
Q 016588          224 VADAGLRNFLGRTDVAGPSSQV-TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN  302 (386)
Q Consensus       224 l~DFgl~~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~  302 (386)
                      |+|||+++.....  ....... .||.+|+|||+......+.++|||||||+++|++||+.|.+...+.....+.+|...
T Consensus       218 lsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~  295 (361)
T KOG1187|consen  218 LSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP  295 (361)
T ss_pred             ccCccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence            9999999665431  1111112 789999999999988999999999999999999999988887665555668888877


Q ss_pred             hhcccchhhhcchhhc-ccCCH-HHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhh
Q 016588          303 SRDFSNLLKILDERLW-STFTN-EGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD  359 (386)
Q Consensus       303 ~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~  359 (386)
                      ......+.+++|+.+. ..++. .....+..++.+|++.+|++||+|.||++.|+.+..
T Consensus       296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            7777789999999987 55554 567789999999999999999999999999965553

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-51  Score=383.54  Aligned_cols=256  Identities=32%  Similarity=0.506  Sum_probs=216.1

Q ss_pred             CCcCCeecccCceEEEEEEeCCCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeCC-eEEEEEEee
Q 016588           85 FSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENN-LQFLIYEYI  158 (386)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~  158 (386)
                      +...+.+|+|+||+||+|.++....||+|++....     .++|.+|+.+|.+++|||||+++|+|.+.. ..++||||+
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~  122 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM  122 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence            33445699999999999999866569999865443     458999999999999999999999999987 789999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-ceecCCCCCCeeeCCCC-ceEEcccccccccCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR-VVHKDFKTANVLVDEDF-IAKVADAGLRNFLGRT  236 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-ivH~dlkp~Nill~~~~-~~kl~DFgl~~~~~~~  236 (386)
                      ++|+|..+++..   ....+++..+++++.||+.||.|||+  .+ ||||||||+|+|++.++ ++||||||+++....+
T Consensus       123 ~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~--~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  123 PGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHS--EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             CCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhc--CCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            999999999653   35789999999999999999999999  56 99999999999999997 9999999999876543


Q ss_pred             CCCCCCccccCcccccchhhhc--ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc
Q 016588          237 DVAGPSSQVTADEIFLASEVKE--FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                      .  ...+...||..|||||++.  ...|+.++||||||+++|||+||+.||....+..   .            ...+..
T Consensus       198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~---~------------~~~v~~  260 (362)
T KOG0192|consen  198 K--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ---V------------ASAVVV  260 (362)
T ss_pred             c--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH---H------------HHHHHh
Confidence            2  2334478999999999999  5699999999999999999999999999877511   1            111222


Q ss_pred             hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhc
Q 016588          315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  362 (386)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~  362 (386)
                      ...+...+..+++.+..++..||..||+.||++.+++..|+.+.....
T Consensus       261 ~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  261 GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence            333445555577889999999999999999999999999999887643

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-52  Score=386.31  Aligned_cols=256  Identities=29%  Similarity=0.484  Sum_probs=223.6

Q ss_pred             cCCCcCCeecccCceEEEEEEeCCCcEEEEEECCC--CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecC
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPG--APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      ..++..+.||+|.||.||.|.++....||+|.+..  ...++|.+|+.+|++|+|+|||+++|+|..++.+||||||++.
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~  285 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK  285 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence            33445678999999999999998888999997554  4557899999999999999999999999999999999999999


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  240 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~  240 (386)
                      |+|.+++..   .....+...+.+.++.||++|++||++  +++|||||..+||||+++..+||+||||++...+.. ..
T Consensus       286 GsLl~yLr~---~~~~~l~~~~Ll~~a~qIaeGM~YLes--~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~  359 (468)
T KOG0197|consen  286 GSLLDYLRT---REGGLLNLPQLLDFAAQIAEGMAYLES--KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-YT  359 (468)
T ss_pred             CcHHHHhhh---cCCCccchHHHHHHHHHHHHHHHHHHh--CCccchhhhhhheeeccCceEEEcccccccccCCCc-ee
Confidence            999999954   246778899999999999999999999  679999999999999999999999999999665533 33


Q ss_pred             CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcc
Q 016588          241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS  319 (386)
Q Consensus       241 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (386)
                      ......-|..|.|||++....|+.+||||||||+||||+| |+.||.++..                .++.+.++.+.+.
T Consensus       360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn----------------~ev~~~le~GyRl  423 (468)
T KOG0197|consen  360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN----------------EEVLELLERGYRL  423 (468)
T ss_pred             ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH----------------HHHHHHHhccCcC
Confidence            3445556778999999999999999999999999999999 8889888763                3344455667777


Q ss_pred             cCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          320 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      +.|..|+++++++|..||+.+|++|||++.+...|+++...
T Consensus       424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            88889999999999999999999999999999999887654

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-52  Score=370.76  Aligned_cols=248  Identities=26%  Similarity=0.351  Sum_probs=208.1

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEEC----CCCChhHHHHHHHHHHcCCCCcccccccceeeCC-eEEEEEEe
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKR----PGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENN-LQFLIYEY  157 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~  157 (386)
                      +.+..+.||+|..|+||++.++ ++..+|+|.+    .+...+++.+|+++++..+|||||++||.|..++ ..+++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            5556789999999999999976 5889999986    3344567899999999999999999999999988 59999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      |++|+|++++.     ..+.+++...-+++.+|++||.|||+. .+||||||||+|+|++..|++||||||.+..+... 
T Consensus       160 MDgGSLd~~~k-----~~g~i~E~~L~~ia~~VL~GL~YLh~~-~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-  232 (364)
T KOG0581|consen  160 MDGGSLDDILK-----RVGRIPEPVLGKIARAVLRGLSYLHEE-RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-  232 (364)
T ss_pred             cCCCCHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHhhc-cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence            99999999884     336689999999999999999999952 67999999999999999999999999999987553 


Q ss_pred             CCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCC--CchhhHHHHHHhhhcccchhhhcch
Q 016588          238 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP--DSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                         ......||..|||||.+++..|+.++||||||++++|+.+|+.||....+  ...-++..            .+.+.
T Consensus       233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~------------~Iv~~  297 (364)
T KOG0581|consen  233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLC------------AIVDE  297 (364)
T ss_pred             ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHH------------HHhcC
Confidence               34567899999999999999999999999999999999999999987522  11112221            12221


Q ss_pred             hhcccCCH-HHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          316 RLWSTFTN-EGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       316 ~~~~~~~~-~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                       ..+..+. .++++++.++..||++||.+|||+.|+++|-
T Consensus       298 -ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp  336 (364)
T KOG0581|consen  298 -PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP  336 (364)
T ss_pred             -CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence             1123334 3778899999999999999999999999873

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-50  Score=360.54  Aligned_cols=247  Identities=24%  Similarity=0.425  Sum_probs=201.5

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      .+|...+.||+|+||+||+|+++ ++..||||.+...     ..+-+..|+.+|+.++|||||++++++...+..|||||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            57788888999999999999965 4889999986544     33457889999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC------CceEEcccccc
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED------FIAKVADAGLR  230 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~------~~~kl~DFgl~  230 (386)
                      ||.+|+|.+++.     ..+.+++.+...++.|++.||++||+  ++||||||||+||||+.+      -.+||+|||+|
T Consensus        90 yC~gGDLs~yi~-----~~~~l~e~t~r~Fm~QLA~alq~L~~--~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   90 YCNGGDLSDYIR-----RRGRLPEATARHFMQQLASALQFLHE--NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             eCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            999999999994     45689999999999999999999999  889999999999999764      56899999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          231 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      +.+...   ......+|++.|||||+++...|+.|+|+||+|+++|++++|+.||....+.   ++....+...      
T Consensus       163 R~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~---eL~~~~~k~~------  230 (429)
T KOG0595|consen  163 RFLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK---ELLLYIKKGN------  230 (429)
T ss_pred             hhCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH---HHHHHHhccc------
Confidence            998643   3445678999999999999999999999999999999999999999976642   2222222211      


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                           ......+......+.+++...++.+|.+|.++.+-..+
T Consensus       231 -----~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~  268 (429)
T KOG0595|consen  231 -----EIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDH  268 (429)
T ss_pred             -----cccCchhhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence                 11122223333445677777778888888777666543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-50  Score=362.48  Aligned_cols=252  Identities=23%  Similarity=0.348  Sum_probs=204.4

Q ss_pred             HhcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC----------ChhHHHHHHHHHHcCCCCcccccccceeeCC
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA----------PTQEFIDEVCFLASIQHRNLVTLLGYCQENN  149 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~----------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  149 (386)
                      ..+.|.+.+.||+|+||.|-+|.. ++++.||||++...          ....+.+|+++|++|+|||||++++++...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            456688889999999999999994 56999999974321          1224679999999999999999999999999


Q ss_pred             eEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC---CceEEcc
Q 016588          150 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED---FIAKVAD  226 (386)
Q Consensus       150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~---~~~kl~D  226 (386)
                      ..||||||++||+|.+++-     ..+.+.+..-..+++|++.|+.|||+  +||+||||||+|||+..+   ..+||+|
T Consensus       250 s~YmVlE~v~GGeLfd~vv-----~nk~l~ed~~K~~f~Qll~avkYLH~--~GI~HRDiKPeNILl~~~~e~~llKItD  322 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVV-----ANKYLREDLGKLLFKQLLTAVKYLHS--QGIIHRDIKPENILLSNDAEDCLLKITD  322 (475)
T ss_pred             ceEEEEEEecCccHHHHHH-----hccccccchhHHHHHHHHHHHHHHHH--cCcccccCCcceEEeccCCcceEEEecc
Confidence            9999999999999999984     44556677778899999999999999  779999999999999765   7899999


Q ss_pred             cccccccCCCCCCCCCccccCcccccchhhhcccCC---CcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhh
Q 016588          227 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF---SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS  303 (386)
Q Consensus       227 Fgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~  303 (386)
                      ||+|+..+.   .......+||+.|.|||++.+..+   ..++|+||+||+||-+++|.+||++...+.  .+.+.+...
T Consensus       323 FGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQI~~G  397 (475)
T KOG0615|consen  323 FGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQILKG  397 (475)
T ss_pred             cchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHHHhcC
Confidence            999999863   344567899999999999987654   347799999999999999999999865422  223322221


Q ss_pred             hcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          304 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                      .-      .+.+..|    ...+++..++|.+||..||++|||+.|+|++-
T Consensus       398 ~y------~f~p~~w----~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp  438 (475)
T KOG0615|consen  398 RY------AFGPLQW----DRISEEALDLINWMLVVDPENRPSADEALNHP  438 (475)
T ss_pred             cc------cccChhh----hhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence            11      1111122    24567789999999999999999999999873

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-49  Score=371.73  Aligned_cols=245  Identities=23%  Similarity=0.391  Sum_probs=212.2

Q ss_pred             cCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCC------CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      .+|...++||+|+|+.||.+.. .+|+.||+|.+++      ...+.+.+|+++-+.|+|||||+++++|++.+.+|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4688999999999999999996 7899999998544      45678999999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      |+|.+++|..++.     .++.+++..+..+..||+.||.|||+  .+|+|||||..|+||+++.++||+|||||..+..
T Consensus        98 ELC~~~sL~el~K-----rrk~ltEpEary~l~QIv~GlkYLH~--~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   98 ELCHRGSLMELLK-----RRKPLTEPEARYFLRQIVEGLKYLHS--LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EecCCccHHHHHH-----hcCCCCcHHHHHHHHHHHHHHHHHHh--cCceecccchhheeecCcCcEEecccceeeeecC
Confidence            9999999988883     56789999999999999999999999  6799999999999999999999999999999864


Q ss_pred             CCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      .+  ......+|||-|.|||++.....+..+||||+||++|-|+.|++||....-   .+.+..+...            
T Consensus       171 ~~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v---kety~~Ik~~------------  233 (592)
T KOG0575|consen  171 DG--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV---KETYNKIKLN------------  233 (592)
T ss_pred             cc--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH---HHHHHHHHhc------------
Confidence            32  234567999999999999999999999999999999999999999997442   2222211111            


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ..  ..|...+.+..+||.++|+.||.+|||+++|+.+
T Consensus       234 ~Y--~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  234 EY--SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             Cc--ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            11  2344566778999999999999999999999976

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.2e-50  Score=390.72  Aligned_cols=263  Identities=29%  Similarity=0.476  Sum_probs=220.9

Q ss_pred             HHhcCCCcCCeecccCceEEEEEEeC------CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCC
Q 016588           80 LATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENN  149 (386)
Q Consensus        80 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  149 (386)
                      ....+....+.||+|+||.||+|...      ....||||.++...    .++|++|++++..++|||||+++|+|..++
T Consensus       483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD  562 (774)
T ss_pred             echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence            34455666788999999999999843      34679999866543    357999999999999999999999999999


Q ss_pred             eEEEEEEeecCCCccccccCCCcC---------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC
Q 016588          150 LQFLIYEYIPNGSVSIHLYGPSQV---------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF  220 (386)
Q Consensus       150 ~~~lv~e~~~~g~L~~~l~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~  220 (386)
                      ..|+|+|||..|||.+||......         ...+++..+.+.||.|||.|+.||.+  +.+|||||..+|+||+++.
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~--~~FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS--HHFVHRDLATRNCLVGENL  640 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh--Ccccccchhhhhceeccce
Confidence            999999999999999998533211         13448899999999999999999998  6699999999999999999


Q ss_pred             ceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHH
Q 016588          221 IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVEL  299 (386)
Q Consensus       221 ~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~  299 (386)
                      .+||+|||+++.+=..++........-+.+|||||.+..++||++||||||||+|||+++ |+.||.+...+   +.++.
T Consensus       641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~---EVIe~  717 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ---EVIEC  717 (774)
T ss_pred             EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH---HHHHH
Confidence            999999999997755455444444556778999999999999999999999999999999 99999987753   33333


Q ss_pred             HHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          300 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      ++            +.++ .+.+++++.++++||..||+.+|.+||+++||-..|+...+.
T Consensus       718 i~------------~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  718 IR------------AGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             HH------------cCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            22            2222 467788899999999999999999999999999999888765

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-50  Score=344.70  Aligned_cols=255  Identities=24%  Similarity=0.369  Sum_probs=206.2

Q ss_pred             cCCCcCCeecccCceEEEEEE-eCCCcEEEEEECC-----CCChhHHHHHHHHHHcCCCCccccccc-ceeeCCe-EEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP-----GAPTQEFIDEVCFLASIQHRNLVTLLG-YCQENNL-QFLI  154 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~~~-~~lv  154 (386)
                      .+|++.+.||+|.||+||++. ..+|..+|.|.+.     ....+++..|+.+|++|+|||||++++ .+..++. +++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            356778899999999999999 5678999999743     334567889999999999999999999 4444444 8999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcC--CCCceecCCCCCCeeeCCCCceEEcccccccc
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL--SPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~  232 (386)
                      ||||..|+|...+.... ...+.+++..+++++.|++.||..+|+.  .+-|+||||||.||+|+.+|.+||+||||++.
T Consensus        99 mE~c~~GDLsqmIk~~K-~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFK-KQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHhhcccCHHHHHHHHH-hccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            99999999998774332 2456789999999999999999999983  23399999999999999999999999999998


Q ss_pred             cCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          233 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      +....  .....++|||.||+||.+....|+.+|||||+||++|||+.-..||.+..   ..++...+.+.         
T Consensus       178 l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n---~~~L~~KI~qg---------  243 (375)
T KOG0591|consen  178 LSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN---LLSLCKKIEQG---------  243 (375)
T ss_pred             hcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc---HHHHHHHHHcC---------
Confidence            86432  23456789999999999999999999999999999999999999999752   22222222211         


Q ss_pred             cchhhcccCC-HHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHH
Q 016588          313 LDERLWSTFT-NEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  356 (386)
Q Consensus       313 ~~~~~~~~~~-~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~  356 (386)
                          -.++.+ ...+.++.+|+..|+..||+.||+.-.++..+..
T Consensus       244 ----d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  244 ----DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             ----CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence                122334 4567889999999999999999996666655544

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-49  Score=380.58  Aligned_cols=267  Identities=26%  Similarity=0.456  Sum_probs=233.1

Q ss_pred             cCCCcCCeecccCceEEEEEEeCC----CcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      ...++.++||.|.||.||+|.++-    ...||||.++...    ..+|+.|..||.+++||||++|.|+........+|
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi  708 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII  708 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence            345667899999999999999653    4579999876554    34699999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      .|||++|+|+.||..    +.+.+.+.++.-+.++|+.|++||.++  ++|||||..+|||++.+..+|++|||+++.+.
T Consensus       709 TEyMENGsLDsFLR~----~DGqftviQLVgMLrGIAsGMkYLsdm--~YVHRDLAARNILVNsnLvCKVsDFGLSRvle  782 (996)
T KOG0196|consen  709 TEYMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIASGMKYLSDM--NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  782 (996)
T ss_pred             hhhhhCCcHHHHHhh----cCCceEeehHHHHHHHHHHHhHHHhhc--CchhhhhhhhheeeccceEEEeccccceeecc
Confidence            999999999999964    446688999999999999999999994  59999999999999999999999999999885


Q ss_pred             CCC-CCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          235 RTD-VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       235 ~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      +.. ......+...+..|.|||.+....++.+|||||||+++||.++ |..||..+..                .++.+.
T Consensus       783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN----------------QdVIka  846 (996)
T KOG0196|consen  783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN----------------QDVIKA  846 (996)
T ss_pred             cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch----------------HHHHHH
Confidence            533 3334445566788999999999999999999999999999887 9999998774                234555


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhcccccccCCC
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEG  371 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~~~~~~~~~~  371 (386)
                      ++..++.+.|.+|+..++.||..||++|-.+||++.|++..|++++.++.++....+..
T Consensus       847 Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~~~  905 (996)
T KOG0196|consen  847 IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAPES  905 (996)
T ss_pred             HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCCCC
Confidence            66777778889999999999999999999999999999999999999998888777753

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.7e-48  Score=334.46  Aligned_cols=266  Identities=19%  Similarity=0.293  Sum_probs=208.5

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCCh-----hHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT-----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      .|+....+|+|+||.||+++.+ +|+.||||++..+..     +-.++|+++|++++|+|+|.++.+|.....++||+||
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~   82 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY   82 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence            5677788999999999999966 499999999665443     3367899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      |+..-|.+.-     .....++...+.+++.|++.|+.|+|+  ++++||||||+|||++.++.+||||||+|+.+... 
T Consensus        83 ~dhTvL~eLe-----~~p~G~~~~~vk~~l~Q~l~ai~~cHk--~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-  154 (396)
T KOG0593|consen   83 CDHTVLHELE-----RYPNGVPSELVKKYLYQLLKAIHFCHK--NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP-  154 (396)
T ss_pred             cchHHHHHHH-----hccCCCCHHHHHHHHHHHHHHhhhhhh--cCeecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence            9985554443     244567888899999999999999999  67999999999999999999999999999988642 


Q ss_pred             CCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhccc-chhhhcch
Q 016588          238 VAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS-NLLKILDE  315 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  315 (386)
                       ....+.+..|.+|.|||.+-+ ..|+.++||||+||++.||++|.+.|.+..+.  ++++......-... +..+++..
T Consensus       155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi--DQLy~I~ktLG~L~prhq~iF~~  231 (396)
T KOG0593|consen  155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI--DQLYLIRKTLGNLIPRHQSIFSS  231 (396)
T ss_pred             -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchH--HHHHHHHHHHcccCHHHHHHhcc
Confidence             234567889999999999988 68999999999999999999999998886653  33333322222111 11111111


Q ss_pred             ---------------hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH--HHHhhhh
Q 016588          316 ---------------RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE--LDRTLDK  360 (386)
Q Consensus       316 ---------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~--L~~~~~~  360 (386)
                                     .......+..+.-+.+++++||+.||.+|++.+|++.+  +++.++.
T Consensus       232 N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er  293 (396)
T KOG0593|consen  232 NPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIER  293 (396)
T ss_pred             CCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHH
Confidence                           11111122344568999999999999999999999964  3444444

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-48  Score=344.30  Aligned_cols=240  Identities=21%  Similarity=0.298  Sum_probs=201.2

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC------CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      .++|+..++||+|+||+||.++.+ +++.+|+|.+++      .......+|..+|..++||.||+++-.|++.+.+|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            468899999999999999999955 589999996443      3355678999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      +||+.||.|..++     .+...+++..+..++.+|+.||.|||+  .|||||||||+|||||.+|+++|+||||++..-
T Consensus       104 ld~~~GGeLf~hL-----~~eg~F~E~~arfYlaEi~lAL~~LH~--~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~  176 (357)
T KOG0598|consen  104 LDYLNGGELFYHL-----QREGRFSEDRARFYLAEIVLALGYLHS--KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL  176 (357)
T ss_pred             EeccCCccHHHHH-----HhcCCcchhHHHHHHHHHHHHHHHHHh--CCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence            9999999999988     456788999999999999999999999  779999999999999999999999999998643


Q ss_pred             CCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                      ..  ...+...+||+.|||||++.+..|+..+|+||+|+++|||++|.+||...+....   ++.+            ..
T Consensus       177 ~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~---~~~I------------~~  239 (357)
T KOG0598|consen  177 KD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM---YDKI------------LK  239 (357)
T ss_pred             cC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH---HHHH------------hc
Confidence            32  2334557999999999999999999999999999999999999999997553211   1111            11


Q ss_pred             hhhcccCCHHHHHHHHHHHhHccCCCCCCCCC
Q 016588          315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS  346 (386)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt  346 (386)
                      .. ....+...+.+.++++.++|..||++|..
T Consensus       240 ~k-~~~~p~~ls~~ardll~~LL~rdp~~RLg  270 (357)
T KOG0598|consen  240 GK-LPLPPGYLSEEARDLLKKLLKRDPRQRLG  270 (357)
T ss_pred             Cc-CCCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence            11 11223334567899999999999999963

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-47  Score=344.29  Aligned_cols=258  Identities=26%  Similarity=0.357  Sum_probs=205.3

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC---hhHHHHHHHHHHcCCCCcccccccceeeCC--eEEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENN--LQFLIYE  156 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e  156 (386)
                      .++...+.||+|+||+||++... ++...|||......   .+.+.+|+.+|++++|||||+++|......  ..+++||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            45666789999999999999965 48999999865444   456899999999999999999999855444  6899999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-CCceEEcccccccccCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLGR  235 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~-~~~~kl~DFgl~~~~~~  235 (386)
                      |+++|+|.+++...    ...+++..+.++..|+++||.|||+  +||+||||||+|||++. ++.+||+|||+++....
T Consensus        97 y~~~GsL~~~~~~~----g~~l~E~~v~~ytr~iL~GL~ylHs--~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRY----GGKLPEPLVRRYTRQILEGLAYLHS--KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             ccCCCcHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHh--CCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            99999999999532    2269999999999999999999998  78999999999999999 79999999999887653


Q ss_pred             -CCCCCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhc
Q 016588          236 -TDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  313 (386)
Q Consensus       236 -~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (386)
                       ...........||+.|||||++... ....++||||+||++.||+||+.||..... ....+.             .+.
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~-~~~~~~-------------~ig  236 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE-EAEALL-------------LIG  236 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc-hHHHHH-------------HHh
Confidence             1222334457899999999999853 234599999999999999999999987411 011111             111


Q ss_pred             chhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      .....+..+...+.+..+++.+|+..||++|||+.++|++.--...+
T Consensus       237 ~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  237 REDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             ccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence            11112245556778899999999999999999999999987554433

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-47  Score=352.00  Aligned_cols=252  Identities=21%  Similarity=0.272  Sum_probs=211.1

Q ss_pred             HHHhcCCCcCCeecccCceEEEEEE-eCCCcEEEEEECCC------CChhHHHHHHHHHHcC-CCCcccccccceeeCCe
Q 016588           79 SLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG------APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNL  150 (386)
Q Consensus        79 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~------~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  150 (386)
                      .....+|...+.||.|+|++|++|+ ..++..+|||++.+      ...+-+..|-+.|.+| .||.|++|+-.|++...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            3456789999999999999999999 45689999997443      3344567888999999 89999999999999999


Q ss_pred             EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  230 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~  230 (386)
                      +|+|+||+++|+|.+++.     ..+.+++.....++.+|+.||+|||+  +|||||||||+|||||++|++||+|||.|
T Consensus       149 LYFvLe~A~nGdll~~i~-----K~Gsfde~caR~YAAeIldAleylH~--~GIIHRDlKPENILLd~dmhikITDFGsA  221 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIK-----KYGSFDETCARFYAAEILDALEYLHS--NGIIHRDLKPENILLDKDGHIKITDFGSA  221 (604)
T ss_pred             eEEEEEecCCCcHHHHHH-----HhCcchHHHHHHHHHHHHHHHHHHHh--cCceeccCChhheeEcCCCcEEEeecccc
Confidence            999999999999999994     45778999999999999999999999  77999999999999999999999999999


Q ss_pred             cccCCCCCC---------CCC--ccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHH
Q 016588          231 NFLGRTDVA---------GPS--SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVEL  299 (386)
Q Consensus       231 ~~~~~~~~~---------~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~  299 (386)
                      +.+......         ...  ...+||..|.+||++.....+..+|+|+|||++|+|+.|++||.+..+-      ..
T Consensus       222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney------li  295 (604)
T KOG0592|consen  222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY------LI  295 (604)
T ss_pred             ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH------HH
Confidence            988643221         111  4578999999999999999999999999999999999999999975541      11


Q ss_pred             HHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          300 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                      ++         ++.+-.  -.+++..++.+.+|+++.|..||.+|+|..++-+|.
T Consensus       296 Fq---------kI~~l~--y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  296 FQ---------KIQALD--YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             HH---------HHHHhc--ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence            11         111111  145556667899999999999999999999988764

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=7.9e-46  Score=348.51  Aligned_cols=263  Identities=22%  Similarity=0.383  Sum_probs=204.1

Q ss_pred             HhcCCCcCCeecccCceEEEEEEe------CCCcEEEEEECCCCC----hhHHHHHHHHHHcC-CCCcccccccceeeC-
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQEN-  148 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-  148 (386)
                      ..++|++.+.||+|+||.||+|..      .++..||+|+.....    ...+.+|+.++..+ +||||+++++++... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            456788999999999999999974      124679999865432    34588999999999 899999999988754 


Q ss_pred             CeEEEEEEeecCCCccccccCCCcC-------------------------------------------------------
Q 016588          149 NLQFLIYEYIPNGSVSIHLYGPSQV-------------------------------------------------------  173 (386)
Q Consensus       149 ~~~~lv~e~~~~g~L~~~l~~~~~~-------------------------------------------------------  173 (386)
                      +..+++|||+++|+|.+++......                                                       
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            4688999999999998887532110                                                       


Q ss_pred             --CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccc
Q 016588          174 --SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF  251 (386)
Q Consensus       174 --~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y  251 (386)
                        ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++...............++..|
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHH--CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              02347788889999999999999998  78999999999999999999999999999865332221122233456779


Q ss_pred             cchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHH
Q 016588          252 LASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFI  330 (386)
Q Consensus       252 ~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  330 (386)
                      +|||++.+..++.++|||||||++|||++ |..||......  ..........             .....+...++++.
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--~~~~~~~~~~-------------~~~~~~~~~~~~l~  307 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--EEFCQRLKDG-------------TRMRAPENATPEIY  307 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHHhcC-------------CCCCCCCCCCHHHH
Confidence            99999998999999999999999999997 99998764431  1111111110             01112233456789


Q ss_pred             HHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          331 QLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       331 ~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      +++.+||+.||++|||+.++++.|++++.+
T Consensus       308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         308 RIMLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-46  Score=344.80  Aligned_cols=248  Identities=22%  Similarity=0.369  Sum_probs=209.4

Q ss_pred             hcCCCcCCeecccCceEEEEEE-eCCCcEEEEEECC---CCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      ...|.....||+|+.|.||.|. ..+++.||||++.   ....+-+.+|+.+|+..+|+|||.+++.+...+.+|+||||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            3457888999999999999999 5568899999743   33345578999999999999999999999988999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +++|+|.+.+.      ...+++.++..++.+++.||+|||.  +||+|||||.+|||++.+|.+||+|||++..+....
T Consensus       352 m~ggsLTDvVt------~~~~~E~qIA~Icre~l~aL~fLH~--~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~  423 (550)
T KOG0578|consen  352 MEGGSLTDVVT------KTRMTEGQIAAICREILQGLKFLHA--RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ  423 (550)
T ss_pred             cCCCchhhhhh------cccccHHHHHHHHHHHHHHHHHHHh--cceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence            99999998883      3458899999999999999999998  789999999999999999999999999998876533


Q ss_pred             CCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhh
Q 016588          238 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  317 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (386)
                      .  ....+.||++|||||++..+.|+++.||||||++++||+-|.+||-...+-.  .++....            ....
T Consensus       424 ~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr--AlyLIa~------------ng~P  487 (550)
T KOG0578|consen  424 S--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--ALYLIAT------------NGTP  487 (550)
T ss_pred             C--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH--HHHHHhh------------cCCC
Confidence            2  3467899999999999999999999999999999999999999998644421  1111111            1112


Q ss_pred             cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ....++..+..+++++.+||+.|+++|+++.|+|+|
T Consensus       488 ~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  488 KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            224455677889999999999999999999999986

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.2e-45  Score=313.67  Aligned_cols=260  Identities=22%  Similarity=0.343  Sum_probs=207.0

Q ss_pred             cCCCcCCeecccCceEEEEEE-eCCCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      ++|...+.+|+|.||.||+|+ ..+|+.||||++....     .....+|++.|+.++|+||+.++++|...+.+.+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            467788999999999999999 5679999999854332     3357899999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      |++. +|...+.+    +...+...++..++.++++|++|||+  +.|+||||||.|+|++++|.+||+|||+++..+..
T Consensus        82 fm~t-dLe~vIkd----~~i~l~pa~iK~y~~m~LkGl~y~H~--~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   82 FMPT-DLEVVIKD----KNIILSPADIKSYMLMTLKGLAYCHS--KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             eccc-cHHHHhcc----cccccCHHHHHHHHHHHHHHHHHHHh--hhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            9976 88888853    45678899999999999999999999  77999999999999999999999999999998764


Q ss_pred             CCCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhh-----hcccchh
Q 016588          237 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS-----RDFSNLL  310 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~  310 (386)
                      ....  .....|.+|.|||.+.| +.|+...|+||.||++.||+-|.+-|.+..+  .+++...++..     ..+.++.
T Consensus       155 ~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD--idQL~~If~~LGTP~~~~WP~~~  230 (318)
T KOG0659|consen  155 NRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD--IDQLSKIFRALGTPTPDQWPEMT  230 (318)
T ss_pred             Cccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch--HHHHHHHHHHcCCCCcccCcccc
Confidence            4332  23378999999998876 4789999999999999999999887777554  33333222211     1122222


Q ss_pred             hhcchhh--------cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          311 KILDERL--------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       311 ~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ...|..-        ....-..++++..+++.+||..||.+|+|+.|++++
T Consensus       231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            2222111        111122345667999999999999999999999976

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-46  Score=372.53  Aligned_cols=261  Identities=29%  Similarity=0.463  Sum_probs=218.8

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCC--Cc----EEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQD--GM----LVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  151 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~----~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  151 (386)
                      ....+..+.||+|+||.||.|...+  +.    .||+|.+.+..    ..+|.+|..+|++++||||++++|+|.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            4566777899999999999999653  33    48999866543    45699999999999999999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQV--SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  229 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl  229 (386)
                      ++++|||++|+|..|+...+..  ....+...+.+.++.|||+|+.||++  ++.|||||..+|+||+....+||+|||+
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~--~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES--KHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh--CCCcCcchhhhheeecccCcEEEcccch
Confidence            9999999999999999755322  24678899999999999999999999  7799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccc
Q 016588          230 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSN  308 (386)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  308 (386)
                      |+.+-..++........-+..|||||.+....|+.|+|||||||++||++| |..||......+.   .           
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v---~-----------  914 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV---L-----------  914 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH---H-----------
Confidence            997655454444333455678999999999999999999999999999999 8899988664211   1           


Q ss_pred             hhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          309 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                       ..+.... +...+..|++.++++|..||+.+|++||++..+++++..+.+.
T Consensus       915 -~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  915 -LDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             -HHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence             1112222 5567788899999999999999999999999999999887755

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-45  Score=331.00  Aligned_cols=262  Identities=24%  Similarity=0.292  Sum_probs=209.9

Q ss_pred             HHhcCCCcCCeecccCceEEEEEE-eCCCcEEEEEECCC----CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           80 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        80 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      ...++|+..++||.|..++||+|. ...+..||||++.-    ...+.+.+|+..++.++||||++++..|..+..+|+|
T Consensus        23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV  102 (516)
T KOG0582|consen   23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV  102 (516)
T ss_pred             CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence            345789999999999999999999 45689999998542    2356789999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      |.||.+|++.+.+...   -...+++..+..|.+++++||.|||+  +|-||||||+.||||+.+|.+||+|||.+..+.
T Consensus       103 mpfMa~GS~ldIik~~---~~~Gl~E~~Ia~iLre~LkaL~YLH~--~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~  177 (516)
T KOG0582|consen  103 MPFMAGGSLLDIIKTY---YPDGLEEASIATILREVLKALDYLHQ--NGHIHRDVKAGNILIDSDGTVKLADFGVSASLF  177 (516)
T ss_pred             ehhhcCCcHHHHHHHH---ccccccHHHHHHHHHHHHHHHHHHHh--cCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence            9999999999988543   33458899999999999999999999  789999999999999999999999999876654


Q ss_pred             CCCCC-CCC-ccccCcccccchhhhcc--cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          235 RTDVA-GPS-SQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       235 ~~~~~-~~~-~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      ..... ... ....++++|||||+++.  ..|+.|+||||||++..||.+|..||...++-  .-+...+++.+.... .
T Consensus       178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm--kvLl~tLqn~pp~~~-t  254 (516)
T KOG0582|consen  178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM--KVLLLTLQNDPPTLL-T  254 (516)
T ss_pred             ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH--HHHHHHhcCCCCCcc-c
Confidence            32211 111 55689999999999653  58999999999999999999999999998872  222222232222111 1


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ..++.    .........+++++..||+.||.+|||+++++++
T Consensus       255 ~~~~~----d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  255 SGLDK----DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             ccCCh----HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            11111    1122334578999999999999999999999965

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-45  Score=336.69  Aligned_cols=264  Identities=23%  Similarity=0.323  Sum_probs=205.5

Q ss_pred             HhcCCCcCCeecccCceEEEEEE-eCCCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeC--CeEE
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQF  152 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  152 (386)
                      ..+.|+.++.||+|.||.||+|. ..+|..||+|++.-..     ..-..+|+.+|++|+||||+++.+.....  ..+|
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            34567788999999999999999 5679999999854332     33467899999999999999999988776  7899


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~  232 (386)
                      ||+|||+. ||.-++.    ...-.++..++..++.|++.||+|||+  +||+|||||.+|||||.+|.+||+|||||++
T Consensus       195 lVFeYMdh-DL~GLl~----~p~vkft~~qIKc~mkQLl~Gl~~cH~--~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~  267 (560)
T KOG0600|consen  195 LVFEYMDH-DLSGLLS----SPGVKFTEPQIKCYMKQLLEGLEYCHS--RGVLHRDIKGSNILIDNNGVLKIADFGLARF  267 (560)
T ss_pred             EEEecccc-hhhhhhc----CCCcccChHHHHHHHHHHHHHHHHHhh--cCeeeccccccceEEcCCCCEEeccccceee
Confidence            99999987 6766663    234578999999999999999999999  7899999999999999999999999999998


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchh-
Q 016588          233 LGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL-  310 (386)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-  310 (386)
                      ..... ....+..+.|.+|.|||.+.|. .|+.+.|+||.||||.||+.|++.|.+..+.+....+-.+...+...... 
T Consensus       268 y~~~~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~  346 (560)
T KOG0600|consen  268 YTPSG-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPV  346 (560)
T ss_pred             ccCCC-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccc
Confidence            76533 2335667789999999999875 89999999999999999999999999877533332222221111111111 


Q ss_pred             -hhc-----------chhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          311 -KIL-----------DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       311 -~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                       +..           .+.+.+. -...+....+|+..+|..||.+|.|+.++|+.
T Consensus       347 ~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  347 SKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             ccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence             000           0011111 11234567899999999999999999999865

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-46  Score=340.16  Aligned_cols=263  Identities=23%  Similarity=0.348  Sum_probs=208.1

Q ss_pred             HhcCCCcCCeecccCceEEEEEE-eCCCcEEEEEECCCC--ChhHH--HHHHHHHHcCC-CCcccccccceeeCC-eEEE
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA--PTQEF--IDEVCFLASIQ-HRNLVTLLGYCQENN-LQFL  153 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~--~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~l  153 (386)
                      ..++|+..+.||.|.||.||+|+ ..++..||||++++.  ..++.  .+|+..|++|+ ||||+++.+++.+++ .+|+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            34678889999999999999999 456889999975433  23343  57999999998 999999999998888 9999


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      |||||+. +|...+..    ++..+++..+..|+.||++||+|+|.  +|+.|||+||+|||+..+..+||+|||+|+.+
T Consensus        88 VfE~Md~-NLYqLmK~----R~r~fse~~irnim~QilqGL~hiHk--~GfFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKD----RNRLFSESDIRNIMYQILQGLAHIHK--HGFFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             eHHhhhh-hHHHHHhh----cCCcCCHHHHHHHHHHHHHHHHHHHh--cCcccccCChhheEecccceeEeccccccccc
Confidence            9999976 88888853    36789999999999999999999999  77999999999999999999999999999987


Q ss_pred             CCCCCCCCCccccCcccccchhhhc-ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchh-hHHHHHHhhhcccch--
Q 016588          234 GRTDVAGPSSQVTADEIFLASEVKE-FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ-DLVELVQNSRDFSNL--  309 (386)
Q Consensus       234 ~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~--  309 (386)
                         ....+.+.+..|++|.|||++. ...|+.+.|+||+||+++|+.+-++.|.+..+.+.- ..++.+.. +.....  
T Consensus       161 ---~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGt-P~~~~~~e  236 (538)
T KOG0661|consen  161 ---RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGT-PDKDSWPE  236 (538)
T ss_pred             ---ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCC-Cccccchh
Confidence               3445678889999999999875 467899999999999999999999988886653221 11111111 111110  


Q ss_pred             ----hhhcchhh-------cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          310 ----LKILDERL-------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       310 ----~~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                          ...+.-.+       ....-+.++.++.+++.+|+..||.+|||+.|++++-
T Consensus       237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence                01111000       0111123667899999999999999999999999874

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-46  Score=346.28  Aligned_cols=243  Identities=24%  Similarity=0.413  Sum_probs=206.1

Q ss_pred             CCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCCCc
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV  163 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  163 (386)
                      .....+-||+|+.|.||+|+++ ++.||||++....    ..+++.|++|+||||+.|.|+|...-.+|+|||||..|.|
T Consensus       125 ~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk----ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL  199 (904)
T KOG4721|consen  125 EISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK----ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL  199 (904)
T ss_pred             HhhhhhhhccCcccceeeeecc-CceehhHHHhhhh----hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence            3445677999999999999986 5789999865432    2568889999999999999999999999999999999999


Q ss_pred             cccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCc
Q 016588          164 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS  243 (386)
Q Consensus       164 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~  243 (386)
                      ...+.     ....+.......+..+||.|+.|||.  +.|||||||.-||||..+..+||+|||-++...+.   ....
T Consensus       200 ~~VLk-----a~~~itp~llv~Wsk~IA~GM~YLH~--hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkM  269 (904)
T KOG4721|consen  200 YEVLK-----AGRPITPSLLVDWSKGIAGGMNYLHL--HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKM  269 (904)
T ss_pred             HHHHh-----ccCccCHHHHHHHHHHhhhhhHHHHH--hhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhh
Confidence            99994     44567777888999999999999999  66999999999999999999999999999876442   4455


Q ss_pred             cccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCH
Q 016588          244 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN  323 (386)
Q Consensus       244 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (386)
                      .+.||..|||||+++....++|+||||||||||||+||..||...+...               .+..+-...+....+.
T Consensus       270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA---------------IIwGVGsNsL~LpvPs  334 (904)
T KOG4721|consen  270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA---------------IIWGVGSNSLHLPVPS  334 (904)
T ss_pred             hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe---------------eEEeccCCcccccCcc
Confidence            6789999999999999999999999999999999999999998654311               1111222233446677


Q ss_pred             HHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHH
Q 016588          324 EGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  356 (386)
Q Consensus       324 ~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~  356 (386)
                      .+++-+.-|++.||+..|.+||++.+++.||+=
T Consensus       335 tcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  335 TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             cCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence            888889999999999999999999999999974

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-45  Score=343.58  Aligned_cols=264  Identities=27%  Similarity=0.427  Sum_probs=212.5

Q ss_pred             HHHHHHhcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCCe
Q 016588           76 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNL  150 (386)
Q Consensus        76 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  150 (386)
                      ++++....++...+.||+|.||+||+|.+..  .||||.+.-.     ..+.|.+|+..+++-+|.||+-+.|+|.+...
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            4555555667778999999999999999853  6999984432     35679999999999999999999999998887


Q ss_pred             EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  230 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~  230 (386)
                       .+|..+|++.+|..+++.    ...+++..+...|+.|+++|+.|||.  ++|||||||..||+|.+++++||+||||+
T Consensus       463 -AIiTqwCeGsSLY~hlHv----~etkfdm~~~idIAqQiaqGM~YLHA--K~IIHrDLKSnNIFl~~~~kVkIgDFGLa  535 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHV----QETKFDMNTTIDIAQQIAQGMDYLHA--KNIIHRDLKSNNIFLHEDLKVKIGDFGLA  535 (678)
T ss_pred             -eeeehhccCchhhhhccc----hhhhhhHHHHHHHHHHHHHhhhhhhh--hhhhhhhccccceEEccCCcEEEecccce
Confidence             899999999999999974    35678999999999999999999999  78999999999999999999999999998


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhcc---cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhccc
Q 016588          231 NFLGRTDVAGPSSQVTADEIFLASEVKEF---RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS  307 (386)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  307 (386)
                      ..-..-..........+...|||||+++.   ..|++++||||||+++|||++|..||.....+..   +      +...
T Consensus       536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI---i------fmVG  606 (678)
T KOG0193|consen  536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI---I------FMVG  606 (678)
T ss_pred             eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe---E------EEec
Confidence            76543322233344557778999999874   4789999999999999999999999994433211   0      0000


Q ss_pred             chhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          308 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      +-.-..|   ......++++++++|+..||..++++||.+.+++..|++++..
T Consensus       607 rG~l~pd---~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  607 RGYLMPD---LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             ccccCcc---chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            0000000   1223345778899999999999999999999999999999874

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-45  Score=315.75  Aligned_cols=235  Identities=22%  Similarity=0.333  Sum_probs=203.5

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC------hhHHHHHHHHHHcCCCCcccccccceeeCCeEEE
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (386)
                      ..++|+..+.||.|+||.|.+++.+ ++..+|+|.++...      .+...+|..+|+.+.||.++++++.+.+.+.+||
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym  121 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM  121 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence            3467888999999999999999965 58899999866543      3456789999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      ||||+++|.|..+++     +.+.+++.....++.||+.||+|||+  .+|++|||||+|||+|.+|.+||+|||.|+.+
T Consensus       122 vmeyv~GGElFS~Lr-----k~~rF~e~~arFYAAeivlAleylH~--~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v  194 (355)
T KOG0616|consen  122 VMEYVPGGELFSYLR-----KSGRFSEPHARFYAAEIVLALEYLHS--LDIIYRDLKPENLLLDQNGHIKITDFGFAKRV  194 (355)
T ss_pred             EEeccCCccHHHHHH-----hcCCCCchhHHHHHHHHHHHHHHHHh--cCeeeccCChHHeeeccCCcEEEEeccceEEe
Confidence            999999999999994     45678999999999999999999999  66999999999999999999999999999976


Q ss_pred             CCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhc
Q 016588          234 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  313 (386)
Q Consensus       234 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (386)
                      ..     .+...+||+.|+|||++..+.|+.++|+|||||++|||+.|.+||....+..               ...+++
T Consensus       195 ~~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~---------------iY~KI~  254 (355)
T KOG0616|consen  195 SG-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ---------------IYEKIL  254 (355)
T ss_pred             cC-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH---------------HHHHHH
Confidence            43     3567899999999999999999999999999999999999999999866511               122233


Q ss_pred             chhhcccCCHHHHHHHHHHHhHccCCCCCCC
Q 016588          314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERR  344 (386)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  344 (386)
                      ...+  .+|...+.++.+|+.+.|+.|-.+|
T Consensus       255 ~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  255 EGKV--KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             hCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence            3333  4556666789999999999999999

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=7.8e-45  Score=336.03  Aligned_cols=252  Identities=23%  Similarity=0.319  Sum_probs=202.6

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC------hhHHHHHHHHHHcCCCCcccccccceeeCCeEEE
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (386)
                      ..++|...+.||+|+||.||+|+.+ +|..+|+|++++..      ...+..|-.+|...++|+||+++-.|++.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            5678999999999999999999955 59999999866543      4557889999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      ||||++||++..+|.     +...|++.....++.+++.|+.-||+  .|+|||||||+|+|||..|++||+||||+.-+
T Consensus       219 iMEylPGGD~mTLL~-----~~~~L~e~~arfYiaE~vlAI~~iH~--~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLM-----RKDTLTEDWARFYIAETVLAIESIHQ--LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             EEEecCCccHHHHHH-----hcCcCchHHHHHHHHHHHHHHHHHHH--cCcccccCChhheeecCCCCEeeccccccchh
Confidence            999999999999883     56778999999999999999999999  67999999999999999999999999997543


Q ss_pred             CCC----------------------CCCC---C--------------------CccccCcccccchhhhcccCCCcccch
Q 016588          234 GRT----------------------DVAG---P--------------------SSQVTADEIFLASEVKEFRRFSEKSDV  268 (386)
Q Consensus       234 ~~~----------------------~~~~---~--------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv  268 (386)
                      ...                      +...   .                    .....|||-|+|||++.+..|+..+|+
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw  371 (550)
T KOG0605|consen  292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW  371 (550)
T ss_pred             hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence            110                      0000   0                    112469999999999999999999999


Q ss_pred             hhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCC--
Q 016588          269 YSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS--  346 (386)
Q Consensus       269 wSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt--  346 (386)
                      ||||||+|||+.|.+||.+..+.+.-.-+      ..+..       .+..+.....+++.++||.+|++ ||++|..  
T Consensus       372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI------~nwr~-------~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~  437 (550)
T KOG0605|consen  372 WSLGCIMYEMLVGYPPFCSETPQETYRKI------VNWRE-------TLKFPEEVDLSDEAKDLITRLLC-DPENRLGSK  437 (550)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HHHhh-------hccCCCcCcccHHHHHHHHHHhc-CHHHhcCcc
Confidence            99999999999999999997763321111      11111       11111122334779999999999 9999965  


Q ss_pred             -HHHHHHH
Q 016588          347 -MSDVVTE  353 (386)
Q Consensus       347 -~~evl~~  353 (386)
                       ++||-+|
T Consensus       438 G~~EIK~H  445 (550)
T KOG0605|consen  438 GAEEIKKH  445 (550)
T ss_pred             cHHHHhcC
Confidence             5555443

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-44  Score=337.67  Aligned_cols=247  Identities=22%  Similarity=0.295  Sum_probs=205.0

Q ss_pred             HhcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC--------ChhHHHHHHHHHHcCC-CCcccccccceeeCCe
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA--------PTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNL  150 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--------~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~  150 (386)
                      ....|...+.||+|+||+|+.|.. .++..||+|+.+..        ..+.+.+|+.+++.++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            456888999999999999999985 46899999975442        2335668999999998 9999999999999999


Q ss_pred             EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC-CceEEccccc
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGL  229 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~-~~~kl~DFgl  229 (386)
                      .|+||||+.+|+|.+++.     ....+.+....+++.|++.|++|||+  +||+||||||+|+|+|.+ +++||+|||+
T Consensus        95 ~~ivmEy~~gGdL~~~i~-----~~g~l~E~~ar~~F~Qlisav~y~H~--~gi~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIV-----NKGRLKEDEARKYFRQLISAVAYCHS--RGIVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             EEEEEEecCCccHHHHHH-----HcCCCChHHHHHHHHHHHHHHHHHHh--CCEeeCCCCHHHEEecCCCCCEEEecccc
Confidence            999999999999999994     35678889999999999999999999  779999999999999999 9999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhcccC-CC-cccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhccc
Q 016588          230 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRR-FS-EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS  307 (386)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  307 (386)
                      +....  .........+|++.|+|||++.+.. |+ .++||||+||+||.|++|..||.....   ..+...+       
T Consensus       168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~---~~l~~ki-------  235 (370)
T KOG0583|consen  168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV---PNLYRKI-------  235 (370)
T ss_pred             ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH---HHHHHHH-------
Confidence            99874  1223456678999999999999988 85 789999999999999999999997332   1111111       


Q ss_pred             chhhhcchhhcccCCHHH-HHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          308 NLLKILDERLWSTFTNEG-MEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                           ....  -.++... +.++..++.+||..||.+|+|+.+++++
T Consensus       236 -----~~~~--~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h  275 (370)
T KOG0583|consen  236 -----RKGE--FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH  275 (370)
T ss_pred             -----hcCC--ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence                 1111  1233333 6778999999999999999999999944

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=6.2e-45  Score=337.33  Aligned_cols=244  Identities=26%  Similarity=0.388  Sum_probs=208.0

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCChhH-----HHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQE-----FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      ++|.+.+.||+|.||.||+|+.+ +.+.||+|.+++....+     +.+|+++++.++||||+.++++|++..++++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46778889999999999999954 58899999876655444     8899999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      |+.+ +|..++     .....+++..+..++.+++.||.|||+  ++|.|||+||+|||++..+++|+||||+++.++. 
T Consensus        82 ~a~g-~L~~il-----~~d~~lpEe~v~~~a~~LVsaL~yLhs--~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-  152 (808)
T KOG0597|consen   82 YAVG-DLFTIL-----EQDGKLPEEQVRAIAYDLVSALYYLHS--NRILHRDMKPQNILLEKGGTLKLCDFGLARAMST-  152 (808)
T ss_pred             hhhh-hHHHHH-----HhccCCCHHHHHHHHHHHHHHHHHHHh--cCcccccCCcceeeecCCCceeechhhhhhhccc-
Confidence            9977 999888     356779999999999999999999999  7799999999999999999999999999998754 


Q ss_pred             CCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchh
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  316 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (386)
                       .....+...||+.|||||...+..|+..+|+||+||++||+++|++||....      ..+.++....        |+-
T Consensus       153 -~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~--------d~v  217 (808)
T KOG0597|consen  153 -NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILK--------DPV  217 (808)
T ss_pred             -CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhc--------CCC
Confidence             2334556789999999999999999999999999999999999999998533      2222222111        111


Q ss_pred             hcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          317 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                         ..+...+..+..++...|.+||.+|.|-.+++.|
T Consensus       218 ---~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  218 ---KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             ---CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence               1233566789999999999999999999999876

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-45  Score=346.04  Aligned_cols=267  Identities=27%  Similarity=0.416  Sum_probs=216.5

Q ss_pred             CHHHHHHHhcCCCcCCeecccCceEEEEEEeCC--C--cE-EEEEECCC------CChhHHHHHHHHHHcCCCCcccccc
Q 016588           74 QMEELSLATKNFSDKNLIGEGKFGEVYKGLLQD--G--ML-VAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLL  142 (386)
Q Consensus        74 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--~--~~-vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~~~  142 (386)
                      ....++...++....+.||+|+||.||+|.++.  +  .. ||+|....      ....++.+|.+++++++|||||++|
T Consensus       148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y  227 (474)
T KOG0194|consen  148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY  227 (474)
T ss_pred             cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence            334555566677778999999999999999643  2  23 89997553      2245789999999999999999999


Q ss_pred             cceeeCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCce
Q 016588          143 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA  222 (386)
Q Consensus       143 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~  222 (386)
                      |++.....+++|||+|.||+|.+++..    ....++..+...++.+.|.||+|||+  ++++||||..+|+|++.++.+
T Consensus       228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k----~~~~v~~~ek~~~~~~AA~Gl~YLh~--k~~IHRDIAARNcL~~~~~~v  301 (474)
T KOG0194|consen  228 GVAVLEEPLMLVMELCNGGSLDDYLKK----NKKSLPTLEKLRFCYDAARGLEYLHS--KNCIHRDIAARNCLYSKKGVV  301 (474)
T ss_pred             EEEcCCCccEEEEEecCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHhHHHHHHH--CCCcchhHhHHHheecCCCeE
Confidence            999999999999999999999999943    23368999999999999999999999  779999999999999999999


Q ss_pred             EEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHH
Q 016588          223 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQ  301 (386)
Q Consensus       223 kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~  301 (386)
                      ||+|||+++.-..  ..........+..|+|||.+....|++++|||||||++||+++ |..||.+....   ++..   
T Consensus       302 KISDFGLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~v~~---  373 (474)
T KOG0194|consen  302 KISDFGLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---EVKA---  373 (474)
T ss_pred             EeCccccccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---HHHH---
Confidence            9999999886531  1111112246678999999999999999999999999999999 88899876642   1111   


Q ss_pred             hhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhcc
Q 016588          302 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN  363 (386)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~~  363 (386)
                               ++.....+...+...+.++..++.+||..+|++||||.++.+.|+.+......
T Consensus       374 ---------kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  374 ---------KIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             ---------HHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence                     11122334445556678899999999999999999999999999998877543

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.7e-43  Score=324.31  Aligned_cols=244  Identities=22%  Similarity=0.345  Sum_probs=197.9

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEECCCCC------hhHHHHHHHHHHcCCCCcccccccceee----CCeEEEEEEe
Q 016588           88 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQE----NNLQFLIYEY  157 (386)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~  157 (386)
                      ...+|+|++|.||+|.+ +++.||+|......      .+.+.+|+.++++++||||++++|++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            46799999999999998 57899999865432      2456799999999999999999999876    4568899999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +++|+|.+++..     ...+++.....++.+++.||.|||+. .+++||||||+|||+++++.+||+|||+++......
T Consensus       104 ~~~g~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~  177 (283)
T PHA02988        104 CTRGYLREVLDK-----EKDLSFKTKLDMAIDCCKGLYNLYKY-TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP  177 (283)
T ss_pred             CCCCcHHHHHhh-----CCCCChhHHHHHHHHHHHHHHHHHhc-CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence            999999999843     34678889999999999999999973 368899999999999999999999999988654321


Q ss_pred             CCCCCccccCcccccchhhhcc--cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          238 VAGPSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                           ....++..|+|||++.+  ..++.++|||||||++|||++|+.||.....   .+....+..            .
T Consensus       178 -----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~---~~~~~~i~~------------~  237 (283)
T PHA02988        178 -----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT---KEIYDLIIN------------K  237 (283)
T ss_pred             -----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHh------------c
Confidence                 23356778999999976  6889999999999999999999999986542   112211111            1


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhh
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  358 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~  358 (386)
                      ......+..+++++.+++.+||+.||++|||+.++++.|+.+.
T Consensus       238 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        238 NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             CCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            1111223345677999999999999999999999999998875

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-45  Score=331.88  Aligned_cols=246  Identities=28%  Similarity=0.387  Sum_probs=204.9

Q ss_pred             cCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      ..|+..+.||+|.||.||+|.. ..++.||+|.++-.    ..+++++|+.+|.+++++||.++||.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            4566778999999999999994 46899999986533    345688999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      |.+|++.+.+.     ....+++..+..+..+++.||.|||+  .+.+|||||+.|||+..+|.+|++|||.+-.+..+.
T Consensus        93 ~~gGsv~~lL~-----~~~~~~E~~i~~ilre~l~~l~ylH~--~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   93 CGGGSVLDLLK-----SGNILDEFEIAVILREVLKGLDYLHS--EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             hcCcchhhhhc-----cCCCCccceeeeehHHHHHHhhhhhh--cceecccccccceeEeccCcEEEEecceeeeeechh
Confidence            99999999884     23334666677789999999999999  669999999999999999999999999998876543


Q ss_pred             CCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhh
Q 016588          238 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  317 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (386)
                      ..  .....||+.|||||++....|+.++||||||++.+||.+|.+|+....+-....                .+....
T Consensus       166 ~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf----------------lIpk~~  227 (467)
T KOG0201|consen  166 KR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF----------------LIPKSA  227 (467)
T ss_pred             hc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE----------------eccCCC
Confidence            33  367889999999999998899999999999999999999999999887622111                111111


Q ss_pred             cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .+.....++..+++++..||+.||+.|||+.++++|
T Consensus       228 PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  228 PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            112222455668999999999999999999999975

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-45  Score=322.08  Aligned_cols=265  Identities=23%  Similarity=0.323  Sum_probs=206.7

Q ss_pred             hcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCC-----CChhHHHHHHHHHHcCCCCcccccccceee-----CCe
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQE-----NNL  150 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~  150 (386)
                      ...|...+.||+|+||.|+.+.. .++..||+|++..     ...++-.+|+++|+.++|+||+.+.+.+..     -+.
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            34566678999999999999994 4689999998542     234567899999999999999999998754     467


Q ss_pred             EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  230 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~  230 (386)
                      +|+|+|+|+ .+|...+.     .++.++......++.|++.||.|+|+  .+|+||||||+|+|++.+...||||||+|
T Consensus       101 vYiV~elMe-tDL~~iik-----~~~~L~d~H~q~f~YQiLrgLKyiHS--AnViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen  101 VYLVFELME-TDLHQIIK-----SQQDLTDDHAQYFLYQILRGLKYIHS--ANVIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             eEEehhHHh-hHHHHHHH-----cCccccHHHHHHHHHHHHHhcchhhc--ccccccccchhheeeccCCCEEeccccce
Confidence            899999995 48888883     34458888999999999999999999  77999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhc-ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccch
Q 016588          231 NFLGRTDVAGPSSQVTADEIFLASEVKE-FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL  309 (386)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  309 (386)
                      +...........+.+..|.+|.|||.+. ...|+.+.||||.||++.||++|++.|.+.+....-.++..+...+..+.+
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l  252 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL  252 (359)
T ss_pred             eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence            9886543344557888999999999875 468999999999999999999999999886654333333222222222221


Q ss_pred             hhhcch--------------hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          310 LKILDE--------------RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       310 ~~~~~~--------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                      ..+-.+              ..+...-++..+...+|+.+||..||.+|+|++|+|+|-
T Consensus       253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP  311 (359)
T KOG0660|consen  253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP  311 (359)
T ss_pred             HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence            111111              011111124457789999999999999999999999873

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=9.4e-44  Score=329.48  Aligned_cols=263  Identities=26%  Similarity=0.395  Sum_probs=200.5

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCC-----------------CcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccc
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQD-----------------GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVT  140 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~  140 (386)
                      .++|...+.||+|+||.||+|..++                 +..||+|......    ..++.+|+.++..++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3578888999999999999998532                 2369999865432    246889999999999999999


Q ss_pred             cccceeeCCeEEEEEEeecCCCccccccCCC--------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcee
Q 016588          141 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPS--------------QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH  206 (386)
Q Consensus       141 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH  206 (386)
                      +++++...+..++||||+++++|.+++....              ......+++..+..++.|++.||.|||+  .+|+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~ivH  161 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS--LNFVH  161 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH--CCccc
Confidence            9999999999999999999999988774321              0112357788899999999999999998  67999


Q ss_pred             cCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc--CCCC
Q 016588          207 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS--GREA  284 (386)
Q Consensus       207 ~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t--g~~p  284 (386)
                      |||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999886543222222223345678999999988889999999999999999987  5567


Q ss_pred             CCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016588          285 SSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  355 (386)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~  355 (386)
                      |......   ............      .........+..++..+.+++.+||+.||++|||+.++.+.|+
T Consensus       242 ~~~~~~~---~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         242 YGELTDE---QVIENAGEFFRD------QGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCcCCHH---HHHHHHHHHhhh------ccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            7664421   112111111000      0001111122334567999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=5.2e-44  Score=340.40  Aligned_cols=260  Identities=23%  Similarity=0.370  Sum_probs=202.7

Q ss_pred             HhcCCCcCCeecccCceEEEEEEe------CCCcEEEEEECCCCC----hhHHHHHHHHHHcC-CCCcccccccceeeCC
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQENN  149 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  149 (386)
                      ..++|+..+.||+|+||.||+|..      +++..||+|.+....    .+.+.+|+.++..+ +||||+++++++...+
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            345788899999999999999973      235689999865332    34578899999999 8999999999999999


Q ss_pred             eEEEEEEeecCCCccccccCCCc---------------------------------------------------------
Q 016588          150 LQFLIYEYIPNGSVSIHLYGPSQ---------------------------------------------------------  172 (386)
Q Consensus       150 ~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------  172 (386)
                      ..++||||+++|+|.+++.....                                                         
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            99999999999999887743210                                                         


Q ss_pred             -------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016588          173 -------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  239 (386)
Q Consensus       173 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~  239 (386)
                                   .....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++........
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                         011247788899999999999999998  77999999999999999999999999999876443222


Q ss_pred             CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          240 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       240 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                      .......++..|+|||.+.+..++.++|||||||++|||++ |..||......  .........             ...
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~~~~~-------------~~~  335 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYKMIKE-------------GYR  335 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHHHHHh-------------Ccc
Confidence            22222334567999999999999999999999999999998 88888764431  111111111             111


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHh
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  357 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~  357 (386)
                      ...+...+.++.+++.+||+.||++|||+.|+++.|++.
T Consensus       336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            111222346789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-44  Score=332.53  Aligned_cols=265  Identities=28%  Similarity=0.399  Sum_probs=215.6

Q ss_pred             HHhcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           80 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        80 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ...+...+.+.||+|.||.|.++.......||||++.+..    ..+|.+|+++|.+|+||||+.++|+|..++.+++++
T Consensus       535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~  614 (807)
T KOG1094|consen  535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT  614 (807)
T ss_pred             cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence            3455667789999999999999999888999999976554    467999999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++|+|..|+.....   +.+......+|+.||+.|++||.+  -++|||||.++|+|+|.++++||+|||+++.+-.
T Consensus       615 EYmEnGDLnqFl~ahea---pt~~t~~~vsi~tqiasgmaYLes--~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys  689 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHEL---PTAETAPGVSICTQIASGMAYLES--LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS  689 (807)
T ss_pred             HHHhcCcHHHHHHhccC---cccccchhHHHHHHHHHHHHHHHh--hchhhccccccceeecCcccEEecCccccccccc
Confidence            99999999999954422   224555667899999999999999  5599999999999999999999999999986644


Q ss_pred             CCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc--CCCCCCCCCCCchhhHHHHHHhhhcccchhhhc
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS--GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  313 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (386)
                      .+.........-+..|||+|.+..++++.++|+|+||+++||+++  ...||+....+.   ..+......      .--
T Consensus       690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~------~~~  760 (807)
T KOG1094|consen  690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFF------RDQ  760 (807)
T ss_pred             CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhc------CCC
Confidence            444444445566788999999999999999999999999999887  778998766432   222111111      111


Q ss_pred             chhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhh
Q 016588          314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  358 (386)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~  358 (386)
                      ........|.-++..++++|..||..|-++|||++++..+|.+..
T Consensus       761 ~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  761 GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence            122234556678889999999999999999999999999987643

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=7.5e-44  Score=339.05  Aligned_cols=263  Identities=23%  Similarity=0.366  Sum_probs=204.3

Q ss_pred             HHHhcCCCcCCeecccCceEEEEEEeC------CCcEEEEEECCCCC----hhHHHHHHHHHHcC-CCCcccccccceee
Q 016588           79 SLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQE  147 (386)
Q Consensus        79 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~~~~~~~~  147 (386)
                      ....++|++.+.||+|+||.||+|...      ++..||+|......    .+.+.+|+.+++.+ +|+||+++++++..
T Consensus        34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            344567889999999999999998842      23579999865432    24578899999999 89999999999999


Q ss_pred             CCeEEEEEEeecCCCccccccCCCc-------------------------------------------------------
Q 016588          148 NNLQFLIYEYIPNGSVSIHLYGPSQ-------------------------------------------------------  172 (386)
Q Consensus       148 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  172 (386)
                      .+..++||||+++|+|.+++.....                                                       
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            9999999999999999887742110                                                       


Q ss_pred             ----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCC
Q 016588          173 ----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS  242 (386)
Q Consensus       173 ----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~  242 (386)
                                .....+++..+.+++.|++.||.|||+  ++|+||||||+|||+++++.+||+|||+++...........
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~--~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS--KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence                      012347788899999999999999998  77999999999999999999999999998765432221111


Q ss_pred             ccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccC
Q 016588          243 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF  321 (386)
Q Consensus       243 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (386)
                      ....++..|+|||++.+..++.++|||||||++|||++ |+.||.......  ........             ......
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~~~~~-------------~~~~~~  336 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYKMVKR-------------GYQMSR  336 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHHHHHc-------------ccCccC
Confidence            22234567999999998899999999999999999997 999998654321  11111111             111111


Q ss_pred             CHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhh
Q 016588          322 TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  358 (386)
Q Consensus       322 ~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~  358 (386)
                      +...+.++.+++.+||+.||.+|||+.++++.|++++
T Consensus       337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            2223467899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-43  Score=320.01  Aligned_cols=268  Identities=27%  Similarity=0.422  Sum_probs=216.4

Q ss_pred             CCcCCeecccCceEEEEEEeCCCcEEEEEECCCCChhHHHHHHHHHHc--CCCCcccccccceeeCC----eEEEEEEee
Q 016588           85 FSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLAS--IQHRNLVTLLGYCQENN----LQFLIYEYI  158 (386)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~----~~~lv~e~~  158 (386)
                      .+..+++|+|+||.||+|.+. ++.||||+++....+.|.+|-+|.+.  ++|+||+++++.-....    ..+||++|.
T Consensus       212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh  290 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH  290 (534)
T ss_pred             hhhHHHhhcCccceeehhhcc-CceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence            344578999999999999986 48999999999999999999999876  48999999999876655    789999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-------CCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL-------SPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      +.|+|.+++      ....++|....+++..++.||+|||+.       .++|+|||||.+||||.+|+++.|+|||+|.
T Consensus       291 ~kGsL~dyL------~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl  364 (534)
T KOG3653|consen  291 PKGSLCDYL------KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL  364 (534)
T ss_pred             cCCcHHHHH------HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence            999999999      456789999999999999999999962       5679999999999999999999999999999


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhccc-CCC-----cccchhhHHHHHHHHHcCCCCCC-CCCCCchhhHHHHHHhhh
Q 016588          232 FLGRTDVAGPSSQVTADEIFLASEVKEFR-RFS-----EKSDVYSFGVFLLELVSGREASS-SLSPDSSQDLVELVQNSR  304 (386)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~-----~~~DvwSlGvil~el~tg~~p~~-~~~~~~~~~~~~~~~~~~  304 (386)
                      .+..+...+..-...||.+|||||++.+. .+.     .+.||||+|.++|||+++...+. +..++........+.+.+
T Consensus       365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP  444 (534)
T KOG3653|consen  365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP  444 (534)
T ss_pred             EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence            98876666666678999999999999864 222     25899999999999999876554 333333333333444444


Q ss_pred             cccchhhhcc-hhhcccCCHH-----HHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhh
Q 016588          305 DFSNLLKILD-ERLWSTFTNE-----GMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD  359 (386)
Q Consensus       305 ~~~~~~~~~~-~~~~~~~~~~-----~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~  359 (386)
                      ..+++...+. .+.++.++..     ....+++.+..||..||+.|.|+.=+-+++.++..
T Consensus       445 t~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~  505 (534)
T KOG3653|consen  445 TLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM  505 (534)
T ss_pred             CHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence            4455444332 2233333332     34679999999999999999999999999888763

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-44  Score=337.56  Aligned_cols=244  Identities=23%  Similarity=0.309  Sum_probs=208.2

Q ss_pred             CCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      -|+..+.||.|+.|.|..|++ .+|+.+|||+++..      ....+.+|+-+|+-+.|||++++|+++++...+|+|.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            356778999999999999995 46999999986654      23458899999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      |+++|-|.+++     ...+.+.+....+++.||+.|+.|+|.  .+|+||||||+|+|||..+++||+|||+|..-.. 
T Consensus        93 yv~gGELFdyl-----v~kG~l~e~eaa~ff~QIi~gv~yCH~--~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~-  164 (786)
T KOG0588|consen   93 YVPGGELFDYL-----VRKGPLPEREAAHFFRQILDGVSYCHA--FNICHRDLKPENLLLDVKNNIKIADFGMASLEVP-  164 (786)
T ss_pred             ecCCchhHHHH-----HhhCCCCCHHHHHHHHHHHHHHHHHhh--hcceeccCCchhhhhhcccCEeeeccceeecccC-
Confidence            99999999998     466789999999999999999999999  5699999999999999999999999999876432 


Q ss_pred             CCCCCCccccCcccccchhhhcccCC-CcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                        .......+|.+.|.+||+++|..| +.++||||+|||||.|+||+.||++..   ...+..-++...           
T Consensus       165 --gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN---ir~LLlKV~~G~-----------  228 (786)
T KOG0588|consen  165 --GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN---IRVLLLKVQRGV-----------  228 (786)
T ss_pred             --CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc---HHHHHHHHHcCc-----------
Confidence              234556789999999999999999 679999999999999999999999532   333333332211           


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                         -+.|.+.+.++.+|+.+|+..||++|.|++||++|.
T Consensus       229 ---f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  229 ---FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             ---ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence               133445667899999999999999999999999985

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.7e-43  Score=322.83  Aligned_cols=256  Identities=30%  Similarity=0.489  Sum_probs=205.2

Q ss_pred             cCCCcCCeecccCceEEEEEEeCC-C-----cEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQD-G-----MLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  152 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  152 (386)
                      .+|+..+.||+|+||.||+|.... +     ..|++|......    ...+.+|+.++..++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            467888999999999999998543 2     579999865433    245788999999999999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCcCC-----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVS-----------RQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI  221 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~  221 (386)
                      ++|||+++++|.+++.......           ...+++..+..++.|++.||.|||+  ++++|+||||+||++++++.
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~--~~i~H~dlkp~Nil~~~~~~  162 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS--HHFVHRDLAARNCLVGEGLT  162 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccccceEEEcCCCc
Confidence            9999999999998875321111           1567888999999999999999998  77999999999999999999


Q ss_pred             eEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHH
Q 016588          222 AKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELV  300 (386)
Q Consensus       222 ~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~  300 (386)
                      ++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.+....   +....+
T Consensus       163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~~~i  239 (283)
T cd05048         163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVIEMI  239 (283)
T ss_pred             EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH
Confidence            99999999886543332222333455778999999988889999999999999999998 99998865532   222211


Q ss_pred             HhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHH
Q 016588          301 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  356 (386)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~  356 (386)
                      ..             ......+..++.++.+++.+||+.||.+|||+.+++++|+.
T Consensus       240 ~~-------------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         240 RS-------------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             Hc-------------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            11             11122334556789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=323.18  Aligned_cols=254  Identities=24%  Similarity=0.315  Sum_probs=202.2

Q ss_pred             HhcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCCC-----------------hhHHHHHHHHHHcCCCCcccccc
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP-----------------TQEFIDEVCFLASIQHRNLVTLL  142 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~~~  142 (386)
                      ..++|++.+.||+|.||.|-+|.. -++..||||++++..                 .+.+.+|+.+|++++|||||+|+
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            346799999999999999999994 458999999744321                 24688999999999999999999


Q ss_pred             cceee--CCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC
Q 016588          143 GYCQE--NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF  220 (386)
Q Consensus       143 ~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~  220 (386)
                      .+..+  .+.+|||+|||..|.+..--     .....+.+.+.++++.+++.||.|||.  +|||||||||+|+||+++|
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~--QgiiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHY--QGIIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHh--cCeeccccchhheEEcCCC
Confidence            99875  56899999999988864322     122338999999999999999999999  7799999999999999999


Q ss_pred             ceEEcccccccccCCCCCC---CCCccccCcccccchhhhccc---CC-CcccchhhHHHHHHHHHcCCCCCCCCCCCch
Q 016588          221 IAKVADAGLRNFLGRTDVA---GPSSQVTADEIFLASEVKEFR---RF-SEKSDVYSFGVFLLELVSGREASSSLSPDSS  293 (386)
Q Consensus       221 ~~kl~DFgl~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~---~~-~~~~DvwSlGvil~el~tg~~p~~~~~~~~~  293 (386)
                      ++||+|||.+.....+...   .......||+.|+|||...+.   .+ +.+.||||+||+||-|+.|+.||.+...   
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~---  324 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE---  324 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH---
Confidence            9999999998876332211   112346799999999998763   23 6789999999999999999999987442   


Q ss_pred             hhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHH
Q 016588          294 QDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  356 (386)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~  356 (386)
                      ..+            ..+++...+..+..++..+++.+||+++|++||+.|.+..+|..|..-
T Consensus       325 ~~l------------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv  375 (576)
T KOG0585|consen  325 LEL------------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV  375 (576)
T ss_pred             HHH------------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence            111            223334444333333566889999999999999999999999887643

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.8e-43  Score=320.08  Aligned_cols=253  Identities=24%  Similarity=0.401  Sum_probs=202.0

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC----CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (386)
                      ..+|++.+.||+|+||.||+|.++    .+..||+|......    ...+.+|+..+++++||||+++++++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            356888899999999999999853    35689999865442    2357889999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      ||||+++|+|.+++..    ....+++..++.++.|++.||+|||+  ++++||||||+|||++.++.++++|||.+...
T Consensus        84 v~e~~~~~~L~~~l~~----~~~~l~~~~~~~~~~~i~~al~~lH~--~~iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          84 VTEYMSNGALDSFLRK----HEGQLVAGQLMGMLPGLASGMKYLSE--MGYVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             EEEeCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            9999999999988843    23468899999999999999999998  77999999999999999999999999987654


Q ss_pred             CCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          234 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       234 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      ..... .......++..|+|||.+.+..++.++|||||||++||+++ |..||......   ........          
T Consensus       158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~~----------  223 (266)
T cd05064         158 KSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKAVED----------  223 (266)
T ss_pred             cccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHHC----------
Confidence            22111 11122334567999999999999999999999999999775 99999765431   11111111          


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHh
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  357 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~  357 (386)
                         ......+..++..+.+++.+||+.+|++|||++++++.|.++
T Consensus       224 ---~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         224 ---GFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ---CCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence               111122344567799999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-43  Score=333.79  Aligned_cols=242  Identities=23%  Similarity=0.331  Sum_probs=202.9

Q ss_pred             HHHhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC------CChhHHHHHHHHHHcC-CCCcccccccceeeCCe
Q 016588           79 SLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNL  150 (386)
Q Consensus        79 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  150 (386)
                      ....++|...++||+|+||+|+++..+ +++.+|||.+++      ...+....|..++... +||.++.++.+|++.++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            345678999999999999999999966 478999997543      3455677888888777 59999999999999999


Q ss_pred             EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  230 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~  230 (386)
                      +|+||||+.||++..+.      ....+++..+..++..|+.||+|||+  +|||+||||.+|||||.+|++||+|||++
T Consensus       444 l~fvmey~~Ggdm~~~~------~~~~F~e~rarfyaAev~l~L~fLH~--~~IIYRDlKLdNiLLD~eGh~kiADFGlc  515 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHI------HTDVFSEPRARFYAAEVVLGLQFLHE--NGIIYRDLKLDNLLLDTEGHVKIADFGLC  515 (694)
T ss_pred             EEEEEEecCCCcEEEEE------ecccccHHHHHHHHHHHHHHHHHHHh--cCceeeecchhheEEcccCcEEecccccc
Confidence            99999999999955444      45678999999999999999999999  78999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          231 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      +..-.  ....+++.+||+.|+|||++.+..|+.++|+|||||+||||+.|..||.+.+++   ++.+.+          
T Consensus       516 Ke~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe---e~FdsI----------  580 (694)
T KOG0694|consen  516 KEGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE---EVFDSI----------  580 (694)
T ss_pred             cccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHH----------
Confidence            86432  233567889999999999999999999999999999999999999999986642   222211          


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCH
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM  347 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~  347 (386)
                        +...  ..+|...+.+...|+.++|.++|++|..+
T Consensus       581 --~~d~--~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  581 --VNDE--VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             --hcCC--CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence              1111  13455667889999999999999999766

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.4e-44  Score=311.30  Aligned_cols=263  Identities=21%  Similarity=0.284  Sum_probs=205.9

Q ss_pred             hcCCCcCCeecccCceEEEEEE-eCCCcEEEEEECCCCChh-----HHHHHHHHHHcCCCCcccccccceee--CCeEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQ-----EFIDEVCFLASIQHRNLVTLLGYCQE--NNLQFL  153 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l  153 (386)
                      -++|+..+.|++|.||.||+|. .++++.||+|+++-....     ...+|+.+|.+++|||||.+-.+...  -+..|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            3467888999999999999999 456899999986644322     36899999999999999999887654  467999


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      |||||+. +|...+.+.    .+++....+..++.|++.|++|||.  +.|+|||||++|+|++..|.+||+|||+|+..
T Consensus       155 VMe~~Eh-DLksl~d~m----~q~F~~~evK~L~~QlL~glk~lH~--~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETM----KQPFLPGEVKTLMLQLLRGLKHLHD--NWILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             eHHHHHh-hHHHHHHhc----cCCCchHHHHHHHHHHHHHHHHHhh--ceeEecccchhheeeccCCcEEecccchhhhh
Confidence            9999987 888888543    3678889999999999999999998  77999999999999999999999999999988


Q ss_pred             CCCCCCCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          234 GRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       234 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      +..  ....+....|.+|.|||.+.+. .|+++.|+||+|||+.||+++++.|.+..+.+..+.+-.....+........
T Consensus       228 gsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~  305 (419)
T KOG0663|consen  228 GSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY  305 (419)
T ss_pred             cCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence            653  2345567789999999998874 7899999999999999999999999886653333322222111111111111


Q ss_pred             cc--------------hhhcccCCHH-HHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          313 LD--------------ERLWSTFTNE-GMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       313 ~~--------------~~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ..              ..++..+... .++.-.+|+..+|..||.+|.|++|.|++
T Consensus       306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            10              1112223222 44678899999999999999999999977

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-43  Score=325.82  Aligned_cols=243  Identities=21%  Similarity=0.271  Sum_probs=199.7

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ++|+..+.||+|+||.||+|... +++.||+|.....      ..+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888999999999999999965 5889999985432      2345788999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++++|.+++.     ....+++.....++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++....
T Consensus        81 e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          81 EYVPGGELFSYLR-----NSGRFSNSTGLFYASEIVCALEYLHS--KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             eCCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            9999999998884     33567888899999999999999998  7799999999999999999999999999886543


Q ss_pred             CCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      .     .....+++.|+|||++.+..++.++|||||||++|||++|..||......   .....+..            .
T Consensus       154 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---~~~~~i~~------------~  213 (291)
T cd05612         154 R-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF---GIYEKILA------------G  213 (291)
T ss_pred             C-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh------------C
Confidence            1     22346788999999999989999999999999999999999999864421   11111111            0


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTEL  354 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~evl~~L  354 (386)
                      .  ..++...+..+.+++.+||+.||.+||+     +++++++-
T Consensus       214 ~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~  255 (291)
T cd05612         214 K--LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR  255 (291)
T ss_pred             C--cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence            0  1122233467899999999999999995     88888773

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.5e-43  Score=321.54  Aligned_cols=261  Identities=18%  Similarity=0.233  Sum_probs=199.2

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      ++|++.+.||+|+||.||++..+ +++.||+|+....     ..+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36888999999999999999975 5788999975432     23467889999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      |++++++..+..     ....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~~~~l~~~~~-----~~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          81 YVEKNMLELLEE-----MPNGVPPEKVRSYIYQLIKAIHWCHK--NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             cCCCCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            999877765431     23467888999999999999999998  77999999999999999999999999999876432


Q ss_pred             CCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc-----------
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD-----------  305 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-----------  305 (386)
                      .. .......++..|+|||++.+..++.++|||||||++|||++|+.||........  +.........           
T Consensus       154 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07848         154 SN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ--LFTIQKVLGPLPAEQMKLFYS  230 (287)
T ss_pred             cc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhhCCCCHHHHHhhhc
Confidence            21 122344678889999999988999999999999999999999999987543211  1111100000           


Q ss_pred             ccchhhhcchhh------cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          306 FSNLLKILDERL------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       306 ~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .........+..      ........+.++.+++.+||+.||++|||++++++|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            000000000000      001111245679999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=4.6e-43  Score=321.92  Aligned_cols=249  Identities=18%  Similarity=0.296  Sum_probs=198.8

Q ss_pred             CCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      .|+..+.||+|+||.||++.. .++..||+|.....      ....+.+|+.+++.++|+|++++++++...+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            367788999999999999995 46899999975432      12346789999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      |+++|+|..++...   ....+++..+..++.|++.||.|||+  ++|+||||||+|||+++++.++|+|||++......
T Consensus        81 ~~~~g~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~--~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05631          81 IMNGGDLKFHIYNM---GNPGFDEQRAIFYAAELCCGLEDLQR--ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG  155 (285)
T ss_pred             ecCCCcHHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence            99999998776422   23457889999999999999999998  77999999999999999999999999998875332


Q ss_pred             CCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchh
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  316 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (386)
                      .   ......++..|+|||++.+..++.++|||||||++|||++|+.||.............  ...           ..
T Consensus       156 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~--~~~-----------~~  219 (285)
T cd05631         156 E---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD--RRV-----------KE  219 (285)
T ss_pred             C---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH--HHh-----------hc
Confidence            1   1223467889999999999999999999999999999999999998755422111110  000           00


Q ss_pred             hcccCCHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHH
Q 016588          317 LWSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTE  353 (386)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~evl~~  353 (386)
                      ....++...+.++.+++.+||+.||++||+     +++++++
T Consensus       220 ~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         220 DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            011223334567899999999999999997     7888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-43  Score=296.94  Aligned_cols=246  Identities=23%  Similarity=0.329  Sum_probs=208.6

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC------CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      .++|.+.+.||+|.||.||.|+.+ ++-.||+|...+      ....++.+|+++-++|+||||.++|++|.+....||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            457888999999999999999955 577899997433      3345688999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      +||..+|.+...+...   ....+++.....++.|+|.||.|+|.  ++|+||||||+|+|++..+..|++|||.+-.-.
T Consensus       101 lEya~~gel~k~L~~~---~~~~f~e~~~a~Yi~q~A~Al~y~h~--k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEG---RMKRFDEQRAATYIKQLANALLYCHL--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP  175 (281)
T ss_pred             EEecCCchHHHHHHhc---ccccccccchhHHHHHHHHHHHHhcc--CCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence            9999999999888532   44567888888999999999999998  789999999999999999999999999987532


Q ss_pred             CCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                          .+.....+||..|.+||...+..++...|+|++|++.||++.|.+||....   ....+..+....          
T Consensus       176 ----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etYkrI~k~~----------  238 (281)
T KOG0580|consen  176 ----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETYKRIRKVD----------  238 (281)
T ss_pred             ----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHHHHHHHcc----------
Confidence                344567889999999999999999999999999999999999999999755   223333222211          


Q ss_pred             hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                          ..++...+..+.++|.+|+..+|.+|.+..|++++
T Consensus       239 ----~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  239 ----LKFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ----ccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence                13345556778999999999999999999999987

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.4e-44  Score=318.97  Aligned_cols=246  Identities=21%  Similarity=0.315  Sum_probs=208.6

Q ss_pred             hcCCCcCCeecccCceEEEEEE-eCCCcEEEEEECCCCC------hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      ..+|++.+.||+|.||.|-+|. +..|+.||||.+.+..      .-.+.+|++||+.|+||||+.+|.+|.+.+...+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            3578888999999999999999 5779999999754433      23478899999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      |||..+|.|.+++     ...+.+++.....++.||..|+.|+|+  ++++|||||.+|||||.++++||+|||++....
T Consensus       132 MEYaS~GeLYDYi-----Ser~~LsErEaRhfFRQIvSAVhYCHk--nrVvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  132 MEYASGGELYDYI-----SERGSLSEREARHFFRQIVSAVHYCHK--NRVVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             EEecCCccHHHHH-----HHhccccHHHHHHHHHHHHHHHHHHhh--ccceecccchhheeecCCCCeeeeccchhhhhc
Confidence            9999999999999     456789999999999999999999999  789999999999999999999999999998875


Q ss_pred             CCCCCCCCccccCcccccchhhhcccCC-CcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhc
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  313 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (386)
                      ..   ......+|++.|.+||++.+..| ++..|.|||||+||-|+.|..||++.+   ...++..+.+           
T Consensus       205 ~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D---hk~lvrQIs~-----------  267 (668)
T KOG0611|consen  205 DK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD---HKRLVRQISR-----------  267 (668)
T ss_pred             cc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch---HHHHHHHhhc-----------
Confidence            43   34567889999999999999988 788999999999999999999999865   2333332222           


Q ss_pred             chhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016588          314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  355 (386)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~  355 (386)
                       ..++.+   +.+.+..-||.+||..+|++|.|++++..|-.
T Consensus       268 -GaYrEP---~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  268 -GAYREP---ETPSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             -ccccCC---CCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence             112111   12345678999999999999999999998753

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=9.1e-43  Score=324.66  Aligned_cols=258  Identities=25%  Similarity=0.424  Sum_probs=203.7

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCc----EEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGM----LVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  152 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  152 (386)
                      ..+|+..+.||+|+||.||+|.+. ++.    .||+|......    .+++.+|+.+++.++||||++++|++... ..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            357889999999999999999853 333    48999865432    34688899999999999999999998765 467


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~  232 (386)
                      +++||+++|+|.+++..    ....+++..++.++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        85 ~v~e~~~~g~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~LH~--~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          85 LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEE--RRLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             eeeecCCCCCHHHHHHh----ccccCCHHHHHHHHHHHHHHHHHHHh--cCeeccccchhheEecCCCcEEEcccccccc
Confidence            99999999999988853    23457888899999999999999998  7799999999999999999999999999987


Q ss_pred             cCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhh
Q 016588          233 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK  311 (386)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (386)
                      ...............+..|+|||.+.+..++.++|||||||++|||++ |..||.+....   ........         
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~~~~~~~---------  226 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSILEK---------  226 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHhC---------
Confidence            654322222222334567999999998999999999999999999998 99998764321   11111111         


Q ss_pred             hcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhc
Q 016588          312 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  362 (386)
Q Consensus       312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~  362 (386)
                          ......+..++.++.+++.+||+.+|.+|||+.+++..|..+..+..
T Consensus       227 ----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~  273 (316)
T cd05108         227 ----GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ  273 (316)
T ss_pred             ----CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence                11112222344678999999999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6.9e-43  Score=321.21  Aligned_cols=262  Identities=20%  Similarity=0.270  Sum_probs=197.1

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      ++|+..+.||.|+||.||+|..+ ++..||+|.....    ....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46888999999999999999965 5889999975422    234677999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +++ +|.+++..    ....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++......
T Consensus        85 ~~~-~l~~~l~~----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          85 LDS-DLKQYLDN----CGNLMSMHNVKIFMFQLLRGLSYCHK--RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             CCc-CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence            975 88777632    23457888899999999999999998  779999999999999999999999999987653221


Q ss_pred             CCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcc---------c
Q 016588          238 VAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF---------S  307 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------~  307 (386)
                        .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||......+...........+..         .
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07871         158 --KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE  235 (288)
T ss_pred             --ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence              12233456888999998865 56899999999999999999999999875432211111110000000         0


Q ss_pred             chhhhcchhhcc----cCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          308 NLLKILDERLWS----TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       308 ~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .......+....    ......+.++.+++.+||+.||.+|||++|+++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            000111111000    0011234568999999999999999999999865

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=8.5e-43  Score=333.48  Aligned_cols=264  Identities=23%  Similarity=0.364  Sum_probs=206.2

Q ss_pred             HHHhcCCCcCCeecccCceEEEEEEeCC------CcEEEEEECCCCC----hhHHHHHHHHHHcCC-CCcccccccceee
Q 016588           79 SLATKNFSDKNLIGEGKFGEVYKGLLQD------GMLVAIKKRPGAP----TQEFIDEVCFLASIQ-HRNLVTLLGYCQE  147 (386)
Q Consensus        79 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~----~~~~~~e~~~l~~l~-h~niv~~~~~~~~  147 (386)
                      ....++|.+.+.||+|+||.||+|....      +..||+|++....    .+.+.+|+.+++.++ ||||+++++++..
T Consensus        33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            3446788899999999999999998521      3469999875432    346889999999996 9999999999999


Q ss_pred             CCeEEEEEEeecCCCccccccCCCc-------------------------------------------------------
Q 016588          148 NNLQFLIYEYIPNGSVSIHLYGPSQ-------------------------------------------------------  172 (386)
Q Consensus       148 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  172 (386)
                      .+..|+||||+++|+|.+++.....                                                       
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            9999999999999999887643210                                                       


Q ss_pred             ------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee
Q 016588          173 ------------------------------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV  216 (386)
Q Consensus       173 ------------------------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill  216 (386)
                                                          .....+++..+..++.|++.||.|||+  ++|+||||||+|||+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivH~dikp~Nill  270 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS--KNCVHRDLAARNVLL  270 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChHhEEE
Confidence                                                001247788889999999999999998  779999999999999


Q ss_pred             CCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhh
Q 016588          217 DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQD  295 (386)
Q Consensus       217 ~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~  295 (386)
                      +.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......  ..
T Consensus       271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--~~  348 (400)
T cd05105         271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--ST  348 (400)
T ss_pred             eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--HH
Confidence            9999999999999886543222222223345677999999998899999999999999999997 88998764321  11


Q ss_pred             HHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhh
Q 016588          296 LVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD  359 (386)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~  359 (386)
                      ....+.             .......+..++.++.+++.+||+.||++|||+.++.+.|+++.+
T Consensus       349 ~~~~~~-------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         349 FYNKIK-------------SGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             HHHHHh-------------cCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            111111             111112233456779999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-43  Score=332.08  Aligned_cols=265  Identities=25%  Similarity=0.426  Sum_probs=229.6

Q ss_pred             HHHHHHHhcCCCcCCeecccCceEEEEEEeCC-CcEEEEEECCCC--ChhHHHHHHHHHHcCCCCcccccccceeeCCeE
Q 016588           75 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  151 (386)
Q Consensus        75 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  151 (386)
                      .+.++....+.++.+.||-|.||.||.|.|+. ...||||.++..  ..++|+.|..+|+.++|||+|+++|+|...-.+
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            36677777788888999999999999999876 678999987665  457899999999999999999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      |+|.|||..|+|.+++..   .++..++....+.++.||+.|+.||..  +++|||||..+|+|+.++..+|++||||++
T Consensus       339 YIiTEfM~yGNLLdYLRe---cnr~ev~avvLlyMAtQIsSaMeYLEk--knFIHRDLAARNCLVgEnhiVKvADFGLsR  413 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRE---CNRSEVPAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHIVKVADFGLSR  413 (1157)
T ss_pred             EEEEecccCccHHHHHHH---hchhhcchhHHHHHHHHHHHHHHHHHH--hhhhhhhhhhhhccccccceEEeeccchhh
Confidence            999999999999999953   456677778888999999999999998  779999999999999999999999999999


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          232 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      ++.... ........-+..|.|||-+..+.++.++|||+|||+|||+.| |..||.+.+-                .++.
T Consensus       414 lMtgDT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl----------------SqVY  476 (1157)
T KOG4278|consen  414 LMTGDT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----------------SQVY  476 (1157)
T ss_pred             hhcCCc-eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH----------------HHHH
Confidence            986532 222333445677999999999999999999999999999998 8889887552                3445


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                      ..+...++...++.|++.+++||..||+.+|.+||++.|+-+.++.+..+.
T Consensus       477 ~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s  527 (1157)
T KOG4278|consen  477 GLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS  527 (1157)
T ss_pred             HHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence            556666777888899999999999999999999999999999999887554

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-42  Score=313.45  Aligned_cols=255  Identities=27%  Similarity=0.468  Sum_probs=204.8

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCC----CcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (386)
                      .++|+..+.||+|+||.||+|....    ...|++|..+...    ..++.+|+.+++.++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            3578889999999999999999642    3579999865432    3457889999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      +|||+++++|.+++..    ....+++..+..++.|++.||.|||+  ++|+|+||||+||++++++.++|+|||+++..
T Consensus        83 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~Lh~--~~i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          83 ITEYMENGSLDKFLRE----NDGKFTVGQLVGMLRGIASGMKYLSE--MNYVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             EEEcCCCCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            9999999999998843    23468899999999999999999998  77999999999999999999999999999877


Q ss_pred             CCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          234 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       234 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      .............++..|+|||.+.+..++.++||||||+++||+++ |..||.....   ...........        
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~--------  225 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKAVEDGY--------  225 (266)
T ss_pred             cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHHHHcCC--------
Confidence            52222222223344567999999998899999999999999999998 9999865442   12222211110        


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhh
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  358 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~  358 (386)
                           ....+...++.+.+++.+||+.+|++||++.+++++|++++
T Consensus       226 -----~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~  266 (266)
T cd05033         226 -----RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI  266 (266)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence                 11122234567899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.1e-43  Score=329.51  Aligned_cols=242  Identities=22%  Similarity=0.299  Sum_probs=198.7

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC------CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ++|+..+.||+|+||.||+|..+ +++.||+|....      ...+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56888899999999999999965 588999997542      23356789999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+.+++|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++....
T Consensus        98 e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         98 EFVVGGELFTHLR-----KAGRFPNDVAKFYHAELVLAFEYLHS--KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             cCCCCChHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            9999999998884     33467888888999999999999999  7799999999999999999999999999886543


Q ss_pred             CCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      .     .....+++.|+|||++.+..++.++|||||||++|||++|..||....+   ....+.+.            ..
T Consensus       171 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~------------~~  230 (329)
T PTZ00263        171 R-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP---FRIYEKIL------------AG  230 (329)
T ss_pred             C-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH---HHHHHHHh------------cC
Confidence            2     1234688899999999999999999999999999999999999976432   11111111            11


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTE  353 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~evl~~  353 (386)
                      .  ...+...+.++.+++.+||+.||.+||+     ++++++|
T Consensus       231 ~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        231 R--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             C--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            1  1122223456899999999999999997     6888866

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.3e-42  Score=317.77  Aligned_cols=255  Identities=27%  Similarity=0.458  Sum_probs=203.6

Q ss_pred             cCCCcCCeecccCceEEEEEEeCC------CcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQD------GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  152 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  152 (386)
                      ++|.+.+.||+|+||.||+|...+      +..||+|......    .+.+.+|+++++.++|+|++++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            467788999999999999998532      4789999865432    346889999999999999999999999999999


Q ss_pred             EEEEeecCCCccccccCCC---------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceE
Q 016588          153 LIYEYIPNGSVSIHLYGPS---------QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAK  223 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~---------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~k  223 (386)
                      +||||+++++|.+++....         ......+++..+..++.|++.|+.|||+  ++++||||||+||+++.++.++
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~h~dlkp~nili~~~~~~k  162 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS--QHFVHRDLATRNCLVGYDLVVK  162 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh--CCeeccccccceEEEcCCCeEE
Confidence            9999999999999885432         1223457888999999999999999998  7799999999999999999999


Q ss_pred             EcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHh
Q 016588          224 VADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQN  302 (386)
Q Consensus       224 l~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~  302 (386)
                      |+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||......   ........
T Consensus       163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~~~~~~  239 (280)
T cd05049         163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVIECITQ  239 (280)
T ss_pred             ECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHc
Confidence            999999876533222222223345677999999999999999999999999999998 99998764431   12221111


Q ss_pred             hhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016588          303 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  355 (386)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~  355 (386)
                                   ......+...+..+.+++.+||+.||++|||+.|+++.|+
T Consensus       240 -------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         240 -------------GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             -------------CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence                         1111222334567899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.1e-41  Score=361.58  Aligned_cols=266  Identities=26%  Similarity=0.448  Sum_probs=209.9

Q ss_pred             cCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCC
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  161 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  161 (386)
                      ..|...+.||+|+||.||+|.. .++..||+|+...... ....|++.+++++||||++++|+|.+.+..|+||||+++|
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g  768 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGK  768 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCC
Confidence            4577788999999999999996 4688999998754322 2345788999999999999999999999999999999999


Q ss_pred             CccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016588          162 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL-SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  240 (386)
Q Consensus       162 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~  240 (386)
                      +|.+++.        .++|..+.+++.|++.||+|||.. .++|+||||||+||+++.++..++. ||.......     
T Consensus       769 ~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-----  834 (968)
T PLN00113        769 NLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-----  834 (968)
T ss_pred             cHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence            9999883        278999999999999999999953 3689999999999999999888775 665443211     


Q ss_pred             CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcc-
Q 016588          241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS-  319 (386)
Q Consensus       241 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  319 (386)
                       .....++..|+|||++.+..++.++|||||||++|||+||+.||..... ......++.+............++.+.. 
T Consensus       835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  912 (968)
T PLN00113        835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRGD  912 (968)
T ss_pred             -CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccCC
Confidence             1123567889999999999999999999999999999999999854332 2334444544333333334444554432 


Q ss_pred             -cCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhcccc
Q 016588          320 -TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLT  365 (386)
Q Consensus       320 -~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~~~~  365 (386)
                       ........++.+++.+||+.||++||||+|+++.|+++.+.....+
T Consensus       913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~~~  959 (968)
T PLN00113        913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSCV  959 (968)
T ss_pred             CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccccccc
Confidence             2344556778999999999999999999999999999887655444

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.2e-42  Score=326.31  Aligned_cols=262  Identities=24%  Similarity=0.384  Sum_probs=203.1

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC------CCcEEEEEECCCCC----hhHHHHHHHHHHcC-CCCcccccccceee-CC
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQE-NN  149 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~~~~~~~~-~~  149 (386)
                      .++|++.+.||+|+||.||+|...      +++.||+|++....    .+.+.+|+.++.++ +|+||++++++|.. ..
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            457888999999999999999632      24689999865432    23567899999999 89999999998764 45


Q ss_pred             eEEEEEEeecCCCccccccCCCcC--------------------------------------------------------
Q 016588          150 LQFLIYEYIPNGSVSIHLYGPSQV--------------------------------------------------------  173 (386)
Q Consensus       150 ~~~lv~e~~~~g~L~~~l~~~~~~--------------------------------------------------------  173 (386)
                      ..++++||+++++|.+++......                                                        
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            788999999999998877432110                                                        


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccc
Q 016588          174 SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA  253 (386)
Q Consensus       174 ~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~a  253 (386)
                      ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.++|+|||+++.+.............++..|+|
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~--~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence            01367899999999999999999998  7899999999999999999999999999987643222222223345667999


Q ss_pred             hhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHH
Q 016588          254 SEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQL  332 (386)
Q Consensus       254 PE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  332 (386)
                      ||++.+..++.++|||||||++|||++ |..||......+  .+.....             .......+...++++.++
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~~~~~-------------~~~~~~~~~~~~~~~~~l  308 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCRRLK-------------EGTRMRAPEYATPEIYSI  308 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHHHHHh-------------ccCCCCCCccCCHHHHHH
Confidence            999999999999999999999999998 999987643321  1111111             111111223345678999


Q ss_pred             HhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          333 IVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       333 i~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      +.+||+.+|++||++.|++++|+++++.
T Consensus       309 ~~~cl~~~p~~RPs~~ell~~l~~~~~~  336 (337)
T cd05054         309 MLDCWHNNPEDRPTFSELVEILGDLLQE  336 (337)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            9999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2e-42  Score=312.53  Aligned_cols=249  Identities=24%  Similarity=0.418  Sum_probs=200.9

Q ss_pred             cCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCC--ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecC
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      ++|+..+.||+|+||.||++..+++..+|+|.....  ...++.+|+.+++.++||||+++++++...+..++||||+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   83 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN   83 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence            457788999999999999999887788999985533  346788999999999999999999999999999999999999


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  240 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~  240 (386)
                      |+|.+++...    ...+++..+..++.|++.||.|||+  ++++||||||+||+++.++.+||+|||.++........ 
T Consensus        84 ~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05114          84 GCLLNYLRQR----QGKLSKDMLLSMCQDVCEGMEYLER--NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-  156 (256)
T ss_pred             CcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHH--CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence            9999887432    2357889999999999999999998  77999999999999999999999999998865432211 


Q ss_pred             CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcc
Q 016588          241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS  319 (386)
Q Consensus       241 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (386)
                      ......++..|+|||.+.+..++.++|+||||+++|||++ |+.||.....   ......+....             +.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~i~~~~-------------~~  220 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEMISRGF-------------RL  220 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHCCC-------------CC
Confidence            1122334567999999998889999999999999999999 8889876442   12222221111             01


Q ss_pred             cCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          320 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                      ..+...+.++.+++.+||+.+|.+|||+.++++.|
T Consensus       221 ~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         221 YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            11122345689999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.5e-42  Score=314.23  Aligned_cols=254  Identities=26%  Similarity=0.452  Sum_probs=205.5

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCC--ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeec
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  159 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  159 (386)
                      .++|+..+.||+|+||.||+|...++..|++|.....  ..+.+.+|+.+++.++|+||+++++.+...+..+++|||++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            4578889999999999999999877888999986543  34678899999999999999999999999999999999999


Q ss_pred             CCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016588          160 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  239 (386)
Q Consensus       160 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~  239 (386)
                      +++|.+++...   ....+++..+..++.|++.||+|||+  .+++||||||+||+++.++.++|+|||++.........
T Consensus        85 ~~~L~~~l~~~---~~~~~~~~~~~~~~~~l~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          85 KGSLLDFLKSD---EGGKVLLPKLIDFSAQIAEGMAYIER--KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             CCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence            99999888532   23457888899999999999999998  77999999999999999999999999999876442211


Q ss_pred             CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          240 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       240 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                       ......++..|+|||...+..++.++|||||||++|||++ |..||......   ..........             .
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~~~~-------------~  222 (261)
T cd05072         160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSALQRGY-------------R  222 (261)
T ss_pred             -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHHHHcCC-------------C
Confidence             1222345667999999988889999999999999999998 99998764421   1111111111             1


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHh
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  357 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~  357 (386)
                      .......+.++.+++.+||+.+|++|||++++.+.|+++
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         223 MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            111223446789999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-42  Score=312.95  Aligned_cols=255  Identities=25%  Similarity=0.441  Sum_probs=205.8

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCC--ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      ..++|+..+.||+|+||.||+|...++..||+|.....  ..+++.+|+.++++++|||++++++++...+..+++|||+
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            34578889999999999999999877788999986543  3467889999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++++|.+++...   ....+++..+..++.|++.||.|||+  ++++||||||+||++++++.++|+|||+++.......
T Consensus        84 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          84 KYGSLLEYLQGG---AGRALKLPQLIDMAAQVASGMAYLEA--QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             cCCcHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            999999988432   23468899999999999999999998  7799999999999999999999999999987653221


Q ss_pred             CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhh
Q 016588          239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  317 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (386)
                      . .......+..|+|||...+..++.++||||||+++|||++ |..||.+....   ........             ..
T Consensus       159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~~-------------~~  221 (261)
T cd05068         159 E-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---EVLQQVDQ-------------GY  221 (261)
T ss_pred             c-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHc-------------CC
Confidence            1 1112223457999999998899999999999999999999 99898764421   11111111             01


Q ss_pred             cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHh
Q 016588          318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  357 (386)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~  357 (386)
                      ....+...+..+.+++.+||+.+|.+||++.++++.|+++
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         222 RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            1122233456789999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=6.2e-43  Score=326.73  Aligned_cols=239  Identities=23%  Similarity=0.280  Sum_probs=194.3

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCC
Q 016588           89 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  161 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  161 (386)
                      +.||+|+||.||++..+ +++.||+|.....      ....+.+|+.+++.++||||+++++++...+..|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999954 5889999975432      2245678999999999999999999999999999999999999


Q ss_pred             CccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCC
Q 016588          162 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP  241 (386)
Q Consensus       162 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~  241 (386)
                      +|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~L~~~l~-----~~~~~~~~~~~~~~~qi~~~L~~lH~--~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~  151 (323)
T cd05571          81 ELFFHLS-----RERVFSEDRARFYGAEIVSALGYLHS--CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GAT  151 (323)
T ss_pred             cHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCc
Confidence            9988874     34567899999999999999999999  77999999999999999999999999998753221  122


Q ss_pred             CccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccC
Q 016588          242 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF  321 (386)
Q Consensus       242 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (386)
                      .....|++.|+|||++.+..++.++|||||||++|||++|..||.....   .........            ..  ..+
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~~~~------------~~--~~~  214 (323)
T cd05571         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILM------------EE--IRF  214 (323)
T ss_pred             ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH---HHHHHHHHc------------CC--CCC
Confidence            2345688999999999999999999999999999999999999976432   111111110            00  122


Q ss_pred             CHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016588          322 TNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  353 (386)
Q Consensus       322 ~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~~  353 (386)
                      +...+.++.+++.+||+.||++||     ++.+++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            334456789999999999999999     79999865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-43  Score=328.27  Aligned_cols=250  Identities=23%  Similarity=0.334  Sum_probs=201.6

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ++|++.+.||+|+||.||+|... +++.||+|.....      ....+.+|+.++..++||||+++++++...+..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36888999999999999999965 4889999985432      2345788999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~-----~~~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          81 EYVPGGDFRTLLN-----NLGVLSEDHARFYMAEMFEAVDALHE--LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             eCCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            9999999999883     33567888999999999999999998  7799999999999999999999999999876533


Q ss_pred             CCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                           ......+++.|+|||++.+..++.++|||||||++|||++|..||.......   ....+.....      .+..
T Consensus       154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~------~~~~  219 (333)
T cd05600         154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE---TWENLKYWKE------TLQR  219 (333)
T ss_pred             -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH---HHHHHHhccc------cccC
Confidence                 2334568889999999999999999999999999999999999998654321   1111111000      0000


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ..........+.++.+++.+||..+|.+|||+++++++
T Consensus       220 ~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         220 PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            00111112345678999999999999999999999977

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.5e-42  Score=314.03  Aligned_cols=253  Identities=29%  Similarity=0.492  Sum_probs=206.9

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCC---hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      ..+|+..+.||.|+||.||+|...++..+++|......   .+.+.+|+.+++.++|+|++++++++...+..++||||+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            45678889999999999999998778899999865443   457889999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++++|.+++...   ....+++..+..++.|++.||.|||+  ++++|+||||+||+++.++.+||+|||++........
T Consensus        85 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          85 EKGSLLAFLRSP---EGQVLPVASLIDMACQVAEGMAYLEE--QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             ccCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            999999998542   23467899999999999999999998  7799999999999999999999999999877643221


Q ss_pred             CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhh
Q 016588          239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  317 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (386)
                      .  .....++..|+|||...+..++.++||||||+++|+|++ |..||.....   ........             ...
T Consensus       160 ~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~~~-------------~~~  221 (261)
T cd05148         160 L--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQIT-------------AGY  221 (261)
T ss_pred             c--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHH-------------hCC
Confidence            1  123345667999999988889999999999999999998 8889876442   11111111             111


Q ss_pred             cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHh
Q 016588          318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  357 (386)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~  357 (386)
                      ....+...++.+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            1122334557789999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2e-42  Score=318.74  Aligned_cols=262  Identities=27%  Similarity=0.466  Sum_probs=206.5

Q ss_pred             HHHhcCCCcCCeecccCceEEEEEEeCC------CcEEEEEECCCCCh----hHHHHHHHHHHcC-CCCcccccccceee
Q 016588           79 SLATKNFSDKNLIGEGKFGEVYKGLLQD------GMLVAIKKRPGAPT----QEFIDEVCFLASI-QHRNLVTLLGYCQE  147 (386)
Q Consensus        79 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~----~~~~~e~~~l~~l-~h~niv~~~~~~~~  147 (386)
                      ....++|+..+.||+|+||.||++....      ...+|+|.......    .++.+|++++..+ +|+||+++++++..
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            3445678888999999999999998542      36799998654322    3477899999999 89999999999999


Q ss_pred             CCeEEEEEEeecCCCccccccCCCc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee
Q 016588          148 NNLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV  216 (386)
Q Consensus       148 ~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill  216 (386)
                      .+..+++|||+++|+|..++.....           .....+++..++.++.|++.||.|||+  ++|+||||||+||++
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivH~dlkp~Nil~  165 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS--KKCIHRDLAARNVLV  165 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH--CCccccccceeeEEE
Confidence            9999999999999999988743210           124568899999999999999999998  779999999999999


Q ss_pred             CCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhh
Q 016588          217 DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQD  295 (386)
Q Consensus       217 ~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~  295 (386)
                      +.++.+||+|||+++...............++..|+|||...+..++.++|||||||++||+++ |..||......   .
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~  242 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE---E  242 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH---H
Confidence            9999999999999987654332222222334567999999988899999999999999999998 88888754421   1


Q ss_pred             HHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhh
Q 016588          296 LVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  358 (386)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~  358 (386)
                      ......             .......+...+.++.+++.+||..||++|||+.++++.|+.++
T Consensus       243 ~~~~~~-------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         243 LFKLLK-------------EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHHHHH-------------cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            111111             11111223344567899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.4e-42  Score=323.79  Aligned_cols=260  Identities=20%  Similarity=0.267  Sum_probs=202.5

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      .++|+..+.||+|+||.||++... ++..+|+|......    .+.+.+|+++++.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            468899999999999999999965 57889999765432    3468899999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      |+++++|.+++.     ....+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++......
T Consensus        84 ~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          84 HMDGGSLDQVLK-----EAKRIPEEILGKVSIAVLRGLAYLREK-HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             cCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHhhc-CCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence            999999999884     234578889999999999999999972 35999999999999999999999999998765332


Q ss_pred             CCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhh-cc---------
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR-DF---------  306 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~---------  306 (386)
                          ......++..|+|||++.+..++.++|||||||++|||++|+.||.......   +........ ..         
T Consensus       158 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  230 (331)
T cd06649         158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSIS  230 (331)
T ss_pred             ----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccC
Confidence                1233467889999999999899999999999999999999999997544311   111110000 00         


Q ss_pred             --------------------c---chhhhcchhhcccC-CHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          307 --------------------S---NLLKILDERLWSTF-TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       307 --------------------~---~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                                          .   .....+........ ....+.++.+++.+||+.||++|||+++++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                                0   00000000000111 112456799999999999999999999999874

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.4e-42  Score=311.56  Aligned_cols=253  Identities=26%  Similarity=0.441  Sum_probs=203.8

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC--hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeec
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP--TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  159 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  159 (386)
                      .+|...+.||+|+||.||+|..+ .+..|++|......  ..++.+|+++++.++|+|++++++++...+..+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   85 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence            45777889999999999999965 47889999865443  3568899999999999999999999999999999999999


Q ss_pred             CCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016588          160 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  239 (386)
Q Consensus       160 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~  239 (386)
                      +++|.+++...   ....+++..++.++.|++.||.|||+  ++++||||||+||++++++.+||+|||++.........
T Consensus        86 ~~~L~~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          86 YGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            99999888432   23457889999999999999999998  78999999999999999999999999998876432211


Q ss_pred             CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          240 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       240 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                       .......+..|+|||.+.+..++.++|||||||++|||++ |..||.....   .........             ...
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~~~~~~~-------------~~~  223 (263)
T cd05052         161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEK-------------GYR  223 (263)
T ss_pred             -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHC-------------CCC
Confidence             1112233556999999998999999999999999999998 8888875432   111111111             111


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHh
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  357 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~  357 (386)
                      ...+...+.++.+++.+||+.||++|||+.++++.|+++
T Consensus       224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            223334557799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.8e-42  Score=315.87  Aligned_cols=259  Identities=27%  Similarity=0.427  Sum_probs=203.7

Q ss_pred             CCCcCCeecccCceEEEEEEeC------CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (386)
                      +|++.+.||+|+||.||+|...      ....+++|......    ...+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4677899999999999999843      12468888765433    2457889999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCc-------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCe
Q 016588          154 IYEYIPNGSVSIHLYGPSQ-------------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANV  214 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Ni  214 (386)
                      ++||+.+++|.+++.....                   .....+++..++.++.|++.||.|||+  ++++||||||+||
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~ivH~dikp~ni  158 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE--MKLVHRDLAARNV  158 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH--CCeehhhhhhheE
Confidence            9999999999988743211                   112457889999999999999999998  7799999999999


Q ss_pred             eeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCch
Q 016588          215 LVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSS  293 (386)
Q Consensus       215 ll~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~  293 (386)
                      |+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.+..+.  
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--  236 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE--  236 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH--
Confidence            999999999999999876543222112223344567999999988889999999999999999998 99998765432  


Q ss_pred             hhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          294 QDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                       .+.....             .......+...+.++.+++.+||+.+|++||++.++++.|++++.+
T Consensus       237 -~~~~~~~-------------~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~  289 (290)
T cd05045         237 -RLFNLLK-------------TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK  289 (290)
T ss_pred             -HHHHHHh-------------CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence             1111111             1111122333456789999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.4e-42  Score=315.87  Aligned_cols=261  Identities=26%  Similarity=0.438  Sum_probs=206.2

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC------CCcEEEEEECCCCC---hhHHHHHHHHHHcCCCCcccccccceeeCCeEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  152 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  152 (386)
                      .++|.+.+.||+|+||.||++...      ++..+++|......   .+.+.+|++++++++|||++++++++...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            457888999999999999999842      24568889865433   346889999999999999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCc--------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEE
Q 016588          153 LIYEYIPNGSVSIHLYGPSQ--------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKV  224 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~--------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl  224 (386)
                      +||||+++++|.+++.....        .....+++..+..++.|++.||+|||+  ++++||||||+||++++++.++|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~--~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS--QHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccCcceEEEccCCcEEe
Confidence            99999999999888753211        122458999999999999999999998  77999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhh
Q 016588          225 ADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNS  303 (386)
Q Consensus       225 ~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~  303 (386)
                      +|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||......   .........
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~---~~~~~i~~~  238 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIECITQG  238 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcC
Confidence            99999886643322222223345667999999998899999999999999999998 88888765421   111111111


Q ss_pred             hcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          304 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      .             ....+...+.++.+++.+||+.||.+|||+.++++.|+++...
T Consensus       239 ~-------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         239 R-------------VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             C-------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            0             0011122345689999999999999999999999999988855

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.3e-42  Score=316.36  Aligned_cols=260  Identities=25%  Similarity=0.434  Sum_probs=206.9

Q ss_pred             cCCCcCCeecccCceEEEEEEeC------CCcEEEEEECCCCCh---hHHHHHHHHHHcCCCCcccccccceeeCCeEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (386)
                      .+|...+.||+|+||.||++...      ++..+++|.......   +.+.+|+++++.++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45777899999999999999742      345688898665443   468899999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCce
Q 016588          154 IYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA  222 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~  222 (386)
                      ||||+++++|.+++.....           .....+++..++.++.|++.||.|||+  ++|+||||||+||+++.++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~Nil~~~~~~~  162 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS--QHFVHRDLATRNCLVGANLLV  162 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccCcceEEEccCCcE
Confidence            9999999999998853211           122458899999999999999999998  779999999999999999999


Q ss_pred             EEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHH
Q 016588          223 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQ  301 (386)
Q Consensus       223 kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~  301 (386)
                      +|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||......   ...+...
T Consensus       163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~~~  239 (291)
T cd05094         163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EVIECIT  239 (291)
T ss_pred             EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHh
Confidence            9999999876543322222233445678999999998999999999999999999999 99998765431   1111111


Q ss_pred             hhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          302 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                                   ...+...+...+..+.+++.+||+.+|++|||+.++++.|+++.+.
T Consensus       240 -------------~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         240 -------------QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             -------------CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence                         1111112223456789999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-44  Score=301.50  Aligned_cols=249  Identities=23%  Similarity=0.313  Sum_probs=206.4

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEE-----CCCCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~-----~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ++.|++.++||+|.|+.|+++.+. +|+.+|+|+     +.....+++.+|+.|.+.|+||||+++.+........|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            456777889999999999998854 588888775     45567788999999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC---CCCceEEcccccccc
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNF  232 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~---~~~~~kl~DFgl~~~  232 (386)
                      |++.|++|..-+-     .+..+++..+-..+.||+++|.|+|.  ++|||||+||+|+||.   ..--+||+|||++..
T Consensus        90 e~m~G~dl~~eIV-----~R~~ySEa~aSH~~rQiLeal~yCH~--n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   90 DLVTGGELFEDIV-----AREFYSEADASHCIQQILEALAYCHS--NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             ecccchHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHHHh--cCceeccCChhheeeeeccCCCceeecccceEEE
Confidence            9999999976652     33556788888999999999999999  8899999999999995   334689999999998


Q ss_pred             cCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          233 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      ++   ......+..|||.|||||++...+|+..+|||+.||+||-|+.|.+||.+.+   ...+++.+....-      -
T Consensus       163 l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~---~~rlye~I~~g~y------d  230 (355)
T KOG0033|consen  163 VN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYEQIKAGAY------D  230 (355)
T ss_pred             eC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc---HHHHHHHHhcccc------C
Confidence            86   3344567789999999999999999999999999999999999999999744   3344444332211      1


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .++..|....    ++.++|+.+||..||.+|.|+.|.|+|
T Consensus       231 ~~~~~w~~is----~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  231 YPSPEWDTVT----PEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             CCCcccCcCC----HHHHHHHHHHhccChhhhccHHHHhCC
Confidence            1333344443    557999999999999999999999987

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.8e-43  Score=317.96  Aligned_cols=246  Identities=31%  Similarity=0.539  Sum_probs=191.6

Q ss_pred             CCeecccCceEEEEEEeC-----CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           88 KNLIGEGKFGEVYKGLLQ-----DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      .+.||.|.||.||+|.+.     .+..|+||......    .+++.+|++.+++++||||++++|++...+..++|+||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            468999999999999976     25789999875432    357889999999999999999999999888899999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++|+|.+++...   ....+++..+..++.|++.||.|||+  ++++|+||+++||+++.++.+||+|||++........
T Consensus        84 ~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~--~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   84 PGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHS--NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHH--TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             cccccccccccc---cccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccc
Confidence            999999998532   24678999999999999999999999  6799999999999999999999999999887633222


Q ss_pred             CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhh
Q 016588          239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  317 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (386)
                      .........+..|+|||.+....++.++||||||+++||+++ |+.||.....   .+....+..             ..
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~~~~~~~-------------~~  222 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEIIEKLKQ-------------GQ  222 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHHHHHHHT-------------TE
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccc-------------cc
Confidence            222233345667999999998889999999999999999999 6788776532   222222211             11


Q ss_pred             cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                      +...+..++..+.+++.+||..||++|||+.++++.|
T Consensus       223 ~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  223 RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            1223334557789999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1e-42  Score=327.03  Aligned_cols=243  Identities=19%  Similarity=0.255  Sum_probs=198.9

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCC--CcEEEEEECC------CCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQD--GMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (386)
                      .++|+..+.||+|+||.||+|..+.  +..||+|...      ....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3468889999999999999998543  3689999753      2234567889999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      ||||+.+|+|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++..
T Consensus       109 v~Ey~~~g~L~~~i~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        109 VLEFVIGGEFFTFLR-----RNKRFPNDVGCFYAAQIVLIFEYLQS--LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV  181 (340)
T ss_pred             EEeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence            999999999998884     33568888999999999999999999  77999999999999999999999999999865


Q ss_pred             CCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhc
Q 016588          234 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  313 (386)
Q Consensus       234 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (386)
                      ...     .....+|+.|+|||++.+..++.++|||||||++|||++|..||....+.   .....+..           
T Consensus       182 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~~~~i~~-----------  242 (340)
T PTZ00426        182 DTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL---LIYQKILE-----------  242 (340)
T ss_pred             CCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH---HHHHHHhc-----------
Confidence            431     23456888999999999888999999999999999999999999865431   11111110           


Q ss_pred             chhhcccCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016588          314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  353 (386)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~~  353 (386)
                       ..  ...+...++.+.+++.+||+.||++|+     |+++++++
T Consensus       243 -~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        243 -GI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             -CC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence             00  012233446689999999999999995     89988876

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.4e-43  Score=314.63  Aligned_cols=260  Identities=24%  Similarity=0.346  Sum_probs=196.9

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCChhHHHHHHHHHHcCCCCcccccccceeeCC-----eEEEEEEe
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENN-----LQFLIYEY  157 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~  157 (386)
                      .|...+++|+|+||.||+|... ++..||||+.-+... --.+|+++|+.++|||||++.-+|....     ...+||||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley  103 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY  103 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence            4566799999999999999955 478999998654322 2247999999999999999988875432     23579999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC-CceEEcccccccccCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRT  236 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~-~~~kl~DFgl~~~~~~~  236 (386)
                      ++. +|...+.... .....++...+.-+..|+.+||.|||+  .+|+||||||+|+|+|.+ |.+||||||.|+.+..+
T Consensus       104 mP~-tL~~~~r~~~-~~~~~mp~~~iKLYt~Qlfrgl~yLh~--~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~  179 (364)
T KOG0658|consen  104 MPE-TLYRVIRHYT-RANQRMPLLEIKLYTYQLFRGLAYLHS--HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG  179 (364)
T ss_pred             chH-HHHHHHHHHh-hcCCCCceeeeHHHHHHHHHHHHHHHh--cCcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence            987 7877774321 134556777778899999999999999  679999999999999976 89999999999998654


Q ss_pred             CCCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhh--hcccchhh--
Q 016588          237 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS--RDFSNLLK--  311 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~--  311 (386)
                      +.   ...+..+..|.|||.+.+ ..|+.+.||||.||++.||+-|++-|.+.+.  .+++.+.++-.  +..+++..  
T Consensus       180 ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~--~dQL~eIik~lG~Pt~e~I~~mn  254 (364)
T KOG0658|consen  180 EP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS--VDQLVEIIKVLGTPTREDIKSMN  254 (364)
T ss_pred             CC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH--HHHHHHHHHHhCCCCHHHHhhcC
Confidence            32   345667888999999876 4899999999999999999999999998553  33343333221  11111111  


Q ss_pred             ---------hcchhhccc-CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          312 ---------ILDERLWST-FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       312 ---------~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                               .+.+..|.. +....+++..+++.++|+.+|.+|.++.|++.+
T Consensus       255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence                     111111212 344556789999999999999999999999965

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.2e-42  Score=325.02  Aligned_cols=262  Identities=19%  Similarity=0.285  Sum_probs=193.1

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeC-----CeEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN-----NLQF  152 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~  152 (386)
                      +|++.+.||+|+||.||+|... ++..||+|+....     ....+.+|+.+++.++||||+++++++...     ...|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4778899999999999999954 5899999975421     234578899999999999999999987543     3579


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~  232 (386)
                      +||||+. ++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 lv~e~~~-~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          81 VVFELME-SDLHQVIK-----ANDDLTPEHHQFFLYQLLRALKYIHT--ANVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EEEecCC-CCHHHHHH-----hcccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            9999996 57877773     33468899999999999999999999  7799999999999999999999999999876


Q ss_pred             cCCCCC-CCCCccccCcccccchhhhcc--cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhccc--
Q 016588          233 LGRTDV-AGPSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS--  307 (386)
Q Consensus       233 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--  307 (386)
                      ...... ........+++.|+|||++.+  ..++.++|||||||++|||++|+.||......................  
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI  232 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            532211 112234568889999999875  678999999999999999999999997654311111110000000000  


Q ss_pred             ---------chhhhcchhhc---ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          308 ---------NLLKILDERLW---STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       308 ---------~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                               ...........   ....+..+.++.+++.+||+.||++|||++|++++
T Consensus       233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                     00000000000   00001234568899999999999999999999976

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=5.7e-42  Score=314.21  Aligned_cols=256  Identities=29%  Similarity=0.455  Sum_probs=201.2

Q ss_pred             cCCCcCCeecccCceEEEEEEe-----CCCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (386)
                      .+|+..+.||+|+||.||+|..     ..+..+++|......    ...+.+|+.+++.++||||+++++++...+..|+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4677789999999999999984     235789999865432    2457889999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCc------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc
Q 016588          154 IYEYIPNGSVSIHLYGPSQ------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI  221 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~  221 (386)
                      ||||+++++|.+++.....            .....+++.....++.|++.||.|||+  ++++||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~nili~~~~~  162 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS--HFFVHKDLAARNILIGEQLH  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--cCeehhccccceEEEcCCCc
Confidence            9999999999988742210            012357888899999999999999998  77999999999999999999


Q ss_pred             eEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHH
Q 016588          222 AKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELV  300 (386)
Q Consensus       222 ~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~  300 (386)
                      +||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.+..+   ....+.+
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~~~~  239 (283)
T cd05090         163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIEMV  239 (283)
T ss_pred             EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH
Confidence            99999999987643222222233345667999999988889999999999999999998 8888876432   1112211


Q ss_pred             HhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHH
Q 016588          301 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  356 (386)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~  356 (386)
                      ...             .....+..++.++.+++.+||+.||++||++.+++++|..
T Consensus       240 ~~~-------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         240 RKR-------------QLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HcC-------------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            111             1112223345678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=9.3e-42  Score=312.25  Aligned_cols=255  Identities=27%  Similarity=0.433  Sum_probs=199.9

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCc----EEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGM----LVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (386)
                      ++|+..+.||+|+||+||+|.+. +++    .+++|......    ..++..|+..++.++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            46778899999999999999963 343    47788754332    2456677888899999999999998764 45678


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      ++||+++|+|.+++..    ....+++..+..++.|++.||.|||+  ++++||||||+|||++.++.+||+|||+++..
T Consensus        86 i~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          86 VTQLSPLGSLLDHVRQ----HRDSLDPQRLLNWCVQIAKGMYYLEE--HRMVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             EEEeCCCCcHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH--CCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence            9999999999999843    23468899999999999999999998  77999999999999999999999999999876


Q ss_pred             CCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          234 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       234 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      .............++..|+|||...+..++.++|||||||++||+++ |..||.+..+..   ..+.+....        
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~~~~~~--------  228 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPDLLEKGE--------  228 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHCCC--------
Confidence            43322222233456677999999988889999999999999999998 999987654321   111111111        


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                           ....+..++.++.+++.+||..||++|||+.|+++.|..+.+.
T Consensus       229 -----~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         229 -----RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             -----cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence                 0111112345678999999999999999999999999888765

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=339.56  Aligned_cols=267  Identities=21%  Similarity=0.278  Sum_probs=212.9

Q ss_pred             HHhcCCCcCCeecccCceEEEEEEeCCC-cEEEEEECC---CCChhHHHHHHHHHHcCC-CCcccccccce-ee------
Q 016588           80 LATKNFSDKNLIGEGKFGEVYKGLLQDG-MLVAIKKRP---GAPTQEFIDEVCFLASIQ-HRNLVTLLGYC-QE------  147 (386)
Q Consensus        80 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~-~~------  147 (386)
                      +...++++.+.|.+|||+.||.|....+ ..+|+|++-   ....+.+.+|+++|+.|+ |+|||.+++.. ..      
T Consensus        34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            4556778889999999999999996665 999999833   334566889999999996 99999999932 21      


Q ss_pred             CCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccc
Q 016588          148 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA  227 (386)
Q Consensus       148 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DF  227 (386)
                      .-+.+|.||||.+|.|-+++....   ...|.+..+++|+.++++|+.+||...++|||||||-+||||+.+++.|||||
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rl---q~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRL---QTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHH---hccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcc
Confidence            135789999999999999996432   23499999999999999999999998889999999999999999999999999


Q ss_pred             ccccccCCCC-CCCC------CccccCcccccchhhhc---ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHH
Q 016588          228 GLRNFLGRTD-VAGP------SSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLV  297 (386)
Q Consensus       228 gl~~~~~~~~-~~~~------~~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~  297 (386)
                      |.+.-.-..- ....      .-.-.-|+.|.+||++.   +...++|+|||+|||+||-|+....||+....       
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------  263 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------  263 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------
Confidence            9976432211 0000      00123578899999874   56789999999999999999999999997543       


Q ss_pred             HHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhccccccc
Q 016588          298 ELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVM  368 (386)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~~~~~~~  368 (386)
                                  ..+++..+..+..+..+..+.+||..||+.||++||++.+++.++.++........++.
T Consensus       264 ------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~  322 (738)
T KOG1989|consen  264 ------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY  322 (738)
T ss_pred             ------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence                        12334444333345678899999999999999999999999999999998765544444

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=6.9e-42  Score=317.44  Aligned_cols=264  Identities=27%  Similarity=0.437  Sum_probs=207.3

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC--------CCcEEEEEECCCCC----hhHHHHHHHHHHcC-CCCcccccccceeeC
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ--------DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQEN  148 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  148 (386)
                      .++|.+.+.||+|+||.||++...        ....+|+|......    ..++.+|+++++.+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            357888999999999999999742        12469999876432    23577899999999 799999999999999


Q ss_pred             CeEEEEEEeecCCCccccccCCCc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC
Q 016588          149 NLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD  217 (386)
Q Consensus       149 ~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~  217 (386)
                      +..|+||||+.+++|.+++.....           .....+++..++.++.|++.||+|||+  .+++||||||+||+++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~gi~H~dlkp~Nill~  174 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVT  174 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH--CCcccccccHHheEEc
Confidence            999999999999999998854321           112458899999999999999999998  7799999999999999


Q ss_pred             CCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhH
Q 016588          218 EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDL  296 (386)
Q Consensus       218 ~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~  296 (386)
                      .++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.....   ...
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~---~~~  251 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EEL  251 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHH
Confidence            999999999999876643222222222334467999999998889999999999999999998 8888865332   111


Q ss_pred             HHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhcc
Q 016588          297 VELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN  363 (386)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~~  363 (386)
                      ......             ......+...+.++.+++.+||..+|.+|||+.++++.|++++....+
T Consensus       252 ~~~~~~-------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~~  305 (307)
T cd05098         252 FKLLKE-------------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSN  305 (307)
T ss_pred             HHHHHc-------------CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhhc
Confidence            211111             111123334456789999999999999999999999999999876443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.1e-41  Score=310.21  Aligned_cols=254  Identities=23%  Similarity=0.383  Sum_probs=195.9

Q ss_pred             CcCCeecccCceEEEEEEeCC-Cc--EEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeC------CeE
Q 016588           86 SDKNLIGEGKFGEVYKGLLQD-GM--LVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN------NLQ  151 (386)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~  151 (386)
                      .+.+.||+|+||.||+|.... +.  .+|+|..+..     ..+.+..|..+++.++|+||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            456889999999999999654 32  6899975432     234578899999999999999999987432      346


Q ss_pred             EEEEEeecCCCccccccCCC-cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPS-QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  230 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~  230 (386)
                      ++++||+.+|+|..++.... ......+++.....++.|++.||.|||+  ++|+||||||+|||++.++.++|+|||++
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS--KSFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhheEEcCCCCEEECCCCcc
Confidence            89999999999988764221 1223458899999999999999999998  77999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccch
Q 016588          231 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNL  309 (386)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  309 (386)
                      +................+..|++||...+..++.++||||||+++|||++ |..||.....   ...........     
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~-----  231 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYDYLRQGN-----  231 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHcCC-----
Confidence            87644322212222345667999999998899999999999999999999 7888876432   12222221111     


Q ss_pred             hhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHh
Q 016588          310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  357 (386)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~  357 (386)
                              ....+...++.+.+++.+||+.||++|||+.++++.|+++
T Consensus       232 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 --------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                    0112223456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.8e-42  Score=310.20  Aligned_cols=250  Identities=26%  Similarity=0.443  Sum_probs=200.4

Q ss_pred             cCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCC--ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecC
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      ++|+..+.||+|+||.||.|...++..+|+|.....  ..+++.+|+.+++.++||||+++++++...+..+++|||+.+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN   83 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence            457788999999999999999877777999976543  245789999999999999999999999988889999999999


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  240 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~  240 (386)
                      ++|.+++..    ....+++..++.++.|++.||.|||+  .+++|+||||+||+++.++.+||+|||.++........ 
T Consensus        84 ~~l~~~i~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05113          84 GCLLNYLRE----HGKRFQPSQLLEMCKDVCEGMAYLES--KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-  156 (256)
T ss_pred             CcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence            999988842    22367899999999999999999998  77999999999999999999999999998765432211 


Q ss_pred             CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcc
Q 016588          241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS  319 (386)
Q Consensus       241 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (386)
                      ......++..|++||...+..++.++|||||||++|||++ |..||......   .........             .+.
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~~-------------~~~  220 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVEKVSQG-------------LRL  220 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHhcC-------------CCC
Confidence            1122334567999999988889999999999999999998 99998754421   111111111             011


Q ss_pred             cCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016588          320 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  355 (386)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~  355 (386)
                      ..+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            112223467899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.2e-42  Score=313.18  Aligned_cols=265  Identities=27%  Similarity=0.411  Sum_probs=202.2

Q ss_pred             CCcCCeecccCceEEEEEEe-----CCCcEEEEEECCCC----ChhHHHHHHHHHHcCCCCcccccccceee--CCeEEE
Q 016588           85 FSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQFL  153 (386)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l  153 (386)
                      |+..+.||+|+||+||++..     .++..||+|.....    ....+.+|+++++.++||||+++++++..  ....++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            37889999999999988653     34678999986543    23567889999999999999999998765  346789


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      +|||+++++|.+++.      ...+++..+..++.|++.||.|||+  ++|+||||||+||++++++.++|+|||+++..
T Consensus        86 v~e~~~~~~l~~~~~------~~~l~~~~~~~i~~~l~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          86 IMEYVPLGSLRDYLP------KHKLNLAQLLLFAQQICEGMAYLHS--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             EecCCCCCCHHHHHH------HcCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccChheEEEcCCCcEEEeeccccccc
Confidence            999999999998883      2358999999999999999999998  77999999999999999999999999998876


Q ss_pred             CCCCCC-CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          234 GRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       234 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      ...... .......++..|+|||.+.+..++.++||||||+++|||++|..|+....... .................+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIEL  236 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhh
Confidence            432211 11122334566999999988889999999999999999999999987644321 1111110000111111222


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhh
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  358 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~  358 (386)
                      .+.......+...+.++.+++.+||+.+|++|||++++++.|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            2222222334455678999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4e-42  Score=314.22  Aligned_cols=257  Identities=24%  Similarity=0.393  Sum_probs=200.7

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeC------CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCe
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNL  150 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  150 (386)
                      ..++|+..+.||+|+||.||+|...      .+..||+|......    ..++.+|+.+++.++||||+++++++...+.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567889999999999999998753      24679999864322    2357889999999999999999999999999


Q ss_pred             EEEEEEeecCCCccccccCCCcC-----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEc
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQV-----SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA  225 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~  225 (386)
                      .++||||+++++|.+++......     ....+++..+..++.|++.||.|||+  ++++||||||+||++++++.++|+
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~vH~dlkp~Nil~~~~~~~~l~  161 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIG  161 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCcchheEEEcCCCCEEEC
Confidence            99999999999999887432111     12346788889999999999999998  779999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhh
Q 016588          226 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSR  304 (386)
Q Consensus       226 DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  304 (386)
                      |||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.....   ...........
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---~~~~~~~~~~~  238 (277)
T cd05062         162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---EQVLRFVMEGG  238 (277)
T ss_pred             CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHcCC
Confidence            9999876543222222222344667999999998889999999999999999999 6888875432   11111111100


Q ss_pred             cccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016588          305 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  355 (386)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~  355 (386)
                                   ....+...+..+.+++.+||+.||++|||+.|+++.|+
T Consensus       239 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         239 -------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             -------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence                         01122334567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-42  Score=308.97  Aligned_cols=249  Identities=28%  Similarity=0.444  Sum_probs=200.2

Q ss_pred             cCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCC--ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecC
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      .+|+..+.||+|+||.||++..+++..+|+|.....  ..+++.+|+++++.++||||+++++++...+..++||||+++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            357788999999999999999877778999986543  345788999999999999999999999999999999999999


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  240 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~  240 (386)
                      ++|.+++..    ....+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||+++....... .
T Consensus        84 ~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~  156 (256)
T cd05059          84 GCLLNYLRE----RKGKLGTEWLLDMCSDVCEAMEYLES--NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-T  156 (256)
T ss_pred             CCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH--CCcccccccHhhEEECCCCcEEECCcccceecccccc-c
Confidence            999988843    23367899999999999999999998  7799999999999999999999999999876543211 1


Q ss_pred             CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcc
Q 016588          241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS  319 (386)
Q Consensus       241 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (386)
                      ......++..|+|||.+.+..++.++|+||||+++||+++ |..||....+.   ........             ....
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~~-------------~~~~  220 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVVESVSA-------------GYRL  220 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHHHHHHc-------------CCcC
Confidence            1122233456999999998899999999999999999999 78888764431   11111111             0111


Q ss_pred             cCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          320 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                      ..+...+.++.+++.+||+.+|++|||+.++++.|
T Consensus       221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            22223456799999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.8e-42  Score=337.24  Aligned_cols=251  Identities=20%  Similarity=0.240  Sum_probs=200.2

Q ss_pred             CCCcCCeecccCceEEEEEEeC-C-CcEEEEEECCCCC---hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-D-GMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      .|...+.||+|+||.||+|... + +..|++|......   ...+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4788899999999999999843 3 5778888654332   234678999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++|+|.+++.... .....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.......
T Consensus       148 ~gg~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRL-KEHLPFQEYEVGLLFYQIVLALDEVHS--RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHh--CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            9999988774321 123467888999999999999999998  7799999999999999999999999999987654332


Q ss_pred             CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                      ........||+.|+|||++.+..++.++|||||||++|||++|..||.....   .........            . ..
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~---~~~~~~~~~------------~-~~  288 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ---REIMQQVLY------------G-KY  288 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHh------------C-CC
Confidence            2233455689999999999999999999999999999999999999975432   111111100            0 01


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ...+...+.++.+++.+||+.||++|||+++++.+
T Consensus       289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence            12223345678999999999999999999999754

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.7e-43  Score=323.01  Aligned_cols=248  Identities=23%  Similarity=0.345  Sum_probs=210.6

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC-----CChhHHHHHHHHHHcCCCCcccccccceeeCCe-EEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNL-QFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv~  155 (386)
                      ++|...+.+|+|+||.++...++ ++..+++|++.-     .......+|+.++++++|||||.+.+.|..++. .++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            46788899999999999999865 467889997332     223457889999999999999999999998888 99999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      +||+||++.+.+...   +...+++..+..++.|++.|+.|||+  ++|+|||||+.||+++.++.++|+|||+|+.++.
T Consensus        84 ~Y~eGg~l~~~i~~~---k~~~f~E~~i~~~~~Q~~~av~ylH~--~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQ---KGVLFPEERILKWFVQILLAVNYLHE--NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             eecCCCCHHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHh--hhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            999999999988543   34678899999999999999999997  7899999999999999999999999999999876


Q ss_pred             CCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      ..  .......||+.|+.||.+.+..|+.++|||||||++|||++-+.+|...+.   ..++.             -+.+
T Consensus       159 ~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m---~~Li~-------------ki~~  220 (426)
T KOG0589|consen  159 ED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM---SELIL-------------KINR  220 (426)
T ss_pred             ch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch---HHHHH-------------HHhh
Confidence            43  244567899999999999999999999999999999999999999987553   11221             1122


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ....+.+...+.++..++..|+..+|+.||++.++|.+
T Consensus       221 ~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  221 GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            23445666777889999999999999999999999976

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=6.5e-42  Score=308.37  Aligned_cols=245  Identities=28%  Similarity=0.454  Sum_probs=194.0

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCCCc
Q 016588           89 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV  163 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  163 (386)
                      +.||+|+||.||+|... +++.+|+|......    ...+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46899999999999964 68899999754332    34688999999999999999999999999999999999999999


Q ss_pred             cccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCc
Q 016588          164 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS  243 (386)
Q Consensus       164 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~  243 (386)
                      .+++..    ....+++..+..++.|++.||.|||+  ++++||||||+||+++.++.+||+|||++.............
T Consensus        81 ~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          81 LTFLRT----EGPRLKVKELIQMVENAAAGMEYLES--KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             HHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            988842    23457899999999999999999998  779999999999999999999999999987654321111111


Q ss_pred             cccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCC
Q 016588          244 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFT  322 (386)
Q Consensus       244 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (386)
                      ....+..|+|||.+.+..++.++|||||||++|||++ |..||......   .......             .......+
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~~~~~~-------------~~~~~~~~  218 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QTREAIE-------------QGVRLPCP  218 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HHHHHHH-------------cCCCCCCc
Confidence            1223456999999988889999999999999999998 88888654321   1111111             11111223


Q ss_pred             HHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016588          323 NEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  355 (386)
Q Consensus       323 ~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~  355 (386)
                      ...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            344567899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-42  Score=327.40  Aligned_cols=250  Identities=23%  Similarity=0.286  Sum_probs=201.3

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC------CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ++|.+.+.||+|+||+||+|... +++.||+|+...      .....+.+|..++..++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36888999999999999999965 588999998543      23456788999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++++|.+++..     ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~--~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          81 EYMPGGDLMNLLIR-----KDVFPEETARFYIAELVLALDSVHK--LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             cCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            99999999988842     3568889999999999999999999  7799999999999999999999999999876643


Q ss_pred             CC---------------------------CCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCC
Q 016588          236 TD---------------------------VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL  288 (386)
Q Consensus       236 ~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~  288 (386)
                      ..                           .........+|+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence            22                           001223456888999999999999999999999999999999999999875


Q ss_pred             CCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCC-HHHHHHH
Q 016588          289 SPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-MSDVVTE  353 (386)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-~~evl~~  353 (386)
                      ...   .....+.   ...       ...........++++.+++.+|++ ||.+||+ +++++++
T Consensus       234 ~~~---~~~~~i~---~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         234 TLQ---ETYNKII---NWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CHH---HHHHHHh---ccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            521   1111111   000       011111111145678999999997 9999999 9999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.2e-42  Score=326.35  Aligned_cols=260  Identities=19%  Similarity=0.213  Sum_probs=196.8

Q ss_pred             hcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecC
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      ..+|++.+.||+|+||.||++.. .+++.||+|...   ...+.+|+++++.++||||+++++++......++|+|++. 
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-  166 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-  166 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-
Confidence            45799999999999999999995 458899999643   3457789999999999999999999999999999999985 


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  240 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~  240 (386)
                      ++|..++.     ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++....... ..
T Consensus       167 ~~L~~~l~-----~~~~l~~~~~~~i~~qi~~aL~ylH~--~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~  238 (391)
T PHA03212        167 TDLYCYLA-----AKRNIAICDILAIERSVLRAIQYLHE--NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-AN  238 (391)
T ss_pred             CCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-cc
Confidence            57776663     23457889999999999999999999  679999999999999999999999999987543211 11


Q ss_pred             CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCch-----hhHHHHHHhhhc----cc----
Q 016588          241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS-----QDLVELVQNSRD----FS----  307 (386)
Q Consensus       241 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~-----~~~~~~~~~~~~----~~----  307 (386)
                      ......+|+.|+|||++.+..++.++|||||||++|||++|..|+........     ..+.........    ..    
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~  318 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ  318 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence            22345789999999999988999999999999999999999988765332111     111111111000    00    


Q ss_pred             -chhhhc---------chhhccc--CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          308 -NLLKIL---------DERLWST--FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       308 -~~~~~~---------~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                       ......         .+..+..  .....+.++.+++.+||+.||++|||++|++++
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence             000000         0000000  001245678999999999999999999999965

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.2e-41  Score=311.43  Aligned_cols=258  Identities=26%  Similarity=0.422  Sum_probs=202.7

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCc----EEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGM----LVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  152 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  152 (386)
                      .++|+..+.||+|+||+||+|.+. ++.    .||+|......    ..++.+|..+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            457888999999999999999853 343    48999865332    34577899999999999999999998754 467


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~  232 (386)
                      +++||+++|+|.+++..    ....+++..++.++.|++.||.|||+  ++++||||||+|||+++++.+||+|||+++.
T Consensus        85 l~~~~~~~g~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~lH~--~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~  158 (279)
T cd05109          85 LVTQLMPYGCLLDYVRE----NKDRIGSQDLLNWCVQIAKGMSYLEE--VRLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (279)
T ss_pred             EEEEcCCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccccceEEEcCCCcEEECCCCceee
Confidence            99999999999988842    23468899999999999999999998  7799999999999999999999999999987


Q ss_pred             cCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhh
Q 016588          233 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK  311 (386)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (386)
                      ..............++..|+|||...+..++.++|||||||++|||++ |..||.....   ......+...        
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~--------  227 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDLLEKG--------  227 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHCC--------
Confidence            643222211222334567999999998899999999999999999998 8888875432   1122211111        


Q ss_pred             hcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhc
Q 016588          312 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  362 (386)
Q Consensus       312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~  362 (386)
                           .....+...+.++.+++.+||+.||++|||+.++++.|+++.....
T Consensus       228 -----~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~  273 (279)
T cd05109         228 -----ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS  273 (279)
T ss_pred             -----CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCc
Confidence                 1111222345678999999999999999999999999988876653

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=325.09  Aligned_cols=256  Identities=27%  Similarity=0.473  Sum_probs=217.8

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeCC---C--cEEEEEECC----CCChhHHHHHHHHHHcCCCCcccccccceeeCCeE
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQD---G--MLVAIKKRP----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  151 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~--~~vavK~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  151 (386)
                      .....+..+.||.|.||.||+|.+.+   |  -.||||.-+    ....+.|+.|..+|++++||||++++|.|... ..
T Consensus       387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~  465 (974)
T KOG4257|consen  387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PM  465 (974)
T ss_pred             ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ce
Confidence            34445566889999999999999532   2  358888633    34577899999999999999999999999875 57


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      |+|||+++-|.|..++.    .+...++..+...++.|+..||.|||+  .+.|||||..+|||+.....+||+|||+++
T Consensus       466 WivmEL~~~GELr~yLq----~nk~sL~l~tL~ly~~Qi~talaYLeS--krfVHRDIAaRNiLVsSp~CVKLaDFGLSR  539 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQ----QNKDSLPLRTLTLYCYQICTALAYLES--KRFVHRDIAARNILVSSPQCVKLADFGLSR  539 (974)
T ss_pred             eEEEecccchhHHHHHH----hccccchHHHHHHHHHHHHHHHHHHHh--hchhhhhhhhhheeecCcceeeecccchhh
Confidence            89999999999999994    456778999999999999999999999  779999999999999999999999999999


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          232 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      .+.+......+ ...-+..|||||.+...+++.+||||.|||.+||++. |..||.+-..                .++.
T Consensus       540 ~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN----------------sDVI  602 (974)
T KOG4257|consen  540 YLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN----------------SDVI  602 (974)
T ss_pred             hccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc----------------cceE
Confidence            99875544333 4456678999999999999999999999999999988 9999987553                2333


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      ..+..+-+.+.|++|++.++.|+.+||..||.+||++.++...|.+++++
T Consensus       603 ~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe  652 (974)
T KOG4257|consen  603 GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE  652 (974)
T ss_pred             EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence            34455556688889999999999999999999999999999999998873

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.6e-41  Score=314.44  Aligned_cols=262  Identities=19%  Similarity=0.262  Sum_probs=195.0

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      .++|...+.||+|+||.||+|... ++..||+|.....    ....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            367899999999999999999965 5889999985432    23457789999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      |+. ++|.+++..    ....++...+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++......
T Consensus        84 ~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          84 YVH-TDLCQYMDK----HPGGLHPENVKLFLFQLLRGLSYIHQ--RYILHRDLKPQNLLISDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             CCC-cCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence            996 566666632    23457888899999999999999999  77999999999999999999999999998754322


Q ss_pred             CCCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhh--hc---ccchh
Q 016588          237 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS--RD---FSNLL  310 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~---~~~~~  310 (386)
                      .  .......+++.|+|||++.+ ..++.++||||+||++|||++|..||.+.... ...+.......  ..   +....
T Consensus       157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         157 S--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI-QDQLERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             C--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH-HHHHHHHHHHhCCCChhhccchh
Confidence            1  12233457888999999865 45789999999999999999999999875431 11111111100  00   00000


Q ss_pred             h--hcchhhcc-cCC---------HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          311 K--ILDERLWS-TFT---------NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       311 ~--~~~~~~~~-~~~---------~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .  ...+.... ..+         ...++++.+++.+||+.||++|||++|+++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence            0  00000000 000         0122568899999999999999999999975

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.2e-41  Score=315.41  Aligned_cols=264  Identities=25%  Similarity=0.433  Sum_probs=207.4

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeC--------CCcEEEEEECCCC----ChhHHHHHHHHHHcC-CCCcccccccceee
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQ--------DGMLVAIKKRPGA----PTQEFIDEVCFLASI-QHRNLVTLLGYCQE  147 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~----~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  147 (386)
                      ..++|.+.+.||+|+||.||+|...        ++..|++|.....    ...++.+|+.+++.+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            3567788899999999999999731        2347999986543    234688899999999 89999999999999


Q ss_pred             CCeEEEEEEeecCCCccccccCCCcC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee
Q 016588          148 NNLQFLIYEYIPNGSVSIHLYGPSQV-----------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV  216 (386)
Q Consensus       148 ~~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill  216 (386)
                      .+..+++|||+.+++|.+++......           ....+++..+..++.|++.||.|||+  +|++||||||+||++
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~--~givH~dlkp~Nili  170 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS--QKCIHRDLAARNVLV  170 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH--CCeeecccccceEEE
Confidence            99999999999999999888543211           12457888999999999999999998  779999999999999


Q ss_pred             CCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhh
Q 016588          217 DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQD  295 (386)
Q Consensus       217 ~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~  295 (386)
                      +.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++||+++ |..||.....   ..
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~  247 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EE  247 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HH
Confidence            9999999999999987654332222333345667999999988889999999999999999998 7778765432   11


Q ss_pred             HHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhc
Q 016588          296 LVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  362 (386)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~  362 (386)
                      ........             .....+..++..+.+++.+||+.+|.+|||+.++++.|++++.-..
T Consensus       248 ~~~~~~~~-------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~  301 (304)
T cd05101         248 LFKLLKEG-------------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT  301 (304)
T ss_pred             HHHHHHcC-------------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence            22111111             1112223455678999999999999999999999999999886543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=8.2e-42  Score=326.56  Aligned_cols=263  Identities=23%  Similarity=0.367  Sum_probs=204.6

Q ss_pred             HHHhcCCCcCCeecccCceEEEEEEeC------CCcEEEEEECCCCC----hhHHHHHHHHHHcCC-CCcccccccceee
Q 016588           79 SLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQ-HRNLVTLLGYCQE  147 (386)
Q Consensus        79 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~e~~~l~~l~-h~niv~~~~~~~~  147 (386)
                      ....++|.+.+.||+|+||.||+|.+.      .+..||+|++....    .+.+.+|+.++..+. ||||+++++++..
T Consensus        33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            344456778899999999999999853      24579999865432    235788999999997 9999999999999


Q ss_pred             CCeEEEEEEeecCCCccccccCCCc-------------------------------------------------------
Q 016588          148 NNLQFLIYEYIPNGSVSIHLYGPSQ-------------------------------------------------------  172 (386)
Q Consensus       148 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  172 (386)
                      .+..++||||+.+|+|.++++....                                                       
T Consensus       113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            9999999999999999988753211                                                       


Q ss_pred             --------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCe
Q 016588          173 --------------------------------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANV  214 (386)
Q Consensus       173 --------------------------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Ni  214 (386)
                                                            .....+++..+..++.|++.||.|||+  ++++||||||+||
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrdlkp~Ni  270 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS--KNCVHRDLAARNV  270 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc--CCcCcccCCcceE
Confidence                                                  011346777889999999999999998  7899999999999


Q ss_pred             eeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCch
Q 016588          215 LVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSS  293 (386)
Q Consensus       215 ll~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~  293 (386)
                      |+++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||....... 
T Consensus       271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~-  349 (401)
T cd05107         271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE-  349 (401)
T ss_pred             EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH-
Confidence            999999999999999886533222111222345678999999988889999999999999999998 888887543211 


Q ss_pred             hhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhh
Q 016588          294 QDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  358 (386)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~  358 (386)
                       .....+             ....+...+..++.++.+++.+||+.+|.+||++.++++.|++++
T Consensus       350 -~~~~~~-------------~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         350 -QFYNAI-------------KRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             -HHHHHH-------------HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence             111111             111111223334577999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-41  Score=309.21  Aligned_cols=255  Identities=23%  Similarity=0.409  Sum_probs=199.3

Q ss_pred             CCcCCeecccCceEEEEEEeCC----CcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeCCe-----
Q 016588           85 FSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNL-----  150 (386)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  150 (386)
                      |++.+.||+|+||.||+|....    +..||+|+.....     ...+.+|++.++.++|||++++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5677899999999999998542    3679999855321     2467889999999999999999998765443     


Q ss_pred             -EEEEEEeecCCCccccccCCCc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccc
Q 016588          151 -QFLIYEYIPNGSVSIHLYGPSQ-VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  228 (386)
Q Consensus       151 -~~lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFg  228 (386)
                       .++++||+++++|..++..... .....+++..+..++.|++.||.|||+  .+++||||||+||++++++.+||+|||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~dfg  158 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN--RNFIHRDLAARNCMLREDMTVCVADFG  158 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh--CCeeccccchheEEECCCCeEEECCcc
Confidence             7899999999999888744321 123468899999999999999999998  779999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhccc
Q 016588          229 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFS  307 (386)
Q Consensus       229 l~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  307 (386)
                      +++................+..|+|||.+.+..++.++|||||||++|||++ |..||.....   ....+.....    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~~~~----  231 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYLRHG----  231 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcC----
Confidence            9887644332222222334567999999988889999999999999999999 8888865432   1222221111    


Q ss_pred             chhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHh
Q 016588          308 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  357 (386)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~  357 (386)
                               .....+..++.++.+++.+||+.||.+|||+.++++.|+++
T Consensus       232 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         232 ---------NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             ---------CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                     11122334556799999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.3e-42  Score=305.38  Aligned_cols=262  Identities=23%  Similarity=0.338  Sum_probs=199.9

Q ss_pred             CCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCc-ccccccceeeCC------e
Q 016588           84 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRN-LVTLLGYCQENN------L  150 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~------~  150 (386)
                      .|...+.||+|+||+||+|.. .+|+.||+|++.-.     ......+|+.+|+.++|+| |+++++++.+.+      .
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            455567799999999999994 46899999984322     3455789999999999999 999999998877      8


Q ss_pred             EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  230 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~  230 (386)
                      +++|+||++. +|..++....... ..++...+..++.|++.||+|||+  ++|+||||||+|||++++|.+||+|||+|
T Consensus        92 l~lvfe~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~--~~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   92 LYLVFEFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHS--HGILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             EEEEEEeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHh--CCeecccCCcceEEECCCCcEeeeccchH
Confidence            8999999976 8888885432111 456678899999999999999999  77999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhh--hc--
Q 016588          231 NFLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS--RD--  305 (386)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~--  305 (386)
                      +...-..  ...+....|.+|.|||++.+. .|+...||||+||+++||++++..|.+..+  .+++....+..  +.  
T Consensus       168 ra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--~~ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  168 RAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--IDQLFRIFRLLGTPNEK  243 (323)
T ss_pred             HHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--HHHHHHHHHHcCCCCcc
Confidence            9664322  223455678899999999887 789999999999999999999999888665  22222222211  11  


Q ss_pred             -ccchhhhcchhh----cc------cCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          306 -FSNLLKILDERL----WS------TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       306 -~~~~~~~~~~~~----~~------~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                       ++......+...    +.      ..-+....+..+++.+||+.+|.+|.|++.+++|
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence             111111111110    00      0001111468999999999999999999999987

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.5e-42  Score=321.57  Aligned_cols=239  Identities=23%  Similarity=0.280  Sum_probs=193.1

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCC
Q 016588           89 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  161 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  161 (386)
                      +.||+|+||.||++..+ ++..||+|.....      ....+.+|+.+++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999954 5889999975432      2345678999999999999999999999999999999999999


Q ss_pred             CccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCC
Q 016588          162 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP  241 (386)
Q Consensus       162 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~  241 (386)
                      +|..++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~  151 (323)
T cd05595          81 ELFFHLS-----RERVFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--AT  151 (323)
T ss_pred             cHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cc
Confidence            9987773     33467899999999999999999998  779999999999999999999999999987532211  11


Q ss_pred             CccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccC
Q 016588          242 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF  321 (386)
Q Consensus       242 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (386)
                      .....+++.|+|||++.+..++.++|||||||++|||++|..||......   .......            ...  ...
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~~~~~------------~~~--~~~  214 (323)
T cd05595         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFELIL------------MEE--IRF  214 (323)
T ss_pred             cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHh------------cCC--CCC
Confidence            23356888999999999899999999999999999999999999764431   1111110            000  012


Q ss_pred             CHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016588          322 TNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  353 (386)
Q Consensus       322 ~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~~  353 (386)
                      +...++++.+++.+||+.||++||     ++.+++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            233456789999999999999998     88888865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=8.1e-42  Score=314.25  Aligned_cols=260  Identities=23%  Similarity=0.306  Sum_probs=192.5

Q ss_pred             cCCCcCCeecccCceEEEEEEeC--CCcEEEEEECCCC-----ChhHHHHHHHHHHcC---CCCccccccccee-----e
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ--DGMLVAIKKRPGA-----PTQEFIDEVCFLASI---QHRNLVTLLGYCQ-----E  147 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~l~~l---~h~niv~~~~~~~-----~  147 (386)
                      ++|+..+.||+|+||.||+|...  ++..||+|.....     ....+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            46888999999999999999853  4678999975422     223566777777665   6999999999875     3


Q ss_pred             CCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccc
Q 016588          148 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA  227 (386)
Q Consensus       148 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DF  227 (386)
                      ....++||||+. ++|.+++...   ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~--~~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEEcCCCCEEEccc
Confidence            456899999996 5887777422   23457889999999999999999999  77999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhh--hc
Q 016588          228 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS--RD  305 (386)
Q Consensus       228 gl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~  305 (386)
                      |+++.....   .......++..|+|||.+.+..++.++|||||||++|||++|..||.+.....  .+.......  ..
T Consensus       155 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~--~~~~i~~~~~~~~  229 (290)
T cd07862         155 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILDVIGLPG  229 (290)
T ss_pred             cceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCC
Confidence            999865432   22334567888999999988899999999999999999999999998755321  111111110  00


Q ss_pred             ccchh---h----hcchhh---cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          306 FSNLL---K----ILDERL---WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       306 ~~~~~---~----~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .....   .    .+....   .....+..++.+.+++.+||+.||++|||+.|++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            00000   0    000000   001112234668899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5.2e-42  Score=321.06  Aligned_cols=239  Identities=23%  Similarity=0.289  Sum_probs=193.9

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCC
Q 016588           89 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  161 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  161 (386)
                      +.||+|+||.||++..+ ++..||+|.....      ....+.+|+.+++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999954 5889999975432      2345778999999999999999999999999999999999999


Q ss_pred             CccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCC
Q 016588          162 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP  241 (386)
Q Consensus       162 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~  241 (386)
                      +|..++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~  151 (328)
T cd05593          81 ELFFHLS-----RERVFSEDRTRFYGAEIVSALDYLHS--GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AAT  151 (328)
T ss_pred             CHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccc
Confidence            9988773     33568899999999999999999998  77999999999999999999999999998753221  112


Q ss_pred             CccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccC
Q 016588          242 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF  321 (386)
Q Consensus       242 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (386)
                      .....+++.|+|||++.+..++.++|||||||++|||++|..||......   ........            ..  ..+
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~---~~~~~~~~------------~~--~~~  214 (328)
T cd05593         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELILM------------ED--IKF  214 (328)
T ss_pred             cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH---HHHHHhcc------------CC--ccC
Confidence            23456888999999999889999999999999999999999999764321   11111100            00  122


Q ss_pred             CHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016588          322 TNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  353 (386)
Q Consensus       322 ~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~~  353 (386)
                      +...+.++.+++.+||+.||++||     ++.+++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            333456789999999999999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4e-42  Score=337.45  Aligned_cols=254  Identities=19%  Similarity=0.303  Sum_probs=202.1

Q ss_pred             HhcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCC-----
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN-----  149 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  149 (386)
                      ..++|.+.+.||+|+||+||+|.. .+++.||+|.+...     ....+.+|+..+..++|+|+++++..+...+     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            346899999999999999999984 46899999985432     1235778999999999999999987764332     


Q ss_pred             ---eEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcc
Q 016588          150 ---LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVAD  226 (386)
Q Consensus       150 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D  226 (386)
                         ..++||||+++|+|.+++.... .....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~-~~~~~l~e~~~~~i~~qll~aL~~lH~--~~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRA-KTNRTFREHEAGLLFIQVLLAVHHVHS--KHMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEeCCCCEEEEe
Confidence               3689999999999998885432 123568889999999999999999999  7799999999999999999999999


Q ss_pred             cccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcc
Q 016588          227 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF  306 (386)
Q Consensus       227 Fgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  306 (386)
                      ||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ........     
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~---~~~~~~~~-----  258 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM---EEVMHKTL-----  258 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHh-----
Confidence            9999876543333333456789999999999999999999999999999999999999975432   11111110     


Q ss_pred             cchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                             . ......+...++++.+++.+||+.||.+|||+.+++++
T Consensus       259 -------~-~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        259 -------A-GRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             -------c-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                   0 01112334456779999999999999999999999875

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1e-41  Score=311.55  Aligned_cols=256  Identities=24%  Similarity=0.387  Sum_probs=200.6

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCC------CcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQD------GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  151 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  151 (386)
                      .++|...+.||+|+||.||+|....      +..|++|......    ...+.+|+.+++.++|+||+++++++...+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4568888999999999999999643      5678999765432    23588899999999999999999999988889


Q ss_pred             EEEEEeecCCCccccccCCCc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC---ceEEcc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQ--VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF---IAKVAD  226 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~---~~kl~D  226 (386)
                      ++||||+++++|.+++.....  .....+++..+..++.|++.||.|||+  ++++||||||+||+++.++   .+||+|
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE--NHFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccchheEEEeccCCCcceEecc
Confidence            999999999999998854321  122358899999999999999999998  7799999999999998654   689999


Q ss_pred             cccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhc
Q 016588          227 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRD  305 (386)
Q Consensus       227 Fgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  305 (386)
                      ||+++................+..|+|||++.+..++.++|||||||++|||++ |..||......   .....+...  
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~~~~~~--  237 (277)
T cd05036         163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVMEFVTGG--  237 (277)
T ss_pred             CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHcC--
Confidence            999987643222111222233457999999998899999999999999999997 99998764432   122211111  


Q ss_pred             ccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016588          306 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  355 (386)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~  355 (386)
                                 .....+...+..+.+++.+||+.+|++|||+.+++++|.
T Consensus       238 -----------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         238 -----------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             -----------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                       111223334567899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-42  Score=319.39  Aligned_cols=237  Identities=20%  Similarity=0.280  Sum_probs=191.2

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEECCC------CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCCCc
Q 016588           91 IGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV  163 (386)
Q Consensus        91 lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  163 (386)
                      ||+|+||.||+|... ++..||+|....      .....+.+|+.+++.++||||+++++++...+..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999965 578999997542      2234577899999999999999999999999999999999999999


Q ss_pred             cccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCc
Q 016588          164 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS  243 (386)
Q Consensus       164 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~  243 (386)
                      .+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++......  ....
T Consensus        81 ~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~  151 (312)
T cd05585          81 FHHLQ-----REGRFDLSRARFYTAELLCALENLHK--FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTN  151 (312)
T ss_pred             HHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Cccc
Confidence            98884     23468889999999999999999998  779999999999999999999999999987543211  1223


Q ss_pred             cccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCH
Q 016588          244 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN  323 (386)
Q Consensus       244 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (386)
                      ...+|+.|+|||.+.+..++.++|||||||++|||++|..||.....   ........            ...  ..++.
T Consensus       152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~---~~~~~~~~------------~~~--~~~~~  214 (312)
T cd05585         152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV---NEMYRKIL------------QEP--LRFPD  214 (312)
T ss_pred             cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH---HHHHHHHH------------cCC--CCCCC
Confidence            45688899999999999999999999999999999999999976432   11111110            000  12233


Q ss_pred             HHHHHHHHHHhHccCCCCCCCCC---HHHHHHH
Q 016588          324 EGMEEFIQLIVRCLDPSSERRPS---MSDVVTE  353 (386)
Q Consensus       324 ~~~~~l~~li~~cl~~dp~~Rpt---~~evl~~  353 (386)
                      ..++++.+++.+||+.||++||+   +.+++.+
T Consensus       215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            44567899999999999999985   5666654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=8.7e-42  Score=312.95  Aligned_cols=255  Identities=29%  Similarity=0.407  Sum_probs=200.3

Q ss_pred             CCCcCCeecccCceEEEEEEeCC------CcEEEEEECCCCCh----hHHHHHHHHHHcCCCCcccccccceeeCCeEEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQD------GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (386)
                      +|...+.||+|+||.||+|...+      +..||+|.......    +.+.+|..++..++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            45667889999999999998532      46899998764432    457789999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCC-----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCce
Q 016588          154 IYEYIPNGSVSIHLYGPS-----------QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA  222 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~  222 (386)
                      ++||+.+++|.+++....           ......+++..+..++.|++.||.|||+  ++|+||||||+||++++++.+
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~--~gi~H~dlkp~Nil~~~~~~~  163 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS--HHVVHKDLATRNVLVFDKLNV  163 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH--cCccccccchhheEecCCCce
Confidence            999999999988874211           0112357888899999999999999998  779999999999999999999


Q ss_pred             EEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHH
Q 016588          223 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQ  301 (386)
Q Consensus       223 kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~  301 (386)
                      ||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.....   .+..+.+.
T Consensus       164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~i~  240 (283)
T cd05091         164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVIEMIR  240 (283)
T ss_pred             EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH
Confidence            9999999887644332222223345678999999988889999999999999999998 7788876432   12222111


Q ss_pred             hhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHH
Q 016588          302 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  356 (386)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~  356 (386)
                      ..             .....+..++..+.+++..||+.+|.+||++.++++.|+.
T Consensus       241 ~~-------------~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         241 NR-------------QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             cC-------------CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            11             1112334456778999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=6.4e-42  Score=321.13  Aligned_cols=262  Identities=19%  Similarity=0.275  Sum_probs=199.8

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      .++|+..+.||+|+||.||++... ++..+|+|......    ...+.+|+++++.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            468999999999999999999965 57889999754332    3468899999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      |+++++|.+++.     ....+++..+..++.+++.||.|||+. .+++||||||+|||++.++.+||+|||++......
T Consensus        84 ~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          84 HMDGGSLDQVLK-----KAGRIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             cCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhc-CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence            999999999884     234578888899999999999999962 36999999999999999999999999998765321


Q ss_pred             CCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhh------------
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR------------  304 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~------------  304 (386)
                          ......++..|+|||.+.+..++.++|||||||++|||++|+.||...................            
T Consensus       158 ----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (333)
T cd06650         158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP  233 (333)
T ss_pred             ----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence                1233467888999999998889999999999999999999999997644321111000000000            


Q ss_pred             ----------cc---cchhhhcc---hhhcccCC-HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          305 ----------DF---SNLLKILD---ERLWSTFT-NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       305 ----------~~---~~~~~~~~---~~~~~~~~-~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                                ..   .......+   .......+ ...+.++.+++.+||+.||++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                      00   00000000   00000111 1134668999999999999999999999865

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.5e-41  Score=321.21  Aligned_cols=245  Identities=23%  Similarity=0.302  Sum_probs=191.6

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      .+|+..+.||+|+||.||+|... +++.||+|......    ...+.+|+++++.++|+||+++++++...+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            34566788999999999999965 58899999864332    34578999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +++++|....         ...+..+..++.|++.||.|||+  ++|+||||||+|||+++++.+||+|||+++......
T Consensus       154 ~~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        154 MDGGSLEGTH---------IADEQFLADVARQILSGIAYLHR--RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             CCCCcccccc---------cCCHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence            9999986432         23566778899999999999998  779999999999999999999999999988764322


Q ss_pred             CCCCCccccCcccccchhhhcc-----cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          238 VAGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      .  ......++..|+|||.+..     ...+.++|||||||++|||++|+.||..........+......          
T Consensus       223 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~----------  290 (353)
T PLN00034        223 D--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM----------  290 (353)
T ss_pred             c--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc----------
Confidence            1  1233468889999998743     2345689999999999999999999984332221111111000          


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                         ......+...+.++.+++.+||+.||++|||+.|++++
T Consensus       291 ---~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        291 ---SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ---cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               00112223445678999999999999999999999987

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.9e-41  Score=306.08  Aligned_cols=254  Identities=27%  Similarity=0.445  Sum_probs=202.5

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCC--ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeec
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  159 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  159 (386)
                      ..+|++.+.||+|+||.||+|...+...|++|+....  ..+.+.+|+.+++.++||||+++++++.. +..++||||++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   83 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence            3568889999999999999999776678999986643  34578899999999999999999998754 45789999999


Q ss_pred             CCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016588          160 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  239 (386)
Q Consensus       160 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~  239 (386)
                      +++|.+++...   ....+++..+..++.|++.||.|||+  ++++||||||+||++++++.++|+|||.+.........
T Consensus        84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          84 KGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCcHHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHH--CCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            99999888532   23457888999999999999999998  77999999999999999999999999999876543221


Q ss_pred             CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          240 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       240 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                       ......++..|+|||...+..++.++||||||+++|||++ |..||......   ........             ...
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~~~~~~~-------------~~~  221 (262)
T cd05071         159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQVER-------------GYR  221 (262)
T ss_pred             -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HHHHHHhc-------------CCC
Confidence             1223345667999999988889999999999999999999 78788754421   11111100             001


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhh
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  358 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~  358 (386)
                      ...+...+..+.+++.+||+.||++|||+.++++.|++..
T Consensus       222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence            1122345567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-41  Score=311.06  Aligned_cols=256  Identities=24%  Similarity=0.395  Sum_probs=203.4

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCC------CcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQD------GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  151 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  151 (386)
                      .++|++.+.||+|+||.||+|....      +..|++|......    ...+.+|+.+++.++|||++++++++...+..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            4578888999999999999998542      3689999865432    23578899999999999999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCcC-----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQV-----SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVAD  226 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D  226 (386)
                      ++||||+++++|.+++......     ....+++..+..++.|++.||.|||+  ++++||||||+||+++.++.+||+|
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~di~p~nill~~~~~~kl~d  162 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA--KKFVHRDLAARNCMVAEDLTVKIGD  162 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccChheEEEcCCCCEEECC
Confidence            9999999999999888543211     12357888999999999999999998  7799999999999999999999999


Q ss_pred             cccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhc
Q 016588          227 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRD  305 (386)
Q Consensus       227 Fgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  305 (386)
                      ||+++...............++..|+|||.+.+..++.++|||||||++||+++ |..||......   .......    
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~~~----  235 (277)
T cd05032         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---EVLKFVI----  235 (277)
T ss_pred             cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---HHHHHHh----
Confidence            999886644332222233445678999999988889999999999999999998 88888754431   1111111    


Q ss_pred             ccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016588          306 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  355 (386)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~  355 (386)
                               .......+...+.++.+++.+||+.+|++|||+.++++.|+
T Consensus       236 ---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         236 ---------DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             ---------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence                     00111223334577999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.5e-41  Score=310.88  Aligned_cols=262  Identities=25%  Similarity=0.424  Sum_probs=206.2

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeCC-----CcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceee-CCe
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQD-----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQE-NNL  150 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~  150 (386)
                      ..++|+..+.||+|+||.||+|....     +..|++|......    ...+.+|+.+++.++|+|++++++++.. +..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            45678889999999999999999755     6789999765432    3457789999999999999999998765 567


Q ss_pred             EEEEEEeecCCCccccccCCCcC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccc
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQV---SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA  227 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DF  227 (386)
                      .++++||+.+++|.+++......   ....+++..+..++.|++.||.|||+  ++++||||||+||++++++.+||+||
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK--RGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccCHhhEEEcCCCcEEECCC
Confidence            88999999999999887432111   12568899999999999999999998  77999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcc
Q 016588          228 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDF  306 (386)
Q Consensus       228 gl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  306 (386)
                      |+++.+.............++..|+|||.+.+..++.++|||||||++||+++ |+.||....+   .+........   
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~---  235 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYLKDG---  235 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHHHcC---
Confidence            99986543222212222345667999999998889999999999999999999 9999876443   1122211111   


Q ss_pred             cchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                                .....+..+++++.+++.+||+.||++|||+.++++.|.++.++
T Consensus       236 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         236 ----------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             ----------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence                      11112223456789999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.9e-41  Score=313.71  Aligned_cols=257  Identities=25%  Similarity=0.380  Sum_probs=202.8

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeC------CCcEEEEEECCCCC----hhHHHHHHHHHHcC-CCCcccccccceeeCC
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQENN  149 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  149 (386)
                      ..++|...+.||+|+||.||++...      .+..+|+|......    .+.+.+|+.+++++ +||||+++++++...+
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            3457888999999999999999731      24579999765432    34588899999999 7999999999999999


Q ss_pred             eEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 016588          150 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  229 (386)
Q Consensus       150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl  229 (386)
                      ..+++|||+.+++|.+++...   ....+++.++..++.|++.||.|||+  ++|+|+||||+|||++.++.++++|||+
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRK---RESFLTLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeehhhhccceEEEcCCCeEEECCCcc
Confidence            999999999999999888432   22347899999999999999999998  7799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccc
Q 016588          230 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSN  308 (386)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  308 (386)
                      ++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......  ........       
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--~~~~~~~~-------  258 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--SKFYKLIK-------  258 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--HHHHHHHH-------
Confidence            886643221111222345677999999998889999999999999999998 99998765431  11111111       


Q ss_pred             hhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHh
Q 016588          309 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  357 (386)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~  357 (386)
                            .......+...++++.+++.+||+.+|++|||+.|+++.|+++
T Consensus       259 ------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         259 ------EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ------cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                  1111111222346789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.6e-41  Score=323.41  Aligned_cols=261  Identities=23%  Similarity=0.339  Sum_probs=195.6

Q ss_pred             CCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCC-----eEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN-----LQF  152 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~  152 (386)
                      +|+..+.||+|+||.||++.. .++..||+|+....     ....+.+|+++++.++|+||+++++++...+     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477889999999999999995 46899999986532     2346788999999999999999999998766     789


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~  232 (386)
                      +|+||+.+ +|...+.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 lv~e~~~~-~l~~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          81 VVTELMQS-DLHKIIV-----SPQPLSSDHVKVFLYQILRGLKYLHS--AGILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             EEeecccc-CHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChHHEEECCCCCEEeccccceee
Confidence            99999974 6766663     34568899999999999999999999  7799999999999999999999999999886


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchh-
Q 016588          233 LGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL-  310 (386)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-  310 (386)
                      ...... .......++..|+|||.+.+. .++.++|||||||++|||++|+.||....+......+...........+. 
T Consensus       153 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~  231 (372)
T cd07853         153 EEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS  231 (372)
T ss_pred             cccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            543221 122334567889999998874 47999999999999999999999998765422111111000000000000 


Q ss_pred             ------hhcchh-h-------cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          311 ------KILDER-L-------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       311 ------~~~~~~-~-------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                            ..+... .       ........++++.+++.+||+.||++|||+.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                  000000 0       001112234678999999999999999999999976

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.3e-41  Score=319.09  Aligned_cols=249  Identities=22%  Similarity=0.291  Sum_probs=195.7

Q ss_pred             CCCcCCeecccCceEEEEEEe----CCCcEEEEEECCC-------CChhHHHHHHHHHHcC-CCCcccccccceeeCCeE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLL----QDGMLVAIKKRPG-------APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQ  151 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~-------~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  151 (386)
                      +|++.+.||+|+||.||++..    .++..||+|....       ...+.+..|+.++..+ +|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            477889999999999999884    3578999997542       1234577899999999 599999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      ++||||+++|+|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus        81 ~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          81 HLILDYVSGGEMFTHLY-----QRDNFSEDEVRFYSGEIILALEHLHK--LGIVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             EEEEeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            99999999999988884     33567888999999999999999998  779999999999999999999999999987


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          232 FLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      ....... .......||..|+|||++.+. .++.++|||||||++|||++|..||..........  ........     
T Consensus       154 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~~~-----  225 (332)
T cd05614         154 EFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSRRILK-----  225 (332)
T ss_pred             cccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHHHHhc-----
Confidence            6533221 122345688999999999865 47889999999999999999999997543321111  11010000     


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  353 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~~  353 (386)
                        .+    ...+...+..+.+++.+||+.||++||     ++++++++
T Consensus       226 --~~----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         226 --CD----PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             --CC----CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence              01    122233456689999999999999999     77788865

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.7e-41  Score=310.62  Aligned_cols=260  Identities=23%  Similarity=0.387  Sum_probs=202.9

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeC------CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCe
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNL  150 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  150 (386)
                      ..++|++.+.||+|+||.||+|..+      .+..||+|......    ...+.+|+.+++.++||||+++++++...+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4568899999999999999999743      24579999865432    2357789999999999999999999999999


Q ss_pred             EEEEEEeecCCCccccccCCCc-----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEc
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQ-----VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA  225 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~  225 (386)
                      .++||||+++|+|.+++.....     .......+..+..++.|++.||.|||+  ++|+||||||+||+++.++.++|+
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dikp~nili~~~~~~~L~  161 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIG  161 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCcCCCCChheEEEcCCCcEEEC
Confidence            9999999999999999853211     112445677888999999999999998  779999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhh
Q 016588          226 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSR  304 (386)
Q Consensus       226 DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  304 (386)
                      |||+++...............++..|+|||.+.+..++.++|+|||||++|||++ |..||.....   .+.......  
T Consensus       162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---~~~~~~~~~--  236 (288)
T cd05061         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---EQVLKFVMD--  236 (288)
T ss_pred             cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHc--
Confidence            9999886543322222222334567999999998889999999999999999998 7788865432   112111111  


Q ss_pred             cccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhh
Q 016588          305 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  358 (386)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~  358 (386)
                                .. ....+...++.+.+++.+||+.||++|||+.++++.|.+.+
T Consensus       237 ----------~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         237 ----------GG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             ----------CC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence                      00 01122233467999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-42  Score=326.08  Aligned_cols=250  Identities=23%  Similarity=0.301  Sum_probs=197.2

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ++|+..+.||+|+||+||+|... +++.||+|.....      ....+.+|+.++..++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            36888999999999999999965 5889999986432      2345778999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.++|+|||++..+..
T Consensus        81 E~~~~g~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          81 EYLPGGDMMTLLM-----KKDTFTEEETRFYIAETILAIDSIHK--LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             CCCCCcHHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            9999999998884     23468899999999999999999999  7799999999999999999999999999875432


Q ss_pred             CCCCC------------------------------------CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHH
Q 016588          236 TDVAG------------------------------------PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELV  279 (386)
Q Consensus       236 ~~~~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~  279 (386)
                      .....                                    ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence            11000                                    011235889999999999999999999999999999999


Q ss_pred             cCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCC---HHHHHHH
Q 016588          280 SGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS---MSDVVTE  353 (386)
Q Consensus       280 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt---~~evl~~  353 (386)
                      +|..||....+.   .....+..   ...       .+........++++.+++.+|+. +|.+|++   +.+++++
T Consensus       234 ~G~~Pf~~~~~~---~~~~~i~~---~~~-------~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         234 VGYPPFCSDNPQ---ETYRKIIN---WKE-------TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             cCCCCCCCCCHH---HHHHHHHc---CCC-------ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            999999865431   11111110   000       00000111234678999999997 9999997   9988875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.4e-41  Score=310.19  Aligned_cols=266  Identities=27%  Similarity=0.416  Sum_probs=200.1

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-----CCcEEEEEECCCCCh---hHHHHHHHHHHcCCCCcccccccceee--CCeE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-----DGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQ  151 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  151 (386)
                      .++|+..+.||+|+||.||++..+     ++..|++|.......   +.+.+|+++++.++||||+++++++..  ....
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            357888899999999999999743     477899998655433   467889999999999999999997653  3468


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      ++|+||+++++|.+++..    ....+++..+..++.|++.||.|||+  ++++||||||+||++++++.++|+|||++.
T Consensus        83 ~lv~e~~~~~~L~~~l~~----~~~~l~~~~~~~~~~~l~~aL~~LH~--~~i~H~dlkp~nili~~~~~~~l~dfg~~~  156 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQK----HRERLDHRKLLLYASQICKGMEYLGS--KRYVHRDLATRNILVESENRVKIGDFGLTK  156 (284)
T ss_pred             EEEEEecCCCCHHHHHHh----cCcCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCCHhhEEECCCCeEEECCCcccc
Confidence            899999999999998842    23458899999999999999999998  779999999999999999999999999998


Q ss_pred             ccCCCCCCC-CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc----c
Q 016588          232 FLGRTDVAG-PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD----F  306 (386)
Q Consensus       232 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~  306 (386)
                      ......... ......++..|+|||...+..++.++|||||||++|||++|..|+......    ..........    .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~~~~  232 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQGQMIV  232 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhcccccccccch
Confidence            764322111 111122344599999999888999999999999999999987765443211    0000000000    0


Q ss_pred             cchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHh
Q 016588          307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  357 (386)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~  357 (386)
                      ..+.+.+........+...+.++.+++.+||..+|++|||+.++++.|+.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            001111111112223334567799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.2e-41  Score=305.36  Aligned_cols=252  Identities=25%  Similarity=0.460  Sum_probs=201.2

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCC--ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeec
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  159 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  159 (386)
                      .++|++.+.||+|+||.||+|..+++..+|+|.....  ..+.+.+|+.++++++|+|++++++++.. +..+++|||++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMS   83 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecC
Confidence            3567888999999999999999877888999986543  34678999999999999999999998754 55789999999


Q ss_pred             CCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016588          160 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  239 (386)
Q Consensus       160 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~  239 (386)
                      +++|.+++...   ....+++..+..++.+++.||.|||+  ++++||||||+||++++++.++|+|||++.........
T Consensus        84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          84 KGSLLDFLKDG---EGRALKLPNLVDMAAQVAAGMAYIER--MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence            99999888532   23457899999999999999999998  77999999999999999999999999999776432211


Q ss_pred             CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          240 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       240 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                       ......++..|+|||...+..++.++|+||||+++|||++ |..||.....   .+.......             ...
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~-------------~~~  221 (260)
T cd05070         159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLEQVER-------------GYR  221 (260)
T ss_pred             -cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHc-------------CCC
Confidence             1122334567999999988889999999999999999999 8888875432   111111111             111


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHH
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  356 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~  356 (386)
                      ...+...+..+.+++.+||+.+|.+|||+.++.+.|++
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            12233345679999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.6e-41  Score=311.16  Aligned_cols=258  Identities=27%  Similarity=0.445  Sum_probs=201.6

Q ss_pred             cCCCcCCeecccCceEEEEEEeCC-C--cEEEEEECCCCC----hhHHHHHHHHHHcC-CCCcccccccceeeCCeEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQD-G--MLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~-~--~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  154 (386)
                      ++|++.+.||+|+||.||+|..++ +  ..+++|..+...    .+.+.+|+.++.++ +||||+++++++...+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            478889999999999999998653 3  246888765422    24678899999999 799999999999999999999


Q ss_pred             EEeecCCCccccccCCCc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceE
Q 016588          155 YEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAK  223 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~k  223 (386)
                      +||+++++|.+++.....           .....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+|
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~k  159 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE--KQFIHRDLAARNVLVGENLASK  159 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCcCCcceEEECCCCeEE
Confidence            999999999988853211           112357889999999999999999998  7799999999999999999999


Q ss_pred             EcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHh
Q 016588          224 VADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQN  302 (386)
Q Consensus       224 l~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~  302 (386)
                      |+|||++......   ........+..|+|||...+..++.++|||||||++|||++ |..||......   +.....  
T Consensus       160 l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---~~~~~~--  231 (297)
T cd05089         160 IADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---ELYEKL--  231 (297)
T ss_pred             ECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH--
Confidence            9999998643211   01111223456999999988889999999999999999997 99998765431   111111  


Q ss_pred             hhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          303 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                                 ........+..++..+.+++.+||+.+|.+|||++++++.|+++++..
T Consensus       232 -----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         232 -----------PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             -----------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence                       111111222334567899999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.7e-42  Score=318.66  Aligned_cols=239  Identities=19%  Similarity=0.279  Sum_probs=192.3

Q ss_pred             CeecccCceEEEEEEe----CCCcEEEEEECCCC-------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           89 NLIGEGKFGEVYKGLL----QDGMLVAIKKRPGA-------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      +.||+|+||.||++..    .+++.||+|.....       ....+.+|+.+++.++||||+++++++..++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999985    34788999975421       223567899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +.+++|.+++.     ....+.+..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~L~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          82 LSGGELFMHLE-----REGIFMEDTACFYLSEISLALEHLHQ--QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             CCCchHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            99999988873     33457788888899999999999998  779999999999999999999999999987542211


Q ss_pred             CCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhh
Q 016588          238 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  317 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (386)
                        .......+++.|+|||++.+..++.++|||||||++|||++|+.||......   .....+.            ... 
T Consensus       155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~---~~~~~~~------------~~~-  216 (323)
T cd05584         155 --TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK---KTIDKIL------------KGK-  216 (323)
T ss_pred             --CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH---HHHHHHH------------cCC-
Confidence              1223456888999999999888999999999999999999999999864421   1111111            010 


Q ss_pred             cccCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016588          318 WSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  353 (386)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~~  353 (386)
                       ...+...++++.+++.+||+.||++||     ++++++++
T Consensus       217 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         217 -LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             -CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence             122333456789999999999999999     88888875

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.3e-41  Score=306.24  Aligned_cols=253  Identities=26%  Similarity=0.457  Sum_probs=202.4

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCC--ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      ..++|++.+.||+|+||.||+|..++++.+|+|.....  ...++.+|+.+++.++|+|++++++++. .+..+++|||+
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            34678889999999999999999888899999986543  3467899999999999999999999864 45689999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      .+++|.+++...   ....+++..+..++.|++.||.|||+  .+++||||||+||+++.++.++|+|||++........
T Consensus        83 ~~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~--~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          83 ENGSLVDFLKTP---EGIKLTINKLIDMAAQIAEGMAFIER--KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            999999887432   23467888999999999999999998  6799999999999999999999999999876643221


Q ss_pred             CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhh
Q 016588          239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  317 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (386)
                       .......++..|+|||++.+..++.++||||||+++||+++ |..||......   ........             ..
T Consensus       158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~-------------~~  220 (260)
T cd05067         158 -TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQNLER-------------GY  220 (260)
T ss_pred             -ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHHHHHc-------------CC
Confidence             11122334567999999988889999999999999999999 99999764421   11111111             11


Q ss_pred             cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHH
Q 016588          318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  356 (386)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~  356 (386)
                      ....+...+.++.+++.+||+.+|++|||++++++.|+.
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         221 RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            112222345679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.2e-41  Score=325.22  Aligned_cols=250  Identities=21%  Similarity=0.261  Sum_probs=193.5

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      .|+..+.||+|+||+||+|... ++..||+|++...      ....+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5788899999999999999854 5889999986432      23457889999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      |+++|+|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++......
T Consensus        82 ~~~gg~L~~~l~-----~~~~~~e~~~~~~~~qi~~aL~~LH~--~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~  154 (381)
T cd05626          82 YIPGGDMMSLLI-----RMEVFPEVLARFYIAELTLAIESVHK--MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT  154 (381)
T ss_pred             cCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence            999999998884     23457888889999999999999998  77999999999999999999999999997543110


Q ss_pred             CC---------------------------------------------CCCCccccCcccccchhhhcccCCCcccchhhH
Q 016588          237 DV---------------------------------------------AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSF  271 (386)
Q Consensus       237 ~~---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSl  271 (386)
                      ..                                             ........||..|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (381)
T cd05626         155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence            00                                             000123468899999999998899999999999


Q ss_pred             HHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHc--cCCCCCCCCCHHH
Q 016588          272 GVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRC--LDPSSERRPSMSD  349 (386)
Q Consensus       272 Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c--l~~dp~~Rpt~~e  349 (386)
                      ||++|||++|..||....+...  ..... .   ..       ...........+.++.+++.+|  +..+|..||++.+
T Consensus       235 G~il~elltG~~Pf~~~~~~~~--~~~i~-~---~~-------~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~  301 (381)
T cd05626         235 GVILFEMLVGQPPFLAPTPTET--QLKVI-N---WE-------NTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADD  301 (381)
T ss_pred             hhHHHHHHhCCCCCcCCCHHHH--HHHHH-c---cc-------cccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence            9999999999999987543211  11000 0   00       0000011112345678899884  4556666999999


Q ss_pred             HHHH
Q 016588          350 VVTE  353 (386)
Q Consensus       350 vl~~  353 (386)
                      ++++
T Consensus       302 ~l~h  305 (381)
T cd05626         302 IKAH  305 (381)
T ss_pred             HhcC
Confidence            9986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.2e-41  Score=330.24  Aligned_cols=263  Identities=23%  Similarity=0.305  Sum_probs=194.5

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCChhHHHHHHHHHHcCCCCcccccccceee--------CCeE
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQE--------NNLQ  151 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------~~~~  151 (386)
                      ...+|+..+.||+|+||.||+|... +++.||+|+.... .....+|+.+++.++||||+++++++..        ....
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~-~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  142 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL  142 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC-cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence            3457999999999999999999964 5889999986543 2345579999999999999999887643        1246


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC-ceEEcccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLR  230 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~-~~kl~DFgl~  230 (386)
                      ++||||+++ +|.+++.... .....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++ .+||+|||++
T Consensus       143 ~lvmE~~~~-~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~gL~yLH~--~~IiHrDLKp~NILl~~~~~~vkL~DFGla  218 (440)
T PTZ00036        143 NVVMEFIPQ-TVHKYMKHYA-RNNHALPLFLVKLYSYQLCRALAYIHS--KFICHRDLKPQNLLIDPNTHTLKLCDFGSA  218 (440)
T ss_pred             EEEEecCCc-cHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence            789999975 5655543211 134568899999999999999999999  7799999999999999665 7999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhh--ccc
Q 016588          231 NFLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR--DFS  307 (386)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~  307 (386)
                      +......   ......+++.|+|||++.+. .|+.++|||||||++|||++|.+||.+....  ..+........  ...
T Consensus       219 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~--~~~~~i~~~~~~p~~~  293 (440)
T PTZ00036        219 KNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV--DQLVRIIQVLGTPTED  293 (440)
T ss_pred             hhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHH
Confidence            8664322   12335678889999998764 6899999999999999999999999875432  12222111110  000


Q ss_pred             ch------------hhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          308 NL------------LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       308 ~~------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ..            .......+...++...++++.+++.+||+.||.+|||+.|++++
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            00            00111112222333445779999999999999999999999966

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.3e-42  Score=326.63  Aligned_cols=252  Identities=21%  Similarity=0.261  Sum_probs=198.7

Q ss_pred             HHhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC------CChhHHHHHHHHHHcCCCCcccccccceeeCCeEE
Q 016588           80 LATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  152 (386)
Q Consensus        80 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  152 (386)
                      ...++|+..+.||+|+||.||++... ++..||+|....      .....+.+|+.+++.++||||+++++++.+.+..|
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            34568899999999999999999965 588999998542      22334678999999999999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~  232 (386)
                      +||||+++|+|..++.      ...++......++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++..
T Consensus       120 lv~Ey~~gg~L~~~l~------~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~  191 (370)
T cd05596         120 MVMEYMPGGDLVNLMS------NYDIPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (370)
T ss_pred             EEEcCCCCCcHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence            9999999999998873      2346778888899999999999999  7799999999999999999999999999886


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccc----CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccc
Q 016588          233 LGRTDVAGPSSQVTADEIFLASEVKEFR----RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN  308 (386)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  308 (386)
                      ...... .......|++.|+|||++.+.    .++.++|||||||++|||++|..||......   .....+....    
T Consensus       192 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i~~~~----  263 (370)
T cd05596         192 MDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTYSKIMDHK----  263 (370)
T ss_pred             ccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH---HHHHHHHcCC----
Confidence            643221 122345688999999998653    4789999999999999999999999864421   1111111000    


Q ss_pred             hhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCC--CCCHHHHHHH
Q 016588          309 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSER--RPSMSDVVTE  353 (386)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~evl~~  353 (386)
                            ..+........+.++.+++.+||+.+|.+  |+|+.+++++
T Consensus       264 ------~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         264 ------NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             ------CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence                  00100111124567899999999999988  9999999877

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.6e-41  Score=318.39  Aligned_cols=263  Identities=24%  Similarity=0.375  Sum_probs=200.9

Q ss_pred             HhcCCCcCCeecccCceEEEEEEe------CCCcEEEEEECCCCC----hhHHHHHHHHHHcC-CCCcccccccceee-C
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQE-N  148 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~~~~~~~~-~  148 (386)
                      ..++|++.+.||+|+||.||+|..      .+++.||||.+....    ...+.+|+.++.++ +||||+++++++.. .
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            345789999999999999999973      246789999865432    23577899999999 68999999998865 4


Q ss_pred             CeEEEEEEeecCCCccccccCCCc--------------------------------------------------------
Q 016588          149 NLQFLIYEYIPNGSVSIHLYGPSQ--------------------------------------------------------  172 (386)
Q Consensus       149 ~~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------  172 (386)
                      ...+++|||+++|+|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            567899999999999888743210                                                        


Q ss_pred             ------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCcccc
Q 016588          173 ------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT  246 (386)
Q Consensus       173 ------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~  246 (386)
                            .....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++................
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                  001346788889999999999999998  779999999999999999999999999987653322211122233


Q ss_pred             CcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHH
Q 016588          247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEG  325 (386)
Q Consensus       247 ~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (386)
                      ++..|+|||.+.+..++.++||||||+++|||++ |..||......  ..........             .....+...
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~-------------~~~~~~~~~  307 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRRLKEG-------------TRMRAPDYT  307 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHHHHHhcc-------------CCCCCCCCC
Confidence            4567999999988899999999999999999997 88888764321  1111111110             011111223


Q ss_pred             HHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          326 MEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       326 ~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      ++++.+++..||+.||++|||+.+++++|+.+++.
T Consensus       308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            35689999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-41  Score=305.62  Aligned_cols=256  Identities=22%  Similarity=0.238  Sum_probs=209.1

Q ss_pred             HHHHhcCCCcCCeecccCceEEEEEEeCC-CcEEEEEECCCCC------hhHHHHHHHHHHcCCCCcccccccceeeCCe
Q 016588           78 LSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNL  150 (386)
Q Consensus        78 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  150 (386)
                      .....+.|+..+.||.|.-|+||++..++ +..+|+|.+++..      ..+.+.|-+||+.++||.+++||..++..+.
T Consensus        72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~  151 (459)
T KOG0610|consen   72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY  151 (459)
T ss_pred             CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence            33445677888999999999999999765 6899999876543      2356779999999999999999999999999


Q ss_pred             EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  230 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~  230 (386)
                      .|+|||||+||+|......   +..+.+++..+..++.+++.||+|||-  .|||.|||||+||||.++|++.|+||.|+
T Consensus       152 ~cl~meyCpGGdL~~Lrqk---Qp~~~fse~~aRFYaAEvl~ALEYLHm--lGivYRDLKPENILvredGHIMLsDFDLS  226 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQK---QPGKRFSESAARFYAAEVLLALEYLHM--LGIVYRDLKPENILVREDGHIMLSDFDLS  226 (459)
T ss_pred             eEEEEecCCCccHHHHHhh---CCCCccchhhHHHHHHHHHHHHHHHHh--hceeeccCCcceeEEecCCcEEeeecccc
Confidence            9999999999999887743   456789999999999999999999999  66999999999999999999999999986


Q ss_pred             cccCC---------------------------------CCC---------------------CCCCccccCcccccchhh
Q 016588          231 NFLGR---------------------------------TDV---------------------AGPSSQVTADEIFLASEV  256 (386)
Q Consensus       231 ~~~~~---------------------------------~~~---------------------~~~~~~~~~~~~y~aPE~  256 (386)
                      ..+..                                 ...                     ...+...+||..|.|||+
T Consensus       227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv  306 (459)
T KOG0610|consen  227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV  306 (459)
T ss_pred             ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence            44311                                 000                     011234568999999999


Q ss_pred             hcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHc
Q 016588          257 KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRC  336 (386)
Q Consensus       257 ~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  336 (386)
                      +.|...+.++|+|+|||++|||+.|..||.+....               ..+.+++...+.-...++.+..+++||.+.
T Consensus       307 I~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~---------------~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~L  371 (459)
T KOG0610|consen  307 IRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK---------------ETLRNIVGQPLKFPEEPEVSSAAKDLIRKL  371 (459)
T ss_pred             eecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCch---------------hhHHHHhcCCCcCCCCCcchhHHHHHHHHH
Confidence            99999999999999999999999999999987652               223334444443333445667899999999


Q ss_pred             cCCCCCCCCC----HHHHHHH
Q 016588          337 LDPSSERRPS----MSDVVTE  353 (386)
Q Consensus       337 l~~dp~~Rpt----~~evl~~  353 (386)
                      |.+||.+|..    +.||-+|
T Consensus       372 LvKdP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  372 LVKDPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             hccChhhhhccccchHHhhcC
Confidence            9999999988    7777654

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.8e-41  Score=312.75  Aligned_cols=260  Identities=27%  Similarity=0.460  Sum_probs=202.3

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCc--EEEEEECCCCC----hhHHHHHHHHHHcC-CCCcccccccceeeCCeEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGM--LVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  153 (386)
                      .++|++.+.||+|+||.||+|..+ ++.  .+++|......    ...+.+|++++.++ +|+||+++++++...+..|+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            357788899999999999999964 343  46777654322    23577899999999 89999999999999999999


Q ss_pred             EEEeecCCCccccccCCCc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCce
Q 016588          154 IYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA  222 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~  222 (386)
                      ||||+++++|.+++.....           .....+++..++.++.|++.||+|||+  ++++||||||+|||++.++.+
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh--CCccccccchheEEecCCCcE
Confidence            9999999999988853321           112357899999999999999999998  789999999999999999999


Q ss_pred             EEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHH
Q 016588          223 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQ  301 (386)
Q Consensus       223 kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~  301 (386)
                      ||+|||++......   ........+..|+|||.+.+..++.++|||||||++|||+| |..||......   +......
T Consensus       164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~~  237 (303)
T cd05088         164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKLP  237 (303)
T ss_pred             EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHHHHHh
Confidence            99999998643211   11111223556999999988889999999999999999998 99998754421   1111111


Q ss_pred             hhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhc
Q 016588          302 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  362 (386)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~  362 (386)
                                   .......+...+.++.+++.+||+.+|++||++.++++.|.+++++..
T Consensus       238 -------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         238 -------------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             -------------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence                         011111222344678999999999999999999999999999887743

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.7e-41  Score=317.27  Aligned_cols=242  Identities=24%  Similarity=0.346  Sum_probs=192.0

Q ss_pred             CCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHH---HcCCCCcccccccceeeCCeEEEE
Q 016588           85 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFL---ASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      |++.+.||+|+||.||+|..+ +++.||+|.....      ..+.+..|..++   +.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567789999999999999965 5889999985422      234466666554   566899999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      |||+++++|..++.      ...+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||+++...
T Consensus        81 ~E~~~~~~L~~~~~------~~~l~~~~~~~~~~qi~~al~~lH~--~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          81 MEYAAGGDLMMHIH------TDVFSEPRAVFYAACVVLGLQYLHE--NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EcCCCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHh--CCeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            99999999987763      3468899999999999999999998  779999999999999999999999999987532


Q ss_pred             CCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                      ...  .......+++.|+|||.+.+..++.++|||||||++|||++|..||......   .....+..            
T Consensus       153 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~---~~~~~i~~------------  215 (324)
T cd05589         153 GFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE---EVFDSIVN------------  215 (324)
T ss_pred             CCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh------------
Confidence            211  2223456888999999999999999999999999999999999999864421   11111110            


Q ss_pred             hhhcccCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016588          315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  353 (386)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~~  353 (386)
                      ..  ...+...+..+.+++.+||+.||.+||     ++.+++++
T Consensus       216 ~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         216 DE--VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             CC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence            00  112233456789999999999999999     57777665

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.6e-41  Score=322.28  Aligned_cols=251  Identities=22%  Similarity=0.273  Sum_probs=194.3

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ++|+..+.||+|+||+||++... +++.||+|+....      ....+.+|..++..++|+||+++++.+.+.+..|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46888999999999999999854 5889999986432      2345778999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~lH~--~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~  153 (363)
T cd05628          81 EFLPGGDMMTLLM-----KKDTLTEEETQFYIAETVLAIDSIHQ--LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK  153 (363)
T ss_pred             cCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence            9999999998884     34568899999999999999999998  7799999999999999999999999999876532


Q ss_pred             CCCC---------------------------------CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCC
Q 016588          236 TDVA---------------------------------GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR  282 (386)
Q Consensus       236 ~~~~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~  282 (386)
                      ....                                 .......||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence            1100                                 0012346899999999999999999999999999999999999


Q ss_pred             CCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccC--CCCCCCCCHHHHHHH
Q 016588          283 EASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLD--PSSERRPSMSDVVTE  353 (386)
Q Consensus       283 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dp~~Rpt~~evl~~  353 (386)
                      .||....+.   .....+.....          .+........++++.+++.+++.  .++..||+++|++++
T Consensus       234 ~Pf~~~~~~---~~~~~i~~~~~----------~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         234 PPFCSETPQ---ETYKKVMNWKE----------TLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCCCHH---HHHHHHHcCcC----------cccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            999864431   11111111000          00000001123567888887554  233456899999987

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.4e-41  Score=304.00  Aligned_cols=244  Identities=23%  Similarity=0.392  Sum_probs=193.6

Q ss_pred             eecccCceEEEEEEeC---CCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCC
Q 016588           90 LIGEGKFGEVYKGLLQ---DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  161 (386)
Q Consensus        90 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  161 (386)
                      .||+|+||.||+|.++   ++..+|+|+.....     .+++.+|+.+++.++||||+++++++.. +..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            5899999999999743   46789999865332     3468889999999999999999998764 4668999999999


Q ss_pred             CccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC-C
Q 016588          162 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA-G  240 (386)
Q Consensus       162 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~-~  240 (386)
                      +|.+++.     ....+++..+..++.|++.||.|||+  ++++||||||+||+++.++.+||+|||++......... .
T Consensus        81 ~L~~~l~-----~~~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          81 PLNKFLQ-----KNKHVTEKNITELVHQVSMGMKYLEE--TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             cHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            9998883     23467889999999999999999998  77999999999999999999999999998876443221 1


Q ss_pred             CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcc
Q 016588          241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS  319 (386)
Q Consensus       241 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (386)
                      ......++..|+|||.+....++.++|+|||||++|||++ |..||.....   ......+..             ....
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~i~~-------------~~~~  217 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEVTQMIES-------------GERM  217 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHC-------------CCCC
Confidence            1122233567999999988888999999999999999998 9999976442   122222211             1111


Q ss_pred             cCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHh
Q 016588          320 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  357 (386)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~  357 (386)
                      ..+...+.++.+++.+||+.||++||++.+|.+.|++.
T Consensus       218 ~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         218 ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            23334557789999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-41  Score=309.82  Aligned_cols=249  Identities=20%  Similarity=0.302  Sum_probs=198.7

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC------hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      +|+..+.||+|+||+||++... ++..||+|......      ...+.+|+.+++.++||||+++++.+...+..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4777899999999999999954 58899999764321      2346789999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      |+++|+|.+++...   ....+++..+..++.|++.||.|||+  ++++||||||+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          81 LMNGGDLKFHIYNM---GNPGFDEERAVFYAAEITCGLEDLHR--ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             ccCCCcHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHH--CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            99999998877432   23468899999999999999999998  77999999999999999999999999998765432


Q ss_pred             CCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchh
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  316 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (386)
                      .   ......++..|+|||.+.+..++.++||||+||++||+++|..||.+.......   +.+..         .+.. 
T Consensus       156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~---------~~~~-  219 (285)
T cd05605         156 E---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVER---------RVKE-  219 (285)
T ss_pred             C---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHH---------Hhhh-
Confidence            2   112346788899999999888999999999999999999999999864432111   11100         0000 


Q ss_pred             hcccCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016588          317 LWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  353 (386)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~~  353 (386)
                      .....+...+..+.+++.+||+.||++||     ++++++++
T Consensus       220 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         220 DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            01122334556789999999999999999     88888776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=5.2e-41  Score=305.25  Aligned_cols=255  Identities=27%  Similarity=0.484  Sum_probs=202.0

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCC-C---cEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQD-G---MLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (386)
                      .++|+..+.||+|+||.||+|.... +   ..+++|......    .+++.+|+++++.++|+|++++.+++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            3467788999999999999999642 3   379999865432    3468889999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      ||||+++++|.+++..    ....+++..+..++.|++.||+|||+  .+++||||||+||+++.++.++++|||++...
T Consensus        84 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          84 ITEYMENGALDKYLRD----HDGEFSSYQLVGMLRGIAAGMKYLSD--MNYVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             EEEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhhEEEcCCCcEEECCCccceec
Confidence            9999999999988842    23567889999999999999999998  77999999999999999999999999998766


Q ss_pred             CCCCCCC-CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhh
Q 016588          234 GRTDVAG-PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK  311 (386)
Q Consensus       234 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (386)
                      ....... .......+..|+|||.+.+..++.++|||||||++||+++ |..||.....   ......+...        
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~~i~~~--------  226 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMKAINDG--------  226 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHHhcC--------
Confidence            4322111 1111223456999999998889999999999999999997 9999876442   1122111110        


Q ss_pred             hcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhh
Q 016588          312 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  358 (386)
Q Consensus       312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~  358 (386)
                           ...+.+...+.++.+++.+||+.+|++||++.++++.|++++
T Consensus       227 -----~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~  268 (268)
T cd05063         227 -----FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL  268 (268)
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence                 111122234567899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5.1e-41  Score=305.05  Aligned_cols=257  Identities=23%  Similarity=0.342  Sum_probs=203.7

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC------CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ++|++.+.||+|+||.||+|... ++..||+|....      .....+.+|+++++.++|||++++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            47888999999999999999954 688999996432      11235788999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++++|.+++.... .....++...+..++.|++.||.|||+  ++++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFK-KQKRLIPERTVWKYFVQLCSAVEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhh-hccCCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999988774321 123457888899999999999999998  7799999999999999999999999999887643


Q ss_pred             CCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      ...  ......++..|+|||.+.+..++.++|+||||+++|||++|..||...... .......+...            
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~~~~~~~------------  223 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLCQKIEQC------------  223 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHHHHHHhcC------------
Confidence            221  112345777899999998888999999999999999999999998653321 11111111110            


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHh
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  357 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~  357 (386)
                      ..........+..+.+++.+||+.+|++|||++++++.++++
T Consensus       224 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         224 DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            001111223456789999999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=5e-41  Score=309.83  Aligned_cols=263  Identities=26%  Similarity=0.393  Sum_probs=202.5

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCC-----------------CcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccc
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQD-----------------GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVT  140 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~  140 (386)
                      .++|.+.+.||+|+||.||+|....                 +..||+|......    .+.+.+|+++++.++|||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4578889999999999999988542                 2458999865443    346788999999999999999


Q ss_pred             cccceeeCCeEEEEEEeecCCCccccccCCCc------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCe
Q 016588          141 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQ------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANV  214 (386)
Q Consensus       141 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Ni  214 (386)
                      +++++...+..++++||+++++|..++.....      .....+++..++.++.|++.||.|||+  .+++||||||+||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~--~~i~H~dlkp~Ni  161 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES--LNFVHRDLATRNC  161 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH--cCccccccchhce
Confidence            99999999999999999999999988854321      112368899999999999999999998  7799999999999


Q ss_pred             eeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc--CCCCCCCCCCCc
Q 016588          215 LVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS--GREASSSLSPDS  292 (386)
Q Consensus       215 ll~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t--g~~p~~~~~~~~  292 (386)
                      +++.++.++|+|||+++...............++..|+|||...+..++.++|||||||++|||++  |..||.....  
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~--  239 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD--  239 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh--
Confidence            999999999999999876543332222333445678999999988889999999999999999998  6677765432  


Q ss_pred             hhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016588          293 SQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  355 (386)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~  355 (386)
                       .............      .........+...+.++.+++.+||+.||++|||+.++++.|.
T Consensus       240 -~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         240 -QQVIENAGHFFRD------DGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             -HHHHHHHHhcccc------ccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence             1111111111000      0111111122334567999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-41  Score=305.25  Aligned_cols=249  Identities=23%  Similarity=0.358  Sum_probs=199.3

Q ss_pred             cCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC--------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA--------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (386)
                      ++|...+.||+|++|.||++.. .++..+++|.....        ....+.+|++++++++||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4688899999999999999995 45889999975422        12357889999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      |+||+++++|.+++.     ....++......++.|++.||.|||+  .+++||||+|+||++++++.++|+|||+++..
T Consensus        82 v~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~  154 (263)
T cd06625          82 FMEYMPGGSVKDQLK-----AYGALTETVTRKYTRQILEGVEYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRL  154 (263)
T ss_pred             EEEECCCCcHHHHHH-----HhCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            999999999988874     23457788889999999999999998  77999999999999999999999999998765


Q ss_pred             CCCCCCCC-CccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          234 GRTDVAGP-SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       234 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      ........ .....++..|+|||.+.+..++.++||||||+++||+++|+.||......  .....             .
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~-------------~  219 (263)
T cd06625         155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM--AAIFK-------------I  219 (263)
T ss_pred             cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH--HHHHH-------------H
Confidence            43211111 12345677899999999888999999999999999999999998764321  11000             0


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .........+...+..+.+++.+||..+|.+|||+.+++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         220 ATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             hccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            01111122333455678999999999999999999999976

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=8.5e-41  Score=300.63  Aligned_cols=244  Identities=29%  Similarity=0.488  Sum_probs=195.6

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCCCcc
Q 016588           89 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVS  164 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  164 (386)
                      ++||+|+||.||+|..+++..+|+|......    ...+.+|+++++.++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            3689999999999998788899999865443    235788999999999999999999999999999999999999999


Q ss_pred             ccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCcc
Q 016588          165 IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ  244 (386)
Q Consensus       165 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~~  244 (386)
                      +++..    ....+++..+..++.+++.||.|||+  ++++||||||+||+++.++.++|+|||++........ .....
T Consensus        81 ~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~  153 (250)
T cd05085          81 SFLRK----KKDELKTKQLVKFALDAAAGMAYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGL  153 (250)
T ss_pred             HHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCC
Confidence            88742    23457899999999999999999998  7799999999999999999999999999876433211 11112


Q ss_pred             ccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCH
Q 016588          245 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN  323 (386)
Q Consensus       245 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (386)
                      ..++..|+|||+..+..++.++||||||+++||+++ |..||......   ........             ......+.
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~~~~~~-------------~~~~~~~~  217 (250)
T cd05085         154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QAREQVEK-------------GYRMSCPQ  217 (250)
T ss_pred             CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHHc-------------CCCCCCCC
Confidence            233556999999998889999999999999999998 88898764321   11111111             11112233


Q ss_pred             HHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016588          324 EGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  355 (386)
Q Consensus       324 ~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~  355 (386)
                      ..+.++.+++.+||+.+|++|||+.++++.|.
T Consensus       218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            34567999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=5.4e-41  Score=312.47  Aligned_cols=261  Identities=27%  Similarity=0.453  Sum_probs=204.5

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC--------CCcEEEEEECCCCC----hhHHHHHHHHHHcC-CCCcccccccceeeC
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ--------DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQEN  148 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  148 (386)
                      ..+|.+.+.||+|+||.||++...        ....+|+|......    ..++.+|+.+++.+ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            457788899999999999999742        24578999865432    23577899999999 699999999999999


Q ss_pred             CeEEEEEEeecCCCccccccCCCc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC
Q 016588          149 NLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD  217 (386)
Q Consensus       149 ~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~  217 (386)
                      +..+++|||+++|+|.+++.....           .....+++..+..++.|++.||.|||+  +|++||||||+|||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~gi~H~dlkp~Nill~  168 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES--RRCIHRDLAARNVLVT  168 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH--CCeeeccccceeEEEc
Confidence            999999999999999988854211           122458899999999999999999998  7899999999999999


Q ss_pred             CCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhH
Q 016588          218 EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDL  296 (386)
Q Consensus       218 ~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~  296 (386)
                      .++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.....   ...
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---~~~  245 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---EEL  245 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---HHH
Confidence            999999999999986643222221222234457999999998889999999999999999999 8888865442   112


Q ss_pred             HHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          297 VELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      ......             ......+..++.++.+++.+||+.+|++|||+.++++.|+++...
T Consensus       246 ~~~~~~-------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         246 FKLLRE-------------GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             HHHHHc-------------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence            221111             011122334456789999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-41  Score=324.97  Aligned_cols=250  Identities=20%  Similarity=0.266  Sum_probs=194.1

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ++|+..+.||+|+||.||++... +++.||+|.....      ..+.+.+|+++++.++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            36888999999999999999854 6889999975422      2345778999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++|+|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~ql~~aL~~LH~--~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~  153 (377)
T cd05629          81 EFLPGGDLMTMLI-----KYDTFSEDVTRFYMAECVLAIEAVHK--LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK  153 (377)
T ss_pred             eCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence            9999999998884     23567888889999999999999999  7799999999999999999999999999864321


Q ss_pred             CCC------------CC---------------------------------CCccccCcccccchhhhcccCCCcccchhh
Q 016588          236 TDV------------AG---------------------------------PSSQVTADEIFLASEVKEFRRFSEKSDVYS  270 (386)
Q Consensus       236 ~~~------------~~---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS  270 (386)
                      ...            ..                                 ......||+.|+|||++.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  233 (377)
T cd05629         154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS  233 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence            000            00                                 001245888999999999999999999999


Q ss_pred             HHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCC---CCH
Q 016588          271 FGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERR---PSM  347 (386)
Q Consensus       271 lGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---pt~  347 (386)
                      |||++|||++|..||....+.   ........   ...       .+........+.++.+++.+|++ +|.+|   +|+
T Consensus       234 lGvil~elltG~~Pf~~~~~~---~~~~~i~~---~~~-------~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~  299 (377)
T cd05629         234 LGAIMFECLIGWPPFCSENSH---ETYRKIIN---WRE-------TLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGA  299 (377)
T ss_pred             cchhhhhhhcCCCCCCCCCHH---HHHHHHHc---cCC-------ccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence            999999999999999764431   11111110   000       00000111234668999999998 66665   599


Q ss_pred             HHHHHH
Q 016588          348 SDVVTE  353 (386)
Q Consensus       348 ~evl~~  353 (386)
                      .+++++
T Consensus       300 ~~~l~h  305 (377)
T cd05629         300 HEIKSH  305 (377)
T ss_pred             HHHhcC
Confidence            999887

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=4.5e-41  Score=309.07  Aligned_cols=257  Identities=27%  Similarity=0.440  Sum_probs=202.0

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC------CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  151 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  151 (386)
                      .++|+..+.||+|+||.||+|..+      ++..+|+|......    ..++.+|+.+++.++|||++++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            457888999999999999999853      36789999865443    34588899999999999999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCc-----------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCe
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQ-----------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANV  214 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Ni  214 (386)
                      ++++||+++++|.+++.....                 .....+++..++.++.|++.||.|||+  ++++||||||+||
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~--~~i~H~dl~p~ni  161 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE--RKFVHRDLATRNC  161 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--CCeecccccHhhe
Confidence            999999999999888853211                 112357888899999999999999998  7899999999999


Q ss_pred             eeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCch
Q 016588          215 LVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSS  293 (386)
Q Consensus       215 ll~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~  293 (386)
                      +++.++.++|+|||++.................+..|+|||...+..++.++|||||||++|||++ |..||.+....  
T Consensus       162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~--  239 (288)
T cd05050         162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE--  239 (288)
T ss_pred             EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence            999999999999999876543322222223334566999999998899999999999999999998 77788654321  


Q ss_pred             hhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHH
Q 016588          294 QDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  356 (386)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~  356 (386)
                       ........            ... ...+...+.++.+++.+||+.+|++|||+.|+++.|++
T Consensus       240 -~~~~~~~~------------~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 -EVIYYVRD------------GNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             -HHHHHHhc------------CCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence             11111111            111 11223345679999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=9e-41  Score=302.48  Aligned_cols=251  Identities=25%  Similarity=0.431  Sum_probs=199.9

Q ss_pred             cCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCC--ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecC
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      ++|...+.||+|+||.||+|....+..+++|.....  ..+.+.+|+.+++.++|+|++++++++.. +..+++|||+.+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~   84 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGK   84 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCC
Confidence            457788899999999999999877778999985533  34578899999999999999999988754 567899999999


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  240 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~  240 (386)
                      ++|.+++...   ....+++..+..++.|++.||.|||+  .+++|+||||+||++++++.++|+|||++......... 
T Consensus        85 ~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05069          85 GSLLDFLKEG---DGKYLKLPQLVDMAAQIADGMAYIER--MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence            9999888532   23457889999999999999999998  77999999999999999999999999999876432211 


Q ss_pred             CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcc
Q 016588          241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS  319 (386)
Q Consensus       241 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (386)
                      ......++..|+|||...+..++.++||||||+++|||++ |..||....+.   ........             ....
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~~-------------~~~~  222 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLEQVER-------------GYRM  222 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHc-------------CCCC
Confidence            1122345667999999988889999999999999999999 88898764421   11111111             0111


Q ss_pred             cCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHH
Q 016588          320 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  356 (386)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~  356 (386)
                      ..+...+..+.+++.+||+.||++||+++++++.|++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            2233445679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.1e-41  Score=315.96  Aligned_cols=239  Identities=20%  Similarity=0.310  Sum_probs=190.9

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEECCC------CChhHHHHHHHHHHcC-CCCcccccccceeeCCeEEEEEEeecC
Q 016588           89 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      +.||+|+||.||+|..+ +++.||+|....      .....+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999965 578999997543      2234567788888776 799999999999999999999999999


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  240 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~  240 (386)
                      |+|..++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++......  .
T Consensus        81 g~L~~~i~-----~~~~l~~~~~~~~~~ql~~~L~~lH~--~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~  151 (320)
T cd05590          81 GDLMFHIQ-----KSRRFDEARARFYAAEITSALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--K  151 (320)
T ss_pred             chHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--C
Confidence            99988773     33568889999999999999999998  779999999999999999999999999987542211  1


Q ss_pred             CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhccc
Q 016588          241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  320 (386)
Q Consensus       241 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (386)
                      ......+++.|+|||.+.+..++.++|||||||++|||++|..||.....   ......+..            ..  ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~~~~~~i~~------------~~--~~  214 (320)
T cd05590         152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE---DDLFEAILN------------DE--VV  214 (320)
T ss_pred             cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHHHHHHhc------------CC--CC
Confidence            22345688899999999988999999999999999999999999986442   111111111            00  01


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCH------HHHHHH
Q 016588          321 FTNEGMEEFIQLIVRCLDPSSERRPSM------SDVVTE  353 (386)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dp~~Rpt~------~evl~~  353 (386)
                      .+...+.++.+++.+||+.||++||++      ++++++
T Consensus       215 ~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         215 YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence            222345678999999999999999998      556554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-41  Score=303.79  Aligned_cols=254  Identities=27%  Similarity=0.488  Sum_probs=205.1

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCC--CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPG--APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      ..++|++.+.||+|+||.||+|..+++..+++|....  ...+++.+|+.+++.++|+|++++++++......++||||+
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            4568889999999999999999987778899998653  34567899999999999999999999999888999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++++|.+++...   ....+++..+..++.+++.|+.|||+  ++++|+||||+||++++++.++|+|||++........
T Consensus        84 ~~~~L~~~i~~~---~~~~~~~~~~~~~~~~i~~al~~lh~--~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          84 SKGSLLDFLKSG---EGKKLRLPQLVDMAAQIAEGMAYLES--RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             CCCCHHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            999999988532   23468899999999999999999998  7799999999999999999999999999887643211


Q ss_pred             CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhh
Q 016588          239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  317 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (386)
                       ........+..|+|||...+..++.++|+||||+++||+++ |+.||.....   .........             ..
T Consensus       159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~~~-------------~~  221 (261)
T cd05034         159 -TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLEQVER-------------GY  221 (261)
T ss_pred             -hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHc-------------CC
Confidence             11122234557999999998889999999999999999998 9999875432   111111111             01


Q ss_pred             cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHH
Q 016588          318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  356 (386)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~  356 (386)
                      ....+...+.++.+++.+||+.+|++||+++++.+.|+.
T Consensus       222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         222 RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            111222335678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=9e-41  Score=302.04  Aligned_cols=245  Identities=24%  Similarity=0.408  Sum_probs=193.3

Q ss_pred             eecccCceEEEEEEeC---CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCCC
Q 016588           90 LIGEGKFGEVYKGLLQ---DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS  162 (386)
Q Consensus        90 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  162 (386)
                      .||+|+||.||+|.+.   .+..||+|......    .+.+.+|+.++++++||||+++++++.. +..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999999854   34579999865443    3457899999999999999999998764 56789999999999


Q ss_pred             ccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC-C
Q 016588          163 VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG-P  241 (386)
Q Consensus       163 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~-~  241 (386)
                      |.+++..    ....+++..++.++.|++.||.|||+  ++++||||||+||+++.++.+||+|||++.......... .
T Consensus        81 L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          81 LNKFLSG----KKDEITVSNVVELMHQVSMGMKYLEG--KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             HHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh--cCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            9988742    23568899999999999999999998  779999999999999999999999999987654322111 1


Q ss_pred             CccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhccc
Q 016588          242 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  320 (386)
Q Consensus       242 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (386)
                      .....++..|+|||.+.+..++.++|||||||++||+++ |..||......   +....+..             .....
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~-------------~~~~~  218 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EVMSFIEQ-------------GKRLD  218 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHHC-------------CCCCC
Confidence            122233567999999988889999999999999999996 99999865431   11111111             11122


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHh
Q 016588          321 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  357 (386)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~  357 (386)
                      .+..+++++.+++.+||+.+|++||++.++.+.|+..
T Consensus       219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            3344567799999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-41  Score=309.70  Aligned_cols=263  Identities=25%  Similarity=0.380  Sum_probs=199.2

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCC---------------CcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccc
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQD---------------GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLL  142 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~  142 (386)
                      .++|.+.+.||+|+||.||++....               ...||+|......    .+.+.+|++++++++|+|+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3578889999999999999987532               2358999865432    24588899999999999999999


Q ss_pred             cceeeCCeEEEEEEeecCCCccccccCCCc-------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCee
Q 016588          143 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQ-------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVL  215 (386)
Q Consensus       143 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nil  215 (386)
                      +++...+..++||||+.+++|.+++.....       .....+++..++.++.|++.||+|||+  .+++||||||+||+
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~Nil  161 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS--LNFVHRDLATRNCL  161 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh--cCeeccccChhhEE
Confidence            999999999999999999999988743211       011346788999999999999999998  77999999999999


Q ss_pred             eCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc--CCCCCCCCCCCch
Q 016588          216 VDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS--GREASSSLSPDSS  293 (386)
Q Consensus       216 l~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t--g~~p~~~~~~~~~  293 (386)
                      +++++.+||+|||++................++..|+|||...+..++.++|||||||++|||++  |..||......  
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~--  239 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE--  239 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH--
Confidence            99999999999999876543222222222344667999999988889999999999999999998  55676654321  


Q ss_pred             hhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016588          294 QDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  355 (386)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~  355 (386)
                       ...........      ..........+...++.+.+++.+||+.||++|||+.++++.|.
T Consensus       240 -~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         240 -QVIENTGEFFR------NQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             -HHHHHHHHhhh------hccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence             11111111000      00011111122233467999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=8.7e-41  Score=308.44  Aligned_cols=263  Identities=24%  Similarity=0.382  Sum_probs=199.8

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-----------------CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccc
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-----------------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVT  140 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~  140 (386)
                      .++|++.+.||+|+||.||++...                 +...+|+|......    .+++.+|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            356889999999999999998532                 23468999865432    346889999999999999999


Q ss_pred             cccceeeCCeEEEEEEeecCCCccccccCCCcC------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCe
Q 016588          141 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQV------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANV  214 (386)
Q Consensus       141 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Ni  214 (386)
                      +++++...+..+++|||+++++|.+++......      ....+++..+..++.|++.||+|||+  .+++||||||+||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dlkp~Ni  161 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS--LNFVHRDLATRNC  161 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH--CCeecccCChheE
Confidence            999999999999999999999999887543211      12357788999999999999999998  6799999999999


Q ss_pred             eeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc--CCCCCCCCCCCc
Q 016588          215 LVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS--GREASSSLSPDS  292 (386)
Q Consensus       215 ll~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t--g~~p~~~~~~~~  292 (386)
                      |++.++.++|+|||+++.+..............+..|++||...+..++.++|+|||||++|||++  |..||.......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999886543222111222334567999999888889999999999999999998  677887544321


Q ss_pred             hhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016588          293 SQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  355 (386)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~  355 (386)
                         .........      ...........+..++..+.+++.+||+.||++|||+.++++.|+
T Consensus       242 ---~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         242 ---VIENTGEFF------RDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             ---HHHHHHHHH------hhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence               111110000      000000111122334567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=5.3e-41  Score=307.41  Aligned_cols=245  Identities=24%  Similarity=0.314  Sum_probs=193.3

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEECCCCC------hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCCCc
Q 016588           91 IGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV  163 (386)
Q Consensus        91 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  163 (386)
                      ||+|+||+||++... +++.+|+|......      .+.+..|+.+++.++|+||+++.+++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999954 58899999864321      23567899999999999999999999999999999999999999


Q ss_pred             cccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCc
Q 016588          164 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS  243 (386)
Q Consensus       164 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~  243 (386)
                      ...+.... .....+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.++|+|||++........  ...
T Consensus        81 ~~~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVD-EENPGFPEPRACFYTAQIISGLEHLHQ--RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            87764321 133568899999999999999999998  7799999999999999999999999999876543221  123


Q ss_pred             cccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCH
Q 016588          244 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN  323 (386)
Q Consensus       244 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (386)
                      ...+++.|+|||.+.+..++.++|||||||++|||++|+.||.........  .....         ......  ...+.
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~---------~~~~~~--~~~~~  222 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQ---------RILNDS--VTYPD  222 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHH---------hhcccC--CCCcc
Confidence            446788899999999999999999999999999999999999864432110  00000         001110  12233


Q ss_pred             HHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016588          324 EGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  353 (386)
Q Consensus       324 ~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~~  353 (386)
                      ..+.++.+++.+||+.||++||     |+++++++
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            4556789999999999999999     67788865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.7e-41  Score=315.48  Aligned_cols=246  Identities=20%  Similarity=0.287  Sum_probs=192.0

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcC-CCCcccccccceeeCCeEEEEEEeecC
Q 016588           89 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      +.||+|+||.||++..+ ++..||+|.++..      ....+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999965 5889999986532      223477889999888 799999999999999999999999999


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  240 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~  240 (386)
                      |+|..++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.....  ..
T Consensus        81 g~L~~~~~-----~~~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~  151 (329)
T cd05588          81 GDLMFHMQ-----RQRKLPEEHARFYSAEISLALNFLHE--RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GD  151 (329)
T ss_pred             CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEECcCccccccccC--CC
Confidence            99987773     33568999999999999999999998  77999999999999999999999999998753211  11


Q ss_pred             CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCc--hhhHHHHHHhhhcccchhhhcchhhc
Q 016588          241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS--SQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       241 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                      ......|+..|+|||++.+..++.++|+|||||++|||++|+.||.......  .....+....        .+....  
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~--------~~~~~~--  221 (329)
T cd05588         152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ--------VILEKQ--  221 (329)
T ss_pred             ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHH--------HHHcCC--
Confidence            2234568889999999999999999999999999999999999997533211  1111111100        001111  


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCCC------HHHHHHH
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRPS------MSDVVTE  353 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt------~~evl~~  353 (386)
                      ...+...+.++.+++.+||+.||.+|||      +++++++
T Consensus       222 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         222 IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence            1223334567899999999999999997      5677654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1e-40  Score=313.24  Aligned_cols=263  Identities=26%  Similarity=0.441  Sum_probs=205.7

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeCC--------CcEEEEEECCCCC----hhHHHHHHHHHHcC-CCCcccccccceee
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQD--------GMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQE  147 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~~~~~~~~  147 (386)
                      ...+|++.+.||+|+||.||+|....        +..||+|......    .+++.+|+.+++++ +||||+++++++..
T Consensus        10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (334)
T cd05100          10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   89 (334)
T ss_pred             CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence            34578889999999999999997421        2368999765432    34688899999999 79999999999999


Q ss_pred             CCeEEEEEEeecCCCccccccCCCc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee
Q 016588          148 NNLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV  216 (386)
Q Consensus       148 ~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill  216 (386)
                      .+..++++||+.+|+|.+++.....           .....+++..+..++.|++.||.|||+  ++++||||||+|||+
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~givH~dlkp~Nill  167 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS--QKCIHRDLAARNVLV  167 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH--CCeeccccccceEEE
Confidence            9999999999999999988753211           123457888999999999999999998  779999999999999


Q ss_pred             CCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhh
Q 016588          217 DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQD  295 (386)
Q Consensus       217 ~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~  295 (386)
                      +.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.....   ..
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~  244 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---EE  244 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH---HH
Confidence            9999999999999886644222222223334567999999998899999999999999999998 7888865432   11


Q ss_pred             HHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          296 LVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                      ....+..             ......+...+.++.+++.+||+.+|++|||+.++++.|+++....
T Consensus       245 ~~~~~~~-------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         245 LFKLLKE-------------GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             HHHHHHc-------------CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence            1111111             1111222334567899999999999999999999999999988543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.5e-41  Score=322.61  Aligned_cols=254  Identities=21%  Similarity=0.269  Sum_probs=198.1

Q ss_pred             HHHHhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC------CChhHHHHHHHHHHcCCCCcccccccceeeCCe
Q 016588           78 LSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNL  150 (386)
Q Consensus        78 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  150 (386)
                      +.....+|+..+.||+|+||.||++... ++..+|+|....      .....+.+|..+++.++||||+++++++.+.+.
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            3345578999999999999999999965 478999997542      223457789999999999999999999999999


Q ss_pred             EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  230 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~  230 (386)
                      .|+||||+++|+|.+++.      ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus       118 ~~lv~Ey~~gg~L~~~l~------~~~~~~~~~~~~~~qil~aL~~LH~--~~IvHrDLKp~NILl~~~~~~kL~DFG~a  189 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMS------NYDVPEKWAKFYTAEVVLALDAIHS--MGLIHRDVKPDNMLLDKHGHLKLADFGTC  189 (370)
T ss_pred             EEEEEcCCCCCcHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEECCCCCEEEEecccc
Confidence            999999999999998883      2347788889999999999999998  77999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhcccC----CCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcc
Q 016588          231 NFLGRTDVAGPSSQVTADEIFLASEVKEFRR----FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF  306 (386)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  306 (386)
                      ........ .......||+.|+|||++.+..    ++.++||||+||++|||++|..||......   .....+....  
T Consensus       190 ~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~---~~~~~i~~~~--  263 (370)
T cd05621         190 MKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV---GTYSKIMDHK--  263 (370)
T ss_pred             eecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH---HHHHHHHhCC--
Confidence            87643221 1123456899999999987543    788999999999999999999999864421   1111111000  


Q ss_pred             cchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCC--CCCHHHHHHH
Q 016588          307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSER--RPSMSDVVTE  353 (386)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~evl~~  353 (386)
                              ..+........+..+.+++..|++.++.+  |+|+.|++++
T Consensus       264 --------~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         264 --------NSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             --------cccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                    00100111123566889999999866644  8999999987

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=6.6e-41  Score=306.78  Aligned_cols=255  Identities=27%  Similarity=0.447  Sum_probs=199.8

Q ss_pred             cCCCcCCeecccCceEEEEEEeC------CCcEEEEEECCCCC---hhHHHHHHHHHHcCCCCcccccccceeeCCeEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (386)
                      .+|...+.||+|+||.||++...      ++..+++|......   .+.+.+|+++++.++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46777899999999999999732      35578888765433   3468899999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCc----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceE
Q 016588          154 IYEYIPNGSVSIHLYGPSQ----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAK  223 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~k  223 (386)
                      ++||+++++|.+++.....          .....+++..+..++.|++.|++|||+  ++++||||||+|||+++++.+|
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~~i~H~dlkp~nil~~~~~~~k  162 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS--LHFVHRDLATRNCLVGQGLVVK  162 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH--CCeecccccHhhEEEcCCCCEE
Confidence            9999999999988753211          112357889999999999999999998  7799999999999999999999


Q ss_pred             EcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHh
Q 016588          224 VADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQN  302 (386)
Q Consensus       224 l~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~  302 (386)
                      |+|||++................+++.|+|||...+..++.++|||||||++|||++ |..||......   ........
T Consensus       163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~~~  239 (280)
T cd05092         163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT---EAIECITQ  239 (280)
T ss_pred             ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH---HHHHHHHc
Confidence            999999876543222112223334677999999998999999999999999999998 88888654321   11111111


Q ss_pred             hhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016588          303 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  355 (386)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~  355 (386)
                      .             .....+..++..+.+++.+||+.||.+||++.++++.|+
T Consensus       240 ~-------------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         240 G-------------RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             C-------------ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            0             001122234566899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.6e-41  Score=317.42  Aligned_cols=240  Identities=23%  Similarity=0.279  Sum_probs=192.9

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCC
Q 016588           89 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  161 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  161 (386)
                      +.||+|+||.||++... ++..||+|.....      ....+..|.+++..++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999954 5889999975432      2345678899999999999999999999999999999999999


Q ss_pred             CccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCC
Q 016588          162 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP  241 (386)
Q Consensus       162 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~  241 (386)
                      +|..++.     ....+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~lH~~-~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~  152 (325)
T cd05594          81 ELFFHLS-----RERVFSEDRARFYGAEIVSALDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT  152 (325)
T ss_pred             cHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhc-CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence            9988773     335688999999999999999999962 479999999999999999999999999987532211  12


Q ss_pred             CccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccC
Q 016588          242 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF  321 (386)
Q Consensus       242 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (386)
                      .....+++.|+|||++.+..++.++|||||||++|||++|..||......   ........            ..  ..+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---~~~~~i~~------------~~--~~~  215 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELILM------------EE--IRF  215 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---HHHHHHhc------------CC--CCC
Confidence            23456888999999999999999999999999999999999999764421   11111110            00  112


Q ss_pred             CHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016588          322 TNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  353 (386)
Q Consensus       322 ~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~~  353 (386)
                      +...+.++.+++.+||+.||++|+     ++.+++++
T Consensus       216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            233456789999999999999996     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.7e-41  Score=324.32  Aligned_cols=249  Identities=20%  Similarity=0.250  Sum_probs=192.8

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      .|+..+.||+|+||+||+|... +++.||+|.+...      ....+.+|+.+++.++||||+++++.+.+.+..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5788899999999999999954 5889999986532      23457889999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      |+++|+|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++......
T Consensus        82 ~~~gg~L~~~l~-----~~~~~~e~~~~~~~~qi~~al~~lH~--~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          82 YIPGGDMMSLLI-----RMGIFPEDLARFYIAELTCAVESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             CCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            999999988874     23457888889999999999999998  77999999999999999999999999997533110


Q ss_pred             CC---------------------------------------------CCCCccccCcccccchhhhcccCCCcccchhhH
Q 016588          237 DV---------------------------------------------AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSF  271 (386)
Q Consensus       237 ~~---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSl  271 (386)
                      ..                                             ........||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (382)
T cd05625         155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  234 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence            00                                             000112468899999999999999999999999


Q ss_pred             HHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCC---HH
Q 016588          272 GVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS---MS  348 (386)
Q Consensus       272 Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt---~~  348 (386)
                      ||++|||++|..||....+..  .......    .       ............++++.+++.+|+ .+|++|++   +.
T Consensus       235 Gvil~elltG~~Pf~~~~~~~--~~~~i~~----~-------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~  300 (382)
T cd05625         235 GVILYEMLVGQPPFLAQTPLE--TQMKVIN----W-------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGAD  300 (382)
T ss_pred             hHHHHHHHhCCCCCCCCCHHH--HHHHHHc----c-------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence            999999999999998654311  1111100    0       000101111223456788888875 59999987   88


Q ss_pred             HHHHH
Q 016588          349 DVVTE  353 (386)
Q Consensus       349 evl~~  353 (386)
                      ++++|
T Consensus       301 ei~~h  305 (382)
T cd05625         301 EIKAH  305 (382)
T ss_pred             HHhcC
Confidence            88765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=9.3e-41  Score=303.57  Aligned_cols=253  Identities=25%  Similarity=0.454  Sum_probs=201.2

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-C---CcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-D---GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      .+|++.+.||+|+||.||+|... +   +..+|+|......    ...+.+|+.+++.++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46788899999999999999853 2   3479999865432    24678899999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      |||+++++|.+++..    ....+++..+..++.|++.||.|||+  ++++||||||+|||++.++.++|+|||++....
T Consensus        84 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          84 TEYMENGSLDAFLRK----HDGQFTVIQLVGMLRGIASGMKYLSD--MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            999999999998843    23457889999999999999999998  779999999999999999999999999988764


Q ss_pred             CCCCCC-CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          235 RTDVAG-PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       235 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      ...... ......++..|+|||.+.+..++.++|+||||+++||+++ |..||......   +........         
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~~~---------  225 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKAIEEG---------  225 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHHHhCC---------
Confidence            322111 1112223457999999998899999999999999999886 99998765431   111111111         


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHh
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  357 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~  357 (386)
                          .....+...+..+.+++.+||+.+|.+|||+.++++.|+++
T Consensus       226 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         226 ----YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ----CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                01112223456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4e-41  Score=313.53  Aligned_cols=238  Identities=24%  Similarity=0.343  Sum_probs=188.5

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcC-CCCcccccccceeeCCeEEEEEEeecC
Q 016588           89 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      +.||+|+||.||+|..+ ++..||+|.....      ..+....|..++... +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999965 4788999975432      233455666777654 899999999999999999999999999


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  240 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~  240 (386)
                      |+|..++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++......  .
T Consensus        81 g~L~~~~~-----~~~~~~~~~~~~~~~qi~~al~~LH~--~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~  151 (316)
T cd05592          81 GDLMFHIQ-----SSGRFDEARARFYAAEIICGLQFLHK--KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G  151 (316)
T ss_pred             CcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence            99988873     23468888999999999999999999  779999999999999999999999999987643222  2


Q ss_pred             CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhccc
Q 016588          241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  320 (386)
Q Consensus       241 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (386)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|..||.+...   ......+..              ....
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~~~~~i~~--------------~~~~  214 (316)
T cd05592         152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DELFDSILN--------------DRPH  214 (316)
T ss_pred             ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHc--------------CCCC
Confidence            23345688999999999988999999999999999999999999986442   111111110              0112


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCHH-HHHH
Q 016588          321 FTNEGMEEFIQLIVRCLDPSSERRPSMS-DVVT  352 (386)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~-evl~  352 (386)
                      .+...+.++.+++.+||+.||++||++. ++++
T Consensus       215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            2333456789999999999999999875 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-43  Score=303.63  Aligned_cols=247  Identities=27%  Similarity=0.397  Sum_probs=210.3

Q ss_pred             CCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCCC
Q 016588           85 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS  162 (386)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  162 (386)
                      |.+.+.||+|+||.||+|.++ +|+.+|+|+++-. ..+++..|+.++.+++.|++|++||.+..+..+|+|||||..|+
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS  114 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS  114 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence            445678999999999999966 5999999997744 57889999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCC
Q 016588          163 VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS  242 (386)
Q Consensus       163 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~  242 (386)
                      ..+.+.    ..++++.+..+..++...++||+|||.  -.-+|||||..||||+.+|.+||+|||.+-.+.++..  ..
T Consensus       115 iSDI~R----~R~K~L~E~EIs~iL~~TLKGL~YLH~--~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA--KR  186 (502)
T KOG0574|consen  115 ISDIMR----ARRKPLSEQEISAVLRDTLKGLQYLHD--LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA--KR  186 (502)
T ss_pred             HHHHHH----HhcCCccHHHHHHHHHHHHhHHHHHHH--HHHHHhhcccccEEEcccchhhhhhccccchhhhhHH--hh
Confidence            999985    456889999999999999999999998  4479999999999999999999999999987754322  23


Q ss_pred             ccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCC
Q 016588          243 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFT  322 (386)
Q Consensus       243 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (386)
                      ....||+.|||||++..-.|+.++||||||++..||.-|++||.+..+-..-             -+. -..+......+
T Consensus       187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI-------------FMI-PT~PPPTF~KP  252 (502)
T KOG0574|consen  187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI-------------FMI-PTKPPPTFKKP  252 (502)
T ss_pred             CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee-------------Eec-cCCCCCCCCCh
Confidence            4567999999999999999999999999999999999999999987762100             000 01122223456


Q ss_pred             HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          323 NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       323 ~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      +.++.++.+++++||..+|++|-|+-++++|
T Consensus       253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  253 EEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            6788999999999999999999999999876

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=7.4e-42  Score=320.45  Aligned_cols=250  Identities=22%  Similarity=0.263  Sum_probs=197.5

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ++|...+.||+|+||.||++... ++..||+|.....      ..+.+.+|+.+++.++|+||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            36888999999999999999954 5889999985432      2345778999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++|+|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~----~~~~l~~~~~~~~~~qi~~aL~~lH~--~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601          81 EYQPGGDLLSLLNR----YEDQFDEDMAQFYLAELVLAIHSVHQ--MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA  154 (330)
T ss_pred             CCCCCCCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence            99999999988842    23568889999999999999999999  7799999999999999999999999999987643


Q ss_pred             CCCCCCCccccCcccccchhhhc------ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccch
Q 016588          236 TDVAGPSSQVTADEIFLASEVKE------FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL  309 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  309 (386)
                      .... ......+++.|+|||++.      ...++.++|||||||++|||++|..||.......   ....+.   .... 
T Consensus       155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~~~i~---~~~~-  226 (330)
T cd05601         155 NKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK---TYNNIM---NFQR-  226 (330)
T ss_pred             CCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH---HHHHHH---cCCC-
Confidence            2221 122346788999999986      4567899999999999999999999997644311   111111   1000 


Q ss_pred             hhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                            .+........+.++.+++.+||+ +|.+|||+++++++
T Consensus       227 ------~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         227 ------FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             ------ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence                  00001111245678999999998 99999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.7e-41  Score=319.87  Aligned_cols=262  Identities=20%  Similarity=0.219  Sum_probs=201.2

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC---CCcEEEEEECCCCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ---DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      ..+|.+.+.||+|+||.||++...   .+..|++|.....  ....+|+++++.++||||+++++++...+..++|||++
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~  168 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY  168 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc
Confidence            457999999999999999999753   3568999986543  34568999999999999999999999999999999998


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      . ++|..++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.++|+|||++........
T Consensus       169 ~-~~l~~~l~-----~~~~l~~~~~~~i~~ql~~aL~~LH~--~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        169 K-CDLFTYVD-----RSGPLPLEQAITIQRRLLEALAYLHG--RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             C-CCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            6 57777762     34568899999999999999999998  7799999999999999999999999999977654333


Q ss_pred             CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchh-hHHHHHHhhhcc----cc-----
Q 016588          239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ-DLVELVQNSRDF----SN-----  308 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~----~~-----  308 (386)
                      ........+|..|+|||++.+..|+.++|||||||++|||++|+.||.+....... .+..........    ..     
T Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  320 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN  320 (392)
T ss_pred             cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence            33334567899999999999999999999999999999999999999876543221 111111110000    00     


Q ss_pred             hhh---hcchhhcccCC-------HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          309 LLK---ILDERLWSTFT-------NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       309 ~~~---~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ..+   ......+....       ...+.++.+++.+||+.||++|||+.|++.+
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            000   00000011000       1224568899999999999999999999987

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.4e-41  Score=324.22  Aligned_cols=250  Identities=22%  Similarity=0.247  Sum_probs=195.6

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC------CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      .+|++.+.||+|+||.||+|... +++.||+|.+..      .....+.+|+++++.++|+||+++++.+.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36888999999999999999954 588999998643      23455788999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++|+|.+++.     ....++...+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++..+..
T Consensus        81 E~~~~g~L~~~i~-----~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          81 DYIPGGDMMSLLI-----RLGIFEEDLARFYIAELTCAIESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             eCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence            9999999999884     23457888888999999999999998  7799999999999999999999999999753311


Q ss_pred             CCC-----------------------------------------CCCCccccCcccccchhhhcccCCCcccchhhHHHH
Q 016588          236 TDV-----------------------------------------AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVF  274 (386)
Q Consensus       236 ~~~-----------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvi  274 (386)
                      ...                                         ........||+.|+|||++.+..++.++|||||||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  233 (376)
T cd05598         154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  233 (376)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence            000                                         000123468899999999999999999999999999


Q ss_pred             HHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCC---CHHHHH
Q 016588          275 LLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP---SMSDVV  351 (386)
Q Consensus       275 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp---t~~evl  351 (386)
                      +|||++|+.||....+...   ...+.   ...       ...........+.++.+++.+|+ .+|.+|+   |+.+++
T Consensus       234 lyell~G~~Pf~~~~~~~~---~~~i~---~~~-------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell  299 (376)
T cd05598         234 LYEMLVGQPPFLADTPAET---QLKVI---NWE-------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIK  299 (376)
T ss_pred             eeehhhCCCCCCCCCHHHH---HHHHh---ccC-------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence            9999999999987553211   11110   000       00000111123456788888876 5999999   899999


Q ss_pred             HH
Q 016588          352 TE  353 (386)
Q Consensus       352 ~~  353 (386)
                      ++
T Consensus       300 ~h  301 (376)
T cd05598         300 AH  301 (376)
T ss_pred             CC
Confidence            77

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.1e-41  Score=314.98  Aligned_cols=239  Identities=20%  Similarity=0.287  Sum_probs=191.4

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcC-CCCcccccccceeeCCeEEEEEEeecC
Q 016588           89 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      +.||+|+||.||+|... +++.||+|.....      ..+.+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999965 4789999985432      234466788888766 799999999999999999999999999


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  240 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~  240 (386)
                      ++|...+.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.......  .
T Consensus        81 ~~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~  151 (321)
T cd05591          81 GDLMFQIQ-----RSRKFDEPRSRFYAAEVTLALMFLHR--HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--V  151 (321)
T ss_pred             CcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEeecccceecccCC--c
Confidence            99988773     33467888899999999999999999  779999999999999999999999999987542211  1


Q ss_pred             CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhccc
Q 016588          241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  320 (386)
Q Consensus       241 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (386)
                      ......++..|+|||++.+..++.++|||||||++|||++|+.||....+   ......+..            ...  .
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~---~~~~~~i~~------------~~~--~  214 (321)
T cd05591         152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE---DDLFESILH------------DDV--L  214 (321)
T ss_pred             cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH---HHHHHHHHc------------CCC--C
Confidence            22345688899999999988999999999999999999999999986442   111211111            000  1


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCC-------CHHHHHHH
Q 016588          321 FTNEGMEEFIQLIVRCLDPSSERRP-------SMSDVVTE  353 (386)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dp~~Rp-------t~~evl~~  353 (386)
                      .+...+.++.+++.+||+.||++||       ++++++++
T Consensus       215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            2222346789999999999999999       78888866

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.1e-40  Score=301.20  Aligned_cols=248  Identities=29%  Similarity=0.429  Sum_probs=198.3

Q ss_pred             cCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCC-ChhHHHHHHHHHHcCCCCccccccccee-eCCeEEEEEEeecC
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQ-ENNLQFLIYEYIPN  160 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~  160 (386)
                      .+|+..+.||+|+||.||++..+ +..+++|..... ..+.+.+|+.+++.++|+|++++++++. ..+..++++||+++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~   84 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK   84 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence            47888899999999999999875 678999986543 3456889999999999999999999754 55678999999999


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  240 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~  240 (386)
                      ++|.+++...   ....+++..+..++.|++.||+|||+  ++++||||||+||++++++.+||+|||++.......   
T Consensus        85 ~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  156 (256)
T cd05082          85 GSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEA--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  156 (256)
T ss_pred             CcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence            9999887432   23357888999999999999999998  779999999999999999999999999987543211   


Q ss_pred             CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcc
Q 016588          241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS  319 (386)
Q Consensus       241 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (386)
                        .....+..|+|||+..+..++.++|||||||++|||++ |+.||.....   ......+...             ...
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~~~-------------~~~  218 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEKG-------------YKM  218 (256)
T ss_pred             --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhcC-------------CCC
Confidence              12233456999999998899999999999999999997 8888875332   1222111111             111


Q ss_pred             cCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHh
Q 016588          320 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  357 (386)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~  357 (386)
                      ..+..++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            22233456789999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-40  Score=304.16  Aligned_cols=257  Identities=26%  Similarity=0.421  Sum_probs=204.0

Q ss_pred             cCCCcCCeecccCceEEEEEEeCC-C----cEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQD-G----MLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~-~----~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (386)
                      .+|+..+.||+|+||.||+|..+. +    ..+++|......    ..++.+|+..++.++|||++++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            567888999999999999998543 3    258999765443    3467889999999999999999999887 77899


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      |+||+++|+|.+++..    ....+++..+..++.|++.||+|||+  ++++||||||+||+++.++.+||+|||+++..
T Consensus        86 v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~--~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          86 ITQLMPLGCLLDYVRN----HKDNIGSQYLLNWCVQIAKGMSYLEE--KRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             EEecCCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHh--CCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence            9999999999998843    23458899999999999999999998  77999999999999999999999999999876


Q ss_pred             CCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          234 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       234 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      ..............+..|+|||......++.++|+||||+++||+++ |..||......   +....+...         
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~---------  227 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIPDLLEKG---------  227 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHhCC---------
Confidence            53222211222233567999999988889999999999999999998 99998765431   112111110         


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhc
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  362 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~  362 (386)
                          .....+..++.++.+++.+||..+|.+|||+.++++.|+++.++..
T Consensus       228 ----~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~  273 (279)
T cd05057         228 ----ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ  273 (279)
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence                0112222344568999999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-40  Score=299.72  Aligned_cols=249  Identities=32%  Similarity=0.512  Sum_probs=201.6

Q ss_pred             CeecccCceEEEEEEeCC----CcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecC
Q 016588           89 NLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      +.||+|+||.||+|....    +..+++|......    .+.+.+|++.++.++|+|++++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            468999999999999653    7889999865443    45788899999999999999999999999999999999999


Q ss_pred             CCccccccCCCcC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          161 GSVSIHLYGPSQV----SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       161 g~L~~~l~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      ++|.+++......    ....+++..+..++.|++.||.|||+  ++++||||+|+||+++.++.++|+|||.+......
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS--KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc--CCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence            9999988532110    13678999999999999999999999  77999999999999999999999999999877553


Q ss_pred             CCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      ..........++..|+|||......++.++||||+|+++|||++ |..||.....   ....+....             
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~-------------  222 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEYLRK-------------  222 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHc-------------
Confidence            32223334556778999999988889999999999999999999 6889887532   112211111             


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  355 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~  355 (386)
                      ......+...+.++.+++.+||+.+|++|||+.+++++|+
T Consensus       223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            1111233344677999999999999999999999999873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-41  Score=324.45  Aligned_cols=254  Identities=26%  Similarity=0.433  Sum_probs=218.0

Q ss_pred             CcCCeecccCceEEEEEEe-CC----CcEEEEEECC----CCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           86 SDKNLIGEGKFGEVYKGLL-QD----GMLVAIKKRP----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~-~~----~~~vavK~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      ...++||+|+||+||+|.+ ..    +-+||+|.+.    .....++.+|+.+|..++|||+++++|+|.... +-||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            4468999999999999984 33    3478888743    234678999999999999999999999998876 678999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      |++.|+|.+++..    .+..+.....+.+..||++||.|||.  ++++||||..+|||+.....+|+.|||+++.+...
T Consensus       778 ~mP~G~LlDyvr~----hr~~igsq~lLnw~~QIAkgM~YLe~--qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  778 LMPLGCLLDYVRE----HRDNIGSQDLLNWCYQIAKGMKYLEE--QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             hcccchHHHHHHH----hhccccHHHHHHHHHHHHHHHHHHHh--cchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            9999999999953    46678888999999999999999998  77999999999999999999999999999998776


Q ss_pred             CCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      ..........-++.|||-|.+....|+.++|||||||++||++| |..||.+....+                +.+.+..
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e----------------I~dlle~  915 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE----------------IPDLLEK  915 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH----------------hhHHHhc
Confidence            65555555566778999999999999999999999999999999 999999877533                2333344


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhc
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  362 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~  362 (386)
                      ..+...|+.++.+++.++.+||..|+..||+++++.+.+.+++++..
T Consensus       916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq  962 (1177)
T KOG1025|consen  916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ  962 (1177)
T ss_pred             cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence            44557788889999999999999999999999999999999988753

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.2e-40  Score=299.60  Aligned_cols=257  Identities=25%  Similarity=0.395  Sum_probs=205.6

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC------CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ++|+..+.||+|+||.||+|... +++.|++|....      .....+.+|++++++++|+|++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888999999999999999976 688999996432      12456889999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++++|..++.... .....+++..+..++.+++.||.|||+  .+++||||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFK-KQKRLIPERTIWKYFVQLCSALEHMHS--KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhc-ccCCCcCHHHHHHHHHHHHHHHHHHHh--CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999999988874321 123457889999999999999999998  7799999999999999999999999999876543


Q ss_pred             CCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      ..  .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||...... .....+...             .
T Consensus       159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~-------------~  222 (267)
T cd08224         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIE-------------K  222 (267)
T ss_pred             CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHHHhhhh-------------c
Confidence            21  1122345677899999999888999999999999999999999998654321 111111110             1


Q ss_pred             hhcccCCH-HHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhh
Q 016588          316 RLWSTFTN-EGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  358 (386)
Q Consensus       316 ~~~~~~~~-~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~  358 (386)
                      ......+. ..+..+.+++.+||..+|++|||+.++++.|.++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         223 CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            11111222 34567899999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.5e-41  Score=315.03  Aligned_cols=244  Identities=21%  Similarity=0.294  Sum_probs=193.9

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC------CChhHHHHHHHHHHcCCC-CcccccccceeeCCeEEEEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQH-RNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~  155 (386)
                      +|+..+.||+|+||.||+|..+ +++.||+|....      ...+.+..|.+++..++| ++|+++++++...+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788899999999999999965 478899997543      233457788899998865 56888999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++|+|..++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.....
T Consensus        81 E~~~~g~L~~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          81 EYVNGGDLMYHIQ-----QVGKFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             cCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            9999999988873     33457888999999999999999999  7799999999999999999999999999864321


Q ss_pred             CCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      ..  .......|++.|+|||++.+..++.++|||||||++|||++|+.||.....   ......+..            .
T Consensus       154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~i~~------------~  216 (324)
T cd05587         154 GG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DELFQSIME------------H  216 (324)
T ss_pred             CC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHc------------C
Confidence            11  122345688899999999999999999999999999999999999986442   111111111            0


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCH-----HHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM-----SDVVTE  353 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~-----~evl~~  353 (386)
                        ....+...+.++.+++.+||+.||.+|++.     .+++++
T Consensus       217 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         217 --NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             --CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence              012223345678999999999999999987     566654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-40  Score=303.20  Aligned_cols=250  Identities=28%  Similarity=0.474  Sum_probs=194.1

Q ss_pred             CeecccCceEEEEEEeCC-Cc--EEEEEECCCC----ChhHHHHHHHHHHcC-CCCcccccccceeeCCeEEEEEEeecC
Q 016588           89 NLIGEGKFGEVYKGLLQD-GM--LVAIKKRPGA----PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~----~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      +.||+|+||.||+|..++ +.  .+++|.....    ..+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999999653 33  4688876532    234678899999999 899999999999999999999999999


Q ss_pred             CCccccccCCCc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 016588          161 GSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  229 (386)
Q Consensus       161 g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl  229 (386)
                      ++|.+++.....           .....+++..+..++.|++.||+|||+  ++++||||||+||++++++.+|++|||+
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~--~~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccccceEEEcCCCeEEECCCCC
Confidence            999988753221           112357889999999999999999998  7899999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccc
Q 016588          230 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSN  308 (386)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  308 (386)
                      +......   ........+..|+|||++....++.++|||||||++|||++ |..||......   .......       
T Consensus       159 ~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~~-------  225 (270)
T cd05047         159 SRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKLP-------  225 (270)
T ss_pred             ccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HHHHHHh-------
Confidence            8643211   11111223456999999988889999999999999999997 99998754321   1111111       


Q ss_pred             hhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhh
Q 016588          309 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD  359 (386)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~  359 (386)
                            .......+...+.++.+++.+||+.+|.+|||+.++++.|+++++
T Consensus       226 ------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~~  270 (270)
T cd05047         226 ------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  270 (270)
T ss_pred             ------CCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence                  111111222344678999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-40  Score=300.52  Aligned_cols=248  Identities=29%  Similarity=0.472  Sum_probs=202.6

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCC--hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeec
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP--TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  159 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  159 (386)
                      ..+|+..+.||+|+||.||+|... ++.|++|......  .+++.+|+.+++.++|+|++++++++.+.+..++||||++
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            457888899999999999999875 7889999865543  4578899999999999999999999998999999999999


Q ss_pred             CCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016588          160 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  239 (386)
Q Consensus       160 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~  239 (386)
                      +++|.+++...   ....+++..+..++.|++.||.|||+  ++++|+||||+||+++.++.++|+|||.++....... 
T Consensus        84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lh~--~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          84 KGSLVDYLRSR---GRAVITLAQQLGFALDVCEGMEYLEE--KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             CCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            99999988432   22368899999999999999999998  7799999999999999999999999999887633211 


Q ss_pred             CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          240 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       240 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                          ....+..|+|||.+....++.++||||||+++||+++ |..||.....   .++...+...             ..
T Consensus       158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~-------------~~  217 (256)
T cd05039         158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPHVEKG-------------YR  217 (256)
T ss_pred             ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHhcC-------------CC
Confidence                2234556999999988889999999999999999997 9999875432   2222211111             11


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHH
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  356 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~  356 (386)
                      ...+...++++.+++.+||+.+|++|||++++++.|++
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         218 MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            12223345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.3e-40  Score=300.42  Aligned_cols=247  Identities=25%  Similarity=0.384  Sum_probs=200.5

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC-----CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      +|+..+.||+|++|.||+|..+ ++..|++|....     ....++.+|+++++.++|||++++++++...+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4677889999999999999965 588999997542     2345688899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +++++|.+++...   ....+++..+..++.+++.||.|||+  .+++|+||||+||+++.++.++|+|||+++......
T Consensus        81 ~~~~~L~~~l~~~---~~~~~~~~~~~~i~~~l~~al~~lH~--~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          81 AENGDLHKLLKMQ---RGRPLPEDQVWRFFIQILLGLAHLHS--KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             CCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            9999999988532   23568888999999999999999998  789999999999999999999999999988664322


Q ss_pred             CCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhh
Q 016588          238 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  317 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (386)
                      .  ......++..|+|||+..+..++.++|+|||||++|||++|..||.....   ........             ...
T Consensus       156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~-------------~~~  217 (256)
T cd08529         156 N--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GALILKII-------------RGV  217 (256)
T ss_pred             c--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH-------------cCC
Confidence            1  12234567789999999988899999999999999999999999976442   11111110             011


Q ss_pred             cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ....+...+..+.+++.+||+.+|++||++.+++++
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         218 FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            112222445678999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.4e-40  Score=308.03  Aligned_cols=260  Identities=26%  Similarity=0.443  Sum_probs=202.5

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCc----EEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGM----LVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  152 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  152 (386)
                      ..+|+..+.||+|+||.||+|... ++.    .+|+|......    ..++.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            356778899999999999999853 343    57888765432    23578899999999999999999998754 467


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~  232 (386)
                      +++||+++|+|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||+++.
T Consensus        85 ~v~e~~~~g~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~  158 (303)
T cd05110          85 LVTQLMPHGCLLDYVHE----HKDNIGSQLLLNWCVQIAKGMMYLEE--RRLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (303)
T ss_pred             eeehhcCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHhh--cCeeccccccceeeecCCCceEEcccccccc
Confidence            89999999999988742    23457888999999999999999998  7799999999999999999999999999987


Q ss_pred             cCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhh
Q 016588          233 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK  311 (386)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (386)
                      ..............++..|+|||.+.+..++.++|||||||++||+++ |+.||.+...   ....+......       
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~~-------  228 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REIPDLLEKGE-------  228 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHCCC-------
Confidence            643322222223345667999999998899999999999999999997 8899876442   11222221111       


Q ss_pred             hcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhccc
Q 016588          312 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNL  364 (386)
Q Consensus       312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~~~  364 (386)
                            ....+..++..+.+++..||..+|++||++.++++.|+.+.+...+.
T Consensus       229 ------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~~~  275 (303)
T cd05110         229 ------RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRY  275 (303)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchhhh
Confidence                  01112223456899999999999999999999999999988775433

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.2e-40  Score=303.08  Aligned_cols=254  Identities=25%  Similarity=0.470  Sum_probs=200.3

Q ss_pred             cCCCcCCeecccCceEEEEEEeCC-C---cEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQD-G---MLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      .+|+..+.||+|+||.||+|.... +   ..|++|......    ..++..|+.+++.++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            356778999999999999999643 3   369999865432    34688899999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      |||+++++|.+++..    ....+++..+..++.|++.||.|||+  ++++|+||||+||+++.++.++|+|||++....
T Consensus        84 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~~l~~al~~lH~--~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          84 TEFMENGALDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLSE--MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EecCCCCcHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccChheEEEcCCCcEEECCCccccccc
Confidence            999999999988843    23467899999999999999999998  779999999999999999999999999987654


Q ss_pred             CCCCCCCCc---cccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          235 RTDVAGPSS---QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       235 ~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      .........   ....+..|+|||.+.+..++.++|||||||++||+++ |..||......   .....+...       
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~~~-------  227 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIEQD-------  227 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHHcC-------
Confidence            322111111   1112446999999998899999999999999999886 99998764421   112211110       


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhh
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  358 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~  358 (386)
                            .....+..++..+.+++.+||+.+|.+||++++++..|+.++
T Consensus       228 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  269 (269)
T cd05065         228 ------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI  269 (269)
T ss_pred             ------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence                  011122334567899999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.5e-41  Score=306.65  Aligned_cols=268  Identities=26%  Similarity=0.382  Sum_probs=199.9

Q ss_pred             cCCCcCCeecccCceEEEEEEe-----CCCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeC--CeE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQ  151 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  151 (386)
                      ..|+..+.||+|+||.||++..     .++..||+|......    ...+.+|+.+++.++|||++++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4567889999999999999974     246789999865332    34688899999999999999999988765  568


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      ++||||+++++|.+++..    ....+++..+..++.|++.||.|||+  +|++||||||+||+++.++.++|+|||++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~i~~~i~~aL~~lH~--~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPR----NKNKINLKQQLKYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             EEEEEccCCCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccchheEEEcCCCCEEECCCcccc
Confidence            899999999999988732    22357899999999999999999998  789999999999999999999999999988


Q ss_pred             ccCCCCCC-CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          232 FLGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       232 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      ........ .......++..|+|||++.+..++.++|||||||++|||+++..|........... ..............
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  236 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKM-IGPTHGQMTVTRLV  236 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhh-cccccccccHHHHH
Confidence            76432221 11223445667999999988889999999999999999999876643321100000 00000000000000


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHh
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  357 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~  357 (386)
                      .......+...+..++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         237 RVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            11111111222334567899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-40  Score=299.49  Aligned_cols=246  Identities=27%  Similarity=0.433  Sum_probs=194.5

Q ss_pred             CeecccCceEEEEEEeCC-C---cEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecC
Q 016588           89 NLIGEGKFGEVYKGLLQD-G---MLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      +.||+|+||.||+|.... +   ..+|+|......    .+++.+|+.+++.++|+|++++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            469999999999998432 2   689999865443    346788999999999999999999876 4467999999999


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  240 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~  240 (386)
                      ++|.+++..     ...+++..+..++.|++.||.|||+  .+++|+||||+||+++.++.+||+|||+++.........
T Consensus        80 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lh~--~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          80 GPLLKYLKK-----RREIPVSDLKELAHQVAMGMAYLES--KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHhh--cCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            999998843     2367899999999999999999998  779999999999999999999999999988764322211


Q ss_pred             -CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          241 -PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       241 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                       ......++..|+|||...+..++.++||||||+++||+++ |..||.....   ......+....             .
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~~~~-------------~  216 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLESGE-------------R  216 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcCC-------------c
Confidence             1112223457999999998899999999999999999998 9999876442   22222221111             1


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhh
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  358 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~  358 (386)
                      ...+..++..+.+++.+||+.+|++|||+.++++.|++..
T Consensus       217 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         217 LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            1223334567899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5.9e-41  Score=312.66  Aligned_cols=239  Identities=21%  Similarity=0.317  Sum_probs=191.6

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEECCC------CChhHHHHHHHHHHcC-CCCcccccccceeeCCeEEEEEEeecC
Q 016588           89 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      +.||+|+||.||+|..+ ++..||+|....      .....+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999965 478999997543      2234567788888877 799999999999999999999999999


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  240 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~  240 (386)
                      ++|..++.     ....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||+++......  .
T Consensus        81 ~~L~~~~~-----~~~~l~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~  151 (318)
T cd05570          81 GDLMFHIQ-----RSGRFDEPRARFYAAEIVLGLQFLHE--RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--V  151 (318)
T ss_pred             CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--C
Confidence            99988773     33468899999999999999999998  779999999999999999999999999986532111  1


Q ss_pred             CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhccc
Q 016588          241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  320 (386)
Q Consensus       241 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (386)
                      ......++..|+|||++.+..++.++|||||||++|||++|..||.....   .........            ..  ..
T Consensus       152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~---~~~~~~i~~------------~~--~~  214 (318)
T cd05570         152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---DELFQSILE------------DE--VR  214 (318)
T ss_pred             cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---HHHHHHHHc------------CC--CC
Confidence            12334578889999999999999999999999999999999999975432   111111110            00  11


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCH-----HHHHHH
Q 016588          321 FTNEGMEEFIQLIVRCLDPSSERRPSM-----SDVVTE  353 (386)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dp~~Rpt~-----~evl~~  353 (386)
                      .+...+..+.+++.+||+.||++|||+     .+++++
T Consensus       215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            222345678999999999999999999     888765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=9.8e-41  Score=312.56  Aligned_cols=246  Identities=20%  Similarity=0.289  Sum_probs=190.6

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcC-CCCcccccccceeeCCeEEEEEEeecC
Q 016588           89 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      +.||+|+||.||+|..+ +++.+|+|.....      ....+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999965 5789999975432      223467788888776 899999999999999999999999999


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  240 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~  240 (386)
                      |+|..++.     ....+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||+++......  .
T Consensus        81 ~~L~~~~~-----~~~~l~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~  151 (329)
T cd05618          81 GDLMFHMQ-----RQRKLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--D  151 (329)
T ss_pred             CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--C
Confidence            99987773     33568899999999999999999998  779999999999999999999999999987532211  1


Q ss_pred             CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCch--hhHHHHHHhhhcccchhhhcchhhc
Q 016588          241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS--QDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       241 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                      ......||..|+|||++.+..++.++|||||||++|||++|..||........  ..........        +....  
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------i~~~~--  221 (329)
T cd05618         152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--------ILEKQ--  221 (329)
T ss_pred             ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH--------HhcCC--
Confidence            22345688899999999999999999999999999999999999964322111  0001111000        00111  


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCCCH------HHHHHH
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRPSM------SDVVTE  353 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~------~evl~~  353 (386)
                      ...+...+.++.+++.+||+.||++|||+      .+++++
T Consensus       222 ~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         222 IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            12333445678999999999999999984      676655

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=286.55  Aligned_cols=265  Identities=22%  Similarity=0.299  Sum_probs=206.4

Q ss_pred             HHhcCCCcCCeecccCceEEEEEE-eCCCcEEEEEECCC---CChhHHHHHHHHHHcCCCCcccccccceeeC-----Ce
Q 016588           80 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG---APTQEFIDEVCFLASIQHRNLVTLLGYCQEN-----NL  150 (386)
Q Consensus        80 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  150 (386)
                      ....+|.+.+.||+|||+-||.++ ..++..+|+|++.-   ...+..++|++.-++++|||+++++++....     ..
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            345789999999999999999999 66788999998543   3455678999999999999999999987543     35


Q ss_pred             EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  230 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~  230 (386)
                      .|++++|+..|+|.+.+.... .....+++.+.+.++.++.+||++||+..+++.||||||.|||+.+++.+++.|||.+
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k-~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~  176 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLK-IKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA  176 (302)
T ss_pred             EEEEeehhccccHHHHHHHHh-hcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence            899999999999988875432 3456789999999999999999999996566999999999999999999999999998


Q ss_pred             cccCCCCCC-------CCCccccCcccccchhhhc---ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHH
Q 016588          231 NFLGRTDVA-------GPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV  300 (386)
Q Consensus       231 ~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~  300 (386)
                      +...-.-..       ........|..|.|||.+.   +...++++|||||||++|+|+.|..||+.... .+..+.   
T Consensus       177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgSla---  252 (302)
T KOG2345|consen  177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGSLA---  252 (302)
T ss_pred             cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCeEE---
Confidence            765321111       1112223566799999875   44568999999999999999999999986443 111111   


Q ss_pred             HhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhh
Q 016588          301 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  358 (386)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~  358 (386)
                               ..+....+..+.....++.+.++++.|++.||.+||++.+++.+++.++
T Consensus       253 ---------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  253 ---------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ---------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                     1111222211222225678999999999999999999999999998875

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.1e-40  Score=310.62  Aligned_cols=238  Identities=22%  Similarity=0.324  Sum_probs=188.8

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcC-CCCcccccccceeeCCeEEEEEEeecC
Q 016588           89 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      +.||+|+||.||+|..+ ++..||+|.....      .......|..++... +||||+++++++.+.+..|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999965 5889999975432      234466677777654 899999999999999999999999999


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  240 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~  240 (386)
                      |+|..++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.++|+|||+++......  .
T Consensus        81 g~L~~~i~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  151 (316)
T cd05620          81 GDLMFHIQ-----DKGRFDLYRATFYAAEIVCGLQFLHS--KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--N  151 (316)
T ss_pred             CcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--C
Confidence            99988873     23567888999999999999999998  779999999999999999999999999987432111  1


Q ss_pred             CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhccc
Q 016588          241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  320 (386)
Q Consensus       241 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (386)
                      ......++..|+|||++.+..++.++|||||||++|||++|..||.....   ....+.....          .    ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~~~~~~~~----------~----~~  214 (316)
T cd05620         152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DELFESIRVD----------T----PH  214 (316)
T ss_pred             ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHhC----------C----CC
Confidence            22345688899999999999999999999999999999999999976432   1111111100          0    11


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCHH-HHHH
Q 016588          321 FTNEGMEEFIQLIVRCLDPSSERRPSMS-DVVT  352 (386)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~-evl~  352 (386)
                      .+...+.++.+++.+||+.||++||++. ++++
T Consensus       215 ~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~  247 (316)
T cd05620         215 YPRWITKESKDILEKLFERDPTRRLGVVGNIRG  247 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            2223446789999999999999999984 5653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5.1e-41  Score=313.82  Aligned_cols=244  Identities=20%  Similarity=0.294  Sum_probs=193.6

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcC-CCCcccccccceeeCCeEEEEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      +|...+.||+|+||.||+|... ++..||+|.....      ....+..|..++..+ +|++|+++++++...+..|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778899999999999999965 4789999975432      123456677777776 5899999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++|+|..++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~~g~L~~~~~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          81 EYVNGGDLMYQIQ-----QVGRFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             cCCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            9999999988873     23457888999999999999999998  7799999999999999999999999999875432


Q ss_pred             CCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      ..  .......|++.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+...+..            .
T Consensus       154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i~~------------~  216 (323)
T cd05616         154 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIME------------H  216 (323)
T ss_pred             CC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHHHHHHh------------C
Confidence            11  122345688899999999999999999999999999999999999986442   112211111            0


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCH-----HHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM-----SDVVTE  353 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~-----~evl~~  353 (386)
                      .  ..++...+.++.+++.+||+.||++|++.     .+++++
T Consensus       217 ~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         217 N--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             C--CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence            0  12233345678999999999999999985     566543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.9e-40  Score=301.38  Aligned_cols=258  Identities=24%  Similarity=0.365  Sum_probs=204.9

Q ss_pred             cCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ++|+..+.||+|+||.||++.. .++..+++|.....      ...++.+|+.+++.++|+||+++++++...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4677889999999999999995 46889999974321      2346788999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++++|.+++.... .....+++..+..++.|++.||.|||+  ++++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFK-KQKRLIPEKTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            9999999988874321 123568899999999999999999998  7799999999999999999999999999876543


Q ss_pred             CCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      ...  ......++..|+|||...+..++.++|+||||+++|||++|..||...... .......+..            .
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~------------~  223 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEQ------------C  223 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhhhhhc------------C
Confidence            221  122345777899999998888999999999999999999999998754321 1111111110            0


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhh
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  358 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~  358 (386)
                      ..........+..+.+++.+||+.||++|||+.+|++.+.++.
T Consensus       224 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         224 DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            0011112235567999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.1e-40  Score=309.61  Aligned_cols=262  Identities=21%  Similarity=0.290  Sum_probs=195.4

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      ++|...+.||+|+||.||+|..+ ++..||+|.....    ....+.+|+.+++.++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            46888999999999999999965 5788999975422    234577899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +++ +|..++..    ....+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++.......
T Consensus        86 ~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          86 LDK-DLKQYMDD----CGNIMSMHNVKIFLYQILRGLAYCHR--RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             CCC-CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence            975 77666632    23457888899999999999999998  779999999999999999999999999987643321


Q ss_pred             CCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhh----
Q 016588          238 VAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI----  312 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  312 (386)
                      .  ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....................    
T Consensus       159 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07872         159 K--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND  236 (309)
T ss_pred             c--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence            1  1223456788999998865 46789999999999999999999999875542221111111000000000000    


Q ss_pred             --cc---hhhc----ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          313 --LD---ERLW----STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       313 --~~---~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                        .+   +...    .......+.++.+++.+||+.||.+|||+.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence              00   0000    00111235678999999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.2e-40  Score=299.92  Aligned_cols=253  Identities=25%  Similarity=0.448  Sum_probs=202.2

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCC--ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      ..++|...+.||+|+||.||++...++..+++|.....  ..+.+.+|+++++.++|+|++++++++.. ...+++|||+
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            34678889999999999999999777788999976543  24578899999999999999999999887 7789999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++++|.+++...   ....+++..+..++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||.+........
T Consensus        83 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  157 (260)
T cd05073          83 AKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  157 (260)
T ss_pred             CCCcHHHHHHhC---CccccCHHHHHHHHHHHHHHHHHHHh--CCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence            999999888432   23457888899999999999999998  7799999999999999999999999999876643221


Q ss_pred             CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhh
Q 016588          239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  317 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (386)
                       .......++..|+|||.+....++.++|+|||||++|++++ |..||......   .........             .
T Consensus       158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~~~-------------~  220 (260)
T cd05073         158 -TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRALERG-------------Y  220 (260)
T ss_pred             -ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHhCC-------------C
Confidence             11222334566999999998889999999999999999999 88898764321   111111111             1


Q ss_pred             cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHH
Q 016588          318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  356 (386)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~  356 (386)
                      ....+...+.++.+++.+||+.+|++||++.++++.|+.
T Consensus       221 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         221 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            111222344678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.4e-40  Score=302.18  Aligned_cols=251  Identities=22%  Similarity=0.299  Sum_probs=197.1

Q ss_pred             cCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC---ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      .+|+..+.||+|+||.||+|.. .++..||+|.....   ....+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            4788899999999999999995 46889999985432   2345778999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||+|+||+++.++.++|+|||++....... 
T Consensus        89 ~~~~L~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-  160 (267)
T cd06646          89 GGGSLQDIYH-----VTGPLSELQIAYVCRETLQGLAYLHS--KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-  160 (267)
T ss_pred             CCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCCEEECcCccceeecccc-
Confidence            9999998874     23467889999999999999999998  779999999999999999999999999988664321 


Q ss_pred             CCCCccccCcccccchhhhc---ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          239 AGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                       .......++..|+|||.+.   ...++.++|+|||||++|||++|+.||....+.....  ..    .. .   ....+
T Consensus       161 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--~~----~~-~---~~~~~  229 (267)
T cd06646         161 -AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--LM----SK-S---NFQPP  229 (267)
T ss_pred             -cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--ee----ec-C---CCCCC
Confidence             1122345777899999874   3457889999999999999999999986543211100  00    00 0   00000


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                      ..  ......+..+.+++.+||+.+|++|||+++++++|
T Consensus       230 ~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         230 KL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            00  11123446789999999999999999999999764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.5e-40  Score=309.64  Aligned_cols=238  Identities=24%  Similarity=0.352  Sum_probs=189.1

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHc-CCCCcccccccceeeCCeEEEEEEeecC
Q 016588           89 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLAS-IQHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      +.||+|+||.||+|... ++..||+|.....      .......|..++.. ++||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999965 4789999975432      23446667777775 4899999999999999999999999999


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  240 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~  240 (386)
                      |+|..++.     ....+++.....++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.......  .
T Consensus        81 g~L~~~l~-----~~~~~~~~~~~~~~~qi~~al~~LH~--~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  151 (316)
T cd05619          81 GDLMFHIQ-----SCHKFDLPRATFYAAEIICGLQFLHS--KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--A  151 (316)
T ss_pred             CcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--C
Confidence            99998873     23467888999999999999999998  779999999999999999999999999987532211  1


Q ss_pred             CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhccc
Q 016588          241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  320 (386)
Q Consensus       241 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (386)
                      ......+|..|+|||++.+..++.++|||||||++|||++|..||.....   ......+...          .    ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~~i~~~----------~----~~  214 (316)
T cd05619         152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELFQSIRMD----------N----PC  214 (316)
T ss_pred             ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhC----------C----CC
Confidence            22345678899999999998999999999999999999999999986442   1122111110          0    11


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCHH-HHHH
Q 016588          321 FTNEGMEEFIQLIVRCLDPSSERRPSMS-DVVT  352 (386)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~-evl~  352 (386)
                      .+...+.++.+++.+||+.||++||++. ++++
T Consensus       215 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         215 YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            2223346689999999999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-40  Score=297.56  Aligned_cols=245  Identities=29%  Similarity=0.487  Sum_probs=195.8

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCCCcc
Q 016588           89 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVS  164 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  164 (386)
                      +.||.|+||.||++...+++.|++|......    ...+.+|++++++++|+||+++++++...+..++||||+.+++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            4689999999999997668999999855432    346889999999999999999999999999999999999999999


Q ss_pred             ccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCcc
Q 016588          165 IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ  244 (386)
Q Consensus       165 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~~  244 (386)
                      +++..    ....+++..+..++.+++.||.|||+  ++++||||||+||+++.++.++|+|||++..............
T Consensus        81 ~~l~~----~~~~~~~~~~~~~~~~~~~~l~~lH~--~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (251)
T cd05041          81 TFLRK----KKNRLTVKKLLQMSLDAAAGMEYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL  154 (251)
T ss_pred             HHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence            88743    23357888999999999999999998  7799999999999999999999999999876543221111122


Q ss_pred             ccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCH
Q 016588          245 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN  323 (386)
Q Consensus       245 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (386)
                      ...+..|+|||.+.+..++.++|+|||||++|||++ |..||.......   .......             ......+.
T Consensus       155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~~~~~~-------------~~~~~~~~  218 (251)
T cd05041         155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TRERIES-------------GYRMPAPQ  218 (251)
T ss_pred             CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HHHHHhc-------------CCCCCCCc
Confidence            233556999999988889999999999999999999 788887654321   1111111             01112233


Q ss_pred             HHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016588          324 EGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  355 (386)
Q Consensus       324 ~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~  355 (386)
                      ..+.++.+++.+||+.+|.+|||+.|+++.|+
T Consensus       219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             cCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            34567999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.8e-40  Score=300.88  Aligned_cols=256  Identities=26%  Similarity=0.454  Sum_probs=202.4

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCC----CcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (386)
                      ..+|...+.||+|+||.||+|...+    ...|++|......    .+.+.+|+.+++.++|||++++++++.+ +..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            3567888999999999999998543    3468999755433    3468889999999999999999998876 45689


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      ||||+++++|.+++..    ....+++..+..++.+++.||.|||+  .+++||||||+||+++.++.++|+|||+++..
T Consensus        84 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          84 VMELAPLGELRSYLQV----NKYSLDLASLILYSYQLSTALAYLES--KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             EEEcCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccChheEEEecCCCeEEccCceeeec
Confidence            9999999999999843    23357899999999999999999998  77999999999999999999999999998876


Q ss_pred             CCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          234 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       234 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      ....... .....++..|+|||.+....++.++||||||+++||+++ |..||......   .........         
T Consensus       158 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~~~~---------  224 (270)
T cd05056         158 EDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGRIENG---------  224 (270)
T ss_pred             cccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHcC---------
Confidence            4432211 122234457999999988889999999999999999986 99998765431   111111110         


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                          .+...+..++.++.+++.+||..+|.+|||+.++++.|+++.++.
T Consensus       225 ----~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~  269 (270)
T cd05056         225 ----ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE  269 (270)
T ss_pred             ----CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence                011223344567999999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.7e-41  Score=315.00  Aligned_cols=235  Identities=22%  Similarity=0.279  Sum_probs=189.5

Q ss_pred             CeecccCceEEEEEEe----CCCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeec
Q 016588           89 NLIGEGKFGEVYKGLL----QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  159 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  159 (386)
                      +.||+|+||.||++..    .++..+|+|.+...     ....+..|++++++++||||+++++++...+..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999874    35789999985432     23356789999999999999999999999999999999999


Q ss_pred             CCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016588          160 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  239 (386)
Q Consensus       160 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~  239 (386)
                      +++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++......  
T Consensus        82 ~~~L~~~l~-----~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--  152 (318)
T cd05582          82 GGDLFTRLS-----KEVMFTEEDVKFYLAELALALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--  152 (318)
T ss_pred             CCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--
Confidence            999988873     23468899999999999999999999  779999999999999999999999999987653321  


Q ss_pred             CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcc
Q 016588          240 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS  319 (386)
Q Consensus       240 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (386)
                      .......++..|+|||.+.+..++.++|||||||++|||++|+.||.....   ......+..            ..  .
T Consensus       153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~---~~~~~~i~~------------~~--~  215 (318)
T cd05582         153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR---KETMTMILK------------AK--L  215 (318)
T ss_pred             CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH---HHHHHHHHc------------CC--C
Confidence            122345688899999999988899999999999999999999999976432   111111110            00  1


Q ss_pred             cCCHHHHHHHHHHHhHccCCCCCCCCCHHH
Q 016588          320 TFTNEGMEEFIQLIVRCLDPSSERRPSMSD  349 (386)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~e  349 (386)
                      ..+...+.++.+++.+||+.||++|||+.+
T Consensus       216 ~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         216 GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            122334567899999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.7e-40  Score=302.26  Aligned_cols=244  Identities=22%  Similarity=0.282  Sum_probs=190.5

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCCCc
Q 016588           91 IGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV  163 (386)
Q Consensus        91 lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  163 (386)
                      ||+|+||.||++..+ +++.+|+|.....      .......|++++++++||||+++++++......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999954 5899999975432      123456699999999999999999999999999999999999999


Q ss_pred             cccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCc
Q 016588          164 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS  243 (386)
Q Consensus       164 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~  243 (386)
                      .+++...   ....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||++.......   ...
T Consensus        81 ~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~  152 (277)
T cd05607          81 KYHIYNV---GERGLEMERVIHYSAQITCGILHLHS--MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TIT  152 (277)
T ss_pred             HHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHH--CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eee
Confidence            8777432   23457888899999999999999998  779999999999999999999999999987664321   122


Q ss_pred             cccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCH
Q 016588          244 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN  323 (386)
Q Consensus       244 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (386)
                      ...++..|+|||++.+..++.++||||+||++|||++|..||........  ..+......         ..... ....
T Consensus       153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~---------~~~~~-~~~~  220 (277)
T cd05607         153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTL---------EDEVK-FEHQ  220 (277)
T ss_pred             ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhh---------ccccc-cccc
Confidence            34577889999999988899999999999999999999999976443211  111111100         00000 0111


Q ss_pred             HHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          324 EGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       324 ~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                      ..+.++.+++.+||+.||++||+++|+++.+
T Consensus       221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         221 NFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             cCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            2356689999999999999999997776443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.6e-40  Score=300.02  Aligned_cols=253  Identities=26%  Similarity=0.361  Sum_probs=189.5

Q ss_pred             CeecccCceEEEEEEeCC---CcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCC
Q 016588           89 NLIGEGKFGEVYKGLLQD---GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  161 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  161 (386)
                      +.||+|+||.||+|...+   +..+++|......    ...+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            358999999999998543   4578999765432    235788999999999999999999999988999999999999


Q ss_pred             CccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCC
Q 016588          162 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP  241 (386)
Q Consensus       162 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~  241 (386)
                      +|.+++...........++..+..++.|++.||.|||+  .+++||||||+||+++.++.++|+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK--NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH--CCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            99998854322223355677888899999999999998  7799999999999999999999999999876543322222


Q ss_pred             CccccCcccccchhhhccc-------CCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhc
Q 016588          242 SSQVTADEIFLASEVKEFR-------RFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  313 (386)
Q Consensus       242 ~~~~~~~~~y~aPE~~~~~-------~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (386)
                      .....++..|+|||++.+.       .++.++|+||||+++|||++ |..||....+..   .......    .......
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~~~----~~~~~~~  231 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYTVR----EQQLKLP  231 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHHhh----cccCCCC
Confidence            2334567779999998642       35789999999999999996 999997654321   1111000    0000111


Q ss_pred             chhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016588          314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  355 (386)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~  355 (386)
                      .+.+    ....++.+.+++..|| .+|++|||+++|++.|.
T Consensus       232 ~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         232 KPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            1111    1123356888999999 68999999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.3e-40  Score=297.84  Aligned_cols=249  Identities=29%  Similarity=0.480  Sum_probs=199.4

Q ss_pred             cCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCC--ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecC
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      .+|+..+.||+|+||.||++...++..+++|.....  ...++.+|+++++.++|||++++++++......++|+||+++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   83 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH   83 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence            467778999999999999999776788999986543  346789999999999999999999999999999999999999


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  240 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~  240 (386)
                      ++|.+++..    ....+++..+..++.+++.|+.|||+  .+++|+||||+||+++.++.++|+|||++........ .
T Consensus        84 ~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~  156 (256)
T cd05112          84 GCLSDYLRA----QRGKFSQETLLGMCLDVCEGMAYLES--SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-T  156 (256)
T ss_pred             CcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHH--CCccccccccceEEEcCCCeEEECCCcceeecccCcc-c
Confidence            999888742    23457888999999999999999998  6799999999999999999999999999876543221 1


Q ss_pred             CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcc
Q 016588          241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS  319 (386)
Q Consensus       241 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (386)
                      .......+..|+|||...+..++.++||||||+++|||++ |..||.....   ....+.....             ...
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~-------------~~~  220 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEVVETINAG-------------FRL  220 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHhCC-------------CCC
Confidence            1122334567999999998899999999999999999998 8888875332   1111111110             000


Q ss_pred             cCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          320 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                      ..+...++.+.+++.+||+.+|++|||+.+++++|
T Consensus       221 ~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         221 YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            11112346789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.2e-40  Score=311.77  Aligned_cols=246  Identities=20%  Similarity=0.272  Sum_probs=191.6

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcC-CCCcccccccceeeCCeEEEEEEeecC
Q 016588           89 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      +.||+|+||.||++... +++.+|+|.....      ..+.+.+|..++.++ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999964 5789999986532      223467888888888 699999999999999999999999999


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  240 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~  240 (386)
                      |+|..++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++......  .
T Consensus        81 ~~L~~~~~-----~~~~l~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~  151 (327)
T cd05617          81 GDLMFHMQ-----RQRKLPEEHARFYAAEICIALNFLHE--RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--D  151 (327)
T ss_pred             CcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--C
Confidence            99987773     33568899999999999999999999  779999999999999999999999999987532211  1


Q ss_pred             CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhccc
Q 016588          241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  320 (386)
Q Consensus       241 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (386)
                      ......+|+.|+|||++.+..++.++|||||||++|||++|..||............+......        ....  ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~--------~~~~--~~  221 (327)
T cd05617         152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--------LEKP--IR  221 (327)
T ss_pred             ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH--------HhCC--CC
Confidence            2234568889999999999999999999999999999999999997544322111111111100        0000  11


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCH------HHHHHH
Q 016588          321 FTNEGMEEFIQLIVRCLDPSSERRPSM------SDVVTE  353 (386)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dp~~Rpt~------~evl~~  353 (386)
                      .+...+..+.+++.+||+.||++|+++      ++++++
T Consensus       222 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         222 IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence            233344668999999999999999985      566554

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.3e-40  Score=319.46  Aligned_cols=261  Identities=18%  Similarity=0.210  Sum_probs=197.2

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCC-CcEEEEEECCCCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecC
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      ..+|.+.+.||+|+||.||+|.... ++.||+|...   ...+.+|++++++++|+||+++++++...+..++|||++. 
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-  243 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-  243 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-
Confidence            3468899999999999999999654 7889999633   2346789999999999999999999999999999999995 


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  240 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~  240 (386)
                      ++|..++..    ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.........
T Consensus       244 ~~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~yLH~--~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        244 SDLYTYLGA----RLRPLGLAQVTAVARQLLSAIDYIHG--EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            577777632    23468999999999999999999998  779999999999999999999999999998764332222


Q ss_pred             CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCc-----hhhHHHHHHhhhcc-cchhh---
Q 016588          241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS-----SQDLVELVQNSRDF-SNLLK---  311 (386)
Q Consensus       241 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~-----~~~~~~~~~~~~~~-~~~~~---  311 (386)
                      ......||..|+|||++.+..++.++|||||||++|||++|..|+.......     ...+...++..... .....   
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~  397 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG  397 (461)
T ss_pred             cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence            2334568999999999999999999999999999999999887654332111     11222222221100 00000   


Q ss_pred             -----hcc----h--------hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          312 -----ILD----E--------RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       312 -----~~~----~--------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                           ...    .        ..|..+. ....++.+|+.+||+.||.+|||+.|+|++
T Consensus       398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        398 SRLVSQYRHRAARNRRPAYTRPAWTRYY-KLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             hHHHHHHHhhhhcccCCccCCcchhhhc-cccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                 000    0        0000000 123468899999999999999999999986

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=7.3e-41  Score=312.77  Aligned_cols=234  Identities=22%  Similarity=0.294  Sum_probs=185.5

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHH-HHHcCCCCcccccccceeeCCeEEEEEEeecC
Q 016588           89 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVC-FLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      +.||+|+||+||+|... +++.||+|.+...      ....+..|.. +++.++||||+++++.+...+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999965 5889999985432      1233445544 45778999999999999999999999999999


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  240 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~  240 (386)
                      |+|..++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.....  ..
T Consensus        81 g~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~  151 (323)
T cd05575          81 GELFFHLQ-----RERSFPEPRARFYAAEIASALGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SK  151 (323)
T ss_pred             CCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CC
Confidence            99988873     34567888899999999999999998  77999999999999999999999999998753221  12


Q ss_pred             CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhccc
Q 016588          241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  320 (386)
Q Consensus       241 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (386)
                      ......+++.|+|||++.+..++.++|||||||++|||++|..||.....   .........            ...  .
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~~~~i~~------------~~~--~  214 (323)
T cd05575         152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT---AEMYDNILN------------KPL--R  214 (323)
T ss_pred             ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH---HHHHHHHHc------------CCC--C
Confidence            23345688899999999999999999999999999999999999986432   111111111            000  1


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCHH
Q 016588          321 FTNEGMEEFIQLIVRCLDPSSERRPSMS  348 (386)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~  348 (386)
                      .+...+..+.+++.+||+.||.+||++.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         215 LKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            1222356789999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3e-40  Score=299.73  Aligned_cols=249  Identities=25%  Similarity=0.409  Sum_probs=198.7

Q ss_pred             CCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCC---------hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP---------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      +|+..+.||.|+||+||+|...+++.+|+|......         ...+.+|+++++.++|+||+++++++...+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            477889999999999999998788999999754321         13477899999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      +||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+|+|+||+|+||++++++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  153 (265)
T cd06631          81 MEFVPGGSISSILN-----RFGPLPEPVFCKYTKQILDGVAYLHN--NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA  153 (265)
T ss_pred             EecCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence            99999999998883     23457888889999999999999998  679999999999999999999999999987653


Q ss_pred             CCC----CCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          235 RTD----VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       235 ~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      ...    .........++..|+|||...+..++.++|+|||||++|||++|..||.......  .... ....       
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~~-~~~~-------  223 (265)
T cd06631         154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--AMFY-IGAH-------  223 (265)
T ss_pred             hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH--HHHH-hhhc-------
Confidence            211    1112233457888999999998889999999999999999999999997643211  1100 0000       


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                          .......+...+.++.+++.+||+.+|.+|||+.+++++
T Consensus       224 ----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         224 ----RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             ----cCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                001112233345678999999999999999999999864

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.8e-40  Score=300.69  Aligned_cols=252  Identities=25%  Similarity=0.335  Sum_probs=187.2

Q ss_pred             CeecccCceEEEEEEeCC---CcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCC
Q 016588           89 NLIGEGKFGEVYKGLLQD---GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  161 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  161 (386)
                      +.||+|+||.||+|...+   ...+++|......    ...+.+|+..++.++|+||+++++.+...+..++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            358999999999997433   4578888754332    235778999999999999999999999999999999999999


Q ss_pred             CccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCC
Q 016588          162 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP  241 (386)
Q Consensus       162 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~  241 (386)
                      +|.+++...........++.....++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ--ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh--cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            99998865432223345677888999999999999999  7799999999999999999999999999865433221111


Q ss_pred             CccccCcccccchhhhcc-------cCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhc
Q 016588          242 SSQVTADEIFLASEVKEF-------RRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  313 (386)
Q Consensus       242 ~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (386)
                      .....++..|+|||+...       ..++.++|||||||++|||++ |..||....+.  ..+.......     .....
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~~~~~~~~~-----~~~~~  231 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE--QVLKQVVREQ-----DIKLP  231 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHHHHhhcc-----CccCC
Confidence            223345667999998753       356889999999999999999 77788754321  1111111110     00111


Q ss_pred             chhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                      .+    ..+...+..+.+++..|| .||++|||+++|++.|
T Consensus       232 ~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         232 KP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             CC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            11    122234466788999999 5999999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=7.5e-41  Score=318.09  Aligned_cols=258  Identities=22%  Similarity=0.280  Sum_probs=199.7

Q ss_pred             HHHHHHHhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC------CChhHHHHHHHHHHcCCCCcccccccceee
Q 016588           75 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQE  147 (386)
Q Consensus        75 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  147 (386)
                      +.++....++|+..+.||+|+||.||++..+ +++.+|+|....      .....+.+|..+++.++||||+++++.+.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            3455556789999999999999999999965 578999997542      123346789999999999999999999999


Q ss_pred             CCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccc
Q 016588          148 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA  227 (386)
Q Consensus       148 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DF  227 (386)
                      .+..|+||||+++|+|..++.      ...++...+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NIll~~~~~ikL~Df  186 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMS------NYDVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADF  186 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHEEECCCCCEEEEeC
Confidence            999999999999999998873      2346788888999999999999999  77999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCccccCcccccchhhhcccC----CCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhh
Q 016588          228 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR----FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS  303 (386)
Q Consensus       228 gl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~  303 (386)
                      |++........ .......||+.|+|||++.+..    ++.++|||||||++|||++|..||......   .....+...
T Consensus       187 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~  262 (371)
T cd05622         187 GTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTYSKIMNH  262 (371)
T ss_pred             CceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH---HHHHHHHcC
Confidence            99987643221 1123456899999999987543    789999999999999999999999864421   111111110


Q ss_pred             hcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCC--CCCHHHHHHHH
Q 016588          304 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSER--RPSMSDVVTEL  354 (386)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~evl~~L  354 (386)
                         ..       .+........+..+.+++..||..++.+  |+++++++++.
T Consensus       263 ---~~-------~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         263 ---KN-------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             ---CC-------cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence               00       0000111234567899999999844433  78999999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2e-40  Score=310.90  Aligned_cols=249  Identities=22%  Similarity=0.302  Sum_probs=207.4

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeCC-CcEEEEEECCCCC------hhHHHHHHHHHHcCC-CCcccccccceeeCCeEE
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAP------TQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQF  152 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  152 (386)
                      ....|++.+.||+|.||.||++..+. |+.+|+|.+++..      ...+.+|+.+|+++. ||||+.+++.+.+.+..+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            34578888999999999999999665 9999999754432      357899999999998 999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC----CceEEcccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED----FIAKVADAG  228 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~----~~~kl~DFg  228 (386)
                      +|||++.+|.|.+.+...      .+++.....++.|++.++.|||+  .||+||||||+|+|+...    +.+|++|||
T Consensus       113 lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~--~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHS--LGVVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             EEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHh--CCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            999999999999988532      38999999999999999999999  779999999999999643    579999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccc
Q 016588          229 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN  308 (386)
Q Consensus       229 l~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  308 (386)
                      ++.....   .......+||+.|+|||++....|+..+||||+||++|.|++|..||.+........  .......    
T Consensus       185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~--~i~~~~~----  255 (382)
T KOG0032|consen  185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL--AILRGDF----  255 (382)
T ss_pred             CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH--HHHcCCC----
Confidence            9998755   334567889999999999999999999999999999999999999999866432211  1111111    


Q ss_pred             hhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          309 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                         .++...|.    ..++.+.+++..|+..||.+|+|+.++|+|
T Consensus       256 ---~f~~~~w~----~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  256 ---DFTSEPWD----DISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             ---CCCCCCcc----ccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence               12222233    335668999999999999999999999996

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.8e-40  Score=314.73  Aligned_cols=258  Identities=20%  Similarity=0.291  Sum_probs=192.9

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeC------C
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN------N  149 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  149 (386)
                      .++|+..+.||+|+||.||++... ++..||+|.+...     ....+.+|+.+++.++||||+++++++...      .
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            468999999999999999999954 5889999986432     244677899999999999999999988643      3


Q ss_pred             eEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 016588          150 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  229 (386)
Q Consensus       150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl  229 (386)
                      ..|+||||+++ +|...+.       ..++...+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus       100 ~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~--~~ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIH-------MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHh-------ccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEecCCC
Confidence            57999999976 4544442       236778888999999999999999  7799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcc---
Q 016588          230 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF---  306 (386)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---  306 (386)
                      ++.....   .......+|+.|+|||.+.+..++.++|||||||++|||++|..||...+...  ............   
T Consensus       170 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~  244 (359)
T cd07876         170 ARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID--QWNKVIEQLGTPSAE  244 (359)
T ss_pred             ccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCcHH
Confidence            8764321   12234567888999999999999999999999999999999999998654311  111111000000   


Q ss_pred             ----------------cc-----hhhhcchhhc---ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          307 ----------------SN-----LLKILDERLW---STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       307 ----------------~~-----~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                                      ..     ..+.......   .......++++.+++.+||+.||++|||+.|++++-
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  316 (359)
T cd07876         245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP  316 (359)
T ss_pred             HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence                            00     0000000000   001111245689999999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=5.6e-40  Score=297.38  Aligned_cols=249  Identities=25%  Similarity=0.458  Sum_probs=189.8

Q ss_pred             CeecccCceEEEEEEeC----CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCccccccccee-eCCeEEEEEEeec
Q 016588           89 NLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQ-ENNLQFLIYEYIP  159 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~  159 (386)
                      +.||+|+||.||+|...    ....+|+|......    .+.+.+|..+++.++|||++++++++. .++..++++||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999853    23579999864322    346778999999999999999999775 4556789999999


Q ss_pred             CCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016588          160 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  239 (386)
Q Consensus       160 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~  239 (386)
                      +++|.+++...    ...+.+..+..++.|++.||.|||+  .+++||||||+|||+++++.+||+|||+++........
T Consensus        81 ~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          81 HGDLRNFIRSE----THNPTVKDLIGFGLQVAKGMEYLAS--KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            99999988432    2345677888999999999999998  77999999999999999999999999998765332111


Q ss_pred             --CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCC-CCCCCCCCCchhhHHHHHHhhhcccchhhhcchh
Q 016588          240 --GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR-EASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  316 (386)
Q Consensus       240 --~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (386)
                        .......++..|+|||...+..++.++|||||||++|||++|+ .||.....   ......+...             
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~-------------  218 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVYLLQG-------------  218 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHhcC-------------
Confidence              1112234566799999998889999999999999999999954 45544321   1111111110             


Q ss_pred             hcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhh
Q 016588          317 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD  359 (386)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~  359 (386)
                      .....+...+..+.+++.+||+.+|++||++.++++.|+++..
T Consensus       219 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         219 RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            0011122234678999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.2e-40  Score=303.44  Aligned_cols=268  Identities=28%  Similarity=0.399  Sum_probs=203.3

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-----CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceee--CCeE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-----DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQ  151 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  151 (386)
                      ++|+..+.||+|+||.||++.+.     ++..+|+|......    ...+.+|+++++.++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            46777899999999999999854     36789999865443    3478899999999999999999999877  5678


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      +++|||+++++|.+++..    ....+++..+..++.|++.||.|||+  ++++|+||||+||+++.++.++|+|||++.
T Consensus        84 ~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQR----HRDQINLKRLLLFSSQICKGMDYLGS--QRYIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             EEEEecCCCCCHHHHHHh----CccccCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHhEEEcCCCCEEEccccccc
Confidence            999999999999998843    23358899999999999999999998  779999999999999999999999999998


Q ss_pred             ccCCCCCC-CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          232 FLGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       232 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      ........ .......++..|++||...+..++.++||||||+++|||++|..|+............. .........+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~  236 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQGQMIVTRLL  236 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-ccccccHHHHH
Confidence            76532211 11112334556999999988889999999999999999999999876543221100000 00000001111


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHh
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  357 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~  357 (386)
                      ..+........+..++.++.+++.+||+.+|++|||+.|+++.|+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            11111222222334557799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=6.3e-41  Score=317.83  Aligned_cols=250  Identities=22%  Similarity=0.288  Sum_probs=194.8

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC------CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ++|+..+.||+|+||.||++... ++..||+|.+..      .....+.+|..++..++||||+++++.+.+.+..|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888899999999999999965 588999998542      23446778999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.++|+|||++.....
T Consensus        81 E~~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~~L~~lH~--~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~  153 (360)
T cd05627          81 EFLPGGDMMTLLM-----KKDTLSEEATQFYIAETVLAIDAIHQ--LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK  153 (360)
T ss_pred             eCCCCccHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence            9999999998884     34568888999999999999999998  7799999999999999999999999999875432


Q ss_pred             CCCC---------------------------------CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCC
Q 016588          236 TDVA---------------------------------GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR  282 (386)
Q Consensus       236 ~~~~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~  282 (386)
                      ....                                 .......||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence            1100                                 0011346889999999999999999999999999999999999


Q ss_pred             CCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCC---HHHHHHH
Q 016588          283 EASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS---MSDVVTE  353 (386)
Q Consensus       283 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt---~~evl~~  353 (386)
                      .||....+..   ....+..   ..       ..+........++++.+++.+|+ .||.+|++   ++++++|
T Consensus       234 ~Pf~~~~~~~---~~~~i~~---~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         234 PPFCSETPQE---TYRKVMN---WK-------ETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCCCCHHH---HHHHHHc---CC-------CceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence            9998655321   1111111   00       00000000113456888998876 49999985   6777765

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.3e-40  Score=302.93  Aligned_cols=248  Identities=21%  Similarity=0.309  Sum_probs=197.0

Q ss_pred             CCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC------hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           85 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      |+..+.||+|+||.||++... +++.+|+|......      ...+.+|+.+++.++|+|++.+++.+...+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            667789999999999999955 58899999754321      23467899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +++++|.+++...   ....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||++.......
T Consensus        82 ~~g~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~--~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          82 MNGGDLKFHIYHM---GEAGFEEGRAVFYAAEICCGLEDLHQ--ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             cCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            9999998887432   23458888999999999999999998  779999999999999999999999999987653321


Q ss_pred             CCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhh
Q 016588          238 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  317 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (386)
                         ......++..|+|||.+.+..++.++|||||||++|||++|..||................             ...
T Consensus       157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~-------------~~~  220 (285)
T cd05630         157 ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-------------KEV  220 (285)
T ss_pred             ---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-------------hhh
Confidence               1123467888999999998899999999999999999999999998644321111110000             000


Q ss_pred             cccCCHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHH
Q 016588          318 WSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTE  353 (386)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~evl~~  353 (386)
                      ....+...+.++.+++.+||+.||++|||     ++|++++
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         221 QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence            01122234466899999999999999999     8898875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=6.1e-40  Score=296.31  Aligned_cols=246  Identities=24%  Similarity=0.374  Sum_probs=194.8

Q ss_pred             CeecccCceEEEEEEeCC--C--cEEEEEECCCCCh----hHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecC
Q 016588           89 NLIGEGKFGEVYKGLLQD--G--MLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      +.||+|++|.||+|.+.+  +  ..||+|.......    +.+.+|+..+++++||||+++++++.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998643  2  3689998665433    468889999999999999999999888 889999999999


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC-
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA-  239 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~-  239 (386)
                      ++|.+++....   ...+++.....++.|++.||.|||+  ++++|+||||+||+++.++.+||+|||++......... 
T Consensus        80 ~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          80 GSLLDRLRKDA---LGHFLISTLCDYAVQIANGMRYLES--KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             CcHHHHHHhcc---cccCcHHHHHHHHHHHHHHHHHHHh--CCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            99999885421   1468899999999999999999998  78999999999999999999999999998876442211 


Q ss_pred             CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          240 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       240 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                      .......++..|+|||.+.+..++.++|||||||++|||++ |..||......   +.......   .         ...
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~~---~---------~~~  219 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QILKKIDK---E---------GER  219 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHh---c---------CCc
Confidence            11123445677999999998899999999999999999998 99998754321   11111111   0         000


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  355 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~  355 (386)
                      ...+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       220 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         220 LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            1122234567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=300.59  Aligned_cols=260  Identities=23%  Similarity=0.436  Sum_probs=206.9

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCChhHHHHHHHHHHc--CCCCcccccccceeeC----CeEEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLAS--IQHRNLVTLLGYCQEN----NLQFLIY  155 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~----~~~~lv~  155 (386)
                      .++....+.||+|.||.||+|.++ |..||||++.......+.+|.+|.+.  |+|+||+.+++.-..+    ..+|||.
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvT  288 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVT  288 (513)
T ss_pred             hheeEEEEEecCccccceeecccc-CCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEee
Confidence            456778899999999999999996 78999999988888889999999876  5999999999875443    3679999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCceecCCCCCCeeeCCCCceEEccccc
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL------SPRVVHKDFKTANVLVDEDFIAKVADAGL  229 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------~~~ivH~dlkp~Nill~~~~~~kl~DFgl  229 (386)
                      +|.+.|+|.+++      ++..++....++++..+|.||++||..      .+.|.|||||+.|||+.+++.+.|+|+||
T Consensus       289 dYHe~GSL~DyL------~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL  362 (513)
T KOG2052|consen  289 DYHEHGSLYDYL------NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  362 (513)
T ss_pred             ecccCCcHHHHH------hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence            999999999999      457889999999999999999999942      46799999999999999999999999999


Q ss_pred             ccccCCC--CCCCCCccccCcccccchhhhccc----CC--CcccchhhHHHHHHHHHcC----------CCCCCCCCCC
Q 016588          230 RNFLGRT--DVAGPSSQVTADEIFLASEVKEFR----RF--SEKSDVYSFGVFLLELVSG----------REASSSLSPD  291 (386)
Q Consensus       230 ~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~----~~--~~~~DvwSlGvil~el~tg----------~~p~~~~~~~  291 (386)
                      |-.....  ..........||..|||||++...    .+  -..+||||||.++||+.-+          +.||.+..+.
T Consensus       363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~  442 (513)
T KOG2052|consen  363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS  442 (513)
T ss_pred             eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence            8665432  122334566899999999998743    12  1358999999999999863          3566654442


Q ss_pred             chhhHHHHHHhhhcccchhhhc-chhhcccCC-----HHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhh
Q 016588          292 SSQDLVELVQNSRDFSNLLKIL-DERLWSTFT-----NEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD  359 (386)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~  359 (386)
                                 .+.++++.+++ ..++++..+     .++...+.++|+.||..+|..|.|+-.+-+.|.++.+
T Consensus       443 -----------DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  443 -----------DPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             -----------CCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence                       22333343332 223333322     3456778999999999999999999999999988874

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.3e-40  Score=311.36  Aligned_cols=238  Identities=22%  Similarity=0.278  Sum_probs=186.3

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHH-HHHHcCCCCcccccccceeeCCeEEEEEEeecC
Q 016588           89 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEV-CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      +.||+|+||.||+|... ++..||+|.....      ....+..|. .+++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999965 4778999985432      122334444 356778999999999999999999999999999


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  240 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~  240 (386)
                      ++|..++.     ....+.......++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+++.....  ..
T Consensus        81 ~~L~~~~~-----~~~~~~~~~~~~~~~qi~~~L~~lH~--~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~  151 (325)
T cd05602          81 GELFYHLQ-----RERCFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NG  151 (325)
T ss_pred             CcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEEccCCCCcccccC--CC
Confidence            99988884     23456778888899999999999998  77999999999999999999999999998754221  12


Q ss_pred             CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhccc
Q 016588          241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  320 (386)
Q Consensus       241 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (386)
                      ......+++.|+|||++.+..++.++|||||||++|||++|..||......   .....+..            ..  ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~------------~~--~~  214 (325)
T cd05602         152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYDNILN------------KP--LQ  214 (325)
T ss_pred             CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---HHHHHHHh------------CC--cC
Confidence            233456889999999999999999999999999999999999999864421   11111111            00  01


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 016588          321 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT  352 (386)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~  352 (386)
                      .....+..+.+++.+||+.||.+||++.+.+.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         215 LKPNITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence            22234566899999999999999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-40  Score=301.23  Aligned_cols=250  Identities=29%  Similarity=0.446  Sum_probs=196.9

Q ss_pred             CCcCCeecccCceEEEEEEeCC-CcEEEEEECCCCChhH-----HHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           85 FSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQE-----FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~-----~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      |+..+.||+|+||+||++.... ++.+|+|.........     ..+|+.+++.++||||+++++++...+..++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            4567899999999999999664 6789999866554332     234889999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++++|.+++.     ....+++..+..++.|++.||.+||+  .+++|+||||+||+++.++.++|+|||.+....  ..
T Consensus        81 ~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~L~~Lh~--~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~  151 (260)
T PF00069_consen   81 PGGSLQDYLQ-----KNKPLSEEEILKIAYQILEALAYLHS--KGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--EN  151 (260)
T ss_dssp             TTEBHHHHHH-----HHSSBBHHHHHHHHHHHHHHHHHHHH--TTEEESSBSGGGEEESTTSEEEESSGTTTEEST--ST
T ss_pred             cccccccccc-----cccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccc--cc
Confidence            9999998884     35678999999999999999999999  679999999999999999999999999987641  22


Q ss_pred             CCCCccccCcccccchhhhc-ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhh
Q 016588          239 AGPSSQVTADEIFLASEVKE-FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  317 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (386)
                      ........++..|+|||+.. +..++.++||||+|+++|+|++|..||.................   .     ......
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~---~-----~~~~~~  223 (260)
T PF00069_consen  152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK---R-----PLPSSS  223 (260)
T ss_dssp             TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH---T-----HHHHHT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc---c-----cccccc
Confidence            22334556788899999998 78889999999999999999999999987521111111111000   0     000000


Q ss_pred             cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                        .........+.+++.+||+.||++|||+.+++++
T Consensus       224 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  224 --QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             --TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             --cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              0000112679999999999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.1e-40  Score=299.45  Aligned_cols=249  Identities=28%  Similarity=0.457  Sum_probs=195.2

Q ss_pred             CeecccCceEEEEEEeCC-------CcEEEEEECCCC----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           89 NLIGEGKFGEVYKGLLQD-------GMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      +.||+|+||.||+|...+       +..+++|.....    ....+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998642       257898875432    345788999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC-----ceEEcccccc
Q 016588          158 IPNGSVSIHLYGPSQV--SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-----IAKVADAGLR  230 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~-----~~kl~DFgl~  230 (386)
                      +++++|.+++......  ....+++..++.++.|++.||.|||+  .+++|+||||+||+++.++     .++++|||++
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ--MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh--CCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            9999999888543211  23457889999999999999999998  7799999999999999877     8999999998


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccch
Q 016588          231 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNL  309 (386)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  309 (386)
                      .................+..|+|||.+.+..++.++|||||||++|||++ |..||.....   .+....+..       
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~~~~-------  228 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQHVTA-------  228 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHHHhc-------
Confidence            76643322222223344567999999998899999999999999999998 9999875432   111111111       


Q ss_pred             hhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016588          310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  355 (386)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~  355 (386)
                            ......+...+..+.+++.+||+.+|.+||++.++++.|.
T Consensus       229 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         229 ------GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             ------CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                  0111223345577899999999999999999999999885

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.5e-40  Score=309.93  Aligned_cols=261  Identities=17%  Similarity=0.238  Sum_probs=194.1

Q ss_pred             HHhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           80 LATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        80 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      ....+|.+.+.||+|+||.||+|... ++..||+|.....   ....|+.+++.++||||+++++++...+..++|+|++
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  139 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY  139 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence            44568999999999999999999965 4678999975433   3356999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      . ++|..++..    ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++......  
T Consensus       140 ~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  210 (357)
T PHA03209        140 S-SDLYTYLTK----RSRPLPIDQALIIEKQILEGLRYLHA--QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--  210 (357)
T ss_pred             C-CcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence            5 577777632    34568899999999999999999999  67999999999999999999999999998754321  


Q ss_pred             CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchh--------hHHHHHHhhh----cc
Q 016588          239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ--------DLVELVQNSR----DF  306 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~--------~~~~~~~~~~----~~  306 (386)
                       .......+|..|+|||++.+..++.++|||||||++|||+++..|+....+....        .+........    ..
T Consensus       211 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  289 (357)
T PHA03209        211 -PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF  289 (357)
T ss_pred             -cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence             1223456888999999999999999999999999999999966655433322211        1111111000    00


Q ss_pred             c-----ch-hhhcchhh--ccc-------CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          307 S-----NL-LKILDERL--WST-------FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       307 ~-----~~-~~~~~~~~--~~~-------~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .     .. ...++...  +..       .....+.++.+++.+||+.||++|||+.|++++
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence            0     00 00000000  000       001223456789999999999999999999976

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=5.3e-40  Score=300.60  Aligned_cols=247  Identities=22%  Similarity=0.330  Sum_probs=194.4

Q ss_pred             CCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           84 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      +|+..+.||+|+||.||+|.. .++..||+|.....    ...++.+|++++++++|||++++++++...+..++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            577889999999999999985 46889999985433    2346888999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++++|..+.         .+++..+..++.|++.||.|||+  .+|+|+||||+||+++.++.++|+|||++......  
T Consensus        82 ~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--  148 (279)
T cd06619          82 DGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWS--LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--  148 (279)
T ss_pred             CCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHH--CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence            999886432         35677888999999999999998  77999999999999999999999999998765432  


Q ss_pred             CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                        ......++..|+|||.+.+..++.++|+|||||++|+|++|+.||.................        ...++...
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--------~~~~~~~~  218 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQ--------CIVDEDPP  218 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHH--------HHhccCCC
Confidence              12334678889999999988999999999999999999999999976443211110000000        00000000


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .......+.++.+++.+||+.+|++||++++++++
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         219 VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            00111234568999999999999999999999976

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.2e-40  Score=297.07  Aligned_cols=247  Identities=20%  Similarity=0.315  Sum_probs=198.4

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC----CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      +|+..+.||+|+||.||++... ++..+++|....    ...+.+.+|..+++.++|+|++++++.+...+..|++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4777899999999999999954 588999997532    22356788999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++++|.+++...   ....++......++.|++.||.|||+  ++++|+||||+||++++++.++++|||++....... 
T Consensus        81 ~~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-  154 (255)
T cd08219          81 DGGDLMQKIKLQ---RGKLFPEDTILQWFVQMCLGVQHIHE--KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-  154 (255)
T ss_pred             CCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCcceEEECCCCcEEEcccCcceeecccc-
Confidence            999998877421   23457888899999999999999998  779999999999999999999999999987664322 


Q ss_pred             CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                       .......++..|+|||++.+..++.++|+||||+++|+|++|..||.....   .........             ...
T Consensus       155 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~---~~~~~~~~~-------------~~~  217 (255)
T cd08219         155 -AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW---KNLILKVCQ-------------GSY  217 (255)
T ss_pred             -cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH---HHHHHHHhc-------------CCC
Confidence             112335677889999999988899999999999999999999999975432   111111110             001


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ...+...+..+.+++.+||+.||++|||+.+++..
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         218 KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            11223345678999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5.5e-40  Score=332.20  Aligned_cols=264  Identities=21%  Similarity=0.214  Sum_probs=203.9

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC------hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ++|++.+.||+|+||.||+|... +++.||+|+.....      .+++.+|+++++.++||||+++++++.+++..|+||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            47888999999999999999964 58899999865321      346889999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCc------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 016588          156 EYIPNGSVSIHLYGPSQ------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  229 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl  229 (386)
                      ||+++++|.+++.....      ......++..++.++.|++.||+|||+  ++|+||||||+|||++.++.++|+|||+
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs--~GIIHRDLKPeNILLd~dg~vKLiDFGL  159 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS--KGVLHRDLKPDNILLGLFGEVVILDWGA  159 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH--CCccccCCchheEEEcCCCCEEEEecCc
Confidence            99999999988743211      112345677889999999999999998  7799999999999999999999999999


Q ss_pred             ccccCCCCC----------------CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCch
Q 016588          230 RNFLGRTDV----------------AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS  293 (386)
Q Consensus       230 ~~~~~~~~~----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~  293 (386)
                      ++.......                ........||+.|+|||.+.+..++.++|||||||++|||++|..||........
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki  239 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI  239 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence            986621110                0011224589999999999999999999999999999999999999976332110


Q ss_pred             hhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCC-CHHHHHHHHHHhhhhhc
Q 016588          294 QDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-SMSDVVTELDRTLDKEM  362 (386)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-t~~evl~~L~~~~~~~~  362 (386)
                         ... .         ....+... ......++.+.+++.+||+.||++|| +++++++.|+..++...
T Consensus       240 ---~~~-~---------~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p  295 (932)
T PRK13184        240 ---SYR-D---------VILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSP  295 (932)
T ss_pred             ---hhh-h---------hccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCc
Confidence               000 0         00011000 00113346688999999999999995 67788888888876533

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.5e-40  Score=309.14  Aligned_cols=238  Identities=19%  Similarity=0.287  Sum_probs=190.1

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcCC-CCcccccccceeeCCeEEEEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  155 (386)
                      +|...+.||+|+||+||+|... ++..||+|+....      ..+.+..|..++..+. |++|+++++++...+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4677899999999999999954 5889999975432      2345677888888875 578888999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++|+|..++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++....
T Consensus        81 Ey~~~g~L~~~i~-----~~~~l~~~~~~~i~~qi~~al~~lH~--~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          81 EYVNGGDLMYHIQ-----QVGKFKEPQAVFYAAEISVGLFFLHR--RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             cCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence            9999999988873     33568899999999999999999998  7799999999999999999999999999875432


Q ss_pred             CCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      ..  .......++..|+|||++.+..++.++|||||||++|||++|..||.....   ......+..            .
T Consensus       154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~i~~------------~  216 (323)
T cd05615         154 DG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELFQSIME------------H  216 (323)
T ss_pred             CC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHh------------C
Confidence            11  122344578899999999988999999999999999999999999986542   111111111            0


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM  347 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~  347 (386)
                      .  ...+...+.++.+++.+||+.+|.+|++.
T Consensus       217 ~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         217 N--VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             C--CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence            0  11223345678999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-41  Score=319.16  Aligned_cols=249  Identities=27%  Similarity=0.392  Sum_probs=209.4

Q ss_pred             CCCcCCeecccCceEEEEEEeCC--C--cEEEEEECCCC----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQD--G--MLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      +.+..++||+|.||.|++|.|..  |  ..||||.+...    ..++|.+|+.+|.+|+|+|+++|||+..+ ....||+
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~  189 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF  189 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence            34456889999999999999763  3  36899986543    45689999999999999999999999988 6677999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      |+++.|+|.+.++.   .....+.......++.|||.|+.||.+  ++.|||||..+|+||-....+|||||||.+-++.
T Consensus       190 ELaplGSLldrLrk---a~~~~llv~~Lcdya~QiA~aM~YLes--krlvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRK---AKKAILLVSRLCDYAMQIAKAMQYLES--KRLVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             hhcccchHHHHHhh---ccccceeHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence            99999999999965   245678888999999999999999998  7899999999999999999999999999998876


Q ss_pred             CCCCCCC-ccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhc
Q 016588          236 TDVAGPS-SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  313 (386)
Q Consensus       236 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (386)
                      .+..... .....+..|+|||.+....++.++|||+|||++|||+| |..||.+-..                .++.+.+
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g----------------~qIL~~i  328 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG----------------IQILKNI  328 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH----------------HHHHHhc
Confidence            5543322 23334567999999999999999999999999999999 7788887553                2334445


Q ss_pred             chhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                      |.+-+...+..|+++++++++.||..+|.+|||+..+.+.+
T Consensus       329 D~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  329 DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             cccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            55556677888999999999999999999999999997443

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.7e-40  Score=304.96  Aligned_cols=262  Identities=20%  Similarity=0.284  Sum_probs=195.4

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      ++|...+.||+|+||.||+|..+ ++..||+|.....    ....+.+|+.+++.++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            57888999999999999999965 5789999975422    234677899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +. ++|..++..    ....+++..+..++.|++.||.|||+  ++|+|+||||+||+++.++.++|+|||++.......
T Consensus        86 ~~-~~l~~~l~~----~~~~~~~~~~~~~~~qi~~aL~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          86 LD-KDLKQYLDD----CGNSINMHNVKLFLFQLLRGLNYCHR--RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             cc-cCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence            97 477777632    23457888999999999999999998  779999999999999999999999999987643221


Q ss_pred             CCCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc--
Q 016588          238 VAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD--  314 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  314 (386)
                        .......++..|+|||.+.+. .++.++|||||||++|||++|+.||...+.........................  
T Consensus       159 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (301)
T cd07873         159 --KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  236 (301)
T ss_pred             --CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence              112233457789999988654 578899999999999999999999986543211111100000000000000000  


Q ss_pred             -------hhhc----ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          315 -------ERLW----STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       315 -------~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                             +...    .......++++.+++.+||+.||.+|||++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                   0000    01112335678999999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=6.5e-40  Score=295.76  Aligned_cols=250  Identities=28%  Similarity=0.421  Sum_probs=203.0

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCC-CcEEEEEECCCCC-hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeec
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAP-TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  159 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  159 (386)
                      .++|+..+.||+|+||.||+|...+ +..+++|...... .+++.+|+++++.++|+|++++++++......|+++||+.
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   81 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG   81 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence            3578889999999999999999765 7899999865432 5678999999999999999999999999999999999999


Q ss_pred             CCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016588          160 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  239 (386)
Q Consensus       160 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~  239 (386)
                      +++|.+++..    ....+++..+..++.|++.||.|||+  .+++|+||+|+||++++++.++|+|||++........ 
T Consensus        82 ~~~L~~~l~~----~~~~l~~~~~~~~~~~l~~~l~~lh~--~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (256)
T cd06612          82 AGSVSDIMKI----TNKTLTEEEIAAILYQTLKGLEYLHS--NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-  154 (256)
T ss_pred             CCcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence            9999988842    24568899999999999999999998  6799999999999999999999999999887644221 


Q ss_pred             CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcc
Q 016588          240 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS  319 (386)
Q Consensus       240 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (386)
                       ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....+....   .....           ......
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~---~~~~~-----------~~~~~~  219 (256)
T cd06612         155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI---FMIPN-----------KPPPTL  219 (256)
T ss_pred             -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh---hhhcc-----------CCCCCC
Confidence             122344677899999999889999999999999999999999998865432110   00000           000011


Q ss_pred             cCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          320 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ..+...+.++.+++.+||+.||++|||++|++++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            1223345678999999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=4.9e-40  Score=302.02  Aligned_cols=259  Identities=22%  Similarity=0.270  Sum_probs=190.6

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcC---CCCcccccccceee-----CC
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASI---QHRNLVTLLGYCQE-----NN  149 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----~~  149 (386)
                      +|+..+.||+|+||+||+|..+ +++.||+|.....     ....+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4778899999999999999965 5889999975432     223456777777655   79999999998754     34


Q ss_pred             eEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 016588          150 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  229 (386)
Q Consensus       150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl  229 (386)
                      ..++++||+.+ +|..++...   ....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||+
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKV---PPPGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEECccCc
Confidence            57899999975 777776422   23458899999999999999999999  7799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhh--hccc
Q 016588          230 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS--RDFS  307 (386)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~  307 (386)
                      +.......   ......++..|+|||++.+..++.++||||+||++|||++|..||.......  .+.......  ....
T Consensus       155 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~  229 (288)
T cd07863         155 ARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFDLIGLPPED  229 (288)
T ss_pred             cccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HHHHHHHHhCCCChh
Confidence            88764321   1223456788999999998899999999999999999999999987644321  111111100  0000


Q ss_pred             chh---h----hcchh---hcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          308 NLL---K----ILDER---LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       308 ~~~---~----~~~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ...   .    ...+.   ......+..++++.+++.+||+.||++|||+.|++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            000   0    00000   0011112345678999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.4e-40  Score=300.47  Aligned_cols=251  Identities=26%  Similarity=0.397  Sum_probs=195.5

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC--CChhHHHHHHHHHHcC-CCCcccccccceeeC------Ce
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG--APTQEFIDEVCFLASI-QHRNLVTLLGYCQEN------NL  150 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~------~~  150 (386)
                      +...|+..+.||+|+||.||+|... +++.+|+|....  .....+.+|+.++..+ +|+|++++++++...      ..
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            3456778889999999999999965 578899998543  3345688899999998 799999999998653      46


Q ss_pred             EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  230 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~  230 (386)
                      .|++|||+.+++|.+++...   ....+++..+..++.|++.||.|||+  ++|+|+||||+||++++++.++|+|||++
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~--~~ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence            89999999999999888532   23467888999999999999999998  67999999999999999999999999998


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhc-----ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc
Q 016588          231 NFLGRTDVAGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD  305 (386)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  305 (386)
                      .......  .......++..|+|||++.     +..++.++|||||||++|||++|..||....+....  .    ....
T Consensus       159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~--~----~~~~  230 (272)
T cd06637         159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL--F----LIPR  230 (272)
T ss_pred             eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH--H----HHhc
Confidence            7653321  2233456778899999986     346788999999999999999999998754431111  0    0000


Q ss_pred             ccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          306 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                               ...........+.++.+++.+||+.||.+|||+.+++++
T Consensus       231 ---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         231 ---------NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             ---------CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence                     000011112234678999999999999999999999865

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=6.4e-40  Score=304.39  Aligned_cols=259  Identities=19%  Similarity=0.288  Sum_probs=199.1

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      ++|+..+.||+|+||.||++... ++..+++|......    ..++.+|+++++.++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36888999999999999999965 57888988755332    24578899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +++++|.+++..     ...+++..+..++.|++.||.|||+. .+++||||||+|||++.++.++|+|||++...... 
T Consensus        81 ~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          81 MDGGSLDQVLKK-----AGRIPENILGKISIAVLRGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             cCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhh-CCEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence            999999999842     35678889999999999999999962 46999999999999999999999999998755321 


Q ss_pred             CCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhccc----------
Q 016588          238 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS----------  307 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----------  307 (386)
                         ......++..|+|||.+.+..++.++|+|||||++|||++|..||.......   ............          
T Consensus       154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  227 (308)
T cd06615         154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVS  227 (308)
T ss_pred             ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCccccc
Confidence               1233467788999999988889999999999999999999999987544211   111111000000          


Q ss_pred             ----------chhhhcch---hhcccCC-HHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          308 ----------NLLKILDE---RLWSTFT-NEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       308 ----------~~~~~~~~---~~~~~~~-~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                                ...+..+.   ......+ ...+.++.+++.+||+.+|++|||+++++++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         228 GHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             CCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                      00000000   0000111 12345689999999999999999999999874

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9.5e-40  Score=296.71  Aligned_cols=247  Identities=25%  Similarity=0.439  Sum_probs=196.8

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC------------hhHHHHHHHHHHcCCCCcccccccceeeCCe
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------------TQEFIDEVCFLASIQHRNLVTLLGYCQENNL  150 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  150 (386)
                      +|.....||.|+||.||+|... ++..+++|......            .+.+.+|+.++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3667789999999999999854 57899999743221            1357789999999999999999999999999


Q ss_pred             EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  230 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~  230 (386)
                      .++++||+++++|..++.     ....+++..+..++.|++.||.|||+  ++++||||+|+||++++++.++|+|||++
T Consensus        81 ~~lv~e~~~~~~L~~~l~-----~~~~l~~~~~~~~~~~l~~~l~~lH~--~~ivH~di~p~nil~~~~~~~~l~dfg~~  153 (267)
T cd06628          81 LNIFLEYVPGGSVAALLN-----NYGAFEETLVRNFVRQILKGLNYLHN--RGIIHRDIKGANILVDNKGGIKISDFGIS  153 (267)
T ss_pred             cEEEEEecCCCCHHHHHH-----hccCccHHHHHHHHHHHHHHHHHHHh--cCcccccCCHHHEEEcCCCCEEecccCCC
Confidence            999999999999998883     23557888889999999999999998  77999999999999999999999999998


Q ss_pred             cccCCCCC----CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcc
Q 016588          231 NFLGRTDV----AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF  306 (386)
Q Consensus       231 ~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  306 (386)
                      +.......    ........++..|+|||.+.+..++.++|+|||||++|+|++|+.||......  .. .   ....  
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~-~---~~~~--  225 (267)
T cd06628         154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--QA-I---FKIG--  225 (267)
T ss_pred             cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--HH-H---HHHh--
Confidence            87643211    11112345677899999999888999999999999999999999999864321  11 1   0000  


Q ss_pred             cchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                             . ......+...+..+.+++.+||+.||.+||++.+++++
T Consensus       226 -------~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         226 -------E-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             -------c-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence                   0 11122333455778999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=7.4e-40  Score=302.27  Aligned_cols=247  Identities=22%  Similarity=0.352  Sum_probs=199.1

Q ss_pred             cCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC---ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      .+|+..+.||+|+||.||+|.. .++..+++|.....   ..+.+.+|+.+++.++|+|++++++.+......|+||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            4788889999999999999995 45889999975432   2356788999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++++|.+++.      ...+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||++........
T Consensus       100 ~~~~L~~~~~------~~~~~~~~~~~i~~ql~~aL~~LH~--~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~  171 (296)
T cd06654         100 AGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (296)
T ss_pred             CCCCHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence            9999998873      2347888999999999999999998  7799999999999999999999999999876543221


Q ss_pred             CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                        ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+.  ........            .....
T Consensus       172 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~--~~~~~~~~------------~~~~~  235 (296)
T cd06654         172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYLIAT------------NGTPE  235 (296)
T ss_pred             --ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH--HhHHHHhc------------CCCCC
Confidence              122345777899999999888999999999999999999999999764431  11111100            00000


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ...+...+..+.+++.+||..+|++|||+.+++++
T Consensus       236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            11223345678999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.1e-40  Score=312.75  Aligned_cols=257  Identities=19%  Similarity=0.284  Sum_probs=193.1

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeC------C
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN------N  149 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  149 (386)
                      .++|+..+.||+|+||.||++... .++.||||++...     ....+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            468999999999999999999954 5788999986432     234677899999999999999999987543      3


Q ss_pred             eEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 016588          150 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  229 (386)
Q Consensus       150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl  229 (386)
                      ..|+||||+++ +|...+.       ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHH-------hcCCHHHHHHHHHHHHHHHHHHhh--CCeecCCCCHHHEEECCCCcEEEEeCCC
Confidence            57999999975 5655552       246788889999999999999998  7799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc-ccc
Q 016588          230 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD-FSN  308 (386)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~  308 (386)
                      ++......   ......++..|+|||++.+..++.++|||||||++|||++|+.||...+...  .....+..... ...
T Consensus       173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~  247 (364)
T cd07875         173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID--QWNKVIEQLGTPCPE  247 (364)
T ss_pred             ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHH
Confidence            98654321   2234467888999999999999999999999999999999999998654311  11111110000 000


Q ss_pred             hhhhcc----------------------hhh----cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          309 LLKILD----------------------ERL----WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       309 ~~~~~~----------------------~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ....+.                      +..    ..........++.+++.+||+.||.+|||+.|++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            000000                      000    000111123568999999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.9e-40  Score=309.70  Aligned_cols=234  Identities=21%  Similarity=0.285  Sum_probs=184.7

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHH-HHHcCCCCcccccccceeeCCeEEEEEEeecC
Q 016588           89 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVC-FLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      +.||+|+||.||+|... ++..||+|.....      ....+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999965 5889999975432      1233445544 57888999999999999999999999999999


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  240 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~  240 (386)
                      ++|..++.     ....+....+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||+++......  .
T Consensus        81 ~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~L~~lH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~  151 (321)
T cd05603          81 GELFFHLQ-----RERCFLEPRARFYAAEVASAIGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--E  151 (321)
T ss_pred             CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--C
Confidence            99987773     33557788888999999999999998  779999999999999999999999999987532211  2


Q ss_pred             CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhccc
Q 016588          241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  320 (386)
Q Consensus       241 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (386)
                      ......+++.|+|||.+.+..++.++|||||||++|||++|..||...+.   ....+.+.            ...  ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~------------~~~--~~  214 (321)
T cd05603         152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV---SQMYDNIL------------HKP--LQ  214 (321)
T ss_pred             ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH---HHHHHHHh------------cCC--CC
Confidence            23345688899999999988999999999999999999999999976432   11111111            010  12


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCHH
Q 016588          321 FTNEGMEEFIQLIVRCLDPSSERRPSMS  348 (386)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~  348 (386)
                      .+...+.++.+++.+||+.||.+||++.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         215 LPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            2233446789999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.8e-40  Score=305.87  Aligned_cols=263  Identities=19%  Similarity=0.272  Sum_probs=186.7

Q ss_pred             CCeecccCceEEEEEEeC---CCcEEEEEECCCC-ChhHHHHHHHHHHcCCCCcccccccceee--CCeEEEEEEeecCC
Q 016588           88 KNLIGEGKFGEVYKGLLQ---DGMLVAIKKRPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQFLIYEYIPNG  161 (386)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g  161 (386)
                      .+.||+|+||.||+|...   ++..+|+|..... ....+.+|+.+++.++||||+++++++..  ....|+++||+.+ 
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-   84 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-   84 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-
Confidence            467999999999999854   4578999986543 34567899999999999999999998854  4568899999865 


Q ss_pred             CccccccCCC----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee----CCCCceEEccccccccc
Q 016588          162 SVSIHLYGPS----QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNFL  233 (386)
Q Consensus       162 ~L~~~l~~~~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill----~~~~~~kl~DFgl~~~~  233 (386)
                      +|..++....    ......+++..+..++.|++.||.|||+  ++|+||||||+|||+    +.++.+||+|||+++..
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~  162 (317)
T cd07868          85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF  162 (317)
T ss_pred             CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh--CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence            6665553211    1122357888999999999999999998  779999999999999    45679999999999876


Q ss_pred             CCCCC-CCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCch-------hhHHHHHHhh-
Q 016588          234 GRTDV-AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSS-------QDLVELVQNS-  303 (386)
Q Consensus       234 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~-------~~~~~~~~~~-  303 (386)
                      ..... ........+|+.|+|||++.+. .++.++||||+||++|||++|+.||........       ..+....... 
T Consensus       163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (317)
T cd07868         163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG  242 (317)
T ss_pred             CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcC
Confidence            43221 1122345678899999998764 589999999999999999999999975443111       1111111000 


Q ss_pred             -------------hcccchhhhcchhhc---------ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          304 -------------RDFSNLLKILDERLW---------STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       304 -------------~~~~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                                   .......+.......         .........++.+++.+||+.||++|||++|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h  314 (317)
T cd07868         243 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  314 (317)
T ss_pred             CCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                         000000000000000         00000112457899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.6e-40  Score=310.69  Aligned_cols=256  Identities=21%  Similarity=0.307  Sum_probs=191.6

Q ss_pred             hcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeC------C
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN------N  149 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  149 (386)
                      .++|+..+.||+|+||.||+|.. .++..||+|+....     ....+.+|+.+++.++||||+++++++...      .
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            46789999999999999999995 45789999986542     224567899999999999999999987533      4


Q ss_pred             eEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 016588          150 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  229 (386)
Q Consensus       150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl  229 (386)
                      ..|++++++ +++|..++.      ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        94 ~~~~~~~~~-~~~l~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          94 EVYLVTNLM-GADLNNIVK------CQKLSDEHVQFLIYQLLRGLKYIHS--AGIIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             cEEEEeecC-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCeecccCChhhEEECCCCCEEEcCCcc
Confidence            568999987 678877662      3458899999999999999999999  7799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc-cc
Q 016588          230 RNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD-FS  307 (386)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~  307 (386)
                      ++.....     .....++..|+|||++.+ ..++.++|||||||++|||++|..||.......  .+......... ..
T Consensus       165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~  237 (343)
T cd07878         165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--QLKRIMEVVGTPSP  237 (343)
T ss_pred             ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCCH
Confidence            8865431     234467888999999876 568999999999999999999999997643211  11111100000 00


Q ss_pred             chhhhcc--------hhhc-------ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          308 NLLKILD--------ERLW-------STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       308 ~~~~~~~--------~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .....+.        ..+.       ........+.+.+++.+||+.||.+|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000000        0000       00001123457899999999999999999999976

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=6.3e-40  Score=299.72  Aligned_cols=244  Identities=28%  Similarity=0.405  Sum_probs=196.8

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      .|+..+.||+|+||.||+|... ++..||+|..+...    .+.+.+|+.+++.++||||+++++++..++..|+|+||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            3455678999999999999854 57889999855332    345788999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++++|.+++.      ...+++..+..++.|++.|+.|||+  ++++|+||+|+||++++++.++++|||++........
T Consensus        85 ~~~~L~~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~--~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          85 GGGSALDLLK------PGPLEETYIATILREILKGLDYLHS--ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHhc--CCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            9999988873      2457888999999999999999998  7799999999999999999999999999876643221


Q ss_pred             CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                        ......++..|+|||.+.+..++.++|+|||||++|||++|..|+....+...   ...             ......
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~-------------~~~~~~  218 (277)
T cd06642         157 --KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---LFL-------------IPKNSP  218 (277)
T ss_pred             --hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---Hhh-------------hhcCCC
Confidence              11223567789999999988899999999999999999999999875443211   000             011111


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .......+..+.+++.+||+.+|++|||+.+++++
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            12223345678999999999999999999999985

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6.3e-40  Score=301.09  Aligned_cols=248  Identities=19%  Similarity=0.291  Sum_probs=195.8

Q ss_pred             CCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC------hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           85 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      |+..+.||+|+||+||+|... +++.+|+|......      ...+.+|+++++.++|+|++.+.+.+..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            566788999999999999964 58899999754321      23467899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +.+++|.+++...   ....+++..+..++.|++.||.|||+  .+|+||||||+||++++++.++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~--~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          82 MNGGDLKFHIYNM---GNPGFEEERALFYAAEILCGLEDLHR--ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             ccCccHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            9999998877432   23468999999999999999999998  779999999999999999999999999987653221


Q ss_pred             CCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhh
Q 016588          238 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  317 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (386)
                         ......++..|+|||.+.+..++.++|+|||||++|||++|..||...........  .......         .  
T Consensus       157 ---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~--~~~~~~~---------~--  220 (285)
T cd05632         157 ---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE--VDRRVLE---------T--  220 (285)
T ss_pred             ---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHhhhc---------c--
Confidence               11234678889999999988999999999999999999999999986443111110  0000000         0  


Q ss_pred             cccCCHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHH
Q 016588          318 WSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTE  353 (386)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~evl~~  353 (386)
                      ....+...+.++.+++.+||+.||++|||     +.+++++
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         221 EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            01122234456899999999999999999     6677765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=6.4e-40  Score=300.71  Aligned_cols=261  Identities=23%  Similarity=0.307  Sum_probs=194.5

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      +|+..+.||+|++|.||+|..+ ++..||+|.....     ....+.+|+.+++.++|||++++++++...+..|+||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4778899999999999999965 5889999975422     235678899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +. ++|.+++...  .....+++..+..++.|++.||.|||+  ++++||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          81 LS-MDLKKYLDSL--PKGQYMDAELVKSYLYQILQGILFCHS--RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             CC-CCHHHHHhcC--CCCCcCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            97 5777776432  123568899999999999999999998  779999999999999999999999999987654321


Q ss_pred             CCCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcc----------
Q 016588          238 VAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF----------  306 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----------  306 (386)
                        .......++..|+|||++.+. .++.++|||||||++|||++|+.||......  .............          
T Consensus       156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  231 (285)
T cd07861         156 --RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI--DQLFRIFRILGTPTEDVWPGVTS  231 (285)
T ss_pred             --ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhcchh
Confidence              111223457789999988654 4688999999999999999999999864421  1111111100000          


Q ss_pred             -cchhhhcch---hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          307 -SNLLKILDE---RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       307 -~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                       .........   ..........++++.+++.+||+.||.+|||+.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence             000000000   00000111234678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2e-39  Score=296.44  Aligned_cols=245  Identities=27%  Similarity=0.402  Sum_probs=200.0

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      ..|+..+.||.|+||.||+|... ++..||+|......    ...+.+|+.+++.++|+|++++++++.+++..++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35677789999999999999965 58899999755332    34678899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +++++|.+++.      ...+++.....++.|++.||.|||+  .+++|+||+|+||+++.++.++++|||++.......
T Consensus        84 ~~~~~L~~~i~------~~~l~~~~~~~~~~~l~~~l~~lh~--~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          84 LGGGSALDLLR------AGPFDEFQIATMLKEILKGLDYLHS--EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCCcHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHh--CCccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence            99999998873      2357888889999999999999998  779999999999999999999999999987664322


Q ss_pred             CCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhh
Q 016588          238 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  317 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (386)
                      .  ......++..|+|||.+.+..++.++|+|||||++|||++|..||....+...   ...             .....
T Consensus       156 ~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~-------------~~~~~  217 (277)
T cd06640         156 I--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV---LFL-------------IPKNN  217 (277)
T ss_pred             c--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH---hhh-------------hhcCC
Confidence            1  12233567789999999888899999999999999999999999876543211   100             01111


Q ss_pred             cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ........+..+.+++.+||+.+|++||++++++++
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            123344566789999999999999999999999877

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.6e-41  Score=288.27  Aligned_cols=256  Identities=20%  Similarity=0.319  Sum_probs=203.5

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-------Ch----hHHHHHHHHHHcC-CCCcccccccceeeC
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-------PT----QEFIDEVCFLASI-QHRNLVTLLGYCQEN  148 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-------~~----~~~~~e~~~l~~l-~h~niv~~~~~~~~~  148 (386)
                      ...|...+.+|+|..++|.++.++ ++..+|+|++...       ..    +.-..|+.||+++ .||+|+++.++++.+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            456777889999999999998854 5788888863211       11    2345689999998 699999999999999


Q ss_pred             CeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccc
Q 016588          149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  228 (386)
Q Consensus       149 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFg  228 (386)
                      ..+++|+|.|+.|.|.+++.     ..-.+++....+|+.|+.+|++|||.  +.||||||||+|||+|++.++||+|||
T Consensus        96 sF~FlVFdl~prGELFDyLt-----s~VtlSEK~tR~iMrqlfegVeylHa--~~IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLT-----SKVTLSEKETRRIMRQLFEGVEYLHA--RNIVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             chhhhhhhhcccchHHHHhh-----hheeecHHHHHHHHHHHHHHHHHHHH--hhhhhcccChhheeeccccceEEeccc
Confidence            99999999999999999993     45668899999999999999999998  669999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhc------ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHh
Q 016588          229 LRNFLGRTDVAGPSSQVTADEIFLASEVKE------FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN  302 (386)
Q Consensus       229 l~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~  302 (386)
                      ++..+..++   .....+||++|+|||.+.      ...|+...|+||+||++|.|+.|.+||.....     +.     
T Consensus       169 Fa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-----ml-----  235 (411)
T KOG0599|consen  169 FACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-----ML-----  235 (411)
T ss_pred             eeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-----HH-----
Confidence            999886543   345678999999999874      35789999999999999999999999885221     00     


Q ss_pred             hhcccchhhhcchh---hcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH--HHhhhhhcc
Q 016588          303 SRDFSNLLKILDER---LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL--DRTLDKEMN  363 (386)
Q Consensus       303 ~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L--~~~~~~~~~  363 (386)
                            +.+.+-.+   ..++.=.+.+++.++|+.+||+.||.+|.|++|+|+|-  .+++.+..+
T Consensus       236 ------MLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r  295 (411)
T KOG0599|consen  236 ------MLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQAR  295 (411)
T ss_pred             ------HHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhccc
Confidence                  11111111   11112224456789999999999999999999999763  445544333

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-39  Score=297.82  Aligned_cols=245  Identities=27%  Similarity=0.385  Sum_probs=199.3

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      ++|+..+.||.|+||.||+|... +++.+++|......    ...+.+|+.+++.++|+|++++.+++.+....++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36778899999999999999965 58899999854332    34678899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +++++|.+++..      ..+++..+..++.|++.||.|||+  ++++|+||+|+||++++++.++|+|||+++......
T Consensus        81 ~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  152 (274)
T cd06609          81 CGGGSCLDLLKP------GKLDETYIAFILREVLLGLEYLHE--EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM  152 (274)
T ss_pred             eCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence            999999988842      268899999999999999999998  779999999999999999999999999998775432


Q ss_pred             CCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhh
Q 016588          238 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  317 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (386)
                        .......++..|+|||.+.+..++.++||||||+++|||++|..||....+..   ........             .
T Consensus       153 --~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~~-------------~  214 (274)
T cd06609         153 --SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR---VLFLIPKN-------------N  214 (274)
T ss_pred             --cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH---HHHHhhhc-------------C
Confidence              12233456778999999998889999999999999999999999997654211   11111100             0


Q ss_pred             cccCCHH-HHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          318 WSTFTNE-GMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       318 ~~~~~~~-~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ....... .+.++.+++.+||+.+|++|||+++++++
T Consensus       215 ~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         215 PPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             CCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            0111111 44668999999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.1e-39  Score=295.68  Aligned_cols=236  Identities=19%  Similarity=0.367  Sum_probs=183.0

Q ss_pred             CeecccCceEEEEEEeCC-------------CcEEEEEECCCCC---hhHHHHHHHHHHcCCCCcccccccceeeCCeEE
Q 016588           89 NLIGEGKFGEVYKGLLQD-------------GMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  152 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  152 (386)
                      +.||+|+||.||+|....             ...|++|......   ...+.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998532             2258888755433   235778899999999999999999999988999


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc-------eEEc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI-------AKVA  225 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~-------~kl~  225 (386)
                      +||||+++++|..++..    ....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.       ++++
T Consensus        81 lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          81 MVEEFVEFGPLDLFMHR----KSDVLTTPWKFKVAKQLASALSYLED--KDLVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             EEEecccCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHhhh--CCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence            99999999999887742    23458888999999999999999998  77999999999999987664       8999


Q ss_pred             ccccccccCCCCCCCCCccccCcccccchhhhc-ccCCCcccchhhHHHHHHHHH-cCCCCCCCCCCCchhhHHHHHHhh
Q 016588          226 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE-FRRFSEKSDVYSFGVFLLELV-SGREASSSLSPDSSQDLVELVQNS  303 (386)
Q Consensus       226 DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlGvil~el~-tg~~p~~~~~~~~~~~~~~~~~~~  303 (386)
                      |||++......      ....++..|+|||.+. +..++.++|||||||++|||+ +|..|+..........       .
T Consensus       155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-------~  221 (262)
T cd05077         155 DPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-------F  221 (262)
T ss_pred             CCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-------H
Confidence            99998654321      2234567799999886 467899999999999999998 5777776533211100       0


Q ss_pred             hcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          304 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                      .         ....  .......+++.+++.+||+.||++||++.++++.|
T Consensus       222 ~---------~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         222 Y---------EGQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             H---------hcCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            0         0000  00111235689999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.8e-40  Score=310.47  Aligned_cols=237  Identities=20%  Similarity=0.281  Sum_probs=186.1

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHH-HHHcCCCCcccccccceeeCCeEEEEEEeecC
Q 016588           89 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVC-FLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      +.||+|+||+||+|... +++.+|+|.....      ....+..|.. +++.++||||+++++++...+..|+||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999954 5889999985432      2234455554 46778999999999999999999999999999


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  240 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~  240 (386)
                      |+|..++.     ....+++..+..++.|++.||.|||+  .||+||||||+|||++.++.+||+|||+++.....  ..
T Consensus        81 ~~L~~~l~-----~~~~~~~~~~~~~~~qi~~al~~lH~--~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~  151 (325)
T cd05604          81 GELFFHLQ-----RERSFPEPRARFYAAEIASALGYLHS--INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SD  151 (325)
T ss_pred             CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CC
Confidence            99987773     34568899999999999999999998  77999999999999999999999999998753221  11


Q ss_pred             CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhccc
Q 016588          241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  320 (386)
Q Consensus       241 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (386)
                      ......++..|+|||++.+..++.++|||||||++|||++|..||......   ........            ..+  .
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~~~~------------~~~--~  214 (325)
T cd05604         152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---EMYDNILH------------KPL--V  214 (325)
T ss_pred             CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH---HHHHHHHc------------CCc--c
Confidence            223456888999999999999999999999999999999999999864421   11111110            000  1


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 016588          321 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVV  351 (386)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl  351 (386)
                      .++..+..+.+++.+|++.+|.+||++.+.+
T Consensus       215 ~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         215 LRPGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence            1122345688999999999999999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.9e-40  Score=311.94  Aligned_cols=258  Identities=19%  Similarity=0.279  Sum_probs=193.2

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeC------
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN------  148 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  148 (386)
                      ..++|+..+.||+|+||.||++... .+..||+|+....     ....+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            3468999999999999999999854 5889999986432     234577899999999999999999987543      


Q ss_pred             CeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccc
Q 016588          149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  228 (386)
Q Consensus       149 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFg  228 (386)
                      ...|+||||+++ ++...+.       ..+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~--~givHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHHEEECCCCCEEEeeCc
Confidence            357999999976 5555442       246788888999999999999998  779999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcc--
Q 016588          229 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF--  306 (386)
Q Consensus       229 l~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--  306 (386)
                      +++......   ......+|..|+|||++.+..++.++|||||||++|||++|+.||.+....  .............  
T Consensus       165 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~  239 (355)
T cd07874         165 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI--DQWNKVIEQLGTPCP  239 (355)
T ss_pred             ccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCH
Confidence            998654321   223346788899999999999999999999999999999999999864421  1111111100000  


Q ss_pred             -------cchhhhcc----------h-----hhc---ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          307 -------SNLLKILD----------E-----RLW---STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       307 -------~~~~~~~~----------~-----~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                             .......+          +     ...   .........++.+++.+||+.||++|||+.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                   00000000          0     000   00111224568999999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1e-39  Score=297.88  Aligned_cols=255  Identities=27%  Similarity=0.437  Sum_probs=199.5

Q ss_pred             cCCCcCCeecccCceEEEEEEeC------CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  152 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  152 (386)
                      .+|+..+.||+|+||.||+|..+      +...+++|......    .+.+.+|++++++++|+|++++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57888899999999999999954      24578999765432    346889999999999999999999999989999


Q ss_pred             EEEEeecCCCccccccCCCcC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQV----SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  228 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFg  228 (386)
                      +||||+++++|.+++......    ....+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.++++|||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~--~~i~H~dlkp~Nili~~~~~~~l~~~~  162 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN--ARFVHRDLAARNCLVSSQREVKVSLLS  162 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh--cCcccCcCccceEEEeCCCcEEEcccc
Confidence            999999999999988533211    11268899999999999999999998  779999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhccc
Q 016588          229 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFS  307 (386)
Q Consensus       229 l~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  307 (386)
                      ++........ .......++..|+|||.+.+..++.++||||||+++|++++ |..||......   ........     
T Consensus       163 ~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~~~~~~-----  233 (275)
T cd05046         163 LSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVLNRLQA-----  233 (275)
T ss_pred             cccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHHHHHHc-----
Confidence            9875432211 11222345667999999988888999999999999999998 77888654321   11111110     


Q ss_pred             chhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016588          308 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  355 (386)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~  355 (386)
                             .......+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       234 -------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         234 -------GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             -------CCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                   01111122234567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=7.8e-40  Score=295.22  Aligned_cols=246  Identities=29%  Similarity=0.484  Sum_probs=196.8

Q ss_pred             cCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCC-ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCC
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  161 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  161 (386)
                      ++|++.+.||+|+||.||++.. .+..+++|..... ..+.+.+|+.+++.++|||++++++++... ..+++|||+.++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~   83 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKG   83 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCC
Confidence            4678889999999999999875 5678999986543 445788999999999999999999988665 468999999999


Q ss_pred             CccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCC
Q 016588          162 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP  241 (386)
Q Consensus       162 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~  241 (386)
                      +|.+++...   ....+++..+..++.|++.||.|||+  ++++||||||+||+++.++.++|+|||++......     
T Consensus        84 ~L~~~l~~~---~~~~~~~~~~~~~~~qi~~al~~lH~--~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----  153 (254)
T cd05083          84 NLVNFLRTR---GRALVSVIQLLQFSLDVAEGMEYLES--KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----  153 (254)
T ss_pred             CHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence            999988532   23457888999999999999999998  78999999999999999999999999998764321     


Q ss_pred             CccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhccc
Q 016588          242 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  320 (386)
Q Consensus       242 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (386)
                      ......+..|+|||.+.+..++.++|+|||||++|||++ |..||......   ........             .....
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~-------------~~~~~  217 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK---EVKECVEK-------------GYRME  217 (254)
T ss_pred             CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH---HHHHHHhC-------------CCCCC
Confidence            112233456999999988889999999999999999998 88888764431   11111111             11111


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHH
Q 016588          321 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  356 (386)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~  356 (386)
                      .+...+..+.+++.+||+.+|++||++.++++.|++
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            223345678999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.4e-39  Score=295.59  Aligned_cols=248  Identities=23%  Similarity=0.331  Sum_probs=193.0

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC--------ChhHHHHHHHHHHcCCCCcccccccceee--CCeE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA--------PTQEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQ  151 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  151 (386)
                      .+|+..+.||+|+||.||+|... ++..|++|.....        ....+.+|+.+++.++||||+++++++..  .+..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            36888999999999999999954 5889999975321        12357789999999999999999998865  4678


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      ++++||+++++|.+++..     ...+++.....++.|++.||.|||+  .+++||||+|+||+++.++.++|+|||++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~LH~--~~i~H~~l~p~nil~~~~~~~~l~dfg~~~  154 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA-----YGALTESVTRKYTRQILEGMSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASK  154 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence            899999999999988842     3457888889999999999999998  779999999999999999999999999987


Q ss_pred             ccCCCCC-CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          232 FLGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       232 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      ....... ........++..|+|||.+.+..++.++|+|||||++|||++|+.||......  .....            
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~--~~~~~------------  220 (266)
T cd06651         155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM--AAIFK------------  220 (266)
T ss_pred             ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH--HHHHH------------
Confidence            6532111 11122345777899999999888999999999999999999999999764321  11100            


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                       ..........+....+.+.+++ +||..+|++|||++|++++
T Consensus       221 -~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         221 -IATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             -HhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence             0000011223334456677787 6888999999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.9e-40  Score=323.55  Aligned_cols=264  Identities=17%  Similarity=0.218  Sum_probs=190.2

Q ss_pred             HHHHhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC--ChhHHHHHHHHHHcCCC------CcccccccceeeC
Q 016588           78 LSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA--PTQEFIDEVCFLASIQH------RNLVTLLGYCQEN  148 (386)
Q Consensus        78 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~l~~l~h------~niv~~~~~~~~~  148 (386)
                      +....++|++.+.||+|+||+||+|... .+..||||++...  ...+...|+.+++.++|      .+++++++++...
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            3345678999999999999999999954 5788999986532  23445667777777654      4588888888754


Q ss_pred             -CeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC-------
Q 016588          149 -NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-------  220 (386)
Q Consensus       149 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~-------  220 (386)
                       +..|+|||++ +++|.+++.     ....+++..+..++.|++.||.|||+. .||+||||||+|||++.++       
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~-----~~~~l~~~~~~~i~~qi~~aL~yLH~~-~gIiHrDlKP~NILl~~~~~~~~~~~  276 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIM-----KHGPFSHRHLAQIIFQTGVALDYFHTE-LHLMHTDLKPENILMETSDTVVDPVT  276 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEecCCccccccc
Confidence             5788999987 667777773     235688999999999999999999962 3799999999999998765       


Q ss_pred             ---------ceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCC
Q 016588          221 ---------IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPD  291 (386)
Q Consensus       221 ---------~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~  291 (386)
                               .+||+|||++.....     ......+|+.|+|||++.+..|+.++|||||||++|||++|+.||......
T Consensus       277 ~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~  351 (467)
T PTZ00284        277 NRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL  351 (467)
T ss_pred             ccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence                     499999998764322     223457889999999999999999999999999999999999999875532


Q ss_pred             chhhHHHHHHh-hh-------cccchhhh----------cchhhc-----cc-C-CHHHHHHHHHHHhHccCCCCCCCCC
Q 016588          292 SSQDLVELVQN-SR-------DFSNLLKI----------LDERLW-----ST-F-TNEGMEEFIQLIVRCLDPSSERRPS  346 (386)
Q Consensus       292 ~~~~~~~~~~~-~~-------~~~~~~~~----------~~~~~~-----~~-~-~~~~~~~l~~li~~cl~~dp~~Rpt  346 (386)
                      .....+..... .+       ........          .++...     .. . .....+.+.+|+.+||+.||++|||
T Consensus       352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t  431 (467)
T PTZ00284        352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN  431 (467)
T ss_pred             HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence            21111111000 00       00000000          000000     00 0 0011356789999999999999999


Q ss_pred             HHHHHHH
Q 016588          347 MSDVVTE  353 (386)
Q Consensus       347 ~~evl~~  353 (386)
                      ++|+++|
T Consensus       432 a~e~L~H  438 (467)
T PTZ00284        432 ARQMTTH  438 (467)
T ss_pred             HHHHhcC
Confidence            9999985

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.6e-39  Score=293.51  Aligned_cols=247  Identities=22%  Similarity=0.328  Sum_probs=196.9

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceee-CCeEEEEEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE-NNLQFLIYE  156 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e  156 (386)
                      +|++.+.||+|++|.||++..+ +++.+++|.....     ..+.+.+|+++++.++|+|++++++.+.. ....|++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788899999999999999954 4788999975422     23457889999999999999999988764 456789999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      |+++++|.+++...   ....+++.++..++.+++.|+.|||+  ++++||||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~l~~~---~~~~l~~~~~~~~~~~l~~~l~~lH~--~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          81 FCEGGDLYHKLKEQ---KGKLLPENQVVEWFVQIAMALQYLHE--KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ccCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            99999999888532   23457899999999999999999998  77999999999999999999999999998876432


Q ss_pred             CCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchh
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  316 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (386)
                      .  .......+++.|+|||...+..++.++|+||||++++|+++|+.||...+.   .........             .
T Consensus       156 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~---~~~~~~~~~-------------~  217 (257)
T cd08223         156 C--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM---NSLVYRIIE-------------G  217 (257)
T ss_pred             C--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHh-------------c
Confidence            2  122344577789999999988999999999999999999999999875332   111111100             0


Q ss_pred             hcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          317 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .....+...++++.+++.+||+.||++|||+.+++++
T Consensus       218 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         218 KLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             CCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0112233455679999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.8e-39  Score=293.11  Aligned_cols=248  Identities=21%  Similarity=0.353  Sum_probs=200.0

Q ss_pred             CCCcCCeecccCceEEEEEEe-CCCcEEEEEECCC-----CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           84 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      +|+..+.||.|+||.||.+.. .++..+++|....     ....++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            478889999999999999984 4588899997432     2345688999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +++++|.+++...   ....+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          81 ANGGTLYDKIVRQ---KGQLFEEEMVLWYLFQIVSAVSYIHK--AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             cCCCcHHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            9999999988532   13467889999999999999999998  679999999999999999999999999987664322


Q ss_pred             CCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhh
Q 016588          238 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  317 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (386)
                      .  ......++..|+|||...+..++.++|+||||+++|||++|..||......   ........            . .
T Consensus       156 ~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---~~~~~~~~------------~-~  217 (256)
T cd08221         156 S--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVVKIVQ------------G-N  217 (256)
T ss_pred             c--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHc------------C-C
Confidence            1  223445788899999998888899999999999999999999998753321   11111110            0 0


Q ss_pred             cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                      +...+...+.++.+++.+||+.+|.+|||++++++++
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         218 YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             CCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            1112233456789999999999999999999999763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-40  Score=306.91  Aligned_cols=252  Identities=23%  Similarity=0.262  Sum_probs=194.0

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC------CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ++|++.+.||+|+||.||++... +++.||+|.+..      ...+.+.+|..++..++|+||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46888999999999999999965 588999998642      22345778999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++|+|.+++..    ....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          81 DYYVGGDLLTLLSK----FEDRLPEDMARFYLAEMVLAIDSVHQ--LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             ecCCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            99999999988842    23467888999999999999999999  7799999999999999999999999999876543


Q ss_pred             CCCCCCCccccCcccccchhhhcc-----cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      ... .......+|+.|+|||++..     ..++.++|||||||++|||++|+.||......   .....+..   .....
T Consensus       155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~---~~~~~i~~---~~~~~  227 (331)
T cd05597         155 DGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKIMN---HKEHF  227 (331)
T ss_pred             CCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH---HHHHHHHc---CCCcc
Confidence            221 11223458889999999863     45788999999999999999999999764321   11111110   00000


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCC--CCCHHHHHHH
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSER--RPSMSDVVTE  353 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~evl~~  353 (386)
                      .      ........++.+.+++.+|++.++++  |+++++++++
T Consensus       228 ~------~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         228 Q------FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             c------CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            0      01111124566889999988654443  7899999988

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-40  Score=313.15  Aligned_cols=243  Identities=27%  Similarity=0.435  Sum_probs=201.3

Q ss_pred             eecccCceEEEEEEe-CCCcEEEEEECCCCC---hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCCCccc
Q 016588           90 LIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSI  165 (386)
Q Consensus        90 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~  165 (386)
                      +||+|.||+||.|+. ++...+|||-++...   .+-+..|+..=++|+|.|||+++|.+..++..-+.||-++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            699999999999994 456789999866543   3457889999999999999999999999999999999999999999


Q ss_pred             cccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC-CCCceEEcccccccccCCCCCCCCCcc
Q 016588          166 HLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGRTDVAGPSSQ  244 (386)
Q Consensus       166 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~-~~~~~kl~DFgl~~~~~~~~~~~~~~~  244 (386)
                      ++...  ...-+-++.++-.+.+||++||.|||.  +.|||||||-+|+|++ -.|.+||+|||-++.+..  ....+..
T Consensus       662 LLrsk--WGPlKDNEstm~fYtkQILeGLkYLHe--n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TET  735 (1226)
T KOG4279|consen  662 LLRSK--WGPLKDNESTMNFYTKQILEGLKYLHE--NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTET  735 (1226)
T ss_pred             HHHhc--cCCCccchhHHHHHHHHHHHHhhhhhh--cceeeccccCCcEEEeeccceEEecccccchhhcc--CCccccc
Confidence            98532  111222677888899999999999999  7799999999999997 468999999999988753  3455678


Q ss_pred             ccCcccccchhhhcc--cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCC
Q 016588          245 VTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFT  322 (386)
Q Consensus       245 ~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (386)
                      ..||..|||||++..  ..|+.++|||||||++.||.||++||.......              ..+.++---...++.|
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--------------AAMFkVGmyKvHP~iP  801 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--------------AAMFKVGMYKVHPPIP  801 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--------------HhhhhhcceecCCCCc
Confidence            899999999999975  478999999999999999999999998755421              1111111122335678


Q ss_pred             HHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 016588          323 NEGMEEFIQLIVRCLDPSSERRPSMSDVVT  352 (386)
Q Consensus       323 ~~~~~~l~~li~~cl~~dp~~Rpt~~evl~  352 (386)
                      .+.+.+.+.++.+|+..||.+||++.++|+
T Consensus       802 eelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            888999999999999999999999999985

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-40  Score=326.81  Aligned_cols=266  Identities=29%  Similarity=0.446  Sum_probs=214.8

Q ss_pred             HHHHhcCCCcCCeecccCceEEEEEEeC--------CCcEEEEEECCCCC----hhHHHHHHHHHHcC-CCCcccccccc
Q 016588           78 LSLATKNFSDKNLIGEGKFGEVYKGLLQ--------DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGY  144 (386)
Q Consensus        78 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~~~~~  144 (386)
                      ++...++....+.||+|.||.|++|...        ....||||..+...    .+.+..|+++|+.+ +|+|++.++|+
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            3444455566679999999999999843        13579999865443    45788999999998 69999999999


Q ss_pred             eeeCCeEEEEEEeecCCCccccccCCC---------cCCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCC
Q 016588          145 CQENNLQFLIYEYIPNGSVSIHLYGPS---------QVSR--QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTAN  213 (386)
Q Consensus       145 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~N  213 (386)
                      |...+..++|+||+..|+|..++...+         ....  ..+...+.+.++.||+.|++||++  .+++||||..+|
T Consensus       371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~--~~~vHRDLAaRN  448 (609)
T KOG0200|consen  371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS--VPCVHRDLAARN  448 (609)
T ss_pred             eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh--CCccchhhhhhh
Confidence            999999999999999999999997654         1111  238899999999999999999998  679999999999


Q ss_pred             eeeCCCCceEEcccccccccCCCCCCC-CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCC
Q 016588          214 VLVDEDFIAKVADAGLRNFLGRTDVAG-PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPD  291 (386)
Q Consensus       214 ill~~~~~~kl~DFgl~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~  291 (386)
                      ||+..+..+||+|||+++......... ..+...-+..|||||.+....|+.++||||||++|||++| |..||.+... 
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-  527 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-  527 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-
Confidence            999999999999999999765433322 1111124566999999999999999999999999999999 8899987432 


Q ss_pred             chhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          292 SSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                       ..++.             +.+.++.+...|..+.++++++|+.||+.+|++||++.++.+.++.++..
T Consensus       528 -~~~l~-------------~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~  582 (609)
T KOG0200|consen  528 -TEELL-------------EFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD  582 (609)
T ss_pred             -HHHHH-------------HHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence             11222             23344445567777889999999999999999999999999999997654

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.5e-39  Score=291.97  Aligned_cols=248  Identities=30%  Similarity=0.500  Sum_probs=197.5

Q ss_pred             CCcCCeecccCceEEEEEEeCC-----CcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           85 FSDKNLIGEGKFGEVYKGLLQD-----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      |++.+.||.|+||.||++....     +..+|+|......    .+.+.+|+..+..++|+|++++++++...+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567889999999999999654     3789999866543    347889999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++++|.+++...   ....+++..+..++.|++.||.|||+  .+++|+||||+||++++++.++|+|||++.....
T Consensus        81 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lh~--~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       81 EYMEGGDLLDYLRKN---RPKELSLSDLLSFALQIARGMEYLES--KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             eccCCCCHHHHHHhh---hhccCCHHHHHHHHHHHHHHHHHHhc--CCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence            999999999888432   11228999999999999999999998  6799999999999999999999999999887654


Q ss_pred             CCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                      ....... ...++..|+|||...+..++.++|+||+|+++++|++ |..||.....   ...........          
T Consensus       156 ~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~~~~----------  221 (258)
T smart00219      156 DDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEYLKKGY----------  221 (258)
T ss_pred             ccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhcCC----------
Confidence            3222111 2336678999999988889999999999999999998 7778765332   22222211111          


Q ss_pred             hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                         ....+...+.++.+++.+||+.||++|||+.|+++.|
T Consensus       222 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      222 ---RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ---CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence               1122223456799999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.4e-40  Score=313.96  Aligned_cols=260  Identities=21%  Similarity=0.270  Sum_probs=201.4

Q ss_pred             CCCcCCeecccCceEEEEEE-eCCCcEEEEEECCCCC--hhHHHHHHHHHHcCC-C-----CcccccccceeeCCeEEEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP--TQEFIDEVCFLASIQ-H-----RNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~~~~~lv  154 (386)
                      +|.+.++||+|+||.|.+|. .++++.||||++++..  ..+-..|+.+|..|+ |     -|+|+++++|...++.|||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV  266 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV  266 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence            67889999999999999999 5569999999976543  345677899999986 3     5999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC--CCceEEcccccccc
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE--DFIAKVADAGLRNF  232 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~--~~~~kl~DFgl~~~  232 (386)
                      .|.+.. +|.+++...   +...++...+..++.||+.||.+||+  .+|||+||||+||||.+  ...+|++|||++.+
T Consensus       267 fELL~~-NLYellK~n---~f~Glsl~~ir~~~~Qil~~L~~L~~--l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  267 FELLST-NLYELLKNN---KFRGLSLPLVRKFAQQILTALLFLHE--LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             ehhhhh-hHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCChhheeeccCCcCceeEEecccccc
Confidence            999865 999999643   45668999999999999999999998  77999999999999964  45899999999987


Q ss_pred             cCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcc------
Q 016588          233 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF------  306 (386)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------  306 (386)
                      .....     ..+.-+..|.|||++.|..|+.+.||||||||++||++|.+.|.+..+.+....+..+...+..      
T Consensus       341 ~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~  415 (586)
T KOG0667|consen  341 ESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA  415 (586)
T ss_pred             cCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            65432     2556677899999999999999999999999999999999888886653332222111111100      


Q ss_pred             cchhhhcch--------------------------------hhcc-------c-CCHHHHHHHHHHHhHccCCCCCCCCC
Q 016588          307 SNLLKILDE--------------------------------RLWS-------T-FTNEGMEEFIQLIVRCLDPSSERRPS  346 (386)
Q Consensus       307 ~~~~~~~~~--------------------------------~~~~-------~-~~~~~~~~l~~li~~cl~~dp~~Rpt  346 (386)
                      ......++.                                ...+       . ........+.+++++||..||.+|+|
T Consensus       416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t  495 (586)
T KOG0667|consen  416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT  495 (586)
T ss_pred             cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence            000000110                                0000       0 11122356899999999999999999


Q ss_pred             HHHHHHHH
Q 016588          347 MSDVVTEL  354 (386)
Q Consensus       347 ~~evl~~L  354 (386)
                      ..++++|-
T Consensus       496 p~qal~Hp  503 (586)
T KOG0667|consen  496 PAQALNHP  503 (586)
T ss_pred             HHHHhcCc
Confidence            99999874

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.6e-39  Score=300.23  Aligned_cols=247  Identities=22%  Similarity=0.341  Sum_probs=199.3

Q ss_pred             cCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC---ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      .+|+..+.||+|+||.||++.. .+++.||+|.....   ..+.+.+|+.+++.++|+|++++++++...+..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            5788899999999999999995 46889999975432   2345788999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++++|.+++.      ...+++..+..++.|++.||.|||+  .+++||||||+||+++.++.++|+|||++........
T Consensus        99 ~~~~L~~~~~------~~~~~~~~~~~~~~~l~~~L~~LH~--~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          99 AGGSLTDVVT------ETCMDEGQIAAVCRECLQALDFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             CCCCHHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            9999998873      2357888999999999999999998  7799999999999999999999999999876543221


Q ss_pred             CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                        ......+++.|+|||.+.+..++.++|+|||||++|++++|..||....+....  ...    .        ......
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~--~~~----~--------~~~~~~  234 (297)
T cd06656         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--YLI----A--------TNGTPE  234 (297)
T ss_pred             --CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe--eee----c--------cCCCCC
Confidence              122345777899999999888999999999999999999999999764431110  000    0        000000


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ...+...+..+.+++.+||+.+|++|||+++++++
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11223345668999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.1e-39  Score=294.82  Aligned_cols=253  Identities=24%  Similarity=0.392  Sum_probs=196.7

Q ss_pred             HHHhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC---hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           79 SLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        79 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      +.+++.+.....||+|+||.||+|... ++..|++|......   .+.+.+|+.+++.++|+||+++++++..++..++|
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            345566666788999999999999954 57789999765443   34688999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-CCceEEccccccc
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKL--EFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAGLRN  231 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~-~~~~kl~DFgl~~  231 (386)
                      +||+++++|.+++...    ...+  +...+..++.|++.||.|||+  ++|+||||||+||+++. ++.++|+|||++.
T Consensus        84 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~  157 (268)
T cd06624          84 MEQVPGGSLSALLRSK----WGPLKDNEQTIIFYTKQILEGLKYLHD--NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK  157 (268)
T ss_pred             EecCCCCCHHHHHHHh----cccCCCcHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence            9999999999988532    1223  677888899999999999998  77999999999999986 6799999999987


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhccc--CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccch
Q 016588          232 FLGRTDVAGPSSQVTADEIFLASEVKEFR--RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL  309 (386)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  309 (386)
                      .......  ......++..|+|||.+.+.  .++.++|+||||+++|+|++|..||......... ...   .       
T Consensus       158 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~-~~~---~-------  224 (268)
T cd06624         158 RLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA-MFK---V-------  224 (268)
T ss_pred             ecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh-Hhh---h-------
Confidence            6543221  12234567889999998654  3789999999999999999999998754321100 000   0       


Q ss_pred             hhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                         .........+...++++.+++.+||+.+|.+|||+.+++++
T Consensus       225 ---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         225 ---GMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             ---hhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence               00001112333455678999999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=7e-40  Score=307.28  Aligned_cols=252  Identities=21%  Similarity=0.249  Sum_probs=194.6

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC------CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ++|++.+.||+|+||.||++..+ ++..+|+|....      .....+.+|..++..++|+||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            36888999999999999999965 477899998643      12334778899999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++|+|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++.....
T Consensus        81 ey~~~g~L~~~l~~----~~~~l~~~~~~~~~~qi~~al~~lH~--~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          81 DYYVGGDLLTLLSK----FEDRLPEDMARFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             eccCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            99999999998842    23457888899999999999999999  7799999999999999999999999999875432


Q ss_pred             CCCCCCCccccCcccccchhhhc-----ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          236 TDVAGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      .. ........||+.|+|||++.     ...++.++|||||||++|||++|+.||......   .....+.....     
T Consensus       155 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~---~~~~~i~~~~~-----  225 (332)
T cd05623         155 DG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKIMNHKE-----  225 (332)
T ss_pred             CC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH---HHHHHHhCCCc-----
Confidence            11 11223356889999999986     346789999999999999999999999864321   11111111000     


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCC--CCCHHHHHHH
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSER--RPSMSDVVTE  353 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~evl~~  353 (386)
                          ....+......+.++.+++.+|++.++.+  |+++++++++
T Consensus       226 ----~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         226 ----RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ----cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence                00011112234567899999988765544  6899999988

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.2e-39  Score=292.56  Aligned_cols=245  Identities=25%  Similarity=0.421  Sum_probs=197.2

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC--------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA--------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      +|+..+.||+|+||.||+|... ++..|++|.....        ..+.+.+|+.+++.++|+|++++++++...+..+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677789999999999999965 6889999974321        234688899999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      +||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.+||+|||++....
T Consensus        81 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~  153 (258)
T cd06632          81 LELVPGGSLAKLLK-----KYGSFPEPVIRLYTRQILLGLEYLHD--RNTVHRDIKGANILVDTNGVVKLADFGMAKQVV  153 (258)
T ss_pred             EEecCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            99999999998883     23457888999999999999999998  779999999999999999999999999987654


Q ss_pred             CCCCCCCCccccCcccccchhhhcccC-CCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhc
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  313 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (386)
                      ...   ......++..|++||.+.... ++.++|+||||+++|+|++|..||....+.  ......    ...       
T Consensus       154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~--~~~~~~----~~~-------  217 (258)
T cd06632         154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV--AAVFKI----GRS-------  217 (258)
T ss_pred             ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH--HHHHHH----Hhc-------
Confidence            322   223445777899999987766 899999999999999999999998764421  111110    000       


Q ss_pred             chhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                        ......+...+.++.+++.+||+.+|.+|||+.+++.+
T Consensus       218 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         218 --KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             --ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence              00112233345678999999999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.1e-39  Score=296.44  Aligned_cols=250  Identities=22%  Similarity=0.324  Sum_probs=195.5

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC---hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      ++|+..+.||+|+||.||+|... ++..||+|..+...   ...+.+|+.+++.++||||+++++.+...+..|+|+||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            35667788999999999999954 58899999754332   335778999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++++|.+++.     ....+++..+..++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||++......  
T Consensus        89 ~~~~L~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--  159 (267)
T cd06645          89 GGGSLQDIYH-----VTGPLSESQIAYVSRETLQGLYYLHS--KGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--  159 (267)
T ss_pred             CCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--
Confidence            9999998873     33468899999999999999999998  67999999999999999999999999998765432  


Q ss_pred             CCCCccccCcccccchhhhc---ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          239 AGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      ........++..|+|||++.   ...++.++|+|||||++|||++|..||....+...  ..........        .+
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~~~~~~~~~~--------~~  229 (267)
T cd06645         160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFLMTKSNFQ--------PP  229 (267)
T ss_pred             ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--HHhhhccCCC--------CC
Confidence            12223456788899999874   45688999999999999999999999875443111  1100000000        00


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ..  ......+..+.+++.+||+.+|++|||+++++++
T Consensus       230 ~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         230 KL--KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             cc--cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            00  0011234568999999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-41  Score=312.46  Aligned_cols=242  Identities=29%  Similarity=0.432  Sum_probs=201.9

Q ss_pred             CCCcCCeecccCceEEEEEE-eCCCcEEEEEECCCCC------hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      .|...+.||.|+||.||-|. .++...||||+..-..      -+++..|+.+|.+++|||.+.+-|++......|||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            46667889999999999999 5568899999854332      2467889999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      ||-| +-.+++.    ...+++.+..+..|+.+.+.||.|||+  .+.||||||..||||++.|.+||+|||.+..... 
T Consensus       107 YClG-SAsDlle----VhkKplqEvEIAAi~~gaL~gLaYLHS--~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-  178 (948)
T KOG0577|consen  107 YCLG-SASDLLE----VHKKPLQEVEIAAITHGALQGLAYLHS--HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-  178 (948)
T ss_pred             HHhc-cHHHHHH----HHhccchHHHHHHHHHHHHHHHHHHHH--hhHHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence            9965 7777763    345678888999999999999999999  5699999999999999999999999999877533 


Q ss_pred             CCCCCCccccCcccccchhhhc---ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhc
Q 016588          237 DVAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  313 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (386)
                           ...+.|||+|||||++.   .+.|+-++||||||++..||.-.++|+..+..  ...++...++...        
T Consensus       179 -----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA--MSALYHIAQNesP--------  243 (948)
T KOG0577|consen  179 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQNESP--------  243 (948)
T ss_pred             -----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH--HHHHHHHHhcCCC--------
Confidence                 45678999999999974   46899999999999999999999999887553  3333333332211        


Q ss_pred             chhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                        .   -..+++++.+..++..||+.-|.+|||.+++++|
T Consensus       244 --t---Lqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  244 --T---LQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             --C---CCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence              1   1245678899999999999999999999998876

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.2e-39  Score=295.75  Aligned_cols=235  Identities=20%  Similarity=0.376  Sum_probs=182.6

Q ss_pred             eecccCceEEEEEEeCC-------------------------CcEEEEEECCCCC---hhHHHHHHHHHHcCCCCccccc
Q 016588           90 LIGEGKFGEVYKGLLQD-------------------------GMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTL  141 (386)
Q Consensus        90 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~~  141 (386)
                      .||+|+||.||+|....                         ...|++|......   ..++.+|..+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            59999999999997421                         1358888765433   2357788999999999999999


Q ss_pred             ccceeeCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC-
Q 016588          142 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-  220 (386)
Q Consensus       142 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~-  220 (386)
                      ++++...+..++||||+++|+|..++..    ....+++..+..++.|++.||+|||+  ++|+||||||+|||++..+ 
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK----EKGRVPVAWKITVAQQLASALSYLED--KNLVHGNVCAKNILLARLGL  155 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHc--CCccCCCCCcccEEEeccCc
Confidence            9999999999999999999999888742    24567888999999999999999998  7799999999999997643 


Q ss_pred             ------ceEEcccccccccCCCCCCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHH-cCCCCCCCCCCCc
Q 016588          221 ------IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELV-SGREASSSLSPDS  292 (386)
Q Consensus       221 ------~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~-tg~~p~~~~~~~~  292 (386)
                            .++++|||++......      ....++..|+|||.+.+ ..++.++|||||||++||++ +|..||....+..
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence                  4799999987643221      12245567999998865 56899999999999999985 6888887654322


Q ss_pred             hhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          293 SQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                      ...   ....             ..  ..+.....++.+++.+||+.+|++|||+.++++.|
T Consensus       230 ~~~---~~~~-------------~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         230 KER---FYEK-------------KH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HHH---HHHh-------------cc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            111   1110             00  11111234689999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.9e-39  Score=297.48  Aligned_cols=259  Identities=21%  Similarity=0.268  Sum_probs=193.5

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      +|+..+.||+|+||.||+|... ++..+++|..+..     ....+.+|+.+++.++|||++++++++.+.+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4777899999999999999965 5889999975432     234577899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +.+ +|.+++..    ....+++..+..++.|+++||.|||+  .+++||||||+||+++.++.++|+|||+++..+...
T Consensus        81 ~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~--~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          81 CDQ-DLKKYFDS----CNGDIDPEIVKSFMFQLLKGLAFCHS--HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             CCC-CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            975 67666532    23558899999999999999999998  779999999999999999999999999987654321


Q ss_pred             CCCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc------ccchh
Q 016588          238 VAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD------FSNLL  310 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~  310 (386)
                        .......++..|+|||.+.+. .++.++|||||||++|||++|..|+......  ............      .....
T Consensus       154 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07839         154 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEESWPGVS  229 (284)
T ss_pred             --CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH--HHHHHHHHHHhCCCChHHhHHhh
Confidence              112233467789999998764 4689999999999999999999886543321  111111110000      00000


Q ss_pred             hhcchh---------hcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          311 KILDER---------LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       311 ~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ...+..         .+.......++++.+++.+||+.||.+|||+++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            000000         0111122345678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5e-39  Score=294.84  Aligned_cols=260  Identities=20%  Similarity=0.273  Sum_probs=197.5

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      ++|+..+.||+|+||.||+|..+ +++.||+|.....     ..+.+.+|+.+++.++|+|++++++++...+..++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            36888899999999999999965 5889999974322     23457889999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      |+++++|..+..     ....+++..+..++.|++.||.|||+  ++++||||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~-----~~~~~~~~~~~~~~~ql~~~l~~LH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          81 YCDHTVLNELEK-----NPRGVPEHLIKKIIWQTLQAVNFCHK--HNCIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             ccCccHHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            999988877663     23458899999999999999999999  77999999999999999999999999998876442


Q ss_pred             CCCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhccc-chhhhcc
Q 016588          237 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS-NLLKILD  314 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  314 (386)
                      ..  ......++..|+|||.+.+ ..++.++||||||+++|||++|..||.+....+.  +........... ......+
T Consensus       154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07847         154 GD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ--LYLIRKTLGDLIPRHQQIFS  229 (286)
T ss_pred             cc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCChHHhhhcc
Confidence            21  1223456778999999876 4578999999999999999999999987553221  111111100000 0000000


Q ss_pred             ----------hhhccc-----CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          315 ----------ERLWST-----FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       315 ----------~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                                +.....     .....+..+.+++.+||+.+|++|||+.|++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence                      000000     011234678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.9e-39  Score=299.54  Aligned_cols=247  Identities=22%  Similarity=0.358  Sum_probs=199.2

Q ss_pred             cCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC---ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      .+|+..+.||.|+||.||+|.. .+++.|++|.....   ..+.+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4688889999999999999984 46889999975432   3456788999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++++|..++.      ...+++..+..++.+++.||.|||+  .+++||||||+||+++.++.++|+|||++........
T Consensus        99 ~~~~L~~~~~------~~~l~~~~~~~i~~~l~~al~~LH~--~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~  170 (296)
T cd06655          99 AGGSLTDVVT------ETCMDEAQIAAVCRECLQALEFLHA--NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS  170 (296)
T ss_pred             CCCcHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence            9999998873      2357899999999999999999999  7799999999999999999999999999876543221


Q ss_pred             CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                        ......++..|+|||.+.+..++.++|+|||||++|++++|..||....+..  .... .....           ...
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~--~~~~-~~~~~-----------~~~  234 (296)
T cd06655         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--ALYL-IATNG-----------TPE  234 (296)
T ss_pred             --cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHhcC-----------Ccc
Confidence              1223457778999999998889999999999999999999999997654311  1111 00000           000


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ...+...+..+.+++.+||..||++|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         235 LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            11222345678999999999999999999999965

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.5e-39  Score=296.52  Aligned_cols=247  Identities=24%  Similarity=0.362  Sum_probs=194.6

Q ss_pred             CCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC---hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecC
Q 016588           85 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      |+..+.||+|+||.||+|... ++..+++|......   .+.+.+|+++++.++|||++++++++...+..++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            456688999999999999965 47788888765433   34578899999999999999999999999999999999999


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  240 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~  240 (386)
                      ++|..++..    ....+++..+..++.|++.||.|||+  .+++||||||+||+++.++.++|+|||++.......  .
T Consensus        87 ~~l~~~~~~----~~~~l~~~~~~~~~~qi~~~L~~LH~--~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~  158 (282)
T cd06643          87 GAVDAVMLE----LERPLTEPQIRVVCKQTLEALNYLHE--NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q  158 (282)
T ss_pred             CcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence            999887642    23468899999999999999999998  779999999999999999999999999987653221  1


Q ss_pred             CCccccCcccccchhhhc-----ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          241 PSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       241 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      ......++..|+|||++.     +..++.++|||||||++|||++|..||....+.  ..........          .+
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~~~----------~~  226 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--RVLLKIAKSE----------PP  226 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--HHHHHHhhcC----------CC
Confidence            223345778899999874     345788999999999999999999998764421  1111111100          00


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                        ....+...+.++.+++.+||+.||.+|||+.+++++
T Consensus       227 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         227 --TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             --CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              011222345678999999999999999999999866

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=7.3e-40  Score=306.98  Aligned_cols=252  Identities=21%  Similarity=0.256  Sum_probs=194.5

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ++|.+.+.||+|+||.||++... +++.||+|.....      ....+.+|..++..++|+||+++++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999965 5788999976431      2334778899999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++|+|..++..    ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.....
T Consensus        81 Ey~~gg~L~~~l~~----~~~~l~~~~~~~~~~qi~~~L~~lH~--~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          81 DYYVGGDLLTLLSK----FEDRLPEDMARFYIAEMVLAIHSIHQ--LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             eCCCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            99999999998842    23467888899999999999999998  7799999999999999999999999999876643


Q ss_pred             CCCCCCCccccCcccccchhhhcc-----cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      ... .......+++.|+|||++.+     ..++.++|||||||++|||++|+.||......   .....+.....  .  
T Consensus       155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~~~i~~~~~--~--  226 (331)
T cd05624         155 DGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKIMNHEE--R--  226 (331)
T ss_pred             CCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH---HHHHHHHcCCC--c--
Confidence            221 11223468889999999875     46788999999999999999999999764421   11111110000  0  


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCC--CCCHHHHHHH
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSER--RPSMSDVVTE  353 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~evl~~  353 (386)
                        .   .........++++.+++.+|++.++.+  |+++++++++
T Consensus       227 --~---~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         227 --F---QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             --c---cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence              0   001111223567899999999876654  4688888876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.4e-39  Score=298.78  Aligned_cols=261  Identities=25%  Similarity=0.364  Sum_probs=200.3

Q ss_pred             HHHHHHHhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC--ChhHHHHHHHHHHcC-CCCccccccccee----
Q 016588           75 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA--PTQEFIDEVCFLASI-QHRNLVTLLGYCQ----  146 (386)
Q Consensus        75 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~l~~l-~h~niv~~~~~~~----  146 (386)
                      ++.+....++|+..+.||+|+||.||++... ++..+++|.....  ....+.+|+.+++.+ +|||++++++++.    
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   89 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV   89 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence            3455556788999999999999999999854 5789999986542  235678899999999 6999999999874    


Q ss_pred             -eCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEc
Q 016588          147 -ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA  225 (386)
Q Consensus       147 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~  225 (386)
                       .++..++||||+++++|.+++.... .....+++..+..++.|++.||.|||+  .+++||||||+||+++.++.++|+
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nili~~~~~~kl~  166 (286)
T cd06638          90 KNGDQLWLVLELCNGGSVTDLVKGFL-KRGERMEEPIIAYILHEALMGLQHLHV--NKTIHRDVKGNNILLTTEGGVKLV  166 (286)
T ss_pred             CCCCeEEEEEeecCCCCHHHHHHHhh-ccCccccHHHHHHHHHHHHHHHHHHHh--CCccccCCCHHhEEECCCCCEEEc
Confidence             3467899999999999988764321 123567888899999999999999998  679999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCccccCcccccchhhhcc-----cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHH
Q 016588          226 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV  300 (386)
Q Consensus       226 DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~  300 (386)
                      |||++........  ......++..|+|||.+..     ..++.++||||+||++|||++|+.||....+..  ....  
T Consensus       167 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~~~--  240 (286)
T cd06638         167 DFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--ALFK--  240 (286)
T ss_pred             cCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HHhh--
Confidence            9999876543211  1223457888999998753     457889999999999999999999987644311  1100  


Q ss_pred             HhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          301 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                        ....      ..+.  ...+...+.++.+++.+||+.||++|||+.|+++++
T Consensus       241 --~~~~------~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         241 --IPRN------PPPT--LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             --cccc------CCCc--ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence              0000      0000  011122345689999999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3.7e-39  Score=293.79  Aligned_cols=255  Identities=21%  Similarity=0.391  Sum_probs=195.6

Q ss_pred             CCcCCeecccCceEEEEEEeC----CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCC------
Q 016588           85 FSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN------  149 (386)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  149 (386)
                      |.+.+.||+|+||.||+|...    ++..||+|.....     ..+++.+|+++++.++|||++++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            566788999999999999853    3678999976543     2345788999999999999999999875432      


Q ss_pred             eEEEEEEeecCCCccccccCCCc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccc
Q 016588          150 LQFLIYEYIPNGSVSIHLYGPSQ-VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  228 (386)
Q Consensus       150 ~~~lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFg  228 (386)
                      ..++++||+.+|+|..++..... .....+++.....++.|++.||+|||+  ++|+||||||+||+++.++.+||+|||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~nili~~~~~~kl~dfg  158 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS--KNFIHRDLAARNCMLNENMTVCVADFG  158 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccchhhEEEcCCCCEEECccc
Confidence            34788999999999877643211 122357888899999999999999998  779999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhccc
Q 016588          229 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFS  307 (386)
Q Consensus       229 l~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  307 (386)
                      +++...............++..|++||.+....++.++|||||||++|||++ |..||.....   ............  
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~~--  233 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLIKGNR--  233 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHHcCCc--
Confidence            9887643222222223345567999999988889999999999999999999 8888875432   112211111100  


Q ss_pred             chhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHh
Q 016588          308 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  357 (386)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~  357 (386)
                                 ...+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       234 -----------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         234 -----------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                       011223446799999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.4e-39  Score=294.88  Aligned_cols=251  Identities=22%  Similarity=0.335  Sum_probs=197.6

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      ++|+..+.||+|+||.||++..+ ++..+|+|......    ...+.+|+.+++.++|+||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36788899999999999999965 68899999754321    34688899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +++++|..++...  .....+++..+..++.+++.||.|||+. .+++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          81 MDAGSLDKLYAGG--VATEGIPEDVLRRITYAVVKGLKFLKEE-HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             cCCCCHHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHhc-CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            9999998887432  1134688999999999999999999962 479999999999999999999999999987653221


Q ss_pred             CCCCCccccCcccccchhhhccc------CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhh
Q 016588          238 VAGPSSQVTADEIFLASEVKEFR------RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK  311 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (386)
                          .....++..|+|||.+.+.      .++.++|+|||||++|||++|..||.......   .....         ..
T Consensus       158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~---------~~  221 (286)
T cd06622         158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQL---------SA  221 (286)
T ss_pred             ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHH---------HH
Confidence                2233467789999988543      35889999999999999999999997543211   11111         01


Q ss_pred             hcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          312 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ..+. .....+...+.++.+++.+||+.+|++||++.+++++
T Consensus       222 ~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         222 IVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             Hhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            1111 1112333456778999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.4e-39  Score=303.12  Aligned_cols=260  Identities=18%  Similarity=0.208  Sum_probs=190.6

Q ss_pred             cCCeeccc--CceEEEEEEe-CCCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           87 DKNLIGEG--KFGEVYKGLL-QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        87 ~~~~lg~G--~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      +.++||+|  +|++||++.. .++..||+|..+...     ...+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            35789999  6899999985 468999999865432     234677999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++|+|.+++...   ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.++++||+..........
T Consensus        82 ~~~~l~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~--~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          82 AYGSAKDLICTH---FMDGMSELAIAYILQGVLKALDYIHH--MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             CCCcHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            999999888432   22457889999999999999999998  7799999999999999999999999986543321110


Q ss_pred             -----CCCCccccCcccccchhhhcc--cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhh-hcc----
Q 016588          239 -----AGPSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS-RDF----  306 (386)
Q Consensus       239 -----~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~----  306 (386)
                           ........++..|+|||++.+  ..++.++|||||||++|||++|+.||.......  ......... ...    
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~  234 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCLLDTT  234 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHhcCCcccccccc
Confidence                 011122345667999999876  468999999999999999999999997644211  011100000 000    


Q ss_pred             ----cch-----hhhcc-----------------hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          307 ----SNL-----LKILD-----------------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       307 ----~~~-----~~~~~-----------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                          ...     ....+                 ...........++++.+++.+||+.||++|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence                000     00000                 000011222345678999999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-39  Score=290.94  Aligned_cols=251  Identities=25%  Similarity=0.355  Sum_probs=200.1

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC---ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      ++|+..+.||.|+||.||+|... ++..+++|.....   ..+.+.+|+.+++.++|||++++++++.+.+..|++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57888899999999999999964 5788999975432   3467889999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      .+++|.+++..    ....++...+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++....... 
T Consensus        83 ~~~~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  155 (262)
T cd06613          83 GGGSLQDIYQV----TRGPLSELQIAYVCRETLKGLAYLHE--TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-  155 (262)
T ss_pred             CCCcHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHh--CCceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence            99999988742    22568899999999999999999998  779999999999999999999999999987654321 


Q ss_pred             CCCCccccCcccccchhhhccc---CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          239 AGPSSQVTADEIFLASEVKEFR---RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                       .......++..|+|||.+.+.   .++.++|+||||+++|||++|+.||....+...  ........         ..+
T Consensus       156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~~~~~~~~---------~~~  223 (262)
T cd06613         156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--LFLISKSN---------FPP  223 (262)
T ss_pred             -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhcc---------CCC
Confidence             112234567789999998776   789999999999999999999999986543211  11100000         000


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                       .........+.++.+++.+||+.+|.+|||+.+++.+
T Consensus       224 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         224 -PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             -ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             0011223445679999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.4e-39  Score=293.25  Aligned_cols=252  Identities=24%  Similarity=0.382  Sum_probs=195.5

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC-------------hhHHHHHHHHHHcCCCCcccccccceeeCC
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-------------TQEFIDEVCFLASIQHRNLVTLLGYCQENN  149 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  149 (386)
                      +|...+.||.|+||.||+|... +++.+|+|......             .+.+.+|+.+++.++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4667889999999999999854 58899999743210             134678999999999999999999999999


Q ss_pred             eEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 016588          150 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  229 (386)
Q Consensus       150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl  229 (386)
                      ..++||||+++++|.+++..     ...+++..+..++.|++.||.|||+  ++++||||+|+||+++.++.++++|||+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~~~nil~~~~~~~~l~d~~~  154 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRT-----YGRFEEQLVRFFTEQVLEGLAYLHS--KGILHRDLKADNLLVDADGICKISDFGI  154 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHhh--CCeeecCCChhhEEEcCCCeEEEeeccc
Confidence            99999999999999988842     2567888889999999999999998  7799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhcccC--CCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhccc
Q 016588          230 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRR--FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS  307 (386)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  307 (386)
                      +................++..|+|||......  ++.++|+||||+++||+++|..||......  ....+..    ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~----~~~  228 (272)
T cd06629         155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--AAMFKLG----NKR  228 (272)
T ss_pred             cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH--HHHHHhh----ccc
Confidence            87654322222223445778899999987654  789999999999999999999998643321  1111100    000


Q ss_pred             chhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          308 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                           .............+..+.+++.+||..+|.+|||+.+++++
T Consensus       229 -----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         229 -----SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             -----cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence                 00001111122345678999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-39  Score=298.12  Aligned_cols=252  Identities=20%  Similarity=0.290  Sum_probs=199.4

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      ++|+..+.||+|+||+||++... ++..+|+|.....    ....+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            46777899999999999999954 5888999974322    245688999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +++++|..++.     ....+++..+..++.+++.||.|||+. .+++||||+|+||++++++.++|+|||++.......
T Consensus        85 ~~~~~L~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~~-~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~  158 (284)
T cd06620          85 MDCGSLDRIYK-----KGGPIPVEILGKIAVAVVEGLTYLYNV-HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI  158 (284)
T ss_pred             CCCCCHHHHHH-----hccCCCHHHHHHHHHHHHHHHHHHHHh-cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence            99999988773     234578999999999999999999962 469999999999999999999999999986543211


Q ss_pred             CCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCch-----hhHHHHHHhhhcccchhhh
Q 016588          238 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS-----QDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~  312 (386)
                          .....++..|+|||.+.+..++.++|+|||||++|++++|..||........     ....+.....         
T Consensus       159 ----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------  225 (284)
T cd06620         159 ----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI---------  225 (284)
T ss_pred             ----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHH---------
Confidence                1234678889999999888899999999999999999999999986554211     1111111111         


Q ss_pred             cchhhcccCC-HHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          313 LDERLWSTFT-NEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       313 ~~~~~~~~~~-~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                      ..... ...+ ...+.++.+++.+||+.||++|||+.|++++.
T Consensus       226 ~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         226 VQEPP-PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             hhccC-CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            10000 1111 12456789999999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-39  Score=331.24  Aligned_cols=254  Identities=22%  Similarity=0.332  Sum_probs=195.8

Q ss_pred             HHhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceee--CCeE
Q 016588           80 LATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQ  151 (386)
Q Consensus        80 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  151 (386)
                      ....+|.+.+.||.|+||+||+|... ++..+|+|.+...     ....+..|+.+++.++||||+++++++..  ....
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            34568999999999999999999965 4778899875422     23468889999999999999999998754  4578


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCceecCCCCCCeeeCC--------
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS-----PRVVHKDFKTANVLVDE--------  218 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~ivH~dlkp~Nill~~--------  218 (386)
                      |+||||+++++|..++.... .....+++..++.|+.||+.||.|||+.+     ++|+||||||+||||+.        
T Consensus        90 yIVMEY~~gGSL~~lL~k~~-~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCY-KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            99999999999998884321 12356899999999999999999999843     45999999999999964        


Q ss_pred             ---------CCceEEcccccccccCCCCCCCCCccccCcccccchhhhcc--cCCCcccchhhHHHHHHHHHcCCCCCCC
Q 016588          219 ---------DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASSS  287 (386)
Q Consensus       219 ---------~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvil~el~tg~~p~~~  287 (386)
                               .+.+||+|||++.......   ......+|+.|+|||++.+  ..++.++|||||||++|||++|..||..
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                     3458999999998764322   1234468899999999854  4588999999999999999999999975


Q ss_pred             CCCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          288 LSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ...  ...+...+...+           .+   .....+.++.+||..||+.+|.+|||+.|++.+
T Consensus       246 ~~~--~~qli~~lk~~p-----------~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        246 ANN--FSQLISELKRGP-----------DL---PIKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             CCc--HHHHHHHHhcCC-----------CC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            432  112221111110           00   011224668999999999999999999999954

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.8e-39  Score=291.16  Aligned_cols=251  Identities=22%  Similarity=0.354  Sum_probs=199.6

Q ss_pred             CCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCCC---------hhHHHHHHHHHHcCCCCcccccccceeeCCeEEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP---------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (386)
                      +|+..+.||+|+||.||++.. .++..+|+|......         .+.+.+|+..++.++|+|++++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477789999999999999984 568899999764322         3467889999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC-ceEEcccccccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNF  232 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~-~~kl~DFgl~~~  232 (386)
                      |+||+++++|.+++.     ....+++..+..++.|++.||.|||+  ++++|+||+|+||+++.++ .++|+|||++..
T Consensus        81 v~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~ql~~al~~LH~--~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~  153 (268)
T cd06630          81 FVEWMAGGSVSHLLS-----KYGAFKEAVIINYTEQLLRGLSYLHE--NQIIHRDVKGANLLIDSTGQRLRIADFGAAAR  153 (268)
T ss_pred             EEeccCCCcHHHHHH-----HhCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence            999999999998884     23467888999999999999999998  7799999999999998776 599999999877


Q ss_pred             cCCCCCC--CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          233 LGRTDVA--GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       233 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      .......  .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.............            
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------------  221 (268)
T cd06630         154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF------------  221 (268)
T ss_pred             cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHH------------
Confidence            6432111  11223456778999999988889999999999999999999999987543321111110            


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      +..........+...+.++.+++.+||+.+|.+|||+.+++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         222 KIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             HHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence            0001111123444556779999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.8e-39  Score=301.15  Aligned_cols=262  Identities=19%  Similarity=0.286  Sum_probs=186.2

Q ss_pred             CeecccCceEEEEEEeCC---CcEEEEEECCCC-ChhHHHHHHHHHHcCCCCccccccccee--eCCeEEEEEEeecCCC
Q 016588           89 NLIGEGKFGEVYKGLLQD---GMLVAIKKRPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQ--ENNLQFLIYEYIPNGS  162 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~g~  162 (386)
                      ..||+|+||.||+|..++   +..||+|..... ....+.+|+.+++.++||||+++++++.  .....++|+||+.+ +
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~   85 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-D   85 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-c
Confidence            579999999999999643   468999986543 3446789999999999999999999885  35678999999875 6


Q ss_pred             ccccccCCC----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee----CCCCceEEcccccccccC
Q 016588          163 VSIHLYGPS----QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       163 L~~~l~~~~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill----~~~~~~kl~DFgl~~~~~  234 (386)
                      |.+++....    ......+++..+..++.|++.||.|||+  .+|+||||||+|||+    +.++.+||+|||+++...
T Consensus        86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~  163 (317)
T cd07867          86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN  163 (317)
T ss_pred             HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh--CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence            655542111    1123457888999999999999999998  779999999999999    566799999999998764


Q ss_pred             CCCCC-CCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCch-------hhHHHHHHhh--
Q 016588          235 RTDVA-GPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS-------QDLVELVQNS--  303 (386)
Q Consensus       235 ~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~-------~~~~~~~~~~--  303 (386)
                      ..... .......+|..|+|||.+.+ ..++.++|||||||++|||+||+.||........       ..+.......  
T Consensus       164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (317)
T cd07867         164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF  243 (317)
T ss_pred             CCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCC
Confidence            42211 12234467888999999876 4579999999999999999999999976443211       1111110000  


Q ss_pred             ------------hcccchhhhcchh------h---cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          304 ------------RDFSNLLKILDER------L---WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       304 ------------~~~~~~~~~~~~~------~---~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                                  .............      +   ...........+.+++.+||+.||.+|||+.|++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h  314 (317)
T cd07867         244 PADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD  314 (317)
T ss_pred             CChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence                        0000000000000      0   000011123458899999999999999999999865

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.8e-39  Score=296.20  Aligned_cols=249  Identities=25%  Similarity=0.352  Sum_probs=196.0

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC---hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      +.|++.+.||.|+||.||+|... ++..+++|......   .+.+.+|+.+++.++|+|++++++.+...+..++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56888899999999999999965 47899999865443   345778999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++++|..++..    ....+++..+..++.|++.||.|||+  .+++||||||+||+++.++.++|+|||++....... 
T Consensus        92 ~~~~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-  164 (292)
T cd06644          92 PGGAVDAIMLE----LDRGLTEPQIQVICRQMLEALQYLHS--MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-  164 (292)
T ss_pred             CCCcHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhc--CCeeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence            99999877632    23457899999999999999999998  779999999999999999999999999987543211 


Q ss_pred             CCCCccccCcccccchhhhc-----ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhc
Q 016588          239 AGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  313 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (386)
                       .......++..|+|||.+.     ...++.++|+|||||++|||++|..||....+.  ...... ....         
T Consensus       165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~~-~~~~---------  231 (292)
T cd06644         165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLKI-AKSE---------  231 (292)
T ss_pred             -cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--HHHHHH-hcCC---------
Confidence             1123345677899999874     345688999999999999999999998764431  111110 0000         


Q ss_pred             chhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .+  ....+...+.++.+++.+||+.+|++||++++++++
T Consensus       232 ~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         232 PP--TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             Cc--cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            00  011222345678999999999999999999999865

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-39  Score=300.01  Aligned_cols=251  Identities=22%  Similarity=0.257  Sum_probs=199.1

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC------hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ++|+..+.||+|+||.||+|... ++..+|+|......      ...+.+|+++++.++|+||+++++.+...+..|+||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888899999999999999965 48899999855332      235788999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+.+++|.+++...   ....+++.....++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          81 DYCPGGELFRLLQRQ---PGKCLSEEVARFYAAEVLLALEYLHL--LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EecCCCCHHHHHHhC---CCCccCHHHHHHHHHHHHHHHHHHHH--CCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            999999999887421   23568899999999999999999998  7799999999999999999999999999765432


Q ss_pred             CCCC---------------------------CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCC
Q 016588          236 TDVA---------------------------GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL  288 (386)
Q Consensus       236 ~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~  288 (386)
                      ....                           .......++..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            1110                           0112335678899999999888999999999999999999999999765


Q ss_pred             CCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCC----HHHHHHH
Q 016588          289 SPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS----MSDVVTE  353 (386)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt----~~evl~~  353 (386)
                      ...  ....             +..............+.++.+++.+||+.||++|||    +++++++
T Consensus       236 ~~~--~~~~-------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         236 NRD--ETFS-------------NILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             chH--HHHH-------------HHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            431  1111             111111111111124577999999999999999999    7777764

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.3e-39  Score=296.72  Aligned_cols=256  Identities=27%  Similarity=0.400  Sum_probs=197.1

Q ss_pred             HHHHHHhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC--ChhHHHHHHHHHHcC-CCCcccccccceee----
Q 016588           76 EELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA--PTQEFIDEVCFLASI-QHRNLVTLLGYCQE----  147 (386)
Q Consensus        76 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----  147 (386)
                      .++......|+..+.||+|+||.||+|... +++.+|+|.....  ...++..|+.++..+ +|+|++++++++..    
T Consensus         9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   88 (282)
T cd06636           9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP   88 (282)
T ss_pred             hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence            344445678888999999999999999964 5789999975433  345678889999888 79999999998853    


Q ss_pred             --CCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEc
Q 016588          148 --NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA  225 (386)
Q Consensus       148 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~  225 (386)
                        .+..|++|||+.+|+|.+++...   ....+++..+..++.|++.||.|||+  .+++|+||+|+||++++++.++|+
T Consensus        89 ~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~--~~ivH~dl~~~nili~~~~~~~l~  163 (282)
T cd06636          89 GHDDQLWLVMEFCGAGSVTDLVKNT---KGNALKEDWIAYICREILRGLAHLHA--HKVIHRDIKGQNVLLTENAEVKLV  163 (282)
T ss_pred             CCCCEEEEEEEeCCCCcHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEe
Confidence              46789999999999999887432   23457788888999999999999998  679999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCccccCcccccchhhhc-----ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHH
Q 016588          226 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV  300 (386)
Q Consensus       226 DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~  300 (386)
                      |||++.......  .......++..|+|||.+.     ...++.++|+|||||++|||++|..||....+...  ... .
T Consensus       164 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~--~~~-~  238 (282)
T cd06636         164 DFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA--LFL-I  238 (282)
T ss_pred             eCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh--hhh-H
Confidence            999987653221  1223345778899999875     34678899999999999999999999976442111  000 0


Q ss_pred             HhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          301 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .            ...........++.++.+++.+||+.||.+|||+.|++++
T Consensus       239 ~------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         239 P------------RNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             h------------hCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence            0            0000111112345679999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.2e-39  Score=290.95  Aligned_cols=235  Identities=25%  Similarity=0.442  Sum_probs=184.8

Q ss_pred             CeecccCceEEEEEEeCC-C----------cEEEEEECCCCC--hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           89 NLIGEGKFGEVYKGLLQD-G----------MLVAIKKRPGAP--TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~-~----------~~vavK~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      +.||+|+||.||+|...+ +          ..+++|......  ...+.+|+.+++.++|||++++++++.. +..++||
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            468999999999999654 3          257778654332  5678899999999999999999999988 7789999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC-------ceEEcccc
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-------IAKVADAG  228 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~-------~~kl~DFg  228 (386)
                      ||+++++|.+++...    ...+++..+..++.|++.||+|||+  ++|+||||||+||+++.++       .+||+|||
T Consensus        80 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          80 EYVKFGPLDVFLHRE----KNNVSLHWKLDVAKQLASALHYLED--KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EcCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhh--CCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            999999999888432    2267888999999999999999998  7799999999999999887       79999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhccc--CCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhc
Q 016588          229 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFR--RFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRD  305 (386)
Q Consensus       229 l~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  305 (386)
                      ++.....      .....++..|+|||.+.+.  .++.++||||||+++|||++ |..|+..........   ...    
T Consensus       154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~---~~~----  220 (259)
T cd05037         154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER---FYQ----  220 (259)
T ss_pred             ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH---HHh----
Confidence            9886543      1123345569999998876  78999999999999999999 567776654221111   000    


Q ss_pred             ccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          306 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                              ..... ..+  ....+.+++.+||..+|.+|||+.++++.|
T Consensus       221 --------~~~~~-~~~--~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         221 --------DQHRL-PMP--DCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             --------cCCCC-CCC--CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                    00000 011  115689999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-40  Score=292.61  Aligned_cols=266  Identities=24%  Similarity=0.369  Sum_probs=221.4

Q ss_pred             HHHHHHHhcCCCcCCeecccCceEEEEEEeCC------CcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccc
Q 016588           75 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQD------GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGY  144 (386)
Q Consensus        75 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~  144 (386)
                      ..++.....+++...++-+|.||.||.|.+++      .+.|.+|.++...    ...+..|...+..+.|||+..+.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            45677778889999999999999999997553      3456666544332    3357788999999999999999998


Q ss_pred             eee-CCeEEEEEEeecCCCcccccc---CCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC
Q 016588          145 CQE-NNLQFLIYEYIPNGSVSIHLY---GPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF  220 (386)
Q Consensus       145 ~~~-~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~  220 (386)
                      +.. ....++++.+..-|+|..|+.   +.+....+.+...+...++.|++.|++|||+  .++||.||..+|++||+..
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~--~~ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN--HGVIHKDIAARNCVIDDQL  433 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh--cCcccchhhhhcceehhhe
Confidence            864 566788999999999999985   2223445667788899999999999999999  6699999999999999999


Q ss_pred             ceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHH
Q 016588          221 IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVEL  299 (386)
Q Consensus       221 ~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~  299 (386)
                      .+||+|=.+++.+-..++..-+.....+..||+||.+....|+.++|+|||||++|||+| |+.||...+|.+       
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE-------  506 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE-------  506 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-------
Confidence            999999999998876666555555667788999999999999999999999999999999 999999877632       


Q ss_pred             HHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhh
Q 016588          300 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  358 (386)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~  358 (386)
                               +...+..+.+...|-+|++++..+|.-||..+|++||+++|+..-|.+-.
T Consensus       507 ---------m~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~  556 (563)
T KOG1024|consen  507 ---------MEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH  556 (563)
T ss_pred             ---------HHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence                     23334455666788899999999999999999999999999999887754

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=6.2e-39  Score=291.18  Aligned_cols=248  Identities=21%  Similarity=0.304  Sum_probs=194.1

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----C---hhHHHHHHHHHHcCCCCcccccccceee--CCeE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----P---TQEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQ  151 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~---~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  151 (386)
                      .+|+..+.||+|+||.||.|... ++..|++|.....     .   .+.+.+|+.+++.++||||+++++++.+  ....
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46888899999999999999964 5889999974311     1   2357789999999999999999998865  3567


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      +++|||+++++|.+++.     ....+++.....++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||++.
T Consensus        82 ~~v~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~  154 (265)
T cd06652          82 SIFMEHMPGGSIKDQLK-----SYGALTENVTRKYTRQILEGVSYLHS--NMIVHRDIKGANILRDSVGNVKLGDFGASK  154 (265)
T ss_pred             EEEEEecCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEecCCCCEEECcCcccc
Confidence            89999999999998873     23457788889999999999999998  779999999999999999999999999987


Q ss_pred             ccCCCCC-CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          232 FLGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       232 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      ....... ........++..|+|||.+.+..++.++|||||||++|||++|+.||......  ......           
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~~-----------  221 (265)
T cd06652         155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM--AAIFKI-----------  221 (265)
T ss_pred             ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH--HHHHHH-----------
Confidence            6543211 11122345778899999998888999999999999999999999998754321  111100           


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                        .........+...+..+.+++.+||. +|++||++++++++
T Consensus       222 --~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         222 --ATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             --hcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence              00001122344455678899999995 99999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-40  Score=307.11  Aligned_cols=238  Identities=21%  Similarity=0.259  Sum_probs=183.3

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcC---CCCcccccccceeeCCeEEEEEEeecC
Q 016588           91 IGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASI---QHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        91 lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      ||+|+||+||+|... ++..||+|.....      .......|..++...   +||||+++++.+...+..|+||||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999965 5889999986432      122344566666554   699999999999999999999999999


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  240 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~  240 (386)
                      |+|..++.     ....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.++|+|||++.......  .
T Consensus        81 g~L~~~l~-----~~~~~~~~~~~~~~~qil~al~~LH~--~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~  151 (330)
T cd05586          81 GELFWHLQ-----KEGRFSEDRAKFYIAELVLALEHLHK--YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--K  151 (330)
T ss_pred             ChHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--C
Confidence            99988773     34568899999999999999999998  779999999999999999999999999987542211  1


Q ss_pred             CCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcc
Q 016588          241 PSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS  319 (386)
Q Consensus       241 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (386)
                      ......||..|+|||.+.+. .++.++|||||||++|||++|..||.....   ......+...            ... 
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~---~~~~~~i~~~------------~~~-  215 (330)
T cd05586         152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT---QQMYRNIAFG------------KVR-  215 (330)
T ss_pred             CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH---HHHHHHHHcC------------CCC-
Confidence            22345688899999998754 479999999999999999999999976432   1111111100            000 


Q ss_pred             cCCHHHHHHHHHHHhHccCCCCCCCC----CHHHHHHH
Q 016588          320 TFTNEGMEEFIQLIVRCLDPSSERRP----SMSDVVTE  353 (386)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dp~~Rp----t~~evl~~  353 (386)
                      ......++++.+++.+||+.||.+||    ++.+++++
T Consensus       216 ~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         216 FPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             CCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence            00112346689999999999999998    56666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.3e-39  Score=294.58  Aligned_cols=236  Identities=22%  Similarity=0.388  Sum_probs=184.0

Q ss_pred             CeecccCceEEEEEEeCC--------CcEEEEEECCCCC---hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           89 NLIGEGKFGEVYKGLLQD--------GMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      +.||+|+||.||+|..+.        ...+++|......   .+.+.+|..+++.++|||++++++++...+..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            468999999999998542        2347888755432   34678899999999999999999999998899999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc--------eEEccccc
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI--------AKVADAGL  229 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~--------~kl~DFgl  229 (386)
                      +++|+|..++...    ...+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.        ++++|||+
T Consensus        81 ~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~--~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          81 VKFGSLDTYLKKN----KNLINISWKLEVAKQLAWALHFLED--KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             CCCCcHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence            9999999988532    3367888999999999999999998  77999999999999987765        68999998


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCC-CCCCCCCCCchhhHHHHHHhhhccc
Q 016588          230 RNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGR-EASSSLSPDSSQDLVELVQNSRDFS  307 (386)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~  307 (386)
                      +.....      .....++..|+|||++.+ ..++.++|||||||++|||++|. .|+....+...   .....      
T Consensus       155 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---~~~~~------  219 (258)
T cd05078         155 SITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---LQFYE------  219 (258)
T ss_pred             ccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---HHHHH------
Confidence            765432      123456677999999876 45799999999999999999985 55544332110   00000      


Q ss_pred             chhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          308 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                             .  ....+.....++.+++.+||+.||++|||++++++.|
T Consensus       220 -------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         220 -------D--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             -------c--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                   0  0112222335689999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-39  Score=295.44  Aligned_cols=260  Identities=21%  Similarity=0.304  Sum_probs=198.9

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC-----CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      +|+..+.||+|+||.||+|..+ +++.|++|....     ...+.+.+|+++++.++|+||+++++++...+..+++|||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            6788899999999999999965 478999997542     2345688999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      ++++++..+..     ....+++..+..++.|++.||.|||+  ++++|+||+|+||++++++.+||+|||++.......
T Consensus        82 ~~~~~l~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          82 VERTLLELLEA-----SPGGLPPDAVRSYIWQLLQAIAYCHS--HNIIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             CCCCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            99877765542     23457889999999999999999998  779999999999999999999999999988765432


Q ss_pred             CCCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhccc---------
Q 016588          238 VAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS---------  307 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------  307 (386)
                      . .......++..|+|||++.+. .++.++|+||||+++|+|++|..||......  ..+...........         
T Consensus       155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07833         155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI--DQLYLIQKCLGPLPPSHQELFSS  231 (288)
T ss_pred             c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHhhhccc
Confidence            2 122345567889999999887 7899999999999999999999998764331  11111111000000         


Q ss_pred             -------chhhhcchh-hcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          308 -------NLLKILDER-LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       308 -------~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                             ......+.. ....++...+.++.+++.+||..+|++|||+++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence                   000000000 0011222346779999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.1e-38  Score=289.38  Aligned_cols=255  Identities=25%  Similarity=0.338  Sum_probs=201.4

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      ++|++.+.||.|+||+||+|... ++..+++|.....    ....+.+|++.++.++|+|++++++.+...+..++|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46888999999999999999954 5788999985432    245688999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +++++|.+++....  ....+++..+..++.|++.||.|||+  .+++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lh~--~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          81 LSGGSLLDIMKSSY--PRGGLDEAIIATVLKEVLKGLEYLHS--NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             cCCCcHHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            99999998884321  12467899999999999999999998  779999999999999999999999999987664432


Q ss_pred             CC--CCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc
Q 016588          238 VA--GPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       238 ~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                      ..  .......++..|+|||.+... .++.++|+|||||++|||++|+.||.......  .........          .
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~~~----------~  224 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLTLQND----------P  224 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHHhcCC----------C
Confidence            22  122334577889999998776 78999999999999999999999997654321  111111110          0


Q ss_pred             hhhccc-CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          315 ERLWST-FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       315 ~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      +.+... .....+..+.+++.+||+.||++|||+++++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            011000 012345678999999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.3e-39  Score=296.12  Aligned_cols=260  Identities=20%  Similarity=0.338  Sum_probs=196.6

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      ++|+..+.||+|+||.||+|..+ +++.+|+|.....     ..+.+.+|+++++.++||||+++++++...+..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            36788899999999999999975 4889999974322     23457889999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      |+++++|..+..     ....+++..+..++.|++.||.|||+  .+++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          81 FVDHTVLDDLEK-----YPNGLDESRVRKYLFQILRGIEFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             cCCccHHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            999988877653     23347899999999999999999998  77999999999999999999999999998765432


Q ss_pred             CCCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhccc-chhhhcc
Q 016588          237 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS-NLLKILD  314 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  314 (386)
                      .  .......++..|+|||+..+ ..++.++||||||+++|||++|..||.....  ............... ......+
T Consensus       154 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07846         154 G--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD--IDQLYHIIKCLGNLIPRHQEIFQ  229 (286)
T ss_pred             c--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch--HHHHHHHHHHhCCCchhhHHHhc
Confidence            2  12233457788999999875 3468899999999999999999988875432  111111111000000 0000000


Q ss_pred             ----------hhhc-----ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          315 ----------ERLW-----STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       315 ----------~~~~-----~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                                +...     ....+..+..+.+++.+||+.+|++|||+.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence                      0000     00112345679999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=9.4e-39  Score=290.61  Aligned_cols=250  Identities=24%  Similarity=0.342  Sum_probs=183.9

Q ss_pred             eecccCceEEEEEEeCCC---cEEEEEECCCC----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCCC
Q 016588           90 LIGEGKFGEVYKGLLQDG---MLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS  162 (386)
Q Consensus        90 ~lg~G~~g~V~~~~~~~~---~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  162 (386)
                      .||+|+||.||++...++   ..+++|.....    ..+.+.+|..+++.++||||+++++.+.+....|+||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            589999999999974332   34667764432    23568889999999999999999999999999999999999999


Q ss_pred             ccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCC
Q 016588          163 VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS  242 (386)
Q Consensus       163 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~  242 (386)
                      |.+++..... .....+...+..++.|++.||+|||+  .+++||||||+|||++.++.++|+|||++............
T Consensus        82 L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQW-HRRNSQLLLLQRMACEIAAGVTHMHK--HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHH--CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            9998854311 12345677788899999999999998  67999999999999999999999999997643221111222


Q ss_pred             ccccCcccccchhhhcc-------cCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc
Q 016588          243 SQVTADEIFLASEVKEF-------RRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       243 ~~~~~~~~y~aPE~~~~-------~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                      ....++..|+|||++..       ..++.++|||||||++|||++ |..||....+   ......+....    .....+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~~~~~~~----~~~~~~  231 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---REVLNHVIKDQ----QVKLFK  231 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHhhc----ccccCC
Confidence            33456778999998743       245789999999999999997 5667765432   11111111100    011112


Q ss_pred             hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                      +..    ....++.+.+++..|| .+|++|||++++++.|
T Consensus       232 ~~~----~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l  266 (268)
T cd05086         232 PQL----ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL  266 (268)
T ss_pred             Ccc----CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence            222    1223456888999999 6799999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-39  Score=295.13  Aligned_cols=249  Identities=22%  Similarity=0.330  Sum_probs=197.7

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC---hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      ++|++.+.||.|+||.||++..+ ++..+++|......   .+.+.+|+++++.++|||++++++++...+..|+||||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            46788899999999999999964 57899999854433   346788999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++++|..++..    ....+++..+..++.|++.||.|||+  .+|+|+||||+||+++.++.++|+|||++....... 
T Consensus        85 ~~~~L~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-  157 (280)
T cd06611          85 DGGALDSIMLE----LERGLTEPQIRYVCRQMLEALNFLHS--HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-  157 (280)
T ss_pred             CCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence            99999988742    23468899999999999999999998  779999999999999999999999999987653321 


Q ss_pred             CCCCccccCcccccchhhhc-----ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhc
Q 016588          239 AGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  313 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (386)
                       .......++..|+|||.+.     ...++.++|+||||+++|||++|..||......   ..........         
T Consensus       158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~---------  224 (280)
T cd06611         158 -QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM---RVLLKILKSE---------  224 (280)
T ss_pred             -cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH---HHHHHHhcCC---------
Confidence             1123345778899999875     345678999999999999999999999765431   1111111000         


Q ss_pred             chhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .+  ....+...+.++.+++.+||+.+|.+|||+++++++
T Consensus       225 ~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         225 PP--TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CC--CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            00  011222345678999999999999999999999876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.2e-38  Score=291.42  Aligned_cols=244  Identities=26%  Similarity=0.403  Sum_probs=197.1

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      -|+..+.||+|+||.||+|... ++..+|+|......    ...+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            4667789999999999999854 57899999754322    246788999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++++|..++.      ...+++..+..++.+++.|+.|||+  .+++|+||+|+||+++.++.++|+|||++........
T Consensus        85 ~~~~l~~~i~------~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          85 GGGSALDLLE------PGPLDETQIATILREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCcHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHcc--CCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence            9999988873      2357889999999999999999998  7899999999999999999999999999876543211


Q ss_pred             CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                        ......++..|+|||...+..++.++|+|||||++|+|++|..||....+..   .....             .....
T Consensus       157 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~-------------~~~~~  218 (277)
T cd06641         157 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK---VLFLI-------------PKNNP  218 (277)
T ss_pred             --hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH---HHHHH-------------hcCCC
Confidence              1123356778999999988888999999999999999999999987644311   11111             00111


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .......+.++.+++.+||+.+|.+||++.+++++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         219 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            12233345678999999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=6e-39  Score=290.56  Aligned_cols=251  Identities=22%  Similarity=0.356  Sum_probs=198.8

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceee--CCeEEEEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQFLIY  155 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~  155 (386)
                      +|+..+.||.|+||.||++... ++..+++|.....     ..+.+.+|+.+++.++|+|++++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4778899999999999999854 5788999975432     23457789999999999999999997753  45679999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcC---CCCceecCCCCCCeeeCCCCceEEcccccccc
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL---SPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~  232 (386)
                      ||+++++|.+++.... .....+++..++.++.|++.||.|||..   +.+++|+||+|+||+++.++.+||+|||++..
T Consensus        81 e~~~~~~L~~~l~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          81 EYCEGGDLAQLIQKCK-KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             hhccCCCHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            9999999998884321 1245688999999999999999999922   27799999999999999999999999999887


Q ss_pred             cCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          233 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      ......  ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.....   ....+...           
T Consensus       160 ~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~-----------  223 (265)
T cd08217         160 LGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLASKIK-----------  223 (265)
T ss_pred             ccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHHHHh-----------
Confidence            654321  12234577889999999988899999999999999999999999986442   11111111           


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                        .......+...+.++.+++.+||+.+|++|||+.+++++
T Consensus       224 --~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         224 --EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             --cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence              111122334456779999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=7.3e-39  Score=289.10  Aligned_cols=247  Identities=21%  Similarity=0.346  Sum_probs=197.7

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC-----CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      +|+..+.||+|+||.||++... +++.+++|....     ....++.+|+.+++.++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4788899999999999999954 588999997432     2234688999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +.+++|.+++...   ....+++..+..++.|++.||.|||+  ++++|+||+|+||+++.++.++++|||++.......
T Consensus        81 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          81 CEGGDLYKKINAQ---RGVLFPEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            9999998877421   22357888999999999999999998  779999999999999999999999999987654322


Q ss_pred             CCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhh
Q 016588          238 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  317 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (386)
                      .  ......++..|+|||+..+..++.++|+|||||+++++++|..||.....   .+......            .. .
T Consensus       156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~---~~~~~~~~------------~~-~  217 (256)
T cd08218         156 E--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM---KNLVLKII------------RG-S  217 (256)
T ss_pred             h--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH---HHHHHHHh------------cC-C
Confidence            1  11223467779999999888899999999999999999999999875321   11111110            00 0


Q ss_pred             cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ....+...+.++.+++.+||+.+|.+||++.+++++
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         218 YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            112233445678999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=7.9e-39  Score=291.07  Aligned_cols=252  Identities=21%  Similarity=0.345  Sum_probs=196.7

Q ss_pred             CCCcCCeecccCceEEEEEEeCC--CcEEEEEECCCC-------------ChhHHHHHHHHHHc-CCCCcccccccceee
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQD--GMLVAIKKRPGA-------------PTQEFIDEVCFLAS-IQHRNLVTLLGYCQE  147 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~-------------~~~~~~~e~~~l~~-l~h~niv~~~~~~~~  147 (386)
                      +|+..+.||+|+||.||+|..+.  +..+|+|.....             ...++.+|+.++.+ ++|||++++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47778899999999999999654  678999964321             12346678887765 799999999999999


Q ss_pred             CCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccc
Q 016588          148 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA  227 (386)
Q Consensus       148 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DF  227 (386)
                      ++..+++|||+++++|.+++.... .....+++..++.++.|++.||.|||+. .+++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLK-EKKQRFTEERIWNIFVQMVLALRYLHKE-KRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHhccC-CceeecCCCHHHEEECCCCcEEEecc
Confidence            999999999999999988763211 1234688889999999999999999952 56999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhccc
Q 016588          228 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS  307 (386)
Q Consensus       228 gl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  307 (386)
                      |++.......   ......++..|++||...+..++.++|+||||+++|||++|+.||......   .......      
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~---~~~~~~~------  226 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML---SLATKIV------  226 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH---HHHHHHh------
Confidence            9988754432   233456777899999999888999999999999999999999998754321   1111111      


Q ss_pred             chhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016588          308 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  355 (386)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~  355 (386)
                            +....+......+.++.+++.+||+.||++||++.|+.+++.
T Consensus       227 ------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         227 ------EAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ------hccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                  111111111123467899999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5.8e-39  Score=295.39  Aligned_cols=242  Identities=23%  Similarity=0.333  Sum_probs=198.1

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC------CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ++|+..+.||+|+||.||++... +++.+|+|....      ...+.+.+|+++++.++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36888899999999999999965 588999997543      23456788999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++++|.+++.     ....++...+..++.|++.||.|||+  ++++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~~~-----~~~~l~~~~~~~~~~qil~~l~~lH~--~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          81 EYVPGGELFSHLR-----KSGRFPEPVARFYAAQVVLALEYLHS--LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             ecCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            9999999998883     33568889999999999999999999  7799999999999999999999999999887643


Q ss_pred             CCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      .     .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.....   ........            ..
T Consensus       154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~------------~~  213 (290)
T cd05580         154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP---IQIYEKIL------------EG  213 (290)
T ss_pred             C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHh------------cC
Confidence            2     2334577889999999888889999999999999999999999876442   11111110            00


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  353 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~~  353 (386)
                        ....+...+..+.+++.+||+.||.+|+     +++|++++
T Consensus       214 --~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         214 --KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             --CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence              0122223356789999999999999999     77788755

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.6e-40  Score=304.59  Aligned_cols=252  Identities=20%  Similarity=0.266  Sum_probs=199.4

Q ss_pred             HHhcCCCcCCeecccCceEEEEEEeCCCcEEEEEEC-----CCCChhHHHHHHHHHHcC-CCCcccccccceeeCCeEEE
Q 016588           80 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKR-----PGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        80 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~-----~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  153 (386)
                      +....|++.+.||+||.+.||++...+.+.+|+|++     +....+-|.+|+..|.+| .|.+|+++++|-..++.+||
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            345678999999999999999999888888888863     333456699999999999 59999999999999999999


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      ||||= .-+|..++...    ........+..+..|++.++.++|+  .||||.||||.|+|+= .|.+||+|||+|..+
T Consensus       438 vmE~G-d~DL~kiL~k~----~~~~~~~~lk~ywkqML~aV~~IH~--~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI  509 (677)
T KOG0596|consen  438 VMECG-DIDLNKILKKK----KSIDPDWFLKFYWKQMLLAVKTIHQ--HGIVHSDLKPANFLLV-KGRLKLIDFGIANAI  509 (677)
T ss_pred             Eeecc-cccHHHHHHhc----cCCCchHHHHHHHHHHHHHHHHHHH--hceeecCCCcccEEEE-eeeEEeeeechhccc
Confidence            99965 45888888432    2223323778899999999999999  6799999999999986 467999999999988


Q ss_pred             CCCCCCCCCccccCcccccchhhhcccC-----------CCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHh
Q 016588          234 GRTDVAGPSSQVTADEIFLASEVKEFRR-----------FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN  302 (386)
Q Consensus       234 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~  302 (386)
                      ......-......||.-||+||.+....           .+.++||||+||+||+|+.|+.||.....     .      
T Consensus       510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----~------  578 (677)
T KOG0596|consen  510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----Q------  578 (677)
T ss_pred             CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----H------
Confidence            7655555556678999999999986432           46789999999999999999999986332     1      


Q ss_pred             hhcccchhhhcchhhcccCCHHH-HHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          303 SRDFSNLLKILDERLWSTFTNEG-MEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                         ...+..+.++.---+|+..- ..++.++|+.||..||++|||+.++|++
T Consensus       579 ---~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  579 ---IAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             ---HHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence               12334445553322333221 1338999999999999999999999976

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.1e-38  Score=287.68  Aligned_cols=246  Identities=23%  Similarity=0.398  Sum_probs=197.2

Q ss_pred             CCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           84 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      +|+..+.||+|+||.||++.. .++..+++|.....     ....+.+|+++++.++|||++++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            477889999999999999985 45889999975432     234688899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC-CceEEcccccccccCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRT  236 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~-~~~kl~DFgl~~~~~~~  236 (386)
                      +++++|.+++...   ....+++..+..++.+++.||.|||+  ++++|+||+|+||+++++ +.++|+|||++......
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~--~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          81 APGGTLAEYIQKR---CNSLLDEDTILHFFVQILLALHHVHT--KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             CCCCCHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            9999999988532   23457888999999999999999998  779999999999999855 46899999998876432


Q ss_pred             CCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchh
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  316 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (386)
                      .   ......++..|+|||.+.+..++.++||||||+++|+|++|..||......   ........             .
T Consensus       156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~~~-------------~  216 (256)
T cd08220         156 S---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---ALVLKIMS-------------G  216 (256)
T ss_pred             c---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HHHHHHHh-------------c
Confidence            2   122345677899999999888899999999999999999999998764421   11111110             0


Q ss_pred             hcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          317 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .....+...+.++.+++.+||+.+|.+|||+.|++++
T Consensus       217 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         217 TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            0111222345678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=7.8e-39  Score=293.23  Aligned_cols=249  Identities=22%  Similarity=0.322  Sum_probs=189.9

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC----hhHHHHHHHH-HHcCCCCcccccccceeeCCeEEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCF-LASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      ++|+..+.||+|+||.||++... ++..||+|..+...    ..++..|+.. ++.++|||++++++++...+..|++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            36888899999999999999965 58999999865432    2345556665 566789999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP-RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      |++ ++|..++.... .....+++..+..++.|++.||.|||+  + +++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVY-DKGLTIPEDILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            997 57766654321 123568899999999999999999998  4 799999999999999999999999999876533


Q ss_pred             CCCCCCCccccCcccccchhhhcc----cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhh
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEF----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK  311 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (386)
                      ..   ......++..|+|||.+.+    ..++.++|+|||||++|||++|..||...... ...+....           
T Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~-----------  221 (283)
T cd06617         157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQLKQVV-----------  221 (283)
T ss_pred             cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHHHHHH-----------
Confidence            21   1122356778999998865    45688999999999999999999998653321 11111110           


Q ss_pred             hcchhhcccC-CHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          312 ILDERLWSTF-TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       312 ~~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                        .. ..... ....+.++.+++.+||..+|.+|||+.+++++
T Consensus       222 --~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         222 --EE-PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             --hc-CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              00 00111 11245678999999999999999999999975

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-39  Score=307.07  Aligned_cols=243  Identities=26%  Similarity=0.422  Sum_probs=195.5

Q ss_pred             CcCCeecccCceEEEEEEeC-CCcEEE---EEE--CC--CCChhHHHHHHHHHHcCCCCcccccccceeeCC--eEEEEE
Q 016588           86 SDKNLIGEGKFGEVYKGLLQ-DGMLVA---IKK--RP--GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENN--LQFLIY  155 (386)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~-~~~~va---vK~--~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~  155 (386)
                      +...+||+|+|-+||+|... +|..||   ||.  +.  +...+.|..|+.+|+.|+||||+++|.++.+..  ...+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            33478999999999999954 466665   332  22  233478999999999999999999999997654  477899


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-CCceEEcccccccccC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLG  234 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~-~~~~kl~DFgl~~~~~  234 (386)
                      |++..|+|..+..     ..+..+...+..|+.||++||.|||++.++|+|||||++||+|+. .|.+||+|+|||+...
T Consensus       123 EL~TSGtLr~Y~k-----k~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r  197 (632)
T KOG0584|consen  123 ELFTSGTLREYRK-----KHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR  197 (632)
T ss_pred             ecccCCcHHHHHH-----HhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence            9999999999883     456788889999999999999999999999999999999999985 5899999999999875


Q ss_pred             CCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                      ...    .....|||.|||||.+. ..|++.+||||||+.++||+|+..||+.=..  .-+.+..+........+.++-|
T Consensus       198 ~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n--~AQIYKKV~SGiKP~sl~kV~d  270 (632)
T KOG0584|consen  198 KSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN--PAQIYKKVTSGIKPAALSKVKD  270 (632)
T ss_pred             ccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC--HHHHHHHHHcCCCHHHhhccCC
Confidence            533    22368999999999998 7899999999999999999999999986222  2233333333333333333322


Q ss_pred             hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                                  ++++++|.+|+.. .++|||+.|+|++
T Consensus       271 ------------Pevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  271 ------------PEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             ------------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence                        4579999999999 9999999999965

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=7.6e-39  Score=289.40  Aligned_cols=245  Identities=20%  Similarity=0.265  Sum_probs=199.1

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC------CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      +|+..+.||.|+||.||+|... ++..+++|....      ...+.+.+|++++++++||||+++++++...+..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4778899999999999999965 588999997542      234578899999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      |+.+++|..++.     ....+++..+..++.|+++||.|||+  ++++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~l~-----~~~~l~~~~~~~~~~~i~~~l~~lh~--~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          81 LLLGGDLRYHLS-----QKVKFSEEQVKFWICEIVLALEYLHS--KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCCCHHHHHH-----hcCCcCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            999999998883     22468888999999999999999998  67999999999999999999999999998765432


Q ss_pred             CCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchh
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  316 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (386)
                      .   ......++..|+|||...+..++.++|+||||+++|+|++|..||................             . 
T Consensus       154 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------------~-  216 (258)
T cd05578         154 T---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE-------------T-  216 (258)
T ss_pred             c---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc-------------c-
Confidence            2   1223456778999999998889999999999999999999999998765431111111100             0 


Q ss_pred             hcccCCHHHHHHHHHHHhHccCCCCCCCCCH--HHHHH
Q 016588          317 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSM--SDVVT  352 (386)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~--~evl~  352 (386)
                      .....+...+.++.+++.+||+.||.+||++  .|+++
T Consensus       217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         217 ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence            1122333455779999999999999999999  66553

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=7.4e-39  Score=294.99  Aligned_cols=243  Identities=18%  Similarity=0.308  Sum_probs=193.7

Q ss_pred             cCCeecccCceEEEEEEeC-CCcEEEEEECCCCC---hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCCC
Q 016588           87 DKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS  162 (386)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  162 (386)
                      ....||+|+||.||++... ++..||+|......   .+.+.+|+.+++.++|+|++++++.+...+..++||||+++++
T Consensus        26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~  105 (292)
T cd06658          26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA  105 (292)
T ss_pred             hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence            3467999999999999854 58899999864332   3457889999999999999999999999999999999999999


Q ss_pred             ccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCC
Q 016588          163 VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS  242 (386)
Q Consensus       163 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~  242 (386)
                      |.+++.      ...+++..+..++.|++.||.|||+  ++|+||||||+||++++++.++|+|||++.......  ...
T Consensus       106 L~~~~~------~~~l~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~  175 (292)
T cd06658         106 LTDIVT------HTRMNEEQIATVCLSVLRALSYLHN--QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKR  175 (292)
T ss_pred             HHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccC
Confidence            988773      2357888999999999999999998  679999999999999999999999999987653321  112


Q ss_pred             ccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCC
Q 016588          243 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFT  322 (386)
Q Consensus       243 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (386)
                      ....++..|+|||...+..++.++|+||||+++|||++|+.||....+..   .......         ...+..  ...
T Consensus       176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~~~~---------~~~~~~--~~~  241 (292)
T cd06658         176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AMRRIRD---------NLPPRV--KDS  241 (292)
T ss_pred             ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh---------cCCCcc--ccc
Confidence            33457788999999988889999999999999999999999987644311   1111110         111111  011


Q ss_pred             HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          323 NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       323 ~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ...+..+.+++.+||+.||.+|||+++++++
T Consensus       242 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         242 HKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            1234568899999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-38  Score=294.56  Aligned_cols=267  Identities=21%  Similarity=0.301  Sum_probs=195.1

Q ss_pred             CCCcCCeecccCceEEEEEEeC---CCcEEEEEECCC------CChhHHHHHHHHHHcCCCCcccccccceeeC--CeEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ---DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQF  152 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  152 (386)
                      +|...+.||+|+||.||+|...   ++..||+|....      ...+.+.+|+.+++.++||||+++++++...  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4677889999999999999964   478999998654      2245678899999999999999999999887  8899


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC----CCceEEcccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE----DFIAKVADAG  228 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~----~~~~kl~DFg  228 (386)
                      +||||+++ ++..++..........++...+..++.|++.||.|||+  .+|+||||||+||+++.    ++.+||+|||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS--NWVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh--CCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            99999976 55555432212223467888999999999999999998  77999999999999999    9999999999


Q ss_pred             cccccCCCCC-CCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCch-------hhHHHH
Q 016588          229 LRNFLGRTDV-AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSS-------QDLVEL  299 (386)
Q Consensus       229 l~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~-------~~~~~~  299 (386)
                      ++........ ........++..|+|||.+.+. .++.++|||||||++|||++|..||........       ..+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI  237 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence            9887644322 1122234567789999988764 578999999999999999999999987654320       011111


Q ss_pred             HHhhhc-----------ccchhhhcchhhcccCC-----------HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          300 VQNSRD-----------FSNLLKILDERLWSTFT-----------NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       300 ~~~~~~-----------~~~~~~~~~~~~~~~~~-----------~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      +.....           ........+......++           ...+.++.+++.+||+.||++|||+.|++++
T Consensus       238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            110000           00000000000000111           0233568999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.5e-38  Score=286.69  Aligned_cols=250  Identities=26%  Similarity=0.375  Sum_probs=196.6

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      +|+..+.||+|+||.||+|... ++..+++|.....     ....+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4778899999999999999954 5889999975433     234688999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +++++|.+++..     ...+++..+..++.+++.||.|||+  .+++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~--~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          81 CSGGTLEELLEH-----GRILDEHVIRVYTLQLLEGLAYLHS--HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             CCCCcHHHHHhh-----cCCCChHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            999999998842     3447788889999999999999998  779999999999999999999999999988764432


Q ss_pred             CCCC--CccccCcccccchhhhcccC---CCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          238 VAGP--SSQVTADEIFLASEVKEFRR---FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       238 ~~~~--~~~~~~~~~y~aPE~~~~~~---~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      ....  .....++..|+|||.+.+..   ++.++||||||+++||+++|..||....... .. ...... ..       
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-~~-~~~~~~-~~-------  223 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-QI-MFHVGA-GH-------  223 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-HH-HHHHhc-CC-------
Confidence            2111  12345677899999988766   8899999999999999999999997643211 10 000000 00       


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                       .+..  +.....+..+.+++.+||+.+|++|||+++++.+
T Consensus       224 -~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         224 -KPPI--PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             -CCCC--CcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence             0000  0111225668899999999999999999998854

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.8e-38  Score=291.85  Aligned_cols=259  Identities=21%  Similarity=0.305  Sum_probs=194.7

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC--------hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP--------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      +|+..+.||+|+||.||+|... +++.|++|......        ...+..|+++++.++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4677889999999999999965 58899999854332        23467899999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      |||+ +++|..++...    ...+++..+..++.|+++||.|||+  .+++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~-~~~L~~~i~~~----~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  153 (298)
T cd07841          81 FEFM-ETDLEKVIKDK----SIVLTPADIKSYMLMTLRGLEYLHS--NWILHRDLKPNNLLIASDGVLKLADFGLARSFG  153 (298)
T ss_pred             Eccc-CCCHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence            9999 88999888432    2368899999999999999999998  779999999999999999999999999988764


Q ss_pred             CCCCCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc--------
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD--------  305 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--------  305 (386)
                      ....  ......++..|+|||.+.+ ..++.++|+|||||++|||++|..||....+.  ..+.........        
T Consensus       154 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  229 (298)
T cd07841         154 SPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI--DQLGKIFEALGTPTEENWPG  229 (298)
T ss_pred             CCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH--HHHHHHHHHcCCCchhhhhh
Confidence            4221  1122345667999998854 45789999999999999999998777654431  111111111000        


Q ss_pred             ccchhhhcchhhcc-----cCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          306 FSNLLKILDERLWS-----TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       306 ~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ..............     ......+.++.+++.+||+.||++|||+.|++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            00000000000000     1112335678999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.4e-38  Score=291.92  Aligned_cols=260  Identities=23%  Similarity=0.265  Sum_probs=197.3

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      +|++.+.||+|+||.||+|... ++..|++|+....     ....+.+|+.+++.++|||++++++++...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4778899999999999999964 5889999985432     245788999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      + +++|.+++...    ...+++..+..++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~-~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          81 M-PSDLSEVLRDE----ERPLPEAQVKSYMRMLLKGVAYMHA--NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             c-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            9 99999887432    3568899999999999999999998  679999999999999999999999999988764422


Q ss_pred             CCCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcc--------cc
Q 016588          238 VAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF--------SN  308 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~  308 (386)
                      . .......++..|+|||.+.+. .++.++||||+|+++|||++|.+||.+..+  ...+..........        ..
T Consensus       154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH--HHHHHHHHHHcCCCChHHHhhccC
Confidence            1 122334577889999998654 468999999999999999999877765432  11111111110000        00


Q ss_pred             ---hhhhcch----hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          309 ---LLKILDE----RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       309 ---~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                         ......+    ..+....++.+..+.+++.+||+.+|++|||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence               0000000    00011112334778999999999999999999999876

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.7e-38  Score=294.37  Aligned_cols=253  Identities=20%  Similarity=0.228  Sum_probs=196.0

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC------hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ++|+..+.||+|+||.||++... .++.|++|......      .+.+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36888899999999999999965 47889999755332      345778999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+++||||||+||+++.++.++|+|||+++....
T Consensus        81 e~~~g~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~  153 (305)
T cd05609          81 EYVEGGDCATLLK-----NIGALPVDMARMYFAETVLALEYLHN--YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM  153 (305)
T ss_pred             ecCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence            9999999999883     23457888899999999999999998  7799999999999999999999999999864211


Q ss_pred             CCC-------------CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHh
Q 016588          236 TDV-------------AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN  302 (386)
Q Consensus       236 ~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~  302 (386)
                      ...             ........++..|+|||.+....++.++|+|||||++||+++|..||.+..+.   .+......
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~---~~~~~~~~  230 (305)
T cd05609         154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---ELFGQVIS  230 (305)
T ss_pred             CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh
Confidence            000             00111234677899999998888999999999999999999999999754321   11111100


Q ss_pred             hhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHH
Q 016588          303 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  356 (386)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~  356 (386)
                      ..           ..+.......+.++.+++.+||+.||++||++.++++.|+.
T Consensus       231 ~~-----------~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         231 DD-----------IEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             cc-----------cCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            00           00011111345668999999999999999997666655544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-39  Score=295.39  Aligned_cols=244  Identities=22%  Similarity=0.277  Sum_probs=206.4

Q ss_pred             CCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           84 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      -|...+.||+|.|..|-+|.+ -+|..||||++++..     ...+.+|++.|+.++|||||++|.+......+|||+|+
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            356678899999999999983 369999999865543     45678999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee-CCCCceEEcccccccccCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV-DEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill-~~~~~~kl~DFgl~~~~~~~  236 (386)
                      -++|+|.+++...    ...+.+....+++.||+.|+.|+|+  ..+|||||||+|+.+ .+-|-+||+|||++..+...
T Consensus        99 GD~GDl~DyImKH----e~Gl~E~La~kYF~QI~~AI~YCHq--LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   99 GDGGDLFDYIMKH----EEGLNEDLAKKYFAQIVHAISYCHQ--LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             cCCchHHHHHHhh----hccccHHHHHHHHHHHHHHHHHHhh--hhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            9999999999643    4568888899999999999999999  569999999999976 56789999999999876443


Q ss_pred             CCCCCCccccCcccccchhhhcccCC-CcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      .   .....+|...|.|||++.+..| .++.|||||||+||.|+.|+.||......               +.+..+.|-
T Consensus       173 ~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS---------------ETLTmImDC  234 (864)
T KOG4717|consen  173 K---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS---------------ETLTMIMDC  234 (864)
T ss_pred             c---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch---------------hhhhhhhcc
Confidence            2   3456678889999999999999 46899999999999999999999875542               223334454


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .+  ..|...+.++++||..||..||.+|.|.+++...
T Consensus       235 KY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  235 KY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             cc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence            44  5677788999999999999999999999998754

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-38  Score=314.18  Aligned_cols=269  Identities=14%  Similarity=0.200  Sum_probs=189.0

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeCC--CcEEEEE------------------ECCC--CChhHHHHHHHHHHcCCCCcc
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQD--GMLVAIK------------------KRPG--APTQEFIDEVCFLASIQHRNL  138 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK------------------~~~~--~~~~~~~~e~~~l~~l~h~ni  138 (386)
                      ..++|++.+.||+|+||+||++..+.  +...+.|                  ....  .....+.+|+.+++.++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            34689999999999999999987532  1111111                  1111  123457889999999999999


Q ss_pred             cccccceeeCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC
Q 016588          139 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE  218 (386)
Q Consensus       139 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~  218 (386)
                      +++++++...+..|+|++++.+ +|..++..................++.|++.||.|||+  ++|+||||||+|||++.
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~--~gIiHrDLKP~NILl~~  302 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD--KKLIHRDIKLENIFLNC  302 (501)
T ss_pred             CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECC
Confidence            9999999999999999999864 66665543221112233456677899999999999998  77999999999999999


Q ss_pred             CCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCC-CCCCCCCchhhHH
Q 016588          219 DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA-SSSLSPDSSQDLV  297 (386)
Q Consensus       219 ~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p-~~~~~~~~~~~~~  297 (386)
                      ++.+||+|||+++.+..... .......|+..|+|||++.+..++.++|||||||++|||++|..+ +..........+.
T Consensus       303 ~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            99999999999987654221 122345688999999999999999999999999999999998754 4433322222332


Q ss_pred             HHHHhhhc----cc----chhhhcchhhcccC----C-----HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          298 ELVQNSRD----FS----NLLKILDERLWSTF----T-----NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       298 ~~~~~~~~----~~----~~~~~~~~~~~~~~----~-----~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      +.......    ..    .+.+.++.......    +     ...+.++.+++.+||+.||.+|||+.|++++
T Consensus       382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            22211100    00    00111110000000    0     0123457888999999999999999999976

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.4e-38  Score=293.92  Aligned_cols=243  Identities=20%  Similarity=0.303  Sum_probs=194.0

Q ss_pred             cCCeecccCceEEEEEEeC-CCcEEEEEECCC---CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCCC
Q 016588           87 DKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG---APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS  162 (386)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  162 (386)
                      ....||+|+||.||++... ++..|++|....   ...+.+.+|+.+++.++|||++++++++..++..++++||+++++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~  104 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA  104 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence            3457999999999999854 588999998532   234567889999999999999999999999999999999999999


Q ss_pred             ccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCC
Q 016588          163 VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS  242 (386)
Q Consensus       163 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~  242 (386)
                      |..++.      ...+++..+..++.|++.||.|||+  ++++||||||+||+++.++.++|+|||++.......  ...
T Consensus       105 L~~~~~------~~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~  174 (297)
T cd06659         105 LTDIVS------QTRLNEEQIATVCESVLQALCYLHS--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKR  174 (297)
T ss_pred             HHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--ccc
Confidence            987762      2457889999999999999999998  779999999999999999999999999987654321  112


Q ss_pred             ccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCC
Q 016588          243 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFT  322 (386)
Q Consensus       243 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (386)
                      ....++..|+|||.+.+..++.++|||||||++|||++|+.||....+.   ...........         +  .....
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~---------~--~~~~~  240 (297)
T cd06659         175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKRLRDSPP---------P--KLKNA  240 (297)
T ss_pred             cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhccCC---------C--Ccccc
Confidence            2345778899999999888999999999999999999999999754321   11111111000         0  00111


Q ss_pred             HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          323 NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       323 ~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ...+..+.+++.+||+.+|++||++++++++
T Consensus       241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         241 HKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            2234568999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.7e-38  Score=291.20  Aligned_cols=260  Identities=24%  Similarity=0.329  Sum_probs=194.5

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      +|+..+.||+|++|.||+|... ++..|++|.....     ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4778899999999999999964 5889999975432     224688999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +. ++|..++...   ....+++..+..++.|++.||+|||+  .+++|+||+|+||+++.++.+||+|||++.......
T Consensus        81 ~~-~~l~~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lh~--~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          81 LH-QDLKKFMDAS---PLSGIPLPLIKSYLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             cc-cCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence            96 5787776432   23568899999999999999999998  779999999999999999999999999987654321


Q ss_pred             CCCCCccccCcccccchhhhcccC-CCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhccc-chh----h
Q 016588          238 VAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS-NLL----K  311 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~----~  311 (386)
                      .  ......++..|+|||...+.. ++.++||||||+++|||+||+.||.....  ............... ...    .
T Consensus       155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07860         155 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE--IDQLFRIFRTLGTPDEVVWPGVTS  230 (284)
T ss_pred             c--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHHhCCCChhhhhhhhH
Confidence            1  122234567799999887644 58899999999999999999999976432  122222221111000 000    0


Q ss_pred             ------hcchhh---cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          312 ------ILDERL---WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       312 ------~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                            .+....   ........+.++.+++.+||+.||.+|||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence                  000000   000011234568899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.2e-38  Score=293.46  Aligned_cols=261  Identities=28%  Similarity=0.414  Sum_probs=200.7

Q ss_pred             CHHHHHHHhcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC--ChhHHHHHHHHHHcC-CCCcccccccceeeC-
Q 016588           74 QMEELSLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA--PTQEFIDEVCFLASI-QHRNLVTLLGYCQEN-  148 (386)
Q Consensus        74 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-  148 (386)
                      ...++....++|...+.||+|+||.||++.. .++..+|+|.....  ....+.+|+.++.++ +|||++++++++... 
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~   92 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD   92 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence            3344555678899999999999999999996 45889999986543  345677899999998 899999999998653 


Q ss_pred             ----CeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEE
Q 016588          149 ----NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKV  224 (386)
Q Consensus       149 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl  224 (386)
                          +..++|+||+++++|.+++.... .....+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||
T Consensus        93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~nili~~~~~~kl  169 (291)
T cd06639          93 KLVGGQLWLVLELCNGGSVTELVKGLL-ICGQRLDEAMISYILYGALLGLQHLHN--NRIIHRDVKGNNILLTTEGGVKL  169 (291)
T ss_pred             ccCCCeeEEEEEECCCCcHHHHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEEcCCCCEEE
Confidence                35899999999999988774321 123567899999999999999999998  67999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCccccCcccccchhhhccc-----CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHH
Q 016588          225 ADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR-----RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVEL  299 (386)
Q Consensus       225 ~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~  299 (386)
                      +|||++........  ......++..|+|||.+...     .++.++|||||||++|||++|..||....+.  ..+...
T Consensus       170 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~~~~~  245 (291)
T cd06639         170 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KTLFKI  245 (291)
T ss_pred             eecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HHHHHH
Confidence            99999876543221  11234567789999987543     3688999999999999999999999865431  111111


Q ss_pred             HHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          300 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ...     .     .+..  ..+......+.+++.+||+.+|++||++.+++++
T Consensus       246 ~~~-----~-----~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         246 PRN-----P-----PPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             hcC-----C-----CCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            000     0     0000  1122334568999999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.1e-38  Score=294.09  Aligned_cols=244  Identities=28%  Similarity=0.386  Sum_probs=192.0

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC---C---hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---P---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ..|...+.||+|+||.||+|... +++.|++|.....   .   .+++.+|+++++.++|||++++.+++.+.+..|+|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45788899999999999999964 5889999975422   1   235788999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+.+ ++.+++..    ....+++..+..++.|++.||.|||+  .+++||||+|+||++++++.++|+|||++.....
T Consensus        95 e~~~g-~l~~~~~~----~~~~l~~~~~~~~~~ql~~~L~~LH~--~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          95 EYCLG-SASDILEV----HKKPLQEVEIAAICHGALQGLAYLHS--HERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HhhCC-CHHHHHHH----cccCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            99974 66555521    23458899999999999999999998  7799999999999999999999999999876532


Q ss_pred             CCCCCCCccccCcccccchhhhc---ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          236 TDVAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      .      ....++..|+|||.+.   ...++.++||||||+++|||++|..||.......  ... ....          
T Consensus       168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~--~~~-~~~~----------  228 (307)
T cd06607         168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALY-HIAQ----------  228 (307)
T ss_pred             C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH--HHH-HHhc----------
Confidence            1      2345677899999874   3568899999999999999999999987543211  000 0000          


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                        ..........+++.+.+++.+||+.+|++||++.+++.+.
T Consensus       229 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         229 --NDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             --CCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence              0001111223556799999999999999999999999763

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-38  Score=288.60  Aligned_cols=245  Identities=24%  Similarity=0.375  Sum_probs=194.5

Q ss_pred             CCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC----ChhHHHHHHHHHHcCC---CCcccccccceeeCCeEEEEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA----PTQEFIDEVCFLASIQ---HRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~  155 (386)
                      .|+..+.||+|+||.||+|.. .++..+++|.....    ...++.+|+.+++.++   |||++++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            467788999999999999995 46889999975432    3456788999999886   999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++++|.+++.      ...+++.....++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~------~~~l~~~~~~~i~~~i~~~l~~lh~--~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          82 EYAEGGSVRTLMK------AGPIAEKYISVIIREVLVALKYIHK--VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             ecCCCCcHHHHHH------ccCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            9999999988873      2367899999999999999999998  7799999999999999999999999999887654


Q ss_pred             CCCCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                      ..  .......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||........   ......         ...
T Consensus       154 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~~~~~---------~~~  219 (277)
T cd06917         154 NS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA---MMLIPK---------SKP  219 (277)
T ss_pred             Cc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh---hhcccc---------CCC
Confidence            32  11233457778999998865 4568999999999999999999999976443111   000000         000


Q ss_pred             hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      +.+..   ...+.++.+++.+||+.||++|||+.+++++
T Consensus       220 ~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         220 PRLED---NGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             CCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            11100   1134678999999999999999999999874

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-38  Score=288.61  Aligned_cols=254  Identities=28%  Similarity=0.415  Sum_probs=197.3

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC--ChhHHHHHHHHHHcC-CCCcccccccceeeCC------e
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA--PTQEFIDEVCFLASI-QHRNLVTLLGYCQENN------L  150 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~------~  150 (386)
                      ..++|+..+.||+|+||.||+|..+ +++.+++|.....  ..+.+.+|+.+++.+ +|+||+++++++....      .
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            3578999999999999999999965 5788999985543  345688999999998 7999999999986544      4


Q ss_pred             EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  230 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~  230 (386)
                      .++||||+++++|.+++.... .....+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~ql~~al~~lH~--~~i~H~~l~p~ni~~~~~~~~~l~d~~~~  160 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLR-KKGKRLKEEWIAYILRETLRGLAYLHE--NKVIHRDIKGQNILLTKNAEVKLVDFGVS  160 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHHHEEEccCCeEEECCCccc
Confidence            899999999999988874321 123567889999999999999999998  77999999999999999999999999998


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhcc-----cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc
Q 016588          231 NFLGRTDVAGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD  305 (386)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  305 (386)
                      .......  .......++..|+|||.+..     ..++.++|||||||++|+|++|..||....+.  .........   
T Consensus       161 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~---  233 (275)
T cd06608         161 AQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RALFKIPRN---  233 (275)
T ss_pred             eecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHHHHhhcc---
Confidence            7654321  12233457788999998753     34678999999999999999999999754321  111111000   


Q ss_pred             ccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          306 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                             ..+.  ...+...++++.+++.+||..||++|||+.+++++
T Consensus       234 -------~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         234 -------PPPT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             -------CCCC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                   0000  11122345678999999999999999999999864

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-38  Score=291.30  Aligned_cols=261  Identities=21%  Similarity=0.294  Sum_probs=192.2

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      ++|+..+.||+|++|.||+|..+ ++..||+|.....    ....+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888899999999999999965 5789999975432    224567899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +.+ +|.+++..    ....+++.....++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||+++......
T Consensus        85 ~~~-~L~~~~~~----~~~~~~~~~~~~~~~ql~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  157 (291)
T cd07844          85 LDT-DLKQYMDD----CGGGLSMHNVRLFLFQLLRGLAYCHQ--RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS  157 (291)
T ss_pred             CCC-CHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence            975 88877642    23467888999999999999999998  779999999999999999999999999987543211


Q ss_pred             CCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhh--hcccchhhh--
Q 016588          238 VAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS--RDFSNLLKI--  312 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~--  312 (386)
                      .  ......++..|+|||...+ ..++.++||||+|+++|||++|..||...... ...+.......  .........  
T Consensus       158 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07844         158 K--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV-EDQLHKIFRVLGTPTEETWPGVSS  234 (291)
T ss_pred             c--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH-HHHHHHHHHhcCCCChhhhhhhhh
Confidence            1  1122245677999998875 45789999999999999999999999764421 11111000000  000000000  


Q ss_pred             -----------c-chhhcccCC-HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          313 -----------L-DERLWSTFT-NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       313 -----------~-~~~~~~~~~-~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                                 . ...+....+ .....++.+++.+||+.+|++|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence                       0 000000000 0011567899999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=5.3e-38  Score=283.07  Aligned_cols=249  Identities=28%  Similarity=0.417  Sum_probs=202.9

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeC--CeEEEEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQFLIY  155 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  155 (386)
                      +|...+.||+|++|.||+|..+ ++..+++|......     .+.+.+|+.++++++|+|++++++.+...  +..++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677889999999999999976 58899999855443     56788999999999999999999999888  8999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++++|.+++..     ...+++..+..++.+++.||.|||+  .+++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~--~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          81 EYVSGGSLSSLLKK-----FGKLPEPVIRKYTRQILEGLAYLHS--NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            99999999988842     3378999999999999999999999  7799999999999999999999999999887654


Q ss_pred             CCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      ...........++..|+|||...+..++.++||||||+++++|++|..||......     ......         ....
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~---------~~~~  219 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MAALYK---------IGSS  219 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHHHHh---------cccc
Confidence            33211233455777899999998888999999999999999999999999875511     111111         1111


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ......+...+..+.+++.+||+.+|.+||++.+++++
T Consensus       220 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         220 GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            11122333446789999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-38  Score=298.92  Aligned_cols=263  Identities=22%  Similarity=0.330  Sum_probs=192.8

Q ss_pred             hcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC----ChhHHHHHHHHHHcCCCCcccccccceeeC-----CeE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN-----NLQ  151 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  151 (386)
                      .++|++.+.||+|+||.||+|.. .++..||+|.....    ....+.+|+.+++.++|+||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            36799999999999999999985 45889999986432    234577899999999999999999987543     357


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      |+++||+.+ +|...+      ....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||++.
T Consensus        84 ~lv~e~~~~-~l~~~~------~~~~l~~~~~~~i~~ql~~aL~~LH~--~~ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          84 YIVQELMET-DLYKLI------KTQHLSNDHIQYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             EEEehhccc-CHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEECCCCCEEECccccee
Confidence            999999975 666555      23468889999999999999999999  779999999999999999999999999987


Q ss_pred             ccCCCCC-CCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccch
Q 016588          232 FLGRTDV-AGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL  309 (386)
Q Consensus       232 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  309 (386)
                      ....... ........++..|+|||.+.+ ..++.++||||+||++|+|++|+.||...+.................+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL  234 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            6543221 111233467888999998754 46899999999999999999999999764321100000000000000001


Q ss_pred             hhhcchhh--------------cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          310 LKILDERL--------------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       310 ~~~~~~~~--------------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ..+.+...              .....+..+.++.+++.+||+.||++|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00000000              000011234668999999999999999999999987

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.1e-38  Score=288.16  Aligned_cols=256  Identities=25%  Similarity=0.331  Sum_probs=196.8

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC----ChhHHHHHHHHHHcCCCCcccccccceee--CCeEEEEEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQFLIYE  156 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e  156 (386)
                      +|...+.||.|++|.||++... +++.+|+|.....    ...++.+|+++++.++||||+++++++..  .+..++|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   81 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME   81 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence            5777899999999999999964 5789999975533    23468899999999999999999998864  447899999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      |+++++|.+++.... .....++...+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++......
T Consensus        82 ~~~~~~L~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~L~~lH~--~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          82 YCEGGSLDSIYKKVK-KRGGRIGEKVLGKIAESVLKGLSYLHS--RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             ecCCCCHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            999999987763221 134557888899999999999999998  77999999999999999999999999998765322


Q ss_pred             CCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCC--chhhHHHHHHhhhcccchhhhcc
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPD--SSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                      .    .....++..|+|||.+.+..++.++|||||||++|+|++|..||......  ...+.......... ..    +.
T Consensus       159 ~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~----~~  229 (287)
T cd06621         159 L----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN-PE----LK  229 (287)
T ss_pred             c----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc-hh----hc
Confidence            1    12334567799999999889999999999999999999999999865321  11122221111000 00    00


Q ss_pred             hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ..  .......++.+.+++.+||+.+|++|||+.|++++
T Consensus       230 ~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         230 DE--PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             cC--CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            00  01011245678999999999999999999999975

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.3e-38  Score=290.87  Aligned_cols=264  Identities=24%  Similarity=0.297  Sum_probs=193.1

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCC-CCcccccccceeeCCe-----
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNL-----  150 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~-----  150 (386)
                      ++|+..+.||+|+||.||+|... ++..||+|.....     ....+.+|+.+++.++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            36888899999999999999965 5889999974432     2346788999999995 6999999999876655     


Q ss_pred             EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-CCceEEccccc
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAGL  229 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~-~~~~kl~DFgl  229 (386)
                      .|+||||+++ +|..++..........+++..+..++.|++.||.|||+  ++|+||||+|+||+++. ++.+||+|||+
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~--~~i~H~dl~~~nil~~~~~~~~kl~dfg~  157 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK--HGVMHRDLKPQNLLVDKQKGLLKIADLGL  157 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChHHEEEecCCCeEEEeeccc
Confidence            8999999986 78777643322223568999999999999999999998  77999999999999998 89999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhh--cc
Q 016588          230 RNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR--DF  306 (386)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~  306 (386)
                      +........  ......+++.|+|||++.+ ..++.++|+||||+++|||++|..||....+.  ..+........  ..
T Consensus       158 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~  233 (295)
T cd07837         158 GRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL--QQLLHIFKLLGTPTE  233 (295)
T ss_pred             ceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHHhCCCCh
Confidence            876532211  1122245677999998865 45789999999999999999999999764431  11111111000  00


Q ss_pred             ---cchhhhcc--------hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          307 ---SNLLKILD--------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       307 ---~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                         ........        +.......+..++++.+++.+||+.||.+|||+.|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence               00000000        000001112345678999999999999999999999865

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.5e-38  Score=288.52  Aligned_cols=250  Identities=24%  Similarity=0.326  Sum_probs=198.3

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      +|+..+.||+|+||.||++..+ +++.+++|......    ..++.+|+++++.++||||+++++.+...+..++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5777889999999999999965 58899999754432    346788999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      .+++|.+++...    ...++......++.|++.||.|||+. .+++|+||||+||+++.++.++|+|||.+........
T Consensus        82 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~-~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          82 DGGSLDKILKEV----QGRIPERILGKIAVAVLKGLTYLHEK-HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             CCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHcCC-CCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            999999888432    25678889999999999999999972 4699999999999999999999999999876532211


Q ss_pred             CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                          ....++..|+|||...+..++.++||||||+++|+|++|..||....... ....+......         ... .
T Consensus       157 ----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~---------~~~-~  221 (265)
T cd06605         157 ----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIV---------NEP-P  221 (265)
T ss_pred             ----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHh---------cCC-C
Confidence                11556778999999998999999999999999999999999997653211 11111111110         100 0


Q ss_pred             ccCCHH-HHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          319 STFTNE-GMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       319 ~~~~~~-~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ...+.. .+.++.+++.+||..||++|||+.+++.+
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            111121 45678999999999999999999999865

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.9e-38  Score=290.37  Aligned_cols=247  Identities=23%  Similarity=0.357  Sum_probs=198.3

Q ss_pred             cCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC---ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      ++|...+.||+|+||.||++.. .++..+++|.....   ..+.+.+|+.+++.++|||++++++++...+..|+|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            5788889999999999999985 35788999985432   3356788999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++++|.+++.      ...+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++........
T Consensus        99 ~~~~L~~~~~------~~~l~~~~~~~i~~~l~~al~~LH~--~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          99 AGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             CCCcHHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHh--CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            9999998873      2356788899999999999999998  7799999999999999999999999998876543221


Q ss_pred             CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                        ......++..|++||.+.+..++.++|+||||+++|++++|..||....+...  ... ...           .+...
T Consensus       171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~--~~~-~~~-----------~~~~~  234 (293)
T cd06647         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYL-IAT-----------NGTPE  234 (293)
T ss_pred             --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh--eee-hhc-----------CCCCC
Confidence              12234577789999999888899999999999999999999999976443111  000 000           00000


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ...+...+..+.+++.+||+.+|++||++.+++.+
T Consensus       235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11122344668999999999999999999999977

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=5.1e-38  Score=284.55  Aligned_cols=249  Identities=24%  Similarity=0.322  Sum_probs=202.4

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      +|+..+.||.|++|.||+|... ++..+++|+....    ....+.+|+..+..++|+|++++++++...+..++|+||+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            6788899999999999999966 4889999985544    2467889999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++++|.+++..     ...+++.....++.|++.|+.|||+. .+++|+||+|+||+++.++.++|+|||++........
T Consensus        82 ~~~~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lh~~-~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          82 DGGSLADLLKK-----VGKIPEPVLAYIARQILKGLDYLHTK-RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             CCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhcc-CCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence            99999999842     36688999999999999999999971 4599999999999999999999999999887643221


Q ss_pred             CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                      .  .....++..|+|||...+..++.++|+||||+++|+|++|..||.................             ...
T Consensus       156 ~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-------------~~~  220 (264)
T cd06623         156 Q--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD-------------GPP  220 (264)
T ss_pred             c--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc-------------CCC
Confidence            1  1234567789999999988899999999999999999999999987653122222211110             011


Q ss_pred             ccCCHH-HHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          319 STFTNE-GMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       319 ~~~~~~-~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ...+.. .+..+.+++.+||+.+|++|||+.+++++
T Consensus       221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            112222 45678999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=6.2e-38  Score=288.59  Aligned_cols=260  Identities=20%  Similarity=0.274  Sum_probs=192.2

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      +.+|...+.||+|+||.||+|... ++..|++|.....    ....+.+|+.+++.++|+||+++++++...+..|+|+|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            467888999999999999999854 5889999985432    22357789999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      |+. +++.+++..    ....+.+..+..++.|++.||.|||+  .+|+|+||||+||+++.++.++|+|||+++.....
T Consensus        84 ~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          84 YMH-TDLAQYMIQ----HPGGLHPYNVRLFMFQLLRGLAYIHG--QHILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             ccc-CCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            996 566655532    23456778888999999999999998  67999999999999999999999999998764332


Q ss_pred             CCCCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhh-----------
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR-----------  304 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-----------  304 (386)
                      ..  ......++..|+|||.+.+. .++.++|||||||++|||++|..||...... .+.+........           
T Consensus       157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV-FEQLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH-HHHHHHHHHHcCCCChhhhhhhh
Confidence            11  12233457789999998754 5788999999999999999999999765431 111111100000           


Q ss_pred             cccchhhhcc----hh----hcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          305 DFSNLLKILD----ER----LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       305 ~~~~~~~~~~----~~----~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ..........    +.    .+...  ..+..+.+++.+|++.||++|||+.|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRL--SRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             hcccccchhccccCCcchhhhcccc--CCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence            0000000000    00    00000  113568899999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-40  Score=331.65  Aligned_cols=250  Identities=23%  Similarity=0.357  Sum_probs=203.5

Q ss_pred             hcCCCcCCeecccCceEEEEEE-eCCCcEEEEEECC-----CCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP-----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      +.+++....||.|.||.||.|. .++|...|+|-+.     ......+.+|+.+|..++|||+|+++|+-.+.+..+|.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            3456667899999999999999 5668899998422     223455788999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      |||++|+|.+.+.     .....++.....+-.|++.|+.|||+  .|||||||||.||+|+.+|.+|++|||.|..+..
T Consensus      1314 EyC~~GsLa~ll~-----~gri~dE~vt~vyt~qll~gla~LH~--~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLE-----HGRIEDEMVTRVYTKQLLEGLAYLHE--HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHhccCcHHHHHH-----hcchhhhhHHHHHHHHHHHHHHHHHh--cCceecCCCccceeeecCCcEEeecccceeEecC
Confidence            9999999999883     33445666667788999999999999  6799999999999999999999999999987754


Q ss_pred             CC--CCCCCccccCcccccchhhhccc---CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          236 TD--VAGPSSQVTADEIFLASEVKEFR---RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       236 ~~--~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      ..  ..+....+.||+.|||||++.+.   .-..+.||||+|||..||+||+.||...+..              +.-+.
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--------------~aIMy 1452 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--------------WAIMY 1452 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--------------hHHHh
Confidence            32  23344577899999999999764   4467899999999999999999999987642              11122


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .+.- +-.++.|...+++-.+++..||+.||++|+++.|++++
T Consensus      1453 ~V~~-gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1453 HVAA-GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             HHhc-cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            2211 11245666678889999999999999999999988866

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.7e-38  Score=286.48  Aligned_cols=240  Identities=20%  Similarity=0.259  Sum_probs=193.0

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCCCc
Q 016588           91 IGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV  163 (386)
Q Consensus        91 lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  163 (386)
                      ||.|+||.||++... ++..+++|.....      ..+.+.+|+.+++.++||||+++++++.+.+..++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999965 4889999975432      234688899999999999999999999999999999999999999


Q ss_pred             cccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCc
Q 016588          164 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS  243 (386)
Q Consensus       164 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~  243 (386)
                      .+++..     ...++...+..++.|++.||.|||+  ++++|+||+|+||+++.++.++|+|||++.......   ...
T Consensus        81 ~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lH~--~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~  150 (262)
T cd05572          81 WTILRD-----RGLFDEYTARFYIACVVLAFEYLHN--RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW  150 (262)
T ss_pred             HHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence            998842     3457888999999999999999998  779999999999999999999999999988764422   122


Q ss_pred             cccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCH
Q 016588          244 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN  323 (386)
Q Consensus       244 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (386)
                      ...++..|++||.+.+..++.++|+||||+++|+|++|..||.....+.. .....            .........++.
T Consensus       151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~------------~~~~~~~~~~~~  217 (262)
T cd05572         151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM-EIYND------------ILKGNGKLEFPN  217 (262)
T ss_pred             cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH-HHHHH------------HhccCCCCCCCc
Confidence            33567789999999888899999999999999999999999987653111 11111            111111123333


Q ss_pred             HHHHHHHHHHhHccCCCCCCCCC-----HHHHHHH
Q 016588          324 EGMEEFIQLIVRCLDPSSERRPS-----MSDVVTE  353 (386)
Q Consensus       324 ~~~~~l~~li~~cl~~dp~~Rpt-----~~evl~~  353 (386)
                      ..++++.+++.+||+.+|++||+     ++|++++
T Consensus       218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence            34677999999999999999999     7777763

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.4e-38  Score=291.59  Aligned_cols=260  Identities=23%  Similarity=0.324  Sum_probs=194.8

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeC--CeEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQFLI  154 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  154 (386)
                      ++|+..+.||.|+||.||+|..+ ++..+++|..+...     ...+.+|+.+++.++||||+++++++...  +..|+|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46788899999999999999965 57889999754321     23467899999999999999999998877  889999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      +||+.+ +|.+++..    ....+++..+..++.|++.||.|||+  ++++|+||||+||+++.++.++|+|||++....
T Consensus        85 ~e~~~~-~L~~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~--~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          85 MEYVEH-DLKSLMET----MKQPFLQSEVKCLMLQLLSGVAHLHD--NWILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             ehhcCc-CHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            999974 88777642    22368899999999999999999998  779999999999999999999999999988765


Q ss_pred             CCCCCCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc--------
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD--------  305 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--------  305 (386)
                      ...  .......++..|+|||.+.+. .++.++|+||||+++|||++|..||........  ..........        
T Consensus       158 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~  233 (293)
T cd07843         158 SPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ--LNKIFKLLGTPTEKIWPG  233 (293)
T ss_pred             CCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCchHHHHH
Confidence            422  112233467789999998754 468999999999999999999999986543211  1111100000        


Q ss_pred             ---c-----cchhhhcchhhcccCCHH-HHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          306 ---F-----SNLLKILDERLWSTFTNE-GMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       306 ---~-----~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                         .     ..........+...++.. .++.+.+++.+||+.||++|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence               0     000000011111222222 35678999999999999999999999865

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.5e-38  Score=284.64  Aligned_cols=247  Identities=23%  Similarity=0.382  Sum_probs=196.3

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC-----CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      +|+..+.||+|+||.||++..+ ++..+++|....     ...+.+.+|+.+++.++|+|++++++.+...+..++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4677889999999999999965 478899997543     2345678999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC-ceEEcccccccccCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNFLGRT  236 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~-~~kl~DFgl~~~~~~~  236 (386)
                      +++++|.+++...   ....+++..+..++.|++.||.|||+  .+++|+||||+||++++++ .++++|||.+......
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          81 CDGGDLMKRINRQ---RGVLFSEDQILSWFVQISLGLKHIHD--RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            9999999888432   22357899999999999999999998  7799999999999999886 4699999998766432


Q ss_pred             CCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchh
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  316 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (386)
                      ..  ......++..|+|||...+..++.++|+||||+++||+++|..||......   .   ......         ...
T Consensus       156 ~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~---~~~~~~---------~~~  218 (257)
T cd08225         156 ME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH---Q---LVLKIC---------QGY  218 (257)
T ss_pred             cc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH---H---HHHHHh---------ccc
Confidence            21  112335777899999998888999999999999999999999998753321   1   111100         000


Q ss_pred             hcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          317 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                       ........+.++.+++.+||+.+|++|||+.+++++
T Consensus       219 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         219 -FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             -CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence             111222344678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=5.6e-38  Score=288.20  Aligned_cols=251  Identities=24%  Similarity=0.371  Sum_probs=200.8

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC--hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP--TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      ....|+..+.||+|++|.||+|..+ ++..+++|......  .+.+.+|++.++.++|+|++++++.+...+..++++||
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   96 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY   96 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence            3456778889999999999999976 58899999865443  56788999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +++++|.+++...    ...+++..+..++.+++.||.|||+  .|++|+||+|+||+++.++.++|+|||++.......
T Consensus        97 ~~~~~L~~~l~~~----~~~l~~~~~~~i~~~i~~~L~~lH~--~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          97 MDGGSLTDIITQN----FVRMNEPQIAYVCREVLQGLEYLHS--QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             cCCCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            9999999998432    1378899999999999999999998  789999999999999999999999999876553321


Q ss_pred             CCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhh
Q 016588          238 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  317 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (386)
                      .  ......++..|++||.+.+..++.++|+||||+++|+|++|..||....+..  . .......           ...
T Consensus       171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~--~-~~~~~~~-----------~~~  234 (286)
T cd06614         171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR--A-LFLITTK-----------GIP  234 (286)
T ss_pred             h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH--H-HHHHHhc-----------CCC
Confidence            1  1123346678999999988889999999999999999999999987544311  1 1100000           000


Q ss_pred             cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .......++..+.+++.+||+.+|.+|||+.+++++
T Consensus       235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         235 PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            001112245678999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.6e-38  Score=291.99  Aligned_cols=254  Identities=20%  Similarity=0.278  Sum_probs=190.8

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC----ChhHHHHHHHHHHcCC-CCcccccccceeeCCeEEEEEEe
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      +|...+.||+|+||.||++... ++..+|+|.....    ....+.+|+.++.++. |+||+++++++...+..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4555678999999999999964 5889999986532    2345788999999985 99999999999998899999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +.. ++.++...........+++..+..++.+++.||+|||+. .+++||||||+||+++.++.++|+|||++.......
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  162 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE-LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI  162 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc-CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence            864 443322110011235688999999999999999999962 479999999999999999999999999987654321


Q ss_pred             CCCCCccccCcccccchhhhccc---CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc
Q 016588          238 VAGPSSQVTADEIFLASEVKEFR---RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                         ......++..|+|||.+.+.   .++.++|||||||++|||++|+.||.....     ..+.......      ...
T Consensus       163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~------~~~  228 (288)
T cd06616         163 ---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK------GDP  228 (288)
T ss_pred             ---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC------CCC
Confidence               11223567789999998766   689999999999999999999999876431     1111111100      001


Q ss_pred             hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      +.+........+.++.+++.+||+.+|++|||+++++++
T Consensus       229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            111112223355679999999999999999999999976

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-39  Score=290.78  Aligned_cols=248  Identities=21%  Similarity=0.305  Sum_probs=203.3

Q ss_pred             HHhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEE
Q 016588           80 LATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  152 (386)
Q Consensus        80 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  152 (386)
                      ...+.|...++||+|+||.||-+..+ +|..+|+|++.+.      ...-.++|-.+|.+++.+.||.+--.+.+.+.++
T Consensus       182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC  261 (591)
T KOG0986|consen  182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC  261 (591)
T ss_pred             ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence            34557888899999999999999955 5888999864332      2334678999999999999999988889999999


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~  232 (386)
                      +|+..|.||+|..++++.   ..+.+++..+..++.+|+.||++||+  .+||.|||||+|||||+.|+++|+|.|||..
T Consensus       262 lVLtlMNGGDLkfHiyn~---g~~gF~e~ra~FYAAEi~cGLehlH~--~~iVYRDLKPeNILLDd~GhvRISDLGLAve  336 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNH---GNPGFDEQRARFYAAEIICGLEHLHR--RRIVYRDLKPENILLDDHGHVRISDLGLAVE  336 (591)
T ss_pred             EEEEeecCCceeEEeecc---CCCCCchHHHHHHHHHHHhhHHHHHh--cceeeccCChhheeeccCCCeEeeccceEEe
Confidence            999999999999999764   34689999999999999999999999  6799999999999999999999999999988


Q ss_pred             cCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          233 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      +....   +.....||.+|||||++.+..|+.+.|+||+||++|||+.|+.||...........++            +.
T Consensus       337 i~~g~---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd------------rr  401 (591)
T KOG0986|consen  337 IPEGK---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD------------RR  401 (591)
T ss_pred             cCCCC---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH------------HH
Confidence            75432   3345589999999999999999999999999999999999999998754322111111            10


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHH
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMS  348 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~  348 (386)
                      +.. ....++...+++.++|....|+.||++|....
T Consensus       402 ~~~-~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  402 TLE-DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             Hhc-chhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence            000 01245566778899999999999999997554

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=5.4e-38  Score=291.57  Aligned_cols=260  Identities=22%  Similarity=0.291  Sum_probs=192.7

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeC--CeEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQFL  153 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  153 (386)
                      .++|+..+.||+|+||.||+|... ++..||+|......     ...+.+|+.++++++|+|++++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            357888999999999999999964 58899999754221     23466899999999999999999998654  56899


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      ||||+.+ +|.+++..    ....+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||++...
T Consensus        86 v~e~~~~-~l~~~l~~----~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          86 VMEYCEQ-DLASLLDN----MPTPFSESQVKCLMLQLLRGLQYLHE--NFIIHRDLKVSNLLLTDKGCLKIADFGLARTY  158 (309)
T ss_pred             EEecCCC-CHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence            9999975 77776632    23568899999999999999999999  77999999999999999999999999998876


Q ss_pred             CCCCCCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc--ccchh
Q 016588          234 GRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD--FSNLL  310 (386)
Q Consensus       234 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~  310 (386)
                      .....  ......++..|+|||.+.+ ..++.++|||||||++|||++|..||....+..   ....+.....  .....
T Consensus       159 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~  233 (309)
T cd07845         159 GLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE---QLDLIIQLLGTPNESIW  233 (309)
T ss_pred             CCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChhhc
Confidence            43221  1122234667999999865 457899999999999999999999998654321   1111111000  00000


Q ss_pred             -hh----------cchhhcc---cCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          311 -KI----------LDERLWS---TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       311 -~~----------~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                       ..          .......   ......++++.+++.+||+.||++|||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence             00          0000000   0001134668899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-38  Score=288.36  Aligned_cols=259  Identities=24%  Similarity=0.311  Sum_probs=193.7

Q ss_pred             CCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           85 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      |+..+.||.|++|.||+|... ++..|++|+....     ....+.+|+++++.++|||++++++++.+.+..|+++||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567789999999999999954 6899999975422     2346888999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      + ++|.+++...   ....+++..+..++.|++.||.|||+  ++++||||+|+||+++.++.++|+|||++........
T Consensus        81 ~-~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~~L~~lH~--~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          81 D-LDLKKYMDSS---PLTGLDPPLIKSYLYQLLQGIAYCHS--HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             C-cCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence            5 5888877432   12468899999999999999999998  7799999999999999999999999999876543211


Q ss_pred             CCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhccc----------
Q 016588          239 AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS----------  307 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----------  307 (386)
                        ......++..|+|||++.+. .++.++|+||||+++|||++|+.||.....  ...+....+......          
T Consensus       155 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07835         155 --TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE--IDQLFRIFRTLGTPDEDVWPGVTSL  230 (283)
T ss_pred             --ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCChHHhhhhhhc
Confidence              11222456789999987654 568899999999999999999999976442  111111111100000          


Q ss_pred             -chhhhcch---hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          308 -NLLKILDE---RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       308 -~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                       ........   ..........+.++.+++.+||+.||.+|||++|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence             00000000   00001122234678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-38  Score=284.29  Aligned_cols=248  Identities=22%  Similarity=0.316  Sum_probs=195.3

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC--------ChhHHHHHHHHHHcCCCCcccccccceeeC--CeE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA--------PTQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQ  151 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  151 (386)
                      .+|...+.||+|+||.||+|... ++..+++|.....        ....+.+|+++++.++|+||+++++++.+.  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46888999999999999999954 5889999974311        123578899999999999999999988654  568


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      ++++||+++++|.+++.     ....+++.....++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||+++
T Consensus        82 ~~v~e~~~~~~L~~~~~-----~~~~l~~~~~~~~~~~i~~al~~LH~--~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  154 (264)
T cd06653          82 SIFVEYMPGGSIKDQLK-----AYGALTENVTRRYTRQILQGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASK  154 (264)
T ss_pred             EEEEEeCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEECcccccc
Confidence            89999999999988873     23457888899999999999999998  779999999999999999999999999988


Q ss_pred             ccCCCCC-CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          232 FLGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       232 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      ....... ........++..|+|||.+.+..++.++|+|||||++||+++|..||.....  .....             
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~-------------  219 (264)
T cd06653         155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA--MAAIF-------------  219 (264)
T ss_pred             ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH--HHHHH-------------
Confidence            6532111 1112234577889999999988899999999999999999999999975432  11111             


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      +..........+...++.+.+++.+||+ +|..|||+.+++.+
T Consensus       220 ~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         220 KIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             HHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence            1111111123444556779999999999 57999999998865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=6.6e-38  Score=286.76  Aligned_cols=239  Identities=21%  Similarity=0.287  Sum_probs=185.1

Q ss_pred             eecccCceEEEEEEeC-CCcEEEEEECCCCC------hhHHHHHHHHH---HcCCCCcccccccceeeCCeEEEEEEeec
Q 016588           90 LIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFL---ASIQHRNLVTLLGYCQENNLQFLIYEYIP  159 (386)
Q Consensus        90 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv~e~~~  159 (386)
                      .||+|+||.||++... +++.+|+|......      ...+.+|..++   ...+|||++.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999964 58899999754321      12234444333   33479999999999999999999999999


Q ss_pred             CCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016588          160 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  239 (386)
Q Consensus       160 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~  239 (386)
                      +++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.++|+|||++.......  
T Consensus        81 ~~~L~~~i~-----~~~~l~~~~~~~i~~qi~~al~~lH~--~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--  151 (279)
T cd05633          81 GGDLHYHLS-----QHGVFSEKEMRFYATEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (279)
T ss_pred             CCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence            999988873     33568999999999999999999998  779999999999999999999999999987553321  


Q ss_pred             CCCccccCcccccchhhhc-ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          240 GPSSQVTADEIFLASEVKE-FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       240 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                        .....++..|+|||... +..++.++|+||+||++|||++|..||...............              ....
T Consensus       152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--------------~~~~  215 (279)
T cd05633         152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--------------LTVN  215 (279)
T ss_pred             --ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh--------------hcCC
Confidence              12345788899999886 456899999999999999999999999865432221111100              0011


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  353 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~~  353 (386)
                      ...+...+.++.+++.+||+.||.+||     |+++++++
T Consensus       216 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         216 VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            122334556789999999999999999     59999886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=5e-38  Score=294.99  Aligned_cols=263  Identities=21%  Similarity=0.303  Sum_probs=195.0

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceee----CCeEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE----NNLQF  152 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~  152 (386)
                      ++|+..+.||+|+||.||+|... ++..|++|+....     ....+.+|+.+++.++||||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            67888999999999999999954 5889999975432     23457789999999999999999998753    35689


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~  232 (386)
                      +|+||+. ++|..++.     ....+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++..
T Consensus        85 lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          85 VVMDLME-SDLHHIIH-----SDQPLTEEHIRYFLYQLLRGLKYIHS--ANVIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEehhh-hhHHHHhc-----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEeccccccee
Confidence            9999996 58887773     23458899999999999999999998  7799999999999999999999999999876


Q ss_pred             cCCCCCC--CCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhccc--
Q 016588          233 LGRTDVA--GPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS--  307 (386)
Q Consensus       233 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--  307 (386)
                      .......  .......++..|+|||.+.+ ..++.++|||||||++|||++|..||......................  
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            5432211  11223467788999998765 467899999999999999999999997654321111100000000000  


Q ss_pred             ------chh---hhcch---hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          308 ------NLL---KILDE---RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       308 ------~~~---~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                            ...   +....   ..+.......++++.+++.+||+.+|++|||+++++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                  000   00000   00011112345779999999999999999999999975

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.9e-38  Score=295.39  Aligned_cols=265  Identities=19%  Similarity=0.261  Sum_probs=195.6

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeC-----CeE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN-----NLQ  151 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  151 (386)
                      .+|...+.||+|+||+||+|... ++..||+|.....     ....+.+|+.+++.++|+||+++++++...     ...
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            47888999999999999999954 5889999975432     234577899999999999999999988654     347


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      |+|+||+. ++|.+++.     ....+++..+..++.|++.||.|||+  ++++||||||+||+++.++.+||+|||++.
T Consensus        85 ~lv~e~~~-~~L~~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~--~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          85 YIVYELMD-TDLHQIIR-----SSQTLSDDHCQYFLYQLLRGLKYIHS--ANVLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEeCCC-CCHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            99999996 57777763     23568899999999999999999998  779999999999999999999999999988


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccc--
Q 016588          232 FLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN--  308 (386)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--  308 (386)
                      ......  .......++..|+|||.+.. ..++.++|||||||++|+|++|..||...+...................  
T Consensus       157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07858         157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG  234 (337)
T ss_pred             ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence            664321  11233456778999998764 4689999999999999999999999976432111110000000000000  


Q ss_pred             ------hhhhc---chhhc---ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH--HHHh
Q 016588          309 ------LLKIL---DERLW---STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE--LDRT  357 (386)
Q Consensus       309 ------~~~~~---~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~--L~~~  357 (386)
                            ..+..   .....   ....+..++++.+++.+||+.+|++|||+++++++  +..+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence                  00000   00000   01112345678999999999999999999999988  5554

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=6.9e-38  Score=282.38  Aligned_cols=247  Identities=23%  Similarity=0.373  Sum_probs=200.7

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      +|+..+.||.|+||.||++... ++..+++|.....     ...++.+|+++++.++|+||+++.+++......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4777899999999999999854 5789999975432     234577899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +++++|..++.... .....+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh~--~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALHE--QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            99999998874321 123567888999999999999999998  77999999999999999999999999998876543 


Q ss_pred             CCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhh
Q 016588          238 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  317 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (386)
                         ......++..|++||...+..++.++|+||||+++|||++|+.||......   ......             ....
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~~~-------------~~~~  217 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRYKV-------------QRGK  217 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH-------------hcCC
Confidence               222345677899999999888999999999999999999999999765421   111111             1111


Q ss_pred             cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ....+...+.++.+++.+||+.+|++|||+.+++++
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            223334556779999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.2e-37  Score=287.26  Aligned_cols=256  Identities=14%  Similarity=0.170  Sum_probs=180.2

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCC----CcEEEEEECCCCCh----h----------HHHHHHHHHHcCCCCccccccc
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----Q----------EFIDEVCFLASIQHRNLVTLLG  143 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~----~----------~~~~e~~~l~~l~h~niv~~~~  143 (386)
                      ..+|++.+.||+|+||.||+|...+    +..+++|.......    +          ....+...+..++|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            4678999999999999999999654    34566665321111    0          1112233455678999999998


Q ss_pred             ceeeCC----eEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC
Q 016588          144 YCQENN----LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED  219 (386)
Q Consensus       144 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~  219 (386)
                      ++....    ..+++++++.. ++.+.+.     .....++..+..++.|++.||.|||+  ++|+||||||+|||++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~iiHrDiKp~Nill~~~  162 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFK-----RIKCKNKKLIKNIMKDMLTTLEYIHE--HGISHGDIKPENIMVDGN  162 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHH-----hhccCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCC
Confidence            765543    34677776643 4444432     11234677788999999999999998  779999999999999999


Q ss_pred             CceEEcccccccccCCCCC-----CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchh
Q 016588          220 FIAKVADAGLRNFLGRTDV-----AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ  294 (386)
Q Consensus       220 ~~~kl~DFgl~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~  294 (386)
                      +.++|+|||+++.......     ........+|+.|+|||+..+..++.++|||||||++|||++|+.||.......  
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~--  240 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG--  240 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--
Confidence            9999999999886642211     111223468999999999999999999999999999999999999998764321  


Q ss_pred             hHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          295 DLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                      ........    ....+......   ....+++++.+++..||..+|++||++.++++.|
T Consensus       241 ~~~~~~~~----~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        241 NLIHAAKC----DFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHHHhHH----HHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            11111100    00001111111   1122357799999999999999999999999876

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=9e-38  Score=286.77  Aligned_cols=246  Identities=19%  Similarity=0.321  Sum_probs=195.0

Q ss_pred             CCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC---ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeec
Q 016588           84 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  159 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  159 (386)
                      .|...+.||+|++|.||++.. .++..+++|.....   ..+.+.+|+.+++.++|||++++++++...+..++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            345567999999999999995 45889999975322   23457889999999999999999999999999999999999


Q ss_pred             CCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016588          160 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  239 (386)
Q Consensus       160 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~  239 (386)
                      +++|.+++..      ..+++..+..++.|++.||.|||+  ++++||||+|+||+++.++.++|+|||.+.......  
T Consensus       100 ~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--  169 (285)
T cd06648         100 GGALTDIVTH------TRMNEEQIATVCLAVLKALSFLHA--QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--  169 (285)
T ss_pred             CCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCChhhEEEcCCCcEEEcccccchhhccCC--
Confidence            9999988732      457888999999999999999998  779999999999999999999999999877553321  


Q ss_pred             CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcc
Q 016588          240 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS  319 (386)
Q Consensus       240 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (386)
                      .......++..|+|||...+..++.++|||||||++|||++|..||....+.   ..........         .+..  
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~---~~~~~~~~~~---------~~~~--  235 (285)
T cd06648         170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL---QAMKRIRDNL---------PPKL--  235 (285)
T ss_pred             cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH---HHHHHHHhcC---------CCCC--
Confidence            1122345778899999998888999999999999999999999998754321   1111111100         0000  


Q ss_pred             cCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          320 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ......+..+.+++.+||+.+|++|||+++++++
T Consensus       236 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         236 KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             cccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            1111244678999999999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.3e-37  Score=290.05  Aligned_cols=249  Identities=28%  Similarity=0.376  Sum_probs=194.8

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      .|...+.||+|+||.||++... ++..+|+|.....      ....+.+|+.+++.++|||++++++++...+..++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3667788999999999999954 5889999985422      12357789999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      |+.+ ++.+.+..    ....+++..+..++.+++.||.|||+  ++++||||+|+||+++.++.++|+|||++..... 
T Consensus       106 ~~~g-~l~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~--~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-  177 (317)
T cd06635         106 YCLG-SASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHS--HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-  177 (317)
T ss_pred             CCCC-CHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence            9975 66665532    23458899999999999999999998  7799999999999999999999999999875432 


Q ss_pred             CCCCCCccccCcccccchhhhc---ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhc
Q 016588          237 DVAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  313 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (386)
                           .....++..|+|||.+.   ...++.++|||||||++|||++|+.||......  ........            
T Consensus       178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~------------  238 (317)
T cd06635         178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQ------------  238 (317)
T ss_pred             -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHHHHHh------------
Confidence                 22345677899999873   456889999999999999999999998764321  11111110            


Q ss_pred             chhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                       ...........++.+.+++.+||+.+|.+||++.++++++......
T Consensus       239 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         239 -NESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             -ccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence             0001111223456789999999999999999999999987655544

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1e-37  Score=286.00  Aligned_cols=261  Identities=25%  Similarity=0.328  Sum_probs=195.5

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      +|+..+.||.|++|.||+|... ++..||+|.....    ....+.+|+.+++.++|+|++++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4778899999999999999965 5889999975432    2356778999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++ +|.+++...  .....+++..+..++.|++.||.|||+  .+++||||||+||++++++.++|+|||++........
T Consensus        81 ~~-~l~~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          81 DK-DLKKYMDTH--GVRGALDPNTVKSFTYQLLKGIAFCHE--NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             Cc-cHHHHHHhc--CCCCCcCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            85 777776432  123468899999999999999999998  6799999999999999999999999999876533211


Q ss_pred             CCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhh--hcccchhhhcc-
Q 016588          239 AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS--RDFSNLLKILD-  314 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-  314 (386)
                        ......++..|++||++.+. .++.++|+|||||++|+|++|..||........  ........  ..........+ 
T Consensus       156 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07836         156 --TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ--LLKIFRIMGTPTESTWPGISQL  231 (284)
T ss_pred             --ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCChhhHHHHhcC
Confidence              12233457789999988654 568899999999999999999999987543211  11111100  00000000000 


Q ss_pred             h-----------hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          315 E-----------RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       315 ~-----------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      +           .......+..+..+.+++.+||+.||.+||++.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0           00011112335678999999999999999999999864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-39  Score=303.87  Aligned_cols=247  Identities=22%  Similarity=0.353  Sum_probs=197.1

Q ss_pred             CCcCCeecccCceEEEEEEeCC-CcEEEEEECC---CCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecC
Q 016588           85 FSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      +.++..||.|+||.||+|..+. +-..|-|.+.   ....++|.-|++||..++||+|+++++.+...+.++++.|||.|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G  113 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG  113 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence            3455679999999999999765 3344555543   33456788899999999999999999999999999999999999


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  240 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~  240 (386)
                      |-.+..+..    -...+.+.++.-+++|++.||.|||+  ++|||||||..|||++-+|.++|+|||.+.....+  ..
T Consensus       114 GAVDaimlE----L~r~LtE~QIqvvc~q~ldALn~LHs--~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~q  185 (1187)
T KOG0579|consen  114 GAVDAIMLE----LGRVLTEDQIQVVCYQVLDALNWLHS--QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQ  185 (1187)
T ss_pred             chHhHHHHH----hccccchHHHHHHHHHHHHHHHHHhh--cchhhhhccccceEEEecCcEeeecccccccchhH--Hh
Confidence            998887743    34678899999999999999999999  77999999999999999999999999997654321  12


Q ss_pred             CCccccCcccccchhhhc-----ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          241 PSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       241 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      ......||++|||||+.+     ...|+.++||||||++|.||..+.+|-....+  ..-+......           +|
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp--MRVllKiaKS-----------eP  252 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP--MRVLLKIAKS-----------EP  252 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch--HHHHHHHhhc-----------CC
Confidence            234568999999999864     46899999999999999999999999776554  1111111110           01


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                       .....|..++..+.+++.+||..||..||++.++++|
T Consensus       253 -PTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  253 -PTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             -CcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence             1123455677889999999999999999999999976

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.2e-37  Score=284.79  Aligned_cols=242  Identities=23%  Similarity=0.301  Sum_probs=189.6

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCCCc
Q 016588           91 IGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV  163 (386)
Q Consensus        91 lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  163 (386)
                      ||+|+||+||++..+ ++..+++|.....      ....+.+|+++++.++|||++++++.+...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999854 5889999975432      233467899999999999999999999999999999999999999


Q ss_pred             cccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCc
Q 016588          164 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS  243 (386)
Q Consensus       164 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~  243 (386)
                      .+++...   ....+++..+..++.|++.||.|||+  .+++||||+|+||++++++.++|+|||++.......   ...
T Consensus        81 ~~~l~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~--~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~  152 (277)
T cd05577          81 KYHIYNV---GEPGFPEARAIFYAAQIICGLEHLHQ--RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIK  152 (277)
T ss_pred             HHHHHHc---CcCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccc
Confidence            9888532   22468899999999999999999998  779999999999999999999999999987654311   122


Q ss_pred             cccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCH
Q 016588          244 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN  323 (386)
Q Consensus       244 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (386)
                      ...++..|+|||...+..++.++|+||||+++|+|++|+.||............   ...         ... .....+.
T Consensus       153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~---------~~~-~~~~~~~  219 (277)
T cd05577         153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL---KRR---------TLE-MAVEYPD  219 (277)
T ss_pred             cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH---Hhc---------ccc-ccccCCc
Confidence            345667799999998888999999999999999999999999765432111100   000         000 0112223


Q ss_pred             HHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016588          324 EGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  353 (386)
Q Consensus       324 ~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~~  353 (386)
                      ..++.+.+++.+||+.||++||     ++.+++++
T Consensus       220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             cCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence            3456789999999999999999     66666643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.9e-37  Score=278.24  Aligned_cols=247  Identities=28%  Similarity=0.429  Sum_probs=199.4

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC---hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeec
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  159 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  159 (386)
                      +|+..+.||+|++|.||++... ++..+++|+.....   ...+.+|++.++.++|+|++++++++...+..++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4677889999999999999965 58899999865443   4678899999999999999999999999999999999999


Q ss_pred             CCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016588          160 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  239 (386)
Q Consensus       160 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~  239 (386)
                      +++|.+++...    ...+++..+..++.+++.||.|||+  .+++|+||+|+||++++++.++|+|||.+........ 
T Consensus        81 ~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  153 (253)
T cd05122          81 GGSLKDLLKST----NQTLTESQIAYVCKELLKGLEYLHS--NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-  153 (253)
T ss_pred             CCcHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhc--CCEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence            99999887432    2568899999999999999999998  7799999999999999999999999999877654321 


Q ss_pred             CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcc
Q 016588          240 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS  319 (386)
Q Consensus       240 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (386)
                        .....++..|++||.+.+..++.++|+||||+++|+|++|..||........   ......    ...     +..  
T Consensus       154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~----~~~-----~~~--  217 (253)
T cd05122         154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA---LFKIAT----NGP-----PGL--  217 (253)
T ss_pred             --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH---HHHHHh----cCC-----CCc--
Confidence              2344567789999999888889999999999999999999999876542111   111100    000     000  


Q ss_pred             cCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          320 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ......+..+.+++.+||+.||++|||+.+++++
T Consensus       218 ~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         218 RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             CcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0111124678999999999999999999999865

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=9.8e-38  Score=285.69  Aligned_cols=255  Identities=20%  Similarity=0.240  Sum_probs=188.9

Q ss_pred             CCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC----hhHHHHHHHHHHcCC-CCcccccccceeeC--CeEEEEEE
Q 016588           85 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQ-HRNLVTLLGYCQEN--NLQFLIYE  156 (386)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e  156 (386)
                      |+..+.||+|+||.||+|... ++..+|+|......    .....+|+..+..+. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            566788999999999999954 58899999754321    223457888888885 99999999999887  88999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      |+.+ ++.+++..    ....+++..+..++.|++.||.|||+  .+++||||+|+||+++. +.+||+|||++......
T Consensus        81 ~~~~-~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~LH~--~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          81 LMDM-NLYELIKG----RKRPLPEKRVKSYMYQLLKSLDHMHR--NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             cCCc-cHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            9975 77666632    23468899999999999999999998  77999999999999999 99999999998876432


Q ss_pred             CCCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhh-c-ccchhhhc
Q 016588          237 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR-D-FSNLLKIL  313 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~  313 (386)
                      ..   .....++..|+|||.+.. ..++.++|||||||++|||++|..||...++.+   ......... . .....+..
T Consensus       153 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  226 (282)
T cd07831         153 PP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKF  226 (282)
T ss_pred             CC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhh
Confidence            21   123456778999997654 456889999999999999999999997754321   111111000 0 00000000


Q ss_pred             c---------hhh----cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          314 D---------ERL----WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       314 ~---------~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .         +..    ........+.++.+++.+||+.+|++|||+++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            0         000    001112346789999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.1e-37  Score=295.04  Aligned_cols=258  Identities=20%  Similarity=0.306  Sum_probs=193.5

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeC------
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN------  148 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  148 (386)
                      ..++|+..+.||+|+||.||+|... ++..||+|.....     ....+.+|+.+++.++|+||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            3468999999999999999999954 6889999986432     234577899999999999999999987543      


Q ss_pred             CeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccc
Q 016588          149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  228 (386)
Q Consensus       149 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFg  228 (386)
                      ...|+||||+.+ +|...+.       ..++...+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~-------~~l~~~~~~~~~~ql~~aL~~LH~--~gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQ-------MDLDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEccCc
Confidence            357999999965 7766652       127788889999999999999998  779999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc-c-
Q 016588          229 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD-F-  306 (386)
Q Consensus       229 l~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~-  306 (386)
                      ++.......   ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+...  ........... . 
T Consensus       164 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~  238 (353)
T cd07850         164 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID--QWNKIIEQLGTPSD  238 (353)
T ss_pred             cceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHhcCCCCH
Confidence            998764322   1223456778999999999999999999999999999999999997644211  00000000000 0 


Q ss_pred             ----------------------cchhhhcchhhc----ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          307 ----------------------SNLLKILDERLW----STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       307 ----------------------~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                                            ....+.......    .......++.+.+++.+||+.||++|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                                  000011111110    01112345678999999999999999999999976

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.5e-37  Score=287.53  Aligned_cols=263  Identities=22%  Similarity=0.287  Sum_probs=193.1

Q ss_pred             HHhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCC----
Q 016588           80 LATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN----  149 (386)
Q Consensus        80 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  149 (386)
                      ...++|++.+.||+|+||.||+|..+ +++.|++|.....     ....+.+|+++++.++|||++++++++....    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34568889999999999999999975 4789999975422     2245678999999999999999999887654    


Q ss_pred             ------eEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceE
Q 016588          150 ------LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAK  223 (386)
Q Consensus       150 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~k  223 (386)
                            ..++|+||+++ ++...+..    ....+++..+..++.|++.||.|||+  ++|+|+||||+||++++++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLES----GLVHFSEDHIKSFMKQLLEGLNYCHK--KNFLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCcEE
Confidence                  78999999986 55555532    23468899999999999999999998  7799999999999999999999


Q ss_pred             EcccccccccCCCCCCCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHh
Q 016588          224 VADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN  302 (386)
Q Consensus       224 l~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~  302 (386)
                      |+|||++........ .......++..|+|||.+.+. .++.++|||||||++|||++|+.||......  ..+......
T Consensus       157 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~--~~~~~~~~~  233 (302)
T cd07864         157 LADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL--AQLELISRL  233 (302)
T ss_pred             eCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHH
Confidence            999999886643221 111223456679999988653 5688999999999999999999999754421  111111110


Q ss_pred             h--hcc---cchhhh-----cc------hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          303 S--RDF---SNLLKI-----LD------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       303 ~--~~~---~~~~~~-----~~------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .  ...   ..+...     .+      ...+. .....+..+.+++.+||+.||.+|||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             hCCCChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0  000   000000     00      00000 111235678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=284.84  Aligned_cols=258  Identities=22%  Similarity=0.334  Sum_probs=195.8

Q ss_pred             CCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           85 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      |+..+.||+|++|.||++... +++.+++|......     ...+.+|+.+++.++|+|++++++++...+..++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            556788999999999999964 68899999754432     346788999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++ ++..++..    ....+++..+..++.|++.||.|||+  ++|+|+||+|+||+++.++.++|+|||.+....... 
T Consensus        81 ~~-~l~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-  152 (283)
T cd05118          81 DT-DLYKLIKD----RQRGLPESLIKSYLYQLLQGLAFCHS--HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-  152 (283)
T ss_pred             CC-CHHHHHHh----hcccCCHHHHHHHHHHHHHHHHHHHH--CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence            75 77766632    22568899999999999999999998  779999999999999999999999999987764432 


Q ss_pred             CCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc-----ccchhh-
Q 016588          239 AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD-----FSNLLK-  311 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~~-  311 (386)
                       .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+  ...........     ...... 
T Consensus       153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd05118         153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID--QLFKIFRTLGTPDPEVWPKFTSL  229 (283)
T ss_pred             -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCchHhcccchhh
Confidence             112234567789999998876 78999999999999999999999987654311  11111110000     000000 


Q ss_pred             -------hcchh--hcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          312 -------ILDER--LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       312 -------~~~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                             .....  .........+.++.+++.+||+.||.+||++++++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                   00000  0011122356789999999999999999999999865

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.3e-37  Score=280.37  Aligned_cols=245  Identities=20%  Similarity=0.233  Sum_probs=188.7

Q ss_pred             HhcCCCcCCee--cccCceEEEEEEeC-CCcEEEEEECCCCChhHHHHHHHHHHcC-CCCcccccccceeeCCeEEEEEE
Q 016588           81 ATKNFSDKNLI--GEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        81 ~~~~~~~~~~l--g~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      ..++|.+.+.+  |+|+||.||++..+ ++..+++|..........  |......+ +|||++++++.+...+..|+|||
T Consensus        12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e   89 (267)
T PHA03390         12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD   89 (267)
T ss_pred             HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence            34566666666  99999999999954 578899998654332222  22222222 79999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC-ceEEcccccccccCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNFLGR  235 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~-~~kl~DFgl~~~~~~  235 (386)
                      |+++++|.+++..     ...+++..+..++.|++.||.|||+  .+++||||||+||+++.++ .++|+|||++.....
T Consensus        90 ~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  162 (267)
T PHA03390         90 YIKDGDLFDLLKK-----EGKLSEAEVKKIIRQLVEALNDLHK--HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT  162 (267)
T ss_pred             cCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence            9999999998842     2378999999999999999999999  6799999999999999998 999999999876543


Q ss_pred             CCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      .      ....++..|+|||++.+..++.++||||||+++|||++|..||....... .+........          ..
T Consensus       163 ~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~----------~~  225 (267)
T PHA03390        163 P------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ----------QK  225 (267)
T ss_pred             C------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh----------cc
Confidence            2      22356778999999998899999999999999999999999998543321 1111111110          00


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCC-HHHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-MSDVVTE  353 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-~~evl~~  353 (386)
                      .  .......+..+.+++.+||+.+|.+||+ +++++++
T Consensus       226 ~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        226 K--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             c--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence            0  1122235567899999999999999996 6988864

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.2e-37  Score=292.70  Aligned_cols=261  Identities=23%  Similarity=0.359  Sum_probs=193.4

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC-----CChhHHHHHHHHHHcC-CCCcccccccceee--CCeEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG-----APTQEFIDEVCFLASI-QHRNLVTLLGYCQE--NNLQF  152 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~--~~~~~  152 (386)
                      .++|+..+.||+|+||.||+|... ++..+++|+...     .....+.+|+.+++++ +||||+++++++..  ....|
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            457888899999999999999965 578999997532     2234577899999999 99999999998864  34689


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~  232 (386)
                      +||||+. ++|..++..      ..+++.....++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++..
T Consensus        86 lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~--~~i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          86 LVFEYME-TDLHAVIRA------NILEDVHKRYIMYQLLKALKYIHS--GNVIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEecccc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            9999997 488777631      267788889999999999999998  7799999999999999999999999999886


Q ss_pred             cCCCCCC---CCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc---
Q 016588          233 LGRTDVA---GPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD---  305 (386)
Q Consensus       233 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---  305 (386)
                      .......   .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||....+...  ..........   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~~  234 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ--LEKIIEVIGPPSA  234 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCH
Confidence            6432221   22334567888999998754 4578899999999999999999999976443211  1110000000   


Q ss_pred             ----------ccchhhhcchhh---cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          306 ----------FSNLLKILDERL---WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       306 ----------~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                                ...+........   ........+.++.+++.+||+.||.+|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                      000000000000   001111245678999999999999999999999976

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=284.91  Aligned_cols=259  Identities=23%  Similarity=0.330  Sum_probs=193.7

Q ss_pred             CCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeC--CeEEEEEE
Q 016588           85 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQFLIYE  156 (386)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e  156 (386)
                      |+..+.||+|+||.||+|... ++..+++|.....     ....+.+|+++++.++|+|++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            566789999999999999965 4789999986543     234678899999999999999999999887  88999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      |+++ +|..++..    ....+++..+..++.|++.||.|||+  .+++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~-~l~~~~~~----~~~~~~~~~~~~i~~~i~~al~~LH~--~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          81 YMDH-DLTGLLDS----PEVKFTESQIKCYMKQLLEGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             cccc-cHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9975 77777632    22468899999999999999999998  67999999999999999999999999998876543


Q ss_pred             CCCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhh--c---ccchh
Q 016588          237 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR--D---FSNLL  310 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~---~~~~~  310 (386)
                      .. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........  +........  .   +....
T Consensus       154 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07840         154 NS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ--LEKIFELCGSPTDENWPGVS  230 (287)
T ss_pred             Cc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCchhhccccc
Confidence            21 11223345677999998765 4578999999999999999999999986553211  111111000  0   00000


Q ss_pred             hh-----------cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          311 KI-----------LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       311 ~~-----------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ..           ....+.......++..+.+++.+||+.+|++|||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            00           00000011111125678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.3e-37  Score=278.95  Aligned_cols=249  Identities=22%  Similarity=0.362  Sum_probs=201.2

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      +|...+.||+|+||.||++... ++..+++|.....     ....+.+|+++++.++|+|++++.+.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4777899999999999999965 5889999985433     345688899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +++++|.+++.... .....+++..+..++.+++.||.|||+  .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~--~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQK-KEGKPFPEEQILDWFVQLCLALKYLHS--RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhh-ccCCCcCHHHHHHHHHHHHHHHHHHHh--CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999998885321 123678999999999999999999998  679999999999999999999999999987764432


Q ss_pred             CCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhh
Q 016588          238 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  317 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (386)
                        .......+++.|+|||...+..++.++|+||+|+++++|++|..||.....   .........             ..
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~-------------~~  219 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL---LELALKILK-------------GQ  219 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH---HHHHHHHhc-------------CC
Confidence              122334577789999999888899999999999999999999999875442   111111100             00


Q ss_pred             cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ....+...+.++.+++.+||..+|++|||+.+++++
T Consensus       220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            112222345678999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.8e-37  Score=287.89  Aligned_cols=261  Identities=20%  Similarity=0.283  Sum_probs=190.5

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCC-------
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN-------  149 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------  149 (386)
                      ++|+..+.||+|+||.||+|... ++..||+|.....     ....+.+|+.+++.++||||+++++++....       
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            47888999999999999999965 5889999975322     1234568999999999999999999886543       


Q ss_pred             -eEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccc
Q 016588          150 -LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  228 (386)
Q Consensus       150 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFg  228 (386)
                       ..++||||+.+ +|...+..    ....+++..+..++.|++.||.|||+  ++++|+||||+||+++.++.+||+|||
T Consensus        92 ~~~~lv~e~~~~-~l~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          92 GSFYLVFEFCEH-DLAGLLSN----KNVKFTLSEIKKVMKMLLNGLYYIHR--NKILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             ceEEEEEcCCCc-CHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEECCCCcEEECcCC
Confidence             45999999975 67666532    23468899999999999999999998  679999999999999999999999999


Q ss_pred             cccccCCCCCC--CCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc
Q 016588          229 LRNFLGRTDVA--GPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD  305 (386)
Q Consensus       229 l~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  305 (386)
                      ++.........  .......++..|+|||.+.+. .++.++||||||+++|||++|..||....+...............
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT  244 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            98766432221  112234567789999988664 468899999999999999999999876553222111111110000


Q ss_pred             ccchh------------------hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          306 FSNLL------------------KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       306 ~~~~~------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .....                  ......++..   .....+.+++.+||+.||.+|||+++++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPY---VKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccc---cCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            00000                  0000000000   012457899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-39  Score=273.16  Aligned_cols=246  Identities=20%  Similarity=0.323  Sum_probs=187.4

Q ss_pred             CCcCCeecccCceEEEEEEeCC-CcEEEEEECCCCCh----hHHHHHHHHHHcC-CCCcccccccceeeCCeEEEEEEee
Q 016588           85 FSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPT----QEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      .+....||+|..|.|+++.+++ +...|||.......    ++++..+.++..- +.|+||+.+|+|..+..+++.||.|
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            3445679999999999999764 88999998654432    3455666666554 4899999999999999999999987


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      .. -++.++.    ....++++..+-++...+.+||.||.. .++|+|||+||+|||+|+.|++|+||||++-++.+...
T Consensus       174 s~-C~ekLlk----rik~piPE~ilGk~tva~v~AL~YLKe-KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA  247 (391)
T KOG0983|consen  174 ST-CAEKLLK----RIKGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA  247 (391)
T ss_pred             HH-HHHHHHH----HhcCCchHHhhhhhHHHHHHHHHHHHH-hcceeecccCccceEEccCCCEEeecccccceeecccc
Confidence            53 3443332    234557888888889999999999986 36799999999999999999999999999887754332


Q ss_pred             CCCCccccCcccccchhhhcc---cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          239 AGPSSQVTADEIFLASEVKEF---RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                         .+...|-+.|||||.+..   ..|+..+||||||++++||.||+.||.+-..+ .             +.+.++++.
T Consensus       248 ---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-F-------------e~ltkvln~  310 (391)
T KOG0983|consen  248 ---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-F-------------EVLTKVLNE  310 (391)
T ss_pred             ---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-H-------------HHHHHHHhc
Confidence               233456667999999864   47889999999999999999999999874432 1             112222221


Q ss_pred             hh-cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          316 RL-WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       316 ~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .. ........++++.+++..||++|+.+||...++++|
T Consensus       311 ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  311 EPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             CCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            11 111222356789999999999999999999999976

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3.8e-38  Score=273.37  Aligned_cols=272  Identities=20%  Similarity=0.279  Sum_probs=201.2

Q ss_pred             HHhcCCCcCCeecccCceEEEEEEeC-C----CcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceee-C
Q 016588           80 LATKNFSDKNLIGEGKFGEVYKGLLQ-D----GMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE-N  148 (386)
Q Consensus        80 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~  148 (386)
                      .....|+....||+|.||.||+|.-+ +    ...+|+|++...     ......+|+..++.++|||++.+..++.+ +
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence            34557889999999999999999632 2    236899986544     34467789999999999999999999877 7


Q ss_pred             CeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC----CceEE
Q 016588          149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED----FIAKV  224 (386)
Q Consensus       149 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~----~~~kl  224 (386)
                      ..+++++||.+. +|...++-.+......++...+.+|+.|++.|+.|||+  +=|+||||||.|||+..+    |.+||
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~--NWvlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS--NWVLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh--hheeeccCCcceEEEeccCCccCeeEe
Confidence            789999999988 67666655544555788999999999999999999999  669999999999999877    89999


Q ss_pred             cccccccccCCCCCC-CCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCC-------chhh
Q 016588          225 ADAGLRNFLGRTDVA-GPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPD-------SSQD  295 (386)
Q Consensus       225 ~DFgl~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~-------~~~~  295 (386)
                      +|||+++.+...-.. ........|.+|.|||.+.|. .|+.+.||||.||++.||+|-.+.|.+....       ..++
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ  257 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ  257 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence            999999987653322 234456788999999998874 7899999999999999999988777653321       1111


Q ss_pred             HHHHHHh--hh---cccchhhhcch---------hhcccC--------CHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          296 LVELVQN--SR---DFSNLLKILDE---------RLWSTF--------TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       296 ~~~~~~~--~~---~~~~~~~~~~~---------~~~~~~--------~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      +...+.-  .+   .++.+.+..+-         ..+...        ...-++...+|+.++|+.||.+|.|+++.+++
T Consensus       258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            1111110  01   11111111110         111110        00011337899999999999999999999987


Q ss_pred             H
Q 016588          354 L  354 (386)
Q Consensus       354 L  354 (386)
                      .
T Consensus       338 ~  338 (438)
T KOG0666|consen  338 P  338 (438)
T ss_pred             c
Confidence            5

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-38  Score=273.64  Aligned_cols=246  Identities=24%  Similarity=0.284  Sum_probs=201.1

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC------hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      -++|...++||+|.||.|.+++.+ ++..+|+|++++..      ...-..|-++|+..+||.+..+--.|+.++.+|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            357888899999999999999954 68999999865542      22345688899999999999999899999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      |||..||.|..++     .....+++.....+...|+.||.|||+  ++||.||||.+|.|||.+|++||+|||+++.--
T Consensus       247 MeyanGGeLf~HL-----srer~FsE~RtRFYGaEIvsAL~YLHs--~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  247 MEYANGGELFFHL-----SRERVFSEDRTRFYGAEIVSALGYLHS--RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             EEEccCceEeeeh-----hhhhcccchhhhhhhHHHHHHhhhhhh--CCeeeeechhhhheeccCCceEeeecccchhcc
Confidence            9999999998887     345667777778899999999999999  779999999999999999999999999987532


Q ss_pred             CCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                        .........+||+.|+|||++....|+.+.|+|.+||++|||+.|+.||...+.   +.+.+.+..            
T Consensus       320 --~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh---~kLFeLIl~------------  382 (516)
T KOG0690|consen  320 --KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH---EKLFELILM------------  382 (516)
T ss_pred             --cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch---hHHHHHHHh------------
Confidence              233445678999999999999999999999999999999999999999997553   223322211            


Q ss_pred             hhhcccCCHHHHHHHHHHHhHccCCCCCCCC--CHHHHHHH
Q 016588          315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRP--SMSDVVTE  353 (386)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp--t~~evl~~  353 (386)
                      ..+  .+|...+++...|+...|..||.+|.  ...++.+.
T Consensus       383 ed~--kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi  421 (516)
T KOG0690|consen  383 EDL--KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEI  421 (516)
T ss_pred             hhc--cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHH
Confidence            111  35555667889999999999999995  33444433

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-37  Score=277.04  Aligned_cols=245  Identities=28%  Similarity=0.453  Sum_probs=198.7

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      +|+..+.||+|++|.||++... +++.+++|......     .+.+.+|++++++++|+|++++++++.+.+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4777899999999999999865 57889999854433     34688999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +++++|.+++.     ....+++..+..++.|++.||.|||+  .|++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~-----~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          81 AENGSLRQIIK-----KFGPFPESLVAVYVYQVLQGLAYLHE--QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             CCCCcHHHHHH-----hccCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            99999998873     23568899999999999999999998  779999999999999999999999999988765432


Q ss_pred             CCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhh
Q 016588          238 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  317 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (386)
                      ..  .....++..|+|||...+..++.++|+||+|+++|+|++|..|+....+.  .......              ...
T Consensus       154 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~--~~~~~~~--------------~~~  215 (254)
T cd06627         154 KD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM--AALFRIV--------------QDD  215 (254)
T ss_pred             cc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH--HHHHHHh--------------ccC
Confidence            21  23345677899999998888899999999999999999999998754421  1111000              001


Q ss_pred             cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ....+...++.+.+++.+||..+|++|||+.+++.+
T Consensus       216 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         216 HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence            112233345678999999999999999999999853

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=4.1e-37  Score=288.07  Aligned_cols=259  Identities=22%  Similarity=0.292  Sum_probs=189.4

Q ss_pred             Ceeccc--CceEEEEEEeC-CCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecC
Q 016588           89 NLIGEG--KFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        89 ~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      ..||+|  +||+||++... +++.||+|......     .+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            346666  89999999964 68999999854322     24577889999999999999999999999999999999999


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC-
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA-  239 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~-  239 (386)
                      +++.+++...   ....+++..+..++.|++.||+|||+  ++++||||||+||+++.++.++++||+.+......... 
T Consensus        84 ~~l~~~l~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~--~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          84 GSANSLLKTY---FPEGMSEALIGNILFGALRGLNYLHQ--NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             CCHHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            9998887432   12357888889999999999999998  77999999999999999999999999865432211110 


Q ss_pred             ----CCCccccCcccccchhhhccc--CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhccc------
Q 016588          240 ----GPSSQVTADEIFLASEVKEFR--RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS------  307 (386)
Q Consensus       240 ----~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------  307 (386)
                          .......++..|+|||++.+.  .++.++|||||||++|||++|..||......  ..............      
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~  236 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--QMLLQKLKGPPYSPLDITTF  236 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--HHHHHHhcCCCCCCcccccc
Confidence                011112345569999998763  4789999999999999999999999765431  11111110000000      


Q ss_pred             ------------ch--------------hhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          308 ------------NL--------------LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       308 ------------~~--------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                                  ..              ....+..+.......++..+.+++.+||+.||++|||+.|++++-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~  309 (328)
T cd08226         237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA  309 (328)
T ss_pred             chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence                        00              000111112222334667899999999999999999999998653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.1e-37  Score=280.47  Aligned_cols=239  Identities=23%  Similarity=0.331  Sum_probs=189.6

Q ss_pred             ecccCceEEEEEEeCC-CcEEEEEECCCCC------hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCCCc
Q 016588           91 IGEGKFGEVYKGLLQD-GMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV  163 (386)
Q Consensus        91 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  163 (386)
                      ||.|+||.||++.... ++.+++|......      .+.+.+|+++++.++|||++++++.+...+..|+++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999764 8999999865432      34678899999999999999999999999999999999999999


Q ss_pred             cccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC-----
Q 016588          164 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV-----  238 (386)
Q Consensus       164 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~-----  238 (386)
                      .+++..     ...+++..+..++.|++.||.|||+  ++++|+||+|+||++++++.++|+|||++........     
T Consensus        81 ~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~lH~--~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          81 ASLLEN-----VGSLDEDVARIYIAEIVLALEYLHS--NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH--cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            888842     2368899999999999999999998  7799999999999999999999999999876433211     


Q ss_pred             -CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhh
Q 016588          239 -AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  317 (386)
Q Consensus       239 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (386)
                       ........++..|++||......++.++|+||||+++||+++|..||......   ........            ...
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~~------------~~~  218 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE---EIFQNILN------------GKI  218 (265)
T ss_pred             ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhc------------CCc
Confidence             11223345677899999998888899999999999999999999999764421   11111111            000


Q ss_pred             cccCCHH--HHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          318 WSTFTNE--GMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       318 ~~~~~~~--~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                        ..+..  .+..+.+++.+||+.+|.+|||+..+.+.
T Consensus       219 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~  254 (265)
T cd05579         219 --EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEI  254 (265)
T ss_pred             --CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHH
Confidence              11111  25678999999999999999999444433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2e-37  Score=283.11  Aligned_cols=247  Identities=20%  Similarity=0.271  Sum_probs=199.1

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcCC-CCcccccccceeeCCeEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv  154 (386)
                      ++|...+.||+|+||.||++... ++..|++|.....      ....+.+|.++++.++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36888899999999999999965 6889999975432      2345788999999998 99999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      |||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.++++|||++....
T Consensus        81 ~e~~~~~~L~~~l~-----~~~~l~~~~~~~i~~ql~~~l~~Lh~--~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          81 LEYAPNGELLQYIR-----KYGSLDEKCTRFYAAEILLALEYLHS--KGIIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             EcCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            99999999998884     33468999999999999999999998  779999999999999999999999999987664


Q ss_pred             CCCCC------------------CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhH
Q 016588          235 RTDVA------------------GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDL  296 (386)
Q Consensus       235 ~~~~~------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~  296 (386)
                      .....                  .......++..|+|||......++.++|+||||++++++++|..||......   ..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~  230 (280)
T cd05581         154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY---LT  230 (280)
T ss_pred             CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH---HH
Confidence            32211                  1122334677899999998888899999999999999999999998865421   11


Q ss_pred             HHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCH----HHHHHH
Q 016588          297 VELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM----SDVVTE  353 (386)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~----~evl~~  353 (386)
                      ..   ...           ......+...++.+.+++.+||+.+|.+|||+    ++++++
T Consensus       231 ~~---~~~-----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         231 FQ---KIL-----------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             HH---HHH-----------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence            11   100           01112333345678999999999999999999    777754

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=6.8e-37  Score=279.93  Aligned_cols=239  Identities=21%  Similarity=0.287  Sum_probs=185.0

Q ss_pred             eecccCceEEEEEEeC-CCcEEEEEECCCCCh------hHHHHHHH---HHHcCCCCcccccccceeeCCeEEEEEEeec
Q 016588           90 LIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT------QEFIDEVC---FLASIQHRNLVTLLGYCQENNLQFLIYEYIP  159 (386)
Q Consensus        90 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~e~~---~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  159 (386)
                      .||+|+||.||++... +++.||+|.......      ..+..|..   .++..+|||++++++++...+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999854 588999997543211      12333433   3445679999999999999999999999999


Q ss_pred             CCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016588          160 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  239 (386)
Q Consensus       160 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~  239 (386)
                      +++|..++.     ....+++..+..++.|++.||.|||+  ++++||||||+||+++.++.++|+|||++.......  
T Consensus        81 g~~L~~~l~-----~~~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--  151 (278)
T cd05606          81 GGDLHYHLS-----QHGVFSEAEMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (278)
T ss_pred             CCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence            999988773     33568999999999999999999998  779999999999999999999999999987653321  


Q ss_pred             CCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          240 GPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       240 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                        .....++..|+|||.+.+. .++.++||||+||++|||++|..||................          ...    
T Consensus       152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----------~~~----  215 (278)
T cd05606         152 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL----------TMA----  215 (278)
T ss_pred             --CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh----------ccC----
Confidence              2234678889999998754 68999999999999999999999998754322211110000          001    


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  353 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~~  353 (386)
                      ...+...+.++.+++.+||..+|.+||     ++.+++++
T Consensus       216 ~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         216 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            112223356789999999999999999     99999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4.5e-37  Score=283.31  Aligned_cols=261  Identities=21%  Similarity=0.275  Sum_probs=191.7

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      ++|+..+.||+|++|.||+|..+ +++.|++|.....     ....+.+|+++++.++|||++++++++...+..|+|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888899999999999999965 5889999975432     23467889999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-CCceEEcccccccccCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLGR  235 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~-~~~~kl~DFgl~~~~~~  235 (386)
                      |+++ +|..++...   .....++..+..++.|++.||.|||+  ++++|+||+|+||+++. ++.+||+|||++.....
T Consensus        82 ~~~~-~l~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~--~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         82 YLDL-DLKKHMDSS---PDFAKNPRLIKTYLYQILRGIAYCHS--HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             cccc-cHHHHHHhC---CCCCcCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            9964 676665321   22335778888999999999999998  77999999999999985 56789999999876543


Q ss_pred             CCCCCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc-ccchh---
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD-FSNLL---  310 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~---  310 (386)
                      ..  .......++..|+|||++.+. .++.++||||+||++|+|++|..||......  ............ .....   
T Consensus       156 ~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~  231 (294)
T PLN00009        156 PV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI--DELFKIFRILGTPNEETWPGV  231 (294)
T ss_pred             Cc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChhhcccc
Confidence            21  111233457789999988764 5789999999999999999999999764431  111111110000 00000   


Q ss_pred             ----hh--cchhhcc----cCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          311 ----KI--LDERLWS----TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       311 ----~~--~~~~~~~----~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                          ..  ..+....    ......++++.+++.+|++.+|++||++.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                00  0000000    0112234668999999999999999999999974

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-37  Score=292.75  Aligned_cols=247  Identities=22%  Similarity=0.303  Sum_probs=205.8

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      ....|.+.+.||+|.|+.|..|.+. ++..||+|.+++..     .+.+.+|+++|+.++|||||+++++......+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            3457888999999999999999954 58999999865543     34578999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      |||+.+|.+.+++..     ...........++.|+..|++|||+  +.|+|||||.+|+||+.+.++||+|||++.++.
T Consensus       134 ~eya~~ge~~~yl~~-----~gr~~e~~ar~~F~q~vsaveYcH~--k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  134 MEYASGGELFDYLVK-----HGRMKEKEARAKFRQIVSAVEYCHS--KNIVHRDLKAENILLDENMNIKIADFGFSTFFD  206 (596)
T ss_pred             EEeccCchhHHHHHh-----cccchhhhhhhhhHHHHHHHHHHhh--cceeccccchhhcccccccceeeeccccceeec
Confidence            999999999999943     3445557888899999999999999  679999999999999999999999999999885


Q ss_pred             CCCCCCCCccccCcccccchhhhcccCC-CcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhc
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  313 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (386)
                      .   .......+|++.|.|||+..+..| ++++|+||+|+++|-|+.|..||++..-....               .+.+
T Consensus       207 ~---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr---------------~rvl  268 (596)
T KOG0586|consen  207 Y---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR---------------PRVL  268 (596)
T ss_pred             c---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc---------------chhe
Confidence            3   345567789999999999999888 78999999999999999999999975532111               1111


Q ss_pred             chhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                      -..++-.+  ..+.++.+++.++|..+|.+|+++.++-++-
T Consensus       269 ~gk~rIp~--~ms~dce~lLrk~lvl~Pskr~~~dqim~~~  307 (596)
T KOG0586|consen  269 RGKYRIPF--YMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR  307 (596)
T ss_pred             eeeecccc--eeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence            22222222  2345689999999999999999999998663

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.3e-37  Score=284.01  Aligned_cols=242  Identities=20%  Similarity=0.348  Sum_probs=192.1

Q ss_pred             CCeecccCceEEEEEEeC-CCcEEEEEECCCC---ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCCCc
Q 016588           88 KNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV  163 (386)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  163 (386)
                      ...||+|+||.||++..+ ++..||+|+....   ....+.+|+.+++.++|+|++++++++...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            357999999999999864 6889999985432   234578899999999999999999999999999999999999999


Q ss_pred             cccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCc
Q 016588          164 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS  243 (386)
Q Consensus       164 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~  243 (386)
                      .+++.      ...+++.....++.|++.||+|||+  .|++|+||+|+||+++.++.++|+|||++.......  ....
T Consensus       105 ~~~~~------~~~~~~~~~~~~~~ql~~~l~~lH~--~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~  174 (292)
T cd06657         105 TDIVT------HTRMNEEQIAAVCLAVLKALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRK  174 (292)
T ss_pred             HHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEcccccceeccccc--cccc
Confidence            88763      2357888999999999999999998  779999999999999999999999999877553321  1123


Q ss_pred             cccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCH
Q 016588          244 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN  323 (386)
Q Consensus       244 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (386)
                      ...++..|+|||...+..++.++|+||+|+++|||++|..||......   .........         ..+..  ....
T Consensus       175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~~~~---------~~~~~--~~~~  240 (292)
T cd06657         175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRDN---------LPPKL--KNLH  240 (292)
T ss_pred             ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhh---------CCccc--CCcc
Confidence            345778899999998888899999999999999999999998764321   111111100         00000  0111


Q ss_pred             HHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          324 EGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       324 ~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ..+..+.+++.+||+.+|.+||++++++++
T Consensus       241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         241 KVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             cCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            234568899999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-37  Score=289.52  Aligned_cols=267  Identities=21%  Similarity=0.304  Sum_probs=200.2

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCC-----eEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN-----LQF  152 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~  152 (386)
                      +|++.+.||+|+||.||+|... ++..+++|+....     ..+.+.+|+.+++.++|+||+++++++...+     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4778899999999999999965 4889999975432     3456889999999999999999999988765     789


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~  232 (386)
                      ++|||+.+ +|..++.     ....+++..+..++.+++.||.|||+  .||+||||||+||+++.++.++|+|||++..
T Consensus        81 lv~e~~~~-~l~~~l~-----~~~~l~~~~~~~i~~~l~~~l~~LH~--~gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          81 IVTELMET-DLHKVIK-----SPQPLTDDHIQYFLYQILRGLKYLHS--ANVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             EEecchhh-hHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            99999974 7877773     23478899999999999999999998  7799999999999999999999999999887


Q ss_pred             cCCCCC-CCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc-----
Q 016588          233 LGRTDV-AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD-----  305 (386)
Q Consensus       233 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-----  305 (386)
                      ...... ........++..|+|||.+.+. .++.++|+||||+++|+|++|..||..................+.     
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  232 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK  232 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence            654321 1122334567789999999887 789999999999999999999999987653211111000000000     


Q ss_pred             ---ccchhhhcc------hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH--HHHhh
Q 016588          306 ---FSNLLKILD------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE--LDRTL  358 (386)
Q Consensus       306 ---~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~--L~~~~  358 (386)
                         .......+.      +..+.......+.++.+++.+||+.+|++|||+++++.+  +++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence               000000000      000011112245678999999999999999999999986  44443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3.1e-37  Score=289.74  Aligned_cols=260  Identities=21%  Similarity=0.287  Sum_probs=191.7

Q ss_pred             cCCC-cCCeecccCceEEEEEEeC-CCcEEEEEECCCCCh-----------------hHHHHHHHHHHcCCCCccccccc
Q 016588           83 KNFS-DKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT-----------------QEFIDEVCFLASIQHRNLVTLLG  143 (386)
Q Consensus        83 ~~~~-~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----------------~~~~~e~~~l~~l~h~niv~~~~  143 (386)
                      ++|. ..+.||.|+||.||+|... +++.||+|.......                 ..+.+|+++++.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3444 3477999999999999954 588999997543211                 14678999999999999999999


Q ss_pred             ceeeCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceE
Q 016588          144 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAK  223 (386)
Q Consensus       144 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~k  223 (386)
                      ++...+..++||||+. ++|.+++.     ....+++.....++.|++.||.|||+  .+++|+||+|+||+++.++.++
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~-----~~~~~~~~~~~~~~~ql~~aL~~LH~--~~i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVD-----RKIRLTESQVKCILLQILNGLNVLHK--WYFMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeecccccHHHeEECCCCCEE
Confidence            9999999999999997 58887773     33457888999999999999999998  7799999999999999999999


Q ss_pred             EcccccccccCCCCC------------CCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCC
Q 016588          224 VADAGLRNFLGRTDV------------AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSP  290 (386)
Q Consensus       224 l~DFgl~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~  290 (386)
                      |+|||++........            ........++..|+|||.+.+. .++.++|+|||||++|||++|..||....+
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999876541110            0111223356779999998764 468999999999999999999999986553


Q ss_pred             CchhhHHHHHHhh--hc---ccchhhh---------cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          291 DSSQDLVELVQNS--RD---FSNLLKI---------LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       291 ~~~~~~~~~~~~~--~~---~~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ..  .+.......  ..   +......         ..+.. .......+.++.+++.+||+.+|++|||++|++.+
T Consensus       240 ~~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        240 ID--QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDL-KTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             HH--HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccH-HHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            21  111111100  00   0000000         00000 00111234678999999999999999999999975

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=295.64  Aligned_cols=269  Identities=23%  Similarity=0.362  Sum_probs=204.3

Q ss_pred             CcCCeecccCceEEEEEEe-CCCcEEEEEECCC----CChhHHHHHHHHHHcCCCCcccccccceeeC------CeEEEE
Q 016588           86 SDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQEN------NLQFLI  154 (386)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~lv  154 (386)
                      ...+.||+|+||.||+|++ .+|+.||||...+    ...+...+|+++|++++|+|||++.+.-...      +...+|
T Consensus        16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv   95 (732)
T KOG4250|consen   16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV   95 (732)
T ss_pred             eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence            4457899999999999995 4699999997544    3456788999999999999999999876543      456899


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC--C--CCceEEcccccc
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD--E--DFIAKVADAGLR  230 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~--~--~~~~kl~DFgl~  230 (386)
                      ||||.+|+|...+...  .+...+++...+.+..++..||.|||+  +||+||||||.||++-  .  ....||+|||.|
T Consensus        96 mEyC~gGsL~~~L~~P--EN~~GLpE~e~l~lL~d~~~al~~LrE--n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   96 MEYCSGGSLRKVLNSP--ENAYGLPESEFLDLLSDLVSALRHLRE--NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EeecCCCcHHHHhcCc--ccccCCCHHHHHHHHHHHHHHHHHHHH--cCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            9999999999999765  456779999999999999999999998  7899999999999983  3  335699999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccch
Q 016588          231 NFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL  309 (386)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  309 (386)
                      +.+++..   ......||+.|.+||.... +.|+..+|.|||||++||+.||..||..........-..+..........
T Consensus       172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v  248 (732)
T KOG4250|consen  172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV  248 (732)
T ss_pred             ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence            9886543   4456789999999999985 78899999999999999999999999875543221111111111110000


Q ss_pred             hhhcc-----hhhc---cc----CCHHHHHHHHHHHhHccCCCCCCCC--CHHHHHHHHHHhhhhh
Q 016588          310 LKILD-----ERLW---ST----FTNEGMEEFIQLIVRCLDPSSERRP--SMSDVVTELDRTLDKE  361 (386)
Q Consensus       310 ~~~~~-----~~~~---~~----~~~~~~~~l~~li~~cl~~dp~~Rp--t~~evl~~L~~~~~~~  361 (386)
                      .-...     +--|   .+    ........+-+++..+|..+|++|.  .+.+..+.++.+++..
T Consensus       249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~  314 (732)
T KOG4250|consen  249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK  314 (732)
T ss_pred             eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence            00000     0001   01    1222335577888899999999999  8888888888877653

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-37  Score=278.48  Aligned_cols=237  Identities=20%  Similarity=0.234  Sum_probs=182.9

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEECCCCCh------hHHHHHHHHH-HcCCCCcccccccceeeCCeEEEEEEeecC
Q 016588           89 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT------QEFIDEVCFL-ASIQHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      +.||.|+||.||+|... +++.||+|.......      ..+..|..++ ...+|+|++++++++..++..|+|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56899999999999964 588999998654321      1233444443 445899999999999999999999999999


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  240 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~  240 (386)
                      ++|..++.     ....+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++.....     
T Consensus        82 ~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----  149 (260)
T cd05611          82 GDCASLIK-----TLGGLPEDWAKQYIAEVVLGVEDLHQ--RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----  149 (260)
T ss_pred             CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence            99998883     23467888999999999999999998  6799999999999999999999999999875432     


Q ss_pred             CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhccc
Q 016588          241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  320 (386)
Q Consensus       241 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (386)
                       .....++..|++||...+..++.++||||||+++|||++|..||.....   ...........          ......
T Consensus       150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~----------~~~~~~  215 (260)
T cd05611         150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---DAVFDNILSRR----------INWPEE  215 (260)
T ss_pred             -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcc----------cCCCCc
Confidence             1233466779999999888889999999999999999999999975432   11111111000          000011


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 016588          321 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVV  351 (386)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl  351 (386)
                      ....+++++.+++.+||+.+|++|||+.++.
T Consensus       216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~  246 (260)
T cd05611         216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQ  246 (260)
T ss_pred             ccccCCHHHHHHHHHHccCCHHHccCCCcHH
Confidence            1223456789999999999999999775443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=8.6e-37  Score=284.05  Aligned_cols=241  Identities=27%  Similarity=0.393  Sum_probs=188.4

Q ss_pred             CCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC------hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           85 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      |...+.||+|+||.||+|... ++..|++|......      ...+.+|+++++.++|||++++++++.+.+..|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            556678999999999999954 58899999854221      23577899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +.+ ++.+++..    ....+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++.....  
T Consensus       103 ~~~-~l~~~l~~----~~~~l~~~~~~~~~~qi~~al~~LH~--~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--  173 (313)
T cd06633         103 CLG-SASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHS--HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--  173 (313)
T ss_pred             CCC-CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence            964 66665532    23458899999999999999999998  7799999999999999999999999998764322  


Q ss_pred             CCCCCccccCcccccchhhhc---ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc
Q 016588          238 VAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                          .....++..|+|||.+.   ...++.++|||||||++|||++|..||.......  .... .....         .
T Consensus       174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~--~~~~-~~~~~---------~  237 (313)
T cd06633         174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYH-IAQND---------S  237 (313)
T ss_pred             ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH--HHHH-HHhcC---------C
Confidence                22345677899999974   4568889999999999999999999987644211  1111 00000         0


Q ss_pred             hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      +   .......+..+.+++.+||+.+|.+||++.+++.+
T Consensus       238 ~---~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         238 P---TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             C---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0   01112234568999999999999999999999976

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-37  Score=279.99  Aligned_cols=260  Identities=25%  Similarity=0.341  Sum_probs=191.5

Q ss_pred             CCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC----hhHHHHHHHHHHcCC-CCcccccccceeeCCeEEEEEEee
Q 016588           85 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      |++.+.||+|++|+||+|... ++..|++|......    .....+|+..++.++ |+|++++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            566789999999999999975 47889999854332    223457889999998 999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                       +++|.+.+...   ....+++..+..++.|++.+|.|||+  ++++|+||+|+||++++++.++|+|||++....... 
T Consensus        81 -~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~--~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-  153 (283)
T cd07830          81 -EGNLYQLMKDR---KGKPFSESVIRSIIYQILQGLAHIHK--HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-  153 (283)
T ss_pred             -CCCHHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence             77888777432   12467899999999999999999998  779999999999999999999999999987654321 


Q ss_pred             CCCCccccCcccccchhhhc-ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhH-HHHHHhhhc--c---cchhh
Q 016588          239 AGPSSQVTADEIFLASEVKE-FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDL-VELVQNSRD--F---SNLLK  311 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~--~---~~~~~  311 (386)
                        ......++..|+|||.+. ...++.++|+||||+++|||++|+.||........... .........  +   .....
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         154 --PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             --CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence              122345677899999875 34578999999999999999999999876543211100 000000000  0   00000


Q ss_pred             hcchhh-------cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          312 ILDERL-------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       312 ~~~~~~-------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ..+...       ........+.++.+++.+||+.||++|||++|++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            000000       000011114678999999999999999999999864

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=5.8e-37  Score=284.56  Aligned_cols=247  Identities=27%  Similarity=0.369  Sum_probs=191.6

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      .|+..+.||.|+||.||+|... ++..+++|.....      ...++.+|+++++.++|+|++++++++...+..++|+|
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            3566788999999999999964 5788999975421      12357789999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      |+. |++.+.+..    ....+++..+..++.|++.||.|||+  .+++||||+|+||+++.++.++|+|||++..... 
T Consensus        96 ~~~-~~l~~~~~~----~~~~l~~~~~~~~~~~l~~~l~~LH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-  167 (308)
T cd06634          96 YCL-GSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (308)
T ss_pred             ccC-CCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHhEEECCCCcEEECCcccceeecC-
Confidence            996 577665532    23457888999999999999999998  7799999999999999999999999999876532 


Q ss_pred             CCCCCCccccCcccccchhhhc---ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhc
Q 016588          237 DVAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  313 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (386)
                           .....++..|+|||.+.   ...++.++|||||||++|||++|..||......  ........            
T Consensus       168 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~------------  228 (308)
T cd06634         168 -----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQ------------  228 (308)
T ss_pred             -----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--HHHHHHhh------------
Confidence                 12345677899999874   356788999999999999999999998654321  11111100            


Q ss_pred             chhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhh
Q 016588          314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  358 (386)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~  358 (386)
                       ...........+..+.+++.+||+.+|++||++++++++.....
T Consensus       229 -~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         229 -NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             -cCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence             00000112234566899999999999999999999998754443

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=5.8e-37  Score=282.90  Aligned_cols=251  Identities=19%  Similarity=0.315  Sum_probs=189.4

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCC-CcEEEEEECCCC----ChhHHHHHHHHHHcC-CCCcccccccceeeCCeEEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGA----PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~----~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      .++|+..+.||+|+||.||+|..+. ++.||+|.....    ...++..|+.++... .|+||+++++++......|++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            3567888999999999999999765 889999986533    223456677766666 5999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+.+ ++..+...    ....+++..+..++.|++.||.|||+. ++|+||||+|+||+++.++.+||+|||++.....
T Consensus        94 e~~~~-~l~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          94 ELMST-CLDKLLKR----IQGPIPEDILGKMTVAIVKALHYLKEK-HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             eccCc-CHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhh-CCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            99854 66555532    234688889999999999999999962 4799999999999999999999999999876543


Q ss_pred             CCCCCCCccccCcccccchhhhcccC----CCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhh
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRR----FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK  311 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (386)
                      ...   .....++..|+|||.+.+..    ++.++||||||+++|||++|+.||...... .+.+.......        
T Consensus       168 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~--------  235 (296)
T cd06618         168 SKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLTKILQEE--------  235 (296)
T ss_pred             CCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHHHHhcCC--------
Confidence            221   12234667799999987554    788999999999999999999998653221 11111100000        


Q ss_pred             hcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          312 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                        .+..  ......+.++.+++.+||+.||.+|||+++++++-
T Consensus       236 --~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         236 --PPSL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             --CCCC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence              0000  11112346789999999999999999999999773

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=9.4e-37  Score=280.62  Aligned_cols=249  Identities=22%  Similarity=0.285  Sum_probs=192.9

Q ss_pred             CCCcCCeecccCceEEEEEEe----CCCcEEEEEECCCC-------ChhHHHHHHHHHHcC-CCCcccccccceeeCCeE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLL----QDGMLVAIKKRPGA-------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQ  151 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~-------~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  151 (386)
                      +|++.+.||.|+||.||.+..    .++..||+|.....       ..+.+.+|+.+++.+ +|+||+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            467789999999999999985    35789999976432       234577899999999 699999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      |+|+||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+++||||+|+|||++.++.++|+|||++.
T Consensus        81 ~lv~e~~~~~~L~~~l~-----~~~~l~~~~~~~~~~qi~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          81 HLILDYINGGELFTHLS-----QRERFKEQEVQIYSGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             EEEEecCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence            99999999999998884     23457888889999999999999998  779999999999999999999999999987


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhccc--CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccch
Q 016588          232 FLGRTDVAGPSSQVTADEIFLASEVKEFR--RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL  309 (386)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  309 (386)
                      ....... .......++..|+|||.+...  .++.++||||||+++|+|++|..||......  ............    
T Consensus       154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~----  226 (290)
T cd05613         154 EFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILK----  226 (290)
T ss_pred             ecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhc----
Confidence            6543221 122234577889999998653  4678999999999999999999998743221  111111111100    


Q ss_pred             hhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016588          310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  353 (386)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~~  353 (386)
                           .  ....+...+..+.+++.+||+.||++||     ++++++++
T Consensus       227 -----~--~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         227 -----S--EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             -----c--CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence                 0  0112233456789999999999999997     67777665

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=9.6e-37  Score=280.28  Aligned_cols=252  Identities=22%  Similarity=0.267  Sum_probs=194.4

Q ss_pred             CCCcCCeecccCceEEEEEEeC----CCcEEEEEECCCC-------ChhHHHHHHHHHHcC-CCCcccccccceeeCCeE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGA-------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQ  151 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-------~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  151 (386)
                      +|+..+.||+|+||.||++...    ++..+|+|.....       ..+.+.+|+.++..+ +|||++++++.+..++..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4677889999999999998842    4678999975422       234577899999999 699999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      ++||||+.+++|.+++.     ....+++..+..++.|++.||.|||+  .+++||||+|+||+++.++.++|+|||++.
T Consensus        81 ~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~ql~~~l~~lH~--~~~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          81 HLILDYVNGGELFTHLY-----QREHFTESEVRVYIAEIVLALDHLHQ--LGIIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             EEEEecCCCCcHHHHHh-----hcCCcCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence            99999999999988873     23457888899999999999999998  779999999999999999999999999987


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhcccC--CCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccch
Q 016588          232 FLGRTDVAGPSSQVTADEIFLASEVKEFRR--FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL  309 (386)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  309 (386)
                      ....... .......++..|++||...+..  .+.++|+||||+++|||++|..||........  ..+.......    
T Consensus       154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~----  226 (288)
T cd05583         154 EFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILK----  226 (288)
T ss_pred             ccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHc----
Confidence            6543221 1122345677899999987654  78899999999999999999999864332111  1111111000    


Q ss_pred             hhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHH
Q 016588          310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  356 (386)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~  356 (386)
                           .  ....+...+..+.+++.+||+.||++|||+.++.+.|+-
T Consensus       227 -----~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         227 -----S--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             -----c--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                 0  012222344668999999999999999998877766544

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.6e-36  Score=282.27  Aligned_cols=258  Identities=19%  Similarity=0.202  Sum_probs=187.6

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCCCc
Q 016588           89 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV  163 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  163 (386)
                      +.+|.|+++.|+++.. ++..||+|+....     ....+.+|+.+++.++|+||+++++++...+..+++|||+++++|
T Consensus         8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l   86 (314)
T cd08216           8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC   86 (314)
T ss_pred             HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence            3344455555555544 5889999985432     234688999999999999999999999999999999999999999


Q ss_pred             cccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC-----
Q 016588          164 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV-----  238 (386)
Q Consensus       164 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~-----  238 (386)
                      .+++...   ....+++.....++.|++.||.|||+  .+|+||||||+||+++.++.++++|||.+........     
T Consensus        87 ~~~l~~~---~~~~~~~~~~~~~~~~l~~~L~~LH~--~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          87 EDLLKTH---FPEGLPELAIAFILKDVLNALDYIHS--KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             HHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            9888532   23457888889999999999999998  6799999999999999999999999998765532111     


Q ss_pred             CCCCccccCcccccchhhhcc--cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc-----------
Q 016588          239 AGPSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD-----------  305 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-----------  305 (386)
                      ........++..|+|||++..  ..++.++|+|||||++|||++|..||......  ....+.......           
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  239 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYPLY  239 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchhhh
Confidence            111223446677999999875  35889999999999999999999999865432  111111110000           


Q ss_pred             ccchhh----hcch----hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          306 FSNLLK----ILDE----RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       306 ~~~~~~----~~~~----~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                      ......    ..++    ............++.+++.+||+.||++|||+++++++-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p  296 (314)
T cd08216         240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS  296 (314)
T ss_pred             cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence            000000    0000    001122234456789999999999999999999999763

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.7e-37  Score=288.74  Aligned_cols=260  Identities=19%  Similarity=0.322  Sum_probs=191.0

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeC------C
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN------N  149 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  149 (386)
                      .++|...+.||+|+||.||+|... ++..||+|+....     ....+.+|+.+++.++||||+++++++...      .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            367888999999999999999954 5889999985432     234577899999999999999999988654      3


Q ss_pred             eEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 016588          150 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  229 (386)
Q Consensus       150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl  229 (386)
                      ..++|+||+.. +|..+.       ...+++..+..++.|++.||.|||+  .+++||||||+||+++.++.++|+|||+
T Consensus        94 ~~~lv~e~~~~-~l~~~~-------~~~~~~~~~~~~~~qi~~aL~~LH~--~~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM-------GHPLSEDKVQYLVYQMLCGLKYIHS--AGIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             eEEEEeccccc-CHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence            46899999864 555443       2357888899999999999999998  6799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhh-ccc
Q 016588          230 RNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR-DFS  307 (386)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~  307 (386)
                      ++.....     .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......  ..+........ ...
T Consensus       164 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~  236 (342)
T cd07879         164 ARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--DQLTQILKVTGVPGP  236 (342)
T ss_pred             CcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCH
Confidence            8764321     223456778999999876 46889999999999999999999999864421  11111110000 000


Q ss_pred             ch---------hhhcc--hhh-c---ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH--HHHhh
Q 016588          308 NL---------LKILD--ERL-W---STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE--LDRTL  358 (386)
Q Consensus       308 ~~---------~~~~~--~~~-~---~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~--L~~~~  358 (386)
                      ..         .....  +.. .   ....+..+.++.+++.+||+.||++|||+.+++.+  ++...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence            00         00000  000 0   00001234568899999999999999999999966  65554

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.5e-37  Score=288.67  Aligned_cols=262  Identities=21%  Similarity=0.313  Sum_probs=194.3

Q ss_pred             HHHHHHhcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeC-
Q 016588           76 EELSLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN-  148 (386)
Q Consensus        76 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~-  148 (386)
                      .++....++|...+.||+|+||.||+|.. .++..||+|+.....     .+.+.+|+.+++.++||||+++++++... 
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            44555678999999999999999999984 468899999865321     34577899999999999999999987543 


Q ss_pred             -----CeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceE
Q 016588          149 -----NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAK  223 (386)
Q Consensus       149 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~k  223 (386)
                           +..|++++++ +++|.+++.      ...+++..+..++.|++.||.|||+  .+|+||||||+||++++++.+|
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVK------CQKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChHHEEEcCCCCEE
Confidence                 3467888876 678877662      2357889999999999999999998  7799999999999999999999


Q ss_pred             EcccccccccCCCCCCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHh
Q 016588          224 VADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN  302 (386)
Q Consensus       224 l~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~  302 (386)
                      |+|||++......     .....++..|+|||...+ ..++.++|||||||++|||++|..||.......  .+......
T Consensus       161 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~  233 (345)
T cd07877         161 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILRL  233 (345)
T ss_pred             Eeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHH
Confidence            9999998765321     223456778999998866 467899999999999999999999987544211  11111110


Q ss_pred             hh-cccchhh------------hcchhh---cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          303 SR-DFSNLLK------------ILDERL---WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       303 ~~-~~~~~~~------------~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .. .......            .+....   ........+.++.+++.+||+.||.+|||+.+++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            00 0000000            000000   000001234568999999999999999999999977

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=6.8e-37  Score=284.12  Aligned_cols=265  Identities=22%  Similarity=0.292  Sum_probs=190.3

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeC-------
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN-------  148 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-------  148 (386)
                      .++|+..+.||+|+||.||+|..+ +++.+++|.....     ....+.+|+++++.++||||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468899999999999999999965 5789999974322     223567899999999999999999987543       


Q ss_pred             -CeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccc
Q 016588          149 -NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA  227 (386)
Q Consensus       149 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DF  227 (386)
                       ...++|+||+.. ++...+..    ....+++..+..++.|+++||.|||+  .+++|+||||+||++++++.++|+||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~----~~~~~~~~~~~~i~~~l~~al~~lH~--~~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN----PSVKLTESQIKCYMLQLLEGINYLHE--NHILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEECcC
Confidence             356999999875 55555532    23468899999999999999999998  67999999999999999999999999


Q ss_pred             ccccccCCCCCCC---------CCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHH
Q 016588          228 GLRNFLGRTDVAG---------PSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLV  297 (386)
Q Consensus       228 gl~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~  297 (386)
                      |++..........         ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+..........
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~  239 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI  239 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            9987654322111         11223457789999987654 5789999999999999999999999765432211111


Q ss_pred             HHHHhhhcc------cchhhhcchhhcccC-------CHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          298 ELVQNSRDF------SNLLKILDERLWSTF-------TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       298 ~~~~~~~~~------~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .........      .......+.......       .....+.+.+++.+||+.||++|||+.+++.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            100000000      000000000000000       01122568899999999999999999999864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-36  Score=277.93  Aligned_cols=258  Identities=24%  Similarity=0.322  Sum_probs=190.8

Q ss_pred             CCcCCeecccCceEEEEEEeCC-CcEEEEEECCCC-----ChhHHHHHHHHHHcC---CCCcccccccceeeCCe-----
Q 016588           85 FSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGA-----PTQEFIDEVCFLASI---QHRNLVTLLGYCQENNL-----  150 (386)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~-----~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~-----  150 (386)
                      |+..+.||+|+||.||+|..+. +..+|+|.....     ....+.+|+.+++++   +|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5667899999999999999764 889999986422     123466777776655   69999999999987766     


Q ss_pred             EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  230 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~  230 (386)
                      .+++|||+.+ +|.+++...   ....+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~---~~~~l~~~~~~~~~~~i~~al~~LH~--~~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKC---PKPGLPPETIKDLMRQLLRGVDFLHS--HRIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eEEEehhccc-CHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCChhhEEEccCCCEEEeccCcc
Confidence            8999999975 787776422   12358899999999999999999999  67999999999999999999999999998


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcc----
Q 016588          231 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF----  306 (386)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----  306 (386)
                      ........   .....++..|+|||.+.+..++.++|+|||||++|||++|..||......+  ............    
T Consensus       155 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  229 (287)
T cd07838         155 RIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEE  229 (287)
T ss_pred             eeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHh
Confidence            77643221   122346778999999998899999999999999999999998887644321  111111110000    


Q ss_pred             -cch----hhhcchhh---cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          307 -SNL----LKILDERL---WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       307 -~~~----~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                       ...    ........   ........+..+.+++.+||+.||.+||++.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence             000    00000000   011122345678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.1e-36  Score=286.70  Aligned_cols=260  Identities=18%  Similarity=0.271  Sum_probs=189.1

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC---ChhHHHHHHHHHHcCCCCcccccccceeeC----------
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQEN----------  148 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----------  148 (386)
                      .+|...+.||.|+||.||+|... ++..|++|.....   ..+.+.+|+++++.++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            67888999999999999999954 5889999975432   345678899999999999999999876543          


Q ss_pred             ----CeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-CCceE
Q 016588          149 ----NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAK  223 (386)
Q Consensus       149 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~-~~~~k  223 (386)
                          ...|+|+||+. ++|..++.      ...+++..+..++.|++.||.|||+  .+++||||||+||+++. ++.++
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~------~~~l~~~~~~~~~~qi~~aL~~LH~--~givH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLE------QGPLSEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEcCCCceEE
Confidence                35789999997 47776662      2357889999999999999999998  67999999999999974 56789


Q ss_pred             EcccccccccCCCCC-CCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHH
Q 016588          224 VADAGLRNFLGRTDV-AGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ  301 (386)
Q Consensus       224 l~DFgl~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~  301 (386)
                      ++|||++........ ........++..|+|||.+.. ..++.++|||||||++|||++|..||....+..  .......
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--~~~~~~~  233 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE--QMQLILE  233 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH
Confidence            999999876543211 111123346778999998654 567889999999999999999999997654311  1111111


Q ss_pred             hhhcc-----cchhhhcchh----hc------ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          302 NSRDF-----SNLLKILDER----LW------STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       302 ~~~~~-----~~~~~~~~~~----~~------~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ..+..     ..........    .+      .......+.++.+++.+||+.||++|||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            00000     0000000000    00      00111234678999999999999999999999965

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=6.7e-37  Score=286.52  Aligned_cols=260  Identities=21%  Similarity=0.288  Sum_probs=192.7

Q ss_pred             HHhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC-----CChhHHHHHHHHHHcCCCCcccccccceee-CCeEE
Q 016588           80 LATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQE-NNLQF  152 (386)
Q Consensus        80 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~  152 (386)
                      ..+++|+..+.||.|+||.||++... ++..||+|+...     .....+.+|+++++.++|||++++.+++.. .+..+
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            35678999999999999999999854 688999997532     224567889999999999999999998865 56789


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~  232 (386)
                      +++||+ +++|..++.      ...++......++.|++.||.|||+  .+++||||+|+||+++.++.++|+|||++..
T Consensus        87 lv~e~~-~~~L~~~~~------~~~~~~~~~~~~~~ql~~aL~~LH~--~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          87 FVTELL-GTDLHRLLT------SRPLEKQFIQYFLYQILRGLKYVHS--AGVVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             EEeehh-ccCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence            999998 457877663      2346777888899999999999999  7799999999999999999999999999875


Q ss_pred             cCCCCCCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHH-HHHHhh-------
Q 016588          233 LGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLV-ELVQNS-------  303 (386)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~-~~~~~~-------  303 (386)
                      ....     .....++..|+|||.+.+ ..++.++|||||||++|||++|..||............ +.....       
T Consensus       158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (328)
T cd07856         158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT  232 (328)
T ss_pred             cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            4321     123456778999998765 56899999999999999999999999765431111000 000000       


Q ss_pred             hcccchhhhcch-hhccc-----CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          304 RDFSNLLKILDE-RLWST-----FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       304 ~~~~~~~~~~~~-~~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .......+.... .....     .....+.++.+++.+||+.+|++|||+++++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000000000000 00000     111234678999999999999999999999866

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-36  Score=276.50  Aligned_cols=258  Identities=24%  Similarity=0.325  Sum_probs=193.7

Q ss_pred             CCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           85 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      |+..+.||+|++|.||+|... +++.+++|.....     ..+.+..|+.+++.++|+|++++++++...+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456688999999999999965 4889999975432     2346788999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      . ++|.+++...    ...+++..+..++.+++.||.|||+  ++|+||||+|+||++++++.++|+|||++........
T Consensus        81 ~-~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          81 D-MDLKKYLDKR----PGPLSPNLIKSIMYQLLRGLAYCHS--HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             C-cCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            7 4888888422    1468899999999999999999999  7799999999999999999999999999877643221


Q ss_pred             CCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhh--ccc---chhhh
Q 016588          239 AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR--DFS---NLLKI  312 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~---~~~~~  312 (386)
                        .......+..|+|||.+.+. .++.++|||||||++||+++|..||.......  .+........  ...   .....
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
T cd07829         154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID--QLFKIFQILGTPTEESWPGVTKL  229 (282)
T ss_pred             --ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--HHHHHHHHhCCCcHHHHHhhccc
Confidence              12223446679999998766 78999999999999999999999987644211  1111110000  000   00000


Q ss_pred             ---------cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          313 ---------LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       313 ---------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                               ..........+..+..+.+++.+||+.||++||++++++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence                     00000000111225679999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2e-36  Score=273.81  Aligned_cols=248  Identities=18%  Similarity=0.272  Sum_probs=191.0

Q ss_pred             CCCcCCeecccCceEEEEEEeCC-CcEEEEEECCC--------CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPG--------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      +|.+.+.||+|+||.||++.... +..+++|....        ....++..|..+++.++|||++++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47788999999999999998543 34444444221        1223466788999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      +||+++++|.+++.... .....+++..+..++.|++.||.|||+  .+++|+||+|+||+++. +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELK-HTGKTLSENQVCEWFIQLLLGVHYMHQ--RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHh-hcccccCHHHHHHHHHHHHHHHHHHHH--cCccccCCChhheEeec-CCEeecccCceeecC
Confidence            99999999988774321 134568899999999999999999998  77999999999999975 569999999987653


Q ss_pred             CCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                      ....  ......++..|+|||...+..++.++|+||||+++|+|++|..||.....      .......         ..
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~---------~~  219 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRI---------VE  219 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHH---------Hc
Confidence            3211  12234567789999999888889999999999999999999999864321      1111110         00


Q ss_pred             hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                       ......+...+.++.+++.+||+.+|++||++.+++++
T Consensus       220 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         220 -GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             -CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence             11112334556789999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.7e-36  Score=284.37  Aligned_cols=260  Identities=22%  Similarity=0.271  Sum_probs=188.8

Q ss_pred             CCCcCCeecccCceEEEEEEeC-C--CcEEEEEECCCC-----ChhHHHHHHHHHHcC-CCCcccccccceee----CCe
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-D--GMLVAIKKRPGA-----PTQEFIDEVCFLASI-QHRNLVTLLGYCQE----NNL  150 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~-----~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~  150 (386)
                      +|+..+.||+|+||.||++... .  +..||+|.....     ..+.+.+|+.+++++ +||||+++++++..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4677889999999999999954 3  678999975432     234578899999999 59999999987532    245


Q ss_pred             EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  230 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~  230 (386)
                      .|+++||+. ++|..++.     ....+++..+..++.|++.||.|||+  ++++||||||+||+++.++.++|+|||++
T Consensus        81 ~~~~~e~~~-~~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          81 LYLYEELME-ADLHQIIR-----SGQPLTDAHFQSFIYQILCGLKYIHS--ANVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             EEEEEeccc-CCHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            788999886 57877773     34568899999999999999999998  77999999999999999999999999999


Q ss_pred             cccCCCCCC--CCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhh--hc
Q 016588          231 NFLGRTDVA--GPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS--RD  305 (386)
Q Consensus       231 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~  305 (386)
                      +........  .......++..|+|||...+ ..++.++|+||+||++|++++|..||.......  .+...+...  ..
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~  230 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD--QLNQILQVLGTPD  230 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH--HHHHHHHHhCCCC
Confidence            865432211  11233467888999998765 468999999999999999999999987644211  000000000  00


Q ss_pred             ccchhhhcc-----------h---hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          306 FSNLLKILD-----------E---RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       306 ~~~~~~~~~-----------~---~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .........           .   ..........+..+.+++.+||+.||++|||+.+++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            000000000           0   00000111124678999999999999999999999855

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-37  Score=248.02  Aligned_cols=259  Identities=22%  Similarity=0.318  Sum_probs=199.5

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECC-----CCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP-----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      +|...+.||+|.||+||+|+.+ +++.||+|.+.     ........+|+.+|+.++|.|||++++.....+.+-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4556788999999999999954 58899999733     33456789999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      |.. +|..+..    ...+.++......++.|++.||.|+|+  +++.||||||+|.|++.+|+.|++|||+++-++-..
T Consensus        83 cdq-dlkkyfd----slng~~d~~~~rsfmlqllrgl~fchs--hnvlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   83 CDQ-DLKKYFD----SLNGDLDPEIVRSFMLQLLRGLGFCHS--HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             hhH-HHHHHHH----hcCCcCCHHHHHHHHHHHHhhhhhhhh--hhhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence            976 7776663    245678889999999999999999999  569999999999999999999999999998775422


Q ss_pred             CCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhh-----hcccchh
Q 016588          238 VAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNS-----RDFSNLL  310 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~  310 (386)
                        ...+....|.+|.+|.++-+ +-|+.+.|+||.||++.|+.. |.+.|.+.+..  +++...++..     ..+..+.
T Consensus       156 --rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd--dqlkrif~~lg~p~ed~wps~t  231 (292)
T KOG0662|consen  156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEDQWPSMT  231 (292)
T ss_pred             --EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH--HHHHHHHHHhCCCccccCCccc
Confidence              22344567889999999876 468999999999999999998 55555554432  2222222211     2223333


Q ss_pred             hhcchhhcccCC---------HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          311 KILDERLWSTFT---------NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       311 ~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      +..|...++.++         +.....-++++.+.+.-+|.+|.+++..+++
T Consensus       232 ~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  232 KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            444433333332         2333456789999999999999999998875

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=308.85  Aligned_cols=256  Identities=27%  Similarity=0.300  Sum_probs=206.0

Q ss_pred             HHHHHHHhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC------CChhHHHHHHHHHHcCCCCcccccccceee
Q 016588           75 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQE  147 (386)
Q Consensus        75 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  147 (386)
                      ..++....++|.+.++||+|+||.|..++++ +++.+|+|++.+      ....-|..|-.+|..-+.+-|+.++-.|++
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            4566677889999999999999999999975 488999997543      345568899999999999999999999999


Q ss_pred             CCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccc
Q 016588          148 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA  227 (386)
Q Consensus       148 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DF  227 (386)
                      .+.+|+||||++||+|-.++.     ....+++..+..++..|+.||.-||+  -|+|||||||+|||||..|++||+||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlS-----k~~~~pE~~ArFY~aEiVlAldslH~--mgyVHRDiKPDNvLld~~GHikLADF  219 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLS-----KFDRLPEDWARFYTAEIVLALDSLHS--MGYVHRDIKPDNVLLDKSGHIKLADF  219 (1317)
T ss_pred             ccceEEEEecccCchHHHHHh-----hcCCChHHHHHHHHHHHHHHHHHHHh--ccceeccCCcceeEecccCcEeeccc
Confidence            999999999999999998884     23368899999999999999999999  56999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCccccCcccccchhhhcc-----cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHh
Q 016588          228 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN  302 (386)
Q Consensus       228 gl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~  302 (386)
                      |.+-.+..... -.....+|||.|.+||++..     +.|+..+|+||+||++|||+.|..||....      +.+.-  
T Consensus       220 GsClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY--  290 (1317)
T KOG0612|consen  220 GSCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETY--  290 (1317)
T ss_pred             hhHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHH--
Confidence            99877754322 22345689999999999862     578999999999999999999999998633      22111  


Q ss_pred             hhcccchhhhcchhhcccCC--HHHHHHHHHHHhHccCCCCCCCCC---HHHHHHHH
Q 016588          303 SRDFSNLLKILDERLWSTFT--NEGMEEFIQLIVRCLDPSSERRPS---MSDVVTEL  354 (386)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~Rpt---~~evl~~L  354 (386)
                             .++.+..-...||  ...+++..+||.+.++ +|+.|..   ++++-.|.
T Consensus       291 -------~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp  339 (1317)
T KOG0612|consen  291 -------GKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP  339 (1317)
T ss_pred             -------HHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence                   1111111111233  2356778999998775 6778877   88887663

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.4e-37  Score=287.38  Aligned_cols=256  Identities=20%  Similarity=0.314  Sum_probs=192.3

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCCe-----
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNL-----  150 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  150 (386)
                      .++|+..+.||+|++|.||+|... ++..||+|.....     ....+.+|+.+++.++|+|++++.+++...+.     
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            567888999999999999999965 5789999986432     22456789999999999999999998766544     


Q ss_pred             -EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 016588          151 -QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  229 (386)
Q Consensus       151 -~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl  229 (386)
                       .++|+||+ +++|.+++.      ...+++..+..++.|++.||.|||+  .||+||||||+||+++.++.++|+|||+
T Consensus        94 ~~~lv~e~~-~~~L~~~~~------~~~l~~~~~~~~~~ql~~aL~~LH~--~gi~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          94 DVYLVTHLM-GADLNNIVK------CQKLSDDHIQFLVYQILRGLKYIHS--AGIIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             cEEEEEecC-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEccccc
Confidence             89999998 568887773      2468899999999999999999998  7799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc-cc
Q 016588          230 RNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD-FS  307 (386)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~  307 (386)
                      +......     .....++..|+|||...+ ..++.++|||||||++||+++|..||.......  .+......... .+
T Consensus       165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~--~~~~i~~~~~~~~~  237 (343)
T cd07851         165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID--QLKRIMNLVGTPDE  237 (343)
T ss_pred             ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHhcCCCCH
Confidence            8865432     233456778999999865 367899999999999999999999997644311  11111110000 00


Q ss_pred             chh---------hhcc---hhhcc---cCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          308 NLL---------KILD---ERLWS---TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       308 ~~~---------~~~~---~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ...         ....   .....   ......++++.+++.+||+.||++|||+.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            000         0000   00000   0011125678999999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-36  Score=270.46  Aligned_cols=233  Identities=24%  Similarity=0.309  Sum_probs=188.8

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCCCc
Q 016588           91 IGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV  163 (386)
Q Consensus        91 lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  163 (386)
                      ||+|+||.||++... ++..+++|.....      ....+..|+.+++.++|+|++++++.+..++..+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999965 4889999975433      234688899999999999999999999999999999999999999


Q ss_pred             cccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCc
Q 016588          164 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS  243 (386)
Q Consensus       164 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~  243 (386)
                      .+++.     ....+++.....++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++.......  ....
T Consensus        81 ~~~l~-----~~~~l~~~~~~~~~~qi~~~l~~lh~--~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~  151 (250)
T cd05123          81 FSHLS-----KEGRFSEERARFYAAEIVLALEYLHS--LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTN  151 (250)
T ss_pred             HHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcceEEEcCCCcEEEeecCcceecccCC--Cccc
Confidence            98884     23357899999999999999999998  779999999999999999999999999987764321  1223


Q ss_pred             cccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCH
Q 016588          244 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN  323 (386)
Q Consensus       244 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (386)
                      ...++..|++||...+..++.++|+||||+++|++++|..||...+.   .........              .....+.
T Consensus       152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~--------------~~~~~~~  214 (250)
T cd05123         152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKILK--------------DPLRFPE  214 (250)
T ss_pred             CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHhc--------------CCCCCCC
Confidence            44567789999999888889999999999999999999999976442   111111110              0112233


Q ss_pred             HHHHHHHHHHhHccCCCCCCCCCHHH
Q 016588          324 EGMEEFIQLIVRCLDPSSERRPSMSD  349 (386)
Q Consensus       324 ~~~~~l~~li~~cl~~dp~~Rpt~~e  349 (386)
                      ..++.+.+++.+||..||++|||+.+
T Consensus       215 ~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         215 FLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            33567899999999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-36  Score=285.31  Aligned_cols=257  Identities=20%  Similarity=0.332  Sum_probs=191.6

Q ss_pred             HhcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCC-----
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN-----  149 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  149 (386)
                      ..++|+..+.||+|+||.||++.. .++..||+|.....     ....+.+|+.+++.++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            356799999999999999999984 46889999986432     1245778999999999999999999886543     


Q ss_pred             -eEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccc
Q 016588          150 -LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  228 (386)
Q Consensus       150 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFg  228 (386)
                       ..++||||+ +++|..++.      ...+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~--~gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMK------HEKLSEDRIQFLVYQMLKGLKYIHA--AGIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeecc
Confidence             458999998 668877763      2457899999999999999999998  779999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc-c
Q 016588          229 LRNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD-F  306 (386)
Q Consensus       229 l~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~  306 (386)
                      ++......     .....++..|+|||.+.+ ..++.++|+||||+++|++++|..||......  ............ .
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~  236 (343)
T cd07880         164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL--DQLMEIMKVTGTPS  236 (343)
T ss_pred             cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCC
Confidence            98765332     123356778999999875 45789999999999999999999999864421  111111110000 0


Q ss_pred             cchhhhcc--------hhh-------cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          307 SNLLKILD--------ERL-------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       307 ~~~~~~~~--------~~~-------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ..+...+.        ..+       ........+.++.+++.+|++.||++|||+.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000000        000       001112234568999999999999999999999954

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=9.7e-37  Score=304.60  Aligned_cols=251  Identities=24%  Similarity=0.371  Sum_probs=183.4

Q ss_pred             HHHhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceee------
Q 016588           79 SLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQE------  147 (386)
Q Consensus        79 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~------  147 (386)
                      ..-..+|+..++||+||||.||+++.+ +|+.+|||+++-..    ...+.+|+..|.+|+|||||+++..+..      
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            445567888999999999999999965 79999999866442    3357889999999999999999854300      


Q ss_pred             ------------------------------------------------------------------------C-------
Q 016588          148 ------------------------------------------------------------------------N-------  148 (386)
Q Consensus       148 ------------------------------------------------------------------------~-------  148 (386)
                                                                                              .       
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                    0       


Q ss_pred             ----------------------------------CeEEEEEEeecCCCccccccCCCcCCCCCC--CHHHHHHHHHHHHH
Q 016588          149 ----------------------------------NLQFLIYEYIPNGSVSIHLYGPSQVSRQKL--EFKHRLSIALGAAK  192 (386)
Q Consensus       149 ----------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l--~~~~~~~i~~~i~~  192 (386)
                                                        ..+|+-||||+..++.+++...      .+  .....++++.+|++
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N------~~~~~~d~~wrLFreIlE  708 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN------HFNSQRDEAWRLFREILE  708 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc------ccchhhHHHHHHHHHHHH
Confidence                                              1246778888776666666321      12  35567899999999


Q ss_pred             HHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC----------------CCCCCCCCccccCcccccchhh
Q 016588          193 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG----------------RTDVAGPSSQVTADEIFLASEV  256 (386)
Q Consensus       193 ~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~----------------~~~~~~~~~~~~~~~~y~aPE~  256 (386)
                      ||.|+|+  .|||||||||.||++|+++.+||+|||+++...                ........+...||..|+|||.
T Consensus       709 GLaYIH~--~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl  786 (1351)
T KOG1035|consen  709 GLAYIHD--QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL  786 (1351)
T ss_pred             HHHHHHh--CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence            9999999  679999999999999999999999999998721                0111223456789999999999


Q ss_pred             hccc---CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHH
Q 016588          257 KEFR---RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLI  333 (386)
Q Consensus       257 ~~~~---~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  333 (386)
                      +.+.   .|+.|+|+||+|+|++||+.-   |..     ..+....+.+... ..+     |.. ..+..+..+.-..+|
T Consensus       787 l~~~~~~~Yn~KiDmYSLGIVlFEM~yP---F~T-----sMERa~iL~~LR~-g~i-----P~~-~~f~~~~~~~e~slI  851 (1351)
T KOG1035|consen  787 LSDTSSNKYNSKIDMYSLGIVLFEMLYP---FGT-----SMERASILTNLRK-GSI-----PEP-ADFFDPEHPEEASLI  851 (1351)
T ss_pred             hcccccccccchhhhHHHHHHHHHHhcc---CCc-----hHHHHHHHHhccc-CCC-----CCC-cccccccchHHHHHH
Confidence            8765   499999999999999999864   332     1111122222111 100     000 112222234457899


Q ss_pred             hHccCCCCCCCCCHHHHHH
Q 016588          334 VRCLDPSSERRPSMSDVVT  352 (386)
Q Consensus       334 ~~cl~~dp~~Rpt~~evl~  352 (386)
                      .+|++.||.+|||+.|+|+
T Consensus       852 ~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  852 RWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHhcCCCccCCCHHHHhh
Confidence            9999999999999999985

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-39  Score=272.02  Aligned_cols=254  Identities=21%  Similarity=0.266  Sum_probs=187.7

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC----ChhHHHHHHHHHHcC-CCCcccccccceeeCCeEEEEEEe
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      +.+....||+|+||+|++-.++ +|+..|||++...    ...+++.|.+...+- +.||||++||.+...+..|+.||+
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL  144 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL  144 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence            4445677999999999999865 5899999985433    234577787765554 789999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      |+- +|+.+..---......+++..+-.|....+.||.||... ..|+|||+||+|||||..|.+||||||++-.+...-
T Consensus       145 Md~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~-lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si  222 (361)
T KOG1006|consen  145 MDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE-LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI  222 (361)
T ss_pred             Hhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH-hhhhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence            964 655433111012345677777778888889999999863 569999999999999999999999999987664321


Q ss_pred             CCCCCccccCcccccchhhhcc--cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          238 VAGPSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                         ..+...|-..|||||.+..  ..|+.+|||||||++|||+.||+.||..+.. ..+++...+...+          +
T Consensus       223 ---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-vfeql~~Vv~gdp----------p  288 (361)
T KOG1006|consen  223 ---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-VFEQLCQVVIGDP----------P  288 (361)
T ss_pred             ---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-HHHHHHHHHcCCC----------C
Confidence               1223345556999999864  3689999999999999999999999998664 1222222221111          1


Q ss_pred             hhc-ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          316 RLW-STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       316 ~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .+. .....+.+..+..++..|+.+|-.+||++.+++++
T Consensus       289 ~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  289 ILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             eecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            110 01112345678999999999999999999999864

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-37  Score=289.12  Aligned_cols=241  Identities=19%  Similarity=0.276  Sum_probs=195.0

Q ss_pred             hcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCCChhHHHHHHHHHHcC-CCCcccccccceeeCCeEEEEEEeec
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIP  159 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  159 (386)
                      ++.|.....+|.|+|+.|-.+.. .+++..++|++... ..+-.+|..++... +|||++++.+.+.+....|+|||++.
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~  399 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD  399 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccc-ccccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence            56788888899999999999884 45888999987665 44455677666555 79999999999999999999999999


Q ss_pred             CCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee-CCCCceEEcccccccccCCCCC
Q 016588          160 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV-DEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       160 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill-~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++-+.+.+..     .... ...+..|+.+++.|+.|||+  +|++||||||+|||+ ++.++++|+|||.++.....  
T Consensus       400 g~ell~ri~~-----~~~~-~~e~~~w~~~lv~Av~~LH~--~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--  469 (612)
T KOG0603|consen  400 GGELLRRIRS-----KPEF-CSEASQWAAELVSAVDYLHE--QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--  469 (612)
T ss_pred             ccHHHHHHHh-----cchh-HHHHHHHHHHHHHHHHHHHh--cCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence            9888776632     2222 25666799999999999999  789999999999999 69999999999999876543  


Q ss_pred             CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                         ....+-|..|.|||+.....|++++||||||++||+|++|+.||...+.+  .++...+                ..
T Consensus       470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i----------------~~  528 (612)
T KOG0603|consen  470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRI----------------QM  528 (612)
T ss_pred             ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhh----------------cC
Confidence               22234566799999999999999999999999999999999999876643  1111111                11


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                      +.+....++..++|+.+||+.||.+||++.++..+-
T Consensus       529 ~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~  564 (612)
T KOG0603|consen  529 PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHP  564 (612)
T ss_pred             CccccccCHHHHHHHHHhccCChhhCcChhhhccCc
Confidence            233456678899999999999999999999998773

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=263.00  Aligned_cols=250  Identities=18%  Similarity=0.249  Sum_probs=195.7

Q ss_pred             HhcCCCcC-CeecccCceEEEEEEeC-CCcEEEEEECCCCChhHHHHHHHHHHcC-CCCcccccccceee----CCeEEE
Q 016588           81 ATKNFSDK-NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQE----NNLQFL  153 (386)
Q Consensus        81 ~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~~~l  153 (386)
                      .+++|++. ++||-|-.|.|..+.++ +++.+|+|.+...  ...++|++.=-.. .|||||.+++++.+    ...+.+
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLi  136 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLI  136 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEe
Confidence            34566655 68999999999999965 5889999986543  4455777754444 69999999998764    467789


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC---CCCceEEcccccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVADAGLR  230 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~---~~~~~kl~DFgl~  230 (386)
                      |||.++||.|...+...   ....+.+..+-.|+.||..|+.|||++  +|.||||||+|+|..   .+..+||+|||+|
T Consensus       137 VmE~meGGeLfsriq~~---g~~afTErea~eI~~qI~~Av~~lH~~--nIAHRDlKpENLLyt~t~~na~lKLtDfGFA  211 (400)
T KOG0604|consen  137 VMECMEGGELFSRIQDR---GDQAFTEREASEIMKQIGLAVRYLHSM--NIAHRDLKPENLLYTTTSPNAPLKLTDFGFA  211 (400)
T ss_pred             eeecccchHHHHHHHHc---ccccchHHHHHHHHHHHHHHHHHHHhc--chhhccCChhheeeecCCCCcceEecccccc
Confidence            99999999999888432   445689999999999999999999994  599999999999996   4557899999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          231 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      +....   .......+-|++|.|||++....|+..+|+||+||++|-|+.|.+||.+........            .+.
T Consensus       212 K~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aisp------------gMk  276 (400)
T KOG0604|consen  212 KETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP------------GMK  276 (400)
T ss_pred             cccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCCh------------hHH
Confidence            97543   233455677899999999999999999999999999999999999998866422110            111


Q ss_pred             hhcchhhcccCC----HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          311 KILDERLWSTFT----NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       311 ~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ..+-.+.+ .|+    ...+++.+++|..+|..+|++|.|++++.++
T Consensus       277 ~rI~~gqy-~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  277 RRIRTGQY-EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             hHhhccCc-cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence            11111111 122    1356789999999999999999999999876

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-37  Score=262.99  Aligned_cols=280  Identities=20%  Similarity=0.312  Sum_probs=203.2

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEEC-----CCCChhHHHHHHHHHHcCCCCcccccccceee--------CC
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKR-----PGAPTQEFIDEVCFLASIQHRNLVTLLGYCQE--------NN  149 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------~~  149 (386)
                      .|.....+|+|.||.||+|..+ .++.||+|+.     +..-.....+|+.+|..++|+|++.++..|..        ..
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            4555678999999999999965 4778899862     23334567899999999999999999998843        24


Q ss_pred             eEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 016588          150 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  229 (386)
Q Consensus       150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl  229 (386)
                      ..|+|+++|+. +|.-.+.+    ....++...+.+++.++..||.|+|.  +.|+|||+|+.|+||+.++.+||+|||+
T Consensus        98 t~ylVf~~ceh-DLaGlLsn----~~vr~sls~Ikk~Mk~Lm~GL~~iHr--~kilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSN----RKVRFSLSEIKKVMKGLMNGLYYIHR--NKILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcC----ccccccHHHHHHHHHHHHHHHHHHHH--hhHHhhcccHhhEEEcCCceEEeecccc
Confidence            58999999987 66666632    23568899999999999999999999  6699999999999999999999999999


Q ss_pred             ccccCCCC--CCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcc
Q 016588          230 RNFLGRTD--VAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF  306 (386)
Q Consensus       230 ~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  306 (386)
                      ++.+...+  .....+....|.+|.+||.+.+ ..|+++.|||+.||++.||+||.+-+++..+.....++..+......
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK  250 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence            97664322  2223445567889999999876 47899999999999999999999888887654444444332111111


Q ss_pred             c--------chhhhcchh-hcc-cC--CHHH------HHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh-h-ccccc
Q 016588          307 S--------NLLKILDER-LWS-TF--TNEG------MEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK-E-MNLTT  366 (386)
Q Consensus       307 ~--------~~~~~~~~~-~~~-~~--~~~~------~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~-~-~~~~~  366 (386)
                      +        .+.+.+... +.. .+  .++.      .++..+|+.+++..||.+|+++.+++.+.--..+- + .++++
T Consensus       251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~pqanl~~  330 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMPQANLQD  330 (376)
T ss_pred             ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcchhhHHH
Confidence            0        111111100 000 00  0011      24688999999999999999999999875433322 1 34444


Q ss_pred             ccCC
Q 016588          367 VMGE  370 (386)
Q Consensus       367 ~~~~  370 (386)
                      ++.+
T Consensus       331 ml~t  334 (376)
T KOG0669|consen  331 MLST  334 (376)
T ss_pred             HHHH
Confidence            4443

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-37  Score=282.42  Aligned_cols=242  Identities=24%  Similarity=0.362  Sum_probs=198.4

Q ss_pred             CCeecccCceEEEEEEeC-CCcEEEEEEC-----CCCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCC
Q 016588           88 KNLIGEGKFGEVYKGLLQ-DGMLVAIKKR-----PGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  161 (386)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  161 (386)
                      .++||+|.||+||-|.++ +|+.||||.+     +....+.+.+|+.||.+++||.||.+...|+..+..++|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            378999999999999965 6999999974     4445577999999999999999999999999999999999999665


Q ss_pred             CccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC---CCceEEcccccccccCCCCC
Q 016588          162 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       162 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~---~~~~kl~DFgl~~~~~~~~~  238 (386)
                      -|...+.    ...+.+++..-..+..||+.||.|||.  ++|+|+||||+||||.+   -..+||||||.|++++... 
T Consensus       649 MLEMILS----sEkgRL~er~TkFlvtQIL~ALr~LH~--knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-  721 (888)
T KOG4236|consen  649 MLEMILS----SEKGRLPERITKFLVTQILVALRYLHF--KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-  721 (888)
T ss_pred             HHHHHHH----hhcccchHHHHHHHHHHHHHHHHHhhh--cceeeccCCchheeeccCCCCCceeeccccceeecchhh-
Confidence            5554442    245678888888899999999999998  77999999999999964   3589999999999997643 


Q ss_pred             CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                        ......||+.|+|||+++.+.|..+-|+||.||++|--++|..||....     +..+.+++..-      +..+..|
T Consensus       722 --FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE-----dIndQIQNAaF------MyPp~PW  788 (888)
T KOG4236|consen  722 --FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE-----DINDQIQNAAF------MYPPNPW  788 (888)
T ss_pred             --hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc-----chhHHhhcccc------ccCCCch
Confidence              2345689999999999999999999999999999999999999998633     23333333221      1233445


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .+..    .+..++|...|+..-++|-|....+.+
T Consensus       789 ~eis----~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  789 SEIS----PEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             hhcC----HHHHHHHHHHHHHHHHHhcchHhhccc
Confidence            4444    457899999999999999999887765

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-36  Score=292.49  Aligned_cols=258  Identities=26%  Similarity=0.393  Sum_probs=212.0

Q ss_pred             HHHHHHHhcCCCcCCeecccCceEEEEEE-eCCCcEEEEEECCCC--ChhHHHHHHHHHHcC-CCCccccccccee----
Q 016588           75 MEELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA--PTQEFIDEVCFLASI-QHRNLVTLLGYCQ----  146 (386)
Q Consensus        75 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l-~h~niv~~~~~~~----  146 (386)
                      ++.+...++.|++.+++|.|.+|.||+++ .++++..|+|+....  ..++...|.++|+.. +|||++.++|++.    
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~   90 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP   90 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence            34444456778899999999999999999 456889999985543  455677888899887 6999999999985    


Q ss_pred             -eCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEc
Q 016588          147 -ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA  225 (386)
Q Consensus       147 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~  225 (386)
                       .++.+|||||||.+|+..+++.+..   ...+.|..+.-|+..++.|+.+||.  +.++|||||-.|||++.++.+||+
T Consensus        91 ~~~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~--nkviHRDikG~NiLLT~e~~VKLv  165 (953)
T KOG0587|consen   91 GNGDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHN--NKVIHRDIKGQNVLLTENAEVKLV  165 (953)
T ss_pred             CCCCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhh--cceeeecccCceEEEeccCcEEEe
Confidence             3578999999999999999997642   6778899999999999999999998  779999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCccccCcccccchhhhcc-----cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHH
Q 016588          226 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV  300 (386)
Q Consensus       226 DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~  300 (386)
                      |||++..+..+.  .......||++|||||++.-     ..|+..+|+||||++..||--|.+|+-++.+...  +..  
T Consensus       166 DFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra--LF~--  239 (953)
T KOG0587|consen  166 DFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA--LFL--  239 (953)
T ss_pred             eeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh--hcc--
Confidence            999998876433  34456789999999999853     3577899999999999999999999998776211  100  


Q ss_pred             HhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          301 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                                -.-.|......+....+++.++|..||..|.++||++.++++|
T Consensus       240 ----------IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  240 ----------IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             ----------CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence                      0112333344566788999999999999999999999999865

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=7.1e-36  Score=266.74  Aligned_cols=220  Identities=17%  Similarity=0.176  Sum_probs=174.9

Q ss_pred             cCceEEEEEEeC-CCcEEEEEECCCCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCCCccccccCCCc
Q 016588           94 GKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQ  172 (386)
Q Consensus        94 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~  172 (386)
                      |.+|.||++... +++.+|+|......  .+..|...+....|||++++++++...+..+++|||+++++|.+++..   
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK---   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH---
Confidence            899999999954 58899999876542  344555555566799999999999999999999999999999888732   


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCccccc
Q 016588          173 VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL  252 (386)
Q Consensus       173 ~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~  252 (386)
                        ...+++..+..++.|++.||.|||+  ++++||||||+||+++.++.++++|||.+.......     ....++..|+
T Consensus        79 --~~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~  149 (237)
T cd05576          79 --FLNIPEECVKRWAAEMVVALDALHR--EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYC  149 (237)
T ss_pred             --hcCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcccc
Confidence              3458899999999999999999998  779999999999999999999999999876654321     2223456699


Q ss_pred             chhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHH
Q 016588          253 ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQL  332 (386)
Q Consensus       253 aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  332 (386)
                      |||...+..++.++|+||+|+++|||++|..|+.......                     ........+...+..+.++
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~l  208 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------------NTHTTLNIPEWVSEEARSL  208 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------------ccccccCCcccCCHHHHHH
Confidence            9999988888999999999999999999998765322100                     0000001222345678999


Q ss_pred             HhHccCCCCCCCCCHH
Q 016588          333 IVRCLDPSSERRPSMS  348 (386)
Q Consensus       333 i~~cl~~dp~~Rpt~~  348 (386)
                      +.+||+.||++|||+.
T Consensus       209 i~~~l~~dp~~R~~~~  224 (237)
T cd05576         209 LQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHccCCHHHhcCCC
Confidence            9999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-36  Score=262.10  Aligned_cols=252  Identities=21%  Similarity=0.350  Sum_probs=196.4

Q ss_pred             CeecccCceEEEEEE-eCCCcEEEEEECCC---CChhHHHHHHHHHHcC-CCCcccccccceeeCCeEEEEEEeecCCCc
Q 016588           89 NLIGEGKFGEVYKGL-LQDGMLVAIKKRPG---APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSV  163 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  163 (386)
                      +.||+|+|+.|--+. ..++..+|||++.+   ....++.+|++++.+. .|+||+.++++|++....|||||-+.||.|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            789999999999888 67899999998554   3467899999999999 599999999999999999999999999999


Q ss_pred             cccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC---ceEEcccccccccCCCCC--
Q 016588          164 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF---IAKVADAGLRNFLGRTDV--  238 (386)
Q Consensus       164 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~---~~kl~DFgl~~~~~~~~~--  238 (386)
                      ..++     ..+..+++....++..+|+.||.|||.  +||.||||||+|||-....   -+|||||.+...+..+..  
T Consensus       164 LshI-----~~~~~F~E~EAs~vvkdia~aLdFlH~--kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s  236 (463)
T KOG0607|consen  164 LSHI-----QKRKHFNEREASRVVKDIASALDFLHT--KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS  236 (463)
T ss_pred             HHHH-----HHhhhccHHHHHHHHHHHHHHHHHHhh--cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence            9888     356778999999999999999999998  8899999999999986543   579999998655433222  


Q ss_pred             ---CCCCccccCcccccchhhhc-----ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCch----hhHHHHHHhhhcc
Q 016588          239 ---AGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS----QDLVELVQNSRDF  306 (386)
Q Consensus       239 ---~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~----~~~~~~~~~~~~~  306 (386)
                         ........|+..|||||+..     ...|+.++|.||||||+|-|+.|.+||.+....+=    ...+..-++    
T Consensus       237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~----  312 (463)
T KOG0607|consen  237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQN----  312 (463)
T ss_pred             CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHH----
Confidence               12223445777899999864     24689999999999999999999999998765210    011111100    


Q ss_pred             cchhhhcchhhcccCCH----HHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          307 SNLLKILDERLWSTFTN----EGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       307 ~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                       .+.+.+.++.+ +||+    ..+.+..+++...+..|+.+|.++.+++++
T Consensus       313 -~LFesIQEGkY-eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh  361 (463)
T KOG0607|consen  313 -KLFESIQEGKY-EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH  361 (463)
T ss_pred             -HHHHHHhccCC-cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence             11111222111 2332    356778999999999999999999999973

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.2e-35  Score=301.20  Aligned_cols=142  Identities=27%  Similarity=0.314  Sum_probs=126.3

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC------hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ++|.+.+.||.|+||.||+|... +++.||+|++....      ...+..|+.++..++||||+++++++...+..|+||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888999999999999999965 58899999865332      256788999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      ||+.+++|.+++..     ...+++..++.++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~-----~~~l~~~~~~~i~~qil~aL~yLH~--~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHI-----YGYFDEEMAVKYISEVALALDYLHR--HGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999988842     3457788899999999999999998  679999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=266.95  Aligned_cols=239  Identities=22%  Similarity=0.301  Sum_probs=194.1

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCC-CcEEEEEECCCCCh------hHHHHHHHHHHcC-CCCcccccccceeeCCeEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPT------QEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  153 (386)
                      ..+|....+||.|+||.|.+|.-+. .+.+|||++++...      +--+.|-++|... +.|.++.+..+++.-+.+|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            4578889999999999999999654 67899998665431      1123456666555 57899999999999999999


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      ||||+.+|+|-.++     +.-+.+.+..+..++.+|+-||-+||+  +||+.||||.+|||||.+|++||+|||+++.-
T Consensus       428 VMEyvnGGDLMyhi-----QQ~GkFKEp~AvFYAaEiaigLFFLh~--kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHI-----QQVGKFKEPVAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             EEEEecCchhhhHH-----HHhcccCCchhhhhhHHHHHHhhhhhc--CCeeeeeccccceEeccCCceEeeeccccccc
Confidence            99999999998777     345667778888999999999999999  78999999999999999999999999998753


Q ss_pred             CCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhc
Q 016588          234 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  313 (386)
Q Consensus       234 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (386)
                      -.  ....+...+||+.|+|||++..+.|+.++|+|||||+||||+.|+.||++.+++   .+.+.+            .
T Consensus       501 i~--~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~---elF~aI------------~  563 (683)
T KOG0696|consen  501 IF--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQAI------------M  563 (683)
T ss_pred             cc--CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHH------------H
Confidence            22  123355778999999999999999999999999999999999999999986542   222111            1


Q ss_pred             chhhcccCCHHHHHHHHHHHhHccCCCCCCCCC
Q 016588          314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS  346 (386)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt  346 (386)
                      +..  -.++...+.+..++.+..+...|.+|..
T Consensus       564 ehn--vsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  564 EHN--VSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             Hcc--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence            111  2456667788899999999999999953

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-36  Score=265.98  Aligned_cols=261  Identities=21%  Similarity=0.260  Sum_probs=199.8

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC--ChhHHHHHHHHHHcCCC--C----cccccccceeeCCeEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA--PTQEFIDEVCFLASIQH--R----NLVTLLGYCQENNLQF  152 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~l~~l~h--~----niv~~~~~~~~~~~~~  152 (386)
                      +.+|.+...+|+|.||.|-.+..+ .+..||+|+++..  ..+.-.-|+++|.++.+  |    -++.+.++|...+..|
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC  167 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC  167 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence            678999999999999999999843 4789999986543  34556778999999832  2    4677788899999999


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC---------------
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD---------------  217 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~---------------  217 (386)
                      +|+|.+ |-++.+++..   .+..+++...+..++.|++++++|||+  .+++|-||||+|||+-               
T Consensus       168 ivfell-G~S~~dFlk~---N~y~~fpi~~ir~m~~QL~~sv~fLh~--~kl~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  168 IVFELL-GLSTFDFLKE---NNYIPFPIDHIRHMGYQLLESVAFLHD--LKLTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             EEEecc-ChhHHHHhcc---CCccccchHHHHHHHHHHHHHHHHHHh--cceeecCCChheEEEeccceEEEeccCCccc
Confidence            999987 5588899853   355678899999999999999999999  7799999999999982               


Q ss_pred             -----CCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCc
Q 016588          218 -----EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS  292 (386)
Q Consensus       218 -----~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~  292 (386)
                           .+..++++|||.|++.....     +....|..|.|||++.+-.++.++||||+||||+|+.||...|.+.+..+
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                 14468999999998764432     45677888999999999999999999999999999999999998877544


Q ss_pred             hhhHHHHHHhhhcccchhhh----------cc---------------hh--h--cccCCHHHHHHHHHHHhHccCCCCCC
Q 016588          293 SQDLVELVQNSRDFSNLLKI----------LD---------------ER--L--WSTFTNEGMEEFIQLIVRCLDPSSER  343 (386)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~----------~~---------------~~--~--~~~~~~~~~~~l~~li~~cl~~dp~~  343 (386)
                      ...+.+.+........+.+.          +|               +.  +  ..........++.+|+.+||..||.+
T Consensus       317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~  396 (415)
T KOG0671|consen  317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR  396 (415)
T ss_pred             HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence            43333332211110001000          00               00  0  00112233456999999999999999


Q ss_pred             CCCHHHHHHH
Q 016588          344 RPSMSDVVTE  353 (386)
Q Consensus       344 Rpt~~evl~~  353 (386)
                      |+|+.|++.+
T Consensus       397 RiTl~EAL~H  406 (415)
T KOG0671|consen  397 RITLREALSH  406 (415)
T ss_pred             cccHHHHhcC
Confidence            9999999976

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-36  Score=271.66  Aligned_cols=256  Identities=23%  Similarity=0.322  Sum_probs=197.5

Q ss_pred             hcCCCcCCeecccCceEEEEEE-eCCCcEEEEEE--CCCCCh--------hHHHHHHHHHHcCCCCccccccccee-eCC
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAPT--------QEFIDEVCFLASIQHRNLVTLLGYCQ-ENN  149 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~--~~~~~~--------~~~~~e~~~l~~l~h~niv~~~~~~~-~~~  149 (386)
                      .++|-..++||+|+|+.||+|. +...+.||||+  +.+...        +...+|..|-+.|+||.||++|+++. +.+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            4467778999999999999999 55678999997  333322        22457888899999999999999986 556


Q ss_pred             eEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC---CCCceEEcc
Q 016588          150 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVAD  226 (386)
Q Consensus       150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~---~~~~~kl~D  226 (386)
                      .+|-|+|||+|.+|+.++.     .....++.....|+.||+.||.||....++|||=||||.||||-   ..|.+||+|
T Consensus       542 sFCTVLEYceGNDLDFYLK-----QhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITD  616 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLK-----QHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITD  616 (775)
T ss_pred             cceeeeeecCCCchhHHHH-----hhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeee
Confidence            7889999999999998883     44667899999999999999999998889999999999999993   568999999


Q ss_pred             cccccccCCCCCCC-----CCccccCcccccchhhhcc----cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHH
Q 016588          227 AGLRNFLGRTDVAG-----PSSQVTADEIFLASEVKEF----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLV  297 (386)
Q Consensus       227 Fgl~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~  297 (386)
                      ||+++++++.....     .++...||.+|++||++--    ...+.++||||.||++|+.+.|+.||...-.  ..+..
T Consensus       617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQdIL  694 (775)
T KOG1151|consen  617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQDIL  694 (775)
T ss_pred             cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HHHHH
Confidence            99999997644332     2345679999999998742    3568899999999999999999999986432  11111


Q ss_pred             HHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          298 ELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      +.       ..+.+.  .....+..+-.+.+..++|.+||+..-++|....++..+
T Consensus       695 qe-------NTIlkA--tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  695 QE-------NTILKA--TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             hh-------hchhcc--eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence            10       111110  011111222345678999999999999999988887643

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2.8e-34  Score=284.70  Aligned_cols=265  Identities=18%  Similarity=0.177  Sum_probs=169.7

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeC-C----CcEEEEEECCCCChhHHHHHHHHHHcCCCCcccccccc------eeeCC
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQ-D----GMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGY------CQENN  149 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~------~~~~~  149 (386)
                      ..++|...+.||+|+||.||+|... +    +..||+|+.......+...+ +.+....+.++..+...      +....
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~-e~l~~~~~~~~~~~~~~~~~~~~~~~~~  208 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMN-ERVRRACPNSCADFVYGFLEPVSSKKED  208 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHH-HHHHhhchhhHHHHHHhhhcccccccCC
Confidence            4678999999999999999999964 4    68999998654332222111 11222223333333222      24566


Q ss_pred             eEEEEEEeecCCCccccccCCCcC---------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCe
Q 016588          150 LQFLIYEYIPNGSVSIHLYGPSQV---------------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANV  214 (386)
Q Consensus       150 ~~~lv~e~~~~g~L~~~l~~~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Ni  214 (386)
                      ..++|+||+.+++|.+++......               .........+..++.|++.||.|||+  ++|+||||||+||
T Consensus       209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~--~gIiHRDLKP~NI  286 (566)
T PLN03225        209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS--TGIVHRDVKPQNI  286 (566)
T ss_pred             ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH--CCEEeCcCCHHHE
Confidence            789999999999998887532110               00111233456799999999999998  7799999999999


Q ss_pred             eeCC-CCceEEcccccccccCCCCCCCCCccccCcccccchhhhccc----------------------CCCcccchhhH
Q 016588          215 LVDE-DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR----------------------RFSEKSDVYSF  271 (386)
Q Consensus       215 ll~~-~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~DvwSl  271 (386)
                      |++. ++.+||+|||+++.+..... .......+++.|+|||.+...                      .++.++|||||
T Consensus       287 Ll~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl  365 (566)
T PLN03225        287 IFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA  365 (566)
T ss_pred             EEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence            9986 57999999999986543221 223345678899999965422                      23446699999


Q ss_pred             HHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhh-cccchhhhcchhhccc----C--CHHHHHHHHHHHhHccCCCCCCC
Q 016588          272 GVFLLELVSGREASSSLSPDSSQDLVELVQNSR-DFSNLLKILDERLWST----F--TNEGMEEFIQLIVRCLDPSSERR  344 (386)
Q Consensus       272 Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~----~--~~~~~~~l~~li~~cl~~dp~~R  344 (386)
                      ||++|||+++..|+...    ...+...+.... ..........+.....    +  ........++|+.+||+.||++|
T Consensus       366 GviL~el~~~~~~~~~~----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR  441 (566)
T PLN03225        366 GLIFLQMAFPNLRSDSN----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR  441 (566)
T ss_pred             HHHHHHHHhCcCCCchH----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence            99999999976653321    111111111100 0001111111110000    0  00011345689999999999999


Q ss_pred             CCHHHHHHH
Q 016588          345 PSMSDVVTE  353 (386)
Q Consensus       345 pt~~evl~~  353 (386)
                      ||+.++++|
T Consensus       442 ~ta~e~L~H  450 (566)
T PLN03225        442 ISAKAALAH  450 (566)
T ss_pred             CCHHHHhCC
Confidence            999999987

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=3e-35  Score=284.31  Aligned_cols=246  Identities=24%  Similarity=0.348  Sum_probs=191.0

Q ss_pred             CCcCCeecccCceE-EEEEEeCCCcEEEEEECCCCChhHHHHHHHHHHcC-CCCcccccccceeeCCeEEEEEEeecCCC
Q 016588           85 FSDKNLIGEGKFGE-VYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGS  162 (386)
Q Consensus        85 ~~~~~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~  162 (386)
                      |...+++|.|+.|+ ||+|.+. ++.||||++-.....-..+|+..|+.- .||||+++++.-.+....|+..|.|.. +
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-s  588 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-S  588 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-h
Confidence            55567899999876 7999995 789999998777777788999999887 699999999999999999999999965 8


Q ss_pred             ccccccCC--CcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-----CCceEEcccccccccCC
Q 016588          163 VSIHLYGP--SQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-----DFIAKVADAGLRNFLGR  235 (386)
Q Consensus       163 L~~~l~~~--~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~-----~~~~kl~DFgl~~~~~~  235 (386)
                      |.+++...  +......   .....+..|++.||++||+  -+||||||||+||||+.     ...++|+|||+++.+..
T Consensus       589 L~dlie~~~~d~~~~~~---i~~~~~l~q~~~GlaHLHs--l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~  663 (903)
T KOG1027|consen  589 LQDLIESSGLDVEMQSD---IDPISVLSQIASGLAHLHS--LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG  663 (903)
T ss_pred             HHHHHhccccchhhccc---ccHHHHHHHHHHHHHHHHh--cccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence            99988653  1111111   3446688999999999999  56999999999999975     25789999999998865


Q ss_pred             CCC-CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcC-CCCCCCCCCCchhhHHHHHHhhhcccchhhhc
Q 016588          236 TDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG-REASSSLSPDSSQDLVELVQNSRDFSNLLKIL  313 (386)
Q Consensus       236 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (386)
                      ... ........||.+|+|||.+.....+.++||||+||++|+.++| ..||.+....+.+    .+........+    
T Consensus       664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N----Il~~~~~L~~L----  735 (903)
T KOG1027|consen  664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN----ILTGNYTLVHL----  735 (903)
T ss_pred             CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh----hhcCccceeee----
Confidence            332 3335677899999999999998888999999999999999996 7898864432111    00010100000    


Q ss_pred             chhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                            ....++  +..+||.+|++.+|..||++.+|+.|
T Consensus       736 ------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  736 ------EPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             ------ccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence                  011111  68999999999999999999999865

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.6e-33  Score=251.08  Aligned_cols=236  Identities=25%  Similarity=0.345  Sum_probs=188.2

Q ss_pred             CceEEEEEEeCC-CcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCCCccccccC
Q 016588           95 KFGEVYKGLLQD-GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG  169 (386)
Q Consensus        95 ~~g~V~~~~~~~-~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~  169 (386)
                      +||.||+|.... +..+++|......    .+.+.+|++.++.++|+|++++++++......++++||+.+++|..++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999999764 8899999865433    57889999999999999999999999999999999999999999988743


Q ss_pred             CCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcc
Q 016588          170 PSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE  249 (386)
Q Consensus       170 ~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~  249 (386)
                      .     ..+++..+..++.+++.++.|||+  .+++|+||+|+||++++++.++++|||.+.......   ......++.
T Consensus        81 ~-----~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~  150 (244)
T smart00220       81 R-----GRLSEDEARFYARQILSALEYLHS--NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP  150 (244)
T ss_pred             c-----cCCCHHHHHHHHHHHHHHHHHHHH--cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence            2     227889999999999999999999  679999999999999999999999999988765432   223345667


Q ss_pred             cccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHH
Q 016588          250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEF  329 (386)
Q Consensus       250 ~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  329 (386)
                      .|++||...+..++.++|+||||++++++++|..||.....  .....+........           ........+.++
T Consensus       151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~~~~~~~~-----------~~~~~~~~~~~~  217 (244)
T smart00220      151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKKIGKPKPP-----------FPPPEWKISPEA  217 (244)
T ss_pred             CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHhccCCC-----------CccccccCCHHH
Confidence            79999999888899999999999999999999999876321  11111111110000           000000034678


Q ss_pred             HHHHhHccCCCCCCCCCHHHHHHH
Q 016588          330 IQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       330 ~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .+++.+||..+|++||++.+++++
T Consensus       218 ~~~i~~~l~~~p~~Rp~~~~~~~~  241 (244)
T smart00220      218 KDLIRKLLVKDPEKRLTAEEALQH  241 (244)
T ss_pred             HHHHHHHccCCchhccCHHHHhhC
Confidence            999999999999999999999863

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-35  Score=271.23  Aligned_cols=247  Identities=17%  Similarity=0.242  Sum_probs=202.9

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCCCc-EEEEEECC------CCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQDGM-LVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-~vavK~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      ..+++....||-|+||.|=++..++.. .+|+|+++      ....+.+..|-.+|...+.|.||++|..+.++..+|++
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            345666778999999999999865433 47777533      33445678899999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      ||-|-||.|...+.     .++.++..+...++..+++|++|||+  ++||.|||||+|.+||.+|-+||.|||+|+.++
T Consensus       499 mEaClGGElWTiLr-----dRg~Fdd~tarF~~acv~EAfeYLH~--k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~  571 (732)
T KOG0614|consen  499 MEACLGGELWTILR-----DRGSFDDYTARFYVACVLEAFEYLHR--KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG  571 (732)
T ss_pred             HHhhcCchhhhhhh-----hcCCcccchhhhhHHHHHHHHHHHHh--cCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence            99999999998884     45678888888999999999999999  779999999999999999999999999999986


Q ss_pred             CCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                      ...   .+-..+||+.|.|||++.++..+.++|.||||+++|||++|.+||++.++-...+++-.  .          +|
T Consensus       572 ~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk--G----------id  636 (732)
T KOG0614|consen  572 SGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILK--G----------ID  636 (732)
T ss_pred             cCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh--h----------hh
Confidence            533   34567899999999999999999999999999999999999999999886433322211  1          11


Q ss_pred             hhhcccCCHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHH
Q 016588          315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTE  353 (386)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~evl~~  353 (386)
                         ...+|........+++++.+..+|.+|..     +.++-+|
T Consensus       637 ---~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH  677 (732)
T KOG0614|consen  637 ---KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH  677 (732)
T ss_pred             ---hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence               11344445566789999999999999976     5666655

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=252.19  Aligned_cols=263  Identities=22%  Similarity=0.336  Sum_probs=201.9

Q ss_pred             CCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeC-----CeEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN-----NLQF  152 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~  152 (386)
                      +.+..+.||-|+||.||.++. ++|+.|+.|+++..     +.+.+.+|+++|.-++|.|+...++...-.     .+.|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            455678999999999999984 56999999986643     345788999999999999999998876543     3457


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~  232 (386)
                      ++.|.+. .+|...+     .+.+.++...+.-+.+||+.||.|||+  .+|.||||||.|.|++.+...||||||+++.
T Consensus       134 V~TELmQ-SDLHKII-----VSPQ~Ls~DHvKVFlYQILRGLKYLHs--A~ILHRDIKPGNLLVNSNCvLKICDFGLARv  205 (449)
T KOG0664|consen  134 VLTELMQ-SDLHKII-----VSPQALTPDHVKVFVYQILRGLKYLHT--ANILHRDIKPGNLLVNSNCILKICDFGLART  205 (449)
T ss_pred             HHHHHHH-hhhhhee-----ccCCCCCcchhhhhHHHHHhhhHHHhh--cchhhccCCCccEEeccCceEEecccccccc
Confidence            8888885 4888777     345667777888899999999999999  7799999999999999999999999999987


Q ss_pred             cCCCCCCCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhh
Q 016588          233 LGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK  311 (386)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (386)
                      -+..+ ....+....|.+|.|||++++. .|+.+.||||.||++.|++.++..|....+....+++..+...+..+.+..
T Consensus       206 ee~d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~  284 (449)
T KOG0664|consen  206 WDQRD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY  284 (449)
T ss_pred             cchhh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence            54422 2233444567889999999875 789999999999999999999999998887666555544433333222221


Q ss_pred             hcc--------hh--------hcc-cCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016588          312 ILD--------ER--------LWS-TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  355 (386)
Q Consensus       312 ~~~--------~~--------~~~-~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~  355 (386)
                      .-+        ..        ++. ..+.....+...+...++..||.+|.+.++.+.++.
T Consensus       285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence            111        00        100 111122345678889999999999999999998864

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.2e-33  Score=270.81  Aligned_cols=264  Identities=19%  Similarity=0.263  Sum_probs=178.4

Q ss_pred             HhcCCCcCCeecccCceEEEEEEe-----------------CCCcEEEEEECCCCC---hhHH--------------HHH
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLL-----------------QDGMLVAIKKRPGAP---TQEF--------------IDE  126 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~---~~~~--------------~~e  126 (386)
                      ..++|.+.++||+|+||.||+|..                 ..++.||||++....   .++|              ..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999963                 234679999854321   1222              335


Q ss_pred             HHHHHcCCCCc-----ccccccceee--------CCeEEEEEEeecCCCccccccCCCc-------------------CC
Q 016588          127 VCFLASIQHRN-----LVTLLGYCQE--------NNLQFLIYEYIPNGSVSIHLYGPSQ-------------------VS  174 (386)
Q Consensus       127 ~~~l~~l~h~n-----iv~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~-------------------~~  174 (386)
                      +.++.+++|.+     +++++++|..        .+..++||||+++++|.++++....                   ..
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            66666776554     4677787753        3567999999999999988864211                   01


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccch
Q 016588          175 RQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS  254 (386)
Q Consensus       175 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aP  254 (386)
                      ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++........ ........++.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~--~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHR--IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeCh
Confidence            2345677888999999999999998  6799999999999999999999999999876533211 111223346789999


Q ss_pred             hhhcccC--------------------C--CcccchhhHHHHHHHHHcCCC-CCCCCCCCchhhHHH--HHHhhhcccch
Q 016588          255 EVKEFRR--------------------F--SEKSDVYSFGVFLLELVSGRE-ASSSLSPDSSQDLVE--LVQNSRDFSNL  309 (386)
Q Consensus       255 E~~~~~~--------------------~--~~~~DvwSlGvil~el~tg~~-p~~~~~~~~~~~~~~--~~~~~~~~~~~  309 (386)
                      |.+....                    |  ..+.||||+||+++||++|.. |+........ ....  .....+.    
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~-~~~~~~~~~~~~r----  454 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT-ELRQYDNDLNRWR----  454 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh-HHhhccchHHHHH----
Confidence            9875322                    1  234799999999999999875 6543221100 0000  0000000    


Q ss_pred             hhhcchhhcccCCHHHHHHHHHHHhHccCCCC---CCCCCHHHHHHH
Q 016588          310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSS---ERRPSMSDVVTE  353 (386)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp---~~Rpt~~evl~~  353 (386)
                       ...............++..++++.+||..+|   .+|+|++|+|+|
T Consensus       455 -~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        455 -MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             -hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence             0000001011112234678999999999866   689999999987

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=2.9e-34  Score=239.39  Aligned_cols=258  Identities=21%  Similarity=0.305  Sum_probs=198.4

Q ss_pred             hcCCCcCCeecccCceEEEEEE-eCCCcEEEEEECCCCChhHHHHHHHHHHcCC-CCcccccccceeeC--CeEEEEEEe
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ-HRNLVTLLGYCQEN--NLQFLIYEY  157 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e~  157 (386)
                      .++|++.+.+|+|.|+.||.|. ..+++.++||++++.....+.+|+.+|.+|. ||||+++++...+.  ....|++||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~  116 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY  116 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence            4578888999999999999999 5568899999999999999999999999996 99999999998764  456799999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-CCceEEcccccccccCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~-~~~~kl~DFgl~~~~~~~  236 (386)
                      +.+.+.....        +.+....+..++.+++.||.|+|+  .||.|||+||.|+++|. .-.++|+|+|+|.+....
T Consensus       117 v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCHS--~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  117 VNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCHS--MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             hccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHHh--cCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            9987765443        456777888899999999999999  67999999999999995 457899999999987553


Q ss_pred             CCCCCCccccCcccccchhhhc-ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhh-----------
Q 016588          237 DVAGPSSQVTADEIFLASEVKE-FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR-----------  304 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-----------  304 (386)
                      ..   ..-...+..|-.||.+- ...|+.+-|+|||||++..|+..+.||...... .+++...+.-..           
T Consensus       187 ~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN-~DQLVkIakVLGt~el~~Yl~KY  262 (338)
T KOG0668|consen  187 KE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVKIAKVLGTDELYAYLNKY  262 (338)
T ss_pred             ce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC-HHHHHHHHHHhChHHHHHHHHHH
Confidence            32   22334566788999875 456788999999999999999999998765542 223332221110           


Q ss_pred             ---cccchhhhc---chhhcccCCH-----HHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          305 ---DFSNLLKIL---DERLWSTFTN-----EGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       305 ---~~~~~~~~~---~~~~~~~~~~-----~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                         -..+...++   ....|..+..     -..++..+++.+.|..|..+|+|+.|...|
T Consensus       263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence               011111111   1122222211     123678999999999999999999999876

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-33  Score=243.25  Aligned_cols=275  Identities=20%  Similarity=0.273  Sum_probs=208.8

Q ss_pred             HHHhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcC-CCCcccccccceeeCCe
Q 016588           79 SLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNL  150 (386)
Q Consensus        79 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  150 (386)
                      ....++|...++||+|+|..|..+.++ +.+.+|+|++++.      ..+-++.|-.++.+- +||.+|.+..+|+....
T Consensus       246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr  325 (593)
T KOG0695|consen  246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR  325 (593)
T ss_pred             ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence            345678999999999999999999954 5789999975432      223356677777665 79999999999999999


Q ss_pred             EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  230 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~  230 (386)
                      +++|.||+++|+|--++     +...++++.....+...|..||.|||+  .||+.||||.+|+|+|..|++||+|+|++
T Consensus       326 lffvieyv~ggdlmfhm-----qrqrklpeeharfys~ei~lal~flh~--rgiiyrdlkldnvlldaeghikltdygmc  398 (593)
T KOG0695|consen  326 LFFVIEYVNGGDLMFHM-----QRQRKLPEEHARFYSAEICLALNFLHE--RGIIYRDLKLDNVLLDAEGHIKLTDYGMC  398 (593)
T ss_pred             EEEEEEEecCcceeeeh-----hhhhcCcHHHhhhhhHHHHHHHHHHhh--cCeeeeeccccceEEccCCceeecccchh
Confidence            99999999999998777     456789999999999999999999999  78999999999999999999999999998


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCc-----hhhHHHHHHhhhc
Q 016588          231 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS-----SQDLVELVQNSRD  305 (386)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~-----~~~~~~~~~~~~~  305 (386)
                      +.--.  ....++..+||+-|.|||++++..|+++.|+|++||+++||+.|..||+--..+.     .+.+.+.      
T Consensus       399 ke~l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv------  470 (593)
T KOG0695|consen  399 KEGLG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV------  470 (593)
T ss_pred             hcCCC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH------
Confidence            75322  2334567899999999999999999999999999999999999999997532211     1111111      


Q ss_pred             ccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCC------HHHHHH--HHHHhhhhhcccccccCCCCceee
Q 016588          306 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS------MSDVVT--ELDRTLDKEMNLTTVMGEGTPTVT  376 (386)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt------~~evl~--~L~~~~~~~~~~~~~~~~~~~~~~  376 (386)
                            ++...++  .|...+-....+++.-|++||.+|..      +.++-.  .++.+-.+.+..+.+.+-..|.+.
T Consensus       471 ------ilekqir--iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i~  541 (593)
T KOG0695|consen  471 ------ILEKQIR--IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQIT  541 (593)
T ss_pred             ------Hhhhccc--ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCccc
Confidence                  1222222  12222334567899999999999953      333332  233344444555556665556544

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-33  Score=262.29  Aligned_cols=204  Identities=23%  Similarity=0.300  Sum_probs=171.0

Q ss_pred             hcCCCcCCeecccCceEEEEEE-eCCCcEEEEEECCC------CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      ..-|..++.||-|+||.|.++. .++...+|+|.+.+      .....+..|..||..-+++-||+||-.|.+.+.+|+|
T Consensus       628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV  707 (1034)
T KOG0608|consen  628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV  707 (1034)
T ss_pred             ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence            3457788999999999999998 44567889986432      2334567899999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      |||++||++-.+|.     ..+.+.+.....++.++..|+++.|.  -|+|||||||+|||||.+|++||+||||++-+.
T Consensus       708 MdYIPGGDmMSLLI-----rmgIFeE~LARFYIAEltcAiesVHk--mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR  780 (1034)
T KOG0608|consen  708 MDYIPGGDMMSLLI-----RMGIFEEDLARFYIAELTCAIESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  780 (1034)
T ss_pred             EeccCCccHHHHHH-----HhccCHHHHHHHHHHHHHHHHHHHHh--ccceecccCccceEEccCCceeeeeccccccce
Confidence            99999999988873     45678888888999999999999999  559999999999999999999999999975431


Q ss_pred             ---------CCC---------------CC----------------CCCccccCcccccchhhhcccCCCcccchhhHHHH
Q 016588          235 ---------RTD---------------VA----------------GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVF  274 (386)
Q Consensus       235 ---------~~~---------------~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvi  274 (386)
                               ..+               ..                ...-...||+-|+|||++....|+..+|+||.|||
T Consensus       781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi  860 (1034)
T KOG0608|consen  781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI  860 (1034)
T ss_pred             eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence                     000               00                00123468999999999999999999999999999


Q ss_pred             HHHHHcCCCCCCCCCCCc
Q 016588          275 LLELVSGREASSSLSPDS  292 (386)
Q Consensus       275 l~el~tg~~p~~~~~~~~  292 (386)
                      ||||+.|+.||....+.+
T Consensus       861 l~em~~g~~pf~~~tp~~  878 (1034)
T KOG0608|consen  861 LYEMLVGQPPFLADTPGE  878 (1034)
T ss_pred             HHHHhhCCCCccCCCCCc
Confidence            999999999999888754

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.98  E-value=1.2e-33  Score=232.30  Aligned_cols=203  Identities=21%  Similarity=0.274  Sum_probs=161.7

Q ss_pred             hcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC----ChhHHHHHHHHHHcC-CCCcccccccceeeCCeEEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA----PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~----~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      .++......||+|+||.|-+-++ .+|...|+|.+...    ...+..+|+.+.... .+|.+|.++|........++.|
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM  124 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM  124 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence            34444567799999999988874 46899999975433    334567777776554 7999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      |.|+. +|+.+...- .......++..+-+|+..+.+||.|||+. ..++|||+||+|||++.+|++|+||||++-.+.+
T Consensus       125 E~M~t-Sldkfy~~v-~~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  125 ELMDT-SLDKFYRKV-LKKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILINYDGQVKICDFGISGYLVD  201 (282)
T ss_pred             HHhhh-hHHHHHHHH-HhcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence            99965 776554211 12456788888999999999999999984 4599999999999999999999999999887754


Q ss_pred             CCCCCCCccccCcccccchhhhcc----cCCCcccchhhHHHHHHHHHcCCCCCCCCCC
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEF----RRFSEKSDVYSFGVFLLELVSGREASSSLSP  290 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwSlGvil~el~tg~~p~~~~~~  290 (386)
                      .-.   .+...|-..|||||.+..    ..|+.++||||||+++.||.++..||..+..
T Consensus       202 SiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  202 SIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             hhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            221   222345556999998764    4789999999999999999999999988664

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=2.2e-32  Score=251.76  Aligned_cols=266  Identities=20%  Similarity=0.209  Sum_probs=200.8

Q ss_pred             HHHhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCCh--hHHHHHHHHHHcCC------CCcccccccceeeCC
Q 016588           79 SLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT--QEFIDEVCFLASIQ------HRNLVTLLGYCQENN  149 (386)
Q Consensus        79 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~e~~~l~~l~------h~niv~~~~~~~~~~  149 (386)
                      +.-..+|.+....|.|.|++|.+|... .+..||||++.+...  ..=+.|+++|++|+      --|+++++..|...+
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn  507 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN  507 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence            344567888889999999999999954 478999999765432  34568999999995      358999999999999


Q ss_pred             eEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC-CceEEcccc
Q 016588          150 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAG  228 (386)
Q Consensus       150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~-~~~kl~DFg  228 (386)
                      ++|||+|-+. -+|.+.+...  ...-.|....+..++.|+..||..|-.  .||+|.||||+|||+++. ..+||||||
T Consensus       508 HLClVFE~Ls-lNLRevLKKy--G~nvGL~ikaVRsYaqQLflALklLK~--c~vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  508 HLCLVFEPLS-LNLREVLKKY--GRNVGLHIKAVRSYAQQLFLALKLLKK--CGVLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             eeEEEehhhh-chHHHHHHHh--CcccceeehHHHHHHHHHHHHHHHHHh--cCeeecccCccceEeccCcceeeeccCc
Confidence            9999999774 4888887543  234567788999999999999999998  569999999999999965 567999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccc
Q 016588          229 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN  308 (386)
Q Consensus       229 l~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  308 (386)
                      .|-..+..+    .+.+..+..|.|||++.|..|+...|+||.||+||||.||+..|.+........+.-.+........
T Consensus       583 SA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km  658 (752)
T KOG0670|consen  583 SASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM  658 (752)
T ss_pred             ccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence            998875533    3344556679999999999999999999999999999999999988765433222211111000000


Q ss_pred             ------hhhhcc--------------------------h------hhcc--cCC---HHHHHHHHHHHhHccCCCCCCCC
Q 016588          309 ------LLKILD--------------------------E------RLWS--TFT---NEGMEEFIQLIVRCLDPSSERRP  345 (386)
Q Consensus       309 ------~~~~~~--------------------------~------~~~~--~~~---~~~~~~l~~li~~cl~~dp~~Rp  345 (386)
                            ..+.+|                          |      .+..  ..+   .....++.+|+.+|+..||++|.
T Consensus       659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi  738 (752)
T KOG0670|consen  659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI  738 (752)
T ss_pred             hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence                  000001                          0      0100  012   22346799999999999999999


Q ss_pred             CHHHHHHH
Q 016588          346 SMSDVVTE  353 (386)
Q Consensus       346 t~~evl~~  353 (386)
                      |..++|+|
T Consensus       739 t~nqAL~H  746 (752)
T KOG0670|consen  739 TVNQALKH  746 (752)
T ss_pred             CHHHHhcC
Confidence            99999976

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=234.34  Aligned_cols=257  Identities=22%  Similarity=0.287  Sum_probs=187.9

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC-----CChhHHHHHHHHHHcCCCCcccccccceeeC------Ce
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQEN------NL  150 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~  150 (386)
                      .+|...+.+|.|.- .|..+... .+++||+|+...     ....+..+|+..+..++|+|+++++.++.-.      ..
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            35666778888887 55555532 478999997332     2334567899999999999999999998644      45


Q ss_pred             EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  230 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~  230 (386)
                      .|+|||++.. +|...+.       -.++-.++..+..|++.|++|||+  .||+||||||+||++..++.+||.|||++
T Consensus        96 ~y~v~e~m~~-nl~~vi~-------~elDH~tis~i~yq~~~~ik~lhs--~~IihRdLkPsnivv~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   96 VYLVMELMDA-NLCQVIL-------MELDHETISYILYQMLCGIKHLHS--AGIIHRDLKPSNIVVNSDCTLKILDFGLA  165 (369)
T ss_pred             HHHHHHhhhh-HHHHHHH-------HhcchHHHHHHHHHHHHHHHHHHh--cceeecccCcccceecchhheeeccchhh
Confidence            6999999964 8877763       335666788899999999999999  78999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchh----------------
Q 016588          231 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ----------------  294 (386)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~----------------  294 (386)
                      +.-+..   -..+.+..+..|.|||++.+..|.+.+||||.||++.||++|...|.+.+..+.-                
T Consensus       166 r~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~  242 (369)
T KOG0665|consen  166 RTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK  242 (369)
T ss_pred             cccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence            864322   3456778899999999999988999999999999999999999888764421110                


Q ss_pred             hHHHHHHhhhcc------cchhhhcchhhcc---cCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          295 DLVELVQNSRDF------SNLLKILDERLWS---TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       295 ~~~~~~~~~~~~------~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ++...+......      ....+.+....+.   +.+..-...+.+++.+||..||++|.++.++|.|
T Consensus       243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            011111110000      0011111111111   1111122558899999999999999999999987

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=5e-30  Score=223.02  Aligned_cols=208  Identities=35%  Similarity=0.528  Sum_probs=179.1

Q ss_pred             ecccCceEEEEEEeCC-CcEEEEEECCCCCh----hHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCCCccc
Q 016588           91 IGEGKFGEVYKGLLQD-GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSI  165 (386)
Q Consensus        91 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~  165 (386)
                      ||+|.+|.||++.... +..+++|.......    +.+.+|+..++.++|++++++++++......++++|++.+++|..
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999754 88999998766544    679999999999999999999999999899999999999899998


Q ss_pred             cccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-CCceEEcccccccccCCCCCCCCCcc
Q 016588          166 HLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLGRTDVAGPSSQ  244 (386)
Q Consensus       166 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~-~~~~kl~DFgl~~~~~~~~~~~~~~~  244 (386)
                      ++...    ...+++..+..++.+++.++.+||+  .+++|+||+|.||+++. ++.++|+|||.+........  ....
T Consensus        81 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~--~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~  152 (215)
T cd00180          81 LLKEN----EGKLSEDEILRILLQILEGLEYLHS--NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT  152 (215)
T ss_pred             HHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence            87422    1467889999999999999999999  67999999999999999 89999999999876643221  1223


Q ss_pred             ccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCH
Q 016588          245 VTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN  323 (386)
Q Consensus       245 ~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (386)
                      ..+...|++||..... .++.++|+|++|++++++                                             
T Consensus       153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------  187 (215)
T cd00180         153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------  187 (215)
T ss_pred             ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence            4456679999998876 788999999999999999                                             


Q ss_pred             HHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          324 EGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       324 ~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                         ..+.+++.+|++.+|++||++.++++++
T Consensus       188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence               3478999999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=3.4e-31  Score=250.47  Aligned_cols=251  Identities=21%  Similarity=0.303  Sum_probs=198.7

Q ss_pred             hcCCCcCCeecccCceEEEEEE-eCCCcEEEEEECCCC---ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      .++|.....+|+|.||.||+++ ..++...|+|.++-.   ..+-.++|+-+++..+||||+.++|.+...+..+++|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            3578888999999999999999 456888888875544   344567899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      |.+|+|.+..+     ....+++.++...++..++||+|||+  .|-+|||||-.|||+++.+.+|++|||.+..++.+-
T Consensus        94 cgggslQdiy~-----~TgplselqiayvcRetl~gl~ylhs--~gk~hRdiKGanilltd~gDvklaDfgvsaqitati  166 (829)
T KOG0576|consen   94 CGGGSLQDIYH-----VTGPLSELQIAYVCRETLQGLKYLHS--QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI  166 (829)
T ss_pred             cCCCcccceee-----ecccchhHHHHHHHhhhhccchhhhc--CCcccccccccceeecccCceeecccCchhhhhhhh
Confidence            99999998874     45778888989999999999999999  668999999999999999999999999987765432


Q ss_pred             CCCCCccccCcccccchhhhc---ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc
Q 016588          238 VAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                        .......||++|||||+..   ...|...+|+|++|+...|+---++|.....+...  +.-.-...   .+-...  
T Consensus       167 --~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~--l~LmTkS~---~qpp~l--  237 (829)
T KOG0576|consen  167 --AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA--LFLMTKSG---FQPPTL--  237 (829)
T ss_pred             --hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH--HHHhhccC---CCCCcc--
Confidence              2234567999999999863   46789999999999999999887777665444211  11000111   111111  


Q ss_pred             hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                           .-.....+.+.++++.|+..+|++|||++.++.+
T Consensus       238 -----kDk~kws~~fh~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  238 -----KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             -----cCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence                 1222345678999999999999999999988753

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=9.8e-31  Score=243.73  Aligned_cols=195  Identities=22%  Similarity=0.363  Sum_probs=165.7

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCC-CcEEEEEECCCCCh-----------hHHHHHHHHHHcCC---CCccccccccee
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPT-----------QEFIDEVCFLASIQ---HRNLVTLLGYCQ  146 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-----------~~~~~e~~~l~~l~---h~niv~~~~~~~  146 (386)
                      ..+|+..+.+|.|+||.|+.|.++. ...|++|.+.+...           -.+-.|+.||..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            3468999999999999999999765 56788886543321           12446999999996   999999999999


Q ss_pred             eCCeEEEEEEee-cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEc
Q 016588          147 ENNLQFLIYEYI-PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA  225 (386)
Q Consensus       147 ~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~  225 (386)
                      +++..||+||-. ++-+|.+++.     -.+.+++.....|++||+.|+++||+  .||||||||-+|+.++.+|-+||+
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE-----~kp~m~E~eAk~IFkQV~agi~hlh~--~~ivhrdikdenvivd~~g~~kli  712 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIE-----FKPRMDEPEAKLIFKQVVAGIKHLHD--QGIVHRDIKDENVIVDSNGFVKLI  712 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhh-----ccCccchHHHHHHHHHHHhccccccc--cCceecccccccEEEecCCeEEEe
Confidence            999999999965 4557777773     44668888899999999999999999  779999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCccccCcccccchhhhcccCC-CcccchhhHHHHHHHHHcCCCCCCC
Q 016588          226 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSS  287 (386)
Q Consensus       226 DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~el~tg~~p~~~  287 (386)
                      |||.+....    .++.....||..|.|||++.|..| +..-|||++|++||.++....||..
T Consensus       713 dfgsaa~~k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  713 DFGSAAYTK----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             eccchhhhc----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            999987753    345566789999999999999988 6778999999999999999988863

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.2e-30  Score=234.82  Aligned_cols=131  Identities=21%  Similarity=0.306  Sum_probs=109.5

Q ss_pred             HhcCCCcCCeecccCceEEEEEE-eCCCcEEEEEECCC--CChhHHHHHHHHHHcCC-----C---Cccccccccee---
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG--APTQEFIDEVCFLASIQ-----H---RNLVTLLGYCQ---  146 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~--~~~~~~~~e~~~l~~l~-----h---~niv~~~~~~~---  146 (386)
                      ...+|.+.++||=|.|++||++. ..+.+.||+|+.+.  ..++.-.+|+++|++++     |   .+||+|++.|.   
T Consensus        76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            34688899999999999999999 55688999998653  35677889999999873     2   58999999986   


Q ss_pred             -eCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee
Q 016588          147 -ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV  216 (386)
Q Consensus       147 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill  216 (386)
                       ++.++|||+|++ |.+|..++..   ...+.++...+..|++||+.||.|||.. .||||-||||+|||+
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~---s~YrGlpl~~VK~I~~qvL~GLdYLH~e-cgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKY---SNYRGLPLSCVKEICRQVLTGLDYLHRE-CGIIHTDLKPENVLL  221 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHH---hCCCCCcHHHHHHHHHHHHHHHHHHHHh-cCccccCCCcceeee
Confidence             456899999998 5567666643   3456789999999999999999999984 589999999999998

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=7.6e-30  Score=218.00  Aligned_cols=250  Identities=18%  Similarity=0.297  Sum_probs=183.3

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCC-CcEEEEEECCCC--ChhHHHHHHHHHHcC-CCCcccccccc-eeeCCeEEEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGA--PTQEFIDEVCFLASI-QHRNLVTLLGY-CQENNLQFLIYE  156 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~e~~~l~~l-~h~niv~~~~~-~~~~~~~~lv~e  156 (386)
                      .+.|.+.+.+|+|.||.+-++.++. ++.+++|.++..  ...+|.+|...--.| .|.||+.-|+. |+..+..++++|
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            3578888999999999999999774 778999986543  456899998876667 58999987764 677788889999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC--CCCceEEcccccccccC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD--EDFIAKVADAGLRNFLG  234 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~--~~~~~kl~DFgl~~~~~  234 (386)
                      |++.|+|..-+.      ...+.+....+++.|++.|+.|+|+  +++||||||.+|||+-  +...+||||||+.+..+
T Consensus       103 ~aP~gdL~snv~------~~GigE~~~K~v~~ql~SAi~fMHs--knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  103 FAPRGDLRSNVE------AAGIGEANTKKVFAQLLSAIEFMHS--KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             cCccchhhhhcC------cccccHHHHHHHHHHHHHHHHHhhc--cchhhcccccceEEEecCCccEEEeeecccccccC
Confidence            999999987773      3557788888999999999999999  7799999999999993  34589999999988654


Q ss_pred             CCCCCCCCccccCcccccchhhhccc-----CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccch
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEFR-----RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL  309 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  309 (386)
                      ..     ......+..|.+||.....     ...+.+|+|.||+++|.++||++||......+ ....++.       ..
T Consensus       175 ~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-~~Y~~~~-------~w  241 (378)
T KOG1345|consen  175 TT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-KPYWEWE-------QW  241 (378)
T ss_pred             ce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-chHHHHH-------HH
Confidence            32     1222334458899876432     34678999999999999999999998543322 2222221       11


Q ss_pred             hhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .+...+.+...+. ..++.+..+.++-+..+|++|=...++.+.
T Consensus       242 ~~rk~~~~P~~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  242 LKRKNPALPKKFN-PFSEKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             hcccCccCchhhc-ccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence            1111121111111 123457889999999999999555555443

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=2.8e-29  Score=226.85  Aligned_cols=265  Identities=23%  Similarity=0.298  Sum_probs=195.6

Q ss_pred             HHHhcCCCcCCeecccCceEEEEEEeC----CCcEEEEEECC-CCChhHHHHHHHHHHcC-CCCcccccccceeeCCeEE
Q 016588           79 SLATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRP-GAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQF  152 (386)
Q Consensus        79 ~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  152 (386)
                      ......|...++||.|.|++||++...    ....||+|.+. .+..+.+.+|+++|..+ .+.||+++.+++..++...
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~  111 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA  111 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence            334567888999999999999999843    36789999754 45667899999999998 5899999999999999999


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-CCceEEccccccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAGLRN  231 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~-~~~~kl~DFgl~~  231 (386)
                      +|+||++.....++..        .++...+..++..++.||.++|.  +|||||||||+|+|.+. .+.-.|.|||++.
T Consensus       112 ivlp~~~H~~f~~l~~--------~l~~~~i~~Yl~~ll~Al~~~h~--~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  112 IVLPYFEHDRFRDLYR--------SLSLAEIRWYLRNLLKALAHLHK--NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             EEecccCccCHHHHHh--------cCCHHHHHHHHHHHHHHhhhhhc--cCccccCCCccccccccccCCceEEechhHH
Confidence            9999999988887773        35678889999999999999999  88999999999999985 5678999999986


Q ss_pred             ccCC-------------C--C----------C-----------------CCCCccccCcccccchhhhccc-CCCcccch
Q 016588          232 FLGR-------------T--D----------V-----------------AGPSSQVTADEIFLASEVKEFR-RFSEKSDV  268 (386)
Q Consensus       232 ~~~~-------------~--~----------~-----------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv  268 (386)
                      ....             .  .          .                 ........||++|.|||++... ..+++.||
T Consensus       182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi  261 (418)
T KOG1167|consen  182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI  261 (418)
T ss_pred             HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence            2100             0  0          0                 0001233589999999998754 45889999


Q ss_pred             hhHHHHHHHHHcCCCCCCCCCCCchhhHHHHH--------Hhhh-cccc--hhh---------------hcc-hhhcc--
Q 016588          269 YSFGVFLLELVSGREASSSLSPDSSQDLVELV--------QNSR-DFSN--LLK---------------ILD-ERLWS--  319 (386)
Q Consensus       269 wSlGvil~el~tg~~p~~~~~~~~~~~~~~~~--------~~~~-~~~~--~~~---------------~~~-~~~~~--  319 (386)
                      ||.||+++-++++..||.....+. ..+.+.+        ++.. ..+.  +.+               .++ +.+++  
T Consensus       262 ws~GVI~Lslls~~~PFf~a~dd~-~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~  340 (418)
T KOG1167|consen  262 WSAGVILLSLLSRRYPFFKAKDDA-DALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR  340 (418)
T ss_pred             eeccceeehhhccccccccCcccc-chHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence            999999999999999997755422 1111111        0000 0000  000               000 00111  


Q ss_pred             -------cCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          320 -------TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       320 -------~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                             ...+..+..+++++.+|++.||.+|.|+++.|+|-
T Consensus       341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp  382 (418)
T KOG1167|consen  341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP  382 (418)
T ss_pred             ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence                   11112234689999999999999999999999763

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=1.7e-28  Score=216.42  Aligned_cols=195  Identities=31%  Similarity=0.450  Sum_probs=166.3

Q ss_pred             CCcCCeecccCceEEEEEEeCC-CcEEEEEECCCC----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeec
Q 016588           85 FSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  159 (386)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  159 (386)
                      |...+.||+|++|.||++.... +..+++|.....    ..+.+.+|++.+..++|+|++++++++...+..++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4566889999999999999765 889999986654    35578889999999999999999999999899999999999


Q ss_pred             CCCccccccCCCcCCCCC-CCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          160 NGSVSIHLYGPSQVSRQK-LEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       160 ~g~L~~~l~~~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      +++|.+++...     .. +++.....++.+++.++.+||+  .+++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 ~~~L~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~  153 (225)
T smart00221       81 GGDLFDYLRKK-----GGKLSEEEARFYLRQILEALEYLHS--LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA  153 (225)
T ss_pred             CCCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence            99999888432     22 7888999999999999999998  6799999999999999999999999999887654320


Q ss_pred             CCCCccccCcccccchhhh-cccCCCcccchhhHHHHHHHHHcCCCCCCC
Q 016588          239 AGPSSQVTADEIFLASEVK-EFRRFSEKSDVYSFGVFLLELVSGREASSS  287 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwSlGvil~el~tg~~p~~~  287 (386)
                       .......++..|++||.. ....++.++|+||||++++||++|+.||..
T Consensus       154 -~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      154 -ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             -ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence             122334566779999998 666778899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=4.4e-29  Score=259.10  Aligned_cols=197  Identities=17%  Similarity=0.183  Sum_probs=138.1

Q ss_pred             cCCC-Ccccccccce-------eeCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 016588          132 SIQH-RNLVTLLGYC-------QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR  203 (386)
Q Consensus       132 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~  203 (386)
                      .++| +||.+++++|       ......+.++|++ +++|.+++..    ....+++..+..++.||+.||.|||+  +|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~--~g  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN----PDRSVDAFECFHVFRQIVEIVNAAHS--QG  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc----ccccccHHHHHHHHHHHHHHHHHHHh--CC
Confidence            3455 6888888877       2334567788877 5599999842    23558999999999999999999998  78


Q ss_pred             ceecCCCCCCeeeCC-------------------CCceEEcccccccccCCCCC--------------CCCCccccCccc
Q 016588          204 VVHKDFKTANVLVDE-------------------DFIAKVADAGLRNFLGRTDV--------------AGPSSQVTADEI  250 (386)
Q Consensus       204 ivH~dlkp~Nill~~-------------------~~~~kl~DFgl~~~~~~~~~--------------~~~~~~~~~~~~  250 (386)
                      |+||||||+||||+.                   ++.+|++|||+++.......              ........+|+.
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            999999999999955                   44556666666653211000              000112357888


Q ss_pred             ccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHH
Q 016588          251 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFI  330 (386)
Q Consensus       251 y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  330 (386)
                      |+|||++.+..|+.++|||||||++|||++|..|+.....     .......        ....+..     ........
T Consensus       181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~~~~--------~~~~~~~-----~~~~~~~~  242 (793)
T PLN00181        181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSSLRH--------RVLPPQI-----LLNWPKEA  242 (793)
T ss_pred             eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHHHHH--------hhcChhh-----hhcCHHHH
Confidence            9999999999999999999999999999998877542110     1110000        0011111     01123456


Q ss_pred             HHHhHccCCCCCCCCCHHHHHHH
Q 016588          331 QLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       331 ~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      +++.+||+.+|.+|||+.|++++
T Consensus       243 ~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        243 SFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHHHhCCCChhhCcChHHHhhc
Confidence            88899999999999999999875

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=1.3e-27  Score=203.28  Aligned_cols=171  Identities=21%  Similarity=0.235  Sum_probs=127.4

Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  240 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~  240 (386)
                      |+|.+++..    ....+++..+..++.|++.||.|||+  .+      ||+|||++.++.+|+  ||++.......   
T Consensus         1 GsL~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~lH~--~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---   63 (176)
T smart00750        1 VSLADILEV----RGRPLNEEEIWAVCLQCLRALRELHR--QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ---   63 (176)
T ss_pred             CcHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHh--cC------CcccEeEcCccceee--ccceEeecccc---
Confidence            577777742    24568999999999999999999998  44      999999999999999  99988764321   


Q ss_pred             CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhccc
Q 016588          241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  320 (386)
Q Consensus       241 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (386)
                          ..+++.|+|||++.+..++.++|||||||++|||++|..||....... ..+..........       ++.. ..
T Consensus        64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~-------~~~~-~~  130 (176)
T smart00750       64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNGMPAD-------DPRD-RS  130 (176)
T ss_pred             ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHHhccC-------Cccc-cc
Confidence                256788999999999999999999999999999999999987543211 1111111111100       0000 01


Q ss_pred             CCHHHHH--HHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          321 FTNEGME--EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       321 ~~~~~~~--~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                      .......  ++.+++.+||+.+|++|||+.++++++..+..+.
T Consensus       131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~  173 (176)
T smart00750      131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAET  173 (176)
T ss_pred             cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence            1122223  6899999999999999999999999998876553

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=8.1e-27  Score=199.69  Aligned_cols=245  Identities=23%  Similarity=0.359  Sum_probs=192.3

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEEC-----CCCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCCC
Q 016588           88 KNLIGEGKFGEVYKGLLQDGMLVAIKKR-----PGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS  162 (386)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~~~~vavK~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  162 (386)
                      ..+|.....|..|+|+++.+.. +.|++     ......+|..|.-.|+.+.||||..++|.|.......++..|++.|+
T Consensus       195 ~tkl~e~hsgelwrgrwqgndi-vakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs  273 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQGNDI-VAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS  273 (448)
T ss_pred             hhhhccCCCcccccccccCcch-hhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence            3457788899999999975544 44542     23345678899999999999999999999999999999999999999


Q ss_pred             ccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCC
Q 016588          163 VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS  242 (386)
Q Consensus       163 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~  242 (386)
                      |...++..   ..-..+-.+..+++.+++.|++|||+..+-|.---|....+++|++.+++|+--. +++.      -..
T Consensus       274 lynvlhe~---t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad-~kfs------fqe  343 (448)
T KOG0195|consen  274 LYNVLHEQ---TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMAD-TKFS------FQE  343 (448)
T ss_pred             HHHHHhcC---ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheeccc-ceee------eec
Confidence            99999754   3345677789999999999999999975444445789999999999988775211 1110      001


Q ss_pred             ccccCcccccchhhhcccCC---CcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcc
Q 016588          243 SQVTADEIFLASEVKEFRRF---SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS  319 (386)
Q Consensus       243 ~~~~~~~~y~aPE~~~~~~~---~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (386)
                      .+..-.+.|++||.++.+.-   -.++|+|||++++||+.|...||....+-               +--.++..++++.
T Consensus       344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm---------------ecgmkialeglrv  408 (448)
T KOG0195|consen  344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM---------------ECGMKIALEGLRV  408 (448)
T ss_pred             cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch---------------hhhhhhhhccccc
Confidence            11223456999999986543   35799999999999999999999987762               2223455667777


Q ss_pred             cCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhh
Q 016588          320 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  358 (386)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~  358 (386)
                      ..++..+..+.+||.-|.+.||.+||.+..++-.|+++.
T Consensus       409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            888888899999999999999999999999999998764

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=1.5e-24  Score=202.16  Aligned_cols=269  Identities=20%  Similarity=0.208  Sum_probs=199.8

Q ss_pred             CCCcCCeecccCceEEEEEEeCC--CcEEEEEECCCC---ChhHHHHHHHHHHcCCC----Ccccccccce-eeCCeEEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQD--GMLVAIKKRPGA---PTQEFIDEVCFLASIQH----RNLVTLLGYC-QENNLQFL  153 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~l~~l~h----~niv~~~~~~-~~~~~~~l  153 (386)
                      +|.+.+.||+|+||.||.+....  ...+|+|.....   ....+..|..++..+..    +++..+++.. ...+..|+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            78999999999999999999654  357888864332   12267788888888862    6888888888 47778899


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC-----CceEEcccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-----FIAKVADAG  228 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~-----~~~kl~DFg  228 (386)
                      ||+.+ +.+|.++....   ..+.++..+.++++.|++.+|.+||+  .|++||||||+|+++...     ..+.|.|||
T Consensus        99 VM~l~-G~sL~dl~~~~---~~~~fs~~T~l~ia~q~l~~l~~lH~--~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRN---PPGRFSRKTVLRIAIQNLNALEDLHS--KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEecc-CccHHHHHHhC---CCCCcCHhHHHHHHHHHHHHHHHHHh--cCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            99977 67888866332   24778999999999999999999999  779999999999999854     468999999


Q ss_pred             cccccC--CCCC----CC-C-CccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHH
Q 016588          229 LRNFLG--RTDV----AG-P-SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV  300 (386)
Q Consensus       229 l~~~~~--~~~~----~~-~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~  300 (386)
                      +++...  ....    .. . .....||..|.++.+..+...+.+.|+||++.++.|+..|..||...............
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~  252 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD  252 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence            998322  1111    11 1 23456999999999999999999999999999999999999999775543221111111


Q ss_pred             HhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh-cccccccCC
Q 016588          301 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE-MNLTTVMGE  370 (386)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~-~~~~~~~~~  370 (386)
                      .....       ...     .....+.++.++...+-..+...+|....+...|.++.... ....++..|
T Consensus       253 ~~~~~-------~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw  311 (322)
T KOG1164|consen  253 PRKLL-------TDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDW  311 (322)
T ss_pred             hhhhc-------ccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCcc
Confidence            10000       000     11222345677777777799999999999999998888774 455555554

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=4.7e-25  Score=205.42  Aligned_cols=163  Identities=18%  Similarity=0.216  Sum_probs=125.1

Q ss_pred             HHhcCCCcCCeecccCceEEEEEEeC--CCcEEEEEECCCC--------ChhHHHHHHHHHHcCCCCcccc-cccceeeC
Q 016588           80 LATKNFSDKNLIGEGKFGEVYKGLLQ--DGMLVAIKKRPGA--------PTQEFIDEVCFLASIQHRNLVT-LLGYCQEN  148 (386)
Q Consensus        80 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~--------~~~~~~~e~~~l~~l~h~niv~-~~~~~~~~  148 (386)
                      ....+|...+.||+|+||+||+|..+  +++.+|||+....        ....+.+|+++|+.++|+|++. ++++    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            34568999999999999999999864  4777899974322        1345889999999999999985 4432    


Q ss_pred             CeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCC-CCCCeeeCCCCceEEccc
Q 016588          149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDF-KTANVLVDEDFIAKVADA  227 (386)
Q Consensus       149 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dl-kp~Nill~~~~~~kl~DF  227 (386)
                      +..|+||||+++++|....      ...      ...++.++++||.|||+  +||+|||| ||+|||++.++.+||+||
T Consensus        91 ~~~~LVmE~~~G~~L~~~~------~~~------~~~~~~~i~~aL~~lH~--~gIiHrDL~KP~NILv~~~~~ikLiDF  156 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLAR------PHG------DPAWFRSAHRALRDLHR--AGITHNDLAKPQNWLMGPDGEAAVIDF  156 (365)
T ss_pred             CCcEEEEEccCCCCHHHhC------ccc------hHHHHHHHHHHHHHHHH--CCCeeCCCCCcceEEEcCCCCEEEEEC
Confidence            4579999999999886221      001      13578899999999999  78999999 999999999999999999


Q ss_pred             ccccccCCCCCCCC------CccccCcccccchhhhccc
Q 016588          228 GLRNFLGRTDVAGP------SSQVTADEIFLASEVKEFR  260 (386)
Q Consensus       228 gl~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~  260 (386)
                      |+++.+........      .....+++.|+|||.+...
T Consensus       157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            99987754322111      1344567778999987654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=5.1e-24  Score=179.59  Aligned_cols=260  Identities=18%  Similarity=0.225  Sum_probs=199.9

Q ss_pred             hcCCCcCCeecccCceEEEEEE-eCCCcEEEEEECC-CCChhHHHHHHHHHHcCCC-CcccccccceeeCCeEEEEEEee
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP-GAPTQEFIDEVCFLASIQH-RNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~-~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      ...|...+.||+|+||.+|.|. ..+|..||+|.-. ......+.-|..+.+.|++ ..|..+..+..+.+.-.+|||.+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL   93 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL   93 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc
Confidence            4578899999999999999999 6679999999844 3344567889999999965 78888888888888889999987


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC---CCceEEcccccccccCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADAGLRNFLGR  235 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~---~~~~kl~DFgl~~~~~~  235 (386)
                       +.+|.++.    +.....++..+++-++.|++.-++|+|.  .+.+||||||+|+|..-   ...+.++|||+++..-+
T Consensus        94 -GPsLEdLf----nfC~R~ftmkTvLMLaDQml~RiEyvH~--r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   94 -GPSLEDLF----NFCSRRFTMKTVLMLADQMLSRIEYVHL--RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             -CccHHHHH----HHHhhhhhHHhHHHHHHHHHHHHHHHHh--hccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence             77888877    3466788999999999999999999998  67999999999999863   35678999999987643


Q ss_pred             CC-----CCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          236 TD-----VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       236 ~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      ..     .........||..|.+-....+...+...|+-|+|.++.++--|..||.+.......+.++.+.......   
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~---  243 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST---  243 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC---
Confidence            22     1233456678999998887777777889999999999999999999999988765555544432222111   


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHh
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  357 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~  357 (386)
                        .-..+...+    |.++.-.+.-|-..--++-|...-+-+.+.-+
T Consensus       244 --~ie~LC~G~----P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL  284 (341)
T KOG1163|consen  244 --PIEVLCKGF----PAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL  284 (341)
T ss_pred             --CHHHHhCCC----cHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence              111222233    35567777888887777888877665555443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=2.6e-23  Score=182.85  Aligned_cols=261  Identities=17%  Similarity=0.253  Sum_probs=205.9

Q ss_pred             CCCcCCeecccCceEEEEEE-eCCCcEEEEEECC-CCChhHHHHHHHHHHcCC-CCcccccccceeeCCeEEEEEEeecC
Q 016588           84 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP-GAPTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      .|.+.+.||+|+||..+.|. +-+++.||||.-+ ++...++..|.+..+.|. .++|...|-|...+..-.||+|++ |
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G  107 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G  107 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence            68889999999999999999 5578999999754 344567889999999884 699999988877777778999987 6


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC-----CceEEcccccccccCC
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-----FIAKVADAGLRNFLGR  235 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~-----~~~kl~DFgl~~~~~~  235 (386)
                      .+|.++.    ..+...++..++..+|.|++.-++|+|+  +..|.|||||+|+||...     ..+.+.|||+|+...+
T Consensus       108 PSLEDLF----D~CgR~FSvKTV~miA~Qmi~rie~vH~--k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  108 PSLEDLF----DLCGRRFSVKTVAMIAKQMITRIEYVHE--KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             cCHHHHH----HHhcCcccHHhHHHHHHHHHHHHHHHHh--cceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            7888877    3577889999999999999999999999  569999999999999643     4689999999998755


Q ss_pred             CCC-----CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          236 TDV-----AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       236 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      ...     ........||..||+-....+...+..-|+-|+|=++++.+-|..||.+.........++.+........+.
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~  261 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIE  261 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHH
Confidence            432     223446679999999988888999999999999999999999999999987655544444332222221111


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      .     +    ..+.+.++..-+.-.=..+-.+-|..+-+...+..+++.
T Consensus       262 ~-----L----c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr  302 (449)
T KOG1165|consen  262 V-----L----CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR  302 (449)
T ss_pred             H-----H----HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence            1     1    222345566666666667778889999888888888866

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=7.6e-25  Score=216.95  Aligned_cols=252  Identities=22%  Similarity=0.260  Sum_probs=183.1

Q ss_pred             CcCCeecccCceEEEEEEeCC-CcEEEEEEC-----CCCChh----HHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           86 SDKNLIGEGKFGEVYKGLLQD-GMLVAIKKR-----PGAPTQ----EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~-----~~~~~~----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ....++|.|++|.|+...... ....+.|..     +.....    .+..|+.+-..++|+|++..+..+.+....+-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            345789999999887776332 332333321     111111    1455777777889999999888887777766679


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      |||++ +|..++.     ....+....+..++.|++.|++|+|+  .||.|||+|++|++++.++.+||+|||.+.....
T Consensus       401 E~~~~-Dlf~~~~-----~~~~~~~~e~~c~fKqL~~Gv~y~h~--~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~  472 (601)
T KOG0590|consen  401 EYCPY-DLFSLVM-----SNGKLTPLEADCFFKQLLRGVKYLHS--MGLAHRDLKLENLLVTENGILKIIDFGAASVFRY  472 (601)
T ss_pred             hcccH-HHHHHHh-----cccccchhhhhHHHHHHHHHHHHHHh--cCceeccCccccEEEecCCceEEeecCcceeecc
Confidence            99999 9988883     22467777888899999999999999  6799999999999999999999999999876543


Q ss_pred             CCCC--CCCccccCcccccchhhhcccCCCc-ccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          236 TDVA--GPSSQVTADEIFLASEVKEFRRFSE-KSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       236 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      ....  .......|...|+|||.+.+..|.+ ..||||.|+++..|.+|+.||......+... .+..     .......
T Consensus       473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~~~~-----~~~~~~~  546 (601)
T KOG0590|consen  473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-KTNN-----YSDQRNI  546 (601)
T ss_pred             CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-hhhc-----ccccccc
Confidence            3222  4455677888899999999999965 5899999999999999999998766543321 0000     0000000


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                       .... ...-...+.+.+.++.+||+.||.+|.|++++++.
T Consensus       547 -~~~~-~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  547 -FEGP-NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             -ccCh-HHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence             0000 01112334567899999999999999999999853

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.90  E-value=1.2e-22  Score=188.47  Aligned_cols=258  Identities=26%  Similarity=0.342  Sum_probs=192.4

Q ss_pred             CCcCCeecccCceEEEEEEeCCCcEEEEEECCCC------ChhHHHHHHHHHHcCCCC-cccccccceeeCCeEEEEEEe
Q 016588           85 FSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHR-NLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~  157 (386)
                      |...+.||.|+||.||.+...  ..+++|.+...      ....+.+|..++..+.|+ +++++.+++......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            566788999999999999976  67888864322      245688999999999887 799999999777778999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC-ceEEcccccccccCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNFLGRT  236 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~-~~kl~DFgl~~~~~~~  236 (386)
                      +.++++..++......  ..+.......+..|++.++.|+|+  .+++|||+||+||+++..+ .++++|||.+......
T Consensus        80 ~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~--~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          80 VDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHS--KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            9999998655322110  367888999999999999999999  6699999999999999988 7999999998865443


Q ss_pred             CCCC----CCccccCcccccchhhhcc---cCCCcccchhhHHHHHHHHHcCCCCCCCCCCC-chhhHHHHHHhhhcccc
Q 016588          237 DVAG----PSSQVTADEIFLASEVKEF---RRFSEKSDVYSFGVFLLELVSGREASSSLSPD-SSQDLVELVQNSRDFSN  308 (386)
Q Consensus       237 ~~~~----~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~  308 (386)
                      ....    ......++..|++||...+   ..++...|+||+|++++++++|..|+...... ........+......  
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--  233 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--  233 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc--
Confidence            3221    3456778999999999987   57889999999999999999999996654431 011111111111100  


Q ss_pred             hhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          309 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                         .................+.+++..|+..+|..|.+..+....
T Consensus       234 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 ---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence               000000000001223568899999999999999999988765

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.89  E-value=4.4e-24  Score=212.46  Aligned_cols=246  Identities=18%  Similarity=0.225  Sum_probs=176.9

Q ss_pred             CCCcCCeecccCceEEEEEEeCCCcEEEEEE----CCCCChhHHHHHHHHH--HcCCCCcccccccceeeCCeEEEEEEe
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK----RPGAPTQEFIDEVCFL--ASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~----~~~~~~~~~~~e~~~l--~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      ++...+.||++.|=+|.+|+.+.|. |+||.    .+......|.++++-.  ..++|||.+.+.-+-......|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5667789999999999999998876 77776    3334455665554443  345899999999888888888899998


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc--CC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL--GR  235 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~--~~  235 (386)
                      ... +|.+.+     ..++-+......-|+.|++.||..+|.  .||+|||||.+||||+..+-+.|+||..-+..  ..
T Consensus       103 vkh-nLyDRl-----STRPFL~~iEKkWiaFQLL~al~qcH~--~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  103 VKH-NLYDRL-----STRPFLVLIEKKWIAFQLLKALSQCHK--LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             Hhh-hhhhhh-----ccchHHHHHHHHHHHHHHHHHHHHHHH--cCccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            865 898888     345667777888899999999999999  77999999999999999999999999875432  22


Q ss_pred             CCCCCCCccc----cCcccccchhhhccc----------C-CCcccchhhHHHHHHHHHcC-CCCCCCCCCCchhhHHHH
Q 016588          236 TDVAGPSSQV----TADEIFLASEVKEFR----------R-FSEKSDVYSFGVFLLELVSG-REASSSLSPDSSQDLVEL  299 (386)
Q Consensus       236 ~~~~~~~~~~----~~~~~y~aPE~~~~~----------~-~~~~~DvwSlGvil~el~tg-~~p~~~~~~~~~~~~~~~  299 (386)
                       +.......+    ..-.+|.|||.+-..          . .+++.||||+||+++||++. .+||.      ..++..+
T Consensus       175 -DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~------LSQL~aY  247 (1431)
T KOG1240|consen  175 -DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT------LSQLLAY  247 (1431)
T ss_pred             -CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc------HHHHHhH
Confidence             111111111    223479999986531          1 56789999999999999995 55543      2222222


Q ss_pred             HHhhh-cccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHH
Q 016588          300 VQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  356 (386)
Q Consensus       300 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~  356 (386)
                      -.... ..+...+.+.           ...+++++..|++.||++|.++++.|+.-..
T Consensus       248 r~~~~~~~e~~Le~Ie-----------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  248 RSGNADDPEQLLEKIE-----------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             hccCccCHHHHHHhCc-----------CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence            21110 0111111111           1247899999999999999999999988433

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.88  E-value=1.1e-22  Score=193.05  Aligned_cols=220  Identities=25%  Similarity=0.361  Sum_probs=164.5

Q ss_pred             HHcCCCCcccccccceeeCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCC
Q 016588          130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDF  209 (386)
Q Consensus       130 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dl  209 (386)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+..    ....+++.....+.++++.||.|||+. +...|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~----~~~~~d~~F~~s~~rdi~~Gl~ylh~s-~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN----EDIKLDYFFILSFIRDISKGLAYLHNS-PIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc----cccCccHHHHHHHHHHHHHHHHHHhcC-cceeeeee
Confidence            3568899999999999999999999999999999999964    346688889999999999999999983 33399999


Q ss_pred             CCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccC-------CCcccchhhHHHHHHHHHcCC
Q 016588          210 KTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR-------FSEKSDVYSFGVFLLELVSGR  282 (386)
Q Consensus       210 kp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~DvwSlGvil~el~tg~  282 (386)
                      ++.|+++|....+||+|||+.................-...|.|||.+....       .+.++|+||||++++|+++.+
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            9999999999999999999987764311111111112234599999987631       466799999999999999999


Q ss_pred             CCCCCCCCCch-hhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          283 EASSSLSPDSS-QDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       283 ~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                      .||........ ..++..+....     ...+-|.++...  +.++++..++..||..+|++||+++++-..++.+....
T Consensus       156 ~~~~~~~~~~~~~eii~~~~~~~-----~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~  228 (484)
T KOG1023|consen  156 GPFDLRNLVEDPDEIILRVKKGG-----SNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG  228 (484)
T ss_pred             CccccccccCChHHHHHHHHhcC-----CCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence            99987544322 22332222200     011111111111  34457899999999999999999999999998877653

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=1.8e-22  Score=173.12  Aligned_cols=137  Identities=19%  Similarity=0.140  Sum_probs=105.6

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEECCCCCh------------hHH-----------------HHHHHHHHcCCCCcc
Q 016588           88 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT------------QEF-----------------IDEVCFLASIQHRNL  138 (386)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------~~~-----------------~~e~~~l~~l~h~ni  138 (386)
                      ...||+|+||.||+|...+|+.||+|+......            ..|                 ..|.+.+..+.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            467999999999999987899999998543211            112                 348899999987776


Q ss_pred             cccccceeeCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCceecCCCCCCeeeC
Q 016588          139 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL-HSLSPRVVHKDFKTANVLVD  217 (386)
Q Consensus       139 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~ivH~dlkp~Nill~  217 (386)
                      .....+...  ..++||||++++++.....     ....++......++.|++.+|.++ |+  .||+||||||+|||++
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~-----~~~~~~~~~~~~i~~qi~~~L~~l~H~--~giiHrDlkP~NIli~  152 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRL-----KDAPLSESKARELYLQVIQIMRILYQD--CRLVHADLSEYNLLYH  152 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhh-----hcCCCCHHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEE
Confidence            544333222  2389999999877654431     234678889999999999999999 67  6799999999999998


Q ss_pred             CCCceEEcccccccccC
Q 016588          218 EDFIAKVADAGLRNFLG  234 (386)
Q Consensus       218 ~~~~~kl~DFgl~~~~~  234 (386)
                       ++.++|+|||++...+
T Consensus       153 -~~~v~LiDFG~a~~~~  168 (190)
T cd05147         153 -DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             -CCcEEEEEccccccCC
Confidence             4789999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.86  E-value=9.3e-22  Score=170.89  Aligned_cols=169  Identities=13%  Similarity=0.128  Sum_probs=129.5

Q ss_pred             HHhcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCC--hhH----------HHHHHHHHHcCCCCcccccccceee
Q 016588           80 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP--TQE----------FIDEVCFLASIQHRNLVTLLGYCQE  147 (386)
Q Consensus        80 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~----------~~~e~~~l~~l~h~niv~~~~~~~~  147 (386)
                      ....+|...+++|.|+||.||.... ++..+|+|.+.+..  .+.          +.+|+..+.++.|++|..+..++..
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            3467899999999999999999765 46689999865321  111          5788889999999999999888553


Q ss_pred             C--------CeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC
Q 016588          148 N--------NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED  219 (386)
Q Consensus       148 ~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~  219 (386)
                      .        +..+++|||++|.+|.++..         ++.    ....+++.++..+|+  .|++|||++|+||+++++
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~--~gi~H~Dikp~Nili~~~  171 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQ--HGMVSGDPHKGNFIVSKN  171 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHH--cCCccCCCChHHEEEeCC
Confidence            3        35789999999999876631         122    245689999999998  779999999999999998


Q ss_pred             CceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHH
Q 016588          220 FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELV  279 (386)
Q Consensus       220 ~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~  279 (386)
                      + ++++|||.........              ....+.....|..++|+||||+++..+.
T Consensus       172 g-i~liDfg~~~~~~e~~--------------a~d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        172 G-LRIIDLSGKRCTAQRK--------------AKDRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             C-EEEEECCCcccccchh--------------hHHHHHHHhHhcccccccceeEeehHHH
Confidence            8 9999999876542211              0111334455778999999999887664

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=5.1e-21  Score=164.63  Aligned_cols=138  Identities=18%  Similarity=0.134  Sum_probs=106.7

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEECCCCCh-----------------------------hHHHHHHHHHHcCCCCcc
Q 016588           88 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT-----------------------------QEFIDEVCFLASIQHRNL  138 (386)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------------------------~~~~~e~~~l~~l~h~ni  138 (386)
                      ...||+|++|+||+|...+|+.||||.......                             ..+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            468999999999999977899999997543211                             113468888999988887


Q ss_pred             cccccceeeCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC
Q 016588          139 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE  218 (386)
Q Consensus       139 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~  218 (386)
                      .....+....  .++||||++++++.....     ....++......++.+++.++.++|+. .||+||||||+|||++ 
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l-----~~~~~~~~~~~~i~~~l~~~l~~lH~~-~givHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRL-----KDVPLEEEEAEELYEQVVEQMRRLYQE-AGLVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhh-----hhccCCHHHHHHHHHHHHHHHHHHHHh-CCEecCCCChhhEEEE-
Confidence            5544443332  489999999875533221     223466778899999999999999972 4699999999999999 


Q ss_pred             CCceEEcccccccccC
Q 016588          219 DFIAKVADAGLRNFLG  234 (386)
Q Consensus       219 ~~~~kl~DFgl~~~~~  234 (386)
                      ++.++|+|||++....
T Consensus       153 ~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCEEEEEcccceecC
Confidence            8899999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.8e-22  Score=191.68  Aligned_cols=222  Identities=24%  Similarity=0.283  Sum_probs=174.2

Q ss_pred             eecccCceEEEEEE----eCCCcEEEEEECCCC-----ChhHHHHHHHHHHcCC-CCcccccccceeeCCeEEEEEEeec
Q 016588           90 LIGEGKFGEVYKGL----LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEYIP  159 (386)
Q Consensus        90 ~lg~G~~g~V~~~~----~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~  159 (386)
                      .+|.|.||.|+.+.    .+.+..+|+|.....     .......|..++...+ ||.++++.-.++.....++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37899999998765    234666777752221     1124456777888886 9999999999999999999999999


Q ss_pred             CCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016588          160 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  239 (386)
Q Consensus       160 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~  239 (386)
                      +|+|...+.     ....+.+.....+...++-+++++|+  .+|+|||+|++||+++.+|++++.|||+++..-..+..
T Consensus        81 gg~lft~l~-----~~~~f~~~~~~~~~aelaLald~lh~--l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~  153 (612)
T KOG0603|consen   81 GGDLFTRLS-----KEVMFDELDVAFYLAELALALDHLHK--LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA  153 (612)
T ss_pred             cchhhhccc-----cCCchHHHHHHHHHHHHHHHHhhcch--hHHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence            999987773     34556677777888899999999999  77999999999999999999999999999876443222


Q ss_pred             CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcc
Q 016588          240 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS  319 (386)
Q Consensus       240 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (386)
                            +||..|||||++.  ....++|+||||++++||+||..||..       +...            .++..  ..
T Consensus       154 ------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~------------~Il~~--~~  204 (612)
T KOG0603|consen  154 ------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMK------------RILKA--EL  204 (612)
T ss_pred             ------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHHH------------HHhhh--cc
Confidence                  7888999999998  567899999999999999999999886       1111            11111  12


Q ss_pred             cCCHHHHHHHHHHHhHccCCCCCCCCCH
Q 016588          320 TFTNEGMEEFIQLIVRCLDPSSERRPSM  347 (386)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~  347 (386)
                      ..+......+.+++..++..+|.+|.-.
T Consensus       205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  205 EMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            4555667778899999999999999655

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=6.4e-21  Score=162.22  Aligned_cols=185  Identities=19%  Similarity=0.104  Sum_probs=134.6

Q ss_pred             cCCeecccCceEEEEEEeCCCcEEEEEECCCCCh--h-----HHHHHHHHHHcCC-CCcccccccceeeCCeEEEEEEee
Q 016588           87 DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT--Q-----EFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~-----~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      ....|++|+||+|+.+.- .+.+++.+.+.....  .     .+.+|+++|++++ |+++++++++    +..+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            457899999999996665 567777665543322  2     4788999999995 5889999886    3468999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCC-CCCCeeeCCCCceEEcccccccccCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDF-KTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dl-kp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      .+.+|.....      .      ....++.|++.+|.++|+  .||+|||| ||+|||++.++.++|+|||++.......
T Consensus        81 ~G~~L~~~~~------~------~~~~~~~qi~~~L~~lH~--~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         81 AGAAMYQRPP------R------GDLAYFRAARRLLQQLHR--CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             cCccHHhhhh------h------hhHHHHHHHHHHHHHHHH--CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            9988754320      0      113467899999999999  77999999 7999999999999999999998654322


Q ss_pred             CC----C-C------CccccCcccccchhhhcc-cCCC-cccchhhHHHHHHHHHcCCCCCCCCCC
Q 016588          238 VA----G-P------SSQVTADEIFLASEVKEF-RRFS-EKSDVYSFGVFLLELVSGREASSSLSP  290 (386)
Q Consensus       238 ~~----~-~------~~~~~~~~~y~aPE~~~~-~~~~-~~~DvwSlGvil~el~tg~~p~~~~~~  290 (386)
                      ..    . .      ......++.|+.|+-... ...+ ...++++-|+-+|.++|+..+..+..+
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence            10    0 0      001123555777764332 2334 567999999999999999988766544

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=1.3e-20  Score=190.75  Aligned_cols=255  Identities=19%  Similarity=0.277  Sum_probs=187.0

Q ss_pred             HHHHHHhcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCChhHHHHHHHHHHcCC---CCcccccccceeeCCeEE
Q 016588           76 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ---HRNLVTLLGYCQENNLQF  152 (386)
Q Consensus        76 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~  152 (386)
                      .+.++....|.+.+.+|.|+||+||+|...+++.||+|.-++...-+|.-=.+++.+|+   -+.|..+.....-.+.-+
T Consensus       691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~  770 (974)
T KOG1166|consen  691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASV  770 (974)
T ss_pred             ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence            45556677899999999999999999998889999999866665555544455555555   234455555555667778


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC-------CCCceEEc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-------EDFIAKVA  225 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~-------~~~~~kl~  225 (386)
                      +|+||.+.|+|.+++.     ..+..++..+..++.|++.-++.||.  .+|||+||||+|+||.       +...++|+
T Consensus       771 lv~ey~~~Gtlld~~N-----~~~~m~e~lv~~~~~qml~ive~lH~--~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  771 LVSEYSPYGTLLDLIN-----TNKVMDEYLVMFFSCQMLRIVEHLHA--MGIIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             eeeeccccccHHHhhc-----cCCCCCchhhhHHHHHHHHHHHHHHh--cceecccCCcceeEeecccCCCCcccceEEE
Confidence            9999999999999984     55678899999999999999999999  5699999999999993       34468999


Q ss_pred             ccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhh--
Q 016588          226 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS--  303 (386)
Q Consensus       226 DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~--  303 (386)
                      |||-+-.+.-............|..+--+|+..|+.++.+.|.|.++.+++-|+.|+.--              +.+.  
T Consensus       844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--------------~~~g~~  909 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--------------VKNGSS  909 (974)
T ss_pred             ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--------------hcCCcc
Confidence            999987654322222334556777888999999999999999999999999999996421              1000  


Q ss_pred             hccc-chhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhc
Q 016588          304 RDFS-NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  362 (386)
Q Consensus       304 ~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~  362 (386)
                      |... .+.+..+.           +...+++..+|+.|-..=|...++...|++.+.+..
T Consensus       910 ~~~~~~~~Ry~~~-----------~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~  958 (974)
T KOG1166|consen  910 WMVKTNFPRYWKR-----------DMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHF  958 (974)
T ss_pred             eeccccchhhhhH-----------HHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHH
Confidence            0000 01111111           224567777777555445888888888888777654

>PRK10345 hypothetical protein; Provisional

Probab=99.82  E-value=4.4e-20  Score=159.86  Aligned_cols=134  Identities=19%  Similarity=0.255  Sum_probs=101.9

Q ss_pred             CCcCCeecccCceEEEEEEeCCCcEEEEEECCCC---ChhHHHHHHHHHHcC-----CCCcccccccceeeCC---eEE-
Q 016588           85 FSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA---PTQEFIDEVCFLASI-----QHRNLVTLLGYCQENN---LQF-  152 (386)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~---~~~-  152 (386)
                      +...+.||+|+||.||. .-.++.. +||+....   ..+.+.+|+.+++.+     +||||++++|++.++.   ..+ 
T Consensus         4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            34467899999999996 3223444 68875433   456789999999999     5799999999998863   333 


Q ss_pred             EEEEe--ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHH-HHhhcCCCCceecCCCCCCeeeCC----CCceEEc
Q 016588          153 LIYEY--IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL-AHLHSLSPRVVHKDFKTANVLVDE----DFIAKVA  225 (386)
Q Consensus       153 lv~e~--~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~ivH~dlkp~Nill~~----~~~~kl~  225 (386)
                      +|+||  +.+++|.+++..      ..+++.  ..++.+++.++ +|||+  ++|+||||||+|||++.    +..++|+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~------~~~~e~--~~~~~~~L~~l~~yLh~--~~IvhrDlKp~NILl~~~~~~~~~~~Li  151 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQ------CRYEED--VAQLRQLLKKLKRYLLD--NRIVTMELKPQNILCQRISESEVIPVVC  151 (210)
T ss_pred             EEecCCCCcchhHHHHHHc------ccccHh--HHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEeccCCCCCcEEEE
Confidence            78999  557899999832      224443  35677888787 89999  77999999999999974    3489999


Q ss_pred             ccccc
Q 016588          226 DAGLR  230 (386)
Q Consensus       226 DFgl~  230 (386)
                      ||+.+
T Consensus       152 Dg~G~  156 (210)
T PRK10345        152 DNIGE  156 (210)
T ss_pred             ECCCC
Confidence            95544

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=3.1e-20  Score=167.19  Aligned_cols=201  Identities=18%  Similarity=0.218  Sum_probs=140.5

Q ss_pred             CCCcccccccceee---------------------------CCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHH
Q 016588          134 QHRNLVTLLGYCQE---------------------------NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI  186 (386)
Q Consensus       134 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i  186 (386)
                      +|||||++.++|.+                           +..+|+||..++. +|..++.      ....+.....-+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~------~~~~s~r~~~~~  346 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW------TRHRSYRTGRVI  346 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh------cCCCchHHHHHH
Confidence            59999999987632                           3457999998866 8888873      334566677779


Q ss_pred             HHHHHHHHHHhhcCCCCceecCCCCCCeee--CCC--CceEEcccccccccCCCCCC----CCCccccCcccccchhhhc
Q 016588          187 ALGAAKGLAHLHSLSPRVVHKDFKTANVLV--DED--FIAKVADAGLRNFLGRTDVA----GPSSQVTADEIFLASEVKE  258 (386)
Q Consensus       187 ~~~i~~~l~~LH~~~~~ivH~dlkp~Nill--~~~--~~~kl~DFgl~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~  258 (386)
                      +.|+++|+.|||+  +||.|||+|.+|||+  |+|  ....++|||.+.-.......    +..-..-|...-||||+..
T Consensus       347 laQlLEav~hL~~--hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  347 LAQLLEAVTHLHK--HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHHH--ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            9999999999999  679999999999999  344  36789999986443221111    1111223556689999875


Q ss_pred             ccC------CCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHH
Q 016588          259 FRR------FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQL  332 (386)
Q Consensus       259 ~~~------~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  332 (386)
                      ...      --.++|.|+.|.+.||+++...||.+..+-. .+...              ..+...+..++.++..+.++
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~r~--------------Yqe~qLPalp~~vpp~~rql  489 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDTRT--------------YQESQLPALPSRVPPVARQL  489 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-echhh--------------hhhhhCCCCcccCChHHHHH
Confidence            321      1247899999999999999999998733210 00000              11111234455566778999


Q ss_pred             HhHccCCCCCCCCCHHHHHHHHHHhh
Q 016588          333 IVRCLDPSSERRPSMSDVVTELDRTL  358 (386)
Q Consensus       333 i~~cl~~dp~~Rpt~~evl~~L~~~~  358 (386)
                      +...|+.||++|++..-....|.=-+
T Consensus       490 V~~lL~r~pskRvsp~iAANvl~LsL  515 (598)
T KOG4158|consen  490 VFDLLKRDPSKRVSPNIAANVLNLSL  515 (598)
T ss_pred             HHHHhcCCccccCCccHHHhHHHHHH
Confidence            99999999999999876666654433

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.82  E-value=2.7e-20  Score=166.52  Aligned_cols=230  Identities=23%  Similarity=0.277  Sum_probs=141.6

Q ss_pred             CCcCCeecccCceEEEEEEeC-CCcEEEEEEC--CCCC----hhHHHHHHHHHHcCC----------CCcccccccce--
Q 016588           85 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKR--PGAP----TQEFIDEVCFLASIQ----------HRNLVTLLGYC--  145 (386)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~--~~~~----~~~~~~e~~~l~~l~----------h~niv~~~~~~--  145 (386)
                      +...+.||.|+++.||.++.. +++.+|+|..  +...    .+++.+|.-....+.          |-.++..++..  
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            344678999999999999965 4899999972  2222    233444443333321          11222222221  


Q ss_pred             -------eeC---C-----eEEEEEEeecCCCcccccc---CCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceec
Q 016588          146 -------QEN---N-----LQFLIYEYIPNGSVSIHLY---GPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHK  207 (386)
Q Consensus       146 -------~~~---~-----~~~lv~e~~~~g~L~~~l~---~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~  207 (386)
                             ...   .     ..+++|+-+ .++|.+++.   .... ....+....++.+..|+++.+++||+  .|++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~-~~~~l~~~arl~lT~Q~I~lvA~Lh~--~GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQ-THSPLAFAARLSLTVQMIRLVANLHS--YGLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTT-TSHHHHHHHHHHHHHHHHHHHHHHHH--TTEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhccc-ccchhHHHHHHHHHHHHHHHHHHHhh--cceEec
Confidence                   111   1     225677766 457766542   1111 12334455667777999999999999  779999


Q ss_pred             CCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccc--------CCCcccchhhHHHHHHHHH
Q 016588          208 DFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR--------RFSEKSDVYSFGVFLLELV  279 (386)
Q Consensus       208 dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~DvwSlGvil~el~  279 (386)
                      ||+|+|++++.+|.++|+||+.....+....     ....+..|.+||.....        .++.+.|.|++|+++|.|.
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            9999999999999999999988765543111     12344668999976442        4788999999999999999


Q ss_pred             cCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCC
Q 016588          280 SGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERR  344 (386)
Q Consensus       280 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  344 (386)
                      +|..||....+....+.                    ...... +.++.++.||..+|+.+|++|
T Consensus       245 C~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999987654222110                    122333 677889999999999999988

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.82  E-value=1.3e-20  Score=187.67  Aligned_cols=212  Identities=23%  Similarity=0.270  Sum_probs=147.7

Q ss_pred             HHhcCCCcCCeecccCceEEEEEEeCC-CcEEEEEECCCCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           80 LATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        80 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      ....+|..++.+..|+||.||...++. .+.+|+|+-++.         .++++     |..+.      +..+.|    
T Consensus        80 p~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~---------lilRn-----ilt~a------~npfvv----  135 (1205)
T KOG0606|consen   80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN---------LILRN-----ILTFA------GNPFVV----  135 (1205)
T ss_pred             CCccccceeEeeccCCCCceeeeeccccccchhhcccccc---------hhhhc-----ccccc------CCccee----
Confidence            345689999999999999999998764 678888643322         12221     11111      111222    


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                        |+-...+.     +.+.++.        +++.+++|||+  .||+|||+||+|.+|+.-|++|++|||+++.......
T Consensus       136 --gDc~tllk-----~~g~lPv--------dmvla~Eylh~--ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 --GDCATLLK-----NIGPLPV--------DMVLAVEYLHS--YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             --chhhhhcc-----cCCCCcc--------hhhHHhHhhcc--CCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence              44444442     2223332        12679999999  6799999999999999999999999999765321100


Q ss_pred             -------------CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc
Q 016588          239 -------------AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD  305 (386)
Q Consensus       239 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  305 (386)
                                   .-.....++|+.|.|||++..+.|+..+|+|++|+++||.+.|+.||.+..+++   +...+-    
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee---lfg~vi----  271 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LFGQVI----  271 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH---HHhhhh----
Confidence                         011235589999999999999999999999999999999999999999876532   221111    


Q ss_pred             ccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCC
Q 016588          306 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS  346 (386)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt  346 (386)
                             -|...|.+.....+.++.+++.+.|+.+|..|.-
T Consensus       272 -------sd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  272 -------SDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             -------hhhccccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence                   1222234444445677899999999999999943

>smart00090 RIO RIO-like kinase

Probab=99.80  E-value=4.3e-19  Score=157.36  Aligned_cols=139  Identities=18%  Similarity=0.137  Sum_probs=107.2

Q ss_pred             CCCcCCeecccCceEEEEEE--eCCCcEEEEEECCCCCh---------------------------hHHHHHHHHHHcCC
Q 016588           84 NFSDKNLIGEGKFGEVYKGL--LQDGMLVAIKKRPGAPT---------------------------QEFIDEVCFLASIQ  134 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~---------------------------~~~~~e~~~l~~l~  134 (386)
                      .|.+.+.||+|+||.||+|.  ..+++.||+|.......                           ..+..|...+..+.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47788999999999999998  56799999997543210                           12457899999886


Q ss_pred             CC--cccccccceeeCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-ceecCCCC
Q 016588          135 HR--NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR-VVHKDFKT  211 (386)
Q Consensus       135 h~--niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-ivH~dlkp  211 (386)
                      +.  .+++++++    ...++||||+++++|.....     ............++.|++.++.+||+  .+ ++||||||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~--~g~iiH~Dikp  177 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL-----KDVEPEEEEEFELYDDILEEMRKLYK--EGELVHGDLSE  177 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCccccccc-----ccCCcchHHHHHHHHHHHHHHHHHHh--cCCEEeCCCCh
Confidence            53  33444432    23489999999988876542     12334555667899999999999998  77 99999999


Q ss_pred             CCeeeCCCCceEEcccccccccC
Q 016588          212 ANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       212 ~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      +||+++ ++.++|+|||.+...+
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhccC
Confidence            999999 8899999999987543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=2.8e-18  Score=150.27  Aligned_cols=131  Identities=21%  Similarity=0.293  Sum_probs=109.1

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEECCCCC-----------hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           89 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      +.||+|++|.||+|.. .+..+++|......           ...+.+|+.++..+.|+++.....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 56788888743221           12467889999999999998888777777788999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~  232 (386)
                      +++++|.+++...        .. ....++.+++.+|.++|+  .+++|+|++|.|||++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~--~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHS--AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHh--CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999998887321        11 678899999999999999  7799999999999999 78899999998764

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.76  E-value=5e-18  Score=147.12  Aligned_cols=141  Identities=21%  Similarity=0.127  Sum_probs=107.8

Q ss_pred             HHHHHhcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCC-------------------------hhHHHHHHHHHH
Q 016588           77 ELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-------------------------TQEFIDEVCFLA  131 (386)
Q Consensus        77 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~e~~~l~  131 (386)
                      .+......|...+.||+|+||.||++..++++.||||..+...                         ......|..++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            3444444477789999999999999998789999999743221                         112566788888


Q ss_pred             cCCCCc--ccccccceeeCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCC
Q 016588          132 SIQHRN--LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDF  209 (386)
Q Consensus       132 ~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dl  209 (386)
                      .+.|++  ++..++    ....++||||+++++|.....     .      .....++.+++.++.++|+  .+++||||
T Consensus        89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~-----~------~~~~~~~~~i~~~l~~lh~--~gi~H~Dl  151 (198)
T cd05144          89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV-----L------EDPEEVLDEILEEIVKAYK--HGIIHGDL  151 (198)
T ss_pred             HHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc-----c------ccHHHHHHHHHHHHHHHHH--CCCCcCCC
Confidence            887764  444443    234589999999998875541     0      2345688899999999999  77999999


Q ss_pred             CCCCeeeCCCCceEEcccccccccC
Q 016588          210 KTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       210 kp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      ||+||++++++.++|+|||.+....
T Consensus       152 ~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         152 SEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CcccEEEcCCCcEEEEECCccccCC
Confidence            9999999999999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.75  E-value=3.3e-19  Score=166.60  Aligned_cols=175  Identities=21%  Similarity=0.342  Sum_probs=129.8

Q ss_pred             eEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 016588          150 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  229 (386)
Q Consensus       150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl  229 (386)
                      .+|+.|++|...+|.+|+...+  .....++...+.++.|++.|+.|     ++.+|+|+||.||+...+..+||.|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~--~~e~~s~s~~~~~~~q~~~~~~y-----k~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRR--TGEERSLSLMLDIFKQIAPAVEY-----KGLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCC--cccccchhHHHHHHHhhccchhh-----ccchhhhccccccccccchhhhhhhhhh
Confidence            4689999999999999996543  34556777889999999999999     4599999999999999999999999999


Q ss_pred             ccccCCCC----CCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc
Q 016588          230 RNFLGRTD----VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD  305 (386)
Q Consensus       230 ~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  305 (386)
                      ........    .....+...+|..||+||.+.+..|+.++||||||++|+|+++-.   +...     ....      .
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f---~T~~-----er~~------t  468 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQF---STQF-----ERIA------T  468 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHh---ccHH-----HHHH------h
Confidence            87765433    122345677999999999999999999999999999999998721   1100     0000      0


Q ss_pred             ccchh-hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHH
Q 016588          306 FSNLL-KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV  350 (386)
Q Consensus       306 ~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ev  350 (386)
                      ..++. ..+++..+...+.     -+.++.+++...|.+||++.+.
T Consensus       469 ~~d~r~g~ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  469 LTDIRDGIIPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             hhhhhcCCCChHHhhcCcH-----HHHHHHHhcCCCcccCchHHHH
Confidence            11111 1122222223332     4689999999999999955444

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.75  E-value=7.8e-18  Score=146.04  Aligned_cols=128  Identities=22%  Similarity=0.308  Sum_probs=102.9

Q ss_pred             eecccCceEEEEEEeCCCcEEEEEECCCCC-----------hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           90 LIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        90 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      .||+|+||.||+|.+ ++..+++|......           ..++.+|++++..++|+++.....++...+..+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999996 46788888733211           134668999999998887766665666666778999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      ++++|.+++...     ..       .++.+++.+|.+||+  .+++|+|++|.||+++ ++.+++.|||++...
T Consensus        80 ~g~~l~~~~~~~-----~~-------~~~~~i~~~l~~lH~--~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEG-----ND-------ELLREIGRLVGKLHK--AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhc-----HH-------HHHHHHHHHHHHHHH--CCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            999998776321     10       689999999999999  7799999999999999 889999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.74  E-value=8e-18  Score=167.31  Aligned_cols=134  Identities=23%  Similarity=0.283  Sum_probs=108.4

Q ss_pred             cCCCcCCeecccCceEEEEEEeCCCcEEEEEE-CCCC----------ChhHHHHHHHHHHcCCCCcccccccceeeCCeE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGA----------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  151 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~-~~~~----------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  151 (386)
                      ..|...+.||+|+||+||+|.+.... +++|+ ....          ..+.+.+|++++..++|++++....++...+..
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            34566789999999999999875443 33332 2111          123578899999999999999888777777778


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      ++||||+++++|.+++.             ....++.+++.+|.+||+  .+++||||||+|||+ +++.++|+|||+++
T Consensus       412 ~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~--~giiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHK--AGIVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             EEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHh--CCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            99999999999987762             346789999999999999  779999999999999 67899999999987


Q ss_pred             cc
Q 016588          232 FL  233 (386)
Q Consensus       232 ~~  233 (386)
                      ..
T Consensus       476 ~~  477 (535)
T PRK09605        476 YS  477 (535)
T ss_pred             cC
Confidence            63

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.66  E-value=1.3e-17  Score=165.72  Aligned_cols=253  Identities=19%  Similarity=0.203  Sum_probs=184.1

Q ss_pred             cCCCcCCeecccCceEEEEEEeCC--CcEEEEEECCCCC--h---hHHHHHHHHHHcCC-CCcccccccceeeCCeEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQD--GMLVAIKKRPGAP--T---QEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~--~---~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv  154 (386)
                      ..|...+.||+|.|+.|-......  ...+|+|......  .   .....|..+-..+. |+|++.+++...+.+..++.
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            356667789999999998887533  4556666533221  1   12233555656665 99999999999999999999


Q ss_pred             EEeecCCCccccc-cCCCcCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCCceecCCCCCCeeeCCCC-ceEEccccccc
Q 016588          155 YEYIPNGSVSIHL-YGPSQVSRQKLEFKHRLSIALGAAKGLAHLH-SLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRN  231 (386)
Q Consensus       155 ~e~~~~g~L~~~l-~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~ivH~dlkp~Nill~~~~-~~kl~DFgl~~  231 (386)
                      .+|..++++...+ +..    ....+....-.++.|+..++.|+| .  .++.|||+||+|.+++..+ ..+++|||+|.
T Consensus       100 ~~~s~g~~~f~~i~~~~----~~~~~~~~~~~~~~ql~s~l~~~H~~--~~~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPD----STGTSSSSASRYLPQLNSGLSYLHPE--NGVTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             cCcccccccccccccCC----ccCCCCcchhhhhhhhccCccccCcc--cccccCCCCCccchhccCCCcccCCCchhhc
Confidence            9999999998777 321    113344455678999999999999 6  7799999999999999999 99999999998


Q ss_pred             ccCC-CCCCCCCccccC-cccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccc
Q 016588          232 FLGR-TDVAGPSSQVTA-DEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN  308 (386)
Q Consensus       232 ~~~~-~~~~~~~~~~~~-~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  308 (386)
                      .... ...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+......... ...+....     
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~~-----  247 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSNK-----  247 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecccc-----
Confidence            7765 344444445566 8889999999875 4478899999999999999999998876653311 11111110     


Q ss_pred             hhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          309 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                        .......|..    ......+++.+++..+|..|.+.+++-..
T Consensus       248 --~~~~~~~~~~----~~~~~~~~l~k~l~~~~~~r~s~~~~~~d  286 (601)
T KOG0590|consen  248 --GRFTQLPWNS----ISDQAHDLLHKILKENPSNRLSIEELKLD  286 (601)
T ss_pred             --cccccCcccc----CChhhhhcccccccCCchhcccccccccc
Confidence              0111112222    23456889999999999999999988644

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.66  E-value=1.1e-15  Score=125.75  Aligned_cols=133  Identities=23%  Similarity=0.274  Sum_probs=110.5

Q ss_pred             cCCeecccCceEEEEEEeCCCcEEEEEECCCCC-hhHHHHHHHHHHcCCC--CcccccccceeeCCeEEEEEEeecCCCc
Q 016588           87 DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-TQEFIDEVCFLASIQH--RNLVTLLGYCQENNLQFLIYEYIPNGSV  163 (386)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~L  163 (386)
                      +.+.||.|.++.||++...+ ..+++|...... ...+.+|...+..++|  .++++++++....+..++++||+.++.+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~   80 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL   80 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence            34679999999999999854 688999865443 3578899999999976  5899998888887889999999988776


Q ss_pred             cccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCceecCCCCCCeeeCCCCceEEcccccccc
Q 016588          164 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS-PRVVHKDFKTANVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       164 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~  232 (386)
                      ..+            +......++.+++.++.++|... .+++|+|++|+||++++.+.+++.|||.+..
T Consensus        81 ~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          81 DEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            533            44566778999999999999742 4699999999999999999999999998764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.64  E-value=8.2e-16  Score=131.94  Aligned_cols=134  Identities=22%  Similarity=0.222  Sum_probs=92.9

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEECCCCCh-----hHH----------------------HHHHHHHHcCCCC--cc
Q 016588           88 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT-----QEF----------------------IDEVCFLASIQHR--NL  138 (386)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~~~----------------------~~e~~~l~~l~h~--ni  138 (386)
                      .+.||+|+||+||+|...+++.||||.......     ..+                      ..|...+..+.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            467999999999999987899999997543211     111                      2344444444332  23


Q ss_pred             cccccceeeCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC
Q 016588          139 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE  218 (386)
Q Consensus       139 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~  218 (386)
                      .+.+++    ...++||||++++.+......     ..... .....++.+++.++.++|+. .+|+|+||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~-----~~~~~-~~~~~~~~~~~~~l~~lh~~-~~ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLK-----DVRLL-EDPEELYDQILELMRKLYRE-AGLVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhh-----hhhhc-ccHHHHHHHHHHHHHHHhhc-cCcCcCCCChhhEEEE-
Confidence            333332    235899999998654322110     00011 45678899999999999972 4699999999999999 


Q ss_pred             CCceEEccccccccc
Q 016588          219 DFIAKVADAGLRNFL  233 (386)
Q Consensus       219 ~~~~kl~DFgl~~~~  233 (386)
                      ++.++++|||.+...
T Consensus       150 ~~~~~liDfg~a~~~  164 (187)
T cd05119         150 DGKVYIIDVPQAVEI  164 (187)
T ss_pred             CCcEEEEECcccccc
Confidence            899999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.63  E-value=1.9e-15  Score=134.26  Aligned_cols=132  Identities=16%  Similarity=0.129  Sum_probs=99.4

Q ss_pred             CCeec-ccCceEEEEEEeCCCcEEEEEECCC----------------CChhHHHHHHHHHHcCCCCcc--cccccceeeC
Q 016588           88 KNLIG-EGKFGEVYKGLLQDGMLVAIKKRPG----------------APTQEFIDEVCFLASIQHRNL--VTLLGYCQEN  148 (386)
Q Consensus        88 ~~~lg-~G~~g~V~~~~~~~~~~vavK~~~~----------------~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~  148 (386)
                      ...|| .|+.|+||.+... +..+++|....                .....+.+|++++..++|+++  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35687 7889999998875 66788885421                122457789999999988775  6666664332


Q ss_pred             -C---eEEEEEEeecC-CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceE
Q 016588          149 -N---LQFLIYEYIPN-GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAK  223 (386)
Q Consensus       149 -~---~~~lv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~k  223 (386)
                       .   ..++|+|++++ .+|.+++..      ..++..    .+.+++.+|.+||+  +||+||||||.|||++.++.++
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~------~~l~~~----~~~~i~~~l~~lH~--~GI~HrDlkp~NILv~~~~~v~  182 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE------APLSEE----QWQAIGQLIARFHD--AGVYHADLNAHNILLDPDGKFW  182 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc------CCCCHH----HHHHHHHHHHHHHH--CCCCCCCCCchhEEEcCCCCEE
Confidence             2   23599999997 688777632      223332    35689999999999  7899999999999999999999


Q ss_pred             Ecccccccc
Q 016588          224 VADAGLRNF  232 (386)
Q Consensus       224 l~DFgl~~~  232 (386)
                      |+|||.+..
T Consensus       183 LIDfg~~~~  191 (239)
T PRK01723        183 LIDFDRGEL  191 (239)
T ss_pred             EEECCCccc
Confidence            999998765

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.57  E-value=1.1e-14  Score=140.50  Aligned_cols=138  Identities=19%  Similarity=0.204  Sum_probs=94.8

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEECCCCChhHHHHHHHHH-------------------------------------
Q 016588           88 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFL-------------------------------------  130 (386)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l-------------------------------------  130 (386)
                      .+.||+|++|+||+|++++|+.||||+..+...+.+..++.++                                     
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            3679999999999999999999999987665444433333222                                     


Q ss_pred             ------HcC----C-CCcccccccceeeCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHH-HHHHhh
Q 016588          131 ------ASI----Q-HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK-GLAHLH  198 (386)
Q Consensus       131 ------~~l----~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~-~l~~LH  198 (386)
                            ..+    + ++++.-..-+.......++||||++|++|.+.....    ....+   ...++..++. .+..+|
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~----~~~~~---~~~ia~~~~~~~l~ql~  274 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD----EAGLD---RKALAENLARSFLNQVL  274 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH----hcCCC---HHHHHHHHHHHHHHHHH
Confidence                  222    1 222221111122234568999999999998765321    11112   3345666655 467788


Q ss_pred             cCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          199 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       199 ~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      .  .|++|+|++|.||++++++.++++|||++..+.
T Consensus       275 ~--~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       275 R--DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             h--CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            7  779999999999999999999999999987664

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.55  E-value=3.1e-15  Score=132.20  Aligned_cols=205  Identities=21%  Similarity=0.256  Sum_probs=141.5

Q ss_pred             HHHcCCCCcccccccceeeCC-----eEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 016588          129 FLASIQHRNLVTLLGYCQENN-----LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR  203 (386)
Q Consensus       129 ~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~  203 (386)
                      -|-++-|.||++++.|+.+..     ...++.||+..|++..++.... .+...+......+++.||+.||.|||+..+.
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~-~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTK-KNQKALFQKAWKKWCTQILSALSYLHSCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHH-HhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence            344557999999999986543     4678999999999999985432 2456677888899999999999999999999


Q ss_pred             ceecCCCCCCeeeCCCCceEEccccccccc--CCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcC
Q 016588          204 VVHKDFKTANVLVDEDFIAKVADAGLRNFL--GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG  281 (386)
Q Consensus       204 ivH~dlkp~Nill~~~~~~kl~DFgl~~~~--~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg  281 (386)
                      |+|+++..+.|++..++-+|+.--.-....  .............+.++|.+||.-.....+.++|||+||+...||..+
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            999999999999999988887532211110  000001112233456779999987767778899999999999999887


Q ss_pred             CCCCC-CCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          282 REASS-SLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       282 ~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                      ...-. +......+.-+.         .....+..           ..=..++.+|++-.|..||+|.+++-|.
T Consensus       279 Eiq~tnseS~~~~ee~ia---------~~i~~len-----------~lqr~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  279 EIQSTNSESKVEVEENIA---------NVIIGLEN-----------GLQRGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             eeccCCCcceeehhhhhh---------hheeeccC-----------ccccCcCcccccCCCCCCcchhhhhcCc
Confidence            64311 111100000000         00000000           0124688999999999999999998764

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.50  E-value=2.5e-14  Score=136.51  Aligned_cols=249  Identities=23%  Similarity=0.241  Sum_probs=178.0

Q ss_pred             HhcCCCcCCeecc--cCceEEEEEEe--C-CCcEEEEEEC--CC---CChhHHHHHHHHHHcC-CCCcccccccceeeCC
Q 016588           81 ATKNFSDKNLIGE--GKFGEVYKGLL--Q-DGMLVAIKKR--PG---APTQEFIDEVCFLASI-QHRNLVTLLGYCQENN  149 (386)
Q Consensus        81 ~~~~~~~~~~lg~--G~~g~V~~~~~--~-~~~~vavK~~--~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  149 (386)
                      ..+.|...+.+|.  |.+|.||.+..  + ++..+|+|+-  +.   .....=.+|+..-.++ .|+|.++.+..+...+
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~  191 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG  191 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence            3456777889999  99999999986  3 4778898862  21   1222334566666666 4999999999999999


Q ss_pred             eEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHH----HHHHhhcCCCCceecCCCCCCeeeCCC-CceEE
Q 016588          150 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK----GLAHLHSLSPRVVHKDFKTANVLVDED-FIAKV  224 (386)
Q Consensus       150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~ivH~dlkp~Nill~~~-~~~kl  224 (386)
                      ..|+-.|++. .+|..+.+..    ...++....+....+...    ||.++|+  ++++|.|+||.||+..++ ..+++
T Consensus       192 ~lfiqtE~~~-~sl~~~~~~~----~~~~p~~~l~~~~~~~~~~~~~al~~~hs--~~~~~~~~kp~~i~~~~~~~s~~~  264 (524)
T KOG0601|consen  192 ILFIQTELCG-ESLQSYCHTP----CNFLPDNLLWNSLRDWLSRDVTALSHLHS--NNIVHDDLKPANIFTTSDWTSCKL  264 (524)
T ss_pred             cceeeecccc-chhHHhhhcc----cccCCchhhhhHHhhhhhcccccccccCC--Ccccccccchhheecccccceeec
Confidence            9999999886 5777666433    233555566667777777    9999999  779999999999999999 89999


Q ss_pred             cccccccccCCCCCCCC---CccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHH
Q 016588          225 ADAGLRNFLGRTDVAGP---SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ  301 (386)
Q Consensus       225 ~DFgl~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~  301 (386)
                      +|||+...++.......   .....+...|++||... ..++..+|+||+|.++.+...+..+........         
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~---------  334 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS---------  334 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC---------
Confidence            99999888765443222   12224666799999887 467899999999999999999876554431111         


Q ss_pred             hhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          302 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                          +.+..+..   +..++......++...+..|++.+|..|++.+.+.++
T Consensus       335 ----W~~~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  335 ----WSQLRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             ----cccccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence                11111111   1122222333445668999999999999999887643

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.41  E-value=3.5e-13  Score=131.66  Aligned_cols=141  Identities=16%  Similarity=0.098  Sum_probs=87.9

Q ss_pred             cCCCcCCeecccCceEEEEEEeCC-CcEEEEEECCCCChhHHH-------------------------------------
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFI-------------------------------------  124 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~-------------------------------------  124 (386)
                      ..|.. +.||+|++|+||+|.+++ |+.||||+..+...+.+.                                     
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45665 789999999999999877 999999987654322211                                     


Q ss_pred             HHHHHHHcCCCCcccccccceee-------------CCeEEEEEEeecCCCccccccCCCc-CCCCCCCHHHHHHHHHHH
Q 016588          125 DEVCFLASIQHRNLVTLLGYCQE-------------NNLQFLIYEYIPNGSVSIHLYGPSQ-VSRQKLEFKHRLSIALGA  190 (386)
Q Consensus       125 ~e~~~l~~l~h~niv~~~~~~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~i  190 (386)
                      +|+.+....  +|+.++...+.+             ....+|||||++|+.+.+....... .....+.......++.|+
T Consensus       199 ~ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi  276 (537)
T PRK04750        199 DELDLMREA--ANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV  276 (537)
T ss_pred             HhhCHHHHH--HHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence            222221111  233333322222             3345699999999998764211100 001122222233333333


Q ss_pred             HHHHHHhhcCCCCceecCCCCCCeeeCCCC----ceEEcccccccccCC
Q 016588          191 AKGLAHLHSLSPRVVHKDFKTANVLVDEDF----IAKVADAGLRNFLGR  235 (386)
Q Consensus       191 ~~~l~~LH~~~~~ivH~dlkp~Nill~~~~----~~kl~DFgl~~~~~~  235 (386)
                             ..  .|++|+|++|.||+++.++    .+++.|||++..+..
T Consensus       277 -------f~--~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 -------FR--DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -------Hh--CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                   33  5699999999999999888    999999999876643

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.38  E-value=2.6e-12  Score=108.21  Aligned_cols=128  Identities=16%  Similarity=0.076  Sum_probs=93.9

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEECCCCC--hhHHHHHHHHHHcCCCCcc-cccccceeeCCeEEEEEEeecCCCcc
Q 016588           88 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP--TQEFIDEVCFLASIQHRNL-VTLLGYCQENNLQFLIYEYIPNGSVS  164 (386)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~L~  164 (386)
                      .+.++.|.++.||++... +..+++|......  ...+..|..+++.+.+.++ .+++.+..  ...++||||+++.++.
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~   79 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELL   79 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccc
Confidence            356889999999999875 6789999865443  3456789999998865443 44554433  3357999999998775


Q ss_pred             ccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC---CCceecCCCCCCeeeCCCCceEEcccccccc
Q 016588          165 IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS---PRVVHKDFKTANVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       165 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~  232 (386)
                      ...          .   .....+.+++.+|..||+.+   .+++|+|++|.||+++ ++.++++|||.+..
T Consensus        80 ~~~----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          80 TED----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            331          0   11235678999999999832   1259999999999999 66899999998653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.35  E-value=1.4e-11  Score=119.11  Aligned_cols=164  Identities=20%  Similarity=0.176  Sum_probs=117.9

Q ss_pred             eCCCcEEEEEECCCCC---hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCCCccccccCCCcCCCCCCCH
Q 016588          104 LQDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF  180 (386)
Q Consensus       104 ~~~~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~  180 (386)
                      ..++.+|.|...+...   .+...+.++.|+.++||||++++......+..|+|+|-+.  .|...+..        +..
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~--------l~~  103 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE--------LGK  103 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--------hHH
Confidence            3356677776543333   3456777889999999999999999999999999999875  34444421        223


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccc
Q 016588          181 KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR  260 (386)
Q Consensus       181 ~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  260 (386)
                      ....--+.||+.||.|||.. .+++|++|..+.|+++..|+.||++|.++........  +.....--..|..|+.+...
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~d-~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s  180 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLNDD-CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhcc-CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence            44555789999999999863 5799999999999999999999999988765433221  11111111225666654332


Q ss_pred             CCCcccchhhHHHHHHHHHcCC
Q 016588          261 RFSEKSDVYSFGVFLLELVSGR  282 (386)
Q Consensus       261 ~~~~~~DvwSlGvil~el~tg~  282 (386)
                      .  ...|.|.|||+++|++.|.
T Consensus       181 ~--~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  181 E--WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             c--cchhhhhHHHHHHHHhCcc
Confidence            2  3569999999999999993

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.30  E-value=3.1e-11  Score=102.85  Aligned_cols=134  Identities=18%  Similarity=0.092  Sum_probs=93.6

Q ss_pred             CeecccCceEEEEEEeCC-------CcEEEEEECCC-------------------------CChhHH----HHHHHHHHc
Q 016588           89 NLIGEGKFGEVYKGLLQD-------GMLVAIKKRPG-------------------------APTQEF----IDEVCFLAS  132 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~-------------------------~~~~~~----~~e~~~l~~  132 (386)
                      ..||.|--+.||.|...+       +..+|||+...                         .....+    .+|...|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            568999999999998542       47899995110                         001122    378888888


Q ss_pred             CC--CCcccccccceeeCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCceecCC
Q 016588          133 IQ--HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL-HSLSPRVVHKDF  209 (386)
Q Consensus       133 l~--h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~ivH~dl  209 (386)
                      +.  .-++++++++    ...++||||+.++.+....     .....++......+..+++.+|..+ |+  .+++|+||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~-----Lkd~~~~~~~~~~i~~~i~~~l~~l~H~--~glVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPK-----LKDAKLNDEEMKNAYYQVLSMMKQLYKE--CNLVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchh-----hhccccCHHHHHHHHHHHHHHHHHHHHh--CCeecCCC
Confidence            84  3566666654    3457999999765442111     1112234445667788999999998 77  67999999


Q ss_pred             CCCCeeeCCCCceEEcccccccccC
Q 016588          210 KTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       210 kp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      ++.|||++ ++.+.++|||.+-...
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeCC
Confidence            99999997 4679999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.28  E-value=3.8e-12  Score=121.68  Aligned_cols=246  Identities=23%  Similarity=0.279  Sum_probs=172.7

Q ss_pred             HHHhcCCCcCCeecccCceEEEEEEeC--CCcEEEEEECCCCChhH-----HHHHHHHHHcC-CCCcccccccceeeCCe
Q 016588           79 SLATKNFSDKNLIGEGKFGEVYKGLLQ--DGMLVAIKKRPGAPTQE-----FIDEVCFLASI-QHRNLVTLLGYCQENNL  150 (386)
Q Consensus        79 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~-----~~~e~~~l~~l-~h~niv~~~~~~~~~~~  150 (386)
                      .....+|.....||.|.|+.|+....+  ++..+++|...+.....     -..|+.+...+ .|.++++++..+.....
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            344567888999999999999998854  47788888644332221     13455555555 58999998888888888


Q ss_pred             EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC-CceEEccccc
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGL  229 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~-~~~kl~DFgl  229 (386)
                      .|+-.|||+++++....     .....++....+++..|++.++.++|+  ..++|+|+||+||++..+ +..++.|||.
T Consensus       341 ~~ip~e~~~~~s~~l~~-----~~~~~~d~~~~~~~~~q~~~~l~~i~s--~~~~~~d~~psni~i~~~~~~~~~~~~~~  413 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRS-----VTSQMLDEDPRLRLTAQILTALNVIHS--KLFVHLDVKPSNILISNDGFFSKLGDFGC  413 (524)
T ss_pred             ccCchhhhcCcchhhhh-----HHHHhcCcchhhhhHHHHHhccccccc--hhhhcccccccceeeccchhhhhcccccc
Confidence            88999999999987665     233456777788999999999999998  679999999999999886 7889999998


Q ss_pred             ccccCCCCCCCCCccccCcccc-cchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccc
Q 016588          230 RNFLGRTDVAGPSSQVTADEIF-LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN  308 (386)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~y-~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  308 (386)
                      ...+....    .........| .+|.......+..+.|++|||..+.|..++..--.....                  
T Consensus       414 ~t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~------------------  471 (524)
T KOG0601|consen  414 WTRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ------------------  471 (524)
T ss_pred             ccccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCccccc------------------
Confidence            86532211    1111223334 355555566778899999999999999998642221110                  


Q ss_pred             hhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016588          309 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  355 (386)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~  355 (386)
                      .. .+..+.....+... .++..+.+.+...++..||.+.++..+.+
T Consensus       472 ~~-~i~~~~~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  472 SL-TIRSGDTPNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             ce-eeecccccCCCchH-HhhhhhhhhhcCCccccchhhhhhcccch
Confidence            00 00111111122222 56788999999999999999998876544

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.24  E-value=3e-12  Score=128.80  Aligned_cols=246  Identities=22%  Similarity=0.225  Sum_probs=168.0

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeCC-CcEEEEEE---CCCC---ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEE
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKK---RPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~---~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (386)
                      ..+++.+.+-+-+|.++.++.+.-.. +...+.|.   .+..   ..+....+-.++-.-++|-+++..-.+.-....+|
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            44567777888899999999877432 43333332   1111   11122222222222345666665555556677899


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      +++|+.+++|...+++..     ..+..-.......+..+++|||+  ..+.|+|++|.|.+...++..+++|||.....
T Consensus       882 ~~~~~~~~~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~s--~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSG-----CLSAEPARSPILERVQSLESLHS--SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             hhHHhccCCchhhhhcCC-----CcccccccchhHHHHhhhhcccc--chhhcccccccchhhcccCCcccCcccccccc
Confidence            999999999988886542     23333344566677889999998  44899999999999999999999999843222


Q ss_pred             CCC-----------------------------CCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCC
Q 016588          234 GRT-----------------------------DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA  284 (386)
Q Consensus       234 ~~~-----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p  284 (386)
                      +-.                             ..........+|+.|.+||...+......+|+|+.|++++|.++|..|
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence            100                             000112234578899999999999999999999999999999999999


Q ss_pred             CCCCCCCchhhHHHHHHhhhcccchhhhcch-hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHH
Q 016588          285 SSSLSPDSSQDLVELVQNSRDFSNLLKILDE-RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMS  348 (386)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~  348 (386)
                      |....+...-               ..++.. ..|...+...+.+..+++...+..+|.+|..+.
T Consensus      1035 ~na~tpq~~f---------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQIF---------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCcchhhhh---------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            9986653211               111111 124555666677889999999999999998776

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.22  E-value=2e-10  Score=100.97  Aligned_cols=138  Identities=22%  Similarity=0.336  Sum_probs=104.4

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEECCCC----ChhHHHHHHHHHHcCCC--CcccccccceeeC---CeEEEEEEeec
Q 016588           89 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGA----PTQEFIDEVCFLASIQH--RNLVTLLGYCQEN---NLQFLIYEYIP  159 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~---~~~~lv~e~~~  159 (386)
                      +.|+.|..+.||++...+|..+++|.....    ....+..|.++++.+.+  .++.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            568999999999999876688999985443    24578899999999865  4467777776653   25689999999


Q ss_pred             CCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 016588          160 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL---------------------------------------  200 (386)
Q Consensus       160 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------------------------------------  200 (386)
                      +.++...+..      ..++......++.+++.+|..||+.                                       
T Consensus        84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            9888765420      2355666667777777777777742                                       


Q ss_pred             ---------------CCCceecCCCCCCeeeCC--CCceEEcccccccc
Q 016588          201 ---------------SPRVVHKDFKTANVLVDE--DFIAKVADAGLRNF  232 (386)
Q Consensus       201 ---------------~~~ivH~dlkp~Nill~~--~~~~kl~DFgl~~~  232 (386)
                                     ...++|+|+.|.||++++  ++.+.++||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                           134699999999999998  66789999987653

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.22  E-value=1e-10  Score=96.57  Aligned_cols=129  Identities=21%  Similarity=0.292  Sum_probs=96.4

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEE-CCCCC----------hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           89 NLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAP----------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~~~~vavK~-~~~~~----------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      ..+++|+-+.+|.+.+. +..+++|. .++..          ...-.+|..++.+++--.|...+=+..+.+...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35788999999999774 34477775 22222          12345788888888655555555556666777799999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      .++..|.+.+...            ...++..+-.-+.-||.  +||+|+||.++||++..+. +.++||||+.+.
T Consensus        81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~--~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          81 IEGELLKDALEEA------------RPDLLREVGRLVGKLHK--AGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             eCChhHHHHHHhc------------chHHHHHHHHHHHHHHh--cCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            9999888887321            24466777777888998  7899999999999998776 899999998753

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.14  E-value=3.9e-10  Score=92.77  Aligned_cols=141  Identities=19%  Similarity=0.221  Sum_probs=99.0

Q ss_pred             cCCeecccCceEEEEEEeCCCcEEEEEEC-CCCC----------hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           87 DKNLIGEGKFGEVYKGLLQDGMLVAIKKR-PGAP----------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~-~~~~----------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ...++-+|+-+.|+++.++ |+...||.. ++..          ..+..+|.+.|.++.--.|.-..=++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4578889999999999985 677778752 2221          234567888888876444544444555655667999


Q ss_pred             EeecC-CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC---ceEEccccccc
Q 016588          156 EYIPN-GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF---IAKVADAGLRN  231 (386)
Q Consensus       156 e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~---~~kl~DFgl~~  231 (386)
                      ||+++ .++.+++....  .....+ .....++..+-+.+.-||.  ++|+|+||..+||+|.+++   .+.++|||++.
T Consensus        90 E~~~g~~~vk~~i~~~~--~~~~~d-~~~~~~~~~iG~~igklH~--ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTM--EDESED-EGLAELARRIGELIGKLHD--NDIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EeccchhHHHHHHHHHc--cCcccc-hhHHHHHHHHHHHHHHhhh--CCeecccccccceEEecCCCcCceEEEeecchh
Confidence            99977 46666664321  112222 2225678888889999998  7899999999999996554   45899999987


Q ss_pred             cc
Q 016588          232 FL  233 (386)
Q Consensus       232 ~~  233 (386)
                      ..
T Consensus       165 ~s  166 (229)
T KOG3087|consen  165 VS  166 (229)
T ss_pred             cc
Confidence            54

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.01  E-value=1.2e-08  Score=96.27  Aligned_cols=167  Identities=19%  Similarity=0.250  Sum_probs=124.3

Q ss_pred             ceEEEEEEeC-CCcEEEEEEC---CCCChhHHHHHHHHHHcCCCCccccccccee----eCCeEEEEEEeecC-CCcccc
Q 016588           96 FGEVYKGLLQ-DGMLVAIKKR---PGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ----ENNLQFLIYEYIPN-GSVSIH  166 (386)
Q Consensus        96 ~g~V~~~~~~-~~~~vavK~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~-g~L~~~  166 (386)
                      -.+.|++..+ +|..|++|++   +.........-++.++++.|.|+|++..++.    ....+++|++|+++ ++|.+.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            3578999844 6888999886   2233444556688999999999999998876    24567899999875 455544


Q ss_pred             ccCCC----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          167 LYGPS----------QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       167 l~~~~----------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      .+...          .......++..++.++.|+..||.++|+  .|..-+-|.|.+||++.+.+++|+..|....+...
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs--sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS--SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh--cCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            33221          1233457788999999999999999999  66888999999999999999999999887665332


Q ss_pred             CCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCC
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE  283 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~  283 (386)
                      .              .+|  +.   --.+-|.=.||.+++.|.||..
T Consensus       447 ~--------------~~~--le---~~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  447 P--------------TEP--LE---SQQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             C--------------Ccc--hh---HHhhhhHHHHHHHHHHHhhccc
Confidence            1              011  11   1235689999999999999964

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.95  E-value=5.1e-09  Score=88.95  Aligned_cols=122  Identities=20%  Similarity=0.199  Sum_probs=76.7

Q ss_pred             EEEEEEeCCCcEEEEEECCCCC-----------------------------hhHHHHHHHHHHcCCCC--ccccccccee
Q 016588           98 EVYKGLLQDGMLVAIKKRPGAP-----------------------------TQEFIDEVCFLASIQHR--NLVTLLGYCQ  146 (386)
Q Consensus        98 ~V~~~~~~~~~~vavK~~~~~~-----------------------------~~~~~~e~~~l~~l~h~--niv~~~~~~~  146 (386)
                      .||.|...++..+|+|+.....                             .....+|.+.|..+..-  ++++++.+. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            3899998889999999522110                             01246799999999754  566766442 


Q ss_pred             eCCeEEEEEEeec--CCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHH-hhcCCCCceecCCCCCCeeeCCCCceE
Q 016588          147 ENNLQFLIYEYIP--NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH-LHSLSPRVVHKDFKTANVLVDEDFIAK  223 (386)
Q Consensus       147 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~ivH~dlkp~Nill~~~~~~k  223 (386)
                         ..++||||++  +..+..+...       .++......++.+++..+.. +|.  .||+|+||.+.|||++++ .+.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~-------~~~~~~~~~~~~~il~~~~~~~~~--~givHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDV-------DLSPEEPKELLEEILEEIIKMLHK--AGIVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHC-------GGGGSTHHHHHHHHHHHHHHHHHC--TTEEESS-STTSEEEETT-CEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhc-------cccchhHHHHHHHHHHHHHHHHHh--cCceecCCChhhEEeecc-eEE
Confidence               2359999998  5444332211       11112334567777775555 467  779999999999999988 999


Q ss_pred             Eccccccccc
Q 016588          224 VADAGLRNFL  233 (386)
Q Consensus       224 l~DFgl~~~~  233 (386)
                      ++|||.+...
T Consensus       147 iIDf~qav~~  156 (188)
T PF01163_consen  147 IIDFGQAVDS  156 (188)
T ss_dssp             E--GTTEEET
T ss_pred             EEecCcceec
Confidence            9999987654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.91  E-value=1.7e-08  Score=90.83  Aligned_cols=138  Identities=14%  Similarity=0.081  Sum_probs=94.6

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEECCCCC--------------hhHHHHHHHHHHcCCCCccc--ccccceee-----
Q 016588           89 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP--------------TQEFIDEVCFLASIQHRNLV--TLLGYCQE-----  147 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------------~~~~~~e~~~l~~l~h~niv--~~~~~~~~-----  147 (386)
                      +.+-......|++..+ +|+.+.||......              ...+.+|...+..+...+|.  ..+++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            3344334445667666 46789999643222              11477888888887433333  33444432     


Q ss_pred             CCeEEEEEEeecCC-CccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-------C
Q 016588          148 NNLQFLIYEYIPNG-SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-------D  219 (386)
Q Consensus       148 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~-------~  219 (386)
                      ...-++|+|++++. +|.+++...   .....+......++.+++..+.-||.  .||+|+|++++|||++.       +
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~---~~~~~~~~~~~~ll~~la~~i~~LH~--~Gi~HgDL~~~NiLl~~~~~~~~~~  181 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADW---ATNPPDPRLKRMLIKRVATMVRDMHA--AGINHRDCYICHFLLHLPFPGREED  181 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHH--CcCccCCCChhhEEEeccccCCCCC
Confidence            23568999999875 777776321   12234455667899999999999999  78999999999999975       4


Q ss_pred             CceEEcccccccc
Q 016588          220 FIAKVADAGLRNF  232 (386)
Q Consensus       220 ~~~kl~DFgl~~~  232 (386)
                      ..+.++||+.+..
T Consensus       182 ~~~~LIDl~r~~~  194 (268)
T PRK15123        182 LKLSVIDLHRAQI  194 (268)
T ss_pred             ceEEEEECCcccc
Confidence            6889999998753

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.88  E-value=7.7e-10  Score=107.67  Aligned_cols=150  Identities=20%  Similarity=0.193  Sum_probs=102.2

Q ss_pred             HHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC-------CCccccCcccccchhhhcccC
Q 016588          189 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG-------PSSQVTADEIFLASEVKEFRR  261 (386)
Q Consensus       189 ~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~  261 (386)
                      +++.|+.|+|.. .++||++|.|++|.++..+..||+.|+.+-.........       ..........|.|||++.+..
T Consensus       107 ~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~  185 (700)
T KOG2137|consen  107 NVADGLAFLHRS-AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT  185 (700)
T ss_pred             cccchhhhhccC-cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence            345899999984 789999999999999999999999999865543311111       111122334699999999888


Q ss_pred             CCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCC
Q 016588          262 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSS  341 (386)
Q Consensus       262 ~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp  341 (386)
                      .+.++|+||+||++|-+..|..+..........  +.          .....+..-......+.++++.+=+.+++..++
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~--~~----------~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~  253 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS--YS----------FSRNLLNAGAFGYSNNLPSELRESLKKLLNGDS  253 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcch--hh----------hhhcccccccccccccCcHHHHHHHHHHhcCCc
Confidence            899999999999999999544433221111100  00          011111111223345667889999999999999


Q ss_pred             CCCCCHHHHH
Q 016588          342 ERRPSMSDVV  351 (386)
Q Consensus       342 ~~Rpt~~evl  351 (386)
                      .-||++.++.
T Consensus       254 ~~rp~~~~l~  263 (700)
T KOG2137|consen  254 AVRPTLDLLL  263 (700)
T ss_pred             ccCcchhhhh
Confidence            9999776654

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.88  E-value=4.5e-08  Score=90.38  Aligned_cols=266  Identities=17%  Similarity=0.131  Sum_probs=154.1

Q ss_pred             cCCeecccCceEEEEEEeCCCcEEEEEECCCCChhHHHHHHHHHHcC-CCCcccccccc------eeeCCe-EEEEEEee
Q 016588           87 DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGY------CQENNL-QFLIYEYI  158 (386)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~------~~~~~~-~~lv~e~~  158 (386)
                      ....||+|+-+.+|-.-.- +..|| |+...-....-.+.+..|.+. .||-+..-+.+      ..+... .-++|..+
T Consensus        15 ~gr~LgqGgea~ly~l~e~-~d~VA-KIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v   92 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV-RDQVA-KIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKV   92 (637)
T ss_pred             CCccccCCccceeeecchh-hchhh-eeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecccC
Confidence            3577999999999854321 11222 442211111112233344443 46644431111      112222 34566666


Q ss_pred             cCCCccccccCC--CcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          159 PNGSVSIHLYGP--SQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       159 ~~g~L~~~l~~~--~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      .+..=-..+++.  +...-...+|...++.+..++.+.+-||.  .|-+-+|+.++|+|+++++.+.|.|=..-....  
T Consensus        93 ~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~--~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~--  168 (637)
T COG4248          93 SGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE--HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINA--  168 (637)
T ss_pred             CCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh--cCCcccccCccceeeecCceEEEEcccceeecc--
Confidence            543211112211  12234567899999999999999999998  668889999999999999999998854322221  


Q ss_pred             CCCCCCccccCcccccchhhhc-----ccCCCcccchhhHHHHHHHHHcC-CCCCCCCCCCch--hhHHHHHHhhhcccc
Q 016588          237 DVAGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSG-REASSSLSPDSS--QDLVELVQNSRDFSN  308 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlGvil~el~tg-~~p~~~~~~~~~--~~~~~~~~~~~~~~~  308 (386)
                       .........+...|.+||.-.     +-.-+...|-|.||+++++++.| ..||++......  ..+...+- .-.+..
T Consensus       169 -ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia-~g~f~y  246 (637)
T COG4248         169 -NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA-HGRFAY  246 (637)
T ss_pred             -CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh-cceeee
Confidence             111122345667799999754     22346789999999999999986 899988553211  00000000 000000


Q ss_pred             hhh---hcchhhcccCCHHHHHHHHHHHhHccCC--CCCCCCCHHHHHHHHHHhhhh
Q 016588          309 LLK---ILDERLWSTFTNEGMEEFIQLIVRCLDP--SSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       309 ~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~--dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      ..+   -..+......-...++++..+..+|+..  ++.-|||++-.+..|..+-.+
T Consensus       247 a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~  303 (637)
T COG4248         247 ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ  303 (637)
T ss_pred             chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence            000   0000011111112346788899999986  467899999999999888776

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.82  E-value=4.1e-08  Score=86.09  Aligned_cols=131  Identities=21%  Similarity=0.149  Sum_probs=91.7

Q ss_pred             CCcCCeecccCceEEEEEEeCCCcEEEEEECCCCC-------------------------hhHHHHHHHHHHcCCCC--c
Q 016588           85 FSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-------------------------TQEFIDEVCFLASIQHR--N  137 (386)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~e~~~l~~l~h~--n  137 (386)
                      ..+...||-|--+.||.|..++|.+++||.-....                         ....++|.++|..|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            34568899999999999999999999999411110                         11246789999998654  7


Q ss_pred             ccccccceeeCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC
Q 016588          138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD  217 (386)
Q Consensus       138 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~  217 (386)
                      +++.+++    +...+||||.++-.|...-          ++....-.++..|+.-+.-+-.  .||||+|+.+-||+++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~--~GiVHGDlSefNIlV~  236 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYR--RGIVHGDLSEFNILVT  236 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHH--cCccccCCchheEEEe
Confidence            7777765    4456999999886554322          0111222344444444444434  6799999999999999


Q ss_pred             CCCceEEccccccc
Q 016588          218 EDFIAKVADAGLRN  231 (386)
Q Consensus       218 ~~~~~kl~DFgl~~  231 (386)
                      ++|.+.++||--+.
T Consensus       237 ~dg~~~vIDwPQ~v  250 (304)
T COG0478         237 EDGDIVVIDWPQAV  250 (304)
T ss_pred             cCCCEEEEeCcccc
Confidence            99999999995443

>PRK09902 hypothetical protein; Provisional

Probab=98.63  E-value=5.1e-07  Score=77.35  Aligned_cols=135  Identities=11%  Similarity=0.040  Sum_probs=98.1

Q ss_pred             ecccCceEEEEEEeCCCcEEEEEECC---------CCChhHHHHHHHHHHcCCC--Cccccccccee-e----CCeEEEE
Q 016588           91 IGEGKFGEVYKGLLQDGMLVAIKKRP---------GAPTQEFIDEVCFLASIQH--RNLVTLLGYCQ-E----NNLQFLI  154 (386)
Q Consensus        91 lg~G~~g~V~~~~~~~~~~vavK~~~---------~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~-~----~~~~~lv  154 (386)
                      -|+||.+.|++..+.+ ..+-+|.-.         +.....|.+|+..+..+..  -.+.+.. ++. .    .-.-+||
T Consensus        26 ~~rgG~SgV~r~~~~g-~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERNG-KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeCC-cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            4679999999988754 468888632         4456789999999998853  2344444 332 1    1235789


Q ss_pred             EEeecC-CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc--eEEccccccc
Q 016588          155 YEYIPN-GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI--AKVADAGLRN  231 (386)
Q Consensus       155 ~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~--~kl~DFgl~~  231 (386)
                      +|-+.+ -+|.+++...   .....+......+..+++..+.-||+  .|+.|+|+-+.||+++.++.  ++++||.-++
T Consensus       104 Te~L~g~~~L~~~l~~~---~~~~~~~~~k~~il~~va~~ia~LH~--~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQH---AVSPYSDEVRQAMLKAVALAFKKMHS--VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcC---CcCCcchHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            997753 4677676321   22345666778899999999999999  77999999999999986666  9999997654


Q ss_pred             c
Q 016588          232 F  232 (386)
Q Consensus       232 ~  232 (386)
                      .
T Consensus       179 ~  179 (216)
T PRK09902        179 R  179 (216)
T ss_pred             h
Confidence            3

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.62  E-value=2.3e-07  Score=90.54  Aligned_cols=137  Identities=19%  Similarity=0.190  Sum_probs=88.5

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEECCCCChhHHHHHHHHHH-------------------------------------
Q 016588           89 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLA-------------------------------------  131 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~-------------------------------------  131 (386)
                      +.|+.++-|+||+|++++|+.||||+..+...+.+...+.+|+                                     
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            6799999999999999999999999866655443333322222                                     


Q ss_pred             ------cC----C-CCcccccccceeeCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHH-HHHhhc
Q 016588          132 ------SI----Q-HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG-LAHLHS  199 (386)
Q Consensus       132 ------~l----~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~-l~~LH~  199 (386)
                            ++    + .+++.-..=|..-.+...|+|||++|-.+.+.....    ....+...   ++..++.+ +..+-.
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~----~~g~d~k~---ia~~~~~~f~~q~~~  283 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK----SAGIDRKE---LAELLVRAFLRQLLR  283 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH----hcCCCHHH---HHHHHHHHHHHHHHh
Confidence                  22    1 222222222223345567999999998888775322    12333222   22222222 122222


Q ss_pred             CCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          200 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       200 ~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                        .|+.|.|..|.||+++.++.+.+.|||+...+.
T Consensus       284 --dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         284 --DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             --cCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence              469999999999999999999999999977654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.59  E-value=2.4e-07  Score=80.57  Aligned_cols=107  Identities=21%  Similarity=0.233  Sum_probs=79.6

Q ss_pred             ChhHHHHHHHHHHcCCC--CcccccccceeeC----CeEEEEEEeecCC-CccccccCCCcCCCCCCCHHHHHHHHHHHH
Q 016588          119 PTQEFIDEVCFLASIQH--RNLVTLLGYCQEN----NLQFLIYEYIPNG-SVSIHLYGPSQVSRQKLEFKHRLSIALGAA  191 (386)
Q Consensus       119 ~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~  191 (386)
                      ......+|...+..+..  -..++.+++....    ...++|+|++++. +|.+++...     ...+......++.+++
T Consensus        54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~-----~~~~~~~~~~ll~~l~  128 (206)
T PF06293_consen   54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW-----EQLDPSQRRELLRALA  128 (206)
T ss_pred             cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh-----cccchhhHHHHHHHHH
Confidence            34467788887777743  3344555555442    2458999999874 677777321     1245556778999999


Q ss_pred             HHHHHhhcCCCCceecCCCCCCeeeCCCC---ceEEcccccccc
Q 016588          192 KGLAHLHSLSPRVVHKDFKTANVLVDEDF---IAKVADAGLRNF  232 (386)
Q Consensus       192 ~~l~~LH~~~~~ivH~dlkp~Nill~~~~---~~kl~DFgl~~~  232 (386)
                      ..+.-||.  +||+|+|+++.|||++.+.   .+.++||+-++.
T Consensus       129 ~~i~~lH~--~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  129 RLIAKLHD--AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHHHH--CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99999999  7899999999999999887   899999987664

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.43  E-value=4.3e-08  Score=94.83  Aligned_cols=190  Identities=22%  Similarity=0.130  Sum_probs=136.2

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCChhHHHHHHHHHHcCCCCc-ccccccceeeCCeEEEEEEeecC
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRN-LVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      +..+...+.+++|+++.+++.+-........+.+...  ....-++++|.+++||| .+..++-+...+..+++++++.+
T Consensus       241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~--l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~  318 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT--LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST  318 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc--hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence            3344455678889999999877322223335544332  34456788999999999 77777777777888899999987


Q ss_pred             C-CccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016588          161 G-SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  239 (386)
Q Consensus       161 g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~  239 (386)
                      + +......    .....+...+...+...-.++++++|+.  .-+|+|    ||+..+ +..+..||+....+....  
T Consensus       319 ~rs~~~~~~----~se~~~~~~~~~~~~r~et~~l~~l~~~--~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--  385 (829)
T KOG0576|consen  319 GRSSALEMT----VSEIALEQYQFAYPLRKETRPLAELHSS--YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--  385 (829)
T ss_pred             CccccccCC----hhhHhhhhhhhhhhhhhhcccccccccc--cccCcc----cccccc-cccccccccCCcccCccc--
Confidence            7 3222221    1223344445556667778899999983  248998    777665 677999999988775543  


Q ss_pred             CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCC
Q 016588          240 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS  287 (386)
Q Consensus       240 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~  287 (386)
                       ......+++.|+|||+.....+....|+|++|+-..++.-|.+|-..
T Consensus       386 -~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  386 -KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             -ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence             33455688889999999999999999999999988888888877665

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.42  E-value=3.4e-06  Score=73.49  Aligned_cols=133  Identities=20%  Similarity=0.220  Sum_probs=87.1

Q ss_pred             eecccCceEEEEEEeCCCcEEEEEECCCCChh---------------------------HHHHHHHHHHcCC--CCcccc
Q 016588           90 LIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---------------------------EFIDEVCFLASIQ--HRNLVT  140 (386)
Q Consensus        90 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------------------------~~~~e~~~l~~l~--h~niv~  140 (386)
                      .|++|.-+.||+|...++..+|+|+.......                           -..+|..-|+++.  +-.+++
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            45567788899999878899999974332211                           0234566666552  445555


Q ss_pred             cccceeeCCeEEEEEEeecCCCc-cccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC
Q 016588          141 LLGYCQENNLQFLIYEYIPNGSV-SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED  219 (386)
Q Consensus       141 ~~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~  219 (386)
                      .+++..    -.|||||+..... .-.|      ..-.+.......+..++++.+.-|-. ..++||+||..-|||++ +
T Consensus       135 Pi~~~~----nVLvMEfIg~~g~pAP~L------kDv~~e~~e~~~~~~~~v~~~~~l~~-~a~LVHgDLSEyNiL~~-~  202 (268)
T COG1718         135 PIAFRN----NVLVMEFIGDDGLPAPRL------KDVPLELEEAEGLYEDVVEYMRRLYK-EAGLVHGDLSEYNILVH-D  202 (268)
T ss_pred             ceeecC----CeEEEEeccCCCCCCCCc------ccCCcCchhHHHHHHHHHHHHHHHHH-hcCcccccchhhheEEE-C
Confidence            555433    2599999865421 1111      11222222456677778888777764 25799999999999999 8


Q ss_pred             CceEEcccccccccC
Q 016588          220 FIAKVADAGLRNFLG  234 (386)
Q Consensus       220 ~~~kl~DFgl~~~~~  234 (386)
                      +.+.++|||-+....
T Consensus       203 ~~p~iID~~QaV~~~  217 (268)
T COG1718         203 GEPYIIDVSQAVTID  217 (268)
T ss_pred             CeEEEEECccccccC
Confidence            899999999876543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.38  E-value=4.8e-06  Score=73.41  Aligned_cols=136  Identities=18%  Similarity=0.121  Sum_probs=84.0

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEECCCC-ChhHHHHHHHHHHcCCCCc--ccccccceeeCCeEEEEEEeecCCC-cc
Q 016588           89 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHRN--LVTLLGYCQENNLQFLIYEYIPNGS-VS  164 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~-L~  164 (386)
                      ..||.|..+.||+.   .+..+++|..... ......+|.++++.+..-.  +.+.+++....+...+|||+++|.+ +.
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~   83 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFS   83 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchh
Confidence            56899999999984   2446778875543 3556889999998885433  4677778777777889999998863 21


Q ss_pred             cc---------------------ccCCCcCCCCCCCHHHHH-HHHH----------HHHH-HHHHhh--cCCCCceecCC
Q 016588          165 IH---------------------LYGPSQVSRQKLEFKHRL-SIAL----------GAAK-GLAHLH--SLSPRVVHKDF  209 (386)
Q Consensus       165 ~~---------------------l~~~~~~~~~~l~~~~~~-~i~~----------~i~~-~l~~LH--~~~~~ivH~dl  209 (386)
                      ..                     +|.... .  ........ .+..          .+.. ...+|.  .....++|+|+
T Consensus        84 ~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~--~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        84 RIISDNPSRLEEIAKIFAEMAKKLHSTKC-D--TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             hhhcCCHHHHHHHHHHHHHHHHHHhCCCC-C--CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence            11                     111000 0  00110000 0000          0011 122222  22345789999


Q ss_pred             CCCCeeeCCCCceEEccccccc
Q 016588          210 KTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       210 kp~Nill~~~~~~kl~DFgl~~  231 (386)
                      .|.||++++++ +.++||+.+.
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcC
Confidence            99999999888 9999998664

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.33  E-value=5.7e-06  Score=73.96  Aligned_cols=74  Identities=19%  Similarity=0.255  Sum_probs=54.6

Q ss_pred             ecccCc-eEEEEEEeCCCcEEEEEECCCCChhHHHHHHHHHHcCC-CCcccccccceeeCCeEEEEEEeecCCCccc
Q 016588           91 IGEGKF-GEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEYIPNGSVSI  165 (386)
Q Consensus        91 lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~  165 (386)
                      |..|.. ..||+...+ +..+.+|+.+.....++.+|+++++.+. +--+.+++++....+..++|||+++|.++..
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            445555 789998765 4788899876654556788999988873 4446677777776667789999999877753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.26  E-value=7.8e-06  Score=79.78  Aligned_cols=138  Identities=17%  Similarity=0.166  Sum_probs=87.6

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEECCCCChhH----------------------------------------HHHHH
Q 016588           88 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQE----------------------------------------FIDEV  127 (386)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~e~  127 (386)
                      .+.||..+.|+||+|++++|+.||||.-.+.-.+.                                        |.+|.
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            36799999999999999999999999744432211                                        22232


Q ss_pred             H----HHHcCCCCc------ccccccceeeCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 016588          128 C----FLASIQHRN------LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL  197 (386)
Q Consensus       128 ~----~l~~l~h~n------iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L  197 (386)
                      +    +.+.+.|-+      |++++..+  .....|+|||++|..+.+.-.-    ....++...+..-+.+...-+ -+
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i----~~~gi~~~~i~~~l~~~~~~q-If  318 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAI----DKRGISPHDILNKLVEAYLEQ-IF  318 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHH----HHcCCCHHHHHHHHHHHHHHH-HH
Confidence            2    222233444      44444333  3456799999999888766421    223344443333333322111 12


Q ss_pred             hcCCCCceecCCCCCCeeeCC----CCceEEcccccccccCC
Q 016588          198 HSLSPRVVHKDFKTANVLVDE----DFIAKVADAGLRNFLGR  235 (386)
Q Consensus       198 H~~~~~ivH~dlkp~Nill~~----~~~~kl~DFgl~~~~~~  235 (386)
                      +   .|.+|+|-.|.||++.+    ++.+.+-|||+...+..
T Consensus       319 ~---~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  319 K---TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             h---cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            2   56999999999999984    67899999999876543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.24  E-value=1.7e-05  Score=68.41  Aligned_cols=136  Identities=14%  Similarity=0.121  Sum_probs=85.8

Q ss_pred             HHhcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCCh--hH----------HHHHHHHHHcCCC---Ccccccccc
Q 016588           80 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT--QE----------FIDEVCFLASIQH---RNLVTLLGY  144 (386)
Q Consensus        80 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~----------~~~e~~~l~~l~h---~niv~~~~~  144 (386)
                      ....+|...+++-......|.+-..+ +..+++|...+...  ++          ..+.+..+..+..   -....++-.
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            34567887788887777777776664 67888886443321  11          1223332333322   222222222


Q ss_pred             ee-----eCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC
Q 016588          145 CQ-----ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED  219 (386)
Q Consensus       145 ~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~  219 (386)
                      ..     -....+++|||++|-.|.+...         ++.    .++..+.+++.-||+  .|+.|+|..|.|++++++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH~--~G~~HGD~hpgNFlv~~~  171 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLHK--HGFYHGDPHPGNFLVSNN  171 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHHH--cCCccCCCCcCcEEEECC
Confidence            22     1234568999999988765431         121    245567788999999  779999999999999965


Q ss_pred             CceEEcccccccc
Q 016588          220 FIAKVADAGLRNF  232 (386)
Q Consensus       220 ~~~kl~DFgl~~~  232 (386)
                      + +++.||+..+.
T Consensus       172 ~-i~iID~~~k~~  183 (229)
T PF06176_consen  172 G-IRIIDTQGKRM  183 (229)
T ss_pred             c-EEEEECccccc
Confidence            5 89999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PLN02876 acyl-CoA dehydrogenase

Probab=98.18  E-value=2.5e-05  Score=82.01  Aligned_cols=76  Identities=17%  Similarity=0.344  Sum_probs=56.4

Q ss_pred             CCeecccCceEEEEEEeCCC---cEEEEEECCCC----ChhHHHHHHHHHHcCC-CCcc--cccccceeeC---CeEEEE
Q 016588           88 KNLIGEGKFGEVYKGLLQDG---MLVAIKKRPGA----PTQEFIDEVCFLASIQ-HRNL--VTLLGYCQEN---NLQFLI  154 (386)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~----~~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~---~~~~lv  154 (386)
                      .+.++.|.++.+|+....++   ..+++|+.+..    ....+.+|.++++.+. |.++  ++++.+|.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46688999999999886553   36777875542    2356889999999995 6665  7777777664   457899


Q ss_pred             EEeecCCCc
Q 016588          155 YEYIPNGSV  163 (386)
Q Consensus       155 ~e~~~~g~L  163 (386)
                      |||+++..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999987654

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.14  E-value=1.1e-05  Score=71.11  Aligned_cols=76  Identities=18%  Similarity=0.279  Sum_probs=55.6

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEECCCC-ChhHHHHHHHHHHcCCCC--ccccccccee---eCCeEEEEEEeecCCC
Q 016588           89 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHR--NLVTLLGYCQ---ENNLQFLIYEYIPNGS  162 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~h~--niv~~~~~~~---~~~~~~lv~e~~~~g~  162 (386)
                      +.++.|..+.||+....+ ..+++|..... ....+..|..+++.+...  .+.+++.+..   .....+++|+++++..
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~   81 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRP   81 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEE
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecccc
Confidence            568999999999999877 68999986554 456788898888887422  3556666442   3345789999999887


Q ss_pred             ccc
Q 016588          163 VSI  165 (386)
Q Consensus       163 L~~  165 (386)
                      +..
T Consensus        82 ~~~   84 (239)
T PF01636_consen   82 LDD   84 (239)
T ss_dssp             HHH
T ss_pred             ccc
Confidence            766

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.02  E-value=7.1e-05  Score=64.24  Aligned_cols=126  Identities=17%  Similarity=0.174  Sum_probs=85.3

Q ss_pred             cCCeecccCceEEEEEEeCCCcEEEEEECCCCC-------------------hhHHHHHHHHHHcCC------CCccccc
Q 016588           87 DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-------------------TQEFIDEVCFLASIQ------HRNLVTL  141 (386)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------~~~~~~e~~~l~~l~------h~niv~~  141 (386)
                      ....||+|+.-.||.  ++++....||+.....                   ..+..+|+.....+.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            356799999999885  4455667888755554                   566777877665554      8899999


Q ss_pred             ccceeeCCeEEEEEEeecCC--C----ccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCee
Q 016588          142 LGYCQENNLQFLIYEYIPNG--S----VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVL  215 (386)
Q Consensus       142 ~~~~~~~~~~~lv~e~~~~g--~----L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nil  215 (386)
                      +|+..++...-+|+|.+.+.  +    |.+++      ....++. ....   .+-+-..||-.  ++|+.+|++|+||+
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l------~~~~~~~-~~~~---~L~~f~~~l~~--~~Iv~~dl~~~NIv  150 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYL------KEGGLTE-ELRQ---ALDEFKRYLLD--HHIVIRDLNPHNIV  150 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHH------HcCCccH-HHHH---HHHHHHHHHHH--cCCeecCCCcccEE
Confidence            99999998888999987542  2    33444      1223333 2222   23333456655  56999999999999


Q ss_pred             eCCC--C--ceEEcc
Q 016588          216 VDED--F--IAKVAD  226 (386)
Q Consensus       216 l~~~--~--~~kl~D  226 (386)
                      +...  +  .+.|+|
T Consensus       151 ~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  151 VQRRDSGEFRLVLID  165 (199)
T ss_pred             EEecCCCceEEEEEe
Confidence            9532  2  567777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK10593 hypothetical protein; Provisional

Probab=97.93  E-value=0.00018  Score=66.16  Aligned_cols=77  Identities=16%  Similarity=0.096  Sum_probs=57.6

Q ss_pred             CcCCeecccCceEEEEEEeCCCcEEEEEECCCC-ChhHHHHHHHHHHcCCC---Ccccccccceee---CCeEEEEEEee
Q 016588           86 SDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQH---RNLVTLLGYCQE---NNLQFLIYEYI  158 (386)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~h---~niv~~~~~~~~---~~~~~lv~e~~  158 (386)
                      ...+.||.|..+.||.....++ .+.+|..+.. ....+..|.+.|+.+.-   -.++++++++..   .+..++|||++
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i   95 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL   95 (297)
T ss_pred             heeeecCCccceeEEEEEcCCC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence            3356799999999999876555 4666765442 45688999999998842   467888887754   36689999999


Q ss_pred             cCCCc
Q 016588          159 PNGSV  163 (386)
Q Consensus       159 ~~g~L  163 (386)
                      ++.++
T Consensus        96 ~G~~~  100 (297)
T PRK10593         96 RGVSV  100 (297)
T ss_pred             CCEec
Confidence            98765

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.91  E-value=2.5e-05  Score=81.01  Aligned_cols=196  Identities=23%  Similarity=0.251  Sum_probs=130.1

Q ss_pred             HHHHHHHHcCCCCcccccccceeeCCeE----EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 016588          124 IDEVCFLASIQHRNLVTLLGYCQENNLQ----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS  199 (386)
Q Consensus       124 ~~e~~~l~~l~h~niv~~~~~~~~~~~~----~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~  199 (386)
                      .-|++.+.++.|+|++.++.|.......    .+..+++..-++...+     ..-...+..+.+.+..+..+||.|+|+
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~-----q~v~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL-----QSVGSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH-----hhccccCHHHHHHHHHHHhhhHHHHHH
Confidence            3466778888999999998886543222    3445667666666655     244567788888899999999999998


Q ss_pred             CCCCceecCCCCC---CeeeCCCCceEEc--ccccccccCCCCCCCCCccccCcccccchhhhcccCCCcc--cchhhHH
Q 016588          200 LSPRVVHKDFKTA---NVLVDEDFIAKVA--DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEK--SDVYSFG  272 (386)
Q Consensus       200 ~~~~ivH~dlkp~---Nill~~~~~~kl~--DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~--~DvwSlG  272 (386)
                      .  ...|.-+..+   +.-.+..+....+  ||+.+........   ......+..+.+||....+.++.+  .|+|.+|
T Consensus       305 ~--~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg  379 (1351)
T KOG1035|consen  305 L--SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLG  379 (1351)
T ss_pred             h--ccceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHHH
Confidence            4  3555545444   4445666677766  8888776644221   122234445788887776655444  7999999


Q ss_pred             HHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 016588          273 VFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT  352 (386)
Q Consensus       273 vil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~  352 (386)
                      .....+..|..+-.....                  ....++     .   .......+...+|+..++++|+++.+++.
T Consensus       380 ll~~~~~~~~~i~~~~~~------------------~~~~l~-----~---~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~  433 (1351)
T KOG1035|consen  380 LLLLQLSQGEDISEKSAV------------------PVSLLD-----V---LSTSELLDALPKCLDEDSEERLSALELLT  433 (1351)
T ss_pred             HHHhhhhhcCcccccccc------------------hhhhhc-----c---ccchhhhhhhhhhcchhhhhccchhhhhh
Confidence            999999987643211100                  000000     0   01114678899999999999999999997


Q ss_pred             HHH
Q 016588          353 ELD  355 (386)
Q Consensus       353 ~L~  355 (386)
                      +.-
T Consensus       434 ~~f  436 (1351)
T KOG1035|consen  434 HPF  436 (1351)
T ss_pred             chh
Confidence            753

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.89  E-value=0.00012  Score=64.95  Aligned_cols=73  Identities=11%  Similarity=0.218  Sum_probs=45.5

Q ss_pred             CeecccCce-EEEEEEeCCCcEEEEEECCCC-ChhHHHHHHHHHHcCCCC---cccccccceeeC---CeEEEEEEeecC
Q 016588           89 NLIGEGKFG-EVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHR---NLVTLLGYCQEN---NLQFLIYEYIPN  160 (386)
Q Consensus        89 ~~lg~G~~g-~V~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~---~~~~lv~e~~~~  160 (386)
                      +.++.|+.. .||+.    +..+++|..+.. ....+.+|.+++..+...   -+.++++.....   ...+++|++++|
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G   78 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEG   78 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecC
Confidence            456766665 58875    235677865443 345788999999887531   334444443322   234789999999


Q ss_pred             CCccc
Q 016588          161 GSVSI  165 (386)
Q Consensus       161 g~L~~  165 (386)
                      .++..
T Consensus        79 ~~l~~   83 (235)
T cd05155          79 ETATA   83 (235)
T ss_pred             CCCCc
Confidence            77753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.87  E-value=7.3e-05  Score=63.79  Aligned_cols=104  Identities=23%  Similarity=0.175  Sum_probs=78.2

Q ss_pred             HHHHHHHHcCCC-CcccccccceeeCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-
Q 016588          124 IDEVCFLASIQH-RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS-  201 (386)
Q Consensus       124 ~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-  201 (386)
                      ..|.-+++.+.+ +++++++|+|-.    ++|.||...+++.......  ..-...+|..+.++|.++++.+.+++... 
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l--~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~   80 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPL--SQFLQSPWEQRAKIALQLLELLEELDHGPL   80 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccc--ccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence            357788888865 699999999954    4789999876654221000  01124589999999999999999998632 


Q ss_pred             CCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          202 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       202 ~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      ..+.-.|++++|+-+++++++|+.|...+...
T Consensus        81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             CcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            23666899999999999999999999865443

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.78  E-value=0.00037  Score=64.12  Aligned_cols=143  Identities=17%  Similarity=0.100  Sum_probs=85.6

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEECCCCChhHHHHHHHHHHcCCCC--cccccccc------eeeCCeEEEEEEeec
Q 016588           88 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHR--NLVTLLGY------CQENNLQFLIYEYIP  159 (386)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~------~~~~~~~~lv~e~~~  159 (386)
                      .+.+..|....+|+....+ ..+++|............|..++..+.+.  .+++++..      ....+..++|+++++
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~   97 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLA   97 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCC
Confidence            4567778888999987654 46888887655556677888888887432  24454442      123456689999999


Q ss_pred             CCCcccc--------------ccCCC----cC--CCCCCCHHHHH----------HHHHHHHHHHHHhhc-----CCCCc
Q 016588          160 NGSVSIH--------------LYGPS----QV--SRQKLEFKHRL----------SIALGAAKGLAHLHS-----LSPRV  204 (386)
Q Consensus       160 ~g~L~~~--------------l~~~~----~~--~~~~l~~~~~~----------~i~~~i~~~l~~LH~-----~~~~i  204 (386)
                      |..+...              ++...    ..  ......|....          .....+...+.++.+     ...++
T Consensus        98 G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l  177 (296)
T cd05153          98 GEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGV  177 (296)
T ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcC
Confidence            8776431              01000    00  00111111110          011112233444432     23469


Q ss_pred             eecCCCCCCeeeCCCCceEEccccccc
Q 016588          205 VHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       205 vH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      +|+|+.|.|+++++++.+.|.||+.+.
T Consensus       178 ~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         178 IHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CccCcCcccEEEeCCceEEEeehhhhc
Confidence            999999999999998778899998654

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.74  E-value=0.00015  Score=60.07  Aligned_cols=127  Identities=22%  Similarity=0.276  Sum_probs=84.3

Q ss_pred             cCCeecccCceEEEEEEeCCCcEEEEEE-CCCCChhHHHHHHHHHHcCCCCccc-ccccceeeCCeEEEEEEeecCCCcc
Q 016588           87 DKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLV-TLLGYCQENNLQFLIYEYIPNGSVS  164 (386)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~~~~vavK~-~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~g~L~  164 (386)
                      ..+.|+.|.+|.||++.+.+ ..+|+|. ...+....+..|.++|..+...++. +++.|-.+    ++.|||..|-.|.
T Consensus        26 v~~~L~KG~~s~Vyl~~~~~-~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L~  100 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWRG-GEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPLG  100 (201)
T ss_pred             hhhhhhcccccEEEEeeccC-ceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcchh
Confidence            35789999999999999974 4788886 4455667899999999998765554 34444332    3559999887776


Q ss_pred             ccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCC-C-CeeeCCCCceEEccccccccc
Q 016588          165 IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKT-A-NVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       165 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp-~-Nill~~~~~~kl~DFgl~~~~  233 (386)
                      ++-...        +-.+    ...+++.-.-|-.  .||-|+.|.- . ||++++ +.+.|+||..|+.-
T Consensus       101 ~~~~~~--------~rk~----l~~vlE~a~~LD~--~GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~k  156 (201)
T COG2112         101 KLEIGG--------DRKH----LLRVLEKAYKLDR--LGIEHGELSRPWKNVLVND-RDVYIIDFDSATFK  156 (201)
T ss_pred             hhhhcc--------cHHH----HHHHHHHHHHHHH--hccchhhhcCCceeEEecC-CcEEEEEccchhhc
Confidence            554211        2222    2334444333333  5688888764 4 555554 48999999888743

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.70  E-value=0.00044  Score=61.29  Aligned_cols=72  Identities=18%  Similarity=0.151  Sum_probs=47.3

Q ss_pred             CeecccCceEEEEEEeCC--CcEEEEEECCCCCh--hHHHHHHHHHHcCCC-CcccccccceeeCCeEEEEEEeecCCCc
Q 016588           89 NLIGEGKFGEVYKGLLQD--GMLVAIKKRPGAPT--QEFIDEVCFLASIQH-RNLVTLLGYCQENNLQFLIYEYIPNGSV  163 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~--~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~g~L  163 (386)
                      +.|..|-...+|+....+  +..+++|.......  .+..+|..++..+.. .-.+++++.+.  +  .++|||+++.++
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~l   79 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRTL   79 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCcC
Confidence            457778888999998654  56788887554322  233578888888843 23344444332  2  379999998776


Q ss_pred             c
Q 016588          164 S  164 (386)
Q Consensus       164 ~  164 (386)
                      .
T Consensus        80 ~   80 (235)
T cd05157          80 E   80 (235)
T ss_pred             C
Confidence            4

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.69  E-value=0.00047  Score=62.05  Aligned_cols=135  Identities=15%  Similarity=0.145  Sum_probs=76.1

Q ss_pred             ecccCceEEEEEEeCCCcEEEEEECCCCCh---hHHHHHHHHHHcCCCCcc-cccccceeeCCeEEEEEEeecCCCcccc
Q 016588           91 IGEGKFGEVYKGLLQDGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNL-VTLLGYCQENNLQFLIYEYIPNGSVSIH  166 (386)
Q Consensus        91 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~L~~~  166 (386)
                      +..|-.+.+|+... ++..+++|.......   -+..+|..+++.+....+ .+++....    -++|+||++|..+...
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence            45677889998874 466788887543321   245789999988854323 34444332    2589999998766432


Q ss_pred             -----------------ccCCCcCCCCCCCHHHH-HHHHHHH---------HHHHHHhhc------CCCCceecCCCCCC
Q 016588          167 -----------------LYGPSQVSRQKLEFKHR-LSIALGA---------AKGLAHLHS------LSPRVVHKDFKTAN  213 (386)
Q Consensus       167 -----------------l~~~~~~~~~~l~~~~~-~~i~~~i---------~~~l~~LH~------~~~~ivH~dlkp~N  213 (386)
                                       +|.... ....++.... ..+..++         ..-+..+-.      ....++|+|+.|.|
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPR-FGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCC-CCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence                             111111 1111221111 1111011         111111111      12358999999999


Q ss_pred             eeeCCCCceEEcccccccc
Q 016588          214 VLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       214 ill~~~~~~kl~DFgl~~~  232 (386)
                      |++++++ +.+.||+.+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999877 78999986653

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.62  E-value=0.00048  Score=58.80  Aligned_cols=122  Identities=20%  Similarity=0.282  Sum_probs=85.2

Q ss_pred             cCCCcCCeecccCc-eEEEEEEeCCCcEEEEEECCC------------------------CChhHHHHHHHHHHcCC---
Q 016588           83 KNFSDKNLIGEGKF-GEVYKGLLQDGMLVAIKKRPG------------------------APTQEFIDEVCFLASIQ---  134 (386)
Q Consensus        83 ~~~~~~~~lg~G~~-g~V~~~~~~~~~~vavK~~~~------------------------~~~~~~~~e~~~l~~l~---  134 (386)
                      ++++..+.||.|.- |.||++... |..+|+|....                        ...+.|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            68888999999999 999999985 67999997110                        11224677888777764   


Q ss_pred             CCcc--cccccceeeC------------------CeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHH
Q 016588          135 HRNL--VTLLGYCQEN------------------NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL  194 (386)
Q Consensus       135 h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l  194 (386)
                      +.++  ++++||..-.                  -..-+|-||.+...              .+..    +-+.++.+-+
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~~----~~~~~~~~dl  177 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQI----RDIPQMLRDL  177 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccch----hHHHHHHHHH
Confidence            4566  8999987322                  11245556554322              1222    2355677788


Q ss_pred             HHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 016588          195 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  230 (386)
Q Consensus       195 ~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~  230 (386)
                      ..+|.  .||+-+|+++.|..     .-+|+|||.+
T Consensus       178 ~~~~k--~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  178 KILHK--LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHH--CCeeeccCcccccc-----CCEEEecccC
Confidence            88998  77999999999986     3489999854

>PRK05231 homoserine kinase; Provisional

Probab=97.61  E-value=0.0025  Score=59.30  Aligned_cols=143  Identities=14%  Similarity=0.079  Sum_probs=78.5

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEECCCCChhHHHHHHHHHHcCCC--Ccccccccc------eeeCCeEEEEEEeec
Q 016588           88 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQH--RNLVTLLGY------CQENNLQFLIYEYIP  159 (386)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~------~~~~~~~~lv~e~~~  159 (386)
                      .+.++.|....+|+....++ .+++|+......+....|...+..|..  -.+.+.+..      ....+..+++++|++
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l~  105 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFLE  105 (319)
T ss_pred             cchhccccccceEEEEeCCC-cEEEEEeccCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEecC
Confidence            35566777789999887655 678887653344555566666666532  123333321      123456789999998


Q ss_pred             CCCcccc--------------ccCCCc------CCCCCCCH-HHHHH------------HHHH-HHHHHHHhhc-----C
Q 016588          160 NGSVSIH--------------LYGPSQ------VSRQKLEF-KHRLS------------IALG-AAKGLAHLHS-----L  200 (386)
Q Consensus       160 ~g~L~~~--------------l~~~~~------~~~~~l~~-~~~~~------------i~~~-i~~~l~~LH~-----~  200 (386)
                      |..+...              ++....      .....+.+ .....            ...+ +...+..+..     .
T Consensus       106 G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l  185 (319)
T PRK05231        106 GKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPAL  185 (319)
T ss_pred             CCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccccC
Confidence            8754211              111000      00001111 11100            1111 1112222221     2


Q ss_pred             CCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          201 SPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       201 ~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      ..+++|+|+.|.||+++++...-+.||+.+.
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            3579999999999999977666899998764

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.59  E-value=0.0019  Score=59.77  Aligned_cols=143  Identities=17%  Similarity=0.079  Sum_probs=82.8

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEECCCC-ChhHHHHHHHHHHcCCC--Ccccccccce------eeCCeEEEEEEee
Q 016588           88 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQH--RNLVTLLGYC------QENNLQFLIYEYI  158 (386)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~h--~niv~~~~~~------~~~~~~~lv~e~~  158 (386)
                      .+.++.|....+|+....++ .+++|+.... ..++...|.+++..|..  -.+++++...      ...+..+++++|+
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i  105 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL  105 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence            45677777789999876555 5777875443 34566677777777742  2244544422      2245678999999


Q ss_pred             cCCCcccc--------------ccCCCcC---CC-C---CCCHHHHH------------HHHHHHHHHHHHhhc-----C
Q 016588          159 PNGSVSIH--------------LYGPSQV---SR-Q---KLEFKHRL------------SIALGAAKGLAHLHS-----L  200 (386)
Q Consensus       159 ~~g~L~~~--------------l~~~~~~---~~-~---~l~~~~~~------------~i~~~i~~~l~~LH~-----~  200 (386)
                      +|..+...              ++.....   .. .   .-.|....            .....+...++++..     .
T Consensus       106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~  185 (307)
T TIGR00938       106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL  185 (307)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            88654311              1110000   00 0   01111100            001122334444432     2


Q ss_pred             CCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          201 SPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       201 ~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      ..+++|+|+.+.|+++++++...+.||+.+.
T Consensus       186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            3679999999999999988877899998754

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.50  E-value=0.0017  Score=61.89  Aligned_cols=72  Identities=17%  Similarity=0.155  Sum_probs=52.3

Q ss_pred             CCeecccCceEEEEEEeCCC-cEEEEEECC----------CCChhHHHHHHHHHHcCC---CCcccccccceeeCCeEEE
Q 016588           88 KNLIGEGKFGEVYKGLLQDG-MLVAIKKRP----------GAPTQEFIDEVCFLASIQ---HRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~~-~~vavK~~~----------~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~l  153 (386)
                      .+.||.|.+..||++...+| +.++||.-.          +...+....|.+.|..+.   ..++++++.+..  +..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEE
Confidence            35789999999999998766 489999732          123456677888887762   356777777633  44679


Q ss_pred             EEEeecCC
Q 016588          154 IYEYIPNG  161 (386)
Q Consensus       154 v~e~~~~g  161 (386)
                      ||||+++.
T Consensus       109 VME~L~~~  116 (401)
T PRK09550        109 VMEDLSDH  116 (401)
T ss_pred             EEecCCCc
Confidence            99998763

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.36  E-value=0.0013  Score=60.68  Aligned_cols=72  Identities=25%  Similarity=0.257  Sum_probs=47.2

Q ss_pred             CeecccCceEEEEEEeCC-------CcEEEEEECCCC--ChhHHHHHHHHHHcCCCCc-ccccccceeeCCeEEEEEEee
Q 016588           89 NLIGEGKFGEVYKGLLQD-------GMLVAIKKRPGA--PTQEFIDEVCFLASIQHRN-LVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~--~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~  158 (386)
                      +.+..|-...+|+....+       +..+++|+....  ...+..+|.+++..+...+ ..++++++..    .+|+||+
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i   79 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI   79 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence            345667777899988654       478889985543  2245678888888874322 3455555542    2589999


Q ss_pred             cCCCcc
Q 016588          159 PNGSVS  164 (386)
Q Consensus       159 ~~g~L~  164 (386)
                      +|..+.
T Consensus        80 ~G~~l~   85 (302)
T cd05156          80 PSRTLT   85 (302)
T ss_pred             CCCcCC
Confidence            887764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.22  E-value=0.00092  Score=60.97  Aligned_cols=74  Identities=18%  Similarity=0.266  Sum_probs=50.3

Q ss_pred             cCCeecccCceEEEEEEeCCCcEEEEEECCCCChhHHHHHHHHHHcCC---CCcccccccceeeCCeEEEEEEeecCC
Q 016588           87 DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ---HRNLVTLLGYCQENNLQFLIYEYIPNG  161 (386)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g  161 (386)
                      ..+.++.|....+|+.. .++..+.||.........|..|.+-|+.|.   .-.+++.+++....+..+|++||++.+
T Consensus        21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             eeEecCCCChhheEEEE-CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            34678889999999988 457789999877656677899998888873   456788888887777779999999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.08  E-value=0.00057  Score=62.05  Aligned_cols=129  Identities=17%  Similarity=0.154  Sum_probs=88.5

Q ss_pred             CCcCCeecccCceEEEEEEeCCCcEEEEEECC--CCC-----------------------hhHHHHHHHHHHcCC-C-Cc
Q 016588           85 FSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRP--GAP-----------------------TQEFIDEVCFLASIQ-H-RN  137 (386)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~-----------------------~~~~~~e~~~l~~l~-h-~n  137 (386)
                      +.+.+.||-|.-+.||.+-...|.+.++|.-.  ..+                       .-...+|+..|+.|. | --
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            56678999999999999999889999998411  000                       001346777777774 2 23


Q ss_pred             ccccccceeeCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC
Q 016588          138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD  217 (386)
Q Consensus       138 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~  217 (386)
                      +++.++    .+..++|||++.+-.|...-+        ..+..+   +...+..-+.-|..  +|+||+|..-=||+++
T Consensus       174 VPkpiD----~~RH~Vvmelv~g~Pl~~v~~--------v~d~~~---ly~~lm~~Iv~la~--~GlIHgDFNEFNimv~  236 (465)
T KOG2268|consen  174 VPKPID----HNRHCVVMELVDGYPLRQVRH--------VEDPPT---LYDDLMGLIVRLAN--HGLIHGDFNEFNIMVK  236 (465)
T ss_pred             CCCccc----ccceeeHHHhhcccceeeeee--------cCChHH---HHHHHHHHHHHHHH--cCceecccchheeEEe
Confidence            444444    355679999998877764432        122222   33344444555665  6799999999999999


Q ss_pred             CCCceEEcccccc
Q 016588          218 EDFIAKVADAGLR  230 (386)
Q Consensus       218 ~~~~~kl~DFgl~  230 (386)
                      +++.++++||--.
T Consensus       237 dd~~i~vIDFPQm  249 (465)
T KOG2268|consen  237 DDDKIVVIDFPQM  249 (465)
T ss_pred             cCCCEEEeechHh
Confidence            9999999999643

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.06  E-value=0.0068  Score=55.16  Aligned_cols=31  Identities=26%  Similarity=0.365  Sum_probs=25.3

Q ss_pred             CCceecCCCCCCeeeCCCCc-eEEcccccccc
Q 016588          202 PRVVHKDFKTANVLVDEDFI-AKVADAGLRNF  232 (386)
Q Consensus       202 ~~ivH~dlkp~Nill~~~~~-~kl~DFgl~~~  232 (386)
                      ..++|+|+.|.||++++++. .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            34899999999999997555 46999997764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.00  E-value=9.5e-05  Score=78.80  Aligned_cols=157  Identities=15%  Similarity=0.074  Sum_probs=110.5

Q ss_pred             HHHHHHcCCCCccccccccee--eCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcC---
Q 016588          126 EVCFLASIQHRNLVTLLGYCQ--ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL---  200 (386)
Q Consensus       126 e~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---  200 (386)
                      |..-++...|+++.....=..  .+...|.+++|+.+|.+.+.+..... ..+.++...+.....+......-+|+.   
T Consensus      1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~e-e~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLE-ESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred             hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccc-cCCcchhchHHHHHHHHHhccchhhhcccC
Confidence            444455567888877655443  23456789999999999888765432 233344433433334435566666653   


Q ss_pred             CCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc
Q 016588          201 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS  280 (386)
Q Consensus       201 ~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t  280 (386)
                      ++-.+|+++|+-|.+|..+..+++.++|+.++..+  .........+++.|+.|+....-.++.++|+|..|+.+|+...
T Consensus      1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred             CccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence            34479999999999999999999999999984322  1112233456778999999888888888999999999999988


Q ss_pred             CCCCC
Q 016588          281 GREAS  285 (386)
Q Consensus       281 g~~p~  285 (386)
                      |..+|
T Consensus      1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred             ccHHH
Confidence            76554

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.86  E-value=0.017  Score=53.22  Aligned_cols=133  Identities=23%  Similarity=0.271  Sum_probs=78.2

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEECCC-----CChhHHHHHHHHHHcCCC--CcccccccceeeCC--eEEEEEEeec
Q 016588           89 NLIGEGKFGEVYKGLLQDGMLVAIKKRPG-----APTQEFIDEVCFLASIQH--RNLVTLLGYCQENN--LQFLIYEYIP  159 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~-----~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~--~~~lv~e~~~  159 (386)
                      +.+..|--..+|..... ++++++. .+.     ....+..+|..+++.+.-  --+...++.|..+.  ..|.||+|++
T Consensus        31 ~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve  108 (321)
T COG3173          31 EEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE  108 (321)
T ss_pred             eeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence            34433443445554443 6777777 332     233456678888887743  23344566776655  6799999999


Q ss_pred             CCCccccccCCCcCCCCCCCHHHHHHHH-HHHHHHHHHhhc---------------------------------------
Q 016588          160 NGSVSIHLYGPSQVSRQKLEFKHRLSIA-LGAAKGLAHLHS---------------------------------------  199 (386)
Q Consensus       160 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~-~~i~~~l~~LH~---------------------------------------  199 (386)
                      +..+.+.+.....      .    ..++ ..++..|.-||+                                       
T Consensus       109 Ge~~~~~~~~~~~------~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p  178 (321)
T COG3173         109 GEVVWSALPPESL------G----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP  178 (321)
T ss_pred             ceeccCcCCcccc------h----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence            8544333211100      0    0011 133333333332                                       


Q ss_pred             -----------C------CCCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          200 -----------L------SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       200 -----------~------~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                                 .      ...++|+|+.+.|+++++...+=+.||+++..-
T Consensus       179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence                       1      135899999999999999888999999988753

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.47  E-value=0.046  Score=52.15  Aligned_cols=70  Identities=13%  Similarity=0.122  Sum_probs=48.9

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEECCC----------CChhHHHHHHHHHHcCC---CCcccccccceeeCCeEEEE
Q 016588           88 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPG----------APTQEFIDEVCFLASIQ---HRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~----------~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv  154 (386)
                      .+.+|.|....||+.... +..++||.-.+          ....+-..|.+.|+.+.   ..++++++.++.+.  -+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--ALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CEEE
Confidence            467899999999998864 45688997331          13334445566666553   35888899888744  5688


Q ss_pred             EEeecC
Q 016588          155 YEYIPN  160 (386)
Q Consensus       155 ~e~~~~  160 (386)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999976

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.43  E-value=0.06  Score=49.77  Aligned_cols=65  Identities=18%  Similarity=0.243  Sum_probs=40.0

Q ss_pred             EEEEEEeCCCcEEEEEECCCCChhHHHHHHHHHHcCCCC--cccccccc------eeeCCeEEEEEEeecCCCcc
Q 016588           98 EVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHR--NLVTLLGY------CQENNLQFLIYEYIPNGSVS  164 (386)
Q Consensus        98 ~V~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~------~~~~~~~~lv~e~~~~g~L~  164 (386)
                      .||+....+| .+++|+... .......|...+..|...  .+++++..      ...++..+.++++++|..+.
T Consensus        11 ~v~~v~t~~g-~~~LK~~~~-~~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~~   83 (313)
T TIGR02906        11 NVYKVETDSG-NKCLKKINY-PPERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGRECD   83 (313)
T ss_pred             cEEEEEeCCC-CeEEEEcCC-CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCCC
Confidence            4888886555 578887643 234556677767666322  33344332      22356788999999886653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.35  E-value=0.03  Score=52.45  Aligned_cols=69  Identities=13%  Similarity=0.184  Sum_probs=45.4

Q ss_pred             eecccCceEEEEEEeCCC-cEEEEEEC-------C---CCChhHHHHHHHHHHcCC--CC-cccccccceeeCCeEEEEE
Q 016588           90 LIGEGKFGEVYKGLLQDG-MLVAIKKR-------P---GAPTQEFIDEVCFLASIQ--HR-NLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        90 ~lg~G~~g~V~~~~~~~~-~~vavK~~-------~---~~~~~~~~~e~~~l~~l~--h~-niv~~~~~~~~~~~~~lv~  155 (386)
                      .+|.|....||++..+++ ..|+||.-       .   +...++..-|.+.|+...  -| .+++++.+  +.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            478999999999997654 57999951       1   223445566777776653  23 55565544  444456899


Q ss_pred             EeecC
Q 016588          156 EYIPN  160 (386)
Q Consensus       156 e~~~~  160 (386)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.32  E-value=0.0066  Score=58.56  Aligned_cols=185  Identities=21%  Similarity=0.293  Sum_probs=97.1

Q ss_pred             EEEEEeCCCcEEEEEECCC-CChhHHHHHHHHHHcCCCCcccccccceee-CCeEEEEEEeecCCCccccccCCCcCCCC
Q 016588           99 VYKGLLQDGMLVAIKKRPG-APTQEFIDEVCFLASIQHRNLVTLLGYCQE-NNLQFLIYEYIPNGSVSIHLYGPSQVSRQ  176 (386)
Q Consensus        99 V~~~~~~~~~~vavK~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~  176 (386)
                      .+.|....|+.+ ..-++- ....++.....+++.+.|+|+..++++... .....+|+|++.. +|.+.+...     .
T Consensus         5 ~~~a~~~~~~~c-~nglplt~~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~-----~   77 (725)
T KOG1093|consen    5 TFFAQEKPGDVC-SNGLPLTPNSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTG-----N   77 (725)
T ss_pred             EEehhcCCCccc-cCCCcCCCcHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhc-----c
Confidence            345554444433 222221 123456677888999999999999988764 3457789999854 777776321     1


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhh
Q 016588          177 KLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV  256 (386)
Q Consensus       177 ~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~  256 (386)
                       +...+          ++      .+++.|-++            .+.+|    .....               |  |  
T Consensus        78 -l~~~s----------~~------~~~~~~~~~------------~~~td----~~~t~---------------~--~--  105 (725)
T KOG1093|consen   78 -LKDES----------LL------AHGVLHLNI------------IYITD----HFLTK---------------Y--P--  105 (725)
T ss_pred             -cchhh----------hc------ccccceehh------------hhccc----ccccc---------------C--C--
Confidence             11100          01      133444222            22333    00000               0  0  


Q ss_pred             hcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhccc-chhhhcchhhcccCCHHHHHHHHHHHhH
Q 016588          257 KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS-NLLKILDERLWSTFTNEGMEEFIQLIVR  335 (386)
Q Consensus       257 ~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~  335 (386)
                         ....+|+||||+|.++.|+.-|...+......   +....+....... .........   .+.-++...+.++.++
T Consensus       106 ---~~~~pKsdVwsl~~i~~el~L~~~l~~~~~~s---~~l~~i~k~~~~d~~~~~~a~e~---~~~~~~d~~~~~~~~~  176 (725)
T KOG1093|consen  106 ---SPIGPKSDVWSLGFIILELYLGISLEAELTES---EYLEILLKYYTDDQELLSTAMEH---LIQLLADKKRLPLLKK  176 (725)
T ss_pred             ---CCCCcchhhhhHHHHHHHHHHhhHHHHHHHHH---HHHHHHHHhccCchhHHHHHHHH---HHHHhhhHhHHHHhcc
Confidence               01124999999999999999886543322210   1111111111110 000011111   1122345668899999


Q ss_pred             ccCCCCCCCCCHHHHH
Q 016588          336 CLDPSSERRPSMSDVV  351 (386)
Q Consensus       336 cl~~dp~~Rpt~~evl  351 (386)
                      |+-..|..||...++.
T Consensus       177 c~~~~~~ir~l~~~~~  192 (725)
T KOG1093|consen  177 CLWLEPIIRPLPMELS  192 (725)
T ss_pred             CCccccccccchhHHh
Confidence            9999999998766554

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.31  E-value=0.048  Score=50.79  Aligned_cols=136  Identities=18%  Similarity=0.139  Sum_probs=88.6

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEECCCCC------------------------hh-----HHHHHHHHHHcCCCCccc
Q 016588           89 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP------------------------TQ-----EFIDEVCFLASIQHRNLV  139 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------------~~-----~~~~e~~~l~~l~h~niv  139 (386)
                      ..|..|--+-||.|...+|..+|||+.+.+.                        ..     -...|++-|++++...|.
T Consensus       150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP  229 (520)
T KOG2270|consen  150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP  229 (520)
T ss_pred             cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            4577888889999998899999999632211                        00     123567777777655544


Q ss_pred             ccccceeeCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC
Q 016588          140 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED  219 (386)
Q Consensus       140 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~  219 (386)
                      ..--....+  ..|||+|+.......-.     .....++...+..+-.+++.-+.-|.+. .+.||.||.--|+|+.+ 
T Consensus       230 ~PePIlLk~--hVLVM~FlGrdgw~aPk-----LKd~~ls~~ka~~~Y~~~v~~MR~lY~~-c~LVHADLSEfN~Lyhd-  300 (520)
T KOG2270|consen  230 CPEPILLKN--HVLVMEFLGRDGWAAPK-----LKDASLSTSKARELYQQCVRIMRRLYQK-CRLVHADLSEFNLLYHD-  300 (520)
T ss_pred             CCCceeeec--ceEeeeeccCCCCcCcc-----cccccCChHHHHHHHHHHHHHHHHHHHH-hceeccchhhhhheEEC-
Confidence            332222222  35899999643322111     2334455566667777777777777543 56999999999999874 


Q ss_pred             CceEEccccccccc
Q 016588          220 FIAKVADAGLRNFL  233 (386)
Q Consensus       220 ~~~kl~DFgl~~~~  233 (386)
                      |.+.++|-+-+-..
T Consensus       301 G~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  301 GKLYIIDVSQSVEH  314 (520)
T ss_pred             CEEEEEEccccccC
Confidence            57789998766544

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.19  E-value=0.038  Score=51.22  Aligned_cols=31  Identities=19%  Similarity=0.189  Sum_probs=27.4

Q ss_pred             CCceecCCCCCCeeeCCCCceEEcccccccc
Q 016588          202 PRVVHKDFKTANVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       202 ~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~  232 (386)
                      .+++|+|+.++|+|+++++.+.++||..+..
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            4799999999999999999999999976653

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02236 choline kinase

Probab=96.07  E-value=0.09  Score=49.51  Aligned_cols=139  Identities=14%  Similarity=0.136  Sum_probs=77.2

Q ss_pred             CeecccCceEEEEEEeCC-----CcEEEEEECCCCChh--HHHHHHHHHHcCCCCcc-cccccceeeCCeEEEEEEeecC
Q 016588           89 NLIGEGKFGEVYKGLLQD-----GMLVAIKKRPGAPTQ--EFIDEVCFLASIQHRNL-VTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~--~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      ..+..|-...+|+....+     +..+++|........  +-.+|..+++.+...++ .++++.+..+    .|.+|+++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g  117 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA  117 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence            445557788999987532     357889976544321  23568888888753333 3555655433    57899987


Q ss_pred             CCcccc-----------------ccCCCcCCCC-CCCHHHHHHHHHH-----------------HHHHHHH----hhc--
Q 016588          161 GSVSIH-----------------LYGPSQVSRQ-KLEFKHRLSIALG-----------------AAKGLAH----LHS--  199 (386)
Q Consensus       161 g~L~~~-----------------l~~~~~~~~~-~l~~~~~~~i~~~-----------------i~~~l~~----LH~--  199 (386)
                      .++...                 +|........ ...+..+..+..+                 +...+..    +..  
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            666421                 1211111111 1112222222211                 1111111    121  


Q ss_pred             CCCCceecCCCCCCeeeCC-CCceEEccccccc
Q 016588          200 LSPRVVHKDFKTANVLVDE-DFIAKVADAGLRN  231 (386)
Q Consensus       200 ~~~~ivH~dlkp~Nill~~-~~~~kl~DFgl~~  231 (386)
                      ....++|+|+++.|||+++ ++.+.++||..+.
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            1235899999999999986 4789999997654

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.04  E-value=0.15  Score=44.56  Aligned_cols=75  Identities=15%  Similarity=0.230  Sum_probs=54.3

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEECCCCChhHHHHHHHHHHcC---CCCcccccccceeeCCeEEEEEEeecCCCcc
Q 016588           89 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI---QHRNLVTLLGYCQENNLQFLIYEYIPNGSVS  164 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  164 (386)
                      +.+..|.--..|.... ...++-||.-.......|..|+.-|..+   +.-++.+++.+-...+..|+|+||++.+.+.
T Consensus        22 ~~v~gG~inea~~v~d-g~~~~FvK~n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          22 EEVSGGDINEAWRLRD-GTDPFFVKCNQREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             cccCCccccceeEeec-CCcceEEEecchhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            3344444444454443 3568889987766677888888766666   4467888888888999999999999987765

>PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane

Probab=95.96  E-value=0.01  Score=46.18  Aligned_cols=33  Identities=30%  Similarity=0.368  Sum_probs=17.7

Q ss_pred             chhhHHHHHHHHHHHHHHHHHHHHHHHHhcCCC
Q 016588            4 TLAAIFGAAAGAVALMGIIFFLSWFCLYRNRSV   36 (386)
Q Consensus         4 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~   36 (386)
                      .-.+|.++++|+++.+++++++++||.+|++++
T Consensus        62 s~~~i~~Ii~gv~aGvIg~Illi~y~irR~~Kk   94 (122)
T PF01102_consen   62 SEPAIIGIIFGVMAGVIGIILLISYCIRRLRKK   94 (122)
T ss_dssp             S-TCHHHHHHHHHHHHHHHHHHHHHHHHHHS--
T ss_pred             cccceeehhHHHHHHHHHHHHHHHHHHHHHhcc
Confidence            344566666666665555555555555555544

Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.67  E-value=0.12  Score=48.30  Aligned_cols=71  Identities=14%  Similarity=0.171  Sum_probs=43.8

Q ss_pred             CeecccCceEEEEEEeCC----CcEEEEEECCCCCh--hHHHHHHHHHHcCCCCcc-cccccceeeCCeEEEEEEeecCC
Q 016588           89 NLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT--QEFIDEVCFLASIQHRNL-VTLLGYCQENNLQFLIYEYIPNG  161 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~--~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g  161 (386)
                      +.|..|-...+|+....+    +..|++|.......  -+-.+|..+++.+...++ +++++++..+    +|.+|+++.
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~   95 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINAR   95 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCC
Confidence            445557777889887543    23788887544322  123578888888854444 3556555322    488998776


Q ss_pred             Cc
Q 016588          162 SV  163 (386)
Q Consensus       162 ~L  163 (386)
                      .+
T Consensus        96 ~l   97 (330)
T PLN02421         96 TL   97 (330)
T ss_pred             CC
Confidence            65

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.42  E-value=0.16  Score=47.35  Aligned_cols=136  Identities=18%  Similarity=0.209  Sum_probs=79.1

Q ss_pred             CceEEEEEEeCCCcEEEEEECCCC-ChhHHHHHHHHHHcCC---CCc---ccccccce--eeCC--eEEEEEEeecCCCc
Q 016588           95 KFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQ---HRN---LVTLLGYC--QENN--LQFLIYEYIPNGSV  163 (386)
Q Consensus        95 ~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~---h~n---iv~~~~~~--~~~~--~~~lv~e~~~~g~L  163 (386)
                      .-..+|+....++.. ++|+.... ...+...|+..+..|.   .+-   +...-|-.  .-.+  ..+-+.+|++|..+
T Consensus        37 ~eN~~f~~~~~~g~~-iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~~  115 (331)
T COG2334          37 EENSNFRVQTEDGRY-ILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRPL  115 (331)
T ss_pred             ccCceEEEEecCCCe-EEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcCc
Confidence            456789988877666 88987664 6677888888888873   121   22222211  1123  67789999999887


Q ss_pred             cc-cc--------------c----CC---CcCCCCCCCHH-------------HHHHHHHHHHHHHHHhhcC------CC
Q 016588          164 SI-HL--------------Y----GP---SQVSRQKLEFK-------------HRLSIALGAAKGLAHLHSL------SP  202 (386)
Q Consensus       164 ~~-~l--------------~----~~---~~~~~~~l~~~-------------~~~~i~~~i~~~l~~LH~~------~~  202 (386)
                      .. .-              +    +.   .........|.             .......++...+..+.+.      ..
T Consensus       116 ~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~~  195 (331)
T COG2334         116 ERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPAL  195 (331)
T ss_pred             CCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCcc
Confidence            72 11              0    00   00001112221             0011223333334443321      22


Q ss_pred             C--ceecCCCCCCeeeCCCCc-eEEccccccc
Q 016588          203 R--VVHKDFKTANVLVDEDFI-AKVADAGLRN  231 (386)
Q Consensus       203 ~--ivH~dlkp~Nill~~~~~-~kl~DFgl~~  231 (386)
                      +  +||+|+-|.||+++.+.. +.+.||+-+.
T Consensus       196 ~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         196 GDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             cceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            3  899999999999998884 8899998553

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=95.42  E-value=0.0057  Score=47.98  Aligned_cols=46  Identities=17%  Similarity=0.273  Sum_probs=40.6

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEECCCCChhHHHHHHHHHHcC
Q 016588           88 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI  133 (386)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l  133 (386)
                      .+.|++|+.|+||+|++++|+.||||...+...+.+...+.+++.+
T Consensus        16 ~~PlasASiaQVh~a~l~~g~~VaVKV~rP~i~~~i~~Dl~~l~~~   61 (119)
T PF03109_consen   16 PEPLASASIAQVHRARLKDGEEVAVKVQRPGIEEQIEADLRILRRL   61 (119)
T ss_pred             cchhhheehhhheeeeecccchhhhhhcchHHHHHHHHHHHHHHHH
Confidence            3679999999999999999999999999888888888888887654

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.30  E-value=0.036  Score=52.21  Aligned_cols=123  Identities=20%  Similarity=0.123  Sum_probs=72.7

Q ss_pred             CeecccCceEEEEEEeC----------------CCcEEEEEECCCCChhHHHHHHHHHHcCC-CCcccc-----------
Q 016588           89 NLIGEGKFGEVYKGLLQ----------------DGMLVAIKKRPGAPTQEFIDEVCFLASIQ-HRNLVT-----------  140 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~----------------~~~~vavK~~~~~~~~~~~~e~~~l~~l~-h~niv~-----------  140 (386)
                      ..||.|+-.+||+|..+                ..+.+|+|...+...+.+...+.+|+... -+|++.           
T Consensus       195 ~PIGsG~IAQVY~atl~~a~lekd~~~~~~~~~~tq~~AiKv~Hp~V~~~ir~Dl~Il~f~Akl~~~vP~l~wL~l~~~v  274 (565)
T KOG1236|consen  195 EPIGSGCIAQVYRATLKTAYLEKDSGKEYVQKLGTQSCAIKVLHPNVEKQIRLDLGILGFGAKLINNVPDLSWLSLPLEV  274 (565)
T ss_pred             cccccchhhhhhhhhhhHHHhhcccchhhhcCCccceeeeeccCccHHHHHHHHHHHHhhhhhhhhhcCccccccCcchH
Confidence            56999999999999742                12468999877776666555555544331 112221           


Q ss_pred             ----------------------cccce-------------eeCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHH
Q 016588          141 ----------------------LLGYC-------------QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS  185 (386)
Q Consensus       141 ----------------------~~~~~-------------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~  185 (386)
                                            +..-+             .-.....++-+|..+-++..++..      ...++....+
T Consensus       275 kqF~v~ln~QvdL~~EA~hL~rF~~NF~~s~~V~fP~P~~~~~~~~vl~E~~~~Gl~v~~~v~~------~~~pe~l~kk  348 (565)
T KOG1236|consen  275 KQFSVGLNAQVDLRQEALHLPRFTNNFSGSKKVLFPKPIAPLHTDLVLVETYERGLSVLRFVKW------KSQPEALVKK  348 (565)
T ss_pred             HHHHHHHHhhcchhhhhhhhHHHHHhcccceeecCCcccccccccceeeeeccccccHHhhhhc------ccChHHHHHH
Confidence                                  11111             111223566667777777666632      2234445555


Q ss_pred             HHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC
Q 016588          186 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE  218 (386)
Q Consensus       186 i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~  218 (386)
                      ++.-.+.|+..+--. .+.+|.|+.|.||++-.
T Consensus       349 va~lg~~AllkMl~v-DNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  349 VAKLGVNALLKMLIV-DNFVHADLHPGNVLIRF  380 (565)
T ss_pred             HHHHHHHHHHHHHHh-hcceecccCCCcEEEEe
Confidence            665555665544322 35999999999999953

>PF02439 Adeno_E3_CR2: Adenovirus E3 region protein CR2; InterPro: IPR003470 Early region 3 (E3) of human adenoviruses (Ads) codes for proteins that appear to control viral interactions with the host []

Probab=95.27  E-value=0.052  Score=32.27  Aligned_cols=24  Identities=25%  Similarity=0.292  Sum_probs=9.1

Q ss_pred             HHHHHHHHHHHHHHHHHHHHHHHH
Q 016588            8 IFGAAAGAVALMGIIFFLSWFCLY   31 (386)
Q Consensus         8 i~~~~~~~~~~~~~~~~~~~~~~~   31 (386)
                      |+++++.+.++++++++++.+|++
T Consensus         8 IIv~V~vg~~iiii~~~~YaCcyk   31 (38)
T PF02439_consen    8 IIVAVVVGMAIIIICMFYYACCYK   31 (38)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHc
Confidence            333333333333444444333333

This region called CR1 (conserved region 1) [] is found three times in Human adenovirus 19 (a subgroup D adenovirus) 49 kDa protein in the E3 region. CR1 is also found in the 20.1 Kd protein of subgroup B adenoviruses. The function of this 80 amino acid region is unknown. This region is probably a divergent immunoglobulin domain.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.17  E-value=0.78  Score=42.81  Aligned_cols=70  Identities=17%  Similarity=0.212  Sum_probs=44.7

Q ss_pred             cCceEEEEEEeCCCcEEEEEECCCC--ChhHHHHHHHHHHcCCCC--cccccc---c--ceeeCCeEEEEEEeecCCCc
Q 016588           94 GKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHR--NLVTLL---G--YCQENNLQFLIYEYIPNGSV  163 (386)
Q Consensus        94 G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~h~--niv~~~---~--~~~~~~~~~lv~e~~~~g~L  163 (386)
                      +.-..||+....++..+++|...+.  ...++..|.+.+..|...  .++...   |  ....++..+.++++++|...
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            4456799998877888999986533  455677888887776321  122222   2  12234567789999987654

>COG3231 Aph Aminoglycoside phosphotransferase [Translation, ribosomal structure and biogenesis]

Probab=94.17  E-value=0.4  Score=41.68  Aligned_cols=123  Identities=20%  Similarity=0.198  Sum_probs=84.0

Q ss_pred             eEEEEEEeCCCcEEEEEECCCCChhHHHHHHHHHHcCCC--CcccccccceeeCCeEEEEEEeecCCCccccccCCCcCC
Q 016588           97 GEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQH--RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVS  174 (386)
Q Consensus        97 g~V~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~  174 (386)
                      +.||+.....+..+.+|+.......++..|...++-+.-  -.+.++.++..+.+.-||+|+-++|.++...-       
T Consensus        33 ~~v~rl~a~~r~g~~~k~~~~~~~a~L~~Ea~RlrWla~~~l~~P~V~~~~~~~~~~wLl~salpG~~~s~~~-------  105 (266)
T COG3231          33 AGVFRLFADSRPGLYLKIASSGPAAELEGEAARLRWLAGQGLGCPRVLGLEDDADQAWLLMSALPGEDASHPR-------  105 (266)
T ss_pred             CeEEEEeccCCCceEEEEecCcchhhhhhHHHHHHHhcccCCCCCceEeeccCcchhHHhhhhcCCCcccchh-------
Confidence            468887766666678888777778899999999987742  23445555556678889999999987764322       


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhcCC-----------------------------------------------------
Q 016588          175 RQKLEFKHRLSIALGAAKGLAHLHSLS-----------------------------------------------------  201 (386)
Q Consensus       175 ~~~l~~~~~~~i~~~i~~~l~~LH~~~-----------------------------------------------------  201 (386)
                       ..++..   +.+--++.+|..||...                                                     
T Consensus       106 -~~~~p~---r~v~~la~aLR~LH~l~~~aCPFd~rl~~rl~~a~~r~~a~~vdesdfd~e~qgr~~~El~d~L~~~rp~  181 (266)
T COG3231         106 -YALDPK---RAVPLLAEALRRLHELPVEACPFDRRLARRLAKARARVRAGLVDESDFDEERQGRTAEELFDELEARRPA  181 (266)
T ss_pred             -hcCCHH---HHHHHHHHHHHHHhcCChhhCCcchHHHHHHHHHHHHHhccCCChhhcChhhcCCCHHHHHHHHHhcCCc
Confidence             112222   23344566667776531                                                     


Q ss_pred             ---CCceecCCCCCCeeeCCCCceEEcccccc
Q 016588          202 ---PRVVHKDFKTANVLVDEDFIAKVADAGLR  230 (386)
Q Consensus       202 ---~~ivH~dlkp~Nill~~~~~~kl~DFgl~  230 (386)
                         --+.|+|=..-|++++.+.-.=.+|+|-.
T Consensus       182 ~edLVv~HGDACLPN~i~d~~rf~GfIDlGrl  213 (266)
T COG3231         182 VEDLVVTHGDACLPNFILDGWRFSGFIDLGRL  213 (266)
T ss_pred             hhhceeecCcccCcceEecCCceEEeeecCcc
Confidence               12589999999999998866567787743

>PRK06148 hypothetical protein; Provisional

Probab=94.14  E-value=0.51  Score=51.06  Aligned_cols=142  Identities=18%  Similarity=0.215  Sum_probs=77.0

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEECCCC-ChhHHHHHHHHHHcCC-------CCcccccc-cc----eee-CC--eEE
Q 016588           89 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQ-------HRNLVTLL-GY----CQE-NN--LQF  152 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~-------h~niv~~~-~~----~~~-~~--~~~  152 (386)
                      +.|+ |..-.+|+....++..+++|+.... .......|...|..|.       -|.+++-. |-    ... .+  ..+
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~v  109 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRLL  109 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCccchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEEE
Confidence            4454 4567889988877888999987644 3334455666666552       23333322 11    111 12  456


Q ss_pred             EEEEeecCCCcccccc---------------------CCCc-CCCCCCCHH-----------------HHHHHHHHHHHH
Q 016588          153 LIYEYIPNGSVSIHLY---------------------GPSQ-VSRQKLEFK-----------------HRLSIALGAAKG  193 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~---------------------~~~~-~~~~~l~~~-----------------~~~~i~~~i~~~  193 (386)
                      -+++|++|..+.....                     .-.. .....+.|.                 ....++.++...
T Consensus       110 rLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~~  189 (1013)
T PRK06148        110 RLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLAR  189 (1013)
T ss_pred             EEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHHH
Confidence            6899999876654110                     0000 000111111                 111222233222


Q ss_pred             HH-----HhhcCCCCceecCCCCCCeeeCCCC--ceE-Eccccccc
Q 016588          194 LA-----HLHSLSPRVVHKDFKTANVLVDEDF--IAK-VADAGLRN  231 (386)
Q Consensus       194 l~-----~LH~~~~~ivH~dlkp~Nill~~~~--~~k-l~DFgl~~  231 (386)
                      ..     .+.+...++||+|+.+.|||++.+.  .+. |.|||-+.
T Consensus       190 ~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        190 FERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             HHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            21     2333345699999999999999875  554 99999754

>PRK12396 5-methylribose kinase; Reviewed

Probab=93.85  E-value=0.21  Score=47.48  Aligned_cols=71  Identities=14%  Similarity=0.175  Sum_probs=47.2

Q ss_pred             CCeecccCceEEEEEEeCC-CcEEEEEE------CC---CCChhHHHHHHHHHHcCC--CC-cccccccceeeCCeEEEE
Q 016588           88 KNLIGEGKFGEVYKGLLQD-GMLVAIKK------RP---GAPTQEFIDEVCFLASIQ--HR-NLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~-~~~vavK~------~~---~~~~~~~~~e~~~l~~l~--h~-niv~~~~~~~~~~~~~lv  154 (386)
                      .+.||.|.-..||++...+ +..|+||.      ..   +...++..-|.+.|+...  -| .+++++.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            4678999999999999743 56799995      11   223455667777777653  23 56666654  34445688


Q ss_pred             EEeecC
Q 016588          155 YEYIPN  160 (386)
Q Consensus       155 ~e~~~~  160 (386)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            898854

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	386
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-38
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-38
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-35
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-35
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-21
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		6e-21
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-20
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-19
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-17
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-17
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-17
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-17
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-17
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-17
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		7e-17
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		9e-17
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-16
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-16
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-16
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-16
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-16
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-16
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-16
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-16
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-16
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-16
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-16
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-16
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-16
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-15
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-15
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-15
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-15
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-14
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-14
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-14
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-14
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-14
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-14
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-14
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-14
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-14
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-14
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-14
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-14
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-14
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-14
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-14
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-14
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-14
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-14
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-14
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-14
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		6e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-14
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-14
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		6e-14
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		6e-14
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-14
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		6e-14
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-14
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		7e-14
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		7e-14
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-14
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		7e-14
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		7e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		7e-14
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		7e-14
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		7e-14
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		8e-14
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		8e-14
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		8e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-13
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-13
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-13
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-13
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-13
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-13
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-13
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-13
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-13
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-13
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-13
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-13
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-13
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-13
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-13
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		5e-13
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-13
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		5e-13
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		6e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-13
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		6e-13
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		7e-13
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		8e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		8e-13
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		9e-13
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		9e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-13
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-13
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		9e-13
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-12
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-12
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-12
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-12
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-12
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-12
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-12
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-12
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-12
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-12
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-12
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-12
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-12
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-12
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-12
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-12
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-12
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-12
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-12
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-12
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		6e-12
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		9e-12
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-11
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-11
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-11
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-11
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-11
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-11
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-11
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-11
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-11
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-11
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-11
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-11
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		5e-11
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-11
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-11
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		5e-11
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-11
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		5e-11
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		5e-11
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		5e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-11
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		5e-11
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		5e-11
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		5e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-11
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-11
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-11
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		6e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		6e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-11
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		7e-11
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-11
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-11
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-11
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-11
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-11
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		9e-11
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-10
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-10
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-10
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-10
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-10
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-10
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-10
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-10
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-10
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-10
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-10
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-10
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-10
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-10
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-10
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-10
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-10
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-10
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-10
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		7e-10
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-09
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-09
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-09
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-09
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-09
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		7e-09
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		8e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		8e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		9e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-08
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-08
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-08
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-08
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-08
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-08
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-08
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-08
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-08
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-08
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-08
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-08
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-08
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-08
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-08
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-08
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-08
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-08
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-08
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-08
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-08
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-08
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-08
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-08
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-08
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-08
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-08
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-08
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-08
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-08
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		6e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		6e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-07
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-07
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-07
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-07
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-07
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-07
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-07
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-07
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-07
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-07
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-07
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-07
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-07
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-07
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-07
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-07
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-07
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-07
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-07
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		8e-07
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		9e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-07
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-06
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-06
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-06
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-06
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-06
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-06
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-06
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-06
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-06
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-06
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-06
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-06
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-06
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-06
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-06
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-06
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-06
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-06
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-06
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-06
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-06
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-06
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-06
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-06
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		5e-06
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-06
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		5e-06
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-06
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		6e-06
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		7e-06
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		7e-06
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-06
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		8e-06
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		8e-06
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		8e-06
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		9e-06
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		9e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		9e-06
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-05
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-05
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-05
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-05
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-05
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-05
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-05
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-05
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-05
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-05
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-05
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-05
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-05
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-05
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-05
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-05
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-05
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-05
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-05
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-05
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-05
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-05
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-05
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-05
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-05
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-05
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-05
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-05
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-05
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-05
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-05
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-05
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-05
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-05
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-05
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-05
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-05
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		5e-05
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-05
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		5e-05
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-05
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-05
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-05
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		6e-05
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-05
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-05
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		7e-05
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		7e-05
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		7e-05
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		9e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		9e-05
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		9e-05
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-04
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-04
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-04
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-04
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-04
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-04
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-04
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-04
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-04
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-04
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-04
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-04
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-04
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-04
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-04
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-04
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-04
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-04
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-04
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-04
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-04
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-04
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-04
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-04
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-04
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-04
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-04
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-04
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-04
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-04
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		5e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-04
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		5e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-04
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-04
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		6e-04
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-04
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		6e-04
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		6e-04
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-04
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		6e-04
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-04
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-04
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-04
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-04
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		7e-04
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-04
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		7e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		7e-04
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-04
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		7e-04
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		8e-04
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-04
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-04
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-04
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		9e-04
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		9e-04

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 103/293 (35%), Positives = 151/293 (51%), Gaps = 6/293 (2%)
Query: 69  EARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFID 125
           E+ R  + +L  AT NF  K LIG G FG+VYKG+L+DG  VA+K+R    +Q   EF  
Sbjct: 25  ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFET 84
Query: 126 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 185
           E+  L+  +H +LV+L+G+C E N   LIY+Y+ NG++  HLYG S +    + ++ RL 
Sbjct: 85  EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG-SDLPTMSMSWEQRLE 143
Query: 186 IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 245
           I                 ++H+D K+ N+L+DE+F+ K+ D G+       D       V
Sbjct: 144 ICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVV 201
Query: 246 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRD 305
                ++  E     R +EKSDVYSFGV L E++  R A             E    S +
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 306 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
              L +I+D  L      E + +F    V+CL  SSE RPSM DV+ +L+  L
Sbjct: 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 105/296 (35%), Positives = 155/296 (52%), Gaps = 12/296 (4%)
Query: 69  EARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFID 125
           E+ R  + +L  AT NF  K LIG G FG+VYKG+L+DG  VA+K+R    +Q   EF  
Sbjct: 25  ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFET 84
Query: 126 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 185
           E+  L+  +H +LV+L+G+C E N   LIY+Y+ NG++  HLYG S +    + ++ RL 
Sbjct: 85  EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG-SDLPTMSMSWEQRLE 143
Query: 186 IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNF---LGRTDVAGPS 242
           I                 ++H+D K+ N+L+DE+F+ K+ D G+      LG+T +    
Sbjct: 144 ICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLX--- 198
Query: 243 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQN 302
             V     ++  E     R +EKSDVYSFGV L E++  R A             E    
Sbjct: 199 XVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE 258
Query: 303 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
           S +   L +I+D  L      E + +F    V+CL  SSE RPSM DV+ +L+  L
Sbjct: 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 98/299 (32%), Positives = 154/299 (51%), Gaps = 9/299 (3%)
Query: 64  ELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK----RPGAP 119
           E+ + + +RF + EL +A+ NFS+KN++G G FG+VYKG L DG LVA+K+    R    
Sbjct: 19  EVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGG 78
Query: 120 TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE 179
             +F  EV  ++   HRNL+ L G+C     + L+Y Y+ NGSV+  L    + S+  L+
Sbjct: 79  ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE-SQPPLD 137
Query: 180 FKHRLSIXXXXXXXXXXXXXX-XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 238
           +  R  I                P+++H+D K AN+L+DE+F A V D GL   +   D 
Sbjct: 138 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDX 197
Query: 239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA--XXXXXXXXXXXX 296
               + V      +A E     + SEK+DV+ +GV LLEL++G+ A              
Sbjct: 198 HVXXA-VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 256
Query: 297 VELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 355
           ++ V+       L  ++D  L   + +E +E+ IQ+ + C   S   RP MS+VV  L+
Sbjct: 257 LDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 98/299 (32%), Positives = 154/299 (51%), Gaps = 9/299 (3%)
Query: 64  ELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ-- 121
           E+ + + +RF + EL +A+ NF +KN++G G FG+VYKG L DG LVA+K+     TQ  
Sbjct: 11  EVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGG 70
Query: 122 --EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE 179
             +F  EV  ++   HRNL+ L G+C     + L+Y Y+ NGSV+  L    + S+  L+
Sbjct: 71  ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE-SQPPLD 129
Query: 180 FKHRLSIXXXXXXXXXXXXXX-XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 238
           +  R  I                P+++H+D K AN+L+DE+F A V D GL   +   D 
Sbjct: 130 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDX 189
Query: 239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA--XXXXXXXXXXXX 296
               + V      +A E     + SEK+DV+ +GV LLEL++G+ A              
Sbjct: 190 HVXXA-VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248
Query: 297 VELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 355
           ++ V+       L  ++D  L   + +E +E+ IQ+ + C   S   RP MS+VV  L+
Sbjct: 249 LDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/238 (31%), Positives = 111/238 (46%), Gaps = 19/238 (7%)
Query: 60  NVGIELSIREARRFQMEELSLATKNFSDK------NLIGEGKFGEVYKGLLQDGMLVAIK 113
           N  +E+S      F   EL   T NF ++      N +GEG FG VYKG + +   VA+K
Sbjct: 2   NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVK 60
Query: 114 KRPGAP-------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIH 166
           K             Q+F  E+  +A  QH NLV LLG+  + +   L+Y Y+PNGS+   
Sbjct: 61  KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 167 LYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVAD 226
           L          L +  R  I                  +H+D K+AN+L+DE F AK++D
Sbjct: 121 L--SCLDGTPPLSWHMRCKIAQGAANGINFLHEN--HHIHRDIKSANILLDEAFTAKISD 176
Query: 227 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 284
            GL     +       S++     ++A E       + KSD+YSFGV LLE+++G  A
Sbjct: 177 FGLARASEKFAQTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPA 233

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 75/238 (31%), Positives = 110/238 (46%), Gaps = 19/238 (7%)
Query: 60  NVGIELSIREARRFQMEELSLATKNFSDK------NLIGEGKFGEVYKGLLQDGMLVAIK 113
           N  +E+S      F   EL   T NF ++      N +GEG FG VYKG + +   VA+K
Sbjct: 2   NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVK 60
Query: 114 KRPGAP-------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIH 166
           K             Q+F  E+  +A  QH NLV LLG+  + +   L+Y Y+PNGS+   
Sbjct: 61  KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 167 LYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVAD 226
           L          L +  R  I                  +H+D K+AN+L+DE F AK++D
Sbjct: 121 L--SCLDGTPPLSWHMRCKIAQGAANGINFLHEN--HHIHRDIKSANILLDEAFTAKISD 176
Query: 227 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 284
            GL     +        ++     ++A E       + KSD+YSFGV LLE+++G  A
Sbjct: 177 FGLARASEKFAQTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPA 233

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 105/225 (46%), Gaps = 19/225 (8%)
Query: 73  FQMEELSLATKNFSDK------NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP------- 119
           F   EL   T NF ++      N +GEG FG VYKG + +   VA+KK            
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 67
Query: 120 TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE 179
            Q+F  E+  +A  QH NLV LLG+  + +   L+Y Y+PNGS+   L          L 
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL--SCLDGTPPLS 125
Query: 180 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 239
           +  R  I                  +H+D K+AN+L+DE F AK++D GL     +    
Sbjct: 126 WHMRCKIAQGAANGINFLHEN--HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 183
Query: 240 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 284
               ++     ++A E       + KSD+YSFGV LLE+++G  A
Sbjct: 184 VMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPA 227

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/225 (32%), Positives = 102/225 (45%), Gaps = 19/225 (8%)
Query: 73  FQMEELSLATKNFSDK------NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP------- 119
           F   EL   T NF ++      N  GEG FG VYKG + +   VA+KK            
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 120 TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE 179
            Q+F  E+   A  QH NLV LLG+  + +   L+Y Y PNGS+   L          L 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRL--SCLDGTPPLS 122
Query: 180 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 239
           +  R  I                  +H+D K+AN+L+DE F AK++D GL     +    
Sbjct: 123 WHXRCKIAQGAANGINFLHEN--HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 180
Query: 240 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 284
              S++     + A E       + KSD+YSFGV LLE+++G  A
Sbjct: 181 VXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPA 224

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 76  EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK-----KRPGAPTQEFIDEVCFL 130
           +++ +   + + K  IG G FG V++     G  VA+K             EF+ EV  +
Sbjct: 30  DDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIM 88
Query: 131 ASIQHRNLVTLLG-YCQENNLQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSIX 187
             ++H N+V  +G   Q  NL  ++ EY+  GS+   +H  G    +R++L+ + RLS+ 
Sbjct: 89  KRLRHPNIVLFMGAVTQPPNLS-IVTEYLSRGSLYRLLHKSG----AREQLDERRRLSMA 143
Query: 188 XXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 247
                         P +VH++ K+ N+LVD+ +  KV D GL      T ++  S+  T 
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTP 203
Query: 248 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
           +  ++A EV      +EKSDVYSFGV L EL +
Sbjct: 204 E--WMAPEVLRDEPSNEKSDVYSFGVILWELAT 234

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 106/223 (47%), Gaps = 11/223 (4%)
Query: 62  GIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGA 118
           G++L         M++  +   + + K+ +G G++GEVY G+ +   + VA+K  K    
Sbjct: 11  GVDLGTENLYFQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTM 70
Query: 119 PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL 178
             +EF+ E   +  I+H NLV LLG C      +++ EY+P G++  +L    + +R+  
Sbjct: 71  EVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYL---RECNRE-- 125
Query: 179 EFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTD 237
           E    + +                  +H+D    N LV E+ + KVAD GL   + G T 
Sbjct: 126 EVTAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTY 185
Query: 238 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            A   ++      + A E   +  FS KSDV++FGV L E+ +
Sbjct: 186 TAHAGAKFPIK--WTAPESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 81/267 (30%), Positives = 118/267 (44%), Gaps = 26/267 (9%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           IG G+FG V+ G   +   VAIK  R GA ++E FI+E   +  + H  LV L G C E 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 74
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 208
               L++E++ +G +S +L        Q+  F     +                 V+H+D
Sbjct: 75  APICLVFEFMEHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRD 128
Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS-EVKEFRRFSEKSD 267
               N LV E+ + KV+D G+  F+   D    SS  T   +  AS EV  F R+S KSD
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 268 VYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTFTNEGME 327
           V+SFGV + E+ S  E             VE      D S   ++   RL ST       
Sbjct: 187 VWSFGVLMWEVFS--EGKIPYENRSNSEVVE------DISTGFRLYKPRLASTHV----- 233
Query: 328 EFIQLIVRCLDPSSERRPSMSDVVTEL 354
              Q++  C     E RP+ S ++ +L
Sbjct: 234 --YQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 11/210 (5%)
Query: 75  MEELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLA 131
           +++  +   + + K+ +G G+FGEVY+G+ +   + VA+K  K      +EF+ E   + 
Sbjct: 3   LDKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 62
Query: 132 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 191
            I+H NLV LLG C      ++I E++  G++  +L    + +RQ  E    + +     
Sbjct: 63  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVSAVVLLYMATQ 117
Query: 192 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEI 250
                        +H+D    N LV E+ + KVAD GL   + G T  A   ++      
Sbjct: 118 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK-- 175
Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
           + A E   + +FS KSDV++FGV L E+ +
Sbjct: 176 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 81/267 (30%), Positives = 118/267 (44%), Gaps = 26/267 (9%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           IG G+FG V+ G   +   VAIK  R GA ++E FI+E   +  + H  LV L G C E 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 74
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 208
               L++E++ +G +S +L        Q+  F     +                 V+H+D
Sbjct: 75  APICLVFEFMEHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 128
Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS-EVKEFRRFSEKSD 267
               N LV E+ + KV+D G+  F+   D    SS  T   +  AS EV  F R+S KSD
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 268 VYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTFTNEGME 327
           V+SFGV + E+ S  E             VE      D S   ++   RL ST       
Sbjct: 187 VWSFGVLMWEVFS--EGKIPYENRSNSEVVE------DISTGFRLYKPRLASTHV----- 233
Query: 328 EFIQLIVRCLDPSSERRPSMSDVVTEL 354
              Q++  C     E RP+ S ++ +L
Sbjct: 234 --YQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 81/267 (30%), Positives = 118/267 (44%), Gaps = 26/267 (9%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           IG G+FG V+ G   +   VAIK  R GA ++E FI+E   +  + H  LV L G C E 
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 208
               L++E++ +G +S +L        Q+  F     +                 V+H+D
Sbjct: 73  APICLVFEFMEHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 126
Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS-EVKEFRRFSEKSD 267
               N LV E+ + KV+D G+  F+   D    SS  T   +  AS EV  F R+S KSD
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 184
Query: 268 VYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTFTNEGME 327
           V+SFGV + E+ S  E             VE      D S   ++   RL ST       
Sbjct: 185 VWSFGVLMWEVFS--EGKIPYENRSNSEVVE------DISTGFRLYKPRLASTHV----- 231
Query: 328 EFIQLIVRCLDPSSERRPSMSDVVTEL 354
              Q++  C     E RP+ S ++ +L
Sbjct: 232 --YQIMNHCWKERPEDRPAFSRLLRQL 256

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 81/267 (30%), Positives = 118/267 (44%), Gaps = 26/267 (9%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           IG G+FG V+ G   +   VAIK  R GA ++E FI+E   +  + H  LV L G C E 
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 77
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 208
               L++E++ +G +S +L        Q+  F     +                 V+H+D
Sbjct: 78  APICLVFEFMEHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 131
Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS-EVKEFRRFSEKSD 267
               N LV E+ + KV+D G+  F+   D    SS  T   +  AS EV  F R+S KSD
Sbjct: 132 LAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 189
Query: 268 VYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTFTNEGME 327
           V+SFGV + E+ S  E             VE      D S   ++   RL ST       
Sbjct: 190 VWSFGVLMWEVFS--EGKIPYENRSNSEVVE------DISTGFRLYKPRLASTHV----- 236
Query: 328 EFIQLIVRCLDPSSERRPSMSDVVTEL 354
              Q++  C     E RP+ S ++ +L
Sbjct: 237 --YQIMNHCWRERPEDRPAFSRLLRQL 261

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 11/210 (5%)
Query: 75  MEELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLA 131
           +++  +   + + K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   + 
Sbjct: 3   LDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 62
Query: 132 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 191
            I+H NLV LLG C      ++I E++  G++  +L    + +RQ  E    + +     
Sbjct: 63  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL---RECNRQ--EVSAVVLLYMATQ 117
Query: 192 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEI 250
                        +H+D    N LV E+ + KVAD GL   + G T  A   ++      
Sbjct: 118 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK-- 175
Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
           + A E   + +FS KSDV++FGV L E+ +
Sbjct: 176 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 129/295 (43%), Gaps = 41/295 (13%)
Query: 88  KNLIGEGKFGEVYKGLLQDG-----MLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNL 138
           + +IG G+FGEVYKG+L+       + VAIK      T+    +F+ E   +    H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 139 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK-LEFKHRLSIXXXXXXXXXXX 197
           + L G   +     +I EY+ NG++   L       R+K  EF     +           
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFL-------REKDGEFSVLQLVGMLRGIAAGMK 161
Query: 198 XXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---FLAS 254
                  VH+D    N+LV+ + + KV+D GL   L   D    +   +  +I   + A 
Sbjct: 162 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL--EDDPEATYTTSGGKIPIRWTAP 219
Query: 255 EVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSN--LLKI 312
           E   +R+F+  SDV+SFG+ + E+++  E                 +   + SN  ++K 
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMTYGE-----------------RPYWELSNHEVMKA 262
Query: 313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTV 367
           +++        +      QL+++C      RRP  +D+V+ LD+ +    +L T+
Sbjct: 263 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTL 317

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 16/213 (7%)
Query: 76  EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK-----KRPGAPTQEFIDEVCFL 130
           +++ +   + + K  IG G FG V++     G  VA+K             EF+ EV  +
Sbjct: 30  DDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIM 88
Query: 131 ASIQHRNLVTLLG-YCQENNLQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSIX 187
             ++H N+V  +G   Q  NL  ++ EY+  GS+   +H  G    +R++L+ + RLS+ 
Sbjct: 89  KRLRHPNIVLFMGAVTQPPNLS-IVTEYLSRGSLYRLLHKSG----AREQLDERRRLSMA 143
Query: 188 XXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 247
                         P +VH+D K+ N+LVD+ +  KV D GL        +    +  T 
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTP 203
Query: 248 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
           +  ++A EV      +EKSDVYSFGV L EL +
Sbjct: 204 E--WMAPEVLRDEPSNEKSDVYSFGVILWELAT 234

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 88  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 19  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 79  CTREPPFYIIIEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLEKKNF 133
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 263
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK--WTAPESLAYNKFS 191
Query: 264 EKSDVYSFGVFLLELVS 280
            KSDV++FGV L E+ +
Sbjct: 192 IKSDVWAFGVLLWEIAT 208

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 88  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 263
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK--WTAPESLAYNKFS 195
Query: 264 EKSDVYSFGVFLLELVS 280
            KSDV++FGV L E+ +
Sbjct: 196 IKSDVWAFGVLLWEIAT 212

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 88  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 83  CTREPPFYIIIEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 263
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 195
Query: 264 EKSDVYSFGVFLLELVS 280
            KSDV++FGV L E+ +
Sbjct: 196 IKSDVWAFGVLLWEIAT 212

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 88  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYL---RECNRQ--EVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 263
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 190
Query: 264 EKSDVYSFGVFLLELVS 280
            KSDV++FGV L E+ +
Sbjct: 191 IKSDVWAFGVLLWEIAT 207

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 88  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLEKKNF 132
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 263
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 190
Query: 264 EKSDVYSFGVFLLELVS 280
            KSDV++FGV L E+ +
Sbjct: 191 IKSDVWAFGVLLWEIAT 207

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 88  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLEKKNF 134
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 263
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK--WTAPESLAYNKFS 192
Query: 264 EKSDVYSFGVFLLELVS 280
            KSDV++FGV L E+ +
Sbjct: 193 IKSDVWAFGVLLWEIAT 209

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 88  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLEKKNF 134
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 263
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 192
Query: 264 EKSDVYSFGVFLLELVS 280
            KSDV++FGV L E+ +
Sbjct: 193 IKSDVWAFGVLLWEIAT 209

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 88  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 19  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 79  CTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLEKKNF 133
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 263
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK--WTAPESLAYNKFS 191
Query: 264 EKSDVYSFGVFLLELVS 280
            KSDV++FGV L E+ +
Sbjct: 192 IKSDVWAFGVLLWEIAT 208

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 88  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 263
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 195
Query: 264 EKSDVYSFGVFLLELVS 280
            KSDV++FGV L E+ +
Sbjct: 196 IKSDVWAFGVLLWEIAT 212

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 88  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 263
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 190
Query: 264 EKSDVYSFGVFLLELVS 280
            KSDV++FGV L E+ +
Sbjct: 191 IKSDVWAFGVLLWEIAT 207

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 88  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 31  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 90
Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 91  CTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLEKKNF 145
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 263
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 146 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 203
Query: 264 EKSDVYSFGVFLLELVS 280
            KSDV++FGV L E+ +
Sbjct: 204 IKSDVWAFGVLLWEIAT 220

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 11/210 (5%)
Query: 75  MEELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLA 131
           +++  +   + + K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   + 
Sbjct: 3   LDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 62
Query: 132 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 191
            I+H NLV LLG C      ++I E++  G++  +L    + +RQ  E    + +     
Sbjct: 63  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVSAVVLLYMATQ 117
Query: 192 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEI 250
                        +H+D    N LV E+ + KVAD GL   + G T  A   ++      
Sbjct: 118 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIK-- 175
Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
           + A E   + +FS KSDV++FGV L E+ +
Sbjct: 176 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 88  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLEKKNF 132
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 263
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 190
Query: 264 EKSDVYSFGVFLLELVS 280
            KSDV++FGV L E+ +
Sbjct: 191 IKSDVWAFGVLLWEIAT 207

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 88  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 263
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 190
Query: 264 EKSDVYSFGVFLLELVS 280
            KSDV++FGV L E+ +
Sbjct: 191 IKSDVWAFGVLLWEIAT 207

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 88  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 263
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 195
Query: 264 EKSDVYSFGVFLLELVS 280
            KSDV++FGV L E+ +
Sbjct: 196 IKSDVWAFGVLLWEIAT 212

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 88  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLEKKNF 136
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 263
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 194
Query: 264 EKSDVYSFGVFLLELVS 280
            KSDV++FGV L E+ +
Sbjct: 195 IKSDVWAFGVLLWEIAT 211

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 88  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYL---RECNRQ--EVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 263
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 190
Query: 264 EKSDVYSFGVFLLELVS 280
            KSDV++FGV L E+ +
Sbjct: 191 IKSDVWAFGVLLWEIAT 207

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 88  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLEKKNF 134
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 263
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 192
Query: 264 EKSDVYSFGVFLLELVS 280
            KSDV++FGV L E+ +
Sbjct: 193 IKSDVWAFGVLLWEIAT 209

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 88  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVSAVVLLYMATQISSAMEYLEKKNF 137
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 263
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 195
Query: 264 EKSDVYSFGVFLLELVS 280
            KSDV++FGV L E+ +
Sbjct: 196 IKSDVWAFGVLLWEIAT 212

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/267 (30%), Positives = 117/267 (43%), Gaps = 26/267 (9%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           IG G+FG V+ G   +   VAIK  R GA ++E FI+E   +  + H  LV L G C E 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 208
               L+ E++ +G +S +L        Q+  F     +                 V+H+D
Sbjct: 76  APICLVTEFMEHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 129
Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS-EVKEFRRFSEKSD 267
               N LV E+ + KV+D G+  F+   D    SS  T   +  AS EV  F R+S KSD
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 187
Query: 268 VYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTFTNEGME 327
           V+SFGV + E+ S  E             VE      D S   ++   RL ST       
Sbjct: 188 VWSFGVLMWEVFS--EGKIPYENRSNSEVVE------DISTGFRLYKPRLASTHV----- 234
Query: 328 EFIQLIVRCLDPSSERRPSMSDVVTEL 354
              Q++  C     E RP+ S ++ +L
Sbjct: 235 --YQIMNHCWRERPEDRPAFSRLLRQL 259

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 112/238 (47%), Gaps = 23/238 (9%)
Query: 47  PSVQRNICIIAGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQD 106
           P+ +RN   I G +   +       +++ME   +  K+      +G G++GEVY+G+ + 
Sbjct: 196 PAPKRNKPTIYGVSPNYD-------KWEMERTDITMKH-----KLGGGQYGEVYEGVWKK 243
Query: 107 -GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV 163
             + VA+K  K      +EF+ E   +  I+H NLV LLG C      ++I E++  G++
Sbjct: 244 YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 303
Query: 164 SIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAK 223
             +L    + +RQ  E    + +                  +H++    N LV E+ + K
Sbjct: 304 LDYL---RECNRQ--EVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVK 358
Query: 224 VADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
           VAD GL   + G T  A   ++      + A E   + +FS KSDV++FGV L E+ +
Sbjct: 359 VADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 114/267 (42%), Gaps = 26/267 (9%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 148
           IG G+FG V+ G   +   VAIK  K       +FI+E   +  + H  LV L G C E 
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQ 94
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 208
               L++E++ +G +S +L        Q+  F     +                 V+H+D
Sbjct: 95  APICLVFEFMEHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 148
Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS-EVKEFRRFSEKSD 267
               N LV E+ + KV+D G+  F+   D    SS  T   +  AS EV  F R+S KSD
Sbjct: 149 LAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 206
Query: 268 VYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTFTNEGME 327
           V+SFGV + E+ S  E             VE      D S   ++   RL ST       
Sbjct: 207 VWSFGVLMWEVFS--EGKIPYENRSNSEVVE------DISTGFRLYKPRLASTHV----- 253
Query: 328 EFIQLIVRCLDPSSERRPSMSDVVTEL 354
              Q++  C     E RP+ S ++ +L
Sbjct: 254 --YQIMNHCWKERPEDRPAFSRLLRQL 278

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 112/238 (47%), Gaps = 23/238 (9%)
Query: 47  PSVQRNICIIAGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQD 106
           P+ +RN   + G +   +       +++ME   +  K+      +G G++GEVY+G+ + 
Sbjct: 235 PAPKRNKPTVYGVSPNYD-------KWEMERTDITMKH-----KLGGGQYGEVYEGVWKK 282
Query: 107 -GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV 163
             + VA+K  K      +EF+ E   +  I+H NLV LLG C      ++I E++  G++
Sbjct: 283 YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 342
Query: 164 SIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAK 223
             +L    + +RQ  E    + +                  +H++    N LV E+ + K
Sbjct: 343 LDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVK 397
Query: 224 VADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
           VAD GL   + G T  A   ++      + A E   + +FS KSDV++FGV L E+ +
Sbjct: 398 VADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 118/272 (43%), Gaps = 26/272 (9%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQ 146
           IG G FG VYKG     + V +     APT    Q F +EV  L   +H N++  +GY  
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVT-APTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 78
Query: 147 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVH 206
           +  L  ++ ++    S+  HL+     S  K E K  + I                 ++H
Sbjct: 79  KPQLA-IVTQWCEGSSLYHHLH----ASETKFEMKKLIDIARQTARGMDYLHAKS--IIH 131
Query: 207 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV---KEFRRFS 263
           +D K+ N+ + ED   K+ D GL     R   +    Q++   +++A EV   ++   +S
Sbjct: 132 RDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 191
Query: 264 EKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTFTN 323
            +SDVY+FG+ L EL++G+              +E+V       +L K+          +
Sbjct: 192 FQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIEMVGRGSLSPDLSKV---------RS 240
Query: 324 EGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 355
              +   +L+  CL    + RPS   ++ E++
Sbjct: 241 NCPKRMKRLMAECLKKKRDERPSFPRILAEIE 272

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQ 146
           IG G FG VYKG     + V I K    PT    Q F +EV  L   +H N++  +GY  
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT 102
Query: 147 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVH 206
           ++NL  ++ ++    S+  HL+       Q+ +F+    I                 ++H
Sbjct: 103 KDNLA-IVTQWCEGSSLYKHLH------VQETKFQMFQLIDIARQTAQGMDYLHAKNIIH 155
Query: 207 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV---KEFRRFS 263
           +D K+ N+ + E    K+ D GL     R   +    Q T   +++A EV   ++   FS
Sbjct: 156 RDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFS 215
Query: 264 EKSDVYSFGVFLLELVSG 281
            +SDVYS+G+ L EL++G
Sbjct: 216 FQSDVYSYGIVLYELMTG 233

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 119/275 (43%), Gaps = 32/275 (11%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQ 146
           IG G FG VYKG     + V +     APT    Q F +EV  L   +H N++  +GY  
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVT-APTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 90
Query: 147 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVH 206
           +  L  ++ ++    S+  HL+     S  K E K  + I                 ++H
Sbjct: 91  KPQLA-IVTQWCEGSSLYHHLH----ASETKFEMKKLIDIARQTARGMDYLHAKS--IIH 143
Query: 207 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV---KEFRRFS 263
           +D K+ N+ + ED   K+ D GL     R   +    Q++   +++A EV   ++   +S
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 264 EKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQN---SRDFSNLLKILDERLWST 320
            +SDVY+FG+ L EL++G+              +E+V     S D S +     +R+   
Sbjct: 204 FQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM--- 258
Query: 321 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 355
                     +L+  CL    + RPS   ++ E++
Sbjct: 259 ---------KRLMAECLKKKRDERPSFPRILAEIE 284

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 118/275 (42%), Gaps = 32/275 (11%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQ 146
           IG G FG VYKG     + V +     APT    Q F +EV  L   +H N++  +GY  
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVT-APTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 90
Query: 147 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVH 206
              L  ++ ++    S+  HL+     S  K E K  + I                 ++H
Sbjct: 91  APQLA-IVTQWCEGSSLYHHLH----ASETKFEMKKLIDIARQTARGMDYLHAKS--IIH 143
Query: 207 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV---KEFRRFS 263
           +D K+ N+ + ED   K+ D GL     R   +    Q++   +++A EV   ++   +S
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 264 EKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQN---SRDFSNLLKILDERLWST 320
            +SDVY+FG+ L EL++G+              +E+V     S D S +     +R+   
Sbjct: 204 FQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM--- 258
Query: 321 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 355
                     +L+  CL    + RPS   ++ E++
Sbjct: 259 ---------KRLMAECLKKKRDERPSFPRILAEIE 284

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 28/207 (13%)
Query: 89  NLIGEGKFGEVYKGL-LQDG----MLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNL 138
            ++G G FG VYKG+ + +G    + VAIK       P A   EF+DE   +AS+ H +L
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKA-NVEFMDEALIMASMDHPHL 102
Query: 139 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXX 198
           V LLG C    +Q L+ + +P+G +         V   K     +L +            
Sbjct: 103 VRLLGVCLSPTIQ-LVTQLMPHGCLL------EYVHEHKDNIGSQLLLNWCVQIAKGMMY 155
Query: 199 XXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE-----IFLA 253
               R+VH+D    NVLV      K+ D GL   L      G   +  AD       ++A
Sbjct: 156 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL-----EGDEKEYNADGGKMPIKWMA 210
Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVS 280
            E   +R+F+ +SDV+S+GV + EL++
Sbjct: 211 LECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 92/195 (47%), Gaps = 15/195 (7%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  I+H  LV L     E 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSEE 85
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV--VH 206
            + +++ EY+  GS+   L G       ++    RL                  R+  VH
Sbjct: 86  PI-YIVTEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 207 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEK 265
           +D + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ K
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 266 SDVYSFGVFLLELVS 280
           SDV+SFG+ L EL +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 91  IGEGKFGEVY----KGLL--QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTL 141
           +GEG FG+V+      LL  QD MLVA+K    A     Q+F  E   L  +QH+++V  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHL--YGPS--------QVSRQKLEFKHRLSIXXXXX 191
            G C E     +++EY+ +G ++  L  +GP          V+   L     L++     
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 192 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF 251
                        VH+D  T N LV +  + K+ D G+   +  TD      +      +
Sbjct: 140 AGMVYLAGL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 197
Query: 252 LASEVKEFRRFSEKSDVYSFGVFLLELVS 280
           +  E   +R+F+ +SDV+SFGV L E+ +
Sbjct: 198 MPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 91  IGEGKFGEVY----KGLL--QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTL 141
           +GEG FG+V+      LL  QD MLVA+K    A     Q+F  E   L  +QH+++V  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHL--YGPS--------QVSRQKLEFKHRLSIXXXXX 191
            G C E     +++EY+ +G ++  L  +GP          V+   L     L++     
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 192 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF 251
                        VH+D  T N LV +  + K+ D G+   +  TD      +      +
Sbjct: 146 AGMVYLAGL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 203
Query: 252 LASEVKEFRRFSEKSDVYSFGVFLLELVS 280
           +  E   +R+F+ +SDV+SFGV L E+ +
Sbjct: 204 MPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 15/212 (7%)
Query: 84  NFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQ 134
           N   K  +GEG FG+V+          QD +LVA+K    A     ++F  E   L ++Q
Sbjct: 14  NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 73
Query: 135 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL--YGPSQV----SRQKLEFKHRLSIXX 188
           H ++V   G C E +   +++EY+ +G ++  L  +GP  V         E      +  
Sbjct: 74  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHI 133
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 248
                           VH+D  T N LV E+ + K+ D G+   +  TD           
Sbjct: 134 AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 193
Query: 249 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
             ++  E   +R+F+ +SDV+S GV L E+ +
Sbjct: 194 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 91  IGEGKFGEVY----KGLL--QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTL 141
           +GEG FG+V+      LL  QD MLVA+K    A     Q+F  E   L  +QH+++V  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHL--YGPS--------QVSRQKLEFKHRLSIXXXXX 191
            G C E     +++EY+ +G ++  L  +GP          V+   L     L++     
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 192 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF 251
                        VH+D  T N LV +  + K+ D G+   +  TD      +      +
Sbjct: 169 AGMVYLAGL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 226
Query: 252 LASEVKEFRRFSEKSDVYSFGVFLLELVS 280
           +  E   +R+F+ +SDV+SFGV L E+ +
Sbjct: 227 MPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 28/207 (13%)
Query: 89  NLIGEGKFGEVYKGL-LQDG----MLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNL 138
            ++G G FG VYKG+ + +G    + VAIK       P A   EF+DE   +AS+ H +L
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKA-NVEFMDEALIMASMDHPHL 79
Query: 139 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXX 198
           V LLG C    +Q L+ + +P+G +         V   K     +L +            
Sbjct: 80  VRLLGVCLSPTIQ-LVTQLMPHGCLL------EYVHEHKDNIGSQLLLNWCVQIAKGMMY 132
Query: 199 XXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE-----IFLA 253
               R+VH+D    NVLV      K+ D GL   L      G   +  AD       ++A
Sbjct: 133 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL-----EGDEKEYNADGGKMPIKWMA 187
Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVS 280
            E   +R+F+ +SDV+S+GV + EL++
Sbjct: 188 LECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 88  KNLIGEGKFGEVYKG------LLQDGMLVAIK--KRPG-APTQEFIDEVCFLASIQHRNL 138
           K  +GEG FG+V+          +D MLVA+K  K P  A  ++F  E   L ++QH ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 139 VTLLGYCQENNLQFLIYEYIPNGSVS--IHLYGP-------SQVSRQKLEFKHRLSIXXX 189
           V   G C + +   +++EY+ +G ++  +  +GP        Q  + K E      +   
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                          VH+D  T N LV  + + K+ D G+   +  TD            
Sbjct: 140 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            ++  E   +R+F+ +SDV+SFGV L E+ +
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 91/193 (47%), Gaps = 11/193 (5%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 82
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 208
            + +++ EY+  GS+   L G +    + L     + +                  VH+D
Sbjct: 83  PI-YIVTEYMNKGSLLDFLKGETG---KYLRLPQLVDMSAQIASGMAYVERM--NYVHRD 136
Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 267
            + AN+LV E+ + KVAD GL   +   D    + Q     I + A E   + RF+ KSD
Sbjct: 137 LRAANILVGENLVCKVADFGLARLI--EDNEWTARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 268 VYSFGVFLLELVS 280
           V+SFG+ L EL +
Sbjct: 195 VWSFGILLTELTT 207

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 26/201 (12%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FGEV+ G   +   VA+K  +PG    Q F++E   + ++QH  LV L       
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTRE 80
Query: 149 NLQFLIYEYIPNGSVSIHLY---GPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 205
              ++I EY+  GS+   L    G   +  + ++F  +++                   +
Sbjct: 81  EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA--------EGMAYIERKNYI 132
Query: 206 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEF 259
           H+D + ANVLV E  + K+AD GL   +         ++ TA E       + A E   F
Sbjct: 133 HRDLRAANVLVSESLMCKIADFGLARVI-------EDNEYTAREGAKFPIKWTAPEAINF 185
Query: 260 RRFSEKSDVYSFGVFLLELVS 280
             F+ KSDV+SFG+ L E+V+
Sbjct: 186 GCFTIKSDVWSFGILLYEIVT 206

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 91/193 (47%), Gaps = 11/193 (5%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 208
            + +++ EY+  GS+   L G +    + L     + +                  VH+D
Sbjct: 252 PI-YIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM--NYVHRD 305
Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 267
            + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ KSD
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 268 VYSFGVFLLELVS 280
           V+SFG+ L EL +
Sbjct: 364 VWSFGILLTELTT 376

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 92/195 (47%), Gaps = 15/195 (7%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV--VH 206
            + +++ EY+  GS+   L G       ++    RL                  R+  VH
Sbjct: 86  PI-YIVIEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 207 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEK 265
           +D + AN+LV E+ + KVAD GL   +   D    + Q     I + A E   + RF+ K
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 266 SDVYSFGVFLLELVS 280
           SDV+SFG+ L EL +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 91/193 (47%), Gaps = 11/193 (5%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 208
            + +++ EY+  GS+   L G +    + L     + +                  VH+D
Sbjct: 252 PI-YIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM--NYVHRD 305
Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 267
            + AN+LV E+ + KVAD GL   +   D    + Q     I + A E   + RF+ KSD
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 268 VYSFGVFLLELVS 280
           V+SFG+ L EL +
Sbjct: 364 VWSFGILLTELTT 376

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 15/220 (6%)
Query: 70  ARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT----QEFID 125
            RR   ++  +     +    IG G FG VYKG     + V +     APT    Q F +
Sbjct: 23  GRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVT-APTPQQLQAFKN 81
Query: 126 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 185
           EV  L   +H N++  +GY  +  L  ++ ++    S+  HL+    +   K E    + 
Sbjct: 82  EVGVLRKTRHVNILLFMGYSTKPQLA-IVTQWCEGSSLYHHLH----IIETKFEMIKLID 136
Query: 186 IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 245
           I                 ++H+D K+ N+ + ED   K+ D GL     R   +    Q+
Sbjct: 137 IARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 194
Query: 246 TADEIFLASEV---KEFRRFSEKSDVYSFGVFLLELVSGR 282
           +   +++A EV   ++   +S +SDVY+FG+ L EL++G+
Sbjct: 195 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 91/193 (47%), Gaps = 11/193 (5%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 78
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 208
            + +++ EY+  GS+   L G +    + L     + +                  VH+D
Sbjct: 79  PI-YIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM--NYVHRD 132
Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 267
            + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ KSD
Sbjct: 133 LRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIKSD 190
Query: 268 VYSFGVFLLELVS 280
           V+SFG+ L EL +
Sbjct: 191 VWSFGILLTELTT 203

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 17/221 (7%)
Query: 70  ARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFI 124
            RR   ++  +     +    IG G FG VYKG       VA+K     APT    Q F 
Sbjct: 22  GRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFK 79
Query: 125 DEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRL 184
           +EV  L   +H N++  +GY  +  L  ++ ++    S+  HL+    +   K E    +
Sbjct: 80  NEVGVLRKTRHVNILLFMGYSTKPQLA-IVTQWCEGSSLYHHLH----IIETKFEMIKLI 134
Query: 185 SIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ 244
            I                 ++H+D K+ N+ + ED   K+ D GL     R   +    Q
Sbjct: 135 DIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 192
Query: 245 VTADEIFLASEV---KEFRRFSEKSDVYSFGVFLLELVSGR 282
           ++   +++A EV   ++   +S +SDVY+FG+ L EL++G+
Sbjct: 193 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCFLASIQHRNLVTLLGYC 145
           IG G FG VYKG       VA+K     APT    Q F +EV  L   +H N++  +GY 
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 146 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 205
            +  L  ++ ++    S+  HL+    +   K E    + I                 ++
Sbjct: 79  TKPQLA-IVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQTAQGMDYLHAKS--II 131
Query: 206 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV---KEFRRF 262
           H+D K+ N+ + ED   K+ D GL     R   +    Q++   +++A EV   ++   +
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 191
Query: 263 SEKSDVYSFGVFLLELVSGR 282
           S +SDVY+FG+ L EL++G+
Sbjct: 192 SFQSDVYAFGIVLYELMTGQ 211

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 92/195 (47%), Gaps = 15/195 (7%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 74
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV--VH 206
            + +++ EY+  GS+   L G       ++    RL                  R+  VH
Sbjct: 75  PI-YIVTEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 126
Query: 207 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEK 265
           +D + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ K
Sbjct: 127 RDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK 184
Query: 266 SDVYSFGVFLLELVS 280
           SDV+SFG+ L EL +
Sbjct: 185 SDVWSFGILLTELTT 199

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 92/195 (47%), Gaps = 15/195 (7%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV--VH 206
            + +++ EY+  GS+   L G       ++    RL                  R+  VH
Sbjct: 86  PI-YIVIEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 207 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEK 265
           +D + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ K
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 266 SDVYSFGVFLLELVS 280
           SDV+SFG+ L EL +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 92/195 (47%), Gaps = 15/195 (7%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV--VH 206
            + +++ EY+  GS+   L G       ++    RL                  R+  VH
Sbjct: 86  PI-YIVTEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 207 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEK 265
           +D + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ K
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 266 SDVYSFGVFLLELVS 280
           SDV+SFG+ L EL +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCFLASIQHRNLVTLLGYC 145
           IG G FG VYKG       VA+K     APT    Q F +EV  L   +H N++  +GY 
Sbjct: 18  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 146 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 205
            +  L  ++ ++    S+  HL+    +   K E    + I                 ++
Sbjct: 76  TKPQLA-IVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQTAQGMDYLHAKS--II 128
Query: 206 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV---KEFRRF 262
           H+D K+ N+ + ED   K+ D GL     R   +    Q++   +++A EV   ++   +
Sbjct: 129 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 188
Query: 263 SEKSDVYSFGVFLLELVSGR 282
           S +SDVY+FG+ L EL++G+
Sbjct: 189 SFQSDVYAFGIVLYELMTGQ 208

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCFLASIQHRNLVTLLGYC 145
           IG G FG VYKG       VA+K     APT    Q F +EV  L   +H N++  +GY 
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 146 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 205
            +  L  ++ ++    S+  HL+    +   K E    + I                 ++
Sbjct: 79  TKPQLA-IVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQTAQGMDYLHAKS--II 131
Query: 206 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV---KEFRRF 262
           H+D K+ N+ + ED   K+ D GL     R   +    Q++   +++A EV   ++   +
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 191
Query: 263 SEKSDVYSFGVFLLELVSGR 282
           S +SDVY+FG+ L EL++G+
Sbjct: 192 SFQSDVYAFGIVLYELMTGQ 211

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 92/195 (47%), Gaps = 15/195 (7%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 76
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV--VH 206
            + +++ EY+  GS+   L G       ++    RL                  R+  VH
Sbjct: 77  PI-YIVTEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 128
Query: 207 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEK 265
           +D + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ K
Sbjct: 129 RDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 266 SDVYSFGVFLLELVS 280
           SDV+SFG+ L EL +
Sbjct: 187 SDVWSFGILLTELTT 201

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 91/193 (47%), Gaps = 11/193 (5%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 208
            + +++ EY+  GS+   L G +    + L     + +                  VH+D
Sbjct: 252 PI-YIVGEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM--NYVHRD 305
Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 267
            + AN+LV E+ + KVAD GL   +   D    + Q     I + A E   + RF+ KSD
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 268 VYSFGVFLLELVS 280
           V+SFG+ L EL +
Sbjct: 364 VWSFGILLTELTT 376

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCFLASIQHRNLVTLLGYC 145
           IG G FG VYKG       VA+K     APT    Q F +EV  L   +H N++  +GY 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 146 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 205
            +  L  ++ ++    S+  HL+    +   K E    + I                 ++
Sbjct: 74  TKPQLA-IVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQTAQGMDYLHAKS--II 126
Query: 206 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV---KEFRRF 262
           H+D K+ N+ + ED   K+ D GL     R   +    Q++   +++A EV   ++   +
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 263 SEKSDVYSFGVFLLELVSGR 282
           S +SDVY+FG+ L EL++G+
Sbjct: 187 SFQSDVYAFGIVLYELMTGQ 206

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 91/193 (47%), Gaps = 11/193 (5%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 334
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 208
            + +++ EY+  GS+   L G +    + L     + +                  VH+D
Sbjct: 335 PI-YIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM--NYVHRD 388
Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 267
            + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ KSD
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 268 VYSFGVFLLELVS 280
           V+SFG+ L EL +
Sbjct: 447 VWSFGILLTELTT 459

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 91/193 (47%), Gaps = 11/193 (5%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 82
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 208
            + +++ EY+  GS+   L G +    + L     + +                  VH+D
Sbjct: 83  PI-YIVTEYMNKGSLLDFLKGETG---KYLRLPQLVDMSAQIASGMAYVERM--NYVHRD 136
Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 267
            + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ KSD
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 268 VYSFGVFLLELVS 280
           V+SFG+ L EL +
Sbjct: 195 VWSFGILLTELTT 207

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 92/195 (47%), Gaps = 15/195 (7%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV--VH 206
            + +++ EY+  GS+   L G       ++    RL                  R+  VH
Sbjct: 86  PI-YIVCEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 207 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEK 265
           +D + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ K
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 266 SDVYSFGVFLLELVS 280
           SDV+SFG+ L EL +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 111/265 (41%), Gaps = 38/265 (14%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 85
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 208
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 86  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 139
Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 262
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 140 LRAANILVSDTLSCKIADFGLARLIE-------DNEYTAREGAKFPIKWTAPEAINYGTF 192
Query: 263 SEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTF 321
           + KSDV+SFG+ L E+V+ GR               E++QN      +++          
Sbjct: 193 TIKSDVWSFGILLTEIVTHGR------IPYPGMTNPEVIQNLERGYRMVR---------- 236
Query: 322 TNEGMEEFIQLIVRCLDPSSERRPS 346
            +   EE  QL+  C     E RP+
Sbjct: 237 PDNCPEELYQLMRLCWKERPEDRPT 261

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 17/200 (8%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCFLASIQHRNLVTLLGYC 145
           IG G FG VYKG       VA+K     APT    Q F +EV  L   +H N++  +GY 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 146 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 205
               L  ++ ++    S+  HL+    +   K E    + I                 ++
Sbjct: 74  TAPQLA-IVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQTAQGMDYLHAKS--II 126
Query: 206 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV---KEFRRF 262
           H+D K+ N+ + ED   K+ D GL     R   +    Q++   +++A EV   ++   +
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 263 SEKSDVYSFGVFLLELVSGR 282
           S +SDVY+FG+ L EL++G+
Sbjct: 187 SFQSDVYAFGIVLYELMTGQ 206

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 15/220 (6%)
Query: 70  ARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT----QEFID 125
            RR   ++  +     +    IG G FG VYKG     + V +     APT    Q F +
Sbjct: 23  GRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVT-APTPQQLQAFKN 81
Query: 126 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 185
           EV  L   +H N++  +GY  +  L  ++ ++    S+  HL+    +   K E    + 
Sbjct: 82  EVGVLRKTRHVNILLFMGYSTKPQLA-IVTQWCEGSSLYHHLH----IIETKFEMIKLID 136
Query: 186 IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 245
           I                 ++H+D K+ N+ + ED   K+ D GL     R   +    Q+
Sbjct: 137 IARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQL 194
Query: 246 TADEIFLASEV---KEFRRFSEKSDVYSFGVFLLELVSGR 282
           +   +++A EV   ++   +S +SDVY+FG+ L EL++G+
Sbjct: 195 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 111/265 (41%), Gaps = 38/265 (14%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 81
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 208
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 82  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 135
Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 262
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 136 LRAANILVSDTLSCKIADFGLARLI-------EDNEXTAREGAKFPIKWTAPEAINYGTF 188
Query: 263 SEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTF 321
           + KSDV+SFG+ L E+V+ GR               E++QN      +++          
Sbjct: 189 TIKSDVWSFGILLTEIVTHGR------IPYPGMTNPEVIQNLERGYRMVR---------- 232
Query: 322 TNEGMEEFIQLIVRCLDPSSERRPS 346
            +   EE  QL+  C     E RP+
Sbjct: 233 PDNCPEELYQLMRLCWKERPEDRPT 257

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 111/265 (41%), Gaps = 38/265 (14%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 86
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 208
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 87  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 140
Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 262
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIE-------DNEYTAREGAKFPIKWTAPEAINYGTF 193
Query: 263 SEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTF 321
           + KSDV+SFG+ L E+V+ GR               E++QN      +++          
Sbjct: 194 TIKSDVWSFGILLTEIVTHGR------IPYPGMTNPEVIQNLERGYRMVR---------- 237
Query: 322 TNEGMEEFIQLIVRCLDPSSERRPS 346
            +   EE  QL+  C     E RP+
Sbjct: 238 PDNCPEELYQLMRLCWKERPEDRPT 262

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 111/265 (41%), Gaps = 38/265 (14%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 208
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 81  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 134
Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 262
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLI-------EDNEXTAREGAKFPIKWTAPEAINYGTF 187
Query: 263 SEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTF 321
           + KSDV+SFG+ L E+V+ GR               E++QN      +++          
Sbjct: 188 TIKSDVWSFGILLTEIVTHGR------IPYPGMTNPEVIQNLERGYRMVR---------- 231
Query: 322 TNEGMEEFIQLIVRCLDPSSERRPS 346
            +   EE  QL+  C     E RP+
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPT 256

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 111/265 (41%), Gaps = 38/265 (14%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 82
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 208
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 83  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 136
Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 262
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 137 LRAANILVSDTLSCKIADFGLARLIE-------DNEXTAREGAKFPIKWTAPEAINYGTF 189
Query: 263 SEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTF 321
           + KSDV+SFG+ L E+V+ GR               E++QN      +++          
Sbjct: 190 TIKSDVWSFGILLTEIVTHGR------IPYPGMTNPEVIQNLERGYRMVR---------- 233
Query: 322 TNEGMEEFIQLIVRCLDPSSERRPS 346
            +   EE  QL+  C     E RP+
Sbjct: 234 PDNCPEELYQLMRLCWKERPEDRPT 258

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 111/265 (41%), Gaps = 38/265 (14%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 208
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 81  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 134
Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 262
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLI-------EDNEYTAREGAKFPIKWTAPEAINYGTF 187
Query: 263 SEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTF 321
           + KSDV+SFG+ L E+V+ GR               E++QN      +++          
Sbjct: 188 TIKSDVWSFGILLTEIVTHGR------IPYPGMTNPEVIQNLERGYRMVR---------- 231
Query: 322 TNEGMEEFIQLIVRCLDPSSERRPS 346
            +   EE  QL+  C     E RP+
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPT 256

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 111/265 (41%), Gaps = 38/265 (14%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 89
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 208
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 90  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 143
Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 262
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 144 LRAANILVSDTLSCKIADFGLARLIE-------DNEXTAREGAKFPIKWTAPEAINYGTF 196
Query: 263 SEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTF 321
           + KSDV+SFG+ L E+V+ GR               E++QN      +++          
Sbjct: 197 TIKSDVWSFGILLTEIVTHGR------IPYPGMTNPEVIQNLERGYRMVR---------- 240
Query: 322 TNEGMEEFIQLIVRCLDPSSERRPS 346
            +   EE  QL+  C     E RP+
Sbjct: 241 PDNCPEELYQLMRLCWKERPEDRPT 265

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 111/265 (41%), Gaps = 38/265 (14%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 88
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 208
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 89  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 142
Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 262
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 143 LRAANILVSDTLSCKIADFGLARLIE-------DNEXTAREGAKFPIKWTAPEAINYGTF 195
Query: 263 SEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTF 321
           + KSDV+SFG+ L E+V+ GR               E++QN      +++          
Sbjct: 196 TIKSDVWSFGILLTEIVTHGR------IPYPGMTNPEVIQNLERGYRMVR---------- 239
Query: 322 TNEGMEEFIQLIVRCLDPSSERRPS 346
            +   EE  QL+  C     E RP+
Sbjct: 240 PDNCPEELYQLMRLCWKERPEDRPT 264

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 111/265 (41%), Gaps = 38/265 (14%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 90
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 208
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 91  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 144
Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 262
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 145 LRAANILVSDTLSCKIADFGLARLIE-------DNEYTAREGAKFPIKWTAPEAINYGTF 197
Query: 263 SEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTF 321
           + KSDV+SFG+ L E+V+ GR               E++QN      +++          
Sbjct: 198 TIKSDVWSFGILLTEIVTHGR------IPYPGMTNPEVIQNLERGYRMVR---------- 241
Query: 322 TNEGMEEFIQLIVRCLDPSSERRPS 346
            +   EE  QL+  C     E RP+
Sbjct: 242 PDNCPEELYQLMRLCWKERPEDRPT 266

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 92/195 (47%), Gaps = 15/195 (7%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 252
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV--VH 206
            + +++ EY+  GS+   L G       ++    RL                  R+  VH
Sbjct: 253 PI-YIVTEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 304
Query: 207 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEK 265
           +D + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ K
Sbjct: 305 RDLRAANILVGENLVCKVADFGLGRLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK 362
Query: 266 SDVYSFGVFLLELVS 280
           SDV+SFG+ L EL +
Sbjct: 363 SDVWSFGILLTELTT 377

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 111/265 (41%), Gaps = 38/265 (14%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 208
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 81  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 134
Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 262
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIE-------DNEXTAREGAKFPIKWTAPEAINYGTF 187
Query: 263 SEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTF 321
           + KSDV+SFG+ L E+V+ GR               E++QN      +++          
Sbjct: 188 TIKSDVWSFGILLTEIVTHGR------IPYPGMTNPEVIQNLERGYRMVR---------- 231
Query: 322 TNEGMEEFIQLIVRCLDPSSERRPS 346
            +   EE  QL+  C     E RP+
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPT 256

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 17/221 (7%)
Query: 70  ARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFI 124
            RR   ++  +     +    IG G FG VYKG       VA+K     APT    Q F 
Sbjct: 15  GRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFK 72
Query: 125 DEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRL 184
           +EV  L   +H N++  +GY  +  L  ++ ++    S+  HL+    +   K E    +
Sbjct: 73  NEVGVLRKTRHVNILLFMGYSTKPQLA-IVTQWCEGSSLYHHLH----IIETKFEMIKLI 127
Query: 185 SIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ 244
            I                 ++H+D K+ N+ + ED   K+ D GL     R   +    Q
Sbjct: 128 DIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ 185
Query: 245 VTADEIFLASEV---KEFRRFSEKSDVYSFGVFLLELVSGR 282
           ++   +++A EV   ++   +S +SDVY+FG+ L EL++G+
Sbjct: 186 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 111/265 (41%), Gaps = 38/265 (14%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 86
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 208
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 87  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 140
Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 262
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIE-------DNEXTAREGAKFPIKWTAPEAINYGTF 193
Query: 263 SEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTF 321
           + KSDV+SFG+ L E+V+ GR               E++QN      +++          
Sbjct: 194 TIKSDVWSFGILLTEIVTHGR------IPYPGMTNPEVIQNLERGYRMVR---------- 237
Query: 322 TNEGMEEFIQLIVRCLDPSSERRPS 346
            +   EE  QL+  C     E RP+
Sbjct: 238 PDNCPEELYQLMRLCWKERPEDRPT 262

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 91/195 (46%), Gaps = 15/195 (7%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV--VH 206
            + +++ EY+  GS+   L G       ++    RL                  R+  VH
Sbjct: 86  PI-YIVTEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 207 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEK 265
           +D   AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ K
Sbjct: 138 RDLAAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 266 SDVYSFGVFLLELVS 280
           SDV+SFG+ L EL +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 111/265 (41%), Gaps = 38/265 (14%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 75
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 208
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 76  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 129
Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 262
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 130 LRAANILVSDTLSCKIADFGLARLI-------EDNEYTAREGAKFPIKWTAPEAINYGTF 182
Query: 263 SEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTF 321
           + KSDV+SFG+ L E+V+ GR               E++QN      +++          
Sbjct: 183 TIKSDVWSFGILLTEIVTHGR------IPYPGMTNPEVIQNLERGYRMVR---------- 226
Query: 322 TNEGMEEFIQLIVRCLDPSSERRPS 346
            +   EE  QL+  C     E RP+
Sbjct: 227 PDNCPEELYQLMRLCWKERPEDRPT 251

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCFLASIQHRNLVTLLGYC 145
           IG G FG VYKG       VA+K     APT    Q F +EV  L   +H N++  +GY 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 146 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 205
            +  L  ++ ++    S+  HL+    +   K E    + I                 ++
Sbjct: 74  TKPQLA-IVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQTAQGMDYLHAKS--II 126
Query: 206 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV---KEFRRF 262
           H+D K+ N+ + ED   K+ D GL     R   +    Q++   +++A EV   ++   +
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 263 SEKSDVYSFGVFLLELVSGR 282
           S +SDVY+FG+ L EL++G+
Sbjct: 187 SFQSDVYAFGIVLYELMTGQ 206

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 90/193 (46%), Gaps = 11/193 (5%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 75
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 208
            +  ++ EY+  GS+   L G +    + L     + +                  VH+D
Sbjct: 76  PIX-IVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM--NYVHRD 129
Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 267
            + AN+LV E+ + KVAD GL   +   D    + Q     I + A E   + RF+ KSD
Sbjct: 130 LRAANILVGENLVCKVADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 187
Query: 268 VYSFGVFLLELVS 280
           V+SFG+ L EL +
Sbjct: 188 VWSFGILLTELTT 200

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 15/195 (7%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV--VH 206
            + +++ EY+  G +   L G       ++    RL                  R+  VH
Sbjct: 86  PI-YIVMEYMSKGCLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 207 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEK 265
           +D + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ K
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 266 SDVYSFGVFLLELVS 280
           SDV+SFG+ L EL +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 92/193 (47%), Gaps = 11/193 (5%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FGEV+ G       VAIK  +PG  + E F++E   +  ++H  LV L     E 
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSEE 76
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 208
            + +++ EY+  GS+   L        + L+  + + +                  +H+D
Sbjct: 77  PI-YIVTEYMNKGSLLDFL---KDGEGRALKLPNLVDMAAQVAAGMAYIERM--NYIHRD 130
Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 267
            ++AN+LV    I K+AD GL   +   D    + Q     I + A E   + RF+ KSD
Sbjct: 131 LRSANILVGNGLICKIADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 188
Query: 268 VYSFGVFLLELVS 280
           V+SFG+ L ELV+
Sbjct: 189 VWSFGILLTELVT 201

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 15/195 (7%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV--VH 206
            + +++ EY+  G +   L G       ++    RL                  R+  VH
Sbjct: 86  PI-YIVTEYMSKGCLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 207 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEK 265
           +D + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ K
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 266 SDVYSFGVFLLELVS 280
           SDV+SFG+ L EL +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 96/219 (43%), Gaps = 17/219 (7%)
Query: 66  SIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFI 124
           S+     F     +L  K       IG+G+FG+V  G  + G  VA+K  +  A  Q F+
Sbjct: 4   SVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFL 62
Query: 125 DEVCFLASIQHRNLVTLLGY-CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR 183
            E   +  ++H NLV LLG   +E    +++ EY+  GS+  +L      SR +      
Sbjct: 63  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR-----SRGRSVLGGD 117
Query: 184 LSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG--P 241
             +                  VH+D    NVLV ED +AKV+D GL      T   G  P
Sbjct: 118 CLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 177
Query: 242 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
                    + A E    ++FS KSDV+SFG+ L E+ S
Sbjct: 178 VK-------WTAPEALREKKFSTKSDVWSFGILLWEIYS 209

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 98/222 (44%), Gaps = 17/222 (7%)
Query: 63  IELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQ 121
           +E ++     F     +L  K       IG+G+FG+V  G  + G  VA+K  +  A  Q
Sbjct: 173 MEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ 231
Query: 122 EFIDEVCFLASIQHRNLVTLLGY-CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF 180
            F+ E   +  ++H NLV LLG   +E    +++ EY+  GS+  +L      SR +   
Sbjct: 232 AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR-----SRGRSVL 286
Query: 181 KHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 240
                +                  VH+D    NVLV ED +AKV+D GL      T   G
Sbjct: 287 GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 346
Query: 241 --PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
             P         + A E    ++FS KSDV+SFG+ L E+ S
Sbjct: 347 KLPVK-------WTAPEALREKKFSTKSDVWSFGILLWEIYS 381

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 116/282 (41%), Gaps = 19/282 (6%)
Query: 91  IGEGKFGEV---YKGLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 142
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 143 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 199
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 109 GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 161
Query: 200 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF-LASEVKE 258
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 221
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
             +FS  SDV+SFGV L EL +  E                 Q      +L+++L     
Sbjct: 222 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 281
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 360
               +   +E   ++  C + +  +RPS  D+   +D+  D+
Sbjct: 282 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 115/281 (40%), Gaps = 19/281 (6%)
Query: 91  IGEGKFGEV---YKGLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 142
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 143 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 199
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 96  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 148
Query: 200 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 258
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
             +FS  SDV+SFGV L EL +  E                 Q      +L+++L     
Sbjct: 209 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 268
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 359
               +   +E   ++  C + +  +RPS  D+   +D+  D
Sbjct: 269 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 309

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 115/281 (40%), Gaps = 19/281 (6%)
Query: 91  IGEGKFGEV---YKGLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 142
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 143 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 199
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 96  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 148
Query: 200 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 258
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
             +FS  SDV+SFGV L EL +  E                 Q      +L+++L     
Sbjct: 209 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 268
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 359
               +   +E   ++  C + +  +RPS  D+   +D+  D
Sbjct: 269 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 309

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 116/282 (41%), Gaps = 19/282 (6%)
Query: 91  IGEGKFGEV---YKGLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 142
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 143 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 199
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 76  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 128
Query: 200 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 258
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 129 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 188
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
             +FS  SDV+SFGV L EL +  E                 Q      +L+++L     
Sbjct: 189 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 248
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 360
               +   +E   ++  C + +  +RPS  D+   +D+  D+
Sbjct: 249 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 290

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 122/292 (41%), Gaps = 41/292 (14%)
Query: 91  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 137
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 186
           ++TLLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 187 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 246
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 163 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 306
               ++A E    R ++ +SDV+SFGV + E+ +                VE        
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVE-------- 266
Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
             L K+L E            E   ++  C      +RP+   +V +LDR L
Sbjct: 267 -ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 115/281 (40%), Gaps = 19/281 (6%)
Query: 91  IGEGKFGEV---YKGLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 142
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 143 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 199
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 78  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 200 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 258
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
             +FS  SDV+SFGV L EL +  E                 Q      +L+++L     
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 250
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 359
               +   +E   ++  C + +  +RPS  D+   +D+  D
Sbjct: 251 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 115/281 (40%), Gaps = 19/281 (6%)
Query: 91  IGEGKFGEV---YKGLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 142
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 143 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 199
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 78  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 200 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 258
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
             +FS  SDV+SFGV L EL +  E                 Q      +L+++L     
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 250
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 359
               +   +E   ++  C + +  +RPS  D+   +D+  D
Sbjct: 251 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 120/292 (41%), Gaps = 41/292 (14%)
Query: 91  IGEGKFGEVYK----GLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 137
           +GEG FG+V      GL +D       VA+K      T+    + I E+  +  I +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 186
           ++ LLG C ++   ++I EY   G++  +L           Y PS    ++L  K  +S 
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 187 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 246
                           + +H+D    NVLV ED + K+AD GL   +   D    ++   
Sbjct: 197 AYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 254
Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 306
               ++A E    R ++ +SDV+SFGV L E+ +                VE        
Sbjct: 255 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVE-------- 300
Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
             L K+L E       +    E   ++  C      +RP+   +V +LDR +
Sbjct: 301 -ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 90/194 (46%), Gaps = 17/194 (8%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLVTLLGY-CQEN 148
           IG+G+FG+V  G  + G  VA+K  +  A  Q F+ E   +  ++H NLV LLG   +E 
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 72
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 208
              +++ EY+  GS+  +L      SR +        +                  VH+D
Sbjct: 73  GGLYIVTEYMAKGSLVDYLR-----SRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 127
Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAG--PSSQVTADEIFLASEVKEFRRFSEKS 266
               NVLV ED +AKV+D GL      T   G  P         + A E    ++FS KS
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-------WTAPEALREKKFSTKS 180
Query: 267 DVYSFGVFLLELVS 280
           DV+SFG+ L E+ S
Sbjct: 181 DVWSFGILLWEIYS 194

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 115/281 (40%), Gaps = 19/281 (6%)
Query: 91  IGEGKFGEV---YKGLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 142
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 143 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 199
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 84  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 136
Query: 200 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 258
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 137 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 196
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
             +FS  SDV+SFGV L EL +  E                 Q      +L+++L     
Sbjct: 197 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 256
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 359
               +   +E   ++  C + +  +RPS  D+   +D+  D
Sbjct: 257 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 297

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 115/281 (40%), Gaps = 19/281 (6%)
Query: 91  IGEGKFGEV---YKGLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 142
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 143 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 199
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 85  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 137
Query: 200 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 258
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 138 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 197
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
             +FS  SDV+SFGV L EL +  E                 Q      +L+++L     
Sbjct: 198 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 257
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 359
               +   +E   ++  C + +  +RPS  D+   +D+  D
Sbjct: 258 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 298

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 115/281 (40%), Gaps = 19/281 (6%)
Query: 91  IGEGKFGEV---YKGLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 142
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 143 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 199
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 81  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 200 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 258
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
             +FS  SDV+SFGV L EL +  E                 Q      +L+++L     
Sbjct: 194 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 253
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 359
               +   +E   ++  C + +  +RPS  D+   +D+  D
Sbjct: 254 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 294

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 115/281 (40%), Gaps = 19/281 (6%)
Query: 91  IGEGKFGEV---YKGLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 142
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 143 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 199
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 82  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 134
Query: 200 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 258
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 135 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 194
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
             +FS  SDV+SFGV L EL +  E                 Q      +L+++L     
Sbjct: 195 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 254
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 359
               +   +E   ++  C + +  +RPS  D+   +D+  D
Sbjct: 255 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 295

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 115/281 (40%), Gaps = 19/281 (6%)
Query: 91  IGEGKFGEV---YKGLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 142
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 143 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 199
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 83  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 135
Query: 200 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 258
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 136 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 195
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
             +FS  SDV+SFGV L EL +  E                 Q      +L+++L     
Sbjct: 196 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 255
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 359
               +   +E   ++  C + +  +RPS  D+   +D+  D
Sbjct: 256 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 296

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 19/197 (9%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FG V  G  +    VAIK  K       EFI+E   + ++ H  LV L G C + 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 76
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS----IXXXXXXXXXXXXXXXPRV 204
              F+I EY+ NG +  +L           E +HR      +                + 
Sbjct: 77  RPIFIITEYMANGCLLNYL----------REMRHRFQTQQLLEMCKDVCEAMEYLESKQF 126
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFS 263
           +H+D    N LV++  + KV+D GL  ++   D    SS+ +   + +   EV  + +FS
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSRGSKFPVRWSPPEVLMYSKFS 184
Query: 264 EKSDVYSFGVFLLELVS 280
            KSD+++FGV + E+ S
Sbjct: 185 SKSDIWAFGVLMWEIYS 201

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 26/201 (12%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FGEV+ G   +   VA+K  +PG    Q F++E   + ++QH  LV L     + 
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 79
Query: 149 NLQFLIYEYIPNGSVSIHLY---GPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 205
              ++I E++  GS+   L    G   +  + ++F  +++                   +
Sbjct: 80  EPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA--------EGMAYIERKNYI 131
Query: 206 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEF 259
           H+D + ANVLV E  + K+AD GL   +         ++ TA E       + A E   F
Sbjct: 132 HRDLRAANVLVSESLMCKIADFGLARVI-------EDNEYTAREGAKFPIKWTAPEAINF 184
Query: 260 RRFSEKSDVYSFGVFLLELVS 280
             F+ KS+V+SFG+ L E+V+
Sbjct: 185 GCFTIKSNVWSFGILLYEIVT 205

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 88/197 (44%), Gaps = 19/197 (9%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FG V  G  +    VAIK  K       EFI+E   + ++ H  LV L G C + 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS----IXXXXXXXXXXXXXXXPRV 204
              F+I EY+ NG +  +L           E +HR      +                + 
Sbjct: 92  RPIFIITEYMANGCLLNYL----------REMRHRFQTQQLLEMCKDVCEAMEYLESKQF 141
Query: 205 VHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS 263
           +H+D    N LV++  + KV+D GL R  L   + +   S+      +   EV  + +FS
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVR--WSPPEVLMYSKFS 199
Query: 264 EKSDVYSFGVFLLELVS 280
            KSD+++FGV + E+ S
Sbjct: 200 SKSDIWAFGVLMWEIYS 216

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 120/292 (41%), Gaps = 41/292 (14%)
Query: 91  IGEGKFGEVYK----GLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 137
           +GEG FG+V      GL +D       VA+K      T+    + I E+  +  I +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 186
           ++ LLG C ++   ++I EY   G++  +L           Y PS    ++L  K  +S 
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 187 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 246
                           + +H+D    NVLV ED + K+AD GL   +   D    ++   
Sbjct: 141 AYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 198
Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 306
               ++A E    R ++ +SDV+SFGV L E+ +                VE        
Sbjct: 199 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVE-------- 244
Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
             L K+L E       +    E   ++  C      +RP+   +V +LDR +
Sbjct: 245 -ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 120/292 (41%), Gaps = 41/292 (14%)
Query: 91  IGEGKFGEVYK----GLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 137
           +GEG FG+V      GL +D       VA+K      T+    + I E+  +  I +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 186
           ++ LLG C ++   ++I EY   G++  +L           Y PS    ++L  K  +S 
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 187 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 246
                           + +H+D    NVLV ED + K+AD GL   +   D    ++   
Sbjct: 148 AYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 205
Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 306
               ++A E    R ++ +SDV+SFGV L E+ +                VE        
Sbjct: 206 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVE-------- 251
Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
             L K+L E       +    E   ++  C      +RP+   +V +LDR +
Sbjct: 252 -ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 302

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 115/281 (40%), Gaps = 19/281 (6%)
Query: 91  IGEGKFGEV---YKGLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 142
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 143 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 199
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 77  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 129
Query: 200 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 258
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 130 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 189
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
             +FS  SDV+SFGV L EL +  E                 Q      +L+++L     
Sbjct: 190 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 249
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 359
               +   +E   ++  C + +  +RPS  D+   +D+  D
Sbjct: 250 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 290

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 120/292 (41%), Gaps = 41/292 (14%)
Query: 91  IGEGKFGEVYK----GLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 137
           +GEG FG+V      GL +D       VA+K      T+    + I E+  +  I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 186
           ++ LLG C ++   ++I EY   G++  +L           Y PS    ++L  K  +S 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 187 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 246
                           + +H+D    NVLV ED + K+AD GL   +   D    ++   
Sbjct: 156 AYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 213
Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 306
               ++A E    R ++ +SDV+SFGV L E+ +                VE        
Sbjct: 214 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVE-------- 259
Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
             L K+L E       +    E   ++  C      +RP+   +V +LDR +
Sbjct: 260 -ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 310

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 120/292 (41%), Gaps = 41/292 (14%)
Query: 91  IGEGKFGEVYK----GLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 137
           +GEG FG+V      GL +D       VA+K      T+    + I E+  +  I +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 186
           ++ LLG C ++   ++I EY   G++  +L           Y PS    ++L  K  +S 
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 187 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 246
                           + +H+D    NVLV ED + K+AD GL   +   D    ++   
Sbjct: 149 AYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 206
Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 306
               ++A E    R ++ +SDV+SFGV L E+ +                VE        
Sbjct: 207 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVE-------- 252
Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
             L K+L E       +    E   ++  C      +RP+   +V +LDR +
Sbjct: 253 -ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 303

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 120/292 (41%), Gaps = 41/292 (14%)
Query: 91  IGEGKFGEVYK----GLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 137
           +GEG FG+V      GL +D       VA+K      T+    + I E+  +  I +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 186
           ++ LLG C ++   ++I EY   G++  +L           Y PS    ++L  K  +S 
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 187 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 246
                           + +H+D    NVLV ED + K+AD GL   +   D    ++   
Sbjct: 145 AYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 202
Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 306
               ++A E    R ++ +SDV+SFGV L E+ +                VE        
Sbjct: 203 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVE-------- 248
Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
             L K+L E       +    E   ++  C      +RP+   +V +LDR +
Sbjct: 249 -ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 299

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 120/292 (41%), Gaps = 41/292 (14%)
Query: 91  IGEGKFGEVYK----GLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 137
           +GEG FG+V      GL +D       VA+K      T+    + I E+  +  I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 186
           ++ LLG C ++   ++I EY   G++  +L           Y PS    ++L  K  +S 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 187 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 246
                           + +H+D    NVLV ED + K+AD GL   +   D    ++   
Sbjct: 156 AYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 213
Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 306
               ++A E    R ++ +SDV+SFGV L E+ +                VE        
Sbjct: 214 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVE-------- 259
Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
             L K+L E       +    E   ++  C      +RP+   +V +LDR +
Sbjct: 260 -ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 310

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 111/265 (41%), Gaps = 38/265 (14%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 76
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 208
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H++
Sbjct: 77  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRN 130
Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 262
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 131 LRAANILVSDTLSCKIADFGLARLI-------EDNEYTAREGAKFPIKWTAPEAINYGTF 183
Query: 263 SEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTF 321
           + KSDV+SFG+ L E+V+ GR               E++QN      +++          
Sbjct: 184 TIKSDVWSFGILLTEIVTHGR------IPYPGMTNPEVIQNLERGYRMVR---------- 227
Query: 322 TNEGMEEFIQLIVRCLDPSSERRPS 346
            +   EE  QL+  C     E RP+
Sbjct: 228 PDNCPEELYQLMRLCWKERPEDRPT 252

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 120/292 (41%), Gaps = 41/292 (14%)
Query: 91  IGEGKFGEVYK----GLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 137
           +GEG FG+V      GL +D       VA+K      T+    + I E+  +  I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 186
           ++ LLG C ++   ++I EY   G++  +L           Y PS    ++L  K  +S 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 187 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 246
                           + +H+D    NVLV ED + K+AD GL   +   D    ++   
Sbjct: 156 AYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 213
Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 306
               ++A E    R ++ +SDV+SFGV L E+ +                VE        
Sbjct: 214 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVE-------- 259
Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
             L K+L E       +    E   ++  C      +RP+   +V +LDR +
Sbjct: 260 -ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 310

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 121/292 (41%), Gaps = 41/292 (14%)
Query: 91  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQE----FIDEVCFLASI-QHRN 137
           +GEG FG+V         K   ++ + VA+K      T+E     + E+  +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 186
           ++ LLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 187 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 246
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 163 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 306
               ++A E    R ++ +SDV+SFGV + E+ +                VE        
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVE-------- 266
Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
             L K+L E            E   ++  C      +RP+   +V +LDR L
Sbjct: 267 -ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 86/204 (42%), Gaps = 19/204 (9%)
Query: 88  KNLIGEGKFGEVYKGLL----QDGMLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLV 139
           + +IG G  GEV  G L    Q  + VAIK      T+    +F+ E   +    H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 199
            L G      L  ++ EY+ NGS+   L           +F     +             
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL------RTHDGQFTIMQLVGMLRGVGAGMRYL 167
Query: 200 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---FLASEV 256
                VH+D    NVLVD + + KV+D GL   L   D    +   T  +I   + A E 
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL--EDDPDAAXTTTGGKIPIRWTAPEA 225
Query: 257 KEFRRFSEKSDVYSFGVFLLELVS 280
             FR FS  SDV+SFGV + E+++
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 120/283 (42%), Gaps = 34/283 (12%)
Query: 88  KNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLV 139
           + +IG G+FGEV  G L+      + VAIK      T+    +F+ E   +    H N++
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 199
            L G   ++    +I E++ NGS+       S + +   +F     +             
Sbjct: 98  HLEGVVTKSTPVMIITEFMENGSLD------SFLRQNDGQFTVIQLVGMLRGIAAGMKYL 151
Query: 200 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS-SQVTADEI---FLASE 255
                VH+D    N+LV+ + + KV+D GL  FL   D + P+ +     +I   + A E
Sbjct: 152 ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL-EDDTSDPTYTSALGGKIPIRWTAPE 210
Query: 256 VKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDE 315
             ++R+F+  SDV+S+G+ + E++S  E                   ++D  N ++  D 
Sbjct: 211 AIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD------------MTNQDVINAIE-QDY 257
Query: 316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
           RL      +      QL++ C       RP    +V  LD+ +
Sbjct: 258 RLPPPM--DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 298

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 117/276 (42%), Gaps = 32/276 (11%)
Query: 90  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 141
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 142 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 200
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---- 153
Query: 201 XPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRT-DVAGPSSQVTADEIFLASEVKE 258
             + VH+D    N ++DE F  KVAD GL R+ L +  D     +       ++A E  +
Sbjct: 154 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQ 211
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
            ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            L 
Sbjct: 212 TQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------LLQ 259
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
             +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 260 PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 292

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 110/265 (41%), Gaps = 38/265 (14%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+ GEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 208
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 81  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 134
Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 262
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIE-------DAEXTAREGAKFPIKWTAPEAINYGTF 187
Query: 263 SEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTF 321
           + KSDV+SFG+ L E+V+ GR               E++QN      +++          
Sbjct: 188 TIKSDVWSFGILLTEIVTHGR------IPYPGMTNPEVIQNLERGYRMVR---------- 231
Query: 322 TNEGMEEFIQLIVRCLDPSSERRPS 346
            +   EE  QL+  C     E RP+
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPT 256

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 86/204 (42%), Gaps = 19/204 (9%)
Query: 88  KNLIGEGKFGEVYKGLL----QDGMLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLV 139
           + +IG G  GEV  G L    Q  + VAIK      T+    +F+ E   +    H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 199
            L G      L  ++ EY+ NGS+   L           +F     +             
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL------RTHDGQFTIMQLVGMLRGVGAGMRYL 167
Query: 200 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---FLASEV 256
                VH+D    NVLVD + + KV+D GL   L   D    +   T  +I   + A E 
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL--EDDPDAAYTTTGGKIPIRWTAPEA 225
Query: 257 KEFRRFSEKSDVYSFGVFLLELVS 280
             FR FS  SDV+SFGV + E+++
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 23/199 (11%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FG V  G  +    VAIK  K       EFI+E   + ++ H  LV L G C + 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 75
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS----IXXXXXXXXXXXXXXXPRV 204
              F+I EY+ NG +  +L           E +HR      +                + 
Sbjct: 76  RPIFIITEYMANGCLLNYL----------REMRHRFQTQQLLEMCKDVCEAMEYLESKQF 125
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFL---GRTDVAGPSSQVTADEIFLASEVKEFRR 261
           +H+D    N LV++  + KV+D GL  ++     T   G    V     +   EV  + +
Sbjct: 126 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR----WSPPEVLMYSK 181
Query: 262 FSEKSDVYSFGVFLLELVS 280
           FS KSD+++FGV + E+ S
Sbjct: 182 FSSKSDIWAFGVLMWEIYS 200

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 23/199 (11%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FG V  G  +    VAIK  K       EFI+E   + ++ H  LV L G C + 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 76
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS----IXXXXXXXXXXXXXXXPRV 204
              F+I EY+ NG +  +L           E +HR      +                + 
Sbjct: 77  RPIFIITEYMANGCLLNYL----------REMRHRFQTQQLLEMCKDVCEAMEYLESKQF 126
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFL---GRTDVAGPSSQVTADEIFLASEVKEFRR 261
           +H+D    N LV++  + KV+D GL  ++     T   G    V     +   EV  + +
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR----WSPPEVLMYSK 182
Query: 262 FSEKSDVYSFGVFLLELVS 280
           FS KSD+++FGV + E+ S
Sbjct: 183 FSSKSDIWAFGVLMWEIYS 201

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 23/199 (11%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FG V  G  +    VAIK  K       EFI+E   + ++ H  LV L G C + 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS----IXXXXXXXXXXXXXXXPRV 204
              F+I EY+ NG +  +L           E +HR      +                + 
Sbjct: 92  RPIFIITEYMANGCLLNYL----------REMRHRFQTQQLLEMCKDVCEAMEYLESKQF 141
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFL---GRTDVAGPSSQVTADEIFLASEVKEFRR 261
           +H+D    N LV++  + KV+D GL  ++     T   G    V     +   EV  + +
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR----WSPPEVLMYSK 197
Query: 262 FSEKSDVYSFGVFLLELVS 280
           FS KSD+++FGV + E+ S
Sbjct: 198 FSSKSDIWAFGVLMWEIYS 216

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 23/199 (11%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FG V  G  +    VAIK  K       EFI+E   + ++ H  LV L G C + 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS----IXXXXXXXXXXXXXXXPRV 204
              F+I EY+ NG +  +L           E +HR      +                + 
Sbjct: 72  RPIFIITEYMANGCLLNYL----------REMRHRFQTQQLLEMCKDVCEAMEYLESKQF 121
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFL---GRTDVAGPSSQVTADEIFLASEVKEFRR 261
           +H+D    N LV++  + KV+D GL  ++     T   G    V     +   EV  + +
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR----WSPPEVLMYSK 177
Query: 262 FSEKSDVYSFGVFLLELVS 280
           FS KSD+++FGV + E+ S
Sbjct: 178 FSSKSDIWAFGVLMWEIYS 196

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 80/312 (25%), Positives = 130/312 (41%), Gaps = 46/312 (14%)
Query: 67  IREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIK----KRP 116
           I + ++ +++E+SL+   F ++  +GE +FG+VYKG L      +    VAIK    K  
Sbjct: 12  INQHKQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE 69
Query: 117 GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVS-- 174
           G   +EF  E    A +QH N+V LLG   ++    +I+ Y  +G +   L   S  S  
Sbjct: 70  GPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDV 129
Query: 175 ---------RQKLE---FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIA 222
                    +  LE   F H ++                  VVHKD  T NVLV +    
Sbjct: 130 GSTDDDRTVKSALEPPDFVHLVA-----QIAAGMEYLSSHHVVHKDLATRNVLVYDKLNV 184
Query: 223 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
           K++D GL   +   D             ++A E   + +FS  SD++S+GV L E+ S  
Sbjct: 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS-- 242
Query: 283 EAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSE 342
                         VE+++N +    +L   D+     +          L++ C +    
Sbjct: 243 YGLQPYCGYSNQDVVEMIRNRQ----VLPCPDDCPAWVYA---------LMIECWNEFPS 289
Query: 343 RRPSMSDVVTEL 354
           RRP   D+ + L
Sbjct: 290 RRPRFKDIHSRL 301

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 23/199 (11%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FG V  G  +    VAIK  K       EFI+E   + ++ H  LV L G C + 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 82
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS----IXXXXXXXXXXXXXXXPRV 204
              F+I EY+ NG +  +L           E +HR      +                + 
Sbjct: 83  RPIFIITEYMANGCLLNYL----------REMRHRFQTQQLLEMCKDVCEAMEYLESKQF 132
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFL---GRTDVAGPSSQVTADEIFLASEVKEFRR 261
           +H+D    N LV++  + KV+D GL  ++     T   G    V     +   EV  + +
Sbjct: 133 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR----WSPPEVLMYSK 188
Query: 262 FSEKSDVYSFGVFLLELVS 280
           FS KSD+++FGV + E+ S
Sbjct: 189 FSSKSDIWAFGVLMWEIYS 207

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 115/281 (40%), Gaps = 19/281 (6%)
Query: 91  IGEGKFGEV---YKGLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 142
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 143 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 199
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 78  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 200 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 258
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
             +FS  SDV+SFGV L EL +  E                 Q      +L+++L     
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 250
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 359
               +   +E   ++  C + +  +RPS  D+   +D+  D
Sbjct: 251 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 120/292 (41%), Gaps = 41/292 (14%)
Query: 91  IGEGKFGEVYK----GLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 137
           +GEG FG+V      GL +D       VA+K      T+    + I E+  +  I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 186
           ++ LLG C ++   ++I EY   G++  +L           + PS    ++L  K  +S 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 187 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 246
                           + +H+D    NVLV ED + K+AD GL   +   D    ++   
Sbjct: 156 AYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGR 213
Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 306
               ++A E    R ++ +SDV+SFGV L E+ +                VE        
Sbjct: 214 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVE-------- 259
Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
             L K+L E       +    E   ++  C      +RP+   +V +LDR +
Sbjct: 260 -ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 310

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 121/292 (41%), Gaps = 41/292 (14%)
Query: 91  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 137
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 186
           ++ LLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 187 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 246
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 163 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGR 220
Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 306
               ++A E    R ++ +SDV+SFGV + E+ +                VE        
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVE-------- 266
Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
             L K+L E            E   ++  C      +RP+   +V +LDR L
Sbjct: 267 -ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 72/304 (23%), Positives = 122/304 (40%), Gaps = 56/304 (18%)
Query: 90  LIGEGKFGEVYKGLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLVTL 141
           +IG G+FGEV +G L+        VAIK   G  T+    EF+ E   +   +H N++ L
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 142 LGYCQENNLQFLIYEYIPNGSVS------------IHLYGPSQVSRQKLEFKHRLSIXXX 189
            G    +    ++ E++ NG++             I L G  +     + +   +S    
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMS---- 138
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                          VH+D    N+LV+ + + KV+D GL  FL         +     +
Sbjct: 139 --------------YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGK 184
Query: 250 I---FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 306
           I   + A E   FR+F+  SD +S+G+ + E++S  E                  +++D 
Sbjct: 185 IPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWD------------MSNQDV 232
Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTT 366
            N ++  D RL      +      QL++ C       RP    VV+ LD+ +    +L  
Sbjct: 233 INAIE-QDYRL--PPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPASLKI 289
Query: 367 VMGE 370
           V  E
Sbjct: 290 VARE 293

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 121/292 (41%), Gaps = 41/292 (14%)
Query: 91  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 137
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 186
           ++ LLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 187 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 246
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 163 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGR 220
Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 306
               ++A E    R ++ +SDV+SFGV + E+ +                VE        
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVE-------- 266
Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
             L K+L E            E   ++  C      +RP+   +V +LDR L
Sbjct: 267 -ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 118/281 (41%), Gaps = 19/281 (6%)
Query: 91  IGEGKFGEV---YKGLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 142
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 143 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 199
           G C      NL+ LI EY+P GS+  +L    Q   ++++  H   +             
Sbjct: 81  GVCYSAGRRNLK-LIMEYLPYGSLRDYL----QAHAERID--HIKLLQYTSQICKGMEYL 133
Query: 200 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 258
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
             +FS  SDV+SFGV L EL +  E                 Q      +L+++L     
Sbjct: 194 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 253
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 359
               +   +E   ++  C + +  +RPS  D+   +D+  D
Sbjct: 254 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 294

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/299 (22%), Positives = 123/299 (41%), Gaps = 34/299 (11%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 131
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 30  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 89
Query: 132 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 191
              H N++ L G   ++    ++ EY+ NGS+       S + +   +F     +     
Sbjct: 90  QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD------SFLRKHDAQFTVIQLVGMLRG 143
Query: 192 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 250
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 144 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 203
Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSN-- 308
           + + E   +R+F+  SDV+S+G+ L E++S  E                 +   + SN  
Sbjct: 204 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----------------RPYWEMSNQD 246
Query: 309 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTV 367
           ++K +DE        +      QL++ C       RP    +V+ LD+ +    +L  +
Sbjct: 247 VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKII 305

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/290 (23%), Positives = 120/290 (41%), Gaps = 34/290 (11%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 131
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 13  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 72
Query: 132 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 191
              H N++ L G   ++    ++ EY+ NGS+       S + +   +F     +     
Sbjct: 73  QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD------SFLRKHDAQFTVIQLVGMLRG 126
Query: 192 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 250
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 127 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 186
Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSN-- 308
           + + E   +R+F+  SDV+S+G+ L E++S  E                 +   + SN  
Sbjct: 187 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----------------RPYWEMSNQD 229
Query: 309 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
           ++K +DE        +      QL++ C       RP    +V+ LD+ +
Sbjct: 230 VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 279

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 123/306 (40%), Gaps = 56/306 (18%)
Query: 88  KNLIGEGKFGEVYKGLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLV 139
           + +IG G+FGEV +G L+        VAIK   G  T+    EF+ E   +   +H N++
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 140 TLLGYCQENNLQFLIYEYIPNGSVS------------IHLYGPSQVSRQKLEFKHRLSIX 187
            L G    +    ++ E++ NG++             I L G  +     + +   +S  
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMS-- 136
Query: 188 XXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 247
                            VH+D    N+LV+ + + KV+D GL  FL         +    
Sbjct: 137 ----------------YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLG 180
Query: 248 DEI---FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSR 304
            +I   + A E   FR+F+  SD +S+G+ + E++S  E                  +++
Sbjct: 181 GKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWD------------MSNQ 228
Query: 305 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNL 364
           D  N ++  D RL      +      QL++ C       RP    VV+ LD+ +    +L
Sbjct: 229 DVINAIE-QDYRL--PPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPASL 285
Query: 365 TTVMGE 370
             V  E
Sbjct: 286 KIVARE 291

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/288 (22%), Positives = 117/288 (40%), Gaps = 30/288 (10%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 131
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 40  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 99
Query: 132 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 191
              H N++ L G   ++    ++ EY+ NGS+       S + +   +F     +     
Sbjct: 100 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD------SFLRKHDAQFTVIQLVGMLRG 153
Query: 192 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 250
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 154 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 213
Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLL 310
           + + E   +R+F+  SDV+S+G+ L E++S  E                        +++
Sbjct: 214 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------------QDVI 258
Query: 311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
           K +DE        +      QL++ C       RP    +V+ LD+ +
Sbjct: 259 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 306

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 115/281 (40%), Gaps = 19/281 (6%)
Query: 91  IGEGKFGEV---YKGLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 142
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 143 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 199
           G C      NL+ LI E++P GS+  +L       + K    H   +             
Sbjct: 81  GVCYSAGRRNLK-LIMEFLPYGSLREYL------QKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 200 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 258
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
             +FS  SDV+SFGV L EL +  E                 Q      +L+++L     
Sbjct: 194 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 253
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 359
               +   +E   ++  C + +  +RPS  D+   +D+  D
Sbjct: 254 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 294

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 68/299 (22%), Positives = 123/299 (41%), Gaps = 34/299 (11%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 131
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 132 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 191
              H N++ L G   ++    ++ EY+ NGS+       S + +   +F     +     
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD------SFLRKHDAQFTVIQLVGMLRG 155
Query: 192 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 250
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSN-- 308
           + + E   +R+F+  SDV+S+G+ L E++S  E                 +   + SN  
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----------------RPYWEMSNQD 258
Query: 309 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTV 367
           ++K +DE        +      QL++ C       RP    +V+ LD+ +    +L  +
Sbjct: 259 VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKII 317

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 68/299 (22%), Positives = 123/299 (41%), Gaps = 34/299 (11%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 131
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 132 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 191
              H N++ L G   ++    ++ EY+ NGS+       S + +   +F     +     
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD------SFLRKHDAQFTVIQLVGMLRG 155
Query: 192 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 250
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSN-- 308
           + + E   +R+F+  SDV+S+G+ L E++S  E                 +   + SN  
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----------------RPYWEMSNQD 258
Query: 309 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTV 367
           ++K +DE        +      QL++ C       RP    +V+ LD+ +    +L  +
Sbjct: 259 VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKII 317

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 121/292 (41%), Gaps = 41/292 (14%)
Query: 91  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 137
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 186
           ++ LLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 187 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 246
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 163 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGR 220
Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 306
               ++A E    R ++ +SDV+SFGV + E+ +                VE        
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVE-------- 266
Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
             L K+L E            E   ++  C      +RP+   +V +LDR L
Sbjct: 267 -ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/297 (22%), Positives = 120/297 (40%), Gaps = 30/297 (10%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 131
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 132 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 191
              H N++ L G   ++    ++ EY+ NGS+       S + +   +F     +     
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD------SFLRKHDAQFTVIQLVGMLRG 155
Query: 192 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 250
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 156 IASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLL 310
           + + E   +R+F+  SDV+S+G+ L E++S  E                        +++
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------------QDVI 260
Query: 311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTV 367
           K +DE        +      QL++ C       RP    +V+ LD+ +    +L  +
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKII 317

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/290 (23%), Positives = 120/290 (41%), Gaps = 34/290 (11%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 131
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 132 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 191
              H N++ L G   ++    ++ EY+ NGS+       S + +   +F     +     
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD------SFLRKHDAQFTVIQLVGMLRG 155
Query: 192 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 250
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSN-- 308
           + + E   +R+F+  SDV+S+G+ L E++S  E                 +   + SN  
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----------------RPYWEMSNQD 258
Query: 309 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
           ++K +DE        +      QL++ C       RP    +V+ LD+ +
Sbjct: 259 VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/297 (22%), Positives = 120/297 (40%), Gaps = 30/297 (10%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 131
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 132 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 191
              H N++ L G   ++    ++ EY+ NGS+       S + +   +F     +     
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD------SFLRKHDAQFTVIQLVGMLRG 155
Query: 192 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 250
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLL 310
           + + E   +R+F+  SDV+S+G+ L E++S  E                        +++
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------------QDVI 260
Query: 311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTV 367
           K +DE        +      QL++ C       RP    +V+ LD+ +    +L  +
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKII 317

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/297 (22%), Positives = 120/297 (40%), Gaps = 30/297 (10%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 131
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 132 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 191
              H N++ L G   ++    ++ EY+ NGS+       S + +   +F     +     
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD------SFLRKHDAQFTVIQLVGMLRG 155
Query: 192 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 250
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIR 215
Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLL 310
           + + E   +R+F+  SDV+S+G+ L E++S  E                        +++
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------------QDVI 260
Query: 311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTV 367
           K +DE        +      QL++ C       RP    +V+ LD+ +    +L  +
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKII 317

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 89/193 (46%), Gaps = 15/193 (7%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLVTLLGY-CQEN 148
           IG+G+FG+V  G  + G  VA+K  +  A  Q F+ E   +  ++H NLV LLG   +E 
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 78
Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 208
              +++ EY+  GS+  +L      SR +        +                  VH+D
Sbjct: 79  GGLYIVTEYMAKGSLVDYLR-----SRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 133
Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRT-DVAGPSSQVTADEIFLASEVKEFRRFSEKSD 267
               NVLV ED +AKV+D GL      T D      + TA E    +       FS KSD
Sbjct: 134 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREAA------FSTKSD 187
Query: 268 VYSFGVFLLELVS 280
           V+SFG+ L E+ S
Sbjct: 188 VWSFGILLWEIYS 200

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 121/292 (41%), Gaps = 41/292 (14%)
Query: 91  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 137
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 186
           ++ LLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 187 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 246
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 163 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 306
               ++A E    R ++ +SDV+SFGV + E+ +                VE        
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVE-------- 266
Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
             L K+L E            E   ++  C      +RP+   +V +LDR L
Sbjct: 267 -ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 115/281 (40%), Gaps = 19/281 (6%)
Query: 91  IGEGKFGEV---YKGLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 142
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 143 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 199
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 79  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 131
Query: 200 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 258
              R +H++  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 132 GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 191
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
             +FS  SDV+SFGV L EL +  E                 Q      +L+++L     
Sbjct: 192 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 251
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 359
               +   +E   ++  C + +  +RPS  D+   +D+  D
Sbjct: 252 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 292

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 121/292 (41%), Gaps = 41/292 (14%)
Query: 91  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 137
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 186
           ++ LLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 187 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 246
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 155 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 212
Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 306
               ++A E    R ++ +SDV+SFGV + E+ +                VE        
Sbjct: 213 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVE-------- 258
Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
             L K+L E            E   ++  C      +RP+   +V +LDR L
Sbjct: 259 -ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 309

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 121/292 (41%), Gaps = 41/292 (14%)
Query: 91  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 137
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 186
           ++ LLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 187 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 246
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 209 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 266
Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 306
               ++A E    R ++ +SDV+SFGV + E+ +                VE        
Sbjct: 267 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVE-------- 312
Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
             L K+L E            E   ++  C      +RP+   +V +LDR L
Sbjct: 313 -ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/297 (22%), Positives = 120/297 (40%), Gaps = 30/297 (10%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 131
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 132 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 191
              H N++ L G   ++    ++ EY+ NGS+       S + +   +F     +     
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD------SFLRKHDAQFTVIQLVGMLRG 155
Query: 192 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 250
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215
Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLL 310
           + + E   +R+F+  SDV+S+G+ L E++S  E                        +++
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------------QDVI 260
Query: 311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTV 367
           K +DE        +      QL++ C       RP    +V+ LD+ +    +L  +
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKII 317

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/305 (24%), Positives = 126/305 (41%), Gaps = 65/305 (21%)
Query: 88  KNLIGEGKFGEVYKGLLQ-DG--MLVAIKKRPGAPTQE----FIDEVCFLASI-QHRNLV 139
           +++IGEG FG+V K  ++ DG  M  AIK+     +++    F  E+  L  +  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 140 TLLGYCQENNLQFLIYEYIPNGSV----------------SIHLYGPSQVSRQKLEFKHR 183
            LLG C+     +L  EY P+G++                +I     S +S Q+L     
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL----- 144
Query: 184 LSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL--------RNFLGR 235
             +                + +H+D    N+LV E+++AK+AD GL        +  +GR
Sbjct: 145 --LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 202
Query: 236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXX 295
             V            ++A E   +  ++  SDV+S+GV L E+VS               
Sbjct: 203 LPVR-----------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS-----LGGTPYCGMT 246
Query: 296 XVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 355
             EL +       L K L+            +E   L+ +C       RPS + ++  L+
Sbjct: 247 CAELYEKLPQGYRLEKPLNCD----------DEVYDLMRQCWREKPYERPSFAQILVSLN 296
Query: 356 RTLDK 360
           R L++
Sbjct: 297 RMLEE 301

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 90  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 141
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 142 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 200
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---- 151
Query: 201 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLASEVKE 258
             + VH+D    N ++DE F  KVAD GL   +   +     ++  A     ++A E  +
Sbjct: 152 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQ 209
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
            ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            L 
Sbjct: 210 TQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------LLQ 257
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
             +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 258 PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 290

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 121/292 (41%), Gaps = 41/292 (14%)
Query: 91  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 137
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 186
           ++ LLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 187 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 246
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 152 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 209
Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 306
               ++A E    R ++ +SDV+SFGV + E+ +                VE        
Sbjct: 210 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVE-------- 255
Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
             L K+L E            E   ++  C      +RP+   +V +LDR L
Sbjct: 256 -ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 306

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 121/292 (41%), Gaps = 41/292 (14%)
Query: 91  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 137
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 186
           ++ LLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 187 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 246
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 150 TYQLARGMEYLASQ--KCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 207
Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 306
               ++A E    R ++ +SDV+SFGV + E+ +                VE        
Sbjct: 208 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVE-------- 253
Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
             L K+L E            E   ++  C      +RP+   +V +LDR L
Sbjct: 254 -ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 304

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 90  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 141
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 142 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 200
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 116 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---- 171
Query: 201 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLASEVKE 258
             + VH+D    N ++DE F  KVAD GL   +   +     ++  A     ++A E  +
Sbjct: 172 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 229
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
            ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            L 
Sbjct: 230 TQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------LLQ 277
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
             +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 278 PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 310

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 90  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 141
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 142 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 200
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---- 157
Query: 201 XPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRT-DVAGPSSQVTADEIFLASEVKE 258
             + VH+D    N ++DE F  KVAD GL R+   +  D     +       ++A E  +
Sbjct: 158 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 215
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
            ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            L 
Sbjct: 216 TQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------LLQ 263
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
             +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 264 PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 296

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/305 (24%), Positives = 126/305 (41%), Gaps = 65/305 (21%)
Query: 88  KNLIGEGKFGEVYKG-LLQDG--MLVAIKKRPGAPTQE----FIDEVCFLASI-QHRNLV 139
           +++IGEG FG+V K  + +DG  M  AIK+     +++    F  E+  L  +  H N++
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 140 TLLGYCQENNLQFLIYEYIPNGSV----------------SIHLYGPSQVSRQKLEFKHR 183
            LLG C+     +L  EY P+G++                +I     S +S Q+L     
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL----- 134
Query: 184 LSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL--------RNFLGR 235
             +                + +H+D    N+LV E+++AK+AD GL        +  +GR
Sbjct: 135 --LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 192
Query: 236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXX 295
             V            ++A E   +  ++  SDV+S+GV L E+VS               
Sbjct: 193 LPVR-----------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS-----LGGTPYCGMT 236
Query: 296 XVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 355
             EL +       L K L+            +E   L+ +C       RPS + ++  L+
Sbjct: 237 CAELYEKLPQGYRLEKPLN----------CDDEVYDLMRQCWREKPYERPSFAQILVSLN 286
Query: 356 RTLDK 360
           R L++
Sbjct: 287 RMLEE 291

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 90  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 141
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 142 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 200
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---- 150
Query: 201 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLASEVKE 258
             + VH+D    N ++DE F  KVAD GL   +   +     ++  A     ++A E  +
Sbjct: 151 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 208
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
            ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            L 
Sbjct: 209 TQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------LLQ 256
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
             +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 257 PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 289

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 119/291 (40%), Gaps = 29/291 (9%)
Query: 68  REARRFQMEELSLATKNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK------RPGAPT 120
           ++A R  M   +LA  NF  +  IG G+F EVY+   L DG+ VA+KK            
Sbjct: 19  QKALRPDMGYNTLA--NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKAR 76
Query: 121 QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF 180
            + I E+  L  + H N++       E+N   ++ E    G +S  +       +QK   
Sbjct: 77  ADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMI---KHFKKQKRLI 133
Query: 181 KHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 240
             R                   RV+H+D K ANV +    + K+ D GL  F      A 
Sbjct: 134 PERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA 193
Query: 241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELV 300
            S  +     +++ E      ++ KSD++S G  L E+ + +                  
Sbjct: 194 HS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--------------FY 237
Query: 301 QNSRDFSNLLKILDERLWSTFTNEGM-EEFIQLIVRCLDPSSERRPSMSDV 350
            +  +  +L K +++  +    ++   EE  QL+  C++P  E+RP ++ V
Sbjct: 238 GDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 90  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 141
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 142 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 200
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---- 152
Query: 201 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLASEVKE 258
             + VH+D    N ++DE F  KVAD GL   +   +     ++  A     ++A E  +
Sbjct: 153 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 210
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
            ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            L 
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------LLQ 258
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
             +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 259 PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 291

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 90  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 141
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 142 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 200
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 89  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---- 144
Query: 201 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLASEVKE 258
             + VH+D    N ++DE F  KVAD GL   +   +     ++  A     ++A E  +
Sbjct: 145 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 202
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
            ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            L 
Sbjct: 203 TQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------LLQ 250
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
             +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 251 PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 283

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 90  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 141
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 142 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 200
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---- 150
Query: 201 XPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRT-DVAGPSSQVTADEIFLASEVKE 258
             + VH+D    N ++DE F  KVAD GL R+   +  D     +       ++A E  +
Sbjct: 151 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 208
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
            ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            L 
Sbjct: 209 TQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------LLQ 256
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
             +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 257 PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 289

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 90  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 141
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 142 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 200
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 115 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---- 170
Query: 201 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLASEVKE 258
             + VH+D    N ++DE F  KVAD GL   +   +     ++  A     ++A E  +
Sbjct: 171 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 228
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
            ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            L 
Sbjct: 229 TQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------LLQ 276
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
             +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 277 PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 309

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 90  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 141
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 142 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 200
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---- 153
Query: 201 XPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRT-DVAGPSSQVTADEIFLASEVKE 258
             + VH+D    N ++DE F  KVAD GL R+   +  D     +       ++A E  +
Sbjct: 154 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 211
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
            ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            L 
Sbjct: 212 TQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------LLQ 259
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
             +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 260 PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 292

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 90  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 141
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 142 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 200
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---- 151
Query: 201 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLASEVKE 258
             + VH+D    N ++DE F  KVAD GL   +   +     ++  A     ++A E  +
Sbjct: 152 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 209
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
            ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            L 
Sbjct: 210 TQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------LLQ 257
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
             +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 258 PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 290

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 90  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 141
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 142 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 200
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---- 211
Query: 201 XPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRT-DVAGPSSQVTADEIFLASEVKE 258
             + VH+D    N ++DE F  KVAD GL R+   +  D     +       ++A E  +
Sbjct: 212 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
            ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            L 
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------LLQ 317
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
             +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 318 PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 350

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/292 (22%), Positives = 121/292 (41%), Gaps = 41/292 (14%)
Query: 91  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 137
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 186
           ++ LLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 187 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 246
                           + +H+D    NVLV E+ + ++AD GL   +   D    ++   
Sbjct: 163 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGR 220
Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 306
               ++A E    R ++ +SDV+SFGV + E+ +                VE        
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVE-------- 266
Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
             L K+L E            E   ++  C      +RP+   +V +LDR L
Sbjct: 267 -ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 90  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 141
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 142 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 200
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---- 147
Query: 201 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLASEVKE 258
             + VH+D    N ++DE F  KVAD GL   +   +     ++  A     ++A E  +
Sbjct: 148 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
            ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            L 
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------LLQ 253
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
             +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 254 PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 286

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 90  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 141
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 142 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 200
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---- 152
Query: 201 XPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRT-DVAGPSSQVTADEIFLASEVKE 258
             + VH+D    N ++DE F  KVAD GL R+   +  D     +       ++A E  +
Sbjct: 153 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 210
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
            ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            L 
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------LLQ 258
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
             +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 259 PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 291

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 90  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 141
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 142 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 200
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---- 149
Query: 201 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLASEVKE 258
             + VH+D    N ++DE F  KVAD GL   +   +     ++  A     ++A E  +
Sbjct: 150 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 207
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
            ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            L 
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------LLQ 255
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
             +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 256 PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 288

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 90  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 141
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 142 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 200
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---- 152
Query: 201 XPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRT-DVAGPSSQVTADEIFLASEVKE 258
             + VH+D    N ++DE F  KVAD GL R+   +  D     +       ++A E  +
Sbjct: 153 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 210
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
            ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            L 
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------LLQ 258
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
             +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 259 PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 291

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 90  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 141
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 142 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 200
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---- 152
Query: 201 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLASEVKE 258
             + VH+D    N ++DE F  KVAD GL   +   +     ++  A     ++A E  +
Sbjct: 153 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 210
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
            ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            L 
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------LLQ 258
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
             +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 259 PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 291

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/294 (22%), Positives = 124/294 (42%), Gaps = 36/294 (12%)
Query: 65  LSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE- 122
           +S +  + ++ +   +  ++   +  +G G+FGEV+         VA+K  +PG+ + E 
Sbjct: 164 MSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA 223
Query: 123 FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKH 182
           F+ E   + ++QH  LV L     +  + ++I E++  GS+ +      + S+Q L    
Sbjct: 224 FLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSL-LDFLKSDEGSKQPLP--- 278
Query: 183 RLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS 242
           +L I                  +H+D + AN+LV    + K+AD GL     +  +    
Sbjct: 279 KL-IDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVGAKFPIK--- 334
Query: 243 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQ 301
                   + A E   F  F+ KSDV+SFG+ L+E+V+ GR                +  
Sbjct: 335 --------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR----------------IPY 370
Query: 302 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 355
                  +++ L+            EE   +++RC     E RP+   + + LD
Sbjct: 371 PGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 424

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 113/278 (40%), Gaps = 30/278 (10%)
Query: 90  LIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLVTL 141
           +IG G+FGEV  G L+      + VAIK      T+    +F+ E   +    H N++ L
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX 201
            G   ++    ++ EY+ NGS+   L       +   +F     +               
Sbjct: 89  EGVVTKSKPVMIVTEYMENGSLDTFL------KKNDGQFTVIQLVGMLRGISAGMKYLSD 142
Query: 202 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFR 260
              VH+D    N+L++ + + KV+D GL   L     A  +++     I + A E   FR
Sbjct: 143 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFR 202
Query: 261 RFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWST 320
           +F+  SDV+S+G+ + E+VS  E                        +++K ++E     
Sbjct: 203 KFTSASDVWSYGIVMWEVVSYGERPYWEMTN---------------QDVIKAVEEGYRLP 247
Query: 321 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
              +      QL++ C       RP   ++V  LD+ +
Sbjct: 248 SPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKLI 285

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/300 (23%), Positives = 128/300 (42%), Gaps = 38/300 (12%)
Query: 65  LSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE- 122
           +S +  + ++ +   +  ++   +  +G G+FGEV+         VA+K  +PG+ + E 
Sbjct: 170 MSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA 229
Query: 123 FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKH 182
           F+ E   + ++QH  LV L     +  + ++I E++  GS+ +      + S+Q L    
Sbjct: 230 FLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSL-LDFLKSDEGSKQPLP--- 284
Query: 183 RLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS 242
           +L I                  +H+D + AN+LV    + K+AD GL   +         
Sbjct: 285 KL-IDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI-------ED 336
Query: 243 SQVTADE------IFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXX 295
           ++ TA E       + A E   F  F+ KSDV+SFG+ L+E+V+ GR             
Sbjct: 337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR------------- 383
Query: 296 XVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 355
              +         +++ L+            EE   +++RC     E RP+   + + LD
Sbjct: 384 ---IPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 440

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 126/305 (41%), Gaps = 46/305 (15%)
Query: 74  QMEELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIK----KRPGAPTQEF 123
           +++E+SL+   F ++  +GE +FG+VYKG L      +    VAIK    K  G   +EF
Sbjct: 2   KLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEF 59
Query: 124 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVS--------- 174
             E    A +QH N+V LLG   ++    +I+ Y  +G +   L   S  S         
Sbjct: 60  RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119
Query: 175 --RQKLE---FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL 229
             +  LE   F H ++                  VVHKD  T NVLV +    K++D GL
Sbjct: 120 TVKSALEPPDFVHLVA-----QIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGL 174
Query: 230 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXX 289
              +   D             ++A E   + +FS  SD++S+GV L E+ S         
Sbjct: 175 FREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS--YGLQPYC 232
Query: 290 XXXXXXXVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 349
                  VE+++N +    +L   D+     +          L++ C +    RRP   D
Sbjct: 233 GYSNQDVVEMIRNRQ----VLPCPDDCPAWVYA---------LMIECWNEFPSRRPRFKD 279
Query: 350 VVTEL 354
           + + L
Sbjct: 280 IHSRL 284

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 119/283 (42%), Gaps = 34/283 (12%)
Query: 88  KNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLV 139
           + +IG G+FGEV  G L+      + VAIK      T+    +F+ E   +    H N++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 199
            L G   ++    +I E++ NGS+       S + +   +F     +             
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLD------SFLRQNDGQFTVIQLVGMLRGIAAGMKYL 125
Query: 200 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS-SQVTADEI---FLASE 255
                VH+     N+LV+ + + KV+D GL  FL   D + P+ +     +I   + A E
Sbjct: 126 ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFL-EDDTSDPTYTSALGGKIPIRWTAPE 184
Query: 256 VKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDE 315
             ++R+F+  SDV+S+G+ + E++S  E                   ++D  N ++  D 
Sbjct: 185 AIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD------------MTNQDVINAIE-QDY 231
Query: 316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
           RL      +      QL++ C       RP    +V  LD+ +
Sbjct: 232 RLPPPM--DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 272

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/292 (22%), Positives = 120/292 (41%), Gaps = 41/292 (14%)
Query: 91  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 137
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 186
           ++ LLG C ++   ++I  Y   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 187 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 246
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 163 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 306
               ++A E    R ++ +SDV+SFGV + E+ +                VE        
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVE-------- 266
Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
             L K+L E            E   ++  C      +RP+   +V +LDR L
Sbjct: 267 -ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/277 (24%), Positives = 118/277 (42%), Gaps = 44/277 (15%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FGEV+         VA+K  +PG+ + E F+ E   + ++QH  LV L     + 
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 82
Query: 149 NLQFLIYEYIPNGSVSIHLY---GPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 205
            + ++I E++  GS+   L    G  Q   + ++F  +++                   +
Sbjct: 83  PI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA--------EGMAFIEQRNYI 133
Query: 206 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEF 259
           H+D + AN+LV    + K+AD GL   +         ++ TA E       + A E   F
Sbjct: 134 HRDLRAANILVSASLVCKIADFGLARVIE-------DNEYTAREGAKFPIKWTAPEAINF 186
Query: 260 RRFSEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 318
             F+ KSDV+SFG+ L+E+V+ GR                +         +++ L+    
Sbjct: 187 GSFTIKSDVWSFGILLMEIVTYGR----------------IPYPGMSNPEVIRALERGYR 230
Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 355
                   EE   +++RC     E RP+   + + LD
Sbjct: 231 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 267

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/305 (23%), Positives = 126/305 (41%), Gaps = 65/305 (21%)
Query: 88  KNLIGEGKFGEVYKGLLQ-DG--MLVAIKKRPGAPTQE----FIDEVCFLASI-QHRNLV 139
           +++IGEG FG+V K  ++ DG  M  AIK+     +++    F  E+  L  +  H N++
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 140 TLLGYCQENNLQFLIYEYIPNGSV----------------SIHLYGPSQVSRQKLEFKHR 183
            LLG C+     +L  EY P+G++                +I     S +S Q+L     
Sbjct: 87  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL----- 141
Query: 184 LSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL--------RNFLGR 235
             +                + +H++    N+LV E+++AK+AD GL        +  +GR
Sbjct: 142 --LHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 199
Query: 236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXX 295
             V            ++A E   +  ++  SDV+S+GV L E+VS               
Sbjct: 200 LPVR-----------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS-----LGGTPYCGMT 243
Query: 296 XVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 355
             EL +       L K L+            +E   L+ +C       RPS + ++  L+
Sbjct: 244 CAELYEKLPQGYRLEKPLNCD----------DEVYDLMRQCWREKPYERPSFAQILVSLN 293
Query: 356 RTLDK 360
           R L++
Sbjct: 294 RMLEE 298

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/292 (22%), Positives = 120/292 (41%), Gaps = 41/292 (14%)
Query: 91  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 137
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 186
           ++ LLG C ++   ++I  Y   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 187 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 246
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 163 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 306
               ++A E    R ++ +SDV+SFGV + E+ +                VE        
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVE-------- 266
Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
             L K+L E            E   ++  C      +RP+   +V +LDR L
Sbjct: 267 -ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 84/197 (42%), Gaps = 15/197 (7%)
Query: 91  IGEGKFGEVYKGLLQ-DGMLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 145
           IG G FGEV+ G L+ D  LVA+K      P     +F+ E   L    H N+V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 146 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 205
            +    +++ E +  G     L    +    +L  K  L +                  +
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL----RTEGARLRVKTLLQMVGDAAAGMEYLESKC--CI 235
Query: 206 HKDFKTANVLVDEDFIAKVADAGL--RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS 263
           H+D    N LV E  + K++D G+      G    +G   QV     + A E   + R+S
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVK--WTAPEALNYGRYS 293
Query: 264 EKSDVYSFGVFLLELVS 280
            +SDV+SFG+ L E  S
Sbjct: 294 SESDVWSFGILLWETFS 310

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 34/206 (16%)
Query: 91  IGEGKFGEVYKGLLQD-GMLVAIKKRP-GAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 148
           +GEG +G VYK + ++ G +VAIK+ P  +  QE I E+  +      ++V   G   +N
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKN 96
Query: 149 NLQFLIYEYIPNGSVS--IHLYGPS----------QVSRQKLEFKHRLSIXXXXXXXXXX 196
              +++ EY   GSVS  I L   +          Q + + LE+ H +            
Sbjct: 97  TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM------------ 144
Query: 197 XXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV 256
                 R +H+D K  N+L++ +  AK+AD G+   L  TD     + V     ++A EV
Sbjct: 145 ------RKIHRDIKAGNILLNTEGHAKLADFGVAGQL--TDXMAKRNXVIGTPFWMAPEV 196
Query: 257 KEFRRFSEKSDVYSFGVFLLELVSGR 282
            +   ++  +D++S G+  +E+  G+
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 84/197 (42%), Gaps = 15/197 (7%)
Query: 91  IGEGKFGEVYKGLLQ-DGMLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 145
           IG G FGEV+ G L+ D  LVA+K      P     +F+ E   L    H N+V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 146 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 205
            +    +++ E +  G     L    +    +L  K  L +                  +
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL----RTEGARLRVKTLLQMVGDAAAGMEYLESKC--CI 235
Query: 206 HKDFKTANVLVDEDFIAKVADAGL--RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS 263
           H+D    N LV E  + K++D G+      G    +G   QV     + A E   + R+S
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK--WTAPEALNYGRYS 293
Query: 264 EKSDVYSFGVFLLELVS 280
            +SDV+SFG+ L E  S
Sbjct: 294 SESDVWSFGILLWETFS 310

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 86/195 (44%), Gaps = 15/195 (7%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FG V  G  +    VA+K  K       EF  E   +  + H  LV   G C + 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75
Query: 149 NLQFLIYEYIPNGSVSIHL--YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVH 206
              +++ EYI NG +  +L  +G      Q LE  + +                  + +H
Sbjct: 76  YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVC--------EGMAFLESHQFIH 127
Query: 207 KDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEK 265
           +D    N LVD D   KV+D G+ R  L    V+   ++      + A EV  + ++S K
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK--WSAPEVFHYFKYSSK 185
Query: 266 SDVYSFGVFLLELVS 280
           SDV++FG+ + E+ S
Sbjct: 186 SDVWAFGILMWEVFS 200

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 119/290 (41%), Gaps = 34/290 (11%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 131
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 132 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 191
              H N++ L G   ++    ++ E + NGS+       S + +   +F     +     
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD------SFLRKHDAQFTVIQLVGMLRG 155
Query: 192 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 250
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 156 IASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSN-- 308
           + + E   +R+F+  SDV+S+G+ L E++S  E                 +   + SN  
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----------------RPYWEMSNQD 258
Query: 309 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
           ++K +DE        +      QL++ C       RP    +V+ LD+ +
Sbjct: 259 VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 119/290 (41%), Gaps = 34/290 (11%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 131
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 13  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 72
Query: 132 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 191
              H N++ L G   ++    ++ E + NGS+       S + +   +F     +     
Sbjct: 73  QFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD------SFLRKHDAQFTVIQLVGMLRG 126
Query: 192 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 250
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 127 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 186
Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSN-- 308
           + + E   +R+F+  SDV+S+G+ L E++S  E                 +   + SN  
Sbjct: 187 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----------------RPYWEMSNQD 229
Query: 309 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
           ++K +DE        +      QL++ C       RP    +V+ LD+ +
Sbjct: 230 VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 279

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 119/290 (41%), Gaps = 34/290 (11%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 131
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 132 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 191
              H N++ L G   ++    ++ E + NGS+       S + +   +F     +     
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD------SFLRKHDAQFTVIQLVGMLRG 155
Query: 192 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 250
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSN-- 308
           + + E   +R+F+  SDV+S+G+ L E++S  E                 +   + SN  
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----------------RPYWEMSNQD 258
Query: 309 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
           ++K +DE        +      QL++ C       RP    +V+ LD+ +
Sbjct: 259 VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 127/294 (43%), Gaps = 42/294 (14%)
Query: 79  SLATKNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKKRPGAPT----------QEFIDEV 127
           +LA      +  IG+G FG V+KG L++D  +VAIK      +          QEF  EV
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 128 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIX 187
             ++++ H N+V L G    +N   ++ E++P G +   L   +   +  ++ +  L I 
Sbjct: 75  FIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIA 132
Query: 188 XXXXXXXXXXXXXXPRVVHKDFKTANVLV---DED--FIAKVADAGL--RNFLGRTDVAG 240
                         P +VH+D ++ N+ +   DE+    AKVAD GL  ++    + + G
Sbjct: 133 LGIEYMQNQN----PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLG 188
Query: 241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELV 300
            + Q  A E   A E      ++EK+D YSF + L  +++G                E  
Sbjct: 189 -NFQWMAPETIGAEE----ESYTEKADTYSFAMILYTILTGEGPFD-----------EYS 232
Query: 301 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
                F N+++  +E L  T   +       +I  C     ++RP  S +V EL
Sbjct: 233 YGKIKFINMIR--EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/306 (22%), Positives = 122/306 (39%), Gaps = 43/306 (14%)
Query: 73  FQMEELSLATKNFSDK---------NLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAP 119
           F  E+ + A + F+ +          +IG G+FGEV  G L+      + VAIK      
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 120 T----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSR 175
           T    ++F+ E   +    H N++ L G   +     +I EY+ NGS+   L       +
Sbjct: 70  TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL------RK 123
Query: 176 QKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 235
               F     +                  VH+D    N+LV+ + + KV+D G+   L  
Sbjct: 124 NDGRFTVIQLVGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLED 183
Query: 236 TDVAGPSSQVTADEI-FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXX 294
              A  +++     I + A E   +R+F+  SDV+S+G+ + E++S  E           
Sbjct: 184 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE----------- 232
Query: 295 XXVELVQNSRDFSN--LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT 352
                 +   D SN  ++K ++E        +      QL++ C       RP    +V 
Sbjct: 233 ------RPYWDMSNQDVIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVN 286
Query: 353 ELDRTL 358
            LD+ +
Sbjct: 287 MLDKLI 292

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 16/197 (8%)
Query: 91  IGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLL 142
           IGEG+FG+V++G+        M VAIK      +    ++F+ E   +    H ++V L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 143 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
           G   EN + ++I E    G +   L    QV +  L+      I                
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFL----QVRKYSLDLASL--ILYAYQLSTALAYLESK 130
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
           R VH+D    NVLV  +   K+ D GL  ++  +     S      + ++A E   FRRF
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 189
Query: 263 SEKSDVYSFGVFLLELV 279
           +  SDV+ FGV + E++
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/278 (21%), Positives = 122/278 (43%), Gaps = 33/278 (11%)
Query: 86  SDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTL 141
            D+ ++G+G +G VY G  L + + +AIK+ P      +Q   +E+     ++H+N+V  
Sbjct: 11  GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQY 70
Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXX 198
           LG   EN    +  E +P GS+S  L   +GP + + Q + F  +  +            
Sbjct: 71  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN--- 127
Query: 199 XXXPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV- 256
               ++VH+D K  NVL++    + K++D G    L   +    +   T    ++A E+ 
Sbjct: 128 ----QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--TETFTGTLQYMAPEII 181
Query: 257 -KEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDE 315
            K  R + + +D++S G  ++E+ +G+                  +     + + K+   
Sbjct: 182 DKGPRGYGKAADIWSLGCTIIEMATGKPP--------------FYELGEPQAAMFKVGMF 227
Query: 316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 353
           ++          E    I++C +P  ++R   +D++ +
Sbjct: 228 KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 265

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/278 (21%), Positives = 122/278 (43%), Gaps = 33/278 (11%)
Query: 86  SDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTL 141
            D+ ++G+G +G VY G  L + + +AIK+ P      +Q   +E+     ++H+N+V  
Sbjct: 25  GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQY 84
Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXX 198
           LG   EN    +  E +P GS+S  L   +GP + + Q + F  +  +            
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN--- 141
Query: 199 XXXPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV- 256
               ++VH+D K  NVL++    + K++D G    L   +    +   T    ++A E+ 
Sbjct: 142 ----QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--TETFTGTLQYMAPEII 195
Query: 257 -KEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDE 315
            K  R + + +D++S G  ++E+ +G+                  +     + + K+   
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPP--------------FYELGEPQAAMFKVGMF 241
Query: 316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 353
           ++          E    I++C +P  ++R   +D++ +
Sbjct: 242 KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 16/197 (8%)
Query: 91  IGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLL 142
           IGEG+FG+V++G+        M VAIK      +    ++F+ E   +    H ++V L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 143 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
           G   EN + ++I E    G +   L    QV +  L+      I                
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFL----QVRKFSLDLASL--ILYAYQLSTALAYLESK 130
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
           R VH+D    NVLV  +   K+ D GL  ++        +S+      ++A E   FRRF
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTXXKASKGKLPIKWMAPESINFRRF 189
Query: 263 SEKSDVYSFGVFLLELV 279
           +  SDV+ FGV + E++
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 114/282 (40%), Gaps = 34/282 (12%)
Query: 88  KNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLV 139
           + +IG G+FGEV  G L+      + VAIK      T    ++F+ E   +    H N++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 199
            L G   +     +I EY+ NGS+   L       +    F     +             
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFL------RKNDGRFTVIQLVGMLRGIGSGMKYL 126
Query: 200 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKE 258
                VH+D    N+LV+ + + KV+D G+   L     A  +++     I + A E   
Sbjct: 127 SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 186
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSN--LLKILDER 316
           +R+F+  SDV+S+G+ + E++S  E                 +   D SN  ++K ++E 
Sbjct: 187 YRKFTSASDVWSYGIVMWEVMSYGE-----------------RPYWDMSNQDVIKAIEEG 229
Query: 317 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
                  +      QL++ C       RP    +V  LD+ +
Sbjct: 230 YRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLI 271

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 114/282 (40%), Gaps = 34/282 (12%)
Query: 88  KNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLV 139
           + +IG G+FGEV  G L+      + VAIK      T    ++F+ E   +    H N++
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 199
            L G   +     +I EY+ NGS+   L       +    F     +             
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLDAFL------RKNDGRFTVIQLVGMLRGIGSGMKYL 132
Query: 200 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKE 258
                VH+D    N+LV+ + + KV+D G+   L     A  +++     I + A E   
Sbjct: 133 SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 192
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSN--LLKILDER 316
           +R+F+  SDV+S+G+ + E++S  E                 +   D SN  ++K ++E 
Sbjct: 193 YRKFTSASDVWSYGIVMWEVMSYGE-----------------RPYWDMSNQDVIKAIEEG 235
Query: 317 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
                  +      QL++ C       RP    +V  LD+ +
Sbjct: 236 YRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLI 277

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 111/282 (39%), Gaps = 43/282 (15%)
Query: 81  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 133
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 192
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 114
Query: 193 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 249
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 115 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTTLCGTL 167
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 309
            +L  E+ E R   EK D++S GV   E + G+              +  V+ +      
Sbjct: 168 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 221
Query: 310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                   +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 222 --------FPDFVTEGARD---LISRLLKHNPSQRPMLREVL 252

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 89  NLIGEGKFGEVYKGL-LQDG-------MLVAIKKRPGAPT-QEFIDEVCFLASIQHRNLV 139
            ++G G FG V+KG+ + +G        +  I+ + G  + Q   D +  + S+ H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 199
            LLG C  ++LQ L+ +Y+P GS+  H      V + +     +L +             
Sbjct: 79  RLLGLCPGSSLQ-LVTQYLPLGSLLDH------VRQHRGALGPQLLLNWGVQIAKGMYYL 131
Query: 200 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 259
               +VH++    NVL+      +VAD G+ + L   D     S+      ++A E   F
Sbjct: 132 EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 260 RRFSEKSDVYSFGVFLLELVS 280
            +++ +SDV+S+GV + EL++
Sbjct: 192 GKYTHQSDVWSYGVTVWELMT 212

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 129
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 73
Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDY------VREHKDNIGSQYLLNWC 126
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 127 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 129
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 72
Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDY------VREHKDNIGSQYLLNWC 125
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 126 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 129
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 70
Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           +AS+ + ++  LLG C  + +Q LI + +P G +         V   K     +  +   
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLL------DYVREHKDNIGSQYLLNWC 123
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 129
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 13  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 71
Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 72  MASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDY------VREHKDNIGSQYLLNWC 124
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 125 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 109/282 (38%), Gaps = 43/282 (15%)
Query: 81  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 133
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 192
           +H N++ L GY  +    +LI EY P G V   L        QKL +F  + +       
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL--------QKLSKFDEQRTATYITEL 122
Query: 193 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 249
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTTLCGTL 175
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 309
            +L  E+ E R   EK D++S GV   E + G+              +  V         
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------- 226
Query: 310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                E  +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 227 -----EFTFPDFVTEGARD---LISRLLKHNPSQRPMLREVL 260

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 111/282 (39%), Gaps = 43/282 (15%)
Query: 81  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 133
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 192
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 121
Query: 193 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 249
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 122 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTTLCGTL 174
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 309
            +L  E+ E R   EK D++S GV   E + G+              +  V+ +      
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 228
Query: 310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                   +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 229 --------FPDFVTEGARD---LISRLLKHNPSQRPMLREVL 259

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 129
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 70
Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           +AS+ + ++  LLG C  + +Q LI + +P G +         V   K     +  +   
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL------DYVREHKDNIGSQYLLNWC 123
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 129
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 16  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 74
Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 75  MASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDY------VREHKDNIGSQYLLNWC 127
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 128 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 187
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 188 KWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 129
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 70
Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           +AS+ + ++  LLG C  + +Q LI + +P G +         V   K     +  +   
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL------DYVREHKDNIGSQYLLNWC 123
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 116/280 (41%), Gaps = 33/280 (11%)
Query: 91  IGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLL 142
           IGEG+FG+V++G+        + VAIK      +    ++F+ E   +    H ++V L+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 143 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
           G   EN + ++I E    G +   L    QV +  L+      I                
Sbjct: 106 GVITENPV-WIIMELCTLGELRSFL----QVRKYSLDLASL--ILYAYQLSTALAYLESK 158
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
           R VH+D    NVLV  +   K+ D GL  ++  +     S      + ++A E   FRRF
Sbjct: 159 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 217
Query: 263 SEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILD-ERLWSTF 321
           +  SDV+ FGV + E++                 V+  Q  ++   + +I + ERL    
Sbjct: 218 TSASDVWMFGVCMWEIL--------------MHGVKPFQGVKNNDVIGRIENGERL--PM 261
Query: 322 TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 361
                     L+ +C      RRP  +++  +L   L++E
Sbjct: 262 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 301

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 89  NLIGEGKFGEVYKGL-LQDG-------MLVAIKKRPGAPT-QEFIDEVCFLASIQHRNLV 139
            ++G G FG V+KG+ + +G        +  I+ + G  + Q   D +  + S+ H ++V
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 199
            LLG C  ++LQ L+ +Y+P GS+  H      V + +     +L +             
Sbjct: 97  RLLGLCPGSSLQ-LVTQYLPLGSLLDH------VRQHRGALGPQLLLNWGVQIAKGMYYL 149
Query: 200 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 259
               +VH++    NVL+      +VAD G+ + L   D     S+      ++A E   F
Sbjct: 150 EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 209
Query: 260 RRFSEKSDVYSFGVFLLELVS 280
            +++ +SDV+S+GV + EL++
Sbjct: 210 GKYTHQSDVWSYGVTVWELMT 230

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 111/282 (39%), Gaps = 43/282 (15%)
Query: 81  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 133
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 192
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 120
Query: 193 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 249
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTTLCGTL 173
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 309
            +L  E+ E R   EK D++S GV   E + G+              +  V+ +      
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 227
Query: 310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                   +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 228 --------FPDFVTEGARD---LISRLLKHNPSQRPMLREVL 258

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 129
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 73
Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 126
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 127 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 111/282 (39%), Gaps = 43/282 (15%)
Query: 81  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 133
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 192
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 116
Query: 193 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 249
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 117 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTTLCGTL 169
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 309
            +L  E+ E R   EK D++S GV   E + G+              +  V+ +      
Sbjct: 170 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 223
Query: 310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                   +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 224 --------FPDFVTEGARD---LISRLLKHNPSQRPMLREVL 254

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 111/282 (39%), Gaps = 43/282 (15%)
Query: 81  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 133
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 192
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 117
Query: 193 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 249
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTXLCGTL 170
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 309
            +L  E+ E R   EK D++S GV   E + G+              +  V+ +      
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 224
Query: 310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                   +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 225 --------FPDFVTEGARD---LISRLLKHNPSQRPMLREVL 255

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 129
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 6   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 64
Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           +AS+ + ++  LLG C  + +Q LI + +P G +         V   K     +  +   
Sbjct: 65  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL------DYVREHKDNIGSQYLLNWC 117
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 118 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 16/197 (8%)
Query: 91  IGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLL 142
           IGEG+FG+V++G+        + VAIK      +    ++F+ E   +    H ++V L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 143 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
           G   EN + ++I E    G +   L    QV +  L+      I                
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFL----QVRKYSLDLASL--ILYAYQLSTALAYLESK 130
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
           R VH+D    NVLV  +   K+ D GL  ++  +     S      + ++A E   FRRF
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 189
Query: 263 SEKSDVYSFGVFLLELV 279
           +  SDV+ FGV + E++
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 129
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 13  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 71
Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           +AS+ + ++  LLG C  + +Q LI + +P G +         V   K     +  +   
Sbjct: 72  MASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLL------DYVREHKDNIGSQYLLNWC 124
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 125 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 116/280 (41%), Gaps = 33/280 (11%)
Query: 91  IGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLL 142
           IGEG+FG+V++G+        + VAIK      +    ++F+ E   +    H ++V L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 143 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
           G   EN + ++I E    G +   L    QV +  L+      I                
Sbjct: 83  GVITENPV-WIIMELCTLGELRSFL----QVRKYSLDLASL--ILYAYQLSTALAYLESK 135
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
           R VH+D    NVLV  +   K+ D GL  ++  +     S      + ++A E   FRRF
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 194
Query: 263 SEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILD-ERLWSTF 321
           +  SDV+ FGV + E++                 V+  Q  ++   + +I + ERL    
Sbjct: 195 TSASDVWMFGVCMWEIL--------------MHGVKPFQGVKNNDVIGRIENGERL--PM 238
Query: 322 TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 361
                     L+ +C      RRP  +++  +L   L++E
Sbjct: 239 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 129
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 73
Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 126
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 127 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 129
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 72
Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 125
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 126 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 129
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 19  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 77
Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 130
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 131 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 133/310 (42%), Gaps = 40/310 (12%)
Query: 89  NLIGEGKFGEVYKGL-LQDG----MLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNL 138
            ++G G FG VYKG+ + DG    + VAIK       P A  +E +DE   +A +    +
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKA-NKEILDEAYVMAGVGSPYV 81
Query: 139 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXX 198
             LLG C  + +Q L+ + +P G +  H+    + +R +L  +  L+             
Sbjct: 82  SRLLGICLTSTVQ-LVTQLMPYGCLLDHV----RENRGRLGSQDLLNWCMQIAKGMSYLE 136
Query: 199 XXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL--GRTDVAGPSSQVTADEIFLASEV 256
               R+VH+D    NVLV      K+ D GL   L    T+      +V    + L S +
Sbjct: 137 DV--RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 194
Query: 257 KEFRRFSEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDE 315
           +  RRF+ +SDV+S+GV + EL++ G +                   +R+  +LL+   E
Sbjct: 195 R--RRFTHQSDVWSYGVTVWELMTFGAKPYDGI-------------PAREIPDLLE-KGE 238
Query: 316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGT-PT 374
           RL          +   ++V+C    SE RP   ++V+E  R          +  E   P 
Sbjct: 239 RLPQPPIC--TIDVYMIMVKCWMIDSECRPRFRELVSEFSRMARDPQRFVVIQNEDLGPA 296
Query: 375 VTLGSHLFRA 384
             L S  +R+
Sbjct: 297 SPLDSTFYRS 306

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 129
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 73
Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 126
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 127 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 129
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 18  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 76
Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           +AS+ + ++  LLG C  + +Q LI + +P G +         V   K     +  +   
Sbjct: 77  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL------DYVREHKDNIGSQYLLNWC 129
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 130 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 189
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 190 KWMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 129
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 22  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 80
Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 81  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 133
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 134 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 193
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 194 KWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 116/280 (41%), Gaps = 33/280 (11%)
Query: 91  IGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLL 142
           IGEG+FG+V++G+        + VAIK      +    ++F+ E   +    H ++V L+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 143 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
           G   EN + ++I E    G +   L    QV +  L+      I                
Sbjct: 81  GVITENPV-WIIMELCTLGELRSFL----QVRKYSLDLASL--ILYAYQLSTALAYLESK 133
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
           R VH+D    NVLV  +   K+ D GL  ++  +     S      + ++A E   FRRF
Sbjct: 134 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 192
Query: 263 SEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILD-ERLWSTF 321
           +  SDV+ FGV + E++                 V+  Q  ++   + +I + ERL    
Sbjct: 193 TSASDVWMFGVCMWEIL--------------MHGVKPFQGVKNNDVIGRIENGERL--PM 236
Query: 322 TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 361
                     L+ +C      RRP  +++  +L   L++E
Sbjct: 237 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 276

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 110/282 (39%), Gaps = 43/282 (15%)
Query: 81  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 133
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 192
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 117
Query: 193 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 249
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTTLCGTL 170
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 309
            +L  E+ E R   EK D++S GV   E + G+              +  V         
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------- 221
Query: 310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                E  +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 222 -----EFTFPDFVTEGARD---LISRLLKHNPSQRPMLREVL 255

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 27/217 (12%)
Query: 91  IGEGKFGEVYK----GLL--QDGMLVAIK---KRPGAPTQ-EFIDEVCFLASIQHRNLVT 140
           IGEG FG V++    GLL  +   +VA+K   +   A  Q +F  E   +A   + N+V 
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 141 LLGYCQENNLQFLIYEYIPNGSV-----SIHLYGPSQVSRQKLEFKHRLS---------- 185
           LLG C       L++EY+  G +     S+  +    +S   L  + R+S          
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 186 --IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 243
             +                + VH+D  T N LV E+ + K+AD GL   +   D      
Sbjct: 175 EQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADG 234
Query: 244 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
                  ++  E   + R++ +SDV+++GV L E+ S
Sbjct: 235 NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 129
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 9   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 67
Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           +AS+ + ++  LLG C  + +Q LI + +P G +         V   K     +  +   
Sbjct: 68  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL------DYVREHKDNIGSQYLLNWC 120
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 121 VQIAEGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 180
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 181 KWMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 129
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 70
Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           +AS+ + ++  LLG C  + +Q LI + +P G +         V   K     +  +   
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLL------DYVREHKDNIGSQYLLNWC 123
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 124/300 (41%), Gaps = 54/300 (18%)
Query: 79  SLATKNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKKRPGAPT----------QEFIDEV 127
           +LA      +  IG+G FG V+KG L++D  +VAIK      +          QEF  EV
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 128 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIX 187
             ++++ H N+V L G    +N   ++ E++P G +   L   +   +  ++ +  L I 
Sbjct: 75  FIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIA 132
Query: 188 XXXXXXXXXXXXXXPRVVHKDFKTANVLV---DED--FIAKVADAG--------LRNFLG 234
                         P +VH+D ++ N+ +   DE+    AKVAD G        +   LG
Sbjct: 133 LGIEYMQNQN----PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGLLG 188
Query: 235 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXX 294
                 P + + A+E            ++EK+D YSF + L  +++G             
Sbjct: 189 NFQWMAPET-IGAEE----------ESYTEKADTYSFAMILYTILTGEGPFD-------- 229
Query: 295 XXVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
              E       F N+++  +E L  T   +       +I  C     ++RP  S +V EL
Sbjct: 230 ---EYSYGKIKFINMIR--EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 110/282 (39%), Gaps = 43/282 (15%)
Query: 81  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 133
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 192
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 117
Query: 193 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 249
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTELCGTL 170
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 309
            +L  E+ E R   EK D++S GV   E + G+              +  V         
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------- 221
Query: 310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                E  +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 222 -----EFTFPDFVTEGARD---LISRLLKHNPSQRPMLREVL 255

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 129
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 37  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 95
Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 96  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 148
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 149 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 208
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 209 KWMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 111/282 (39%), Gaps = 43/282 (15%)
Query: 81  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 133
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 192
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 117
Query: 193 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 249
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTDLCGTL 170
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 309
            +L  E+ E R   EK D++S GV   E + G+              +  V+ +      
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 224
Query: 310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                   +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 225 --------FPDFVTEGARD---LISRLLKHNPSQRPMLREVL 255

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 111/282 (39%), Gaps = 43/282 (15%)
Query: 81  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 133
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 192
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 117
Query: 193 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 249
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTDLCGTL 170
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 309
            +L  E+ E R   EK D++S GV   E + G+              +  V+ +      
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 224
Query: 310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                   +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 225 --------FPDFVTEGARD---LISRLLKHNPSQRPMLREVL 255

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 110/282 (39%), Gaps = 43/282 (15%)
Query: 81  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 133
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 192
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 120
Query: 193 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 249
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTTLCGTL 173
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 309
            +L  E+ E R   EK D++S GV   E + G+              +  V         
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------- 224
Query: 310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                E  +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 225 -----EFTFPDFVTEGARD---LISRLLKHNPSQRPMLREVL 258

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 109/282 (38%), Gaps = 43/282 (15%)
Query: 81  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 133
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 192
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 122
Query: 193 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 249
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTTLCGTL 175
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 309
            +L  E  E R   EK D++S GV   E + G+              +  V         
Sbjct: 176 DYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------- 226
Query: 310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                E  +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 227 -----EFTFPDFVTEGARD---LISRLLKHNPSQRPXLREVL 260

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 16/197 (8%)
Query: 91  IGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLL 142
           IGEG+FG+V++G+        + VAIK      +    ++F+ E   +    H ++V L+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 143 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
           G   EN + ++I E    G +   L    QV +  L+      I                
Sbjct: 80  GVITENPV-WIIMELCTLGELRSFL----QVRKYSLDLASL--ILYAYQLSTALAYLESK 132
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
           R VH+D    NVLV  +   K+ D GL  ++  +     S      + ++A E   FRRF
Sbjct: 133 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 191
Query: 263 SEKSDVYSFGVFLLELV 279
           +  SDV+ FGV + E++
Sbjct: 192 TSASDVWMFGVCMWEIL 208

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 110/282 (39%), Gaps = 43/282 (15%)
Query: 81  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 133
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 192
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 122
Query: 193 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 249
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTDLCGTL 175
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 309
            +L  E+ E R   EK D++S GV   E + G+              +  V         
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------- 226
Query: 310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                E  +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 227 -----EFTFPDFVTEGARD---LISRLLKHNPSQRPMLREVL 260

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 110/282 (39%), Gaps = 43/282 (15%)
Query: 81  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 133
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 192
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 118
Query: 193 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 249
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTDLCGTL 171
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 309
            +L  E+ E R   EK D++S GV   E + G+              +  V         
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------- 222
Query: 310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                E  +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 223 -----EFTFPDFVTEGARD---LISRLLKHNPSQRPMLREVL 256

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 16/197 (8%)
Query: 91  IGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLL 142
           IGEG+FG+V++G+        + VAIK      +    ++F+ E   +    H ++V L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 143 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
           G   EN + ++I E    G +   L    QV +  L+      I                
Sbjct: 75  GVITENPV-WIIMELCTLGELRSFL----QVRKYSLDLASL--ILYAYQLSTALAYLESK 127
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
           R VH+D    NVLV  +   K+ D GL  ++  +     S      + ++A E   FRRF
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 186
Query: 263 SEKSDVYSFGVFLLELV 279
           +  SDV+ FGV + E++
Sbjct: 187 TSASDVWMFGVCMWEIL 203

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 110/282 (39%), Gaps = 43/282 (15%)
Query: 81  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 133
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 192
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 122
Query: 193 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 249
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTTLCGTL 175
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 309
            +L  E+ E R   EK D++S GV   E + G+              +  V         
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------- 226
Query: 310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                E  +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 227 -----EFTFPDFVTEGARD---LISRLLKHNPSQRPMLREVL 260

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 111/282 (39%), Gaps = 43/282 (15%)
Query: 81  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 133
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 192
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 117
Query: 193 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA---DE 249
                     RV+H+D K  N+L+      K+AD G         V  PSS+  A     
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRAALCGTL 170
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 309
            +L  E+ E R   EK D++S GV   E + G+              +  V+ +      
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 224
Query: 310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                   +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 225 --------FPDFVTEGARD---LISRLLKHNPSQRPMLREVL 255

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 109/282 (38%), Gaps = 43/282 (15%)
Query: 81  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 133
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 192
           +H N++ L GY  +    +LI EY P G V   L        QKL +F  + +       
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL--------QKLSKFDEQRTATYITEL 122
Query: 193 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ---VTADE 249
                     RV+H+D K  N+L+      K+AD G         V  PSS+   +    
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRXXLXGTL 175
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 309
            +L  E+ E R   EK D++S GV   E + G+              +  V         
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------- 226
Query: 310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                E  +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 227 -----EFTFPDFVTEGARD---LISRLLKHNPSQRPMLREVL 260

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 111/282 (39%), Gaps = 43/282 (15%)
Query: 81  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 133
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 192
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 120
Query: 193 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ---VTADE 249
                     RV+H+D K  N+L+      K+AD G         V  PSS+   +    
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRXXLCGTL 173
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 309
            +L  E+ E R   EK D++S GV   E + G+              +  V+ +      
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 227
Query: 310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                   +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 228 --------FPDFVTEGARD---LISRLLKHNPSQRPMLREVL 258

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 87/197 (44%), Gaps = 16/197 (8%)
Query: 91  IGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLL 142
           IGEG+FG+V++G+        M VAIK      +    ++F+ E   +    H ++V L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 143 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
           G   EN + ++I E    G +   L    QV +  L+      I                
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFL----QVRKFSLDLASL--ILYAYQLSTALAYLESK 130
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
           R VH+D    NVLV      K+ D GL  ++  +     S      + ++A E   FRRF
Sbjct: 131 RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 189
Query: 263 SEKSDVYSFGVFLLELV 279
           +  SDV+ FGV + E++
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 111/282 (39%), Gaps = 43/282 (15%)
Query: 81  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 133
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 192
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 117
Query: 193 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ---VTADE 249
                     RV+H+D K  N+L+      K+AD G         V  PSS+   +    
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRXXLCGTL 170
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 309
            +L  E+ E R   EK D++S GV   E + G+              +  V+ +      
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 224
Query: 310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                   +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 225 --------FPDFVTEGARD---LISRLLKHNPSQRPMLREVL 255

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 16/197 (8%)
Query: 91  IGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLL 142
           IGEG+FG+V++G+        M VAIK      +    ++F+ E   +    H ++V L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 143 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
           G   EN + ++I E    G +   L    QV +  L+      I                
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFL----QVRKFSLDLASL--ILYAYQLSTALAYLESK 510
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
           R VH+D    NVLV  +   K+ D GL  ++  +     S      + ++A E   FRRF
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 569
Query: 263 SEKSDVYSFGVFLLELV 279
           +  SDV+ FGV + E++
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 110/282 (39%), Gaps = 43/282 (15%)
Query: 81  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 133
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 192
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 120
Query: 193 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA---DE 249
                     RV+H+D K  N+L+      K+AD G         V  PSS+  A     
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRAALCGTL 173
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 309
            +L  E+ E R   EK D++S GV   E + G+              +  V         
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------- 224
Query: 310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                E  +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 225 -----EFTFPDFVTEGARD---LISRLLKHNPSQRPMLREVL 258

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 111/282 (39%), Gaps = 43/282 (15%)
Query: 81  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 133
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 192
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 120
Query: 193 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ---VTADE 249
                     RV+H+D K  N+L+      K+AD G         V  PSS+   +    
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRDDLCGTL 173
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 309
            +L  E+ E R   EK D++S GV   E + G+              +  V+ +      
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 227
Query: 310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                   +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 228 --------FPDFVTEGARD---LISRLLKHNPSQRPMLREVL 258

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 110/282 (39%), Gaps = 43/282 (15%)
Query: 81  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 133
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 192
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 134
Query: 193 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 249
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 135 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTTLCGTL 187
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 309
            +L  E+ E R   EK D++S GV   E + G+              +  V         
Sbjct: 188 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------- 238
Query: 310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                E  +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 239 -----EFTFPDFVTEGARD---LISRLLKHNPSQRPMLREVL 272

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 126/294 (42%), Gaps = 42/294 (14%)
Query: 79  SLATKNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKKRPGAPT----------QEFIDEV 127
           +LA      +  IG+G FG V+KG L++D  +VAIK      +          QEF  EV
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 128 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIX 187
             ++++ H N+V L G    +N   ++ E++P G +   L   +   +  ++ +  L I 
Sbjct: 75  FIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIA 132
Query: 188 XXXXXXXXXXXXXXPRVVHKDFKTANVLV---DED--FIAKVADAGL--RNFLGRTDVAG 240
                         P +VH+D ++ N+ +   DE+    AKVAD  L  ++    + + G
Sbjct: 133 LGIEYMQNQN----PPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGLLG 188
Query: 241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELV 300
            + Q  A E   A E      ++EK+D YSF + L  +++G                E  
Sbjct: 189 -NFQWMAPETIGAEE----ESYTEKADTYSFAMILYTILTGEGPFD-----------EYS 232
Query: 301 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
                F N+++  +E L  T   +       +I  C     ++RP  S +V EL
Sbjct: 233 YGKIKFINMIR--EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 87/209 (41%), Gaps = 24/209 (11%)
Query: 83  KNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQH 135
           ++F     +G+GKFG VY       K +L   +L   +        +   EV   + ++H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 136 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXX 195
            N++ L GY  +    +LI EY P G+V   L   S+   Q+       +          
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQR-------TATYITELANA 124
Query: 196 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADEIFL 252
                  RV+H+D K  N+L+  +   K+AD G         V  PSS+ T       +L
Sbjct: 125 LSYCHSKRVIHRDIKPENLLLGSNGELKIADFGW-------SVHAPSSRRTTLCGTLDYL 177
Query: 253 ASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
             E+ E R   EK D++S GV   E + G
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 111/274 (40%), Gaps = 31/274 (11%)
Query: 83  KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLVTL 141
           K    + ++G G FG V K   +    VAIK+    +  + FI E+  L+ + H N+V L
Sbjct: 9   KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKL 67
Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX 201
            G C   N   L+ EY   GS+   L+G   +        H +S                
Sbjct: 68  YGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTA--AHAMSWCLQCSQGVAYLHSMQ 123
Query: 202 PR-VVHKDFKTANVL-VDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 259
           P+ ++H+D K  N+L V    + K+ D G        D+    +       ++A EV E 
Sbjct: 124 PKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVFEG 178
Query: 260 RRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRD--FSNLLKILDERL 317
             +SEK DV+S+G+ L E+++ R+               +   +R     NL K ++   
Sbjct: 179 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE--- 235
Query: 318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                         L+ RC      +RPSM ++V
Sbjct: 236 -------------SLMTRCWSKDPSQRPSMEEIV 256

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 110/282 (39%), Gaps = 43/282 (15%)
Query: 81  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 133
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 192
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 118
Query: 193 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ---VTADE 249
                     RV+H+D K  N+L+      K+AD G         V  PSS+   +    
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRDTLCGTL 171
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 309
            +L  E+ E R   EK D++S GV   E + G+              +  V         
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------- 222
Query: 310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                E  +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 223 -----EFTFPDFVTEGARD---LISRLLKHNPSQRPMLREVL 256

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 18/213 (8%)
Query: 77  ELSLATKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVC 128
           +  +A ++     ++GEG FGEVY+G+  +     + VA+K      T    ++F+ E  
Sbjct: 18  QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 77
Query: 129 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXX 188
            + ++ H ++V L+G  +E    ++I E  P G +  +L       R K   K    +  
Sbjct: 78  IMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYL------ERNKNSLKVLTLVLY 130
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 248
                           VH+D    N+LV      K+ D GL  ++   D    S  VT  
Sbjct: 131 SLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS--VTRL 188
Query: 249 EI-FLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            I +++ E   FRRF+  SDV+ F V + E++S
Sbjct: 189 PIKWMSPESINFRRFTTASDVWMFAVCMWEILS 221

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 18/213 (8%)
Query: 77  ELSLATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPT----QEFIDEVC 128
           +  +A ++     ++GEG FGEVY+G+      + + VA+K      T    ++F+ E  
Sbjct: 6   QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 65
Query: 129 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXX 188
            + ++ H ++V L+G  +E    ++I E  P G +  +L       R K   K    +  
Sbjct: 66  IMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYL------ERNKNSLKVLTLVLY 118
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 248
                           VH+D    N+LV      K+ D GL  ++   D    S  VT  
Sbjct: 119 SLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS--VTRL 176
Query: 249 EI-FLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            I +++ E   FRRF+  SDV+ F V + E++S
Sbjct: 177 PIKWMSPESINFRRFTTASDVWMFAVCMWEILS 209

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 110/282 (39%), Gaps = 43/282 (15%)
Query: 81  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 133
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 192
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 119
Query: 193 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ---VTADE 249
                     RV+H+D K  N+L+      K+AD G         V  PSS+   +    
Sbjct: 120 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRXXLCGTL 172
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 309
            +L  E+ E R   EK D++S GV   E + G+              +  V         
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------- 223
Query: 310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                E  +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 224 -----EFTFPDFVTEGARD---LISRLLKHNPSQRPMLREVL 257

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 18/213 (8%)
Query: 77  ELSLATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPT----QEFIDEVC 128
           +  +A ++     ++GEG FGEVY+G+      + + VA+K      T    ++F+ E  
Sbjct: 2   QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 61
Query: 129 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXX 188
            + ++ H ++V L+G  +E    ++I E  P G +  +L       R K   K    +  
Sbjct: 62  IMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYL------ERNKNSLKVLTLVLY 114
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 248
                           VH+D    N+LV      K+ D GL  ++   D    S  VT  
Sbjct: 115 SLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS--VTRL 172
Query: 249 EI-FLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            I +++ E   FRRF+  SDV+ F V + E++S
Sbjct: 173 PIKWMSPESINFRRFTTASDVWMFAVCMWEILS 205

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 111/274 (40%), Gaps = 31/274 (11%)
Query: 83  KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLVTL 141
           K    + ++G G FG V K   +    VAIK+    +  + FI E+  L+ + H N+V L
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKL 66
Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX 201
            G C   N   L+ EY   GS+   L+G   +        H +S                
Sbjct: 67  YGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTA--AHAMSWCLQCSQGVAYLHSMQ 122
Query: 202 PR-VVHKDFKTANVL-VDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 259
           P+ ++H+D K  N+L V    + K+ D G        D+    +       ++A EV E 
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVFEG 177
Query: 260 RRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRD--FSNLLKILDERL 317
             +SEK DV+S+G+ L E+++ R+               +   +R     NL K ++   
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE--- 234
Query: 318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                         L+ RC      +RPSM ++V
Sbjct: 235 -------------SLMTRCWSKDPSQRPSMEEIV 255

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 112/282 (39%), Gaps = 43/282 (15%)
Query: 81  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 133
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 192
           +H N++ L GY  ++   +LI EY P G+V   L        QKL +F  + +       
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 117
Query: 193 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA---DE 249
                     +V+H+D K  N+L+      K+AD G         V  PSS+  A     
Sbjct: 118 ANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRAALCGTL 170
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 309
            +L  E+ E R   EK D++S GV   E + G+              +  V+ +      
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFT------ 224
Query: 310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                   +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 225 --------FPDFVTEGARD---LISRLLKHNPSQRPMLREVL 255

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 113/281 (40%), Gaps = 42/281 (14%)
Query: 90  LIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFID-------EVCFLASIQHRNLVTLL 142
           +IG G FG+VY+     G  VA+K     P ++          E    A ++H N++ L 
Sbjct: 14  IIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 143 GYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX 201
           G C +E NL  L+ E+   G ++  L G     R   +     ++               
Sbjct: 73  GVCLKEPNL-CLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 202 PRVVHKDFKTANVLVDEDF--------IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 253
           P ++H+D K++N+L+ +          I K+ D GL     RT     +        ++A
Sbjct: 128 P-IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYA----WMA 182
Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKIL 313
            EV     FS+ SDV+S+GV L EL++G               V +              
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM-------------- 228
Query: 314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
             +L     +   E F +L+  C +P    RPS ++++ +L
Sbjct: 229 -NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 81  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 133
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 192
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 143
Query: 193 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 249
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 144 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTTLCGTL 196
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
            +L  E+ E R   EK D++S GV   E + G+
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 111/282 (39%), Gaps = 43/282 (15%)
Query: 81  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 133
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 192
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 120
Query: 193 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 249
                     RV+H+D K  N+L+      K+A+ G         V  PSS+ T      
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGW-------SVHAPSSRRTTLCGTL 173
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 309
            +L  E+ E R   EK D++S GV   E + G+              +  V+ +      
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 227
Query: 310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                   +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 228 --------FPDFVTEGARD---LISRLLKHNPSQRPMLREVL 258

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 18/211 (8%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK---------KRPGAPTQEFIDEVCF 129
           L    F    ++G G FG VYKGL + +G  V I            P A  +E +DE   
Sbjct: 46  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKA-NKEILDEAYV 104
Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 105 MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 157
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 158 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 217
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 218 KWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 110/282 (39%), Gaps = 43/282 (15%)
Query: 81  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 133
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 192
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 118
Query: 193 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ---VTADE 249
                     RV+H+D K  N+L+      K+AD G            PSS+   ++   
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SCHAPSSRRTTLSGTL 171
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 309
            +L  E+ E R   EK D++S GV   E + G+              +  V         
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------- 222
Query: 310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                E  +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 223 -----EFTFPDFVTEGARD---LISRLLKHNPSQRPMLREVL 256

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 87/197 (44%), Gaps = 16/197 (8%)
Query: 91  IGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLL 142
           IGEG+FG+V++G+        M VAIK      +    ++F+ E   +    H ++V L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 143 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
           G   EN + ++I E    G +   L    QV +  L+      I                
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFL----QVRKFSLDLASL--ILYAYQLSTALAYLESK 510
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
           R VH+D    NVLV      K+ D GL  ++  +     S      + ++A E   FRRF
Sbjct: 511 RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 569
Query: 263 SEKSDVYSFGVFLLELV 279
           +  SDV+ FGV + E++
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 24/209 (11%)
Query: 83  KNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQH 135
           ++F     +G+GKFG VY       K +L   +L   +        +   EV   + ++H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 136 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXX 195
            N++ L GY  +    +LI EY P G+V   L   S+   Q+       +          
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQR-------TATYITELANA 124
Query: 196 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ---VTADEIFL 252
                  RV+H+D K  N+L+  +   K+AD G         V  PSS+   +     +L
Sbjct: 125 LSYCHSKRVIHRDIKPENLLLGSNGELKIADFGW-------SVHAPSSRRDTLCGTLDYL 177
Query: 253 ASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
             E+ E R   EK D++S GV   E + G
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 113/282 (40%), Gaps = 38/282 (13%)
Query: 90  LIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLVTL 141
           +IG G+FGEV  G L+      + VAIK      T+    +F+ E   +    H N+V L
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHL 109
Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX 201
            G         ++ E++ NG++   L       +   +F     +               
Sbjct: 110 EGVVTRGKPVMIVIEFMENGALDAFL------RKHDGQFTVIQLVGMLRGIAAGMRYLAD 163
Query: 202 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---FLASEVKE 258
              VH+D    N+LV+ + + KV+D GL   +   D        T  +I   + A E  +
Sbjct: 164 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVI--EDDPEAVYTTTGGKIPVRWTAPEAIQ 221
Query: 259 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSN--LLKILDER 316
           +R+F+  SDV+S+G+ + E++S  E                 +   D SN  ++K ++E 
Sbjct: 222 YRKFTSASDVWSYGIVMWEVMSYGE-----------------RPYWDMSNQDVIKAIEEG 264
Query: 317 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
                  +      QL++ C       RP    +V  LD+ +
Sbjct: 265 YRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGILDKMI 306

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 110/282 (39%), Gaps = 43/282 (15%)
Query: 81  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 133
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 192
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 119
Query: 193 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 249
                     RV+H+D K  N+L+      K+A+ G         V  PSS+ T      
Sbjct: 120 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGW-------SVHAPSSRRTTLCGTL 172
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 309
            +L  E+ E R   EK D++S GV   E + G+              +  V         
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------- 223
Query: 310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                E  +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 224 -----EFTFPDFVTEGARD---LISRLLKHNPSQRPMLREVL 257

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 129
           L    F    ++  G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 19  LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 77
Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDY------VREHKDNIGSQYLLNWC 130
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 131 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 18/211 (8%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 129
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 16  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 74
Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           +AS+ + ++  LLG C  + +Q LI + +P G +         V   K     +  +   
Sbjct: 75  MASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLL------DYVREHKDNIGSQYLLNWC 127
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        R+VH+D    NVLV      K+ D G    LG  +    +       
Sbjct: 128 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 187
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 188 KWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 129
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 72
Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDY------VREHKDNIGSQYLLNWC 125
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        R+VH+D    NVLV      K+ D G    LG  +    +       
Sbjct: 126 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 129
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 72
Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDY------VREHKDNIGSQYLLNWC 125
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        R+VH+D    NVLV      K+ D G    LG  +    +       
Sbjct: 126 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 23/201 (11%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQE----FIDEVCFLASIQHRNLVTLL-GYC 145
           +G+G FG+VYK   ++  ++A  K     ++E    ++ E+  LAS  H N+V LL  + 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 146 QENNLQFLIYEYIPNGSVS---IHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
            ENNL  LI E+   G+V    + L  P   S+ ++  K  L                  
Sbjct: 105 YENNLWILI-EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN--------- 154
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLR----NFLGRTDVAGPSSQVTADEIFLASEVKE 258
           +++H+D K  N+L   D   K+AD G+       + R D    +    A E+ +    K+
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKD 214
Query: 259 FRRFSEKSDVYSFGVFLLELV 279
            R +  K+DV+S G+ L+E+ 
Sbjct: 215 -RPYDYKADVWSLGITLIEMA 234

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 81  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 133
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 192
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 143
Query: 193 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ---VTADE 249
                     RV+H+D K  N+L+      K+AD G         V  PSS+   +    
Sbjct: 144 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRDDLCGTL 196
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
            +L  E+ E R   EK D++S GV   E + G+
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 129
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 70
Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 123
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        R+VH+D    NVLV      K+ D G    LG  +    +       
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 183
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 129
           L    F    ++  G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 19  LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 77
Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 130
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 131 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 129
           L    F    ++  G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 12  LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 70
Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 123
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 129
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 72
Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 125
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        R+VH+D    NVLV      K+ D G    LG  +    +       
Sbjct: 126 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 25/202 (12%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQE----FIDEVCFLASIQHRNLVTLL-GYC 145
           +G+G FG+VYK   ++  ++A  K     ++E    ++ E+  LAS  H N+V LL  + 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 146 QENNLQFLIYEYIPNGSVS---IHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
            ENNL  LI E+   G+V    + L  P   S+ ++  K  L                  
Sbjct: 105 YENNLWILI-EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN--------- 154
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGL-----RNFLGRTDVAGPSSQVTADEIFLASEVK 257
           +++H+D K  N+L   D   K+AD G+     R    R    G +    A E+ +    K
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIG-TPYWMAPEVVMCETSK 213
Query: 258 EFRRFSEKSDVYSFGVFLLELV 279
           + R +  K+DV+S G+ L+E+ 
Sbjct: 214 D-RPYDYKADVWSLGITLIEMA 234

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 80  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 129
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 19  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 77
Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 130
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        R+VH+D    NVLV      K+ D G    LG  +    +       
Sbjct: 131 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 190
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 23/201 (11%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQE----FIDEVCFLASIQHRNLVTLL-GYC 145
           +G+G FG+VYK   ++  ++A  K     ++E    ++ E+  LAS  H N+V LL  + 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 146 QENNLQFLIYEYIPNGSVS---IHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
            ENNL  LI E+   G+V    + L  P   S+ ++  K  L                  
Sbjct: 105 YENNLWILI-EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN--------- 154
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLR----NFLGRTDVAGPSSQVTADEIFLASEVKE 258
           +++H+D K  N+L   D   K+AD G+       + R D    +    A E+ +    K+
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 259 FRRFSEKSDVYSFGVFLLELV 279
            R +  K+DV+S G+ L+E+ 
Sbjct: 215 -RPYDYKADVWSLGITLIEMA 234

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 86/207 (41%), Gaps = 21/207 (10%)
Query: 84  NFSDKNLIGEGKFGEVYKG-LLQDGMLVAIK---KRPGAPT--QEFIDEVCFLASIQHRN 137
           N+     IG+G F +V     +  G  VAIK   K    PT  Q+   EV  +  + H N
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXX 197
           +V L    +     +LI EY   G V  +L    ++  ++   K R  +           
Sbjct: 73  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK-- 130
Query: 198 XXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL---GRTDVAGPSSQVTADEIFLAS 254
                R+VH+D K  N+L+D D   K+AD G  N     G+ D    S    A E+F   
Sbjct: 131 -----RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGK 185
Query: 255 EVKEFRRFSEKSDVYSFGVFLLELVSG 281
           +         + DV+S GV L  LVSG
Sbjct: 186 KYD-----GPEVDVWSLGVILYTLVSG 207

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 86/207 (41%), Gaps = 21/207 (10%)
Query: 84  NFSDKNLIGEGKFGEVYKG-LLQDGMLVAIK---KRPGAPT--QEFIDEVCFLASIQHRN 137
           N+     IG+G F +V     +  G  VAIK   K    PT  Q+   EV  +  + H N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXX 197
           +V L    +     +LI EY   G V  +L    ++  ++   K R  +           
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK-- 133
Query: 198 XXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL---GRTDVAGPSSQVTADEIFLAS 254
                R+VH+D K  N+L+D D   K+AD G  N     G+ D    +    A E+F   
Sbjct: 134 -----RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGK 188
Query: 255 EVKEFRRFSEKSDVYSFGVFLLELVSG 281
           +         + DV+S GV L  LVSG
Sbjct: 189 KYD-----GPEVDVWSLGVILYTLVSG 210

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 75/325 (23%), Positives = 127/325 (39%), Gaps = 42/325 (12%)
Query: 63  IELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIK--K 114
           + LS+   +  +  +     KN      +GEG+FG+V K              VA+K  K
Sbjct: 3   LSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK 62
Query: 115 RPGAPTQ--EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL----- 167
              +P++  + + E   L  + H +++ L G C ++    LI EY   GS+   L     
Sbjct: 63  ENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRK 122
Query: 168 YGPSQVSRQKLEFKHRLS------------IXXXXXXXXXXXXXXXPRVVHKDFKTANVL 215
            GP  +          L             I                ++VH+D    N+L
Sbjct: 123 VGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL 182
Query: 216 VDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFL 275
           V E    K++D GL   +   D     SQ      ++A E      ++ +SDV+SFGV L
Sbjct: 183 VAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 276 LELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVR 335
            E+V+                   +   R F NLLK    R+     +   EE  +L+++
Sbjct: 243 WEIVT-----------LGGNPYPGIPPERLF-NLLKT-GHRM--ERPDNCSEEMYRLMLQ 287
Query: 336 CLDPSSERRPSMSDVVTELDRTLDK 360
           C     ++RP  +D+  +L++ + K
Sbjct: 288 CWKQEPDKRPVFADISKDLEKMMVK 312

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 75/325 (23%), Positives = 127/325 (39%), Gaps = 42/325 (12%)
Query: 63  IELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIK--K 114
           + LS+   +  +  +     KN      +GEG+FG+V K              VA+K  K
Sbjct: 3   LSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK 62
Query: 115 RPGAPTQ--EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL----- 167
              +P++  + + E   L  + H +++ L G C ++    LI EY   GS+   L     
Sbjct: 63  ENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRK 122
Query: 168 YGPSQVSRQKLEFKHRLS------------IXXXXXXXXXXXXXXXPRVVHKDFKTANVL 215
            GP  +          L             I                ++VH+D    N+L
Sbjct: 123 VGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL 182
Query: 216 VDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFL 275
           V E    K++D GL   +   D     SQ      ++A E      ++ +SDV+SFGV L
Sbjct: 183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 276 LELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVR 335
            E+V+                   +   R F NLLK    R+     +   EE  +L+++
Sbjct: 243 WEIVT-----------LGGNPYPGIPPERLF-NLLKT-GHRM--ERPDNCSEEMYRLMLQ 287
Query: 336 CLDPSSERRPSMSDVVTELDRTLDK 360
           C     ++RP  +D+  +L++ + K
Sbjct: 288 CWKQEPDKRPVFADISKDLEKMMVK 312

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 110/274 (40%), Gaps = 38/274 (13%)
Query: 90  LIGEGKFGEVYKGLLQDGMLVAIKK---RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYC 145
           ++G+G FG+  K   ++   V + K   R    TQ  F+ EV  +  ++H N++  +G  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 146 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 205
            ++     I EYI  G+    L G  +    +  +  R+S                  ++
Sbjct: 77  YKDKRLNFITEYIKGGT----LRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM--NII 130
Query: 206 HKDFKTANVLVDEDFIAKVADAGLRNFL--------GRTDVAGPSSQ----VTADEIFLA 253
           H+D  + N LV E+    VAD GL   +        G   +  P  +    V  +  ++A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFS-NLLKI 312
            E+   R + EK DV+SFG+ L E++    A             + +  + DF  N+   
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP-----------DYLPRTMDFGLNVRGF 239
Query: 313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 346
           LD              F  + VRC D   E+RPS
Sbjct: 240 LDRYCPPNCP----PSFFPITVRCCDLDPEKRPS 269

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 75/325 (23%), Positives = 126/325 (38%), Gaps = 42/325 (12%)
Query: 63  IELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIK--K 114
           + LS+   +  +  +     KN      +GEG+FG+V K              VA+K  K
Sbjct: 3   LSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK 62
Query: 115 RPGAPTQ--EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL----- 167
              +P++  + + E   L  + H +++ L G C ++    LI EY   GS+   L     
Sbjct: 63  ENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRK 122
Query: 168 YGPSQVSRQKLEFKHRLS------------IXXXXXXXXXXXXXXXPRVVHKDFKTANVL 215
            GP  +          L             I                 +VH+D    N+L
Sbjct: 123 VGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNIL 182
Query: 216 VDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFL 275
           V E    K++D GL   +   D     SQ      ++A E      ++ +SDV+SFGV L
Sbjct: 183 VAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 276 LELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVR 335
            E+V+                   +   R F NLLK    R+     +   EE  +L+++
Sbjct: 243 WEIVT-----------LGGNPYPGIPPERLF-NLLKT-GHRM--ERPDNCSEEMYRLMLQ 287
Query: 336 CLDPSSERRPSMSDVVTELDRTLDK 360
           C     ++RP  +D+  +L++ + K
Sbjct: 288 CWKQEPDKRPVFADISKDLEKMMVK 312

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 89/201 (44%), Gaps = 21/201 (10%)
Query: 91  IGEGKFGEVYKGLL---QDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLVTLLG 143
           +G G FG V +G+    +  + VAIK        A T+E + E   +  + +  +V L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 144 YCQENNLQFLIYEYIPNGSVSIHLYGPSQ---VSRQKLEFKHRLSIXXXXXXXXXXXXXX 200
            CQ   L  L+ E    G +   L G  +   VS    E  H++S+              
Sbjct: 78  VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVA-ELLHQVSMGMKYLEEK------ 129
Query: 201 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEF 259
               VH+D    NVL+     AK++D GL   LG  D    +       + + A E   F
Sbjct: 130 --NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 260 RRFSEKSDVYSFGVFLLELVS 280
           R+FS +SDV+S+GV + E +S
Sbjct: 188 RKFSSRSDVWSYGVTMWEALS 208

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 21/222 (9%)
Query: 76  EELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ----EFID 125
           +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A +     EF++
Sbjct: 3   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 62
Query: 126 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 185
           E   +      ++V LLG   +     +I E +  G +  +L    +  R ++E    L+
Sbjct: 63  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLA 118
Query: 186 -------IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 238
                  I                + VH+D    N +V EDF  K+ D G+   +  TD 
Sbjct: 119 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDX 178
Query: 239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
                +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 179 XRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 97/232 (41%), Gaps = 21/232 (9%)
Query: 66  SIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAP 119
           S   A  +  +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A 
Sbjct: 2   SFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 61
Query: 120 TQ----EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSR 175
           +     EF++E   +      ++V LLG   +     +I E +  G +  +L    +  R
Sbjct: 62  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLR 117
Query: 176 QKLEFKHRLS-------IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAG 228
            ++E    L+       I                + VH+D    N +V EDF  K+ D G
Sbjct: 118 PEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG 177
Query: 229 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
           +   +  TD      +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 178 MTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 23/202 (11%)
Query: 91  IGEGKFGEVYKGLLQDGML---VAIKKRPGAPTQE------FIDEVCFLASIQHRNLVTL 141
           +G G    VY  L +D +L   VAIK     P ++      F  EV   + + H+N+V++
Sbjct: 19  LGGGGMSTVY--LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 142 LGYCQENNLQFLIYEYI--PNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 199
           +   +E++  +L+ EYI  P  S  I  +GP  V           +I             
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDT---------AINFTNQILDGIKHA 127
Query: 200 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 259
              R+VH+D K  N+L+D +   K+ D G+   L  T +   ++ V     + + E  + 
Sbjct: 128 HDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGTVQYFSPEQAKG 186
Query: 260 RRFSEKSDVYSFGVFLLELVSG 281
               E +D+YS G+ L E++ G
Sbjct: 187 EATDECTDIYSIGIVLYEMLVG 208

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 96/228 (42%), Gaps = 21/228 (9%)
Query: 70  ARRFQMEELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ-- 121
           A  F  +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A +   
Sbjct: 3   ADVFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE 62
Query: 122 --EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE 179
             EF++E   +      ++V LLG   +     +I E +  G +  +L    +  R ++E
Sbjct: 63  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEME 118
Query: 180 FKHRLS-------IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 232
               L+       I                + VH+D    N +V EDF  K+ D G+   
Sbjct: 119 NNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 178
Query: 233 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
           +  TD      +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 179 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 18/206 (8%)
Query: 86  SDKNLIGEGKFGEVYKG----LLQDGMLVAIKK----RPGAPTQEFIDEVCFLASIQHRN 137
           SD+ +IG+G FG VY G      Q+ +  AIK           + F+ E   +  + H N
Sbjct: 25  SDR-VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 138 LVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXX 196
           ++ L+G       L  ++  Y+ +G +   +  P +    K      L +          
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ 143
Query: 197 XXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEI-FLAS 254
                 + VH+D    N ++DE F  KVAD GL R+ L R   +    +     + + A 
Sbjct: 144 ------KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197
Query: 255 EVKEFRRFSEKSDVYSFGVFLLELVS 280
           E  +  RF+ KSDV+SFGV L EL++
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 21/222 (9%)
Query: 76  EELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ----EFID 125
           +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A +     EF++
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 126 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 185
           E   +      ++V LLG   +     +I E +  G +  +L    +  R ++E    L+
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLA 120
Query: 186 -------IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 238
                  I                + VH+D    N +V EDF  K+ D G+   +  TD 
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 180
Query: 239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
                +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 181 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 35/206 (16%)
Query: 91  IGEGKFGEVYKGLLQD-GMLVA---IKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 146
           +G+G FG+VYK   ++ G L A   I+ +     +++I E+  LA+  H  +V LLG   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 147 ENNLQFLIYEYIPNGSVSI-------HLYGP--SQVSRQKLEFKHRLSIXXXXXXXXXXX 197
            +   +++ E+ P G+V          L  P    V RQ LE  + L             
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH------------ 126
Query: 198 XXXXPRVVHKDFKTANVLVDEDFIAKVADAG-----LRNFLGRTDVAGPSSQVTADEIFL 252
                R++H+D K  NVL+  +   ++AD G     L+    R    G +    A E+ +
Sbjct: 127 ---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIG-TPYWMAPEVVM 182
Query: 253 ASEVKEFRRFSEKSDVYSFGVFLLEL 278
              +K+   +  K+D++S G+ L+E+
Sbjct: 183 CETMKD-TPYDYKADIWSLGITLIEM 207

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 21/222 (9%)
Query: 76  EELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ----EFID 125
           +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A +     EF++
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 70
Query: 126 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 185
           E   +      ++V LLG   +     +I E +  G +  +L    +  R ++E    L+
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLA 126
Query: 186 -------IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 238
                  I                + VH+D    N +V EDF  K+ D G+   +  TD 
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 186
Query: 239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
                +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 187 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 35/207 (16%)
Query: 91  IGEGKFGEVYKGLLQD-GMLVA---IKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 146
           +G+G FG+VYK   ++ G L A   I+ +     +++I E+  LA+  H  +V LLG   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 147 ENNLQFLIYEYIPNGSVSI-------HLYGP--SQVSRQKLEFKHRLSIXXXXXXXXXXX 197
            +   +++ E+ P G+V          L  P    V RQ LE  + L             
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH------------ 134
Query: 198 XXXXPRVVHKDFKTANVLVDEDFIAKVADAG-----LRNFLGRTDVAGPSSQVTADEIFL 252
                R++H+D K  NVL+  +   ++AD G     L+    R    G +    A E+ +
Sbjct: 135 ---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIG-TPYWMAPEVVM 190
Query: 253 ASEVKEFRRFSEKSDVYSFGVFLLELV 279
              +K+   +  K+D++S G+ L+E+ 
Sbjct: 191 CETMKD-TPYDYKADIWSLGITLIEMA 216

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 21/222 (9%)
Query: 76  EELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ----EFID 125
           +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A +     EF++
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 70
Query: 126 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 185
           E   +      ++V LLG   +     +I E +  G +  +L    +  R ++E    L+
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLA 126
Query: 186 -------IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 238
                  I                + VH+D    N +V EDF  K+ D G+   +  TD 
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 186
Query: 239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
                +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 187 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 27/212 (12%)
Query: 89  NLIGEGKFGEVYKGLL--QDG--MLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLV 139
            ++GEG+FG V +G L  +DG  + VA+K            +EF+ E   +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 140 TLLGYCQENNLQ-----FLIYEYIPNGSVSIHLY------GPSQVSRQKLEFKHRLSIXX 188
            LLG C E + Q      +I  ++  G +  +L       GP  +  Q L  K  + I  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTL-LKFMVDIAL 158
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 248
                           +H+D    N ++ +D    VAD GL   +   D           
Sbjct: 159 GMEYLSNR------NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212
Query: 249 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
             ++A E    R ++ KSDV++FGV + E+ +
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 90/200 (45%), Gaps = 19/200 (9%)
Query: 91  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 145
           +GEG +GEV   +    ++ + V I   KR     +    E+C  A + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 146 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 125
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 263 -SEKSDVYSFGVFLLELVSG 281
            +E  DV+S G+ L  +++G
Sbjct: 185 HAEPVDVWSCGIVLTAMLAG 204

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 97/232 (41%), Gaps = 21/232 (9%)
Query: 66  SIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAP 119
           S   A  +  +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A 
Sbjct: 2   SFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 61
Query: 120 TQ----EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSR 175
           +     EF++E   +      ++V LLG   +     +I E +  G +  +L    +  R
Sbjct: 62  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLR 117
Query: 176 QKLEFKHRLS-------IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAG 228
            ++E    L+       I                + VH+D    N +V EDF  K+ D G
Sbjct: 118 PEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG 177
Query: 229 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
           +   +  TD      +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 178 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 15/219 (6%)
Query: 76  EELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ----EFID 125
           +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A +     EF++
Sbjct: 8   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 67
Query: 126 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG--PSQVSRQKLEFKHR 183
           E   +      ++V LLG   +     +I E +  G +  +L    P+  +   L     
Sbjct: 68  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA-PPS 126
Query: 184 LS--IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP 241
           LS  I                + VH+D    N +V EDF  K+ D G+   +  TD    
Sbjct: 127 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 186
Query: 242 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
             +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 187 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 21/222 (9%)
Query: 76  EELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ----EFID 125
           +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A +     EF++
Sbjct: 40  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 99
Query: 126 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 185
           E   +      ++V LLG   +     +I E +  G +  +L    +  R ++E    L+
Sbjct: 100 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLA 155
Query: 186 -------IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 238
                  I                + VH+D    N +V EDF  K+ D G+   +  TD 
Sbjct: 156 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 215
Query: 239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
                +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 216 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/288 (21%), Positives = 117/288 (40%), Gaps = 40/288 (13%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           +GEG +G VYK     G +VA+K+        G P+   I E+  L  + H N+V+L+  
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA-IREISLLKELHHPNIVSLIDV 87
Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
                   L++E++      +     ++   Q  + K  L                  R+
Sbjct: 88  IHSERCLTLVFEFMEKDLKKV--LDENKTGLQDSQIKIYL-----YQLLRGVAHCHQHRI 140
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----ADEIFLASEVKEFR 260
           +H+D K  N+L++ D   K+AD GL    G    +     VT    A ++ + S     +
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGS-----K 195
Query: 261 RFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELV---QNSRDFSNL-------- 309
           ++S   D++S G    E+++G+              +  +    N R++  +        
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255
Query: 310 --LKILDERLWSTFTNEGMEEFIQLI--VRCLDPSSERRPSMSDVVTE 353
              ++ +++ WS+      +E I L+  + C DP+  +R S  D +  
Sbjct: 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPN--KRISARDAMNH 301

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 27/204 (13%)
Query: 91  IGEGKFGEVYKGLL---QDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLVTLLG 143
           +G G FG V +G+    +  + VAIK        A T+E + E   +  + +  +V L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 144 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL------EFKHRLSIXXXXXXXXXXX 197
            CQ   L  L+ E    G +   L G     R+++      E  H++S+           
Sbjct: 404 VCQAEAL-MLVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEK--- 455
Query: 198 XXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEV 256
                  VH++    NVL+     AK++D GL   LG  D    +       + + A E 
Sbjct: 456 -----NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 510
Query: 257 KEFRRFSEKSDVYSFGVFLLELVS 280
             FR+FS +SDV+S+GV + E +S
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALS 534

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/288 (21%), Positives = 117/288 (40%), Gaps = 40/288 (13%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           +GEG +G VYK     G +VA+K+        G P+   I E+  L  + H N+V+L+  
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA-IREISLLKELHHPNIVSLIDV 87
Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
                   L++E++      +     ++   Q  + K  L                  R+
Sbjct: 88  IHSERCLTLVFEFMEKDLKKV--LDENKTGLQDSQIKIYL-----YQLLRGVAHCHQHRI 140
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----ADEIFLASEVKEFR 260
           +H+D K  N+L++ D   K+AD GL    G    +     VT    A ++ + S     +
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGS-----K 195
Query: 261 RFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELV---QNSRDFSNL-------- 309
           ++S   D++S G    E+++G+              +  +    N R++  +        
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255
Query: 310 --LKILDERLWSTFTNEGMEEFIQLI--VRCLDPSSERRPSMSDVVTE 353
              ++ +++ WS+      +E I L+  + C DP+  +R S  D +  
Sbjct: 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPN--KRISARDAMNH 301

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 21/222 (9%)
Query: 76  EELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ----EFID 125
           +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A +     EF++
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 126 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 185
           E   +      ++V LLG   +     +I E +  G +  +L    +  R ++E    L+
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLA 133
Query: 186 -------IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 238
                  I                + VH+D    N +V EDF  K+ D G+   +  TD 
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 193
Query: 239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
                +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 194 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 82/200 (41%), Gaps = 21/200 (10%)
Query: 91  IGEGKFGEVYKG-LLQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           IG+G F +V     +  G  VA+K     +   +  Q+   EV  +  + H N+V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
            +     +L+ EY   G V  +L    ++  ++   K R  +                 +
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF-------I 134
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRN---FLGRTDVAGPSSQVTADEIFLASEVKEFRR 261
           VH+D K  N+L+D D   K+AD G  N   F  + D    S    A E+F   +      
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD---- 190
Query: 262 FSEKSDVYSFGVFLLELVSG 281
              + DV+S GV L  LVSG
Sbjct: 191 -GPEVDVWSLGVILYTLVSG 209

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 82/200 (41%), Gaps = 21/200 (10%)
Query: 91  IGEGKFGEVYKG-LLQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           IG+G F +V     +  G  VA+K     +   +  Q+   EV  +  + H N+V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
            +     +L+ EY   G V  +L    ++  ++   K R  +                 +
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF-------I 134
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRN---FLGRTDVAGPSSQVTADEIFLASEVKEFRR 261
           VH+D K  N+L+D D   K+AD G  N   F  + D    S    A E+F   +      
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD---- 190
Query: 262 FSEKSDVYSFGVFLLELVSG 281
              + DV+S GV L  LVSG
Sbjct: 191 -GPEVDVWSLGVILYTLVSG 209

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 15/219 (6%)
Query: 76  EELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ----EFID 125
           +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A +     EF++
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 126 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG--PSQVSRQKLEFKHR 183
           E   +      ++V LLG   +     +I E +  G +  +L    P+  +   L     
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA-PPS 136
Query: 184 LS--IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP 241
           LS  I                + VH+D    N +V EDF  K+ D G+   +  TD    
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196
Query: 242 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
             +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 83  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 135
           K FSD   IG G FG VY    +++  +VAIKK      +     Q+ I EV FL  ++H
Sbjct: 54  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 136 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXX 195
            N +   G     +  +L+ EY   GS S  L    +V ++ L+     ++         
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYC-LGSASDLL----EVHKKPLQEVEIAAVTHGALQGLA 168
Query: 196 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 255
                   ++H+D K  N+L+ E  + K+ D       G   +  P++       ++A E
Sbjct: 169 YLHSH--NMIHRDVKAGNILLSEPGLVKLGD------FGSASIMAPANXFVGTPYWMAPE 220
Query: 256 V---KEFRRFSEKSDVYSFGVFLLELV 279
           V    +  ++  K DV+S G+  +EL 
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELA 247

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 85/207 (41%), Gaps = 21/207 (10%)
Query: 84  NFSDKNLIGEGKFGEVYKG-LLQDGMLVAIK---KRPGAPT--QEFIDEVCFLASIQHRN 137
           N+  +  IG+G F +V     +  G  VA+K   K    PT  Q+   EV  +  + H N
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXX 197
           +V L    +     +L+ EY   G V  +L    ++  ++   K R  +           
Sbjct: 76  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKY- 134
Query: 198 XXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL---GRTDVAGPSSQVTADEIFLAS 254
                 +VH+D K  N+L+D D   K+AD G  N      + D    S    A E+F   
Sbjct: 135 ------IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGK 188
Query: 255 EVKEFRRFSEKSDVYSFGVFLLELVSG 281
           +         + DV+S GV L  LVSG
Sbjct: 189 KYD-----GPEVDVWSLGVILYTLVSG 210

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 84/212 (39%), Gaps = 21/212 (9%)
Query: 79  SLATKNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIK-----KRPGAPTQEFIDEVCFLAS 132
            L   N+     IG+G F +V     +  G  VA+K     +   +  Q+   EV  +  
Sbjct: 3   DLHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKV 62
Query: 133 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXX 192
           + H N+V L    +     +L+ EY   G V  +L     +  ++   K R  +      
Sbjct: 63  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYC 122
Query: 193 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRN---FLGRTDVAGPSSQVTADE 249
                      +VH+D K  N+L+D D   K+AD G  N   F  + D    S    A E
Sbjct: 123 HQKF-------IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPE 175
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
           +F   +         + DV+S GV L  LVSG
Sbjct: 176 LFQGKKYD-----GPEVDVWSLGVILYTLVSG 202

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 93/222 (41%), Gaps = 21/222 (9%)
Query: 76  EELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ----EFID 125
           +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A +     EF++
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 126 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 185
           E   +      ++V LLG   +     +I E +  G +  +L    +  R ++E    L+
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLA 120
Query: 186 -------IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 238
                  I                + VH+D    N  V EDF  K+ D G+   +  TD 
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDY 180
Query: 239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
                +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 181 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 83  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 135
           K FSD   IG G FG VY    +++  +VAIKK      +     Q+ I EV FL  ++H
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 136 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXX 195
            N +   G     +  +L+ EY   GS S  L    +V ++ L+     ++         
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYC-LGSASDLL----EVHKKPLQEVEIAAVTHGALQGLA 129
Query: 196 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 255
                   ++H+D K  N+L+ E  + K+ D       G   +  P++       ++A E
Sbjct: 130 YLHSH--NMIHRDVKAGNILLSEPGLVKLGD------FGSASIMAPANXFVGTPYWMAPE 181
Query: 256 V---KEFRRFSEKSDVYSFGVFLLELV 279
           V    +  ++  K DV+S G+  +EL 
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELA 208

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 98/216 (45%), Gaps = 32/216 (14%)
Query: 81  ATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFID-----EVCFLASIQ 134
           + + + +  L+GEG +G V K   +D G +VAIKK   +   + +      E+  L  ++
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 135 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXX 194
           H NLV LL  C++    +L++E++ +  +      P+ +  Q ++ K+   I        
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQ-KYLFQIINGIGFCH 141
Query: 195 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---- 250
                    ++H+D K  N+LV +  + K+ D G      RT +A P  +V  DE+    
Sbjct: 142 SH------NIIHRDIKPENILVSQSGVVKLCDFG----FART-LAAP-GEVYDDEVATRW 189
Query: 251 -----FLASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
                 L  +VK    + +  DV++ G  + E+  G
Sbjct: 190 YRAPELLVGDVK----YGKAVDVWAIGCLVTEMFMG 221

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 121 QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF 180
           Q+   EV  +  + H N+V L    +     +L+ EY   G V  +L    ++  ++   
Sbjct: 58  QKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA 117
Query: 181 KHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRN---FLGRTD 237
           K R  +                 +VH+D K  N+L+D D   K+AD G  N   F  + D
Sbjct: 118 KFRQIVSAVQYCHQKF-------IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLD 170
Query: 238 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
               S    A E+F   +         + DV+S GV L  LVSG
Sbjct: 171 TFCGSPPYAAPELFQGKKYD-----GPEVDVWSLGVILYTLVSG 209

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 91  IGEGKFGEV----YKGLLQD-GMLVAIKK-RPGAPTQEFID---EVCFLASIQHRNLVTL 141
           +GEG FG+V    Y     + G  VA+K  +P +      D   E+  L ++ H N+V  
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 142 LGYCQEN--NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 199
            G C E+  N   LI E++P+GS+  +L      ++ K+  K +L               
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL----PKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 200 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE--IFLASEVK 257
              + VH+D    NVLV+ +   K+ D GL   +  TD    + +   D    + A E  
Sbjct: 145 R--QYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEXXTVKDDRDSPVFWYAPECL 201
Query: 258 EFRRFSEKSDVYSFGVFLLELVS 280
              +F   SDV+SFGV L EL++
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLT 224

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 81  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 133
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 62
Query: 134 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 177
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQ----LLQG 118
Query: 178 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 237
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 119 LAFCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 160
Query: 238 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 161 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 83  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 135
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 61
Query: 136 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 179
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLS 117
Query: 180 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 239
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 118 FCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 159
Query: 240 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 160 YTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 81  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 133
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 60
Query: 134 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 177
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 116
Query: 178 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 237
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 117 LAFCH------------------SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV 158
Query: 238 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 159 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 81  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 133
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 62
Query: 134 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 177
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 118
Query: 178 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 237
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 119 LAFCHSH------------------RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV 160
Query: 238 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 161 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 83  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 135
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 61
Query: 136 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 179
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 117
Query: 180 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 239
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 118 FCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 159
Query: 240 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 160 YTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 83  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 135
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 60
Query: 136 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 179
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 116
Query: 180 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 239
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 117 FCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158
Query: 240 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 159 YTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 81  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 133
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 61
Query: 134 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 177
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQ----LLQG 117
Query: 178 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 237
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 118 LAFCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 159
Query: 238 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 160 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 82/200 (41%), Gaps = 21/200 (10%)
Query: 91  IGEGKFGEVYKG-LLQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           IG+G F +V     +  G  VA+K     +   +  Q+   EV  +  + H N+V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
            +     +L+ EY   G V  +L    ++  ++   K R  +                 +
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF-------I 134
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRN---FLGRTDVAGPSSQVTADEIFLASEVKEFRR 261
           VH+D K  N+L+D D   K+AD G  N   F  + D    +    A E+F   +      
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYD---- 190
Query: 262 FSEKSDVYSFGVFLLELVSG 281
              + DV+S GV L  LVSG
Sbjct: 191 -GPEVDVWSLGVILYTLVSG 209

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 81  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 133
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 59
Query: 134 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 177
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 115
Query: 178 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 237
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 116 LAFCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157
Query: 238 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 158 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 81  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 133
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 59
Query: 134 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 177
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 115
Query: 178 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 237
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 116 LAFCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157
Query: 238 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 158 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 81  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 133
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 60
Query: 134 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 177
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 116
Query: 178 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 237
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 117 LAFCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 158
Query: 238 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 159 RTYTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 81  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 133
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 62
Query: 134 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 177
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 118
Query: 178 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 237
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 119 LAFCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 160
Query: 238 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 161 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 81  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 133
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 61
Query: 134 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 177
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 117
Query: 178 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 237
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 118 LAFCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 159
Query: 238 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 160 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 81  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 133
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 61
Query: 134 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 177
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 117
Query: 178 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 237
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 118 LAFCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 159
Query: 238 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 160 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 83  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 135
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 68
Query: 136 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 179
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 124
Query: 180 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 239
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 125 FCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 166
Query: 240 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 167 YTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 81  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 133
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 59
Query: 134 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 177
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 115
Query: 178 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 237
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 116 LAFCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157
Query: 238 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 158 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 83  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 135
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 60
Query: 136 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 179
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQ----LLQGLA 116
Query: 180 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 239
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 117 FCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158
Query: 240 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 159 YTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 83  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 135
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 60
Query: 136 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 179
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 116
Query: 180 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 239
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 117 FCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158
Query: 240 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 159 YTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 91  IGEGKFGEV----YKGLLQD-GMLVAIKK-RPGAPTQEFID---EVCFLASIQHRNLVTL 141
           +GEG FG+V    Y     + G  VA+K  +P +      D   E+  L ++ H N+V  
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 142 LGYCQEN--NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 199
            G C E+  N   LI E++P+GS+  +L      ++ K+  K +L               
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL----PKNKNKINLKQQLKYAVQICKGMDYLGS 132
Query: 200 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE--IFLASEVK 257
              + VH+D    NVLV+ +   K+ D GL   +  TD    + +   D    + A E  
Sbjct: 133 R--QYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEXXTVKDDRDSPVFWYAPECL 189
Query: 258 EFRRFSEKSDVYSFGVFLLELVS 280
              +F   SDV+SFGV L EL++
Sbjct: 190 MQSKFYIASDVWSFGVTLHELLT 212

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 81  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 133
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 59
Query: 134 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 177
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQ----LLQG 115
Query: 178 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 237
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 116 LAFCHSH------------------RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV 157
Query: 238 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 158 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 83  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 135
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 61
Query: 136 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 179
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 117
Query: 180 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 239
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 118 FCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 159
Query: 240 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 160 YTHEVVTLWYRAPEILLGX-----KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 83  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 135
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 60
Query: 136 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 179
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 116
Query: 180 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 239
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 117 FCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158
Query: 240 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 159 YXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 81  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 133
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 61
Query: 134 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 177
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 117
Query: 178 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 237
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 118 LAFCHSH------------------RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV 159
Query: 238 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 160 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 81  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 133
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 59
Query: 134 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 177
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 115
Query: 178 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 237
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 116 LAFCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157
Query: 238 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 158 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 81  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 133
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 62
Query: 134 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 177
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQ----LLQG 118
Query: 178 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 237
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 119 LAFCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 160
Query: 238 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 161 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 81  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 133
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 63
Query: 134 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 177
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 119
Query: 178 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 237
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 120 LAFCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 161
Query: 238 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 162 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 81  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 133
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 62
Query: 134 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 177
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 118
Query: 178 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 237
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 119 LAFCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 160
Query: 238 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 161 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 83  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 135
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 60
Query: 136 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 179
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 116
Query: 180 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 239
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 117 FCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158
Query: 240 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 159 YXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 83  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 135
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 68
Query: 136 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 179
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 124
Query: 180 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 239
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 125 FCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 166
Query: 240 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 167 YTHEVVTLWYRAPEILLGX-----KYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 81  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 133
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 60
Query: 134 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 177
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 116
Query: 178 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 237
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 117 LAFCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 158
Query: 238 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 159 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 83  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 135
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 61
Query: 136 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 179
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 117
Query: 180 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 239
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 118 FCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 159
Query: 240 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 160 YTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 81  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 133
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 60
Query: 134 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 177
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 116
Query: 178 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 237
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 117 LAFCHSH------------------RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV 158
Query: 238 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 159 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 83  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 135
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 65
Query: 136 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 179
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 121
Query: 180 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 239
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 122 FCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 163
Query: 240 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 164 YTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 91  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 145
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 146 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 73  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 123
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 124 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 263 -SEKSDVYSFGVFLLELVSG 281
            +E  DV+S G+ L  +++G
Sbjct: 183 HAEPVDVWSCGIVLTAMLAG 202

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 91  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 145
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 146 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 263 -SEKSDVYSFGVFLLELVSG 281
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 91  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 145
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 146 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 125
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 263 -SEKSDVYSFGVFLLELVSG 281
            +E  DV+S G+ L  +++G
Sbjct: 185 HAEPVDVWSCGIVLTAMLAG 204

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 91  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 145
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 146 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 263 -SEKSDVYSFGVFLLELVSG 281
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 91  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 145
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 146 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 263 -SEKSDVYSFGVFLLELVSG 281
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 81  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 133
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 62
Query: 134 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 177
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 118
Query: 178 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 237
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 119 LAFCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 160
Query: 238 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 161 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 91  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 145
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 146 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 125
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 263 -SEKSDVYSFGVFLLELVSG 281
            +E  DV+S G+ L  +++G
Sbjct: 185 HAEPVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 91  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 145
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 146 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 125
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 263 -SEKSDVYSFGVFLLELVSG 281
            +E  DV+S G+ L  +++G
Sbjct: 185 HAEPVDVWSCGIVLTAMLAG 204

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 91  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 145
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 146 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 125
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 263 -SEKSDVYSFGVFLLELVSG 281
            +E  DV+S G+ L  +++G
Sbjct: 185 HAEPVDVWSCGIVLTAMLAG 204

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 91  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 145
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 146 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 125
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 263 -SEKSDVYSFGVFLLELVSG 281
            +E  DV+S G+ L  +++G
Sbjct: 185 HAEPVDVWSCGIVLTAMLAG 204

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 83  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 135
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 62
Query: 136 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 179
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 118
Query: 180 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 239
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 119 FCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 160
Query: 240 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 161 YXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 112/281 (39%), Gaps = 28/281 (9%)
Query: 91  IGEGKFGEV----YKGLLQD-GMLVAIKK-RPGAPTQE--FIDEVCFLASIQHRNLVTLL 142
           +G+G FG V    Y  L  + G LVA+K+ +   P Q+  F  E+  L ++    +V   
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 143 G--YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 200
           G  Y        L+ EY+P+G +   L    Q  R +L+    L                
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFL----QRHRARLDASRLLLYSSQICKGMEYLGSR 130
Query: 201 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKEF 259
             R VH+D    N+LV+ +   K+AD GL   L          +     IF  A E    
Sbjct: 131 --RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSD 188
Query: 260 RRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLK-----ILD 314
             FS +SDV+SFGV L EL +                + ++   RD   L +        
Sbjct: 189 NIFSRQSDVWSFGVVLYELFT----YCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEG 244
Query: 315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 355
           +RL +        E  +L+  C  PS + RPS S +  +LD
Sbjct: 245 QRLPAPPACPA--EVHELMKLCWAPSPQDRPSFSALGPQLD 283

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 91  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 145
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 146 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 263 -SEKSDVYSFGVFLLELVSG 281
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 91  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 145
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 146 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 263 -SEKSDVYSFGVFLLELVSG 281
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 91  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 145
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 146 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 125
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 263 -SEKSDVYSFGVFLLELVSG 281
            +E  DV+S G+ L  +++G
Sbjct: 185 HAEPVDVWSCGIVLTAMLAG 204

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 91  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 145
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 146 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 263 -SEKSDVYSFGVFLLELVSG 281
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 91  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 145
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 146 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 263 -SEKSDVYSFGVFLLELVSG 281
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 91  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 145
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 146 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 263 -SEKSDVYSFGVFLLELVSG 281
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 91  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 145
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 146 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 263 -SEKSDVYSFGVFLLELVSG 281
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 112/281 (39%), Gaps = 28/281 (9%)
Query: 91  IGEGKFGEV----YKGLLQD-GMLVAIKK-RPGAPTQE--FIDEVCFLASIQHRNLVTLL 142
           +G+G FG V    Y  L  + G LVA+K+ +   P Q+  F  E+  L ++    +V   
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 143 G--YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 200
           G  Y        L+ EY+P+G +   L    Q  R +L+    L                
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFL----QRHRARLDASRLLLYSSQICKGMEYLGSR 134
Query: 201 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKEF 259
             R VH+D    N+LV+ +   K+AD GL   L          +     IF  A E    
Sbjct: 135 --RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 192
Query: 260 RRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLK-----ILD 314
             FS +SDV+SFGV L EL +                + ++   RD   L +        
Sbjct: 193 NIFSRQSDVWSFGVVLYELFT----YCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEG 248
Query: 315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 355
           +RL +        E  +L+  C  PS + RPS S +  +LD
Sbjct: 249 QRLPAPPACPA--EVHELMKLCWAPSPQDRPSFSALGPQLD 287

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 121 QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF 180
           Q+   EV  +  + H N+V L    +     +L+ EY   G V  +L    ++  ++   
Sbjct: 58  QKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA 117
Query: 181 KHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRN---FLGRTD 237
           K R  +                 +VH+D K  N+L+D D   K+AD G  N   F  + D
Sbjct: 118 KFRQIVSAVQYCHQKF-------IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLD 170
Query: 238 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
               S    A E+F   +         + DV+S GV L  LVSG
Sbjct: 171 EFCGSPPYAAPELFQGKKYD-----GPEVDVWSLGVILYTLVSG 209

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 113/281 (40%), Gaps = 28/281 (9%)
Query: 91  IGEGKFGEV----YKGLLQD-GMLVAIKK-RPGAPTQE--FIDEVCFLASIQHRNLVTLL 142
           +G+G FG V    Y  L  + G LVA+K+ +   P Q+  F  E+  L ++    +V   
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 143 G--YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 200
           G  Y        L+ EY+P+G +   L    Q  R +L+    L                
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFL----QRHRARLDASRLLLYSSQICKGMEYLGSR 133
Query: 201 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKEF 259
             R VH+D    N+LV+ +   K+AD GL   L          +     IF  A E    
Sbjct: 134 --RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 191
Query: 260 RRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLK-----ILD 314
             FS +SDV+SFGV L EL +                + ++ + RD   L +        
Sbjct: 192 NIFSRQSDVWSFGVVLYELFT----YCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEG 247
Query: 315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 355
           +RL +        E  +L+  C  PS + RPS S +  +LD
Sbjct: 248 QRLPAPPACPA--EVHELMKLCWAPSPQDRPSFSALGPQLD 286

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 119/292 (40%), Gaps = 41/292 (14%)
Query: 91  IGEGKFGEVYKGLLQD-----GMLVAIK--KRPGAPTQE--FIDEVCFLASIQHRNLVTL 141
           +GEG FG+V            G +VA+K  K    P     +  E+  L ++ H +++  
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 142 LGYCQEN---NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXX 198
            G C++    +LQ L+ EY+P GS+  +L   S    Q L F  ++              
Sbjct: 99  KGCCEDAGAASLQ-LVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQIC--------EGMAY 149
Query: 199 XXXPRVVHKDFKTANVLVDEDFIAKVADAGLRN--------FLGRTDVAGPSSQVTADEI 250
                 +H+D    NVL+D D + K+ D GL          +  R D   P         
Sbjct: 150 LHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPV-------F 202
Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLL 310
           + A E  +  +F   SDV+SFGV L EL++  ++            + + Q       L 
Sbjct: 203 WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDS-SQSPPTKFLELIGIAQGQMTVLRLT 261
Query: 311 KILD--ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 360
           ++L+  ERL     ++   E   L+  C +  +  RP+  +++  L    +K
Sbjct: 262 ELLERGERL--PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 35/225 (15%)
Query: 84  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAPTQEFIDEVCFLASIQH----- 135
           +F +  ++G+G FG+V K     D    AIKK           + EV  LAS+ H     
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 136 --------RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIX 187
                   RN V  +   ++ +  F+  EY  NG++   L     +++Q+ E+  RL   
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL-YDLIHSENLNQQRDEY-WRL--- 121
Query: 188 XXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT---------DV 238
                           ++H+D K  N+ +DE    K+ D GL   + R+         ++
Sbjct: 122 -FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 239 AGPSSQVTA---DEIFLASEVKEFR-RFSEKSDVYSFGVFLLELV 279
            G S  +T+     +++A+EV +    ++EK D+YS G+   E++
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 112/281 (39%), Gaps = 28/281 (9%)
Query: 91  IGEGKFGEV----YKGLLQD-GMLVAIKK-RPGAPTQE--FIDEVCFLASIQHRNLVTLL 142
           +G+G FG V    Y  L  + G LVA+K+ +   P Q+  F  E+  L ++    +V   
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 143 G--YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 200
           G  Y        L+ EY+P+G +   L    Q  R +L+    L                
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFL----QRHRARLDASRLLLYSSQICKGMEYLGSR 146
Query: 201 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKEF 259
             R VH+D    N+LV+ +   K+AD GL   L          +     IF  A E    
Sbjct: 147 --RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 204
Query: 260 RRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLK-----ILD 314
             FS +SDV+SFGV L EL +                + ++   RD   L +        
Sbjct: 205 NIFSRQSDVWSFGVVLYELFT----YCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG 260
Query: 315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 355
           +RL +        E  +L+  C  PS + RPS S +  +LD
Sbjct: 261 QRLPAPPACPA--EVHELMKLCWAPSPQDRPSFSALGPQLD 299

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/319 (20%), Positives = 132/319 (41%), Gaps = 35/319 (10%)
Query: 65  LSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLL--QDGMLVAIKKR------- 115
           L I +  + ++E++ +  + F+   ++G+G+FG V +  L  +DG  V +  +       
Sbjct: 5   LGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII 64
Query: 116 PGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENN------LQFLIYEYIPNGSVSIHLYG 169
             +  +EF+ E   +    H ++  L+G    +       +  +I  ++ +G +   L  
Sbjct: 65  ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLA 124
Query: 170 PSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL 229
            S++         +  +                  +H+D    N ++ ED    VAD GL
Sbjct: 125 -SRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGL 183
Query: 230 --RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXX 287
             + + G     G +S++     +LA E      ++  SDV++FGV + E+++  +    
Sbjct: 184 SRKIYSGDYYRQGCASKLPVK--WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYA 241
Query: 288 XXXXXXXXXVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM 347
                       ++N+  ++ L  I   RL      E MEE   L+ +C     ++RPS 
Sbjct: 242 G-----------IENAEIYNYL--IGGNRL--KQPPECMEEVYDLMYQCWSADPKQRPSF 286
Query: 348 SDVVTELDRTLDKEMNLTT 366
           + +  EL+  L     L+T
Sbjct: 287 TCLRMELENILGHLSVLST 305

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 85  FSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT--QEFIDEVCFLASIQHR 136
             DK L G G FG V KG  Q         +  +K     P    E + E   +  + + 
Sbjct: 14  LEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 72
Query: 137 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXX 195
            +V ++G C+  +   L+ E    G ++ +L     V  + + E  H++S+         
Sbjct: 73  YIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES- 130
Query: 196 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLA 253
                    VH+D    NVL+     AK++D GL   L R D     +Q        + A
Sbjct: 131 -------NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENXYKAQTHGKWPVKWYA 182
Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVS 280
            E   + +FS KSDV+SFGV + E  S
Sbjct: 183 PECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 89/227 (39%), Gaps = 55/227 (24%)
Query: 83  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 135
           +NF     IGEG +G VYK   +  G +VA+ K        G P+   I E+  L  + H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTA-IREISLLKELNH 61
Query: 136 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 179
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 117
Query: 180 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 239
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 118 FCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 159
Query: 240 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 160 YTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 89/227 (39%), Gaps = 55/227 (24%)
Query: 83  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 135
           +NF     IGEG +G VYK   +  G +VA+ K        G P+   I E+  L  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTA-IREISLLKELNH 60
Query: 136 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 179
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 116
Query: 180 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 239
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 117 FCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158
Query: 240 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 159 YTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/205 (21%), Positives = 81/205 (39%), Gaps = 17/205 (8%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ----------EFIDEVCFLASIQHRNLVT 140
           +G+G FG VY+G  +D +    + R    T           EF++E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLY-----GPSQVSRQKLEFKHRLSIXXXXXXXXX 195
           LLG   +     ++ E + +G +  +L        +   R     +  + +         
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 196 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 255
                  + VH+D    N +V  DF  K+ D G+   +  TD      +      ++A E
Sbjct: 145 YLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPE 202
Query: 256 VKEFRRFSEKSDVYSFGVFLLELVS 280
             +   F+  SD++SFGV L E+ S
Sbjct: 203 SLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/205 (21%), Positives = 81/205 (39%), Gaps = 17/205 (8%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ----------EFIDEVCFLASIQHRNLVT 140
           +G+G FG VY+G  +D +    + R    T           EF++E   +      ++V 
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLY-----GPSQVSRQKLEFKHRLSIXXXXXXXXX 195
           LLG   +     ++ E + +G +  +L        +   R     +  + +         
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 196 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 255
                  + VH+D    N +V  DF  K+ D G+   +  TD      +      ++A E
Sbjct: 142 YLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPE 199
Query: 256 VKEFRRFSEKSDVYSFGVFLLELVS 280
             +   F+  SD++SFGV L E+ S
Sbjct: 200 SLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/205 (21%), Positives = 81/205 (39%), Gaps = 17/205 (8%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ----------EFIDEVCFLASIQHRNLVT 140
           +G+G FG VY+G  +D +    + R    T           EF++E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLY-----GPSQVSRQKLEFKHRLSIXXXXXXXXX 195
           LLG   +     ++ E + +G +  +L        +   R     +  + +         
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 196 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 255
                  + VH+D    N +V  DF  K+ D G+   +  TD      +      ++A E
Sbjct: 145 YLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPE 202
Query: 256 VKEFRRFSEKSDVYSFGVFLLELVS 280
             +   F+  SD++SFGV L E+ S
Sbjct: 203 SLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 85  FSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT--QEFIDEVCFLASIQHR 136
             DK L G G FG V KG  Q         +  +K     P    E + E   +  + + 
Sbjct: 20  LEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 78
Query: 137 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXX 195
            +V ++G C+  +   L+ E    G ++ +L     V  + + E  H++S+         
Sbjct: 79  YIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES- 136
Query: 196 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLA 253
                    VH+D    NVL+     AK++D GL   L R D     +Q        + A
Sbjct: 137 -------NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYA 188
Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVS 280
            E   + +FS KSDV+SFGV + E  S
Sbjct: 189 PECINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 85  FSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT--QEFIDEVCFLASIQHR 136
             DK L G G FG V KG  Q         +  +K     P    E + E   +  + + 
Sbjct: 30  LEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 88
Query: 137 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXX 195
            +V ++G C+  +   L+ E    G ++ +L     V  + + E  H++S+         
Sbjct: 89  YIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES- 146
Query: 196 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLA 253
                    VH+D    NVL+     AK++D GL   L R D     +Q        + A
Sbjct: 147 -------NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYA 198
Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVS 280
            E   + +FS KSDV+SFGV + E  S
Sbjct: 199 PECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 85  FSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT--QEFIDEVCFLASIQHR 136
             DK L G G FG V KG  Q         +  +K     P    E + E   +  + + 
Sbjct: 30  LEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 88
Query: 137 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXX 195
            +V ++G C+  +   L+ E    G ++ +L     V  + + E  H++S+         
Sbjct: 89  YIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES- 146
Query: 196 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLA 253
                    VH+D    NVL+     AK++D GL   L R D     +Q        + A
Sbjct: 147 -------NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYA 198
Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVS 280
            E   + +FS KSDV+SFGV + E  S
Sbjct: 199 PECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 85  FSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT--QEFIDEVCFLASIQHR 136
             DK L G G FG V KG  Q         +  +K     P    E + E   +  + + 
Sbjct: 8   LEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 66
Query: 137 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXX 195
            +V ++G C+  +   L+ E    G ++ +L     V  + + E  H++S+         
Sbjct: 67  YIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES- 124
Query: 196 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLA 253
                    VH+D    NVL+     AK++D GL   L R D     +Q        + A
Sbjct: 125 -------NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYA 176
Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVS 280
            E   + +FS KSDV+SFGV + E  S
Sbjct: 177 PECINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 36/210 (17%)
Query: 91  IGEGKFGEVYKGLLQD-----GMLVAIK--KRPGAPTQE--FIDEVCFLASIQHRNLVTL 141
           +GEG FG+V            G +VA+K  K    P     +  E+  L ++ H +++  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 142 LGYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXX 198
            G C+   E +LQ L+ EY+P GS+  +L   S    Q L F  ++              
Sbjct: 82  KGCCEDQGEKSLQ-LVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQIC--------EGMAY 132
Query: 199 XXXPRVVHKDFKTANVLVDEDFIAKVADAGLRN--------FLGRTDVAGPSSQVTADEI 250
                 +H++    NVL+D D + K+ D GL          +  R D   P         
Sbjct: 133 LHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV-------F 185
Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
           + A E  +  +F   SDV+SFGV L EL++
Sbjct: 186 WYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 36/210 (17%)
Query: 91  IGEGKFGEVYKGLLQD-----GMLVAIK--KRPGAPTQE--FIDEVCFLASIQHRNLVTL 141
           +GEG FG+V            G +VA+K  K    P     +  E+  L ++ H +++  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 142 LGYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXX 198
            G C+   E +LQ L+ EY+P GS+  +L   S    Q L F  ++              
Sbjct: 82  KGCCEDQGEKSLQ-LVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQIC--------EGMAY 132
Query: 199 XXXPRVVHKDFKTANVLVDEDFIAKVADAGLRN--------FLGRTDVAGPSSQVTADEI 250
                 +H++    NVL+D D + K+ D GL          +  R D   P         
Sbjct: 133 LHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV-------F 185
Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
           + A E  +  +F   SDV+SFGV L EL++
Sbjct: 186 WYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 19/200 (9%)
Query: 91  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 145
           +GEG  GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 146 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 263 -SEKSDVYSFGVFLLELVSG 281
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 85  FSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT--QEFIDEVCFLASIQHR 136
             DK L G G FG V KG  Q         +  +K     P    E + E   +  + + 
Sbjct: 10  LEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 68
Query: 137 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXX 195
            +V ++G C+  +   L+ E    G ++ +L     V  + + E  H++S+         
Sbjct: 69  YIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES- 126
Query: 196 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLA 253
                    VH+D    NVL+     AK++D GL   L R D     +Q        + A
Sbjct: 127 -------NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYA 178
Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVS 280
            E   + +FS KSDV+SFGV + E  S
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 85  FSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT--QEFIDEVCFLASIQHR 136
             DK L G G FG V KG  Q         +  +K     P    E + E   +  + + 
Sbjct: 14  LEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 72
Query: 137 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXX 195
            +V ++G C+  +   L+ E    G ++ +L     V  + + E  H++S+         
Sbjct: 73  YIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES- 130
Query: 196 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLA 253
                    VH+D    NVL+     AK++D GL   L R D     +Q        + A
Sbjct: 131 -------NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYA 182
Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVS 280
            E   + +FS KSDV+SFGV + E  S
Sbjct: 183 PECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 85  FSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT--QEFIDEVCFLASIQHR 136
             DK L G G FG V KG  Q         +  +K     P    E + E   +  + + 
Sbjct: 28  LEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 86
Query: 137 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXX 195
            +V ++G C+  +   L+ E    G ++ +L     V  + + E  H++S+         
Sbjct: 87  YIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES- 144
Query: 196 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLA 253
                    VH+D    NVL+     AK++D GL   L R D     +Q        + A
Sbjct: 145 -------NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYA 196
Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVS 280
            E   + +FS KSDV+SFGV + E  S
Sbjct: 197 PECINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 85/205 (41%), Gaps = 22/205 (10%)
Query: 87  DKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT--QEFIDEVCFLASIQHRNL 138
           DK L G G FG V KG  Q         +  +K     P    E + E   +  + +  +
Sbjct: 374 DKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 432
Query: 139 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXXXX 197
           V ++G C+  +   L+ E    G ++ +L     V  + + E  H++S+           
Sbjct: 433 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES--- 488
Query: 198 XXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLASE 255
                  VH+D    NVL+     AK++D GL   L R D     +Q        + A E
Sbjct: 489 -----NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYAPE 542
Query: 256 VKEFRRFSEKSDVYSFGVFLLELVS 280
              + +FS KSDV+SFGV + E  S
Sbjct: 543 CINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 80/200 (40%), Gaps = 21/200 (10%)
Query: 91  IGEGKFGEVYKG-LLQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           IG+G F +V     +  G  VA+K     +   +  Q+   EV     + H N+V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
            +     +L+ EY   G V  +L    +   ++   K R  +                 +
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKF-------I 134
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRN---FLGRTDVAGPSSQVTADEIFLASEVKEFRR 261
           VH+D K  N+L+D D   K+AD G  N   F  + D    +    A E+F   +      
Sbjct: 135 VHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYD---- 190
Query: 262 FSEKSDVYSFGVFLLELVSG 281
              + DV+S GV L  LVSG
Sbjct: 191 -GPEVDVWSLGVILYTLVSG 209

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 85  FSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT--QEFIDEVCFLASIQHR 136
             DK L G G FG V KG  Q         +  +K     P    E + E   +  + + 
Sbjct: 373 LEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 431
Query: 137 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXX 195
            +V ++G C+  +   L+ E    G ++ +L     V  + + E  H++S+         
Sbjct: 432 YIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES- 489
Query: 196 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLA 253
                    VH+D    NVL+     AK++D GL   L R D     +Q        + A
Sbjct: 490 -------NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYA 541
Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVS 280
            E   + +FS KSDV+SFGV + E  S
Sbjct: 542 PECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 15/202 (7%)
Query: 85  FSDKNLIGEGKFGEVYKGLLQDGM-LVAIK----KRPGAPTQEFIDEVCFLASIQHRNLV 139
           F+  + IG+G FGEVYKG+      +VAIK    +      ++   E+  L+      + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 199
              G   ++   ++I EY+  GS ++ L  P  +    +    R  +             
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGS-ALDLLKPGPLEETYIATILREILKGLDYLHSE---- 135
Query: 200 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 259
              R +H+D K ANVL+ E    K+AD G+   L  TD     +       ++A EV + 
Sbjct: 136 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNXFVGTPFWMAPEVIKQ 190
Query: 260 RRFSEKSDVYSFGVFLLELVSG 281
             +  K+D++S G+  +EL  G
Sbjct: 191 SAYDFKADIWSLGITAIELAKG 212

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 22/207 (10%)
Query: 90  LIGEGKFGEVYKG-LLQDGMLVAIK--KRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYC 145
           L+G G +G+VYKG  ++ G L AIK     G   +E   E+  L     HRN+ T  G  
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 146 QENNLQ------FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 199
            + N        +L+ E+   GSV+  L   ++ +  K E+   +               
Sbjct: 91  IKKNPPGMDDQLWLVMEFCGAGSVT-DLIKNTKGNTLKEEWIAYIC----REILRGLSHL 145
Query: 200 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV--- 256
              +V+H+D K  NVL+ E+   K+ D G+   L RT   G  +       ++A EV   
Sbjct: 146 HQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIAC 203
Query: 257 --KEFRRFSEKSDVYSFGVFLLELVSG 281
                  +  KSD++S G+  +E+  G
Sbjct: 204 DENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/205 (21%), Positives = 81/205 (39%), Gaps = 17/205 (8%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ----------EFIDEVCFLASIQHRNLVT 140
           +G+G FG VY+G  +D +    + R    T           EF++E   +      ++V 
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLY-----GPSQVSRQKLEFKHRLSIXXXXXXXXX 195
           LLG   +     ++ E + +G +  +L        +   R     +  + +         
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 196 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 255
                  + VH+D    N +V  DF  K+ D G+   +  TD      +      ++A E
Sbjct: 144 YLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE 201
Query: 256 VKEFRRFSEKSDVYSFGVFLLELVS 280
             +   F+  SD++SFGV L E+ S
Sbjct: 202 SLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/205 (21%), Positives = 81/205 (39%), Gaps = 17/205 (8%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ----------EFIDEVCFLASIQHRNLVT 140
           +G+G FG VY+G  +D +    + R    T           EF++E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLY-----GPSQVSRQKLEFKHRLSIXXXXXXXXX 195
           LLG   +     ++ E + +G +  +L        +   R     +  + +         
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 196 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 255
                  + VH+D    N +V  DF  K+ D G+   +  TD      +      ++A E
Sbjct: 145 YLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE 202
Query: 256 VKEFRRFSEKSDVYSFGVFLLELVS 280
             +   F+  SD++SFGV L E+ S
Sbjct: 203 SLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 77  ELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE--VCFLASIQ 134
           E SL   N     LIG G++G VYKG L D   VA+K    A  Q FI+E  +  +  ++
Sbjct: 7   EPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLME 65
Query: 135 HRNLVTLL----GYCQENNLQF-LIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSIX 187
           H N+   +        +  +++ L+ EY PNGS+   + L+    VS  +L       + 
Sbjct: 66  HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGL- 124
Query: 188 XXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 247
                         P + H+D  + NVLV  D    ++D GL   L    +  P  +  A
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 248 --DEI----FLASEV-------KEFRRFSEKSDVYSFGVFLLEL 278
              E+    ++A EV       ++     ++ D+Y+ G+   E+
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 79/205 (38%), Gaps = 30/205 (14%)
Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 143
           +GEG +GEVYK +       VAIK+        G P    I EV  L  +QHRN++ L  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA-IREVSLLKELQHRNIIELKS 100
Query: 144 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPR 203
               N+   LI+EY  N         P    R    F ++L                  R
Sbjct: 101 VIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQL--------INGVNFCHSRR 152
Query: 204 VVHKDFKTANVLV-----DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 258
            +H+D K  N+L+      E  + K+ D GL    G      P  Q T + I L     E
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-----PIRQFTHEIITLWYRPPE 207
Query: 259 F----RRFSEKSDVYSFGVFLLELV 279
                R +S   D++S      E++
Sbjct: 208 ILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 90/204 (44%), Gaps = 21/204 (10%)
Query: 91  IGEGKFGEVYKGLL----QDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTL 141
           IGEG FG   K +L    +DG    IK     +      +E   EV  LA+++H N+V  
Sbjct: 32  IGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY 88
Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK-LEFKHRLSIXXXXXXXXXXXXXX 200
               +EN   +++ +Y   G +        +++ QK + F+    +              
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLF------KRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 201 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 260
             +++H+D K+ N+ + +D   ++ D G+   L  T     +        +L+ E+ E +
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--VELARACIGTPYYLSPEICENK 200
Query: 261 RFSEKSDVYSFGVFLLELVSGREA 284
            ++ KSD+++ G  L EL + + A
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHA 224

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 93/214 (43%), Gaps = 22/214 (10%)
Query: 81  ATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKK-----RPGAPTQEFIDEVCFLASIQ 134
           ++  F     +G G +  VYKGL +  G+ VA+K+       G P+   I E+  +  ++
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA-IREISLMKELK 61
Query: 135 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQ-VSRQKLEFKHRLSIXXXXXXX 193
           H N+V L       N   L++E++ N    +  Y  S+ V       +  L         
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDN---DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 194 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT-----AD 248
                    +++H+D K  N+L+++    K+ D GL    G   V   SS+V      A 
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG-IPVNTFSSEVVTLWYRAP 177
Query: 249 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
           ++ + S     R +S   D++S G  L E+++G+
Sbjct: 178 DVLMGS-----RTYSTSIDIWSCGCILAEMITGK 206

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 97/225 (43%), Gaps = 35/225 (15%)
Query: 84  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAPTQEFIDEVCFLASIQH----- 135
           +F +  ++G+G FG+V K     D    AIKK           + EV  LAS+ H     
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 136 --------RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIX 187
                   RN V  +   ++ +  F+  EY  N ++   L     +++Q+ E+  RL   
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTL-YDLIHSENLNQQRDEY-WRL--- 121
Query: 188 XXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT---------DV 238
                           ++H+D K  N+ +DE    K+ D GL   + R+         ++
Sbjct: 122 -FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 239 AGPSSQVTA---DEIFLASEVKEFR-RFSEKSDVYSFGVFLLELV 279
            G S  +T+     +++A+EV +    ++EK D+YS G+   E++
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 36/214 (16%)
Query: 83  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKR--PGAPTQEFI-DEVCFLASIQHRNL 138
           K ++    IG+G  G VY  + +  G  VAI++      P +E I +E+  +   ++ N+
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 139 VTLLGYCQENNLQFLIYEYIPNGS----VSIHLYGPSQVSR------QKLEFKHRLSIXX 188
           V  L      +  +++ EY+  GS    V+       Q++       Q LEF H      
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH------ 133
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR-TDVAGPSSQVTA 247
                         +V+H+D K+ N+L+  D   K+ D G   F  + T      S++  
Sbjct: 134 ------------SNQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSEMVG 178
Query: 248 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
              ++A EV   + +  K D++S G+  +E++ G
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 88/200 (44%), Gaps = 19/200 (9%)
Query: 91  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 145
           +GEG +GEV   +    ++ + V I   KR     +    E+     + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 146 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 263 -SEKSDVYSFGVFLLELVSG 281
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 94/222 (42%), Gaps = 31/222 (13%)
Query: 79  SLAT------KNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK------RPGAPTQEFID 125
           SLAT      ++F   NL+G+G F  VY+   +  G+ VAIK             Q   +
Sbjct: 1   SLATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN 60
Query: 126 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQ--VSRQKLEFKHR 183
           EV     ++H +++ L  Y +++N  +L+ E   NG ++ +L    +     +   F H+
Sbjct: 61  EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ 120
Query: 184 LSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 243
           +                   ++H+D   +N+L+  +   K+AD GL      T +  P  
Sbjct: 121 IITGMLYLHSHG--------ILHRDLTLSNLLLTRNMNIKIADFGL-----ATQLKMPHE 167
Query: 244 Q---VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
           +   +     +++ E+        +SDV+S G     L+ GR
Sbjct: 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 88/200 (44%), Gaps = 19/200 (9%)
Query: 91  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 145
           +GEG +GEV   +    ++ + V I   KR     +    E+     + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 146 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 263 -SEKSDVYSFGVFLLELVSG 281
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/205 (21%), Positives = 81/205 (39%), Gaps = 17/205 (8%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ----------EFIDEVCFLASIQHRNLVT 140
           +G+G FG VY+G  +D +    + R    T           EF++E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLY-----GPSQVSRQKLEFKHRLSIXXXXXXXXX 195
           LLG   +     ++ E + +G +  +L        +   R     +  + +         
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 196 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 255
                  + VH++    N +V  DF  K+ D G+   +  TD      +      ++A E
Sbjct: 145 YLNAK--KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE 202
Query: 256 VKEFRRFSEKSDVYSFGVFLLELVS 280
             +   F+  SD++SFGV L E+ S
Sbjct: 203 SLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/205 (21%), Positives = 81/205 (39%), Gaps = 17/205 (8%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ----------EFIDEVCFLASIQHRNLVT 140
           +G+G FG VY+G  +D +    + R    T           EF++E   +      ++V 
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLY-----GPSQVSRQKLEFKHRLSIXXXXXXXXX 195
           LLG   +     ++ E + +G +  +L        +   R     +  + +         
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 196 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 255
                  + VH++    N +V  DF  K+ D G+   +  TD      +      ++A E
Sbjct: 146 YLNAK--KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE 203
Query: 256 VKEFRRFSEKSDVYSFGVFLLELVS 280
             +   F+  SD++SFGV L E+ S
Sbjct: 204 SLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 15/202 (7%)
Query: 85  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLV 139
           F+    IG+G FGEV+KG+  +   +VAIK    +      ++   E+  L+      + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 199
              G   ++   ++I EY+  GS ++ L  P  +   ++    R  +             
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGPLDETQIATILREILKGLDYLHSE---- 123
Query: 200 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 259
              + +H+D K ANVL+ E    K+AD G+   L  TD     +       ++A EV + 
Sbjct: 124 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNXFVGTPFWMAPEVIKQ 178
Query: 260 RRFSEKSDVYSFGVFLLELVSG 281
             +  K+D++S G+  +EL  G
Sbjct: 179 SAYDSKADIWSLGITAIELARG 200

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 88/200 (44%), Gaps = 19/200 (9%)
Query: 91  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 145
           +GEG +GEV   +    ++ + V I   KR     +    E+     + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 146 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 125
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 262
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 184
Query: 263 -SEKSDVYSFGVFLLELVSG 281
            +E  DV+S G+ L  +++G
Sbjct: 185 HAEPVDVWSCGIVLTAMLAG 204

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 15/202 (7%)
Query: 85  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLV 139
           F+    IG+G FGEV+KG+  +   +VAIK    +      ++   E+  L+      + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 199
              G   ++   ++I EY+  GS ++ L  P  +   ++    R  +             
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGPLDETQIATILREILKGLDYLHSE---- 123
Query: 200 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 259
              + +H+D K ANVL+ E    K+AD G+   L  TD     +       ++A EV + 
Sbjct: 124 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQ 178
Query: 260 RRFSEKSDVYSFGVFLLELVSG 281
             +  K+D++S G+  +EL  G
Sbjct: 179 SAYDSKADIWSLGITAIELARG 200

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 120/295 (40%), Gaps = 47/295 (15%)
Query: 91  IGEGKFGEVYKGLLQD-----GMLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTL 141
           +GEG FG+V            G +VA+K  + G   Q    +  E+  L ++ H ++V  
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 142 LGYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXX 198
            G C+   E ++Q L+ EY+P GS+  +L        Q L F  ++              
Sbjct: 76  KGCCEDQGEKSVQ-LVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQIC--------EGMAY 126
Query: 199 XXXPRVVHKDFKTANVLVDEDFIAKVADAGLRN--------FLGRTDVAGPSSQVTADEI 250
                 +H+     NVL+D D + K+ D GL          +  R D   P         
Sbjct: 127 LHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV-------F 179
Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLL 310
           + A E  +  +F   SDV+SFGV L EL++  ++             EL+ +++    +L
Sbjct: 180 WYAPECLKECKFYYASDVWSFGVTLYELLTYCDS----NQSPHTKFTELIGHTQGQMTVL 235
Query: 311 KILD-----ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 360
           ++ +     ERL     +    E   L+  C +  +  RP+  ++V  L    +K
Sbjct: 236 RLTELLERGERL--PRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQEK 288

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 120/295 (40%), Gaps = 47/295 (15%)
Query: 91  IGEGKFGEVYKGLLQD-----GMLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTL 141
           +GEG FG+V            G +VA+K  + G   Q    +  E+  L ++ H ++V  
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 142 LGYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXX 198
            G C+   E ++Q L+ EY+P GS+  +L        Q L F  ++              
Sbjct: 77  KGCCEDQGEKSVQ-LVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQIC--------EGMAY 127
Query: 199 XXXPRVVHKDFKTANVLVDEDFIAKVADAGLRN--------FLGRTDVAGPSSQVTADEI 250
                 +H+     NVL+D D + K+ D GL          +  R D   P         
Sbjct: 128 LHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV-------F 180
Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLL 310
           + A E  +  +F   SDV+SFGV L EL++  ++             EL+ +++    +L
Sbjct: 181 WYAPECLKECKFYYASDVWSFGVTLYELLTYCDS----NQSPHTKFTELIGHTQGQMTVL 236
Query: 311 KILD-----ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 360
           ++ +     ERL     +    E   L+  C +  +  RP+  ++V  L    +K
Sbjct: 237 RLTELLERGERL--PRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQEK 289

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 92/234 (39%), Gaps = 38/234 (16%)
Query: 76  EELSLATKNFSDKNLIGEGKFGEVYKGLL-----QDGML-VAIKK-RPGAPTQE---FID 125
           E+      N      +G G FG+V +        +D +L VA+K  +  A   E    + 
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 98
Query: 126 EVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQV 173
           E+  ++ + QH N+V LLG C       +I EY   G +   L           Y PS  
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHN 158
Query: 174 SRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL---- 229
             ++L  +  L                    +H+D    NVL+    +AK+ D GL    
Sbjct: 159 PEEQLSSRDLLHFSSQVAQGMAFLASK--NCIHRDVAARNVLLTNGHVAKIGDFGLARDI 216
Query: 230 ---RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
               N++ + +   P   +  + IF          ++ +SDV+S+G+ L E+ S
Sbjct: 217 MNDSNYIVKGNARLPVKWMAPESIFDCV-------YTVQSDVWSYGILLWEIFS 263

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 15/202 (7%)
Query: 85  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLV 139
           F+    IG+G FGEV+KG+  +   +VAIK    +      ++   E+  L+      + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 199
              G   ++   ++I EY+  GS ++ L  P  +   ++    R  +             
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGPLDETQIATILREILKGLDYLHSE---- 138
Query: 200 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 259
              + +H+D K ANVL+ E    K+AD G+   L  TD     +       ++A EV + 
Sbjct: 139 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNXFVGTPFWMAPEVIKQ 193
Query: 260 RRFSEKSDVYSFGVFLLELVSG 281
             +  K+D++S G+  +EL  G
Sbjct: 194 SAYDSKADIWSLGITAIELARG 215

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 92/214 (42%), Gaps = 36/214 (16%)
Query: 83  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKR--PGAPTQEFI-DEVCFLASIQHRNL 138
           K ++    IG+G  G VY  + +  G  VAI++      P +E I +E+  +   ++ N+
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 139 VTLLGYCQENNLQFLIYEYIPNGS----VSIHLYGPSQVSR------QKLEFKHRLSIXX 188
           V  L      +  +++ EY+  GS    V+       Q++       Q LEF H      
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH------ 133
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR-TDVAGPSSQVTA 247
                         +V+H+D K+ N+L+  D   K+ D G   F  + T      S +  
Sbjct: 134 ------------SNQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSXMVG 178
Query: 248 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
              ++A EV   + +  K D++S G+  +E++ G
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 92/214 (42%), Gaps = 36/214 (16%)
Query: 83  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKR--PGAPTQEFI-DEVCFLASIQHRNL 138
           K ++    IG+G  G VY  + +  G  VAI++      P +E I +E+  +   ++ N+
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 80
Query: 139 VTLLGYCQENNLQFLIYEYIPNGS----VSIHLYGPSQVSR------QKLEFKHRLSIXX 188
           V  L      +  +++ EY+  GS    V+       Q++       Q LEF H      
Sbjct: 81  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH------ 134
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR-TDVAGPSSQVTA 247
                         +V+H+D K+ N+L+  D   K+ D G   F  + T      S +  
Sbjct: 135 ------------SNQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSXMVG 179
Query: 248 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
              ++A EV   + +  K D++S G+  +E++ G
Sbjct: 180 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 213

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 15/202 (7%)
Query: 85  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLV 139
           F+    IG+G FGEV+KG+  +   +VAIK    +      ++   E+  L+      + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 199
              G   ++   ++I EY+  GS ++ L  P  +   ++    R  +             
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGPLDETQIATILREILKGLDYLHSE---- 143
Query: 200 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 259
              + +H+D K ANVL+ E    K+AD G+   L  TD     +       ++A EV + 
Sbjct: 144 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQ 198
Query: 260 RRFSEKSDVYSFGVFLLELVSG 281
             +  K+D++S G+  +EL  G
Sbjct: 199 SAYDSKADIWSLGITAIELARG 220

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 92/214 (42%), Gaps = 36/214 (16%)
Query: 83  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKR--PGAPTQEFI-DEVCFLASIQHRNL 138
           K ++    IG+G  G VY  + +  G  VAI++      P +E I +E+  +   ++ N+
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 139 VTLLGYCQENNLQFLIYEYIPNGS----VSIHLYGPSQVSR------QKLEFKHRLSIXX 188
           V  L      +  +++ EY+  GS    V+       Q++       Q LEF H      
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH------ 133
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR-TDVAGPSSQVTA 247
                         +V+H+D K+ N+L+  D   K+ D G   F  + T      S +  
Sbjct: 134 ------------SNQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSTMVG 178
Query: 248 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
              ++A EV   + +  K D++S G+  +E++ G
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 49/223 (21%)
Query: 82  TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFID--------EVCFLAS 132
            K +   + +GEG+F  VYK   ++   +VAIKK       E  D        E+  L  
Sbjct: 9   AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 133 IQHRNLVTLL-GYCQENNLQFLIYEY--------IPNGSVSI---HLYGPSQVSRQKLEF 180
           + H N++ LL  +  ++N+  L++++        I + S+ +   H+     ++ Q LE+
Sbjct: 69  LSHPNIIGLLDAFGHKSNIS-LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEY 127
Query: 181 KHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 240
            H+  I                  +H+D K  N+L+DE+ + K+AD GL    G  + A 
Sbjct: 128 LHQHWI------------------LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 169
Query: 241 PSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELV 279
               VT    A E+   +     R +    D+++ G  L EL+
Sbjct: 170 XHQVVTRWYRAPELLFGA-----RMYGVGVDMWAVGCILAELL 207

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 112/289 (38%), Gaps = 37/289 (12%)
Query: 91  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASIQHR-NLV 139
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I H  N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 140 TLLGYCQENNLQFL-IYEYIPNGSVSIHL---------YGPSQVSRQKLEFKHRLSIXXX 189
            LLG C +     + I E+   G++S +L         Y P  + +  L  +H +     
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        + +H+D    N+L+ E  + K+ D GL   + +              
Sbjct: 157 VAKGMEFLASR--KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 214
Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 309
            ++A E    R ++ +SDV+SFGV L E+ S                   V+   +F   
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGVKIDEEFCRR 263
Query: 310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
           LK         +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 264 LKEGTRMRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 78/174 (44%), Gaps = 17/174 (9%)
Query: 115 RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ--FLIYEYIPNGSV-SIHLYGPS 171
           +P  P ++   E+  L  + H N+V L+    + N    ++++E +  G V  +    P 
Sbjct: 75  QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPL 134
Query: 172 QVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRN 231
              + +  F+  +                  +++H+D K +N+LV ED   K+AD G+ N
Sbjct: 135 SEDQARFYFQDLIK---------GIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 232 FLGRTDVAGPSSQVTADEIFLASE-VKEFRR-FSEKS-DVYSFGVFLLELVSGR 282
               +D     S       F+A E + E R+ FS K+ DV++ GV L   V G+
Sbjct: 186 EFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/205 (21%), Positives = 80/205 (39%), Gaps = 17/205 (8%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ----------EFIDEVCFLASIQHRNLVT 140
           +G+G FG VY+G  +D +    + R    T           EF++E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLY-----GPSQVSRQKLEFKHRLSIXXXXXXXXX 195
           LLG   +     ++ E + +G +  +L        +   R     +  + +         
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 196 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 255
                  + VH+D    N +V  DF  K+ D G+   +  T       +      ++A E
Sbjct: 145 YLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAPE 202
Query: 256 VKEFRRFSEKSDVYSFGVFLLELVS 280
             +   F+  SD++SFGV L E+ S
Sbjct: 203 SLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 23/206 (11%)
Query: 85  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLV 139
           F+    IG+G FGEV+KG+  +   +VAIK    +      ++   E+  L+      + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 140 TLLGYCQENNLQFLIYEYIPNGS-VSIHLYGPS---QVSRQKLEFKHRLSIXXXXXXXXX 195
              G   + +  ++I EY+  GS + +   GP    Q++    E    L           
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE----- 139
Query: 196 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 255
                  + +H+D K ANVL+ E    K+AD G+   L  TD     +       ++A E
Sbjct: 140 -------KKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPE 190
Query: 256 VKEFRRFSEKSDVYSFGVFLLELVSG 281
           V +   +  K+D++S G+  +EL  G
Sbjct: 191 VIQQSAYDSKADIWSLGITAIELAKG 216

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 25/203 (12%)
Query: 91  IGEGKFGEVYKGLLQDGMLVA------IKKRPGAPTQE---FIDEVCFLASIQHRNLVTL 141
           +G G +GEV   L +D +  A      IKK     T      +DEV  L  + H N++ L
Sbjct: 12  LGSGAYGEVL--LCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 69
Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX 201
             + ++    +L+ E    G +   +     + RQK  F    +                
Sbjct: 70  YEFFEDKRNYYLVMEVYRGGELFDEI-----ILRQK--FSEVDAAVIMKQVLSGTTYLHK 122
Query: 202 PRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 258
             +VH+D K  N+L++    D + K+ D GL       +V G   +      ++A EV  
Sbjct: 123 HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKMKERLGTAYYIAPEVLR 179
Query: 259 FRRFSEKSDVYSFGVFLLELVSG 281
            +++ EK DV+S GV L  L+ G
Sbjct: 180 -KKYDEKCDVWSCGVILYILLCG 201

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 71/297 (23%), Positives = 120/297 (40%), Gaps = 51/297 (17%)
Query: 91  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASIQHR-NLV 139
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I H  N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 140 TLLGYCQENNLQFL-IYEYIPNGSVSIHL------YGPSQVSRQKLEFKHRLS----IXX 188
            LLG C +     + I E+   G++S +L      + P +V+ + L +K  L+    I  
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL-YKDFLTLEHLICY 190
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAGP 241
                         + +H+D    N+L+ E  + K+ D GL        +++ + D   P
Sbjct: 191 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 250
Query: 242 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQ 301
              +  + IF        R ++ +SDV+SFGV L E+ S                   V+
Sbjct: 251 LKWMAPETIF-------DRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGVK 292
Query: 302 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
              +F   LK         +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 293 IDEEFCRRLKEGTRMRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 71/297 (23%), Positives = 120/297 (40%), Gaps = 51/297 (17%)
Query: 91  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASIQHR-NLV 139
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 140 TLLGYC-QENNLQFLIYEYIPNGSVSIHL------YGPSQVSRQKLEFKHRLS----IXX 188
            LLG C +      +I E+   G++S +L      + P +V+ + L +K  L+    I  
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDL-YKDFLTLEHLICY 144
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAGP 241
                         + +H+D    N+L+ E  + K+ D GL        +++ + D   P
Sbjct: 145 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 204
Query: 242 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQ 301
              +  + IF        R ++ +SDV+SFGV L E+ S                   V+
Sbjct: 205 LKWMAPETIF-------DRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGVK 246
Query: 302 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
              +F   LK         +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 247 IDEEFCRRLKEGTRMRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 300

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 25/203 (12%)
Query: 91  IGEGKFGEVYKGLLQDGMLVA------IKKRPGAPTQE---FIDEVCFLASIQHRNLVTL 141
           +G G +GEV   L +D +  A      IKK     T      +DEV  L  + H N++ L
Sbjct: 29  LGSGAYGEVL--LCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 86
Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX 201
             + ++    +L+ E    G +   +     + RQK  F    +                
Sbjct: 87  YEFFEDKRNYYLVMEVYRGGELFDEI-----ILRQK--FSEVDAAVIMKQVLSGTTYLHK 139
Query: 202 PRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 258
             +VH+D K  N+L++    D + K+ D GL       +V G   +      ++A EV  
Sbjct: 140 HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKMKERLGTAYYIAPEVLR 196
Query: 259 FRRFSEKSDVYSFGVFLLELVSG 281
            +++ EK DV+S GV L  L+ G
Sbjct: 197 -KKYDEKCDVWSCGVILYILLCG 218

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 71/297 (23%), Positives = 120/297 (40%), Gaps = 51/297 (17%)
Query: 91  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASIQHR-NLV 139
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 140 TLLGYC-QENNLQFLIYEYIPNGSVSIHL------YGPSQVSRQKLEFKHRLS----IXX 188
            LLG C +      +I E+   G++S +L      + P +V+ + L +K  L+    I  
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDL-YKDFLTLEHLICY 144
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAGP 241
                         + +H+D    N+L+ E  + K+ D GL        +++ + D   P
Sbjct: 145 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 204
Query: 242 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQ 301
              +  + IF        R ++ +SDV+SFGV L E+ S                   V+
Sbjct: 205 LKWMAPETIF-------DRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGVK 246
Query: 302 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
              +F   LK         +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 247 IDEEFCRRLKEGTRMRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 300

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/302 (20%), Positives = 111/302 (36%), Gaps = 50/302 (16%)
Query: 91  IGEGKFGEVYK----GLLQD--GMLVAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 139
           +G G FG+V +    GL++    M VA+K  +P A   E    + E+  L+ +  H N+V
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSIXX 188
            LLG C       +I EY   G +   L             P+ +   +L       +  
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNFLGRTDVAGP 241
                           +H+D    N+L+    I K+ D GL        N++ + +   P
Sbjct: 169 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 228
Query: 242 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQ 301
              +  + IF          ++ +SDV+S+G+FL EL S   +                 
Sbjct: 229 VKWMAPESIFNCV-------YTFESDVWSYGIFLWELFSLGSSPYPGMPVD--------- 272
Query: 302 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 361
                S   K++ E            E   ++  C D    +RP+   +V  +++ + + 
Sbjct: 273 -----SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 327
Query: 362 MN 363
            N
Sbjct: 328 TN 329

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 71/297 (23%), Positives = 120/297 (40%), Gaps = 51/297 (17%)
Query: 91  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASIQHR-NLV 139
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 140 TLLGYC-QENNLQFLIYEYIPNGSVSIHL------YGPSQVSRQKLEFKHRLS----IXX 188
            LLG C +      +I E+   G++S +L      + P +V+ + L +K  L+    I  
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL-YKDFLTLEHLICY 153
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAGP 241
                         + +H+D    N+L+ E  + K+ D GL        +++ + D   P
Sbjct: 154 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 213
Query: 242 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQ 301
              +  + IF        R ++ +SDV+SFGV L E+ S                   V+
Sbjct: 214 LKWMAPETIF-------DRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGVK 255
Query: 302 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
              +F   LK         +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 256 IDEEFCRRLKEGTRMRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/302 (20%), Positives = 111/302 (36%), Gaps = 50/302 (16%)
Query: 91  IGEGKFGEVYK----GLLQD--GMLVAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 139
           +G G FG+V +    GL++    M VA+K  +P A   E    + E+  L+ +  H N+V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSIXX 188
            LLG C       +I EY   G +   L             P+ +   +L       +  
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNFLGRTDVAGP 241
                           +H+D    N+L+    I K+ D GL        N++ + +   P
Sbjct: 167 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 226
Query: 242 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQ 301
              +  + IF          ++ +SDV+S+G+FL EL S   +                 
Sbjct: 227 VKWMAPESIFNCV-------YTFESDVWSYGIFLWELFSLGSSPYPGMPVD--------- 270
Query: 302 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 361
                S   K++ E            E   ++  C D    +RP+   +V  +++ + + 
Sbjct: 271 -----SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 325
Query: 362 MN 363
            N
Sbjct: 326 TN 327

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/302 (20%), Positives = 111/302 (36%), Gaps = 50/302 (16%)
Query: 91  IGEGKFGEVYK----GLLQD--GMLVAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 139
           +G G FG+V +    GL++    M VA+K  +P A   E    + E+  L+ +  H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSIXX 188
            LLG C       +I EY   G +   L             P+ +   +L       +  
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNFLGRTDVAGP 241
                           +H+D    N+L+    I K+ D GL        N++ + +   P
Sbjct: 151 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 210
Query: 242 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQ 301
              +  + IF          ++ +SDV+S+G+FL EL S   +                 
Sbjct: 211 VKWMAPESIFNCV-------YTFESDVWSYGIFLWELFSLGSSPYPGMPVD--------- 254
Query: 302 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 361
                S   K++ E            E   ++  C D    +RP+   +V  +++ + + 
Sbjct: 255 -----SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309
Query: 362 MN 363
            N
Sbjct: 310 TN 311

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 74/152 (48%), Gaps = 13/152 (8%)
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFLGR-TDVAGPSSQVT--ADEIFLASEVKE-FR 260
           +H+D K  N+L+ ED   ++AD G+  FL    D+     + T      ++A EV E  R
Sbjct: 138 IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVR 197
Query: 261 RFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL-LKILDERLWS 319
            +  K+D++SFG+  +EL +G  A            +  +QN  D  +L   + D+ +  
Sbjct: 198 GYDFKADIWSFGITAIELATG--AAPYHKYPPMKVLMLTLQN--DPPSLETGVQDKEMLK 253
Query: 320 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
            +     + F ++I  CL    E+RP+ ++++
Sbjct: 254 KYG----KSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/302 (20%), Positives = 111/302 (36%), Gaps = 50/302 (16%)
Query: 91  IGEGKFGEVYK----GLLQD--GMLVAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 139
           +G G FG+V +    GL++    M VA+K  +P A   E    + E+  L+ +  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSIXX 188
            LLG C       +I EY   G +   L             P+ +   +L       +  
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNFLGRTDVAGP 241
                           +H+D    N+L+    I K+ D GL        N++ + +   P
Sbjct: 174 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLP 233
Query: 242 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQ 301
              +  + IF          ++ +SDV+S+G+FL EL S   +                 
Sbjct: 234 VKWMAPESIFNCV-------YTFESDVWSYGIFLWELFSLGSSPYPGMPVD--------- 277
Query: 302 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 361
                S   K++ E            E   ++  C D    +RP+   +V  +++ + + 
Sbjct: 278 -----SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 332
Query: 362 MN 363
            N
Sbjct: 333 TN 334

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 92/214 (42%), Gaps = 36/214 (16%)
Query: 83  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKR--PGAPTQEFI-DEVCFLASIQHRNL 138
           K ++    IG+G  G VY  + +  G  VAI++      P +E I +E+  +   ++ N+
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 80
Query: 139 VTLLGYCQENNLQFLIYEYIPNGS----VSIHLYGPSQVSR------QKLEFKHRLSIXX 188
           V  L      +  +++ EY+  GS    V+       Q++       Q LEF H      
Sbjct: 81  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH------ 134
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR-TDVAGPSSQVTA 247
                         +V+H++ K+ N+L+  D   K+ D G   F  + T      S +  
Sbjct: 135 ------------SNQVIHRNIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSTMVG 179
Query: 248 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
              ++A EV   + +  K D++S G+  +E++ G
Sbjct: 180 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 213

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/302 (20%), Positives = 111/302 (36%), Gaps = 50/302 (16%)
Query: 91  IGEGKFGEVYK----GLLQD--GMLVAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 139
           +G G FG+V +    GL++    M VA+K  +P A   E    + E+  L+ +  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSIXX 188
            LLG C       +I EY   G +   L             P+ +   +L       +  
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNFLGRTDVAGP 241
                           +H+D    N+L+    I K+ D GL        N++ + +   P
Sbjct: 174 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 233
Query: 242 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQ 301
              +  + IF          ++ +SDV+S+G+FL EL S   +                 
Sbjct: 234 VKWMAPESIFNCV-------YTFESDVWSYGIFLWELFSLGSSPYPGMPVD--------- 277
Query: 302 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 361
                S   K++ E            E   ++  C D    +RP+   +V  +++ + + 
Sbjct: 278 -----SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 332
Query: 362 MN 363
            N
Sbjct: 333 TN 334

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 82/202 (40%), Gaps = 26/202 (12%)
Query: 91  IGEGKFGEVYKGLLQDG-MLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVTLL 142
           +G+GKFG VY    +    +VA+K       ++ G   Q    E+   A + H N++ L 
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQ-LRREIEIQAHLHHPNILRLY 89
Query: 143 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
            Y  +    +LI EY P G     LY   Q S     F  + +                 
Sbjct: 90  NYFYDRRRIYLILEYAPRGE----LYKELQKS---CTFDEQRTATIMEELADALMYCHGK 142
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS---SQVTADEIFLASEVKEF 259
           +V+H+D K  N+L+      K+AD G         V  PS     +     +L  E+ E 
Sbjct: 143 KVIHRDIKPENLLLGLKGELKIADFGW-------SVHAPSLRRKTMCGTLDYLPPEMIEG 195
Query: 260 RRFSEKSDVYSFGVFLLELVSG 281
           R  +EK D++  GV   EL+ G
Sbjct: 196 RMHNEKVDLWCIGVLCYELLVG 217

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 74/152 (48%), Gaps = 13/152 (8%)
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFLGR-TDVAGPSSQVT--ADEIFLASEVKE-FR 260
           +H+D K  N+L+ ED   ++AD G+  FL    D+     + T      ++A EV E  R
Sbjct: 143 IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVR 202
Query: 261 RFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL-LKILDERLWS 319
            +  K+D++SFG+  +EL +G  A            +  +QN  D  +L   + D+ +  
Sbjct: 203 GYDFKADIWSFGITAIELATG--AAPYHKYPPMKVLMLTLQN--DPPSLETGVQDKEMLK 258
Query: 320 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
            +     + F ++I  CL    E+RP+ ++++
Sbjct: 259 KYG----KSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 116/290 (40%), Gaps = 37/290 (12%)
Query: 91  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASIQHR-NLV 139
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 140 TLLGYC-QENNLQFLIYEYIPNGSVSIHL------YGPSQVSRQKLEFKHRLS----IXX 188
            LLG C +      +I E+   G++S +L      + P +V+ + L +K  L+    I  
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL-YKDFLTLEHLICY 144
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 248
                         + +H+D    N+L+ E  + K+ D GL   + +             
Sbjct: 145 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 204
Query: 249 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSN 308
             ++A E    R ++ +SDV+SFGV L E+ S                   V+   +F  
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGVKIDEEFCR 253
Query: 309 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
            LK         +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 254 RLKEGTRMRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 300

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 116/290 (40%), Gaps = 37/290 (12%)
Query: 91  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 139
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 140 TLLGYC-QENNLQFLIYEYIPNGSVSIHL------YGPSQVSRQKLEFKHRLS----IXX 188
            LLG C +      +I E+   G++S +L      + P +V+ + L +K  L+    I  
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL-YKDFLTLEHLICY 153
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 248
                         + +H+D    N+L+ E  + K+ D GL   + +             
Sbjct: 154 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 249 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSN 308
             ++A E    R ++ +SDV+SFGV L E+ S                   V+   +F  
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGVKIDEEFCR 262
Query: 309 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
            LK         +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 263 RLKEGTRMRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 116/290 (40%), Gaps = 37/290 (12%)
Query: 91  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASIQHR-NLV 139
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 140 TLLGYC-QENNLQFLIYEYIPNGSVSIHL------YGPSQVSRQKLEFKHRLS----IXX 188
            LLG C +      +I E+   G++S +L      + P +V+ + L +K  L+    I  
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDL-YKDFLTLEHLICY 144
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 248
                         + +H+D    N+L+ E  + K+ D GL   + +             
Sbjct: 145 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 204
Query: 249 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSN 308
             ++A E    R ++ +SDV+SFGV L E+ S                   V+   +F  
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGVKIDEEFCR 253
Query: 309 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
            LK         +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 254 RLKEGTRMRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 300

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 91/228 (39%), Gaps = 32/228 (14%)
Query: 76  EELSLATKNFSDKNLIGEGKFGEVYKGLL-----QDGML-VAIKK-RPGAPTQE---FID 125
           E+      N      +G G FG+V +        +D +L VA+K  +  A   E    + 
Sbjct: 31  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 90
Query: 126 EVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK-----LE 179
           E+  ++ + QH N+V LLG C       +I EY   G +   L   ++    K     LE
Sbjct: 91  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLE 150
Query: 180 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNF 232
            +  L                    +H+D    NVL+    +AK+ D GL        N+
Sbjct: 151 LRDLLHFSSQVAQGMAFLASK--NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 208
Query: 233 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
           + + +   P   +  + IF          ++ +SDV+S+G+ L E+ S
Sbjct: 209 IVKGNARLPVKWMAPESIFDCV-------YTVQSDVWSYGILLWEIFS 249

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 66/306 (21%), Positives = 123/306 (40%), Gaps = 55/306 (17%)
Query: 83  KNFSDKNLIGEGKFGEVYK----GLLQDG--MLVAIK----KRPGAPTQEFIDEVCFLAS 132
           +N     ++G G FG+V      G+ + G  + VA+K    K   +  +  + E+  +  
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 133 I-QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL------YGPSQV---SRQKLEFKH 182
           +  H N+V LLG C  +   +LI+EY   G +  +L      +   ++   ++++LE + 
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 183 RLSIXX-------XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL------ 229
            L++                         VH+D    NVLV    + K+ D GL      
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 230 -RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXX 288
             N++ R +   P   +  + +F          ++ KSDV+S+G+ L E+ S        
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGI-------YTIKSDVWSYGILLWEIFS-LGVNPYP 276
Query: 289 XXXXXXXXVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMS 348
                    +L+QN          +D+  ++T      EE   ++  C    S +RPS  
Sbjct: 277 GIPVDANFYKLIQNGFK-------MDQPFYAT------EEIYIIMQSCWAFDSRKRPSFP 323
Query: 349 DVVTEL 354
           ++ + L
Sbjct: 324 NLTSFL 329

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 115/288 (39%), Gaps = 40/288 (13%)
Query: 84  NFSDKNLIGEGKFGEVYKGLLQDGMLVA----IKKRPGAPTQEFIDEVCFLASIQHRNLV 139
           NF  K  + E   GE++KG  Q   +V     ++      +++F +E   L    H N++
Sbjct: 13  NFLTK--LNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 140 TLLGYCQENNLQF--LIYEYIPNGSVSIHLY-GPSQVSRQKLEFKHRLSIXXXXXXXXXX 196
            +LG CQ        LI  ++P GS+   L+ G + V  Q    K  L +          
Sbjct: 71  PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM----ARGMAF 126
Query: 197 XXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLR-NFLGRTDVAGPSSQVTADEIFLASE 255
                P +      + +V++DED  A+++ A ++ +F     +  P+    A E      
Sbjct: 127 LHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPA--WVAPEALQKKP 184
Query: 256 VKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL---LKI 312
               RR    +D++SF V L ELV+ RE                     D SN+   +K+
Sbjct: 185 EDTNRR---SADMWSFAVLLWELVT-REVPFA-----------------DLSNMEIGMKV 223
Query: 313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 360
             E L  T          +L+  C++    +RP    +V  L++  DK
Sbjct: 224 ALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 29/208 (13%)
Query: 94  GKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE--VCFLASIQHRNLVTLLGYCQE-NNL 150
           G+FG V+K  L +   VA+K  P    Q +  E  +     ++H NL+  +   +  +NL
Sbjct: 26  GRFGCVWKAQLMND-FVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGSNL 84
Query: 151 Q---FLIYEYIPNGSVSIHLYGP----------SQVSRQKLEFKHRLSIXXXXXXXXXXX 197
           +   +LI  +   GS++ +L G           ++   + L + H               
Sbjct: 85  EVELWLITAFHDKGSLTDYLKGNIITWNELCHVAETMSRGLSYLHE-------DVPWCRG 137
Query: 198 XXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK 257
               P + H+DFK+ NVL+  D  A +AD GL          G +        ++A EV 
Sbjct: 138 EGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVL 197
Query: 258 E----FRRFS-EKSDVYSFGVFLLELVS 280
           E    F+R +  + D+Y+ G+ L ELVS
Sbjct: 198 EGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 91/228 (39%), Gaps = 32/228 (14%)
Query: 76  EELSLATKNFSDKNLIGEGKFGEVYKGLL-----QDGML-VAIKK-RPGAPTQE---FID 125
           E+      N      +G G FG+V +        +D +L VA+K  +  A   E    + 
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 98
Query: 126 EVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK-----LE 179
           E+  ++ + QH N+V LLG C       +I EY   G +   L   ++    K     LE
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLE 158
Query: 180 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNF 232
            +  L                    +H+D    NVL+    +AK+ D GL        N+
Sbjct: 159 LRDLLHFSSQVAQGMAFLASK--NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 216
Query: 233 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
           + + +   P   +  + IF          ++ +SDV+S+G+ L E+ S
Sbjct: 217 IVKGNARLPVKWMAPESIFDCV-------YTVQSDVWSYGILLWEIFS 257

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 68/298 (22%), Positives = 115/298 (38%), Gaps = 53/298 (17%)
Query: 91  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASIQHR-NLV 139
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I H  N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 140 TLLGYCQENNLQFL-IYEYIPNGSVSIHLY-----------GPSQVSRQKLEFKHRLSIX 187
            LLG C +     + I E+   G++S +L             P  + +  L  +H +   
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 188 XXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAG 240
                          + +H+D    N+L+ E  + K+ D GL        +++ + D   
Sbjct: 157 FQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 214
Query: 241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELV 300
           P   +  + IF        R ++ +SDV+SFGV L E+ S                   V
Sbjct: 215 PLKWMAPETIF-------DRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGV 256
Query: 301 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
           +   +F   LK         +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 257 KIDEEFCRRLKEGTRMRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 311

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/204 (20%), Positives = 89/204 (43%), Gaps = 18/204 (8%)
Query: 79  SLATKNFSDKNLIGEGKFGEVYK-GLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRN 137
           +L T +F   +LI     G  Y   +L+  ++V +K+      +   DE   L+ + H  
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-----VEHTNDERLMLSIVTHPF 67
Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXX 197
           ++ + G  Q+    F+I +YI  G +   L       R+   F + ++            
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGELFSLL-------RKSQRFPNPVAKFYAAEVCLALE 120
Query: 198 XXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK 257
                 ++++D K  N+L+D++   K+ D G   +     V   +  +     ++A EV 
Sbjct: 121 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTYXLCGTPDYIAPEVV 175
Query: 258 EFRRFSEKSDVYSFGVFLLELVSG 281
             + +++  D +SFG+ + E+++G
Sbjct: 176 STKPYNKSIDWWSFGILIYEMLAG 199

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 87/215 (40%), Gaps = 21/215 (9%)
Query: 83  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 132
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 133 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 188
           + H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 91  LNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 148
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQV 245
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 149 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 206
Query: 246 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 207 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 117/294 (39%), Gaps = 45/294 (15%)
Query: 91  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASIQHR-NLV 139
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 140 TLLGYC-QENNLQFLIYEYIPNGSVSIHL------YGPSQVSRQKLEFKHRLS----IXX 188
            LLG C +      +I E+   G++S +L      + P +V+ + L +K  L+    I  
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL-YKDFLTLEHLICY 153
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 248
                         + +H+D    N+L+ E  + K+ D G    L R     P      D
Sbjct: 154 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG----LARDIYKDPDXVRKGD 209
Query: 249 E----IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSR 304
                 ++A E    R ++ +SDV+SFGV L E+ S                   V+   
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGVKIDE 258
Query: 305 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
           +F   LK         +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 259 EFCRRLKEGTRMRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/239 (23%), Positives = 93/239 (38%), Gaps = 41/239 (17%)
Query: 76  EELSLATKNFSDKNLIGEGKFGEVYKGLL-----QDGML-VAIKK-RPGAPTQE---FID 125
           E+      N      +G G FG+V +        +D +L VA+K  +  A   E    + 
Sbjct: 24  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 83
Query: 126 EVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSV-------SIHLYGPSQVSRQK 177
           E+  ++ + QH N+V LLG C       +I EY   G +       +  + GPS    Q 
Sbjct: 84  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQD 143
Query: 178 LE---------FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAG 228
            E          + R  +                  +H+D    NVL+    +AK+ D G
Sbjct: 144 PEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFG 203
Query: 229 L-------RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
           L        N++ + +   P   +  + IF          ++ +SDV+S+G+ L E+ S
Sbjct: 204 LARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-------YTVQSDVWSYGILLWEIFS 255

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 90/205 (43%), Gaps = 19/205 (9%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI--QHRNLVTLL-----G 143
           IG+G++GEV+ G  + G  VA+K         +  E     ++  +H N++  +     G
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKG 103
Query: 144 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPR 203
                 L +LI +Y  NGS+  +L   +  ++  L+  +                   P 
Sbjct: 104 TGSWTQL-YLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA 162
Query: 204 VVHKDFKTANVLVDEDFIAKVADAGLR-NFLGRT-DVAGPSSQVTADEIFLASEV----- 256
           + H+D K+ N+LV ++    +AD GL   F+  T +V  P +     + ++  EV     
Sbjct: 163 IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL 222
Query: 257 --KEFRRFSEKSDVYSFGVFLLELV 279
               F+ +   +D+YSFG+ L E+ 
Sbjct: 223 NRNHFQSYI-MADMYSFGLILWEVA 246

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 87/215 (40%), Gaps = 21/215 (9%)
Query: 83  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 132
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 104
Query: 133 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 188
           + H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 105 LNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 162
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQV 245
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 163 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 220
Query: 246 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 221 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/216 (21%), Positives = 92/216 (42%), Gaps = 21/216 (9%)
Query: 77  ELSLATKNFSDKNLIGEGKFGEVY----KGLLQDGMLVAIKKRPGAPTQE----FIDEVC 128
           ++ L  ++F    ++G+G FG+V+    K   Q   + A+KK       +     +++  
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 129 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXX 188
              + +H  L  +    Q     F + EY+  G +  H+    +    +  F     I  
Sbjct: 72  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG 131
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL--RNFLGRTDVAGPSSQVT 246
                          +V++D K  N+L+D+D   K+AD G+   N LG       +++  
Sbjct: 132 LQFLHSKG-------IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG----DAKTNEFC 180
Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
               ++A E+   ++++   D +SFGV L E++ G+
Sbjct: 181 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI--QHRNLVTLLGYCQEN 148
           IG+G+FGEV++G  + G  VA+K       + +  E     ++  +H N++  +    ++
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 108
Query: 149 NLQF----LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
           N  +    L+ +Y  +GS+  +L   +      ++     +                P +
Sbjct: 109 NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 168
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLR----NFLGRTDVAGPSSQVTADEIFLASEV---- 256
            H+D K+ N+LV ++    +AD GL     +     D+A P+ +V     ++A EV    
Sbjct: 169 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA-PNHRVGTKR-YMAPEVLDDS 226
Query: 257 ---KEFRRFSEKSDVYSFGVFLLELV 279
              K F  F +++D+Y+ G+   E+ 
Sbjct: 227 INMKHFESF-KRADIYAMGLVFWEIA 251

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 92/218 (42%), Gaps = 25/218 (11%)
Query: 77  ELSLATKNFSDKNLIGEGKFGEVY----KGLLQDGMLVAIKKRPGAPTQE----FIDEVC 128
           ++ L  ++F    ++G+G FG+V+    K   Q   + A+KK       +     +++  
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 129 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXX 188
              + +H  L  +    Q     F + EY+  G +  H+    +    +  F     I  
Sbjct: 71  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG 130
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL--RNFLG--RTDVAGPSSQ 244
                          +V++D K  N+L+D+D   K+AD G+   N LG  +T+    +  
Sbjct: 131 LQFLHSKG-------IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPD 183
Query: 245 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
             A EI L       ++++   D +SFGV L E++ G+
Sbjct: 184 YIAPEILLG------QKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI--QHRNLVTLLGYCQEN 148
           IG+G+FGEV++G  + G  VA+K       + +  E     ++  +H N++  +    ++
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 95
Query: 149 NLQF----LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
           N  +    L+ +Y  +GS+  +L   +      ++     +                P +
Sbjct: 96  NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 155
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLR----NFLGRTDVAGPSSQVTADEIFLASEV---- 256
            H+D K+ N+LV ++    +AD GL     +     D+A P+ +V     ++A EV    
Sbjct: 156 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA-PNHRVGTKR-YMAPEVLDDS 213
Query: 257 ---KEFRRFSEKSDVYSFGVFLLELV 279
              K F  F +++D+Y+ G+   E+ 
Sbjct: 214 INMKHFESF-KRADIYAMGLVFWEIA 238

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 83  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 132
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 133 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 188
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 91  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 148
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQV 245
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 149 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCA 206
Query: 246 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 207 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/230 (23%), Positives = 90/230 (39%), Gaps = 32/230 (13%)
Query: 76  EELSLATKNFSDKNLIGEGKFGEVYKGLL-----QDGML-VAIKK-RPGAPTQE---FID 125
           E+      N      +G G FG+V +        +D +L VA+K  +  A   E    + 
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 98
Query: 126 EVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF---- 180
           E+  ++ + QH N+V LLG C       +I EY   G +   L   S+V      F    
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 181 ---KHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-------R 230
                R  +                  +H+D    NVL+    +AK+ D GL        
Sbjct: 159 STLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 231 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
           N++ + +   P   +  + IF          ++ +SDV+S+G+ L E+ S
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCV-------YTVQSDVWSYGILLWEIFS 261

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI--QHRNLVTLLGYCQEN 148
           IG+G+FGEV++G  + G  VA+K       + +  E     ++  +H N++  +    ++
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 70
Query: 149 NLQF----LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
           N  +    L+ +Y  +GS+  +L   +      ++     +                P +
Sbjct: 71  NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 130
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLR----NFLGRTDVAGPSSQVTADEIFLASEV---- 256
            H+D K+ N+LV ++    +AD GL     +     D+A P+ +V     ++A EV    
Sbjct: 131 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA-PNHRVGTKR-YMAPEVLDDS 188
Query: 257 ---KEFRRFSEKSDVYSFGVFLLELV 279
              K F  F +++D+Y+ G+   E+ 
Sbjct: 189 INMKHFESF-KRADIYAMGLVFWEIA 213

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 80/201 (39%), Gaps = 23/201 (11%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           IGEG +G VYK     G   A+KK        G P+   I E+  L  ++H N+V L   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT-IREISILKELKHSNIVKLYDV 68
Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
                   L++E++      +       V    LE     S                 RV
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKL-----LDVCEGGLESVTAKSFLLQLLNGIAYCHDR--RV 121
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF----R 260
           +H+D K  N+L++ +   K+AD GL    G      P  + T + + L     +     +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGI-----PVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 261 RFSEKSDVYSFGVFLLELVSG 281
           ++S   D++S G    E+V+G
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNG 197

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 83  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 132
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 133 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 188
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 91  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 148
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQV 245
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 149 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 206
Query: 246 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 207 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 111/290 (38%), Gaps = 38/290 (13%)
Query: 91  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 139
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I  H N+V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 140 TLLGYC-QENNLQFLIYEYIPNGSVSIHLYG----------PSQVSRQKLEFKHRLSIXX 188
            LLG C +      +I E+   G++S +L            P  + +  L  +H +    
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 248
                         + +H+D    N+L+ E  + K+ D GL   + +             
Sbjct: 156 QVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 249 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSN 308
             ++A E    R ++ +SDV+SFGV L E+ S                   V+   +F  
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGVKIDEEFCR 262
Query: 309 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
            LK         +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 263 RLKEGTRMRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI--QHRNLVTLLGYCQEN 148
           IG+G+FGEV++G  + G  VA+K       + +  E     ++  +H N++  +    ++
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 72
Query: 149 NLQF----LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
           N  +    L+ +Y  +GS+  +L   +      ++     +                P +
Sbjct: 73  NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 132
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLR----NFLGRTDVAGPSSQVTADEIFLASEV---- 256
            H+D K+ N+LV ++    +AD GL     +     D+A P+ +V     ++A EV    
Sbjct: 133 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA-PNHRVGTKR-YMAPEVLDDS 190
Query: 257 ---KEFRRFSEKSDVYSFGVFLLELV 279
              K F  F +++D+Y+ G+   E+ 
Sbjct: 191 INMKHFESF-KRADIYAMGLVFWEIA 215

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/230 (23%), Positives = 90/230 (39%), Gaps = 32/230 (13%)
Query: 76  EELSLATKNFSDKNLIGEGKFGEVYKGLL-----QDGML-VAIKK-RPGAPTQE---FID 125
           E+      N      +G G FG+V +        +D +L VA+K  +  A   E    + 
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 98
Query: 126 EVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF---- 180
           E+  ++ + QH N+V LLG C       +I EY   G +   L   S+V      F    
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 181 ---KHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-------R 230
                R  +                  +H+D    NVL+    +AK+ D GL        
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 231 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
           N++ + +   P   +  + IF          ++ +SDV+S+G+ L E+ S
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCV-------YTVQSDVWSYGILLWEIFS 261

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 83  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 132
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 37  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 96
Query: 133 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 188
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 97  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 154
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQV 245
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 155 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 212
Query: 246 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 213 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 83  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 132
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 22  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 81
Query: 133 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 188
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 82  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 139
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQV 245
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 140 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 197
Query: 246 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 198 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 83  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 132
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 133 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 188
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 147
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQV 245
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 148 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 205
Query: 246 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI--QHRNLVTLLGYCQEN 148
           IG+G+FGEV++G  + G  VA+K       + +  E     ++  +H N++  +    ++
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 69
Query: 149 NLQF----LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
           N  +    L+ +Y  +GS+  +L   +      ++     +                P +
Sbjct: 70  NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 129
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLR----NFLGRTDVAGPSSQVTADEIFLASEV---- 256
            H+D K+ N+LV ++    +AD GL     +     D+A P+ +V     ++A EV    
Sbjct: 130 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA-PNHRVGTKR-YMAPEVLDDS 187
Query: 257 ---KEFRRFSEKSDVYSFGVFLLELV 279
              K F  F +++D+Y+ G+   E+ 
Sbjct: 188 INMKHFESF-KRADIYAMGLVFWEIA 212

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 80/201 (39%), Gaps = 23/201 (11%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           IGEG +G VYK     G   A+KK        G P+   I E+  L  ++H N+V L   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT-IREISILKELKHSNIVKLYDV 68
Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
                   L++E++      +       V    LE     S                 RV
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKL-----LDVCEGGLESVTAKSFLLQLLNGIAYCHDR--RV 121
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF----R 260
           +H+D K  N+L++ +   K+AD GL    G      P  + T + + L     +     +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGI-----PVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 261 RFSEKSDVYSFGVFLLELVSG 281
           ++S   D++S G    E+V+G
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNG 197

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI--QHRNLVTLLGYCQEN 148
           IG+G+FGEV++G  + G  VA+K       + +  E     ++  +H N++  +    ++
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 75
Query: 149 NLQF----LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
           N  +    L+ +Y  +GS+  +L   +      ++     +                P +
Sbjct: 76  NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 135
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLR----NFLGRTDVAGPSSQVTADEIFLASEV---- 256
            H+D K+ N+LV ++    +AD GL     +     D+A P+ +V     ++A EV    
Sbjct: 136 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA-PNHRVGTKR-YMAPEVLDDS 193
Query: 257 ---KEFRRFSEKSDVYSFGVFLLELV 279
              K F  F +++D+Y+ G+   E+ 
Sbjct: 194 INMKHFESF-KRADIYAMGLVFWEIA 218

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 83  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 132
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 47  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 106
Query: 133 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 188
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 107 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 164
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQV 245
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 165 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 222
Query: 246 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 223 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 80/201 (39%), Gaps = 23/201 (11%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           IGEG +G VYK     G   A+KK        G P+   I E+  L  ++H N+V L   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT-IREISILKELKHSNIVKLYDV 68
Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
                   L++E++      +       V    LE     S                 RV
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKL-----LDVCEGGLESVTAKSFLLQLLNGIAYCHDR--RV 121
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----ADEIFLASEVKEFR 260
           +H+D K  N+L++ +   K+AD GL    G          VT    A ++ + S     +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS-----K 176
Query: 261 RFSEKSDVYSFGVFLLELVSG 281
           ++S   D++S G    E+V+G
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNG 197

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 83  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 132
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 104
Query: 133 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 188
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 105 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 162
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQV 245
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 163 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 220
Query: 246 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 221 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 83  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 132
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 133 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 188
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 147
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQV 245
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 148 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 205
Query: 246 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 83  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 132
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 133 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 188
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 188
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQV 245
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 189 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCA 246
Query: 246 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 83  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 132
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 48  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 107
Query: 133 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 188
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 108 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 165
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQV 245
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 166 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCA 223
Query: 246 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 224 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 83  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 132
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 57  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 116
Query: 133 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 188
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 117 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 174
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQV 245
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 175 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 232
Query: 246 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 233 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 22/203 (10%)
Query: 91  IGEGKFGEVYKGLLQ----DGMLVAIKK-RPGAPTQ-----EFIDEVCFLASIQHRNLVT 140
           +G+G FG V +G         + VA+K  +P   +Q     +FI EV  + S+ HRNL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 200
           L G      ++ ++ E  P GS+        ++ + +  F                    
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLL------DRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 201 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAGPSSQVTADEIFLASEVK 257
             R +H+D    N+L+    + K+ D GL   L + D   V     +V     + A E  
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPF--AWCAPESL 186
Query: 258 EFRRFSEKSDVYSFGVFLLELVS 280
           + R FS  SD + FGV L E+ +
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 22/203 (10%)
Query: 91  IGEGKFGEVYKGLLQ----DGMLVAIKK-RPGAPTQ-----EFIDEVCFLASIQHRNLVT 140
           +G+G FG V +G         + VA+K  +P   +Q     +FI EV  + S+ HRNL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 200
           L G      ++ ++ E  P GS+        ++ + +  F                    
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLL------DRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 201 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAGPSSQVTADEIFLASEVK 257
             R +H+D    N+L+    + K+ D GL   L + D   V     +V     + A E  
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF--AWCAPESL 186
Query: 258 EFRRFSEKSDVYSFGVFLLELVS 280
           + R FS  SD + FGV L E+ +
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 22/203 (10%)
Query: 91  IGEGKFGEVYKGLLQ----DGMLVAIKK-RPGAPTQ-----EFIDEVCFLASIQHRNLVT 140
           +G+G FG V +G         + VA+K  +P   +Q     +FI EV  + S+ HRNL+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 200
           L G      ++ ++ E  P GS+        ++ + +  F                    
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLL------DRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 132
Query: 201 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAGPSSQVTADEIFLASEVK 257
             R +H+D    N+L+    + K+ D GL   L + D   V     +V     + A E  
Sbjct: 133 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF--AWCAPESL 190
Query: 258 EFRRFSEKSDVYSFGVFLLELVS 280
           + R FS  SD + FGV L E+ +
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 22/203 (10%)
Query: 91  IGEGKFGEVYKGLLQ----DGMLVAIKK-RPGAPTQ-----EFIDEVCFLASIQHRNLVT 140
           +G+G FG V +G         + VA+K  +P   +Q     +FI EV  + S+ HRNL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 200
           L G      ++ ++ E  P GS+        ++ + +  F                    
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLL------DRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 201 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAGPSSQVTADEIFLASEVK 257
             R +H+D    N+L+    + K+ D GL   L + D   V     +V     + A E  
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF--AWCAPESL 186
Query: 258 EFRRFSEKSDVYSFGVFLLELVS 280
           + R FS  SD + FGV L E+ +
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFT 209

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 86/219 (39%), Gaps = 26/219 (11%)
Query: 74  QMEELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK-------KRPGAPTQEFID 125
           +M +      +F     +G+GKFG VY     Q+  ++A+K       ++ G   Q    
Sbjct: 6   EMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRR 64
Query: 126 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 185
           E+   + ++H N++ +  Y  +    +L+ E+ P G +   L    +   Q+       S
Sbjct: 65  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQR-------S 117
Query: 186 IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS--- 242
                            +V+H+D K  N+L+      K+AD G         V  PS   
Sbjct: 118 ATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGW-------SVHAPSLRR 170
Query: 243 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
             +     +L  E+ E +   EK D++  GV   E + G
Sbjct: 171 RXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 83  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 132
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISK 104
Query: 133 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 188
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 105 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 162
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQV 245
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 163 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 220
Query: 246 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 221 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 22/203 (10%)
Query: 91  IGEGKFGEVYKGLLQ----DGMLVAIK-KRPGAPTQ-----EFIDEVCFLASIQHRNLVT 140
           +G+G FG V +G         + VA+K  +P   +Q     +FI EV  + S+ HRNL+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 200
           L G      ++ ++ E  P GS+        ++ + +  F                    
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLL------DRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 132
Query: 201 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAGPSSQVTADEIFLASEVK 257
             R +H+D    N+L+    + K+ D GL   L + D   V     +V     + A E  
Sbjct: 133 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF--AWCAPESL 190
Query: 258 EFRRFSEKSDVYSFGVFLLELVS 280
           + R FS  SD + FGV L E+ +
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMFT 213

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 88/220 (40%), Gaps = 44/220 (20%)
Query: 83  KNFSDKNLIGEGKFGEVYKGLLQD---GMLVAIKKRPGAPTQ----EFIDEVCFLASIQH 135
           K F  K  +G G F EV   L ++   G L A+K  P    +       +E+  L  I+H
Sbjct: 22  KIFEFKETLGTGAFSEVV--LAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKH 79
Query: 136 RNLVTLLGYCQENNLQFLIYEYIPNGS-----VSIHLYGPSQVS---RQKLE---FKHRL 184
            N+V L    +  N  +L+ + +  G      V    Y     S   RQ L+   + HR+
Sbjct: 80  ENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRM 139
Query: 185 SIXXXXXXXXXXXXXXXPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGP 241
            I                  VH+D K  N+L    DE+    ++D GL    G+ DV   
Sbjct: 140 GI------------------VHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMST 181
Query: 242 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
           +        ++A EV   + +S+  D +S GV    L+ G
Sbjct: 182 ACGTPG---YVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 22/203 (10%)
Query: 91  IGEGKFGEVYKGLLQ----DGMLVAIKK-RPGAPTQ-----EFIDEVCFLASIQHRNLVT 140
           +G+G FG V +G         + VA+K  +P   +Q     +FI EV  + S+ HRNL+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 200
           L G      ++ ++ E  P GS+        ++ + +  F                    
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLL------DRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 138
Query: 201 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAGPSSQVTADEIFLASEVK 257
             R +H+D    N+L+    + K+ D GL   L + D   V     +V     + A E  
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF--AWCAPESL 196
Query: 258 EFRRFSEKSDVYSFGVFLLELVS 280
           + R FS  SD + FGV L E+ +
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFT 219

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 22/203 (10%)
Query: 91  IGEGKFGEVYKGLLQ----DGMLVAIKK-RPGAPTQ-----EFIDEVCFLASIQHRNLVT 140
           +G+G FG V +G         + VA+K  +P   +Q     +FI EV  + S+ HRNL+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 200
           L G      ++ ++ E  P GS+        ++ + +  F                    
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLL------DRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 138
Query: 201 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAGPSSQVTADEIFLASEVK 257
             R +H+D    N+L+    + K+ D GL   L + D   V     +V     + A E  
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPF--AWCAPESL 196
Query: 258 EFRRFSEKSDVYSFGVFLLELVS 280
           + R FS  SD + FGV L E+ +
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 86/219 (39%), Gaps = 26/219 (11%)
Query: 74  QMEELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK-------KRPGAPTQEFID 125
           +M +      +F     +G+GKFG VY     Q+  ++A+K       ++ G   Q    
Sbjct: 5   EMPKRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRR 63
Query: 126 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 185
           E+   + ++H N++ +  Y  +    +L+ E+ P G +   L    +   Q+       S
Sbjct: 64  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQR-------S 116
Query: 186 IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS--- 242
                            +V+H+D K  N+L+      K+AD G         V  PS   
Sbjct: 117 ATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGW-------SVHAPSLRR 169
Query: 243 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
             +     +L  E+ E +   EK D++  GV   E + G
Sbjct: 170 RXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 83/201 (41%), Gaps = 14/201 (6%)
Query: 91  IGEGKFGEVYKGLLQ-DGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           IG G +G   K   + DG ++  K+        A  Q  + EV  L  ++H N+V     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 145 C--QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
              + N   +++ EY   G ++  +   ++  RQ L+ +  L +                
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 203 ---RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 259
               V+H+D K ANV +D     K+ D GL   L   +    + +      +++ E    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDF--AKEFVGTPYYMSPEQMNR 190
Query: 260 RRFSEKSDVYSFGVFLLELVS 280
             ++EKSD++S G  L EL +
Sbjct: 191 MSYNEKSDIWSLGCLLYELCA 211

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/159 (23%), Positives = 67/159 (42%), Gaps = 28/159 (17%)
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAGPSSQVTADEIFLASE 255
           + +H+D    N+L+ E+ + K+ D GL        +++ + D   P   +  + IF    
Sbjct: 219 KCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIF---- 274
Query: 256 VKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDE 315
               + +S KSDV+S+GV L E+ S                   VQ   DF + L+   E
Sbjct: 275 ---DKIYSTKSDVWSYGVLLWEIFS-----------LGGSPYPGVQMDEDFCSRLR---E 317
Query: 316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
            +          E  Q+++ C     + RP  +++V +L
Sbjct: 318 GMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 68/294 (23%), Positives = 117/294 (39%), Gaps = 49/294 (16%)
Query: 91  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 139
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 140 TLLGYC-QENNLQFLIYEYIPNGSVSIHL------YGPSQ-VSRQKLEFKHRLSIXXXXX 191
            LLG C +      +I E+   G++S +L      + P + + +  L  +H +       
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 192 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAGPSSQ 244
                      + +H+D    N+L+ E  + K+ D GL        +++ + D   P   
Sbjct: 155 KGMEFLASR--KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 212
Query: 245 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSR 304
           +  + IF        R ++ +SDV+SFGV L E+ S                   V+   
Sbjct: 213 MAPETIF-------DRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGVKIDE 254
Query: 305 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
           +F   LK         +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 255 EFCRRLKEGTRMRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 305

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 81/206 (39%), Gaps = 32/206 (15%)
Query: 91  IGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFID-----EVCFLASIQHRNLVTLLGY 144
           IGEG +G V+K   +D G +VAIKK   +     I      E+  L  ++H NLV LL  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
            +      L++EY  +  +        ++ R +      L                    
Sbjct: 71  FRRKRRLHLVFEYCDHTVL-------HELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC 123
Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR---- 260
           +H+D K  N+L+ +  + K+ D G    L      GPS     DE+      + +R    
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLL-----TGPSDYYD-DEV----ATRWYRSPEL 173
Query: 261 -----RFSEKSDVYSFGVFLLELVSG 281
                ++    DV++ G    EL+SG
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/273 (21%), Positives = 109/273 (39%), Gaps = 37/273 (13%)
Query: 31  YRNRSVSRTS---ETGSSEPSVQRNICIIAGRNVGIELSIREARRFQMEELSLATKNFSD 87
           + N SV+R++         P+  R    +  +  G     RE +R   E+   A +   D
Sbjct: 86  FENMSVTRSNSLRRDSPPPPARARQENGMPEKPPGPRSPQREPQRVSHEQFRAALQLVVD 145
Query: 88  KN----------LIGEGKFGEVYKGLLQD-GMLVAIKK---RPGAPTQEFIDEVCFLASI 133
                        IGEG  G V    ++  G LVA+KK   R     +   +EV  +   
Sbjct: 146 PGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 205
Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGS----VSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           QH N+V +       +  +++ E++  G+    V+       Q++   L     LS+   
Sbjct: 206 QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHA 265
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ-VTAD 248
                         V+H+D K+ ++L+  D   K++D G   F  +     P  + +   
Sbjct: 266 QG------------VIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGT 310
Query: 249 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
             ++A E+     +  + D++S G+ ++E+V G
Sbjct: 311 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 343

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 18/218 (8%)
Query: 75  MEELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT------QEFIDEV 127
           +E   +    F D  ++G G FGEV+   ++  G L A KK            Q  + E 
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 128 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS-VSIHLYGPSQVSRQKLEFKHRLSI 186
             LA +  R +V+L  Y  E      +   I NG  +  H+Y    V      F+   +I
Sbjct: 237 KILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIY---NVDEDNPGFQEPRAI 292
Query: 187 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL--GRTDVAGPSSQ 244
                            ++++D K  NVL+D+D   +++D GL   L  G+T   G    
Sbjct: 293 FYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG---- 348
Query: 245 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                 F+A E+     +    D ++ GV L E+++ R
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 28/216 (12%)
Query: 82  TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEF----IDEVCFLASIQHR 136
           + +F  K+L+GEG +G V     +  G +VAIKK        F    + E+  L   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 137 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXX 196
           N++T+    + ++ +     YI    +   L+    +S Q L   H              
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLH--RVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 197 XXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT--DVAGPSSQVT-------- 246
                  V+H+D K +N+L++ +   KV D GL   +  +  D + P+ Q +        
Sbjct: 128 LHGS--NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVAT 185
Query: 247 ----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLEL 278
               A E+ L S      ++S   DV+S G  L EL
Sbjct: 186 RWYRAPEVMLTSA-----KYSRAMDVWSCGCILAEL 216

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 18/218 (8%)
Query: 75  MEELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT------QEFIDEV 127
           +E   +    F D  ++G G FGEV+   ++  G L A KK            Q  + E 
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 128 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS-VSIHLYGPSQVSRQKLEFKHRLSI 186
             LA +  R +V+L  Y  E      +   I NG  +  H+Y    V      F+   +I
Sbjct: 237 KILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIY---NVDEDNPGFQEPRAI 292
Query: 187 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL--GRTDVAGPSSQ 244
                            ++++D K  NVL+D+D   +++D GL   L  G+T   G    
Sbjct: 293 FYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG---- 348
Query: 245 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                 F+A E+     +    D ++ GV L E+++ R
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 18/218 (8%)
Query: 75  MEELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT------QEFIDEV 127
           +E   +    F D  ++G G FGEV+   ++  G L A KK            Q  + E 
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 128 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS-VSIHLYGPSQVSRQKLEFKHRLSI 186
             LA +  R +V+L  Y  E      +   I NG  +  H+Y    V      F+   +I
Sbjct: 237 KILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIY---NVDEDNPGFQEPRAI 292
Query: 187 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL--GRTDVAGPSSQ 244
                            ++++D K  NVL+D+D   +++D GL   L  G+T   G    
Sbjct: 293 FYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG---- 348
Query: 245 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                 F+A E+     +    D ++ GV L E+++ R
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 28/216 (12%)
Query: 82  TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEF----IDEVCFLASIQHR 136
           + +F  K+L+GEG +G V     +  G +VAIKK        F    + E+  L   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 137 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXX 196
           N++T+    + ++ +     YI    +   L+    +S Q L   H              
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLH--RVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 197 XXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT--DVAGPSSQVT-------- 246
                  V+H+D K +N+L++ +   KV D GL   +  +  D + P+ Q +        
Sbjct: 128 LHGS--NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVAT 185
Query: 247 ----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLEL 278
               A E+ L S      ++S   DV+S G  L EL
Sbjct: 186 RWYRAPEVMLTSA-----KYSRAMDVWSCGCILAEL 216

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 18/218 (8%)
Query: 75  MEELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT------QEFIDEV 127
           +E   +    F D  ++G G FGEV+   ++  G L A KK            Q  + E 
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 128 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS-VSIHLYGPSQVSRQKLEFKHRLSI 186
             LA +  R +V+L  Y  E      +   I NG  +  H+Y    V      F+   +I
Sbjct: 237 KILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIY---NVDEDNPGFQEPRAI 292
Query: 187 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL--GRTDVAGPSSQ 244
                            ++++D K  NVL+D+D   +++D GL   L  G+T   G    
Sbjct: 293 FYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG---- 348
Query: 245 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                 F+A E+     +    D ++ GV L E+++ R
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 92/223 (41%), Gaps = 51/223 (22%)
Query: 88  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPT--QEFIDEVCFLASIQHRNLVTL- 141
           K  +G G FG V + + QD G  VAIK  ++  +P   + +  E+  +  + H N+V+  
Sbjct: 19  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 142 -----LGYCQENNLQFLIYEYIPNGSVSIHLY----------GP-----SQVSRQKLEFK 181
                L     N+L  L  EY   G +  +L           GP     S +S   L + 
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS-SALRYL 137
Query: 182 HRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTDV 238
           H                    R++H+D K  N+++    +  I K+ D G    L + ++
Sbjct: 138 HE------------------NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179
Query: 239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
               ++      +LA E+ E ++++   D +SFG    E ++G
Sbjct: 180 C---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 92/223 (41%), Gaps = 51/223 (22%)
Query: 88  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPT--QEFIDEVCFLASIQHRNLVTL- 141
           K  +G G FG V + + QD G  VAIK  ++  +P   + +  E+  +  + H N+V+  
Sbjct: 20  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 79
Query: 142 -----LGYCQENNLQFLIYEYIPNGSVSIHLY----------GP-----SQVSRQKLEFK 181
                L     N+L  L  EY   G +  +L           GP     S +S   L + 
Sbjct: 80  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS-SALRYL 138
Query: 182 HRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTDV 238
           H                    R++H+D K  N+++    +  I K+ D G    L + ++
Sbjct: 139 HE------------------NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 180
Query: 239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
               ++      +LA E+ E ++++   D +SFG    E ++G
Sbjct: 181 C---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 28/216 (12%)
Query: 82  TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEF----IDEVCFLASIQHR 136
           + +F  K+L+GEG +G V     +  G +VAIKK        F    + E+  L   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 137 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXX 196
           N++T+    + ++ +     YI    +   L+    +S Q L   H              
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLH--RVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 197 XXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT--DVAGPSSQVT-------- 246
                  V+H+D K +N+L++ +   KV D GL   +  +  D + P+ Q +        
Sbjct: 128 LHGS--NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 247 ----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLEL 278
               A E+ L S      ++S   DV+S G  L EL
Sbjct: 186 RWYRAPEVMLTSA-----KYSRAMDVWSCGCILAEL 216

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 42/84 (50%), Gaps = 14/84 (16%)
Query: 204 VVHKDFKTANVLVDEDFIAKVADAGLRNFLG-----RTDVAGPSSQVTADEIFLASEVKE 258
           VVH+D K  NVL+D    AK+AD GL N +      RT    P+        + A EV  
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN--------YAAPEVIS 183
Query: 259 FRRFS-EKSDVYSFGVFLLELVSG 281
            R ++  + D++S GV L  L+ G
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCG 207

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 49/232 (21%), Positives = 91/232 (39%), Gaps = 34/232 (14%)
Query: 126 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 185
           E+  +  ++H  LV L    Q+    F++ + +  G +  HL       +Q + FK    
Sbjct: 65  ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL-------QQNVHFKEETV 117
Query: 186 IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 245
                            R++H+D K  N+L+DE     + D  +   L R       +Q+
Sbjct: 118 KLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR------ETQI 171
Query: 246 T---ADEIFLASEVKEFRR---FSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVEL 299
           T     + ++A E+   R+   +S   D +S GV   EL+ GR              V  
Sbjct: 172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT 231
Query: 300 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-MSDV 350
            + +                T+ +   +E + L+ + L+P+ ++R S +SDV
Sbjct: 232 FETTV--------------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDV 269

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 84/201 (41%), Gaps = 14/201 (6%)
Query: 91  IGEGKFGEVYKGLLQ-DGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           IG G +G   K   + DG ++  K+        A  Q  + EV  L  ++H N+V     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 145 C--QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
              + N   +++ EY   G ++  +   ++  RQ L+ +  L +                
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 203 ---RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 259
               V+H+D K ANV +D     K+ D GL   L   D +   + V     +++ E    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKTFV-GTPYYMSPEQMNR 190
Query: 260 RRFSEKSDVYSFGVFLLELVS 280
             ++EKSD++S G  L EL +
Sbjct: 191 MSYNEKSDIWSLGCLLYELCA 211

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 88/218 (40%), Gaps = 55/218 (25%)
Query: 91  IGEGKFGEVYKGL--LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLG 143
           +GEG +  VYKG   L D  LVA+K+       GAP    I EV  L  ++H N+VTL  
Sbjct: 10  LGEGTYATVYKGKSKLTDN-LVALKEIRLEHEEGAPCTA-IREVSLLKDLKHANIVTLHD 67
Query: 144 YCQENNLQFLIYEYIPNG---------------SVSIHLYGPSQVSRQKLEFKHRLSIXX 188
                    L++EY+                  +V + L+   Q+ R  L + HR     
Sbjct: 68  IIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLF---QLLR-GLAYCHR----- 118
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT-- 246
                         +V+H+D K  N+L++E    K+AD GL            +  VT  
Sbjct: 119 -------------QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLW 165
Query: 247 --ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
               +I L S       +S + D++  G    E+ +GR
Sbjct: 166 YRPPDILLGS-----TDYSTQIDMWGVGCIFYEMATGR 198

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 118/294 (40%), Gaps = 49/294 (16%)
Query: 91  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASIQHR-NLV 139
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 140 TLLGYC-QENNLQFLIYEYIPNGSVSIHL------YGPSQ-VSRQKLEFKHRLSIXXXXX 191
            LLG C +      +I E+   G++S +L      + P + + +  L  +H   I     
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEH--LIXYSFQ 152
Query: 192 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAGPSSQ 244
                      + +H+D    N+L+ E  + K+ D GL        +++ + D   P   
Sbjct: 153 VAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKW 212
Query: 245 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSR 304
           +  + IF        R ++ +SDV+SFGV L E+ S                   V+   
Sbjct: 213 MAPETIF-------DRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGVKIDE 254
Query: 305 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
           +F   LK         +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 255 EFXRRLKEGTRMRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 305

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 29/210 (13%)
Query: 91  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI--QHRNLVTLLG---YC 145
           +G+G++GEV++GL   G  VA+K       Q +  E     ++  +H N++  +      
Sbjct: 16  VGKGRYGEVWRGLWH-GESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFIASDMTS 74
Query: 146 QENNLQ-FLIYEYIPNGSVSIHLYGPSQVSRQKLE--FKHRLSIXXXXXXXXXXX----X 198
           + ++ Q +LI  Y  +GS+   L       RQ LE     RL++                
Sbjct: 75  RNSSTQLWLITHYHEHGSLYDFL------QRQTLEPHLALRLAVSAACGLAHLHVEIFGT 128
Query: 199 XXXPRVVHKDFKTANVLVDEDFIAKVADAGLR--NFLGRTDVAGPSSQVTADEIFLASEV 256
              P + H+DFK+ NVLV  +    +AD GL   +  G   +   ++     + ++A EV
Sbjct: 129 QGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEV 188
Query: 257 KE-------FRRFSEKSDVYSFGVFLLELV 279
            +       F  + + +D+++FG+ L E+ 
Sbjct: 189 LDEQIRTDCFESY-KWTDIWAFGLVLWEIA 217

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 84/201 (41%), Gaps = 14/201 (6%)
Query: 91  IGEGKFGEVYKGLLQ-DGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           IG G +G   K   + DG ++  K+        A  Q  + EV  L  ++H N+V     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 145 C--QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
              + N   +++ EY   G ++  +   ++  RQ L+ +  L +                
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 203 ---RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 259
               V+H+D K ANV +D     K+ D GL   L   D +   + V     +++ E    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKAFV-GTPYYMSPEQMNR 190
Query: 260 RRFSEKSDVYSFGVFLLELVS 280
             ++EKSD++S G  L EL +
Sbjct: 191 MSYNEKSDIWSLGCLLYELCA 211

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/281 (20%), Positives = 110/281 (39%), Gaps = 35/281 (12%)
Query: 72  RFQMEELSLATKN-FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEF------ 123
           +++  E    TKN F    ++G+G FGEV    ++  G + A KK      ++       
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 124 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR 183
           ++E   L  +  R +V+L    +  +   L+   +  G +  H+Y   Q       F   
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG-----FPEA 286
Query: 184 LSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 243
            ++                R+V++D K  N+L+D+    +++D GL        V  P  
Sbjct: 287 RAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL-------AVHVPEG 339
Query: 244 QVTADEI----FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVEL 299
           Q     +    ++A EV +  R++   D ++ G  L E+++G+              VE 
Sbjct: 340 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE- 398
Query: 300 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPS 340
                    L+K + E     F+ +      QL+  C DP+
Sbjct: 399 --------RLVKEVPEEYSERFSPQARSLCSQLL--CKDPA 429

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/281 (20%), Positives = 110/281 (39%), Gaps = 35/281 (12%)
Query: 72  RFQMEELSLATKN-FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEF------ 123
           +++  E    TKN F    ++G+G FGEV    ++  G + A KK      ++       
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 124 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR 183
           ++E   L  +  R +V+L    +  +   L+   +  G +  H+Y   Q       F   
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG-----FPEA 286
Query: 184 LSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 243
            ++                R+V++D K  N+L+D+    +++D GL        V  P  
Sbjct: 287 RAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL-------AVHVPEG 339
Query: 244 QVTADEI----FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVEL 299
           Q     +    ++A EV +  R++   D ++ G  L E+++G+              VE 
Sbjct: 340 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE- 398
Query: 300 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPS 340
                    L+K + E     F+ +      QL+  C DP+
Sbjct: 399 --------RLVKEVPEEYSERFSPQARSLCSQLL--CKDPA 429

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 93/225 (41%), Gaps = 35/225 (15%)
Query: 84  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAPTQEFIDEVCFLASIQH----- 135
           +F +  ++G+G FG+V K     D    AIKK           + EV  LAS+ H     
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVR 66
Query: 136 --------RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIX 187
                   RN V      ++ +  F+  EY  N ++   L     +++Q+ E+  RL   
Sbjct: 67  YYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTL-YDLIHSENLNQQRDEY-WRL--- 121
Query: 188 XXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT---------DV 238
                           ++H++ K  N+ +DE    K+ D GL   + R+         ++
Sbjct: 122 -FRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 239 AGPSSQVTA---DEIFLASEVKEFR-RFSEKSDVYSFGVFLLELV 279
            G S  +T+      ++A+EV +    ++EK D YS G+   E +
Sbjct: 181 PGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 86/200 (43%), Gaps = 24/200 (12%)
Query: 91  IGEGKFGEVYKGLLQD-GMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 146
           IGEG  G V    ++  G LVA+KK   R     +   +EV  +   QH N+V +     
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 147 ENNLQFLIYEYIPNGS----VSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
             +  +++ E++  G+    V+       Q++   L     LS+                
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG----------- 136
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ-VTADEIFLASEVKEFRR 261
            V+H+D K+ ++L+  D   K++D G   F  +     P  + +     ++A E+     
Sbjct: 137 -VIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRLP 192
Query: 262 FSEKSDVYSFGVFLLELVSG 281
           +  + D++S G+ ++E+V G
Sbjct: 193 YGPEVDIWSLGIMVIEMVDG 212

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 86/200 (43%), Gaps = 24/200 (12%)
Query: 91  IGEGKFGEVYKGLLQD-GMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 146
           IGEG  G V    ++  G LVA+KK   R     +   +EV  +   QH N+V +     
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 147 ENNLQFLIYEYIPNGS----VSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
             +  +++ E++  G+    V+       Q++   L     LS+                
Sbjct: 99  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG----------- 147
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ-VTADEIFLASEVKEFRR 261
            V+H+D K+ ++L+  D   K++D G   F  +     P  + +     ++A E+     
Sbjct: 148 -VIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRLP 203
Query: 262 FSEKSDVYSFGVFLLELVSG 281
           +  + D++S G+ ++E+V G
Sbjct: 204 YGPEVDIWSLGIMVIEMVDG 223

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 86/200 (43%), Gaps = 24/200 (12%)
Query: 91  IGEGKFGEVYKGLLQD-GMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 146
           IGEG  G V    ++  G LVA+KK   R     +   +EV  +   QH N+V +     
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 147 ENNLQFLIYEYIPNGS----VSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
             +  +++ E++  G+    V+       Q++   L     LS+                
Sbjct: 92  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG----------- 140
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ-VTADEIFLASEVKEFRR 261
            V+H+D K+ ++L+  D   K++D G   F  +     P  + +     ++A E+     
Sbjct: 141 -VIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRLP 196
Query: 262 FSEKSDVYSFGVFLLELVSG 281
           +  + D++S G+ ++E+V G
Sbjct: 197 YGPEVDIWSLGIMVIEMVDG 216

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 86/200 (43%), Gaps = 24/200 (12%)
Query: 91  IGEGKFGEVYKGLLQD-GMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 146
           IGEG  G V    ++  G LVA+KK   R     +   +EV  +   QH N+V +     
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 147 ENNLQFLIYEYIPNGS----VSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
             +  +++ E++  G+    V+       Q++   L     LS+                
Sbjct: 97  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG----------- 145
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ-VTADEIFLASEVKEFRR 261
            V+H+D K+ ++L+  D   K++D G   F  +     P  + +     ++A E+     
Sbjct: 146 -VIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRLP 201
Query: 262 FSEKSDVYSFGVFLLELVSG 281
           +  + D++S G+ ++E+V G
Sbjct: 202 YGPEVDIWSLGIMVIEMVDG 221

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 35/209 (16%)
Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 143
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 144 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 194
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 195 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 254
                    ++H+D K +N+ V+ED   K+ DAGL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDAGLAR---HTD--DEMTGYVATRWYRAP 191
Query: 255 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 282
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 86/208 (41%), Gaps = 19/208 (9%)
Query: 83  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 134
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 135 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 193
           H+N++ LL  +  + +L+     YI    +  +L   SQV   ++E  H           
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---SQVI--QMELDHERMSYLLYQML 136
Query: 194 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 253
                     ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 137 VGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTP---YVVTRYYRA 193
Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVSG 281
            EV     + E  D++S GV + E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 86/200 (43%), Gaps = 24/200 (12%)
Query: 91  IGEGKFGEVYKGLLQD-GMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 146
           IGEG  G V    ++  G LVA+KK   R     +   +EV  +   QH N+V +     
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 147 ENNLQFLIYEYIPNGS----VSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 202
             +  +++ E++  G+    V+       Q++   L     LS+                
Sbjct: 142 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG----------- 190
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ-VTADEIFLASEVKEFRR 261
            V+H+D K+ ++L+  D   K++D G   F  +     P  + +     ++A E+     
Sbjct: 191 -VIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRLP 246
Query: 262 FSEKSDVYSFGVFLLELVSG 281
           +  + D++S G+ ++E+V G
Sbjct: 247 YGPEVDIWSLGIMVIEMVDG 266

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 86/208 (41%), Gaps = 19/208 (9%)
Query: 83  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 134
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVVAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 135 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 193
           H+N++ LL  +  + +L+     YI    +  +L   SQV   ++E  H           
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---SQVI--QMELDHERMSYLLYQML 136
Query: 194 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 253
                     ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 137 VGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTP---YVVTRYYRA 193
Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVSG 281
            EV     + E  D++S GV + E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 83/198 (41%), Gaps = 14/198 (7%)
Query: 121 QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF 180
           +E  +E+  L S+ H N++ L    ++    +L+ E+   G +   +     ++R K  F
Sbjct: 91  EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI-----INRHK--F 143
Query: 181 KHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDED---FIAKVADAGLRNFLGRTD 237
               +                  +VH+D K  N+L++        K+ D GL +F  + D
Sbjct: 144 DECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK-D 202
Query: 238 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXV 297
                   TA   ++A EV + ++++EK DV+S GV +  L+ G               V
Sbjct: 203 YKLRDRLGTA--YYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV 259
Query: 298 ELVQNSRDFSNLLKILDE 315
           E  +   DF++   I DE
Sbjct: 260 EKGKYYFDFNDWKNISDE 277

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 92/218 (42%), Gaps = 24/218 (11%)
Query: 76  EELSLATKNFSD----KNLIGEGKFGE----VYKGLLQDGMLVAIKKRPGAPTQEFIDEV 127
           E L   +  FSD    K  IG G + E    V+K    +  +  I K    P++E   E+
Sbjct: 16  ENLYFQSMVFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEI--EI 73
Query: 128 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIX 187
             L   QH N++TL     +    +L+ E +  G +        ++ RQK  F  R +  
Sbjct: 74  -LLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELL------DKILRQKF-FSEREASF 125
Query: 188 XXXXXXXXXXXXXXPRVVHKDFKTANVL-VDEDF---IAKVADAGLRNFLGRTDVAGPSS 243
                           VVH+D K +N+L VDE       ++ D G    L   +    + 
Sbjct: 126 VLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTP 185
Query: 244 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
             TA+  F+A EV + + + E  D++S G+ L  +++G
Sbjct: 186 CYTAN--FVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 41/88 (46%), Gaps = 22/88 (25%)
Query: 204 VVHKDFKTANVLVDEDFIAKVADAGLRNFL----------GRTDVAGPSSQVTADEIFLA 253
           VVH+D K  NVL+D    AK+AD GL N +          G  + A P  +V +  ++  
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAP--EVISGRLYAG 194
Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVSG 281
            EV          D++S GV L  L+ G
Sbjct: 195 PEV----------DIWSSGVILYALLCG 212

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 64/287 (22%), Positives = 111/287 (38%), Gaps = 27/287 (9%)
Query: 94  GKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE--VCFLASIQHRNLVTLLGYCQENNL- 150
           G+FG V+K  L +   VA+K  P    Q + +E  V  L  ++H N++  +G  +     
Sbjct: 35  GRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV 93
Query: 151 ---QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS--IXXXXXXXXXXXXXXXPRVV 205
               +LI  +   GS+S  L        +       ++  +               P + 
Sbjct: 94  DVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAIS 153
Query: 206 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE----FRR 261
           H+D K+ NVL+  +  A +AD GL         AG +        ++A EV E    F+R
Sbjct: 154 HRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQR 213
Query: 262 FS-EKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDER---- 316
            +  + D+Y+ G+ L EL S   A             E +       ++ +++  +    
Sbjct: 214 DAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRP 273
Query: 317 ----LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV---VTELDR 356
                W    + GM    + I  C D  +E R S   V   +T++ R
Sbjct: 274 VLRDYWQ--KHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 41/88 (46%), Gaps = 22/88 (25%)
Query: 204 VVHKDFKTANVLVDEDFIAKVADAGLRNFL----------GRTDVAGPSSQVTADEIFLA 253
           VVH+D K  NVL+D    AK+AD GL N +          G  + A P  +V +  ++  
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAP--EVISGRLYAG 189
Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVSG 281
            EV          D++S GV L  L+ G
Sbjct: 190 PEV----------DIWSCGVILYALLCG 207

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/159 (22%), Positives = 70/159 (44%), Gaps = 14/159 (8%)
Query: 124 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR 183
           ++E   L ++    LV L    ++N+  +++ EY+P G +  HL    + S     F   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 184 LSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPS 242
             +                 ++++D K  N+L+D+    KVAD G  +   GRT     +
Sbjct: 149 QIVLTFEYLHSLD-------LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGT 201
Query: 243 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
            +  A EI L+      + +++  D ++ GV + E+ +G
Sbjct: 202 PEYLAPEIILS------KGYNKAVDWWALGVLIYEMAAG 234

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/146 (23%), Positives = 65/146 (44%), Gaps = 10/146 (6%)
Query: 138 LVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXX 196
            +T L  C Q  +  + + EY+  G +  H+    QV R    FK   ++          
Sbjct: 82  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI---QQVGR----FKEPHAVFYAAEIAIGL 134
Query: 197 XXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV 256
                  ++++D K  NV++D +   K+AD G+        V       T D  ++A E+
Sbjct: 135 FFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPD--YIAPEI 192
Query: 257 KEFRRFSEKSDVYSFGVFLLELVSGR 282
             ++ + +  D ++FGV L E+++G+
Sbjct: 193 IAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/157 (21%), Positives = 66/157 (42%), Gaps = 32/157 (20%)
Query: 138 LVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXX 196
            +T L  C Q  +  + + EY+  G +  H+    QV R    FK   ++          
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI---QQVGR----FKEPHAVFYAAEIAIGL 455
Query: 197 XXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTDVAGPSSQV 245
                  ++++D K  NV++D +   K+AD G+           + F G  D        
Sbjct: 456 FFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPD-------- 507
Query: 246 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                ++A E+  ++ + +  D ++FGV L E+++G+
Sbjct: 508 -----YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 24/209 (11%)
Query: 85  FSD----KNLIGEGKFGE----VYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHR 136
           FSD    K  IG G + E    V+K    +  +  I K    P++E   E+  L   QH 
Sbjct: 25  FSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEI--EI-LLRYGQHP 81
Query: 137 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXX 196
           N++TL     +    +L+ E +  G +        ++ RQK  F  R +           
Sbjct: 82  NIITLKDVYDDGKHVYLVTELMRGGELL------DKILRQKF-FSEREASFVLHTIGKTV 134
Query: 197 XXXXXPRVVHKDFKTANVL-VDEDF---IAKVADAGLRNFLGRTDVAGPSSQVTADEIFL 252
                  VVH+D K +N+L VDE       ++ D G    L   +    +   TA+  F+
Sbjct: 135 EYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTAN--FV 192
Query: 253 ASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
           A EV + + + E  D++S G+ L  +++G
Sbjct: 193 APEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 85/209 (40%), Gaps = 35/209 (16%)
Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 143
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 144 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 194
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 96  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 195 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 254
                    ++H+D K +N+ V+ED   K+ D GL         A   +   A   + A 
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH-----TADEMTGYVATRWYRAP 198
Query: 255 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 282
           E+   +  +++  D++S G  + EL++GR
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 85/209 (40%), Gaps = 35/209 (16%)
Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 143
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 144 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 194
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 96  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 195 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 254
                    ++H+D K +N+ V+ED   K+ D GL         A   +   A   + A 
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH-----TADEMTGYVATRWYRAP 198
Query: 255 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 282
           E+   +  +++  D++S G  + EL++GR
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 85/209 (40%), Gaps = 35/209 (16%)
Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 143
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 144 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 194
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 96  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 195 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 254
                    ++H+D K +N+ V+ED   K+ D GL         A   +   A   + A 
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH-----TADEMTGYVATRWYRAP 198
Query: 255 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 282
           E+   +  +++  D++S G  + EL++GR
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/159 (22%), Positives = 70/159 (44%), Gaps = 14/159 (8%)
Query: 124 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR 183
           ++E   L ++    LV L    ++N+  +++ EY+P G +  HL    + S     F   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAA 148
Query: 184 LSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPS 242
             +                 ++++D K  N+L+D+    KVAD G  +   GRT     +
Sbjct: 149 QIVLTFEYLHSLD-------LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGT 201
Query: 243 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
            +  A EI L+      + +++  D ++ GV + E+ +G
Sbjct: 202 PEYLAPEIILS------KGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 27/216 (12%)
Query: 81  ATKNFSDK----NLIGEGKFGEVY----KGLLQDGMLVAIKKRP---GAPTQEFIDEVCF 129
           +T  FSD+     ++G+G FGEV     K   Q+  +  I KR        +  + EV  
Sbjct: 26  STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 85
Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           L  + H N++ L  + ++    +L+ E    G +   +     +SR++  F    +    
Sbjct: 86  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-----ISRKR--FSEVDAARII 138
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        ++VH+D K  N+L++    +K  DA +R           +S+   D+
Sbjct: 139 RQVLSGITYMHKNKIVHRDLKPENLLLE----SKSKDANIRIIDFGLSTHFEASKKMKDK 194
Query: 250 I----FLASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
           I    ++A EV     + EK DV+S GV L  L+SG
Sbjct: 195 IGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 229

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 85/208 (40%), Gaps = 19/208 (9%)
Query: 83  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 134
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 135 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 193
           H+N++ LL  +  + +L+     YI    +  +L   SQV +  +E  H           
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---SQVIQ--MELDHERMSYLLYQML 136
Query: 194 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 253
                     ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP---YVVTRYYRA 193
Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVSG 281
            EV     + E  D++S G  + E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 27/216 (12%)
Query: 81  ATKNFSDK----NLIGEGKFGEVY----KGLLQDGMLVAIKKRP---GAPTQEFIDEVCF 129
           +T  FSD+     ++G+G FGEV     K   Q+  +  I KR        +  + EV  
Sbjct: 20  STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 79
Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           L  + H N++ L  + ++    +L+ E    G +   +     +SR++  F    +    
Sbjct: 80  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-----ISRKR--FSEVDAARII 132
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        ++VH+D K  N+L++    +K  DA +R           +S+   D+
Sbjct: 133 RQVLSGITYMHKNKIVHRDLKPENLLLE----SKSKDANIRIIDFGLSTHFEASKKMKDK 188
Query: 250 I----FLASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
           I    ++A EV     + EK DV+S GV L  L+SG
Sbjct: 189 IGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/159 (22%), Positives = 70/159 (44%), Gaps = 14/159 (8%)
Query: 124 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR 183
           ++E   L ++    LV L    ++N+  +++ EY+P G +  HL    + S     F   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAA 148
Query: 184 LSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPS 242
             +                 ++++D K  N+L+D+    KVAD G  +   GRT     +
Sbjct: 149 QIVLTFEYLHSLD-------LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGT 201
Query: 243 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
            +  A EI L+      + +++  D ++ GV + E+ +G
Sbjct: 202 PEYLAPEIILS------KGYNKAVDWWALGVLIYEMAAG 234

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/165 (21%), Positives = 69/165 (41%), Gaps = 32/165 (19%)
Query: 130 LASIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXX 188
           LA +     +T L  C Q  +  + + EY+  G +  H+    QV +    FK   ++  
Sbjct: 73  LALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI---QQVGK----FKEPQAVFY 125
Query: 189 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTD 237
                          ++++D K  NV++D +   K+AD G+           R F G  D
Sbjct: 126 AAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPD 185
Query: 238 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                        ++A E+  ++ + +  D +++GV L E+++G+
Sbjct: 186 -------------YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 57/144 (39%), Gaps = 30/144 (20%)
Query: 150 LQFLIYEYIPNGSVS--IHLYGPSQVSR---------QKLEFKHRLSIXXXXXXXXXXXX 198
           L +++ EY+   ++   +H  GP    R         Q L F H+  I            
Sbjct: 90  LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGI------------ 137
Query: 199 XXXPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVK 257
                 +H+D K AN+L+      KV D G+ R      +    ++ V     +L+ E  
Sbjct: 138 ------IHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQA 191
Query: 258 EFRRFSEKSDVYSFGVFLLELVSG 281
                  +SDVYS G  L E+++G
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 85/208 (40%), Gaps = 19/208 (9%)
Query: 83  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 134
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 135 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 193
           H+N++ LL  +  + +L+     YI    +  +L   SQV   ++E  H           
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---SQVI--QMELDHERMSYLLYQML 136
Query: 194 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 253
                     ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTP---YVVTRYYRA 193
Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVSG 281
            EV     + E  D++S G  + E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 87/211 (41%), Gaps = 25/211 (11%)
Query: 83  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 134
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 135 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 193
           H+N++ LL  +  + +L+     YI      + L   +     ++E  H           
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYI-----VMELMDANLCQVIQMELDHERMSYLLYQML 136
Query: 194 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--- 250
                     ++H+D K +N++V  D   K+ D G    L RT  AG S  +T + +   
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LART--AGTSFMMTPEVVTRY 190
Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
           + A EV     + E  D++S G  + E++ G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 27/216 (12%)
Query: 81  ATKNFSDK----NLIGEGKFGEVY----KGLLQDGMLVAIKKRP---GAPTQEFIDEVCF 129
           +T  FSD+     ++G+G FGEV     K   Q+  +  I KR        +  + EV  
Sbjct: 43  STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 102
Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           L  + H N++ L  + ++    +L+ E    G +   +     +SR++  F    +    
Sbjct: 103 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-----ISRKR--FSEVDAARII 155
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        ++VH+D K  N+L++    +K  DA +R           +S+   D+
Sbjct: 156 RQVLSGITYMHKNKIVHRDLKPENLLLE----SKSKDANIRIIDFGLSTHFEASKKMKDK 211
Query: 250 I----FLASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
           I    ++A EV     + EK DV+S GV L  L+SG
Sbjct: 212 IGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 246

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 143
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 144 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 194
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 195 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 254
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDGGLAR---HTD--DEMTGYVATRWYRAP 191
Query: 255 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 282
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 143
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 144 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 194
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKXQKLTDDHVQFLIYQILRGL 138
Query: 195 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 254
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLAR---HTD--DEMTGYVATRWYRAP 191
Query: 255 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 282
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 27/216 (12%)
Query: 81  ATKNFSDK----NLIGEGKFGEVY----KGLLQDGMLVAIKKRP---GAPTQEFIDEVCF 129
           +T  FSD+     ++G+G FGEV     K   Q+  +  I KR        +  + EV  
Sbjct: 44  STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 103
Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 189
           L  + H N++ L  + ++    +L+ E    G +   +     +SR++  F    +    
Sbjct: 104 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-----ISRKR--FSEVDAARII 156
Query: 190 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
                        ++VH+D K  N+L++    +K  DA +R           +S+   D+
Sbjct: 157 RQVLSGITYMHKNKIVHRDLKPENLLLE----SKSKDANIRIIDFGLSTHFEASKKMKDK 212
Query: 250 I----FLASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
           I    ++A EV     + EK DV+S GV L  L+SG
Sbjct: 213 IGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 247

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 92/213 (43%), Gaps = 31/213 (14%)
Query: 90  LIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVCFLASIQ-HRNLVTLLGY 144
           L+GEG + +V   + LQ+G   A+K   K+ G        EV  L   Q ++N++ L+ +
Sbjct: 20  LLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEF 79
Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 204
            +++   +L++E +  GS+  H      + +QK  F  R +                  +
Sbjct: 80  FEDDTRFYLVFEKLQGGSILAH------IQKQK-HFNEREASRVVRDVAAALDFLHTKGI 132
Query: 205 VHKDFKTANVLVDED---FIAKVADAGLRNFLGRTDVAGPSSQVTADEI--------FLA 253
            H+D K  N+L +        K+ D  L + +   +   P   +T  E+        ++A
Sbjct: 133 AHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTP---ITTPELTTPCGSAEYMA 189
Query: 254 SEVKEF-----RRFSEKSDVYSFGVFLLELVSG 281
            EV E        + ++ D++S GV L  ++SG
Sbjct: 190 PEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 35/152 (23%), Positives = 69/152 (45%), Gaps = 21/152 (13%)
Query: 204 VVHKDFKTANVLVDEDFIAKVADAGLRNFL----GRTDVAGPSSQVTADEIFLASEVKEF 259
           V+H+D K +NVL++     K+ D G+  +L     +T  AG    +  + I    E+ + 
Sbjct: 175 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERI--NPELNQ- 231
Query: 260 RRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWS 319
           + +S KSD++S G+ ++EL   R                       F  L ++++E    
Sbjct: 232 KGYSVKSDIWSLGITMIELAILRFPYDSW--------------GTPFQQLKQVVEEPSPQ 277
Query: 320 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
              ++   EF+    +CL  +S+ RP+  +++
Sbjct: 278 LPADKFSAEFVDFTSQCLKKNSKERPTYPELM 309

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 85/208 (40%), Gaps = 19/208 (9%)
Query: 83  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 134
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 135 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 193
           H+N++ LL  +  + +L+     YI    +  +L   SQV   ++E  H           
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---SQVI--QMELDHERMSYLLYQML 136
Query: 194 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 253
                     ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 137 VGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTP---YVVTRYYRA 193
Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVSG 281
            EV     + E  D++S G  + E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/163 (23%), Positives = 65/163 (39%), Gaps = 28/163 (17%)
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAGPSSQVTADEIFLASE 255
           + +H+D    N+L+ E  + K+ D GL        +++ + D   P   +  + IF    
Sbjct: 213 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF---- 268
Query: 256 VKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDE 315
               R ++ +SDV+SFGV L E+ S                   V+   +F   LK    
Sbjct: 269 ---DRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGVKIDEEFCRRLKEGTR 314
Query: 316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
                +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 315 MRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 39/175 (22%), Positives = 67/175 (38%), Gaps = 34/175 (19%)
Query: 123 FIDEVCFLASIQHRNLVTLLGYCQENN----LQFLIYEYIPNGSVS--IHLYGPSQVSR- 175
           F  E    A++ H  +V +    +       L +++ EY+   ++   +H  GP    R 
Sbjct: 59  FRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 176 --------QKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADA 227
                   Q L F H+  I                  +H+D K AN+++      KV D 
Sbjct: 119 IEVIADACQALNFSHQNGI------------------IHRDVKPANIMISATNAVKVMDF 160
Query: 228 GL-RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
           G+ R      +    ++ V     +L+ E         +SDVYS G  L E+++G
Sbjct: 161 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/90 (28%), Positives = 44/90 (48%), Gaps = 22/90 (24%)
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFL----------GRTDVAGPSSQVTADEIFL 252
           ++VH+D K  N+L+D++   K+AD GL N +          G  + A P  +V   +++ 
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAP--EVINGKLYA 185
Query: 253 ASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
             EV          DV+S G+ L  ++ GR
Sbjct: 186 GPEV----------DVWSCGIVLYVMLVGR 205

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 143
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 144 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 194
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKXQKLTDDHVQFLIYQILRGL 138
Query: 195 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 254
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 191
Query: 255 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 282
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 143
           IG G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 93
Query: 144 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 194
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 94  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 195 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 254
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLAR---HTD--DEMTGYVATRWYRAP 196
Query: 255 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 282
           E+   +  +++  D++S G  + EL++GR
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 53/227 (23%), Positives = 95/227 (41%), Gaps = 59/227 (25%)
Query: 84  NFSDKNLIGEGKFGEV----YKGLLQDGMLVAIKKRPGAPT--QEFID-EVCFLASIQHR 136
           N+     +GEG FG+V    +    Q   L  I K+  A +  Q  I+ E+ +L  ++H 
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 137 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK-----------LEFKHRLS 185
           +++ L    +  +   ++ EY  N  +  ++    ++S Q+           +E+ HR  
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR-- 131
Query: 186 IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL----------GR 235
                            ++VH+D K  N+L+DE    K+AD GL N +          G 
Sbjct: 132 ----------------HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGS 175
Query: 236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
            + A P  +V + +++   EV          DV+S GV L  ++  R
Sbjct: 176 PNYAAP--EVISGKLYAGPEV----------DVWSCGVILYVMLCRR 210

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 51/249 (20%), Positives = 92/249 (36%), Gaps = 49/249 (19%)
Query: 63  IELSIREARRFQ---------MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGM---LV 110
           + LS+  AR F          ++E  +  +      LIG+G+FG+VY G     +   L+
Sbjct: 4   MNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLI 63
Query: 111 AIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI---------YEYIPNG 161
            I++      + F  EV      +H N+V  +G C       +I         Y  + + 
Sbjct: 64  DIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA 123
Query: 162 SVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFI 221
            + + +    Q++++ ++    L                   ++HKD K+ NV  D   +
Sbjct: 124 KIVLDVNKTRQIAQEIVKGMGYLHAKG---------------ILHKDLKSKNVFYDNGKV 168
Query: 222 AKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR------------FSEKSDVY 269
             + D GL +  G         ++     +L     E  R            FS+ SDV+
Sbjct: 169 V-ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVF 227
Query: 270 SFGVFLLEL 278
           + G    EL
Sbjct: 228 ALGTIWYEL 236

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 38/163 (23%), Positives = 65/163 (39%), Gaps = 28/163 (17%)
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAGPSSQVTADEIFLASE 255
           + +H+D    N+L+ E  + K+ D GL        +++ + D   P   +  + IF    
Sbjct: 211 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF---- 266
Query: 256 VKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDE 315
               R ++ +SDV+SFGV L E+ S                   V+   +F   LK    
Sbjct: 267 ---DRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGVKIDEEFCRRLKEGTR 312
Query: 316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
                +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 313 MRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 352

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 85/208 (40%), Gaps = 19/208 (9%)
Query: 83  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 134
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 135 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 193
           H+N++ LL  +  + +L+     YI    +  +L   SQV   ++E  H           
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---SQVI--QMELDHERMSYLLYQML 136
Query: 194 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 253
                     ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTP---YVVTRYYRA 193
Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVSG 281
            EV     + E  D++S G  + E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 82/208 (39%), Gaps = 19/208 (9%)
Query: 83  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 134
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 82
Query: 135 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 193
           H+N++ LL  +  + +L+     YI      + L   +     ++E  H           
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYI-----VMELMDANLCQVIQMELDHERMSYLLYQML 137
Query: 194 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 253
                     ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP---YVVTRYYRA 194
Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVSG 281
            EV     + E  D++S G  + E++ G
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 82/208 (39%), Gaps = 19/208 (9%)
Query: 83  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 134
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 135 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 193
           H+N++ LL  +  + +L+     YI      + L   +     ++E  H           
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYI-----VMELMDANLCQVIQMELDHERMSYLLYQML 136
Query: 194 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 253
                     ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP---YVVTRYYRA 193
Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVSG 281
            EV     + E  D++S G  + E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 38/163 (23%), Positives = 65/163 (39%), Gaps = 28/163 (17%)
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAGPSSQVTADEIFLASE 255
           + +H+D    N+L+ E  + K+ D GL        +++ + D   P   +  + IF    
Sbjct: 220 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF---- 275
Query: 256 VKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDE 315
               R ++ +SDV+SFGV L E+ S                   V+   +F   LK    
Sbjct: 276 ---DRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGVKIDEEFCRRLKEGTR 321
Query: 316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
                +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 322 MRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 361

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 38/163 (23%), Positives = 65/163 (39%), Gaps = 28/163 (17%)
Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAGPSSQVTADEIFLASE 255
           + +H+D    N+L+ E  + K+ D GL        +++ + D   P   +  + IF    
Sbjct: 218 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF---- 273
Query: 256 VKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDE 315
               R ++ +SDV+SFGV L E+ S                   V+   +F   LK    
Sbjct: 274 ---DRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGVKIDEEFCRRLKEGTR 319
Query: 316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
                +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 320 MRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 359

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 53/227 (23%), Positives = 95/227 (41%), Gaps = 59/227 (25%)
Query: 84  NFSDKNLIGEGKFGEV----YKGLLQDGMLVAIKKRPGAPT--QEFID-EVCFLASIQHR 136
           N+     +GEG FG+V    +    Q   L  I K+  A +  Q  I+ E+ +L  ++H 
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 137 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK-----------LEFKHRLS 185
           +++ L    +  +   ++ EY  N  +  ++    ++S Q+           +E+ HR  
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR-- 130
Query: 186 IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL----------GR 235
                            ++VH+D K  N+L+DE    K+AD GL N +          G 
Sbjct: 131 ----------------HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGS 174
Query: 236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
            + A P  +V + +++   EV          DV+S GV L  ++  R
Sbjct: 175 PNYAAP--EVISGKLYAGPEV----------DVWSCGVILYVMLCRR 209

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 82/208 (39%), Gaps = 19/208 (9%)
Query: 83  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 134
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 135 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 193
           H+N++ LL  +  + +L+     YI      + L   +     ++E  H           
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYI-----VMELMDANLCQVIQMELDHERMSYLLYQML 136
Query: 194 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 253
                     ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP---YVVTRYYRA 193
Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVSG 281
            EV     + E  D++S G  + E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 143
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 144 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 194
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 195 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 254
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDYGLAR---HTD--DEMTGYVATRWYRAP 191
Query: 255 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 282
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 143
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 144 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 194
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 195 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 254
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDRGLAR---HTD--DEMTGYVATRWYRAP 191
Query: 255 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 282
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 143
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKL-SKPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 100
Query: 144 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 194
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 101 VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 150
Query: 195 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 254
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 151 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 203
Query: 255 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 282
           E+   +  +++  D++S G  + EL++GR
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 45/165 (27%)
Query: 91  IGEGKFGEVYKGLLQD-GMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 143
           IG+G FGEV+K   +  G  VA+KK      + G P    + E+  L  ++H N+V L+ 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA-LREIKILQLLKHENVVNLIE 84
Query: 144 YCQE-----NNLQ---FLIYEYIPN---GSVSIHL--YGPSQVSR------QKLEFKHRL 184
            C+      N  +   +L++++  +   G +S  L  +  S++ R        L + HR 
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR- 143
Query: 185 SIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL 229
                             +++H+D K ANVL+  D + K+AD GL
Sbjct: 144 -----------------NKILHRDMKAANVLITRDGVLKLADFGL 171

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	386
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-102
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-96
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-88
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-69
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-57
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	7e-57
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-56
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-56
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-54
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	5e-54
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-52
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-51
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-50
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-50
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-50
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-50
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-49
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-48
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	9e-42
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-41
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	7e-40
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-39
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-39
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	8e-39
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-38
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-38
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-38
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-38
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	6e-38
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-37
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-37
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-37
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-37
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-36
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-36
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-36
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-36
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	8e-36
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	9e-36
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-35
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-35
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-35
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-35
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-35
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-35
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	9e-35
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-34
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-34
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-34
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	7e-34
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	9e-34
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	9e-34
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-33
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-33
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-33
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-33
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-33
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	9e-33
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-32
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-32
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-32
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-32
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-32
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-32
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-32
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	6e-32
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	9e-32
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-31
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-31
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	6e-31
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-31
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-30
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-30
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	9e-29
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-28
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-28
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-28
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-27
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-27
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-26
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-25
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-25
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-24
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-24
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-24
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-24
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-23
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-23
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-23
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-23
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-22
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-22
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-22
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-22
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-22
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-22
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-21
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	5e-21
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	9e-21
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-20
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-20
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-20
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-20
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-19
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-19
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-19
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-19
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-19
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	6e-19
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-18
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-18
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-18
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-18
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-18
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-17
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-17
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-17
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-17
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-17
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-17
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-17
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-17
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-17
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-17
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-17
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-17
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-17
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-16
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-16
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-16
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-16
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-16
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-16
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-16
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-16
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-16
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-16
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-05
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	7e-16
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-15
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-15
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-15
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-15
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-15
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	9e-15
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-14
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-14
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-14
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-14
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-14
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-14
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-14
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-14
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-14
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-14
3bhy_A	283	Death-associated protein kinase 3; death associate	8e-14
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	9e-14
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-13
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-13
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-13
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-13
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-13
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-13
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-13
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-13
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-13
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-13
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-13
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-13
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-13
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-13
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-13
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-12
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-12
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-12
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-12
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	8e-12
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	9e-12
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-11
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-11
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-11
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	6e-11
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-11
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	9e-11
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-10
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-10
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-10
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-10
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	6e-10
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	8e-10
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-09
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-09
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	6e-09
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	6e-09
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	7e-09
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	8e-09
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-08
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-08
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-08
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-08
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-08
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-07
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-06
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-06
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-06
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-06
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	7e-06
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	8e-06
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-05
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-05
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-05
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	7e-05
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-04
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-04
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-04
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-04
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-04
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-04
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-04
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-04
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-04
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	8e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	8e-04
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	8e-04

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  304 bits (780), Expect = e-102
 Identities = 112/292 (38%), Positives = 167/292 (57%), Gaps = 12/292 (4%)

Query: 69  EARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFID 125
           E+ R  + +L  AT NF  K LIG G FG+VYKG+L+DG  VA+K+R    +Q   EF  
Sbjct: 25  ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFET 84

Query: 126 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 185
           E+  L+  +H +LV+L+G+C E N   LIY+Y+ NG++  HLYG        + ++ RL 
Sbjct: 85  EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL-PTMSMSWEQRLE 143

Query: 186 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNF--LGRTDVAGPS 242
           I +GAA+GL +LH+    ++H+D K+ N+L+DE+F+ K+ D G+ +    L +T +   S
Sbjct: 144 ICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL---S 198

Query: 243 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 302
           + V     ++  E     R +EKSDVYSFGV L E++  R A     P    +L E    
Sbjct: 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE 258

Query: 303 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
           S +   L +I+D  L      E + +F    V+CL  SSE RPSM DV+ +L
Sbjct: 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  290 bits (744), Expect = 1e-96
 Identities = 113/307 (36%), Positives = 173/307 (56%), Gaps = 25/307 (8%)

Query: 64  ELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ-- 121
           E+ + + +RF + EL +A+ NFS+KN++G G FG+VYKG L DG LVA+K+     TQ  
Sbjct: 11  EVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG 70

Query: 122 --EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE 179
             +F  EV  ++   HRNL+ L G+C     + L+Y Y+ NGSV+  L    + S+  L+
Sbjct: 71  ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE-SQPPLD 129

Query: 180 FKHRLSIALGAAKGLAHLH-SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR--- 235
           +  R  IALG+A+GLA+LH    P+++H+D K AN+L+DE+F A V D GL   +     
Sbjct: 130 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 189

Query: 236 ---TDVAGPSSQVTADEIF--LASEVKEFRRFSEKSDVYSFGVFLLELVSGREA--SSSL 288
              T V G     T       +A E     + SEK+DV+ +GV LLEL++G+ A   + L
Sbjct: 190 HVTTAVRG-----T----IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240

Query: 289 SPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMS 348
           + D    L++ V+       L  ++D  L   + +E +E+ IQ+ + C   S   RP MS
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300

Query: 349 DVVTELD 355
           +VV  L+
Sbjct: 301 EVVRMLE 307

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  268 bits (687), Expect = 2e-88
 Identities = 92/313 (29%), Positives = 144/313 (46%), Gaps = 35/313 (11%)

Query: 63  IELSIREARRFQMEELSLATKNFSDK------NLIGEGKFGEVYKGLLQDGMLVAIKKRP 116
           +E+S      F   EL   T NF ++      N +GEG FG VYKG + +   VA+KK  
Sbjct: 5   LEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLA 63

Query: 117 GAPT-------QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG 169
                      Q+F  E+  +A  QH NLV LLG+  + +   L+Y Y+PNGS+   L  
Sbjct: 64  AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 123

Query: 170 PSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 229
                   L +  R  IA GAA G+  LH      +H+D K+AN+L+DE F AK++D GL
Sbjct: 124 LD--GTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLDEAFTAKISDFGL 179

Query: 230 RNFLGRTDVAGPSSQV------TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE 283
                +      +S++       A E             + KSD+YSFGV LLE+++G  
Sbjct: 180 ARASEKFAQTVMTSRIVGTTAYMAPEALRG-------EITPKSDIYSFGVVLLEIITGLP 232

Query: 284 ASSSLSPDSSQDLVELVQNS-RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSE 342
           A         Q L+++ +    +   +   +D+++ +   +  +E    +  +CL     
Sbjct: 233 AVDEHREP--QLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKN 289

Query: 343 RRPSMSDVVTELD 355
           +RP +  V   L 
Sbjct: 290 KRPDIKKVQQLLQ 302

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  219 bits (559), Expect = 6e-69
 Identities = 71/318 (22%), Positives = 119/318 (37%), Gaps = 35/318 (11%)

Query: 73  FQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE--VCFL 130
              E L   +       +   G+FG V+K  L     VA+K  P    Q + +E  V  L
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSL 72

Query: 131 ASIQHRNLVTLLGYCQENNLQ----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 186
             ++H N++  +G  +         +LI  +   GS+S  L          + +     I
Sbjct: 73  PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL------KANVVSWNELCHI 126

Query: 187 ALGAAKGLAHLHS--------LSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTD 237
           A   A+GLA+LH           P + H+D K+ NVL+  +  A +AD GL   F     
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186

Query: 238 VAGPSSQV-----TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS 292
                 QV      A E+ L   +   R    + D+Y+ G+ L EL S   A+     + 
Sbjct: 187 AGDTHGQVGTRRYMAPEV-LEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245

Query: 293 SQDLVELVQNSRDFSNLLKILDERLW------STFTNEGMEEFIQLIVRCLDPSSERRPS 346
                E +       ++ +++  +            + GM    + I  C D  +E R S
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305

Query: 347 MSDVVTELDRTLDKEMNL 364
              V   +   + +  N+
Sbjct: 306 AGCVGERIT-QMQRLTNI 322

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  188 bits (480), Expect = 2e-57
 Identities = 84/292 (28%), Positives = 135/292 (46%), Gaps = 39/292 (13%)

Query: 84  NFSD---KNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCFLASIQH 135
            + D   K  IG G FG V++     G  VA+K             EF+ EV  +  ++H
Sbjct: 35  PWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93

Query: 136 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 195
            N+V  +G   +     ++ EY+  GS+   L+     +R++L+ + RLS+A   AKG+ 
Sbjct: 94  PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSG--AREQLDERRRLSMAYDVAKGMN 151

Query: 196 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----RNFLGRTDVAGPSSQVTADEI 250
           +LH+ +P +VH++ K+ N+LVD+ +  KV D GL       FL     AG     T    
Sbjct: 152 YLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAG-----TP--E 204

Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 310
           ++A EV      +EKSDVYSFGV L EL + ++   +L+P  +Q +  +           
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP--AQVVAAVGFK-------- 254

Query: 311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 362
               +RL          +   +I  C      +RPS + ++  L R L K  
Sbjct: 255 ---CKRL--EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL-RPLIKSA 300

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  186 bits (474), Expect = 7e-57
 Identities = 63/293 (21%), Positives = 119/293 (40%), Gaps = 37/293 (12%)

Query: 75  MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCF 129
            ++L+  TK       + E   GE++KG  Q G  + +K  +    +    ++F +E   
Sbjct: 9   FKQLNFLTK-------LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPR 60

Query: 130 LASIQHRNLVTLLGYCQENNLQFL--IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 187
           L    H N++ +LG CQ         I  ++P GS+   L+  +      ++    +  A
Sbjct: 61  LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF---VVDQSQAVKFA 117

Query: 188 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 247
           L  A+G+A LH+L P +      + +V++DED  A+++ A ++           +    A
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMY-APAWVA 176

Query: 248 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 307
            E     + K        +D++SF V L ELV+     + LS    +  +++        
Sbjct: 177 PEAL---QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN--MEIGMKVALE----- 226

Query: 308 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 360
                   R   T          +L+  C++    +RP    +V  L++  DK
Sbjct: 227 ------GLRP--TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  185 bits (471), Expect = 3e-56
 Identities = 72/316 (22%), Positives = 124/316 (39%), Gaps = 55/316 (17%)

Query: 62  GIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK------ 114
           G E            E+    +       IG+G FG V+KG L++D  +VAIK       
Sbjct: 5   GSEFPKSRLPTLADNEIEYEKQ-------IGKGGFGLVHKGRLVKDKSVVAIKSLILGDS 57

Query: 115 ----RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGP 170
                     QEF  EV  ++++ H N+V L G         ++ E++P G +   L   
Sbjct: 58  EGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDK 115

Query: 171 SQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-----DFIAKVA 225
           +      +++  +L + L  A G+ ++ + +P +VH+D ++ N+ +          AKVA
Sbjct: 116 AH----PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171

Query: 226 DAGLRNFLGRTDVAGPSSQV-----TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
           D G    L +  V   S  +      A E   A E      ++EK+D YSF + L  +++
Sbjct: 172 DFG----LSQQSVHSVSGLLGNFQWMAPETIGAEE----ESYTEKADTYSFAMILYTILT 223

Query: 281 GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPS 340
           G       S    + +  + +              R   T   +       +I  C    
Sbjct: 224 GEGPFDEYSYGKIKFINMIREE-----------GLRP--TIPEDCPPRLRNVIELCWSGD 270

Query: 341 SERRPSMSDVVTELDR 356
            ++RP  S +V EL  
Sbjct: 271 PKKRPHFSYIVKELSE 286

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  186 bits (474), Expect = 3e-56
 Identities = 75/345 (21%), Positives = 123/345 (35%), Gaps = 49/345 (14%)

Query: 73  FQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE--VCFL 130
               E SL   N     LIG G++G VYKG L D   VA+K    A  Q FI+E  +  +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRV 61

Query: 131 ASIQHRNLVTLLGYCQENNLQ-----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 185
             ++H N+   +   +           L+ EY PNGS+  +L      S    ++     
Sbjct: 62  PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL------SLHTSDWVSSCR 115

Query: 186 IALGAAKGLAHLHS-------LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 238
           +A    +GLA+LH+         P + H+D  + NVLV  D    ++D GL   L    +
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175

Query: 239 AGPSSQVTAD------------EIF-LASEVKEFRRFSEKSDVYSFGVFLLELVSGREAS 285
             P  +  A             E+   A  +++     ++ D+Y+ G+   E+       
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235

Query: 286 SSLSPDSS-----QDLVELVQNSRDFSNLLKILDERL-----WSTFTNEGMEEFIQLIVR 335
                        Q  V       D   L+    +R      W   +   +    + I  
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENS-LAVRSLKETIED 294

Query: 336 CLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPTVTLGSH 380
           C D  +E R +           + + M +       +PT     H
Sbjct: 295 CWDQDAEARLTAQXAE----ERMAELMMIWERNKSVSPTAHHHHH 335

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  180 bits (458), Expect = 4e-54
 Identities = 70/269 (26%), Positives = 118/269 (43%), Gaps = 27/269 (10%)

Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENN 149
           +G G FG V K   +    VAIK+    +  + FI E+  L+ + H N+V L G C    
Sbjct: 16  VGRGAFGVVCKAKWR-AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPV 74

Query: 150 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR-VVHKD 208
              L+ EY   GS+   L+G   +        H +S  L  ++G+A+LHS+ P+ ++H+D
Sbjct: 75  --CLVMEYAEGGSLYNVLHGAEPLP--YYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130

Query: 209 FKTANVLVDEDF-IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSD 267
            K  N+L+     + K+ D G    +         S       ++A EV E   +SEK D
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSA-----AWMAPEVFEGSNYSEKCD 185

Query: 268 VYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGME 327
           V+S+G+ L E+++ R+    +    +  ++  V N             R          +
Sbjct: 186 VFSWGIILWEVITRRKPFDEIG-GPAFRIMWAVHN-----------GTRP--PLIKNLPK 231

Query: 328 EFIQLIVRCLDPSSERRPSMSDVVTELDR 356
               L+ RC      +RPSM ++V  +  
Sbjct: 232 PIESLMTRCWSKDPSQRPSMEEIVKIMTH 260

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  179 bits (456), Expect = 5e-54
 Identities = 76/290 (26%), Positives = 135/290 (46%), Gaps = 35/290 (12%)

Query: 75  MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCF 129
             ++++  +       IG G FG VYKG       VA+K     APT    Q F +EV  
Sbjct: 23  DGQITVGQR-------IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGV 73

Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG 189
           L   +H N++  +GY     L  ++ ++    S+  HL      S  K E K  + IA  
Sbjct: 74  LRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHL----HASETKFEMKKLIDIARQ 128

Query: 190 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
            A+G+ +LH+    ++H+D K+ N+ + ED   K+ D GL     R   +    Q++   
Sbjct: 129 TARGMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186

Query: 250 IFLASEV---KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 306
           +++A EV   ++   +S +SDVY+FG+ L EL++G+   S+++      ++E+V      
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIEMVGRGSLS 244

Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 356
            +L K+              +   +L+  CL    + RPS   ++ E++ 
Sbjct: 245 PDLSKVRSNCP---------KRMKRLMAECLKKKRDERPSFPRILAEIEE 285

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  173 bits (441), Expect = 1e-51
 Identities = 65/285 (22%), Positives = 114/285 (40%), Gaps = 38/285 (13%)

Query: 88  KNLIGEGKFGEVYKGLL-QDGMLVAIKK--RPGAPTQ-EFIDEVCFLASIQHRNLVTLLG 143
             ++G+G FG+  K    + G ++ +K+  R    TQ  F+ EV  +  ++H N++  +G
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74

Query: 144 YC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 202
              ++  L   I EYI  G++   +    +    +  +  R+S A   A G+A+LHS++ 
Sbjct: 75  VLYKDKRL-NFITEYIKGGTLRGII----KSMDSQYPWSQRVSFAKDIASGMAYLHSMN- 128

Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS-------- 254
            ++H+D  + N LV E+    VAD GL   +          +                  
Sbjct: 129 -IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187

Query: 255 ----EVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 310
               E+   R + EK DV+SFG+ L E++    A     P +    + +           
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD-----R 242

Query: 311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 355
                             F  + VRC D   E+RPS   +   L+
Sbjct: 243 YC---------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  169 bits (430), Expect = 2e-50
 Identities = 72/300 (24%), Positives = 124/300 (41%), Gaps = 55/300 (18%)

Query: 75  MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT------QEFIDEV 127
             EL+L          IG G FG+VY+     G  VA+K  R           +    E 
Sbjct: 6   FAELTLEEI-------IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEA 57

Query: 128 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 187
              A ++H N++ L G C +     L+ E+   G ++  L      S +++     ++ A
Sbjct: 58  KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL------SGKRIPPDILVNWA 111

Query: 188 LGAAKGLAHLHSLSPR-VVHKDFKTANVLVDEDF--------IAKVADAGLRNFLGRTDV 238
           +  A+G+ +LH  +   ++H+D K++N+L+ +          I K+ D GL     RT  
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK 171

Query: 239 ---AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQD 295
              AG  +       ++A EV     FS+ SDV+S+GV L EL++G      +       
Sbjct: 172 MSAAGAYA-------WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG--LAV 222

Query: 296 LVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 355
              +  N              L     +   E F +L+  C +P    RPS ++++ +L 
Sbjct: 223 AYGVAMN-----------KLAL--PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  171 bits (435), Expect = 2e-50
 Identities = 63/302 (20%), Positives = 130/302 (43%), Gaps = 35/302 (11%)

Query: 89  NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE--VCFLASIQHRNLVTLLGYCQ 146
             IG+G+FGEV++G  + G  VA+K       + +  E  +     ++H N++  +    
Sbjct: 48  ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADN 106

Query: 147 ENNLQ----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS--- 199
           ++N      +L+ +Y  +GS+  +L      +R  +  +  + +AL  A GLAHLH    
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYL------NRYTVTVEGMIKLALSTASGLAHLHMEIV 160

Query: 200 ---LSPRVVHKDFKTANVLVDEDFIAKVADAGL---RNFLGRTDVAGPSSQV-----TAD 248
                P + H+D K+ N+LV ++    +AD GL    +    T    P+ +V      A 
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220

Query: 249 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 308
           E+   S   +     +++D+Y+ G+   E+   R +   +  D      +LV +      
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPSDPSVEE 279

Query: 309 LLK-ILDERL-----WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 362
           + K + +++L         + E +    +++  C   +   R +   +   L + L ++ 
Sbjct: 280 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ-LSQQE 338

Query: 363 NL 364
            +
Sbjct: 339 GI 340

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  171 bits (434), Expect = 3e-50
 Identities = 65/302 (21%), Positives = 129/302 (42%), Gaps = 35/302 (11%)

Query: 89  NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE--VCFLASIQHRNLVTLLGYCQ 146
             IG+G++GEV+ G  + G  VA+K         +  E  +     ++H N++  +    
Sbjct: 43  KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADI 101

Query: 147 ENNLQ----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS- 201
           +        +LI +Y  NGS+  +L          L+ K  L +A  +  GL HLH+   
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYL------KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155

Query: 202 -----PRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVA--GPSSQV-----TAD 248
                P + H+D K+ N+LV ++    +AD GL   F+  T+     P+++V        
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215

Query: 249 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 308
           E+   S  +   +    +D+YSFG+ L E+   R  S  +  +      +LV +   + +
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLPYHDLVPSDPSYED 274

Query: 309 LLK-ILDERL-----WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 362
           + + +  ++L         ++E + +  +L+  C   +   R +   V   L   + +  
Sbjct: 275 MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL-AKMSESQ 333

Query: 363 NL 364
           ++
Sbjct: 334 DI 335

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  168 bits (427), Expect = 1e-49
 Identities = 61/302 (20%), Positives = 118/302 (39%), Gaps = 50/302 (16%)

Query: 89  NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE--VCFLASIQHRNLVTLLGYCQ 146
             +G+G++GEV++G  Q G  VA+K       + +  E  +     ++H N++  +    
Sbjct: 14  ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDM 72

Query: 147 ENNLQ----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS- 201
            +       +LI  Y   GS+  +L          L+    L I L  A GLAHLH    
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYL------QLTTLDTVSCLRIVLSIASGLAHLHIEIF 126

Query: 202 -----PRVVHKDFKTANVLVDEDFIAKVADAGL---RNFLGRTDVAGPSSQV-----TAD 248
                P + H+D K+ N+LV ++    +AD GL    +        G + +V      A 
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186

Query: 249 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP------------DSSQDL 296
           E+   +   +     ++ D+++FG+ L E+     ++  +               S +D+
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246

Query: 297 VELV--QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
            ++V     R       I +   W   ++  +    +L+  C   +   R +   +   L
Sbjct: 247 RKVVCVDQQR-----PNIPNR--WF--SDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297

Query: 355 DR 356
            +
Sbjct: 298 TK 299

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  165 bits (421), Expect = 2e-48
 Identities = 57/293 (19%), Positives = 105/293 (35%), Gaps = 44/293 (15%)

Query: 84  NFSD---KNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCFLASIQH 135
            F       LIG+G+FG+VY G       VAI+            + F  EV      +H
Sbjct: 31  PFEQLEIGELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88

Query: 136 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 195
            N+V  +G C       +I       ++   +       +  L+      IA    KG+ 
Sbjct: 89  ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA----KIVLDVNKTRQIAQEIVKGMG 144

Query: 196 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD------- 248
           +LH  +  ++HKD K+ NV  D   +  + D GL +  G         ++          
Sbjct: 145 YLH--AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHL 201

Query: 249 --EIF---LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS 303
             EI         ++   FS+ SDV++ G    EL +      +      + ++  +   
Sbjct: 202 APEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA---EAIIWQMGT- 257

Query: 304 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 356
                +   L +           +E   +++ C     E RP+ + ++  L++
Sbjct: 258 ----GMKPNLSQIGMG-------KEISDILLFCWAFEQEERPTFTKLMDMLEK 299

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  148 bits (375), Expect = 9e-42
 Identities = 80/326 (24%), Positives = 133/326 (40%), Gaps = 50/326 (15%)

Query: 59  RNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLL-----QDGMLVAIK 113
             +G     R+  +F+   L            +G+G FG V            G +VA+K
Sbjct: 24  GAMGSAFEDRDPTQFEERHLKF-------LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK 76

Query: 114 K-RPGAPTQ--EFIDEVCFLASIQHRNLVTLLGYCQENNLQ--FLIYEYIPNGSVSIHLY 168
           K +        +F  E+  L S+QH N+V   G C     +   LI EY+P GS+  +L 
Sbjct: 77  KLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL- 135

Query: 169 GPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 228
              Q  +++++    L       KG+ +L +   R +H+D  T N+LV+ +   K+ D G
Sbjct: 136 ---QKHKERIDHIKLLQYTSQICKGMEYLGTK--RYIHRDLATRNILVENENRVKIGDFG 190

Query: 229 L-RNFLGRTDVAGPSSQVTADE-----IF-LASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
           L +      +           E     IF  A E     +FS  SDV+SFGV L EL + 
Sbjct: 191 LTKVLPQDKEYY------KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 244

Query: 282 REASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGME-------EFIQLIV 334
            E S S   +  + +    Q      +L+++L         N  +        E   ++ 
Sbjct: 245 IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN-------NGRLPRPDGCPDEIYMIMT 297

Query: 335 RCLDPSSERRPSMSDVVTELDRTLDK 360
            C + +  +RPS  D+   +D+  D+
Sbjct: 298 ECWNNNVNQRPSFRDLALRVDQIRDQ 323

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  146 bits (370), Expect = 2e-41
 Identities = 76/294 (25%), Positives = 124/294 (42%), Gaps = 43/294 (14%)

Query: 91  IGEGKFGEVYKGLL-----QDGMLVAIKK-RPGAPTQ--EFIDEVCFLASIQHRNLVTLL 142
           +G+G FG V            G +VA+KK +        +F  E+  L S+QH N+V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 143 GYCQENNLQ--FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 200
           G C     +   LI EY+P GS+  +L    Q  +++++    L       KG+ +L + 
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQICKGMEYLGTK 133

Query: 201 SPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADE-----IF-LA 253
             R +H+D  T N+LV+ +   K+ D GL +      +           E     IF  A
Sbjct: 134 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF------KVKEPGESPIFWYA 185

Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 313
            E     +FS  SDV+SFGV L EL +  E S S   +  + +    Q      +L+++L
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245

Query: 314 DERLWSTFTNEGME-------EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 360
                    N  +        E   ++  C + +  +RPS  D+   +D+  D 
Sbjct: 246 KN-------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  143 bits (362), Expect = 7e-40
 Identities = 82/324 (25%), Positives = 130/324 (40%), Gaps = 53/324 (16%)

Query: 66  SIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKK-RPGAP 119
           + ++   F+   L   ++       +G+G FG V            G LVA+K+ +   P
Sbjct: 13  ACQDPTIFEERHLKYISQ-------LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP 65

Query: 120 TQ--EFIDEVCFLASIQHRNLVTLLGYCQENNLQ--FLIYEYIPNGSVSIHLYGPSQVSR 175
            Q  +F  E+  L ++    +V   G       Q   L+ EY+P+G +   L    Q  R
Sbjct: 66  DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL----QRHR 121

Query: 176 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLG 234
            +L+    L  +    KG+ +L S   R VH+D    N+LV+ +   K+AD GL +    
Sbjct: 122 ARLDASRLLLYSSQICKGMEYLGSR--RCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179

Query: 235 RTDVAGPSSQVTADE-----IF-LASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSS 287
             D           E     IF  A E      FS +SDV+SFGV L EL +   ++ S 
Sbjct: 180 DKDYY------VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP 233

Query: 288 LSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGME-------EFIQLIVRCLDPS 340
            +        E    +   S LL++L+E        + +        E  +L+  C  PS
Sbjct: 234 SAEFLRMMGCERDVPAL--SRLLELLEE-------GQRLPAPPACPAEVHELMKLCWAPS 284

Query: 341 SERRPSMSDVVTELDRTLDKEMNL 364
            + RPS S +  +LD         
Sbjct: 285 PQDRPSFSALGPQLDMLWSGSRGC 308

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  142 bits (359), Expect = 1e-39
 Identities = 71/294 (24%), Positives = 118/294 (40%), Gaps = 51/294 (17%)

Query: 91  IGEGKFGEVYKGLL-----QDGMLVAIKK-RPGAPT---QEFIDEVCFLASIQHRNLVTL 141
           +GEG FG+V            G  VA+K  +P +      +   E+  L ++ H N+V  
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88

Query: 142 LGYCQENNLQ--FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 199
            G C E+      LI E++P+GS+  +L      ++ K+  K +L  A+   KG+ +L S
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL----PKNKNKINLKQQLKYAVQICKGMDYLGS 144

Query: 200 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF-LASEVKE 258
              + VH+D    NVLV+ +   K+ D GL   +                +F  A E   
Sbjct: 145 R--QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLM 202

Query: 259 FRRFSEKSDVYSFGVFLLELVS-GREASSSLSPD-----------SSQDLVELVQNSRDF 306
             +F   SDV+SFGV L EL++     SS ++             +   LV  ++     
Sbjct: 203 QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE---- 258

Query: 307 SNLLKILDERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDR 356
                   +RL              E  QL+ +C +     R S  +++   + 
Sbjct: 259 -------GKRL------PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  143 bits (362), Expect = 3e-39
 Identities = 75/284 (26%), Positives = 118/284 (41%), Gaps = 42/284 (14%)

Query: 91  IGEGKFGEVYKGLLQ-DGMLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTLLGYC 145
           IG G FGEV+ G L+ D  LVA+K  R   P     +F+ E   L    H N+V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 146 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 205
            +    +++ E +  G     L    +    +L  K  L +   AA G+ +L S     +
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL----RTEGARLRVKTLLQMVGDAAAGMEYLESK--CCI 235

Query: 206 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---FLASEVKEFRRF 262
           H+D    N LV E  + K++D G+            ++     ++   + A E   + R+
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVY---AASGGLRQVPVKWTAPEALNYGRY 292

Query: 263 SEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLVELVQNSRDFSNLLKILDERLW 318
           S +SDV+SFG+ L E  S G        P    S+Q   E V+              RL 
Sbjct: 293 SSESDVWSFGILLWETFSLGAS------PYPNLSNQQTREFVEK-----------GGRLP 335

Query: 319 STFTNEGMEEFI-QLIVRCLDPSSERRPSMSDVVTELDRTLDKE 361
                E   + + +L+ +C      +RPS S +  EL     + 
Sbjct: 336 CP---ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  138 bits (351), Expect = 8e-39
 Identities = 77/291 (26%), Positives = 124/291 (42%), Gaps = 64/291 (21%)

Query: 88  KNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT-QEFIDEVCFLASIQHRNLVTLLGYC 145
              IG G+FG V+ G   +   VAIK  R GA + ++FI+E   +  + H  LV L G C
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 146 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 205
            E     L+ E++ +G +S +L    +  R     +  L + L   +G+A+L      V+
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYL----RTQRGLFAAETLLGMCLDVCEGMAYLEEA--CVI 126

Query: 206 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS----------- 254
           H+D    N LV E+ + KV+D G+             ++   D+ + +S           
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGM-------------TRFVLDDQYTSSTGTKFPVKWAS 173

Query: 255 -EVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLVELVQNSRDFSNL 309
            EV  F R+S KSDV+SFGV + E+ S G+       P    S+ ++VE +         
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGK------IPYENRSNSEVVEDIST------- 220

Query: 310 LKILDERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDR 356
                 RL                 Q++  C     E RP+ S ++ +L  
Sbjct: 221 ----GFRL------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 261

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  138 bits (351), Expect = 1e-38
 Identities = 66/289 (22%), Positives = 125/289 (43%), Gaps = 50/289 (17%)

Query: 88  KNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT-QEFIDEVCFLASIQHRNLVTLLGYC 145
              +G G+FG V  G  +    VAIK  + G+ +  EFI+E   + ++ H  LV L G C
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 146 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 205
            +    F+I EY+ NG +  +L    +  R + + +  L +     + + +L S   + +
Sbjct: 89  TKQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCEAMEYLESK--QFL 142

Query: 206 HKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV----TADEIFLASEVKEFR 260
           H+D    N LV++  + KV+D GL R  L     +   S+     +  E+ +      + 
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM------YS 196

Query: 261 RFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLVELVQNSRDFSNLLKILDER 316
           +FS KSD+++FGV + E+ S G+       P    ++ +  E +               R
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGK------MPYERFTNSETAEHIAQ-----------GLR 239

Query: 317 LWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 361
           L              +   ++  C    ++ RP+   +++ +   +D+E
Sbjct: 240 L------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  137 bits (348), Expect = 2e-38
 Identities = 67/295 (22%), Positives = 123/295 (41%), Gaps = 64/295 (21%)

Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT-QEFIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FG V  G  +    VA+K  + G+ +  EF  E   +  + H  LV   G C + 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75

Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 208
              +++ EYI NG +  +L    +   + LE    L +     +G+A L S   + +H+D
Sbjct: 76  YPIYIVTEYISNGCLLNYL----RSHGKGLEPSQLLEMCYDVCEGMAFLESH--QFIHRD 129

Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS------------EV 256
               N LVD D   KV+D G+             ++   D+ +++S            EV
Sbjct: 130 LAARNCLVDRDLCVKVSDFGM-------------TRYVLDDQYVSSVGTKFPVKWSAPEV 176

Query: 257 KEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLVELVQNSRDFSNLLKI 312
             + ++S KSDV++FG+ + E+ S G+       P    ++ ++V  V            
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFSLGK------MPYDLYTNSEVVLKVSQ---------- 220

Query: 313 LDERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 363
              RL                 Q++  C     E+RP+   +++ ++   +K+ +
Sbjct: 221 -GHRL------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDKH 268

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  137 bits (347), Expect = 4e-38
 Identities = 76/294 (25%), Positives = 124/294 (42%), Gaps = 58/294 (19%)

Query: 88  KNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLVTLLGYC- 145
              IG+G+FG+V  G  + G  VA+K  +  A  Q F+ E   +  ++H NLV LLG   
Sbjct: 26  LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 84

Query: 146 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 205
           +E    +++ EY+  GS+  +L       R  L     L  +L   + + +L       V
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGN--NFV 139

Query: 206 HKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV------TADEIFLASEVKE 258
           H+D    NVLV ED +AKV+D GL +      + +            TA E         
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALR------ 187

Query: 259 FRRFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLVELVQNSRDFSNLLKILD 314
            ++FS KSDV+SFG+ L E+ S GR       P      +D+V  V+             
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGR------VPYPRIPLKDVVPRVEK-----------G 230

Query: 315 ERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNL 364
            ++      +  +       +++  C    +  RPS   +  +L+     E++L
Sbjct: 231 YKM------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHELHL 278

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  141 bits (358), Expect = 5e-38
 Identities = 73/294 (24%), Positives = 128/294 (43%), Gaps = 42/294 (14%)

Query: 89  NLIGEGKFGEVYKGLLQD-GMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYC 145
           + +G G++GEVY+G+ +   + VA+K  +      E F+ E   +  I+H NLV LLG C
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 285

Query: 146 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 205
                 ++I E++  G++  +L    + +RQ++     L +A   +  + +L       +
Sbjct: 286 TREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK--NFI 340

Query: 206 HKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSE 264
           H++    N LV E+ + KVAD GL R   G T  A   ++      + A E   + +FS 
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFSI 398

Query: 265 KSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN 323
           KSDV++FGV L E+ + G      +       + EL++            D R       
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGI---DLSQVYELLEK-----------DYR------- 437

Query: 324 EGM-------EEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGE 370
             M       E+  +L+  C   +   RPS +++    +    +      V  E
Sbjct: 438 --MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 489

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  140 bits (356), Expect = 6e-38
 Identities = 76/297 (25%), Positives = 122/297 (41%), Gaps = 64/297 (21%)

Query: 88  KNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLVTLLGYC- 145
              IG+G+FG+V  G  + G  VA+K  +  A  Q F+ E   +  ++H NLV LLG   
Sbjct: 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 256

Query: 146 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 205
           +E    +++ EY+  GS+  +L       R  L     L  +L   + + +L       V
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGN--NFV 311

Query: 206 HKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV------TADEIFLASEVKE 258
           H+D    NVLV ED +AKV+D GL +      + +            TA E         
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALR------ 359

Query: 259 FRRFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLVELVQNSRDFSNLLKILD 314
            ++FS KSDV+SFG+ L E+ S GR       P      +D+V  V+             
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGR------VPYPRIPLKDVVPRVEK-----------G 402

Query: 315 ERLWSTFTNEGME-------EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNL 364
            +         M+           ++  C    +  RP+   +  +L+     E++L
Sbjct: 403 YK---------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHELHL 450

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  136 bits (345), Expect = 2e-37
 Identities = 68/297 (22%), Positives = 119/297 (40%), Gaps = 49/297 (16%)

Query: 91  IGEGKFGEVYKGLLQD-----GMLVAIKK-RPGAPT---QEFIDEVCFLASIQHRNLVTL 141
           +GEG FG+V            G +VA+K  +  A       +  E+  L ++ H +++  
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 142 LGYCQENNLQ--FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 199
            G C++       L+ EY+P GS+  +L       R  +     L  A    +G+A+LH+
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYL------PRHSIGLAQLLLFAQQICEGMAYLHA 152

Query: 200 LSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADE-----IF-L 252
                +H+D    NVL+D D + K+ D GL +      +           E     +F  
Sbjct: 153 Q--HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY------RVREDGDSPVFWY 204

Query: 253 ASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK 311
           A E  +  +F   SDV+SFGV L EL++    + S  +       +   Q       L +
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA--QGQMTVLRLTE 262

Query: 312 ILDERLWSTFTNEGME-------EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 361
           +L+         E +        E   L+  C +  +  RP+  +++  L    +K 
Sbjct: 263 LLER-------GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  136 bits (345), Expect = 2e-37
 Identities = 68/300 (22%), Positives = 126/300 (42%), Gaps = 58/300 (19%)

Query: 76  EELSLATKNFSDKNLIGEGKFGEVYKGLLQDG-----MLVAIKK-RPGAPTQ---EFIDE 126
            E             +G G FG VYKGL         + VAIK+ R     +   E +DE
Sbjct: 15  TEFKKIKV-------LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67

Query: 127 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 186
              +AS+ + ++  LLG C  + +Q LI + +P G +  ++    +  +  +  ++ L+ 
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNW 122

Query: 187 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 246
            +  AKG+ +L     R+VH+D    NVLV      K+ D GL   LG  +      +  
Sbjct: 123 CVQIAKGMNYLEDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-----KEYH 175

Query: 247 ADEIFL-----ASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELV 300
           A+   +     A E    R ++ +SDV+S+GV + EL++ G +    +      ++  ++
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSIL 232

Query: 301 QNSRDFSNLLKILDERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDR 356
           +             ERL              +   ++ +C    ++ RP   +++ E  +
Sbjct: 233 EK-----------GERL------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSK 275

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  139 bits (351), Expect = 3e-37
 Identities = 67/287 (23%), Positives = 120/287 (41%), Gaps = 58/287 (20%)

Query: 89  NLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT-QEFIDEVCFLASIQHRNLVTLLGYCQ 146
             +G G+FGEV+         VA+K  +PG+ + + F+ E   + ++QH  LV L     
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 253

Query: 147 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 206
           +  + ++I E++  GS+   L         K      +  +   A+G+A +       +H
Sbjct: 254 KEPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQR--NYIH 307

Query: 207 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS------------ 254
           +D + AN+LV    + K+AD GL             ++V  D  + A             
Sbjct: 308 RDLRAANILVSASLVCKIADFGL-------------ARVIEDNEYTAREGAKFPIKWTAP 354

Query: 255 EVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 313
           E   F  F+ KSDV+SFG+ L+E+V+ GR     +   S+ +++  ++            
Sbjct: 355 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM---SNPEVIRALER----------- 400

Query: 314 DERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDR 356
             R+         E    E   +++RC     E RP+   + + LD 
Sbjct: 401 GYRM------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 441

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  138 bits (349), Expect = 5e-37
 Identities = 72/284 (25%), Positives = 123/284 (43%), Gaps = 52/284 (18%)

Query: 89  NLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQ 146
             +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249

Query: 147 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 206
           E  + +++ EY+  GS+   L G +    + L     + +A   A G+A++  +    VH
Sbjct: 250 EEPI-YIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERM--NYVH 303

Query: 207 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS------------ 254
           +D + AN+LV E+ + KVAD GL             +++  D  + A             
Sbjct: 304 RDLRAANILVGENLVCKVADFGL-------------ARLIEDNEYTARQGAKFPIKWTAP 350

Query: 255 EVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 313
           E   + RF+ KSDV+SFG+ L EL + GR     +    ++++++ V+            
Sbjct: 351 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQVER----------- 396

Query: 314 DERLWSTFTNEGM-EEFIQLIVRCLDPSSERRPSMSDVVTELDR 356
             R+          E    L+ +C     E RP+   +   L+ 
Sbjct: 397 GYRMPCP---PECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 437

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  138 bits (350), Expect = 1e-36
 Identities = 72/284 (25%), Positives = 123/284 (43%), Gaps = 52/284 (18%)

Query: 89  NLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQ 146
             +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332

Query: 147 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 206
           E  + +++ EY+  GS+   L G +    + L     + +A   A G+A++  +    VH
Sbjct: 333 EEPI-YIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERM--NYVH 386

Query: 207 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS------------ 254
           +D + AN+LV E+ + KVAD GL             +++  D  + A             
Sbjct: 387 RDLRAANILVGENLVCKVADFGL-------------ARLIEDNEYTARQGAKFPIKWTAP 433

Query: 255 EVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 313
           E   + RF+ KSDV+SFG+ L EL + GR     +    ++++++ V+            
Sbjct: 434 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQVER----------- 479

Query: 314 DERLWSTFTNEGM-EEFIQLIVRCLDPSSERRPSMSDVVTELDR 356
             R+          E    L+ +C     E RP+   +   L+ 
Sbjct: 480 GYRMPCP---PECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 520

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  133 bits (336), Expect = 2e-36
 Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 33/204 (16%)

Query: 91  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT-QEFIDEVCFLASIQHRNLVTLLGYCQEN 148
           +G G+FGEV+ G       VA+K  + G+ +   F+ E   +  +QH+ LV L     + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80

Query: 149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 208
            + ++I EY+ NGS+   L  PS     KL     L +A   A+G+A +       +H+D
Sbjct: 81  PI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEER--NYIHRD 134

Query: 209 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS------------EV 256
            + AN+LV +    K+AD GL             +++  D  + A             E 
Sbjct: 135 LRAANILVSDTLSCKIADFGL-------------ARLIEDNEYTAREGAKFPIKWTAPEA 181

Query: 257 KEFRRFSEKSDVYSFGVFLLELVS 280
             +  F+ KSDV+SFG+ L E+V+
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVT 205

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  132 bits (335), Expect = 2e-36
 Identities = 74/306 (24%), Positives = 130/306 (42%), Gaps = 64/306 (20%)

Query: 88  KNLIGEGKFGEVYKGLLQDG-MLVAIKK-RPGAPT-QEFIDEVCFLASIQHRNLVTLLGY 144
           K+ +G G++GEVY+G+ +   + VA+K  +      +EF+ E   +  I+H NLV LLG 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 204
           C      ++I E++  G++  +L    + +RQ++     L +A   +  + +L       
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK--NF 132

Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS---------- 254
           +H+D    N LV E+ + KVAD GL             S++   + + A           
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGL-------------SRLMTGDTYTAHAGAKFPIKWT 179

Query: 255 --EVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLVELVQNSRDFSN 308
             E   + +FS KSDV++FGV L E+ + G       SP        + EL++       
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGM------SPYPGIDLSQVYELLEK------ 227

Query: 309 LLKILDERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNL 364
                D R+      E  E    +  +L+  C   +   RPS +++    +    +    
Sbjct: 228 -----DYRM------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 276

Query: 365 TTVMGE 370
             V  E
Sbjct: 277 DEVEKE 282

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  133 bits (337), Expect = 3e-36
 Identities = 77/324 (23%), Positives = 132/324 (40%), Gaps = 60/324 (18%)

Query: 70  ARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGML-----VAIKK-RPGAPTQ-- 121
           AR F+  EL            +G G FG V+KG+           V IK     +  Q  
Sbjct: 7   ARIFKETELRKLKV-------LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF 59

Query: 122 -EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF 180
               D +  + S+ H ++V LLG C  ++LQ L+ +Y+P GS+  H+    +  R  L  
Sbjct: 60  QAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHV----RQHRGALGP 114

Query: 181 KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 240
           +  L+  +  AKG+ +L      +VH++    NVL+      +VAD G+ + L   D   
Sbjct: 115 QLLLNWGVQIAKGMYYLEEH--GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL 172

Query: 241 PSSQV------TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSS 293
             S+        A E         F +++ +SDV+S+GV + EL++ G E  + L     
Sbjct: 173 LYSEAKTPIKWMALESIH------FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL--- 223

Query: 294 QDLVELVQNSRDFSNLLKILDERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSD 349
            ++ +L++             ERL         +    +   ++V+C       RP+  +
Sbjct: 224 AEVPDLLEK-----------GERL------AQPQICTIDVYMVMVKCWMIDENIRPTFKE 266

Query: 350 VVTELDRTLDKEMNLTTVMGEGTP 373
           +  E  R          +  E  P
Sbjct: 267 LANEFTRMARDPPRYLVIKRESGP 290

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  132 bits (334), Expect = 8e-36
 Identities = 76/289 (26%), Positives = 117/289 (40%), Gaps = 58/289 (20%)

Query: 91  IGEGKFGEVYKGLLQDG----MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVTLL 142
           IG G  GEV  G L+      + VAIK  + G   ++   F+ E   +    H N++ L 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116

Query: 143 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 202
           G      L  ++ EY+ NGS+   L    +    +      + +  G   G+ +L  L  
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL----RTHDGQFTIMQLVGMLRGVGAGMRYLSDL-- 170

Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV------TADEIFLASE 255
             VH+D    NVLVD + + KV+D GL R      D A  ++        TA E      
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA--- 227

Query: 256 VKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLVELVQNSRDFSNLLK 311
              FR FS  SDV+SFGV + E+++ G        P    +++D++  V+          
Sbjct: 228 ---FRTFSSASDVWSFGVVMWEVLAYGE------RPYWNMTNRDVISSVEE--------- 269

Query: 312 ILDERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDR 356
               RL                 QL++ C      +RP  S +V+ LD 
Sbjct: 270 --GYRL------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDA 310

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  132 bits (334), Expect = 9e-36
 Identities = 69/306 (22%), Positives = 130/306 (42%), Gaps = 51/306 (16%)

Query: 91  IGEGKFGEVYKGLLQDG-----MLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTL 141
           +G G FG VYKGL         + VAIK+ R     +   E +DE   +AS+ + ++  L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 201
           LG C  + +Q LI + +P G +  ++    +  +  +  ++ L+  +  AKG+ +L    
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLEDR- 136

Query: 202 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-----ASEV 256
            R+VH+D    NVLV      K+ D GL   LG  +      +  A+   +     A E 
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-----KEYHAEGGKVPIKWMALES 190

Query: 257 KEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 315
              R ++ +SDV+S+GV + EL++ G +    +      ++  +++             E
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSILEK-----------GE 236

Query: 316 RLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEG 371
           RL              +   ++V+C    ++ RP   +++ E  +          + G+ 
Sbjct: 237 RL------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDE 290

Query: 372 TPTVTL 377
              +  
Sbjct: 291 RMHLPS 296

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  131 bits (331), Expect = 1e-35
 Identities = 71/294 (24%), Positives = 118/294 (40%), Gaps = 46/294 (15%)

Query: 88  KNLIGEGKFGEVYKGLLQDG----MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLV 139
             +IG+G FG VY G   D     +  AIK        Q+   F+ E   +  + H N++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 140 TLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 198
            L+G       L  ++  Y+ +G +   +    +  ++    K  +S  L  A+G+ +L 
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFI----RSPQRNPTVKDLISFGLQVARGMEYLA 141

Query: 199 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF----LAS 254
               + VH+D    N ++DE F  KVAD GL   +   +         A         A 
Sbjct: 142 EQ--KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHA--RLPVKWTAL 197

Query: 255 EVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 313
           E  +  RF+ KSDV+SFGV L EL++ G      + P    DL   +   R         
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP---FDLTHFLAQGR--------- 245

Query: 314 DERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 363
             RL         E       Q++ +C +     RP+   +V E+++ +   + 
Sbjct: 246 --RL------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  132 bits (333), Expect = 1e-35
 Identities = 74/298 (24%), Positives = 133/298 (44%), Gaps = 47/298 (15%)

Query: 91  IGEGKFGEVYKGLLQDG-----MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVTL 141
           IG G+FGEVYKG+L+       + VAIK  + G   ++   F+ E   +    H N++ L
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111

Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 201
            G   +     +I EY+ NG++   L    +    +      + +  G A G+ +L ++ 
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFL----REKDGEFSVLQLVGMLRGIAAGMKYLANM- 166

Query: 202 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFR 260
              VH+D    N+LV+ + + KV+D GL   L     A  ++      I + A E   +R
Sbjct: 167 -NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225

Query: 261 RFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLVELVQNSRDFSNLLKILDER 316
           +F+  SDV+SFG+ + E+++ G        P    S+ ++++ + +             R
Sbjct: 226 KFTSASDVWSFGIVMWEVMTYGE------RPYWELSNHEVMKAIND-----------GFR 268

Query: 317 LWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGE 370
           L                 QL+++C      RRP  +D+V+ LD+ +    +L T+   
Sbjct: 269 L------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADF 320

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  130 bits (330), Expect = 2e-35
 Identities = 66/288 (22%), Positives = 113/288 (39%), Gaps = 52/288 (18%)

Query: 88  KNLIGEGKFGEVYKGLLQDG---MLVAIKK-RPGAP---TQEFIDEVCFLASIQHRNLVT 140
              +G G FG V +G+ +     + VAIK  + G     T+E + E   +  + +  +V 
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 200
           L+G CQ   L  L+ E    G +   L       R+++   +   +    + G+ +L   
Sbjct: 75  LIGVCQAEAL-MLVMEMAGGGPLHKFL----VGKREEIPVSNVAELLHQVSMGMKYLEEK 129

Query: 201 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAGPSSQV----TADEIFLA 253
               VH+D    NVL+     AK++D GL   LG  D    A  + +      A E    
Sbjct: 130 --NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN- 186

Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKI 312
                FR+FS +SDV+S+GV + E +S G++    +      +++  ++           
Sbjct: 187 -----FRKFSSRSDVWSYGVTMWEALSYGQKPYKKM---KGPEVMAFIEQ---------- 228

Query: 313 LDERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDR 356
             +R+      E       E   L+  C     E RP    V   +  
Sbjct: 229 -GKRM------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 269

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  130 bits (328), Expect = 3e-35
 Identities = 71/295 (24%), Positives = 116/295 (39%), Gaps = 54/295 (18%)

Query: 91  IGEGKFGEVYKGLLQ----DGMLVAIKK-RPGAPTQ-----EFIDEVCFLASIQHRNLVT 140
           +G+G FG V +G         + VA+K  +P   +Q     +FI EV  + S+ HRNL+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 200
           L G      ++ ++ E  P GS+   L    +  +           A+  A+G+ +L S 
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRL----RKHQGHFLLGTLSRYAVQVAEGMGYLESK 140

Query: 201 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAGPSSQV----TADEIFLA 253
             R +H+D    N+L+    + K+ D GL   L + D   V     +V     A E    
Sbjct: 141 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK- 197

Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKI 312
                 R FS  SD + FGV L E+ + G+E    L+      ++  +            
Sbjct: 198 -----TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILHKIDKEG-------- 241

Query: 313 LDERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 363
             ERL         E    +   ++V+C     E RP+   +   L      +M 
Sbjct: 242 --ERL------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR 288

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  130 bits (328), Expect = 4e-35
 Identities = 72/292 (24%), Positives = 120/292 (41%), Gaps = 52/292 (17%)

Query: 89  NLIGEGKFGEVYKGLLQDG----MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVT 140
            +IG G FG VY G L D     +  A+K         E   F+ E   +    H N+++
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 141 LLGYCQENNLQ-FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 199
           LLG C  +     ++  Y+ +G +   +    +        K  +   L  AKG+ +L S
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKYLAS 146

Query: 200 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-----AS 254
              + VH+D    N ++DE F  KVAD GL   +   +     S        L     A 
Sbjct: 147 K--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE---YYSVHNKTGAKLPVKWMAL 201

Query: 255 EVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 313
           E  + ++F+ KSDV+SFGV L EL++ G      ++     D+   +   R        L
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVYLLQGR-------RL 251

Query: 314 D------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 359
                  + L+            +++++C  P +E RPS S++V+ +     
Sbjct: 252 LQPEYCPDPLY------------EVMLKCWHPKAEMRPSFSELVSRISAIFS 291

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  131 bits (332), Expect = 4e-35
 Identities = 70/297 (23%), Positives = 117/297 (39%), Gaps = 54/297 (18%)

Query: 89  NLIGEGKFGEVYKGLLQDG----MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVT 140
            +IG G FG VY G L D     +  A+K         E   F+ E   +    H N+++
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 141 LLGYCQENNLQ-FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 199
           LLG C  +     ++  Y+ +G +   +    +        K  +   L  AKG+  L S
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKFLAS 210

Query: 200 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-----AS 254
              + VH+D    N ++DE F  KVAD GL   +   +     S        L     A 
Sbjct: 211 K--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE---FDSVHNKTGAKLPVKWMAL 265

Query: 255 EVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 313
           E  + ++F+ KSDV+SFGV L EL++ G      ++     D+   +             
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVYLLQ----------- 311

Query: 314 DERLWSTFTNEGME-------EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 363
             R         +           +++++C  P +E RPS S++V+ +       + 
Sbjct: 312 GRR---------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  128 bits (325), Expect = 9e-35
 Identities = 68/305 (22%), Positives = 130/305 (42%), Gaps = 69/305 (22%)

Query: 88  KNLIGEGKFGEVYKGLL------QDGMLVAIKK-RPGAPT--QEFIDEVCFLASIQHRNL 138
           K  +GEG FG+V+          +D MLVA+K  +       ++F  E   L ++QH ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79

Query: 139 VTLLGYCQENNLQFLIYEYIPNGS-----------VSIHLYGPSQVSRQKLEFKHRLSIA 187
           V   G C + +   +++EY+ +G              I + G  + ++ +L     L IA
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 188 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD--VAGPSSQV 245
              A G+ +L S     VH+D  T N LV  + + K+ D G+   +  TD    G  + +
Sbjct: 140 SQIASGMVYLASQ--HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197

Query: 246 ----TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLV 297
                  E  +      +R+F+ +SDV+SFGV L E+ + G+       P    S+ +++
Sbjct: 198 PIRWMPPESIM------YRKFTTESDVWSFGVILWEIFTYGK------QPWFQLSNTEVI 245

Query: 298 ELVQNSRDFSNLLKILD------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
           E +   R       +L+      + ++             +++ C     ++R ++ ++ 
Sbjct: 246 ECITQGR-------VLERPRVCPKEVY------------DVMLGCWQREPQQRLNIKEIY 286

Query: 352 TELDR 356
             L  
Sbjct: 287 KILHA 291

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  129 bits (327), Expect = 1e-34
 Identities = 72/314 (22%), Positives = 126/314 (40%), Gaps = 68/314 (21%)

Query: 91  IGEGKFGEVYKGLLQDG------MLVAIKK-RPGAPTQ--EFIDEVCFLASIQHRNLVTL 141
           +GEG FG+V+     +       MLVA+K  +  + +   +F  E   L  +QH+++V  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 142 LGYCQENNLQFLIYEYIPNGS----------VSIHLYGPSQVSRQKLEFKHRLSIALGAA 191
            G C E     +++EY+ +G            +  L G   V+   L     L++A   A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168

Query: 192 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV--AGPSSQV---- 245
            G+ +L  L    VH+D  T N LV +  + K+ D G+   +  TD    G  + +    
Sbjct: 169 AGMVYLAGL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 226

Query: 246 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLVELVQ 301
              E  L      +R+F+ +SDV+SFGV L E+ + G+       P    S+ + ++ + 
Sbjct: 227 MPPESIL------YRKFTTESDVWSFGVVLWEIFTYGK------QPWYQLSNTEAIDCIT 274

Query: 302 NSRDFSNLLKILD------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 355
             R        L+        ++             ++  C     ++R S+ DV   L 
Sbjct: 275 QGR-------ELERPRACPPEVY------------AIMRGCWQREPQQRHSIKDVHARLQ 315

Query: 356 RTLDKEMNLTTVMG 369
                      V+G
Sbjct: 316 ALAQAPPVYLDVLG 329

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  128 bits (324), Expect = 2e-34
 Identities = 69/319 (21%), Positives = 115/319 (36%), Gaps = 84/319 (26%)

Query: 91  IGEGKFGEVYKGLL------QDGMLVAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 139
           +G G FG+V +            M VA+K  +P A   E    + E+  L+ +  H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 140 TLLGYCQENNLQFLIYEYIPNGS-------------VSIHLYGPSQVSRQKLEFKHRLSI 186
            LLG C       +I EY   G               S       +     L+ +  LS 
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150

Query: 187 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 246
           +   AKG+A L S     +H+D    N+L+    I K+ D GL            +  + 
Sbjct: 151 SYQVAKGMAFLASK--NCIHRDLAARNILLTHGRITKICDFGL------------ARDIK 196

Query: 247 ADEIFLASE-----VK-------EFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSS 293
            D  ++        VK           ++ +SDV+S+G+FL EL S G      +  D  
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-- 254

Query: 294 QDLVELVQNSRDFSNLLKILDERLWSTFTNEG--ME-------EFIQLIVRCLDPSSERR 344
               ++++                      EG  M        E   ++  C D    +R
Sbjct: 255 SKFYKMIK----------------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292

Query: 345 PSMSDVVTELDRTLDKEMN 363
           P+   +V  +++ + +  N
Sbjct: 293 PTFKQIVQLIEKQISESTN 311

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  129 bits (326), Expect = 3e-34
 Identities = 69/302 (22%), Positives = 124/302 (41%), Gaps = 52/302 (17%)

Query: 91  IGEGKFGEVYKGLLQ----DGMLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTLL 142
           +G G+FGEV  G L+      + VAIK  + G   +   +F+ E   +    H N++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112

Query: 143 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 202
           G   ++    ++ EY+ NGS+   L    +    +      + +  G A G+ +L  +  
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMKYLSDM-- 166

Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV------TADEIFLASE 255
             VH+D    N+L++ + + KV+D GL R      + A  +         T+ E      
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA--- 223

Query: 256 VKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 314
              +R+F+  SDV+S+G+ L E++S G      +   S+QD+++ V              
Sbjct: 224 ---YRKFTSASDVWSYGIVLWEVMSYGERPYWEM---SNQDVIKAVDE-----------G 266

Query: 315 ERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGE 370
            RL                 QL++ C       RP    +V+ LD+ +    +L  +   
Sbjct: 267 YRL------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSA 320

Query: 371 GT 372
             
Sbjct: 321 AA 322

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  127 bits (321), Expect = 7e-34
 Identities = 74/311 (23%), Positives = 129/311 (41%), Gaps = 75/311 (24%)

Query: 88  KNLIGEGKFGEVYKGLLQDG---MLVAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 139
           +++IGEG FG+V K  ++     M  AIK+ +  A   +   F  E+  L  +  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 140 TLLGYCQENNLQFLIYEYIPNGS-----------VSIHLYGPSQVSRQKLEFKHRLSIAL 188
            LLG C+     +L  EY P+G+            +   +  +  +   L  +  L  A 
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 189 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTA 247
             A+G+ +L     + +H+D    N+LV E+++AK+AD GL R      +V         
Sbjct: 150 DVARGMDYLSQK--QFIHRDLAARNILVGENYVAKIADFGLSRG----QEVY----VKKT 199

Query: 248 DEIF----LASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLVEL 299
                   +A E   +  ++  SDV+S+GV L E+VS G       +P    +  +L E 
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG------TPYCGMTCAELYEK 253

Query: 300 VQNSRDFSNLLKILDERLWSTFTNEG--ME-------EFIQLIVRCLDPSSERRPSMSDV 350
           +                       +G  +E       E   L+ +C       RPS + +
Sbjct: 254 LP----------------------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 291

Query: 351 VTELDRTLDKE 361
           +  L+R L++ 
Sbjct: 292 LVSLNRMLEER 302

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  126 bits (318), Expect = 9e-34
 Identities = 76/308 (24%), Positives = 118/308 (38%), Gaps = 76/308 (24%)

Query: 88  KNLIGEGKFGEVYKGLLQDG------MLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRN 137
              +GE +FG+VYKG L           VAIK  +  A      EF  E    A +QH N
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 138 LVTLLGYCQENNLQFLIYEYIPNGS-----------VSIHLYGPSQVSRQKLEFKHRLSI 186
           +V LLG   ++    +I+ Y  +G              +      +  +  LE    + +
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 187 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD--VAGPSSQ 244
               A G+ +L S    VVHKD  T NVLV +    K++D GL   +   D      +S 
Sbjct: 134 VAQIAAGMEYLSSH--HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191

Query: 245 V----TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDL 296
           +     A E  +      + +FS  SD++S+GV L E+ S G        P    S+QD+
Sbjct: 192 LPIRWMAPEAIM------YGKFSIDSDIWSYGVVLWEVFSYGL------QPYCGYSNQDV 239

Query: 297 VELVQNSRDFSNLLKILDERLWSTFTNEG--ME-------EFIQLIVRCLDPSSERRPSM 347
           VE+++                          +            L++ C +    RRP  
Sbjct: 240 VEMIR----------------------NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRF 277

Query: 348 SDVVTELD 355
            D+ + L 
Sbjct: 278 KDIHSRLR 285

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  125 bits (317), Expect = 9e-34
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 26/203 (12%)

Query: 91  IGEGKFGEVYKGLLQDG----MLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTLL 142
           +GEG FGEVY+G+  +     + VA+K  +         +F+ E   + ++ H ++V L+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 143 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 202
           G  +E    ++I E  P G +  +L    + ++  L+    +  +L   K +A+L S+  
Sbjct: 80  GIIEEEPT-WIIMELYPYGELGHYL----ERNKNSLKVLTLVLYSLQICKAMAYLESI-- 132

Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD-VAGPSSQV----TADEIFLASEVK 257
             VH+D    N+LV      K+ D GL  ++   D      +++     + E        
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESIN----- 187

Query: 258 EFRRFSEKSDVYSFGVFLLELVS 280
            FRRF+  SDV+ F V + E++S
Sbjct: 188 -FRRFTTASDVWMFAVCMWEILS 209

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  125 bits (316), Expect = 1e-33
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 26/203 (12%)

Query: 91  IGEGKFGEVYKGLLQDG----MLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTLL 142
           IGEG+FG+V++G+        + VAIK  +         +F+ E   +    H ++V L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 143 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 202
           G   EN + ++I E    G +   L    QV +  L+    +  A   +  LA+L S   
Sbjct: 83  GVITENPV-WIIMELCTLGELRSFL----QVRKYSLDLASLILYAYQLSTALAYLESK-- 135

Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD-VAGPSSQV----TADEIFLASEVK 257
           R VH+D    NVLV  +   K+ D GL  ++  +        ++     A E        
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN----- 190

Query: 258 EFRRFSEKSDVYSFGVFLLELVS 280
            FRRF+  SDV+ FGV + E++ 
Sbjct: 191 -FRRFTSASDVWMFGVCMWEILM 212

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  126 bits (319), Expect = 1e-33
 Identities = 61/322 (18%), Positives = 109/322 (33%), Gaps = 88/322 (27%)

Query: 88  KNLIGEGKFGEVYKGLLQD------GMLVAIKK-RPGAPTQE---FIDEVCFLASI-QHR 136
              +G G FG+V +            + VA+K  +  A   E    + E+  ++ + QH 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 137 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHL---------YGPSQVSRQKLEFKHRLSIA 187
           N+V LLG C       +I EY   G +   L              ++      +  L  +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 188 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 247
              A+G+A L S     +H+D    NVL+    +AK+ D GL            +  +  
Sbjct: 171 SQVAQGMAFLASK--NCIHRDVAARNVLLTNGHVAKIGDFGL------------ARDIMN 216

Query: 248 DEIFLASE-----VK-------EFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP---- 290
           D  ++        VK           ++ +SDV+S+G+ L E+ S G       +P    
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL------NPYPGI 270

Query: 291 DSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEG--ME-------EFIQLIVRCLDPSS 341
             +    +LV+                      +G  M            ++  C     
Sbjct: 271 LVNSKFYKLVK----------------------DGYQMAQPAFAPKNIYSIMQACWALEP 308

Query: 342 ERRPSMSDVVTELDRTLDKEMN 363
             RP+   + + L     ++  
Sbjct: 309 THRPTFQQICSFLQEQAQEDRR 330

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  125 bits (316), Expect = 2e-33
 Identities = 54/219 (24%), Positives = 90/219 (41%), Gaps = 33/219 (15%)

Query: 76  EELSLATKNFSDKNLIGEGKFGEVYKGLLQDG---MLVAIKK-RPGAPTQ----EFIDEV 127
           + L+L  K       +G G FG V KG  Q       VA+K  +  A       E + E 
Sbjct: 16  KLLTLEDK------ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA 69

Query: 128 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 187
             +  + +  +V ++G C+  +   L+ E    G ++ +L     V  + +     + + 
Sbjct: 70  NVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNI-----IELV 123

Query: 188 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 247
              + G+ +L       VH+D    NVL+     AK++D GL   L   +     +   A
Sbjct: 124 HQVSMGMKYLEES--NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-----NYYKA 176

Query: 248 DEI------FLASEVKEFRRFSEKSDVYSFGVFLLELVS 280
                    + A E   + +FS KSDV+SFGV + E  S
Sbjct: 177 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  125 bits (316), Expect = 3e-33
 Identities = 64/301 (21%), Positives = 117/301 (38%), Gaps = 58/301 (19%)

Query: 91  IGEGKFGEVYKGLLQDG------MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVT 140
           +G+G FG VY+G+ +          VAIK     A  +E   F++E   +      ++V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHL-----YGPSQVSRQKLEFKHRLSIALGAAKGLA 195
           LLG   +     +I E +  G +  +L        +            + +A   A G+A
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152

Query: 196 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD--VAGPSSQV----TADE 249
           +L++   + VH+D    N +V EDF  K+ D G+   +  TD    G    +     + E
Sbjct: 153 YLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 210

Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSN 308
                       F+  SDV+SFGV L E+ +   +    LS    + ++  V        
Sbjct: 211 SLK------DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQVLRFVMEGG---- 257

Query: 309 LLKILD------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 362
              +LD      + L+            +L+  C   + + RPS  ++++ +   ++   
Sbjct: 258 ---LLDKPDNCPDMLF------------ELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 302

Query: 363 N 363
            
Sbjct: 303 R 303

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  124 bits (313), Expect = 7e-33
 Identities = 62/304 (20%), Positives = 122/304 (40%), Gaps = 66/304 (21%)

Query: 88  KNLIGEGKFGEVYKGLLQDG----MLVAIK--KRPGAPTQE---FIDEVCFLASIQHRNL 138
             ++GEG+FG V +G L+      + VA+K  K   +  +E   F+ E   +    H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 139 VTLLGYC-----QENNLQFLIYEYIPNGSVSIHL-YGPSQVSRQKLEFKHRLSIALGAAK 192
           + LLG C     Q      +I  ++  G +  +L Y   +   + +  +  L   +  A 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 193 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV--AGPSSQV----T 246
           G+ +L +     +H+D    N ++ +D    VAD GL   +   D    G  +++     
Sbjct: 159 GMEYLSNR--NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216

Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLVELVQN 302
           A E          R ++ KSDV++FGV + E+ + G       +P     + ++ + + +
Sbjct: 217 AIESLA------DRVYTSKSDVWAFGVTMWEIATRGM------TPYPGVQNHEMYDYLLH 264

Query: 303 SRDFSNLLKILDERLWSTFTNEGME-------EFIQLIVRCLDPSSERRPSMSDVVTELD 355
                        R         ++       E  +++  C       RP+ S +  +L+
Sbjct: 265 GH-----------R---------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE 304

Query: 356 RTLD 359
           + L+
Sbjct: 305 KLLE 308

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  125 bits (315), Expect = 9e-33
 Identities = 72/359 (20%), Positives = 134/359 (37%), Gaps = 60/359 (16%)

Query: 29  CLYRNRSVSRTSETGSSEPSVQRNICIIAGRN-----VGIELSIREARRFQMEELSLATK 83
            LY   ++    ++   + S  R   I+   N      G   SI + +    + ++L   
Sbjct: 19  NLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITL--- 75

Query: 84  NFSDKNLIGEGKFGEVYKGLLQDG------MLVAIKK-RPGAPTQE---FIDEVCFLASI 133
                  +G G FGEVY+G +         + VA+K        Q+   F+ E   ++  
Sbjct: 76  ----IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 131

Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL--YGPSQVSRQKLEFKHRLSIALGAA 191
            H+N+V  +G   ++  +F++ E +  G +   L    P       L     L +A   A
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191

Query: 192 KGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTD--VAGPSSQV- 245
            G  +L       +H+D    N L+       +AK+ D G+   + R      G  + + 
Sbjct: 192 CGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLP 249

Query: 246 ---TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQ 301
                 E F+         F+ K+D +SFGV L E+ S G     S S    Q+++E V 
Sbjct: 250 VKWMPPEAFM------EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEFVT 300

Query: 302 NSRDFSNLLKILDERLWSTFTNEG-MEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 359
           +             R+      +       +++ +C     E RP+ + ++  ++    
Sbjct: 301 SGG-----------RMDPP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  128 bits (323), Expect = 1e-32
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 25/203 (12%)

Query: 91  IGEGKFGEVYKGLLQDG---MLVAIKK-RPGAP---TQEFIDEVCFLASIQHRNLVTLLG 143
           +G G FG V +G+ +     + VAIK  + G     T+E + E   +  + +  +V L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 144 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 203
            CQ   L  L+ E    G +   L       R+++   +   +    + G+ +L      
Sbjct: 404 VCQAEAL-MLVMEMAGGGPLHKFL----VGKREEIPVSNVAELLHQVSMGMKYLEEK--N 456

Query: 204 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI------FLASEVK 257
            VH++    NVL+     AK++D GL   LG  D     S  TA         + A E  
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD-----SYYTARSAGKWPLKWYAPECI 511

Query: 258 EFRRFSEKSDVYSFGVFLLELVS 280
            FR+FS +SDV+S+GV + E +S
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALS 534

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  123 bits (311), Expect = 2e-32
 Identities = 62/292 (21%), Positives = 114/292 (39%), Gaps = 48/292 (16%)

Query: 91  IGEGKFGEVYKGLLQDG------MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVT 140
           +G G FGEVY+G +         + VA+K        Q+   F+ E   ++   H+N+V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97

Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHL--YGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 198
            +G   ++  +F++ E +  G +   L    P       L     L +A   A G  +L 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157

Query: 199 SLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTD--VAGPSSQV----TADE 249
                 +H+D    N L+       +AK+ D G+   + R      G  + +       E
Sbjct: 158 EN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 215

Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSN 308
            F+         F+ K+D +SFGV L E+ S G     S    S+Q+++E V +      
Sbjct: 216 AFM------EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK---SNQEVLEFVTSGG---- 262

Query: 309 LLKILDERLWSTFTNEG-MEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 359
                  R+      +       +++ +C     E RP+ + ++  ++    
Sbjct: 263 -------RMDPP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  123 bits (310), Expect = 2e-32
 Identities = 60/326 (18%), Positives = 127/326 (38%), Gaps = 61/326 (18%)

Query: 65  LSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDG----MLVAIKK-RPGAP 119
           L I +  + ++E++ +  + F+   ++G+G+FG V +  L+      + VA+K  +    
Sbjct: 5   LGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII 64

Query: 120 T----QEFIDEVCFLASIQHRNLVTLLGYC------QENNLQFLIYEYIPNGSVSIHLYG 169
                +EF+ E   +    H ++  L+G            +  +I  ++ +G +   L  
Sbjct: 65  ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLA 124

Query: 170 PS-QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 228
                +   L  +  +   +  A G+ +L S     +H+D    N ++ ED    VAD G
Sbjct: 125 SRIGENPFNLPLQTLVRFMVDIACGMEYLSSR--NFIHRDLAARNCMLAEDMTVCVADFG 182

Query: 229 LRNFLGRTDV--AGPSSQV----TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-G 281
           L   +   D    G +S++     A E            ++  SDV++FGV + E+++ G
Sbjct: 183 LSRKIYSGDYYRQGCASKLPVKWLALESLA------DNLYTVHSDVWAFGVTMWEIMTRG 236

Query: 282 REASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGME-------EFIQLIV 334
           +   + +      ++   +               R         ++       E   L+ 
Sbjct: 237 QTPYAGIEN---AEIYNYLIGGN-----------R---------LKQPPECMEEVYDLMY 273

Query: 335 RCLDPSSERRPSMSDVVTELDRTLDK 360
           +C     ++RPS + +  EL+  L  
Sbjct: 274 QCWSADPKQRPSFTCLRMELENILGH 299

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  122 bits (309), Expect = 3e-32
 Identities = 70/314 (22%), Positives = 114/314 (36%), Gaps = 75/314 (23%)

Query: 91  IGEGKFGEVYKGLLQD------GMLVAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 139
           +G G FG+V +              VA+K  + GA   E    + E+  L  I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94

Query: 140 TLLGYC-QENNLQFLIYEYIPNGS-----------VSIHLYGPSQVSRQKLEFKHRLSIA 187
            LLG C +      +I E+   G+              +   P  + +  L  +H +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154

Query: 188 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 247
              AKG+  L S   + +H+D    N+L+ E  + K+ D GL   + +            
Sbjct: 155 FQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----VRKG 208

Query: 248 DEIF----LASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP----DSSQDLVE 298
           D       +A E    R ++ +SDV+SFGV L E+ S G       SP       ++   
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA------SPYPGVKIDEEFCR 262

Query: 299 LVQNSRDFSNLLKILDERLWSTFTNEG--ME-------EFIQLIVRCLDPSSERRPSMSD 349
            ++                      EG  M        E  Q ++ C      +RP+ S+
Sbjct: 263 RLK----------------------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE 300

Query: 350 VVTELDRTLDKEMN 363
           +V  L   L     
Sbjct: 301 LVEHLGNLLQANAQ 314

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  123 bits (310), Expect = 3e-32
 Identities = 71/312 (22%), Positives = 130/312 (41%), Gaps = 65/312 (20%)

Query: 88  KNLIGEGKFGEVYKGLLQD--------GMLVAIKK-RPGAPTQE---FIDEVCFLASI-Q 134
              +GEG FG+V                + VA+K  +  A  ++    + E+  +  I +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 135 HRNLVTLLGYCQENNLQFLIYEYIPNGS-----------VSIHLYGPSQVSRQKLEFKHR 183
           H+N++ LLG C ++   ++I EY   G+              + Y  ++V  +++ FK  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 184 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 243
           +S     A+G+ +L S   + +H+D    NVLV E+ + K+AD GL   +   D      
Sbjct: 160 VSCTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY---- 213

Query: 244 QVTADEIF----LASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVE 298
           + T +       +A E    R ++ +SDV+SFGV + E+ + G      +     ++L +
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EELFK 270

Query: 299 LVQNSRDFSNLLKILDERLWSTFTNEGME-------EFIQLIVRCLDPSSERRPSMSDVV 351
           L++              R         M+       E   ++  C      +RP+   +V
Sbjct: 271 LLKEGH-----------R---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310

Query: 352 TELDRTLDKEMN 363
            +LDR L    N
Sbjct: 311 EDLDRILTLTTN 322

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  126 bits (319), Expect = 4e-32
 Identities = 77/313 (24%), Positives = 127/313 (40%), Gaps = 52/313 (16%)

Query: 64  ELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDG----MLVAIKK-RPGA 118
            +        Q E + L          IGEG+FG+V++G+        M VAIK  +   
Sbjct: 378 TMPSTRDYEIQRERIELGRC-------IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT 430

Query: 119 PTQ---EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSR 175
                 +F+ E   +    H ++V L+G   EN + ++I E    G +   L    QV +
Sbjct: 431 SDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFL----QVRK 485

Query: 176 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 235
             L+    +  A   +  LA+L S   R VH+D    NVLV  +   K+ D GL  ++  
Sbjct: 486 FSLDLASLILYAYQLSTALAYLESK--RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543

Query: 236 TDVAGPSSQVTADEIFL-----ASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS 289
           +          A +  L     A E   FRRF+  SDV+ FGV + E++  G +    + 
Sbjct: 544 STY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 597

Query: 290 PDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFI-QLIVRCLDPSSERRPSMS 348
                D++  ++N            ERL            +  L+ +C      RRP  +
Sbjct: 598 N---NDVIGRIEN-----------GERLPMP---PNCPPTLYSLMTKCWAYDPSRRPRFT 640

Query: 349 DVVTELDRTLDKE 361
           ++  +L   L++E
Sbjct: 641 ELKAQLSTILEEE 653

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  122 bits (309), Expect = 6e-32
 Identities = 80/374 (21%), Positives = 150/374 (40%), Gaps = 67/374 (17%)

Query: 28  FCLYRNRSVSRTS--ETGSSEPSVQRNICIIAGRNVGIELSIREARRFQMEELSLATKNF 85
             L R  +VS  S     S+ P V+    + +  +  +   + E    +  +        
Sbjct: 24  IPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKL 83

Query: 86  SDKNLIGEGKFGEVYKGLLQD--------GMLVAIKK-RPGAPTQE---FIDEVCFLASI 133
           +    +GEG FG+V                + VA+K  +  A  ++    + E+  +  I
Sbjct: 84  TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 143

Query: 134 -QHRNLVTLLGYCQENNLQFLIYEYIPNGS-----------VSIHLYGPSQVSRQKLEFK 181
            +H+N++ LLG C ++   ++I EY   G+              + Y  ++V  +++ FK
Sbjct: 144 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203

Query: 182 HRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP 241
             +S     A+G+ +L S   + +H+D    NVLV E+ + K+AD GL   +   D    
Sbjct: 204 DLVSCTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY-- 259

Query: 242 SSQVTADEIF----LASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDL 296
             + T +       +A E    R ++ +SDV+SFGV + E+ + G      +     ++L
Sbjct: 260 --KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EEL 314

Query: 297 VELVQNSRDFSNLLKILDERLWSTFTNEGME-------EFIQLIVRCLDPSSERRPSMSD 349
            +L++              R         M+       E   ++  C      +RP+   
Sbjct: 315 FKLLKEGH-----------R---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQ 354

Query: 350 VVTELDRTLDKEMN 363
           +V +LDR L    N
Sbjct: 355 LVEDLDRILTLTTN 368

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  122 bits (308), Expect = 6e-32
 Identities = 68/331 (20%), Positives = 111/331 (33%), Gaps = 97/331 (29%)

Query: 88  KNLIGEGKFGEVYKGLLQDG------MLVAIKK-RPGAPTQE---FIDEVCFLASI-QHR 136
             ++G G FG+V              + VA+K  +  A + E    + E+  +  +  H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 137 NLVTLLGYCQENNLQFLIYEYIPNGS------------------VSIHLYGPSQVSRQKL 178
           N+V LLG C  +   +LI+EY   G                            +     L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 179 EFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 238
            F+  L  A   AKG+  L       VH+D    NVLV    + K+ D GL         
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK--SCVHRDLAARNVLVTHGKVVKICDFGL--------- 218

Query: 239 AGPSSQVTADEIFLASE-----VK-------EFRRFSEKSDVYSFGVFLLELVS-GREAS 285
              +  + +D  ++        VK           ++ KSDV+S+G+ L E+ S G    
Sbjct: 219 ---ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV--- 272

Query: 286 SSLSP----DSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEG--ME-------EFIQL 332
              +P        +  +L+Q                       G  M+       E   +
Sbjct: 273 ---NPYPGIPVDANFYKLIQ----------------------NGFKMDQPFYATEEIYII 307

Query: 333 IVRCLDPSSERRPSMSDVVTELDRTLDKEMN 363
           +  C    S +RPS  ++ + L   L     
Sbjct: 308 MQSCWAFDSRKRPSFPNLTSFLGCQLADAEE 338

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  121 bits (305), Expect = 9e-32
 Identities = 71/317 (22%), Positives = 123/317 (38%), Gaps = 80/317 (25%)

Query: 91  IGEGKFGEVYKGLLQDG------MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVT 140
           +GEG+FG+V K              VA+K  +  A   E    + E   L  + H +++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 141 LLGYCQENNLQFLIYEYIPNGS-------------------VSIHLYGPSQVSRQKLEFK 181
           L G C ++    LI EY   GS                    S +         + L   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150

Query: 182 HRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD--VA 239
             +S A   ++G+ +L  +  ++VH+D    N+LV E    K++D GL   +   D  V 
Sbjct: 151 DLISFAWQISQGMQYLAEM--KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVK 208

Query: 240 GPSSQV----TADE-IFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSS 293
               ++     A E +F          ++ +SDV+SFGV L E+V+ G      + P   
Sbjct: 209 RSQGRIPVKWMAIESLF-------DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP--- 258

Query: 294 QDLVELVQNSRDFSNLLKILDERLWSTFTNEG--ME-------EFIQLIVRCLDPSSERR 344
           + L  L++                       G  ME       E  +L+++C     ++R
Sbjct: 259 ERLFNLLK----------------------TGHRMERPDNCSEEMYRLMLQCWKQEPDKR 296

Query: 345 PSMSDVVTELDRTLDKE 361
           P  +D+  +L++ + K 
Sbjct: 297 PVFADISKDLEKMMVKR 313

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  122 bits (308), Expect = 1e-31
 Identities = 76/314 (24%), Positives = 129/314 (41%), Gaps = 69/314 (21%)

Query: 88  KNLIGEGKFGEVYKGLLQD--------GMLVAIKK-RPGAPTQE---FIDEVCFLASI-Q 134
              +GEG FG+V                  VA+K  +  A  ++    I E+  +  I +
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 135 HRNLVTLLGYCQENNLQFLIYEYIPNGS-----------VSIHLYGPSQVSRQKLEFKHR 183
           H+N++ LLG C ++   ++I EY   G+              + Y PS    ++L  K  
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 184 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 243
           +S A   A+G+ +L S   + +H+D    NVLV ED + K+AD GL   +   D      
Sbjct: 194 VSCAYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY---- 247

Query: 244 QVTADEIF----LASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVE 298
           + T +       +A E    R ++ +SDV+SFGV L E+ + G      +     ++L +
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EELFK 304

Query: 299 LVQNSRDFSNLLKILDERLWSTFTNEG--ME-------EFIQLIVRCLDPSSERRPSMSD 349
           L++                      EG  M+       E   ++  C      +RP+   
Sbjct: 305 LLK----------------------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQ 342

Query: 350 VVTELDRTLDKEMN 363
           +V +LDR +    N
Sbjct: 343 LVEDLDRIVALTSN 356

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  121 bits (305), Expect = 2e-31
 Identities = 72/323 (22%), Positives = 114/323 (35%), Gaps = 86/323 (26%)

Query: 88  KNLIGEGKFGEVYKGLLQDG------MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRN 137
              IGEG FG V++             +VA+K  +  A       F  E   +A   + N
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 138 LVTLLGYCQENNLQFLIYEYIPNGS-------------------VSIHLYGPSQVSRQKL 178
           +V LLG C       L++EY+  G                            S      L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 179 EFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTD 237
               +L IA   A G+A+L     + VH+D  T N LV E+ + K+AD GL RN +   D
Sbjct: 172 SCAEQLCIARQVAAGMAYLSER--KFVHRDLATRNCLVGENMVVKIADFGLSRN-IYSAD 228

Query: 238 --VAGPSSQV----TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP 290
              A  +  +       E         + R++ +SDV+++GV L E+ S G        P
Sbjct: 229 YYKADGNDAIPIRWMPPESIF------YNRYTTESDVWAYGVVLWEIFSYGL------QP 276

Query: 291 ---DSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEG--ME-------EFIQLIVRCLD 338
               + ++++  V+                      +G  +        E   L+  C  
Sbjct: 277 YYGMAHEEVIYYVR----------------------DGNILACPENCPLELYNLMRLCWS 314

Query: 339 PSSERRPSMSDVVTELDRTLDKE 361
                RPS   +   L R  ++ 
Sbjct: 315 KLPADRPSFCSIHRILQRMCERA 337

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  118 bits (299), Expect = 6e-31
 Identities = 64/279 (22%), Positives = 105/279 (37%), Gaps = 36/279 (12%)

Query: 79  SLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQE---FIDEVCFLAS 132
           S   ++F   + +G G +GEV+K    +DG L A+K    P    ++    + EV     
Sbjct: 53  SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEK 112

Query: 133 I-QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA 191
           + QH   V L    +E  + +L  E     S+  H     +     L             
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC----EAWGASLPEAQVWGYLRDTL 167

Query: 192 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF 251
             LAHLHS    +VH D K AN+ +      K+ D GL   LG         Q   D  +
Sbjct: 168 LALAHLHSQ--GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG--EVQE-GDPRY 222

Query: 252 LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 311
           +A E+ +   +   +DV+S G+ +LE+    E      P   +   +L Q          
Sbjct: 223 MAPELLQ-GSYGTAADVFSLGLTILEVACNMEL-----PHGGEGWQQLRQ---------G 267

Query: 312 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
            L     +  +     E   ++V  L+P  + R +   +
Sbjct: 268 YLPPEFTAGLS----SELRSVLVMMLEPDPKLRATAEAL 302

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  118 bits (298), Expect = 6e-31
 Identities = 54/300 (18%), Positives = 116/300 (38%), Gaps = 63/300 (21%)

Query: 91  IGEGKFGEVYKGLLQD--------GMLVAIKK-RPGAPTQ--EFIDEVCFLASIQHRNLV 139
           +G+G F +++KG+ ++           V +K            F +    ++ + H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 199
              G C   +   L+ E++  GS+  +L    + ++  +    +L +A   A  +  L  
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYL----KKNKNCINILWKLEVAKQLAAAMHFLEE 131

Query: 200 LSPRVVHKDFKTANVLVDEDF--------IAKVADAGLRNFLGRTDVAGPSSQVTADEIF 251
               ++H +    N+L+  +           K++D G+            S  V   +I 
Sbjct: 132 N--TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI------------SITVLPKDIL 177

Query: 252 ------LASE-VKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNS 303
                 +  E ++  +  +  +D +SFG  L E+ S G +  S+L    SQ  ++  ++ 
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL---DSQRKLQFYED- 233

Query: 304 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 363
                       +L      +  E    LI  C+D   + RPS   ++ +L+     ++ 
Sbjct: 234 ----------RHQL---PAPKAAELA-NLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  116 bits (292), Expect = 4e-30
 Identities = 61/290 (21%), Positives = 117/290 (40%), Gaps = 43/290 (14%)

Query: 82  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAPT---QEFIDEVCFLASI-Q 134
           T  F +   IG G+FG V+K +   DG + AIK+  +P A +   Q  + EV   A + Q
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 135 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 194
           H ++V       E++   +  EY   GS++      +       +      + L   +GL
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLA-DAISENYRIMSYFKEAELKDLLLQVGRGL 128

Query: 195 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA-------GPSSQVTA 247
            ++HS+   +VH D K +N+ +    I   A          ++         G  +++++
Sbjct: 129 RYIHSM--SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 248 DEIF------LASEV-KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV 300
            ++       LA+EV +E      K+D+++  + ++             P +     E+ 
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL-----PRNGDQWHEIR 241

Query: 301 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
           Q       +      ++ S       +EF +L+   + P  ERRPS   +
Sbjct: 242 QG--RLPRI-----PQVLS-------QEFTELLKVMIHPDPERRPSAMAL 277

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  116 bits (293), Expect = 6e-30
 Identities = 59/311 (18%), Positives = 108/311 (34%), Gaps = 43/311 (13%)

Query: 68  REARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAPTQEFI 124
           RE   FQ   + +  K++     +GEG F  V     L DG   A+K+        +E  
Sbjct: 14  RENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEA 73

Query: 125 D-EVCFLASIQHRNLVTLLGYCQENNLQ----FLIYEYIPNGSVSIHLYGPSQVSRQKLE 179
             E        H N++ L+ YC          +L+  +   G++   +    +     L 
Sbjct: 74  QREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIE-RLKDKGNFLT 132

Query: 180 FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 239
               L + LG  +GL  +H+      H+D K  N+L+ ++    + D G  N        
Sbjct: 133 EDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190

Query: 240 GPSSQVTADEI-------FLASEV---KEFRRFSEKSDVYSFGVFLLELVSGREASSSLS 289
              +    D         + A E+   +      E++DV+S G  L  ++ G        
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE------G 244

Query: 290 P----DSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP 345
           P        D V L   ++        L        +        QL+   +     +RP
Sbjct: 245 PYDMVFQKGDSVALAVQNQ--------LSIPQSPRHS----SALWQLLNSMMTVDPHQRP 292

Query: 346 SMSDVVTELDR 356
            +  ++++L+ 
Sbjct: 293 HIPLLLSQLEA 303

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  112 bits (282), Expect = 9e-29
 Identities = 60/276 (21%), Positives = 105/276 (38%), Gaps = 51/276 (18%)

Query: 90  LIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLLG 143
            IG G F  VYKGL  +  + VA       K   +  Q F +E   L  +QH N+V    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 144 Y----CQENNLQFLIYEYIPNGSVS--IHLYGP------SQVSRQKLEFKHRLSIALGAA 191
                 +      L+ E + +G++   +  +            RQ L+            
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILK------------ 140

Query: 192 KGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 250
            GL  LH+ +P ++H+D K  N+ +       K+ D GL      +     +   T +  
Sbjct: 141 -GLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA--KAVIGTPE-- 195

Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 310
           F+A E+ E  ++ E  DVY+FG+ +LE+ +     S      +  +   V +        
Sbjct: 196 FMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTS-------- 244

Query: 311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 346
            +           E ++E I+    C+  + + R S
Sbjct: 245 GVKPASFDKVAIPE-VKEIIE---GCIRQNKDERYS 276

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  112 bits (283), Expect = 1e-28
 Identities = 74/279 (26%), Positives = 118/279 (42%), Gaps = 33/279 (11%)

Query: 83  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAPT----QEFIDEVCFLASIQH 135
            NF  +  IG G+F EVY+   L DG+ VA+KK             + I E+  L  + H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 136 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR--LSIALGAAKG 193
            N++       E+N   ++ E    G +S  +       +QK     R      +     
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMI---KHFKKQKRLIPERTVWKYFVQLCSA 148

Query: 194 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV-TADEIF 251
           L H+HS   RV+H+D K ANV +    + K+ D GL R F  +T  A   S V T    +
Sbjct: 149 LEHMHSR--RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTP--YY 202

Query: 252 LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 311
           ++ E      ++ KSD++S G  L E+ + +            +L  L +         K
Sbjct: 203 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG----DKMNLYSLCK---------K 249

Query: 312 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
           I         ++   EE  QL+  C++P  E+RP ++ V
Sbjct: 250 IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  112 bits (283), Expect = 2e-28
 Identities = 54/279 (19%), Positives = 114/279 (40%), Gaps = 39/279 (13%)

Query: 83  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHR 136
           + +     IGEG FG+       +DG    IK+           +E   EV  LA+++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 137 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 196
           N+V      +EN   +++ +Y   G +   +   +       +    L   +     L H
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRI---NAQKGVLFQEDQILDWFVQICLALKH 140

Query: 197 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV-TADEIFLAS 254
           +H    +++H+D K+ N+ + +D   ++ D G+ R      ++A   + + T    +L+ 
Sbjct: 141 VHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA--RACIGTP--YYLSP 194

Query: 255 EVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 314
           E+ E + ++ KSD+++ G  L EL + +          +  +  LV          KI+ 
Sbjct: 195 EICENKPYNNKSDIWALGCVLYELCTLK------HAFEAGSMKNLVL---------KIIS 239

Query: 315 ---ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
                +   ++     +   L+ +    +   RPS++ +
Sbjct: 240 GSFPPVSLHYS----YDLRSLVSQLFKRNPRDRPSVNSI 274

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  110 bits (277), Expect = 7e-28
 Identities = 51/295 (17%), Positives = 95/295 (32%), Gaps = 49/295 (16%)

Query: 83  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQEFIDEVCFLASIQHRN 137
            +F     +G G FG V++     D    AIK+          ++ + EV  LA ++H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 138 LVTLLGYCQENNLQ------------FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 185
           +V       E N              ++  +     ++   +    + + ++ E    L 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN--GRCTIEERERSVCLH 122

Query: 186 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 245
           I L  A+ +  LHS    ++H+D K +N+    D + KV D GL   + + +        
Sbjct: 123 IFLQIAEAVEFLHSK--GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180

Query: 246 TADEIFLAS----------EVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQD 295
                              E      +S K D++S G+ L EL+                
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMER------- 233

Query: 296 LVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
                         L  +    +     +       ++   L PS   RP   ++
Sbjct: 234 -----------VRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  109 bits (274), Expect = 1e-27
 Identities = 55/286 (19%), Positives = 111/286 (38%), Gaps = 49/286 (17%)

Query: 83  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTL 141
            +F +  LIG G FG+V+K     DG    IK+      ++   EV  LA + H N+V  
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-NEKAEREVKALAKLDHVNIVHY 69

Query: 142 LGYCQENNLQ----------------FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 185
            G     +                  F+  E+   G++   +    +   +KL+    L 
Sbjct: 70  NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI---EKRRGEKLDKVLALE 126

Query: 186 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 245
           +     KG+ ++HS   +++++D K +N+ + +    K+ D GL   L        +   
Sbjct: 127 LFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TRSK 182

Query: 246 -TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR 304
            T    +++ E    + + ++ D+Y+ G+ L EL+   +     +   +           
Sbjct: 183 GTLR--YMSPEQISSQDYGKEVDLYALGLILAELLHVCD-----TAFETSKFFT------ 229

Query: 305 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
                  + D  +   F     ++   L+ + L    E RP+ S++
Sbjct: 230 ------DLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEI 265

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  108 bits (271), Expect = 3e-27
 Identities = 62/286 (21%), Positives = 113/286 (39%), Gaps = 44/286 (15%)

Query: 83  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHR 136
           +++     IG G +G   K     DG ++  K+        A  Q  + EV  L  ++H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 137 NLVTLLG--YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR--LSIALGAAK 192
           N+V        + N   +++ EY   G ++  +   ++ ++++        L +      
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI---TKGTKERQYLDEEFVLRVMTQLTL 122

Query: 193 GLAHLHS---LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT-DVAGPSSQV-TA 247
            L   H        V+H+D K ANV +D     K+ D GL   L      A   + V T 
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KTFVGTP 180

Query: 248 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 307
              +++ E      ++EKSD++S G  L EL +         P ++    EL        
Sbjct: 181 --YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELAG------ 226

Query: 308 NLLKILD---ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
              KI +    R+   ++    +E  ++I R L+     RPS+ ++
Sbjct: 227 ---KIREGKFRRIPYRYS----DELNEIITRMLNLKDYHRPSVEEI 265

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  106 bits (267), Expect = 2e-26
 Identities = 65/324 (20%), Positives = 107/324 (33%), Gaps = 66/324 (20%)

Query: 68  REARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEF 123
           R+   F  + + L       + ++ EG F  VY+   +  G   A+K          +  
Sbjct: 13  RDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAI 72

Query: 124 IDEVCFLASIQ-HRNLVTLLGYC-------QENNLQFLIYEYIPNGSVSIHLYGPSQVSR 175
           I EVCF+  +  H N+V                  +FL+   +  G +   L      SR
Sbjct: 73  IQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLK--KMESR 130

Query: 176 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 235
             L     L I     + + H+H   P ++H+D K  N+L+      K+ D G    +  
Sbjct: 131 GPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI-- 188

Query: 236 TDVAGPSSQVTADEIFLASEVKE---------------FRRF--SEKSDVYSFGVFLLEL 278
                P    +A    L  E                  +  F   EK D+++ G  L  L
Sbjct: 189 --SHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL 246

Query: 279 VSGREASSSLSPDSSQDLVELVQNSRDF--SNLLKILDERL----WSTFTNEGMEEFIQL 332
              +       P               F     L+I++ +       T        F  L
Sbjct: 247 CFRQ------HP---------------FEDGAKLRIVNGKYSIPPHDTQY----TVFHSL 281

Query: 333 IVRCLDPSSERRPSMSDVVTELDR 356
           I   L  + E R S+++VV +L  
Sbjct: 282 IRAMLQVNPEERLSIAEVVHQLQE 305

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  105 bits (263), Expect = 1e-25
 Identities = 55/233 (23%), Positives = 91/233 (39%), Gaps = 34/233 (14%)

Query: 65  LSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEF 123
           + + E  +    E        + +  +G G FGEV++    Q G   A+KK      +  
Sbjct: 40  VLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV- 98

Query: 124 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVS--IHLYGP------SQVSR 175
            +E+   A +    +V L G  +E     +  E +  GS+   I   G            
Sbjct: 99  -EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG 157

Query: 176 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGL----- 229
           Q LE             GL +LH+   R++H D K  NVL+  D   A + D G      
Sbjct: 158 QALE-------------GLEYLHTR--RILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202

Query: 230 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
            + LG++ + G     T  E  +A EV   +    K D++S    +L +++G 
Sbjct: 203 PDGLGKSLLTGDYIPGT--ETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  102 bits (256), Expect = 5e-25
 Identities = 56/301 (18%), Positives = 104/301 (34%), Gaps = 56/301 (18%)

Query: 82  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNL 138
             +F +  ++G+G FG+V K     D    AIK  +         + EV  LAS+ H+ +
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64

Query: 139 VTLLG-YCQENNLQ------------FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 185
           V     + +  N              F+  EY  NG++   +           +      
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI----HSENLNQQRDEYWR 120

Query: 186 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQ 244
           +     + L+++HS    ++H+D K  N+ +DE    K+ D GL +N     D+    SQ
Sbjct: 121 LFRQILEALSYIHSQ--GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 245 VTADEIFLAS-----------EVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDS 292
                    +           EV +     +EK D+YS G+   E++            +
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--------FST 230

Query: 293 SQDLVELVQNSRDFSNLLKI---LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 349
             + V +         L  +                 +   ++I   +D    +RP    
Sbjct: 231 GMERVNI------LKKLRSVSIEFPPDFDDNKM----KVEKKIIRLLIDHDPNKRPGART 280

Query: 350 V 350
           +
Sbjct: 281 L 281

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  101 bits (253), Expect = 1e-24
 Identities = 71/287 (24%), Positives = 116/287 (40%), Gaps = 59/287 (20%)

Query: 82  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID----EVCFLASIQHR 136
            + F+    IG+G FGEV+KG+  +   +VAIK       ++ I+    E+  L+     
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 137 NLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 195
            +    G Y ++  L ++I EY+  GS    L  P       L+     +I     KGL 
Sbjct: 81  YVTKYYGSYLKDTKL-WIIMEYLGGGSAL-DLLEP-----GPLDETQIATILREILKGLD 133

Query: 196 HLHSLSPRVVHKDFKTANVLVDEDFIAKVAD----AGLRNFLGR--TDVAGPSSQVTADE 249
           +LHS   + +H+D K ANVL+ E    K+AD      L +   +  T V  P        
Sbjct: 134 YLHSE--KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTP-------- 183

Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL 309
            ++A EV +   +  K+D++S G+  +EL  G    S L P                  L
Sbjct: 184 FWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP---------------MKVL 228

Query: 310 LKI-------LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 349
             I       L+   +S       +   + +  CL+     RP+  +
Sbjct: 229 FLIPKNNPPTLEGN-YS-------KPLKEFVEACLNKEPSFRPTAKE 267

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  100 bits (250), Expect = 3e-24
 Identities = 59/283 (20%), Positives = 119/283 (42%), Gaps = 50/283 (17%)

Query: 82  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK---RPGAPTQEFIDEVCFLASIQHRN 137
            K ++    IG+G  G VY  + +  G  VAI++   +     +  I+E+  +   ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 138 LVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 196
           +V  L  Y   + L +++ EY+  GS++        V+   ++     ++     + L  
Sbjct: 79  IVNYLDSYLVGDEL-WVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALEF 131

Query: 197 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI------ 250
           LHS   +V+H+D K+ N+L+  D   K+ D G              +Q+T ++       
Sbjct: 132 LHSN--QVIHRDIKSDNILLGMDGSVKLTDFGF------------CAQITPEQSKRSTMV 177

Query: 251 ----FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 306
               ++A EV   + +  K D++S G+  +E++ G     + +P   + L  +  N    
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--LRALYLIATNGTP- 234

Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 349
               ++ +    S         F   + RCL+   E+R S  +
Sbjct: 235 ----ELQNPEKLS-------AIFRDFLNRCLEMDVEKRGSAKE 266

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  100 bits (250), Expect = 4e-24
 Identities = 64/290 (22%), Positives = 123/290 (42%), Gaps = 35/290 (12%)

Query: 79  SLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQEFIDEVCFLASI 133
           S+   ++  + +IG G    V           VAIK+    +      E + E+  ++  
Sbjct: 11  SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC 70

Query: 134 QHRNLVTLLG-YCQENNLQFLIYEYIPNGSVS---IHLYGPSQVSRQKLEFKHRLSIALG 189
            H N+V+    +  ++ L +L+ + +  GSV     H+    +     L+     +I   
Sbjct: 71  HHPNIVSYYTSFVVKDEL-WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129

Query: 190 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT-DVAGPSSQVTAD 248
             +GL +LH      +H+D K  N+L+ ED   ++AD G+  FL    D+     + T  
Sbjct: 130 VLEGLEYLHKN--GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT-- 185

Query: 249 EIF------LASEV-KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ 301
             F      +A EV ++ R +  K+D++SFG+  +EL +G        P   + L+  +Q
Sbjct: 186 --FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP--MKVLMLTLQ 241

Query: 302 NS--RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 349
           N      + +      + +        + F ++I  CL    E+RP+ ++
Sbjct: 242 NDPPSLETGVQDKEMLKKYG-------KSFRKMISLCLQKDPEKRPTAAE 284

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 99.3 bits (248), Expect = 7e-24
 Identities = 71/290 (24%), Positives = 116/290 (40%), Gaps = 57/290 (19%)

Query: 82  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK---RPGAPTQEFIDEVCFLASIQHRN 137
            + +     +G+G FG+VYK    + G L A K    +     +++I E+  LA+  H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 138 LVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 196
           +V LLG Y  +  L +++ E+ P G+V   +        + L       +     + L  
Sbjct: 78  IVKLLGAYYHDGKL-WIMIEFCPGGAVDAIM----LELDRGLTEPQIQVVCRQMLEALNF 132

Query: 197 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAG----LRNFLG-RTDVAGPSSQVT----A 247
           LHS   R++H+D K  NVL+  +   ++AD G        L  R    G     T    A
Sbjct: 133 LHSK--RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIG-----TPYWMA 185

Query: 248 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 307
            E+ +   +K+   +  K+D++S G+ L+E+         L+P                 
Sbjct: 186 PEVVMCETMKD-TPYDYKADIWSLGITLIEMAQIEPPHHELNP---------------MR 229

Query: 308 NLLKI--------LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 349
            LLKI        L    WS        EF   +   LD + E RPS + 
Sbjct: 230 VLLKIAKSDPPTLLTPSKWS-------VEFRDFLKIALDKNPETRPSAAQ 272

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 99.4 bits (248), Expect = 1e-23
 Identities = 77/312 (24%), Positives = 125/312 (40%), Gaps = 64/312 (20%)

Query: 69  EARRFQMEELSLA-----TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP--GAPT 120
           ++    ++E+ L+        F    L+G G +G+VYKG  ++ G L AIK     G   
Sbjct: 5   DSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE 64

Query: 121 QEFIDEVCFLASI-QHRNLVTLLG-YCQENNLQF-----LIYEYIPNGSVSIHLYGPSQV 173
           +E   E+  L     HRN+ T  G + ++N         L+ E+   GSV+  L   ++ 
Sbjct: 65  EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT-DLIKNTK- 122

Query: 174 SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVAD----AGL 229
               L+ +    I     +GL+HLH    +V+H+D K  NVL+ E+   K+ D    A L
Sbjct: 123 -GNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179

Query: 230 RNFLG-RTDVAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 284
              +G R    G     T    A E+    E  +   +  KSD++S G+  +E+  G   
Sbjct: 180 DRTVGRRNTFIG-----TPYWMAPEVIACDENPD-ATYDFKSDLWSLGITAIEMAEGAPP 233

Query: 285 SSSLSPDSSQDLVELVQNSRDFSNLLKI-------LDERLWSTFTNEGMEEFIQLIVRCL 337
              + P                  L  I       L  + WS       ++F   I  CL
Sbjct: 234 LCDMHP---------------MRALFLIPRNPAPRLKSKKWS-------KKFQSFIESCL 271

Query: 338 DPSSERRPSMSD 349
             +  +RP+   
Sbjct: 272 VKNHSQRPATEQ 283

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 98.2 bits (245), Expect = 2e-23
 Identities = 72/305 (23%), Positives = 132/305 (43%), Gaps = 52/305 (17%)

Query: 64  ELSIREARRFQMEELSLA------TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP 116
            + +R   R Q+++L          + F     +GEG +G VYK +  + G +VAIK+ P
Sbjct: 4   TVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP 63

Query: 117 GAP-TQEFIDEVCFLASIQHRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVS 174
                QE I E+  +      ++V   G Y +  +L +++ EY   GSVS  +    ++ 
Sbjct: 64  VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL-WIVMEYCGAGSVS-DII---RLR 118

Query: 175 RQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 234
            + L      +I     KGL +LH +  R +H+D K  N+L++ +  AK+AD     F  
Sbjct: 119 NKTLTEDEIATILQSTLKGLEYLHFM--RKIHRDIKAGNILLNTEGHAKLAD-----F-- 169

Query: 235 RTDVAGPSSQVTADEI----------FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 284
                G + Q+T              ++A EV +   ++  +D++S G+  +E+  G+  
Sbjct: 170 -----GVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

Query: 285 SSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERR 344
            + + P   + +  +  N              LWS       + F   + +CL  S E+R
Sbjct: 225 YADIHP--MRAIFMIPTNPPP-----TFRKPELWS-------DNFTDFVKQCLVKSPEQR 270

Query: 345 PSMSD 349
            + + 
Sbjct: 271 ATATQ 275

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 98.2 bits (244), Expect = 6e-23
 Identities = 34/312 (10%), Positives = 73/312 (23%), Gaps = 53/312 (16%)

Query: 77  ELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK------KRPGAPTQEFIDEVCF 129
            LS   +       +  G    V+    ++     A+K      +   +  +   +    
Sbjct: 56  LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115

Query: 130 LASIQHRNLVTLLGYCQENNLQ--------------------------FLIYEYIP-NGS 162
            A +   +        +                                L+      +  
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLE 175

Query: 163 VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA 222
           +         V R          +     +  A+L S    +VH  F   N+ +  D   
Sbjct: 176 LLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK--GLVHGHFTPDNLFIMPDGRL 233

Query: 223 KVADAGLRNFLG-RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
            + D      +G R   +         E   AS       F+   + +  G+ +  +   
Sbjct: 234 MLGDVSALWKVGTRGPASSVPVTYAPREFLNAST----ATFTHALNAWQLGLSIYRVWCL 289

Query: 282 REASSSLSP--DSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDP 339
                   P    +  +    +           L     +       +    LI R L+ 
Sbjct: 290 F------LPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLP----DFVKTLIGRFLNF 339

Query: 340 SSERRPSMSDVV 351
              RR    + +
Sbjct: 340 DRRRRLLPLEAM 351

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 96.7 bits (241), Expect = 8e-23
 Identities = 58/280 (20%), Positives = 109/280 (38%), Gaps = 50/280 (17%)

Query: 82  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK---RPGAPTQEFIDEVCFLASIQHRN 137
                    IGEG  G V        G  VA+K    R     +   +EV  +   QH N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 138 LVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 196
           +V +   Y     L +++ E++  G+++        VS+ +L  +   ++     + LA+
Sbjct: 104 VVEMYKSYLVGEEL-WVLMEFLQGGALT------DIVSQVRLNEEQIATVCEAVLQALAY 156

Query: 197 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI------ 250
           LH+    V+H+D K+ ++L+  D   K++D G              +Q++ D        
Sbjct: 157 LHA--QGVIHRDIKSDSILLTLDGRVKLSDFGF------------CAQISKDVPKRKSLV 202

Query: 251 ----FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 306
               ++A EV     ++ + D++S G+ ++E+V G     S SP   Q +  L  +    
Sbjct: 203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRLRDSPPP- 259

Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 346
               K+ +    S             + R L    + R +
Sbjct: 260 ----KLKNSHKVS-------PVLRDFLERMLVRDPQERAT 288

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 95.8 bits (239), Expect = 1e-22
 Identities = 56/214 (26%), Positives = 103/214 (48%), Gaps = 35/214 (16%)

Query: 87  DKNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVCFLASIQHRNLVTLL 142
           D+ ++G+G +G VY G  L + + +AIK   +R    +Q   +E+     ++H+N+V  L
Sbjct: 26  DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85

Query: 143 GYCQENNLQFLIYEYIPNGSVS---IHLYGPSQVS--------RQKLEFKHRLSIALGAA 191
           G   EN    +  E +P GS+S      +GP + +        +Q LE            
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILE------------ 133

Query: 192 KGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 250
            GL +LH    ++VH+D K  NVL++    + K++D G    L   +    +   T    
Sbjct: 134 -GLKYLH--DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTL--Q 188

Query: 251 FLASEV--KEFRRFSEKSDVYSFGVFLLELVSGR 282
           ++A E+  K  R + + +D++S G  ++E+ +G+
Sbjct: 189 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 96.9 bits (241), Expect = 2e-22
 Identities = 55/329 (16%), Positives = 101/329 (30%), Gaps = 63/329 (19%)

Query: 69  EARRFQMEELSLATKNFSDKNLIGEG--KFGEVYKGL-LQDGMLVAIK-----KRPGAPT 120
                 M         +    +IG+G      V        G  V ++            
Sbjct: 11  NLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMV 70

Query: 121 QEFIDEVCFLASIQHRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE 179
                E+       H N+V     +  +N L +++  ++  GS    L            
Sbjct: 71  TFLQGELHVSKLFNHPNIVPYRATFIADNEL-WVVTSFMAYGSAK-DLI--------CTH 120

Query: 180 FKHRLS---IAL---GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG----L 229
           F   ++   IA    G  K L ++H +    VH+  K +++L+  D    ++       +
Sbjct: 121 FMDGMNELAIAYILQGVLKALDYIHHM--GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178

Query: 230 RNFLGRTDVAGPSSQVTADEIF-LASEV--KEFRRFSEKSDVYSFGVFLLELVSG----- 281
            +   R  V     + +   +  L+ EV  +  + +  KSD+YS G+   EL +G     
Sbjct: 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 238

Query: 282 ------------REASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGME-- 327
                             L   S+    EL  +         + D    ST      +  
Sbjct: 239 DMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP 298

Query: 328 ----------EFIQLIVRCLDPSSERRPS 346
                      F   + +CL  + + RPS
Sbjct: 299 SHPYHRTFSPHFHHFVEQCLQRNPDARPS 327

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 95.9 bits (239), Expect = 2e-22
 Identities = 55/287 (19%), Positives = 107/287 (37%), Gaps = 43/287 (14%)

Query: 83  KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRN 137
           + +S    IG G   +V++ L +   + AIK     +        + +E+ +L  +Q  +
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 138 L--VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 195
              + L  Y   +   +++ E   N  ++  L       ++ ++   R S      + + 
Sbjct: 69  DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVH 122

Query: 196 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV-T----ADE 249
            +H     +VH D K AN L+ +  + K+ D G+       T      SQV T      E
Sbjct: 123 TIHQH--GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179

Query: 250 IFL-----ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-DSSQDLVELVQNS 303
                       K   + S KSDV+S G  L  +  G+      +P     + +      
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TPFQQIINQISK---- 229

Query: 304 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
                L  I+D      F +   ++   ++  CL    ++R S+ ++
Sbjct: 230 -----LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 96.4 bits (240), Expect = 2e-22
 Identities = 60/339 (17%), Positives = 120/339 (35%), Gaps = 43/339 (12%)

Query: 31  YRNRSVSRTSETGSSEPSVQRNICIIAGRNVGIELSIREARRFQMEELSLATKNFSDKNL 90
           + + S      +G  E +  +                 +A     E +S+  + +S    
Sbjct: 4   HHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQ 63

Query: 91  IGEGKFGEVYKGLLQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNL--VTLLG 143
           IG G   +V++ L +   + AIK     +        + +E+ +L  +Q  +   + L  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123

Query: 144 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 203
           Y   +   +++ E   N  ++  L       ++ ++   R S      + +  +H     
Sbjct: 124 YEITDQYIYMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVHTIHQH--G 175

Query: 204 VVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV-T----ADEIFL----- 252
           +VH D K AN L+ +  + K+ D G+       T      SQV        E        
Sbjct: 176 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234

Query: 253 ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-DSSQDLVELVQNSRDFSNLLK 311
               K   + S KSDV+S G  L  +  G+      +P     + +           L  
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGK------TPFQQIINQISK---------LHA 279

Query: 312 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
           I+D      F +   ++   ++  CL    ++R S+ ++
Sbjct: 280 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 94.7 bits (236), Expect = 4e-22
 Identities = 56/294 (19%), Positives = 111/294 (37%), Gaps = 43/294 (14%)

Query: 76  EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK-----KRPGAPTQEFIDEVCFL 130
           + +S+  + +S    IG G   +V++ L +   + AIK     +        + +E+ +L
Sbjct: 21  QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 80

Query: 131 ASIQHRNL--VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 188
             +Q  +   + L  Y   +   +++ E   N  ++  L       ++ ++   R S   
Sbjct: 81  NKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWK 134

Query: 189 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV-T 246
              + +  +H     +VH D K AN L+ +  + K+ D G+       T      SQV T
Sbjct: 135 NMLEAVHTIHQH--GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGT 191

Query: 247 ----ADEIFL-----ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-DSSQDL 296
                 E            K   + S KSDV+S G  L  +  G+      +P     + 
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TPFQQIINQ 245

Query: 297 VELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
           +           L  I+D      F +   ++   ++  CL    ++R S+ ++
Sbjct: 246 ISK---------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 95.2 bits (237), Expect = 4e-22
 Identities = 74/292 (25%), Positives = 120/292 (41%), Gaps = 66/292 (22%)

Query: 82  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQ 134
            K FSD   IG G FG VY    +++  +VAIKK      +     Q+ I EV FL  ++
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 135 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 193
           H N +   G Y +E+   +L+ EY    +  +      +V ++ L+     ++  GA +G
Sbjct: 113 HPNTIQYRGCYLREHTA-WLVMEYCLGSASDLL-----EVHKKPLQEVEIAAVTHGALQG 166

Query: 194 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF-- 251
           LA+LHS    ++H+D K  N+L+ E  + K+ D     F       G +S +     F  
Sbjct: 167 LAYLHSH--NMIHRDVKAGNILLSEPGLVKLGD-----F-------GSASIMAPANSFVG 212

Query: 252 ----LASEV---KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR 304
               +A EV    +  ++  K DV+S G+  +EL   +    +++               
Sbjct: 213 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------------- 258

Query: 305 DFSNLLKI-------LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 349
             S L  I       L    WS       E F   +  CL    + RP+   
Sbjct: 259 -MSALYHIAQNESPALQSGHWS-------EYFRNFVDSCLQKIPQDRPTSEV 302

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 91.5 bits (228), Expect = 4e-21
 Identities = 62/306 (20%), Positives = 115/306 (37%), Gaps = 70/306 (22%)

Query: 90  LIGEGKFGEVYKGLLQDGML---VAIK--KRPGAPTQEFID----EVCFLASIQHRNLVT 140
            +G G    VY    +D +L   VAIK    P    +E +     EV   + + H+N+V+
Sbjct: 18  KLGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 141 LLGYCQENNLQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 198
           ++   +E++  +L+ EYI   ++S  I  +GP       L     ++       G+ H H
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-------LSVDTAINFTNQILDGIKHAH 128

Query: 199 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS---- 254
            +  R+VH+D K  N+L+D +   K+ D G+         A   + +T     L +    
Sbjct: 129 DM--RIVHRDIKPQNILIDSNKTLKIFDFGIA-------KALSETSLTQTNHVLGTVQYF 179

Query: 255 --EVKEFRRFSEKSDVYSFGVFLLELVSGR---------------------EASSSLSPD 291
             E  +     E +D+YS G+ L E++ G                        ++ +  D
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKD 239

Query: 292 SSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
             Q L  ++  +       K    R  +      ++E    +   L      R +     
Sbjct: 240 IPQSLSNVILRA-----TEKDKANRYKT------IQEMKDDLSSVLHE---NRANEDVYE 285

Query: 352 TELDRT 357
            +  +T
Sbjct: 286 LDKMKT 291

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 92.3 bits (229), Expect = 5e-21
 Identities = 45/308 (14%), Positives = 97/308 (31%), Gaps = 42/308 (13%)

Query: 76  EELSLATKNFSDKNLIGEGKFGEVYKG------LLQDGMLVAIKK-RPGAPTQEFI--DE 126
            E  L +K     +L+GEG F +VY+         ++     +K  +P  P + +I    
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117

Query: 127 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 186
           +  L        +         N   L+ E    G++   +        + +     +S 
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 187 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD--------V 238
           A+     +  +H     ++H D K  N ++   F+ +  +  L   L   D        +
Sbjct: 178 AMRMLYMIEQVHDC--EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235

Query: 239 AGPSSQVTAD---EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQD 295
               +  TA      F   E+   + ++ + D +     +  ++ G             +
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT------YMKVKNE 289

Query: 296 LVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 355
                          + L  RL      +   EF  +++    P     PS+  +  +L 
Sbjct: 290 ---------GGECKPEGLFRRLPHL---DMWNEFFHVMLNI--PDCHHLPSLDLLRQKLK 335

Query: 356 RTLDKEMN 363
           +   +   
Sbjct: 336 KVFQQHYT 343

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 90.0 bits (224), Expect = 9e-21
 Identities = 74/273 (27%), Positives = 114/273 (41%), Gaps = 43/273 (15%)

Query: 89  NLIGEGKFGEVYKG-LLQDGMLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVT 140
             +G+GKFG VY     Q   ++A+K       ++ G   Q    EV   + ++H N++ 
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILR 73

Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 200
           L GY  +    +LI EY P G+V   L         K + +   +     A  L++ HS 
Sbjct: 74  LYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCHSK 128

Query: 201 SPRVVHKDFKTANVLVDEDFIAKVADAGL---RNFLGRTDVAGPSSQVTADEIFLASEVK 257
             RV+H+D K  N+L+      K+AD G         RTD+ G     T D  +L  E+ 
Sbjct: 129 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG-----TLD--YLPPEMI 179

Query: 258 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 317
           E R   EK D++S GV   E + G+       P  +    E  +         +I     
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQETYK---------RISRVEF 224

Query: 318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
             TF +   E    LI R L  +  +RP + +V
Sbjct: 225 --TFPDFVTEGARDLISRLLKHNPSQRPMLREV 255

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 93.0 bits (231), Expect = 1e-20
 Identities = 51/282 (18%), Positives = 103/282 (36%), Gaps = 54/282 (19%)

Query: 90  LIGEGKFGEVYKG--LLQDGMLVAIKKRPGAPTQEFID----EVCFLASIQHRNLVTLLG 143
            I  G  G +Y       +G  V +K    +   E       E  FLA + H ++V +  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 144 YCQENN-----LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 198
           + +  +     + +++ EY+   S+        +   QKL     ++  L     L++LH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLK-------RSKGQKLPVAEAIAYLLEILPALSYLH 199

Query: 199 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD-VAGPSSQVTADEIFLASEVK 257
           S+   +V+ D K  N+++ E+ + K+ D G  + +     + G     T    F A E+ 
Sbjct: 200 SI--GLVYNDLKPENIMLTEEQL-KLIDLGAVSRINSFGYLYG-----TPG--FQAPEIV 249

Query: 258 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 317
                +  +D+Y+ G  L  L       +    D   +   +++    +           
Sbjct: 250 R-TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGR--------- 299

Query: 318 WSTFTNEGMEEFIQLIVRCLDPSSERRP-SMSDVVTELDRTL 358
                         L+ R +DP   +R  +  ++  +L   L
Sbjct: 300 --------------LLRRAIDPDPRQRFTTAEEMSAQLTGVL 327

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 56/282 (19%), Positives = 103/282 (36%), Gaps = 59/282 (20%)

Query: 90  LIGEGKFGEVYKG-LLQDGMLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVTL 141
            +G+G F + ++        + A K        +P    +    E+    S+ H+++V  
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF 106

Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIALGAAKGLAHLHSL 200
            G+ ++N+  F++ E     S+           R+ L E + R         G  +LH  
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELH-----KRRKALTEPEAR-YYLRQIVLGCQYLHRN 160

Query: 201 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-------- 252
             RV+H+D K  N+ ++ED   K+ D GL            +++V  D            
Sbjct: 161 --RVIHRDLKLGNLFLNEDLEVKIGDFGL------------ATKVEYDGERKKVLCGTPN 206

Query: 253 --ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 310
             A EV   +  S + DV+S G  +  L+ G+       P  +  L E            
Sbjct: 207 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK------PPFETSCLKETYL--------- 251

Query: 311 KILDERL-WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
           +I           N        LI + L      RP++++++
Sbjct: 252 RIKKNEYSIPKHINPVAAS---LIQKMLQTDPTARPTINELL 290

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 90.8 bits (225), Expect = 2e-20
 Identities = 36/332 (10%), Positives = 90/332 (27%), Gaps = 76/332 (22%)

Query: 67  IREARRFQME-ELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAP 119
               + F++E EL    +      ++G+       +    + G    +      +RP + 
Sbjct: 56  WNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN 115

Query: 120 TQE--------------------------FIDEVCFLASIQHRNLVTLLGYCQ---ENNL 150
             +                          FI     +   Q + ++ +    +     + 
Sbjct: 116 AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR 175

Query: 151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFK 210
            FL      N      +      + + L    RL + L   + LA LH     +VH   +
Sbjct: 176 FFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--GLVHTYLR 233

Query: 211 TANVLVDEDFIAKVADAGL-------RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS 263
             ++++D+     +                       P  ++ A    ++         +
Sbjct: 234 PVDIVLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEPP--ELEARRATISYHRDRRTLMT 291

Query: 264 EKSDVYSFGVFLLELVSGREASSSLSP---DSSQDLVELV-QNSRDFSNLLKILDERLWS 319
              D ++ G+ +  +           P   D++    E + ++ ++    ++        
Sbjct: 292 FSFDAWALGLVIYWIWCAD------LPITKDAALGGSEWIFRSCKNIPQPVR-------- 337

Query: 320 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                       L+   L    E R      +
Sbjct: 338 -----------ALLEGFLRYPKEDRLLPLQAM 358

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 89.6 bits (223), Expect = 2e-20
 Identities = 55/281 (19%), Positives = 103/281 (36%), Gaps = 57/281 (20%)

Query: 90  LIGEGKFGEVYKG-LLQDGMLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVTL 141
            +G+G F + ++        + A K        +P    +    E+    S+ H+++V  
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF 80

Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIALGAAKGLAHLHSL 200
            G+ ++N+  F++ E     S+           R+ L E + R         G  +LH  
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLELH-----KRRKALTEPEAR-YYLRQIVLGCQYLHRN 134

Query: 201 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-------- 252
             RV+H+D K  N+ ++ED   K+ D GL            +++V  D            
Sbjct: 135 --RVIHRDLKLGNLFLNEDLEVKIGDFGL------------ATKVEYDGERKKVLCGTPN 180

Query: 253 --ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 310
             A EV   +  S + DV+S G  +  L+ G+       P  +  L E            
Sbjct: 181 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK------PPFETSCLKETYL--------- 225

Query: 311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
           +I       +           LI + L      RP++++++
Sbjct: 226 RIKKNEY--SIPKHINPVAASLIQKMLQTDPTARPTINELL 264

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 60/285 (21%), Positives = 107/285 (37%), Gaps = 34/285 (11%)

Query: 76  EELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVC-----F 129
           +      ++  D   IG G +G V K +    G ++A+K+      ++   ++       
Sbjct: 15  QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74

Query: 130 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG 189
           + S     +V   G        ++  E + + S          V    +  +    I L 
Sbjct: 75  MRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLA 133

Query: 190 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAGPSSQV 245
             K L HL   + +++H+D K +N+L+D     K+ D G    L + + +T  AG     
Sbjct: 134 TVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRP-- 190

Query: 246 TADEIFLASEV----KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ 301
                ++A E        + +  +SDV+S G+ L EL +GR      +    Q    L Q
Sbjct: 191 -----YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ----LTQ 241

Query: 302 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 346
             +     L   +ER +S         FI  +  CL     +RP 
Sbjct: 242 VVKGDPPQLSNSEEREFS-------PSFINFVNLCLTKDESKRPK 279

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 88.7 bits (220), Expect = 1e-19
 Identities = 57/288 (19%), Positives = 101/288 (35%), Gaps = 52/288 (18%)

Query: 84  NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFL-ASIQHRNLVTLL 142
           +F  K+++G G  G +    + D   VA+K+           EV  L  S +H N++   
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYF 84

Query: 143 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR--LSIALGAAKGLAHLHSL 200
              ++   Q++  E                V ++         +++      GLAHLHSL
Sbjct: 85  CTEKDRQFQYIAIELCAATLQEY-------VEQKDFAHLGLEPITLLQQTTSGLAHLHSL 137

Query: 201 SPRVVHKDFKTANVLVDE------------DF-IAKVADAGLRNFLGRTDVAGPSSQVTA 247
              +VH+D K  N+L+              DF + K    G  +F  R+ V G       
Sbjct: 138 --NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG---- 191

Query: 248 DEIFLASEV---KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP--DSSQDLVELVQN 302
              ++A E+         +   D++S G     ++S         P   S Q    ++  
Sbjct: 192 ---WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH-----PFGKSLQRQANILLG 243

Query: 303 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
           +     L     E+              +LI + +    ++RPS   V
Sbjct: 244 ACSLDCL---HPEKHED-------VIARELIEKMIAMDPQKRPSAKHV 281

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 88.7 bits (220), Expect = 2e-19
 Identities = 54/308 (17%), Positives = 111/308 (36%), Gaps = 47/308 (15%)

Query: 74  QMEELSLATKNFSD----KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCF 129
           ++  +    ++  +    + ++G G  G V       G  VA+K+         + E+  
Sbjct: 2   RIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKL 61

Query: 130 L-ASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSI 186
           L  S  H N++        +   ++  E   N ++   +     S  + +  +  + +S+
Sbjct: 62  LTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISL 120

Query: 187 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-------------EDFIAKVADAGLRNFL 233
               A G+AHLHSL  +++H+D K  N+LV              E+    ++D GL   L
Sbjct: 121 LRQIASGVAHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178

Query: 234 GRTDVAGPSSQVT--------ADEIFLAS-EVKEFRRFSEKSDVYSFGVFLLELVSGREA 284
                +  ++           A E+   S  ++  RR +   D++S G     ++S  + 
Sbjct: 179 DSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

Query: 285 SSSLSP--DSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSE 342
                P  D       +++           +      +   E       LI + +D    
Sbjct: 239 -----PFGDKYSRESNIIRGIFSLDE----MKCLHDRSLIAEA----TDLISQMIDHDPL 285

Query: 343 RRPSMSDV 350
           +RP+   V
Sbjct: 286 KRPTAMKV 293

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 87.8 bits (217), Expect = 3e-19
 Identities = 32/303 (10%), Positives = 78/303 (25%), Gaps = 66/303 (21%)

Query: 90  LIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDE-------------------- 126
           ++G+       +    + G    +        P    I +                    
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 127 --------VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK- 177
                      L     +  +  +   + +      +   P    ++  +G   +S    
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 178 ---LEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 234
              L    RL + L   + LA LH     +VH   +  ++++D+     +         G
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY--GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262

Query: 235 RTDVAGPSSQVTADEIFLASEVKEFRR-----FSEKSDVYSFGVFLLELVSGREASSSLS 289
            + V+         E   A  +  F +      +   D ++ G+ +  +           
Sbjct: 263 ASAVSPIGRGFAPPE-TTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD------L 315

Query: 290 PDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGM-EEFIQLIVRCLDPSSERRPSMS 348
           P++    +   +          I           + + +    L+   L    E R    
Sbjct: 316 PNTDDAALGGSE---------WIFRS-------CKNIPQPVRALLEGFLRYPKEDRLLPL 359

Query: 349 DVV 351
             +
Sbjct: 360 QAM 362

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 86.8 bits (215), Expect = 4e-19
 Identities = 64/369 (17%), Positives = 130/369 (35%), Gaps = 80/369 (21%)

Query: 64  ELSIREARRFQMEEL--------SLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKK 114
           EL + E +R ++E           L   +F   + +G G  G V+K      G+++A K 
Sbjct: 6   ELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKL 65

Query: 115 RPGAPTQEFIDEVC----FLASIQHRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYG 169
                     +++      L       +V   G +  +  +  +  E++  GS+   L  
Sbjct: 66  IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLKK 124

Query: 170 PSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG- 228
             ++  Q L       +++   KGL +L     +++H+D K +N+LV+     K+ D G 
Sbjct: 125 AGRIPEQILG-----KVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGV 178

Query: 229 ---LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR--- 282
              L + +  + V   S        +++ E  +   +S +SD++S G+ L+E+  GR   
Sbjct: 179 SGQLIDSMANSFVGTRS--------YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

Query: 283 ------------------------EASSSLSPDSSQDLVELVQNSRDFSNLLKI------ 312
                                       +     ++  ++       F  L  I      
Sbjct: 231 PPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPP 290

Query: 313 -LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD------VVTELDRTLDKEMNLT 365
            L   ++S        EF   + +CL  +   R  +        +       +D    L 
Sbjct: 291 KLPSGVFS-------LEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLC 343

Query: 366 TVMGEGTPT 374
           + +G   P+
Sbjct: 344 STIGLNQPS 352

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 85.0 bits (211), Expect = 6e-19
 Identities = 64/280 (22%), Positives = 108/280 (38%), Gaps = 59/280 (21%)

Query: 90  LIGEGKFGEVYKG-LLQDGMLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVTL 141
            +G+GKFG VY     Q+  ++A+K       ++ G   Q    E+   + ++H N++ +
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREIEIQSHLRHPNILRM 79

Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA------AKGLA 195
             Y  +    +L+ E+ P G     LY       ++L+   R      A      A  L 
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGE----LY-------KELQKHGRFDEQRSATFMEELADALH 128

Query: 196 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV-----TADEI 250
           + H    +V+H+D K  N+L+      K+AD G         V  PS +      T D  
Sbjct: 129 YCHER--KVIHRDIKPENLLMGYKGELKIADFGW-------SVHAPSLRRRTMCGTLD-- 177

Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 310
           +L  E+ E +   EK D++  GV   E + G        P  S    E  +         
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM------PPFDSPSHTETHR--------- 222

Query: 311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
           +I++  L   F     +    LI + L     +R  +  V
Sbjct: 223 RIVNVDL--KFPPFLSDGSKDLISKLLRYHPPQRLPLKGV 260

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 84.8 bits (210), Expect = 1e-18
 Identities = 53/316 (16%), Positives = 107/316 (33%), Gaps = 36/316 (11%)

Query: 75  MEELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCF 129
           M   S +   +   +++G+G    V++G   + G L AIK         P    + E   
Sbjct: 1   MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV 60

Query: 130 LASIQHRNLVTLLGYCQENNLQ--FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 187
           L  + H+N+V L    +E   +   LI E+ P GS+   L  PS  +   L     L + 
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS--NAYGLPESEFLIVL 118

Query: 188 LGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNFLGRTDVAGPSS 243
                G+ HL      +VH++ K  N++     D   + K+ D G    L   +     S
Sbjct: 119 RDVVGGMNHLREN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VS 174

Query: 244 QV-----TADEIF--LASEVKEFRRFSEKSDVYSFGVFLLELVSGREA-SSSLSPDSSQD 295
                     +++          +++    D++S GV      +G         P  +++
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234

Query: 296 LVELVQNSRDFSNLLKILDER-----------LWSTFTNEGMEEFIQLIVRCLDPSSERR 344
           ++  +   +    +  +               +  + +         ++   L+   E+ 
Sbjct: 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKC 294

Query: 345 PSMSDVVTELDRTLDK 360
                   E    L +
Sbjct: 295 WGFDQFFAETSDILHR 310

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 84.1 bits (209), Expect = 2e-18
 Identities = 56/244 (22%), Positives = 99/244 (40%), Gaps = 55/244 (22%)

Query: 67  IREARRFQMEELSLATKNFSDK----NLIGEGKFGEVYKGLLQDGMLVAIKK------RP 116
           +           +L  +   +K      +GEG +G VYK     G +VA+K+        
Sbjct: 1   MHHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDE 60

Query: 117 GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP--------NGSVSIHLY 168
           G P+   I E+  L  + H N+V+L+          L++E++              +   
Sbjct: 61  GIPSTA-IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQ-- 117

Query: 169 GPSQV---SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA 225
             SQ+     Q L             +G+AH H    R++H+D K  N+L++ D   K+A
Sbjct: 118 -DSQIKIYLYQLL-------------RGVAHCHQH--RILHRDLKPQNLLINSDGALKLA 161

Query: 226 DAGL-RNFLGRTDVAGPSSQ--VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLEL 278
           D GL R F          +   VT    A ++ + S     +++S   D++S G    E+
Sbjct: 162 DFGLARAF---GIPVRSYTHEVVTLWYRAPDVLMGS-----KKYSTSVDIWSIGCIFAEM 213

Query: 279 VSGR 282
           ++G+
Sbjct: 214 ITGK 217

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 83.0 bits (206), Expect = 3e-18
 Identities = 60/285 (21%), Positives = 108/285 (37%), Gaps = 66/285 (23%)

Query: 90  LIGEGKFGEVYKGL-LQDGMLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVTL 141
           L+G+G F  VY+   +  G+ VAIK        + G   +   +EV     ++H +++ L
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILEL 76

Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA------AKGLA 195
             Y +++N  +L+ E   NG ++ +L      +R K       S             G+ 
Sbjct: 77  YNYFEDSNYVYLVLEMCHNGEMNRYL-----KNRVK-----PFSENEARHFMHQIITGML 126

Query: 196 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL--- 252
           +LHS    ++H+D   +N+L+  +   K+AD GL            ++Q+          
Sbjct: 127 YLHSH--GILHRDLTLSNLLLTRNMNIKIADFGL------------ATQLKMPHEKHYTL 172

Query: 253 -------ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD 305
                  + E+        +SDV+S G     L+ GR       P  +  +         
Sbjct: 173 CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR------PPFDTDTVKNT------ 220

Query: 306 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
              L K++         +    E   LI + L  +   R S+S V
Sbjct: 221 ---LNKVVLADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSV 260

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 83.7 bits (207), Expect = 5e-18
 Identities = 53/316 (16%), Positives = 107/316 (33%), Gaps = 36/316 (11%)

Query: 75  MEELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCF 129
           M   S +   +   +++G+G    V++G   + G L AIK         P    + E   
Sbjct: 1   MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV 60

Query: 130 LASIQHRNLVTLLGYCQENNLQ--FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 187
           L  + H+N+V L    +E   +   LI E+ P GS+   L  PS  +   L     L + 
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS--NAYGLPESEFLIVL 118

Query: 188 LGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNFLGRTDVAGPSS 243
                G+ HL      +VH++ K  N++     D   + K+ D G    L   +     S
Sbjct: 119 RDVVGGMNHLREN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VS 174

Query: 244 QV-----TADEIF--LASEVKEFRRFSEKSDVYSFGVFLLELVSGREA-SSSLSPDSSQD 295
                     +++          +++    D++S GV      +G         P  +++
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234

Query: 296 LVELVQNSRDFSNLLKILDER-----------LWSTFTNEGMEEFIQLIVRCLDPSSERR 344
           ++  +   +    +  +               +  + +         ++   L+   E+ 
Sbjct: 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKC 294

Query: 345 PSMSDVVTELDRTLDK 360
                   E    L +
Sbjct: 295 WGFDQFFAETSDILHR 310

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 81.5 bits (202), Expect = 1e-17
 Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 30/215 (13%)

Query: 84  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRN 137
            F     +G G +  VYKGL    G+ VA+K+       G P+   I E+  +  ++H N
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA-IREISLMKELKHEN 64

Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 197
           +V L       N   L++E++ N             + + LE            +GLA  
Sbjct: 65  IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124

Query: 198 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQ-----VT----A 247
           H    +++H+D K  N+L+++    K+ D GL R F        P +      VT    A
Sbjct: 125 HEN--KILHRDLKPQNLLINKRGQLKLGDFGLARAF------GIPVNTFSSEVVTLWYRA 176

Query: 248 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
            ++ + S     R +S   D++S G  L E+++G+
Sbjct: 177 PDVLMGS-----RTYSTSIDIWSCGCILAEMITGK 206

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 81.3 bits (201), Expect = 2e-17
 Identities = 53/287 (18%), Positives = 110/287 (38%), Gaps = 43/287 (14%)

Query: 76  EELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID----EVCFL 130
           +       +  +   +G G  G+V+K    + G ++A+K+   +  +E       ++  +
Sbjct: 18  QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77

Query: 131 -ASIQHRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 188
             S     +V   G +    ++ F+  E +   +  +       +     E      + +
Sbjct: 78  LKSHDCPYIVQCFGTFITNTDV-FIAMELMGTCAEKLKKRMQGPIP----ERILG-KMTV 131

Query: 189 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAGPSSQ 244
              K L +L      V+H+D K +N+L+DE    K+ D G    L +   +   AG ++ 
Sbjct: 132 AIVKALYYLKEKH-GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAA- 189

Query: 245 VTADEIFLASEVKEFRR-----FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVEL 299
                 ++A E  +        +  ++DV+S G+ L+EL +G+    +   D    L ++
Sbjct: 190 ------YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV-LTKV 242

Query: 300 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 346
           +Q       LL       +S        +F   +  CL     +RP 
Sbjct: 243 LQEE---PPLLP--GHMGFS-------GDFQSFVKDCLTKDHRKRPK 277

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 81.5 bits (202), Expect = 2e-17
 Identities = 56/229 (24%), Positives = 100/229 (43%), Gaps = 57/229 (24%)

Query: 83  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQEF-------IDEVCFLASI 133
           K +   + +GEG+F  VYK        +VAIKK + G  ++         + E+  L  +
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 134 QHRNLVTLLG-YCQENNLQFLIYEYIPN------GSVSIHLYGPSQV---SRQKLEFKHR 183
            H N++ LL  +  ++N+  L+++++           S+ L  PS +       L     
Sbjct: 70  SHPNIIGLLDAFGHKSNI-SLVFDFMETDLEVIIKDNSLVL-TPSHIKAYMLMTL----- 122

Query: 184 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGP- 241
                   +GL +LH     ++H+D K  N+L+DE+ + K+AD GL ++F        P 
Sbjct: 123 --------QGLEYLHQH--WILHRDLKPNNLLLDENGVLKLADFGLAKSF------GSPN 166

Query: 242 ---SSQV-T----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
              + QV T    A E+   +     R +    D+++ G  L EL+   
Sbjct: 167 RAYTHQVVTRWYRAPELLFGA-----RMYGVGVDMWAVGCILAELLLRV 210

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 80.6 bits (200), Expect = 2e-17
 Identities = 49/230 (21%), Positives = 88/230 (38%), Gaps = 58/230 (25%)

Query: 83  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 135
           + +     IGEG +G V+K    +   +VA+K+        G P+   + E+C L  ++H
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA-LREICLLKELKH 60

Query: 136 RNLVTLLGYCQENNLQFLIYEYIP--------NGSVSIHLYGPSQV---SRQKLEFKHRL 184
           +N+V L      +    L++E+          + +  +    P  V     Q L      
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLL------ 111

Query: 185 SIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSS 243
                  KGL   HS    V+H+D K  N+L++ +   K+A+ GL R F        P  
Sbjct: 112 -------KGLGFCHSR--NVLHRDLKPQNLLINRNGELKLANFGLARAF------GIPVR 156

Query: 244 QVT---------ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 284
             +           ++   +     + +S   D++S G    EL +    
Sbjct: 157 CYSAEVVTLWYRPPDVLFGA-----KLYSTSIDMWSAGCIFAELANAGRP 201

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 80.6 bits (200), Expect = 3e-17
 Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 35/216 (16%)

Query: 83  KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHR 136
           + +     IGEG +G VYK     G   A+KK        G P+   I E+  L  ++H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT-IREISILKELKHS 60

Query: 137 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 196
           N+V L           L++E++        L     V    LE     S  L    G+A+
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQD-----LKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115

Query: 197 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQ-----VT---- 246
            H    RV+H+D K  N+L++ +   K+AD GL R F        P  +     VT    
Sbjct: 116 CHDR--RVLHRDLKPQNLLINREGELKIADFGLARAF------GIPVRKYTHEIVTLWYR 167

Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
           A ++ + S     +++S   D++S G    E+V+G 
Sbjct: 168 APDVLMGS-----KKYSTTIDIWSVGCIFAEMVNGT 198

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 82.1 bits (203), Expect = 3e-17
 Identities = 63/300 (21%), Positives = 117/300 (39%), Gaps = 65/300 (21%)

Query: 78  LSLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEV 127
           ++    + S+       +G G +GEV         +  AIK         +   + ++EV
Sbjct: 28  ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87

Query: 128 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 187
             L  + H N++ L  + ++    +L+ E    G     L+        ++  + + +  
Sbjct: 88  AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE----LF-------DEIIHRMKFNEV 136

Query: 188 LGAA------KGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR--- 235
             A        G+ +LH  +  +VH+D K  N+L+   ++D + K+ D GL         
Sbjct: 137 DAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK 194

Query: 236 -TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---D 291
             +  G     TA   ++A EV   +++ EK DV+S GV L  L++G        P    
Sbjct: 195 MKERLG-----TAY--YIAPEVLR-KKYDEKCDVWSIGVILFILLAGY------PPFGGQ 240

Query: 292 SSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
           + Q+++  V+  +  F       D   W   +         LI + L   S+RR S    
Sbjct: 241 TDQEILRKVEKGKYTF-------DSPEWKNVSEGA----KDLIKQMLQFDSQRRISAQQA 289

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 80.0 bits (198), Expect = 3e-17
 Identities = 59/271 (21%), Positives = 107/271 (39%), Gaps = 40/271 (14%)

Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVC-----FLASIQHRNLVTLLG- 143
           +G G +G V K   +  G ++A+K+       +    +       + ++     VT  G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 144 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 203
             +E ++ ++  E + + S+    Y       Q +       IA+   K L HLHS    
Sbjct: 75  LFREGDV-WICMELM-DTSLD-KFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLS 130

Query: 204 VVHKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAGPSSQVTADEIFLASEV--- 256
           V+H+D K +NVL++     K+ D G    L + + +   AG          ++A E    
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKP-------YMAPERINP 183

Query: 257 -KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 315
               + +S KSD++S G+ ++EL   R    S         ++ V            L  
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF--QQLKQVVEEPSPQ-----LPA 236

Query: 316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 346
             +S        EF+    +CL  +S+ RP+
Sbjct: 237 DKFS-------AEFVDFTSQCLKKNSKERPT 260

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 80.3 bits (199), Expect = 4e-17
 Identities = 48/210 (22%), Positives = 80/210 (38%), Gaps = 38/210 (18%)

Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAP-TQEFIDEVCFLASIQHRNLVTLL 142
           IGEG +G V+K      G +VAIKK       P        + E+  L  ++H NLV LL
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA--LREIRMLKQLKHPNLVNLL 68

Query: 143 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 202
              +      L++EY  +      +       ++ +      SI     + +   H    
Sbjct: 69  EVFRRKRRLHLVFEYCDH-----TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH-- 121

Query: 203 RVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVT---------ADEIFL 252
             +H+D K  N+L+ +  + K+ D G  R         GPS             + E+ +
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLL------TGPSDYYDDEVATRWYRSPELLV 175

Query: 253 ASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                   ++    DV++ G    EL+SG 
Sbjct: 176 GD-----TQYGPPVDVWAIGCVFAELLSGV 200

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 80.0 bits (198), Expect = 4e-17
 Identities = 63/310 (20%), Positives = 110/310 (35%), Gaps = 73/310 (23%)

Query: 90  LIGEGKFGEVYKGLLQDGML---VAIK--KRPGAPTQEFID----EVCFLASIQHRNLVT 140
           ++G G   EV+    +D      VA+K  +   A    F      E    A++ H  +V 
Sbjct: 19  ILGFGGMSEVHLA--RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 141 LLGYCQENN----LQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSIALGAAKGL 194
           +    +       L +++ EY+   ++   +H  GP       +  K  + +   A + L
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-------MTPKRAIEVIADACQAL 129

Query: 195 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLA 253
              H     ++H+D K AN+++      KV D G+ R       +A   + VT     + 
Sbjct: 130 NFSHQN--GIIHRDVKPANIMISATNAVKVMDFGIAR------AIADSGNSVTQTAAVIG 181

Query: 254 S------EVKEFRRFSEKSDVYSFGVFLLELVSGR--------------------EASSS 287
           +      E         +SDVYS G  L E+++G                        S+
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA 241

Query: 288 LSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM 347
                S DL  +V  +     L K  + R  +        E    +VR  +      P  
Sbjct: 242 RHEGLSADLDAVVLKA-----LAKNPENRYQT------AAEMRADLVRVHNG---EPPEA 287

Query: 348 SDVVTELDRT 357
             V+T+ +RT
Sbjct: 288 PKVLTDAERT 297

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 81.7 bits (202), Expect = 5e-17
 Identities = 66/297 (22%), Positives = 117/297 (39%), Gaps = 67/297 (22%)

Query: 82  TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFLA 131
              F+++     ++G+G FGEV K          A+K           T   + EV  L 
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76

Query: 132 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA 191
            + H N++ L    ++++  +++ E    G     L+        ++  + R S    AA
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGE----LF-------DEIIKRKRFSEH-DAA 124

Query: 192 K-------GLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR----TD 237
           +       G+ ++H     +VH+D K  N+L+   ++D   K+ D GL     +     D
Sbjct: 125 RIIKQVFSGITYMHKH--NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD 182

Query: 238 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---DSSQ 294
             G     TA   ++A EV     + EK DV+S GV L  L+SG        P    +  
Sbjct: 183 RIG-----TAY--YIAPEVLR-GTYDEKCDVWSAGVILYILLSGT------PPFYGKNEY 228

Query: 295 DLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
           D+++ V+  +  F       D   W T +++       LI + L      R + +  
Sbjct: 229 DILKRVETGKYAF-------DLPQWRTISDDA----KDLIRKMLTFHPSLRITATQC 274

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 80.3 bits (199), Expect = 5e-17
 Identities = 39/157 (24%), Positives = 68/157 (43%), Gaps = 16/157 (10%)

Query: 84  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHR 136
            + +  L+GEG +G V K      G +VAIKK               + E+  L  ++H 
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA-MREIKLLKQLRHE 84

Query: 137 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 196
           NLV LL  C++    +L++E+     V   +    ++    L+++           G+  
Sbjct: 85  NLVNLLEVCKKKKRWYLVFEF-----VDHTILDDLELFPNGLDYQVVQKYLFQIINGIGF 139

Query: 197 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNF 232
            HS    ++H+D K  N+LV +  + K+ D G  R  
Sbjct: 140 CHSH--NIIHRDIKPENILVSQSGVVKLCDFGFARTL 174

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 80.5 bits (199), Expect = 7e-17
 Identities = 58/307 (18%), Positives = 110/307 (35%), Gaps = 66/307 (21%)

Query: 71  RRFQMEELSLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVA---IKKRPGAPTQE 122
           +++  + + +   +  D       +G G FG V++ +    G +     I          
Sbjct: 35  KKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT 94

Query: 123 FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG------SVSIHLYGPSQVS-- 174
             +E+  +  + H  L+ L    ++     LI E++  G      +   +    ++V   
Sbjct: 95  VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY 154

Query: 175 -RQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV--DEDFIAKVADAGLRN 231
            RQ  E             GL H+H     +VH D K  N++    +    K+ D GL  
Sbjct: 155 MRQACE-------------GLKHMHEH--SIVHLDIKPENIMCETKKASSVKIIDFGLAT 199

Query: 232 FLGR----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS 287
            L                TA+  F A E+ +       +D+++ GV    L+SG      
Sbjct: 200 KLNPDEIVKVTTA-----TAE--FAAPEIVDREPVGFYTDMWAIGVLGYVLLSG------ 246

Query: 288 LSP---DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSER 343
           LSP   +   + ++ V+    +F       DE  +S+ + E  +     I   L     +
Sbjct: 247 LSPFAGEDDLETLQNVKRCDWEF-------DEDAFSSVSPEAKD----FIKNLLQKEPRK 295

Query: 344 RPSMSDV 350
           R ++ D 
Sbjct: 296 RLTVHDA 302

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 39/210 (18%), Positives = 76/210 (36%), Gaps = 35/210 (16%)

Query: 90  LIGEGKFGEVYKGLLQDGML---VAIK--KRPGAPTQEFID----EVCFLASIQHRNLVT 140
           L+G G  G+VY+   +D +    VA+K      +    F      E      +Q  ++V 
Sbjct: 41  LVGRGGMGDVYEA--EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 141 LLGYCQENNLQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 198
           +  + + +   ++    I    ++  +   GP       L     ++I       L   H
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP-------LAPPRAVAIVRQIGSALDAAH 151

Query: 199 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS---- 254
           +      H+D K  N+LV  D  A + D G+         A    ++T     + +    
Sbjct: 152 AA--GATHRDVKPENILVSADDFAYLVDFGIA-------SATTDEKLTQLGNTVGTLYYM 202

Query: 255 --EVKEFRRFSEKSDVYSFGVFLLELVSGR 282
             E       + ++D+Y+    L E ++G 
Sbjct: 203 APERFSESHATYRADIYALTCVLYECLTGS 232

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 80.3 bits (198), Expect = 1e-16
 Identities = 59/308 (19%), Positives = 114/308 (37%), Gaps = 68/308 (22%)

Query: 71  RRFQMEELSLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVA---IKKRPGAPTQE 122
           +++  + + +   +  D       +G G FG V++      G   A   +     +  + 
Sbjct: 141 KQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET 200

Query: 123 FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG-------SVSIHL--YGPSQV 173
              E+  ++ ++H  LV L    +++N   +IYE++  G            +      + 
Sbjct: 201 VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY 260

Query: 174 SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLR 230
            RQ  +             GL H+H  +   VH D K  N++      + + K+ D GL 
Sbjct: 261 MRQVCK-------------GLCHMHENN--YVHLDLKPENIMFTTKRSNEL-KLIDFGLT 304

Query: 231 NFLGR----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASS 286
             L          G     TA+  F A EV E +     +D++S GV    L+SG     
Sbjct: 305 AHLDPKQSVKVTTG-----TAE--FAAPEVAEGKPVGYYTDMWSVGVLSYILLSG----- 352

Query: 287 SLSP---DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSE 342
            LSP   ++  + +  V++   +        D+  +S  + +G +     I + L     
Sbjct: 353 -LSPFGGENDDETLRNVKSCDWNM-------DDSAFSGISEDGKD----FIRKLLLADPN 400

Query: 343 RRPSMSDV 350
            R ++   
Sbjct: 401 TRMTIHQA 408

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 78.2 bits (193), Expect = 1e-16
 Identities = 28/202 (13%), Positives = 50/202 (24%), Gaps = 49/202 (24%)

Query: 90  LIGEGKFGEVYKGLLQDGML---VAIK------KRPGAPTQEFIDEVCFLASIQHRNLVT 140
             G     + ++    D  L   VA+         P    QE +     L+ I    +  
Sbjct: 38  FHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 200
           +L          ++ E+I  GS+        +V+         +      A      H  
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQ-------EVADTSPSPVGAIRAMQSLAAAADAAHRA 148

Query: 201 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 260
              V       + V V  D    +A                ++                 
Sbjct: 149 G--VALSIDHPSRVRVSIDGDVVLAYPA---------TMPDANP---------------- 181

Query: 261 RFSEKSDVYSFGVFLLELVSGR 282
               + D+   G  L  L+  R
Sbjct: 182 ----QDDIRGIGASLYALLVNR 199

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 67/301 (22%), Positives = 113/301 (37%), Gaps = 66/301 (21%)

Query: 78  LSLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFID----E 126
           +  +T  FSD+     ++G+G FGEV        G   A+K   +     +   +    E
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76

Query: 127 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 186
           V  L  + H N++ L  + ++    +L+ E    G     L+        ++  + R S 
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE----LF-------DEIISRKRFSE 125

Query: 187 ALGAA------KGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR-- 235
              A        G+ ++H     +VH+D K  N+L+    +D   ++ D GL        
Sbjct: 126 VDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183

Query: 236 --TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP--- 290
              D  G     TA   ++A EV     + EK DV+S GV L  L+SG        P   
Sbjct: 184 KMKDKIG-----TAY--YIAPEVLH-GTYDEKCDVWSTGVILYILLSGC------PPFNG 229

Query: 291 DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 349
            +  D+++ V+  +  F       +   W   +         LI + L      R S  D
Sbjct: 230 ANEYDILKKVEKGKYTF-------ELPQWKKVSESA----KDLIRKMLTYVPSMRISARD 278

Query: 350 V 350
            
Sbjct: 279 A 279

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 80.5 bits (198), Expect = 1e-16
 Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 27/216 (12%)

Query: 84  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFID-EVCFLASIQHRNL 138
            +  K  +G G FG V + +    G  VAIK   +      +E    E+  +  + H N+
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 139 VTLL------GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK-LEFKHRLS-IALGA 190
           V+             N+L  L  EY   G +  +L         K    +  LS I+   
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA- 133

Query: 191 AKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTDVAGPSSQV-T 246
              L +LH    R++H+D K  N+++    +  I K+ D G    L + ++   +  V T
Sbjct: 134 ---LRYLHEN--RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC--TEFVGT 186

Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
               +LA E+ E ++++   D +SFG    E ++G 
Sbjct: 187 --LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 51/307 (16%), Positives = 102/307 (33%), Gaps = 72/307 (23%)

Query: 91  IGEGKFGEVYKGLLQDGMLVAIK----------KRPGAPTQEFID----------EVCFL 130
           + +GKF ++     +D    A+K          +       + I           E+  +
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 131 ASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 190
             I++   +T  G     +  ++IYEY+ N S+              L+  +   I +  
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFD-----EYFFVLDKNYTCFIPIQV 152

Query: 191 AK--------GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS 242
            K          +++H+    + H+D K +N+L+D++   K++D G              
Sbjct: 153 IKCIIKSVLNSFSYIHNEK-NICHRDVKPSNILMDKNGRVKLSDFGE------------- 198

Query: 243 SQVTADEI---------FLASEVKEFRRF--SEKSDVYSFGVFLLELVSGR---EASSSL 288
           S+   D+          F+  E           K D++S G+ L  +           SL
Sbjct: 199 SEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258

Query: 289 SPDSSQDLVELVQNSR-----DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSER 343
                 +L   ++        D ++ L  L  +  +   N    E I  +   L  +   
Sbjct: 259 -----VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAE 313

Query: 344 RPSMSDV 350
           R +  D 
Sbjct: 314 RITSEDA 320

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 78.4 bits (194), Expect = 2e-16
 Identities = 60/224 (26%), Positives = 93/224 (41%), Gaps = 51/224 (22%)

Query: 83  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHR 136
           + +   + +GEG +  VYKG       LVA+K+       GAP    I EV  L  ++H 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCT-AIREVSLLKDLKHA 60

Query: 137 NLVTLLGYCQENNLQFLIYEYIP--------NGSVSIHLYGPSQVSRQKLEFKHRLSIAL 188
           N+VTL           L++EY+         +    I+      V   KL     L    
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIIN---MHNV---KLFLFQLL---- 110

Query: 189 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQ--- 244
              +GLA+ H    +V+H+D K  N+L++E    K+AD GL R        + P+     
Sbjct: 111 ---RGLAYCHR--QKVLHRDLKPQNLLINERGELKLADFGLARAK------SIPTKTYDN 159

Query: 245 --VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
             VT      +I L S       +S + D++  G    E+ +GR
Sbjct: 160 EVVTLWYRPPDILLGS-----TDYSTQIDMWGVGCIFYEMATGR 198

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 65/308 (21%), Positives = 118/308 (38%), Gaps = 78/308 (25%)

Query: 82  TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK----------------KRPGAPT 120
                +       +G G +GEV            AIK                K      
Sbjct: 31  EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFH 90

Query: 121 QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF 180
           +E  +E+  L S+ H N++ L    ++    +L+ E+   G     L+       +++  
Sbjct: 91  EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE----LF-------EQIIN 139

Query: 181 KHRLSIALGAAK-------GLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLR 230
           +H+      AA        G+ +LH  +  +VH+D K  N+L+   +     K+ D GL 
Sbjct: 140 RHKFDEC-DAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLS 196

Query: 231 NFLGR----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASS 286
           +F  +     D  G     TA   ++A EV + ++++EK DV+S GV +  L+ G     
Sbjct: 197 SFFSKDYKLRDRLG-----TAY--YIAPEVLK-KKYNEKCDVWSCGVIMYILLCGY---- 244

Query: 287 SLSP---DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSE 342
              P    + QD+++ V+  +  F       D   W   ++E      +LI   L     
Sbjct: 245 --PPFGGQNDQDIIKKVEKGKYYF-------DFNDWKNISDEA----KELIKLMLTYDYN 291

Query: 343 RRPSMSDV 350
           +R +  + 
Sbjct: 292 KRCTAEEA 299

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 77.7 bits (192), Expect = 4e-16
 Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 40/217 (18%)

Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAP-TQEFIDEVCFLASIQHRNLVTLL 142
           IG+G FGEV+K    + G  VA+KK      + G P T   + E+  L  ++H N+V L+
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA--LREIKILQLLKHENVVNLI 82

Query: 143 GYCQENNLQ--------FLIYEYIPNGSVSIH-LYGPSQVSRQKLEFKHRLSIALGAAKG 193
             C+             +L++++        H L G       K        +      G
Sbjct: 83  EICRTKASPYNRCKGSIYLVFDFCE------HDLAGLLSNVLVKFTLSEIKRVMQMLLNG 136

Query: 194 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNF--LGRTDVAGPSSQV-T--- 246
           L ++H    +++H+D K ANVL+  D + K+AD GL R F     +     +++V T   
Sbjct: 137 LYYIHRN--KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 194

Query: 247 -ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
              E+ L       R +    D++  G  + E+ +  
Sbjct: 195 RPPELLLGE-----RDYGPPIDLWGAGCIMAEMWTRS 226

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 77.6 bits (191), Expect = 4e-16
 Identities = 37/240 (15%), Positives = 78/240 (32%), Gaps = 32/240 (13%)

Query: 121 QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF 180
                ++  +     +N V  L         ++  +     ++   +    + S +  E 
Sbjct: 106 DAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMN--RRCSLEDREH 163

Query: 181 KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVA 239
              L I +  A+ +  LHS    ++H+D K +N+    D + KV D GL        +  
Sbjct: 164 GVCLHIFIQIAEAVEFLHSK--GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221

Query: 240 GPSSQVTADEIF---------LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP 290
              + + A             ++ E      +S K D++S G+ L EL+           
Sbjct: 222 TVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-- 279

Query: 291 DSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
                             ++  +    +     +   +   ++   L PS   RP  +D+
Sbjct: 280 ----------------VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDI 323

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 44.1 bits (104), Expect = 4e-05
 Identities = 19/109 (17%), Positives = 33/109 (30%), Gaps = 5/109 (4%)

Query: 83  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQEFIDEVCFLASIQHRN 137
            +F     +G G FG V++     D    AIK+          ++ + EV  LA ++H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 186
           +V       E   +    E             P            ++  
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRR 114

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 77.5 bits (191), Expect = 7e-16
 Identities = 47/213 (22%), Positives = 88/213 (41%), Gaps = 29/213 (13%)

Query: 91  IGEGKFGEVYKGLLQD---GMLVAIKK--RPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 145
           +G G +G VYK   +D       A+K+    G        E+  L  ++H N+++L    
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-MSACREIALLRELKHPNVISLQKVF 87

Query: 146 QENNLQ--FLIYEYIPN---GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 200
             +  +  +L+++Y  +     +  H    +     +L      S+      G+ +LH+ 
Sbjct: 88  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA- 146

Query: 201 SPRVVHKDFKTANVLVDEDF----IAKVADAGL-RNF--LGRTDVAGPSSQVT----ADE 249
              V+H+D K AN+LV  +       K+AD G  R F    +         VT    A E
Sbjct: 147 -NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 205

Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
           + L +     R +++  D+++ G    EL++  
Sbjct: 206 LLLGA-----RHYTKAIDIWAIGCIFAELLTSE 233

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 76.1 bits (188), Expect = 1e-15
 Identities = 54/228 (23%), Positives = 83/228 (36%), Gaps = 56/228 (24%)

Query: 84  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHR 136
            +     +GEG +GEVYK +       VAIK+        G P    I EV  L  +QHR
Sbjct: 35  RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA-IREVSLLKELQHR 93

Query: 137 NLVTLLGYCQENNLQFLIYEYIP-------NGSVSIHLYGPSQV---SRQKLEFKHRLSI 186
           N++ L      N+   LI+EY         + +  +       +     Q +        
Sbjct: 94  NIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVS---MRVIKSFLYQLI-------- 142

Query: 187 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA-----KVADAGL-RNFLGRTDVAG 240
                 G+   H  S R +H+D K  N+L+     +     K+ D GL R F        
Sbjct: 143 -----NGVNFCH--SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF---GIPIR 192

Query: 241 PSSQ--VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
             +   +T      EI L S     R +S   D++S      E++   
Sbjct: 193 QFTHEIITLWYRPPEILLGS-----RHYSTSVDIWSIACIWAEMLMKT 235

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 72/348 (20%), Positives = 125/348 (35%), Gaps = 71/348 (20%)

Query: 34  RSVSRTSETGSSEPSVQRNICIIAGRNVGIELSI-REARRFQMEELSLATKNFSD----- 87
           RS    ++   S   +   + + + R   + + I      F    ++      +      
Sbjct: 33  RSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVS 92

Query: 88  -KNLIGEGKFGEVYKGL-LQDGMLVA---IKKRPGAPTQEFIDEVCFLASIQHRNLVTLL 142
              ++G G+FG+V+K      G+ +A   IK R     +E  +E+  +  + H NL+ L 
Sbjct: 93  KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLY 152

Query: 143 GYCQENNLQFLIYEYIPNGSV------SIHLYGPSQVS---RQKLEFKHRLSIALGAAKG 193
              +  N   L+ EY+  G +        +           +Q  E             G
Sbjct: 153 DAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE-------------G 199

Query: 194 LAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR----TDVAGPSSQVT 246
           + H+H +   ++H D K  N+L    D   I K+ D GL              G     T
Sbjct: 200 IRHMHQM--YILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPREKLKVNFG-----T 251

Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---DSSQDLVELVQNS 303
            +  FLA EV  +   S  +D++S GV    L+SG      LSP   D+  + +  +   
Sbjct: 252 PE--FLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG------LSPFLGDNDAETLNNILAC 303

Query: 304 R-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
           R D        ++  +   + E  E     I + L      R S S+ 
Sbjct: 304 RWDL-------EDEEFQDISEEAKE----FISKLLIKEKSWRISASEA 340

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 76.0 bits (187), Expect = 1e-15
 Identities = 51/330 (15%), Positives = 98/330 (29%), Gaps = 83/330 (25%)

Query: 82  TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFID----EVC 128
                 K      IG+G +G V   +  Q   + AIK     +      + ++    EV 
Sbjct: 21  LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVR 80

Query: 129 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSI 186
            +  + H N+  L    ++     L+ E    G +   ++++      +  ++       
Sbjct: 81  LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140

Query: 187 ALG--------------------------AAK-------GLAHLHSLSPRVVHKDFKTAN 213
                                         +         L +LH+    + H+D K  N
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ--GICHRDIKPEN 198

Query: 214 VLV--DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-----FLASEV--KEFRRFSE 264
            L   ++ F  K+ D GL     + +                  F+A EV       +  
Sbjct: 199 FLFSTNKSFEIKLVDFGLSKEFYKLN---NGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255

Query: 265 KSDVYSFGVFLLELVSGREASSSLSP---DSSQDLVELVQNSR-DFSNLLKILDERLWST 320
           K D +S GV L  L+ G        P    +  D +  V N +  F       +   ++ 
Sbjct: 256 KCDAWSAGVLLHLLLMGA------VPFPGVNDADTISQVLNKKLCF-------ENPNYNV 302

Query: 321 FTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
            +         L+   L+ + + R      
Sbjct: 303 LSPLA----RDLLSNLLNRNVDERFDAMRA 328

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 74.5 bits (184), Expect = 3e-15
 Identities = 62/299 (20%), Positives = 104/299 (34%), Gaps = 67/299 (22%)

Query: 79  SLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVCFL 130
           S+ T N         ++G G F EV+       G L A+K   K P        +E+  L
Sbjct: 1   SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVL 60

Query: 131 ASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYG------PSQVSRQKLEFKH 182
             I+H N+VTL    +     +L+ + +  G +   I   G       S V +Q L    
Sbjct: 61  KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLS--- 117

Query: 183 RLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR---T 236
                      + +LH     +VH+D K  N+L    +E+    + D GL         +
Sbjct: 118 ----------AVKYLHEN--GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS 165

Query: 237 DVAG-PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---DS 292
              G P         ++A EV   + +S+  D +S GV    L+ G        P   ++
Sbjct: 166 TACGTPG--------YVAPEVLAQKPYSKAVDCWSIGVITYILLCGY------PPFYEET 211

Query: 293 SQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
              L E ++    +F       +   W   +    +     I   L+     R +    
Sbjct: 212 ESKLFEKIKEGYYEF-------ESPFWDDISESAKD----FICHLLEKDPNERYTCEKA 259

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 75.5 bits (186), Expect = 4e-15
 Identities = 63/278 (22%), Positives = 109/278 (39%), Gaps = 54/278 (19%)

Query: 32  RNRSVSRTSETGSSEPSVQRNICIIAGRNVGIELSIREARRFQMEELSLATKNFSDKNLI 91
           R R+ S        +         ++    G +++   A   Q  +      +++D  +I
Sbjct: 4   RPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQ-EVSYTDTKVI 62

Query: 92  GEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLGY 144
           G G FG VY+  L D G LVAIKK          D      E+  +  + H N+V L  +
Sbjct: 63  GNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLDHCNIVRLRYF 115

Query: 145 CQENNLQF------LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG------AAK 192
              +  +       L+ +Y+P       +Y   +V+R     K  L +           +
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPE-----TVY---RVARHYSRAKQTLPVIYVKLYMYQLFR 167

Query: 193 GLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRTDVAGPSSQ---VT-- 246
            LA++HS    + H+D K  N+L+D D  + K+ D G      +  V G  +     +  
Sbjct: 168 SLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFG----SAKQLVRGEPNVSYICSRY 221

Query: 247 --ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
             A E+   +       ++   DV+S G  L EL+ G+
Sbjct: 222 YRAPELIFGA-----TDYTSSIDVWSAGCVLAELLLGQ 254

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 73.0 bits (180), Expect = 9e-15
 Identities = 64/293 (21%), Positives = 117/293 (39%), Gaps = 59/293 (20%)

Query: 82  TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFLA 131
              F+++     ++G+G FGEV K          A+K           T   + EV  L 
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76

Query: 132 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGPSQVSRQKLEFKHRLSIALG 189
            + H N++ L    ++++  +++ E    G +   I       + R++        I   
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI-------IKRKRFSEHDAARIIKQ 129

Query: 190 AAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR----TDVAGPS 242
              G+ ++H  +  +VH+D K  N+L+   ++D   K+ D GL     +     D  G  
Sbjct: 130 VFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG-- 185

Query: 243 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP----DSSQDLVE 298
              TA   ++A EV     + EK DV+S GV L  L+SG       +P     +  D+++
Sbjct: 186 ---TA--YYIAPEVLR-GTYDEKCDVWSAGVILYILLSG-------TPPFYGKNEYDILK 232

Query: 299 LVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
            V+  +  F       D   W T +++  +    LI + L      R + +  
Sbjct: 233 RVETGKYAF-------DLPQWRTISDDAKD----LIRKMLTFHPSLRITATQC 274

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 60/310 (19%), Positives = 111/310 (35%), Gaps = 75/310 (24%)

Query: 77  ELSLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK--------KRPGAPTQEF 123
           +++     F D      +IG+G F  V + +  + G   A+K          PG  T++ 
Sbjct: 14  DMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDL 73

Query: 124 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG---------SVSIHLYG---PS 171
             E      ++H ++V LL     + + ++++E++            + +  +Y     S
Sbjct: 74  KREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS 133

Query: 172 QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAG 228
              RQ LE              L + H     ++H+D K   VL+   +     K+   G
Sbjct: 134 HYMRQILE-------------ALRYCHDN--NIIHRDVKPHCVLLASKENSAPVKLGGFG 178

Query: 229 LRNFLGR-----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE 283
           +   LG          G     T    F+A EV +   + +  DV+  GV L  L+SG  
Sbjct: 179 VAIQLGESGLVAGGRVG-----TPH--FMAPEVVKREPYGKPVDVWGCGVILFILLSGC- 230

Query: 284 ASSSLSP--DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPS 340
                 P   + + L E +   +          + R WS  +    +    L+ R L   
Sbjct: 231 -----LPFYGTKERLFEGIIKGKYKM-------NPRQWSHISESAKD----LVRRMLMLD 274

Query: 341 SERRPSMSDV 350
              R ++ + 
Sbjct: 275 PAERITVYEA 284

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 60/306 (19%), Positives = 109/306 (35%), Gaps = 73/306 (23%)

Query: 79  SLATKNFSD----KNLIGEGKFGEVYKGL-LQDGMLVAIK---------KRPGAPTQEFI 124
           +   +   D       +G G+F  V K      G+  A K          R G   +E  
Sbjct: 4   TFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIE 63

Query: 125 DEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS-----VSIHLYGPSQVS---RQ 176
            EV  L  + H N++TL    +      LI E +  G               + +   +Q
Sbjct: 64  REVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123

Query: 177 KLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNF 232
            L+             G+ +LH+    + H D K  N+++          K+ D GL + 
Sbjct: 124 ILD-------------GVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168

Query: 233 LGR----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL 288
           +       ++ G     T +  F+A E+  +     ++D++S GV    L+SG       
Sbjct: 169 IEDGVEFKNIFG-----TPE--FVAPEIVNYEPLGLEADMWSIGVITYILLSG------A 215

Query: 289 SP---DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERR 344
           SP   D+ Q+ +  +     DF       DE  +S  +    +     I + L   + +R
Sbjct: 216 SPFLGDTKQETLANITAVSYDF-------DEEFFSQTSELAKD----FIRKLLVKETRKR 264

Query: 345 PSMSDV 350
            ++ + 
Sbjct: 265 LTIQEA 270

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 60/303 (19%), Positives = 109/303 (35%), Gaps = 73/303 (24%)

Query: 82  TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK---------KRPGAPTQEFIDEV 127
            +   D       +G G+F  V K      G+  A K          R G   +E   EV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66

Query: 128 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS-----VSIHLYGPSQVS---RQKLE 179
             L  + H N++TL    +      LI E +  G               + +   +Q L+
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126

Query: 180 FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNFLGR 235
                        G+ +LH+    + H D K  N+++          K+ D GL + +  
Sbjct: 127 -------------GVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171

Query: 236 ----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP- 290
                ++ G     T +  F+A E+  +     ++D++S GV    L+SG       SP 
Sbjct: 172 GVEFKNIFG-----TPE--FVAPEIVNYEPLGLEADMWSIGVITYILLSG------ASPF 218

Query: 291 --DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM 347
             D+ Q+ +  + +   DF       DE  +S  +    +     I + L   + +R ++
Sbjct: 219 LGDTKQETLANITSVSYDF-------DEEFFSHTSELAKD----FIRKLLVKETRKRLTI 267

Query: 348 SDV 350
            + 
Sbjct: 268 QEA 270

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 71.8 bits (177), Expect = 2e-14
 Identities = 60/288 (20%), Positives = 106/288 (36%), Gaps = 69/288 (23%)

Query: 90  LIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFID-EVCFLASIQHRNLVTLLGY 144
            +GEG +GEV   +       VA+K    +      E I  E+C    + H N+V   G+
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGAAKGLAHL 197
            +E N+Q+L  EY   G +   +          +        F   ++       G+ +L
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMA-------GVVYL 121

Query: 198 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL----- 252
           H +   + H+D K  N+L+DE    K++D GL              +    E  L     
Sbjct: 122 HGI--GITHRDIKPENLLLDERDNLKISDFGLATV----------FRYNNRERLLNKMCG 169

Query: 253 -----ASEVKEFRRFS-EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 306
                A E+ + R F  E  DV+S G+ L  +++G      L  D   D  +        
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE-----LPWDQPSDSCQE------- 217

Query: 307 SNLLKILDERL----WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
                  +++     W    +      + L+ + L  +   R ++ D+
Sbjct: 218 --YSDWKEKKTYLNPWKKIDSAP----LALLHKILVENPSARITIPDI 259

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 72.8 bits (179), Expect = 3e-14
 Identities = 57/323 (17%), Positives = 117/323 (36%), Gaps = 66/323 (20%)

Query: 63  IELSIREARRF-----QMEELSLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAI 112
           I LS+   + F      +++ S+  K   D+      +G G  GEV      +    VAI
Sbjct: 106 IALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAI 165

Query: 113 K---KRPGAPTQE--------FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG 161
           +   KR  A               E+  L  + H  ++ +  +    +  +++ E +  G
Sbjct: 166 RIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGG 224

Query: 162 SV--SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV--- 216
            +   +       V  ++L+              + +LH     ++H+D K  NVL+   
Sbjct: 225 ELFDKV-------VGNKRLKEATCKLYFYQMLLAVQYLHEN--GIIHRDLKPENVLLSSQ 275

Query: 217 DEDFIAKVADAGLRNFLGR----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFG 272
           +ED + K+ D G    LG       + G  + + A E+           ++   D +S G
Sbjct: 276 EEDCLIKITDFGHSKILGETSLMRTLCGTPTYL-APEVL---VSVGTAGYNRAVDCWSLG 331

Query: 273 VFLLELVSGREASSSLSP----DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGME 327
           V L   +SG        P     +   L + + + + +F          +W+  + + ++
Sbjct: 332 VILFICLSGY------PPFSEHRTQVSLKDQITSGKYNF-------IPEVWAEVSEKALD 378

Query: 328 EFIQLIVRCLDPSSERRPSMSDV 350
               L+ + L    + R +  + 
Sbjct: 379 ----LVKKLLVVDPKARFTTEEA 397

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 71.9 bits (177), Expect = 3e-14
 Identities = 64/303 (21%), Positives = 110/303 (36%), Gaps = 73/303 (24%)

Query: 82  TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK---------KRPGAPTQEFIDEV 127
            +N  D       +G G+F  V K      G+  A K          R G   ++   EV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65

Query: 128 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS-----VSIHLYGPSQVS---RQKLE 179
             L  IQH N++TL    +      LI E +  G               + +   +Q L 
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125

Query: 180 FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNFLGR 235
                        G+ +LHSL   + H D K  N+++          K+ D GL + +  
Sbjct: 126 -------------GVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170

Query: 236 ----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP- 290
                ++ G     T +  F+A E+  +     ++D++S GV    L+SG       SP 
Sbjct: 171 GNEFKNIFG-----TPE--FVAPEIVNYEPLGLEADMWSIGVITYILLSG------ASPF 217

Query: 291 --DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM 347
             D+ Q+ +  V     +F       ++  +S  +    +     I R L    ++R ++
Sbjct: 218 LGDTKQETLANVSAVNYEF-------EDEYFSNTSALAKD----FIRRLLVKDPKKRMTI 266

Query: 348 SDV 350
            D 
Sbjct: 267 QDS 269

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 71.5 bits (176), Expect = 4e-14
 Identities = 59/232 (25%), Positives = 87/232 (37%), Gaps = 60/232 (25%)

Query: 84  NFSDKNLIGEGKFGEVYKG--LLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQ- 134
            +     IGEG +G+V+K   L   G  VA+K+        G P    I EV  L  ++ 
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST-IREVAVLRHLET 70

Query: 135 --HRNLVTLL------GYCQENNLQFLIYEYIPN------GSVSIHLYGPSQV---SRQK 177
             H N+V L          +E  L  L++E++          V         +     Q 
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKL-TLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 129

Query: 178 LEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRT 236
           L             +GL  LHS   RVVH+D K  N+LV      K+AD GL R +    
Sbjct: 130 L-------------RGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLARIY---- 170

Query: 237 DVAGPSSQ--VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                 +   VT    A E+ L S       ++   D++S G    E+   +
Sbjct: 171 SFQMALTSVVVTLWYRAPEVLLQS------SYATPVDLWSVGCIFAEMFRRK 216

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 71.5 bits (176), Expect = 5e-14
 Identities = 55/294 (18%), Positives = 103/294 (35%), Gaps = 65/294 (22%)

Query: 83  KNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQH 135
           K   +K      +G G+FG V++ +          K  K  G        E+  L   +H
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60

Query: 136 RNLVTLLGYCQENNLQFLIYEYIPNG-------SVSIHL--YGPSQVSRQKLEFKHRLSI 186
           RN++ L    +      +I+E+I          + +  L          Q  E       
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE------- 113

Query: 187 ALGAAKGLAHLHSLSPRVVHKDFKTANVLV--DEDFIAKVADAGLRNFLGR----TDVAG 240
                  L  LHS +  + H D +  N++         K+ + G    L        +  
Sbjct: 114 ------ALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT 165

Query: 241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---DSSQDLV 297
                  +  + A EV +    S  +D++S G  +  L+SG      ++P   +++Q ++
Sbjct: 166 -----APE--YYAPEVHQHDVVSTATDMWSLGTLVYVLLSG------INPFLAETNQQII 212

Query: 298 ELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
           E + N+   F       DE  +   + E M+     + R L    + R + S+ 
Sbjct: 213 ENIMNAEYTF-------DEEAFKEISIEAMD----FVDRLLVKERKSRMTASEA 255

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 71.1 bits (175), Expect = 5e-14
 Identities = 53/233 (22%), Positives = 82/233 (35%), Gaps = 60/233 (25%)

Query: 84  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK---------RPGAPTQEFIDEVCFLASI 133
            +     IG G +G VYK      G  VA+K            G P    + EV  L  +
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPIST-VREVALLRRL 68

Query: 134 Q---HRNLVTLLGYCQENNLQ-----FLIYEYIPN------GSVSIHLYGPSQV---SRQ 176
           +   H N+V L+  C  +         L++E++                    +    RQ
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 128

Query: 177 KLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGR 235
            L             +GL  LH+    +VH+D K  N+LV      K+AD GL R +   
Sbjct: 129 FL-------------RGLDFLHAN--CIVHRDLKPENILVTSGGTVKLADFGLARIY--- 170

Query: 236 TDVAGPSSQ--VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                  +   VT    A E+ L S       ++   D++S G    E+   +
Sbjct: 171 -SYQMALTPVVVTLWYRAPEVLLQS------TYATPVDMWSVGCIFAEMFRRK 216

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 70.7 bits (174), Expect = 5e-14
 Identities = 56/290 (19%), Positives = 99/290 (34%), Gaps = 55/290 (18%)

Query: 82  TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVCFLASI 133
             + +      N IG G +GEV   +     +  A K   K        F  E+  + S+
Sbjct: 4   KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL 63

Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGPSQVSRQKLEFKHRLSIALGAA 191
            H N++ L    ++N   +L+ E    G +   +       V ++         I     
Sbjct: 64  DHPNIIRLYETFEDNTDIYLVMELCTGGELFERV-------VHKRVFRESDAARIMKDVL 116

Query: 192 KGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR----TDVAGPSSQ 244
             +A+ H L   V H+D K  N L      D   K+ D GL              G    
Sbjct: 117 SAVAYCHKL--NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVG---- 170

Query: 245 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---DSSQDLVELVQ 301
            T    +++ +V E   +  + D +S GV +  L+ G        P    +  +++  ++
Sbjct: 171 -TP--YYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGY------PPFSAPTDSEVMLKIR 220

Query: 302 NSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
                F        E+ W   + +       LI R L  S ++R +    
Sbjct: 221 EGTFTF-------PEKDWLNVSPQAES----LIRRLLTKSPKQRITSLQA 259

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 71.5 bits (175), Expect = 6e-14
 Identities = 66/288 (22%), Positives = 107/288 (37%), Gaps = 40/288 (13%)

Query: 82  TKNFSDKNLIGE-GKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVT 140
           TK      +I E  KFG +   L          K  GA  ++  D V  +     R L +
Sbjct: 96  TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDS 155

Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 200
           +       +  F+  + +   S       P  + +  L  +H +  +   AKG+  L S 
Sbjct: 156 ITSSQSSASSGFVEEKSL---SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR 212

Query: 201 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 260
             + +H+D    N+L+ E  + K+ D GL   + +               ++A E    R
Sbjct: 213 --KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR 270

Query: 261 RFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS 319
            ++ +SDV+SFGV L E+ S G       SP         V+   +F   LK        
Sbjct: 271 VYTIQSDVWSFGVLLWEIFSLGA------SPYPG------VKIDEEFCRRLK-------- 310

Query: 320 TFTNEG--ME-------EFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
               EG  M        E  Q ++ C      +RP+ S++V  L   L
Sbjct: 311 ----EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 71.2 bits (175), Expect = 7e-14
 Identities = 52/219 (23%), Positives = 91/219 (41%), Gaps = 38/219 (17%)

Query: 82  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 134
            K +     +G G +G V   +  + G  VAIKK    P Q  I       E+  L  +Q
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-PFQSEIFAKRAYRELLLLKHMQ 81

Query: 135 HRNLVTLL------GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 188
           H N++ LL         +     +L+  ++      +      ++   K   +    +  
Sbjct: 82  HENVIGLLDVFTPASSLRNFYDFYLVMPFMQ---TDLQ-----KIMGLKFSEEKIQYLVY 133

Query: 189 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT-- 246
              KGL ++HS    VVH+D K  N+ V+ED   K+ D G    L R   A  +  V   
Sbjct: 134 QMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFG----LARHADAEMTGYVVTR 187

Query: 247 ---ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
              A E+ L+     +  +++  D++S G  + E+++G+
Sbjct: 188 WYRAPEVILS-----WMHYNQTVDIWSVGCIMAEMLTGK 221

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 70.3 bits (173), Expect = 8e-14
 Identities = 62/290 (21%), Positives = 108/290 (37%), Gaps = 69/290 (23%)

Query: 91  IGEGKFGEVYKGL-LQDGMLVAIK---------KRPGAPTQEFIDEVCFLASIQHRNLVT 140
           +G G+F  V K      G   A K          R G   +E   EV  L  I+H N++T
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 141 LLGYCQENNLQFLIYEYIPNGS-----VSIHLYGPSQVS---RQKLEFKHRLSIALGAAK 192
           L    +      LI E +  G               + +   +Q L+             
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD------------- 119

Query: 193 GLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNFLGR----TDVAGPSSQ 244
           G+ +LHS   R+ H D K  N+++      +   K+ D G+ + +       ++ G    
Sbjct: 120 GVHYLHSK--RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFG---- 173

Query: 245 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---DSSQDLVELVQ 301
            T +  F+A E+  +     ++D++S GV    L+SG       SP   ++ Q+ +  + 
Sbjct: 174 -TPE--FVAPEIVNYEPLGLEADMWSIGVITYILLSG------ASPFLGETKQETLTNIS 224

Query: 302 NSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
               DF       DE  +S  +    +     I R L    +RR +++  
Sbjct: 225 AVNYDF-------DEEYFSNTSELAKD----FIRRLLVKDPKRRMTIAQS 263

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 70.4 bits (173), Expect = 9e-14
 Identities = 60/288 (20%), Positives = 106/288 (36%), Gaps = 69/288 (23%)

Query: 90  LIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFID-EVCFLASIQHRNLVTLLGY 144
            +GEG +GEV   +       VA+K    +      E I  E+C    + H N+V   G+
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGAAKGLAHL 197
            +E N+Q+L  EY   G +   +          +        F   ++       G+ +L
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMA-------GVVYL 121

Query: 198 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL----- 252
           H +   + H+D K  N+L+DE    K++D GL              +    E  L     
Sbjct: 122 HGI--GITHRDIKPENLLLDERDNLKISDFGLATV----------FRYNNRERLLNKMCG 169

Query: 253 -----ASEVKEFRRFS-EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 306
                A E+ + R F  E  DV+S G+ L  +++G      L  D   D  +        
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE-----LPWDQPSDSCQE------- 217

Query: 307 SNLLKILDERL----WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
                  +++     W    +      + L+ + L  +   R ++ D+
Sbjct: 218 --YSDWKEKKTYLNPWKKIDSAP----LALLHKILVENPSARITIPDI 259

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 57/299 (19%), Positives = 109/299 (36%), Gaps = 57/299 (19%)

Query: 81  ATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPT---------QEF 123
           +T  F +      ++G G    V + +        A+K      G            +  
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70

Query: 124 IDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGPSQVSRQKLEF 180
           + EV  L  +  H N++ L    + N   FL+++ +  G +   +         +  L  
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-------TEKVTLSE 123

Query: 181 KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR----T 236
           K    I     + +  LH L   +VH+D K  N+L+D+D   K+ D G    L       
Sbjct: 124 KETRKIMRALLEVICALHKL--NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR 181

Query: 237 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP----DS 292
           +V G  S + A EI   S       + ++ D++S GV +  L++G       SP      
Sbjct: 182 EVCGTPSYL-APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG-------SPPFWHRK 233

Query: 293 SQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
              ++ ++ +    F           W  +++   +    L+ R L    ++R +  + 
Sbjct: 234 QMLMLRMIMSGNYQF-------GSPEWDDYSDTVKD----LVSRFLVVQPQKRYTAEEA 281

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 61/272 (22%), Positives = 108/272 (39%), Gaps = 55/272 (20%)

Query: 45  SEPSVQRNICIIAGRNVGIELSIREARRFQMEELSLA---------------TKNFSDKN 89
           SEP++   I    G +  +++S   A+ + M +  +                 K + +  
Sbjct: 10  SEPTLDVKIAFCQGFDKQVDVS-YIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLK 68

Query: 90  LIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLL 142
            IG G  G V           VAIKK    P Q          E+  +  + H+N+++LL
Sbjct: 69  PIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHKNIISLL 127

Query: 143 G-YCQENNLQFL--IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 199
             +  +  L+    +Y  +     ++      QV + +L+ +    +      G+ HLHS
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDANLC-----QVIQMELDHERMSYLLYQMLCGIKHLHS 182

Query: 200 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---------ADEI 250
               ++H+D K +N++V  D   K+ D G    L RT  AG S  +T         A E+
Sbjct: 183 AG--IIHRDLKPSNIVVKSDCTLKILDFG----LART--AGTSFMMTPYVVTRYYRAPEV 234

Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
            L         + E  D++S G  + E+V  +
Sbjct: 235 ILGM------GYKENVDIWSVGCIMGEMVRHK 260

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 69.5 bits (171), Expect = 1e-13
 Identities = 64/301 (21%), Positives = 110/301 (36%), Gaps = 74/301 (24%)

Query: 82  TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFLA 131
           +  FSD       +G+G F  V + +    G+  A K     K      Q+   E     
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 132 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGPSQVSRQKL-E------FKH 182
            +QH N+V L    QE +  +L+++ +  G +   I       V+R+   E       + 
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI-------VAREFYSEADASHCIQQ 113

Query: 183 RLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR---- 235
            L         +A+ HS    +VH++ K  N+L+    +    K+AD GL   +      
Sbjct: 114 ILE-------SIAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 164

Query: 236 TDVAG-PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---- 290
              AG P         +L+ EV +   +S+  D+++ GV L  L+ G        P    
Sbjct: 165 HGFAGTPG--------YLSPEVLKKDPYSKPVDIWACGVILYILLVG-------YPPFWD 209

Query: 291 DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 349
           +    L   ++    D+           W T T E       LI   L  + ++R +   
Sbjct: 210 EDQHRLYAQIKAGAYDY-------PSPEWDTVTPEA----KSLIDSMLTVNPKKRITADQ 258

Query: 350 V 350
            
Sbjct: 259 A 259

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 69/316 (21%), Positives = 118/316 (37%), Gaps = 96/316 (30%)

Query: 88  KNLIGEGKFGEVYKGL-LQDGMLVAIK--------KRPGAPTQEFID------------- 125
           K+ IG+G +G V       D    A+K        ++ G P +                 
Sbjct: 18  KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77

Query: 126 --------EVCFLASIQHRNLVTL---LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVS 174
                   E+  L  + H N+V L   L    E++L ++++E +  G V          +
Sbjct: 78  GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVM------EVPT 130

Query: 175 RQKLE-------FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA 227
            + L        F+  +        G+ +LH    +++H+D K +N+LV ED   K+AD 
Sbjct: 131 LKPLSEDQARFYFQDLIK-------GIEYLHYQ--KIIHRDIKPSNLLVGEDGHIKIADF 181

Query: 228 GLRNFLGRTDV-----AG-PSSQVTADEIFLASEV--KEFRRFS-EKSDVYSFGVFLLEL 278
           G+ N    +D       G P+        F+A E   +  + FS +  DV++ GV L   
Sbjct: 182 GVSNEFKGSDALLSNTVGTPA--------FMAPESLSETRKIFSGKALDVWAMGVTLYCF 233

Query: 279 VSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL----WSTFTNEGMEEFIQLIV 334
           V G+       P   + ++ L           KI  + L             E+   LI 
Sbjct: 234 VFGQ-----C-PFMDERIMCL---------HSKIKSQALEFPDQPDIA----EDLKDLIT 274

Query: 335 RCLDPSSERRPSMSDV 350
           R LD + E R  + ++
Sbjct: 275 RMLDKNPESRIVVPEI 290

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 60/302 (19%), Positives = 108/302 (35%), Gaps = 69/302 (22%)

Query: 79  SLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVC 128
           ++    F+++      +G+G F  V + + +  G   A       K      Q+   E  
Sbjct: 3   TITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREAR 62

Query: 129 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGP------SQVSRQKLEF 180
               ++H N+V L     E    +LI++ +  G +   I           S   +Q LE 
Sbjct: 63  ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE- 121

Query: 181 KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR-- 235
                        + H H +   VVH++ K  N+L+    +    K+AD GL   +    
Sbjct: 122 ------------AVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167

Query: 236 ---TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-- 290
                 AG     T    +L+ EV     + +  D+++ GV L  L+ G        P  
Sbjct: 168 QAWFGFAG-----TPG--YLSPEVLRKDPYGKPVDLWACGVILYILLVGY------PPFW 214

Query: 291 -DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMS 348
            +    L + ++    DF           W T T E  +    LI + L  +  +R + +
Sbjct: 215 DEDQHRLYQQIKAGAYDF-------PSPEWDTVTPEAKD----LINKMLTINPSKRITAA 263

Query: 349 DV 350
           + 
Sbjct: 264 EA 265

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 68.8 bits (169), Expect = 2e-13
 Identities = 63/298 (21%), Positives = 110/298 (36%), Gaps = 67/298 (22%)

Query: 82  TKNFSDK----NLIGEGKFGEVYKG-LLQDGMLVAIK----KRPGAPTQEFIDEVCFLAS 132
                D       +G G FG+V+       G+   IK     R   P ++   E+  L S
Sbjct: 17  QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKS 76

Query: 133 IQHRNLVTLLGYCQENNLQFLIYEY---------IPNGSVSIHLYGPSQVSRQKLEFKHR 183
           + H N++ +    ++ +  +++ E          I +            V+      K  
Sbjct: 77  LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL---MKQM 133

Query: 184 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR----T 236
           ++        LA+ HS    VVHKD K  N+L          K+ D GL          T
Sbjct: 134 MN-------ALAYFHSQ--HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHST 184

Query: 237 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---DSS 293
           + AG     TA  +++A EV + R  + K D++S GV +  L++G        P    S 
Sbjct: 185 NAAG-----TA--LYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGC------LPFTGTSL 230

Query: 294 QDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
           +++ +       ++               T + ++    L+ + L    ERRPS + V
Sbjct: 231 EEVQQKATYKEPNY--------AVECRPLTPQAVD----LLKQMLTKDPERRPSAAQV 276

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 51/220 (23%), Positives = 96/220 (43%), Gaps = 44/220 (20%)

Query: 85  FSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFID-EVCFLASIQHRNLVTLL 142
           +++  +IG G FG V++  L +   VAIKK         F + E+  +  ++H N+V L 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK---RFKNRELQIMRIVKHPNVVDLK 98

Query: 143 GYCQENNLQ------FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG------A 190
            +   N  +       L+ EY+P       +Y   + SR   + K  + + L        
Sbjct: 99  AFFYSNGDKKDEVFLNLVLEYVPE-----TVY---RASRHYAKLKQTMPMLLIKLYMYQL 150

Query: 191 AKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRTDVAGPSSQ---VT 246
            + LA++HS+   + H+D K  N+L+D    + K+ D G      +  +AG  +     +
Sbjct: 151 LRSLAYIHSI--GICHRDIKPQNLLLDPPSGVLKLIDFG----SAKILIAGEPNVSYICS 204

Query: 247 ----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
               A E+   +       ++   D++S G  + EL+ G+
Sbjct: 205 RYYRAPELIFGA-----TNYTTNIDIWSTGCVMAELMQGQ 239

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 68.5 bits (168), Expect = 4e-13
 Identities = 66/313 (21%), Positives = 117/313 (37%), Gaps = 70/313 (22%)

Query: 82  TKNFSD-----KNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVCFLAS 132
           +  F D     ++++GEG    V   + L      A+K   K+PG        EV  L  
Sbjct: 7   SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66

Query: 133 IQ-HRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGP------SQVSRQKLEFKHR 183
            Q HRN++ L+ + +E +  +L++E +  GS+   IH          S V +        
Sbjct: 67  CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVAS---- 122

Query: 184 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAG 240
                     L  LH+    + H+D K  N+L    ++    K+ D  L + +       
Sbjct: 123 ---------ALDFLHNK--GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171

Query: 241 PSSQVTADEI-----FLASEV-----KEFRRFSEKSDVYSFGVFLLELVSG--------- 281
           P S            ++A EV     +E   + ++ D++S GV L  L+SG         
Sbjct: 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG 231

Query: 282 ---REASSSLSPDSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCL 337
                      P     L E +Q  + +F        ++ W+  +    +    LI + L
Sbjct: 232 SDCGWDRGEACPACQNMLFESIQEGKYEF-------PDKDWAHISCAAKD----LISKLL 280

Query: 338 DPSSERRPSMSDV 350
              +++R S + V
Sbjct: 281 VRDAKQRLSAAQV 293

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 68.9 bits (169), Expect = 5e-13
 Identities = 67/306 (21%), Positives = 112/306 (36%), Gaps = 70/306 (22%)

Query: 75  MEELSLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFI 124
            E +  A+  FSD       +G+G F  V + +    G+  A K     K      Q+  
Sbjct: 17  SEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE 76

Query: 125 DEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS-----VSIHLYG---PSQVSRQ 176
            E      +QH N+V L    QE +  +L+++ +  G      V+   Y     S   +Q
Sbjct: 77  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ 136

Query: 177 KLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFL 233
            LE              +A+ HS    +VH++ K  N+L+    +    K+AD GL   +
Sbjct: 137 ILE-------------SIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181

Query: 234 GR----TDVAG-PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL 288
                    AG P         +L+ EV +   +S+  D+++ GV L  L+ G       
Sbjct: 182 NDSEAWHGFAGTPG--------YLSPEVLKKDPYSKPVDIWACGVILYILLVGY------ 227

Query: 289 SP---DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERR 344
            P   +    L   ++    D+           W T T E       LI   L  + ++R
Sbjct: 228 PPFWDEDQHRLYAQIKAGAYDY-------PSPEWDTVTPEAKS----LIDSMLTVNPKKR 276

Query: 345 PSMSDV 350
            +    
Sbjct: 277 ITADQA 282

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 68.1 bits (167), Expect = 5e-13
 Identities = 65/289 (22%), Positives = 97/289 (33%), Gaps = 73/289 (25%)

Query: 90  LIGEGKFGEVYKGL-LQDGMLVAIK--------KRPGAPTQEFID-EVCFL----ASIQH 135
           L+G+G FG V+ G  L D + VAIK                     EV  L    A   H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 136 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK--- 192
             ++ LL + +      L+ E          L+         +  K  L           
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPA---QDLF-------DYITEKGPLGEGPSRCFFGQ 147

Query: 193 ---GLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGR---TDVAG-PSSQ 244
               + H HS    VVH+D K  N+L+D     AK+ D G    L     TD  G     
Sbjct: 148 VVAAIQHCHSR--GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRV-- 203

Query: 245 VTADEIFLASEVKEFRRFS-EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS 303
                 +   E     ++    + V+S G+ L ++V G        P             
Sbjct: 204 ------YSPPEWISRHQYHALPATVWSLGILLYDMVCGD------IP------------- 238

Query: 304 RDFSNLLKILDERLW--STFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
             F    +IL+  L   +  + +       LI RCL P    RPS+ ++
Sbjct: 239 --FERDQEILEAELHFPAHVSPDC----CALIRRCLAPKPSSRPSLEEI 281

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 68.4 bits (168), Expect = 5e-13
 Identities = 56/302 (18%), Positives = 107/302 (35%), Gaps = 72/302 (23%)

Query: 82  TKNFSDK-----NLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFL 130
            +NF++        +G GKF  V + +    G   A K     +R      E + E+  L
Sbjct: 23  MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVL 82

Query: 131 ASIQHR-NLVTLLGYCQENNLQFLIYEYIPNG-------SVSIHLYGPSQVS---RQKLE 179
              +    ++ L    +  +   LI EY   G            +   + V    +Q LE
Sbjct: 83  ELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE 142

Query: 180 FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLG-- 234
                        G+ +LH     +VH D K  N+L+         K+ D G+   +G  
Sbjct: 143 -------------GVYYLHQN--NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187

Query: 235 --RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-- 290
               ++ G     T +  +LA E+  +   +  +D+++ G+    L++        SP  
Sbjct: 188 CELREIMG-----TPE--YLAPEILNYDPITTATDMWNIGIIAYMLLTH------TSPFV 234

Query: 291 -DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMS 348
            + +Q+    +     D+        E  +S+ +    +     I   L  + E+RP+  
Sbjct: 235 GEDNQETYLNISQVNVDY-------SEETFSSVSQLATD----FIQSLLVKNPEKRPTAE 283

Query: 349 DV 350
             
Sbjct: 284 IC 285

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 68.6 bits (168), Expect = 5e-13
 Identities = 46/231 (19%), Positives = 94/231 (40%), Gaps = 47/231 (20%)

Query: 81  ATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFID------- 125
           A K F  K    ++IG G    V + +    G   A+K         + E ++       
Sbjct: 88  AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR 147

Query: 126 -EVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGPSQVSRQKL-E- 179
            E   L  +  H +++TL+   + ++  FL+++ +  G +   +         +  L E 
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-------TEKVALSEK 200

Query: 180 -----FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 234
                 +  L         ++ LH+    +VH+D K  N+L+D++   +++D G    L 
Sbjct: 201 ETRSIMRSLLE-------AVSFLHAN--NIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251

Query: 235 R----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
                 ++ G    + A EI   S  +    + ++ D+++ GV L  L++G
Sbjct: 252 PGEKLRELCGTPGYL-APEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 68.1 bits (167), Expect = 5e-13
 Identities = 65/285 (22%), Positives = 114/285 (40%), Gaps = 70/285 (24%)

Query: 91  IGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFID-EVCFLASIQHRNLVTLLGY 144
           IG+G F +V     +  G  VAIK     +    + + +  EV  +  + H N+V L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGAAKGLAHL 197
            +     +LI EY   G V  +L     V+  +++       F+  +S        + + 
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYL-----VAHGRMKEKEARSKFRQIVS-------AVQYC 130

Query: 198 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI------- 250
           H    R+VH+D K  N+L+D D   K+AD G             S++ T           
Sbjct: 131 HQK--RIVHRDLKAENLLLDADMNIKIADFGF------------SNEFTVGGKLDAFCGA 176

Query: 251 --FLASEVKEFRRFS-EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 307
             + A E+ + +++   + DV+S GV L  LVSG        P   Q+L EL +      
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS------LPFDGQNLKELRE------ 224

Query: 308 NLLKILDE--RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
              ++L    R+    +     +   L+ R L  +  +R ++  +
Sbjct: 225 ---RVLRGKYRIPFYMS----TDCENLLKRFLVLNPIKRGTLEQI 262

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 68.5 bits (168), Expect = 6e-13
 Identities = 50/225 (22%), Positives = 84/225 (37%), Gaps = 41/225 (18%)

Query: 82  TKNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKKRPGAPTQEF--IDEVCFLASIQHRNL 138
              F  + + G+G FG V  G     GM VAIKK    P      +  +  LA + H N+
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNI 81

Query: 139 VTLL------GYCQENNL-QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG-- 189
           V L       G     ++   ++ EY+P+   ++H     +  R     +      L   
Sbjct: 82  VQLQSYFYTLGERDRRDIYLNVVMEYVPD---TLH-----RCCRNYYRRQVAPPPILIKV 133

Query: 190 ----AAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGRTDVAGPSSQ 244
                 + +  LH  S  V H+D K  NVLV+  D   K+ D G      +       + 
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG----SAKKLSPSEPNV 189

Query: 245 ---VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
               +    A E+   +     + ++   D++S G    E++ G 
Sbjct: 190 AYICSRYYRAPELIFGN-----QHYTTAVDIWSVGCIFAEMMLGE 229

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 68.2 bits (167), Expect = 6e-13
 Identities = 53/223 (23%), Positives = 92/223 (41%), Gaps = 45/223 (20%)

Query: 82  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 134
            K + +   IG G  G V           VAIKK    P Q          E+  +  + 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 82

Query: 135 HRNLVTLLG-YCQENNLQ-----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 188
           H+N++ LL  +  + +L+     +++ E +     ++      QV + +L+ +    +  
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMD---ANLC-----QVIQMELDHERMSYLLY 134

Query: 189 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT-- 246
               G+ HLHS    ++H+D K +N++V  D   K+ D G    L RT  AG S  +T  
Sbjct: 135 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFG----LART--AGTSFMMTPY 186

Query: 247 -------ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                  A E+ L         + E  D++S G  + E++ G 
Sbjct: 187 VVTRYYRAPEVILGM------GYKENVDIWSVGCIMGEMIKGG 223

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 67.8 bits (166), Expect = 7e-13
 Identities = 61/289 (21%), Positives = 102/289 (35%), Gaps = 75/289 (25%)

Query: 90  LIGEGKFGEVYKGL-LQDGMLVAIK--------KRPGAPTQEFID-EVCFLASIQHR--N 137
           L+G G FG VY G+ + D + VAIK             P    +  EV  L  +      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 138 LVTLLGYCQENNLQFLIYEYI-PNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALG 189
           ++ LL + +  +   LI E   P   +   +       R  L+       F   L     
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFI-----TERGALQEELARSFFWQVLE---- 160

Query: 190 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI-AKVADAGLRNFLGR---TDVAG-PSSQ 244
               + H H+    V+H+D K  N+L+D +    K+ D G    L     TD  G     
Sbjct: 161 ---AVRHCHNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV-- 213

Query: 245 VTADEIFLASEVKEFRRFS-EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS 303
                 +   E   + R+    + V+S G+ L ++V G        P             
Sbjct: 214 ------YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD------IP------------- 248

Query: 304 RDFSNLLKILDERLW--STFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
             F +  +I+  +++     ++E       LI  CL      RP+  ++
Sbjct: 249 --FEHDEEIIRGQVFFRQRVSSECQ----HLIRWCLALRPSDRPTFEEI 291

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 66.9 bits (164), Expect = 1e-12
 Identities = 48/217 (22%), Positives = 84/217 (38%), Gaps = 42/217 (19%)

Query: 90  LIGEGKFGEVYKGL-LQDGMLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVTL 141
           L+GEG +G+V + L  +     A+K       +R          E+  L  ++H+N++ L
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 142 ---LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGAA 191
              L   ++  + +++ EY   G   +       V  ++         F   +       
Sbjct: 72  VDVLYNEEKQKM-YMVMEYCVCGMQEMLDS----VPEKRFPVCQAHGYFCQLID------ 120

Query: 192 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP------SSQV 245
            GL +LHS    +VHKD K  N+L+      K++  G+   L              S   
Sbjct: 121 -GLEYLHSQ--GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177

Query: 246 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
              EI   + +  F  F  K D++S GV L  + +G 
Sbjct: 178 QPPEIA--NGLDTFSGF--KVDIWSAGVTLYNITTGL 210

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 49/236 (20%), Positives = 89/236 (37%), Gaps = 53/236 (22%)

Query: 78  LSLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQE------- 122
           +S+  K   D+      +G G  GEV      +    VAIK   KR  A           
Sbjct: 1   MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL 60

Query: 123 -FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGPSQVSRQKLE 179
               E+  L  + H  ++ +  +    +  +++ E +  G +   +       V  ++L+
Sbjct: 61  NVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKV-------VGNKRLK 112

Query: 180 -------FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGL 229
                  F   L         + +LH     ++H+D K  NVL+   +ED + K+ D G 
Sbjct: 113 EATCKLYFYQMLL-------AVQYLHEN--GIIHRDLKPENVLLSSQEEDCLIKITDFGH 163

Query: 230 RNFLGR----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 281
              LG       + G  + + A E+ ++        ++   D +S GV L   +SG
Sbjct: 164 SKILGETSLMRTLCGTPTYL-APEVLVS---VGTAGYNRAVDCWSLGVILFICLSG 215

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 65.5 bits (160), Expect = 5e-12
 Identities = 52/289 (17%), Positives = 101/289 (34%), Gaps = 75/289 (25%)

Query: 91  IGEGKFGEVYKGL-LQDGMLVAIK-------KRPGAPTQEFID----EVCFLASIQHRNL 138
           +G G FG V+  +  +    V +K                 +     E+  L+ ++H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 139 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK------ 192
           + +L   +      L+ E   +G   + L+         ++   RL   L +        
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSG---LDLF-------AFIDRHPRLDEPLASYIFRQLVS 141

Query: 193 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL----------GRTDVAGPS 242
            + +L      ++H+D K  N+++ EDF  K+ D G   +L          G  +   P 
Sbjct: 142 AVGYLRLK--DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAP- 198

Query: 243 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 302
            +V     +   E+          +++S GV L  LV         +P            
Sbjct: 199 -EVLMGNPYRGPEL----------EMWSLGVTLYTLVFEE------NP------------ 229

Query: 303 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
              F  L + ++  +         +E + L+   L P  ERR ++  +V
Sbjct: 230 ---FCELEETVEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLV 273

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 65.6 bits (160), Expect = 6e-12
 Identities = 38/162 (23%), Positives = 70/162 (43%), Gaps = 25/162 (15%)

Query: 82  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 134
              +  ++LIG G +G V +     +  +VAIKK      ++ ID      E+  L  + 
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-VFEDLIDCKRILREIAILNRLN 110

Query: 135 HRNLVTLLG-YCQENNLQF----LIYEYIPNGSVSIHLYGPSQV--SRQKLEFKHRLSIA 187
           H ++V +L     ++  +F    ++ E               ++  +   L   H  ++ 
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIAD---SDFK-----KLFRTPVYLTELHIKTLL 162

Query: 188 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 229
                G+ ++HS    ++H+D K AN LV++D   KV D GL
Sbjct: 163 YNLLVGVKYVHS--AGILHRDLKPANCLVNQDCSVKVCDFGL 202

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 65.0 bits (159), Expect = 8e-12
 Identities = 48/221 (21%), Positives = 95/221 (42%), Gaps = 37/221 (16%)

Query: 82  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 134
              +++ + IGEG +G V       + + VAIKK   +P +          E+  L   +
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFR 83

Query: 135 HRNLVTLL-----GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSR-QKLEFKHRLSIAL 188
           H N++ +         ++    +++ + +      ++     ++ + Q L   H      
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLME---TDLY-----KLLKTQHLSNDHICYFLY 135

Query: 189 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQ--V 245
              +GL ++HS +  V+H+D K +N+L++     K+ D GL R      D  G  ++   
Sbjct: 136 QILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193

Query: 246 T----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
           T    A EI L       + +++  D++S G  L E++S R
Sbjct: 194 TRWYRAPEIMLN-----SKGYTKSIDIWSVGCILAEMLSNR 229

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 64.7 bits (158), Expect = 9e-12
 Identities = 54/297 (18%), Positives = 94/297 (31%), Gaps = 69/297 (23%)

Query: 82  TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVA---IKKRPGAPTQEFIDEVCFLASI 133
               SD     + +G G    VY+          A   +KK      +    E+  L  +
Sbjct: 48  RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRL 105

Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGP------SQVSRQKLEFKHRLS 185
            H N++ L    +      L+ E +  G +   I   G       +   +Q LE      
Sbjct: 106 SHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILE------ 159

Query: 186 IALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR----TDV 238
                   +A+LH     +VH+D K  N+L      D   K+AD GL   +        V
Sbjct: 160 -------AVAYLHEN--GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV 210

Query: 239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP----DSSQ 294
            G     T    + A E+     +  + D++S G+    L+ G        P       Q
Sbjct: 211 CG-----TPG--YCAPEILRGCAYGPEVDMWSVGIITYILLCGF------EPFYDERGDQ 257

Query: 295 DLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
            +   + N    F           W   +    +    L+ + +    ++R +    
Sbjct: 258 FMFRRILNCEYYF-------ISPWWDEVSLNAKD----LVRKLIVLDPKKRLTTFQA 303

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 44/227 (19%), Positives = 80/227 (35%), Gaps = 42/227 (18%)

Query: 82  TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK--------RPGAPTQEFID------EV 127
              ++ +  I  G +G V  G+  +G+ VAIK+        R      +         E+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 128 CFLASIQHRNLVTLL-----GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKH 182
             L    H N++ L            +  +L+ E +        L       R  +  +H
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-----DLAQVIHDQRIVISPQH 135

Query: 183 RLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS 242
                     GL  LH     VVH+D    N+L+ ++    + D      L R D A  +
Sbjct: 136 IQYFMYHILLGLHVLHE--AGVVHRDLHPGNILLADNNDITICDFN----LAREDTADAN 189

Query: 243 SQ---VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                      A E+ +      F+ F++  D++S G  + E+ + +
Sbjct: 190 KTHYVTHRWYRAPELVMQ-----FKGFTKLVDMWSAGCVMAEMFNRK 231

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 63.1 bits (154), Expect = 2e-11
 Identities = 61/304 (20%), Positives = 107/304 (35%), Gaps = 69/304 (22%)

Query: 80  LATKNFSD-------KNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVC 128
           +    F            +GEG F    K +  +     A+K   KR  A TQ+   E+ 
Sbjct: 1   MKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EIT 57

Query: 129 FLASIQ-HRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGP------SQVSRQKLE 179
            L   + H N+V L     +    FL+ E +  G +   I           S + R+ + 
Sbjct: 58  ALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS 117

Query: 180 FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR- 235
                         ++H+H +   VVH+D K  N+L    +++   K+ D G        
Sbjct: 118 -------------AVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162

Query: 236 ----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG----REASSS 287
                         T    + A E+     + E  D++S GV L  ++SG    +    S
Sbjct: 163 NQPLKTPCF-----TLH--YAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRS 215

Query: 288 LSPDSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 346
           L+  S+ ++++ ++     F       +   W   + E       LI   L     +R  
Sbjct: 216 LTCTSAVEIMKKIKKGDFSF-------EGEAWKNVSQEA----KDLIQGLLTVDPNKRLK 264

Query: 347 MSDV 350
           MS +
Sbjct: 265 MSGL 268

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 62.7 bits (153), Expect = 4e-11
 Identities = 56/302 (18%), Positives = 113/302 (37%), Gaps = 62/302 (20%)

Query: 75  MEELSLATKNFSD----KNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDE 126
           +++L   +  F+D    K  IG G +    + +     M  A+K   K    PT+E I+ 
Sbjct: 10  VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE-IEI 68

Query: 127 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGP------SQVSRQKL 178
           +      QH N++TL     +    +++ E +  G +   I           S V     
Sbjct: 69  LLRY--GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTIT 126

Query: 179 EFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNFLG 234
           +              + +LH+    VVH+D K +N+L           ++ D G    L 
Sbjct: 127 K-------------TVEYLHAQ--GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171

Query: 235 R-----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS 289
                           TA+  F+A EV E + +    D++S GV L  +++G    ++  
Sbjct: 172 AENGLLMTPCY-----TAN--FVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP 224

Query: 290 PDSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMS 348
            D+ ++++  + + +              W++ ++        L+ + L     +R + +
Sbjct: 225 DDTPEEILARIGSGKFSL-------SGGYWNSVSDTA----KDLVSKMLHVDPHQRLTAA 273

Query: 349 DV 350
            V
Sbjct: 274 LV 275

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 62.4 bits (152), Expect = 6e-11
 Identities = 53/220 (24%), Positives = 96/220 (43%), Gaps = 39/220 (17%)

Query: 82  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 134
            + + + + +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMK 86

Query: 135 HRNLVTLL------GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSR-QKLEFKHRLSIA 187
           H N++ LL         +E N  +L+   +      ++      + + QKL   H   + 
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLMG---ADLN-----NIVKCQKLTDDHVQFLI 138

Query: 188 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT- 246
               +GL ++HS    ++H+D K +N+ V+ED   K+ D G    L R      +  V  
Sbjct: 139 YQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFG----LARHTADEMTGYVAT 192

Query: 247 ----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
               A EI L      +  +++  D++S G  + EL++GR
Sbjct: 193 RWYRAPEIMLN-----WMHYNQTVDIWSVGCIMAELLTGR 227

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 62.0 bits (151), Expect = 7e-11
 Identities = 50/220 (22%), Positives = 93/220 (42%), Gaps = 39/220 (17%)

Query: 82  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 134
              + D   +G G +G V   +  + G  VAIKK    P Q  +       E+  L  ++
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMR 82

Query: 135 HRNLVTLLG--YCQENNLQF----LIYEYIPNGSVSIHLYGPSQVSR-QKLEFKHRLSIA 187
           H N++ LL      E    F    L+  ++      +      ++ + +KL       + 
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPFMG---TDLG-----KLMKHEKLGEDRIQFLV 134

Query: 188 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT- 246
               KGL ++H+    ++H+D K  N+ V+ED   K+ D G    L R   +  +  V  
Sbjct: 135 YQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFG----LARQADSEMTGYVVT 188

Query: 247 ----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
               A E+ L      + R+++  D++S G  + E+++G+
Sbjct: 189 RWYRAPEVILN-----WMRYTQTVDIWSVGCIMAEMITGK 223

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 62.1 bits (151), Expect = 9e-11
 Identities = 47/245 (19%), Positives = 91/245 (37%), Gaps = 46/245 (18%)

Query: 82  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 134
             N+  K+LIG G +G VY          VAIKK      ++ ID      E+  L  ++
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-MFEDLIDCKRILREITILNRLK 83

Query: 135 HRNLVTLLGYCQ-ENNLQF----LIYEYIPNGSVSIHLYGPSQV--SRQKLEFKHRLSIA 187
              ++ L      ++ L+F    ++ E        +      ++  +   L  +H  +I 
Sbjct: 84  SDYIIRLYDLIIPDDLLKFDELYIVLEIAD---SDLK-----KLFKTPIFLTEEHIKTIL 135

Query: 188 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVT 246
                G   +H     ++H+D K AN L+++D   KV D GL R      D    +    
Sbjct: 136 YNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193

Query: 247 ADEIFLASEVKE--------------------FRRFSEKSDVYSFGVFLLELVSGREASS 286
            +E    ++  +                       +++  D++S G    EL++  ++  
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253

Query: 287 SLSPD 291
           +   +
Sbjct: 254 NDPTN 258

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 52/303 (17%), Positives = 112/303 (36%), Gaps = 62/303 (20%)

Query: 82  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQ-HRNL 138
             ++     +G GK+ EV++ + + +   V +K  +P    ++   E+  L +++   N+
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKIKREIKILENLRGGPNI 93

Query: 139 VTLLG--YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 196
           +TL        +    L++E++ N      LY       Q L             K L +
Sbjct: 94  ITLADIVKDPVSRTPALVFEHVNNTDFK-QLY-------QTLTDYDIRFYMYEILKALDY 145

Query: 197 LHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGRTDVAGPSSQVT--------- 246
            HS+   ++H+D K  NV++D E    ++ D GL  F        P  +           
Sbjct: 146 CHSM--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF------YHPGQEYNVRVASRYFK 197

Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA--------------SSSLSPDS 292
             E+ +     +++ +    D++S G  L  ++  +E               +  L  + 
Sbjct: 198 GPELLV-----DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 252

Query: 293 SQDLVEL--VQNSRDFSNLLKILDERLWSTFTNEGM-----EEFIQLIVRCL--DPSSER 343
             D ++   ++    F+++L     + W  F +         E +  + + L  D     
Sbjct: 253 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ--S 310

Query: 344 RPS 346
           R +
Sbjct: 311 RLT 313

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 57/228 (25%), Positives = 94/228 (41%), Gaps = 44/228 (19%)

Query: 82  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 134
           + +F  K+L+GEG +G V        G +VAIKK    P  + +       E+  L   +
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFALRTLREIKILKHFK 67

Query: 135 HRNLVTLL-----GYCQENNLQFLIYEYIPNGSVSIHLYGPSQV-SRQKLEFKHRLSIAL 188
           H N++T+         +  N  ++I E +      +H     +V S Q L   H      
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQ---TDLH-----RVISTQMLSDDHIQYFIY 119

Query: 189 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----RNFLGRTDVAGPSS 243
              + +  LH  +  V+H+D K +N+L++ +   KV D GL      +    ++  G  S
Sbjct: 120 QTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177

Query: 244 QVT---------ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
            +          A E+ L S      ++S   DV+S G  L EL   R
Sbjct: 178 GMVEFVATRWYRAPEVMLTS-----AKYSRAMDVWSCGCILAELFLRR 220

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 60.7 bits (148), Expect = 1e-10
 Identities = 53/219 (24%), Positives = 85/219 (38%), Gaps = 54/219 (24%)

Query: 90  LIGEGKFGEVYKGL-LQDGMLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVTL 141
            +G G FG+V  G     G  VA+K       +      +    E+  L   +H +++ L
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK-REIQNLKLFRHPHIIKL 76

Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGAAKGL 194
                     F++ EY+  G +  ++         ++E       F+  LS        +
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYI-----CKHGRVEEMEARRLFQQILS-------AV 124

Query: 195 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-- 252
            + H     VVH+D K  NVL+D    AK+AD GL N +             +D  FL  
Sbjct: 125 DYCHRH--MVVHRDLKPENVLLDAHMNAKIADFGLSNMM-------------SDGEFLRT 169

Query: 253 --------ASEVKEFRRFS-EKSDVYSFGVFLLELVSGR 282
                   A EV   R ++  + D++S GV L  L+ G 
Sbjct: 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 60.7 bits (148), Expect = 2e-10
 Identities = 45/223 (20%), Positives = 86/223 (38%), Gaps = 32/223 (14%)

Query: 82  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 134
              + D   +G G  G V+  +       VAIKK       +         E+  +  + 
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKK---IVLTDPQSVKHALREIKIIRRLD 66

Query: 135 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGP------SQVSR-QKLEFKHRLSIA 187
           H N+V +      +  Q            S+++         + V     L  +H     
Sbjct: 67  HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFM 126

Query: 188 LGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGL-RNFLGRTDVAGPSSQ- 244
               +GL ++HS +  V+H+D K AN+ ++ ED + K+ D GL R         G  S+ 
Sbjct: 127 YQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184

Query: 245 -VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
            VT    +  + L+        +++  D+++ G    E+++G+
Sbjct: 185 LVTKWYRSPRLLLSP-----NNYTKAIDMWAAGCIFAEMLTGK 222

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 59.8 bits (145), Expect = 6e-10
 Identities = 54/229 (23%), Positives = 93/229 (40%), Gaps = 19/229 (8%)

Query: 66  SIREARRFQ---MEELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQ 121
           S+   R  Q   +E   +    F D  ++G G FGEV+   ++  G L A KK      +
Sbjct: 165 SLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK 224

Query: 122 EFIDEVC------FLASIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVS 174
           +             LA +  R +V+L  Y  +      L+   +  G +  H+Y   + +
Sbjct: 225 KRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN 283

Query: 175 RQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 234
               E +     A     GL HLH     ++++D K  NVL+D+D   +++D GL     
Sbjct: 284 PGFQEPRAIFYTA-QIVSGLEHLHQR--NIIYRDLKPENVLLDDDGNVRISDLGLAV-EL 339

Query: 235 RTDVAGPSSQV-TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
           +           T    F+A E+     +    D ++ GV L E+++ R
Sbjct: 340 KAGQTKTKGYAGTPG--FMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 59.4 bits (144), Expect = 8e-10
 Identities = 55/218 (25%), Positives = 89/218 (40%), Gaps = 52/218 (23%)

Query: 90  LIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFID----EVCFLASIQHRNLVTLL 142
            +G G FG+V  G     G  VA+K   R    + + +     E+  L   +H +++ L 
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 143 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGAAKGLA 195
                 +  F++ EY+  G +  ++         +L+       F+  LS       G+ 
Sbjct: 83  QVISTPSDIFMVMEYVSGGELFDYI-----CKNGRLDEKESRRLFQQILS-------GVD 130

Query: 196 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL--- 252
           + H     VVH+D K  NVL+D    AK+AD GL N +             +D  FL   
Sbjct: 131 YCHRH--MVVHRDLKPENVLLDAHMNAKIADFGLSNMM-------------SDGEFLRTS 175

Query: 253 -------ASEVKEFRRFS-EKSDVYSFGVFLLELVSGR 282
                  A EV   R ++  + D++S GV L  L+ G 
Sbjct: 176 CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 44/247 (17%), Positives = 83/247 (33%), Gaps = 59/247 (23%)

Query: 82  TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLV 139
           +K +S    +G G FG V +    + G   A+KK       +    E+  +  + H N++
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK--NRELDIMKVLDHVNII 63

Query: 140 TLL------GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFK------------ 181
            L+      G  +    Q         G  +        V     + K            
Sbjct: 64  KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT 123

Query: 182 -HRLSIALGAAK-----------------GLAHLHSLSPRVVHKDFKTANVLVD-EDFIA 222
            H++  +   +                   +  +HSL   + H+D K  N+LV+ +D   
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL--GICHRDIKPQNLLVNSKDNTL 181

Query: 223 KVADAGLRNFLGRTDVAGPSSQ---VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFL 275
           K+ D G      +  +    S     +    A E+ L +       ++   D++S G   
Sbjct: 182 KLCDFG----SAKKLIPSEPSVAYICSRFYRAPELMLGA-----TEYTPSIDLWSIGCVF 232

Query: 276 LELVSGR 282
            EL+ G+
Sbjct: 233 GELILGK 239

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 67/310 (21%), Positives = 102/310 (32%), Gaps = 55/310 (17%)

Query: 59  RNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY----KGLLQDGMLVAIK- 113
           + V   L   E    +++E+ L   +F    +IG G F EV     K     G + A+K 
Sbjct: 37  KYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKI 93

Query: 114 -------KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSI 165
                  KR       F +E   L +   R +  L  +  Q+ N  +L+ EY   G +  
Sbjct: 94  MNKWDMLKR--GEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLT 150

Query: 166 HLYGPSQVSRQKLEFKHRLS------IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED 219
            L      S+        ++      I +     +  +H L    VH+D K  N+L+D  
Sbjct: 151 LL------SKFGERIPAEMARFYLAEIVM----AIDSVHRLG--YVHRDIKPDNILLDRC 198

Query: 220 FIAKVADAGLRNFLGRTDVAGPSSQV-TAD----EIFLASEVKEFRRFSEKS-DVYSFGV 273
              ++AD G    L           V T D    EI  A              D ++ GV
Sbjct: 199 GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGV 258

Query: 274 FLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLI 333
           F  E+  G       +P  +    E       +   L +              EE    I
Sbjct: 259 FAYEMFYG------QTPFYADSTAETYGKIVHYKEHLSLPLVDEGVP------EEARDFI 306

Query: 334 VRCLDPSSER 343
            R L P   R
Sbjct: 307 QRLLCPPETR 316

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 58.3 bits (140), Expect = 2e-09
 Identities = 50/358 (13%), Positives = 105/358 (29%), Gaps = 83/358 (23%)

Query: 22  IFFLSW-FCLYRNRSVSRTSETGSSEPSVQRNICIIAG--RNVGIELSIREARRFQMEEL 78
              L W     +   V +  E       ++ N   +    +    + S+   R +  +  
Sbjct: 64  TLRLFWTLLSKQEEMVQKFVEE-----VLRINYKFLMSPIKTEQRQPSMMT-RMYIEQRD 117

Query: 79  SLATKN--FSDKNLIGEGKFGEVYKGLLQ---------DGM-------LVAIKKRPGAPT 120
            L   N  F+  N+     + ++ + LL+         DG+       +           
Sbjct: 118 RLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQ 177

Query: 121 QEFIDEVCFLASIQHRNLVTLLGYCQE-----NNLQFLIYEYIPNGSVSIHLYGPSQVSR 175
            +   ++ +L           L  C         LQ L+Y+  PN +        S +  
Sbjct: 178 CKMDFKIFWLN----------LKNCNSPETVLEMLQKLLYQIDPNWTSRSD--HSSNIKL 225

Query: 176 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKV----ADAGLRN 231
           +    +  L   L +     + + L   +V  + + A      +   K+        + +
Sbjct: 226 RIHSIQAELRRLLKSKP---YENCL---LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTD 279

Query: 232 FLGRTDVAGPSSQVTADEI---FLASEVKEFRRFSEKSDVYSFGVFLLELVSG--REASS 286
           FL     A  ++ ++ D         EVK                +L        RE  +
Sbjct: 280 FLS----AATTTHISLDHHSMTLTPDEVKSL-----------LLKYLDCRPQDLPREVLT 324

Query: 287 SLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERR 344
             +P     + E +   RD            W     + +   I+  +  L+P+  R+
Sbjct: 325 -TNPRRLSIIAESI---RDGLATWD-----NWKHVNCDKLTTIIESSLNVLEPAEYRK 373

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 56.2 bits (136), Expect = 6e-09
 Identities = 52/232 (22%), Positives = 100/232 (43%), Gaps = 42/232 (18%)

Query: 82  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 134
            + +     +G+G +G V+K +  + G +VA+KK      Q   D      E+  L  + 
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD-AFQNSTDAQRTFREIMILTELS 66

Query: 135 -HRNLVTLLGYCQENNLQ--FLIYEYIPNGSVSIHLYGPSQVSR-QKLEFKHRLSIALGA 190
            H N+V LL   + +N +  +L+++Y+      +H      V R   LE  H+  +    
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYME---TDLH-----AVIRANILEPVHKQYVVYQL 118

Query: 191 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADE 249
            K + +LHS    ++H+D K +N+L++ +   KVAD GL R+F+    V         + 
Sbjct: 119 IKVIKYLHS--GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176

Query: 250 IFLASEVKEF-------------------RRFSEKSDVYSFGVFLLELVSGR 282
                + +                      ++++  D++S G  L E++ G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 56.3 bits (136), Expect = 6e-09
 Identities = 52/240 (21%), Positives = 96/240 (40%), Gaps = 44/240 (18%)

Query: 66  SIREARRFQ---MEELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQ 121
           SI   R  Q   +E   +    F    ++G+G FGEV    ++  G + A KK      +
Sbjct: 164 SIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK 223

Query: 122 EFIDEVC------FLASIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVS 174
           +   E         L  +  R +V+L  Y  +  +   L+   +  G +  H+Y      
Sbjct: 224 KRKGEAMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIY-----H 277

Query: 175 RQKLEFKHRLSIALGA--AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL--- 229
             +  F    ++   A    GL  LH    R+V++D K  N+L+D+    +++D GL   
Sbjct: 278 MGQAGFPEARAVFYAAEICCGLEDLHRE--RIVYRDLKPENILLDDHGHIRISDLGLAVH 335

Query: 230 -------RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                  +  +G                ++A EV +  R++   D ++ G  L E+++G+
Sbjct: 336 VPEGQTIKGRVGTVG-------------YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 56.3 bits (136), Expect = 7e-09
 Identities = 70/316 (22%), Positives = 125/316 (39%), Gaps = 69/316 (21%)

Query: 59  RNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY----KGLLQDGMLVAIK- 113
           +N+   L   +    +++++ L  ++F    +IG G FGEV     K       + A+K 
Sbjct: 50  KNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKI 106

Query: 114 -------KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIH 166
                  KR  A T  F +E   L +   + + TL    Q++N  +L+ +Y   G +   
Sbjct: 107 LNKWEMLKR--AETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTL 164

Query: 167 LYGPSQVSRQKLEFKHRLS------IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF 220
           L      S+ +      ++      + +     +  +H L    VH+D K  N+L+D + 
Sbjct: 165 L------SKFEDRLPEEMARFYLAEMVI----AIDSVHQLH--YVHRDIKPDNILMDMNG 212

Query: 221 IAKVADAGL-----RNFLGRTDVA-GPSSQVTAD----EIFLASEVKEFRRFSEKSDVYS 270
             ++AD G       +   ++ VA G     T D    EI  A E  +  R+  + D +S
Sbjct: 213 HIRLADFGSCLKLMEDGTVQSSVAVG-----TPDYISPEILQAMEGGK-GRYGPECDWWS 266

Query: 271 FGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGM---E 327
            GV + E++ G       +P  ++ LVE            KI++ +    F  +     E
Sbjct: 267 LGVCMYEMLYG------ETPFYAESLVETYG---------KIMNHKERFQFPTQVTDVSE 311

Query: 328 EFIQLIVRCLDPSSER 343
               LI R +     R
Sbjct: 312 NAKDLIRRLICSREHR 327

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 55.8 bits (135), Expect = 8e-09
 Identities = 46/220 (20%), Positives = 80/220 (36%), Gaps = 58/220 (26%)

Query: 90  LIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID-----------EVCFLASIQHRN 137
            IG G FG            LVA+K         +I+           E+    S++H N
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVK---------YIERGAAIDENVQREIINHRSLRHPN 77

Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGA 190
           +V             +I EY   G +   +      +  +         F+  LS     
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASGGELYERI-----CNAGRFSEDEARFFFQQLLS----- 127

Query: 191 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA--KVADAGLRNF-----LGRTDVAGPSS 243
             G+++ HS+  ++ H+D K  N L+D       K+ D G           ++ V  P+ 
Sbjct: 128 --GVSYCHSM--QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA- 182

Query: 244 QVTADEIFLASEVKEFRRFS-EKSDVYSFGVFLLELVSGR 282
                  ++A EV   + +  + +DV+S GV L  ++ G 
Sbjct: 183 -------YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 46/219 (21%), Positives = 89/219 (40%), Gaps = 55/219 (25%)

Query: 90  LIGEGKFGEVYKGL-LQDGMLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVTL 141
            +GEG FG+V      +    VA+K       K+     +    E+ +L  ++H +++ L
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE-REISYLKLLRHPHIIKL 74

Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGAAKGL 194
                      ++ EY   G +  ++     V ++++        F+  +         +
Sbjct: 75  YDVITTPTDIVMVIEYA-GGELFDYI-----VEKKRMTEDEGRRFFQQIIC-------AI 121

Query: 195 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-- 252
            + H    ++VH+D K  N+L+D++   K+AD GL N +              D  FL  
Sbjct: 122 EYCHRH--KIVHRDLKPENLLLDDNLNVKIADFGLSNIM-------------TDGNFLKT 166

Query: 253 --------ASEVKEFRRFS-EKSDVYSFGVFLLELVSGR 282
                   A EV   + ++  + DV+S G+ L  ++ GR
Sbjct: 167 SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 51/314 (16%), Positives = 101/314 (32%), Gaps = 68/314 (21%)

Query: 68  REARRFQMEELSLATKNFSD-----KNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGA 118
                   +         +D     K ++G G  G+V +    + G   A+K     P A
Sbjct: 9   SSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA 68

Query: 119 PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ----FLIYEYIPNGSV--SIHLYGP-- 170
             +          +    ++V +L   +  +       +I E +  G +   I   G   
Sbjct: 69  RQEVDH----HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA 124

Query: 171 ------SQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFI 221
                 +++ R                  +  LHS +  + H+D K  N+L    ++D +
Sbjct: 125 FTEREAAEIMRDIGT-------------AIQFLHSHN--IAHRDVKPENLLYTSKEKDAV 169

Query: 222 AKVADAGLRNFLGR---TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLEL 278
            K+ D G      +             T    ++A EV    ++ +  D++S GV +  L
Sbjct: 170 LKLTDFGFAKETTQNALQTPCY-----TPY--YVAPEVLGPEKYDKSCDMWSLGVIMYIL 222

Query: 279 VSGREA-SSSLSPDSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRC 336
           + G     S+     S  +   ++  +  F           WS  + +      QLI   
Sbjct: 223 LCGFPPFYSNTGQAISPGMKRRIRLGQYGF-------PNPEWSEVSEDA----KQLIRLL 271

Query: 337 LDPSSERRPSMSDV 350
           L      R +++  
Sbjct: 272 LKTDPTERLTITQF 285

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 54.1 bits (129), Expect = 2e-08
 Identities = 35/194 (18%), Positives = 57/194 (29%), Gaps = 46/194 (23%)

Query: 80  LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRP-----------GAPTQEFIDEVC 128
           L T+       IGEG FGEV++ +  D   VAIK                  +E + E+ 
Sbjct: 17  LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 129 FL---------ASIQHRNLVTLLGY--CQENNLQFLIYEYI----PNGSVSIHL--YGPS 171
                         +    + L      Q +    L+  +       GS +     +   
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135

Query: 172 QV----------------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVL 215
           Q+                  +        SI       LA   + S R  H+D    NVL
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA-SLRFEHRDLHWGNVL 194

Query: 216 VDEDFIAKVADAGL 229
           + +  + K+     
Sbjct: 195 LKKTSLKKLHYTLN 208

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 62/277 (22%), Positives = 116/277 (41%), Gaps = 48/277 (17%)

Query: 45  SEPSVQRNICIIAGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY---- 100
             P++++N      +N+   LS  +    ++ +L +  +++    +IG G FGEV     
Sbjct: 37  DFPALRKN------KNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRH 90

Query: 101 KGLLQDGMLVAIK--------KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF 152
           K       + A+K        KR  + +  F +E   +A      +V L    Q++   +
Sbjct: 91  KS---TRKVYAMKLLSKFEMIKR--SDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 145

Query: 153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKH-RLSIA-LGAAKGLAHLHSLSPRVVHKDFK 210
           ++ EY+P G +   +      S   +  K  R   A +  A  L  +HS+    +H+D K
Sbjct: 146 MVMEYMPGGDLVNLM------SNYDVPEKWARFYTAEVVLA--LDAIHSMG--FIHRDVK 195

Query: 211 TANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV-TADEIFLASEV----KEFRRFSEK 265
             N+L+D+    K+AD G    + +  +    + V T D  +++ EV         +  +
Sbjct: 196 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD--YISPEVLKSQGGDGYYGRE 253

Query: 266 SDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 302
            D +S GVFL E++ G       +P  +  LV     
Sbjct: 254 CDWWSVGVFLYEMLVG------DTPFYADSLVGTYSK 284

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 53.4 bits (129), Expect = 4e-08
 Identities = 46/215 (21%), Positives = 86/215 (40%), Gaps = 30/215 (13%)

Query: 83  KNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIK---KRPGAPTQEF---IDEVCFLASIQH 135
           ++F    ++GEG F  V     L      AIK   KR      +      E   ++ + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 136 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG---AAK 192
              V L    Q++   +    Y  NG +  ++        +K                A+
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--------RK---IGSFDETCTRFYTAE 138

Query: 193 ---GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV-TA 247
               L +LH     ++H+D K  N+L++ED   ++ D G  +     +  A  +S V TA
Sbjct: 139 IVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 196

Query: 248 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
              +++ E+   +   + SD+++ G  + +LV+G 
Sbjct: 197 Q--YVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 51.4 bits (123), Expect = 3e-07
 Identities = 57/236 (24%), Positives = 94/236 (39%), Gaps = 34/236 (14%)

Query: 66  SIREARRFQMEELSLATK----NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPT 120
           S +  R  Q + + L       +FS   +IG G FGEVY     D G + A+K       
Sbjct: 168 SDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI 227

Query: 121 QEFIDEVCFLA---------SIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGP 170
           +    E   L          +     +V +  Y     +    I + +  G +  HL   
Sbjct: 228 KMKQGETLALNERIMLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQH 286

Query: 171 SQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL- 229
              S   + F +   I LG    L H+H+    VV++D K AN+L+DE    +++D GL 
Sbjct: 287 GVFSEADMRF-YAAEIILG----LEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLA 339

Query: 230 -RNFLGRTDVAGPSSQV-TADEIFLASEV-KEFRRFSEKSDVYSFGVFLLELVSGR 282
                 +       + V T    ++A EV ++   +   +D +S G  L +L+ G 
Sbjct: 340 CDFSKKKP-----HASVGTHG--YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 51/347 (14%), Positives = 111/347 (31%), Gaps = 76/347 (21%)

Query: 37  SRTSETGSSEPSVQRNICIIAGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKF 96
           +         P++                        Q+++ ++         ++G G  
Sbjct: 16  APAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGIN 75

Query: 97  GEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEV-CFLASIQHRNLVTLLGYCQENNLQ 151
           G+V +    +     A+K     P     +   EV     + Q  ++V ++   +     
Sbjct: 76  GKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVDVYENLYAG 130

Query: 152 ----FLIYEYIPNGSV--SIHLYGP--------SQVSRQKLEFKHRLSIALGAAKGLAHL 197
                ++ E +  G +   I   G         S++ +   E              + +L
Sbjct: 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE-------------AIQYL 177

Query: 198 HSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF--- 251
           HS++  + H+D K  N+L      + I K+ D G             + + T+       
Sbjct: 178 HSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF------------AKETTSHNSLTTP 223

Query: 252 ------LASEVKEFRRFSEKSDVYSFGVFLLELVSGREA-SSSLSPDSSQDLVELVQNSR 304
                 +A EV    ++ +  D++S GV +  L+ G     S+     S  +   ++  +
Sbjct: 224 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 283

Query: 305 -DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
            +F           WS  + E       LI   L     +R ++++ 
Sbjct: 284 YEF-------PNPEWSEVSEEV----KMLIRNLLKTEPTQRMTITEF 319

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 63/241 (26%), Positives = 97/241 (40%), Gaps = 63/241 (26%)

Query: 90  LIGEGKFGEVYKGLLQD-GMLVAIK---KRPGAPTQEFI---DEV-------CFLASIQH 135
           L+G+G FG+V     +  G   A+K   K       E I   DEV         L + +H
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKK-------EVIVAKDEVAHTLTENRVLQNSRH 207

Query: 136 RNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA--AK 192
             L  L  Y  Q ++    + EY   G +  HL      SR+++ F    +   GA    
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGELFFHL------SRERV-FSEDRARFYGAEIVS 259

Query: 193 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTDVAGP 241
            L +LHS    VV++D K  N+++D+D   K+ D GL           + F G  +    
Sbjct: 260 ALDYLHSEK-NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE---- 314

Query: 242 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ 301
                    +LA EV E   +    D +  GV + E++ GR       P  +QD  +L +
Sbjct: 315 ---------YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHEKLFE 359

Query: 302 N 302
            
Sbjct: 360 L 360

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 47.3 bits (113), Expect = 5e-06
 Identities = 51/216 (23%), Positives = 94/216 (43%), Gaps = 39/216 (18%)

Query: 84  NFSDKNLIGEGKFGEVYKGLLQ---DGMLVAIK---KRPGAPTQEF---IDEVCFLASIQ 134
            F     +G G FG V   L++    G   A+K   K+     ++    ++E   L ++ 
Sbjct: 42  QFDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99

Query: 135 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS------IAL 188
              LV L    ++N+  +++ EY+  G +  HL       R+   F    +      I L
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-------RRIGRFSEPHARFYAAQIVL 152

Query: 189 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTD-VAGPSSQVT 246
                  +LHSL   ++++D K  N+L+D+    +V D G  +   GRT  + G     T
Sbjct: 153 ----TFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG-----T 201

Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
            +   LA E+   + +++  D ++ GV + E+ +G 
Sbjct: 202 PE--ALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 47.0 bits (112), Expect = 5e-06
 Identities = 32/134 (23%), Positives = 51/134 (38%), Gaps = 20/134 (14%)

Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQH-RNLVTLLGYCQE 147
           IG G FG++Y G  +  G  VAIK         +   E      +Q    + T+     E
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE 76

Query: 148 NNLQFLIYEYIPNGSVSIHLYGPS-----QVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 202
            +   ++ E          L GPS         +K   K  L +A      + ++HS + 
Sbjct: 77  GDYNVMVME----------LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN- 125

Query: 203 RVVHKDFKTANVLV 216
             +H+D K  N L+
Sbjct: 126 -FIHRDVKPDNFLM 138

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 46.9 bits (111), Expect = 7e-06
 Identities = 34/134 (25%), Positives = 52/134 (38%), Gaps = 20/134 (14%)

Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLV-TLLGYCQE 147
           IG G FGE+Y G  +Q    VAIK         + + E      +Q    +  +  +  E
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVE 74

Query: 148 NNLQFLIYEYIPNGSVSIHLYGPS-----QVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 202
            +   L+ +          L GPS         +KL  K  L +A      +  +HS S 
Sbjct: 75  GDYNVLVMD----------LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS- 123

Query: 203 RVVHKDFKTANVLV 216
             +H+D K  N L+
Sbjct: 124 -FLHRDIKPDNFLM 136

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 55/242 (22%), Positives = 99/242 (40%), Gaps = 65/242 (26%)

Query: 90  LIGEGKFGEV----YKGLLQDGMLVAIKKRPGAPTQEFI---DEV--------CFLASIQ 134
           ++G+G FG+V     KG      L A+K       ++ +   D+V              +
Sbjct: 348 VLGKGSFGKVMLSERKG---TDELYAVK----ILKKDVVIQDDDVECTMVEKRVLALPGK 400

Query: 135 HRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA--A 191
              L  L   C Q  +  + + EY+  G +  H+        Q   FK   ++   A  A
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ-------QVGRFKEPHAVFYAAEIA 452

Query: 192 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTDVAG 240
            GL  L S    ++++D K  NV++D +   K+AD G+           + F G  D   
Sbjct: 453 IGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPD--- 507

Query: 241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV 300
                     ++A E+  ++ + +  D ++FGV L E+++G+      +P   +D  EL 
Sbjct: 508 ----------YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ------APFEGEDEDELF 551

Query: 301 QN 302
           Q+
Sbjct: 552 QS 553

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 44.7 bits (106), Expect = 2e-05
 Identities = 31/134 (23%), Positives = 51/134 (38%), Gaps = 20/134 (14%)

Query: 91  IGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQH-RNLVTLLGYCQE 147
           IGEG FG +++G  L +   VAIK     +   +  DE      +     +  +  + QE
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE 77

Query: 148 NNLQFLIYEYIPNGSVSIHLYGPS-----QVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 202
                L+ +          L GPS      +  +K   K     A      +  +H  S 
Sbjct: 78  GLHNVLVID----------LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS- 126

Query: 203 RVVHKDFKTANVLV 216
            +V++D K  N L+
Sbjct: 127 -LVYRDIKPDNFLI 139

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 65/257 (25%), Positives = 111/257 (43%), Gaps = 51/257 (19%)

Query: 90  LIGEGKFGEVYKGLLQ---DGMLVAIK---KRPGAPTQEF---IDEVCFLASIQHRNLVT 140
            IG+G FG+V   ++Q      + A+K   K+      E      E+  +  ++H  LV 
Sbjct: 22  AIGKGSFGKVC--IVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79

Query: 141 LLGYCQ-ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKH---RLSIA-LGAAKGLA 195
           L    Q E ++ F++ + +  G +  HL       +Q + FK    +L I  L  A  L 
Sbjct: 80  LWYSFQDEEDM-FMVVDLLLGGDLRYHL-------QQNVHFKEETVKLFICELVMA--LD 129

Query: 196 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTD---VAGPSSQVTADEIF 251
           +L +   R++H+D K  N+L+DE     + D  +       T    +AG     T    +
Sbjct: 130 YLQNQ--RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAG-----TKP--Y 180

Query: 252 LASEV---KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN------ 302
           +A E+   ++   +S   D +S GV   EL+ GR      S  SS+++V   +       
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP 240

Query: 303 ---SRDFSNLLKILDER 316
              S++  +LLK L E 
Sbjct: 241 SAWSQEMVSLLKKLLEP 257

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 44.1 bits (105), Expect = 4e-05
 Identities = 62/244 (25%), Positives = 93/244 (38%), Gaps = 70/244 (28%)

Query: 90  LIGEGKFGEV----YKGLLQDGMLVAIK---KRPGAPTQEFI---DEV-------CFLAS 132
           L+G+G FG+V     K     G   A+K   K       E I   DEV         L +
Sbjct: 12  LLGKGTFGKVILVREKA---TGRYYAMKILRK-------EVIIAKDEVAHTVTESRVLQN 61

Query: 133 IQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA- 190
            +H  L  L  Y  Q ++    + EY   G +  HL        ++  F    +   GA 
Sbjct: 62  TRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLS-------RERVFTEERARFYGAE 113

Query: 191 -AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTDV 238
               L +LHS    VV++D K  N+++D+D   K+ D GL           + F G  + 
Sbjct: 114 IVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE- 170

Query: 239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVE 298
                       +LA EV E   +    D +  GV + E++ GR       P  +QD   
Sbjct: 171 ------------YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHER 212

Query: 299 LVQN 302
           L + 
Sbjct: 213 LFEL 216

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 43.3 bits (103), Expect = 7e-05
 Identities = 37/162 (22%), Positives = 69/162 (42%), Gaps = 32/162 (19%)

Query: 84  NFSDKNLIGEGKFGEVY----KGLLQDGMLVAIK---KRPGAPTQEF---IDEVCFLASI 133
           +F     +G G FG V+    +    +G   A+K   K      ++     DE   L+ +
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63

Query: 134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS------IA 187
            H  ++ + G  Q+    F+I +YI  G +   L       R+   F + ++      + 
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL-------RKSQRFPNPVAKFYAAEVC 116

Query: 188 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 229
           L     L +LHS    ++++D K  N+L+D++   K+ D G 
Sbjct: 117 L----ALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGF 152

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 48/296 (16%), Positives = 99/296 (33%), Gaps = 67/296 (22%)

Query: 73  FQMEELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEV- 127
            Q+++ ++         ++G G  G+V +    +     A+K           +   EV 
Sbjct: 8   LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVE 62

Query: 128 CFLASIQHRNLVTLLGYCQENNLQ----FLIYEYIPNGSV--SIHLYGPSQVSRQKLEFK 181
               + Q  ++V ++   +          ++ E +  G +   I         R    F 
Sbjct: 63  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI-------QDRGDQAFT 115

Query: 182 HR--LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRT 236
            R    I     + + +LHS++  + H+D K  N+L      + I K+ D G        
Sbjct: 116 EREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFG-------- 165

Query: 237 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA-SSSLSPDSSQD 295
                           A E     ++ +  D++S GV +  L+ G     S+     S  
Sbjct: 166 ---------------FAKETTG-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 209

Query: 296 LVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
           +   ++  + +F           WS  + E       LI   L     +R ++++ 
Sbjct: 210 MKTRIRMGQYEF-------PNPEWSEVSEEV----KMLIRNLLKTEPTQRMTITEF 254

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 30/135 (22%), Positives = 49/135 (36%), Gaps = 22/135 (16%)

Query: 91  IGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQH-RNLVTLLGYCQ 146
           IG G FGE+  G  L     VAIK         Q    E  F   +     +  +  +  
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ-LHLEYRFYKQLGSGDGIPQVYYFGP 75

Query: 147 ENNLQFLIYEYIPNGSVSIHLYGPS-----QVSRQKLEFKHRLSIALGAAKGLAHLHSLS 201
                 ++ E          L GPS      +  +    K  L IA+     + ++HS +
Sbjct: 76  CGKYNAMVLE----------LLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN 125

Query: 202 PRVVHKDFKTANVLV 216
             ++++D K  N L+
Sbjct: 126 --LIYRDVKPENFLI 138

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 52/314 (16%), Positives = 102/314 (32%), Gaps = 69/314 (21%)

Query: 90  LIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 146
            +G G F  V+    + +   VA+K  +     T+   DE+  L  +   +         
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85

Query: 147 ENNLQFLIYEYIPNGSVSIH------LYGPSQVSRQKLEFKHRLSIALGAA------KGL 194
            + L+ L +     G   +H      + G + ++  K      + +            GL
Sbjct: 86  NHILKLLDHFNH-KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 144

Query: 195 AHLHSLSPRVVHKDFKTANVLVDE------DFIAKVADAGLRNFLGR---TDVAGPSSQV 245
            ++H     ++H D K  NVL++           K+AD G   +        +   + + 
Sbjct: 145 DYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI--QTREY 201

Query: 246 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR---EASSSLSPDSSQD------- 295
            + E+ L +       +   +D++S    + EL++G    E     S     D       
Sbjct: 202 RSPEVLLGA------PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255

Query: 296 --------LVELVQNSRDF----SNLLKILDERLWST---------FTNEGMEEFIQLIV 334
                   L+   + +R F      L  I   + W           F+ +  +E    + 
Sbjct: 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 315

Query: 335 RCL--DPSSERRPS 346
             L  DP   +R  
Sbjct: 316 PMLQLDP--RKRAD 327

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 42.2 bits (100), Expect = 2e-04
 Identities = 49/219 (22%), Positives = 84/219 (38%), Gaps = 53/219 (24%)

Query: 90  LIGEGKFGEVY----KGLLQDGMLVAIK---KRPGAPTQEFI---DEV--------CFLA 131
           ++G+G FG+V     K     G L A+K   K       + I   D+V            
Sbjct: 30  VLGKGSFGKVMLARVKE---TGDLYAVKVLKK-------DVILQDDDVECTMTEKRILSL 79

Query: 132 SIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 190
           +  H  L  L   C Q  +  F + E++  G +  H+        +   F    +    A
Sbjct: 80  ARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQ-------KSRRFDEARARFYAA 131

Query: 191 --AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVA----GPSS 243
                L  LH     ++++D K  NVL+D +   K+AD G+ +  +          G   
Sbjct: 132 EIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCG--- 186

Query: 244 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
             T D  ++A E+ +   +    D ++ GV L E++ G 
Sbjct: 187 --TPD--YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 41.8 bits (99), Expect = 2e-04
 Identities = 62/273 (22%), Positives = 106/273 (38%), Gaps = 76/273 (27%)

Query: 64  ELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY----KGLLQDGMLVAIK---KRP 116
           E++I    +   E+       F    ++G+G FG+V+            L A+K   K  
Sbjct: 7   EIAITHHVKEGHEKADP--SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK-- 62

Query: 117 GAPTQEFI---DEV------CFLASIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIH 166
                  +   D V        L  + H  +V L  Y  Q     +LI +++  G +   
Sbjct: 63  -----ATLKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTR 116

Query: 167 LYGPSQVSRQKLEFKHRLS------IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF 220
           L      S++ + F           +AL     L HLHSL   ++++D K  N+L+DE+ 
Sbjct: 117 L------SKEVM-FTEEDVKFYLAELALA----LDHLHSLG--IIYRDLKPENILLDEEG 163

Query: 221 IAKVADAGL-----------RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVY 269
             K+ D GL            +F G           T +  ++A EV   R  ++ +D +
Sbjct: 164 HIKLTDFGLSKESIDHEKKAYSFCG-----------TVE--YMAPEVVNRRGHTQSADWW 210

Query: 270 SFGVFLLELVSGREASSSLSPDSSQDLVELVQN 302
           SFGV + E+++G        P   +D  E +  
Sbjct: 211 SFGVLMFEMLTG------TLPFQGKDRKETMTM 237

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 48/226 (21%), Positives = 80/226 (35%), Gaps = 66/226 (29%)

Query: 90  LIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQ------------ 134
           +IG+G FG+V K    +    VA+K  +      ++  +E+  L  ++            
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163

Query: 135 ------HRN---LVT-LLGYCQENNLQFLIYEYI-PNGSVSIHLYGPSQVSRQKLEFKHR 183
                  RN   +   LL      NL    YE I  N      L    + +   L+    
Sbjct: 164 MLENFTFRNHICMTFELLSM----NL----YELIKKNKFQGFSLPLVRKFAHSILQ---- 211

Query: 184 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE--DFIAKVADAGLRNFLGRTDVAGP 241
                     L  LH    R++H D K  N+L+ +      KV D G   +  +      
Sbjct: 212 ---------CLDALHKN--RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR----V 256

Query: 242 SSQVT-----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
            + +      A E+ L +      R+    D++S G  L EL++G 
Sbjct: 257 YTYIQSRFYRAPEVILGA------RYGMPIDMWSLGCILAELLTGY 296

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 40.7 bits (96), Expect = 5e-04
 Identities = 59/241 (24%), Positives = 97/241 (40%), Gaps = 63/241 (26%)

Query: 90  LIGEGKFGEV----YKGLLQDGMLVAIK---KRPGAPTQEFI---DEV--------CFLA 131
           ++G+G FG+V    +K         AIK   K       + +   D+V            
Sbjct: 24  MLGKGSFGKVFLAEFKK---TNQFFAIKALKK-------DVVLMDDDVECTMVEKRVLSL 73

Query: 132 SIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRL---SIA 187
           + +H  L  +     Q     F + EY+  G +  H+    Q   +    +       I 
Sbjct: 74  AWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEII 128

Query: 188 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGL-RNFLGRTDVA----GP 241
           LG    L  LHS    +V++D K  N+L+D+D  I K+AD G+ +  +          G 
Sbjct: 129 LG----LQFLHSKG--IVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCG- 180

Query: 242 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ 301
               T D  ++A E+   ++++   D +SFGV L E++ G       SP   QD  EL  
Sbjct: 181 ----TPD--YIAPEILLGQKYNHSVDWWSFGVLLYEMLIG------QSPFHGQDEEELFH 228

Query: 302 N 302
           +
Sbjct: 229 S 229

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 40.7 bits (96), Expect = 5e-04
 Identities = 51/225 (22%), Positives = 91/225 (40%), Gaps = 65/225 (28%)

Query: 90  LIGEGKFGEV----YKGLLQDGMLVAIK---KRPGAPTQEFI---DEV--------CFLA 131
           ++G+G FG+V     KG      L A+K   K       + +   D+V            
Sbjct: 27  VLGKGSFGKVMLSERKG---TDELYAVKILKK-------DVVIQDDDVECTMVEKRVLAL 76

Query: 132 SIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 190
             +   L  L   C Q  +  + + EY+  G +  H+        Q   FK   ++   A
Sbjct: 77  PGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ-------QVGRFKEPHAVFYAA 128

Query: 191 --AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTD 237
             A GL  L S    ++++D K  NV++D +   K+AD G+           + F G  D
Sbjct: 129 EIAIGLFFLQSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPD 186

Query: 238 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
                        ++A E+  ++ + +  D ++FGV L E+++G+
Sbjct: 187 -------------YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 40.7 bits (96), Expect = 6e-04
 Identities = 52/219 (23%), Positives = 88/219 (40%), Gaps = 46/219 (21%)

Query: 90  LIGEGKFGEVY----KGLLQDGMLVAIK---KRPGAPTQEFID----EVCFLASIQHRNL 138
           ++G G +G+V+          G L A+K   K       +  +    E   L  I+    
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120

Query: 139 VTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS------IALGAA 191
           +  L Y  Q      LI +YI  G +  HL      S+++  F           I L   
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGELFTHL------SQRER-FTEHEVQIYVGEIVLA-- 171

Query: 192 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL--RNFLGRTDVA----GPSSQV 245
             L HLH L   ++++D K  N+L+D +    + D GL        T+ A    G     
Sbjct: 172 --LEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG----- 222

Query: 246 TADEIFLASEV-KEFRRFSEKS-DVYSFGVFLLELVSGR 282
           T +  ++A ++ +      +K+ D +S GV + EL++G 
Sbjct: 223 TIE--YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 40.2 bits (95), Expect = 7e-04
 Identities = 43/232 (18%), Positives = 84/232 (36%), Gaps = 76/232 (32%)

Query: 90  LIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEF--------------IDEVC------- 128
           ++G+G +G+V          V  +K  GA T +                 +         
Sbjct: 24  VLGKGGYGKV--------FQV--RKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN 73

Query: 129 FLASIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS-- 185
            L  ++H  +V L+ Y  Q     +LI EY+  G + + L        ++  F    +  
Sbjct: 74  ILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLE-------REGIFMEDTACF 125

Query: 186 ----IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----------R 230
               I++     L HLH     ++++D K  N++++     K+ D GL            
Sbjct: 126 YLAEISMA----LGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH 179

Query: 231 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
            F G           T +  ++A E+      +   D +S G  + ++++G 
Sbjct: 180 TFCG-----------TIE--YMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 40.3 bits (95), Expect = 8e-04
 Identities = 51/220 (23%), Positives = 89/220 (40%), Gaps = 55/220 (25%)

Query: 90  LIGEGKFGEVY----KGLLQDGMLVAIK---KRPGAPTQEFI---DEV--------CFLA 131
           +IG G + +V     K       + A+K   K       E +   +++         F  
Sbjct: 16  VIGRGSYAKVLLVRLKK---TDRIYAMKVVKK-------ELVNDDEDIDWVQTEKHVFEQ 65

Query: 132 SIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRL---SIA 187
           +  H  LV L   C Q  +  F + EY+  G +  H+    Q  R+  E   R     I+
Sbjct: 66  ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEIS 120

Query: 188 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVA----GPS 242
           L     L +LH     ++++D K  NVL+D +   K+ D G+ +  L   D      G  
Sbjct: 121 LA----LNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG-- 172

Query: 243 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
              T +  ++A E+     +    D ++ GV + E+++GR
Sbjct: 173 ---TPN--YIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 40.1 bits (94), Expect = 8e-04
 Identities = 28/172 (16%), Positives = 51/172 (29%), Gaps = 47/172 (27%)

Query: 91  IGEGKFGEVYKGL---------LQDGMLVAIK---------------KRPGAPTQEFIDE 126
                 G +Y+                  ++K               +R   P Q  +++
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQ--VNK 107

Query: 127 VCFLASIQHRNLVTLLGY-CQENNLQFLIYEYIPNGSVSIHLYGPS------QVSRQKLE 179
              L S     + T +G+   ++  +FL+              G S         +  L 
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLP----------SLGRSLQSALDVSPKHVLS 157

Query: 180 FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKV--ADAGL 229
            +  L +A      L  LH      VH +    N+ VD +  ++V  A  G 
Sbjct: 158 ERSVLQVACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGF 207

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 40.1 bits (94), Expect = 8e-04
 Identities = 49/230 (21%), Positives = 77/230 (33%), Gaps = 70/230 (30%)

Query: 89  NLIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQ----------- 134
           +LIG+G FG+V K     +   VAIK  K   A   +   EV  L  +            
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119

Query: 135 -------HRN---LVT-LLGYCQENNLQFLIYEYI-PNGSVSIHLYGPSQVSRQKLEFKH 182
                   RN   LV  +L Y    NL    Y+ +       + L    + ++Q      
Sbjct: 120 HLKRHFMFRNHLCLVFEMLSY----NL----YDLLRNTNFRGVSLNLTRKFAQQMCT--- 168

Query: 183 RLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV--DEDFIAKVADAGLRNFLGRTDVAG 240
                      L  L +    ++H D K  N+L+   +    K+ D G            
Sbjct: 169 ----------ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG------------ 206

Query: 241 PSSQVTADEIFL--------ASEVKEFRRFSEKSDVYSFGVFLLELVSGR 282
            SS      I+         + EV     +    D++S G  L+E+ +G 
Sbjct: 207 -SSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	386
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.82
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.71
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.34
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.27
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.15
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.93
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.68
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.52
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.51
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.4
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.34
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.28
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.17
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.88
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.86
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.74
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.57
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.57
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.33
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.27
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.21
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.13
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.13
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.03
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.9
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.66
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.57
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	96.4
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.91
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	95.9
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	95.89
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.65
2l8s_A	54	Integrin alpha-1; transmembrane region, detergent	94.38
2knc_A	54	Integrin alpha-IIB; transmembrane signaling, prote	94.24
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	93.21
2k9y_A	41	Ephrin type-A receptor 2; receptor tyrosine kinase	92.93
2k1a_A	42	Integrin alpha-IIB; single-PASS transmembrane segm	91.54
2l34_A	33	TYRO protein tyrosine kinase-binding protein; immu	90.19
2klu_A	70	T-cell surface glycoprotein CD4; cell membrane, di	90.17
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	89.96
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	89.23
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	89.18
2knc_B	79	Integrin beta-3; transmembrane signaling, protein	83.82
2lx0_A	32	Membrane fusion protein P14; membrane fusion prote	83.0
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	82.9
2k9j_B	43	Integrin beta-3; transmembrane complex, cell adhes	82.65
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	80.67

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.3e-59  Score=436.46  Aligned_cols=262  Identities=26%  Similarity=0.428  Sum_probs=209.0

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC------CCcEEEEEECCCCC---hhHHHHHHHHHHcCCCCcccccccceeeCCeEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  152 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  152 (386)
                      .++|.+.+.||+|+||+||+|.++      ++..||||+++...   .++|.+|+++|++++|||||+++|+|.+.+..|
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            346777789999999999999864      36789999976544   346899999999999999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCc----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCce
Q 016588          153 LIYEYIPNGSVSIHLYGPSQ----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA  222 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~  222 (386)
                      +|||||++|+|.+++.....          .....+++..++.++.|++.||.|||+  ++|+||||||+||||+.++.+
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG--LHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecccccHhhEEECCCCcE
Confidence            99999999999999864321          123568999999999999999999999  779999999999999999999


Q ss_pred             EEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHH
Q 016588          223 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQ  301 (386)
Q Consensus       223 kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~  301 (386)
                      ||+|||+++...............+|+.|||||++.+..|+.++|||||||++|||+| |+.||.....   .+....+.
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~i~  274 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TEAIDCIT  274 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---HHHHHHHH
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---HHHHHHHH
Confidence            9999999997755444444455678999999999999999999999999999999999 8999987542   22222221


Q ss_pred             hhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          302 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                      .             ..+...+..+++++.+|+.+||+.||++|||+.||+++|+.+.+..
T Consensus       275 ~-------------g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p  321 (329)
T 4aoj_A          275 Q-------------GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP  321 (329)
T ss_dssp             H-------------TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred             c-------------CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence            1             1122345556778999999999999999999999999999988653

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.5e-60  Score=433.70  Aligned_cols=260  Identities=27%  Similarity=0.429  Sum_probs=214.6

Q ss_pred             cCCCcCCeecccCceEEEEEEeC------CCcEEEEEECCCCC---hhHHHHHHHHHHcCCCCcccccccceeeCCeEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (386)
                      ++|.+.+.||+|+||+||+|.+.      ++..||||+++...   .++|.+|+++|++++|||||+++|+|.+.+..|+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            56778899999999999999864      36789999976544   3468999999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCC--------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEc
Q 016588          154 IYEYIPNGSVSIHLYGPS--------QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA  225 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~--------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~  225 (386)
                      |||||++|+|.+++....        ......+++..++.++.|++.||.|||+  ++|+||||||+||||+.++.+||+
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDlKp~NILl~~~~~~Ki~  170 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS--QHFVHRDLATRNCLVGENLLVKIG  170 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEEC
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCccCHhhEEECCCCcEEEC
Confidence            999999999999985421        1234579999999999999999999999  779999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhh
Q 016588          226 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSR  304 (386)
Q Consensus       226 DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  304 (386)
                      |||+|+...............+|+.|||||++.+..|+.++|||||||++|||+| |+.||.+...   .++...+..  
T Consensus       171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~i~~--  245 (299)
T 4asz_A          171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIECITQ--  245 (299)
T ss_dssp             CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHHHH--
T ss_pred             CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHc--
Confidence            9999987655433333344568999999999999999999999999999999999 8999987543   222222211  


Q ss_pred             cccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          305 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                                 ..+...+..+++++.+|+.+||+.||++|||++++++.|+++.+.
T Consensus       246 -----------~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          246 -----------GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             -----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----------CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence                       112234555677899999999999999999999999999988765

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.8e-59  Score=431.47  Aligned_cols=256  Identities=30%  Similarity=0.411  Sum_probs=213.5

Q ss_pred             CCCcCCeecccCceEEEEEEeC------CCcEEEEEECCCC----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (386)
                      ++++.+.||+|+||+||+|.+.      +++.||||.+...    ..++|.+|+.++++++|||||+++|+|.+.+..++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            4556788999999999999863      4678999986533    34679999999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCce
Q 016588          154 IYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA  222 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~  222 (386)
                      |||||++|+|.+++.....           .....+++..++.++.|++.||.|||+  ++|+||||||+||||++++.+
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDLK~~NILl~~~~~~  184 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS--HHVVHKDLATRNVLVYDKLNV  184 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCE
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCCCCCCccccceEECCCCCE
Confidence            9999999999999854321           123568999999999999999999999  779999999999999999999


Q ss_pred             EEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHH
Q 016588          223 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQ  301 (386)
Q Consensus       223 kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~  301 (386)
                      ||+|||+++...............||+.|||||++.+..|+.++|||||||++|||+| |..||.+...   .++...+.
T Consensus       185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~~~~i~  261 (308)
T 4gt4_A          185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVVEMIR  261 (308)
T ss_dssp             EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHHHHHHH
T ss_pred             EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH
Confidence            9999999987755444444556678999999999999999999999999999999998 8999987543   22222222


Q ss_pred             hhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHh
Q 016588          302 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  357 (386)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~  357 (386)
                      .             ..+.+.+..+++++.+|+.+||+.||++|||+.||+++|+.+
T Consensus       262 ~-------------~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          262 N-------------RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             T-------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             c-------------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            1             122344556778899999999999999999999999999754

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=5.4e-58  Score=420.15  Aligned_cols=258  Identities=26%  Similarity=0.424  Sum_probs=203.2

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ..+++++.+.||+|+||+||+|.+++  .||||.++...     .+.|.+|+.++++++|||||+++|++.+ +..|+||
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm  110 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT  110 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence            45678888999999999999999753  58999865322     3468899999999999999999999865 4579999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      |||++|+|.+++..    ....+++..+..++.|++.||+|||+  ++|+||||||+||||++++.+||+|||+|+....
T Consensus       111 Ey~~gGsL~~~l~~----~~~~l~~~~~~~i~~qia~gL~yLH~--~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  184 (307)
T 3omv_A          111 QWCEGSSLYKHLHV----QETKFQMFQLIDIARQTAQGMDYLHA--KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR  184 (307)
T ss_dssp             ECCSSCBHHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred             EcCCCCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence            99999999999853    24568999999999999999999999  7799999999999999999999999999987754


Q ss_pred             CCCCCCCccccCcccccchhhhcc---cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEF---RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      ...........||+.|||||++.+   ..|+.++|||||||++|||+||+.||.+....  ..+...+......      
T Consensus       185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--~~~~~~~~~~~~~------  256 (307)
T 3omv_A          185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--DQIIFMVGRGYAS------  256 (307)
T ss_dssp             ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHTTCCC------
T ss_pred             CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--HHHHHHHhcCCCC------
Confidence            433334456689999999999964   35899999999999999999999999875531  1122222111111      


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhh
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  358 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~  358 (386)
                        +. ....+.++++++.+|+.+||+.||++|||+.|++++|+.+.
T Consensus       257 --p~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          257 --PD-LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             --CC-STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             --CC-cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence              11 12234456678999999999999999999999999998764

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=5.1e-58  Score=429.06  Aligned_cols=272  Identities=24%  Similarity=0.379  Sum_probs=221.5

Q ss_pred             cCHHHHHHHhcCCCcCCeecccCceEEEEEEeCC------CcEEEEEECCCCC----hhHHHHHHHHHHcCCC-Cccccc
Q 016588           73 FQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQD------GMLVAIKKRPGAP----TQEFIDEVCFLASIQH-RNLVTL  141 (386)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~----~~~~~~e~~~l~~l~h-~niv~~  141 (386)
                      +....+++..++|++.+.||+|+||+||+|.+..      ++.||||.+....    .+++.+|+++|.+++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            4455667778899999999999999999998542      3579999876543    2458899999999965 999999


Q ss_pred             ccceee-CCeEEEEEEeecCCCccccccCCCc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCC
Q 016588          142 LGYCQE-NNLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDF  209 (386)
Q Consensus       142 ~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dl  209 (386)
                      +|+|.. ++..|+|||||++|+|.+++.....           .....+++..+..++.||+.||.|||+  ++||||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~--~~iiHRDL  211 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDL  211 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh--CCeecCcc
Confidence            999876 4678999999999999999854321           123458999999999999999999999  77999999


Q ss_pred             CCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCC
Q 016588          210 KTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL  288 (386)
Q Consensus       210 kp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~  288 (386)
                      ||+|||+++++.+||+|||+|+.+.............+|+.|||||++.+..|+.++|||||||++|||+| |..||.+.
T Consensus       212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~  291 (353)
T 4ase_A          212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  291 (353)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999997754333333345568899999999999999999999999999999998 89999875


Q ss_pred             CCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          289 SPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                      ...  ..+...             +....+...+..+++++.+++.+||+.||++|||+.|++++|+++++..
T Consensus       292 ~~~--~~~~~~-------------i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~  349 (353)
T 4ase_A          292 KID--EEFCRR-------------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  349 (353)
T ss_dssp             CCS--HHHHHH-------------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             CHH--HHHHHH-------------HHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence            532  112221             1222233445556678999999999999999999999999999998754

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.8e-57  Score=419.41  Aligned_cols=260  Identities=21%  Similarity=0.222  Sum_probs=211.7

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCC
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  161 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  161 (386)
                      +.|+..+.||+|+||+||+|..+ +++.||||+++....  ..+|+.+++.++|||||++++++.+.+..|+|||||++|
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg  135 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG  135 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence            45777888999999999999965 589999998754322  247999999999999999999999999999999999999


Q ss_pred             CccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC-ceEEcccccccccCCCCCC-
Q 016588          162 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNFLGRTDVA-  239 (386)
Q Consensus       162 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~-~~kl~DFgl~~~~~~~~~~-  239 (386)
                      +|.+++.     ....+++..+..++.|++.||+|||+  ++|+||||||+||||+.++ .+||+|||+|+.+...... 
T Consensus       136 ~L~~~l~-----~~~~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          136 SLGQLIK-----QMGCLPEDRALYYLGQALEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             BHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             cHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            9999984     34568999999999999999999999  7799999999999999987 6999999999887543221 


Q ss_pred             --CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhh
Q 016588          240 --GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  317 (386)
Q Consensus       240 --~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (386)
                        .......||+.|||||++.+..|+.++|||||||++|||++|..||.+......   ...+....           ..
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~i~~~~-----------~~  274 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---CLKIASEP-----------PP  274 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---HHHHHHSC-----------CG
T ss_pred             ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HHHHHcCC-----------CC
Confidence              122345799999999999999999999999999999999999999987654322   11111110           01


Q ss_pred             cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhcccc
Q 016588          318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLT  365 (386)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~~~~  365 (386)
                      ....++.+++++.+++.+||+.||++|||+.|++++|...+.+...+.
T Consensus       275 ~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~  322 (336)
T 4g3f_A          275 IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLK  322 (336)
T ss_dssp             GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSC
T ss_pred             chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhcc
Confidence            112344556779999999999999999999999999999987754443

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.6e-57  Score=416.28  Aligned_cols=247  Identities=17%  Similarity=0.227  Sum_probs=209.9

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECC------CCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ++|++.+.||+|+||+||+|... +++.||||++.      ....+.+.+|+++|+.++||||+++++++.+.+..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            46999999999999999999964 58999999854      344567899999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      |||++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+|+.+..
T Consensus       112 Ey~~gG~L~~~i~-----~~~~l~e~~~~~~~~qi~~al~ylH~--~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          112 SYAKNGELLKYIR-----KIGSFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             CCCTTEEHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             ecCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            9999999999983     34678999999999999999999999  7799999999999999999999999999998765


Q ss_pred             CCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      ..........+||+.|||||++.+..|+.++||||+||++|||++|..||.+.+.   ..+...+...            
T Consensus       185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~i~~~------------  249 (311)
T 4aw0_A          185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---GLIFAKIIKL------------  249 (311)
T ss_dssp             TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHT------------
T ss_pred             CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcC------------
Confidence            4444445567899999999999999999999999999999999999999986432   2222222111            


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .  ..++...++++.+|+.+||+.||++|||++|++.+
T Consensus       250 ~--~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~  285 (311)
T 4aw0_A          250 E--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  285 (311)
T ss_dssp             C--CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred             C--CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence            0  12333445678999999999999999999997643

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=9.3e-57  Score=417.14  Aligned_cols=247  Identities=18%  Similarity=0.330  Sum_probs=207.0

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECC---CCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      ..|+..+.||+|+||+||+|..+ +++.||||++.   ....+.+.+|+.+|+.++|||||++++++.+.+..|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46889999999999999999965 58999999853   334567899999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++|+|.+++.      ...+++..+..++.|++.||+|||+  ++|+||||||+||||+.++.+||+|||+++.+.... 
T Consensus       154 ~gg~L~~~l~------~~~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-  224 (346)
T 4fih_A          154 EGGALTDIVT------HTRMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-  224 (346)
T ss_dssp             TTEEHHHHHH------HSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-
T ss_pred             CCCcHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-
Confidence            9999999883      3458999999999999999999999  779999999999999999999999999998775422 


Q ss_pred             CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                       .......||+.|||||++.+..|+.++|||||||++|||++|..||.+...   ......+....         .+  .
T Consensus       225 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~i~~~~---------~~--~  289 (346)
T 4fih_A          225 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIRDNL---------PP--R  289 (346)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSS---------CC--C
T ss_pred             -CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHHHcCC---------CC--C
Confidence             223456899999999999999999999999999999999999999986442   12222221110         00  1


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .......++++.+|+.+||+.||++|||++|+++|
T Consensus       290 ~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          290 LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            11223345678999999999999999999999876

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.8e-57  Score=422.48  Aligned_cols=248  Identities=21%  Similarity=0.344  Sum_probs=200.2

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      ++|++.+.||+|+||+||+|... +++.||||++....     .+.+.+|+.+|+.++|||||++++++.+.+..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            58999999999999999999964 58999999864332     3468899999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      ||++|+|.+++...   ....+++..+..++.|++.||.|||+  ++|+||||||+||||+.++.+||+|||+|+.....
T Consensus       104 y~~gg~L~~~i~~~---~~~~~~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQ---KGVLFQEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             CCTTCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHH--TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             CCCCCcHHHHHHHc---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            99999999998432   23457888999999999999999999  77999999999999999999999999999876432


Q ss_pred             CCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchh
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  316 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (386)
                      .  .......||+.|||||++.+..|+.++|||||||++|||++|+.||.+...   ..+...+...             
T Consensus       179 ~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~~i~~~-------------  240 (350)
T 4b9d_A          179 V--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM---KNLVLKIISG-------------  240 (350)
T ss_dssp             H--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHT-------------
T ss_pred             c--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHHHcC-------------
Confidence            1  112345799999999999999999999999999999999999999986442   2222211111             


Q ss_pred             hcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          317 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .....+...++++.+|+.+||+.||++|||++|++++
T Consensus       241 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          241 SFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0112233455778999999999999999999999975

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.2e-56  Score=406.57  Aligned_cols=244  Identities=25%  Similarity=0.391  Sum_probs=195.3

Q ss_pred             CcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceee----CCeEEEEE
Q 016588           86 SDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE----NNLQFLIY  155 (386)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~  155 (386)
                      +..+.||+|+||+||+|... ++..||+|++...     ..+.+.+|++++++++|||||++++++.+    .+..|+||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            45567999999999999965 5889999985422     23468899999999999999999999865    35689999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-CCceEEcccccccccC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLG  234 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~-~~~~kl~DFgl~~~~~  234 (386)
                      |||++|+|.+++.     ....+++..+..++.|++.||+|||+.+++|+||||||+||||+. ++.+||+|||+|+...
T Consensus       109 Ey~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          109 ELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             ECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            9999999999984     346789999999999999999999984444999999999999984 7999999999998643


Q ss_pred             CCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                      .    .......||+.|||||++.+ .|+.++|||||||++|||+||+.||.+...  ...+...+.....         
T Consensus       184 ~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~--~~~~~~~i~~~~~---------  247 (290)
T 3fpq_A          184 A----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGVK---------  247 (290)
T ss_dssp             T----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTCC---------
T ss_pred             C----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc--HHHHHHHHHcCCC---------
Confidence            3    22345689999999999875 699999999999999999999999976442  1222222211110         


Q ss_pred             hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      +   ...+...++++.+|+.+||+.||++|||++|+++|
T Consensus       248 ~---~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          248 P---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             C---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             C---CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0   01112233568999999999999999999999876

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.6e-56  Score=410.99  Aligned_cols=271  Identities=21%  Similarity=0.357  Sum_probs=201.6

Q ss_pred             cCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCChhHHHHHHHH--HHcCCCCcccccccceeeCC----eEEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCF--LASIQHRNLVTLLGYCQENN----LQFLIYE  156 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~~~~----~~~lv~e  156 (386)
                      ++|.+.+.||+|+||+||+|.+ +|+.||||++......++..|.++  +..++||||++++|++...+    ..|||||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E   81 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence            3567778999999999999998 488999999876666666555554  46789999999999997653    5799999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCceecCCCCCCeeeCCCCceEEcccccc
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL------SPRVVHKDFKTANVLVDEDFIAKVADAGLR  230 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------~~~ivH~dlkp~Nill~~~~~~kl~DFgl~  230 (386)
                      |+++|+|.+++.      ...+++..+.+++.|++.||+|||+.      .++|+||||||+||||+.++++||+|||++
T Consensus        82 y~~~gsL~~~l~------~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           82 YHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             CCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CCCCCcHHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            999999999984      34588999999999999999999973      238999999999999999999999999999


Q ss_pred             cccCCCCC--CCCCccccCcccccchhhhccc------CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHh
Q 016588          231 NFLGRTDV--AGPSSQVTADEIFLASEVKEFR------RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN  302 (386)
Q Consensus       231 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~  302 (386)
                      +.......  ........||+.|||||++.+.      .|+.++|||||||++|||+||..|+.......... ......
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~-~~~~~~  234 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-YDLVPS  234 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT-TTTSCS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc-hhcccc
Confidence            87654322  1223345799999999998764      36789999999999999999987765433211000 000000


Q ss_pred             hhcccchhh-hcchhhcccC-----CHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          303 SRDFSNLLK-ILDERLWSTF-----TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       303 ~~~~~~~~~-~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                      .+....+.+ +....+++..     ..++++.+.+|+.+||+.||++|||+.|+++.|+++.++.
T Consensus       235 ~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~  299 (303)
T 3hmm_A          235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             cchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence            000000011 1112222222     2246678999999999999999999999999999988663

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.3e-55  Score=396.52  Aligned_cols=243  Identities=22%  Similarity=0.291  Sum_probs=190.9

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC------CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ++|++.+.||+|+||+||+|... +++.||+|.+..      .....+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999954 689999997542      23456899999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+ +|+|.+++.     ....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+|+....
T Consensus        93 Ey~-~g~L~~~l~-----~~~~l~e~~~~~~~~qi~~al~ylH~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           93 EYA-GNELFDYIV-----QRDKMSEQEARRFFQQIISAVEYCHR--HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             ECC-CEEHHHHHH-----HSCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             eCC-CCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            999 678888873     34679999999999999999999999  7799999999999999999999999999987643


Q ss_pred             CCCCCCCccccCcccccchhhhcccCC-CcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                      ..   ......||+.|+|||++.+..| +.++||||+||++|||++|+.||.+..   ...+...+....          
T Consensus       165 ~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~---~~~~~~~i~~~~----------  228 (275)
T 3hyh_A          165 GN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES---IPVLFKNISNGV----------  228 (275)
T ss_dssp             -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTC----------
T ss_pred             CC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcCC----------
Confidence            22   2345679999999999998876 579999999999999999999997633   222222221110          


Q ss_pred             hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                          ..++...++++.+++.+||+.||++|||++|+++|
T Consensus       229 ----~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          229 ----YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                12233445678999999999999999999999986

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.6e-55  Score=418.53  Aligned_cols=247  Identities=19%  Similarity=0.338  Sum_probs=206.8

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECC---CCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      ..|+..+.||+|+||.||+|..+ +|+.||||++.   ....+.+.+|+.+|+.++|||||++++++.+.+.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            46999999999999999999965 58999999853   334567899999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++|+|.+++.      ...+++..+..++.|++.||+|||+  ++|+||||||+||||+.++.+||+|||+|+.+.... 
T Consensus       231 ~gG~L~~~i~------~~~l~e~~~~~~~~qil~aL~ylH~--~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-  301 (423)
T 4fie_A          231 EGGALTDIVT------HTRMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-  301 (423)
T ss_dssp             TTEEHHHHHH------HSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred             CCCcHHHHHh------ccCCCHHHHHHHHHHHHHHHHHHHH--CCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence            9999999883      3458999999999999999999999  779999999999999999999999999998775422 


Q ss_pred             CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                       .......||+.|||||++.+..|+.++|||||||++|||++|..||.+..+   ......+....         .+.  
T Consensus       302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~i~~~~---------~~~--  366 (423)
T 4fie_A          302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIRDNL---------PPR--  366 (423)
T ss_dssp             -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSC---------CCC--
T ss_pred             -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHHHcCC---------CCC--
Confidence             223456899999999999999999999999999999999999999986442   12222221110         011  


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .......++++.+|+.+||+.||++|||+.|+++|
T Consensus       367 ~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          367 LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            11222345678999999999999999999999876

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=7.9e-56  Score=404.90  Aligned_cols=245  Identities=20%  Similarity=0.251  Sum_probs=196.5

Q ss_pred             cCCCcCCeecccCceEEEEEEeC----CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (386)
                      ++|++.+.||+|+||+||+|...    +++.||+|.++..     ....+.+|++++++++|||||++++++.+.+..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57899999999999999999852    4679999985432     23358889999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      |||||++|+|.+++.     ....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+|+..
T Consensus       104 vmEy~~gg~L~~~l~-----~~~~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLS-----KEVMFTEEDVKFYLAELALALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EECCCTTCEEHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEcCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            999999999999984     34578999999999999999999999  77999999999999999999999999999875


Q ss_pred             CCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhc
Q 016588          234 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  313 (386)
Q Consensus       234 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (386)
                      ....  .......||+.|||||++.+..|+.++||||+||++|||++|..||.+.+.   ..+...+.+.          
T Consensus       177 ~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~~i~~~----------  241 (304)
T 3ubd_A          177 IDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR---KETMTMILKA----------  241 (304)
T ss_dssp             ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHC----------
T ss_pred             cCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH---HHHHHHHHcC----------
Confidence            4322  223456799999999999999999999999999999999999999986442   2222211111          


Q ss_pred             chhhcccCCHHHHHHHHHHHhHccCCCCCCCCCH-----HHHHHH
Q 016588          314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM-----SDVVTE  353 (386)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~-----~evl~~  353 (386)
                          ...++...++++.+|+.+||+.||++|||+     +|+++|
T Consensus       242 ----~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          242 ----KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             ----CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence                012334456778999999999999999985     566654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=6.1e-54  Score=393.56  Aligned_cols=249  Identities=22%  Similarity=0.340  Sum_probs=184.6

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCC--------
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENN--------  149 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--------  149 (386)
                      .+|+..+.||+|+||+||+|..+ +++.||||++....    .+.+.+|+++|++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            35888999999999999999965 58999999854322    346889999999999999999999986544        


Q ss_pred             ----eEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEc
Q 016588          150 ----LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA  225 (386)
Q Consensus       150 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~  225 (386)
                          ..|+|||||++|+|.+++....  .....++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~al~ylH~--~~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRC--TIEERERSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCC--SGGGSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcC--CCChhHHHHHHHHHHHHHHHHHHHHH--CcCccccCcHHHeEECCCCcEEEc
Confidence                3699999999999999985431  22345667788999999999999999  779999999999999999999999


Q ss_pred             ccccccccCCCCCC----------CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhh
Q 016588          226 DAGLRNFLGRTDVA----------GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQD  295 (386)
Q Consensus       226 DFgl~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~  295 (386)
                      |||+|+........          .......||+.|||||++.+..|+.++|||||||++|||++   ||....     +
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~  232 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----E  232 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----H
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----H
Confidence            99999887543221          11234579999999999999999999999999999999996   664311     1


Q ss_pred             HHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          296 LVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ...........      ..+    .......+.+.+++.+||+.||++|||+.|++++
T Consensus       233 ~~~~~~~~~~~------~~p----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          233 RVRTLTDVRNL------KFP----PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             HHHHHHHHHTT------CCC----HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHhcC------CCC----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            11111111100      000    0111233457889999999999999999999874

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.6e-52  Score=393.69  Aligned_cols=263  Identities=21%  Similarity=0.294  Sum_probs=199.6

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceee------CCe
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQE------NNL  150 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~  150 (386)
                      ++|++.+.||+|+||+||+|... +|+.||||+++...     .+.+.+|+++|+.++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999964 68999999865432     2357789999999999999999998753      367


Q ss_pred             EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  230 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~  230 (386)
                      +|+|||||+ |+|.+++.     ....+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||++
T Consensus       134 ~~ivmE~~~-g~L~~~i~-----~~~~l~~~~~~~~~~qil~al~ylH~--~~iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIH-----SSQPLTLEHVRYFLYQLLRGLKYMHS--AQVIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             EEEEEECCS-EEHHHHHT-----SSSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEeCCC-CCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CcCcCCCcCccccccCCCCCEEEeeccee
Confidence            899999996 67888884     34679999999999999999999999  77999999999999999999999999999


Q ss_pred             cccCCCC--CCCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhccc
Q 016588          231 NFLGRTD--VAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS  307 (386)
Q Consensus       231 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  307 (386)
                      +.+....  .........||+.|+|||++.+. .|+.++||||+||++|||++|+.||.+.+.......+......+...
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~  285 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA  285 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence            8764322  22334567899999999998875 56999999999999999999999998754322111111111101000


Q ss_pred             chhh--------h---cch---hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          308 NLLK--------I---LDE---RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       308 ~~~~--------~---~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ....        .   +.+   ..+....+..++++.+|+.+||+.||++|||++|+++|
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0000        0   000   00000111234678999999999999999999999986

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.1e-50  Score=381.73  Aligned_cols=262  Identities=23%  Similarity=0.251  Sum_probs=198.3

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeC----CCcEEEEEECC-CCChhHHHHHHHHHHcC-CCCcccccccceeeCCeEEEE
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRP-GAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  154 (386)
                      ..++|++.+.||+|+||+||+|..+    +++.||+|++. .....++.+|+++|+.+ +||||+++++++.+.+..|+|
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lv   98 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA   98 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEE
Confidence            4578999999999999999999853    46789999754 44456788999999998 699999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC-CceEEccccccccc
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFL  233 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~-~~~kl~DFgl~~~~  233 (386)
                      |||+++|+|.+++.        .+++..+..++.|++.||+|||+  +||+||||||+|||++.+ +.+||+|||+|+..
T Consensus        99 mE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~--~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~  168 (361)
T 4f9c_A           99 MPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQ--FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT  168 (361)
T ss_dssp             EECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence            99999999998872        37889999999999999999999  779999999999999876 79999999999865


Q ss_pred             CCCCC--------------------------CCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCC
Q 016588          234 GRTDV--------------------------AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASS  286 (386)
Q Consensus       234 ~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~  286 (386)
                      .....                          ........||+.|+|||++.+. .|+.++||||+||++|||++|+.||.
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~  248 (361)
T 4f9c_A          169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY  248 (361)
T ss_dssp             TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence            43211                          0112345799999999999875 58999999999999999999999997


Q ss_pred             CCCCCchhhHHHHHHhh--hcc-------------------cchhhhc---------chhh---------cccCCHHHHH
Q 016588          287 SLSPDSSQDLVELVQNS--RDF-------------------SNLLKIL---------DERL---------WSTFTNEGME  327 (386)
Q Consensus       287 ~~~~~~~~~~~~~~~~~--~~~-------------------~~~~~~~---------~~~~---------~~~~~~~~~~  327 (386)
                      ..... ...+.......  ...                   .......         .+..         ........++
T Consensus       249 ~~~~~-~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~  327 (361)
T 4f9c_A          249 KASDD-LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD  327 (361)
T ss_dssp             CCSSH-HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred             CCCCH-HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence            54431 11111111000  000                   0000000         0000         0011112346


Q ss_pred             HHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          328 EFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       328 ~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ++.+|+.+||+.||++|||++|+++|
T Consensus       328 ~a~DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          328 EAYDLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            78999999999999999999999976

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.7e-50  Score=373.11  Aligned_cols=284  Identities=38%  Similarity=0.623  Sum_probs=239.2

Q ss_pred             CHHHHHHHhcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCC---hhHHHHHHHHHHcCCCCcccccccceeeCCe
Q 016588           74 QMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNL  150 (386)
Q Consensus        74 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  150 (386)
                      ...++....++|...+.||+|+||.||+|..+++..||+|+.....   .+.+.+|+.+++.++||||+++++++...+.
T Consensus        30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  109 (321)
T 2qkw_B           30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE  109 (321)
T ss_dssp             CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred             cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence            3344455678999999999999999999998889999999865443   3568899999999999999999999999999


Q ss_pred             EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  230 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~  230 (386)
                      .++||||+++++|.+++.... .....+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  186 (321)
T 2qkw_B          110 MILIYKYMENGNLKRHLYGSD-LPTMSMSWEQRLEICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGIS  186 (321)
T ss_dssp             CEEEEECCTTCBTGGGSSSSC-CCSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred             EEEEEEcCCCCcHHHHHhccC-CCccccCHHHHHHHHHHHHHHHHHhcC--CCeecCCCCHHHEEECCCCCEEEeecccc
Confidence            999999999999999986432 123468999999999999999999999  77999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          231 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      ................+|+.|+|||.+.+..++.++|||||||++|||++|+.||....+........+.........+.
T Consensus       187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (321)
T 2qkw_B          187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE  266 (321)
T ss_dssp             EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred             cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence            87654333333344567889999999998999999999999999999999999998877665555555544444444455


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      ...++.+....+...+..+.+++.+||+.||++|||+.|++++|+.+++.
T Consensus       267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            55666666677788899999999999999999999999999999998864

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=6.6e-50  Score=396.71  Aligned_cols=247  Identities=21%  Similarity=0.287  Sum_probs=200.9

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC------CChhHHHHH---HHHHHcCCCCcccccccceeeCCeE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDE---VCFLASIQHRNLVTLLGYCQENNLQ  151 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~e---~~~l~~l~h~niv~~~~~~~~~~~~  151 (386)
                      -++|++.++||+|+||+||+|..+ +++.||||++..      .......+|   +.+++.++|||||++++++.+.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            457999999999999999999965 589999998542      222334444   5666778999999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      |+||||++||+|..++.     ....+++..+..++.||+.||.|||+  +||+||||||+||||+.+|++||+|||+|+
T Consensus       268 ylVmEy~~GGdL~~~l~-----~~~~l~E~~a~~y~~qIl~aL~yLH~--~gIiHRDLKPeNILld~~G~vKL~DFGlA~  340 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLS-----QHGVFSEADMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLAC  340 (689)
T ss_dssp             EEEECCCCSCBHHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEecCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCchHHeEEeCCCCEEecccceee
Confidence            99999999999999983     34678999999999999999999999  779999999999999999999999999998


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          232 FLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      ......    ....+||+.|||||++.. ..|+.++|||||||++|||++|..||.+........+......        
T Consensus       341 ~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~--------  408 (689)
T 3v5w_A          341 DFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--------  408 (689)
T ss_dssp             ECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH--------
T ss_pred             ecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC--------
Confidence            765422    345689999999999964 5799999999999999999999999986543322221111110        


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHH
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTE  353 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~evl~~  353 (386)
                          .  ...++...++++.+|+.+||+.||++|++     ++|+++|
T Consensus       409 ----~--~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          409 ----M--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             ----C--CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             ----C--CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence                0  11233445677899999999999999998     6788765

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.4e-49  Score=366.66  Aligned_cols=286  Identities=37%  Similarity=0.619  Sum_probs=238.0

Q ss_pred             hhcccCHHHHHHHhcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccc
Q 016588           69 EARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGY  144 (386)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~  144 (386)
                      ....+...++....++|+..+.||+|+||.||+|..++++.||+|+.....    ...+.+|+.+++.++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            345678899999999999999999999999999998789999999865433    2368999999999999999999999


Q ss_pred             eeeCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCceecCCCCCCeeeCCCCceE
Q 016588          145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL-SPRVVHKDFKTANVLVDEDFIAK  223 (386)
Q Consensus       145 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~ivH~dlkp~Nill~~~~~~k  223 (386)
                      +...+..++||||+++|+|.+++.... .....+++..+..++.|++.||.|||+. .++|+||||||+|||++.++.+|
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERP-ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCS-TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            999999999999999999999886432 2345689999999999999999999983 11799999999999999999999


Q ss_pred             EcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCC--CCchhhHHHHHH
Q 016588          224 VADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--PDSSQDLVELVQ  301 (386)
Q Consensus       224 l~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~--~~~~~~~~~~~~  301 (386)
                      |+|||++....... ........+|+.|+|||.+.+..++.++|||||||++|||++|..||....  ........++..
T Consensus       175 l~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  253 (326)
T 3uim_A          175 VGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK  253 (326)
T ss_dssp             ECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred             eccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence            99999998764322 222334458999999999998889999999999999999999999996311  112233444555


Q ss_pred             hhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHH
Q 016588          302 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  356 (386)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~  356 (386)
                      ............+.......+...+..+.+++.+||+.||++|||+.|++++|++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            5444555566666666777888889999999999999999999999999999976

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.6e-49  Score=393.64  Aligned_cols=249  Identities=21%  Similarity=0.289  Sum_probs=204.9

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC---hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      ++|++.+.||+|+||.||+|..+ +|+.||+|.+....   .+.+.+|+.+|+.++||||+++++++.+.+..|+|||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            57899999999999999999965 58999999865433   345889999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC--CceEEcccccccccCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED--FIAKVADAGLRNFLGRT  236 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~--~~~kl~DFgl~~~~~~~  236 (386)
                      ++|+|.+++..    ....+++..+..++.||+.||+|||+  ++|+||||||+|||++.+  +.+||+|||+++.+...
T Consensus       237 ~gg~L~~~i~~----~~~~l~e~~~~~~~~qi~~al~ylH~--~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          237 SGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCBHHHHHTC----TTSCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             CCCcHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            99999988842    33568999999999999999999999  779999999999999854  89999999999987543


Q ss_pred             CCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchh
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  316 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (386)
                      .   ......||+.|+|||++.+..|+.++||||+||++|||++|..||.+...   ......+.....      .+...
T Consensus       311 ~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~---~~~~~~i~~~~~------~~~~~  378 (573)
T 3uto_A          311 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETLRNVKSCDW------NMDDS  378 (573)
T ss_dssp             S---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHTTCC------CCCSG
T ss_pred             C---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHHHhCCC------CCCcc
Confidence            2   23456799999999999999999999999999999999999999986442   222222211110      01111


Q ss_pred             hcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          317 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .+    ...++++.+|+.+||+.||++|||+.|+++|
T Consensus       379 ~~----~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          379 AF----SGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             GG----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cc----cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11    2234668999999999999999999999985

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=8e-48  Score=364.98  Aligned_cols=263  Identities=25%  Similarity=0.448  Sum_probs=215.3

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC--------CCcEEEEEECCCCCh----hHHHHHHHHHHcC-CCCcccccccceeeC
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ--------DGMLVAIKKRPGAPT----QEFIDEVCFLASI-QHRNLVTLLGYCQEN  148 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~----~~~~~e~~~l~~l-~h~niv~~~~~~~~~  148 (386)
                      .++|++.+.||+|+||.||+|...        ++..||+|.......    +.+.+|+.+++.+ +||||+++++++...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            467888899999999999999852        345799999765432    4578999999999 899999999999999


Q ss_pred             CeEEEEEEeecCCCccccccCCCc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC
Q 016588          149 NLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD  217 (386)
Q Consensus       149 ~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~  217 (386)
                      +..|+||||+++|+|.+++.....           .....+++..++.++.|++.||.|||+  ++|+||||||+|||++
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~  237 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVT  237 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEC
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCeeccccchhhEEEC
Confidence            999999999999999998854321           122457899999999999999999999  7799999999999999


Q ss_pred             CCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhH
Q 016588          218 EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDL  296 (386)
Q Consensus       218 ~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~  296 (386)
                      .++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||......   .+
T Consensus       238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---~~  314 (370)
T 2psq_A          238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---EL  314 (370)
T ss_dssp             TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GH
T ss_pred             CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HH
Confidence            999999999999987655443333445567788999999999999999999999999999999 99999875432   22


Q ss_pred             HHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhc
Q 016588          297 VELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  362 (386)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~  362 (386)
                      ...+..             ......+..++.++.+++.+||+.||++|||+.|+++.|+.++....
T Consensus       315 ~~~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~  367 (370)
T 2psq_A          315 FKLLKE-------------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  367 (370)
T ss_dssp             HHHHHT-------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHHhc-------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            222111             11223344556779999999999999999999999999999986543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.8e-46  Score=346.57  Aligned_cols=282  Identities=32%  Similarity=0.522  Sum_probs=226.2

Q ss_pred             hhcccCHHHHHHHhcCCCcC------CeecccCceEEEEEEeCCCcEEEEEECCCC-------ChhHHHHHHHHHHcCCC
Q 016588           69 EARRFQMEELSLATKNFSDK------NLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-------PTQEFIDEVCFLASIQH  135 (386)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~l~~l~h  135 (386)
                      ....|++.++...+.+|...      +.||+|+||.||+|.. ++..||+|+....       ..+.+.+|+.+++.++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            34568888999999888877      8999999999999987 5789999985432       23568899999999999


Q ss_pred             CcccccccceeeCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCee
Q 016588          136 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVL  215 (386)
Q Consensus       136 ~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nil  215 (386)
                      |||+++++++.+.+..++||||+++++|.+++...  .....+++..+..++.|++.||.|||+  .+|+||||||+||+
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dlkp~Nil  165 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL--DGTPPLSWHMRCKIAQGAANGINFLHE--NHHIHRDIKSANIL  165 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTG--GGCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEE
Confidence            99999999999999999999999999999888532  224568999999999999999999999  77999999999999


Q ss_pred             eCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchh-
Q 016588          216 VDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ-  294 (386)
Q Consensus       216 l~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~-  294 (386)
                      ++.++.+||+|||++................+++.|+|||.+.+ .++.++||||||+++|||++|..||......... 
T Consensus       166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~  244 (307)
T 2nru_A          166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL  244 (307)
T ss_dssp             ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT
T ss_pred             EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH
Confidence            99999999999999987654332222334568899999999875 4789999999999999999999999876543221 


Q ss_pred             hHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhh
Q 016588          295 DLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD  359 (386)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~  359 (386)
                      ........  ....+...+++.. ...+...++.+.+++.+||+.||++|||+.+++++|+++..
T Consensus       245 ~~~~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          245 DIKEEIED--EEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HHHHHHHT--TSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHHhhh--hhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            11111111  1122333333332 34566778889999999999999999999999999998753

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=9.5e-48  Score=357.80  Aligned_cols=272  Identities=25%  Similarity=0.326  Sum_probs=210.3

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCChh--HHHHHHHHHHcCCCCcccccccceeeCC----eEEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ--EFIDEVCFLASIQHRNLVTLLGYCQENN----LQFLIY  155 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~  155 (386)
                      .++|+..+.||+|+||+||+|... ++.||||++......  ....|+.+++.++||||+++++++....    ..++||
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~  101 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT  101 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence            467888999999999999999875 789999997654433  3556788899999999999999998743    479999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcC--------CCCceecCCCCCCeeeCCCCceEEccc
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL--------SPRVVHKDFKTANVLVDEDFIAKVADA  227 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------~~~ivH~dlkp~Nill~~~~~~kl~DF  227 (386)
                      ||+++|+|.+++.      ...+++..+..++.|++.||.|||+.        .++|+||||||+|||++.++.+||+||
T Consensus       102 e~~~~g~L~~~l~------~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A          102 AFHEKGSLSDFLK------ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             ECCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred             ecCCCCCHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence            9999999999983      24589999999999999999999982        117999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCccccCcccccchhhhcc-----cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHh
Q 016588          228 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN  302 (386)
Q Consensus       228 gl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~  302 (386)
                      |+++...............+|+.|+|||++.+     ..++.++|||||||++|||++|+.||.+...............
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  255 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ  255 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred             CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence            99987765444444445678999999999986     3456788999999999999999999987654332222221111


Q ss_pred             hhcccchhhhc-chhhccc-----CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          303 SRDFSNLLKIL-DERLWST-----FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       303 ~~~~~~~~~~~-~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      ........... .......     .....++++.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            11111111111 1111111     1224567799999999999999999999999999998764

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=6.2e-48  Score=366.78  Aligned_cols=259  Identities=28%  Similarity=0.432  Sum_probs=212.3

Q ss_pred             HHhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           80 LATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        80 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      ...++|...+.||+|+||.||+|... +++.||+|......    .+++.+|+.+++.++||||+++++++...+..|+|
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence            34567888899999999999999976 68999999876543    23578899999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      |||+++|+|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++...
T Consensus       191 ~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~  264 (377)
T 3cbl_A          191 MELVQGGDFLTFLRT----EGARLRVKTLLQMVGDAAAGMEYLES--KCCIHRDLAARNCLVTEKNVLKISDFGMSREEA  264 (377)
T ss_dssp             EECCTTCBHHHHHHH----HGGGCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred             EEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence            999999999998842    23458899999999999999999999  779999999999999999999999999998654


Q ss_pred             CCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhc
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  313 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (386)
                      ............++..|+|||.+.+..++.++|||||||++|||++ |..||.....   ......+.            
T Consensus       265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~---~~~~~~~~------------  329 (377)
T 3cbl_A          265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---QQTREFVE------------  329 (377)
T ss_dssp             TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---HHHHHHHH------------
T ss_pred             CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH------------
Confidence            3222222222335677999999998899999999999999999998 9999986542   11121111            


Q ss_pred             chhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                       ...+...+..+++++.+++.+||+.||++|||++++++.|+++.++
T Consensus       330 -~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          330 -KGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             -TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence             1112233444567799999999999999999999999999998765

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.9e-47  Score=345.29  Aligned_cols=256  Identities=28%  Similarity=0.434  Sum_probs=212.2

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCC--ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeec
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  159 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  159 (386)
                      .++|+..+.||+|+||.||+|...++..||+|+....  ..+++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            4578888999999999999999888889999986543  45679999999999999999999999999999999999999


Q ss_pred             CCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016588          160 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  239 (386)
Q Consensus       160 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~  239 (386)
                      +++|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++........ 
T Consensus        89 ~~~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  161 (269)
T 4hcu_A           89 HGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-  161 (269)
T ss_dssp             TCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred             CCcHHHHHHh----cCcccCHHHHHHHHHHHHHHHHHHHh--CCeecCCcchheEEEcCCCCEEecccccccccccccc-
Confidence            9999998843    34568899999999999999999999  7799999999999999999999999999987643221 


Q ss_pred             CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          240 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       240 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |..||.....   ..........             ..
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~---~~~~~~~~~~-------------~~  225 (269)
T 4hcu_A          162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDISTG-------------FR  225 (269)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTT-------------CC
T ss_pred             ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHHhcC-------------cc
Confidence            12233445678999999999999999999999999999999 8999876442   1122111111             11


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      ...+...++++.+++.+||+.||++|||+.+++++|+++.+.
T Consensus       226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          226 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            122233456789999999999999999999999999999875

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.2e-47  Score=354.69  Aligned_cols=262  Identities=27%  Similarity=0.433  Sum_probs=210.5

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC----CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (386)
                      ..+|.+.+.||+|+||.||+|...    .+..||||......    .+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            457888899999999999999964    34569999876542    3458899999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      ||||+++++|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++..
T Consensus       128 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          128 VTEYMENGSLDTFLRT----HDGQFTIMQLVGMLRGVGAGMRYLSD--LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             EEECCTTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EeeCCCCCcHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            9999999999999843    23568999999999999999999999  77999999999999999999999999999876


Q ss_pred             CCCCCC-CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhh
Q 016588          234 GRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK  311 (386)
Q Consensus       234 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (386)
                      ...... .......+|..|+|||.+.+..++.++|||||||++|||++ |..||.....   ......+..         
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~~~~~~~~---------  269 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN---RDVISSVEE---------  269 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHHHT---------
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHc---------
Confidence            542211 11223345778999999999999999999999999999999 9999976442   122221111         


Q ss_pred             hcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhcccc
Q 016588          312 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLT  365 (386)
Q Consensus       312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~~~~  365 (386)
                          ......+..+++++.+++.+||+.||++|||+.++++.|+.+++...+..
T Consensus       270 ----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~~  319 (325)
T 3kul_A          270 ----GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLR  319 (325)
T ss_dssp             ----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC---
T ss_pred             ----CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccccc
Confidence                11223334456779999999999999999999999999999998765554

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.6e-47  Score=345.88  Aligned_cols=258  Identities=25%  Similarity=0.427  Sum_probs=211.0

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCC--ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      ..++|+..+.||+|+||.||++..+++..||+|+....  ..+++.+|+++++.++||||+++++++.+.+..++||||+
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            35678889999999999999999988889999986644  4567999999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++++|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++........
T Consensus       102 ~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  175 (283)
T 3gen_A          102 ANGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  175 (283)
T ss_dssp             TTCBHHHHHHC----GGGCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred             CCCcHHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence            99999998853    23568999999999999999999999  7799999999999999999999999999987643221


Q ss_pred             CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhh
Q 016588          239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  317 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (386)
                       .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||......   .....+..             ..
T Consensus       176 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~~-------------~~  238 (283)
T 3gen_A          176 -TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAEHIAQ-------------GL  238 (283)
T ss_dssp             -HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHHHT-------------TC
T ss_pred             -ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh---HHHHHHhc-------------cc
Confidence             11233446778999999999999999999999999999998 99999865431   11111111             11


Q ss_pred             cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                      ....+...++.+.+++.+||+.||++|||+.+++++|.++++++
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e  282 (283)
T 3gen_A          239 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE  282 (283)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence            11222333467899999999999999999999999999998764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.1e-47  Score=350.84  Aligned_cols=260  Identities=29%  Similarity=0.417  Sum_probs=203.0

Q ss_pred             HHhcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           80 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        80 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      ....+|++.+.||+|+||+||+|.. ++..||+|+.....     .+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV  112 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence            4456888899999999999999987 57889999865432     23578999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--ceecCCCCCCeeeCCCCceEEcccccccc
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR--VVHKDFKTANVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~--ivH~dlkp~Nill~~~~~~kl~DFgl~~~  232 (386)
                      |||+++++|.+++...  .....+++..++.++.|++.||.|||+  .+  |+||||||+|||++.++.+||+|||+++.
T Consensus       113 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  188 (309)
T 3p86_A          113 TEYLSRGSLYRLLHKS--GAREQLDERRRLSMAYDVAKGMNYLHN--RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL  188 (309)
T ss_dssp             EECCTTCBHHHHHHST--THHHHSCHHHHHHHHHHHHHHHHHHHT--SSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred             EecCCCCcHHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHc--CCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence            9999999999988532  112348899999999999999999999  66  99999999999999999999999999976


Q ss_pred             cCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          233 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      .....  .......+|+.|+|||.+.+..++.++|||||||++|||++|..||......   ........          
T Consensus       189 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~---~~~~~~~~----------  253 (309)
T 3p86_A          189 KASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA---QVVAAVGF----------  253 (309)
T ss_dssp             ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH---HHHHHHHH----------
T ss_pred             ccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh----------
Confidence            54321  1233456888999999999999999999999999999999999999865431   11111110          


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                        .......+...++++.+++.+||+.||++|||+.++++.|+.+++..
T Consensus       254 --~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          254 --KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             --SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             --cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence              00112333445577999999999999999999999999999998763

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.1e-46  Score=346.64  Aligned_cols=248  Identities=22%  Similarity=0.359  Sum_probs=205.0

Q ss_pred             hcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECC---CCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      .++|+..+.||+|+||+||+|.. .+++.||+|...   ....+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            45799999999999999999995 468999999743   33456788999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +++++|.+++.      ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.......
T Consensus        99 ~~~~~L~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (297)
T 3fxz_A           99 LAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (297)
T ss_dssp             CTTCBHHHHHH------HSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             CCCCCHHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHh--CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence            99999999883      2358899999999999999999999  779999999999999999999999999988765422


Q ss_pred             CCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhh
Q 016588          238 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  317 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (386)
                        .......+|+.|+|||.+.+..++.++|||||||++|||++|..||....+.  ...........            .
T Consensus       171 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~------------~  234 (297)
T 3fxz_A          171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYLIATNGT------------P  234 (297)
T ss_dssp             --CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHHCS------------C
T ss_pred             --cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCC------------C
Confidence              2234557899999999999999999999999999999999999999764421  11111111000            0


Q ss_pred             cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ....+...++.+.+++.+||+.||++|||++|++++
T Consensus       235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          235 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            112233445678999999999999999999999976

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=348.55  Aligned_cols=260  Identities=25%  Similarity=0.394  Sum_probs=210.2

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC---hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      .++|...+.||+|+||+||+|... ++..||+|+.....   .+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            357788899999999999999965 58899999864433   34688999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +++++|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.......
T Consensus        89 ~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           89 IKGGTLRGIIKS----MDSQYPWSQRVSFAKDIASGMAYLHS--MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             CTTCBHHHHHHH----CCTTSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             cCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            999999999843    24568999999999999999999999  779999999999999999999999999998764322


Q ss_pred             CCC------------CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc
Q 016588          238 VAG------------PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD  305 (386)
Q Consensus       238 ~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  305 (386)
                      ...            ......||+.|+|||.+.+..++.++||||||+++|||++|..|+....+......         
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~---------  233 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG---------  233 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS---------
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh---------
Confidence            211            11145689999999999999999999999999999999999999876554221100         


Q ss_pred             ccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          306 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                       .......+    ...+..+++.+.+++.+||+.||++|||+.++++.|+++....
T Consensus       234 -~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          234 -LNVRGFLD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             -BCHHHHHH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -hhhhcccc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence             00111111    1122334456899999999999999999999999999988663

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-47  Score=360.90  Aligned_cols=270  Identities=23%  Similarity=0.343  Sum_probs=215.4

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC------CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  151 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  151 (386)
                      .++|+..+.||+|+||.||+|...      ++..||||++....    ...+.+|+.+++.++||||+++++++.+.+..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            467888999999999999999943      35689999976432    23578899999999999999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC---ceEEcc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQ--VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF---IAKVAD  226 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~---~~kl~D  226 (386)
                      ++||||+++|+|.+++.....  .....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++   .+||+|
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChhhEEEecCCCCceEEECC
Confidence            999999999999998854321  123468899999999999999999999  7799999999999999554   599999


Q ss_pred             cccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhc
Q 016588          227 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRD  305 (386)
Q Consensus       227 Fgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  305 (386)
                      ||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||.....   ......+..   
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~---~~~~~~i~~---  301 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEFVTS---  301 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHHT---
T ss_pred             CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHc---
Confidence            999986543333333445567889999999999999999999999999999998 9999976442   222222211   


Q ss_pred             ccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhcccccccC
Q 016588          306 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMG  369 (386)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~~~~~~~~  369 (386)
                                ......+..++..+.+++.+||+.||++|||+.+++++|+.+.+.........+
T Consensus       302 ----------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~~~~~~p  355 (367)
T 3l9p_A          302 ----------GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALP  355 (367)
T ss_dssp             ----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHHTCCCC
T ss_pred             ----------CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhhccCCCc
Confidence                      111223334456789999999999999999999999999999887554443333

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.9e-47  Score=360.80  Aligned_cols=272  Identities=24%  Similarity=0.376  Sum_probs=216.1

Q ss_pred             ccCHHHHHHHhcCCCcCCeecccCceEEEEEEe------CCCcEEEEEECCCCCh----hHHHHHHHHHHcC-CCCcccc
Q 016588           72 RFQMEELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAPT----QEFIDEVCFLASI-QHRNLVT  140 (386)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~----~~~~~e~~~l~~l-~h~niv~  140 (386)
                      .+....+....++|++.+.||+|+||.||+|.+      .+++.||||+......    +.+.+|++++..+ +||||++
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            344566666788999999999999999999983      2357899998765432    3588999999999 7999999


Q ss_pred             cccceeeCC-eEEEEEEeecCCCccccccCCCcC----------------------------------------------
Q 016588          141 LLGYCQENN-LQFLIYEYIPNGSVSIHLYGPSQV----------------------------------------------  173 (386)
Q Consensus       141 ~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~----------------------------------------------  173 (386)
                      +++++...+ ..++||||+++|+|.+++......                                              
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            999988754 489999999999999988643210                                              


Q ss_pred             ---------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          174 ---------------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       174 ---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                                     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.......
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                           01228899999999999999999999  7799999999999999999999999999987644333


Q ss_pred             CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhh
Q 016588          239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  317 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (386)
                      ........+|..|+|||++.+..++.++|||||||++|||++ |..||.+.....  .......             ...
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~-------------~~~  313 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLK-------------EGT  313 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHHHHH-------------HTC
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHHHHH-------------cCC
Confidence            223344567888999999999999999999999999999998 999998755321  1111111             111


Q ss_pred             cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      ....+...++++.+++.+||+.||++|||+.|++++|+++++.
T Consensus       314 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence            1223333456789999999999999999999999999998865

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=7.5e-47  Score=358.62  Aligned_cols=260  Identities=26%  Similarity=0.448  Sum_probs=201.3

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC----CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (386)
                      ..+|+..+.||+|+||.||+|...    ++..||||......    .+++.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            457899999999999999999864    46789999876442    3468899999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      ||||+++++|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++..
T Consensus       124 v~e~~~~~sL~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          124 VTEYMENGSLDSFLRK----HDAQFTVIQLVGMLRGIASGMKYLSD--MGYVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             EEECCTTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEeCCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            9999999999999853    23468999999999999999999999  77999999999999999999999999999876


Q ss_pred             CCCCC-CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhh
Q 016588          234 GRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK  311 (386)
Q Consensus       234 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (386)
                      ..... ........++..|+|||++.+..++.++|||||||++|||++ |..||.....   ......+           
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~~~~~i-----------  263 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDVIKAV-----------  263 (373)
T ss_dssp             ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HHHHHHH-----------
T ss_pred             ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH-----------
Confidence            54221 111223345677999999999999999999999999999998 9999976542   1222111           


Q ss_pred             hcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhcc
Q 016588          312 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN  363 (386)
Q Consensus       312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~~  363 (386)
                        ........+..++..+.+++.+||+.||++|||+.++++.|+++++....
T Consensus       264 --~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~  313 (373)
T 2qol_A          264 --DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS  313 (373)
T ss_dssp             --HTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGGG
T ss_pred             --HcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCccc
Confidence              11122233344567799999999999999999999999999999876543

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.1e-47  Score=352.59  Aligned_cols=262  Identities=27%  Similarity=0.427  Sum_probs=213.6

Q ss_pred             HhcCCCcCCeecccCceEEEEEEe------CCCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCe
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNL  150 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  150 (386)
                      ..++|...+.||+|+||.||+|..      .++..||+|......    .+.+.+|+.+++.++||||+++++++...+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            456788899999999999999985      234789999976543    2457889999999999999999999999999


Q ss_pred             EEEEEEeecCCCccccccCCCcC-------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCC
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQV-------------------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKT  211 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp  211 (386)
                      .++||||+++++|.+++......                   ....+++..+..++.|++.||.|||+  ++|+||||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dikp  178 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE--MKLVHRDLAA  178 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH--TTEECCCCSG
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH--CCCcccccch
Confidence            99999999999999988543210                   12348899999999999999999999  7799999999


Q ss_pred             CCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCC
Q 016588          212 ANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP  290 (386)
Q Consensus       212 ~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~  290 (386)
                      +||+++.++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987654333333344567788999999998889999999999999999999 9999987553


Q ss_pred             CchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          291 DSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      .   .....+..             ......+...++++.+++.+||+.||++|||+.+++++|++++++
T Consensus       259 ~---~~~~~~~~-------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          259 E---RLFNLLKT-------------GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             G---GHHHHHHT-------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             H---HHHHHhhc-------------CCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            2   22222211             111223334557799999999999999999999999999998865

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=357.34  Aligned_cols=267  Identities=26%  Similarity=0.415  Sum_probs=217.3

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeC--------CCcEEEEEECCCCCh----hHHHHHHHHHHcC-CCCcccccccceee
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQ--------DGMLVAIKKRPGAPT----QEFIDEVCFLASI-QHRNLVTLLGYCQE  147 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~----~~~~~e~~~l~~l-~h~niv~~~~~~~~  147 (386)
                      ..++|.+.+.||+|+||.||+|...        .+..||+|+......    ..+.+|+++++.+ +||||+++++++..
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            4567888999999999999999852        235799998655432    4578999999999 89999999999999


Q ss_pred             CCeEEEEEEeecCCCccccccCCCc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee
Q 016588          148 NNLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV  216 (386)
Q Consensus       148 ~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill  216 (386)
                      .+..++||||+++|+|.+++.....           .....+++..++.++.|++.||.|||+  .+|+||||||+|||+
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLV  224 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCcceEEE
Confidence            9999999999999999998854321           112468999999999999999999999  779999999999999


Q ss_pred             CCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhh
Q 016588          217 DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQD  295 (386)
Q Consensus       217 ~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~  295 (386)
                      +.++.+||+|||+++...............+|..|+|||++.+..++.++|||||||++|||++ |..||.....   ..
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~---~~  301 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EE  301 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HH
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HH
Confidence            9999999999999987765444344455567888999999999999999999999999999999 9999876442   22


Q ss_pred             HHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhcccc
Q 016588          296 LVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLT  365 (386)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~~~~  365 (386)
                      ....+..             ......+..+++++.+++.+||+.||++|||+.|++++|++++....+..
T Consensus       302 ~~~~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~  358 (382)
T 3tt0_A          302 LFKLLKE-------------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE  358 (382)
T ss_dssp             HHHHHHT-------------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred             HHHHHHc-------------CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence            2222211             11222333455679999999999999999999999999999997754443

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=8.3e-47  Score=342.02  Aligned_cols=256  Identities=25%  Similarity=0.416  Sum_probs=210.5

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCC--ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeec
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  159 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  159 (386)
                      .++|+..+.||+|+||.||+|..+++..||+|.....  ..+++.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS   86 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence            4678889999999999999999888889999986543  45678999999999999999999999999999999999999


Q ss_pred             CCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016588          160 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  239 (386)
Q Consensus       160 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~  239 (386)
                      +++|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++.........
T Consensus        87 ~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           87 NGCLLNYLRS----HGKGLEPSQLLEMCYDVCEGMAFLES--HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             TCBHHHHHHH----HGGGCCHHHHHHHHHHHHHHHHHHHH--TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             CCcHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            9999998842    23458999999999999999999999  77999999999999999999999999999876443221


Q ss_pred             CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          240 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       240 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                       ......+|..|+|||.+.+..++.++||||||+++|||++ |..||......   .........             ..
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~~~-------------~~  223 (268)
T 3sxs_A          161 -SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS---EVVLKVSQG-------------HR  223 (268)
T ss_dssp             -ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHHHTT-------------CC
T ss_pred             -cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH---HHHHHHHcC-------------CC
Confidence             1233445677999999998899999999999999999999 99998764421   111111111             11


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      ...+...++.+.+++.+||+.||++|||+.+++++|+.+.++
T Consensus       224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          224 LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            112223346789999999999999999999999999988765

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=9.9e-47  Score=353.63  Aligned_cols=265  Identities=26%  Similarity=0.409  Sum_probs=213.0

Q ss_pred             HHHhcCCCcCCeecccCceEEEEEEeC------CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeC
Q 016588           79 SLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQEN  148 (386)
Q Consensus        79 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~  148 (386)
                      ....++|+..+.||+|+||.||+|...      ++..||+|......    .+.+.+|+.+++.++||||+++++++.+.
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  122 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG  122 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence            345678999999999999999999964      34789999976543    34588999999999999999999999999


Q ss_pred             CeEEEEEEeecCCCccccccCCCcC-------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCC
Q 016588          149 NLQFLIYEYIPNGSVSIHLYGPSQV-------------------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDF  209 (386)
Q Consensus       149 ~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dl  209 (386)
                      +..++||||+++++|.+++......                   ....+++..++.++.|++.||.|||+  ++|+||||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dl  200 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDL  200 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCC
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCC
Confidence            9999999999999999988542110                   12568999999999999999999999  77999999


Q ss_pred             CCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCC
Q 016588          210 KTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL  288 (386)
Q Consensus       210 kp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~  288 (386)
                      ||+|||++.++.+||+|||++................+|..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            99999999999999999999987654333333344567888999999999999999999999999999999 99999764


Q ss_pred             CCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          289 SPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                      ..   ......+...             .....+..++.++.+++.+||+.||++|||+.+++++|+++.++.
T Consensus       281 ~~---~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          281 AH---EEVIYYVRDG-------------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             CH---HHHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             Ch---HHHHHHHhCC-------------CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence            42   2222111111             111233345567999999999999999999999999999998764

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=8.3e-47  Score=352.20  Aligned_cols=257  Identities=25%  Similarity=0.423  Sum_probs=205.4

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCc----EEEEEECCC----CChhHHHHHHHHHHcCCCCcccccccceeeCCeEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGM----LVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  152 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  152 (386)
                      .++|+..+.||+|+||+||+|... +++    +||+|....    ...+.+.+|+.+++.++||||+++++++...+ .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            356888899999999999999954 343    468887543    34467899999999999999999999998765 67


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~  232 (386)
                      +|+||+.+|+|.+++..    ....+++..++.++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           93 LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEEECCTTCBHHHHHHH----STTSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred             EEEEecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence            89999999999998843    24568899999999999999999999  6799999999999999999999999999988


Q ss_pred             cCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhh
Q 016588          233 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK  311 (386)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (386)
                      ..............+|..|+|||.+.+..++.++|||||||++|||++ |..||.......   ....+.          
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~~----------  233 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILE----------  233 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHH----------
T ss_pred             ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHHHHH----------
Confidence            765444334445566788999999999999999999999999999999 999998755322   222111          


Q ss_pred             hcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          312 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                         .......+..++.++.+++.+||+.||++|||+.+++++|+.+.+..
T Consensus       234 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~  280 (327)
T 3poz_A          234 ---KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             ---TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred             ---cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence               11122233445567999999999999999999999999999998764

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.4e-46  Score=350.58  Aligned_cols=245  Identities=25%  Similarity=0.336  Sum_probs=203.5

Q ss_pred             hcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ..+|+..+.||+|+||.||+|.. .+++.||+|+....     ..+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            35789999999999999999996 56899999985432     2345789999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++++|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.....
T Consensus        94 e~~~~~~L~~~l~-----~~~~l~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           94 EYASGGEVFDYLV-----AHGRMKEKEARSKFRQIVSAVQYCHQ--KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             CCCTTCBHHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred             ECCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence            9999999999883     33568899999999999999999999  7799999999999999999999999999987643


Q ss_pred             CCCCCCCccccCcccccchhhhcccCCC-cccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRFS-EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                      .   .......+|+.|+|||++.+..++ .++||||+||++|||++|..||.+...   ......+...           
T Consensus       167 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~-----------  229 (328)
T 3fe3_A          167 G---GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL---KELRERVLRG-----------  229 (328)
T ss_dssp             S---CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHC-----------
T ss_pred             C---CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHhC-----------
Confidence            2   223456789999999999988875 799999999999999999999986442   1122111110           


Q ss_pred             hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                       .  ...+...+.++.+++.+||+.||.+|||++|++++
T Consensus       230 -~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          230 -K--YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             -C--CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             -C--CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence             0  11223345678999999999999999999999976

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.5e-46  Score=350.14  Aligned_cols=258  Identities=26%  Similarity=0.394  Sum_probs=206.0

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCc----EEEEEECCC----CChhHHHHHHHHHHcCCCCcccccccceeeCCeEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGM----LVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  152 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  152 (386)
                      .++|+..+.||+|+||+||+|... ++.    .|++|....    .....+.+|+.+++.++||||+++++++.. +..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccE
Confidence            357888899999999999999964 343    378887432    233567889999999999999999999864 5688


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~  232 (386)
                      +||||+.+|+|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        91 ~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQ----HRGALGPQLLLNWGVQIAKGMYYLEE--HGMVHRNLAARNVLLKSPSQVQVADFGVADL  164 (325)
T ss_dssp             EEEECCTTCBSHHHHHS----SGGGSCTTHHHHHHHHHHHHHHHHHH--TTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred             EEEEeCCCCCHHHHHHH----ccccCCHHHHHHHHHHHHHHHHHHHh--CCCCCCccchheEEECCCCeEEECCCCcccc
Confidence            99999999999998853    23567888999999999999999999  6799999999999999999999999999998


Q ss_pred             cCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhh
Q 016588          233 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK  311 (386)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (386)
                      ..............++..|+|||.+.+..++.++|||||||++|||++ |..||.......   ....+...        
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~--------  233 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPDLLEKG--------  233 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHHHHHTT--------
T ss_pred             cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHHHHHcC--------
Confidence            765444444455667788999999999999999999999999999999 999998755432   11211111        


Q ss_pred             hcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhc
Q 016588          312 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  362 (386)
Q Consensus       312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~  362 (386)
                           .....+..++.++.+++.+||+.||++|||+.+++++|+.+.+...
T Consensus       234 -----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~  279 (325)
T 3kex_A          234 -----ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPP  279 (325)
T ss_dssp             -----CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHH
T ss_pred             -----CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence                 1112222334567899999999999999999999999999987653

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.6e-46  Score=349.71  Aligned_cols=251  Identities=21%  Similarity=0.311  Sum_probs=203.7

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      .++|++.+.||+|+||+||+|... +++.||+|+....    ..+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            357889999999999999999965 6889999985432    23568899999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      |+++++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++......
T Consensus        86 ~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           86 YCSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             CCTTEEGGGGSB-----TTTBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             cCCCCcHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            999999999884     34568999999999999999999999  77999999999999999999999999999876443


Q ss_pred             CCCCCCccccCcccccchhhhcccCC-CcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      ..........+|+.|+|||++.+..+ +.++|||||||++|||++|..||........ ....+...             
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~-------------  224 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEK-------------  224 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHTT-------------
T ss_pred             CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhcc-------------
Confidence            33333445678999999999987775 7789999999999999999999987554221 11111110             


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ..........++++.+++.+||+.||++|||+.|++++
T Consensus       225 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          225 KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            00001112234668899999999999999999999876

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.7e-47  Score=350.16  Aligned_cols=269  Identities=27%  Similarity=0.419  Sum_probs=206.8

Q ss_pred             hcCCCcCCeecccCceEEEEEEe-----CCCcEEEEEECCCCCh---hHHHHHHHHHHcCCCCcccccccceee--CCeE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQ  151 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  151 (386)
                      .++|++.+.||+|+||+||+|.+     .+++.||+|+......   +.+.+|+.+++.++||||+++++++..  ....
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            46788899999999999999984     2578999998765543   467899999999999999999998854  3568


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      ++||||+++++|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++.
T Consensus        89 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             EEEEECCTTCBHHHHHHH----CGGGCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             EEEEEeCCCCCHHHHHHh----cccccCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            999999999999999843    23458899999999999999999999  779999999999999999999999999998


Q ss_pred             ccCCCCC-CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc----c
Q 016588          232 FLGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD----F  306 (386)
Q Consensus       232 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~  306 (386)
                      ....... ........++..|+|||.+.+..++.++||||||+++|||++|..|+.....    ...........    .
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~~~  238 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA----EFMRMIGNDKQGQMIV  238 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH----HHHHHHCTTCCTHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH----HHHhhhcCccccchhH
Confidence            7654322 1222334567779999999999999999999999999999999998765321    11111000000    0


Q ss_pred             cchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      ......+........+..+++++.+++.+||+.||++|||+.|+++.|+++.++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            011112222223344556678899999999999999999999999999998765

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.3e-46  Score=348.34  Aligned_cols=265  Identities=22%  Similarity=0.373  Sum_probs=197.4

Q ss_pred             HHhcCCCcCCeecccCceEEEEEEeCC-C---cEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCCe
Q 016588           80 LATKNFSDKNLIGEGKFGEVYKGLLQD-G---MLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNL  150 (386)
Q Consensus        80 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  150 (386)
                      ...++|+..+.||+|+||.||+|.... +   ..||+|.....     ..+.+.+|+.+++.++||||+++++++...+.
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            345689999999999999999999654 3   27999986543     23568899999999999999999999987665


Q ss_pred             E------EEEEEeecCCCccccccCCCc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceE
Q 016588          151 Q------FLIYEYIPNGSVSIHLYGPSQ-VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAK  223 (386)
Q Consensus       151 ~------~lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~k  223 (386)
                      .      ++||||+++++|.+++..... .....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+|
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS--RNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc--CCcccCCCCcceEEEcCCCCEE
Confidence            5      999999999999988843211 122358899999999999999999999  7799999999999999999999


Q ss_pred             EcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHh
Q 016588          224 VADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQN  302 (386)
Q Consensus       224 l~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~  302 (386)
                      |+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||......   ........
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~~~~  254 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---EIYNYLIG  254 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHHT
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---HHHHHHhc
Confidence            999999987654433333344556778999999999999999999999999999999 89999875532   11111111


Q ss_pred             hhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhc
Q 016588          303 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  362 (386)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~  362 (386)
                                   ......+...++++.+++.+||+.||++|||+.++++.|+++++...
T Consensus       255 -------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~  301 (323)
T 3qup_A          255 -------------GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS  301 (323)
T ss_dssp             -------------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             -------------CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence                         11122333455779999999999999999999999999999998854

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.3e-46  Score=346.51  Aligned_cols=265  Identities=24%  Similarity=0.395  Sum_probs=213.5

Q ss_pred             HhcCCCcCCeecccCceEEEEEEe------CCCcEEEEEECCCCC----hhHHHHHHHHHHcC-CCCcccccccceeeCC
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQENN  149 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  149 (386)
                      ..++|+..+.||+|+||.||+|..      .++..||+|......    .+.+.+|+.+++.+ +||||+++++++...+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            346788899999999999999984      246789999876443    35688999999999 9999999999999999


Q ss_pred             eEEEEEEeecCCCccccccCCCc-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee
Q 016588          150 LQFLIYEYIPNGSVSIHLYGPSQ-------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV  216 (386)
Q Consensus       150 ~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill  216 (386)
                      ..++||||+++|+|.+++.....             .....+++..++.++.|++.||.|||+  ++|+||||||+||++
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~  178 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILL  178 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCccceEEE
Confidence            99999999999999998853321             012358999999999999999999999  779999999999999


Q ss_pred             CCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhh
Q 016588          217 DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQD  295 (386)
Q Consensus       217 ~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~  295 (386)
                      +.++.+||+|||++................+|..|+|||.+.+..++.++||||||+++|||++ |..||.......  .
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~  256 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--K  256 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--H
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--H
Confidence            9999999999999987754332222334456778999999999999999999999999999999 999998755321  1


Q ss_pred             HHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhc
Q 016588          296 LVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  362 (386)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~  362 (386)
                      ......             .......+...++++.+++.+||+.||.+|||+.+++++|++++.+..
T Consensus       257 ~~~~~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  310 (313)
T 1t46_A          257 FYKMIK-------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST  310 (313)
T ss_dssp             HHHHHH-------------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             HHHHhc-------------cCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence            111111             111122233445678999999999999999999999999999997743

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=6.2e-46  Score=341.75  Aligned_cols=261  Identities=21%  Similarity=0.356  Sum_probs=204.0

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCChhHHHHHHHHHHc--CCCCcccccccceee----CCeEEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLAS--IQHRNLVTLLGYCQE----NNLQFLIY  155 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~----~~~~~lv~  155 (386)
                      .++|+..+.||+|+||+||+|.. +++.||||+........+..|.+++..  ++||||+++++++..    .+..++||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~   85 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT   85 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEeh
Confidence            45788999999999999999998 588999999877777777788888776  799999999998654    35689999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCCceecCCCCCCeeeCCCCceEEccc
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH--------SLSPRVVHKDFKTANVLVDEDFIAKVADA  227 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~ivH~dlkp~Nill~~~~~~kl~DF  227 (386)
                      ||+++|+|.+++.      ...+++..+..++.|++.||.|||        +  ++|+||||||+|||++.++.+||+||
T Consensus        86 e~~~~g~L~~~l~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~--~~ivH~Dlkp~Nill~~~~~~kl~Df  157 (301)
T 3q4u_A           86 HYHEMGSLYDYLQ------LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK--PAIAHRDLKSKNILVKKNGQCCIADL  157 (301)
T ss_dssp             CCCTTCBHHHHHT------TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB--CEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             hhccCCCHHHHHh------hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC--CCeecCCCChHhEEEcCCCCEEEeeC
Confidence            9999999999983      346899999999999999999999        6  77999999999999999999999999


Q ss_pred             ccccccCCCCCC--CCCccccCcccccchhhhccc------CCCcccchhhHHHHHHHHHcC----------CCCCCCCC
Q 016588          228 GLRNFLGRTDVA--GPSSQVTADEIFLASEVKEFR------RFSEKSDVYSFGVFLLELVSG----------REASSSLS  289 (386)
Q Consensus       228 gl~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwSlGvil~el~tg----------~~p~~~~~  289 (386)
                      |+++........  .......+|+.|+|||++.+.      .++.++|||||||++|||++|          ..||....
T Consensus       158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence            999765432211  112344789999999999876      445799999999999999999          78887654


Q ss_pred             CCchhhHHHHHHhhhcccchhhhcchhh-cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHh
Q 016588          290 PDSSQDLVELVQNSRDFSNLLKILDERL-WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  357 (386)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~  357 (386)
                      +..... .. .........    ..+.. ....+...++++.+++.+||+.||++|||+.++++.|+++
T Consensus       238 ~~~~~~-~~-~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          238 PNDPSF-ED-MRKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CSSCCH-HH-HHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcch-hh-hhHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            422111 11 110000000    00000 0112334678899999999999999999999999999875

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.4e-46  Score=366.06  Aligned_cols=261  Identities=24%  Similarity=0.434  Sum_probs=213.5

Q ss_pred             HHHHHhcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCC--ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           77 ELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        77 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      .+....++|+..+.||+|+||.||+|..+++..||||.+...  ..+.+.+|+.+++.++||||+++++++. .+..++|
T Consensus       182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv  260 (454)
T 1qcf_A          182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII  260 (454)
T ss_dssp             CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence            334456678888999999999999999988889999986543  4578999999999999999999999987 5678999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      |||+++|+|.+++...   ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++...
T Consensus       261 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          261 TEFMAKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             ECCCTTCBHHHHHHSH---HHHTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             EeecCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            9999999999998532   22357888999999999999999999  779999999999999999999999999998764


Q ss_pred             CCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhc
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  313 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (386)
                      ..... ......+|..|+|||++....++.++|||||||++|||++ |..||.+...   ......+.            
T Consensus       336 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~------------  399 (454)
T 1qcf_A          336 DNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRALE------------  399 (454)
T ss_dssp             CHHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHH------------
T ss_pred             CCcee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH------------
Confidence            32111 1223345778999999999999999999999999999999 9999986542   12222111            


Q ss_pred             chhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                       ...+...+..+++++.+++.+||+.||++|||++++++.|+++...
T Consensus       400 -~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          400 -RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             -HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             -cCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence             1122233445667899999999999999999999999999988754

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=6.6e-46  Score=360.72  Aligned_cols=255  Identities=28%  Similarity=0.413  Sum_probs=210.0

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCC-ChhHHHHHHHHHHcCCCCcccccccceeeCC-eEEEEEEee
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQENN-LQFLIYEYI  158 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~  158 (386)
                      ..++|+..+.||+|+||.||+|..+ ++.||||..+.. ..+.+.+|+.++++++||||+++++++...+ ..|+||||+
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~  269 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM  269 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence            3467888899999999999999985 779999986543 4577999999999999999999999987655 789999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++|+|.+++...   ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.....  
T Consensus       270 ~~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  342 (450)
T 1k9a_A          270 AKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  342 (450)
T ss_dssp             TTCBHHHHHHHH---CTTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             CCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence            999999998532   22347889999999999999999999  77999999999999999999999999999864322  


Q ss_pred             CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhh
Q 016588          239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  317 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (386)
                         .....++..|+|||.+.+..++.++|||||||++|||++ |..||.......   ....+.             ...
T Consensus       343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i~-------------~~~  403 (450)
T 1k9a_A          343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVE-------------KGY  403 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHHHHH-------------TTC
T ss_pred             ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH-------------cCC
Confidence               122356778999999999999999999999999999998 999998765422   222111             112


Q ss_pred             cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhc
Q 016588          318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  362 (386)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~  362 (386)
                      +...+..+++++.++|.+||+.||++|||+.++++.|+.+.....
T Consensus       404 ~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~l  448 (450)
T 1k9a_A          404 KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHEL  448 (450)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred             CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhhc
Confidence            233445566789999999999999999999999999999886643

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.6e-46  Score=369.09  Aligned_cols=259  Identities=25%  Similarity=0.445  Sum_probs=215.3

Q ss_pred             HHhcCCCcCCeecccCceEEEEEEeCC-CcEEEEEECCCC--ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           80 LATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        80 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      ....+|+..+.||+|+||.||+|.++. +..||||.+...  ..+++.+|+.++++++||||+++++++...+..|+|||
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            345678888999999999999999765 889999986543  45789999999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      |+++|+|.+++...   ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       297 ~~~~g~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          297 FMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEK--KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             CCTTCBHHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred             ccCCCCHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence            99999999998532   33568899999999999999999999  77999999999999999999999999999876442


Q ss_pred             CCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      .. .......++..|+|||++.+..++.++|||||||++|||++ |..||......   .....+             ..
T Consensus       372 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~~~-------------~~  434 (495)
T 1opk_A          372 TY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELL-------------EK  434 (495)
T ss_dssp             CE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHH-------------HT
T ss_pred             ce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHH-------------Hc
Confidence            21 12233445678999999999999999999999999999999 99999875532   222221             22


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      ..+...+..+++++.+|+.+||+.||++|||+.++++.|+.+.++
T Consensus       435 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          435 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence            222334445667899999999999999999999999999988754

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.8e-45  Score=336.03  Aligned_cols=263  Identities=17%  Similarity=0.233  Sum_probs=214.3

Q ss_pred             hcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECC-CCChhHHHHHHHHHHcC-CCCcccccccceeeCCeEEEEEEee
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP-GAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      .++|+..+.||+|+||.||+|.. .+++.||+|... ....+.+.+|+.+++.+ +|+|++++++++......++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   88 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   88 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence            45788999999999999999995 568999999854 33456789999999999 7999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc-----eEEccccccccc
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI-----AKVADAGLRNFL  233 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~-----~kl~DFgl~~~~  233 (386)
                       +++|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.     +||+|||++...
T Consensus        89 -~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           89 -GPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             -CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             -CCCHHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence             8999998842    23458999999999999999999998  77999999999999987776     999999999876


Q ss_pred             CCCCCC-----CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccc
Q 016588          234 GRTDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN  308 (386)
Q Consensus       234 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  308 (386)
                      ......     .......+|+.|+|||.+.+..++.++|||||||++|||++|..||..............+........
T Consensus       162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (298)
T 1csn_A          162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  241 (298)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence            543221     123455689999999999999999999999999999999999999998665444333332222111111


Q ss_pred             hhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          309 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      .     +..    ...+++++.+++.+||+.||++|||+.++++.|+++.++
T Consensus       242 ~-----~~~----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~  284 (298)
T 1csn_A          242 L-----REL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  284 (298)
T ss_dssp             H-----HHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             H-----HHH----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence            1     111    112346789999999999999999999999999999876

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.2e-46  Score=344.16  Aligned_cols=264  Identities=20%  Similarity=0.323  Sum_probs=207.2

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC---C---hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---P---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      .++|++.+.||+|+||.||+|... ++..||+|.....   .   .+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            357889999999999999999954 5889999974221   1   24678999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      |||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++....
T Consensus        90 ~e~~~g~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           90 MEYIEGPTLSEYIE-----SHGPLSVDTAINFTNQILDGIKHAHD--MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             EECCCSCBHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             EeCCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            99999999999883     33568999999999999999999999  779999999999999999999999999998764


Q ss_pred             CCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                      .... .......+|+.|+|||.+.+..++.++||||||+++|||++|..||.+....  .........  .        .
T Consensus       163 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~--~~~~~~~~~--~--------~  229 (294)
T 4eqm_A          163 ETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV--SIAIKHIQD--S--------V  229 (294)
T ss_dssp             -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH--HHHHHHHSS--C--------C
T ss_pred             cccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHhhc--c--------C
Confidence            3221 2223456889999999999999999999999999999999999999864421  111111100  0        0


Q ss_pred             hhhcccCCHHHHHHHHHHHhHccCCCCCCCC-CHHHHHHHHHHhhhhhcccc
Q 016588          315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-SMSDVVTELDRTLDKEMNLT  365 (386)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-t~~evl~~L~~~~~~~~~~~  365 (386)
                      +..........++.+.+++.+||+.||++|| +++++.+.|+.++.+.....
T Consensus       230 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~  281 (294)
T 4eqm_A          230 PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANE  281 (294)
T ss_dssp             CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTC
T ss_pred             CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCc
Confidence            1111122233456789999999999999998 99999999999887654443

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=7.4e-46  Score=343.37  Aligned_cols=263  Identities=22%  Similarity=0.365  Sum_probs=201.6

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      .++|+..+.||+|+||+||+|...+++.||+|+.....     ...+.+|+++++.++||||+++++++.+.+..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            36788999999999999999998889999999864322     3468899999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      |+++ +|.+.+..    ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       100 ~~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A          100 FMEK-DLKKVLDE----NKTGLQDSQIKIYLYQLLRGVAHCHQ--HRILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             CCSE-EHHHHHHT----CTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             CCCC-CHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            9985 67666632    34558899999999999999999999  77999999999999999999999999999876432


Q ss_pred             CCCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhh---
Q 016588          237 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI---  312 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  312 (386)
                      .  .......+|+.|+|||++.+ ..++.++|||||||++|||++|..||.+.........................   
T Consensus       173 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  250 (311)
T 3niz_A          173 V--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL  250 (311)
T ss_dssp             C--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred             c--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence            2  22234467889999999876 56899999999999999999999999876654322211111111111100000   


Q ss_pred             ----------cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          313 ----------LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       313 ----------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                                .....+....+..++++.+++.+||+.||++|||++|++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                      00011111112234678999999999999999999999975

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.3e-45  Score=348.10  Aligned_cols=249  Identities=21%  Similarity=0.273  Sum_probs=203.6

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC---------ChhHHHHHHHHHHcCCCCcccccccceeeCCeE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  151 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  151 (386)
                      .++|.+.+.||+|+||.||+|..+ ++..||+|.+...         ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            357888999999999999999965 5889999974322         235789999999999999999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC----ceEEccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF----IAKVADA  227 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~----~~kl~DF  227 (386)
                      |+||||+++|+|.+++.     ....+++..+..++.|++.||.|||+  .||+||||||+|||++.++    .+||+||
T Consensus        91 ~lv~e~~~gg~L~~~l~-----~~~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           91 VLILELVSGGELFDFLA-----QKESLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEECCCSCBHHHHHT-----TCSCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            99999999999999983     34568999999999999999999999  7799999999999998777    7999999


Q ss_pred             ccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhccc
Q 016588          228 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS  307 (386)
Q Consensus       228 gl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  307 (386)
                      |++.......   ......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+...   ......+.....  
T Consensus       164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~---~~~~~~i~~~~~--  235 (361)
T 2yab_A          164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANITAVSY--  235 (361)
T ss_dssp             SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHTTCC--
T ss_pred             CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCC--
Confidence            9998765422   23445689999999999999999999999999999999999999986432   222221111100  


Q ss_pred             chhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          308 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                          ..++..+..    .++++.+++.+||+.||++|||+.|++++
T Consensus       236 ----~~~~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          236 ----DFDEEFFSQ----TSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             ----CCCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ----CCCchhccC----CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                011112222    23568999999999999999999999864

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.5e-45  Score=342.60  Aligned_cols=263  Identities=16%  Similarity=0.199  Sum_probs=212.8

Q ss_pred             hcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCC-CChhHHHHHHHHHHcC-CCCcccccccceeeCCeEEEEEEee
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG-APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      ..+|+..+.||+|+||.||+|.. .+++.||||.... ...+.+.+|+.+++.+ +||||+++++++...+..++||||+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~   87 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL   87 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence            35788899999999999999995 4689999998543 3455789999999999 9999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc-----eEEccccccccc
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI-----AKVADAGLRNFL  233 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~-----~kl~DFgl~~~~  233 (386)
                       +++|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.     +||+|||+++..
T Consensus        88 -~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           88 -GPSLEDLFDL----CDRTFSLKTVLMIAIQLISRMEYVHS--KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             -CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             -CCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence             8999998842    24578999999999999999999999  67999999999999998887     999999999876


Q ss_pred             CCCCCCC-----CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccc
Q 016588          234 GRTDVAG-----PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN  308 (386)
Q Consensus       234 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  308 (386)
                      .......     ......||+.|+|||++.+..++.++|||||||++|||++|..||..............+........
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~  240 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP  240 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence            4422211     12456789999999999999999999999999999999999999998765443333332211111000


Q ss_pred             hhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          309 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                      .     ..+    ....+ ++.+++..||+.||.+||++.++++.|+++.++.
T Consensus       241 ~-----~~~----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          241 I-----EVL----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             H-----HHH----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             H-----HHH----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence            0     000    11123 7899999999999999999999999999988774

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=6.1e-46  Score=347.29  Aligned_cols=246  Identities=23%  Similarity=0.279  Sum_probs=204.5

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECC------CCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      .++|+..+.||+|+||.||+|..+ +++.||+|.+.      ......+.+|..+++.++||||+++++++.+.+..|+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            357888999999999999999965 58999999853      33456788999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      |||+++|+|..++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           84 MEYANGGELFFHLS-----RERVFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EECCTTCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EeCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            99999999988873     34568899999999999999999999  779999999999999999999999999998643


Q ss_pred             CCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                      ..  ........||+.|+|||++.+..++.++|||||||++|||++|..||.....   ......+..            
T Consensus       157 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i~~------------  219 (337)
T 1o6l_A          157 SD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELILM------------  219 (337)
T ss_dssp             CT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH------------
T ss_pred             cC--CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH---HHHHHHHHc------------
Confidence            21  1223456789999999999999999999999999999999999999976432   222211111            


Q ss_pred             hhhcccCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016588          315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  353 (386)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~~  353 (386)
                      ..  ..++...++++.+++.+||+.||++||     +++|+++|
T Consensus       220 ~~--~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          220 EE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             CC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CC--CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            00  122334456789999999999999999     89999876

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=7.7e-46  Score=338.16  Aligned_cols=256  Identities=26%  Similarity=0.434  Sum_probs=197.5

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCC----CcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (386)
                      .++|+..+.||+|+||.||+|....    +..||+|......    .+.+.+|+.+++.++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            4578889999999999999999643    4579999866533    345788999999999999999999985 456789


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      ||||+++++|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++..
T Consensus        93 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           93 IMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             EEECCTTEEHHHHHHH----TTTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEecCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecccccHHHEEECCCCCEEECcccccccc
Confidence            9999999999998842    23468899999999999999999999  77999999999999999999999999999876


Q ss_pred             CCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          234 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       234 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      ..... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......   +....+...         
T Consensus       167 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~~i~~~---------  233 (281)
T 1mp8_A          167 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIENG---------  233 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHHTT---------
T ss_pred             Ccccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHHHHHcC---------
Confidence            54221 12233456778999999999999999999999999999997 89999865432   222222111         


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                          .....+..+++.+.+++.+||+.||++|||+.++++.|++++++.
T Consensus       234 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          234 ----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                111233445577899999999999999999999999999998764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-46  Score=349.89  Aligned_cols=265  Identities=25%  Similarity=0.379  Sum_probs=210.5

Q ss_pred             HHhcCCCcCCeecccCceEEEEEEe------CCCcEEEEEECCCC----ChhHHHHHHHHHHcC-CCCcccccccceeeC
Q 016588           80 LATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGA----PTQEFIDEVCFLASI-QHRNLVTLLGYCQEN  148 (386)
Q Consensus        80 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~----~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  148 (386)
                      ...++|...+.||+|+||.||+|..      .++..||+|.....    ..+.+.+|+.+++.+ +||||+++++++...
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            3457889999999999999999995      23568999986532    345789999999999 899999999999999


Q ss_pred             CeEEEEEEeecCCCccccccCCCcC------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCC
Q 016588          149 NLQFLIYEYIPNGSVSIHLYGPSQV------------------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFK  210 (386)
Q Consensus       149 ~~~~lv~e~~~~g~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlk  210 (386)
                      +..++||||+++|+|.+++......                  ....+++..++.++.|++.||.|||+  +||+|||||
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dik  199 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLA  199 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH--TTEEETTCS
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCC
Confidence            9999999999999999988543210                  11347899999999999999999999  779999999


Q ss_pred             CCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCC
Q 016588          211 TANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS  289 (386)
Q Consensus       211 p~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~  289 (386)
                      |+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999999999987654332222334456778999999999999999999999999999998 999998765


Q ss_pred             CCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          290 PDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                      ...  ........             ......+...++++.+++.+||+.||.+|||+.+++++|+.++...
T Consensus       280 ~~~--~~~~~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          280 VDA--NFYKLIQN-------------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             CSH--HHHHHHHT-------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             cHH--HHHHHHhc-------------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            421  11111111             1112233344577999999999999999999999999999988663

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.7e-46  Score=336.12  Aligned_cols=256  Identities=28%  Similarity=0.425  Sum_probs=211.0

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCC--ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeec
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  159 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  159 (386)
                      .++|+..+.||+|+||.||+|...++..||+|.....  ..+.+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            4578888999999999999999888889999986544  45678999999999999999999999999999999999999


Q ss_pred             CCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016588          160 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  239 (386)
Q Consensus       160 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~  239 (386)
                      +++|.+++..    ....+++..+..++.|++.||.|||+  ++++||||||+||+++.++.+||+|||++........ 
T Consensus        87 ~~~L~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-  159 (267)
T 3t9t_A           87 HGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-  159 (267)
T ss_dssp             TCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred             CCcHHHHHhh----CcccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence            9999998842    23568899999999999999999999  7799999999999999999999999999987643211 


Q ss_pred             CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          240 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       240 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |..||.....   ......+...             ..
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~i~~~-------------~~  223 (267)
T 3t9t_A          160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDISTG-------------FR  223 (267)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTT-------------CC
T ss_pred             cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH---HHHHHHHhcC-------------Cc
Confidence            11223456778999999999999999999999999999999 8999876432   1111111111             11


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      ...+...+..+.+++.+||+.||++|||+.+++++|+++.++
T Consensus       224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          224 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            122223456789999999999999999999999999999865

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.4e-45  Score=340.42  Aligned_cols=258  Identities=20%  Similarity=0.303  Sum_probs=207.9

Q ss_pred             ccCHHHHHHHhcC----------CCcCCeecccCceEEEEEEeC-CCcEEEEEECCC---CChhHHHHHHHHHHcCCCCc
Q 016588           72 RFQMEELSLATKN----------FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG---APTQEFIDEVCFLASIQHRN  137 (386)
Q Consensus        72 ~~~~~~~~~~~~~----------~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~l~~l~h~n  137 (386)
                      .++.+++..+++.          |...+.||+|+||.||+|... +++.||||+...   ...+.+.+|+.+++.++|||
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  103 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN  103 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence            4556666555543          566678999999999999976 689999998532   33566889999999999999


Q ss_pred             ccccccceeeCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC
Q 016588          138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD  217 (386)
Q Consensus       138 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~  217 (386)
                      |+++++++...+..++||||+++++|.+++.      ...+++..+..++.|++.||.|||+  .+|+||||||+|||++
T Consensus       104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~------~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~  175 (321)
T 2c30_A          104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVS------QVRLNEEQIATVCEAVLQALAYLHA--QGVIHRDIKSDSILLT  175 (321)
T ss_dssp             BCCEEEEEEETTEEEEEECCCCSCBHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEC
T ss_pred             cceEEEEEEECCEEEEEEecCCCCCHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEC
Confidence            9999999999999999999999999999873      3458999999999999999999999  7799999999999999


Q ss_pred             CCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHH
Q 016588          218 EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLV  297 (386)
Q Consensus       218 ~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~  297 (386)
                      .++.+||+|||++.......  .......+|+.|+|||++.+..++.++||||||+++|||++|..||.....   ....
T Consensus       176 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~---~~~~  250 (321)
T 2c30_A          176 LDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAM  250 (321)
T ss_dssp             TTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHH
T ss_pred             CCCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHH
Confidence            99999999999988764422  123445789999999999999999999999999999999999999976432   1111


Q ss_pred             HHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          298 ELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ..+....         .+..  ......++++.+++.+||+.||++|||+.+++++
T Consensus       251 ~~~~~~~---------~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          251 KRLRDSP---------PPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             HHHHHSS---------CCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHhcCC---------CCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1111110         0000  1112334668999999999999999999999976

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=9.7e-46  Score=335.43  Aligned_cols=248  Identities=26%  Similarity=0.435  Sum_probs=195.1

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCC-------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      .++|+..+.||+|+||.||+|... ++.||+|.....       ..+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            357888999999999999999975 789999985432       235688999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC---ceecCCCCCCeeeCC--------CCceE
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR---VVHKDFKTANVLVDE--------DFIAK  223 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~---ivH~dlkp~Nill~~--------~~~~k  223 (386)
                      |||+++++|.+++.      ...+++..+..++.|++.||.|||+  ++   |+||||||+|||++.        ++.+|
T Consensus        85 ~e~~~~~~L~~~~~------~~~~~~~~~~~i~~~l~~~l~~lH~--~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k  156 (271)
T 3dtc_A           85 MEFARGGPLNRVLS------GKRIPPDILVNWAVQIARGMNYLHD--EAIVPIIHRDLKSSNILILQKVENGDLSNKILK  156 (271)
T ss_dssp             EECCTTEEHHHHHT------SSCCCHHHHHHHHHHHHHHHHHHHH--SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred             EEcCCCCCHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHh--CCCCceeecCCchHHEEEecccccccccCcceE
Confidence            99999999998873      3468899999999999999999999  66   899999999999986        77899


Q ss_pred             EcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhh
Q 016588          224 VADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS  303 (386)
Q Consensus       224 l~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~  303 (386)
                      |+|||++.......    .....+++.|+|||.+.+..++.++||||||+++|||++|..||......   .....    
T Consensus       157 l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~----  225 (271)
T 3dtc_A          157 ITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL---AVAYG----  225 (271)
T ss_dssp             ECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH---HHHHH----
T ss_pred             EccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHh----
Confidence            99999998654322    22346888999999999999999999999999999999999999864421   11111    


Q ss_pred             hcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHh
Q 016588          304 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  357 (386)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~  357 (386)
                              ..........+..+++.+.+++.+||+.||++|||+.|++++|+++
T Consensus       226 --------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          226 --------VAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             --------HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             --------hhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                    1111111223344557799999999999999999999999999754

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.9e-45  Score=338.41  Aligned_cols=269  Identities=20%  Similarity=0.309  Sum_probs=209.8

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC----CChhHHHHHHHHHHcCCCCcccccccceeeCC--eEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENN--LQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~  155 (386)
                      ++|++.+.||+|+||+||+|... +++.||+|+...    ...+.+.+|+++++.++||||+++++++...+  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            56888999999999999999965 488999998653    33466889999999999999999999987654  789999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee----CCCCceEEccccccc
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRN  231 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill----~~~~~~kl~DFgl~~  231 (386)
                      ||+++++|.+++....  ....+++..+..++.|++.||.|||+  .+|+||||||+|||+    +.++.+||+|||+++
T Consensus        89 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             ECCTTCBHHHHHHSGG--GTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             eCCCCCCHHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            9999999999985431  22348999999999999999999999  779999999999999    888899999999998


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhc--------ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCch-hhHHHHHHh
Q 016588          232 FLGRTDVAGPSSQVTADEIFLASEVKE--------FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS-QDLVELVQN  302 (386)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~-~~~~~~~~~  302 (386)
                      ......   ......+|+.|+|||++.        +..++.++|||||||++|||++|..||........ ......+..
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             ecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            765432   223456889999999986        46789999999999999999999999986554222 122211111


Q ss_pred             hhcccc---hhhhcc------h--hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhh
Q 016588          303 SRDFSN---LLKILD------E--RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  358 (386)
Q Consensus       303 ~~~~~~---~~~~~~------~--~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~  358 (386)
                      ......   ......      +  ..........+..+.+++.+||+.||++|||++|++++..+-.
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            111000   000000      0  0112345677888999999999999999999999999987544

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=4e-46  Score=359.52  Aligned_cols=261  Identities=22%  Similarity=0.272  Sum_probs=208.4

Q ss_pred             CHHHHHHHhcCCCcCCeecccCceEEEEEEeCC-CcEEEEEECCC------CChhHHHHHHHHHHcCCCCccccccccee
Q 016588           74 QMEELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQ  146 (386)
Q Consensus        74 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~  146 (386)
                      ...++....++|+..+.||+|+||+||+|..+. ++.||+|++..      .....+.+|..++..++||||+++++++.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            345556667899999999999999999999764 78999998542      23345889999999999999999999999


Q ss_pred             eCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcc
Q 016588          147 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVAD  226 (386)
Q Consensus       147 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D  226 (386)
                      +.+..|+||||+++|+|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~----~~~~l~e~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~NILl~~~g~vkL~D  218 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSK----FEDRLPEEMARFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILMDMNGHIRLAD  218 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHH----ccCCCCHHHHHHHHHHHHHHHHHHHh--CCeEecccCHHHeeEcCCCCEEEcc
Confidence            99999999999999999999843    24568999999999999999999999  7799999999999999999999999


Q ss_pred             cccccccCCCCCCCCCccccCcccccchhhhc-----ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHH
Q 016588          227 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ  301 (386)
Q Consensus       227 Fgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~  301 (386)
                      ||+++....... .......||+.|+|||++.     ...|+.++|||||||++|||++|+.||.+...   ......+.
T Consensus       219 FGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~---~~~~~~i~  294 (437)
T 4aw2_A          219 FGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL---VETYGKIM  294 (437)
T ss_dssp             CTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHH
T ss_pred             hhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh---hHHHHhhh
Confidence            999976643221 1223457899999999987     45689999999999999999999999986442   11121111


Q ss_pred             hhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCC--CCCHHHHHHH
Q 016588          302 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSER--RPSMSDVVTE  353 (386)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~evl~~  353 (386)
                      ....     ...    .+......++++.+++.+||+.+|++  ||+++|+++|
T Consensus       295 ~~~~-----~~~----~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          295 NHKE-----RFQ----FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             THHH-----HCC----CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             hccc-----ccc----CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            1000     000    01111224567899999999998888  9999999976

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=339.20  Aligned_cols=247  Identities=24%  Similarity=0.318  Sum_probs=195.4

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC-----------------------------hhHHHHHHHHHH
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----------------------------TQEFIDEVCFLA  131 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------------------------~~~~~~e~~~l~  131 (386)
                      .++|+..+.||+|+||.||+|... +++.||+|......                             .+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            357889999999999999999964 58899999753321                             256889999999


Q ss_pred             cCCCCcccccccceee--CCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCC
Q 016588          132 SIQHRNLVTLLGYCQE--NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDF  209 (386)
Q Consensus       132 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dl  209 (386)
                      .++||||+++++++.+  .+..++||||+++++|.+++      ....+++..+..++.|++.||.|||+  ++|+||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dl  163 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP------TLKPLSEDQARFYFQDLIKGIEYLHY--QKIIHRDI  163 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS------CSSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh------hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCC
Confidence            9999999999999986  56889999999999998765      23568999999999999999999999  77999999


Q ss_pred             CCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccC---CCcccchhhHHHHHHHHHcCCCCCC
Q 016588          210 KTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR---FSEKSDVYSFGVFLLELVSGREASS  286 (386)
Q Consensus       210 kp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwSlGvil~el~tg~~p~~  286 (386)
                      ||+|||++.++.+||+|||++........  ......+|+.|+|||.+.+..   ++.++|||||||++|||++|..||.
T Consensus       164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  241 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM  241 (298)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            99999999999999999999987644221  123456889999999987655   3778999999999999999999997


Q ss_pred             CCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          287 SLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ....   ......+...            ..........++++.+++.+||+.||++|||+.|++++
T Consensus       242 ~~~~---~~~~~~~~~~------------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          242 DERI---MCLHSKIKSQ------------ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             CSSH---HHHHHHHHHC------------CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             CccH---HHHHHHHhcc------------cCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            6432   1111111110            00001112334678999999999999999999999865

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=5.4e-46  Score=361.56  Aligned_cols=258  Identities=26%  Similarity=0.446  Sum_probs=207.1

Q ss_pred             HHhcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCC--ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           80 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        80 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      ...++|+..+.||+|+||.||+|..+++..||||.....  ..+++.+|+.++++++||||+++++++.+ +..++||||
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            345678888999999999999999988888999987643  45679999999999999999999999876 668999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +++|+|.+++...   ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++......
T Consensus       260 ~~~gsL~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  334 (452)
T 1fmk_A          260 MSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  334 (452)
T ss_dssp             CTTCBHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             hcCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence            9999999998421   23458899999999999999999999  779999999999999999999999999998765322


Q ss_pred             CCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchh
Q 016588          238 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  316 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (386)
                      . .......+|..|+|||.+.+..++.++|||||||++|||++ |..||.+...   ......+.             ..
T Consensus       335 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~-------------~~  397 (452)
T 1fmk_A          335 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVE-------------RG  397 (452)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHH-------------TT
T ss_pred             e-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH-------------cC
Confidence            1 12233446778999999999999999999999999999999 9999986542   11221111             11


Q ss_pred             hcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          317 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      .+...+..+++.+.+++.+||+.||++|||++++++.|+++...
T Consensus       398 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          398 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence            22233445667899999999999999999999999999988754

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.7e-45  Score=344.22  Aligned_cols=263  Identities=25%  Similarity=0.442  Sum_probs=212.0

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeC--------CCcEEEEEECCCCC----hhHHHHHHHHHHcC-CCCcccccccceee
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQ--------DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQE  147 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~~~~~~~~  147 (386)
                      ..++|+..+.||+|+||.||+|...        ++..||+|......    .+.+.+|+.+++.+ +||||+++++++..
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3468889999999999999999863        46789999976543    24578899999999 89999999999999


Q ss_pred             CCeEEEEEEeecCCCccccccCCCcC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee
Q 016588          148 NNLQFLIYEYIPNGSVSIHLYGPSQV-----------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV  216 (386)
Q Consensus       148 ~~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill  216 (386)
                      .+..++||||+++++|.+++......           ....+++..++.++.|++.||.|||+  ++|+||||||+|||+
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLV  190 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCccceEEE
Confidence            99999999999999999998643211           12358899999999999999999999  779999999999999


Q ss_pred             CCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhh
Q 016588          217 DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQD  295 (386)
Q Consensus       217 ~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~  295 (386)
                      +.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|||++ |..||.....   ..
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~  267 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EE  267 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HH
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH---HH
Confidence            9999999999999987654333233344556788999999998889999999999999999999 9999876442   22


Q ss_pred             HHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          296 LVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                      ....+...             .....+..++.++.+++.+||+.||.+|||+.++++.|++++...
T Consensus       268 ~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~  320 (334)
T 2pvf_A          268 LFKLLKEG-------------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  320 (334)
T ss_dssp             HHHHHHHT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHhcC-------------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            22221111             112233344567899999999999999999999999999998764

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.2e-45  Score=348.71  Aligned_cols=246  Identities=23%  Similarity=0.351  Sum_probs=203.8

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECC------CCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ++|++.+.||+|+||.||++... +++.||+|.+.      ......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            57888999999999999999965 48899999753      334567889999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+.+|+|..++.     ....+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+++....
T Consensus        95 e~~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           95 DLLLGGDLRYHLQ-----QNVHFKEETVKLFICELVMALDYLQN--QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             CCCTTEEHHHHHH-----TTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             ecCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            9999999998884     34568999999999999999999999  7799999999999999999999999999987643


Q ss_pred             CCCCCCCccccCcccccchhhhcc---cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEF---RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      .   .......||+.|+|||++..   ..|+.++|||||||++|||++|..||..................         
T Consensus       168 ~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~---------  235 (384)
T 4fr4_A          168 E---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT---------  235 (384)
T ss_dssp             T---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC---------
T ss_pred             C---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc---------
Confidence            2   22345678999999999864   45899999999999999999999999875544333322221110         


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCC-HHHHHH
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-MSDVVT  352 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-~~evl~  352 (386)
                           ...++...+.++.+++.+||+.||++||+ ++++++
T Consensus       236 -----~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          236 -----VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             -----ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                 11233445577999999999999999998 677664

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=343.92  Aligned_cols=258  Identities=24%  Similarity=0.412  Sum_probs=202.3

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCc----EEEEEECC----CCChhHHHHHHHHHHcCCCCcccccccceeeCCeEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGM----LVAIKKRP----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  152 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  152 (386)
                      ..+|+..+.||+|+||.||+|... +++    +|++|...    ....+.+.+|+.+++.++||||+++++++...+ .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            467889999999999999999954 343    46777643    234567899999999999999999999998765 77


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~  232 (386)
                      +|+||+.+|+|.+++..    ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~v~~~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~  166 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEECCCSSCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred             EEEEecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhh--CCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence            89999999999998843    24568899999999999999999999  7799999999999999999999999999987


Q ss_pred             cCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhh
Q 016588          233 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK  311 (386)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (386)
                      ..............+|..|+|||.+.+..++.++|||||||++|||++ |..||.......   ....+.          
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~~~----------  233 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILE----------  233 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHH----------
T ss_pred             ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHHHH----------
Confidence            755443333445566778999999999999999999999999999999 999998755322   222111          


Q ss_pred             hcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhc
Q 016588          312 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  362 (386)
Q Consensus       312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~  362 (386)
                         .......+..++.++.+++.+||+.||.+|||+.|+++.|+++.+...
T Consensus       234 ---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  281 (327)
T 3lzb_A          234 ---KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQ  281 (327)
T ss_dssp             ---TTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHH
T ss_pred             ---cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcC
Confidence               111222334455679999999999999999999999999999987643

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.2e-45  Score=338.08  Aligned_cols=260  Identities=24%  Similarity=0.342  Sum_probs=199.2

Q ss_pred             cCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      ++|+..+.||+|+||+||+|...+++.||+|+.....     .+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            4688899999999999999998779999999864332     35688999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +++ +|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             CSE-EHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             cCC-CHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence            975 88777742    23568899999999999999999999  779999999999999999999999999998764321


Q ss_pred             CCCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc-----ccchhh
Q 016588          238 VAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD-----FSNLLK  311 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~~  311 (386)
                        .......+|+.|+|||++.+. .++.++|||||||++|||++|..||.+...  ...+.........     +.....
T Consensus       155 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T 1ob3_A          155 --RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE--ADQLMRIFRILGTPNSKNWPNVTE  230 (288)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             --cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHHCCCChhhchhhhc
Confidence              122334678899999998764 589999999999999999999999986542  1111111111100     000000


Q ss_pred             --hcc-------hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          312 --ILD-------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       312 --~~~-------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                        ..+       +..+.......++++.+++.+||+.||++|||++|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence              001       111112223345678999999999999999999999875

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=9.4e-46  Score=337.06  Aligned_cols=257  Identities=26%  Similarity=0.459  Sum_probs=209.8

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCC--ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      ..++|+..+.||+|+||.||+|..+++..||+|.....  ..+.+.+|+++++.++||||+++++++.. +..++||||+
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~   89 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence            44678889999999999999999888889999986543  45678999999999999999999999874 4578999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++++|.+++...   ....+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++........
T Consensus        90 ~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T 1qpc_A           90 ENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (279)
T ss_dssp             TTCBHHHHTTSH---HHHTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             CCCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence            999999998432   12368899999999999999999999  7799999999999999999999999999987654322


Q ss_pred             CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhh
Q 016588          239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  317 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (386)
                      . ......++..|+|||.+.+..++.++||||||+++|||++ |..||.....   ......+...             .
T Consensus       165 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~-------------~  227 (279)
T 1qpc_A          165 T-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PEVIQNLERG-------------Y  227 (279)
T ss_dssp             E-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTT-------------C
T ss_pred             c-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH---HHHHHHHhcc-------------c
Confidence            1 1233445678999999998889999999999999999999 8999876442   1222211111             1


Q ss_pred             cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      ....+...++++.+++.+||+.||++|||+.++++.|+++...
T Consensus       228 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence            1122334456799999999999999999999999999998865

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.1e-45  Score=339.67  Aligned_cols=265  Identities=24%  Similarity=0.369  Sum_probs=207.0

Q ss_pred             HHHhcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCChhHHHHHHHHHHcC--CCCcccccccceeeC----CeEE
Q 016588           79 SLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI--QHRNLVTLLGYCQEN----NLQF  152 (386)
Q Consensus        79 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~----~~~~  152 (386)
                      ....++|++.+.||+|+||.||+|... ++.||+|+........+..|.+++...  +||||+++++++...    +..+
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  111 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY  111 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence            334568999999999999999999985 889999997666666677777777665  899999999999877    7899


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCceecCCCCCCeeeCCCCceEEcc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL------SPRVVHKDFKTANVLVDEDFIAKVAD  226 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------~~~ivH~dlkp~Nill~~~~~~kl~D  226 (386)
                      +||||+++|+|.+++.      ...+++..+..++.|++.||.|||+.      .++|+||||||+|||++.++.+||+|
T Consensus       112 lv~e~~~~g~L~~~l~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D  185 (337)
T 3mdy_A          112 LITDYHENGSLYDYLK------STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD  185 (337)
T ss_dssp             EEECCCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             EEEeccCCCcHHHHhh------ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence            9999999999999983      23588999999999999999999983      12899999999999999999999999


Q ss_pred             cccccccCCCCCC--CCCccccCcccccchhhhcccCCCcc------cchhhHHHHHHHHHcC----------CCCCCCC
Q 016588          227 AGLRNFLGRTDVA--GPSSQVTADEIFLASEVKEFRRFSEK------SDVYSFGVFLLELVSG----------REASSSL  288 (386)
Q Consensus       227 Fgl~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~------~DvwSlGvil~el~tg----------~~p~~~~  288 (386)
                      ||++.........  .......+|+.|+|||++.+..++..      +|||||||++|||++|          ..||...
T Consensus       186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~  265 (337)
T 3mdy_A          186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL  265 (337)
T ss_dssp             CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence            9999766432221  11234578999999999987766665      9999999999999999          6666654


Q ss_pred             CCCchhhHHHHHHhhhcccchhhhcchhhcccC-----CHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          289 SPDSSQDLVELVQNSRDFSNLLKILDERLWSTF-----TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      .+.....  ........        ........     ...+++++.+++.+||+.||++|||+.+++++|+.+.++
T Consensus       266 ~~~~~~~--~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  332 (337)
T 3mdy_A          266 VPSDPSY--EDMREIVC--------IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES  332 (337)
T ss_dssp             SCSSCCH--HHHHHHHT--------TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cCCCCch--hhhHHHHh--------hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence            4322110  10111000        01111111     236778899999999999999999999999999999876

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=343.57  Aligned_cols=248  Identities=21%  Similarity=0.287  Sum_probs=202.0

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC---------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  152 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  152 (386)
                      ++|...+.||+|+||.||+|... ++..||+|.....         ..+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            46888899999999999999965 5889999974322         2467899999999999999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC----ceEEcccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF----IAKVADAG  228 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~----~~kl~DFg  228 (386)
                      +||||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++    .+||+|||
T Consensus        91 lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           91 LILELVAGGELFDFLA-----EKESLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEECCCSCBHHHHHT-----TSSCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEcCCCCCHHHHHH-----hcCCcCHHHHHHHHHHHHHHHHHHHH--CCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            9999999999999984     34568899999999999999999999  7799999999999999887    89999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccc
Q 016588          229 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN  308 (386)
Q Consensus       229 l~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  308 (386)
                      ++.......   ......+|+.|+|||++.+..++.++|||||||++|||++|..||.....   ......+.....   
T Consensus       164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~~~~~~~---  234 (326)
T 2y0a_A          164 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANVSAVNY---  234 (326)
T ss_dssp             TCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHHTCC---
T ss_pred             CCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH---HHHHHHHHhcCC---
Confidence            998764322   22345689999999999999999999999999999999999999976432   111111111100   


Q ss_pred             hhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          309 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                         ......+.    ..+..+.+++.+||+.||++|||+.|++++
T Consensus       235 ---~~~~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          235 ---EFEDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             ---CCCHHHHT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ---CcCccccc----cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence               00111111    223568999999999999999999999985

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.4e-46  Score=344.12  Aligned_cols=251  Identities=20%  Similarity=0.241  Sum_probs=204.2

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC--hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP--TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      .++|++.+.||+|+||.||+|... ++..+|+|......  ...+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   83 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence            357888999999999999999965 58899999865443  345789999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC--CCceEEcccccccccCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE--DFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~--~~~~kl~DFgl~~~~~~~  236 (386)
                      ++++|.+++..    ....+++..+..++.|++.||.|||+  +||+||||||+|||++.  ++.+||+|||++......
T Consensus        84 ~g~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~--~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           84 SGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            99999998842    23468999999999999999999999  77999999999999987  789999999999876432


Q ss_pred             CCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchh
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  316 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (386)
                      .   ......+|+.|+|||++.+..++.++|||||||++|||++|..||.....   ......+......      ....
T Consensus       158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~------~~~~  225 (321)
T 1tki_A          158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQIIENIMNAEYT------FDEE  225 (321)
T ss_dssp             C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHTCCC------CCHH
T ss_pred             C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH---HHHHHHHHcCCCC------CChh
Confidence            2   22345688899999999988889999999999999999999999986442   2222222111100      0111


Q ss_pred             hcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          317 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                      .+.    ..+.++.+++.+||+.||++|||+.|++++-
T Consensus       226 ~~~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp  259 (321)
T 1tki_A          226 AFK----EISIEAMDFVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             HHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             hhc----cCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence            111    2245689999999999999999999999864

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.6e-45  Score=336.95  Aligned_cols=259  Identities=25%  Similarity=0.444  Sum_probs=214.2

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeCC-CcEEEEEECCCCC--hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAP--TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      ..++|+..+.||+|+||.||+|.... +..||+|......  .+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   90 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   90 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence            45678889999999999999999764 8899999865443  45788999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +++++|.+++...   ....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++.......
T Consensus        91 ~~~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           91 MTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             CTTEEHHHHHHHC---CTTTSCHHHHHHHHHHHHHHHHHHHH--HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             CCCCcHHHHHHhc---ccCCccHhHHHHHHHHHHHHHHHHHH--CCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            9999999988432   34568999999999999999999999  679999999999999999999999999998765422


Q ss_pred             CCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchh
Q 016588          238 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  316 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (386)
                      . .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......   .......             ..
T Consensus       166 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~~~~~~~-------------~~  228 (288)
T 3kfa_A          166 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELLE-------------KD  228 (288)
T ss_dssp             S-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHHH-------------TT
T ss_pred             c-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHh-------------cc
Confidence            1 12223445678999999999999999999999999999999 99998875532   1222111             11


Q ss_pred             hcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          317 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                      .....+..+++++.+++.+||+.||++|||+.++++.|+.+..+.
T Consensus       229 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~  273 (288)
T 3kfa_A          229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  273 (288)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence            122333445577999999999999999999999999999988764

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=346.78  Aligned_cols=250  Identities=20%  Similarity=0.303  Sum_probs=196.6

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCC-----hhHHHHHHHHHHcCCC--CcccccccceeeCCeEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQH--RNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv  154 (386)
                      .++|++.+.||+|+||.||++...+++.||+|++....     .+.+.+|+.+++.++|  |||+++++++...+..|+|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            45788899999999999999998889999999854322     2467899999999976  9999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      || +.+++|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++ ++.+||+|||+++...
T Consensus        88 ~e-~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~al~~lH~--~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           88 ME-CGNIDLNSWLK-----KKKSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             EC-CCSEEHHHHHH-----HSCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred             Ee-CCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence            99 56789998884     34568899999999999999999999  7799999999999997 6789999999998775


Q ss_pred             CCCCCCCCccccCcccccchhhhcc-----------cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhh
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEF-----------RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS  303 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~  303 (386)
                      ............+|+.|+|||++.+           ..++.++|||||||++|||++|..||...... ..         
T Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~---------  228 (343)
T 3dbq_A          159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-IS---------  228 (343)
T ss_dssp             -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-HH---------
T ss_pred             cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-HH---------
Confidence            4333333345678999999999875           67899999999999999999999999764321 11         


Q ss_pred             hcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          304 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                          ......++......+...+.++.+++.+||+.||.+|||+.|++++.
T Consensus       229 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          229 ----KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             ----HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             ----HHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence                11112222222233333446789999999999999999999999874

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.2e-45  Score=342.23  Aligned_cols=272  Identities=24%  Similarity=0.377  Sum_probs=214.6

Q ss_pred             cCHHHHHHHhcCCCcCCeecccCceEEEEEEe------CCCcEEEEEECCCCCh----hHHHHHHHHHHcC-CCCccccc
Q 016588           73 FQMEELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAPT----QEFIDEVCFLASI-QHRNLVTL  141 (386)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~----~~~~~e~~~l~~l-~h~niv~~  141 (386)
                      +....+....++|++.+.||+|+||.||+|..      .+++.||+|.......    ..+.+|+.++..+ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            34455555678899999999999999999984      2467899998665432    3578899999999 79999999


Q ss_pred             ccceeeCC-eEEEEEEeecCCCccccccCCCcC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCC
Q 016588          142 LGYCQENN-LQFLIYEYIPNGSVSIHLYGPSQV-----------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDF  209 (386)
Q Consensus       142 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dl  209 (386)
                      ++++...+ ..++||||+++++|.+++......           ....+++..+..++.|++.||.|||+  ++|+||||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~di  174 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDL  174 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH--TTCCCSCC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh--CCcccccC
Confidence            99987654 589999999999999988543211           02237899999999999999999999  77999999


Q ss_pred             CCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCC
Q 016588          210 KTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL  288 (386)
Q Consensus       210 kp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~  288 (386)
                      ||+||+++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999999999987644322222334456778999999999999999999999999999998 99999875


Q ss_pred             CCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          289 SPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                      ....  .........             .....+...++++.+++.+||+.||.+|||+.+++++|+++++..
T Consensus       255 ~~~~--~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          255 KIDE--EFCRRLKEG-------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             CCSH--HHHHHHHHT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             chhH--HHHHHhccC-------------ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            5321  111111111             111223334567899999999999999999999999999998764

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=8.9e-46  Score=348.36  Aligned_cols=247  Identities=20%  Similarity=0.294  Sum_probs=199.5

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC------CChhHHHHHHHHHHcC-CCCcccccccceeeCCeEE
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQF  152 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  152 (386)
                      ..++|+..+.||+|+||.||+|..+ +++.||+|++..      .....+..|..++..+ +||||+++++++.+.+..|
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            4578999999999999999999965 588999998543      2345678899999988 7999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~  232 (386)
                      +||||+++|+|..++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus       101 lv~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NILl~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQ-----KSRRFDEARARFYAAEIISALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE  173 (353)
T ss_dssp             EEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCCcccCCCHHHEEECCCCCEEEccccceee
Confidence            9999999999998883     34568999999999999999999999  7799999999999999999999999999985


Q ss_pred             cCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          233 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      ....  ........||+.|+|||++.+..|+.++|||||||++|||++|..||.....   ......+..          
T Consensus       174 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~~i~~----------  238 (353)
T 3txo_A          174 GICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE---DDLFEAILN----------  238 (353)
T ss_dssp             SCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH----------
T ss_pred             cccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH---HHHHHHHHc----------
Confidence            4321  1223455789999999999999999999999999999999999999986442   222221111          


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCH------HHHHHH
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM------SDVVTE  353 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~------~evl~~  353 (386)
                        ..  ..++...++++.+++.+||+.||++||++      +++++|
T Consensus       239 --~~--~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          239 --DE--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             --CC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             --CC--CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence              11  12233345678999999999999999998      777764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=6.1e-45  Score=346.91  Aligned_cols=254  Identities=19%  Similarity=0.273  Sum_probs=201.1

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC------CChhHHHHHHHHHHcC-CCCcccccccceeeCCeEE
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQF  152 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  152 (386)
                      ..++|+..+.||+|+||.||+|..+ +++.||+|++..      ...+.+..|..++..+ +||||+++++++.+.+..|
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            3467899999999999999999965 478999997542      2234578899999887 8999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~  232 (386)
                      +||||+++|+|..++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus       130 lV~E~~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~LH~--~givHrDLKp~NILl~~~g~ikL~DFGla~~  202 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQ-----RQRKLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  202 (396)
T ss_dssp             EEEECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEcCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence            9999999999988883     34568999999999999999999999  7799999999999999999999999999986


Q ss_pred             cCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchh--hHHHHHHhhhcccchh
Q 016588          233 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ--DLVELVQNSRDFSNLL  310 (386)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~  310 (386)
                      ....  ........||+.|+|||++.+..|+.++|||||||++|||++|..||.........  ...+...        .
T Consensus       203 ~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~--------~  272 (396)
T 4dc2_A          203 GLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF--------Q  272 (396)
T ss_dssp             CCCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHH--------H
T ss_pred             cccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHH--------H
Confidence            3221  22344567899999999999999999999999999999999999999754321110  0000000        0


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCH------HHHHHH
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM------SDVVTE  353 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~------~evl~~  353 (386)
                      .+...  ...++...+.++.+++.+||+.||++||++      +|+++|
T Consensus       273 ~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          273 VILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             HHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             HHhcc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence            01111  112344456778999999999999999996      566554

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.2e-45  Score=335.92  Aligned_cols=260  Identities=20%  Similarity=0.268  Sum_probs=198.3

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      ++|+..+.||+|+||+||+|... +++.||+|+....     ....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            47888999999999999999965 5889999985322     23568899999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      |++++ +...+.    .....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++......
T Consensus        82 ~~~~~-l~~~~~----~~~~~l~~~~~~~~~~ql~~~l~~lH~--~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           82 FCDQD-LKKYFD----SCNGDLDPEIVKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSEE-HHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred             cCCCC-HHHHHH----hCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence            99864 444432    234568999999999999999999999  77999999999999999999999999999876432


Q ss_pred             CCCCCCccccCcccccchhhhcccC-CCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHh-hhc-----ccch
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN-SRD-----FSNL  309 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~-----~~~~  309 (386)
                      .  .......+|+.|+|||++.+.. ++.++|||||||++|||++|..|+.....  .......+.. ...     +...
T Consensus       155 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~--~~~~~~~i~~~~~~~~~~~~~~~  230 (292)
T 3o0g_A          155 V--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSM  230 (292)
T ss_dssp             C--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTG
T ss_pred             c--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHHhCCCChhhhhhh
Confidence            2  2234456788999999997765 79999999999999999999888654332  1122221111 100     0000


Q ss_pred             hhhcch---------hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          310 LKILDE---------RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       310 ~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ....+.         ..........++++.+++.+||+.||++|||++|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            000000         00111222345678999999999999999999999875

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-45  Score=340.58  Aligned_cols=243  Identities=22%  Similarity=0.318  Sum_probs=203.3

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC------CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      .++|+..+.||+|+||.||+|... +++.||+|....      ...+.+.+|..+++.++||||+++++++.+.+..|+|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            357888999999999999999965 589999998542      3456678899999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      |||+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++...
T Consensus        85 ~e~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~  157 (318)
T 1fot_A           85 MDYIEGGELFSLLR-----KSQRFPNPVAKFYAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP  157 (318)
T ss_dssp             ECCCCSCBHHHHHH-----HTSSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             EeCCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence            99999999999884     34568899999999999999999998  779999999999999999999999999998754


Q ss_pred             CCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                      ..     .....||+.|+|||++.+..++.++|||||||++|||++|..||.....   ......+..            
T Consensus       158 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i~~------------  217 (318)
T 1fot_A          158 DV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---MKTYEKILN------------  217 (318)
T ss_dssp             SC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHH------------
T ss_pred             Cc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHh------------
Confidence            32     2345789999999999999999999999999999999999999976432   111111111            


Q ss_pred             hhhcccCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016588          315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  353 (386)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~~  353 (386)
                      ..  ..++...++++.+++.+||+.||++||     +++++++|
T Consensus       218 ~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          218 AE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             CC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence            11  122334456789999999999999999     89999865

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-45  Score=333.82  Aligned_cols=258  Identities=25%  Similarity=0.386  Sum_probs=208.8

Q ss_pred             cCCCcCC-eecccCceEEEEEEeC---CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           83 KNFSDKN-LIGEGKFGEVYKGLLQ---DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        83 ~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      ++|...+ .||+|+||.||+|...   ++..||+|......    .+.+.+|+++++.++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4455555 8999999999999853   57789999876532    34588999999999999999999999 45568999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      |||+++++|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++....
T Consensus        88 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           88 MEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             EECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEeCCCCCHHHHHHh----CCccCCHHHHHHHHHHHHHHHHHHHH--CCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            999999999998842    34568999999999999999999999  779999999999999999999999999998764


Q ss_pred             CCCC-CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          235 RTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       235 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      .... ........+|+.|+|||.+.+..++.++||||||+++|||++ |..||......   .....+..          
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~i~~----------  228 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIEQ----------  228 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHHHT----------
T ss_pred             cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHhc----------
Confidence            3222 122233456788999999998889999999999999999998 99999875531   12221111          


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhcc
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN  363 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~~  363 (386)
                         ..+...+..+++++.+++.+||+.||++|||+.+++++|+.+..+...
T Consensus       229 ---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  276 (287)
T 1u59_A          229 ---GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  276 (287)
T ss_dssp             ---TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred             ---CCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence               111233445567899999999999999999999999999999977543

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=4.6e-46  Score=347.11  Aligned_cols=283  Identities=27%  Similarity=0.365  Sum_probs=210.7

Q ss_pred             hcCCCcCCeecccCceEEEEEEe-----CCCcEEEEEECCCCCh---hHHHHHHHHHHcCCCCccccccccee--eCCeE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQ--ENNLQ  151 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~  151 (386)
                      .++|+..+.||+|+||.||+|.+     .++..||+|+......   +.+.+|+++++.++||||+++++++.  +.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            45788899999999999999984     3578999998765543   34889999999999999999999886  45678


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      ++||||+++++|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.
T Consensus       102 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQR----HRARLDASRLLLYSSQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             EEEEECCTTCBHHHHHHH----HGGGCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             EEEEeecCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCChhhEEECCCCCEEEcccccce
Confidence            999999999999998842    23458999999999999999999999  779999999999999999999999999998


Q ss_pred             ccCCCCC-CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHH---Hhhhccc
Q 016588          232 FLGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV---QNSRDFS  307 (386)
Q Consensus       232 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~~~  307 (386)
                      ....... ........++..|+|||.+.+..++.++||||||+++|||++|..||......    .....   .......
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~----~~~~~~~~~~~~~~~  251 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE----FLRMMGCERDVPALS  251 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHCC----CCHHH
T ss_pred             ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch----hhhhcccccccccHH
Confidence            7643222 11233445778899999999988999999999999999999999987653211    00000   0000011


Q ss_pred             chhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhcccccccCCCCce
Q 016588          308 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPT  374 (386)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~~~~~~~~~~~~~  374 (386)
                      ..............+..+++++.+++.+||+.||++|||+.+++++|+.+...............|.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~p~  318 (327)
T 3lxl_A          252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPE  318 (327)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----------------
T ss_pred             HHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccccccccCcC
Confidence            1222223333344455667789999999999999999999999999999988765555444433333

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=7.9e-45  Score=332.30  Aligned_cols=250  Identities=26%  Similarity=0.432  Sum_probs=202.1

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCCh----------hHHHHHHHHHHcCCCCcccccccceeeCCe
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT----------QEFIDEVCFLASIQHRNLVTLLGYCQENNL  150 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  150 (386)
                      .++|+..+.||+|+||.||+|... +++.||+|.......          +.+.+|+.+++.++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            367888999999999999999964 688999998643221          56889999999999999999999987765 


Q ss_pred             EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--ceecCCCCCCeeeCCCCc-----eE
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR--VVHKDFKTANVLVDEDFI-----AK  223 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~--ivH~dlkp~Nill~~~~~-----~k  223 (386)
                       ++||||+++++|.+++..    ....+++..+..++.|++.||.|||+  .+  |+||||||+|||++.++.     +|
T Consensus        97 -~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~~ivH~dikp~Nil~~~~~~~~~~~~k  169 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLD----KAHPIKWSVKLRLMLDIALGIEYMQN--QNPPIVHRDLRSPNIFLQSLDENAPVCAK  169 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHT--SSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred             -eEEEEecCCCCHHHHHhc----ccCCccHHHHHHHHHHHHHHHHHHHh--CCCCeecCCCCcceEEEeccCCCCceeEE
Confidence             699999999999887743    34568999999999999999999999  66  999999999999988776     99


Q ss_pred             EcccccccccCCCCCCCCCccccCcccccchhhhc--ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHH
Q 016588          224 VADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE--FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ  301 (386)
Q Consensus       224 l~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~  301 (386)
                      |+|||+++....     ......+++.|+|||.+.  ...++.++|||||||++|||++|..||.......... .....
T Consensus       170 l~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~  243 (287)
T 4f0f_A          170 VADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF-INMIR  243 (287)
T ss_dssp             ECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH-HHHHH
T ss_pred             eCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH-HHHHh
Confidence            999999875433     233456888999999983  4567899999999999999999999998765432211 11111


Q ss_pred             hhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHh
Q 016588          302 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  357 (386)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~  357 (386)
                                  ........+..+++++.+++.+||+.||++|||++++++.|+++
T Consensus       244 ------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          244 ------------EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             ------------HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             ------------ccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                        11112233445567799999999999999999999999999764

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.2e-45  Score=346.01  Aligned_cols=249  Identities=20%  Similarity=0.284  Sum_probs=202.3

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      .++|+..+.||+|+||.||+|..+ ++..||+|.+....     .+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            457899999999999999999965 58899999864332     245788999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC---CceEEcccccccc
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED---FIAKVADAGLRNF  232 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~---~~~kl~DFgl~~~  232 (386)
                      ||+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.+   +.+||+|||++..
T Consensus       108 e~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          108 DLVTGGELFEDIV-----AREFYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             CCCCSCBHHHHHT-----TCSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             ecCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            9999999988884     34568899999999999999999999  779999999999999865   4599999999987


Q ss_pred             cCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          233 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      .....   ......+|+.|+|||++.+..|+.++|||||||++|||++|..||.....   ......+......      
T Consensus       181 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~~~~~~i~~~~~~------  248 (362)
T 2bdw_A          181 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYAQIKAGAYD------  248 (362)
T ss_dssp             CTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCCC------
T ss_pred             ecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhCCCC------
Confidence            65322   22345789999999999998999999999999999999999999976432   2222222111100      


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .....+    ...++++.+++.+||+.||++|||+.+++++
T Consensus       249 ~~~~~~----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          249 YPSPEW----DTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             CCTTGG----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CCcccc----cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            001111    1234668999999999999999999999876

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=7.9e-45  Score=336.53  Aligned_cols=267  Identities=22%  Similarity=0.393  Sum_probs=201.6

Q ss_pred             HHHHHHhcCCCcCCeecccCceEEEEEEeC----CCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCccccccccee
Q 016588           76 EELSLATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQ  146 (386)
Q Consensus        76 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~  146 (386)
                      ++.....++|...+.||+|+||.||+|...    ++..||+|......     .+.+.+|+.+++.++||||+++++++.
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  106 (313)
T 3brb_A           27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI  106 (313)
T ss_dssp             TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence            334445678889999999999999999854    24589999865332     245889999999999999999999987


Q ss_pred             eCC-----eEEEEEEeecCCCccccccCCCc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC
Q 016588          147 ENN-----LQFLIYEYIPNGSVSIHLYGPSQ-VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF  220 (386)
Q Consensus       147 ~~~-----~~~lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~  220 (386)
                      ..+     ..++||||+++++|.+++..... .....+++..++.++.|++.||.|||+  ++|+||||||+||+++.++
T Consensus       107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dikp~NIli~~~~  184 (313)
T 3brb_A          107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN--RNFLHRDLAARNCMLRDDM  184 (313)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT--TTCCCCCCSGGGEEECTTS
T ss_pred             eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCC
Confidence            654     34999999999999988743211 234568999999999999999999999  7799999999999999999


Q ss_pred             ceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHH
Q 016588          221 IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVEL  299 (386)
Q Consensus       221 ~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~  299 (386)
                      .+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||......   .....
T Consensus       185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~  261 (313)
T 3brb_A          185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMYDY  261 (313)
T ss_dssp             CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHH
T ss_pred             cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHHH
Confidence            999999999987654333333344556778999999999999999999999999999999 88888765432   12221


Q ss_pred             HHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          300 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      ....             .....+..+++++.+++.+||+.||++|||+.+++++|++++++
T Consensus       262 ~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~  309 (313)
T 3brb_A          262 LLHG-------------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES  309 (313)
T ss_dssp             HHTT-------------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHcC-------------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            1111             11122334456799999999999999999999999999999875

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.3e-45  Score=342.79  Aligned_cols=272  Identities=24%  Similarity=0.376  Sum_probs=210.8

Q ss_pred             CCCcCCeecccCceEEEEEEeC-----CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceee--CCeEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-----DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQF  152 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~  152 (386)
                      .|+..+.||+|+||+||++.++     +++.||+|+.....    .+.+.+|+++++.++||||+++++++.+  ....+
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  111 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ  111 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence            3488899999999999998743     57899999876543    3458899999999999999999999987  46789


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~  232 (386)
                      +||||+++++|.+++.      ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++..
T Consensus       112 lv~e~~~~~~L~~~l~------~~~~~~~~~~~i~~~l~~~l~~LH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          112 LVMEYVPLGSLRDYLP------RHSIGLAQLLLFAQQICEGMAYLHA--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             EEECCCTTCBHHHHGG------GSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEecccCCcHHHHHh------hCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCchheEEEcCCCCEEECCcccccc
Confidence            9999999999999983      2348899999999999999999999  7799999999999999999999999999987


Q ss_pred             cCCCCC-CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhh
Q 016588          233 LGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK  311 (386)
Q Consensus       233 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (386)
                      ...... ........+|..|+|||.+.+..++.++||||||+++|||++|..||....... .................+
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~  262 (318)
T 3lxp_A          184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLTE  262 (318)
T ss_dssp             CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHHHHHHHHH
T ss_pred             ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccchhHHHHHH
Confidence            654321 112334457778999999999899999999999999999999999987532100 000000000000111222


Q ss_pred             hcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhccc
Q 016588          312 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNL  364 (386)
Q Consensus       312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~~~  364 (386)
                      .+........+..++.++.+++.+||+.||++|||+.++++.|+.+.++..+.
T Consensus       263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~  315 (318)
T 3lxp_A          263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ  315 (318)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred             HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence            22333334445556678999999999999999999999999999998775443

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=6.3e-46  Score=355.46  Aligned_cols=257  Identities=21%  Similarity=0.281  Sum_probs=206.3

Q ss_pred             HHHHHHhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC------CChhHHHHHHHHHHcCCCCcccccccceeeC
Q 016588           76 EELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQEN  148 (386)
Q Consensus        76 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  148 (386)
                      .++....++|+..+.||+|+||+||+|..+ +++.||+|++..      .....+.+|..+++.++||||+++++++.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            344456678999999999999999999975 488999997532      3345688999999999999999999999999


Q ss_pred             CeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccc
Q 016588          149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  228 (386)
Q Consensus       149 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFg  228 (386)
                      +..|+||||+++|+|.+++.      ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~------~~~~~e~~~~~~~~qi~~aL~~LH~--~givHrDLKp~NILl~~~g~ikL~DFG  213 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMS------NYDVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFG  213 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEeCCCCCcHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeeECCCCCEEEeccc
Confidence            99999999999999998883      2357899999999999999999999  779999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhcccC----CCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhh
Q 016588          229 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR----FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR  304 (386)
Q Consensus       229 l~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~  304 (386)
                      +++....... .......||+.|+|||++.+..    |+.++|||||||++|||++|..||.....   ......+....
T Consensus       214 ~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~~  289 (410)
T 3v8s_A          214 TCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGTYSKIMNHK  289 (410)
T ss_dssp             TCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTHH
T ss_pred             eeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh---hhHHHHHHhcc
Confidence            9987644221 1123457999999999998765    78999999999999999999999986442   12221111100


Q ss_pred             cccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCC--CCCHHHHHHHH
Q 016588          305 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSER--RPSMSDVVTEL  354 (386)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~evl~~L  354 (386)
                      .          .+..+.....++++.+++.+||+.+|.+  ||+++|+++|-
T Consensus       290 ~----------~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp  331 (410)
T 3v8s_A          290 N----------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  331 (410)
T ss_dssp             H----------HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred             c----------cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence            0          0000111134567899999999999988  99999999873

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.3e-45  Score=336.98  Aligned_cols=259  Identities=26%  Similarity=0.396  Sum_probs=201.6

Q ss_pred             cCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCC-ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCC
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  161 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  161 (386)
                      ++|+..+.||+|+||.||+|... +..||+|..... ..+.+.+|+.++++++||||+++++++.+  ..++||||++++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~   84 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGG   84 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTC
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCC
Confidence            56788899999999999999985 688999987544 34568999999999999999999999874  378999999999


Q ss_pred             CccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCceecCCCCCCeeeCCCCc-eEEcccccccccCCCCCC
Q 016588          162 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS-PRVVHKDFKTANVLVDEDFI-AKVADAGLRNFLGRTDVA  239 (386)
Q Consensus       162 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-~~ivH~dlkp~Nill~~~~~-~kl~DFgl~~~~~~~~~~  239 (386)
                      +|.+++....  ....++...++.++.|++.||.|||+.. ++|+||||||+|||++.++. +||+|||++......   
T Consensus        85 ~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           85 SLYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             BHHHHHHCSS--SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CHHHHHhccC--CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            9999985431  2235788899999999999999999843 57999999999999998886 799999998765331   


Q ss_pred             CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcc
Q 016588          240 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS  319 (386)
Q Consensus       240 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (386)
                        .....+++.|+|||.+.+..++.++||||||+++|||++|..||......... .......             ....
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~-------------~~~~  223 (307)
T 2eva_A          160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-IMWAVHN-------------GTRP  223 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH-HHHHHHT-------------TCCC
T ss_pred             --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH-HHHHHhc-------------CCCC
Confidence              22345788999999999999999999999999999999999999865432111 1111110             0111


Q ss_pred             cCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhcccc
Q 016588          320 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLT  365 (386)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~~~~  365 (386)
                      ......+..+.+++.+||+.||++|||+.++++.|+.+.+......
T Consensus       224 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~  269 (307)
T 2eva_A          224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD  269 (307)
T ss_dssp             CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTT
T ss_pred             CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCC
Confidence            2223345678999999999999999999999999999987654433

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.6e-45  Score=335.16  Aligned_cols=260  Identities=27%  Similarity=0.448  Sum_probs=195.3

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ...+|+..+.||+|+||+||+|....  .||+|......     .+.+.+|+.+++.++||||+++++++ ..+..++||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            45689999999999999999998643  59999854322     24588999999999999999999965 445678999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++++|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++.....
T Consensus        99 e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A           99 QWCEGSSLYHHLHA----SETKFEMKKLIDIARQTARGMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR  172 (289)
T ss_dssp             ECCCEEEHHHHHTT----C---CCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred             EecCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHh--CCcccccCccceEEECCCCCEEEccceecccccc
Confidence            99999999988843    34568899999999999999999999  7799999999999999999999999999986654


Q ss_pred             CCCCCCCccccCcccccchhhhc---ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          236 TDVAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      ...........+|+.|+|||.+.   +..++.++||||||+++|||++|..||.....  ...............     
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~-----  245 (289)
T 3og7_A          173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIEMVGRGSLSP-----  245 (289)
T ss_dssp             -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC--HHHHHHHHHHTSCCC-----
T ss_pred             ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch--HHHHHHHhcccccCc-----
Confidence            33333334556889999999986   56788999999999999999999999987543  222222222111110     


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                          ........+++++.+++.+||+.||++|||+.++++.|+++.++
T Consensus       246 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~e  289 (289)
T 3og7_A          246 ----DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE  289 (289)
T ss_dssp             ----CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTCC
T ss_pred             ----chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhhC
Confidence                01122334457799999999999999999999999999998753

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.6e-45  Score=332.27  Aligned_cols=252  Identities=24%  Similarity=0.354  Sum_probs=203.0

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeC--CeEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQFLI  154 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  154 (386)
                      .++|+..+.||+|+||.||+|..+ +..||+|......     .+.+.+|+.+++.++||||+++++++.+.  +..++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            357888999999999999999985 7889999865432     34588999999999999999999999876  788999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      |||+++|+|.+++...   ....+++..+..++.|++.||.|||+.+.+|+||||||+||+++.++.++++|||++....
T Consensus        88 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEG---TNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EECCTTCBHHHHHHSC---SSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             ecccCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            9999999999999532   2235899999999999999999999833339999999999999999999999998865432


Q ss_pred             CCCCCCCCccccCcccccchhhhcccCCCc---ccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhh
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEFRRFSE---KSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK  311 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (386)
                      .       ....+|+.|+|||.+.+..++.   ++|||||||++|||++|..||......   .....            
T Consensus       165 ~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~------------  222 (271)
T 3kmu_A          165 S-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM---EIGMK------------  222 (271)
T ss_dssp             C-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH---HHHHH------------
T ss_pred             c-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH---HHHHH------------
Confidence            2       2345788899999998755444   799999999999999999999864421   11111            


Q ss_pred             hcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhh
Q 016588          312 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD  359 (386)
Q Consensus       312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~  359 (386)
                      ..........+...++++.+++.+||+.||++|||++++++.|+++.+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          223 VALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             HHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            111112223344456779999999999999999999999999998865

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=8.4e-46  Score=346.08  Aligned_cols=265  Identities=22%  Similarity=0.361  Sum_probs=211.2

Q ss_pred             HHhcCCCcCCeecccCceEEEEEEeCC-C-----cEEEEEECCCCC----hhHHHHHHHHHHcC-CCCcccccccceeeC
Q 016588           80 LATKNFSDKNLIGEGKFGEVYKGLLQD-G-----MLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQEN  148 (386)
Q Consensus        80 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  148 (386)
                      ...++|...+.||+|+||.||+|.... +     ..||+|......    .+.+.+|+.+++.+ +||||+++++++...
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  122 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG  122 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence            345788999999999999999999643 2     479999866543    34588999999999 899999999999999


Q ss_pred             CeEEEEEEeecCCCccccccCCCc---------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC
Q 016588          149 NLQFLIYEYIPNGSVSIHLYGPSQ---------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED  219 (386)
Q Consensus       149 ~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~  219 (386)
                      +..++||||+++|+|.+++.....         .....+++..++.++.|++.||.|||+  ++|+||||||+|||++.+
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS--KNCIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGCEEEGG
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc--CCcccCCcccceEEECCC
Confidence            999999999999999988843210         013457899999999999999999999  779999999999999999


Q ss_pred             CceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHH
Q 016588          220 FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVE  298 (386)
Q Consensus       220 ~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~  298 (386)
                      +.+||+|||++................+|..|+|||.+.+..++.++|||||||++|||++ |..||.......  ....
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~  278 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--KFYK  278 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--HHHH
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--HHHH
Confidence            9999999999987644322222233456778999999999999999999999999999999 889998755321  1111


Q ss_pred             HHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          299 LVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                      ....             ......+...++.+.+++.+||+.||.+|||+.+++++|+++..+.
T Consensus       279 ~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  328 (333)
T 2i1m_A          279 LVKD-------------GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED  328 (333)
T ss_dssp             HHHH-------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHhc-------------CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence            1111             1111222334567899999999999999999999999999988763

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=5.3e-45  Score=345.02  Aligned_cols=267  Identities=16%  Similarity=0.175  Sum_probs=204.4

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCC------CcEEEEEECCCCChh--------------HHHHHHHHHHcCCCCccccc
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQD------GMLVAIKKRPGAPTQ--------------EFIDEVCFLASIQHRNLVTL  141 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~--------------~~~~e~~~l~~l~h~niv~~  141 (386)
                      .++|++.+.||+|+||.||+|....      +..||+|........              .+..|+..+..++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4578899999999999999999754      368999986544321              12334455667789999999


Q ss_pred             ccceeeC----CeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC
Q 016588          142 LGYCQEN----NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD  217 (386)
Q Consensus       142 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~  217 (386)
                      ++++...    ...|+||||+ +++|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+|||++
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~--~~iiHrDlkp~Nill~  186 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA----NAKRFSRKTVLQLSLRILDILEYIHE--HEYVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEE
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCeEEecCCHHHEEEe
Confidence            9998764    4579999999 9999998842    33568999999999999999999999  6799999999999999


Q ss_pred             --CCCceEEcccccccccCCCCCC-----CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCC
Q 016588          218 --EDFIAKVADAGLRNFLGRTDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP  290 (386)
Q Consensus       218 --~~~~~kl~DFgl~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~  290 (386)
                        .++.+||+|||+++........     .......+|+.|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              8899999999999876542221     112344589999999999999999999999999999999999999986443


Q ss_pred             CchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          291 DSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                      ...  ......... .......+++.+.   ...+++++.+++..||+.||++||++.++++.|++++++.
T Consensus       267 ~~~--~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  331 (364)
T 3op5_A          267 DPK--YVRDSKIRY-RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI  331 (364)
T ss_dssp             CHH--HHHHHHHHH-HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             CHH--HHHHHHHHh-hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence            211  111111111 1122223332221   1223467899999999999999999999999999999773

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.9e-45  Score=353.71  Aligned_cols=250  Identities=19%  Similarity=0.244  Sum_probs=201.5

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      .++|+..+.||+|+||.||+|... +++.+|+|++....     .+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            457888999999999999999854 68899999854432     345789999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC---CCCceEEcccccccc
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNF  232 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~---~~~~~kl~DFgl~~~  232 (386)
                      ||+.+|+|.+.+.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++   .++.+||+|||++..
T Consensus        90 E~~~gg~L~~~i~-----~~~~~~e~~~~~i~~qil~aL~~lH~--~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           90 DLVTGGELFEDIV-----AREYYSEADASHCIQQILEAVLHCHQ--MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             CCCBCCBHHHHHH-----HCSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EeCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            9999999988884     34568999999999999999999999  7799999999999998   567899999999987


Q ss_pred             cCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          233 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      .....  .......||+.|+|||++.+..|+.++||||+||++|+|++|..||.....   ......+......      
T Consensus       163 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~~~~------  231 (444)
T 3soa_A          163 VEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ---HRLYQQIKAGAYD------  231 (444)
T ss_dssp             CCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHTCCC------
T ss_pred             ecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHhCCCC------
Confidence            65422  122346789999999999998999999999999999999999999976432   2222222111100      


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .....+    ...++++.+++.+||+.||++|||+.|++++
T Consensus       232 ~~~~~~----~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          232 FPSPEW----DTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             CCTTTT----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCcccc----ccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            001111    1234668999999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.4e-44  Score=329.24  Aligned_cols=264  Identities=18%  Similarity=0.240  Sum_probs=207.7

Q ss_pred             hcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECC-CCChhHHHHHHHHHHcCCCCcccccccce-eeCCeEEEEEEee
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP-GAPTQEFIDEVCFLASIQHRNLVTLLGYC-QENNLQFLIYEYI  158 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~  158 (386)
                      .++|+..+.||+|+||.||+|.. .+++.||+|... ....+.+.+|+.+++.++|++++..++.+ ...+..++||||+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence            46899999999999999999995 568899999733 33445788999999999988877766655 6678889999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee---CCCCceEEcccccccccCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill---~~~~~~kl~DFgl~~~~~~  235 (386)
                       +++|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+|||+   +.++.+||+|||++.....
T Consensus        88 -~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           88 -GPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             -CCBHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             -CCCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence             8899988842    24568999999999999999999999  679999999999999   7889999999999987654


Q ss_pred             CCCC-----CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          236 TDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       236 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      ....     .......+|+.|+|||.+.+..++.++|||||||++|||++|..||........................ 
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-  239 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-  239 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-
T ss_pred             cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh-
Confidence            3221     1233567899999999999999999999999999999999999999886654443333322211110000 


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                          +..    ....++++.+++.+||+.||++|||+.++++.|+++.++.
T Consensus       240 ----~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~  282 (296)
T 4hgt_A          240 ----EVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             ----HHH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ----hhh----hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence                001    1122467899999999999999999999999999999874

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=7.4e-46  Score=344.74  Aligned_cols=267  Identities=23%  Similarity=0.380  Sum_probs=213.0

Q ss_pred             HHHHHhcCCCcCCeecccCceEEEEEEeC------CCcEEEEEECCCCCh----hHHHHHHHHHHcCCCCccccccccee
Q 016588           77 ELSLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQ  146 (386)
Q Consensus        77 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~  146 (386)
                      ++....++|+..+.||+|+||.||+|...      ++..||+|.......    ..+.+|+.+++.++||||+++++++.
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            33445678999999999999999999854      367899998764432    35788999999999999999999999


Q ss_pred             eCCeEEEEEEeecCCCccccccCCCc-----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc
Q 016588          147 ENNLQFLIYEYIPNGSVSIHLYGPSQ-----VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI  221 (386)
Q Consensus       147 ~~~~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~  221 (386)
                      +.+..++||||+++++|.+++.....     .....+++..++.++.|++.||.|||+  ++|+||||||+||+++.++.
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~NIli~~~~~  176 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFT  176 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCSGGGEEECTTCC
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCCccCCCccceEEEcCCCe
Confidence            99999999999999999998853211     112456889999999999999999999  77999999999999999999


Q ss_pred             eEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHH
Q 016588          222 AKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELV  300 (386)
Q Consensus       222 ~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~  300 (386)
                      +||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||.....   ......+
T Consensus       177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~  253 (322)
T 1p4o_A          177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQVLRFV  253 (322)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HHHHHHH
T ss_pred             EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---HHHHHHH
Confidence            99999999986644332222233456778999999999999999999999999999999 8888876442   1222111


Q ss_pred             HhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          301 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                      ...             .....+..++..+.+++.+||+.||++|||+.|++++|++..+..
T Consensus       254 ~~~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~  301 (322)
T 1p4o_A          254 MEG-------------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  301 (322)
T ss_dssp             HTT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             HcC-------------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccC
Confidence            111             111223345567899999999999999999999999999887654

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-44  Score=338.75  Aligned_cols=263  Identities=27%  Similarity=0.470  Sum_probs=205.2

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCC-----CcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQD-----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  152 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  152 (386)
                      ..+|+..+.||+|+||.||+|....     +..||+|......    ...+.+|+.+++.++||||+++++++...+..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            3567778999999999999998543     2369999865432    235788999999999999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~  232 (386)
                      +||||+++++|.+++..    ....+++..++.++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++..
T Consensus       123 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          123 IITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             EEEECCTTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEeCCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence            99999999999998842    23568899999999999999999999  6799999999999999999999999999987


Q ss_pred             cCCCCC-CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          233 LGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       233 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      ...... ........++..|+|||.+.+..++.++|||||||++|||++ |..||.....   ......+..        
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~~~~~--------  265 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMKAIND--------  265 (333)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHT--------
T ss_pred             hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHC--------
Confidence            654221 112223345778999999998999999999999999999999 9999976442   222221111        


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhccccc
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTT  366 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~~~~~  366 (386)
                           ......+..++..+.+++.+||+.||++|||+.++++.|+++++.......
T Consensus       266 -----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~~~  316 (333)
T 1mqb_A          266 -----GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKT  316 (333)
T ss_dssp             -----TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGGS
T ss_pred             -----CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhhhh
Confidence                 111122334557799999999999999999999999999999977555443

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-44  Score=331.76  Aligned_cols=257  Identities=25%  Similarity=0.395  Sum_probs=203.7

Q ss_pred             CCCcCCeecccCceEEEEEEeCC-C---cEEEEEECCCCCh----hHHHHHHHHHHcCCCCcccccccceeeCCeE-EEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQD-G---MLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQ-FLI  154 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~lv  154 (386)
                      .|...+.||+|+||+||+|...+ +   ..+|+|.......    +.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            45556899999999999998532 2   3799998654332    4578999999999999999999999776554 899


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      |||+.+++|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||+++...
T Consensus       102 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A          102 LPYMCHGDLLQFIRS----PQRNPTVKDLISFGLQVARGMEYLAE--QKFVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             ECCCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EecccCCCHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            999999999998843    34567899999999999999999999  779999999999999999999999999998664


Q ss_pred             CCC--CCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          235 RTD--VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       235 ~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      ...  .........+++.|+|||.+.+..++.++||||||+++|||++|..|+.....  ............        
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~~~~--------  245 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--PFDLTHFLAQGR--------  245 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--GGGHHHHHHTTC--------
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC--HHHHHHHhhcCC--------
Confidence            422  12233445678889999999999999999999999999999996655443222  122222221111        


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                           ....+...++.+.+++.+||+.||.+|||+.++++.|+++++..
T Consensus       246 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l  289 (298)
T 3pls_A          246 -----RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL  289 (298)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             -----CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence                 11223334567899999999999999999999999999998763

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=5.7e-45  Score=332.34  Aligned_cols=256  Identities=26%  Similarity=0.432  Sum_probs=203.9

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCC----CcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (386)
                      .++|...+.||+|+||.||+|....    +..||+|......    .+.+.+|+.+++.++||||+++++++.++ ..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence            4578888999999999999998542    3469999876542    35688899999999999999999998754 4689


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      ||||+++++|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++...
T Consensus        90 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           90 IMELYPYGELGHYLER----NKNSLKVLTLVLYSLQICKAMAYLES--INCVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             EEECCTTCBHHHHHHH----HTTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             EEecCCCCCHHHHHHh----ccccCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence            9999999999998842    23458899999999999999999999  77999999999999999999999999999876


Q ss_pred             CCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          234 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       234 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      ..... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......   .........         
T Consensus       164 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~---~~~~~~~~~---------  230 (281)
T 3cc6_A          164 EDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK---DVIGVLEKG---------  230 (281)
T ss_dssp             ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG---GHHHHHHHT---------
T ss_pred             ccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH---HHHHHHhcC---------
Confidence            54221 12233456778999999999999999999999999999998 99999764432   222221111         


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                          .....+...++.+.+++.+||+.||++|||+.+++++|+++.+.+
T Consensus       231 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  275 (281)
T 3cc6_A          231 ----DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME  275 (281)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence                111222334567899999999999999999999999999988654

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.9e-45  Score=342.79  Aligned_cols=248  Identities=23%  Similarity=0.339  Sum_probs=203.2

Q ss_pred             HHhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC------CChhHHHHHHHHHHcC-CCCcccccccceeeCCeE
Q 016588           80 LATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQ  151 (386)
Q Consensus        80 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  151 (386)
                      ...++|...+.||+|+||.||+|..+ +++.||+|.+..      ...+.+..|..++..+ +||||+++++++.+.+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            45678999999999999999999975 588999998542      3455678899999876 899999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      |+||||+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        94 ~lv~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~vkL~DFG~a~  166 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQ-----SCHKFDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCK  166 (345)
T ss_dssp             EEEEECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence            99999999999998883     33568899999999999999999999  779999999999999999999999999998


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhh
Q 016588          232 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK  311 (386)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (386)
                      ......  .......||+.|+|||++.+..++.++|||||||++|||++|..||.+...   ......+...        
T Consensus       167 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i~~~--------  233 (345)
T 1xjd_A          167 ENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EELFHSIRMD--------  233 (345)
T ss_dssp             CCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHC--------
T ss_pred             hcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHhC--------
Confidence            643211  223456789999999999999999999999999999999999999986442   2222211110        


Q ss_pred             hcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHH-HHHHH
Q 016588          312 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMS-DVVTE  353 (386)
Q Consensus       312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~-evl~~  353 (386)
                            ...++...++++.+++.+||+.||++||++. ++++|
T Consensus       234 ------~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          234 ------NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             ------CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             ------CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence                  0122333456789999999999999999998 66643

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.1e-45  Score=343.39  Aligned_cols=244  Identities=18%  Similarity=0.258  Sum_probs=201.5

Q ss_pred             cCCCcCCeecccCceEEEEEEe-CCCcEEEEEECC------CCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      .+|.+.+.||+|+||.||+|.. .+++.||+|+..      ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5788899999999999999996 468999999753      233457889999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+ +|+|.+++.     ....+++..+..++.|++.||.|||+  .||+||||||+|||++.++.+||+|||++.....
T Consensus        89 E~~-~g~l~~~l~-----~~~~l~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           89 EYA-GGELFDYIV-----EKKRMTEDEGRRFFQQIICAIEYCHR--HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             CCC-CEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             ECC-CCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            999 678887773     34568999999999999999999999  6799999999999999999999999999987644


Q ss_pred             CCCCCCCccccCcccccchhhhcccCC-CcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                      ..   ......+|+.|+|||.+.+..+ +.++|||||||++|+|++|..||........                .+.+.
T Consensus       161 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------------~~~i~  221 (336)
T 3h4j_B          161 GN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------------FKKVN  221 (336)
T ss_dssp             SB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------------BCCCC
T ss_pred             Cc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------------HHHHH
Confidence            32   2234568899999999988776 7899999999999999999999976443211                00011


Q ss_pred             hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                      .. ....+...++++.+++.+||+.||.+|||++|++++-
T Consensus       222 ~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  260 (336)
T 3h4j_B          222 SC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP  260 (336)
T ss_dssp             SS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred             cC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence            10 1123334556789999999999999999999999764

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.4e-45  Score=349.28  Aligned_cols=249  Identities=20%  Similarity=0.303  Sum_probs=195.9

Q ss_pred             cCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCC-----hhHHHHHHHHHHcCC--CCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQ--HRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~  155 (386)
                      .+|++.+.||+|+||.||+|...+++.||||++....     .+.+.+|+.+++.++  ||||+++++++...+..|+||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            4588999999999999999998779999999854322     356889999999996  599999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      | +.+++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++ ++.+||+|||+++....
T Consensus       136 E-~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~lH~--~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          136 E-CGNIDLNSWLK-----KKKSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             E-CCSEEHHHHHH-----HCSSCCHHHHHHHHHHHHHHHHHHHT--TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             e-cCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            9 56789998884     23467888999999999999999999  7799999999999996 58899999999987654


Q ss_pred             CCCCCCCccccCcccccchhhhcc-----------cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhh
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEF-----------RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR  304 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~  304 (386)
                      ...........||+.|+|||++.+           ..++.++|||||||++|||++|..||...... ...         
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-~~~---------  276 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISK---------  276 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-HHH---------
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-HHH---------
Confidence            333223345678999999999875           36899999999999999999999999764321 111         


Q ss_pred             cccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          305 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                          +..++++......+...+.++.+++.+||+.||++|||+.|++++-
T Consensus       277 ----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp  322 (390)
T 2zmd_A          277 ----LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  322 (390)
T ss_dssp             ----HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             ----HHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence                1112222222223333346789999999999999999999999764

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1e-45  Score=340.59  Aligned_cols=267  Identities=26%  Similarity=0.389  Sum_probs=207.6

Q ss_pred             cCCCcCCeecccCceEEEEEEe-----CCCcEEEEEECCCC----ChhHHHHHHHHHHcCCCCcccccccceeeC--CeE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQ  151 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  151 (386)
                      +.|+..+.||+|+||.||+|.+     .+++.||+|+....    ..+.+.+|+.+++.++||||+++++++...  +..
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4578889999999999999984     35789999986533    346789999999999999999999999876  668


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      ++||||+++++|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++.
T Consensus       101 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPK----NKNKINLKQQLKYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             EEEEECCTTCBHHHHHHH----HTTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEeCCCCcHHHHHHh----ccccCCHHHHHHHHHHHHHHHHHhhc--CCcccCCCchheEEEcCCCCEEECcccccc
Confidence            999999999999998842    33568999999999999999999999  779999999999999999999999999998


Q ss_pred             ccCCCCC-CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhh---hccc
Q 016588          232 FLGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS---RDFS  307 (386)
Q Consensus       232 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~  307 (386)
                      ....... ........+|..|+|||.+.+..++.++||||||+++|||++|..|+.....    .........   ....
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~  250 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA----LFLKMIGPTHGQMTVT  250 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH----HHHHHHCSCCGGGHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh----HHhhccCCcccccCHH
Confidence            7654321 1223345677789999999999999999999999999999999987543210    000000000   0001


Q ss_pred             chhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhh
Q 016588          308 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD  359 (386)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~  359 (386)
                      ..............+...++++.+++.+||+.||++|||+.++++.|+.+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~  302 (302)
T 4e5w_A          251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK  302 (302)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             HHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence            1111122222333445566789999999999999999999999999998864

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=5.1e-45  Score=344.59  Aligned_cols=252  Identities=20%  Similarity=0.201  Sum_probs=193.2

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC--CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG--APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      .++|+..+.||+|+||+||++... +++.||+|+...  ...+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   98 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA   98 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence            457889999999999999999965 689999998543  33567889999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc--eEEcccccccccCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI--AKVADAGLRNFLGRT  236 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~--~kl~DFgl~~~~~~~  236 (386)
                      ++|+|.+++.     ....+++..+..++.|++.||.|||+  +||+||||||+|||++.++.  +||+|||+++.....
T Consensus        99 ~~~~L~~~l~-----~~~~~~~~~~~~i~~ql~~~L~~LH~--~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           99 SGGELYERIC-----NAGRFSEDEARFFFQQLLSGVSYCHS--MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             CSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             CCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            9999998883     34568999999999999999999999  77999999999999987765  999999998754221


Q ss_pred             CCCCCCccccCcccccchhhhcccCCCcc-cchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFRRFSEK-SDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                         .......+|+.|+|||++.+..++.+ +|||||||++|||++|..||........  .........         ..
T Consensus       172 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~---------~~  237 (361)
T 3uc3_A          172 ---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRIL---------SV  237 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHH---------TT
T ss_pred             ---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHh---------cC
Confidence               12234568999999999988887665 8999999999999999999987554221  111111111         11


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                      ..........++++.+++.+||+.||++|||+.|+++|-
T Consensus       238 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp  276 (361)
T 3uc3_A          238 KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHS  276 (361)
T ss_dssp             CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred             CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence            111111112346789999999999999999999999873

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.2e-45  Score=342.44  Aligned_cols=277  Identities=24%  Similarity=0.303  Sum_probs=202.6

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCChhHHHHHHHHHH--cCCCCccccccccee-----eCCeEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLA--SIQHRNLVTLLGYCQ-----ENNLQFLI  154 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~--~l~h~niv~~~~~~~-----~~~~~~lv  154 (386)
                      .++|+..+.||+|+||.||+|.. +++.||+|++.......+..|.+++.  .++||||+++++.+.     .....++|
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv   90 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV   90 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence            46888999999999999999987 57899999987666667777766654  479999999997543     33467899


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-------CCCceecCCCCCCeeeCCCCceEEccc
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL-------SPRVVHKDFKTANVLVDEDFIAKVADA  227 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------~~~ivH~dlkp~Nill~~~~~~kl~DF  227 (386)
                      |||+++|+|.+++.      ....++..+..++.|++.||.|||+.       .++|+||||||+|||++.++.+||+||
T Consensus        91 ~e~~~~g~L~~~l~------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF  164 (336)
T 3g2f_A           91 MEYYPNGSLXKYLS------LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF  164 (336)
T ss_dssp             ECCCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred             EecCCCCcHHHHHh------hcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence            99999999999883      23447889999999999999999983       117999999999999999999999999


Q ss_pred             ccccccCCCCC------CCCCccccCcccccchhhhcc-------cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCch-
Q 016588          228 GLRNFLGRTDV------AGPSSQVTADEIFLASEVKEF-------RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS-  293 (386)
Q Consensus       228 gl~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~-  293 (386)
                      |+++.......      ........+|+.|+|||++.+       ..++.++|||||||++|||++|..|+........ 
T Consensus       165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~  244 (336)
T 3g2f_A          165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY  244 (336)
T ss_dssp             TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred             cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence            99987653221      122234568999999999976       4567789999999999999999777654332111 


Q ss_pred             hhH-HHHHHhhhcccchhhh-cchhhccc------CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhcccc
Q 016588          294 QDL-VELVQNSRDFSNLLKI-LDERLWST------FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLT  365 (386)
Q Consensus       294 ~~~-~~~~~~~~~~~~~~~~-~~~~~~~~------~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~~~~  365 (386)
                      ... ................ .....+..      .....++++.+++.+||+.||++|||+.|+++.|++++....+..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~  324 (336)
T 3g2f_A          245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK  324 (336)
T ss_dssp             CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred             HHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence            100 0000000000000000 01111111      122466789999999999999999999999999999997754433

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.6e-44  Score=332.06  Aligned_cols=257  Identities=25%  Similarity=0.444  Sum_probs=202.1

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCC----CcEEEEEECCCCC----hhHHHHHHHHHHcCCCCccccccccee-eCCeEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQ-ENNLQF  152 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~  152 (386)
                      ..+|+..+.||+|+||+||+|...+    ...+|+|......    .+.+.+|+.++++++||||+++++++. ..+..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3467888999999999999998542    2368999865433    245789999999999999999999854 556789


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~  232 (386)
                      +||||+++++|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++..
T Consensus       104 ~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~ql~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKYLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARD  177 (298)
T ss_dssp             EEEECCTTCBHHHHHHC----TTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred             EEEeCCCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCchheEEECCCCCEEECccccccc
Confidence            99999999999999843    34567899999999999999999999  7799999999999999999999999999987


Q ss_pred             cCCCCC--CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccch
Q 016588          233 LGRTDV--AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNL  309 (386)
Q Consensus       233 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  309 (386)
                      ......  ........+|+.|+|||.+.+..++.++||||||+++|||++ |.+||.......   ........      
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~~~~~~------  248 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQG------  248 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHHHHHTT------
T ss_pred             ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHHHHhcC------
Confidence            644221  122334556778999999999999999999999999999999 555655543321   11111111      


Q ss_pred             hhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                             .....+...++.+.+++.+||+.||++|||+.++++.|++++++
T Consensus       249 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  292 (298)
T 3f66_A          249 -------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  292 (298)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                   11122233456789999999999999999999999999999875

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.1e-44  Score=336.34  Aligned_cols=265  Identities=20%  Similarity=0.315  Sum_probs=188.2

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC----CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      .++|+..+.||+|+||.||+|... +++.||+|....    ...+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            457889999999999999999954 589999997532    234678899999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          157 YIPNGSVSIHLYGPSQ-VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      |++ ++|.+++..... .....+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||++.....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  160 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE--NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI  160 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence            998 588877743211 122458899999999999999999999  7799999999999999999999999999987643


Q ss_pred             CCCCCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc-cc----ch
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD-FS----NL  309 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~----~~  309 (386)
                      ..  .......+|+.|+|||++.+. .++.++|||||||++|||++|..||.+.....  .+......... ..    ..
T Consensus       161 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          161 PV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE--QLKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             CC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCTTTCGGG
T ss_pred             Cc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCChhHhhhh
Confidence            22  122345678899999999764 68999999999999999999999998654321  11111111000 00    00


Q ss_pred             hhh--cch------------hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          310 LKI--LDE------------RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       310 ~~~--~~~------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ...  ..+            .+........+.++.+++.+||+.||++|||+.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence            000  000            00111112234678999999999999999999999876

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6e-45  Score=345.33  Aligned_cols=256  Identities=26%  Similarity=0.455  Sum_probs=194.3

Q ss_pred             CCCcCCeecccCceEEEEEEeC--CC--cEEEEEECCCCC----hhHHHHHHHHHHcCCCCccccccccee-eCCeEEEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ--DG--MLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQ-ENNLQFLI  154 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv  154 (386)
                      .|...+.||+|+||.||+|...  ++  ..||+|......    .+.+.+|+.+++.++||||+++++++. ..+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4566789999999999999853  22  468999865432    356889999999999999999999865 45678999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      |||+++|+|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++...
T Consensus       170 ~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EECCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EECCCCCCHHHHHhh----cccCCCHHHHHHHHHHHHHHHHHHHH--CCEecCccchheEEECCCCCEEEeecccccccc
Confidence            999999999999843    33457888999999999999999999  779999999999999999999999999998764


Q ss_pred             CCCCC--CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhh
Q 016588          235 RTDVA--GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK  311 (386)
Q Consensus       235 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (386)
                      .....  .......+|..|+|||.+.+..++.++|||||||++|||++ |..||.......   ........        
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~~~~~--------  312 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQG--------  312 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHHHHTT--------
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHHHHcC--------
Confidence            32211  12234456778999999999999999999999999999999 677776654322   11111111        


Q ss_pred             hcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          312 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                           .....+..++..+.+++.+||+.||++|||+.++++.|++++...
T Consensus       313 -----~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~  357 (373)
T 3c1x_A          313 -----RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  357 (373)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence                 111223344567999999999999999999999999999998663

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=8.5e-44  Score=326.71  Aligned_cols=264  Identities=18%  Similarity=0.232  Sum_probs=209.9

Q ss_pred             hcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECC-CCChhHHHHHHHHHHcCCCCcccccccce-eeCCeEEEEEEee
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP-GAPTQEFIDEVCFLASIQHRNLVTLLGYC-QENNLQFLIYEYI  158 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~  158 (386)
                      .++|+..+.||+|+||.||+|.. .+++.||+|... ....+.+.+|+.+++.++|++++..+.++ ...+..++||||+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence            46788999999999999999995 568999999743 33456789999999999988877666655 5677889999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee---CCCCceEEcccccccccCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill---~~~~~~kl~DFgl~~~~~~  235 (386)
                       +++|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+|||+   +.++.+||+|||++.....
T Consensus        88 -~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  160 (296)
T 3uzp_A           88 -GPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             -CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             -CCCHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence             8899988842    24568999999999999999999999  779999999999999   4888999999999987654


Q ss_pred             CCCC-----CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          236 TDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       236 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      ....     .......+|+.|+|||.+.+..++.++|||||||++|||++|..||..............+........  
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--  238 (296)
T 3uzp_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--  238 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC--
T ss_pred             cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc--
Confidence            3221     123455788999999999999999999999999999999999999988665433333332221111000  


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                         .+..    ....++++.+++.+||+.||++|||+.++++.|+++.++.
T Consensus       239 ---~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  282 (296)
T 3uzp_A          239 ---IEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             ---HHHH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             ---hHHH----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence               0011    1223466899999999999999999999999999998774

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.9e-45  Score=341.69  Aligned_cols=249  Identities=21%  Similarity=0.353  Sum_probs=193.5

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC----CChhHHHHHHHHHHcCCCCcccccccceeeCC--------
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENN--------  149 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--------  149 (386)
                      ++|+..+.||+|+||.||+|..+ +++.||||+...    ...+.+.+|+.+++.++||||+++++++.+.+        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            56888899999999999999976 689999998542    23456889999999999999999999885543        


Q ss_pred             -------------------------------------------------eEEEEEEeecCCCccccccCCCcCCCCCCCH
Q 016588          150 -------------------------------------------------LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF  180 (386)
Q Consensus       150 -------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~  180 (386)
                                                                       ..++||||+++++|.+++....  ......+
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~  163 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC--SLEDREH  163 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC--SGGGSCH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc--Cccchhh
Confidence                                                             3799999999999999986432  2345567


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC----------CCCccccCccc
Q 016588          181 KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA----------GPSSQVTADEI  250 (386)
Q Consensus       181 ~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~----------~~~~~~~~~~~  250 (386)
                      ..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++........          .......+|+.
T Consensus       164 ~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHHh--CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            7789999999999999999  77999999999999999999999999999877543211          12234568999


Q ss_pred             ccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHH
Q 016588          251 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFI  330 (386)
Q Consensus       251 y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  330 (386)
                      |+|||.+.+..++.++|||||||++|||++|..|+..        ...........          .........++++.
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--------~~~~~~~~~~~----------~~~~~~~~~~~~~~  303 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------RVRIITDVRNL----------KFPLLFTQKYPQEH  303 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------HHHHHHHHHTT----------CCCHHHHHHCHHHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--------HHHHHHHhhcc----------CCCcccccCChhHH
Confidence            9999999999999999999999999999998654221        11111110000          00011123345679


Q ss_pred             HHHhHccCCCCCCCCCHHHHHHH
Q 016588          331 QLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       331 ~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      +++.+||+.||++|||+.|++++
T Consensus       304 ~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          304 MMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHccCCCCcCCCHHHHhhc
Confidence            99999999999999999999975

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.5e-45  Score=336.44  Aligned_cols=258  Identities=23%  Similarity=0.354  Sum_probs=206.0

Q ss_pred             HhcCCCcCC-eecccCceEEEEEEeC---CCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeCCeE
Q 016588           81 ATKNFSDKN-LIGEGKFGEVYKGLLQ---DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  151 (386)
Q Consensus        81 ~~~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  151 (386)
                      ...+|.+.+ .||+|+||.||+|...   .+..||+|......     .+.+.+|+.+++.++||||+++++++ ..+..
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            345677777 9999999999999642   36789999865432     45688999999999999999999999 56678


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      ++||||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++.
T Consensus        93 ~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  165 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQ-----QNRHVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSK  165 (291)
T ss_dssp             EEEEECCTTEEHHHHHH-----HCTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEeCCCCCHHHHHH-----hCcCCCHHHHHHHHHHHHHHHHHHHh--CCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence            89999999999999884     23458899999999999999999999  679999999999999999999999999998


Q ss_pred             ccCCCCCC-CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccch
Q 016588          232 FLGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNL  309 (386)
Q Consensus       232 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  309 (386)
                      ........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||.....   ......+..       
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~-------  235 (291)
T 1xbb_A          166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEK-------  235 (291)
T ss_dssp             ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHT-------
T ss_pred             eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHc-------
Confidence            76442221 11223345678999999998889999999999999999999 9999986442   222221111       


Q ss_pred             hhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhc
Q 016588          310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  362 (386)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~  362 (386)
                            ......+..+++++.+++.+||+.||++|||+.++++.|+++.....
T Consensus       236 ------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  282 (291)
T 1xbb_A          236 ------GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  282 (291)
T ss_dssp             ------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred             ------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence                  11122334456779999999999999999999999999999987744

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=363.16  Aligned_cols=249  Identities=25%  Similarity=0.396  Sum_probs=201.2

Q ss_pred             eecccCceEEEEEEeC---CCcEEEEEECCCC----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCCC
Q 016588           90 LIGEGKFGEVYKGLLQ---DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS  162 (386)
Q Consensus        90 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  162 (386)
                      .||+|+||.||+|.++   ++..||||.+...    ..+++.+|+++++.++||||+++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999864   4567999986543    35679999999999999999999999976 56899999999999


Q ss_pred             ccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC-CC
Q 016588          163 VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA-GP  241 (386)
Q Consensus       163 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~-~~  241 (386)
                      |.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++........ ..
T Consensus       422 L~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~LH~--~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  495 (613)
T 2ozo_A          422 LHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEE--KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA  495 (613)
T ss_dssp             HHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred             HHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence            9998843    34568999999999999999999999  77999999999999999999999999999876432211 11


Q ss_pred             CccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhccc
Q 016588          242 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  320 (386)
Q Consensus       242 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (386)
                      .....+|..|+|||++.+..++.++|||||||++|||++ |..||......   +....+.             ...+..
T Consensus       496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~i~-------------~~~~~~  559 (613)
T 2ozo_A          496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIE-------------QGKRME  559 (613)
T ss_dssp             ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHHHHH-------------TTCCCC
T ss_pred             ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHHH-------------cCCCCC
Confidence            223345678999999999999999999999999999998 99999876542   2222211             112233


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          321 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                      .+..+++++.+++.+||+.||++|||+.++++.|+.+....
T Consensus       560 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~  600 (613)
T 2ozo_A          560 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  600 (613)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence            44556678999999999999999999999999999987663

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=4.5e-45  Score=343.30  Aligned_cols=243  Identities=20%  Similarity=0.279  Sum_probs=203.7

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC------CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      .++|+..+.||+|+||.||+|... +++.||+|.+..      ...+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            357888999999999999999965 589999998532      3456788999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      |||+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++...
T Consensus       120 ~e~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~  192 (350)
T 1rdq_E          120 MEYVAGGEMFSHLR-----RIGRFSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             EECCTTCBHHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EcCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCccceEEECCCCCEEEcccccceecc
Confidence            99999999999884     23568899999999999999999999  779999999999999999999999999998764


Q ss_pred             CCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                      ..     .....||+.|+|||++.+..++.++|||||||++|||++|..||.....   ......+..            
T Consensus       193 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i~~------------  252 (350)
T 1rdq_E          193 GR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVS------------  252 (350)
T ss_dssp             SC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH------------
T ss_pred             CC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH---HHHHHHHHc------------
Confidence            32     2345789999999999999999999999999999999999999986432   122211111            


Q ss_pred             hhhcccCCHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHH
Q 016588          315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTE  353 (386)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~evl~~  353 (386)
                      ..  ..++...+.++.+++.+||+.||++||+     +++++++
T Consensus       253 ~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          253 GK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             CC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CC--CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence            00  1223344567899999999999999998     8888865

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=7.8e-45  Score=338.76  Aligned_cols=270  Identities=23%  Similarity=0.348  Sum_probs=209.6

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC------CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  151 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  151 (386)
                      .++|+..+.||+|+||.||+|...      ++..||+|.+....    ..++.+|+.+++.++||||+++++++...+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            468899999999999999999842      46789999975432    24578899999999999999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC---CCceEEcc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQ--VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVAD  226 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~---~~~~kl~D  226 (386)
                      |+||||+++++|.+++.....  .....+++..++.++.|++.||.|||+  .+|+||||||+|||++.   +..+||+|
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--~~i~H~dlkp~NIli~~~~~~~~~kl~D  186 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGD  186 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh--CCeecCcCCHhHEEEecCCCcceEEECc
Confidence            999999999999998854321  122458899999999999999999999  77999999999999984   45699999


Q ss_pred             cccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhc
Q 016588          227 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRD  305 (386)
Q Consensus       227 Fgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  305 (386)
                      ||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||.....   ......+...  
T Consensus       187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~~~~--  261 (327)
T 2yfx_A          187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEFVTSG--  261 (327)
T ss_dssp             CHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHHTT--
T ss_pred             cccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---HHHHHHHhcC--
Confidence            999876544333333344567888999999999999999999999999999998 8899876432   2222221111  


Q ss_pred             ccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhcccccccC
Q 016588          306 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMG  369 (386)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~~~~~~~~  369 (386)
                                 .....+..++..+.+++.+||+.||.+|||+.+++++|+.+..+.........
T Consensus       262 -----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~~~  314 (327)
T 2yfx_A          262 -----------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALP  314 (327)
T ss_dssp             -----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHHTCCCC
T ss_pred             -----------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHHhccccc
Confidence                       11122334456789999999999999999999999999998877544443333

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.3e-44  Score=337.30  Aligned_cols=259  Identities=27%  Similarity=0.469  Sum_probs=206.7

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcE--EEEEECCC----CChhHHHHHHHHHHcC-CCCcccccccceeeCCeEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGML--VAIKKRPG----APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~--vavK~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  154 (386)
                      ++|+..+.||+|+||.||+|... ++..  +++|....    ...+.+.+|+++++.+ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            57888999999999999999954 4554  48887543    2345688999999999 899999999999999999999


Q ss_pred             EEeecCCCccccccCCCc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceE
Q 016588          155 YEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAK  223 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~k  223 (386)
                      |||+++++|.+++.....           .....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+|
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~~~~~k  182 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAK  182 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECGGGCEE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCccceEEEcCCCeEE
Confidence            999999999999854320           123468999999999999999999999  7799999999999999999999


Q ss_pred             EcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHh
Q 016588          224 VADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQN  302 (386)
Q Consensus       224 l~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~  302 (386)
                      |+|||+++.....   .......++..|+|||.+.+..++.++|||||||++|||++ |..||.....   ......+  
T Consensus       183 L~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~~~--  254 (327)
T 1fvr_A          183 IADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKL--  254 (327)
T ss_dssp             ECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHG--
T ss_pred             EcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH---HHHHHHh--
Confidence            9999998754321   12233456778999999998889999999999999999998 9999976542   1111111  


Q ss_pred             hhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhc
Q 016588          303 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  362 (386)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~  362 (386)
                                 ........+...++++.+++.+||+.||++|||+.+++++|++++++..
T Consensus       255 -----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  303 (327)
T 1fvr_A          255 -----------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  303 (327)
T ss_dssp             -----------GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             -----------hcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence                       1111122333455779999999999999999999999999999998743

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.2e-45  Score=364.19  Aligned_cols=258  Identities=26%  Similarity=0.446  Sum_probs=211.0

Q ss_pred             HHhcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCC--ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           80 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        80 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      ...++|++.+.||+|+||.||+|.++++..||||++...  ..+++.+|+.++++++||||+++++++.+ +..|+||||
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            345677888999999999999999988888999986543  45689999999999999999999999876 668999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +++|+|.+++...   ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++......
T Consensus       343 ~~~gsL~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  417 (535)
T 2h8h_A          343 MSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  417 (535)
T ss_dssp             CTTEEHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred             hcCCcHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence            9999999998421   22458899999999999999999999  779999999999999999999999999998764321


Q ss_pred             CCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchh
Q 016588          238 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  316 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (386)
                      . .......++..|+|||++.+..++.++|||||||++|||++ |..||.+...   ......+.             ..
T Consensus       418 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~---~~~~~~i~-------------~~  480 (535)
T 2h8h_A          418 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVE-------------RG  480 (535)
T ss_dssp             H-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH---HHHHHHHH-------------TT
T ss_pred             e-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH-------------cC
Confidence            1 11223346678999999999999999999999999999999 8999986542   12222111             11


Q ss_pred             hcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          317 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      .+...+..+++++.+||.+||+.||++|||++++++.|+++...
T Consensus       481 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          481 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence            12233445567799999999999999999999999999988754

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=7.8e-45  Score=338.86  Aligned_cols=246  Identities=18%  Similarity=0.256  Sum_probs=194.4

Q ss_pred             hcCCCcCCeecccCceEEEEEEe----CCCcEEEEEECCCC-------ChhHHHHHHHHHHcCCCCcccccccceeeCCe
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLL----QDGMLVAIKKRPGA-------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNL  150 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  150 (386)
                      .++|+..+.||+|+||.||++..    .++..||+|.....       ....+.+|+.+++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            45788999999999999999996    46889999986543       23457789999999999999999999999999


Q ss_pred             EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  230 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~  230 (386)
                      .|+||||+++++|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus        96 ~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLE-----REGIFMEDTACFYLAEISMALGHLHQ--KGIIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             EEEEEECCTTEEHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             EEEEEeCCCCCcHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHh--CCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            999999999999998883     33567889999999999999999999  77999999999999999999999999998


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          231 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      +......  .......+|+.|+|||++.+..++.++|||||||++|||++|..||.....   ......+...       
T Consensus       169 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~-------  236 (327)
T 3a62_A          169 KESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR---KKTIDKILKC-------  236 (327)
T ss_dssp             ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHT-------
T ss_pred             cccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhC-------
Confidence            7643221  122345688999999999999999999999999999999999999986442   1111111110       


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  353 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~~  353 (386)
                             ....+...+.++.+++.+||+.||++||     +++++++|
T Consensus       237 -------~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          237 -------KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             -------CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             -------CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence                   0122333456789999999999999999     77888875

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.8e-44  Score=338.67  Aligned_cols=252  Identities=20%  Similarity=0.278  Sum_probs=199.9

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC------hhHHHHHHHHHHcC-CCCcccccccceeeCCeEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  154 (386)
                      ++|+..+.||+|+||.||+|..+ +++.||+|++....      .+.+.+|..++..+ +||||+++++++.+.+..|+|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            57888999999999999999965 58899999854321      23477899999887 899999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      |||+++|+|..++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++...
T Consensus        89 ~e~~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQ-----RQRKLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             ECCCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            99999999998883     33568999999999999999999999  779999999999999999999999999998643


Q ss_pred             CCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhh--HHHHHHhhhcccchhhh
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQD--LVELVQNSRDFSNLLKI  312 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  312 (386)
                      ...  .......||+.|+|||++.+..++.++|||||||++|||++|..||..........  ......        ..+
T Consensus       162 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--------~~i  231 (345)
T 3a8x_A          162 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF--------QVI  231 (345)
T ss_dssp             CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHH--------HHH
T ss_pred             CCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHH--------HHH
Confidence            211  22345678999999999999999999999999999999999999997643211100  000000        000


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCH------HHHHHH
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM------SDVVTE  353 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~------~evl~~  353 (386)
                      ...  ...++...+.++.+++.+||+.||++||++      +|+++|
T Consensus       232 ~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          232 LEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             HHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             HcC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence            011  112334455778999999999999999996      566654

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2e-44  Score=337.84  Aligned_cols=266  Identities=22%  Similarity=0.372  Sum_probs=211.6

Q ss_pred             HHHHHhcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCChhHHHHHHHHHHc--CCCCcccccccceeeCC----e
Q 016588           77 ELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLAS--IQHRNLVTLLGYCQENN----L  150 (386)
Q Consensus        77 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~----~  150 (386)
                      ......++|+..+.||+|+||.||+|.. +++.||+|.........+.+|.+++..  ++||||+++++++...+    .
T Consensus        36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~  114 (342)
T 1b6c_B           36 VQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ  114 (342)
T ss_dssp             HHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred             ecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence            3344567899999999999999999998 488999999877777788899999887  78999999999998765    7


Q ss_pred             EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCCceecCCCCCCeeeCCCCce
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH--------SLSPRVVHKDFKTANVLVDEDFIA  222 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~ivH~dlkp~Nill~~~~~~  222 (386)
                      .++||||+++|+|.+++.      ...+++..++.++.|++.||.|||        +  ++|+||||||+|||++.++.+
T Consensus       115 ~~lv~e~~~~g~L~~~l~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~--~~ivH~Dlkp~NIll~~~~~~  186 (342)
T 1b6c_B          115 LWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK--PAIAHRDLKSKNILVKKNGTC  186 (342)
T ss_dssp             EEEEECCCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB--CEEECSCCSGGGEEECTTSCE
T ss_pred             eEEEEeecCCCcHHHHHh------ccCccHHHHHHHHHHHHHHHHHHHHHHhhhccc--CCeeeCCCCHHHEEECCCCCE
Confidence            899999999999999983      235889999999999999999999        6  779999999999999999999


Q ss_pred             EEcccccccccCCCCCC--CCCccccCcccccchhhhccc------CCCcccchhhHHHHHHHHHcC----------CCC
Q 016588          223 KVADAGLRNFLGRTDVA--GPSSQVTADEIFLASEVKEFR------RFSEKSDVYSFGVFLLELVSG----------REA  284 (386)
Q Consensus       223 kl~DFgl~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwSlGvil~el~tg----------~~p  284 (386)
                      ||+|||++.........  .......+++.|+|||.+.+.      .++.++|||||||++|||++|          ..|
T Consensus       187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p  266 (342)
T 1b6c_B          187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  266 (342)
T ss_dssp             EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence            99999999776442211  123345688999999998765      233689999999999999999          678


Q ss_pred             CCCCCCCchhhHHHHHHhhhcccchhhhcchhhccc-----CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhh
Q 016588          285 SSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST-----FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD  359 (386)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~  359 (386)
                      |......... ........         ........     ....+++.+.+++.+||+.||++|||+.+++++|+++.+
T Consensus       267 ~~~~~~~~~~-~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~  336 (342)
T 1b6c_B          267 YYDLVPSDPS-VEEMRKVV---------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  336 (342)
T ss_dssp             TTTTSCSSCC-HHHHHHHH---------TTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccccCcCccc-HHHHHHHH---------HHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence            7765432211 11111110         01111111     123567789999999999999999999999999999987


Q ss_pred             hh
Q 016588          360 KE  361 (386)
Q Consensus       360 ~~  361 (386)
                      +.
T Consensus       337 ~~  338 (342)
T 1b6c_B          337 QE  338 (342)
T ss_dssp             TT
T ss_pred             Hh
Confidence            63

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=8.7e-45  Score=341.97  Aligned_cols=276  Identities=17%  Similarity=0.198  Sum_probs=210.9

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCC---------CcEEEEEECCCCChhHHHHHHHHHHcCCCCcccc------------
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQD---------GMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVT------------  140 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~------------  140 (386)
                      .++|++.+.||+|+||.||+|....         ++.||+|.....  +.+.+|+++++.++||||++            
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  118 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA  118 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence            3678999999999999999999653         788999987543  57889999999999999998            


Q ss_pred             ---cccceee-CCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee
Q 016588          141 ---LLGYCQE-NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV  216 (386)
Q Consensus       141 ---~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill  216 (386)
                         +++++.. .+..|+||||+ +++|.+++...   ....+++..+..++.|++.||.|||+  ++|+||||||+|||+
T Consensus       119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS---PKHVLSERSVLQVACRLLDALEFLHE--NEYVHGNVTAENIFV  192 (352)
T ss_dssp             CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCCGGGEEE
T ss_pred             ccchhhccccCCcEEEEEecCC-CcCHHHHHHhC---CcCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCHHHEEE
Confidence               4555555 67889999999 99999998532   23678999999999999999999999  779999999999999


Q ss_pred             CCCC--ceEEcccccccccCCCCCC-----CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCC
Q 016588          217 DEDF--IAKVADAGLRNFLGRTDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS  289 (386)
Q Consensus       217 ~~~~--~~kl~DFgl~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~  289 (386)
                      +.++  .+||+|||+++........     .......+|+.|+|||.+.+..++.++|||||||++|||++|..||....
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            9998  9999999999876542211     12234578899999999999999999999999999999999999998755


Q ss_pred             CCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh-ccccccc
Q 016588          290 PDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE-MNLTTVM  368 (386)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~-~~~~~~~  368 (386)
                      ... .............  .........   .....++++.+++.+||+.||++|||++++++.|++++++. ....+..
T Consensus       273 ~~~-~~~~~~~~~~~~~--~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~  346 (352)
T 2jii_A          273 PNT-EDIMKQKQKFVDK--PGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPI  346 (352)
T ss_dssp             TCH-HHHHHHHHHHHHS--CCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCC
T ss_pred             cCH-HHHHHHHHhccCC--hhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccc
Confidence            322 1111111111000  000000000   00122466899999999999999999999999999999774 3444444


Q ss_pred             CCC
Q 016588          369 GEG  371 (386)
Q Consensus       369 ~~~  371 (386)
                      .|.
T Consensus       347 dw~  349 (352)
T 2jii_A          347 GLP  349 (352)
T ss_dssp             CCC
T ss_pred             cCc
Confidence            443

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.3e-44  Score=338.97  Aligned_cols=253  Identities=19%  Similarity=0.291  Sum_probs=201.9

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECC--------CCChhHHHHHHHHHHcCCCCcccccccceeeCCeEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP--------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  152 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  152 (386)
                      .++|++.+.||+|+||.||+|..+ +++.||+|++.        ....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            357889999999999999999965 58999999743        124567899999999999999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc---eEEccccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI---AKVADAGL  229 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~---~kl~DFgl  229 (386)
                      +||||+++++|.+.+.... .....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRA-DAGFVYSEAVASHYMRQILEALRYCHD--NNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999987774321 123457899999999999999999999  77999999999999986654   99999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccch
Q 016588          230 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL  309 (386)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  309 (386)
                      +........  ......+|+.|+|||++.+..++.++|||||||++|||++|..||....    ......+.....    
T Consensus       180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~i~~~~~----  249 (351)
T 3c0i_A          180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFEGIIKGKY----  249 (351)
T ss_dssp             CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHHHHHHHTCC----
T ss_pred             eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHHHHHHcCCC----
Confidence            987654221  1234568999999999999999999999999999999999999998632    122221111100    


Q ss_pred             hhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                        ...+..+..    .++++.+++.+||+.||++|||+.|++++
T Consensus       250 --~~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          250 --KMNPRQWSH----ISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             --CCCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --CCCcccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              011111222    23568999999999999999999999975

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=340.94  Aligned_cols=250  Identities=18%  Similarity=0.209  Sum_probs=189.0

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeec
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  159 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  159 (386)
                      .++|+..+.||+|+||.||+|... +++.||+|..... ..+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  131 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT  131 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence            467889999999999999999976 4789999986543 34567889999999999999999999999999999999999


Q ss_pred             CCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC---CCceEEcccccccccCCC
Q 016588          160 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       160 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~---~~~~kl~DFgl~~~~~~~  236 (386)
                      +++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.   ++.+||+|||+++.....
T Consensus       132 ~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          132 GGELFDRIV-----EKGYYSERDAADAVKQILEAVAYLHE--NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             SCBHHHHHT-----TCSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             CCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            999998884     34568899999999999999999999  77999999999999975   889999999999876432


Q ss_pred             CCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchh
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  316 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (386)
                      .   ......+|+.|+|||++.+..++.++|||||||++|||++|..||......  ......+.....          .
T Consensus       205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~i~~~~~----------~  269 (349)
T 2w4o_A          205 V---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--QFMFRRILNCEY----------Y  269 (349)
T ss_dssp             -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--HHHHHHHHTTCC----------C
T ss_pred             c---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--HHHHHHHHhCCC----------c
Confidence            1   223456889999999999999999999999999999999999999764431  111111111100          0


Q ss_pred             hcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          317 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .........+.++.+++.+||+.||++|||+.|++++
T Consensus       270 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          270 FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0011112344678999999999999999999999975

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.8e-45  Score=332.95  Aligned_cols=255  Identities=29%  Similarity=0.420  Sum_probs=201.2

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCC-ChhHHHHHHHHHHcCCCCcccccccceee-CCeEEEEEEee
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQE-NNLQFLIYEYI  158 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~  158 (386)
                      ..++|+..+.||+|+||.||++..+ +..||+|..... ..+.+.+|+.+++.++||||+++++++.. .+..++||||+
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   97 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   97 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             ChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence            3467889999999999999999875 789999986644 45678999999999999999999998654 45789999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++++|.+++...   ....+++..+..++.|++.||.|||+  ++++||||||+||+++.++.+||+|||++....... 
T Consensus        98 ~~~~L~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  171 (278)
T 1byg_A           98 AKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  171 (278)
T ss_dssp             TTEEHHHHHHHH---HHHHCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCHHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHHh--CCccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence            999999988421   12337888999999999999999999  779999999999999999999999999987654321 


Q ss_pred             CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhh
Q 016588          239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  317 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (386)
                          ....++..|+|||.+.+..++.++||||||+++|||++ |..||.....   ......+.             ...
T Consensus       172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~~-------------~~~  231 (278)
T 1byg_A          172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVE-------------KGY  231 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHHT-------------TTC
T ss_pred             ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHh-------------cCC
Confidence                22346778999999999999999999999999999998 9999876542   12221111             111


Q ss_pred             cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhc
Q 016588          318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  362 (386)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~  362 (386)
                      ....+...++.+.+++.+||+.||++|||+.++++.|+++.....
T Consensus       232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~~  276 (278)
T 1byg_A          232 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL  276 (278)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhhc
Confidence            123334455779999999999999999999999999999887654

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.1e-44  Score=340.88  Aligned_cols=247  Identities=19%  Similarity=0.284  Sum_probs=202.9

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeCC-CcEEEEEECCC------CChhHHHHHHHHHHcC-CCCcccccccceeeCCeEE
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPG------APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQF  152 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~------~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  152 (386)
                      ..++|+..+.||+|+||.||+|..+. ++.||+|+...      ...+.+..|..++..+ +||||+++++++.+.+..|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            45789999999999999999999764 78999998542      3456688899999988 7999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~  232 (386)
                      +||||+++|+|.+++.     ....+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+++.
T Consensus        98 lv~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQ-----QVGRFKEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  170 (353)
T ss_dssp             EEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEeCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence            9999999999998884     23568899999999999999999999  7799999999999999999999999999986


Q ss_pred             cCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          233 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      ....  ........||+.|+|||++.+..++.++|||||||++|||++|..||.+...   ..+...+..          
T Consensus       171 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~~i~~----------  235 (353)
T 2i0e_A          171 NIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIME----------  235 (353)
T ss_dssp             CCCT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH----------
T ss_pred             cccC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH---HHHHHHHHh----------
Confidence            4321  1223456789999999999999999999999999999999999999986432   222221111          


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHH
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTE  353 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~evl~~  353 (386)
                        ..  ..++...+.++.+++.+||+.||.+||+     ++++++|
T Consensus       236 --~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          236 --HN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             --CC--CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             --CC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence              11  1233345577899999999999999995     4777655

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=342.78  Aligned_cols=260  Identities=13%  Similarity=0.155  Sum_probs=212.8

Q ss_pred             HHhcCCCcCCeecccCceEEEEEE------eCCCcEEEEEECCCCChhHHHHHHHHHHcCC---CCcccccccceeeCCe
Q 016588           80 LATKNFSDKNLIGEGKFGEVYKGL------LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ---HRNLVTLLGYCQENNL  150 (386)
Q Consensus        80 ~~~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~  150 (386)
                      ...++|...+.||+|+||+||+|.      ..+++.||+|........++..|..++..++   |+|++++++++...+.
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~  141 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG  141 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence            345678889999999999999994      4457899999988888889999999999886   9999999999999999


Q ss_pred             EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-----------C
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-----------D  219 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~-----------~  219 (386)
                      .|+||||+++|+|.+++..........+++..+..++.|++.||.|||+  .+|+||||||+|||++.           +
T Consensus       142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~--~~ivHrDiKp~NIll~~~~~~~~~~~~~~  219 (365)
T 3e7e_A          142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD--CEIIHGDIKPDNFILGNGFLEQDDEDDLS  219 (365)
T ss_dssp             EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECGGGTCC------C
T ss_pred             cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh--CCeecCCCCHHHEEecccccCcccccccc
Confidence            9999999999999999854322345679999999999999999999999  77999999999999998           8


Q ss_pred             CceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHH
Q 016588          220 FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVEL  299 (386)
Q Consensus       220 ~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~  299 (386)
                      +.+||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||++|+.||........      
T Consensus       220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------  293 (365)
T 3e7e_A          220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC------  293 (365)
T ss_dssp             TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE------
T ss_pred             CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce------
Confidence            99999999999765432222233455789999999999999999999999999999999999999865332110      


Q ss_pred             HHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCC-CCHHHHHHHHHHhhhhhc
Q 016588          300 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERR-PSMSDVVTELDRTLDKEM  362 (386)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R-pt~~evl~~L~~~~~~~~  362 (386)
                              ..    .... ...  ...+.+.+++..|++.+|.+| |++.++.+.|++++++..
T Consensus       294 --------~~----~~~~-~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~  342 (365)
T 3e7e_A          294 --------KP----EGLF-RRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY  342 (365)
T ss_dssp             --------EE----CSCC-TTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             --------ee----chhc-ccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence                    00    0000 011  124567899999999999999 688899999999887743

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-44  Score=344.75  Aligned_cols=250  Identities=20%  Similarity=0.271  Sum_probs=203.2

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC---hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      .++|++.+.||+|+||.||+|... +++.||+|......   ...+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            357899999999999999999965 58899999865443   34688999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC--CCceEEcccccccccCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE--DFIAKVADAGLRNFLGR  235 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~--~~~~kl~DFgl~~~~~~  235 (386)
                      +++++|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.  ++.+||+|||++.....
T Consensus       130 ~~gg~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          130 LSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             CCCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             CCCCcHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            999999988842    23468999999999999999999999  77999999999999974  57899999999987643


Q ss_pred             CCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      ..   ......+|+.|+|||++.+..++.++|||||||++|||++|..||.+...   ......+.....      ..++
T Consensus       204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~i~~~~~------~~~~  271 (387)
T 1kob_A          204 DE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQNVKRCDW------EFDE  271 (387)
T ss_dssp             TS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHHCCC------CCCS
T ss_pred             Cc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCC------CCCc
Confidence            22   22345689999999999999999999999999999999999999986432   111111111100      0011


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                          ......++++.+++.+||+.||++|||+.|++++
T Consensus       272 ----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          272 ----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             ----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                1112345678999999999999999999999986

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.1e-44  Score=333.28  Aligned_cols=260  Identities=20%  Similarity=0.261  Sum_probs=196.4

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      ++|+..+.||+|+||+||+|... +++.||+|+.....     .+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57888999999999999999965 48999999854433     2457789999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      |+++++|..++.     ....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++......
T Consensus        83 ~~~~~~l~~~~~-----~~~~~~~~~~~~i~~~l~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           83 YCDHTVLHELDR-----YQRGVPEHLVKSITWQTLQAVNFCHK--HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             CCSEEHHHHHHH-----TSSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             eCCCchHHHHHh-----hhcCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            999999988773     34568899999999999999999999  77999999999999999999999999999876432


Q ss_pred             CCCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccc-hhh---
Q 016588          237 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN-LLK---  311 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~---  311 (386)
                      ..  ......+++.|+|||.+.+ ..++.++||||||+++|||++|..||.+.......  ............ ...   
T Consensus       156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  231 (311)
T 4agu_A          156 SD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL--YLIRKTLGDLIPRHQQVFS  231 (311)
T ss_dssp             ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCSCCHHHHHHHH
T ss_pred             cc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhcccccccccccc
Confidence            21  2234467888999999876 56799999999999999999999999875532211  111111000000 000   


Q ss_pred             ---------hcchhhc---ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          312 ---------ILDERLW---STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       312 ---------~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                               ..++...   ....+..+.++.+++.+||+.||++|||++|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence                     0000000   00001244668999999999999999999999976

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=334.67  Aligned_cols=262  Identities=23%  Similarity=0.277  Sum_probs=197.3

Q ss_pred             HhcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCC--------CChhHHHHHHHHHHcC---CCCcccccccceeeC
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG--------APTQEFIDEVCFLASI---QHRNLVTLLGYCQEN  148 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~--------~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~  148 (386)
                      ..++|+..+.||+|+||+||+|.. .+++.||+|....        .....+.+|+.+++.+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            356899999999999999999995 4689999997431        1234677888877766   499999999999775


Q ss_pred             C-----eEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceE
Q 016588          149 N-----LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAK  223 (386)
Q Consensus       149 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~k  223 (386)
                      .     ..++||||+. ++|.+++...   ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+|
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKA---PPPGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTC---CTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCTTTEEECTTSCEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCEE
Confidence            4     5799999997 5888888532   23448999999999999999999999  6799999999999999999999


Q ss_pred             EcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhh
Q 016588          224 VADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS  303 (386)
Q Consensus       224 l~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~  303 (386)
                      |+|||+++.....   .......+|+.|+|||++.+..++.++|||||||++|||++|..||.......  .+.......
T Consensus       161 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~  235 (308)
T 3g33_A          161 LADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFDLI  235 (308)
T ss_dssp             ECSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH--HHHHHHHHH
T ss_pred             EeeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHh
Confidence            9999999876432   22345678999999999999999999999999999999999999998754321  111111111


Q ss_pred             hc--ccchh---hh----cch---hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          304 RD--FSNLL---KI----LDE---RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       304 ~~--~~~~~---~~----~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ..  .....   ..    +.+   .......+..++++.+++.+||+.||++|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            00  00000   00    000   00000112234678999999999999999999999976

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.6e-44  Score=326.77  Aligned_cols=251  Identities=21%  Similarity=0.313  Sum_probs=202.8

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC----CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      .++|+..+.||+|+||.||+|... +++.||+|....    ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            357888999999999999999965 588999998532    224578899999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      |+++++|.+++.     ....+++..+..++.|++.||.|||+  ++++||||||+||+++.++.+||+|||++......
T Consensus        86 ~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           86 YCSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             CCTTEEGGGGSB-----TTTBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             ecCCCcHHHHHh-----hccCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            999999999884     33568899999999999999999999  77999999999999999999999999998765433


Q ss_pred             CCCCCCccccCcccccchhhhcccCC-CcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      ..........+++.|+|||.+.+..+ +.++||||||+++|||++|..||........ ....+... ..          
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~-~~----------  226 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEK-KT----------  226 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHTT-CT----------
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhhc-cc----------
Confidence            22223345568889999999987665 7789999999999999999999987554221 11111110 00          


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                        ........+..+.+++.+||+.||++|||++|++++
T Consensus       227 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          227 --YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             --TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence              001112234668999999999999999999999875

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.7e-44  Score=350.21  Aligned_cols=244  Identities=23%  Similarity=0.294  Sum_probs=203.4

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC------CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      .+|...+.||+|+||.||+|... +++.||||++..      .....+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            57888999999999999999965 689999998542      23457889999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.....
T Consensus        96 E~~~gg~L~~~l~-----~~~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           96 EYVSGGELFDYIC-----KNGRLDEKESRRLFQQILSGVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             ECCSSEEHHHHTT-----SSSSCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             eCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            9999999999884     34568999999999999999999999  7799999999999999999999999999987644


Q ss_pred             CCCCCCCccccCcccccchhhhcccCC-CcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                      ..   ......+|+.|+|||++.+..+ +.++|||||||++|||++|..||.....   ..+...+..            
T Consensus       169 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~------------  230 (476)
T 2y94_A          169 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---PTLFKKICD------------  230 (476)
T ss_dssp             TC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---HHHHHHHHT------------
T ss_pred             cc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---HHHHHHHhc------------
Confidence            22   2334568999999999988766 6899999999999999999999986442   112111111            


Q ss_pred             hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ..  ...+...++++.+++.+||+.||++|||++|++++
T Consensus       231 ~~--~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          231 GI--FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             TC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             CC--cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence            10  01222344678999999999999999999999975

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=340.45  Aligned_cols=264  Identities=16%  Similarity=0.153  Sum_probs=196.9

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC----CCcEEEEEECCCCC--------------hhHHHHHHHHHHcCCCCccccccc
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAP--------------TQEFIDEVCFLASIQHRNLVTLLG  143 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--------------~~~~~~e~~~l~~l~h~niv~~~~  143 (386)
                      .++|...+.||+|+||.||+|...    ++..+|+|......              ...+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            357888999999999999999965    46789999855432              123567788888999999999999


Q ss_pred             ceee----CCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC
Q 016588          144 YCQE----NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED  219 (386)
Q Consensus       144 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~  219 (386)
                      ++..    .+..|+||||+ +++|.+++..     ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.+
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ-----NGTFKKSTVLQLGIRMLDVLEYIHE--NEYVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBG-----GGBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEESS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCcCHHHEEEccC
Confidence            9887    77899999999 8999998842     3378999999999999999999999  679999999999999887


Q ss_pred             C--ceEEcccccccccCCCCCC-----CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCc
Q 016588          220 F--IAKVADAGLRNFLGRTDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS  292 (386)
Q Consensus       220 ~--~~kl~DFgl~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~  292 (386)
                      +  .+||+|||+++........     .......+|..|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence            7  9999999999876432211     11234568899999999999999999999999999999999999996533221


Q ss_pred             hhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhh
Q 016588          293 SQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD  359 (386)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~  359 (386)
                      .. .........  ..........   ......++++.+++.+||+.||++|||++++++.|+++..
T Consensus       268 ~~-~~~~~~~~~--~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          268 VA-VQTAKTNLL--DELPQSVLKW---APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HH-HHHHHHHHH--HTTTHHHHHH---SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HH-HHHHHHhhc--ccccHHHHhh---ccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            11 111110000  0000000000   0011334679999999999999999999999999977543

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.9e-44  Score=343.69  Aligned_cols=272  Identities=19%  Similarity=0.305  Sum_probs=212.3

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC----CChhHHHHHHHHHHcCCCCcccccccceeeCC--eEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENN--LQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~  155 (386)
                      ++|.+.+.||+|+||+||+|... +++.||+|.+..    ...+.+.+|+++++.++||||+++++++...+  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            56888999999999999999965 489999998653    33466889999999999999999999988654  779999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee----CCCCceEEccccccc
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRN  231 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill----~~~~~~kl~DFgl~~  231 (386)
                      ||+++|+|.+++....  ....+++..+..++.|++.||.|||+  ++|+||||||+|||+    +.++.+||+|||+++
T Consensus        89 e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             CCCTTEEHHHHTTSGG--GTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             ecCCCCCHHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHH--CCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            9999999999985431  22348999999999999999999999  779999999999999    788889999999998


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhcc--------cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCc-hhhHHHHHHh
Q 016588          232 FLGRTDVAGPSSQVTADEIFLASEVKEF--------RRFSEKSDVYSFGVFLLELVSGREASSSLSPDS-SQDLVELVQN  302 (386)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~-~~~~~~~~~~  302 (386)
                      .......   .....+|+.|+|||++.+        ..++.++|||||||++|||++|..||....... ..........
T Consensus       165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             ECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             EccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            7654321   233568889999999875        567889999999999999999999997654322 1122211111


Q ss_pred             hhcccch---hhhcc--------hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          303 SRDFSNL---LKILD--------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       303 ~~~~~~~---~~~~~--------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                      .......   .....        ...........+..+.+++.+||+.||++|||+.++++.+++++++.
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~  311 (396)
T 4eut_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM  311 (396)
T ss_dssp             SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred             CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence            1110000   00000        00112344677888999999999999999999999999999998764

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-45  Score=351.42  Aligned_cols=260  Identities=21%  Similarity=0.239  Sum_probs=205.3

Q ss_pred             CHHHHHHHhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcCCCCccccccccee
Q 016588           74 QMEELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQ  146 (386)
Q Consensus        74 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~  146 (386)
                      ..++.....++|+..+.||+|+||.||++..+ +++.||+|++...      ..+.+.+|..++..++||||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            44555566789999999999999999999975 6899999986432      2345788999999999999999999999


Q ss_pred             eCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcc
Q 016588          147 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVAD  226 (386)
Q Consensus       147 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D  226 (386)
                      +.+..|+||||+++|+|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++++||+|
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~----~~~~l~~~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~NILld~~g~vkL~D  205 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSK----FGERIPAEMARFYLAEIVMAIDSVHR--LGYVHRDIKPDNILLDRCGHIRLAD  205 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHH----HSSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECC
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccCHHHeeecCCCCEEEee
Confidence            99999999999999999999842    23468899999999999999999999  7799999999999999999999999


Q ss_pred             cccccccCCCCCCCCCccccCcccccchhhhc-------ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHH
Q 016588          227 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKE-------FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVEL  299 (386)
Q Consensus       227 Fgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~  299 (386)
                      ||+++....... .......||+.|+|||++.       ...|+.++|||||||++|||++|..||.....   ......
T Consensus       206 FGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~  281 (412)
T 2vd5_A          206 FGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST---AETYGK  281 (412)
T ss_dssp             CTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHH
T ss_pred             chhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH---HHHHHH
Confidence            999987644221 1123457899999999987       35689999999999999999999999986442   111111


Q ss_pred             HHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCC---CCHHHHHHH
Q 016588          300 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERR---PSMSDVVTE  353 (386)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---pt~~evl~~  353 (386)
                      +......     ..    .+......++++.+++.+||+ +|++|   |+++|+++|
T Consensus       282 i~~~~~~-----~~----~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          282 IVHYKEH-----LS----LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             HHTHHHH-----CC----CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             HHhcccC-----cC----CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            1110000     00    011112345678999999999 99998   589998876

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=5.5e-45  Score=339.56  Aligned_cols=250  Identities=21%  Similarity=0.302  Sum_probs=181.1

Q ss_pred             CCeecccCceEEEEEEeC-CCcEEEEEECCCCChhHHHHHHHHHHcCC-CCcccccccceeeCCeEEEEEEeecCCCccc
Q 016588           88 KNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEYIPNGSVSI  165 (386)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~  165 (386)
                      .+.||+|+||.||+|... +++.||+|+........+.+|+.+++.+. ||||+++++++.+.+..|+||||+++|+|.+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~   95 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFE   95 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHH
Confidence            478999999999999965 58999999987766778899999999996 9999999999999999999999999999999


Q ss_pred             cccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC---ceEEcccccccccCCCCCCCCC
Q 016588          166 HLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF---IAKVADAGLRNFLGRTDVAGPS  242 (386)
Q Consensus       166 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~---~~kl~DFgl~~~~~~~~~~~~~  242 (386)
                      ++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++   .+||+|||+++......  ...
T Consensus        96 ~l~-----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~  166 (325)
T 3kn6_A           96 RIK-----KKKHFSETEASYIMRKLVSAVSHMHD--VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPL  166 (325)
T ss_dssp             HHH-----HCSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred             HHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--Ccc
Confidence            884     34568999999999999999999999  7799999999999997665   89999999998654322  222


Q ss_pred             ccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCch-hhHHHHHHhhhcccchhhhcchhhcccC
Q 016588          243 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS-QDLVELVQNSRDFSNLLKILDERLWSTF  321 (386)
Q Consensus       243 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (386)
                      ....+|+.|+|||++.+..++.++|||||||++|||++|..||........ ....+......... .  ......+   
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~-~--~~~~~~~---  240 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD-F--SFEGEAW---  240 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC-C--CCCSHHH---
T ss_pred             cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC-C--CCCcccc---
Confidence            344678899999999999999999999999999999999999987553211 11111111111000 0  0001111   


Q ss_pred             CHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          322 TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       322 ~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                       ...++++.+++.+||+.||++|||++|++++
T Consensus       241 -~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          241 -KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             -HTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             -cCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence             1234678999999999999999999999865

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2e-44  Score=363.40  Aligned_cols=248  Identities=23%  Similarity=0.365  Sum_probs=199.6

Q ss_pred             CeecccCceEEEEEEeC---CCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecC
Q 016588           89 NLIGEGKFGEVYKGLLQ---DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      +.||+|+||.||+|.+.   .+..||||+++...     .+++.+|+.+++.++||||+++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            37999999999999753   35789999865432     3578999999999999999999999865 457899999999


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC-C
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV-A  239 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~-~  239 (386)
                      |+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus       454 g~L~~~l~-----~~~~l~~~~~~~i~~qi~~~L~yLH~--~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          454 GPLNKYLQ-----QNRHVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             EEHHHHHH-----HCTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            99999983     34568899999999999999999999  7799999999999999999999999999987654322 1


Q ss_pred             CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          240 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       240 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                      .......+|..|+|||++.+..++.++|||||||++|||++ |..||.+...   ......+.             ....
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~~~~i~-------------~~~~  590 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLE-------------KGER  590 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHH-------------TTCC
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH-------------cCCC
Confidence            22233456778999999999999999999999999999998 9999987543   12222111             1122


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      ...+..+++++.+++.+||+.||++|||+.++++.|+++..+
T Consensus       591 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  632 (635)
T 4fl3_A          591 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  632 (635)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            234445667899999999999999999999999999998765

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=5.8e-45  Score=340.78  Aligned_cols=239  Identities=21%  Similarity=0.317  Sum_probs=199.3

Q ss_pred             hcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC-----------ChhHHHHHHHHHHcCCCCcccccccceeeCC
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----------PTQEFIDEVCFLASIQHRNLVTLLGYCQENN  149 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  149 (386)
                      .++|+..+.||+|+||.||+|.. .++..||+|.....           ..+.+.+|+.+++.++||||+++++++.+.+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            46789999999999999999995 45889999975432           2345778999999999999999999999999


Q ss_pred             eEEEEEEeecCC-CccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccc
Q 016588          150 LQFLIYEYIPNG-SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  228 (386)
Q Consensus       150 ~~~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFg  228 (386)
                      ..++||||+..| +|..++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~-----~~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFID-----RHPRLDEPLASYIFRQLVSAVGYLRL--KDIIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHH-----TCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEEEeCCCCccHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEEeccCHHHEEEcCCCcEEEeecc
Confidence            999999999777 8888873     34568999999999999999999999  779999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhcccCC-CcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhccc
Q 016588          229 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS  307 (386)
Q Consensus       229 l~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  307 (386)
                      ++.......   ......+|+.|+|||++.+..+ +.++|||||||++|||++|..||......                
T Consensus       176 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------  236 (335)
T 3dls_A          176 SAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------------  236 (335)
T ss_dssp             TCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------
T ss_pred             cceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------
Confidence            998764422   2334568999999999988877 88999999999999999999999752210                


Q ss_pred             chhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          308 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                           .....  ..+...++++.+++.+||+.||++|||+++++++
T Consensus       237 -----~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          237 -----VEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -----TTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -----Hhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 00000  1112234678999999999999999999999987

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.1e-44  Score=339.62  Aligned_cols=253  Identities=19%  Similarity=0.310  Sum_probs=202.0

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCChhHHHHHHHHHHcC-CCCcccccccceeeCCeEEEEEEeec
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIP  159 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  159 (386)
                      .++|+..+.||+|+||.||+|..+ +++.||+|.+.... ....+|++++.++ +||||+++++++.+.+..|+||||++
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~   99 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMK   99 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT-CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc-CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCC
Confidence            457889999999999999999965 58899999865443 3456788888887 79999999999999999999999999


Q ss_pred             CCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC----CceEEcccccccccCC
Q 016588          160 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED----FIAKVADAGLRNFLGR  235 (386)
Q Consensus       160 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~----~~~kl~DFgl~~~~~~  235 (386)
                      +|+|.+++.     ....+++..+..++.|++.||.|||+  +||+||||||+|||+.++    +.+||+|||+++....
T Consensus       100 gg~L~~~i~-----~~~~~~~~~~~~~~~qi~~al~~lH~--~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~  172 (342)
T 2qr7_A          100 GGELLDKIL-----RQKFFSEREASAVLFTITKTVEYLHA--QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA  172 (342)
T ss_dssp             SCBHHHHHH-----TCTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred             CCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence            999998884     34568999999999999999999999  779999999999998433    3599999999987643


Q ss_pred             CCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      ..  .......+|+.|+|||++.+..|+.++|||||||++|||++|..||..........+...+.....          
T Consensus       173 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~----------  240 (342)
T 2qr7_A          173 EN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKF----------  240 (342)
T ss_dssp             TT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCC----------
T ss_pred             CC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCc----------
Confidence            22  223345678999999999988899999999999999999999999986543333333322221110          


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                      ..........++++.+++.+||+.||++|||+.+++++-
T Consensus       241 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp  279 (342)
T 2qr7_A          241 SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP  279 (342)
T ss_dssp             CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred             ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence            001111223456789999999999999999999999764

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.3e-45  Score=345.02  Aligned_cols=268  Identities=21%  Similarity=0.253  Sum_probs=204.6

Q ss_pred             ccCHHHHHHHhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC--hhHHHHHHHHHHcCC-----CCccccccc
Q 016588           72 RFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP--TQEFIDEVCFLASIQ-----HRNLVTLLG  143 (386)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~e~~~l~~l~-----h~niv~~~~  143 (386)
                      .+...+.....++|.+.+.||+|+||+||+|... +++.||+|......  ...+..|..+++.++     ||||+++++
T Consensus        24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~  103 (360)
T 3llt_A           24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHG  103 (360)
T ss_dssp             SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred             eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence            3444444455678999999999999999999964 58899999876432  345778999999886     999999999


Q ss_pred             ceeeCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-----
Q 016588          144 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-----  218 (386)
Q Consensus       144 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~-----  218 (386)
                      ++...+..++||||+ +++|.+++...   ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.     
T Consensus       104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~~  177 (360)
T 3llt_A          104 KFMYYDHMCLIFEPL-GPSLYEIITRN---NYNGFHIEDIKLYCIEILKALNYLRK--MSLTHTDLKPENILLDDPYFEK  177 (360)
T ss_dssp             EEEETTEEEEEECCC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCTTCCE
T ss_pred             eeeECCeeEEEEcCC-CCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCcccEEEccccccc
Confidence            999999999999999 88999888432   23458899999999999999999999  77999999999999975     


Q ss_pred             --------------------CCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHH
Q 016588          219 --------------------DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLEL  278 (386)
Q Consensus       219 --------------------~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el  278 (386)
                                          ++.+||+|||++......     .....+|+.|+|||++.+..++.++|||||||++|||
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el  252 (360)
T 3llt_A          178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL  252 (360)
T ss_dssp             EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred             cccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence                                789999999999865432     2345678899999999999999999999999999999


Q ss_pred             HcCCCCCCCCCCCchhhHHHHHHhhhc-cc--chh--------hhcch-hh---cccC-----------------CHHHH
Q 016588          279 VSGREASSSLSPDSSQDLVELVQNSRD-FS--NLL--------KILDE-RL---WSTF-----------------TNEGM  326 (386)
Q Consensus       279 ~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~--~~~--------~~~~~-~~---~~~~-----------------~~~~~  326 (386)
                      ++|+.||.......   .......... ..  ...        ...+. ..   +...                 .....
T Consensus       253 l~g~~pf~~~~~~~---~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  329 (360)
T 3llt_A          253 YTGSLLFRTHEHME---HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKH  329 (360)
T ss_dssp             HHSSCSCCCSSHHH---HHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCC
T ss_pred             HHCCCCCCCCcHHH---HHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchH
Confidence            99999998754321   1111111100 00  000        00000 00   0000                 00012


Q ss_pred             HHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          327 EEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       327 ~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      +.+.+++.+||+.||++|||+.|++++
T Consensus       330 ~~l~~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          330 ELFCDFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            568899999999999999999999865

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.1e-44  Score=340.59  Aligned_cols=244  Identities=28%  Similarity=0.410  Sum_probs=196.8

Q ss_pred             cCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCCC------hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      +.|+..+.||+|+||+||+|.. .+++.||+|+.....      .+.+.+|+++++.++||||+++++++...+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4588889999999999999995 568999999854322      245789999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+. |+|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.....
T Consensus       134 e~~~-g~l~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             ECCS-EEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             ecCC-CCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            9997 577666632    24568899999999999999999999  6799999999999999999999999999986543


Q ss_pred             CCCCCCCccccCcccccchhhhc---ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          236 TDVAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                            .....+|+.|+|||++.   ...++.++|||||||++|||++|..||.....  ...+.......         
T Consensus       207 ------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~--~~~~~~~~~~~---------  269 (348)
T 1u5q_A          207 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQNE---------  269 (348)
T ss_dssp             ------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSC---------
T ss_pred             ------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhcC---------
Confidence                  22356889999999985   46789999999999999999999999976442  11111111100         


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                       .+   ...+...++.+.+++.+||+.||++|||+++++++.
T Consensus       270 -~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~  307 (348)
T 1u5q_A          270 -SP---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  307 (348)
T ss_dssp             -CC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             -CC---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence             00   111223456789999999999999999999999764

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.6e-45  Score=349.10  Aligned_cols=261  Identities=22%  Similarity=0.327  Sum_probs=188.2

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCC-CCcccccccceeeC--CeEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQ-HRNLVTLLGYCQEN--NLQF  152 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~  152 (386)
                      .++|+..+.||+|+||.||+|... +++.||+|++...     ....+.+|+.+++.+. ||||+++++++...  ...|
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            468999999999999999999954 5899999986432     2345778999999997 99999999998754  3789


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~  232 (386)
                      +||||++ ++|..++.      ...+++..+..++.|++.||.|||+  .||+||||||+|||++.++.+||+|||+++.
T Consensus        88 lv~e~~~-~~L~~~~~------~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIR------ANILEPVHKQYVVYQLIKVIKYLHS--GGLLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             EEEECCS-EEHHHHHH------HTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEecccC-cCHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            9999997 58877773      2468889999999999999999999  7799999999999999999999999999986


Q ss_pred             cCCCC-------------------CCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCc
Q 016588          233 LGRTD-------------------VAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDS  292 (386)
Q Consensus       233 ~~~~~-------------------~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~  292 (386)
                      .....                   .........+|+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            53211                   1112334578999999999986 678999999999999999999999998754321


Q ss_pred             hhhHHHHHHhh--hcccchhhhcc-----------------hh-h------------cccCCHHHHHHHHHHHhHccCCC
Q 016588          293 SQDLVELVQNS--RDFSNLLKILD-----------------ER-L------------WSTFTNEGMEEFIQLIVRCLDPS  340 (386)
Q Consensus       293 ~~~~~~~~~~~--~~~~~~~~~~~-----------------~~-~------------~~~~~~~~~~~l~~li~~cl~~d  340 (386)
                        .+.......  +....+.....                 .. .            .......+++++.+|+.+||+.|
T Consensus       239 --~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d  316 (388)
T 3oz6_A          239 --QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN  316 (388)
T ss_dssp             --HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred             --HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence              111111100  00000000000                 00 0            00011123467899999999999


Q ss_pred             CCCCCCHHHHHHH
Q 016588          341 SERRPSMSDVVTE  353 (386)
Q Consensus       341 p~~Rpt~~evl~~  353 (386)
                      |++|||++|+++|
T Consensus       317 P~~R~t~~e~l~H  329 (388)
T 3oz6_A          317 PNKRISANDALKH  329 (388)
T ss_dssp             GGGSCCHHHHTTS
T ss_pred             cccCCCHHHHhCC
Confidence            9999999999987

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=8.6e-44  Score=331.93  Aligned_cols=257  Identities=18%  Similarity=0.251  Sum_probs=202.2

Q ss_pred             hcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCCChhHHHHHHHHHHcCC-CCcccccccceee--CCeEEEEEEe
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLASIQ-HRNLVTLLGYCQE--NNLQFLIYEY  157 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~e~  157 (386)
                      .++|+..+.||+|+||+||+|.. .+++.||+|.......+.+.+|+.+++.++ ||||+++++++..  ....++||||
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~  114 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH  114 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence            35788999999999999999985 468999999988888889999999999997 9999999999987  6678999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC-ceEEcccccccccCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNFLGRT  236 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~-~~kl~DFgl~~~~~~~  236 (386)
                      +.+++|..++.        .+++..+..++.|++.||.|||+  ++|+||||||+|||++.++ .+||+|||+++.....
T Consensus       115 ~~~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          115 VNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             CCCCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             cCchhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            99999988772        37888999999999999999999  7799999999999999776 8999999999876432


Q ss_pred             CCCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          237 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      .   ......++..|+|||.+.+ ..++.++|||||||++|||++|..||...... ...+....... ........++.
T Consensus       185 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~l~~~~~~~-~~~~~~~~~~~  259 (330)
T 3nsz_A          185 Q---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVRIAKVL-GTEDLYDYIDK  259 (330)
T ss_dssp             C---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH-HHHHHHHHHHH-CHHHHHHHHHH
T ss_pred             C---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch-HHHHHHHHHhc-CCchhhhHHHH
Confidence            2   2234567888999999877 67899999999999999999999999654331 11111111100 00000000000


Q ss_pred             -----------------------hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          316 -----------------------RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       316 -----------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                                             ..........++++.+++.+||+.||++|||++|++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                                   00011112245779999999999999999999999975

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.7e-44  Score=347.96  Aligned_cols=257  Identities=20%  Similarity=0.282  Sum_probs=191.8

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeC------C
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN------N  149 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  149 (386)
                      .++|+..+.||+|+||+||+|... +++.||||++...     ..+.+.+|+.+++.++||||+++++++...      +
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            467899999999999999999954 5889999986432     234678999999999999999999998654      4


Q ss_pred             eEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 016588          150 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  229 (386)
Q Consensus       150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl  229 (386)
                      ..|+||||++++ |...+.       ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+
T Consensus       141 ~~~lv~E~~~~~-l~~~~~-------~~l~~~~~~~~~~qil~aL~~lH~--~~iiHrDlkp~NIll~~~~~~kl~DFG~  210 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChHhEEEeCCCCEEEEEEEe
Confidence            679999999865 544442       237889999999999999999999  6799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcc-c-
Q 016588          230 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF-S-  307 (386)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~-  307 (386)
                      ++.....   .......+|+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..  ..+...+...... . 
T Consensus       211 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~--~~~~~i~~~lg~p~~~  285 (464)
T 3ttj_A          211 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI--DQWNKVIEQLGTPCPE  285 (464)
T ss_dssp             C-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCSCCHH
T ss_pred             eeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCHH
Confidence            9876432   2234567899999999999999999999999999999999999999875421  1111111110000 0 


Q ss_pred             ----------------------chhhhcchhhcccC---CHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          308 ----------------------NLLKILDERLWSTF---TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       308 ----------------------~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                                            ..............   ....++++.+|+.+||+.||++|||++|+++|
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                                  00000000000000   01125679999999999999999999999986

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=334.89  Aligned_cols=242  Identities=24%  Similarity=0.311  Sum_probs=188.4

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC--h---hHHHHHHHHHHcC-CCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP--T---QEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ++|+..+.||+|+||+||+|... +++.||||+.....  .   .....|+..+..+ +||||+++++++.+.+..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            57889999999999999999976 68999999854321  1   2344555555544 8999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+ +++|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++.....
T Consensus       137 e~~-~~~L~~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          137 ELC-GPSLQQHCEA----WGASLPEAQVWGYLRDTLLALAHLHS--QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             ECC-CCBHHHHHHH----HCSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             ecc-CCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            999 5688777742    23568999999999999999999999  6799999999999999999999999999887643


Q ss_pred             CCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      ..   ......+|+.|+|||++.+ .++.++|||||||++|||++|..|+....     . ...+...        ...+
T Consensus       210 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-----~-~~~~~~~--------~~~~  271 (311)
T 3p1a_A          210 AG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-----G-WQQLRQG--------YLPP  271 (311)
T ss_dssp             --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----H-HHHHTTT--------CCCH
T ss_pred             CC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----H-HHHHhcc--------CCCc
Confidence            22   2334568999999999886 78999999999999999999977654311     1 1111100        0111


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ..    +...++++.+++.+||+.||++|||++|++++
T Consensus       272 ~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          272 EF----TAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             HH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cc----ccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence            11    11234678999999999999999999999975

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.6e-44  Score=342.28  Aligned_cols=265  Identities=18%  Similarity=0.221  Sum_probs=201.2

Q ss_pred             hcCCCcCCeeccc--CceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEE
Q 016588           82 TKNFSDKNLIGEG--KFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        82 ~~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (386)
                      ..+|++.+.||+|  +||.||+|... +++.||+|++...     ..+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4578899999999  99999999975 5899999985432     13457789999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      ||||+++++|.+++...   ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++...
T Consensus       104 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTH---FMDGMNELAIAYILQGVLKALDYIHH--MGYVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEECCTTCBHHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEccCCCCHHHHHhhh---cccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            99999999999988432   23568999999999999999999999  77999999999999999999999999987654


Q ss_pred             CCCC-----CCCCCccccCcccccchhhhcc--cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc-
Q 016588          234 GRTD-----VAGPSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD-  305 (386)
Q Consensus       234 ~~~~-----~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-  305 (386)
                      ....     .........+|..|+|||++.+  ..++.++|||||||++|||++|..||.+......  .......... 
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~  256 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPC  256 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC-------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhcCCCCc
Confidence            2211     1122234468888999999987  5789999999999999999999999987554321  1110000000 


Q ss_pred             c--------cc-------------hhhhc---c------hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          306 F--------SN-------------LLKIL---D------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       306 ~--------~~-------------~~~~~---~------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .        ..             .....   .      .......+...++++.+|+.+||+.||++|||+.|++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence            0        00             00000   0      000011223345679999999999999999999999976

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4e-44  Score=326.41  Aligned_cols=245  Identities=26%  Similarity=0.375  Sum_probs=199.9

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC------CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      .++|+..+.||+|+||.||+|... ++..||+|....      .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            457888999999999999999965 477999997532      2345688999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      |||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||++....
T Consensus        88 ~e~~~~~~l~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~LH~--~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           88 LEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             ECCCTTEEHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHT--TTCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EecCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            99999999998883     33568899999999999999999998  779999999999999999999999999986543


Q ss_pred             CCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                      ..    ......+++.|+|||.+.+..++.++||||||+++|+|++|..||.....   .........            
T Consensus       161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~------------  221 (279)
T 3fdn_A          161 SS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---QETYKRISR------------  221 (279)
T ss_dssp             -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHH------------
T ss_pred             cc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH---HHHHHHHHh------------
Confidence            32    12345678899999999999999999999999999999999999986432   111111111            


Q ss_pred             hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                        .....+...++.+.+++.+||+.||++|||++|++++-
T Consensus       222 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~  259 (279)
T 3fdn_A          222 --VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP  259 (279)
T ss_dssp             --TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred             --CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence              01122333456789999999999999999999999873

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.9e-44  Score=338.52  Aligned_cols=261  Identities=20%  Similarity=0.208  Sum_probs=198.6

Q ss_pred             HHHHhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECC--------CCChhHHHHHHHHHHcCCCCcccccccceeeC
Q 016588           78 LSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP--------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN  148 (386)
Q Consensus        78 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  148 (386)
                      +....++|+..+.||+|+||.||+|... ++..||+|...        ....+.+.+|+.+++.++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            3345578999999999999999999964 57899999743        23346788999999999999999999999999


Q ss_pred             CeEEEEEEeecCCCccccccCCCc-----------------------------------CCCCCCCHHHHHHHHHHHHHH
Q 016588          149 NLQFLIYEYIPNGSVSIHLYGPSQ-----------------------------------VSRQKLEFKHRLSIALGAAKG  193 (386)
Q Consensus       149 ~~~~lv~e~~~~g~L~~~l~~~~~-----------------------------------~~~~~l~~~~~~~i~~~i~~~  193 (386)
                      +..++||||+++|+|.+++.....                                   .....+++..+..++.|++.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            999999999999999888742100                                   001223567788899999999


Q ss_pred             HHHhhcCCCCceecCCCCCCeeeCCCC--ceEEcccccccccCCCCC--CCCCccccCcccccchhhhcc--cCCCcccc
Q 016588          194 LAHLHSLSPRVVHKDFKTANVLVDEDF--IAKVADAGLRNFLGRTDV--AGPSSQVTADEIFLASEVKEF--RRFSEKSD  267 (386)
Q Consensus       194 l~~LH~~~~~ivH~dlkp~Nill~~~~--~~kl~DFgl~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D  267 (386)
                      |.|||+  .+|+||||||+|||++.++  .+||+|||++........  ........+|+.|+|||.+.+  ..++.++|
T Consensus       181 l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          181 LHYLHN--QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHHH--TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHHH--CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            999999  6799999999999998776  899999999986543221  112345568899999999875  67899999


Q ss_pred             hhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCH
Q 016588          268 VYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM  347 (386)
Q Consensus       268 vwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~  347 (386)
                      ||||||++|||++|..||......  .............       .    .......++++.+++.+||+.||.+|||+
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~-------~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~  325 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDA--DTISQVLNKKLCF-------E----NPNYNVLSPLARDLLSNLLNRNVDERFDA  325 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCCT-------T----SGGGGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChH--HHHHHHHhccccc-------C----CcccccCCHHHHHHHHHHcCCChhHCCCH
Confidence            999999999999999999865421  1111111110000       0    01111234678999999999999999999


Q ss_pred             HHHHHH
Q 016588          348 SDVVTE  353 (386)
Q Consensus       348 ~evl~~  353 (386)
                      .+++++
T Consensus       326 ~~~l~h  331 (345)
T 3hko_A          326 MRALQH  331 (345)
T ss_dssp             HHHHHS
T ss_pred             HHHhcC
Confidence            999975

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=342.66  Aligned_cols=244  Identities=23%  Similarity=0.316  Sum_probs=192.8

Q ss_pred             CCeecccCceEEEEEEeC-CCcEEEEEECCCCC---hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecCCCc
Q 016588           88 KNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV  163 (386)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  163 (386)
                      .+.||+|+||.||+|... ++..||+|+.....   .+.+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            567999999999999964 58999999866543   45688999999999999999999999999999999999999999


Q ss_pred             cccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee--CCCCceEEcccccccccCCCCCCCC
Q 016588          164 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV--DEDFIAKVADAGLRNFLGRTDVAGP  241 (386)
Q Consensus       164 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill--~~~~~~kl~DFgl~~~~~~~~~~~~  241 (386)
                      .+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+|||+  +.++.+||+|||+++.......   
T Consensus       174 ~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---  244 (373)
T 2x4f_A          174 FDRIID----ESYNLTELDTILFMKQICEGIRHMHQ--MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---  244 (373)
T ss_dssp             HHHHHH----TGGGCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---
T ss_pred             HHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---
Confidence            888742    23468899999999999999999999  779999999999999  6778999999999987654322   


Q ss_pred             CccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccC
Q 016588          242 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF  321 (386)
Q Consensus       242 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (386)
                      .....+|+.|+|||++.+..++.++|||||||++|||++|..||.+...  ...+.......+..       ....+   
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~~~i~~~~~~~-------~~~~~---  312 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND--AETLNNILACRWDL-------EDEEF---  312 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHHTCCCS-------CSGGG---
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhccCCC-------Chhhh---
Confidence            2334688999999999988999999999999999999999999986442  11111111111110       01111   


Q ss_pred             CHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          322 TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       322 ~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                       ...++++.+++.+||+.||++|||+.|++++
T Consensus       313 -~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          313 -QDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             -TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -ccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             1234678999999999999999999999985

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=9.3e-44  Score=330.67  Aligned_cols=248  Identities=21%  Similarity=0.282  Sum_probs=201.9

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC---------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  152 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  152 (386)
                      ++|++.+.||+|+||.||+|... ++..||+|.....         ..+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            46888999999999999999965 5889999974322         2456899999999999999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC----ceEEcccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF----IAKVADAG  228 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~----~~kl~DFg  228 (386)
                      +||||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++    .+||+|||
T Consensus        92 lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~lH~--~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           92 LILELVSGGELFDFLA-----QKESLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEECCCCSCBHHHHHH-----TCSCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEcCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            9999999999999884     23568899999999999999999999  7799999999999999887    79999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccc
Q 016588          229 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN  308 (386)
Q Consensus       229 l~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  308 (386)
                      ++.......   ......+|+.|+|||.+.+..++.++|||||||++|||++|..||.....   ......+.....   
T Consensus       165 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~---  235 (321)
T 2a2a_A          165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANITSVSY---  235 (321)
T ss_dssp             TCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHTTCC---
T ss_pred             cceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhccc---
Confidence            998765422   22345688999999999999999999999999999999999999976432   111111111100   


Q ss_pred             hhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          309 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                         ...+....    ..++.+.+++.+||+.||++|||+.|++++
T Consensus       236 ---~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          236 ---DFDEEFFS----HTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             ---CCCHHHHT----TCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             ---ccChhhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence               01111111    223568999999999999999999999975

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5.3e-44  Score=353.21  Aligned_cols=251  Identities=20%  Similarity=0.309  Sum_probs=206.7

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECC------CCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEE
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (386)
                      ..++|...+.||+|+||.||+|..+ +++.||+|++.      ......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            3467888999999999999999965 58999999853      2344568899999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      ||||+++|+|.+++...   ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++..
T Consensus       262 VmEy~~gg~L~~~l~~~---~~~~l~e~~~~~i~~qIl~aL~yLH~--~gIvHrDLKPeNILld~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHM---GQAGFPEARAVFYAAEICCGLEDLHR--ERIVYRDLKPENILLDDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             EECCCCSCBHHHHHHSS---SSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEcCCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeccCCchheEEEeCCCCeEEEecccceec
Confidence            99999999999888532   23458999999999999999999999  77999999999999999999999999999876


Q ss_pred             CCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCch-hhHHHHHHhhhcccchhhh
Q 016588          234 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS-QDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       234 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  312 (386)
                      ....   ......||+.|+|||++.+..|+.++|||||||++|||++|..||........ ..+...+...         
T Consensus       337 ~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~---------  404 (576)
T 2acx_A          337 PEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV---------  404 (576)
T ss_dssp             CTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC---------
T ss_pred             ccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc---------
Confidence            4322   22345789999999999998999999999999999999999999987553221 1111111110         


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  353 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~~  353 (386)
                           ...++...+.++.+++.+||+.||++||     +++|+++|
T Consensus       405 -----~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          405 -----PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             -----cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence                 1123334557789999999999999999     78888876

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.7e-44  Score=331.12  Aligned_cols=254  Identities=21%  Similarity=0.303  Sum_probs=193.8

Q ss_pred             cCCCcC-CeecccCceEEEEEEe-CCCcEEEEEECCC---CChhHHHHHHHHHHcC-CCCcccccccceeeCCeEEEEEE
Q 016588           83 KNFSDK-NLIGEGKFGEVYKGLL-QDGMLVAIKKRPG---APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        83 ~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      +.|.+. +.||+|+||.||+|.. .+++.||+|+...   ...+.+.+|+.++.++ +||||+++++++.+.+..|+|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            467764 7899999999999995 4689999998543   2356789999999885 79999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc---eEEccccccccc
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI---AKVADAGLRNFL  233 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~---~kl~DFgl~~~~  233 (386)
                      |+++++|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.   +||+|||++...
T Consensus        92 ~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           92 KMRGGSILSHIH-----KRRHFNELEASVVVQDVASALDFLHN--KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             CCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             cCCCCcHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHh--CCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            999999999884     23568899999999999999999999  67999999999999998776   999999998765


Q ss_pred             CCCCC-----CCCCccccCcccccchhhhcc-----cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchh---------
Q 016588          234 GRTDV-----AGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ---------  294 (386)
Q Consensus       234 ~~~~~-----~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~---------  294 (386)
                      .....     ........+|+.|+|||++.+     ..++.++|||||||++|||++|..||.........         
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            42211     111223458899999999875     56889999999999999999999999876543211         


Q ss_pred             ---hHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          295 ---DLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       295 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                         .+...+.....      ......+.    ..+.++.+++.+||+.||++|||+.|++++
T Consensus       245 ~~~~~~~~i~~~~~------~~~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          245 CQNMLFESIQEGKY------EFPDKDWA----HISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHHHHHHCCC------CCCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHHHhccCc------ccCchhcc----cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence               01111110000      00000011    234668999999999999999999999986

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1e-44  Score=331.84  Aligned_cols=250  Identities=21%  Similarity=0.379  Sum_probs=198.4

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCC-C-------cEEEEEECCCC---ChhHHHHHHHHHHcCCCCcccccccceeeCCe
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQD-G-------MLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNL  150 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~-~-------~~vavK~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  150 (386)
                      .++|...+.||+|+||.||+|.... +       ..||+|.....   ..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            3578888999999999999998543 3       47999986543   34568899999999999999999999999999


Q ss_pred             EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc--------e
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI--------A  222 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~--------~  222 (386)
                      .++||||+++++|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.        +
T Consensus        87 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKK----NKNCINILWKLEVAKQLAAAMHFLEE--NTLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHH----TGGGCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             CEEEEECCCCCCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHhh--CCeECCCcCcceEEEecCCccccccccee
Confidence            9999999999999999842    23448899999999999999999999  77999999999999998887        9


Q ss_pred             EEcccccccccCCCCCCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHH
Q 016588          223 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ  301 (386)
Q Consensus       223 kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~  301 (386)
                      ||+|||++.....      .....++..|+|||.+.+ ..++.++|||||||++|||++|..|+.....  .........
T Consensus       161 kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~--~~~~~~~~~  232 (289)
T 4fvq_A          161 KLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD--SQRKLQFYE  232 (289)
T ss_dssp             EECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--HHHHHHHHH
T ss_pred             eeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc--hHHHHHHhh
Confidence            9999999875432      123446778999999987 6789999999999999999996554443221  111111111


Q ss_pred             hhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          302 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      ..               ...+...++++.+++.+||+.||++|||+.+++++|++++.-
T Consensus       233 ~~---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          233 DR---------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             TT---------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             cc---------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            10               011112234589999999999999999999999999998854

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=336.69  Aligned_cols=262  Identities=20%  Similarity=0.284  Sum_probs=193.6

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCCh----hHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      ++|...+.||+|+||+||+|... +++.||+|+......    ..+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            46888999999999999999965 688999998653322    2355799999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +++ +|.+++..    ....+++..+..++.|++.||.|||+  .||+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  154 (324)
T 3mtl_A           82 LDK-DLKQYLDD----CGNIINMHNVKLFLFQLLRGLAYCHR--QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  154 (324)
T ss_dssp             CSE-EHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred             ccc-CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence            974 78777742    34568899999999999999999999  779999999999999999999999999998654321


Q ss_pred             CCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchh
Q 016588          238 VAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  316 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (386)
                        .......+|+.|+|||++.+ ..++.++|||||||++|||++|..||.+................+............
T Consensus       155 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  232 (324)
T 3mtl_A          155 --KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  232 (324)
T ss_dssp             ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred             --cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence              22234467889999999876 568999999999999999999999998754322111111111111111111110000


Q ss_pred             ---------h----cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          317 ---------L----WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       317 ---------~----~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                               .    ........++++.+++.+||+.||++|||++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                     0    000111234678999999999999999999999975

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.1e-44  Score=341.17  Aligned_cols=244  Identities=21%  Similarity=0.266  Sum_probs=191.4

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHH-HHcCCCCcccccccceeeCCeEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCF-LASIQHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~l  153 (386)
                      .++|+..+.||+|+||.||+|..+ ++..||+|++...      ....+..|..+ ++.++||||+++++++.+.+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            357889999999999999999965 4789999975322      23345566666 466899999999999999999999


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      ||||+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++..
T Consensus       117 v~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~ikL~DFG~a~~~  189 (373)
T 2r5t_A          117 VLDYINGGELFYHLQ-----RERCFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPENILLDSQGHIVLTDFGLCKEN  189 (373)
T ss_dssp             EEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred             EEeCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence            999999999998883     33567888999999999999999999  77999999999999999999999999999864


Q ss_pred             CCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhc
Q 016588          234 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  313 (386)
Q Consensus       234 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (386)
                      ...  ........||+.|+|||++.+..|+.++|||||||++|||++|..||.....   ......+..           
T Consensus       190 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~~i~~-----------  253 (373)
T 2r5t_A          190 IEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AEMYDNILN-----------  253 (373)
T ss_dssp             BCC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH---HHHHHHHHH-----------
T ss_pred             ccC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHh-----------
Confidence            321  1234456789999999999999999999999999999999999999976432   122211111           


Q ss_pred             chhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 016588          314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV  351 (386)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl  351 (386)
                       ..  ..++...+.++.+++.+||+.||++||++.+.+
T Consensus       254 -~~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          254 -KP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             -SC--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             -cc--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence             11  122233456789999999999999999986433

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.5e-44  Score=339.96  Aligned_cols=269  Identities=19%  Similarity=0.288  Sum_probs=198.6

Q ss_pred             cCHHHHHHHhcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCC--------------hhHHHHHHHHHHcCCCCcc
Q 016588           73 FQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP--------------TQEFIDEVCFLASIQHRNL  138 (386)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------------~~~~~~e~~~l~~l~h~ni  138 (386)
                      ....++....++|+..+.||+|+||.||+|...++..||+|+.....              .+.+.+|+.+++.++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            34567778889999999999999999999998789999999753211              1568899999999999999


Q ss_pred             cccccceee-----CCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCC
Q 016588          139 VTLLGYCQE-----NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTAN  213 (386)
Q Consensus       139 v~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~N  213 (386)
                      +++++++..     ....|+||||+. |+|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+|
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~N  164 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD----QRIVISPQHIQYFMYHILLGLHVLHE--AGVVHRDLHPGN  164 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGG
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH--CcCEecCCChHH
Confidence            999999843     346899999998 577777642    34568999999999999999999999  679999999999


Q ss_pred             eeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCc
Q 016588          214 VLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDS  292 (386)
Q Consensus       214 ill~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~  292 (386)
                      ||++.++.+||+|||++......   .......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.......
T Consensus       165 Il~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  241 (362)
T 3pg1_A          165 ILLADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN  241 (362)
T ss_dssp             EEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             EEEcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999999999999999754332   22334567888999999877 678999999999999999999999998754211


Q ss_pred             hhhHHHHHHhhhc--ccch--------hhhcc-------hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          293 SQDLVELVQNSRD--FSNL--------LKILD-------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       293 ~~~~~~~~~~~~~--~~~~--------~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                        .+.........  ....        .....       ...+.......++.+.+++.+||+.||++|||+.|++++
T Consensus       242 --~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          242 --QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             --HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence              11111110000  0000        00000       000111122334678999999999999999999999976

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=9.3e-44  Score=323.52  Aligned_cols=248  Identities=21%  Similarity=0.291  Sum_probs=200.2

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCC-CcEEEEEECC---CCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      .++|+..+.||+|+||.||+|.... +..+|+|+..   ....+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            3568889999999999999999654 7789999754   34467789999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee---CCCCceEEcccccccccC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill---~~~~~~kl~DFgl~~~~~  234 (386)
                      +++++|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+||++   +.++.+||+|||++....
T Consensus        88 ~~~~~L~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           88 CTGGELFERVV-----HKRVFRESDAARIMKDVLSAVAYCHK--LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             CCSCBHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             cCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            99999988873     34568899999999999999999999  779999999999999   788999999999998764


Q ss_pred             CCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                      ...   ......+|+.|+|||.+.+. ++.++||||||+++|||++|..||.....   .............      ..
T Consensus       161 ~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~------~~  227 (277)
T 3f3z_A          161 PGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD---SEVMLKIREGTFT------FP  227 (277)
T ss_dssp             TTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCC------CC
T ss_pred             Ccc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhCCCC------CC
Confidence            322   22345688899999998754 89999999999999999999999986442   1111111111000      00


Q ss_pred             hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ...+.    ..++++.+++.+||+.||++|||+.+++++
T Consensus       228 ~~~~~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          228 EKDWL----NVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             HHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             chhhh----cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00111    234668999999999999999999999975

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=6e-44  Score=325.86  Aligned_cols=249  Identities=20%  Similarity=0.255  Sum_probs=201.2

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      .++|+..+.||+|+||.||+|... ++..||+|.....     ..+.+.+|+.+++.++||||+++++++...+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            467889999999999999999965 5889999985432     1345788999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc---eEEcccccccc
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI---AKVADAGLRNF  232 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~---~kl~DFgl~~~  232 (386)
                      ||+++++|.+.+.     ....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.   +||+|||++..
T Consensus        85 e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           85 DLVTGGELFEDIV-----AREFYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             CCCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             ecCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            9999999988773     34568899999999999999999999  77999999999999986655   99999999977


Q ss_pred             cCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          233 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      .....   ......+++.|+|||.+.+..++.++||||||+++|+|++|..||.....   .............      
T Consensus       158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~------  225 (284)
T 3kk8_A          158 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYAQIKAGAYD------  225 (284)
T ss_dssp             CCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCCC------
T ss_pred             cccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch---hHHHHHHHhcccc------
Confidence            64422   22345688899999999999999999999999999999999999976432   1222211111000      


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                          .........++++.+++.+||+.||++|||+.|++++
T Consensus       226 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          226 ----YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             ----CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ----CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                0001112334668999999999999999999999986

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.9e-44  Score=335.24  Aligned_cols=261  Identities=22%  Similarity=0.291  Sum_probs=192.8

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      ..++|+..+.||+|+||+||+|... +++.||+|++....     .+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            4568999999999999999999954 68899999865432     23467899999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee-----CCCCceEEccccc
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV-----DEDFIAKVADAGL  229 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill-----~~~~~~kl~DFgl  229 (386)
                      |||+++ +|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||+     +.++.+||+|||+
T Consensus       112 ~e~~~~-~L~~~~~-----~~~~~~~~~~~~i~~ql~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          112 FEYAEN-DLKKYMD-----KNPDVSMRVIKSFLYQLINGVNFCHS--RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             EECCSE-EHHHHHH-----HCTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             EecCCC-CHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            999975 8888873     33468899999999999999999999  779999999999999     4556699999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhh--cc
Q 016588          230 RNFLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR--DF  306 (386)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~  306 (386)
                      +.......  .......+|+.|+|||++.+. .++.++|||||||++|||++|..||.....  ...+........  ..
T Consensus       184 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~~~~~~~~~~  259 (329)
T 3gbz_A          184 ARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE--IDQLFKIFEVLGLPDD  259 (329)
T ss_dssp             HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCT
T ss_pred             ccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH--HHHHHHHHHHhCCCch
Confidence            98764321  122344578889999999874 489999999999999999999999986443  122222211110  00


Q ss_pred             cchhhhc-------------chhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          307 SNLLKIL-------------DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       307 ~~~~~~~-------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .......             ...+........++++.+++.+||+.||++|||++|++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence            0000000             0000000111134678999999999999999999999875

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.5e-44  Score=347.63  Aligned_cols=247  Identities=22%  Similarity=0.266  Sum_probs=194.4

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECC------CCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      .++|+..+.||+|+||.||+|... +++.||+|++.      ......+.+|+.+++.++||||+++++++...+..|+|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            457888999999999999999964 58899999753      22345677899999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      |||+++|+|.+++.     ....+++..+..++.|++.||.|||+. +||+||||||+|||++.++.+||+|||+++...
T Consensus       227 ~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~-~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLS-----RERVFSEDRARFYGAEIVSALDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHHH-TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHhhc-CCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            99999999988883     345688999999999999999999961 469999999999999999999999999998643


Q ss_pred             CCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                      ...  .......||+.|+|||++.+..|+.++|||||||++|||++|..||.....   ......+...           
T Consensus       301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i~~~-----------  364 (446)
T 4ejn_A          301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILME-----------  364 (446)
T ss_dssp             C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHC-----------
T ss_pred             CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHHHHHHHhC-----------
Confidence            221  223456789999999999999999999999999999999999999976442   2222211110           


Q ss_pred             hhhcccCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016588          315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  353 (386)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~~  353 (386)
                       .  ..++...++++.+++.+||+.||.+||     |++|+++|
T Consensus       365 -~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          365 -E--IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             -C--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -C--CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence             0  122333456789999999999999999     99999975

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=9e-45  Score=338.26  Aligned_cols=269  Identities=27%  Similarity=0.418  Sum_probs=208.1

Q ss_pred             hcCCCcCCeecccCceEEEEEEe-----CCCcEEEEEECCCCC---hhHHHHHHHHHHcCCCCcccccccceeeCC--eE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENN--LQ  151 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~  151 (386)
                      .++|+..+.||+|+||.||+|.+     .+++.||+|+.....   .+.+.+|+.+++.++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            45688899999999999999984     358899999865543   346889999999999999999999886643  67


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      ++||||+++++|.+++..    ....+++..++.++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++.
T Consensus       120 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             EEEECCCTTCBHHHHHHH----STTSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEECCCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh--CCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence            999999999999998842    23458899999999999999999999  779999999999999999999999999998


Q ss_pred             ccCCCCCC-CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc----c
Q 016588          232 FLGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD----F  306 (386)
Q Consensus       232 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~  306 (386)
                      ........ .......++..|+|||.+.+..++.++||||||+++|||++|..|+.....    ...........    .
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~----~~~~~~~~~~~~~~~~  269 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA----EFMRMIGNDKQGQMIV  269 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH----HHHHHHCTTCCTHHHH
T ss_pred             hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH----HHHHhhccccchhhhH
Confidence            76543211 112334567779999999988899999999999999999999988764211    01110000000    0


Q ss_pred             cchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      ..+.+.+........+..+++++.+++.+||+.||++|||+.++++.|+++.++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            011112222222233445667899999999999999999999999999998765

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.3e-43  Score=339.44  Aligned_cols=252  Identities=17%  Similarity=0.219  Sum_probs=192.4

Q ss_pred             cCCCcC-CeecccCceEEEEEEeC-CCcEEEEEECCCCChhHHHHHHHHHHc-CCCCcccccccceee----CCeEEEEE
Q 016588           83 KNFSDK-NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLAS-IQHRNLVTLLGYCQE----NNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~----~~~~~lv~  155 (386)
                      ++|... +.||+|+||+||+|... +++.||||++..  ...+.+|+.++.+ .+||||+++++++..    .+..|+||
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~--~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~  138 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM  138 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc--chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEE
Confidence            455555 68999999999999965 588999998753  3567889988754 589999999998875    56789999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC---CCceEEcccccccc
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADAGLRNF  232 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~---~~~~kl~DFgl~~~  232 (386)
                      ||+++|+|.+++...   ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.   ++.+||+|||+++.
T Consensus       139 E~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~  213 (400)
T 1nxk_A          139 ECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  213 (400)
T ss_dssp             ECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EeCCCCcHHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence            999999999998532   23468999999999999999999999  77999999999999997   78999999999986


Q ss_pred             cCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchh-hHHHHHHhhhcccchhh
Q 016588          233 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ-DLVELVQNSRDFSNLLK  311 (386)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~  311 (386)
                      ....   .......+|+.|+|||++.+..|+.++|||||||++|||++|..||......... .....+..... .    
T Consensus       214 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~-~----  285 (400)
T 1nxk_A          214 TTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-E----  285 (400)
T ss_dssp             CC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC-C----
T ss_pred             cCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc-c----
Confidence            5432   1233456789999999999999999999999999999999999999875543211 11111111000 0    


Q ss_pred             hcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          312 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                       ...    ......++++.+++.+||+.||++|||+.|++++-
T Consensus       286 -~~~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          286 -FPN----PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  323 (400)
T ss_dssp             -CCT----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             -CCC----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence             000    01123456789999999999999999999999874

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.4e-43  Score=341.27  Aligned_cols=250  Identities=19%  Similarity=0.300  Sum_probs=191.5

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----------ChhHHHHHHHHHHcCCCCcccccccceeeC
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----------PTQEFIDEVCFLASIQHRNLVTLLGYCQEN  148 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  148 (386)
                      ..++|...+.||+|+||+||+|... +++.||+|++...           ....+.+|+.++++++||||+++++++.. 
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            4578999999999999999999965 5789999974321           12357899999999999999999999754 


Q ss_pred             CeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC---CceEEc
Q 016588          149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED---FIAKVA  225 (386)
Q Consensus       149 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~---~~~kl~  225 (386)
                      +..|+||||+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.+   ..+||+
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVV-----GNKRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTS-----SSCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             CceEEEEEcCCCCcHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEecCCCcceEEEe
Confidence            55799999999999998884     34568999999999999999999999  679999999999999754   459999


Q ss_pred             ccccccccCCCCCCCCCccccCcccccchhhhcc---cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHh
Q 016588          226 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF---RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN  302 (386)
Q Consensus       226 DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~  302 (386)
                      |||+++......   ......+|+.|+|||++.+   ..|+.++|||||||++|||++|..||......  ..+......
T Consensus       285 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~~~i~~  359 (419)
T 3i6u_A          285 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKDQITS  359 (419)
T ss_dssp             CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS--CCHHHHHHT
T ss_pred             ecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch--HHHHHHHhc
Confidence            999998765422   2334568999999999853   57788999999999999999999999865432  122222211


Q ss_pred             hhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          303 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ....      ..+..+..    .++++.+++.+||+.||++|||++|++++
T Consensus       360 ~~~~------~~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          360 GKYN------FIPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             TCCC------CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCC------CCchhhcc----cCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            1100      01111112    34568999999999999999999999986

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.5e-44  Score=337.34  Aligned_cols=256  Identities=20%  Similarity=0.324  Sum_probs=193.1

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeC------C
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN------N  149 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  149 (386)
                      .++|+..+.||+|+||.||+|... +++.||+|+.....     .+.+.+|+.+++.++||||+++++++...      .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            357888999999999999999964 68999999864322     24578899999999999999999998765      3


Q ss_pred             eEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 016588          150 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  229 (386)
Q Consensus       150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl  229 (386)
                      ..|+||||+ +++|.+++.      ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~-~~~L~~~~~------~~~l~~~~~~~~~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMK------HEKLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecC-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCcCHHHEEEcCCCCEEEEeeec
Confidence            469999999 779988873      2458899999999999999999999  7799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcc-c
Q 016588          230 RNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF-S  307 (386)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~  307 (386)
                      ++.....     .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....  ..+.......... .
T Consensus       175 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~l~~i~~~~g~~~~  247 (367)
T 1cm8_A          175 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL--DQLKEIMKVTGTPPA  247 (367)
T ss_dssp             CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCH
T ss_pred             ccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCH
Confidence            9875432     334578899999999887 67999999999999999999999999875431  1111111110000 0


Q ss_pred             chhh------------hc---chhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          308 NLLK------------IL---DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       308 ~~~~------------~~---~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ....            .+   ....+.......++++.+++.+||+.||++|||++|+++|
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            0000            00   0001112223345678999999999999999999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=7.8e-44  Score=324.88  Aligned_cols=250  Identities=22%  Similarity=0.339  Sum_probs=203.3

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCChhHHHHHHHHHHcCCCCcccccccceee-------------
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQE-------------  147 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------------  147 (386)
                      ..+|+..+.||+|+||.||+|... +++.||+|..... .+.+.+|+++++.++||||+++++++..             
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~   88 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSS   88 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC-SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccc
Confidence            356888999999999999999975 6899999987543 3578899999999999999999998754             


Q ss_pred             ---CCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEE
Q 016588          148 ---NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKV  224 (386)
Q Consensus       148 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl  224 (386)
                         ....++||||+++++|.+++...   ....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl  163 (284)
T 2a19_B           89 RSKTKCLFIQMEFCDKGTLEQWIEKR---RGEKLDKVLALELFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKI  163 (284)
T ss_dssp             CCEEEEEEEEECCCCSCBHHHHHHHG---GGSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEE
T ss_pred             ccCcceEEEEEeccCCCCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCCHHHEEEcCCCCEEE
Confidence               45579999999999999998432   23568899999999999999999999  77999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhh
Q 016588          225 ADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR  304 (386)
Q Consensus       225 ~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~  304 (386)
                      +|||++.......   ......+++.|+|||.+.+..++.++||||||+++|||++|..|+...     ........   
T Consensus       164 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~~~~~~---  232 (284)
T 2a19_B          164 GDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----SKFFTDLR---  232 (284)
T ss_dssp             CCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HHHHHHHH---
T ss_pred             Ccchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----HHHHHHhh---
Confidence            9999988765422   223446888999999999999999999999999999999998775321     11111000   


Q ss_pred             cccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          305 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                               ..    ..+...+.++.+++.+||+.||++|||+.|++++|..+.+..
T Consensus       233 ---------~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          233 ---------DG----IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             ---------TT----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             ---------cc----cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence                     01    112223456899999999999999999999999999887653

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=8.7e-44  Score=346.85  Aligned_cols=263  Identities=20%  Similarity=0.281  Sum_probs=181.8

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceee-----CCeE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQE-----NNLQ  151 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~~  151 (386)
                      ++|++.+.||+|+||+||+|... +++.||||++....     .+.+.+|+.+|+.++||||+++++++..     .+..
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            67999999999999999999955 58899999865422     3457899999999999999999999843     3578


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      |+||||+. ++|..++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus       133 ~lv~e~~~-~~L~~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH~--~~iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          133 YVVLEIAD-SDFKKLFR-----TPVYLTELHIKTLLYNLLVGVKYVHS--AGILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEECCCS-EEHHHHHH-----SSCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEeccc-cchhhhcc-----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCcCCCCCChhhEEECCCCCEeecccccch
Confidence            99999985 68887773     34568999999999999999999999  779999999999999999999999999998


Q ss_pred             ccCCCCCC-------------------------CCCccccCcccccchhhh-cccCCCcccchhhHHHHHHHHHc-----
Q 016588          232 FLGRTDVA-------------------------GPSSQVTADEIFLASEVK-EFRRFSEKSDVYSFGVFLLELVS-----  280 (386)
Q Consensus       232 ~~~~~~~~-------------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwSlGvil~el~t-----  280 (386)
                      ........                         .......+|+.|+|||++ ....|+.++|||||||++|||++     
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~  284 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN  284 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence            76432211                         123445689999999986 45679999999999999999999     


Q ss_pred             ------CCCCCCCCCCCch-----------------hhHHHHHHhh---hcccchhh-----------hcch---hhccc
Q 016588          281 ------GREASSSLSPDSS-----------------QDLVELVQNS---RDFSNLLK-----------ILDE---RLWST  320 (386)
Q Consensus       281 ------g~~p~~~~~~~~~-----------------~~~~~~~~~~---~~~~~~~~-----------~~~~---~~~~~  320 (386)
                            |+++|.+......                 .+....+...   .....+..           .+..   .....
T Consensus       285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (458)
T 3rp9_A          285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE  364 (458)
T ss_dssp             CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred             ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence                  5556554331000                 0000000000   00000000           0000   00001


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          321 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       321 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ..+..++++.+|+.+||+.||++|||++|+++|
T Consensus       365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H  397 (458)
T 3rp9_A          365 RFPASSADAIHLLKRMLVFNPNKRITINECLAH  397 (458)
T ss_dssp             GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            112235678999999999999999999999986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.9e-44  Score=330.78  Aligned_cols=258  Identities=17%  Similarity=0.206  Sum_probs=198.0

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC------hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      .++|++.+.||+|+||.||+|... +++.||+|......      .+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            468999999999999999999965 58899999865432      25688999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      |||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++....
T Consensus       113 ~e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          113 MRLINGVDLAAMLR-----RQGPLAPPRAVAIVRQIGSALDAAHA--AGATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EECCCCEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEecCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            99999999999884     23568899999999999999999999  779999999999999999999999999987764


Q ss_pred             CCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                      .... .......+++.|+|||.+.+..++.++||||||+++|||++|..||.....   ............         
T Consensus       186 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~---------  252 (309)
T 2h34_A          186 DEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL---SVMGAHINQAIP---------  252 (309)
T ss_dssp             ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH---HHHHHHHHSCCC---------
T ss_pred             cccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH---HHHHHHhccCCC---------
Confidence            4221 122345688899999999988999999999999999999999999976332   111111111000         


Q ss_pred             hhhcccCCHHHHHHHHHHHhHccCCCCCCCC-CHHHHHHHHHHhhhhh
Q 016588          315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-SMSDVVTELDRTLDKE  361 (386)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-t~~evl~~L~~~~~~~  361 (386)
                        .....+...+.++.+++.+||+.||++|| |++++++.|++.+...
T Consensus       253 --~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          253 --RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             --CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             --CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence              00112233446689999999999999999 9999999999887663

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=9.1e-43  Score=340.00  Aligned_cols=264  Identities=19%  Similarity=0.235  Sum_probs=211.2

Q ss_pred             hcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECC-CCChhHHHHHHHHHHcCCC-CcccccccceeeCCeEEEEEEee
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP-GAPTQEFIDEVCFLASIQH-RNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~-~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      .++|++.+.||+|+||.||+|.. .++..||||+.. .....++..|+++++.++| +++..+..++...+..++||||+
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~   85 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL   85 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence            36789999999999999999995 468999999743 3344578999999999976 56666666777888999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee---CCCCceEEcccccccccCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill---~~~~~~kl~DFgl~~~~~~  235 (386)
                       +++|.+++..    ....+++..++.++.||+.||.|||+  ++|+||||||+|||+   +.++.+||+|||+++....
T Consensus        86 -g~sL~~ll~~----~~~~l~~~~~~~i~~qi~~aL~yLH~--~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           86 -GPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVHS--KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             -CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             -CCCHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence             8899998842    24568999999999999999999999  779999999999999   6889999999999987654


Q ss_pred             CCCC-----CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          236 TDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       236 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      ....     .......+|..|+|||.+.+..++.++|||||||++|||++|..||...........+..+..........
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE  238 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred             CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence            3221     12235678999999999999999999999999999999999999999876654444333322211111111


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                           .+..    .+++++.+++..||+.||++||++.+|++.|++++.+.
T Consensus       239 -----~l~~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          239 -----ALCR----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             -----HHHT----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             -----HHhc----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence                 1111    22467899999999999999999999999999998653

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=6.5e-44  Score=326.17  Aligned_cols=250  Identities=22%  Similarity=0.322  Sum_probs=194.7

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECC----CCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      ++|...+.||+|+||.||++... ++..+|+|+..    ....+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            46788899999999999999964 58899999743    23457789999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee---CCCCceEEcccccccccC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill---~~~~~~kl~DFgl~~~~~  234 (386)
                      +++++|.+++.... .....+++..+..++.|++.||.|||+  .+|+||||||+||++   +.++.+||+|||++....
T Consensus       102 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQ-ARGKALSEGYVAELMKQMMNALAYFHS--QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhh-hcccCCCHHHHHHHHHHHHHHHHHHHh--CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            99999988874321 123568899999999999999999999  779999999999999   456789999999998764


Q ss_pred             CCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                      ...   ......+++.|+|||.+. ..++.++||||||+++|||++|..||.....   ...........          
T Consensus       179 ~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~---~~~~~~~~~~~----------  241 (285)
T 3is5_A          179 SDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL---EEVQQKATYKE----------  241 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCC----------
T ss_pred             Ccc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH---HHHHhhhccCC----------
Confidence            322   223456888999999986 5689999999999999999999999986442   11111111100          


Q ss_pred             hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      +... ......++++.+++.+||+.||++|||+.|++++
T Consensus       242 ~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          242 PNYA-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             CCCC-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             cccc-cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000 0001123568999999999999999999999875

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1e-44  Score=335.62  Aligned_cols=257  Identities=19%  Similarity=0.273  Sum_probs=192.8

Q ss_pred             hcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCCC------hhHHHHHHHHHHcCCCCcccccccceeeCC----e
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENN----L  150 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~  150 (386)
                      .++|++.+.||+|+||.||+|.. .+++.||+|......      ...+.+|+.+++.++||||+++++++...+    .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            35788999999999999999995 568999999865432      135788999999999999999999987644    3


Q ss_pred             EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  230 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~  230 (386)
                      .|+||||+++++|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus        91 ~~lv~e~~~g~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EEEEEECCCEEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             cEEEEecCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence            499999999999999884     33568999999999999999999999  77999999999999999999999999999


Q ss_pred             cccCCCCCC-CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccch
Q 016588          231 NFLGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL  309 (386)
Q Consensus       231 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  309 (386)
                      ......... .......+|+.|+|||.+.+..++.++|||||||++|||++|..||......  ...........   . 
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~--~~~~~~~~~~~---~-  237 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV--SVAYQHVREDP---I-  237 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHCCC---C-
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHhcCCC---C-
Confidence            876442221 2223456889999999999999999999999999999999999999764421  11111111000   0 


Q ss_pred             hhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHH-HHHHhh
Q 016588          310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT-ELDRTL  358 (386)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~-~L~~~~  358 (386)
                          .+.   ......++++.+++.+||+.||++||+..+++. .+....
T Consensus       238 ----~~~---~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          238 ----PPS---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             ----CHH---HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ----Ccc---cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence                000   011123466899999999999999997776664 444443

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=7.4e-44  Score=329.55  Aligned_cols=261  Identities=24%  Similarity=0.357  Sum_probs=197.4

Q ss_pred             cCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      .+|++.+.||+|+||.||+|.. .++..||+|+....      ....+.+|+.+++.++||||+++++++...+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            4688899999999999999995 46899999986532      1345789999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++++|.+++.... .....+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||++.....
T Consensus       112 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFK-KQKRLIPERTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             ECCCSCBHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             ecCCCCCHHHHHHHhc-ccccCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            9999999998874321 124568899999999999999999999  7799999999999999999999999999886643


Q ss_pred             CCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      ..  .......++..|+|||.+.+..++.++||||||+++|||++|..||.+.... .......+....           
T Consensus       189 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~-----------  254 (310)
T 2wqm_A          189 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEQCD-----------  254 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC-HHHHHHHHHTTC-----------
T ss_pred             CC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh-HHHHHHHhhccc-----------
Confidence            22  1123446788899999999999999999999999999999999999764322 111111111100           


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                       .........++++.+++.+||+.||++|||+.++++.|+++....
T Consensus       255 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~  299 (310)
T 2wqm_A          255 -YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT  299 (310)
T ss_dssp             -SCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -CCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence             000111234567899999999999999999999999999998763

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=9.6e-44  Score=324.69  Aligned_cols=243  Identities=21%  Similarity=0.300  Sum_probs=202.0

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECC------CCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ++|...+.||+|+||.||+|... ++..||+|...      ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57888999999999999999965 57889999753      233567889999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++++|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++.....
T Consensus        94 e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           94 EFAPRGELYKELQ-----KHGRFDEQRSATFMEELADALHYCHE--RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             CCCTTEEHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EeCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            9999999998884     23468899999999999999999998  7799999999999999999999999999876543


Q ss_pred             CCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      .    ......+++.|+|||.+.+..++.++||||||+++|||++|..||.....   ......+..            .
T Consensus       167 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~------------~  227 (284)
T 2vgo_A          167 L----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH---TETHRRIVN------------V  227 (284)
T ss_dssp             S----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHT------------T
T ss_pred             c----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH---hHHHHHHhc------------c
Confidence            2    12345688899999999998999999999999999999999999976432   111111110            0


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                        ....+...+.++.+++.+||+.||++|||+++++++
T Consensus       228 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          228 --DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             --ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence              012233345678999999999999999999999976

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.5e-43  Score=347.38  Aligned_cols=253  Identities=22%  Similarity=0.303  Sum_probs=205.5

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC------CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      .++|...+.||+|+||.||+|..+ +++.||+|++..      ...+.+.+|..+++.++||||+++++++.+.+..|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            367888899999999999999975 589999998532      3345688999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      |||+++|+|..++.... .....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++...
T Consensus       264 mE~~~gg~L~~~l~~~~-~~~~~l~e~~~~~~~~qi~~aL~~LH~--~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVD-EDNPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSS-TTSCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhh-cccccccHHHHHHHHHHHHHHHHHHHH--cCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            99999999998885432 124568999999999999999999999  779999999999999999999999999998764


Q ss_pred             CCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCch-hhHHHHHHhhhcccchhhhc
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS-QDLVELVQNSRDFSNLLKIL  313 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  313 (386)
                      ...  .......||+.|+|||++.+..|+.++|||||||++|||++|..||........ ..+...+..           
T Consensus       341 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~-----------  407 (543)
T 3c4z_A          341 AGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE-----------  407 (543)
T ss_dssp             TTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH-----------
T ss_pred             CCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh-----------
Confidence            322  122345789999999999999999999999999999999999999987543211 111111110           


Q ss_pred             chhhcccCCHHHHHHHHHHHhHccCCCCCCCCCH-----HHHHHH
Q 016588          314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM-----SDVVTE  353 (386)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~-----~evl~~  353 (386)
                       .  ...++...+.++.+++.+||+.||++||++     +++++|
T Consensus       408 -~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          408 -Q--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             -C--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             -c--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence             0  012334455778999999999999999975     566643

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.2e-43  Score=332.25  Aligned_cols=264  Identities=20%  Similarity=0.280  Sum_probs=196.9

Q ss_pred             cCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceee--------C
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE--------N  148 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------~  148 (386)
                      .+|+..+.||+|+||.||+|.. .+++.||+|+....     ....+.+|+.+++.++||||+++++++..        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            5788899999999999999996 46899999985332     23468899999999999999999999876        4


Q ss_pred             CeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccc
Q 016588          149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  228 (386)
Q Consensus       149 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFg  228 (386)
                      +..++||||+++ +|...+..    ....+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ceEEEEEeccCC-CHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCHHHEEEcCCCCEEEccch
Confidence            568999999986 66555532    23568999999999999999999999  779999999999999999999999999


Q ss_pred             cccccCCCCC--CCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc
Q 016588          229 LRNFLGRTDV--AGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD  305 (386)
Q Consensus       229 l~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  305 (386)
                      +++.......  ........+|+.|+|||++.+ ..++.++|||||||++|||++|..||.+..................
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            9987653221  222344567899999999876 4579999999999999999999999987543221111111111100


Q ss_pred             ccchhhhcchhhcc--------cCC--HH-----HHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          306 FSNLLKILDERLWS--------TFT--NE-----GMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       306 ~~~~~~~~~~~~~~--------~~~--~~-----~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ..............        ...  ..     .++++.+++.+||+.||++|||++|++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            00000000000000        000  00     13558899999999999999999999986

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.1e-44  Score=323.75  Aligned_cols=246  Identities=23%  Similarity=0.344  Sum_probs=182.3

Q ss_pred             cCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCC------CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ++|+..+.||+|+||.||+|.. .+++.||+|....      ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            4688899999999999999996 4689999998542      23467889999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++++|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++.....
T Consensus        91 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           91 EMCHNGEMNRYLKN----RVKPFSENEARHFMHQIITGMLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             ECCTTEEHHHHHHT----CSSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             ecCCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            99999999988843    23568999999999999999999999  7799999999999999999999999999887643


Q ss_pred             CCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      ...  ......+++.|+|||.+.+..++.++||||||+++|||++|..||........   .   .         .....
T Consensus       165 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~---~---------~~~~~  227 (278)
T 3cok_A          165 PHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---L---N---------KVVLA  227 (278)
T ss_dssp             -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSS
T ss_pred             CCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH---H---H---------HHhhc
Confidence            221  12234678899999999988899999999999999999999999986543211   0   0         00000


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .  ...+...+.++.+++.+||+.||++|||+++++++
T Consensus       228 ~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          228 D--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             c--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence            0  01223345678999999999999999999999875

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.1e-43  Score=325.44  Aligned_cols=246  Identities=26%  Similarity=0.388  Sum_probs=203.4

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC----CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      +.|+..+.||+|+||.||+|... +++.||+|....    ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            46888899999999999999854 588999998542    2346789999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +++++|.+++.      ...+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++.......
T Consensus       102 ~~~~~L~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          102 LGGGSALDLLE------PGPLDETQIATILREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             CTTEEHHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             CCCCcHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            99999998883      3468899999999999999999999  779999999999999999999999999998764422


Q ss_pred             CCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhh
Q 016588          238 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  317 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (386)
                        .......+++.|+|||.+.+..++.++||||||+++|||++|..||......   ........             ..
T Consensus       174 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~-------------~~  235 (303)
T 3a7i_A          174 --IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM---KVLFLIPK-------------NN  235 (303)
T ss_dssp             --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHH-------------SC
T ss_pred             --cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH---HHHHHhhc-------------CC
Confidence              1223456888999999999999999999999999999999999999764421   11111111             01


Q ss_pred             cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       318 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                      ....+...+..+.+++.+||+.||++|||+.+++++.
T Consensus       236 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          236 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence            1122223446689999999999999999999999864

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.5e-44  Score=335.95  Aligned_cols=252  Identities=23%  Similarity=0.278  Sum_probs=201.5

Q ss_pred             hcCCCcCCeecccCceEEEEEEe----CCCcEEEEEECCC-------CChhHHHHHHHHHHcC-CCCcccccccceeeCC
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLL----QDGMLVAIKKRPG-------APTQEFIDEVCFLASI-QHRNLVTLLGYCQENN  149 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~-------~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  149 (386)
                      ..+|+..+.||+|+||.||++..    .+++.||||++..       ...+.+.+|+.+++.+ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            36789999999999999999996    3688999998543       2345677899999999 6999999999999999


Q ss_pred             eEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 016588          150 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  229 (386)
Q Consensus       150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl  229 (386)
                      ..++||||+++++|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus       133 ~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~DfG~  205 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLS-----QRERFTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGL  205 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             eEEEEeecCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence            9999999999999999884     23568899999999999999999999  7799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhcc--cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhccc
Q 016588          230 RNFLGRTDVAGPSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS  307 (386)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  307 (386)
                      ++....... .......+|+.|+|||++.+  ..++.++|||||||++|||++|..||.........  .........  
T Consensus       206 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~--  280 (355)
T 1vzo_A          206 SKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILK--  280 (355)
T ss_dssp             EEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHH--
T ss_pred             CeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhc--
Confidence            986543221 12234568999999999985  35789999999999999999999999865432211  111111000  


Q ss_pred             chhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHHH
Q 016588          308 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTEL  354 (386)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~~L  354 (386)
                               .....+...+..+.+++.+||+.||++||     |+.|++++.
T Consensus       281 ---------~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          281 ---------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             ---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             ---------cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                     01123344556789999999999999999     999999875

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-43  Score=331.77  Aligned_cols=262  Identities=20%  Similarity=0.314  Sum_probs=196.3

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC--------hhHHHHHHHHHHcCCCCcccccccceeeCCeE
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP--------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  151 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  151 (386)
                      ..++|+..+.||+|+||.||+|... +++.||+|......        ...+.+|+.+++.++||||+++++++.+.+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            3468999999999999999999965 58999999865321        24678999999999999999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      ++||||+++ +|..++..    ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        88 ~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             EEEEECCSE-EHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             EEEEEcCCC-CHHHHHHh----cCcCCCHHHHHHHHHHHHHHHHHHHH--CCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence            999999986 77777642    23457788899999999999999999  779999999999999999999999999998


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc-----
Q 016588          232 FLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD-----  305 (386)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-----  305 (386)
                      ......  .......+|+.|+|||.+.+. .++.++|||||||++|||++|..||.+...  ...+.........     
T Consensus       161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~--~~~~~~i~~~~~~~~~~~  236 (346)
T 1ua2_A          161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD--LDQLTRIFETLGTPTEEQ  236 (346)
T ss_dssp             TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCTTT
T ss_pred             eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHHcCCCChhh
Confidence            764322  223345678899999998754 589999999999999999999999876542  1112221111100     


Q ss_pred             ccchhhhcch---hhccc-----CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          306 FSNLLKILDE---RLWST-----FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       306 ~~~~~~~~~~---~~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      +.......+.   .....     .....++++.+++.+||+.||++|||+.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            0000000000   00000     012334679999999999999999999999986

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=8.5e-44  Score=324.70  Aligned_cols=248  Identities=22%  Similarity=0.293  Sum_probs=198.7

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC---------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  152 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  152 (386)
                      ++|+..+.||+|+||.||+|... +++.||+|.....         ..+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            46888999999999999999976 5889999974322         2567899999999999999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC----ceEEcccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF----IAKVADAG  228 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~----~~kl~DFg  228 (386)
                      +||||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+++||||||+||+++.++    .+||+|||
T Consensus        85 lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           85 LILELVSGGELFDFLA-----EKESLTEDEATQFLKQILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEeecCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            9999999999999883     34568999999999999999999999  7799999999999998877    89999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccc
Q 016588          229 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN  308 (386)
Q Consensus       229 l~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  308 (386)
                      ++.......   ......+++.|+|||.+.+..++.++||||||+++|||++|..||.....   ............   
T Consensus       158 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~---  228 (283)
T 3bhy_A          158 IAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK---QETLTNISAVNY---  228 (283)
T ss_dssp             TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTTCC---
T ss_pred             cceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch---HHHHHHhHhccc---
Confidence            998764322   22344688899999999989999999999999999999999999986442   111111111100   


Q ss_pred             hhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          309 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                         ........    ..++.+.+++.+||+.||++|||+.+++++
T Consensus       229 ---~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          229 ---DFDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             ---CCCHHHHT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             ---CCcchhcc----cCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence               00111111    223568999999999999999999999975

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.1e-44  Score=340.04  Aligned_cols=265  Identities=20%  Similarity=0.281  Sum_probs=197.1

Q ss_pred             HHHhcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCCChhHHHHHHHHHHcCCCCcccccccceee----------
Q 016588           79 SLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQE----------  147 (386)
Q Consensus        79 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----------  147 (386)
                      ....++|+..+.||+|+||+||+|.. .+++.||+|+.... .....+|+.+++.++||||+++++++..          
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~   81 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ   81 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECC-TTSCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecC-cchHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence            34567899999999999999999995 46899999986433 2334579999999999999999999843          


Q ss_pred             ----------------------------CCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 016588          148 ----------------------------NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS  199 (386)
Q Consensus       148 ----------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~  199 (386)
                                                  ....++||||+++ +|.+.+.... .....+++..+..++.|++.||.|||+
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~  159 (383)
T 3eb0_A           82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFI-RSGRSIPMNLISIYIYQLFRAVGFIHS  159 (383)
T ss_dssp             ----------------------------CCEEEEEECCCSE-EHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             cccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence                                        3348899999984 7666553211 134568899999999999999999998


Q ss_pred             CCCCceecCCCCCCeeeC-CCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHH
Q 016588          200 LSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLE  277 (386)
Q Consensus       200 ~~~~ivH~dlkp~Nill~-~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~e  277 (386)
                        .||+||||||+|||++ .++.+||+|||+++......   ......+|+.|+|||.+.+. .++.++||||+||++||
T Consensus       160 --~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e  234 (383)
T 3eb0_A          160 --LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE  234 (383)
T ss_dssp             --TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred             --CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence              7799999999999997 68899999999998764322   23345678889999998765 48999999999999999


Q ss_pred             HHcCCCCCCCCCCCchhhHHHHHHhhhcc--cchhh------------hcchhhcccCCHHHHHHHHHHHhHccCCCCCC
Q 016588          278 LVSGREASSSLSPDSSQDLVELVQNSRDF--SNLLK------------ILDERLWSTFTNEGMEEFIQLIVRCLDPSSER  343 (386)
Q Consensus       278 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  343 (386)
                      |++|..||.+...  .+.+...+......  ..+..            .........++...++++.+++.+||+.||++
T Consensus       235 ll~g~~pf~~~~~--~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  312 (383)
T 3eb0_A          235 LILGKPLFSGETS--IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL  312 (383)
T ss_dssp             HHHSSCSSCCSSH--HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred             HHhCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence            9999999987543  22222222111100  00000            00111111233345577999999999999999


Q ss_pred             CCCHHHHHHH
Q 016588          344 RPSMSDVVTE  353 (386)
Q Consensus       344 Rpt~~evl~~  353 (386)
                      |||+.|+++|
T Consensus       313 R~t~~e~l~h  322 (383)
T 3eb0_A          313 RINPYEAMAH  322 (383)
T ss_dssp             SCCHHHHHTS
T ss_pred             CCCHHHHhcC
Confidence            9999999965

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=5.3e-43  Score=331.34  Aligned_cols=251  Identities=20%  Similarity=0.336  Sum_probs=201.3

Q ss_pred             HHhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC-----------hhHHHHHHHHHHcC-CCCccccccccee
Q 016588           80 LATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----------TQEFIDEVCFLASI-QHRNLVTLLGYCQ  146 (386)
Q Consensus        80 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------~~~~~~e~~~l~~l-~h~niv~~~~~~~  146 (386)
                      ...++|...+.||+|+||.||+|... +|+.||||+.....           .+.+.+|+.+++.+ +||||+++++++.
T Consensus        91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  170 (365)
T 2y7j_A           91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE  170 (365)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            34567889999999999999999975 68999999854332           34577899999999 7999999999999


Q ss_pred             eCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcc
Q 016588          147 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVAD  226 (386)
Q Consensus       147 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D  226 (386)
                      ..+..|+||||+++++|.+++.     ....+++..+..++.|++.||.|||+  .||+||||||+|||++.++.+||+|
T Consensus       171 ~~~~~~lv~e~~~g~~L~~~l~-----~~~~l~~~~~~~i~~qi~~~L~~LH~--~gi~H~Dlkp~NIl~~~~~~ikl~D  243 (365)
T 2y7j_A          171 SSSFMFLVFDLMRKGELFDYLT-----EKVALSEKETRSIMRSLLEAVSFLHA--NNIVHRDLKPENILLDDNMQIRLSD  243 (365)
T ss_dssp             BSSEEEEEECCCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECC
T ss_pred             eCCEEEEEEEeCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEEEe
Confidence            9999999999999999999884     33568899999999999999999999  7799999999999999999999999


Q ss_pred             cccccccCCCCCCCCCccccCcccccchhhhccc------CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHH
Q 016588          227 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR------RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV  300 (386)
Q Consensus       227 Fgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~  300 (386)
                      ||++..+....   ......+|+.|+|||++.+.      .++.++|||||||++|||++|..||.....   ......+
T Consensus       244 fG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---~~~~~~i  317 (365)
T 2y7j_A          244 FGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ---ILMLRMI  317 (365)
T ss_dssp             CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH
T ss_pred             cCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH---HHHHHHH
Confidence            99988765422   23345789999999998643      578999999999999999999999976432   1111111


Q ss_pred             HhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          301 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ......      .....+..    .+..+.+++.+||+.||++|||+.+++++
T Consensus       318 ~~~~~~------~~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          318 MEGQYQ------FSSPEWDD----RSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HHTCCC------CCHHHHSS----SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhCCCC------CCCccccc----CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            111000      00011111    23568999999999999999999999975

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=7.5e-44  Score=349.66  Aligned_cols=248  Identities=23%  Similarity=0.376  Sum_probs=202.0

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECC------CCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      .++|+..+.||+|+||.||+|... +++.||||++.      ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            357888999999999999999965 68999999853      23456789999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee---CCCCceEEccccccc
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRN  231 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill---~~~~~~kl~DFgl~~  231 (386)
                      |||+.+++|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||+   +.++.+||+|||++.
T Consensus       105 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          105 GEVYTGGELFDEII-----SRKRFSEVDAARIIRQVLSGITYMHK--NKIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             ECCCCSCBHHHHHH-----TCSCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EecCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            99999999988884     34568899999999999999999999  779999999999999   567899999999998


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhh
Q 016588          232 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK  311 (386)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (386)
                      .....   .......+|+.|+|||++.+ .|+.++||||+||++|+|++|..||.+...   ......+......     
T Consensus       178 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~-----  245 (484)
T 3nyv_A          178 HFEAS---KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE---YDILKKVEKGKYT-----  245 (484)
T ss_dssp             HBCCC---CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCC-----
T ss_pred             Ecccc---cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHcCCCC-----
Confidence            76432   22344568999999999876 699999999999999999999999987442   2222222111100     


Q ss_pred             hcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          312 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                       .....+    ...++++.+++.+||+.||++|||+.|++++
T Consensus       246 -~~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          246 -FELPQW----KKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             -CCSGGG----GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -CCCccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence             000111    2234668999999999999999999999976

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=5.1e-44  Score=333.85  Aligned_cols=261  Identities=21%  Similarity=0.351  Sum_probs=196.7

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      .++|+..+.||+|+||.||+|... +++.||+|+.....     .+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            357888999999999999999965 48899999753322     234678999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++++|..+..     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++.....
T Consensus       104 e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          104 EFVDHTILDDLEL-----FPNGLDYQVVQKYLFQIINGIGFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             ECCSEEHHHHHHH-----STTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecCCcchHHHHHh-----hccCCCHHHHHHHHHHHHHHHHHHHH--CCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            9999998887763     34568999999999999999999999  7799999999999999999999999999976643


Q ss_pred             CCCCCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcc-cc-----
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF-SN-----  308 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~-----  308 (386)
                      ..  .......+++.|+|||.+.+. .++.++|||||||++|||++|..||......  ..+.......... ..     
T Consensus       177 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~  252 (331)
T 4aaa_A          177 PG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI--DQLYHIMMCLGNLIPRHQELF  252 (331)
T ss_dssp             ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCSCCHHHHHHH
T ss_pred             Cc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCChhhhhHh
Confidence            22  122344678889999999875 7899999999999999999999999875432  1111111110000 00     


Q ss_pred             -----hhhhcchhhc-----ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          309 -----LLKILDERLW-----STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       309 -----~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                           ......+...     ....+..++++.+++.+||+.||++|||+.|++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                 0000000000     00111345679999999999999999999999976

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.5e-43  Score=356.68  Aligned_cols=258  Identities=26%  Similarity=0.437  Sum_probs=205.6

Q ss_pred             HHhcCCCcCCeecccCceEEEEEEeCC----CcEEEEEECCCCCh----hHHHHHHHHHHcCCCCcccccccceeeCCeE
Q 016588           80 LATKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  151 (386)
Q Consensus        80 ~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  151 (386)
                      ...++|+..+.||+|+||.||+|....    +..||+|.......    +.+.+|+.+++.++||||+++++++.+ +..
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~  465 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV  465 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cce
Confidence            345678888999999999999998642    46799998654332    568899999999999999999999854 568


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      |+||||+++|+|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus       466 ~lv~E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQV----RKFSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             EEEEECCTTCBHHHHHHH----TTTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             EEEEEcCCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccchHhEEEeCCCCEEEEecCCCe
Confidence            999999999999998842    23458899999999999999999999  779999999999999999999999999998


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          232 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      ....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |..||.+...   .+....+..        
T Consensus       540 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~---~~~~~~i~~--------  607 (656)
T 2j0j_A          540 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIEN--------  607 (656)
T ss_dssp             SCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHH--------
T ss_pred             ecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHc--------
Confidence            7654222 12233456778999999999999999999999999999997 8999886442   222221111        


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                           ......+..+++.+.+++.+||+.||++|||+.++++.|++++++.
T Consensus       608 -----~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~  653 (656)
T 2j0j_A          608 -----GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  653 (656)
T ss_dssp             -----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence                 1112234445677999999999999999999999999999998763

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.8e-43  Score=341.92  Aligned_cols=197  Identities=21%  Similarity=0.318  Sum_probs=162.4

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeC-----Ce
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN-----NL  150 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  150 (386)
                      .++|.+.+.||+|+||.||+|... +++.||||++....     .+.+.+|+.+++.++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            358899999999999999999965 58899999865432     24678999999999999999999998765     57


Q ss_pred             EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  230 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~  230 (386)
                      .|+||||+. ++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++
T Consensus       105 ~~lv~e~~~-~~L~~~~~-----~~~~l~~~~~~~i~~qil~aL~~LH~--~givHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFK-----TPIFLTEEHIKTILYNLLLGENFIHE--SGIIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             EEEEEECCS-EEHHHHHH-----SSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecCC-cCHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            899999986 58888883     34568999999999999999999999  77999999999999999999999999999


Q ss_pred             cccCCCCCC--------------------CCCccccCcccccchhhh-cccCCCcccchhhHHHHHHHHHcCCCCCC
Q 016588          231 NFLGRTDVA--------------------GPSSQVTADEIFLASEVK-EFRRFSEKSDVYSFGVFLLELVSGREASS  286 (386)
Q Consensus       231 ~~~~~~~~~--------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwSlGvil~el~tg~~p~~  286 (386)
                      +........                    .......+|+.|+|||++ ....|+.++|||||||++|||++|..||.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            876442211                    123566789999999986 55679999999999999999998654443

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2e-43  Score=348.15  Aligned_cols=248  Identities=23%  Similarity=0.391  Sum_probs=199.7

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC----------------CChhHHHHHHHHHHcCCCCcccccccc
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG----------------APTQEFIDEVCFLASIQHRNLVTLLGY  144 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~----------------~~~~~~~~e~~~l~~l~h~niv~~~~~  144 (386)
                      .++|...+.||+|+||+||+|... ++..||+|.+..                ...+.+.+|+.+++.++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            468999999999999999999965 578999997542                224568899999999999999999999


Q ss_pred             eeeCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC---c
Q 016588          145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF---I  221 (386)
Q Consensus       145 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~---~  221 (386)
                      +.+.+..|+||||+++|+|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++   .
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQII-----NRHKFDECDAANIMKQILSGICYLHK--HNIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESSTTCCSS
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCcHHHEEEecCCCCcc
Confidence            999999999999999999988873     34568999999999999999999999  7799999999999998775   6


Q ss_pred             eEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHH
Q 016588          222 AKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ  301 (386)
Q Consensus       222 ~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~  301 (386)
                      +||+|||++.......   ......+|+.|+|||++. ..|+.++||||+||++|+|++|..||.+...   ......+.
T Consensus       188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~  260 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND---QDIIKKVE  260 (504)
T ss_dssp             EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH
T ss_pred             EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH
Confidence            9999999998764422   233456899999999987 4689999999999999999999999987442   22222222


Q ss_pred             hhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          302 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .....      .....+..    .++++.+++.+||+.||.+|||++|++++
T Consensus       261 ~~~~~------~~~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          261 KGKYY------FDFNDWKN----ISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             HCCCC------CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cCCCC------CCccccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            11100      01111122    24568999999999999999999999976

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.1e-43  Score=323.48  Aligned_cols=247  Identities=25%  Similarity=0.391  Sum_probs=194.2

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceee----CCeEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE----NNLQF  152 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~  152 (386)
                      ..|...+.||+|+||.||+|... ++..||+|.....     ..+.+.+|+.+++.++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            34677788999999999999964 5788999975322     23458899999999999999999998865    45689


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC-CCCceEEccccccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRN  231 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~-~~~~~kl~DFgl~~  231 (386)
                      +||||+++++|.+++.     ....+++..+..++.|++.||.|||+.+.+|+||||||+|||++ .++.+||+|||++.
T Consensus       106 lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEecCCCCHHHHHH-----HccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            9999999999999983     33568899999999999999999998323399999999999998 78999999999997


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhh
Q 016588          232 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK  311 (386)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (386)
                      .....    ......+++.|+|||.+. ..++.++||||||+++|+|++|..||.....  ..............     
T Consensus       181 ~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~-----  248 (290)
T 1t4h_A          181 LKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGVKP-----  248 (290)
T ss_dssp             GCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTCCC-----
T ss_pred             ccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc--HHHHHHHHhccCCc-----
Confidence            64332    223456888999999887 4589999999999999999999999976443  11121111111100     


Q ss_pred             hcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          312 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                             ...+...++++.+++.+||+.||++|||+.+++++
T Consensus       249 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          249 -------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             -------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                   01111223568999999999999999999999975

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.2e-43  Score=335.84  Aligned_cols=255  Identities=22%  Similarity=0.328  Sum_probs=180.7

Q ss_pred             cCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeC------Ce
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN------NL  150 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~  150 (386)
                      ++|+..+.||+|+||.||+|.. .+++.||+|++....     .+.+.+|+.+++.++||||+++++++...      ..
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            6788999999999999999995 468999999875432     34577899999999999999999998653      56


Q ss_pred             EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  230 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~  230 (386)
                      .|+|+|++ +++|.+++.      ...+++..+..++.|++.||.|||+  .||+||||||+|||++.++.+||+|||++
T Consensus       109 ~~lv~e~~-~~~L~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVK------CQKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECC----
T ss_pred             EEEEeccc-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHhhEEECCCCCEEEeecccc
Confidence            79999998 678888873      2468999999999999999999999  77999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc--cc
Q 016588          231 NFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD--FS  307 (386)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~  307 (386)
                      +.....     .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....  ..+.........  ..
T Consensus       180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~l~~i~~~~g~p~~~  252 (367)
T 2fst_X          180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--DQLKLILRLVGTPGAE  252 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCSCCHH
T ss_pred             cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHH
Confidence            865431     234578899999999887 67899999999999999999999999875431  111111111000  00


Q ss_pred             chhhhcch-------hh-------cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          308 NLLKILDE-------RL-------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       308 ~~~~~~~~-------~~-------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ....+...       .+       ........++++.+|+.+||+.||++|||+.|++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            00000000       00       000011234668999999999999999999999976

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.5e-43  Score=345.00  Aligned_cols=247  Identities=22%  Similarity=0.348  Sum_probs=200.1

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECC-----CCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP-----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      ++|++.+.||+|+||+||+|... +++.||+|++.     ......+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            56888999999999999999965 68899999842     3456678999999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC---CCCceEEccccccccc
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFL  233 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~---~~~~~kl~DFgl~~~~  233 (386)
                      |+.+++|.+.+.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++   .++.+||+|||+++..
T Consensus       102 ~~~~~~L~~~~~-----~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A          102 LYTGGELFDEII-----KRKRFSEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             CCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             cCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            999999988873     33568999999999999999999999  7799999999999995   4568999999999876


Q ss_pred             CCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhc
Q 016588          234 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  313 (386)
Q Consensus       234 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (386)
                      ....   ......+|+.|+|||++.+ .|+.++||||+||++|+|++|..||.+...   ......+......      .
T Consensus       175 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~------~  241 (486)
T 3mwu_A          175 QQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDILKRVETGKYA------F  241 (486)
T ss_dssp             CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCCC------S
T ss_pred             CCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCC------C
Confidence            4322   2334568999999999875 599999999999999999999999986442   2222222111100      0


Q ss_pred             chhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      +...+    ...++++.+++.+||+.||++|||+.+++++
T Consensus       242 ~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          242 DLPQW----RTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             CSGGG----GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             CCccc----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00111    1234668999999999999999999999986

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2e-42  Score=319.00  Aligned_cols=249  Identities=20%  Similarity=0.257  Sum_probs=196.1

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC-------CChhHHHHHHHHHHcCCCCcccccccce--eeCCeE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG-------APTQEFIDEVCFLASIQHRNLVTLLGYC--QENNLQ  151 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-------~~~~~~~~e~~~l~~l~h~niv~~~~~~--~~~~~~  151 (386)
                      .++|.+.+.||+|+||.||++... ++..||+|....       .....+.+|+.+++.++||||+++++++  .+.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            368999999999999999999964 588999998643       2345688999999999999999999998  445678


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      ++||||++++ |.+++..   .....+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++.
T Consensus        84 ~lv~e~~~~~-l~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~LH~--~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDS---VPEKRFPVCQAHGYFCQLIDGLEYLHS--QGIVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             EEEEECCSEE-HHHHHHH---STTCSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEehhccCC-HHHHHHh---CcccccCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCcccEEEcCCCcEEeecccccc
Confidence            9999999876 5555532   134568899999999999999999999  779999999999999999999999999998


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhcccCC--CcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccch
Q 016588          232 FLGRTDVAGPSSQVTADEIFLASEVKEFRRF--SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL  309 (386)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  309 (386)
                      ...............+++.|+|||.+.+...  +.++||||||+++|||++|..||.....   ......+...      
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~i~~~------  228 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI---YKLFENIGKG------  228 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHC------
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH---HHHHHHHhcC------
Confidence            7654332233334568889999999876443  7799999999999999999999986432   1111111110      


Q ss_pred             hhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                              ....+..+++.+.+++.+||+.||++|||++|++++
T Consensus       229 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          229 --------SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             --------CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             --------CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                    012223345678999999999999999999999986

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.7e-43  Score=324.69  Aligned_cols=246  Identities=19%  Similarity=0.304  Sum_probs=201.9

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ++|...+.||+|+||.||++... +++.+|+|.....      ..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            56888899999999999999965 4789999975432      2346788999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++.....
T Consensus        95 e~~~~~~L~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           95 ELCRRRSLLELHK-----RRKALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             ECCTTCBHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            9999999988873     33568899999999999999999999  7799999999999999999999999999987643


Q ss_pred             CCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      ..  .......+++.|+|||.+.+..++.++||||||+++|||++|..||.....   .........            .
T Consensus       168 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~------------~  230 (294)
T 2rku_A          168 DG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---KETYLRIKK------------N  230 (294)
T ss_dssp             TT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHT------------T
T ss_pred             Cc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhh------------c
Confidence            22  122345688899999999988899999999999999999999999976442   111111110            0


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                      .  ...+...+..+.+++.+||+.||++|||++|++++-
T Consensus       231 ~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~  267 (294)
T 2rku_A          231 E--YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDE  267 (294)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             c--CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence            0  112233446789999999999999999999999763

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4.5e-43  Score=331.77  Aligned_cols=263  Identities=20%  Similarity=0.296  Sum_probs=199.3

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeC-----CeE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQEN-----NLQ  151 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  151 (386)
                      ..+|+..+.||+|+||.||+|... ++..||+|+.....    .+.+.+|+++++.++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            357899999999999999999965 58899999875433    24578999999999999999999998654     468


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      |+||||+. ++|.+++.      ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.
T Consensus       106 ~iv~e~~~-~~L~~~l~------~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLK------TQHLSNDHICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             EEEEECCS-EEHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEcccC-cCHHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCChHhEEECCCCCEEEEeCcceE
Confidence            99999997 48887773      3458899999999999999999999  779999999999999999999999999998


Q ss_pred             ccCCCCC-CCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccch
Q 016588          232 FLGRTDV-AGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL  309 (386)
Q Consensus       232 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  309 (386)
                      ....... ........+|+.|+|||++.+ ..++.++|||||||++|||++|..||.+......................
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  256 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  256 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            7654322 222345578999999998754 45899999999999999999999999875543221111110000000000


Q ss_pred             hhhcc--------------hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          310 LKILD--------------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       310 ~~~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ....+              ...+.......+.++.+++.+||+.||++|||+.|++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000              000011112234678999999999999999999999976

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=7e-43  Score=320.46  Aligned_cols=251  Identities=23%  Similarity=0.402  Sum_probs=196.9

Q ss_pred             cCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC---ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      .+|.....||+|+||.||+|.. .++..||+|.....   ..+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            3455567999999999999995 45889999985432   3467889999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-CCceEEcccccccccCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~-~~~~kl~DFgl~~~~~~~~  237 (386)
                      ++++|.+++...  .....+++..+..++.|++.||.|||+  .+|+||||||+||+++. ++.+||+|||++.......
T Consensus       102 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A          102 PGGSLSALLRSK--WGPLKDNEQTIGFYTKQILEGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             SEEEHHHHHHHT--TCCCTTCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred             CCCCHHHHHHhh--ccCCCccHHHHHHHHHHHHHHHHHHHh--CCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence            999999988532  122356788889999999999999999  77999999999999987 8999999999998764322


Q ss_pred             CCCCCccccCcccccchhhhcccC--CCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          238 VAGPSSQVTADEIFLASEVKEFRR--FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                        .......+++.|+|||++.+..  ++.++||||||+++|||++|..||........ ..... .            ..
T Consensus       178 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~-~------------~~  241 (295)
T 2clq_A          178 --PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-AMFKV-G------------MF  241 (295)
T ss_dssp             -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH-HHHHH-H------------HH
T ss_pred             --CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH-HHHhh-c------------cc
Confidence              1223456888999999987643  88999999999999999999999975432111 00000 0            00


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ......+...+.++.+++.+||+.||++|||+.+++++
T Consensus       242 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          242 KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11122333455678999999999999999999999865

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=6.9e-44  Score=326.52  Aligned_cols=258  Identities=25%  Similarity=0.357  Sum_probs=196.3

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC--CCc--EEEEEECCCC------ChhHHHHHHHHHHcCCCCcccccccceeeCCeE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ--DGM--LVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  151 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  151 (386)
                      .++|+..+.||+|+||+||+|.+.  ++.  .||+|.....      ..+.+.+|+.+++.++||||+++++++...+ .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            357888999999999999999853  233  6899975432      2356889999999999999999999998765 7


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      ++|+||+++++|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++.
T Consensus        96 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRK----HQGHFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             EEEEECCTTCBHHHHHHH----HGGGSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             eeeEecccCCCHHHHHHh----ccCCcCHHHHHHHHHHHHHHHHHHHh--CCcccCCCchheEEEcCCCCEEEccccccc
Confidence            899999999999988842    23568899999999999999999999  779999999999999999999999999988


Q ss_pred             ccCCCCCC-CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccch
Q 016588          232 FLGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNL  309 (386)
Q Consensus       232 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  309 (386)
                      ........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||.....   .........       
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~-------  239 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILHKIDK-------  239 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHT-------
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH---HHHHHHHHc-------
Confidence            76442211 12223456778999999998889999999999999999999 9999986542   111111111       


Q ss_pred             hhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                           .......+...++++.+++.+||+.||++|||+.++++.|+++....
T Consensus       240 -----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  286 (291)
T 1u46_A          240 -----EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD  286 (291)
T ss_dssp             -----SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             -----cCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence                 01111223345577999999999999999999999999999887543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.5e-43  Score=338.45  Aligned_cols=261  Identities=22%  Similarity=0.292  Sum_probs=194.3

Q ss_pred             cCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCChhHHHHHHHHHHcCCCCcccccccceeeCC------eEEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENN------LQFLIYE  156 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e  156 (386)
                      .+|+..+.||+|+||+||+|....+..+|+|+..... ....+|+++++.++||||+++++++...+      ..++|||
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~-~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e  118 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK-RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE  118 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT-TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc-chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence            4688899999999999999998777779998754321 22347999999999999999999985433      3789999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC-CCCceEEcccccccccCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~-~~~~~kl~DFgl~~~~~~  235 (386)
                      |++++.+.......  .....+++..+..++.|++.||.|||+  .+|+||||||+|||++ .++.+||+|||+++....
T Consensus       119 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~  194 (394)
T 4e7w_A          119 YVPETVYRASRHYA--KLKQTMPMLLIKLYMYQLLRSLAYIHS--IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA  194 (394)
T ss_dssp             CCSEEHHHHHHHHH--HTTSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             ccCccHHHHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence            99875443322110  124568899999999999999999999  7799999999999999 799999999999987643


Q ss_pred             CCCCCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc--ccchhh-
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD--FSNLLK-  311 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~-  311 (386)
                      ..   ......+|+.|+|||.+.+. .|+.++|||||||++|||++|+.||.+...  ...+.........  ...+.. 
T Consensus       195 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~l~~i~~~~g~p~~~~~~~~  269 (394)
T 4e7w_A          195 GE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG--IDQLVEIIKVLGTPSREQIKTM  269 (394)
T ss_dssp             TC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCHHHHHHH
T ss_pred             CC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHHHHhh
Confidence            22   23345678899999998765 589999999999999999999999987543  2222222211100  000000 


Q ss_pred             -----------hcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          312 -----------ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       312 -----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                                 .........++...++++.+++.+||+.||++|||+.|+++|
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence                       000001111223345679999999999999999999999986

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.8e-43  Score=346.38  Aligned_cols=247  Identities=24%  Similarity=0.394  Sum_probs=196.9

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECC-----CCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP-----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      ++|+..+.||+|+||+||+|... ++..||+|++.     ......+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            46888999999999999999965 58899999753     2335678999999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC---CCceEEccccccccc
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADAGLRNFL  233 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~---~~~~kl~DFgl~~~~  233 (386)
                      |+++|+|.+.+.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.   ++.+||+|||++...
T Consensus       117 ~~~~g~L~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          117 CYKGGELFDEII-----HRMKFNEVDAAVIIKQVLSGVTYLHK--HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             CCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             cCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            999999988773     34568899999999999999999999  77999999999999976   455999999999876


Q ss_pred             CCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhc
Q 016588          234 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  313 (386)
Q Consensus       234 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (386)
                      ....   ......+|+.|+|||++. ..|+.++||||+||++|+|++|..||.+...   ......+.....      ..
T Consensus       190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~------~~  256 (494)
T 3lij_A          190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD---QEILRKVEKGKY------TF  256 (494)
T ss_dssp             BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCC------CC
T ss_pred             CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCC------CC
Confidence            5422   233456899999999987 5689999999999999999999999987543   222222211110      00


Q ss_pred             chhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ....+.    ..++++.+++.+||+.||.+|||+.|++++
T Consensus       257 ~~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          257 DSPEWK----NVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             CSGGGT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             Cchhcc----cCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            111122    234568999999999999999999999976

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.7e-44  Score=327.29  Aligned_cols=253  Identities=23%  Similarity=0.355  Sum_probs=199.9

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCccccccccee--eCCeEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQ--ENNLQFL  153 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~l  153 (386)
                      .++|+..+.||+|+||.||++... +++.||+|......     .+.+.+|+.+++.++||||+++++++.  ..+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            357888999999999999999965 58899999854322     345889999999999999999999874  4678999


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-----ceecCCCCCCeeeCCCCceEEcccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR-----VVHKDFKTANVLVDEDFIAKVADAG  228 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-----ivH~dlkp~Nill~~~~~~kl~DFg  228 (386)
                      ||||+++++|.+++.... .....+++..++.++.|++.||.|||+  .+     |+||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGT-KERQYLDEEFVLRVMTQLTLALKECHR--RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHH--HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhc-ccCCCCCHHHHHHHHHHHHHHHHHHhc--ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            999999999999885321 123458999999999999999999998  66     9999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccc
Q 016588          229 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN  308 (386)
Q Consensus       229 l~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  308 (386)
                      ++........  ......++..|+|||.+.+..++.++||||||+++|||++|..||.....   ......+...     
T Consensus       162 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~i~~~-----  231 (279)
T 2w5a_A          162 LARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGKIREG-----  231 (279)
T ss_dssp             HHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHT-----
T ss_pred             hheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHHHHHhhc-----
Confidence            9887643211  11234578889999999988999999999999999999999999986542   2222211111     


Q ss_pred             hhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016588          309 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  355 (386)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~  355 (386)
                              .....+...+.++.+++.+||+.||++|||+.|+++++.
T Consensus       232 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          232 --------KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             --------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             --------ccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence                    111223344567899999999999999999999998753

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.5e-43  Score=328.76  Aligned_cols=246  Identities=19%  Similarity=0.301  Sum_probs=202.4

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      .++|...+.||+|+||.||++... +++.+|+|.....      ..+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            457888999999999999999965 4789999985432      235688899999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      |||+++++|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++....
T Consensus       120 ~e~~~~~~L~~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          120 LELCRRRSLLELHK-----RRKALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             ECCCTTCBHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            99999999988873     33568899999999999999999999  779999999999999999999999999998764


Q ss_pred             CCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                      ...  .......++..|+|||.+.+..++.++||||||+++|||++|..||.....   ..........           
T Consensus       193 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~-----------  256 (335)
T 2owb_A          193 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---KETYLRIKKN-----------  256 (335)
T ss_dssp             STT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHT-----------
T ss_pred             cCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH---HHHHHHHhcC-----------
Confidence            322  123345688899999999998999999999999999999999999976432   1111111110           


Q ss_pred             hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                         ....+...+.++.+++.+||+.||++|||+.|++++
T Consensus       257 ---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          257 ---EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ---CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               001222344668999999999999999999999975

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.4e-44  Score=337.50  Aligned_cols=263  Identities=20%  Similarity=0.269  Sum_probs=201.4

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      .++|+..+.||+|+||.||+|... ++..||+|......    .+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            457888999999999999999965 58899999865432    3467899999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      |+++++|.+++.     ....+++..+..++.|++.||.|||+. ++|+||||||+|||++.++.+||+|||++......
T Consensus       112 ~~~~~~L~~~l~-----~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          112 HMDGGSLDQVLK-----KAGRIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             CCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHH-HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             CCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHh-CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            999999999884     234688999999999999999999972 26999999999999999999999999998765321


Q ss_pred             CCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHH----------------
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV----------------  300 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~----------------  300 (386)
                          ......+|+.|+|||++.+..++.++|||||||++|||++|..||...............                
T Consensus       186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence                123346788999999999999999999999999999999999999864432111100000                


Q ss_pred             -------Hhhhcccchhhhcc----hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          301 -------QNSRDFSNLLKILD----ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       301 -------~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                             .............+    ...........+.++.+++.+||+.||++|||++|++++-
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  326 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA  326 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred             CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence                   00000000000000    0000111122456799999999999999999999999763

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.8e-43  Score=321.57  Aligned_cols=244  Identities=23%  Similarity=0.349  Sum_probs=195.2

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcC-CCCcccccccceeeCCeEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  154 (386)
                      ..+|+..+.||+|+||+||+|... +++.||+|.....     ...++.+|+..+..+ +||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            357888999999999999999975 6899999985432     234678899999998 899999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC----------------
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE----------------  218 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~----------------  218 (386)
                      |||+++++|.+++.... .....+++..+..++.|++.||.|||+  ++|+||||||+|||++.                
T Consensus        90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENY-RIMSYFKEAELKDLLLQVGRGLRYIHS--MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhc-ccccCCCHHHHHHHHHHHHHHHHHHHh--CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            99999999999884321 112568899999999999999999999  77999999999999984                


Q ss_pred             ---CCceEEcccccccccCCCCCCCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchh
Q 016588          219 ---DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ  294 (386)
Q Consensus       219 ---~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~  294 (386)
                         ...+||+|||++......      ....+++.|+|||.+.+. .++.++|||||||++|||++|..|+....     
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----  235 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD-----  235 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----
T ss_pred             cCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----
Confidence               447999999998876432      223578899999999866 56689999999999999999987654311     


Q ss_pred             hHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          295 DLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      . ......             ......+...++++.+++.+||+.||++|||+.+++++
T Consensus       236 ~-~~~~~~-------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          236 Q-WHEIRQ-------------GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             H-HHHHHT-------------TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             H-HHHHHc-------------CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence            1 111111             11112233345678999999999999999999999876

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.4e-44  Score=342.11  Aligned_cols=242  Identities=12%  Similarity=0.108  Sum_probs=184.2

Q ss_pred             hcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCC------CChhHHHHHHH---HHHcCCCCcccccc-------cc
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG------APTQEFIDEVC---FLASIQHRNLVTLL-------GY  144 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~------~~~~~~~~e~~---~l~~l~h~niv~~~-------~~  144 (386)
                      .++|+..+.||+|+||+||+|.. .+++.||||++..      ...+.+.+|+.   .++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            35688889999999999999995 5689999998532      22356889994   45556899999998       44


Q ss_pred             eeeCC-----------------eEEEEEEeecCCCccccccCCCcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCce
Q 016588          145 CQENN-----------------LQFLIYEYIPNGSVSIHLYGPSQV--SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV  205 (386)
Q Consensus       145 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~iv  205 (386)
                      +...+                 ..|+||||+ +|+|.+++......  ....+++..++.++.|++.||.|||+  ++|+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~iv  228 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLV  228 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH--TTEE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh--CCee
Confidence            44332                 278999999 67999888532111  11234457888899999999999999  6799


Q ss_pred             ecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhccc-----------CCCcccchhhHHHH
Q 016588          206 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR-----------RFSEKSDVYSFGVF  274 (386)
Q Consensus       206 H~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DvwSlGvi  274 (386)
                      ||||||+|||++.++.+||+|||+++..+.     ......+ +.|+|||++.+.           .++.++|||||||+
T Consensus       229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             cCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            999999999999999999999999986433     1223455 789999999987           89999999999999


Q ss_pred             HHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          275 LLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       275 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      +|||++|..||........               ......      .....++++.+++.+||+.||++|||+.|++++
T Consensus       303 l~elltg~~Pf~~~~~~~~---------------~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  360 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGG---------------SEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET  360 (377)
T ss_dssp             HHHHHHSSCCC------CC---------------SGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred             HHHHHHCCCCCcccccccc---------------hhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence            9999999999976443111               000100      112234668999999999999999999999963

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4e-43  Score=356.23  Aligned_cols=247  Identities=19%  Similarity=0.289  Sum_probs=204.1

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECC------CCChhHHHHHHHHHHcC-CCCcccccccceeeCCeEE
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQF  152 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  152 (386)
                      ...+|+..+.||+|+||.||+|..+ +++.||||++.      ....+.+..|..++..+ +||||+++++++.+.+..|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            4567899999999999999999965 58899999854      23455678899999987 7999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~  232 (386)
                      +||||+++|+|..++.     ....+++..+..++.|++.||.|||+  ++|+||||||+||||+.++.+||+|||+++.
T Consensus       419 lV~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~gIiHrDLKp~NILl~~~g~ikL~DFGla~~  491 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQ-----QVGRFKEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  491 (674)
T ss_dssp             EEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred             EEEeCcCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence            9999999999998884     33568999999999999999999999  7799999999999999999999999999986


Q ss_pred             cCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          233 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      .....  .......||+.|+|||++.+..|+.++|||||||++|||++|..||.+...   ..+...+.           
T Consensus       492 ~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~---~~~~~~i~-----------  555 (674)
T 3pfq_A          492 NIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIM-----------  555 (674)
T ss_dssp             CCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH-----------
T ss_pred             cccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH---HHHHHHHH-----------
Confidence            43221  234456799999999999999999999999999999999999999986442   22222111           


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCH-----HHHHHH
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM-----SDVVTE  353 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~-----~evl~~  353 (386)
                       ...  ..++...++++.+|+.+||+.||++||++     +|+++|
T Consensus       556 -~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          556 -EHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             -SSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             -hCC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence             111  12334456779999999999999999998     677654

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.8e-43  Score=327.47  Aligned_cols=252  Identities=17%  Similarity=0.212  Sum_probs=199.2

Q ss_pred             HhcCCCcC-CeecccCceEEEEEEeC-CCcEEEEEECCC-----CChhHHHHHHHHHHcC-CCCcccccccceeeCCeEE
Q 016588           81 ATKNFSDK-NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG-----APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQF  152 (386)
Q Consensus        81 ~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  152 (386)
                      ..+.|... +.||+|+||.||+|... +++.||+|....     .....+.+|+.++..+ +||||+++++++.+.+..+
T Consensus        26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~  105 (327)
T 3lm5_A           26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII  105 (327)
T ss_dssp             HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence            34566666 88999999999999965 589999997543     2346788999999999 5799999999999999999


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC---CCceEEccccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADAGL  229 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~---~~~~kl~DFgl  229 (386)
                      +||||+++|+|.+++...   ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.   ++.+||+|||+
T Consensus       106 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~ql~~~L~~LH~--~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~  180 (327)
T 3lm5_A          106 LILEYAAGGEIFSLCLPE---LAEMVSENDVIRLIKQILEGVYYLHQ--NNIVHLDLKPQNILLSSIYPLGDIKIVDFGM  180 (327)
T ss_dssp             EEEECCTTEEGGGGGSSC---C-CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred             EEEEecCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH--CCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence            999999999999888432   34568999999999999999999999  77999999999999998   78999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccch
Q 016588          230 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL  309 (386)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  309 (386)
                      ++......   ......+|+.|+|||++.+..++.++|||||||++|||++|..||.....   ...........     
T Consensus       181 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~-----  249 (327)
T 3lm5_A          181 SRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN---QETYLNISQVN-----  249 (327)
T ss_dssp             CEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTC-----
T ss_pred             ccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHHHhcc-----
Confidence            98764322   22345688999999999999999999999999999999999999976442   11111111110     


Q ss_pred             hhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                           ...........++.+.+++.+||+.||++|||+++++++
T Consensus       250 -----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          250 -----VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             -----CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             -----cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence                 011111222345678999999999999999999999876

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=9.5e-43  Score=328.79  Aligned_cols=271  Identities=23%  Similarity=0.259  Sum_probs=190.7

Q ss_pred             HHHHHHhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECC--CCChhHHHHHHHHHHcCCCCcccccccceeeCCe--
Q 016588           76 EELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP--GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNL--  150 (386)
Q Consensus        76 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--  150 (386)
                      .......++|++.+.||+|+||.||+|... ++..||||+..  ........+++..+..++||||+++++++...+.  
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            445556789999999999999999999965 58899999753  3344567788888999999999999999865433  


Q ss_pred             -----EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-CCceEE
Q 016588          151 -----QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKV  224 (386)
Q Consensus       151 -----~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~-~~~~kl  224 (386)
                           .++||||++++ |...+... ......+++..+..++.|++.||.|||.++++|+||||||+|||++. ++.+||
T Consensus        96 ~~~~~~~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl  173 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPDT-LHRCCRNY-YRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKL  173 (360)
T ss_dssp             TTCEEEEEEEECCSCB-HHHHHHHH-HTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred             ccceeEEEEeeccccc-HHHHHHHH-hhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEE
Confidence                 78999999874 43322111 02345678889999999999999999933378999999999999996 899999


Q ss_pred             cccccccccCCCCCCCCCccccCcccccchhhhcccC-CCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhh
Q 016588          225 ADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS  303 (386)
Q Consensus       225 ~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~  303 (386)
                      +|||++.......   ......+|+.|+|||++.+.. ++.++|||||||++|||++|..||......  ..+.......
T Consensus       174 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~~~~~~~  248 (360)
T 3e3p_A          174 CDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA--GQLHEIVRVL  248 (360)
T ss_dssp             CCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHH
T ss_pred             eeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH--HHHHHHHHHc
Confidence            9999998765422   223456788999999986654 899999999999999999999999875432  1111111111


Q ss_pred             hcc-cchhhhcc----------------hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          304 RDF-SNLLKILD----------------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       304 ~~~-~~~~~~~~----------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ... .......+                ...........++++.+++.+||+.||.+|||+.|++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            000 00000000                011112222356789999999999999999999999976

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=9e-43  Score=316.75  Aligned_cols=245  Identities=22%  Similarity=0.288  Sum_probs=194.5

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC------CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      .++|.+.+.||+|+||.||+|... +++.||+|....      ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            357888999999999999999975 689999998532      3345788999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      |||+++++|.+++.     ....+++..+..++.|++.||.|||+  ++++||||||+||+++.++.+||+|||++....
T Consensus        90 ~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  162 (276)
T 2h6d_A           90 MEYVSGGELFDYIC-----KHGRVEEMEARRLFQQILSAVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  162 (276)
T ss_dssp             EECCCSCBHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred             EeccCCCcHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence            99999999998884     23468899999999999999999999  779999999999999999999999999998764


Q ss_pred             CCCCCCCCccccCcccccchhhhcccCC-CcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhc
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  313 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (386)
                      ...   ......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||.....   ......+....         
T Consensus       163 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~---------  227 (276)
T 2h6d_A          163 DGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV---PTLFKKIRGGV---------  227 (276)
T ss_dssp             C----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCC---------
T ss_pred             CCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHhhcCc---------
Confidence            322   1233467888999999987765 6899999999999999999999976332   11111111100         


Q ss_pred             chhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                           ...+...+..+.+++.+||+.||++|||+++++++
T Consensus       228 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          228 -----FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -----ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                 11222334668999999999999999999999986

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=7.9e-43  Score=323.15  Aligned_cols=251  Identities=25%  Similarity=0.393  Sum_probs=199.6

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC-CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG-APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      ..++|+..+.||+|+||.||+|... +++.||+|.... ...+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  106 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC  106 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence            4567899999999999999999965 489999998543 34577999999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++++|.+++..    ....+++..+..++.|++.||.|||+  .+++|+||||+||+++.++.+||+|||++....... 
T Consensus       107 ~~~~L~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-  179 (314)
T 3com_A          107 GAGSVSDIIRL----RNKTLTEDEIATILQSTLKGLEYLHF--MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-  179 (314)
T ss_dssp             TTEEHHHHHHH----HTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-
T ss_pred             CCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-
Confidence            99999988841    24568899999999999999999999  779999999999999999999999999997764321 


Q ss_pred             CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                       .......+++.|+|||.+.+..++.++||||||+++|||++|..||......   ..........         .+  .
T Consensus       180 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~---------~~--~  244 (314)
T 3com_A          180 -AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM---RAIFMIPTNP---------PP--T  244 (314)
T ss_dssp             -SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHSC---------CC--C
T ss_pred             -cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHhcCC---------Cc--c
Confidence             1223456888999999999989999999999999999999999999864421   1111111100         00  0


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ...+...+..+.+++.+||+.||++|||+.+++++
T Consensus       245 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          245 FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            01122345678999999999999999999999975

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.8e-44  Score=334.87  Aligned_cols=258  Identities=21%  Similarity=0.299  Sum_probs=185.5

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC---hhHHHHHHHHHHcCC-CCccccccccee--------e
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQ-HRNLVTLLGYCQ--------E  147 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~l~~l~-h~niv~~~~~~~--------~  147 (386)
                      ...+|++.+.||+|+||.||+|... +++.||+|++....   ...+.+|+.++..+. ||||+++++++.        .
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            3457889999999999999999964 68899999754333   345788999999995 999999999883        4


Q ss_pred             CCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccc
Q 016588          148 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA  227 (386)
Q Consensus       148 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DF  227 (386)
                      ....++||||+. |+|.+++...  .....+++..++.++.|++.||.|||+.+++|+||||||+|||++.++.+||+||
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKM--ESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHH--HTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             CceEEEEEEecC-CCHHHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecC
Confidence            456899999996 6888777421  1245689999999999999999999983223999999999999999999999999


Q ss_pred             ccccccCCCCCCC----------CCccccCcccccchhhh---cccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchh
Q 016588          228 GLRNFLGRTDVAG----------PSSQVTADEIFLASEVK---EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ  294 (386)
Q Consensus       228 gl~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~---~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~  294 (386)
                      |++..........          ......+|+.|+|||++   .+..++.++|||||||++|||++|..||.......  
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--  260 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--  260 (337)
T ss_dssp             TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--
Confidence            9998765422111          11234578889999998   56678999999999999999999999997533210  


Q ss_pred             hHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          295 DLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                          ..             ............+..+.+++.+||+.||++|||+.|++++|+.+...
T Consensus       261 ----~~-------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~  309 (337)
T 3ll6_A          261 ----IV-------------NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA  309 (337)
T ss_dssp             ----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----hh-------------cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                00             00010111112234578999999999999999999999999998865

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.5e-43  Score=323.53  Aligned_cols=266  Identities=23%  Similarity=0.336  Sum_probs=187.9

Q ss_pred             HHHhcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEE
Q 016588           79 SLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        79 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (386)
                      ....++|...+.||+|+||.||+|.. .++..||+|.....    ..+++.+|+.+++.++||||+++++++...+..++
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            34567899999999999999999995 46889999976532    34567889999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCC---cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 016588          154 IYEYIPNGSVSIHLYGPS---QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  230 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~---~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~  230 (386)
                      ||||+++++|.+++....   ......+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK--NGQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            999999999998874210   1124568999999999999999999999  77999999999999999999999999998


Q ss_pred             cccCCCCC---CCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcc
Q 016588          231 NFLGRTDV---AGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF  306 (386)
Q Consensus       231 ~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  306 (386)
                      ........   ........+++.|+|||.+.+ ..++.++||||||+++|||++|..||.......  ........... 
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~-  245 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK--VLMLTLQNDPP-  245 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HHHHHHTSSCC-
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh--HHHHHhccCCC-
Confidence            76643211   111234568889999999876 578999999999999999999999998755322  11111111000 


Q ss_pred             cchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .......+.    ......+.++.+++.+||+.||.+|||+.+++++
T Consensus       246 ~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          246 SLETGVQDK----EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             CTTC---------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ccccccccc----hhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            000001111    1122234568999999999999999999999975

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.4e-43  Score=325.33  Aligned_cols=248  Identities=22%  Similarity=0.304  Sum_probs=200.6

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC---ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      .++|...+.||+|+||.||++... +++.||+|.....   ..+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            356888999999999999999965 6889999985433   345688999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee---CCCCceEEcccccccccC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill---~~~~~~kl~DFgl~~~~~  234 (386)
                      +++++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+||++   +.++.+||+|||++....
T Consensus        88 ~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           88 VSGGELFDRIL-----ERGVYTEKDASLVIQQVLSAVKYLHE--NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             CCSCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             CCCccHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            99999988873     23568899999999999999999999  779999999999999   788999999999987643


Q ss_pred             CCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                      ..    ......+++.|+|||.+.+..++.++||||||+++|||++|..||.....   ......+.....         
T Consensus       161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~---------  224 (304)
T 2jam_A          161 NG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE---SKLFEKIKEGYY---------  224 (304)
T ss_dssp             CB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHCCC---------
T ss_pred             CC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHcCCC---------
Confidence            21    22344588899999999998999999999999999999999999976432   122221111100         


Q ss_pred             hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                       ..........++++.+++.+||+.||++|||+++++++
T Consensus       225 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          225 -EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             -CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             -CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             00011222345678999999999999999999999975

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=330.30  Aligned_cols=253  Identities=27%  Similarity=0.423  Sum_probs=195.3

Q ss_pred             HHHhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECC--CCChhHHHHHHHHHHcC-CCCcccccccceee------C
Q 016588           79 SLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP--GAPTQEFIDEVCFLASI-QHRNLVTLLGYCQE------N  148 (386)
Q Consensus        79 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~------~  148 (386)
                      ....++|+..+.||+|+||.||+|... +++.||+|...  ....+.+.+|+.+++.+ +||||+++++++..      .
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   99 (326)
T 2x7f_A           20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   99 (326)
T ss_dssp             CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred             cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence            335678899999999999999999964 68899999853  33457789999999998 79999999999876      5


Q ss_pred             CeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccc
Q 016588          149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  228 (386)
Q Consensus       149 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFg  228 (386)
                      +..++||||+++++|.+++...   ....+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~kl~Dfg  174 (326)
T 2x7f_A          100 DQLWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLVDFG  174 (326)
T ss_dssp             CEEEEEEECCTTEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTCCEEECCCT
T ss_pred             ceEEEEEEcCCCCcHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCcHHHEEEcCCCCEEEeeCc
Confidence            6889999999999999988532   23568899999999999999999999  779999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhc-----ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhh
Q 016588          229 LRNFLGRTDVAGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS  303 (386)
Q Consensus       229 l~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~  303 (386)
                      ++.......  .......+++.|+|||.+.     +..++.++|||||||++|||++|..||......   .........
T Consensus       175 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~  249 (326)
T 2x7f_A          175 VSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---RALFLIPRN  249 (326)
T ss_dssp             TTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHS
T ss_pred             CceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHhhcC
Confidence            988764321  1223446888999999987     567899999999999999999999999764421   111111100


Q ss_pred             hcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          304 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .         .+   .......+..+.+++.+||+.||++|||+.+++++
T Consensus       250 ~---------~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          250 P---------AP---RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             C---------CC---CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             c---------cc---cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0         00   01112234678999999999999999999999975

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4.3e-43  Score=338.81  Aligned_cols=259  Identities=18%  Similarity=0.240  Sum_probs=198.4

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC--hhHHHHHHHHHHcC------CCCcccccccceeeCCeEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP--TQEFIDEVCFLASI------QHRNLVTLLGYCQENNLQF  152 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~e~~~l~~l------~h~niv~~~~~~~~~~~~~  152 (386)
                      ..+|++.+.||+|+||+||+|... +++.||||++....  ...+.+|+.+++.+      +|+||+++++++...+..+
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  175 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC  175 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence            356889999999999999999855 58899999876543  24577788888776      5789999999999999999


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc--eEEcccccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI--AKVADAGLR  230 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~--~kl~DFgl~  230 (386)
                      +||||+. ++|.+++...   ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.  +||+|||++
T Consensus       176 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          176 MTFELLS-MNLYELIKKN---KFQGFSLPLVRKFAHSILQCLDALHK--NRIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEECCCC-CBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHH--HTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEeccC-CCHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence            9999996 5888777432   23458999999999999999999999  67999999999999999887  999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcc----
Q 016588          231 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF----  306 (386)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----  306 (386)
                      .....     ......+|+.|+|||++.+..++.++|||||||++|||++|..||.+....  ..+..........    
T Consensus       250 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~--~~l~~i~~~~~~p~~~~  322 (429)
T 3kvw_A          250 CYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG--DQLACMIELLGMPSQKL  322 (429)
T ss_dssp             EETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHH
T ss_pred             eecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCCHHH
Confidence            76533     223457888999999999999999999999999999999999999875432  1111111110000    


Q ss_pred             ----cchhhhcchhhc------------------------------------ccCCHHHHHHHHHHHhHccCCCCCCCCC
Q 016588          307 ----SNLLKILDERLW------------------------------------STFTNEGMEEFIQLIVRCLDPSSERRPS  346 (386)
Q Consensus       307 ----~~~~~~~~~~~~------------------------------------~~~~~~~~~~l~~li~~cl~~dp~~Rpt  346 (386)
                          ......++...+                                    .......++++.+++.+||+.||++|||
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt  402 (429)
T 3kvw_A          323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT  402 (429)
T ss_dssp             HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence                000001110000                                    0001112466899999999999999999


Q ss_pred             HHHHHHH
Q 016588          347 MSDVVTE  353 (386)
Q Consensus       347 ~~evl~~  353 (386)
                      +.|++++
T Consensus       403 a~e~L~H  409 (429)
T 3kvw_A          403 PGQALRH  409 (429)
T ss_dssp             HHHHHTS
T ss_pred             HHHHhCC
Confidence            9999976

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=328.31  Aligned_cols=261  Identities=20%  Similarity=0.266  Sum_probs=200.1

Q ss_pred             hcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC---ChhHHHHHHHHHHcCCCCccccccccee----eCCeEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQ----ENNLQFL  153 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~~~l  153 (386)
                      .++|+..+.||+|+||.||++.. .+++.||+|.+...   ..+.+.+|+.+++.++||||+++++++.    ..+..++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            46789999999999999999996 56899999975433   3456889999999999999999999986    3457899


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      ||||+++++|.+++.... .....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++...
T Consensus       108 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLK-DKGNFLTEDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            999999999998885321 134668999999999999999999999  67999999999999999999999999998764


Q ss_pred             CCCCCCC-------CCccccCcccccchhhhcccC---CCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhh
Q 016588          234 GRTDVAG-------PSSQVTADEIFLASEVKEFRR---FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS  303 (386)
Q Consensus       234 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~  303 (386)
                      .......       ......+++.|+|||.+.+..   ++.++||||||+++|||++|..||....... ........  
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~--  261 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-DSVALAVQ--  261 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-SCHHHHHH--
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-chhhHHhh--
Confidence            3211000       011234688899999987543   6899999999999999999999986421110 01111111  


Q ss_pred             hcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhh
Q 016588          304 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD  359 (386)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~  359 (386)
                                 ...........+.++.+++.+||+.||.+|||+.+++++|+.+..
T Consensus       262 -----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          262 -----------NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             -----------CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             -----------ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence                       111112223345679999999999999999999999999988753

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.6e-43  Score=323.92  Aligned_cols=251  Identities=23%  Similarity=0.295  Sum_probs=184.0

Q ss_pred             hcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCCChh-----HHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQ-----EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      .++|+..+.||+|+||.||+|.. .+++.||+|+.......     .+.++...++.++||||+++++++.+.+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            46788899999999999999996 46899999986544222     2333444577789999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP-RVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      ||+++ +|.+++.... .....+++..+..++.|++.||.|||+  + +|+||||||+||+++.++.+||+|||++....
T Consensus        86 e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMDT-SLDKFYKQVI-DKGQTIPEDILGKIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCSE-EHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHH--HSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhcc-chHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99975 7766653211 134578999999999999999999998  5 79999999999999999999999999998764


Q ss_pred             CCCCCCCCccccCcccccchhhh----cccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          235 RTDVAGPSSQVTADEIFLASEVK----EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      ...   ......+++.|+|||.+    .+..++.++|||||||++|||++|..||...... .........         
T Consensus       162 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~---------  228 (290)
T 3fme_A          162 DDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-FQQLKQVVE---------  228 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-HHHHHHHHH---------
T ss_pred             ccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-HHHHHHHhc---------
Confidence            422   22334688889999996    5567899999999999999999999999764321 111111111         


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                          ...........++++.+++.+||+.||++|||+.|++++
T Consensus       229 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          229 ----EPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             ----SCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             ----cCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence                111111122345678999999999999999999999985

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.4e-43  Score=325.59  Aligned_cols=253  Identities=20%  Similarity=0.300  Sum_probs=195.9

Q ss_pred             HHHhcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCC-----ChhHHHHHHHHHHcCC--CCcccccccceeeCCeE
Q 016588           79 SLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQ--HRNLVTLLGYCQENNLQ  151 (386)
Q Consensus        79 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~  151 (386)
                      ....++|++.+.||+|+||.||++...+++.||+|.....     ..+.+.+|+.+++.++  |+||+++++++...+..
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~  103 (313)
T 3cek_A           24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  103 (313)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred             eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence            3445678999999999999999999888999999985432     2356789999999996  59999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      ++||| +.+++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||+++ +.+||+|||++.
T Consensus       104 ~lv~e-~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~  174 (313)
T 3cek_A          104 YMVME-CGNIDLNSWLK-----KKKSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIVD-GMLKLIDFGIAN  174 (313)
T ss_dssp             EEEEC-CCSEEHHHHHH-----HCSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEET-TEEEECCCSSSC
T ss_pred             EEEEe-cCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcccEEEEC-CeEEEeeccccc
Confidence            99999 56789998884     23568899999999999999999999  67999999999999964 899999999998


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhcc-----------cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHH
Q 016588          232 FLGRTDVAGPSSQVTADEIFLASEVKEF-----------RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV  300 (386)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~  300 (386)
                      ...............+++.|+|||.+.+           ..++.++||||||+++|||++|..||...... ...     
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~-----  248 (313)
T 3cek_A          175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISK-----  248 (313)
T ss_dssp             C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-HHH-----
T ss_pred             cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-HHH-----
Confidence            7654333223344568899999999875           46888999999999999999999999764421 111     


Q ss_pred             HhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          301 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                              .....++......+...+.++.+++.+||+.||++|||+.|++++-
T Consensus       249 --------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~  294 (313)
T 3cek_A          249 --------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  294 (313)
T ss_dssp             --------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             --------HHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence                    1111222222223333356789999999999999999999999764

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=7.8e-43  Score=330.96  Aligned_cols=258  Identities=19%  Similarity=0.285  Sum_probs=189.1

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeCC------
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENN------  149 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  149 (386)
                      .++|+..+.||+|+||.||+|... +++.||+|+.....     .+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            357899999999999999999954 58899999864321     245788999999999999999999987654      


Q ss_pred             eEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 016588          150 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  229 (386)
Q Consensus       150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl  229 (386)
                      ..|+||||+++ +|.+.+.       ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGL  173 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             ceEEEEEcCCC-CHHHHHh-------hccCHHHHHHHHHHHHHHHHHHHH--CCeecccCCHHHEEEcCCCCEEEEEeec
Confidence            78999999975 6766662       347888999999999999999999  7799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc----
Q 016588          230 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD----  305 (386)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----  305 (386)
                      ++......   ......+|+.|+|||++.+..++.++|||||||++|||++|..||.+....  ..+.........    
T Consensus       174 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~  248 (371)
T 2xrw_A          174 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI--DQWNKVIEQLGTPCPE  248 (371)
T ss_dssp             -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHC-CCCCCHH
T ss_pred             cccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHH
Confidence            98764321   223456888999999999999999999999999999999999999875421  111111110000    


Q ss_pred             ------------------c--cchhhhcchhhcccC---CHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          306 ------------------F--SNLLKILDERLWSTF---TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       306 ------------------~--~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                                        .  ...............   ....+.++.+++.+||+.||++|||++|++++-
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  320 (371)
T 2xrw_A          249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP  320 (371)
T ss_dssp             HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence                              0  000000000000000   112357899999999999999999999999864

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.2e-43  Score=327.51  Aligned_cols=265  Identities=22%  Similarity=0.312  Sum_probs=199.3

Q ss_pred             HHHHHhcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCCeE
Q 016588           77 ELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  151 (386)
Q Consensus        77 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  151 (386)
                      +.....++|+..+.||+|+||.||+|..+.  .+|+|.....     ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (319)
T 2y4i_B           27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL  104 (319)
T ss_dssp             GSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred             cccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence            333456789999999999999999999754  4889975432     235677899999999999999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      ++||||+++++|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+||+++ ++.+||+|||++.
T Consensus       105 ~iv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~  177 (319)
T 2y4i_B          105 AIITSLCKGRTLYSVVRD----AKIVLDVNKTRQIAQEIVKGMGYLHA--KGILHKDLKSKNVFYD-NGKVVITDFGLFS  177 (319)
T ss_dssp             EEECBCCCSEEHHHHTTS----SCCCCCSHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred             EEEeecccCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCChhhEEEe-CCCEEEeecCCcc
Confidence            999999999999999843    23468889999999999999999999  6799999999999998 6799999999987


Q ss_pred             ccCCCC---CCCCCccccCcccccchhhhcc---------cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHH
Q 016588          232 FLGRTD---VAGPSSQVTADEIFLASEVKEF---------RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVEL  299 (386)
Q Consensus       232 ~~~~~~---~~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~  299 (386)
                      ......   .........++..|+|||.+.+         ..++.++||||||+++|||++|..||.....   ......
T Consensus       178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~  254 (319)
T 2y4i_B          178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA---EAIIWQ  254 (319)
T ss_dssp             ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH---HHHHHH
T ss_pred             ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH
Confidence            653211   1122334457889999999874         3578899999999999999999999986442   111111


Q ss_pred             HHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhcccc
Q 016588          300 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLT  365 (386)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~~~~  365 (386)
                      .....         .+..   .....+.++.+++.+||+.||++|||+.++++.|+++.++.....
T Consensus       255 ~~~~~---------~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~  308 (319)
T 2y4i_B          255 MGTGM---------KPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLS  308 (319)
T ss_dssp             HHTTC---------CCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--------
T ss_pred             hccCC---------CCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCC
Confidence            11110         0100   111233558999999999999999999999999999988765544

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.7e-42  Score=331.10  Aligned_cols=261  Identities=18%  Similarity=0.258  Sum_probs=199.7

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC--hhHHHHHHHHHHcCC--------CCccccccccee----
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP--TQEFIDEVCFLASIQ--------HRNLVTLLGYCQ----  146 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~e~~~l~~l~--------h~niv~~~~~~~----  146 (386)
                      .++|++.+.||+|+||+||+|... +++.||+|+.....  .+.+.+|+.+++.++        |+||+++++++.    
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~  115 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV  115 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence            367999999999999999999854 58899999876542  356788999998884        788999999987    


Q ss_pred             eCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CceecCCCCCCeeeCCCC-----
Q 016588          147 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP-RVVHKDFKTANVLVDEDF-----  220 (386)
Q Consensus       147 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~ivH~dlkp~Nill~~~~-----  220 (386)
                      +....++||||+.+ ++.+++..   .....+++..+..++.|++.||.|||+  + ||+||||||+|||++.++     
T Consensus       116 ~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~lH~--~~givHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          116 NGTHICMVFEVLGH-HLLKWIIK---SNYQGLPLPCVKKIIQQVLQGLDYLHT--KCRIIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             TEEEEEEEECCCCC-BHHHHHHH---TTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECCCCSGGGEEECCCHHHHHH
T ss_pred             CCceEEEEEeccCc-cHHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHeeEeccchhhhh
Confidence            55688999999954 55555432   123568999999999999999999998  6 799999999999999775     


Q ss_pred             --------------------------------------------ceEEcccccccccCCCCCCCCCccccCcccccchhh
Q 016588          221 --------------------------------------------IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV  256 (386)
Q Consensus       221 --------------------------------------------~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~  256 (386)
                                                                  .+||+|||++......     .....+|+.|+|||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence                                                        7999999999876432     234468899999999


Q ss_pred             hcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHH---HHh-hhcccc-h-------hhhcch---------
Q 016588          257 KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVEL---VQN-SRDFSN-L-------LKILDE---------  315 (386)
Q Consensus       257 ~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~---~~~-~~~~~~-~-------~~~~~~---------  315 (386)
                      +.+..++.++|||||||++|||++|..||..............   ... ...... .       ......         
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            9999999999999999999999999999987654332111111   111 000000 0       000000         


Q ss_pred             --------h--hcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          316 --------R--LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       316 --------~--~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                              .  -....+...+..+.+|+.+||+.||++|||+.|++++
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence                    0  0013456677889999999999999999999999975

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.4e-43  Score=339.78  Aligned_cols=261  Identities=25%  Similarity=0.303  Sum_probs=193.7

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCChhHHHHHHHHHHcCCCCcccccccceeeC------CeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN------NLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~lv~  155 (386)
                      .+|+..+.||+|+||.||+|... +++.||||++... .....+|+++++.++||||+++++++...      ...++||
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~  132 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL  132 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-TTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc-chhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence            46888999999999999999975 5899999986543 23345799999999999999999988532      2367899


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC-CceEEcccccccccC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLG  234 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~-~~~kl~DFgl~~~~~  234 (386)
                      ||+++ ++...+... ......+++..+..++.|++.||.|||+  ++|+||||||+|||++.+ +.+||+|||+++...
T Consensus       133 e~~~~-~l~~~~~~~-~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~  208 (420)
T 1j1b_A          133 DYVPE-TVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  208 (420)
T ss_dssp             ECCCE-EHHHHHHHH-HHTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             hcccc-cHHHHHHHH-hhccCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence            99986 454443211 0134568899999999999999999998  779999999999999965 678999999998764


Q ss_pred             CCCCCCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc--ccchhh
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD--FSNLLK  311 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~  311 (386)
                      ...   ......+|+.|+|||++.+. .|+.++|||||||++|||++|+.||.+...  ...+...+.....  ...+..
T Consensus       209 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~--~~~l~~i~~~lg~p~~~~~~~  283 (420)
T 1j1b_A          209 RGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG--VDQLVEIIKVLGTPTREQIRE  283 (420)
T ss_dssp             TTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCSCCHHHHHH
T ss_pred             cCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHHHHh
Confidence            322   22345678999999998764 789999999999999999999999987442  2222222221110  000000


Q ss_pred             h-------cchh-----hcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          312 I-------LDER-----LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       312 ~-------~~~~-----~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .       ..+.     ....++...+.++.+|+.+||+.||++|||+.|+++|
T Consensus       284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            0       0000     0011223345779999999999999999999999975

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=9.1e-43  Score=324.10  Aligned_cols=249  Identities=19%  Similarity=0.301  Sum_probs=194.9

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC-----------hhHHHHHHHHHHcCCCCcccccccceeeCC
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----------TQEFIDEVCFLASIQHRNLVTLLGYCQENN  149 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  149 (386)
                      .++|.+.+.||+|+||.||+|... +++.||||......           ...+.+|+++++.++||||+++++++...+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            357888999999999999999965 57899999854321           235789999999999999999999987665


Q ss_pred             eEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc---eEEcc
Q 016588          150 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI---AKVAD  226 (386)
Q Consensus       150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~---~kl~D  226 (386)
                       .|+||||+++++|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.   +||+|
T Consensus        89 -~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVV-----GNKRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             -EEEEEECCTTEETHHHHS-----TTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             -eEEEEecCCCCcHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence             799999999999998884     34568899999999999999999999  77999999999999987654   99999


Q ss_pred             cccccccCCCCCCCCCccccCcccccchhhhc---ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhh
Q 016588          227 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS  303 (386)
Q Consensus       227 Fgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~  303 (386)
                      ||++.......   ......+++.|+|||++.   ...++.++|||||||++|||++|..||.......  .+...+...
T Consensus       161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~  235 (322)
T 2ycf_A          161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQITSG  235 (322)
T ss_dssp             CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHHHHT
T ss_pred             Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHHHhC
Confidence            99998764321   112345788999999974   4678999999999999999999999998654321  122221111


Q ss_pred             hcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          304 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .. .     ..+..+.    ..++++.+++.+||+.||++|||+.+++++
T Consensus       236 ~~-~-----~~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          236 KY-N-----FIPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             CC-C-----CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cc-c-----cCchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            10 0     0111111    234568999999999999999999999864

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1e-42  Score=319.91  Aligned_cols=249  Identities=20%  Similarity=0.313  Sum_probs=200.1

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC------------hhHHHHHHHHHHcCC-CCcccccccceee
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------------TQEFIDEVCFLASIQ-HRNLVTLLGYCQE  147 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------------~~~~~~e~~~l~~l~-h~niv~~~~~~~~  147 (386)
                      .++|+..+.||+|+||.||+|... +++.||+|......            .+.+.+|+.+++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            468899999999999999999975 58899999864332            245778999999995 9999999999999


Q ss_pred             CCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccc
Q 016588          148 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA  227 (386)
Q Consensus       148 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DF  227 (386)
                      .+..++||||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+||
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLT-----EKVTLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             CCeEEEEEeccCCCcHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEEcCCCcEEEecc
Confidence            999999999999999999884     23568899999999999999999999  77999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCccccCcccccchhhhc------ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHH
Q 016588          228 GLRNFLGRTDVAGPSSQVTADEIFLASEVKE------FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ  301 (386)
Q Consensus       228 gl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~  301 (386)
                      |++.......   ......+++.|+|||.+.      ...++.++||||||+++|||++|..||.....   ......+.
T Consensus       169 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~  242 (298)
T 1phk_A          169 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---MLMLRMIM  242 (298)
T ss_dssp             TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH
T ss_pred             cchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH---HHHHHHHh
Confidence            9998764322   223456788999999985      34678999999999999999999999976432   11111111


Q ss_pred             hhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          302 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ....          ..........+..+.+++.+||+.||++|||+.|++++
T Consensus       243 ~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          243 SGNY----------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             HTCC----------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             cCCc----------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence            1100          00001112345678999999999999999999999864

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.2e-42  Score=326.63  Aligned_cols=264  Identities=17%  Similarity=0.221  Sum_probs=202.8

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCC------h--------------hHHHHHHHHHHcCCCCccccc
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP------T--------------QEFIDEVCFLASIQHRNLVTL  141 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------~--------------~~~~~e~~~l~~l~h~niv~~  141 (386)
                      .++|+..+.||+|+||.||+|.. ++..||+|......      .              +.+.+|+.+++.++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46889999999999999999999 89999999743211      1              789999999999999999999


Q ss_pred             ccceeeCCeEEEEEEeecCCCccccccCC---CcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC
Q 016588          142 LGYCQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE  218 (386)
Q Consensus       142 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~  218 (386)
                      ++++.+.+..++||||+++++|.+++...   .......+++..+..++.|++.||.|||+ .+||+||||||+||+++.
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dl~p~Nil~~~  187 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN-EKNICHRDVKPSNILMDK  187 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TSCEECCCCCGGGEEECT
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc-cCCEeecCCChHhEEEcC
Confidence            99999999999999999999999983210   11125678999999999999999999997 246999999999999999


Q ss_pred             CCceEEcccccccccCCCCCCCCCccccCcccccchhhhccc-CCCc-ccchhhHHHHHHHHHcCCCCCCCCCCCchhhH
Q 016588          219 DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSE-KSDVYSFGVFLLELVSGREASSSLSPDSSQDL  296 (386)
Q Consensus       219 ~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~  296 (386)
                      ++.+||+|||++......    ......++..|+|||.+.+. .++. ++|||||||++|||++|..||......  ...
T Consensus       188 ~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~  261 (348)
T 2pml_X          188 NGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VEL  261 (348)
T ss_dssp             TSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HHH
T ss_pred             CCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHH
Confidence            999999999999876432    23345688899999999877 5666 999999999999999999999875542  222


Q ss_pred             HHHHHhhh-cccch----hhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          297 VELVQNSR-DFSNL----LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       297 ~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ...+.... .....    ................+.++.+++.+||+.||.+|||+.|++++
T Consensus       262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            22221110 00000    00000000000113345678999999999999999999999975

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.5e-43  Score=335.88  Aligned_cols=250  Identities=12%  Similarity=0.021  Sum_probs=177.4

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC------hhHHHHHH---HHHHcCCCCccccccc-------ce
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEV---CFLASIQHRNLVTLLG-------YC  145 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~e~---~~l~~l~h~niv~~~~-------~~  145 (386)
                      .+|...+.||+|+||.||+|... +++.||+|++....      .+.+.+|+   ..|+. +||||++++.       ++
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence            45888899999999999999965 68999999865433      23466774   45555 7999887553       33


Q ss_pred             eeC-----------------CeEEEEEEeecCCCccccccCCCcCCCCCCCHHHH------HHHHHHHHHHHHHhhcCCC
Q 016588          146 QEN-----------------NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR------LSIALGAAKGLAHLHSLSP  202 (386)
Q Consensus       146 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~~  202 (386)
                      ...                 ...|+||||++ ++|.+++...    ...+.+..+      ..++.|++.||.|||+  +
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~--~  213 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL----DFVYVFRGDEGILALHILTAQLIRLAANLQS--K  213 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH----HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH--T
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh----ccccchhhhhhhhhHHHHHHHHHHHHHHHHH--C
Confidence            222                 34799999998 8999988532    222344444      6778999999999999  7


Q ss_pred             CceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcc--cCCCcccchhhHHHHHHHHHc
Q 016588          203 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVS  280 (386)
Q Consensus       203 ~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvil~el~t  280 (386)
                      +|+||||||+|||++.++.+||+|||+++..+..     .....+++.|+|||++.+  ..++.++|||||||++|||++
T Consensus       214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt  288 (371)
T 3q60_A          214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC  288 (371)
T ss_dssp             TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence            7999999999999999999999999999876431     113456688999999987  789999999999999999999


Q ss_pred             CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          281 GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       281 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      |..||....+.....        ......................++.+.+++.+||+.||++|||+.+++++
T Consensus       289 g~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          289 LFLPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             SSCSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             CCCCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            999998765432110        00000011111111111222445779999999999999999999999864

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3e-42  Score=320.83  Aligned_cols=262  Identities=23%  Similarity=0.317  Sum_probs=198.9

Q ss_pred             HhcCCCcCCeecccCceEEEEEEe--CCCcEEEEEECC-----CCChhHHHHHHHHHHcC---CCCccccccccee----
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLL--QDGMLVAIKKRP-----GAPTQEFIDEVCFLASI---QHRNLVTLLGYCQ----  146 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~-----~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~----  146 (386)
                      ..++|+..+.||+|+||.||+|..  .+++.||+|+..     ......+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            346899999999999999999997  357899999743     22234677888877766   8999999999987    


Q ss_pred             -eCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEc
Q 016588          147 -ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA  225 (386)
Q Consensus       147 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~  225 (386)
                       .....++||||+. ++|.+++...   ....+++..+..++.|++.||.|||+  .||+||||||+||+++.++.+||+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~--~gi~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCCHHHeEEcCCCCEEEe
Confidence             5567899999997 5888887432   23458899999999999999999999  779999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhh-
Q 016588          226 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR-  304 (386)
Q Consensus       226 DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-  304 (386)
                      |||++.......   ......++..|+|||.+.+..++.++|||||||++|||++|..||.+....  ..+........ 
T Consensus       163 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~  237 (326)
T 1blx_A          163 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGKILDVIGL  237 (326)
T ss_dssp             SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCC
T ss_pred             cCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHHcCC
Confidence            999998764322   223456788899999999999999999999999999999999999875431  11111111100 


Q ss_pred             -cccchhh-------hc---chhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          305 -DFSNLLK-------IL---DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       305 -~~~~~~~-------~~---~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                       .......       ..   ............+..+.+++.+||+.||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence             0000000       00   0000112223345678999999999999999999999965

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.5e-42  Score=321.68  Aligned_cols=260  Identities=19%  Similarity=0.285  Sum_probs=200.2

Q ss_pred             hcCCCcCCeecccCceEEEEEEe-C-CCcEEEEEECCCCC--hhHHHHHHHHHHcCCCC------cccccccceeeCCeE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLL-Q-DGMLVAIKKRPGAP--TQEFIDEVCFLASIQHR------NLVTLLGYCQENNLQ  151 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~-~-~~~~vavK~~~~~~--~~~~~~e~~~l~~l~h~------niv~~~~~~~~~~~~  151 (386)
                      .++|++.+.||+|+||.||+|.. . +++.||+|+.....  .+.+.+|+.+++.++|+      +++++++++...+..
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~   92 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI   92 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence            35788999999999999999986 3 57899999876533  35678899999888654      599999999999999


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-------------
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-------------  218 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~-------------  218 (386)
                      ++||||+ +++|.+++...   ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.             
T Consensus        93 ~lv~e~~-~~~l~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           93 CIVFELL-GLSTYDFIKEN---GFLPFRLDHIRKMAYQICKSVNFLHS--NKLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEECC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEEcCC-CCCHHHHHHhc---CCCCCcHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHEEEeccccccccCCcccc
Confidence            9999999 78888887432   22467899999999999999999999  77999999999999987             


Q ss_pred             ------CCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCc
Q 016588          219 ------DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS  292 (386)
Q Consensus       219 ------~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~  292 (386)
                            ++.+||+|||++......     .....+|+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  241 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE  241 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred             ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence                  668999999999865332     234568899999999999999999999999999999999999998754322


Q ss_pred             hhhHHHHHHhhhcccchhh---------------------------hcch-hhcccCCHHHHHHHHHHHhHccCCCCCCC
Q 016588          293 SQDLVELVQNSRDFSNLLK---------------------------ILDE-RLWSTFTNEGMEEFIQLIVRCLDPSSERR  344 (386)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~---------------------------~~~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~R  344 (386)
                      ............. ..+..                           ...+ ..........++++.+++.+||+.||.+|
T Consensus       242 ~~~~~~~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  320 (339)
T 1z57_A          242 HLAMMERILGPLP-KHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR  320 (339)
T ss_dssp             HHHHHHHHHCSCC-HHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHhCCCC-HHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence            1111111100000 00000                           0000 00112234567889999999999999999


Q ss_pred             CCHHHHHHH
Q 016588          345 PSMSDVVTE  353 (386)
Q Consensus       345 pt~~evl~~  353 (386)
                      ||+.|++++
T Consensus       321 pt~~ell~h  329 (339)
T 1z57_A          321 ITLREALKH  329 (339)
T ss_dssp             CCHHHHTTS
T ss_pred             cCHHHHhcC
Confidence            999999875

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.1e-42  Score=327.99  Aligned_cols=255  Identities=20%  Similarity=0.328  Sum_probs=192.7

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeCCeE----
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ----  151 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~----  151 (386)
                      .++|...+.||+|+||.||+|... +++.||+|+.....     ...+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            357888999999999999999954 58999999865432     34678899999999999999999999876654    


Q ss_pred             --EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 016588          152 --FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  229 (386)
Q Consensus       152 --~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl  229 (386)
                        ++||||+. ++|...+       ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+
T Consensus       121 ~~~lv~e~~~-~~l~~~~-------~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIM-------GMEFSEEKIQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             CCEEEEECCC-EEHHHHT-------TSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             eEEEEEcccc-ccHHHHh-------hcCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence              99999997 5777666       2348899999999999999999999  7799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcc-c
Q 016588          230 RNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF-S  307 (386)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~  307 (386)
                      ++.....     .....+|+.|+|||.+.+ ..++.++|||||||++|||++|..||.+....  ..+.......... .
T Consensus       191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~  263 (371)
T 4exu_A          191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--DQLTQILKVTGVPGT  263 (371)
T ss_dssp             C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCH
T ss_pred             ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCcH
Confidence            9865432     234567889999999887 68899999999999999999999999865421  1111111110000 0


Q ss_pred             chhhh------------cchhh---cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          308 NLLKI------------LDERL---WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       308 ~~~~~------------~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .....            .....   ........++++.+++.+||+.||++|||+.|++++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            00000            00000   001112235678999999999999999999999976

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.4e-42  Score=331.37  Aligned_cols=266  Identities=18%  Similarity=0.264  Sum_probs=181.4

Q ss_pred             CCc-CCeecccCceEEEEEEeC---CCcEEEEEECCCC-ChhHHHHHHHHHHcCCCCccccccccee--eCCeEEEEEEe
Q 016588           85 FSD-KNLIGEGKFGEVYKGLLQ---DGMLVAIKKRPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQ--ENNLQFLIYEY  157 (386)
Q Consensus        85 ~~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~  157 (386)
                      |.+ .++||+|+||+||+|..+   ++..||+|++... ....+.+|+.+++.++||||+++++++.  .....|+||||
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~  101 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY  101 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEEC
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeC
Confidence            444 468999999999999965   4788999987644 3557889999999999999999999995  46789999999


Q ss_pred             ecCCCccccccCCC----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee----CCCCceEEccccc
Q 016588          158 IPNGSVSIHLYGPS----QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGL  229 (386)
Q Consensus       158 ~~~g~L~~~l~~~~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill----~~~~~~kl~DFgl  229 (386)
                      +.+ +|.+++....    ......+++..+..++.|++.||.|||+  .+|+||||||+|||+    +.++.+||+|||+
T Consensus       102 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  178 (405)
T 3rgf_A          102 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGF  178 (405)
T ss_dssp             CSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred             CCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence            975 6666553111    0122358899999999999999999999  779999999999999    7788999999999


Q ss_pred             ccccCCCCC-CCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCc-------hhhHHHHH
Q 016588          230 RNFLGRTDV-AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDS-------SQDLVELV  300 (386)
Q Consensus       230 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~-------~~~~~~~~  300 (386)
                      ++....... ........+|+.|+|||++.+. .++.++|||||||++|||++|..||.......       ...+...+
T Consensus       179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~  258 (405)
T 3rgf_A          179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  258 (405)
T ss_dssp             CC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHH
T ss_pred             ceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHH
Confidence            987653211 1223445789999999999874 58999999999999999999999997654321       11111111


Q ss_pred             Hhhhc-----ccchhh---------hcchhhccc---------CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          301 QNSRD-----FSNLLK---------ILDERLWST---------FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       301 ~~~~~-----~~~~~~---------~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .....     +.....         .+.......         .....++++.+|+.+||+.||++|||++|++++
T Consensus       259 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          259 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             HHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            11100     000000         000000000         000113568899999999999999999999987

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.9e-42  Score=323.29  Aligned_cols=254  Identities=20%  Similarity=0.324  Sum_probs=192.9

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeCCe------
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNL------  150 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------  150 (386)
                      ++|...+.||+|+||.||+|... +++.||+|......     .+.+.+|+.+++.++||||+++++++...+.      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            57888999999999999999964 58999999865432     2457889999999999999999999877653      


Q ss_pred             EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  230 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~  230 (386)
                      .|+||||+. ++|.+++.       ..+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++
T Consensus       104 ~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CEEEEECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             EEEEecccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEeECCCCcEEEeecccc
Confidence            499999997 58877662       248899999999999999999999  77999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcc-cc
Q 016588          231 NFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF-SN  308 (386)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~  308 (386)
                      ......     .....+|+.|+|||.+.+ ..++.++|||||||++|||++|..||.+....  ..+.......... ..
T Consensus       174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~  246 (353)
T 3coi_A          174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--DQLTQILKVTGVPGTE  246 (353)
T ss_dssp             TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH--HHHHHHHHHHCBCCHH
T ss_pred             cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHH
Confidence            865432     234567889999999877 67899999999999999999999999875421  1111111110000 00


Q ss_pred             hh------------hhcchh---hcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          309 LL------------KILDER---LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       309 ~~------------~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ..            ..+...   .........+.++.+++.+||+.||++|||+.+++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             HHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            00            000000   0111223445779999999999999999999999976

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1e-42  Score=320.51  Aligned_cols=250  Identities=24%  Similarity=0.347  Sum_probs=196.5

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC---CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG---APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      .++|++.+.||+|+||.||+|... ++..||+|....   ...+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            467888999999999999999975 488999998543   3456788999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +++++|.+++..    ....+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||++.......
T Consensus        98 ~~~~~l~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  171 (302)
T 2j7t_A           98 CPGGAVDAIMLE----LDRGLTEPQIQVVCRQMLEALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL  171 (302)
T ss_dssp             CTTEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred             CCCCcHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence            999999888742    23568899999999999999999999  779999999999999999999999999875432111


Q ss_pred             CCCCCccccCcccccchhhhc-----ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          238 VAGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                        .......+++.|+|||.+.     +..++.++||||||+++|||++|..||......   ...........       
T Consensus       172 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~-------  239 (302)
T 2j7t_A          172 --QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVLLKIAKSDP-------  239 (302)
T ss_dssp             --HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHSCC-------
T ss_pred             --cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHHHHhccCC-------
Confidence              1122346788899999984     567899999999999999999999999865421   11111111000       


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                        +  ....+...+.++.+++.+||+.||++|||+.+++++
T Consensus       240 --~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          240 --P--TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             --C--CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             --c--ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence              0  011223345678999999999999999999999874

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.8e-42  Score=326.08  Aligned_cols=261  Identities=23%  Similarity=0.309  Sum_probs=195.4

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeC-----CeE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQEN-----NLQ  151 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  151 (386)
                      .++|...+.||+|+||.||+|... +++.||||......    ...+.+|+.+++.++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            357888999999999999999965 58899999875433    23567899999999999999999987653     678


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      ++||||+. ++|.+++.      ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.
T Consensus        90 ~lv~e~~~-~~L~~~~~------~~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIS------TQMLSDDHIQYFIYQTLRAVKVLHG--SNVIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             EEEECCCS-EEHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEeccC-ccHHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence            99999997 58887773      2468899999999999999999999  779999999999999999999999999998


Q ss_pred             ccCCCCCCC--------CCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHh
Q 016588          232 FLGRTDVAG--------PSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN  302 (386)
Q Consensus       232 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~  302 (386)
                      .........        ......+|+.|+|||++.+ ..++.++|||||||++|||++|..||.+.....  .+......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~  238 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH--QLLLIFGI  238 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHH
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHH
Confidence            764322111        1223467899999998764 678999999999999999999999998754211  11111110


Q ss_pred             h--hcccc-h--------hhhcch------hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          303 S--RDFSN-L--------LKILDE------RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       303 ~--~~~~~-~--------~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .  ..... .        ......      ..........++++.+++.+||+.||++|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0  00000 0        000000      00000112344678999999999999999999999975

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=9.2e-42  Score=324.86  Aligned_cols=199  Identities=23%  Similarity=0.265  Sum_probs=168.3

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC--hhHHHHHHHHHHcCC-CC-----cccccccceeeCCeEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP--TQEFIDEVCFLASIQ-HR-----NLVTLLGYCQENNLQF  152 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~~~~  152 (386)
                      .++|+..+.||+|+||+||+|... +++.||||++....  ..++..|+.+++.++ |+     +++++++++...+..+
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  132 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC  132 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence            468999999999999999999965 58899999876442  345677888888774 44     5999999999999999


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC--CCCceEEcccccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD--EDFIAKVADAGLR  230 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~--~~~~~kl~DFgl~  230 (386)
                      +||||+. ++|.+++...   ....+++..+..++.|++.||.|||++..+|+||||||+|||++  .++.+||+|||++
T Consensus       133 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          133 LVFEMLS-YNLYDLLRNT---NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEECCC-CBHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEecCC-CCHHHHHhhc---CcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            9999996 4888887432   22458899999999999999999996557899999999999994  5788999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCC
Q 016588          231 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS  289 (386)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~  289 (386)
                      ......     .....+|+.|+|||++.+..++.++|||||||++|||++|..||.+..
T Consensus       209 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          209 CQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             EETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            876432     234568889999999999999999999999999999999999998754

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.5e-42  Score=320.24  Aligned_cols=260  Identities=19%  Similarity=0.315  Sum_probs=189.5

Q ss_pred             cCCCcCCeecccCceEEEEEEeCC-CcEEEEEECCCCC---hhHHHHHHHHHHcCCCCcccccccce-------------
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYC-------------  145 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~-------------  145 (386)
                      ++|...+.||+|+||.||+|.... ++.||+|......   .+.+.+|+.+++.++||||+++++++             
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            578889999999999999999764 8999999865443   34678999999999999999999876             


Q ss_pred             -eeCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC-CCCceE
Q 016588          146 -QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAK  223 (386)
Q Consensus       146 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~-~~~~~k  223 (386)
                       ...+..++||||++ |+|.+++.      ...+++..+..++.|++.||.|||+  ++|+||||||+|||++ .++.+|
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLE------QGPLLEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTTEEE
T ss_pred             ccccCceeEEeeccC-CCHHHHhh------cCCccHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCeEE
Confidence             34467899999997 58988873      3458899999999999999999999  7799999999999997 567999


Q ss_pred             EcccccccccCCCCC-CCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHH
Q 016588          224 VADAGLRNFLGRTDV-AGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ  301 (386)
Q Consensus       224 l~DFgl~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~  301 (386)
                      |+|||++........ ........++..|+|||.+.+ ..++.++|||||||++|||++|..||......  ........
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~~~~  239 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL--EQMQLILE  239 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHH
Confidence            999999987643211 122334456888999998865 67899999999999999999999999875431  11111111


Q ss_pred             hhhccc--c---hhhhc----chhh------cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          302 NSRDFS--N---LLKIL----DERL------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       302 ~~~~~~--~---~~~~~----~~~~------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ......  .   ....+    ....      ........+.++.+++.+||+.||++|||++|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            110000  0   00000    0000      001112245678999999999999999999999975

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4.6e-42  Score=314.12  Aligned_cols=248  Identities=22%  Similarity=0.340  Sum_probs=198.7

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECC-----CCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP-----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      .++|++.+.||+|+||.||+|... +++.||+|...     ....+.+.+|+.+++.++||||+++++++...+..++|+
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            457899999999999999999965 68899999843     234567899999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC---CceEEcccccccc
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED---FIAKVADAGLRNF  232 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~---~~~kl~DFgl~~~  232 (386)
                      ||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+++||||||+||+++.+   +.+||+|||++..
T Consensus       101 e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A          101 ELYTGGELFDEII-----KRKRFSEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             CCCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             EccCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            9999999988773     23468899999999999999999999  779999999999999754   4799999999887


Q ss_pred             cCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          233 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      .....   ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||.....   ......+......      
T Consensus       174 ~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~------  240 (287)
T 2wei_A          174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDILKRVETGKYA------  240 (287)
T ss_dssp             BCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCC------
T ss_pred             ecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCC------
Confidence            64322   1223457788999999875 489999999999999999999999986442   1222211111000      


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .+...+    ...++++.+++.+||+.||++|||+.+++++
T Consensus       241 ~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          241 FDLPQW----RTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             CCSGGG----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             CCchhh----hhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            000001    1234668999999999999999999999985

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.5e-42  Score=321.74  Aligned_cols=255  Identities=21%  Similarity=0.311  Sum_probs=176.4

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCCh----hHHHHHHH-HHHcCCCCcccccccceeeCCeEEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT----QEFIDEVC-FLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      .++|+..+.||+|+||.||+|... +++.||+|.......    .++..|.. +++.++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            468888999999999999999975 688999998654322    23455555 667789999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP-RVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      ||+++ +|.+++..........+++..+..++.|++.||.|||+  + +|+||||||+|||++.++.+||+|||++....
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH--HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc--cCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence            99985 76666532111224668899999999999999999998  6 79999999999999999999999999998764


Q ss_pred             CCCCCCCCccccCcccccchhhh----cccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          235 RTDVAGPSSQVTADEIFLASEVK----EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      ...   ......+++.|+|||.+    .+..++.++|||||||++|||++|..||.......     +...      ...
T Consensus       178 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~------~~~  243 (327)
T 3aln_A          178 DSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQLT------QVV  243 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------C------CCC
T ss_pred             ccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HHHH------HHh
Confidence            322   12234678889999998    45678999999999999999999999998643210     0000      000


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ....+.+........++++.+++.+||+.||++|||+.+++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            0000111111112345678999999999999999999999875

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1e-41  Score=323.09  Aligned_cols=259  Identities=17%  Similarity=0.251  Sum_probs=197.7

Q ss_pred             hcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCCC--hhHHHHHHHHHHcCC-----------CCcccccccceee
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP--TQEFIDEVCFLASIQ-----------HRNLVTLLGYCQE  147 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~  147 (386)
                      ..+|++.+.||+|+||+||+|.. .+++.||+|......  .+.+.+|+.+++.++           ||||+++++++..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            35788999999999999999996 468899999876442  356788999988875           8999999999876


Q ss_pred             CC----eEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CceecCCCCCCeeeC-----
Q 016588          148 NN----LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP-RVVHKDFKTANVLVD-----  217 (386)
Q Consensus       148 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~ivH~dlkp~Nill~-----  217 (386)
                      .+    ..++||||+ +++|.+++...   ....+++..+..++.|++.||.|||+  + +|+||||||+|||++     
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~--~~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKY---EHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETT
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHh---hccCCcHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChHHeEEeccCCC
Confidence            54    789999999 88998887432   23458899999999999999999998  6 799999999999994     


Q ss_pred             -CCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCch---
Q 016588          218 -EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS---  293 (386)
Q Consensus       218 -~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~---  293 (386)
                       ..+.+||+|||++......     .....+|+.|+|||++.+..++.++|||||||++|||++|..||........   
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence             4458999999999876432     2334678899999999999999999999999999999999999987553221   


Q ss_pred             -hhHHHHHHhhhcccc-----------------------------hhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCC
Q 016588          294 -QDLVELVQNSRDFSN-----------------------------LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSER  343 (386)
Q Consensus       294 -~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  343 (386)
                       ..+............                             ......  .....+...++++.+++.+||+.||++
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~  324 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT--EKYKFSKDEAKEISDFLSPMLQLDPRK  324 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH--HTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhh--hcccCCcchHHHHHHHHHHHhccCccc
Confidence             111111111100000                             000000  012355677889999999999999999


Q ss_pred             CCCHHHHHHH
Q 016588          344 RPSMSDVVTE  353 (386)
Q Consensus       344 Rpt~~evl~~  353 (386)
                      |||++|++++
T Consensus       325 Rpt~~ell~h  334 (373)
T 1q8y_A          325 RADAGGLVNH  334 (373)
T ss_dssp             CBCHHHHHTC
T ss_pred             cCCHHHHhhC
Confidence            9999999975

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.1e-42  Score=331.19  Aligned_cols=251  Identities=20%  Similarity=0.226  Sum_probs=188.1

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCChhHHHHHHHHHHcC-CCCcccccccceeeCCeEEEEEEeecC
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      ..+|...+.||+|+||+|+.....+++.||||++.......+.+|+.+++.+ +||||+++++++.+.+..|+||||+. 
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-  101 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-  101 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence            4467888999999999976655667899999998776667788999999999 79999999999999999999999996 


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-----CCceEEcccccccccCC
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-----DFIAKVADAGLRNFLGR  235 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~-----~~~~kl~DFgl~~~~~~  235 (386)
                      |+|.+++....    .......+..++.|++.||.|||+  .+|+||||||+|||++.     ...+||+|||+++....
T Consensus       102 g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A          102 ATLQEYVEQKD----FAHLGLEPITLLQQTTSGLAHLHS--LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             EEHHHHHHSSS----CCCCSSCHHHHHHHHHHHHHHHHH--TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             CCHHHHHHhcC----CCccchhHHHHHHHHHHHHHHHHH--CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            58888885331    223333456899999999999999  77999999999999953     34678999999987653


Q ss_pred             CCC-CCCCccccCcccccchhhhc---ccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          236 TDV-AGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       236 ~~~-~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      ... ........+|+.|+|||++.   ...++.++|||||||++|||++ |..||.......    .........     
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~----~~~~~~~~~-----  246 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----ANILLGACS-----  246 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH----HHHHTTCCC-----
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH----HHHHhccCC-----
Confidence            221 12234567899999999997   4567889999999999999999 888886533211    111000000     


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                          .. ........+..+.+++.+||+.||++|||+++++++
T Consensus       247 ----~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          247 ----LD-CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             ----CT-TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ----cc-ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence                00 011123445678999999999999999999999954

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4e-42  Score=332.60  Aligned_cols=255  Identities=19%  Similarity=0.251  Sum_probs=188.5

Q ss_pred             CCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCChhHHHHHHHHHHcC-CCCcccccccceeeCCeEEEEEEeecCCC
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGS  162 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~  162 (386)
                      .|...+.||+|+||+||.+...+++.||||+......+.+.+|+.+++.+ +||||+++++++.+.+..|+||||+. |+
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gs   94 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LN   94 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EE
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CC
Confidence            34456889999999998777667999999987666667788999999876 89999999999999999999999996 69


Q ss_pred             ccccccCCCcCCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC-------------CceEEccc
Q 016588          163 VSIHLYGPSQVSR--QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-------------FIAKVADA  227 (386)
Q Consensus       163 L~~~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~-------------~~~kl~DF  227 (386)
                      |.+++........  ....+..+..++.|++.||.|||+  ++|+||||||+|||++.+             +.+||+||
T Consensus        95 L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF  172 (434)
T 2rio_A           95 LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF  172 (434)
T ss_dssp             HHHHHHTC------------CCHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred             HHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence            9988854321111  111233457799999999999999  779999999999999654             48999999


Q ss_pred             ccccccCCCCCC--CCCccccCcccccchhhhcc-------cCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHH
Q 016588          228 GLRNFLGRTDVA--GPSSQVTADEIFLASEVKEF-------RRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLV  297 (386)
Q Consensus       228 gl~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~  297 (386)
                      |+++........  .......+|+.|+|||++.+       ..++.++|||||||++|||++ |..||.......    .
T Consensus       173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~----~  248 (434)
T 2rio_A          173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE----S  248 (434)
T ss_dssp             TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH----H
T ss_pred             ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH----H
Confidence            999877543221  11234568999999999975       578999999999999999999 899987543211    1


Q ss_pred             HHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          298 ELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ..........        ..........++++.+++.+||+.||++|||+.+++++
T Consensus       249 ~i~~~~~~~~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          249 NIIRGIFSLD--------EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             HHHHTCCCCC--------CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHhcCCCCcc--------cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence            1111111111        11112234567889999999999999999999999864

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=5.7e-42  Score=315.19  Aligned_cols=251  Identities=23%  Similarity=0.380  Sum_probs=189.8

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC--ChhHHHHHHHHHHcCCCCcccccccceee-----------
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQE-----------  147 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----------  147 (386)
                      .++|+..+.||+|+||.||+|... +++.||+|.....  ..+.+.+|+.+++.++||||+++++++.+           
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            357888999999999999999964 6899999986432  23568899999999999999999998754           


Q ss_pred             --CCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEc
Q 016588          148 --NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA  225 (386)
Q Consensus       148 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~  225 (386)
                        .+..|+||||+++++|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHS----ENLNQQRDEYWRLFRQILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHH----SCGGGCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             ccCCceEEEEecCCCCCHHHhhhc----cccccchHHHHHHHHHHHHHHHHHHh--CCeecccCCHHhEEEcCCCCEEEe
Confidence              4578999999999999999842    23456788899999999999999999  679999999999999999999999


Q ss_pred             ccccccccCCCCC------------CCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCc
Q 016588          226 DAGLRNFLGRTDV------------AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDS  292 (386)
Q Consensus       226 DFgl~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~  292 (386)
                      |||++........            ........+++.|+|||.+.+. .++.++|||||||++|||++   ||...    
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~----  231 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG----  231 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH----
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc----
Confidence            9999887643210            1122345678889999999864 68999999999999999998   44321    


Q ss_pred             hhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          293 SQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                       .+..........       .........+...+..+.+++.+||+.||.+|||+.+++++
T Consensus       232 -~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          232 -MERVNILKKLRS-------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             -HHHHHHHHHHHS-------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -hhHHHHHHhccc-------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence             111111111110       01111122334455678999999999999999999999975

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.3e-41  Score=318.28  Aligned_cols=260  Identities=19%  Similarity=0.254  Sum_probs=196.2

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CC-cEEEEEECCCCC--hhHHHHHHHHHHcCCCCc------ccccccceeeCCeE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DG-MLVAIKKRPGAP--TQEFIDEVCFLASIQHRN------LVTLLGYCQENNLQ  151 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-~~vavK~~~~~~--~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~~  151 (386)
                      .++|++.+.||+|+||+||+|... ++ ..||+|......  .+.+.+|+.+++.++|++      ++.+++++...+..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~   97 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM   97 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence            368899999999999999999964 34 689999876532  356788999999887655      88999999999999


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee---------------
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---------------  216 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill---------------  216 (386)
                      ++||||+. +++.+++..   .....+++..+..++.|++.||.|||+  ++|+||||||+|||+               
T Consensus        98 ~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~i~~qi~~~L~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           98 CIAFELLG-KNTFEFLKE---NNFQPYPLPHVRHMAYQLCHALRFLHE--NQLTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEECCC-CBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEeccC-CChHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEecccccccccccccc
Confidence            99999994 566555532   123468899999999999999999998  779999999999999               


Q ss_pred             ----CCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCc
Q 016588          217 ----DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS  292 (386)
Q Consensus       217 ----~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~  292 (386)
                          +.++.+||+|||+++.....     .....+|+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE  246 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                56789999999999865332     234568899999999999999999999999999999999999998654321


Q ss_pred             hhhHHHHHHhhhcccchhhh-----------------------cch-----hhcccCCHHHHHHHHHHHhHccCCCCCCC
Q 016588          293 SQDLVELVQNSRDFSNLLKI-----------------------LDE-----RLWSTFTNEGMEEFIQLIVRCLDPSSERR  344 (386)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~-----------------------~~~-----~~~~~~~~~~~~~l~~li~~cl~~dp~~R  344 (386)
                      ............ ...+...                       ...     ..........+.++.+++.+||+.||++|
T Consensus       247 ~~~~~~~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          247 HLVMMEKILGPI-PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHCCC-CHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHcCCC-cHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            111111110000 0000000                       000     00011223446689999999999999999


Q ss_pred             CCHHHHHHH
Q 016588          345 PSMSDVVTE  353 (386)
Q Consensus       345 pt~~evl~~  353 (386)
                      ||+.|++++
T Consensus       326 pt~~e~l~h  334 (355)
T 2eu9_A          326 ITLAEALLH  334 (355)
T ss_dssp             CCHHHHTTS
T ss_pred             cCHHHHhcC
Confidence            999999865

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.3e-42  Score=322.97  Aligned_cols=244  Identities=23%  Similarity=0.357  Sum_probs=196.9

Q ss_pred             HHHHHHhcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC---------ChhHHHHHHHHHHcCC--CCccccccc
Q 016588           76 EELSLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA---------PTQEFIDEVCFLASIQ--HRNLVTLLG  143 (386)
Q Consensus        76 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---------~~~~~~~e~~~l~~l~--h~niv~~~~  143 (386)
                      .+.....++|+..+.||+|+||.||+|.. .+++.||+|.....         ..+.+.+|+.+++.++  |+||+++++
T Consensus        36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~  115 (320)
T 3a99_A           36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD  115 (320)
T ss_dssp             ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred             cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence            33344567899999999999999999995 46889999975322         2245778999999996  599999999


Q ss_pred             ceeeCCeEEEEEEeecC-CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC-CCCc
Q 016588          144 YCQENNLQFLIYEYIPN-GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFI  221 (386)
Q Consensus       144 ~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~-~~~~  221 (386)
                      ++...+..++|+|++.+ ++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++ +++.
T Consensus       116 ~~~~~~~~~lv~e~~~~~~~L~~~l~-----~~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~  188 (320)
T 3a99_A          116 WFERPDSFVLILERPEPVQDLFDFIT-----ERGALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNRGE  188 (320)
T ss_dssp             EEECSSEEEEEEECCSSEEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTE
T ss_pred             EEecCCcEEEEEEcCCCCccHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCcEeCCCCHHHEEEeCCCCC
Confidence            99999999999999976 89988883     24568899999999999999999999  7799999999999999 7899


Q ss_pred             eEEcccccccccCCCCCCCCCccccCcccccchhhhcccCC-CcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHH
Q 016588          222 AKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV  300 (386)
Q Consensus       222 ~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~  300 (386)
                      +||+|||++.......    .....+|+.|+|||++.+..+ +.++|||||||++|||++|..||....        ...
T Consensus       189 ~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------~~~  256 (320)
T 3a99_A          189 LKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------EII  256 (320)
T ss_dssp             EEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HHH
T ss_pred             EEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------hhh
Confidence            9999999998765422    234568889999999987766 688999999999999999999986421        000


Q ss_pred             HhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          301 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ...               ...+...++++.+++.+||+.||++|||+++++++
T Consensus       257 ~~~---------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          257 RGQ---------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             HCC---------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ccc---------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000               01122334678999999999999999999999875

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1e-41  Score=318.92  Aligned_cols=253  Identities=18%  Similarity=0.232  Sum_probs=172.9

Q ss_pred             hcCCCcC-CeecccCceEEEEEEeC-CCcEEEEEECCCCChhHHHHHH-HHHHcCCCCcccccccceee----CCeEEEE
Q 016588           82 TKNFSDK-NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEV-CFLASIQHRNLVTLLGYCQE----NNLQFLI  154 (386)
Q Consensus        82 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~----~~~~~lv  154 (386)
                      .++|.+. +.||+|+||+||+|... +++.||+|+....  ....+|+ ..++.++||||+++++++..    .+..++|
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv  104 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLII  104 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEE
Confidence            4577775 46999999999999966 5899999987543  2333444 34566799999999999876    4568999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC---CCceEEccccccc
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADAGLRN  231 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~---~~~~kl~DFgl~~  231 (386)
                      |||+++|+|.+++...   ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.   ++.+||+|||++.
T Consensus       105 ~e~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~--~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~  179 (336)
T 3fhr_A          105 MECMEGGELFSRIQER---GDQAFTEREAAEIMRDIGTAIQFLHS--HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK  179 (336)
T ss_dssp             EECCTTEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EeccCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence            9999999999998532   23468999999999999999999999  77999999999999976   4569999999998


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhh
Q 016588          232 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK  311 (386)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (386)
                      .....    ......+|+.|+|||++.+..++.++|||||||++|||++|..||.............   ...      .
T Consensus       180 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~------~  246 (336)
T 3fhr_A          180 ETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK---RRI------R  246 (336)
T ss_dssp             EC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred             ecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH---Hhh------h
Confidence            65432    1234467888999999988889999999999999999999999997654322110000   000      0


Q ss_pred             hcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          312 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                      ..............++++.+++.+||+.||++|||+.|++++-
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  289 (336)
T 3fhr_A          247 LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP  289 (336)
T ss_dssp             ----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             ccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            0000000111123456789999999999999999999999863

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.3e-42  Score=317.40  Aligned_cols=242  Identities=24%  Similarity=0.357  Sum_probs=189.7

Q ss_pred             HHHHhcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCCC---------hhHHHHHHHHHHcC----CCCccccccc
Q 016588           78 LSLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP---------TQEFIDEVCFLASI----QHRNLVTLLG  143 (386)
Q Consensus        78 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---------~~~~~~e~~~l~~l----~h~niv~~~~  143 (386)
                      .....++|+..+.||+|+||.||+|.. .+++.||+|......         ...+.+|+.++.++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            344567899999999999999999985 458899999865432         23456789999888    8999999999


Q ss_pred             ceeeCCeEEEEEEe-ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC-CCCc
Q 016588          144 YCQENNLQFLIYEY-IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFI  221 (386)
Q Consensus       144 ~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~-~~~~  221 (386)
                      ++...+..++|+|+ +.+++|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+||+++ .++.
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~  178 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYIT-----EKGPLGEGPSRCFFGQVVAAIQHCHS--RGVVHRDIKDENILIDLRRGC  178 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--HTEECCCCSGGGEEEETTTTE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChhhEEEeCCCCe
Confidence            99999999999999 78899999884     23468999999999999999999999  6799999999999999 8899


Q ss_pred             eEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCC-cccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHH
Q 016588          222 AKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS-EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV  300 (386)
Q Consensus       222 ~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~  300 (386)
                      +||+|||++.......    .....++..|+|||++.+..+. .++||||||+++|||++|+.||....        ...
T Consensus       179 ~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~  246 (312)
T 2iwi_A          179 AKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------EIL  246 (312)
T ss_dssp             EEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HHH
T ss_pred             EEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------HHh
Confidence            9999999998765422    2345688889999999877764 58999999999999999999986421        000


Q ss_pred             HhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          301 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ..               ....+...+.++.+++.+||+.||++|||++|++++
T Consensus       247 ~~---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          247 EA---------------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             HT---------------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             hh---------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00               011223345678999999999999999999999975

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=6.3e-41  Score=310.72  Aligned_cols=249  Identities=20%  Similarity=0.291  Sum_probs=176.1

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCChh-----HHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQ-----EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      .++|+..+.||+|+||.||+|... +++.||+|........     .+.++..+++.++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            357888899999999999999975 6899999986543321     2334445677889999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP-RVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      ||+ ++++..+..    .....+++..+..++.|++.||.|||+  + +|+||||||+||+++.++.+||+|||++....
T Consensus       104 e~~-~~~~~~l~~----~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  176 (318)
T 2dyl_A          104 ELM-GTCAEKLKK----RMQGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV  176 (318)
T ss_dssp             CCC-SEEHHHHHH----HHTSCCCHHHHHHHHHHHHHHHHHHHH--HHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             ecc-CCcHHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHHh--hCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence            999 444444331    123568899999999999999999997  4 79999999999999999999999999987654


Q ss_pred             CCCCCCCCccccCcccccchhhhc-----ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccch
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL  309 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  309 (386)
                      ...   ......+++.|+|||.+.     ...++.++|||||||++|||++|..||......  ............    
T Consensus       177 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~----  247 (318)
T 2dyl_A          177 DDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEVLTKVLQEEP----  247 (318)
T ss_dssp             -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHHHHHSCC----
T ss_pred             CCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--HHHHHHHhccCC----
Confidence            322   223446788899999984     457889999999999999999999999864321  111111111000    


Q ss_pred             hhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                           +..  ......+.++.+++.+||+.||.+|||+.+++++
T Consensus       248 -----~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          248 -----PLL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             -----CCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             -----CCC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                 000  1111234668999999999999999999999975

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.2e-40  Score=302.91  Aligned_cols=229  Identities=13%  Similarity=0.035  Sum_probs=182.2

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCCh------hHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT------QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      .+|++.+.||+|+||.||+|... +++.||+|.+.....      +.+.+|+.++..++||||+++++++...+..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            57888999999999999999975 489999999765432      56889999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++++|.+++..      . .....+..++.|++.||.|||+  +||+||||||+|||++.++.+||+++|       
T Consensus       111 e~~~g~~L~~~l~~------~-~~~~~~~~i~~ql~~aL~~lH~--~givH~Dikp~NIll~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADT------S-PSPVGAIRAMQSLAAAADAAHR--AGVALSIDHPSRVRVSIDGDVVLAYPA-------  174 (286)
T ss_dssp             ECCCEEEHHHHHTT------C-CCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred             EecCCCCHHHHHhc------C-CChHHHHHHHHHHHHHHHHHHH--CCCccCCCCcccEEEcCCCCEEEEecc-------
Confidence            99999999999832      1 3455788899999999999999  779999999999999999999998553       


Q ss_pred             CCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                                     |++|       ++.++|||||||++|||++|+.||..........            ........
T Consensus       175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~------------~~~~~~~~  220 (286)
T 3uqc_A          175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA------------PAERDTAG  220 (286)
T ss_dssp             ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE------------ECCBCTTS
T ss_pred             ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH------------HHHHHhcc
Confidence                           3332       6889999999999999999999998755421100            00000000


Q ss_pred             hh--cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhc
Q 016588          316 RL--WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  362 (386)
Q Consensus       316 ~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~  362 (386)
                      ..  ........++++.+++.+||+.||++| |+.|+++.|+++.....
T Consensus       221 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          221 QPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             CBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             CCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence            00  001122344678999999999999999 99999999999886643

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3e-40  Score=329.75  Aligned_cols=267  Identities=20%  Similarity=0.252  Sum_probs=201.4

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceee------CCeE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQE------NNLQ  151 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~~  151 (386)
                      ++|++.+.||+|+||.||+|... ++..||+|......    .+.+.+|+.+++.++||||+++++++..      .+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            67999999999999999999964 58899999865432    3457889999999999999999998755      6778


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCc---eEEcccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI---AKVADAG  228 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~---~kl~DFg  228 (386)
                      ++||||+++|+|.+++....  ....+++..+..++.|++.||.|||+  .||+||||||+||+++.++.   +||+|||
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~--~~~~lse~~i~~I~~QLl~aL~yLHs--~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFE--NCCGLKEGPIRTLLSDISSALRYLHE--NRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSS--CTTCCCSSHHHHHHHHHHHHHHHHHH--TTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEeCCCCCHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            99999999999999885432  23357888899999999999999999  77999999999999997664   8999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhh-----
Q 016588          229 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS-----  303 (386)
Q Consensus       229 l~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~-----  303 (386)
                      ++.......   ......+|+.|+|||.+.+..++.++|||||||++|||++|..||......     ..+....     
T Consensus       170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~  241 (676)
T 3qa8_A          170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSN  241 (676)
T ss_dssp             CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC----
T ss_pred             ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccc
Confidence            998765432   223457888999999999999999999999999999999999999763210     0000000     


Q ss_pred             ---hcccchhhh--cch--hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHH-----HHHHHHHhhhhh
Q 016588          304 ---RDFSNLLKI--LDE--RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD-----VVTELDRTLDKE  361 (386)
Q Consensus       304 ---~~~~~~~~~--~~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~e-----vl~~L~~~~~~~  361 (386)
                         .........  ...  ..........++.+.+++.+||+.||++|||+.+     ..+.++.+++..
T Consensus       242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k  311 (676)
T 3qa8_A          242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK  311 (676)
T ss_dssp             --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred             hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence               000000000  000  0112244557788999999999999999999998     567777777653

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.3e-39  Score=331.86  Aligned_cols=239  Identities=21%  Similarity=0.312  Sum_probs=192.1

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC--CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCe-----
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ--DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNL-----  150 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  150 (386)
                      .++|++.+.||+|+||.||+|...  +++.||||.+....    ...+.+|+.+++.++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            368999999999999999999965  58899999865433    2357789999999999999999999987655     


Q ss_pred             EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  230 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~  230 (386)
                      .|+||||+++++|.+++.       ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.+ .+||+|||++
T Consensus       159 ~~lv~E~~~g~~L~~~~~-------~~l~~~~~~~~~~qi~~aL~~lH~--~giiHrDlkp~NIll~~~-~~kl~DFG~a  228 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKG-------QKLPVAEAIAYLLEILPALSYLHS--IGLVYNDLKPENIMLTEE-QLKLIDLGAV  228 (681)
T ss_dssp             EEEEEECCCCEECC-----------CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred             eEEEEEeCCCCcHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHH--CCCeecccChHHeEEeCC-cEEEEecccc
Confidence            799999999999987762       268999999999999999999999  779999999999999986 8999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          231 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      +.....      ....+|+.|+|||++.+. ++.++|||||||++|||++|..|+.........                
T Consensus       229 ~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~----------------  285 (681)
T 2pzi_A          229 SRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP----------------  285 (681)
T ss_dssp             EETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC----------------
T ss_pred             hhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc----------------
Confidence            876432      345688999999998765 489999999999999999998887653211000                


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCC-CHHHHHHHHHHhhhh
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-SMSDVVTELDRTLDK  360 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-t~~evl~~L~~~~~~  360 (386)
                         ..    ......++.+.+++.+||+.||++|| +++++.+.|..++++
T Consensus       286 ---~~----~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  329 (681)
T 2pzi_A          286 ---ED----DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE  329 (681)
T ss_dssp             ---TT----CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred             ---cc----ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence               00    00012235689999999999999999 566677777777655

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.2e-39  Score=299.96  Aligned_cols=228  Identities=18%  Similarity=0.250  Sum_probs=177.6

Q ss_pred             cCCCcC-CeecccCceEEEEEEe-CCCcEEEEEECCCCChhHHHHHHHHH-HcCCCCcccccccceee----CCeEEEEE
Q 016588           83 KNFSDK-NLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFL-ASIQHRNLVTLLGYCQE----NNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~~~~~lv~  155 (386)
                      ++|... +.||+|+||.||+|.. .+++.||+|....  ...+.+|+.++ +..+||||+++++++..    .+..++||
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~   94 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM   94 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEE
Confidence            456665 7899999999999996 4588999998754  45678899888 55699999999999876    67789999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC---CCceEEcccccccc
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADAGLRNF  232 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~---~~~~kl~DFgl~~~  232 (386)
                      ||+++++|.+++...   ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.   ++.+||+|||++..
T Consensus        95 e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  169 (299)
T 3m2w_A           95 ECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  169 (299)
T ss_dssp             CCCCSCBHHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             eecCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence            999999999988532   23468999999999999999999999  77999999999999998   78999999999875


Q ss_pred             cCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          233 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      ...                        ..++.++|||||||++|||++|..||.........            ......
T Consensus       170 ~~~------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~------------~~~~~~  213 (299)
T 3m2w_A          170 TTG------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------------PGMKTR  213 (299)
T ss_dssp             CTT------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------CCSCCS
T ss_pred             ccc------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh------------HHHHHH
Confidence            421                        34677899999999999999999999765431100            000000


Q ss_pred             cchhhcccCC----HHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016588          313 LDERLWSTFT----NEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  354 (386)
Q Consensus       313 ~~~~~~~~~~----~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L  354 (386)
                      ..... ...+    ...++++.+++.+||+.||++|||+.|++++-
T Consensus       214 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp  258 (299)
T 3m2w_A          214 IRMGQ-YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  258 (299)
T ss_dssp             SCTTC-CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             Hhhcc-ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence            00000 0111    12346789999999999999999999999863

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=5.4e-40  Score=307.25  Aligned_cols=241  Identities=17%  Similarity=0.153  Sum_probs=182.0

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCC-----------hhHHHHHHHHHHcCC----------------
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----------TQEFIDEVCFLASIQ----------------  134 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~l~~l~----------------  134 (386)
                      .++|+..+.||+|+||+||+|.. +++.||||++....           .+.+.+|+.+++.++                
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            35677889999999999999998 67999999854321           267889999998886                


Q ss_pred             ----------CCcccccccceee-------------CCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHH
Q 016588          135 ----------HRNLVTLLGYCQE-------------NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA  191 (386)
Q Consensus       135 ----------h~niv~~~~~~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~  191 (386)
                                ||||+++++++.+             .+..|+||||+++|++.+.+.      ...+++..+..++.|++
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~------~~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR------TKLSSLATAKSILHQLT  171 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT------TTCCCHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH------hcCCCHHHHHHHHHHHH
Confidence                      6777777776665             788999999999997766662      24578999999999999


Q ss_pred             HHHHHhh-cCCCCceecCCCCCCeeeCCCC--------------------ceEEcccccccccCCCCCCCCCccccCccc
Q 016588          192 KGLAHLH-SLSPRVVHKDFKTANVLVDEDF--------------------IAKVADAGLRNFLGRTDVAGPSSQVTADEI  250 (386)
Q Consensus       192 ~~l~~LH-~~~~~ivH~dlkp~Nill~~~~--------------------~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~  250 (386)
                      .||.||| +  ++|+||||||+|||++.++                    .+||+|||+++....       ....||+.
T Consensus       172 ~aL~~lH~~--~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~  242 (336)
T 2vuw_A          172 ASLAVAEAS--LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDV  242 (336)
T ss_dssp             HHHHHHHHH--HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCC
T ss_pred             HHHHHHHHh--CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeec
Confidence            9999999 8  6799999999999999887                    899999999987643       23478899


Q ss_pred             ccchhhhcccCCCcccchhhHHHH-HHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHH
Q 016588          251 FLASEVKEFRRFSEKSDVYSFGVF-LLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEF  329 (386)
Q Consensus       251 y~aPE~~~~~~~~~~~DvwSlGvi-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  329 (386)
                      |+|||++.+.. +.++||||+|++ .+++++|..||.....  .....+.......       .............++++
T Consensus       243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~--~~~~~~~~~~~~~-------~~~~~~~~~~~~~s~~~  312 (336)
T 2vuw_A          243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW--LHYLTDKMLKQMT-------FKTKCNTPAMKQIKRKI  312 (336)
T ss_dssp             TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH--HHHHHHHHHHTCC-------CSSCCCSHHHHHHHHHH
T ss_pred             ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh--hhHHHHhhhhhhc-------cCcccchhhhhhcCHHH
Confidence            99999998766 899999998777 7778888887642100  0001111100000       00111111233577889


Q ss_pred             HHHHhHccCCCCCCCCCHHHHH-HH
Q 016588          330 IQLIVRCLDPSSERRPSMSDVV-TE  353 (386)
Q Consensus       330 ~~li~~cl~~dp~~Rpt~~evl-~~  353 (386)
                      .+|+.+||+.|     |++|++ +|
T Consensus       313 ~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          313 QEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHGGGSS-----SHHHHHHHC
T ss_pred             HHHHHHHhccC-----CHHHHHhcC
Confidence            99999999976     999998 64

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-39  Score=312.65  Aligned_cols=241  Identities=12%  Similarity=0.070  Sum_probs=177.1

Q ss_pred             cCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCC------CChhHHHHHHHHHHcCCC-Ccccccccc----------
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG------APTQEFIDEVCFLASIQH-RNLVTLLGY----------  144 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~------~~~~~~~~e~~~l~~l~h-~niv~~~~~----------  144 (386)
                      .+|...+.||+|+||+||+|.. .+++.||||+...      ...+.+.+|+.+++.++| +|......+          
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            3466778999999999999995 4689999998552      124568899999999976 332222111          


Q ss_pred             -----------eee-----CCeEEEEEEeecCCCccccccCCC--cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcee
Q 016588          145 -----------CQE-----NNLQFLIYEYIPNGSVSIHLYGPS--QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH  206 (386)
Q Consensus       145 -----------~~~-----~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH  206 (386)
                                 +..     ....+++|+++ +++|.+++....  ......+++..++.++.|++.||.|||+  ++|+|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~iiH  234 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLVH  234 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH--TTEEC
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh--CCccc
Confidence                       111     12346677755 678887773110  1124557788899999999999999999  77999


Q ss_pred             cCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhh----------cccCCCcccchhhHHHHHH
Q 016588          207 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK----------EFRRFSEKSDVYSFGVFLL  276 (386)
Q Consensus       207 ~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~DvwSlGvil~  276 (386)
                      |||||+|||++.++.+||+|||+++..+..     .....+ +.|+|||++          .+..++.++|||||||++|
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~  308 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY  308 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence            999999999999999999999998875432     233455 789999999          5556888999999999999


Q ss_pred             HHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          277 ELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       277 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ||++|+.||........               ....+..      ....++++.+++.+||+.||++|||+.+++++
T Consensus       309 elltg~~Pf~~~~~~~~---------------~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          309 WIWCADLPNTDDAALGG---------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             HHHHSSCCCCTTGGGSC---------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHCCCCCCCcchhhh---------------HHHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            99999999976442110               0111110      01234668999999999999999998888654

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=1.9e-31  Score=265.11  Aligned_cols=179  Identities=17%  Similarity=0.048  Sum_probs=124.1

Q ss_pred             ecccCceEEEEEE-eCCCcEEEEEECCCCC-------------hhHHHHHHHHHHcC-CCCcccccccceeeCCeEEEEE
Q 016588           91 IGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-------------TQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        91 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-------------~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      .+.|++|.+..+. .-.|+.+++|.+....             .+++.+|+++|+++ +|+||+++++++.+++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            4455555555444 2247789999753321             24588999999999 7999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||++|++|.+.+.     ....++..   .|+.||+.||+|+|+  +|||||||||+|||+++++.+||+|||+++....
T Consensus       322 Eyv~G~~L~d~i~-----~~~~l~~~---~I~~QIl~AL~ylH~--~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          322 EKLPGRLLSDMLA-----AGEEIDRE---KILGSLLRSLAALEK--QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             ECCCSEEHHHHHH-----TTCCCCHH---HHHHHHHHHHHHHHH--TTCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             ecCCCCcHHHHHH-----hCCCCCHH---HHHHHHHHHHHHHHH--CCceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            9999999999994     33455553   588999999999999  7799999999999999999999999999987643


Q ss_pred             CCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCC
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR  282 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~  282 (386)
                      ..  .......||+.|+|||++.+ .+..++|+||+|++++++.++.
T Consensus       392 ~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          392 DC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             ----CCSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred             CC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhcccc
Confidence            22  22345679999999999986 4677899999999988876654

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=6.9e-29  Score=245.42  Aligned_cols=183  Identities=19%  Similarity=0.187  Sum_probs=142.1

Q ss_pred             CcCCeecccCceEEEEEEeCCCcEEEEEECCCCC-----------hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           86 SDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      ...+.||+|+||.||+|.. .+..+++|+.....           .+.+.+|++++++++||||+++..++...+..|+|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3457899999999999954 46788888633221           22378999999999999999777777777778999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      |||+++++|.+++..             +..++.|++.||.|||+  ++|+||||||+|||++.  .+||+|||+++...
T Consensus       418 mE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~--~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~  480 (540)
T 3en9_A          418 MSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHK--NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN  480 (540)
T ss_dssp             EECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHH--TTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred             EECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHH--CcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence            999999999998842             45799999999999999  77999999999999999  99999999998875


Q ss_pred             CCCCCC-----CCccccCcccccchhhhcc--cCCCcccchhhHHHHHHHHHcCCCCCC
Q 016588          235 RTDVAG-----PSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASS  286 (386)
Q Consensus       235 ~~~~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvil~el~tg~~p~~  286 (386)
                      ......     ......+|+.|+|||++..  ..|+..+|+||..+-..+-+.++.+|.
T Consensus       481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            422111     1134568999999999987  678889999999998888887776653

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=5.1e-25  Score=200.25  Aligned_cols=161  Identities=18%  Similarity=0.089  Sum_probs=124.9

Q ss_pred             HHHHHHhcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCC---------------------hhHHHHHHHHHHcCC
Q 016588           76 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP---------------------TQEFIDEVCFLASIQ  134 (386)
Q Consensus        76 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---------------------~~~~~~e~~~l~~l~  134 (386)
                      ..+......|...+.||+|+||.||+|...+++.||+|......                     ...+.+|+.+++.++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            34444455666779999999999999999779999999864321                     245789999999998


Q ss_pred             CCcccccccceeeCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCe
Q 016588          135 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANV  214 (386)
Q Consensus       135 h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Ni  214 (386)
                        | +++.+++.. +..|+||||+++++|.+ +..           .....++.|++.||.|||+  .||+||||||+||
T Consensus       163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~--~giiHrDlkp~NI  224 (282)
T 1zar_A          163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYH--RGIVHGDLSQYNV  224 (282)
T ss_dssp             --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHH--TTEECSCCSTTSE
T ss_pred             --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHH--CCCEeCCCCHHHE
Confidence              5 777776544 45699999999999987 411           1234699999999999998  7799999999999


Q ss_pred             eeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcc----------cCCCcccchhh
Q 016588          215 LVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF----------RRFSEKSDVYS  270 (386)
Q Consensus       215 ll~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------~~~~~~~DvwS  270 (386)
                      |++ ++.+||+|||+++...               .++|||.+..          ..|+..+|+|.
T Consensus       225 Ll~-~~~vkl~DFG~a~~~~---------------~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          225 LVS-EEGIWIIDFPQSVEVG---------------EEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             EEE-TTEEEECCCTTCEETT---------------STTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             EEE-CCcEEEEECCCCeECC---------------CCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            999 9999999999987532               2688998753          34455556654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.82  E-value=6.9e-21  Score=170.81  Aligned_cols=133  Identities=18%  Similarity=0.110  Sum_probs=101.0

Q ss_pred             CCcCCeecccCceEEEEEEe-CCCcE--EEEEECCCCCh---------------------------hHHHHHHHHHHcCC
Q 016588           85 FSDKNLIGEGKFGEVYKGLL-QDGML--VAIKKRPGAPT---------------------------QEFIDEVCFLASIQ  134 (386)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~---------------------------~~~~~e~~~l~~l~  134 (386)
                      |.+.+.||+|+||.||+|.. .+|+.  ||||.......                           ..+.+|+.++..++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56778999999999999997 67888  99997432210                           25788999999998


Q ss_pred             CCcc--cccccceeeCCeEEEEEEeecC-C----CccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCCcee
Q 016588          135 HRNL--VTLLGYCQENNLQFLIYEYIPN-G----SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH-SLSPRVVH  206 (386)
Q Consensus       135 h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~ivH  206 (386)
                      |+++  +.++++    +..++||||+.+ |    +|.+....        .++..+..++.|++.||.||| +  .||+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~--~givH  194 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQE--AELVH  194 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHT--SCEEC
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHH--CCEEe
Confidence            8764  333332    345899999942 4    44433211        123356789999999999999 8  77999


Q ss_pred             cCCCCCCeeeCCCCceEEccccccccc
Q 016588          207 KDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       207 ~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      |||||+|||++.  .++|+|||++...
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999998  9999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.71  E-value=6.8e-18  Score=157.77  Aligned_cols=137  Identities=13%  Similarity=0.052  Sum_probs=94.5

Q ss_pred             cCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCC-----------------hhHHHHHHHHHHcCCCCcccccccce
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----------------TQEFIDEVCFLASIQHRNLVTLLGYC  145 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~~~~~~  145 (386)
                      .-|.+.+.||+|++|.||+|...+|+.||||+.....                 ......+.++.....|+|+.+++...
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            3488899999999999999998889999999743211                 11122222222222344444443221


Q ss_pred             e------eCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCC
Q 016588          146 Q------ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED  219 (386)
Q Consensus       146 ~------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~  219 (386)
                      .      ..+..++||||+++++|..+...           .....++.|++.+|.+||+  .|||||||||.|||++++
T Consensus       175 v~vp~p~~~~~~~LVME~i~G~~L~~l~~~-----------~~~~~l~~qll~~l~~lH~--~gIVHrDLKp~NILl~~d  241 (397)
T 4gyi_A          175 FPVPEPIAQSRHTIVMSLVDALPMRQVSSV-----------PDPASLYADLIALILRLAK--HGLIHGDFNEFNILIREE  241 (397)
T ss_dssp             CSCCCEEEEETTEEEEECCSCEEGGGCCCC-----------SCHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEEEEE
T ss_pred             CCCCeeeeccCceEEEEecCCccHhhhccc-----------HHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHEEEeCC
Confidence            1      11123699999999888655421           1234678999999999999  679999999999999877


Q ss_pred             C----------ceEEcccccccc
Q 016588          220 F----------IAKVADAGLRNF  232 (386)
Q Consensus       220 ~----------~~kl~DFgl~~~  232 (386)
                      +          .+.|+||+-+-.
T Consensus       242 gd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          242 KDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             ECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CCcccccccccceEEEEeCCccc
Confidence            6          389999986654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.34  E-value=2.6e-12  Score=114.91  Aligned_cols=139  Identities=14%  Similarity=0.086  Sum_probs=109.3

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCC---CChhHHHHHHHHHHcCC-CCcccccccceeeCCeEEEEEEe
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPG---APTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      ...|+....++.|+.+.||++... +..+++|..+.   .....+.+|..+++.+. +..+.++++++...+..|+||||
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   91 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             hccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence            356777778888889999999864 67899998654   44557899999999884 67888999999988999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC------------------------------------
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS------------------------------------  201 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------  201 (386)
                      ++|.+|......          ......++.+++.+|..||+..                                    
T Consensus        92 i~G~~l~~~~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T 3tm0_A           92 ADGVLCSEEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             CSSEEHHHHCCT----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred             cCCeehhhccCC----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence            999888765311          1112367888999999999710                                    


Q ss_pred             ---------------------CCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          202 ---------------------PRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       202 ---------------------~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                                           ..++|+|++|.||+++++..+.|+||+.+.
T Consensus       162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                 348999999999999876666799998654

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.27  E-value=6.1e-12  Score=112.09  Aligned_cols=127  Identities=18%  Similarity=0.182  Sum_probs=96.7

Q ss_pred             cccCceEEEEEEeCCCcEEEEEECCCCChhHHHHHHHHHHcCCCCc--ccccccceeeCCeEEEEEEeecCCCccccccC
Q 016588           92 GEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRN--LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG  169 (386)
Q Consensus        92 g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~  169 (386)
                      +.|..+.||++...++..+++|.........+..|..+++.+.+.+  +.+++++....+..++||||+++.++.  ...
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~  106 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH  106 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc
Confidence            4566699999987777889999866555567889999999885434  566888888777889999999998874  210


Q ss_pred             CCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC------------------------------------------------
Q 016588          170 PSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS------------------------------------------------  201 (386)
Q Consensus       170 ~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------------------  201 (386)
                              ..   ...++.+++..|..||+..                                                
T Consensus       107 --------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  175 (264)
T 1nd4_A          107 --------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK  175 (264)
T ss_dssp             --------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred             --------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence                    11   1246777788888888632                                                


Q ss_pred             --------CCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          202 --------PRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       202 --------~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                              ..++|+|++|.||+++++..+.|.||+.+.
T Consensus       176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                    129999999999999887667799999765

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.15  E-value=1.6e-10  Score=108.19  Aligned_cols=139  Identities=14%  Similarity=0.235  Sum_probs=105.4

Q ss_pred             CcCCeecccCceEEEEEEeCCCcEEEEEECC--CC----ChhHHHHHHHHHHcCC--CCcccccccceeeC---CeEEEE
Q 016588           86 SDKNLIGEGKFGEVYKGLLQDGMLVAIKKRP--GA----PTQEFIDEVCFLASIQ--HRNLVTLLGYCQEN---NLQFLI  154 (386)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~----~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~---~~~~lv  154 (386)
                      ...+.++.|.++.||+....+ ..+++|+.+  ..    ....+.+|..+++.+.  +..+++++.++.+.   +..|+|
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             ceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            345678999999999998754 578888765  32    2356889999999986  45678888888766   457899


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL----------------------------------  200 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------------------------------  200 (386)
                      |||+++..+.+..       ...++......++.+++..|..||+.                                  
T Consensus       120 me~v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (359)
T 3dxp_A          120 MEFVSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE  192 (359)
T ss_dssp             EECCCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred             EEecCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence            9999988775422       12356777888999999999999962                                  


Q ss_pred             ----------------------CCCceecCCCCCCeeeCCCCc--eEEcccccccc
Q 016588          201 ----------------------SPRVVHKDFKTANVLVDEDFI--AKVADAGLRNF  232 (386)
Q Consensus       201 ----------------------~~~ivH~dlkp~Nill~~~~~--~kl~DFgl~~~  232 (386)
                                            ...++|+|+++.|||+++++.  +.+.||+.+..
T Consensus       193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                  146899999999999997753  68999998764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.93  E-value=3e-10  Score=103.85  Aligned_cols=184  Identities=19%  Similarity=0.187  Sum_probs=113.7

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEECCCC-ChhHHHHHHHHHHcC-CCCc--ccccccceeeCC---eEEEEEEeecC
Q 016588           88 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASI-QHRN--LVTLLGYCQENN---LQFLIYEYIPN  160 (386)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l-~h~n--iv~~~~~~~~~~---~~~lv~e~~~~  160 (386)
                      .+.++.|....||+..    ..+++|..... ....+.+|..+++.+ .+..  +.+++......+   ..|+||++++|
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G  100 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG  100 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence            4678999999999863    45888875433 245688999999887 3332  344444443332   34889999999


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL----------------------------------------  200 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------------------------------------  200 (386)
                      .++.....       ..++......++.+++..|..||+.                                        
T Consensus       101 ~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A          101 VPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             EECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             eECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            88764321       2345555566666777666666641                                        


Q ss_pred             ----------------CCCceecCCCCCCeeeCC--CCceEEcccccccccCCCCCCCCCccc---cCcc-------cc-
Q 016588          201 ----------------SPRVVHKDFKTANVLVDE--DFIAKVADAGLRNFLGRTDVAGPSSQV---TADE-------IF-  251 (386)
Q Consensus       201 ----------------~~~ivH~dlkp~Nill~~--~~~~kl~DFgl~~~~~~~~~~~~~~~~---~~~~-------~y-  251 (386)
                                      ...++|+|++|.||++++  ...+.+.||+.+..-............   .+..       .| 
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                            134799999999999998  556789999987653221100000000   0000       01 


Q ss_pred             -cc-hhhhcccCCCcccchhhHHHHHHHHHcCCCC
Q 016588          252 -LA-SEVKEFRRFSEKSDVYSFGVFLLELVSGREA  284 (386)
Q Consensus       252 -~a-PE~~~~~~~~~~~DvwSlGvil~el~tg~~p  284 (386)
                       .. |+....  ...-.+.|+++.++|.+.+|..+
T Consensus       254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~  286 (304)
T 3sg8_A          254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMD  286 (304)
T ss_dssp             CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHH
T ss_pred             CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHH
Confidence             11 222111  12235899999999999999754

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.51  E-value=1.8e-07  Score=83.58  Aligned_cols=133  Identities=22%  Similarity=0.231  Sum_probs=91.9

Q ss_pred             eecccCce-EEEEEEeC-CCcEEEEEECCCCChhHHHHHHHHHHcCC-CCcccccccceeeCCeEEEEEEeecCCCcccc
Q 016588           90 LIGEGKFG-EVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIH  166 (386)
Q Consensus        90 ~lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~  166 (386)
                      .+..|..| .||+.... ++..+++|..+.....++.+|...|+.+. +--+.++++++.+.+..++|||++++.++.+.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~  110 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQV  110 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccccc
Confidence            34445554 68988754 46678999877666778899999998884 33477888899999999999999998776543


Q ss_pred             ccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcC----------------------------------------------
Q 016588          167 LYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL----------------------------------------------  200 (386)
Q Consensus       167 l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------------------------------------------  200 (386)
                      ....         ......+..+++..|.-||+.                                              
T Consensus       111 ~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          111 LEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             ccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            2100         011122334444444444431                                              


Q ss_pred             ----------CCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          201 ----------SPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       201 ----------~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                                ...++|+|+.+.|||+++++.+-|.||+.+.
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                      0126899999999999988777899998765

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.40  E-value=6.2e-07  Score=81.77  Aligned_cols=134  Identities=16%  Similarity=0.137  Sum_probs=86.3

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEECCCC-ChhHHHHHHHHHHcCCCC---ccccccccee-eCCeEEEEEEeecCCC
Q 016588           88 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHR---NLVTLLGYCQ-ENNLQFLIYEYIPNGS  162 (386)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~g~  162 (386)
                      .+.++.|....||+.    +..+++|+.... ....+..|..+|+.+.+.   .+.+.+.+.. ..+..++|||+++|..
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~   99 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI   99 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence            456788888999987    456788874321 235688999999998642   3556666663 3456789999999987


Q ss_pred             ccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhc-------------------------------------------
Q 016588          163 VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS-------------------------------------------  199 (386)
Q Consensus       163 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-------------------------------------------  199 (386)
                      +.....       ..++......++.+++..|..||+                                           
T Consensus       100 l~~~~~-------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A          100 LGEDGM-------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             CHHHHH-------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             Cchhhh-------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            764211       011222223333333333333332                                           


Q ss_pred             ---------------CCCCceecCCCCCCeeeCC---CCc-eEEcccccccc
Q 016588          200 ---------------LSPRVVHKDFKTANVLVDE---DFI-AKVADAGLRNF  232 (386)
Q Consensus       200 ---------------~~~~ivH~dlkp~Nill~~---~~~-~kl~DFgl~~~  232 (386)
                                     ....++|+|+.|.||+++.   ++. ..|.||+.+..
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                           1235799999999999997   455 48999987654

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.28  E-value=2.5e-06  Score=79.35  Aligned_cols=77  Identities=9%  Similarity=0.021  Sum_probs=55.7

Q ss_pred             Cee-cccCceEEEEEEeC-------CCcEEEEEECCCCC------hhHHHHHHHHHHcCC-C--CcccccccceeeC---
Q 016588           89 NLI-GEGKFGEVYKGLLQ-------DGMLVAIKKRPGAP------TQEFIDEVCFLASIQ-H--RNLVTLLGYCQEN---  148 (386)
Q Consensus        89 ~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~------~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~---  148 (386)
                      +.| +.|..+.+|+....       ++..+++|..+...      ...+..|..+++.+. +  -.+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            557 78888999988754       25678889755432      356888999888874 2  3567778777654   


Q ss_pred             CeEEEEEEeecCCCccc
Q 016588          149 NLQFLIYEYIPNGSVSI  165 (386)
Q Consensus       149 ~~~~lv~e~~~~g~L~~  165 (386)
                      +..++|||++++..+.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            35689999999877654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.17  E-value=9.5e-06  Score=74.71  Aligned_cols=141  Identities=18%  Similarity=0.262  Sum_probs=80.0

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEECCCCChhHHHHHHHHHHcCC--CCccccccc------ceeeCCeEEEEEEeecC
Q 016588           89 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ--HRNLVTLLG------YCQENNLQFLIYEYIPN  160 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~------~~~~~~~~~lv~e~~~~  160 (386)
                      +.|+.|..+.||+....++ .+++|+... ...++..|..+++.+.  .-.+++++.      +....+..+++|+|++|
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~-~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~G  115 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR-PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIEG  115 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECS-CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCCC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCC-CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeecC
Confidence            4465677899999987654 588898765 3445556666666553  123344443      12346678999999998


Q ss_pred             CCccc--------------cccCCCc----CC-----CCCCCHHHH-------------------------------HHH
Q 016588          161 GSVSI--------------HLYGPSQ----VS-----RQKLEFKHR-------------------------------LSI  186 (386)
Q Consensus       161 g~L~~--------------~l~~~~~----~~-----~~~l~~~~~-------------------------------~~i  186 (386)
                      ..+..              .++....    ..     .....|...                               ..+
T Consensus       116 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (346)
T 2q83_A          116 RPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDGF  195 (346)
T ss_dssp             BCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHHH
T ss_pred             ccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHHH
Confidence            66531              0110000    00     001122110                               011


Q ss_pred             HHHHHHHHHHhhc-----------CCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          187 ALGAAKGLAHLHS-----------LSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       187 ~~~i~~~l~~LH~-----------~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      ...+..++.+|+.           ....++|+|+.+.|||++.++.+.++||+.+.
T Consensus       196 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          196 IEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            1123345556642           23679999999999999888889999998654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.88  E-value=5.4e-05  Score=68.91  Aligned_cols=140  Identities=16%  Similarity=0.138  Sum_probs=92.7

Q ss_pred             cCCeecccCceEEEEEEeCCCcEEEEEECCCCChhHHHHHHHHHHcCC---CCcccccccceeeCCeEEEEEEeecCCCc
Q 016588           87 DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ---HRNLVTLLGYCQENNLQFLIYEYIPNGSV  163 (386)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g~L  163 (386)
                      ..+.++.|....+|+.... +..+++|..+......+..|...|+.+.   ...+++++.++...+..++|||++++..+
T Consensus        40 ~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLINDE-VQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             EEEEECCSSSSEEEEEESS-SCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             eeEEeCCccceeeeEEEEC-CCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            3467899999999998864 6678889866555667889999888873   36788888888878889999999998765


Q ss_pred             cc-----------cccCCCc-----------------CCCCCCCHHHHH---HHH----------------HHHHHH-HH
Q 016588          164 SI-----------HLYGPSQ-----------------VSRQKLEFKHRL---SIA----------------LGAAKG-LA  195 (386)
Q Consensus       164 ~~-----------~l~~~~~-----------------~~~~~l~~~~~~---~i~----------------~~i~~~-l~  195 (386)
                      ..           .++....                 .+...-+|....   ++.                ..+..- ..
T Consensus       119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~  198 (312)
T 3jr1_A          119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD  198 (312)
T ss_dssp             CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred             CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence            32           1111100                 011112444321   111                111111 12


Q ss_pred             Hh--hcCCCCceecCCCCCCeeeCCCCceEEcccc
Q 016588          196 HL--HSLSPRVVHKDFKTANVLVDEDFIAKVADAG  228 (386)
Q Consensus       196 ~L--H~~~~~ivH~dlkp~Nill~~~~~~kl~DFg  228 (386)
                      .|  |...+.++|+|+.+.|++++.++ +.+.||.
T Consensus       199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            34  22236699999999999999887 8899974

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.86  E-value=3.3e-05  Score=72.91  Aligned_cols=72  Identities=14%  Similarity=0.077  Sum_probs=48.1

Q ss_pred             CCeecccCceEEEEEEeC-CCcEEEEEECCCC----------ChhHHHHHHHHHHcCCC--C-cccccccceeeCCeEEE
Q 016588           88 KNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----------PTQEFIDEVCFLASIQH--R-NLVTLLGYCQENNLQFL  153 (386)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----------~~~~~~~e~~~l~~l~h--~-niv~~~~~~~~~~~~~l  153 (386)
                      .+.+|.|..+.||++... ++..+++|...+.          ..+.+..|.++++.+..  + .+.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            467899999999999754 4678999964321          23456789888887732  3 34455544  3444579


Q ss_pred             EEEeecCC
Q 016588          154 IYEYIPNG  161 (386)
Q Consensus       154 v~e~~~~g  161 (386)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999763

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.74  E-value=0.00014  Score=65.34  Aligned_cols=76  Identities=17%  Similarity=0.224  Sum_probs=54.4

Q ss_pred             CCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCC---hhHHHHHHHHHHcCC-C--CcccccccceeeCCeEEEEEEe
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP---TQEFIDEVCFLASIQ-H--RNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      .....+.+|.|..+.||+....+|+.+.+|+.+...   ...+..|...|+.|. .  --+++.+++  +.  .++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEEe
Confidence            444567789999999999999999999999855332   345788999998874 2  223444443  22  3689999


Q ss_pred             ecCCCc
Q 016588          158 IPNGSV  163 (386)
Q Consensus       158 ~~~g~L  163 (386)
                      ++.+..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            887654

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.57  E-value=0.00016  Score=66.30  Aligned_cols=142  Identities=11%  Similarity=0.022  Sum_probs=73.0

Q ss_pred             CeecccCceE-EEEEEeCCCcEEEEEECCCCChhHHHHHHHHHHcCC--CCcccccccceeeCCeEEEEEEeecCCCccc
Q 016588           89 NLIGEGKFGE-VYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ--HRNLVTLLGYCQENNLQFLIYEYIPNGSVSI  165 (386)
Q Consensus        89 ~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~  165 (386)
                      +.|+.|.... +|+....++..+++|..+......+..|..+++.+.  .-.+.+++.+....+  +++||++.+..+.+
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l~~  101 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALFTE  101 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBHHH
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcchHH
Confidence            4465554444 667765446677788765543355667777777763  233556666544333  68999987655433


Q ss_pred             cccC---------------------CCcCCCCCCCHHHHH-------H-------------HHHHHHHHHHHh----hcC
Q 016588          166 HLYG---------------------PSQVSRQKLEFKHRL-------S-------------IALGAAKGLAHL----HSL  200 (386)
Q Consensus       166 ~l~~---------------------~~~~~~~~l~~~~~~-------~-------------i~~~i~~~l~~L----H~~  200 (386)
                      ++..                     ........++.....       .             ....+...+..+    ...
T Consensus       102 ~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~~  181 (333)
T 3csv_A          102 VINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLEG  181 (333)
T ss_dssp             HHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCCS
T ss_pred             HhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcccC
Confidence            2211                     000000111111000       0             000111122222    112


Q ss_pred             CCCceecCCCCCCeeeCCC----CceEEcccccccc
Q 016588          201 SPRVVHKDFKTANVLVDED----FIAKVADAGLRNF  232 (386)
Q Consensus       201 ~~~ivH~dlkp~Nill~~~----~~~kl~DFgl~~~  232 (386)
                      ...++|+|+.+.||+++.+    +.+.+.||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            3569999999999999874    6789999987754

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.57  E-value=0.0013  Score=59.76  Aligned_cols=142  Identities=11%  Similarity=0.030  Sum_probs=78.4

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEECCC-CChhHHHHHHHHHHcCCCC--cccccccc------eeeCCeEEEEEEeec
Q 016588           89 NLIGEGKFGEVYKGLLQDGMLVAIKKRPG-APTQEFIDEVCFLASIQHR--NLVTLLGY------CQENNLQFLIYEYIP  159 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~-~~~~~~~~e~~~l~~l~h~--niv~~~~~------~~~~~~~~lv~e~~~  159 (386)
                      +.|+.|....+|+....++ .+++|.... ...+.+..|..++..+...  .+.+++..      ....+..++++++++
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~  106 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE  106 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCC
Confidence            4466788889999987655 577887655 3455677888888776321  13344322      123456789999998


Q ss_pred             CCCcccc--------------ccCC--C--cCCCCCC---CHHHHHH------------HHHHHHHHHHHhhc-----CC
Q 016588          160 NGSVSIH--------------LYGP--S--QVSRQKL---EFKHRLS------------IALGAAKGLAHLHS-----LS  201 (386)
Q Consensus       160 ~g~L~~~--------------l~~~--~--~~~~~~l---~~~~~~~------------i~~~i~~~l~~LH~-----~~  201 (386)
                      |..+...              ++..  .  .......   .|.....            +...+...+.++..     ..
T Consensus       107 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~  186 (322)
T 2ppq_A          107 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP  186 (322)
T ss_dssp             CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred             CcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCC
Confidence            8665321              1100  0  0000001   1211000            00113334444432     12


Q ss_pred             CCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          202 PRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       202 ~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      .+++|+|+.+.|||++++..+.+.||+.+.
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            468999999999999987666899998654

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.33  E-value=0.00078  Score=64.13  Aligned_cols=73  Identities=19%  Similarity=0.209  Sum_probs=50.4

Q ss_pred             CCeecccCceEEEEEEeCC--------CcEEEEEECCCCCh-hHHHHHHHHHHcCCCCc-ccccccceeeCCeEEEEEEe
Q 016588           88 KNLIGEGKFGEVYKGLLQD--------GMLVAIKKRPGAPT-QEFIDEVCFLASIQHRN-LVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~-~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~  157 (386)
                      .+.|+.|....+|+....+        +..+++|+...... ..+.+|..+++.+...+ .+++++.+.+    .+|+||
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~  153 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  153 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence            3567788889999998653        46889998644233 67778999888874323 3566665543    289999


Q ss_pred             ecCCCcc
Q 016588          158 IPNGSVS  164 (386)
Q Consensus       158 ~~~g~L~  164 (386)
                      +++.++.
T Consensus       154 l~G~~l~  160 (429)
T 1nw1_A          154 IPSRPLS  160 (429)
T ss_dssp             CCEEECC
T ss_pred             eCCcccC
Confidence            9865543

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.27  E-value=0.003  Score=57.46  Aligned_cols=75  Identities=9%  Similarity=0.137  Sum_probs=50.3

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEECCC--CChhHHHHHHHHHHcCCC--Ccccccccc-----eeeCCeEEEEEEeec
Q 016588           89 NLIGEGKFGEVYKGLLQDGMLVAIKKRPG--APTQEFIDEVCFLASIQH--RNLVTLLGY-----CQENNLQFLIYEYIP  159 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~e~~~l~~l~h--~niv~~~~~-----~~~~~~~~lv~e~~~  159 (386)
                      ..++ |....||+....+|..+++|...+  .....+..|..++..+..  -.+++++..     ....+..++++++++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~  110 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  110 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence            3466 778899998876677799998653  245677788888877732  224444443     223456688999998


Q ss_pred             CCCcc
Q 016588          160 NGSVS  164 (386)
Q Consensus       160 ~g~L~  164 (386)
                      +..+.
T Consensus       111 G~~~~  115 (328)
T 1zyl_A          111 GRQFE  115 (328)
T ss_dssp             CEECC
T ss_pred             CCCCC
Confidence            76543

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.21  E-value=0.0017  Score=62.26  Aligned_cols=73  Identities=14%  Similarity=0.043  Sum_probs=47.3

Q ss_pred             CCeecccCceEEEEEEeCC-CcEEEEEECCCCChh--HHHHHHHHHHcCCCCcc-cccccceeeCCeEEEEEEeecCCCc
Q 016588           88 KNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQ--EFIDEVCFLASIQHRNL-VTLLGYCQENNLQFLIYEYIPNGSV  163 (386)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~--~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~L  163 (386)
                      .+.|+.|-...+|+....+ +..+++|+.......  +-..|..++..+...++ .++++++.  +.  +|+||+++.+|
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~G~~l  188 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMDGYAL  188 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCCSEEC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeCCccC
Confidence            3467778889999998765 477888875433211  22588888988864444 56777663  22  59999987555


Q ss_pred             c
Q 016588          164 S  164 (386)
Q Consensus       164 ~  164 (386)
                      .
T Consensus       189 ~  189 (458)
T 2qg7_A          189 S  189 (458)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.13  E-value=0.0014  Score=59.16  Aligned_cols=69  Identities=9%  Similarity=0.009  Sum_probs=43.6

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEECCCCC--hhHHHHHHHHHHcCCCCcc-cccccceeeCCeEEEEEEee-cCCCc
Q 016588           88 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP--TQEFIDEVCFLASIQHRNL-VTLLGYCQENNLQFLIYEYI-PNGSV  163 (386)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~g~L  163 (386)
                      .+.|+.|....+|+.     ..+++|+.....  ..+..+|..+++.+...++ .+++++..+  .-++++||+ ++.++
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~g~~l   95 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAGAQTM   95 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTTCEEC
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCCCccC
Confidence            577888999999998     457888755432  1234578877777632222 455554432  346899999 65554

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.13  E-value=0.0011  Score=61.91  Aligned_cols=139  Identities=15%  Similarity=0.156  Sum_probs=80.7

Q ss_pred             CeecccCceEEEEEEeCC--------CcEEEEEECCCC--ChhHHHHHHHHHHcCC-CCcccccccceeeCCeEEEEEEe
Q 016588           89 NLIGEGKFGEVYKGLLQD--------GMLVAIKKRPGA--PTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~--~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      +.+..|-...+|+....+        +..+++|+....  ......+|..+++.+. +.-..++++++.++    +||||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~  131 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQY  131 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEEC
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEE
Confidence            457678888999998642        468999985432  3456778999888774 33336667665542    89999


Q ss_pred             ecCCCcccc-----------------ccCCCcCCCCCCC--HHHHHHHHHHHHH-------------------HHHH---
Q 016588          158 IPNGSVSIH-----------------LYGPSQVSRQKLE--FKHRLSIALGAAK-------------------GLAH---  196 (386)
Q Consensus       158 ~~~g~L~~~-----------------l~~~~~~~~~~l~--~~~~~~i~~~i~~-------------------~l~~---  196 (386)
                      +++..|...                 +|.....-.....  +.++.++..++..                   .+..   
T Consensus       132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~  211 (379)
T 3feg_A          132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK  211 (379)
T ss_dssp             CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred             ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence            998665421                 1111111111122  3344444433321                   1222   


Q ss_pred             -hhc--CCCCceecCCCCCCeeeCCC----CceEEccccccc
Q 016588          197 -LHS--LSPRVVHKDFKTANVLVDED----FIAKVADAGLRN  231 (386)
Q Consensus       197 -LH~--~~~~ivH~dlkp~Nill~~~----~~~kl~DFgl~~  231 (386)
                       |..  ....++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence             222  12358999999999999876    789999998664

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.03  E-value=0.0011  Score=62.86  Aligned_cols=30  Identities=27%  Similarity=0.513  Sum_probs=26.8

Q ss_pred             CCceecCCCCCCeeeCCCCceEEcccccccc
Q 016588          202 PRVVHKDFKTANVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       202 ~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~  232 (386)
                      ..++|+|++|.|||++.++ +.+.||+.+..
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            6799999999999999876 99999988765

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.90  E-value=0.0078  Score=55.22  Aligned_cols=66  Identities=11%  Similarity=0.112  Sum_probs=42.9

Q ss_pred             cCceEEEEEEeCCCcEEEEEECCCCChhHHHHHHHHHHcCC---CCcccccccc------eeeCCeEEEEEEeecCCCc
Q 016588           94 GKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ---HRNLVTLLGY------CQENNLQFLIYEYIPNGSV  163 (386)
Q Consensus        94 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~------~~~~~~~~lv~e~~~~g~L  163 (386)
                      |....||+....++ .+++|+......   ..|...+..|.   -|++++.+..      ....+..+++|+|+++..+
T Consensus        34 g~~N~vy~v~~~~g-~~vLK~~~~~~~---~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~~~  108 (339)
T 3i1a_A           34 DTNAFAYQADSESK-SYFIKLKYGYHD---EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPNG  108 (339)
T ss_dssp             CSSCEEEEEECSSC-EEEEEEEECSSC---CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCCBT
T ss_pred             ccccceEEEEeCCC-CEEEEEecCccc---hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCCcC
Confidence            33678999987666 889997554332   35666666552   2224555432      2345678999999998765

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.66  E-value=0.0041  Score=57.74  Aligned_cols=71  Identities=15%  Similarity=0.119  Sum_probs=43.1

Q ss_pred             CeecccCceEEEEEEeCC---------CcEEEEEECCCCChh--HHHHHHHHHHcCCCCc-ccccccceeeCCeEEEEEE
Q 016588           89 NLIGEGKFGEVYKGLLQD---------GMLVAIKKRPGAPTQ--EFIDEVCFLASIQHRN-LVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~--~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e  156 (386)
                      +.++.|....+|+....+         +..+++|+.......  +...|..+++.+...+ ..++++..  .+  ++|||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~e  114 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIEE  114 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEEE
Confidence            457778888999998653         267888876543221  2467888888774223 44666443  22  58999


Q ss_pred             eecCCCc
Q 016588          157 YIPNGSV  163 (386)
Q Consensus       157 ~~~~g~L  163 (386)
                      |+++..+
T Consensus       115 ~i~G~~l  121 (369)
T 3c5i_A          115 WLYGDPL  121 (369)
T ss_dssp             CCCSEEC
T ss_pred             EecCCcC
Confidence            9987554

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.57  E-value=0.0056  Score=51.84  Aligned_cols=102  Identities=13%  Similarity=0.088  Sum_probs=63.0

Q ss_pred             CccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCCC
Q 016588          162 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP  241 (386)
Q Consensus       162 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~  241 (386)
                      +|.+.+.    ....++++.+++.++.|.+.+|.-+-..... ..+=+.|..|++..+|.+...+ +.+.          
T Consensus        34 SL~eIL~----~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           34 SLEEILR----LYNQPINEEQAWAVCYQCCGSLRAAARRRQP-RHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EHHHHHH----HHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             cHHHHHH----HcCCCcCHHHHHHHHHHHHHHHHhhhhcccC-CceecCCcceEEecCCceeccc-cccc----------
Confidence            4555552    3467899999999999999998776210011 1233456899999999987764 1111          


Q ss_pred             CccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCC
Q 016588          242 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA  284 (386)
Q Consensus       242 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p  284 (386)
                          .....+.+||... ...+.+.=|||+|+++|..+--..|
T Consensus        98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                0111256777653 2346777899999999999875544

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=96.40  E-value=0.0083  Score=36.40  Aligned_cols=32  Identities=13%  Similarity=0.068  Sum_probs=18.7

Q ss_pred             hhhHHHHHHHHHHHHHHHHHHHHHHHHhcCCC
Q 016588            5 LAAIFGAAAGAVALMGIIFFLSWFCLYRNRSV   36 (386)
Q Consensus         5 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~   36 (386)
                      ...|.+.+++++++++++++++|++.||++..
T Consensus         9 ~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~   40 (44)
T 2l2t_A            9 TPLIAAGVIGGLFILVIVGLTFAVYVRRKSIK   40 (44)
T ss_dssp             SHHHHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred             cceEEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence            34556666665656566666666666655543

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=95.90  E-value=0.0093  Score=36.28  Aligned_cols=28  Identities=18%  Similarity=0.171  Sum_probs=14.3

Q ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHhcCC
Q 016588            8 IFGAAAGAVALMGIIFFLSWFCLYRNRS   35 (386)
Q Consensus         8 i~~~~~~~~~~~~~~~~~~~~~~~~~~~   35 (386)
                      |.+.+++++++++++++++|++.+|++.
T Consensus        13 IA~gVVgGv~~~~ii~~~~~~~~RRr~~   40 (44)
T 2ks1_B           13 IATGMVGALLLLLVVALGIGLFMRRRHI   40 (44)
T ss_dssp             STHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred             EEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence            4444444444445555555555555544

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=95.89  E-value=0.012  Score=34.69  Aligned_cols=31  Identities=16%  Similarity=0.109  Sum_probs=21.3

Q ss_pred             ccchhhHHHHHHHHHHHHHHHHHHHHHHHHh
Q 016588            2 SVTLAAIFGAAAGAVALMGIIFFLSWFCLYR   32 (386)
Q Consensus         2 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~   32 (386)
                      +++-++|.|+++++++.+++++.+.|++++|
T Consensus         7 ~ls~GaIAGiVvG~v~gv~li~~l~~~~~rr   37 (38)
T 2k1k_A            7 GLTGGEIVAVIFGLLLGAALLLGILVFRSRR   37 (38)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred             CCCCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence            4567788888888887666666665555543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.65  E-value=0.028  Score=53.11  Aligned_cols=73  Identities=8%  Similarity=-0.018  Sum_probs=48.0

Q ss_pred             CCeecccCceEEEEEEeCC--------CcEEEEEECCCCC--hhHHHHHHHHHHcCC-CCcccccccceeeCCeEEEEEE
Q 016588           88 KNLIGEGKFGEVYKGLLQD--------GMLVAIKKRPGAP--TQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~--~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      .+.+..|-...+|+....+        +..+++++.....  .-+..+|..+++.+. +.-..++++.+.  +  ++|+|
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~~I~e  150 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP--E--GRIEE  150 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--CEEEE
Confidence            3557678889999998753        5788999855432  223467888888774 323455555332  2  58999


Q ss_pred             eecCCCcc
Q 016588          157 YIPNGSVS  164 (386)
Q Consensus       157 ~~~~g~L~  164 (386)
                      |+++..|.
T Consensus       151 fI~G~~l~  158 (424)
T 3mes_A          151 FIDGEPLT  158 (424)
T ss_dssp             CCCSEECC
T ss_pred             EeCCccCC
Confidence            99986653

>2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens}

Probab=94.38  E-value=0.13  Score=32.52  Aligned_cols=33  Identities=21%  Similarity=0.306  Sum_probs=23.3

Q ss_pred             cchhhHHHHHHHHHHHHHHHHHHHHHHHHhcCC
Q 016588            3 VTLAAIFGAAAGAVALMGIIFFLSWFCLYRNRS   35 (386)
Q Consensus         3 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~   35 (386)
                      +.+++|++++++++.++++++++.|-|-..+|+
T Consensus         7 vp~WiIi~svl~GLLLL~Lii~~LwK~GFFKR~   39 (54)
T 2l8s_A            7 VPLWVILLSAFAGLLLLMLLILALWKIGFFKRP   39 (54)
T ss_dssp             CCTHHHHHHHHHHHHHHHHHHHHHHHHHHTTSC
T ss_pred             CchHHHHHHHHHHHHHHHHHHHHHHHcCcccCC
Confidence            456777777777777777777777766554444

>2knc_A Integrin alpha-IIB; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens}

Probab=94.24  E-value=0.17  Score=32.14  Aligned_cols=33  Identities=15%  Similarity=0.350  Sum_probs=23.2

Q ss_pred             cchhhHHHHHHHHHHHHHHHHHHHHHHHHhcCC
Q 016588            3 VTLAAIFGAAAGAVALMGIIFFLSWFCLYRNRS   35 (386)
Q Consensus         3 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~   35 (386)
                      +.+++|++++++++.++++++++.|-|-..+|+
T Consensus        10 vp~wiIi~svl~GLllL~li~~~LwK~GFFkR~   42 (54)
T 2knc_A           10 IPIWWVLVGVLGGLLLLTILVLAMWKVGFFKRN   42 (54)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTT
T ss_pred             cchHHHHHHHHHHHHHHHHHHHHHHHcCcccCC
Confidence            456777777777777777777777765554444

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=93.21  E-value=0.2  Score=30.25  Aligned_cols=7  Identities=43%  Similarity=0.696  Sum_probs=3.0

Q ss_pred             HHHHHHH
Q 016588            8 IFGAAAG   14 (386)
Q Consensus         8 i~~~~~~   14 (386)
                      |+++++|
T Consensus        14 Ia~~vVG   20 (44)
T 2jwa_A           14 IISAVVG   20 (44)
T ss_dssp             HHHHHHH
T ss_pred             hHHHHHH
Confidence            4444444

>2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens}

Probab=92.93  E-value=0.078  Score=31.82  Aligned_cols=26  Identities=23%  Similarity=0.314  Sum_probs=11.7

Q ss_pred             hhHHHHHHHHHHHHHHHHHHHHHHHH
Q 016588            6 AAIFGAAAGAVALMGIIFFLSWFCLY   31 (386)
Q Consensus         6 ~~i~~~~~~~~~~~~~~~~~~~~~~~   31 (386)
                      ++|++.++++++++++++++.|+++|
T Consensus        13 ~~I~~~vv~Gv~ll~~iv~~~~~~~r   38 (41)
T 2k9y_A           13 LAVIGGVAVGVVLLLVLAGVGFFIHR   38 (41)
T ss_dssp             THHHHHHHHHHHHHHHHHHHHHSSSS
T ss_pred             EEEEeehhHHHHHHHHHHHHheeEee
Confidence            44444444444444423344444443

>2k1a_A Integrin alpha-IIB; single-PASS transmembrane segment, alternative splicing, calcium, cell adhesion, cleavage on PAIR of basic residues; NMR {Homo sapiens} PDB: 2k9j_A

Probab=91.54  E-value=0.33  Score=29.09  Aligned_cols=32  Identities=16%  Similarity=0.351  Sum_probs=22.2

Q ss_pred             cchhhHHHHHHHHHHHHHHHHHHHHHHHHhcC
Q 016588            3 VTLAAIFGAAAGAVALMGIIFFLSWFCLYRNR   34 (386)
Q Consensus         3 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~   34 (386)
                      +.+++|++++++++.++++++++.|-|-..+|
T Consensus         8 vp~wiIi~s~l~GLllL~li~~~LwK~GFFkR   39 (42)
T 2k1a_A            8 IPIWWVLVGVLGGLLLLTILVLAMWKVGFFKR   39 (42)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHHHHTTTTCC
T ss_pred             cchHHHHHHHHHHHHHHHHHHHHHHHcCcccC
Confidence            45677777777777777777777776544443

>2l34_A TYRO protein tyrosine kinase-binding protein; immunoreceptor, transmembrane assembly, DAP12, protein bindi; NMR {Homo sapiens} PDB: 2l35_B

Probab=90.19  E-value=0.46  Score=26.82  Aligned_cols=29  Identities=21%  Similarity=0.369  Sum_probs=20.0

Q ss_pred             CccchhhHHHHHHHHHHHHHHHHHHHHHH
Q 016588            1 MSVTLAAIFGAAAGAVALMGIIFFLSWFC   29 (386)
Q Consensus         1 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~   29 (386)
                      +++..+++.|++++.++..+++.++.|++
T Consensus         2 ~~L~~gaIaGIVvgdi~~t~~i~~~vy~~   30 (33)
T 2l34_A            2 STVSPGVLAGIVVGDLVLTVLIALAVYFL   30 (33)
T ss_dssp             CCCCTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             cccCcceEEeEeHHHHHHHHHHHHHHhhe
Confidence            35677888888888877666665555543

>2klu_A T-cell surface glycoprotein CD4; cell membrane, disulfide bond, HOST- virus interaction, immune response, immunoglobulin domain, lipoprotein; NMR {Homo sapiens}

Probab=90.17  E-value=0.41  Score=31.36  Aligned_cols=14  Identities=29%  Similarity=0.738  Sum_probs=6.1

Q ss_pred             hHHHHHHHHHHHHH
Q 016588            7 AIFGAAAGAVALMG   20 (386)
Q Consensus         7 ~i~~~~~~~~~~~~   20 (386)
                      +++|.+++.+++..
T Consensus        12 ivlGg~~~lll~~g   25 (70)
T 2klu_A           12 IVLGGVAGLLLFIG   25 (70)
T ss_dssp             HHHHHHHHHHHHHH
T ss_pred             HHHhHHHHHHHHHH
Confidence            44454444443333

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=89.96  E-value=0.44  Score=28.85  Aligned_cols=31  Identities=13%  Similarity=-0.159  Sum_probs=19.1

Q ss_pred             hhhHHHHHHHHHHHHHHHHHHHHHHHHhcCC
Q 016588            5 LAAIFGAAAGAVALMGIIFFLSWFCLYRNRS   35 (386)
Q Consensus         5 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~   35 (386)
                      +++.++..++++++++++++++|..++++++
T Consensus        13 IA~gVVgGv~~~~ii~~~~~~~~RRr~~~~k   43 (44)
T 2ks1_B           13 IATGMVGALLLLLVVALGIGLFMRRRHIVRK   43 (44)
T ss_dssp             STHHHHHHHHHHHHHHHHHHHHHHTTTCCSC
T ss_pred             EEeehhHHHHHHHHHHHHHHHHhhhhHhhcc
Confidence            3444444334445566777888888887765

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=89.23  E-value=1.7  Score=36.60  Aligned_cols=116  Identities=9%  Similarity=0.072  Sum_probs=76.1

Q ss_pred             CCCcccccccceeeCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCC
Q 016588          134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTAN  213 (386)
Q Consensus       134 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~N  213 (386)
                      .||+++.. .+-...+.+.+.++.  ..+...|-      .-...+...+++++..++....+++.    -+|--|.|+|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~--~~~~~~f~------~ik~~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~N  109 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDI--NDNHTPFD------NIKSFTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDE  109 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECC--CTTSEEGG------GGGGSCHHHHHHHHHHGGGGGGGGGS----SEECCCSGGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEc--CcccCCHH------HHHhcCHHHHHHHHHHHHHHHHHhcC----ceEEEEecce
Confidence            57877765 344555665554443  33333332      23457788999999999887766654    5788899999


Q ss_pred             eeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCC
Q 016588          214 VLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASS  286 (386)
Q Consensus       214 ill~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~  286 (386)
                      ++++.++.+++.--|+...+.                   |     ..++...=.-.+=|++..+++++..|.
T Consensus       110 L~f~~~~~p~i~~RGik~~l~-------------------P-----~~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNVVD-------------------P-----LPVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EEECTTSCEEESCCEETTTBS-------------------C-----CCCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEEcCCCCEEEEEccCccCCC-------------------C-----CCCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999998877654321                   1     011222223456778888898876654

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=89.18  E-value=0.47  Score=28.69  Aligned_cols=32  Identities=13%  Similarity=-0.004  Sum_probs=20.1

Q ss_pred             hhhHHHHHHHHHHHHHHHHHHHHHHHHhcCCC
Q 016588            5 LAAIFGAAAGAVALMGIIFFLSWFCLYRNRSV   36 (386)
Q Consensus         5 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~   36 (386)
                      +++.++..+.++++++++++++|..+++++++
T Consensus        12 IA~gVVgGv~~v~ii~~~~~~~~RRRr~~~kr   43 (44)
T 2l2t_A           12 IAAGVIGGLFILVIVGLTFAVYVRRKSIKKKR   43 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHTTCSSCCC
T ss_pred             EEEeehHHHHHHHHHHHHHHHHhhhhhhhhcc
Confidence            44444444445555667778888888877654

>2knc_B Integrin beta-3; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens}

Probab=83.82  E-value=1.5  Score=30.36  Aligned_cols=25  Identities=24%  Similarity=0.557  Sum_probs=15.1

Q ss_pred             chhhHHHHHHHHHHHHHHHHHHHHH
Q 016588            4 TLAAIFGAAAGAVALMGIIFFLSWF   28 (386)
Q Consensus         4 ~~~~i~~~~~~~~~~~~~~~~~~~~   28 (386)
                      -+++|++.+++++++++++++++|.
T Consensus         9 n~~~Iv~gvi~gilliGllllliwk   33 (79)
T 2knc_B            9 DILVVLLSVMGAILLIGLAALLIWK   33 (79)
T ss_dssp             CSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CchhhHHHHHHHHHHHHHHHHHHHH
Confidence            4455655566666666666666664

>2lx0_A Membrane fusion protein P14; membrane fusion protein transmembrane domain, P14 fast prote ARCH, micelle-peptide complex, membrane protein; NMR {Synthetic}

Probab=83.00  E-value=2.5  Score=22.22  Aligned_cols=23  Identities=35%  Similarity=0.635  Sum_probs=15.8

Q ss_pred             HHHHHHHHHHHHHHHHHHHHHHH
Q 016588            9 FGAAAGAVALMGIIFFLSWFCLY   31 (386)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~   31 (386)
                      .-+++|.++++.++++.+|.+..
T Consensus         6 weviaglvalltflafgfwlfky   28 (32)
T 2lx0_A            6 WEVIAGLVALLTFLAFGFWLFKY   28 (32)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHH
Confidence            34556777777887787777654

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=82.90  E-value=3.1  Score=35.04  Aligned_cols=85  Identities=7%  Similarity=0.018  Sum_probs=57.7

Q ss_pred             CCCcccccccceeeCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHH-HhhcCCCCceecCCCCC
Q 016588          134 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA-HLHSLSPRVVHKDFKTA  212 (386)
Q Consensus       134 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~-~LH~~~~~ivH~dlkp~  212 (386)
                      .||++  -...-.+.+.+.+.++.-++  ...|-      .-...+...+++++..++.... +++.    -+|--|.|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~--~~~f~------~i~~~~~~eKlrll~nl~~L~~~~~~~----r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSS--FLTFA------AIRKTTLLSRIRAAIHLVSKVKHHSAR----RLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTT--CEEHH------HHHTSCHHHHHHHHHHHHHHHSSCCSS----SEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcc--cCcHH------HHHhcCHHHHHHHHHHHHHHHHHhhhC----ceeEEEeCc
Confidence            57777  23333556665555554322  22222      1245678889999999887666 5543    678889999


Q ss_pred             CeeeCCCCceEEcccccccc
Q 016588          213 NVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       213 Nill~~~~~~kl~DFgl~~~  232 (386)
                      |+++|.++.+++.-.|+...
T Consensus       114 NL~f~~~~~p~i~hRGi~~~  133 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKES  133 (219)
T ss_dssp             GEEECTTCCEEESCCEETTT
T ss_pred             eEEEeCCCcEEEEEcCCccc
Confidence            99999999999998886543

>2k9j_B Integrin beta-3; transmembrane complex, cell adhesion, cleavage on basic residues, disease mutation, glycoprotein, pyrrolidone carboxylic acid; NMR {Homo sapiens} PDB: 2rmz_A 2rn0_A 2l91_A

Probab=82.65  E-value=2.2  Score=25.62  Aligned_cols=28  Identities=25%  Similarity=0.505  Sum_probs=17.2

Q ss_pred             cchhhHHHHHHHHHHHHHHHHHHHHHHH
Q 016588            3 VTLAAIFGAAAGAVALMGIIFFLSWFCL   30 (386)
Q Consensus         3 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~   30 (386)
                      +-+.+|++.+++++++++++.++.|.++
T Consensus         7 ~n~~~Iv~gvi~~ivliGl~lLliwk~~   34 (43)
T 2k9j_B            7 PDILVVLLSVMGAILLIGLAALLIWKLL   34 (43)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCEeehHHHHHHHHHHHHHHHHHHHHHH
Confidence            3455666666666666676666666544

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=80.67  E-value=0.23  Score=47.41  Aligned_cols=57  Identities=7%  Similarity=0.026  Sum_probs=17.5

Q ss_pred             cCCeecccCceEEEEEEeCC-CcEEEE------EECCC-----CChhHHHHHHHHHHcCCCCccccccccee
Q 016588           87 DKNLIGEGKFGEVYKGLLQD-GMLVAI------KKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQ  146 (386)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~-~~~vav------K~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~  146 (386)
                      ..+.+|   ||.||+|.+.. ..+||+      |....     .....+.+|..+++.++|||+++.+++..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            345665   99999999764 467888      64332     22345778888888899999999988764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	386
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-58
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-56
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-56
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-54
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	7e-54
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-53
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-53
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-51
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-51
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-51
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-51
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-51
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-50
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-50
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	8e-50
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-49
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-49
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-48
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-47
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-47
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	5e-47
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-47
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	7e-47
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-46
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-46
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-46
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-46
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-45
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-45
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-44
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-43
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-42
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-41
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-40
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-40
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-39
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-38
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-37
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-37
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-37
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-37
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-36
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-36
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-36
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-36
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-35
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	8e-35
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-34
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-34
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-34
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-33
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-31
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-31
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	8e-31
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-30
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-30
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-27
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-27
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-27
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-26
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-24
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	9e-24
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	8e-17

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 1e-58
 Identities = 71/289 (24%), Positives = 130/289 (44%), Gaps = 28/289 (9%)

Query: 76  EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCFL 130
           ++  +     +    IG G FG VYKG       VA+K     APT    Q F +EV  L
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVL 58

Query: 131 ASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 190
              +H N++  +GY     L  ++ ++    S+  HL+        K E    + IA   
Sbjct: 59  RKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHII----ETKFEMIKLIDIARQT 113

Query: 191 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 250
           A+G+ +LH+    ++H+D K+ N+ + ED   K+ D GL     R   +    Q++   +
Sbjct: 114 AQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171

Query: 251 FLASEV---KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 307
           ++A EV   ++   +S +SDVY+FG+ L EL++G+   S+++      ++ +V       
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIFMVGRGYLSP 229

Query: 308 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 356
           +L K+              +   +L+  CL    + RP    ++  ++ 
Sbjct: 230 DLSKVRSNCP---------KAMKRLMAECLKKKRDERPLFPQILASIEL 269

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 3e-56
 Identities = 73/279 (26%), Positives = 123/279 (44%), Gaps = 24/279 (8%)

Query: 83  KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVT 140
              +    IG G+FG V+ G   +   VAIK  +      ++FI+E   +  + H  LV 
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64

Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 200
           L G C E     L++E++ +G     L    +  R     +  L + L   +G+A+L   
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGC----LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE-- 118

Query: 201 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 260
              V+H+D    N LV E+ + KV+D G+  F+        +      + + + EV  F 
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK-WASPEVFSFS 177

Query: 261 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 320
           R+S KSDV+SFGV + E+ S  +      P  ++   E+V+   D S   ++   RL S 
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGK-----IPYENRSNSEVVE---DISTGFRLYKPRLAS- 228

Query: 321 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 359
                     Q++  C     E RP+ S ++ +L    +
Sbjct: 229 ------THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 4e-56
 Identities = 72/275 (26%), Positives = 117/275 (42%), Gaps = 24/275 (8%)

Query: 83  KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVT 140
           +       +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV 
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72

Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 200
           L     +  + ++I EY+ NGS+   L  P   S  KL     L +A   A+G+A +   
Sbjct: 73  LYAVVTQEPI-YIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEER 128

Query: 201 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 260
           +   +H+D + AN+LV +    K+AD GL   +   +             + A E   + 
Sbjct: 129 N--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYG 185

Query: 261 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 320
            F+ KSDV+SFG+ L E+V+         P       E++QN          L+      
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRI-----PYPGMTNPEVIQN----------LERGYRMV 230

Query: 321 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 355
             +   EE  QL+  C     E RP+   + + L+
Sbjct: 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  179 bits (455), Expect = 1e-54
 Identities = 68/293 (23%), Positives = 128/293 (43%), Gaps = 24/293 (8%)

Query: 71  RRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEV 127
                ++  +   + + K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E 
Sbjct: 5   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEA 64

Query: 128 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 187
             +  I+H NLV LLG C      ++I E++  G++  +L    + +RQ++     L +A
Sbjct: 65  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR---ECNRQEVSAVVLLYMA 121

Query: 188 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 247
              +  + +L       +H+D    N LV E+ + KVAD GL   +   D     +    
Sbjct: 122 TQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKF 178

Query: 248 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 307
              + A E   + +FS KSDV++FGV L E+ +                        D S
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG---------------MSPYPGIDLS 223

Query: 308 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 360
            + ++L++           E+  +L+  C   +   RPS +++    +    +
Sbjct: 224 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  178 bits (452), Expect = 7e-54
 Identities = 68/312 (21%), Positives = 126/312 (40%), Gaps = 41/312 (13%)

Query: 73  FQMEELSLATKNFSDK---------NLIGEGKFGEVYKGLL----QDGMLVAIKKRPGAP 119
           F  E+ + A + F+ +          +IG G+FGEV  G L    +  + VAIK      
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 120 T----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSR 175
           T    ++F+ E   +    H N++ L G   ++    +I E++ NGS    L    + + 
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGS----LDSFLRQND 122

Query: 176 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 235
            +      + +  G A G+ +L       VH+D    N+LV+ + + KV+D GL  FL  
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 236 TDVAGPSSQVTAD---EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS 292
                  +          + A E  ++R+F+  SDV+S+G+ + E++S  E         
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW----- 235

Query: 293 SQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT 352
                          +++  +++        +      QL++ C       RP    +V 
Sbjct: 236 ----------DMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285

Query: 353 ELDRTLDKEMNL 364
            LD+ +    +L
Sbjct: 286 TLDKMIRNPNSL 297

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 2e-53
 Identities = 64/274 (23%), Positives = 119/274 (43%), Gaps = 24/274 (8%)

Query: 83  KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVT 140
           K+ +    +G G+FG V  G  +    VAIK  K       EFI+E   + ++ H  LV 
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63

Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 200
           L G C +    F+I EY+ NG +  +L       R + + +  L +     + + +L   
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYLR----EMRHRFQTQQLLEMCKDVCEAMEYLE-- 117

Query: 201 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 260
           S + +H+D    N LV++  + KV+D GL  ++   +             +   EV  + 
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF-PVRWSPPEVLMYS 176

Query: 261 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 320
           +FS KSD+++FGV + E+ S  +      P       E  ++    +  L++    L S 
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK-----MPYERFTNSETAEH---IAQGLRLYRPHLAS- 227

Query: 321 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
                 E+   ++  C    ++ RP+   +++ +
Sbjct: 228 ------EKVYTIMYSCWHEKADERPTFKILLSNI 255

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 4e-53
 Identities = 76/288 (26%), Positives = 118/288 (40%), Gaps = 30/288 (10%)

Query: 77  ELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQH 135
            L++  K       IG+G+FG+V  G    G  VA+K  +  A  Q F+ E   +  ++H
Sbjct: 3   ALNM--KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRH 59

Query: 136 RNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 194
            NLV LLG   +E    +++ EY+  GS+  +L       R  L     L  +L   + +
Sbjct: 60  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAM 116

Query: 195 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 254
            +L       VH+D    NVLV ED +AKV+D GL      T   G          + A 
Sbjct: 117 EYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-----WTAP 169

Query: 255 EVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 314
           E    ++FS KSDV+SFG+ L E+ S         P     L ++V        + K   
Sbjct: 170 EALREKKFSTKSDVWSFGILLWEIYSFGRV-----PYPRIPLKDVVP------RVEKGYK 218

Query: 315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 362
                           +++  C    +  RPS   +  +L+     E+
Sbjct: 219 MDAPDGCP----PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL 262

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 1e-51
 Identities = 69/275 (25%), Positives = 115/275 (41%), Gaps = 24/275 (8%)

Query: 83  KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVT 140
           ++   +  +G+G FGEV+ G       VAIK  K      + F+ E   +  ++H  LV 
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76

Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 200
           L     E  + +++ EY+  GS+   L G    + + L     + +A   A G+A++   
Sbjct: 77  LYAVVSEEPI-YIVTEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVE-- 130

Query: 201 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 260
               VH+D + AN+LV E+ + KVAD GL   +   +           + + A E   + 
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYG 189

Query: 261 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 320
           RF+ KSDV+SFG+ L EL +         P       E          +L  ++      
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRV-----PYPGMVNRE----------VLDQVERGYRMP 234

Query: 321 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 355
              E  E    L+ +C     E RP+   +   L+
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 2e-51
 Identities = 60/301 (19%), Positives = 122/301 (40%), Gaps = 36/301 (11%)

Query: 88  KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFID--EVCFLASIQHRNLVTLLGYC 145
           +  IG+G+FGEV++G    G  VA+K       + +    E+     ++H N++  +   
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 66

Query: 146 QENNLQ----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL- 200
            ++N      +L+ +Y  +GS+  +L      +R  +  +  + +AL  A GLAHLH   
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYL------NRYTVTVEGMIKLALSTASGLAHLHMEI 120

Query: 201 -----SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG---------RTDVAGPSSQVT 246
                 P + H+D K+ N+LV ++    +AD GL                   G    + 
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM- 179

Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 306
           A E+   S   +     +++D+Y+ G+   E+     +   +  D      +LV +    
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC-SIGGIHEDYQLPYYDLVPSDPSV 238

Query: 307 SNLLKILDERL------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 360
             + K++ E+           + E +    +++  C   +   R +   +   L +   +
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298

Query: 361 E 361
           E
Sbjct: 299 E 299

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 3e-51
 Identities = 71/294 (24%), Positives = 129/294 (43%), Gaps = 31/294 (10%)

Query: 84  NFSDKNLIGEGKFGEVYKGLLQDG-----MLVAIKKRPGAPTQ----EFIDEVCFLASIQ 134
             + + +IG G+FGEVYKG+L+       + VAIK      T+    +F+ E   +    
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67

Query: 135 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 194
           H N++ L G   +     +I EY+ NG++   L         +      + +  G A G+
Sbjct: 68  HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGM 123

Query: 195 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLA 253
            +L +     VH+D    N+LV+ + + KV+D GL   L     A  ++      I + A
Sbjct: 124 KYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 313
            E   +R+F+  SDV+SFG+ + E+++  E                         ++K +
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGE---------------RPYWELSNHEVMKAI 226

Query: 314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTV 367
           ++        +      QL+++C      RRP  +D+V+ LD+ +    +L T+
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTL 280

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 3e-51
 Identities = 54/306 (17%), Positives = 112/306 (36%), Gaps = 44/306 (14%)

Query: 78  LSLATKNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK-----RPGAPTQEFIDEVCFLA 131
           + L   +F   + +G G  G V+K      G+++A K      +P     + I E+  L 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR-NQIIRELQVLH 59

Query: 132 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA 191
                 +V   G    +    +  E++  GS+   L         ++  +    +++   
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-----KAGRIPEQILGKVSIAVI 114

Query: 192 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF 251
           KGL +L     +++H+D K +N+LV+     K+ D G+   L  +     ++       +
Sbjct: 115 KGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSY 169

Query: 252 LASEVKEFRRFSEKSDVYSFGVFLLELVSGR---------------------------EA 284
           ++ E  +   +S +SD++S G+ L+E+  GR                             
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229

Query: 285 SSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERR 344
             +     S   ++       F  L  I++E      +     EF   + +CL  +   R
Sbjct: 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 289

Query: 345 PSMSDV 350
             +  +
Sbjct: 290 ADLKQL 295

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  171 bits (435), Expect = 3e-51
 Identities = 66/277 (23%), Positives = 116/277 (41%), Gaps = 32/277 (11%)

Query: 82  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQ 134
            K FSD   IG G FG VY    +++  +VAIKK      +     Q+ I EV FL  ++
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 135 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 194
           H N +   G     +  +L+ EY    +  +         ++ L+     ++  GA +GL
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV-----HKKPLQEVEIAAVTHGALQGL 128

Query: 195 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 254
           A+LHS    ++H+D K  N+L+ E  + K+ D G  + +   +    +    A E+ LA 
Sbjct: 129 AYLHSH--NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAM 186

Query: 255 EVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 314
           +     ++  K DV+S G+  +EL   +       P  + + +           L  I  
Sbjct: 187 DEG---QYDGKVDVWSLGITCIELAERK------PPLFNMNAMSA---------LYHIAQ 228

Query: 315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
               +  +    E F   +  CL    + RP+   ++
Sbjct: 229 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 2e-50
 Identities = 68/304 (22%), Positives = 113/304 (37%), Gaps = 40/304 (13%)

Query: 84  NFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKK-RPGAPTQE---FIDEVCFLASI 133
             S    +G G FG+V +            M VA+K  +P A   E    + E+  L+ +
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83

Query: 134 -QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLY-------------GPSQVSRQKLE 179
             H N+V LLG C       +I EY   G +   L                 +     L+
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 180 FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 239
            +  LS +   AKG+A L S     +H+D    N+L+    I K+ D GL   +      
Sbjct: 144 LEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201

Query: 240 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVEL 299
                      ++A E      ++ +SDV+S+G+FL EL S   +     P  S+     
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK----- 256

Query: 300 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 359
                      K++ E            E   ++  C D    +RP+   +V  +++ + 
Sbjct: 257 ---------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307

Query: 360 KEMN 363
           +  N
Sbjct: 308 ESTN 311

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  168 bits (427), Expect = 4e-50
 Identities = 71/312 (22%), Positives = 112/312 (35%), Gaps = 46/312 (14%)

Query: 74  QMEELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKK----RPGAPTQEF 123
           ++  L     N      IGEG FG V++         +   +VA+K            +F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 124 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG-------------- 169
             E   +A   + N+V LLG C       L++EY+  G ++  L                
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 170 -----PSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKV 224
                 S      L    +L IA   A G+A+L     + VH+D  T N LV E+ + K+
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRNCLVGENMVVKI 181

Query: 225 ADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 284
           AD GL   +   D             ++  E   + R++ +SDV+++GV L E+ S    
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG-- 239

Query: 285 SSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERR 344
              L P       E++           + D  +          E   L+  C       R
Sbjct: 240 ---LQPYYGMAHEEVIY---------YVRDGNI-LACPENCPLELYNLMRLCWSKLPADR 286

Query: 345 PSMSDVVTELDR 356
           PS   +   L R
Sbjct: 287 PSFCSIHRILQR 298

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 8e-50
 Identities = 67/288 (23%), Positives = 115/288 (39%), Gaps = 31/288 (10%)

Query: 76  EELSLATKNFSDKNL-IGEGKFGEVYKGLLQ---DGMLVAIKK----RPGAPTQEFIDEV 127
           ++L L   N    ++ +G G FG V +G+ +     + VAIK        A T+E + E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 128 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 187
             +  + +  +V L+G CQ   L  L+ E    G +   L G     R+++   +   + 
Sbjct: 61  QIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGK----REEIPVSNVAELL 115

Query: 188 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 247
              + G+ +L       VH+D    NVL+     AK++D GL   LG  D    +     
Sbjct: 116 HQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173

Query: 248 DEI-FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 306
             + + A E   FR+FS +SDV+S+GV + E +S  +           +++  ++  +  
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ--KPYKKMKGPEVMAFIEQGKRM 231

Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
                            E   E   L+  C     E RP    V   +
Sbjct: 232 E-------------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 2e-49
 Identities = 62/279 (22%), Positives = 112/279 (40%), Gaps = 30/279 (10%)

Query: 84  NFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRN 137
           ++     IG G +G   K     DG ++  K+        A  Q  + EV  L  ++H N
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 138 LVTLLGYC--QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 195
           +V        + N   +++ EY   G ++  +   ++  RQ L+ +  L +       L 
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALK 123

Query: 196 HLHSLS---PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL 252
             H  S     V+H+D K ANV +D     K+ D GL   L        +   T    ++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTP--YYM 181

Query: 253 ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 312
           + E      ++EKSD++S G  L EL +         P ++    EL         + + 
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELAG------KIREG 229

Query: 313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
              R+   ++    +E  ++I R L+     RPS+ +++
Sbjct: 230 KFRRIPYRYS----DELNEIITRMLNLKDYHRPSVEEIL 264

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 4e-49
 Identities = 70/312 (22%), Positives = 125/312 (40%), Gaps = 34/312 (10%)

Query: 63  IELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGA 118
           +   + +A +  +   S    +F    +IG G FG VY G L D     +  A+K     
Sbjct: 9   LNPELVQAVQHVVIGPSSLIVHF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI 66

Query: 119 PTQ----EFIDEVCFLASIQHRNLVTLLGYCQE-NNLQFLIYEYIPNGSVSIHLYGPSQV 173
                  +F+ E   +    H N+++LLG C        ++  Y+ +G     L    + 
Sbjct: 67  TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGD----LRNFIRN 122

Query: 174 SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL 233
                  K  +   L  AKG+  L S   + VH+D    N ++DE F  KVAD GL   +
Sbjct: 123 ETHNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDM 180

Query: 234 GRTDVAGP--SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPD 291
              +       +       ++A E  + ++F+ KSDV+SFGV L EL++         P 
Sbjct: 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PY 235

Query: 292 SSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
              +  ++           ++L             +   +++++C  P +E RPS S++V
Sbjct: 236 PDVNTFDITVYLL---QGRRLLQPEYCP-------DPLYEVMLKCWHPKAEMRPSFSELV 285

Query: 352 TELDRTLDKEMN 363
           + +       + 
Sbjct: 286 SRISAIFSTFIG 297

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 5e-48
 Identities = 71/298 (23%), Positives = 129/298 (43%), Gaps = 39/298 (13%)

Query: 83  KNFSDKNLIGEGKFGEVYKGLLQDG---MLVAIKKRPGAPT----QEFIDEVCFLASI-Q 134
            +   +++IGEG FG+V K  ++     M  AIK+     +    ++F  E+  L  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 135 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHR 183
           H N++ LLG C+     +L  EY P+G++   L           +  +  +   L  +  
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 184 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 243
           L  A   A+G+ +L     + +H+D    N+LV E+++AK+AD GL +      V     
Sbjct: 130 LHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGL-SRGQEVYVKKTMG 186

Query: 244 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS 303
           ++     ++A E   +  ++  SDV+S+GV L E+VS        +P       EL +  
Sbjct: 187 RLPVR--WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-----TPYCGMTCAELYEK- 238

Query: 304 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 361
                L +               +E   L+ +C       RPS + ++  L+R L++ 
Sbjct: 239 -----LPQGYRLEKPLNCD----DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 1e-47
 Identities = 68/301 (22%), Positives = 125/301 (41%), Gaps = 31/301 (10%)

Query: 85  FSDKNLIGEGKFGEVYKGLLQD-----GMLVAIKKRPGAPT----QEFIDEVCFLASIQH 135
           F    ++G G FG VYKGL         + VAIK+   A +    +E +DE   +AS+ +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 136 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 195
            ++  LLG C  + +  LI + +P G     L    +  +  +  ++ L+  +  AKG+ 
Sbjct: 71  PHVCRLLGICLTSTV-QLITQLMPFGC----LLDYVREHKDNIGSQYLLNWCVQIAKGMN 125

Query: 196 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 255
           +L     R+VH+D    NVLV      K+ D GL   LG  +    +        ++A E
Sbjct: 126 YLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183

Query: 256 VKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 315
               R ++ +SDV+S+GV + EL++                     +    S +  IL++
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFG---------------SKPYDGIPASEISSILEK 228

Query: 316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPTV 375
                       +   ++V+C    ++ RP   +++ E  +          + G+    +
Sbjct: 229 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHL 288

Query: 376 T 376
            
Sbjct: 289 P 289

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 2e-47
 Identities = 58/274 (21%), Positives = 109/274 (39%), Gaps = 27/274 (9%)

Query: 83  KNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRN 137
           +++     +GEG +GEV           VA+K    KR     +    E+C    + H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 197
           +V   G+ +E N+Q+L  EY   G +   +          +              G+ +L
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYL 119

Query: 198 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK 257
           H +   + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ 
Sbjct: 120 HGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177

Query: 258 EFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 316
           + R F +E  DV+S G+ L  +++G        P  S       +  + + N  K +D  
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQEYSDWKEKKTYLNPWKKID-- 233

Query: 317 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
                        + L+ + L  +   R ++ D+
Sbjct: 234 ----------SAPLALLHKILVENPSARITIPDI 257

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 5e-47
 Identities = 67/280 (23%), Positives = 114/280 (40%), Gaps = 31/280 (11%)

Query: 90  LIGEGKFGEVYKGLL----QDGMLVAIKKRPGAPTQE----FIDEVCFLASIQHRNLVTL 141
            IGEG+FG+V++G+        + VAIK      +      F+ E   +    H ++V L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 142 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 201
           +G   EN + ++I E    G     L    QV +  L+    +  A   +  LA+L S  
Sbjct: 74  IGVITENPV-WIIMELCTLGE----LRSFLQVRKYSLDLASLILYAYQLSTALAYLES-- 126

Query: 202 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 261
            R VH+D    NVLV  +   K+ D GL  ++  +     S      + ++A E   FRR
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRR 185

Query: 262 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF 321
           F+  SDV+ FGV + E++          P       +++        +       +    
Sbjct: 186 FTSASDVWMFGVCMWEILMHGV-----KPFQGVKNNDVIGR------IENGERLPMPPNC 234

Query: 322 TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 361
                     L+ +C      RRP  +++  +L   L++E
Sbjct: 235 P----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 6e-47
 Identities = 62/300 (20%), Positives = 124/300 (41%), Gaps = 32/300 (10%)

Query: 76  EELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAPTQ----EFID 125
           +E  +A +  +    +G+G FG VY+G+       +    VAIK    A +     EF++
Sbjct: 13  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 72

Query: 126 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLY-----GPSQVSRQKLEF 180
           E   +      ++V LLG   +     +I E +  G +  +L        +         
Sbjct: 73  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132

Query: 181 KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 240
              + +A   A G+A+L++   + VH+D    N +V EDF  K+ D G+   +  TD   
Sbjct: 133 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190

Query: 241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV 300
              +      +++ E  +   F+  SDV+SFGV L E+ +  E      P       +++
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-----QPYQGLSNEQVL 245

Query: 301 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 360
           +          +++  L     +   +   +L+  C   + + RPS  ++++ +   ++ 
Sbjct: 246 R---------FVMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (404), Expect = 7e-47
 Identities = 76/299 (25%), Positives = 126/299 (42%), Gaps = 41/299 (13%)

Query: 84  NFSDKNLIGEGKFGEVYKGLL--------QDGMLVAIKKRPGAPTQ----EFIDEVCFLA 131
                  +GEG FG+V                  VA+K      T+    + I E+  + 
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73

Query: 132 SI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLE 179
            I +H+N++ LLG C ++   ++I EY   G++  +L           Y PS    ++L 
Sbjct: 74  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133

Query: 180 FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 239
            K  +S A   A+G+ +L S   + +H+D    NVLV ED + K+AD GL   +   D  
Sbjct: 134 SKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191

Query: 240 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVEL 299
             ++       ++A E    R ++ +SDV+SFGV L E+ +        SP     + E 
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG-----SPYPGVPVEE- 245

Query: 300 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
                    L K+L E       +    E   ++  C      +RP+   +V +LDR +
Sbjct: 246 ---------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 2e-46
 Identities = 69/288 (23%), Positives = 115/288 (39%), Gaps = 42/288 (14%)

Query: 71  RRFQMEELSLATKNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK------RPGAPTQEF 123
           R++ +E       +F     +G+GKFG VY     Q   ++A+K              + 
Sbjct: 1   RQWALE-------DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 53

Query: 124 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR 183
             EV   + ++H N++ L GY  +    +LI EY P G+V   L         K + +  
Sbjct: 54  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-----KLSKFDEQRT 108

Query: 184 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 243
            +     A  L++ HS   RV+H+D K  N+L+      K+AD G       +      +
Sbjct: 109 ATYITELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRT 162

Query: 244 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS 303
            +     +L  E+ E R   EK D++S GV   E + G+       P  +    E  +  
Sbjct: 163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQETYK-- 214

Query: 304 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
                  +I       TF +   E    LI R L  +  +RP + +V+
Sbjct: 215 -------RISRVEF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 2e-46
 Identities = 60/277 (21%), Positives = 104/277 (37%), Gaps = 32/277 (11%)

Query: 87  DKNLIGEGKFGEVYKGLLQD---GMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNL 138
           +   +G G FG V KG  Q       VA+K         A   E + E   +  + +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 139 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 198
           V ++G C+  +   L+ E    G ++ +L        + ++ K+ + +    + G+ +L 
Sbjct: 71  VRMIGICEAESW-MLVMEMAELGPLNKYLQ-----QNRHVKDKNIIELVHQVSMGMKYLE 124

Query: 199 SLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVK 257
                 VH+D    NVL+     AK++D GL +      +     +       + A E  
Sbjct: 125 E--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182

Query: 258 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 317
            + +FS KSDV+SFGV + E  S  +      P       E+            +L++  
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQK-----PYRGMKGSEV----------TAMLEKGE 227

Query: 318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
                     E   L+  C     E RP  + V   L
Sbjct: 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 5e-46
 Identities = 60/272 (22%), Positives = 113/272 (41%), Gaps = 35/272 (12%)

Query: 91  IGEGKFGEVYKGLL-QDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
           IG G F  VYKGL  +  + VA  +        +  Q F +E   L  +QH N+V     
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 145 CQE----NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 200
            +          L+ E + +G++  +L        + ++ K   S      KGL  LH+ 
Sbjct: 77  WESTVKGKKCIVLVTELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQFLHTR 131

Query: 201 SPRVVHKDFKTANVLV-DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 259
           +P ++H+D K  N+ +       K+ D GL      +     +  V     F+A E+ E 
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE- 186

Query: 260 RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS 319
            ++ E  DVY+FG+ +LE+ +             Q+  ++ +         ++      +
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSE-----YPYSECQNAAQIYR---------RVTSGVKPA 232

Query: 320 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 351
           +F    + E  ++I  C+  + + R S+ D++
Sbjct: 233 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 5e-46
 Identities = 61/271 (22%), Positives = 109/271 (40%), Gaps = 31/271 (11%)

Query: 89  NLIGEGKFGEVYKG-LLQDGMLVAIK---KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 144
             +G+G FG+VYK    +  +L A K    +     ++++ E+  LAS  H N+V LL  
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 204
               N  +++ E+   G+V   +        + L       +       L +LH    ++
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLE----LERPLTESQIQVVCKQTLDALNYLHDN--KI 131

Query: 205 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV----TADEIFLASEVKEFR 260
           +H+D K  N+L   D   K+AD G+     RT     S        A E+ +    K+ R
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD-R 190

Query: 261 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 320
            +  K+DV+S G+ L+E+           P    + + +         LLKI      + 
Sbjct: 191 PYDYKADVWSLGITLIEMAEIE------PPHHELNPMRV---------LLKIAKSEPPTL 235

Query: 321 FTNEGM-EEFIQLIVRCLDPSSERRPSMSDV 350
                    F   + +CL+ + + R + S +
Sbjct: 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 2e-45
 Identities = 64/301 (21%), Positives = 103/301 (34%), Gaps = 45/301 (14%)

Query: 84  NFSDKNLIGEGKFGEVYKGLLQD------GMLVAIKKRPGAPTQ----EFIDEVCFLASI 133
           N     ++G G FG+V              + VA+K              + E+  +  +
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97

Query: 134 -QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG------------------PSQVS 174
             H N+V LLG C  +   +LI+EY   G +  +L                      +  
Sbjct: 98  GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157

Query: 175 RQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 234
              L F+  L  A   AKG+  L       VH+D    NVLV    + K+ D GL   + 
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215

Query: 235 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ 294
                           ++A E      ++ KSDV+S+G+ L E+ S         P    
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN-----PYPGI 270

Query: 295 DLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
            +           N  K++             EE   ++  C    S +RPS  ++ + L
Sbjct: 271 PVDA---------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321

Query: 355 D 355
            
Sbjct: 322 G 322

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 6e-45
 Identities = 53/273 (19%), Positives = 110/273 (40%), Gaps = 28/273 (10%)

Query: 82  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVCFLASIQHRN 137
            K ++    IG+G  G VY  + +  G  VAI+    +     +  I+E+  +   ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 197
           +V  L      +  +++ EY+  GS++  +          ++     ++     + L  L
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFL 132

Query: 198 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK 257
           HS   +V+H+D K+ N+L+  D   K+ D G    +         S +     ++A EV 
Sbjct: 133 HSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVV 188

Query: 258 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 317
             + +  K D++S G+  +E++ G        P  +++ +  +             +   
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGE------PPYLNENPLRALYL--------IATNGTP 234

Query: 318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
                 +    F   + RCLD   E+R S  ++
Sbjct: 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 1e-44
 Identities = 64/283 (22%), Positives = 107/283 (37%), Gaps = 32/283 (11%)

Query: 83  KNFSDKNLIGEGKFGEVYKGLL----QDGMLVAIKK------RPGAPTQEFIDEVCFLAS 132
           K+      +G+G FG V +G         + VA+K              +FI EV  + S
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 133 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK 192
           + HRNL+ L G      +  ++ E  P GS    L    +  +           A+  A+
Sbjct: 68  LDHRNLIRLYGVVLTPPM-KMVTELAPLGS----LLDRLRKHQGHFLLGTLSRYAVQVAE 122

Query: 193 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIF 251
           G+ +L   S R +H+D    N+L+    + K+ D GL R      D             +
Sbjct: 123 GMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180

Query: 252 LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 311
            A E  + R FS  SD + FGV L E+ +  +      P    +  +++          K
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILH---------K 226

Query: 312 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 354
           I  E        +  ++   ++V+C     E RP+   +   L
Sbjct: 227 IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  151 bits (382), Expect = 4e-43
 Identities = 57/273 (20%), Positives = 102/273 (37%), Gaps = 28/273 (10%)

Query: 84  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVCFLASIQHRNLV 139
           ++     +G G FG V++      G   A K       +  +    E+  ++ ++H  LV
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86

Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 199
            L    +++N   +IYE++  G +   +         K+     +       KGL H+H 
Sbjct: 87  NLHDAFEDDNEMVMIYEFMSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHE 142

Query: 200 LSPRVVHKDFKTANVLV--DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK 257
                VH D K  N++         K+ D GL   L            T    F A EV 
Sbjct: 143 N--NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVA 197

Query: 258 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 317
           E +     +D++S GV    L+SG       SP   ++  E ++N +   +    +D+  
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL------SPFGGENDDETLRNVK---SCDWNMDDSA 248

Query: 318 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
           +S  +    E+    I + L      R ++   
Sbjct: 249 FSGIS----EDGKDFIRKLLLADPNTRMTIHQA 277

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 2e-42
 Identities = 46/274 (16%), Positives = 94/274 (34%), Gaps = 31/274 (11%)

Query: 84  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHR 136
           +F    ++GEG F  V     L      AIK                  E   ++ + H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 137 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 196
             V L    Q++   +    Y  NG +  ++           +              L +
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-----KIGSFDETCTRFYTAEIVSALEY 123

Query: 197 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV 256
           LH     ++H+D K  N+L++ED   ++ D G    L        ++       +++ E+
Sbjct: 124 LHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181

Query: 257 KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 316
              +   + SD+++ G  + +LV+G        P  + +   + Q         KI+   
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGL------PPFRAGNEYLIFQ---------KIIKLE 226

Query: 317 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
               F  +   +   L+ + L   + +R    ++
Sbjct: 227 Y--DFPEKFFPKARDLVEKLLVLDATKRLGCEEM 258

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 5e-41
 Identities = 67/298 (22%), Positives = 113/298 (37%), Gaps = 39/298 (13%)

Query: 84  NFSDKNLIGEGKFGEVYKGL------LQDGMLVAIKK----RPGAPTQEFIDEVCFLASI 133
                  +G G FG+V +              VA+K        +  +  + E+  L  I
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73

Query: 134 QHR-NLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYG-----------PSQVSRQKLEF 180
            H  N+V LLG C +      +I E+   G++S +L             P  + +  L  
Sbjct: 74  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133

Query: 181 KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 240
           +H +  +   AKG+  L S   + +H+D    N+L+ E  + K+ D GL   + +     
Sbjct: 134 EHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191

Query: 241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV 300
                     ++A E    R ++ +SDV+SFGV L E+ S        SP     + E  
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKIDEE- 245

Query: 301 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 358
                     + L E       +    E  Q ++ C      +RP+ S++V  L   L
Sbjct: 246 --------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  142 bits (360), Expect = 1e-40
 Identities = 52/284 (18%), Positives = 103/284 (36%), Gaps = 37/284 (13%)

Query: 84  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT------------QEFIDEVCFL 130
           N+  K ++G G    V + +        A+K                   +  + EV  L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 131 ASIQ-HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG 189
             +  H N++ L    + N   FL+++ +  G +  +L       +  L  K    I   
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-----EKVTLSEKETRKIMRA 118

Query: 190 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP---SSQVT 246
             + +  LH L   +VH+D K  N+L+D+D   K+ D G    L   +       +    
Sbjct: 119 LLEVICALHKL--NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYL 176

Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 306
           A EI   S       + ++ D++S GV +  L++G        P   +  + +++     
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------PPFWHRKQMLMLRMIMSG 230

Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
           +      +   +S       +    L+ R L    ++R +  + 
Sbjct: 231 NYQFGSPEWDDYS-------DTVKDLVSRFLVVQPQKRYTAEEA 267

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 2e-40
 Identities = 53/277 (19%), Positives = 101/277 (36%), Gaps = 31/277 (11%)

Query: 83  KNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQH 135
           K   +K      +G G+FG V++ +          K  K  G        E+  L   +H
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60

Query: 136 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 195
           RN++ L    +      +I+E+I    +   +      S  +L  +  +S      + L 
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERI----NTSAFELNEREIVSYVHQVCEALQ 116

Query: 196 HLHSLSPRVVHKDFKTANVLVD--EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 253
            LHS    + H D +  N++         K+ + G    L   D             + A
Sbjct: 117 FLHSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPE---YYA 171

Query: 254 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 313
            EV +    S  +D++S G  +  L+SG    +    +++Q ++E + N+          
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGI---NPFLAETNQQIIENIMNAE------YTF 222

Query: 314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
           DE  +   +     E +  + R L    + R + S+ 
Sbjct: 223 DEEAFKEIS----IEAMDFVDRLLVKERKSRMTASEA 255

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  141 bits (357), Expect = 2e-39
 Identities = 56/267 (20%), Positives = 103/267 (38%), Gaps = 28/267 (10%)

Query: 90  LIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 145
            +G G FG V++ +    G +   K              +E+  +  + H  L+ L    
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 146 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 205
           ++     LI E++  G +   +         K+     ++    A +GL H+H     +V
Sbjct: 96  EDKYEMVLILEFLSGGELFDRI----AAEDYKMSEAEVINYMRQACEGLKHMHEH--SIV 149

Query: 206 HKDFKTANVLVD--EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS 263
           H D K  N++ +  +    K+ D GL   L   ++       TA   F A E+ +     
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTTATAEFAAPEIVDREPVG 206

Query: 264 EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN 323
             +D+++ GV    L+SG       SP + +D +E +QN +         DE  +S+ + 
Sbjct: 207 FYTDMWAIGVLGYVLLSGL------SPFAGEDDLETLQNVK---RCDWEFDEDAFSSVS- 256

Query: 324 EGMEEFIQLIVRCLDPSSERRPSMSDV 350
               E    I   L     +R ++ D 
Sbjct: 257 ---PEAKDFIKNLLQKEPRKRLTVHDA 280

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 3e-38
 Identities = 63/285 (22%), Positives = 102/285 (35%), Gaps = 25/285 (8%)

Query: 84  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRN 137
           NF     IGEG +G VYK      G +VA+KK              I E+  L  + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 197
           +V LL      N  +L++E++                   +      S      +GLA  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA----LTGIPLPLIKSYLFQLLQGLAFC 118

Query: 198 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK 257
           H  S RV+H+D K  N+L++ +   K+AD GL    G   V   + +V          + 
Sbjct: 119 H--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTLWYRAPEILL 175

Query: 258 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSP------------DSSQDLVELVQNSRD 305
             + +S   D++S G    E+V+ R      S                + +   V +  D
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235

Query: 306 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
           +         + +S       E+   L+ + L     +R S    
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  137 bits (345), Expect = 1e-37
 Identities = 55/281 (19%), Positives = 99/281 (35%), Gaps = 38/281 (13%)

Query: 78  LSLATKNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIK---------KRPGAPTQEFIDEV 127
           L++   +FS   +IG G FGEVY       G + A+K         K+           +
Sbjct: 1   LTM--NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 58

Query: 128 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 187
             +++     +V +       +    I + +  G +  HL                   A
Sbjct: 59  SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS-----QHGVFSEADMRFYA 113

Query: 188 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 247
                GL H+H  +  VV++D K AN+L+DE    +++D GL     +            
Sbjct: 114 AEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVG 167

Query: 248 DEIFLASEV-KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 306
              ++A EV ++   +   +D +S G  L +L+ G           ++D  E+ + +   
Sbjct: 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP---FRQHKTKDKHEIDRMTLTM 224

Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM 347
                     L  +F+     E   L+   L     RR   
Sbjct: 225 -------AVELPDSFS----PELRSLLEGLLQRDVNRRLGC 254

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 3e-37
 Identities = 60/287 (20%), Positives = 110/287 (38%), Gaps = 27/287 (9%)

Query: 84  NFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLL 142
           +++D  +IG G FG VY+  L   G LVAIKK      +    E+  +  + H N+V L 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLR 79

Query: 143 GYCQENNLQ------FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 196
            +   +  +       L+ +Y+P     +  +     ++Q L   +         + LA+
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAY 137

Query: 197 LHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 255
           +H  S  + H+D K  N+L+D D  + K+ D G    L R +     S + +        
Sbjct: 138 IH--SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAPEL 193

Query: 256 VKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS------------SQDLVELVQNS 303
           +     ++   DV+S G  L EL+ G+      S               +++ +  +  +
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253

Query: 304 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
                  +I        F      E I L  R L+ +   R +  + 
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  134 bits (337), Expect = 3e-37
 Identities = 58/284 (20%), Positives = 99/284 (34%), Gaps = 25/284 (8%)

Query: 84  NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNL 138
            +     IGEG +G VYK     G   A+KK              I E+  L  ++H N+
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 139 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 198
           V L           L++E++        L     V    LE     S  L    G+A+ H
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQ-----DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 199 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 258
               RV+H+D K  N+L++ +   K+AD GL    G       + ++          +  
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-YTHEIVTLWYRAPDVLMG 174

Query: 259 FRRFSEKSDVYSFGVFLLELVSGR------------EASSSLSPDSSQDLVELVQNSRDF 306
            +++S   D++S G    E+V+G                  +    +      V     +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 307 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
                + +   W +F     E  I L+ + L     +R +    
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  133 bits (336), Expect = 5e-37
 Identities = 46/283 (16%), Positives = 89/283 (31%), Gaps = 27/283 (9%)

Query: 90  LIGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLVTLLGYC-Q 146
            IG G FG++Y G  +  G  VAIK         +   E      +Q    +  + +C  
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA 73

Query: 147 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 206
           E +   ++ E +      +  +       +K   K  L +A      + ++HS     +H
Sbjct: 74  EGDYNVMVMELLGPSLEDLFNF-----CSRKFSLKTVLLLADQMISRIEYIHSK--NFIH 126

Query: 207 KDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-----FLASEVKE 258
           +D K  N L+    +  +  + D GL                    +     + +     
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186

Query: 259 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 318
               S + D+ S G  L+    G      L   + +   E +   +     +    E L 
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-----MSTPIEVLC 241

Query: 319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 361
             +      EF   +  C     + +P  S +         ++
Sbjct: 242 KGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 1e-36
 Identities = 57/283 (20%), Positives = 102/283 (36%), Gaps = 30/283 (10%)

Query: 89  NLIGEGKFGEVYKG-LLQDGMLVAIKK--------RPGAPTQEFIDEVCFLASIQHRNLV 139
           + +GEG+F  VYK        +VAIKK              +  + E+  L  + H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 140 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 199
            LL      +   L+++++      I      + +   L   H  +  L   +GL +LH 
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVII-----KDNSLVLTPSHIKAYMLMTLQGLEYLH- 117

Query: 200 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV-KE 258
               ++H+D K  N+L+DE+ + K+AD GL    G  + A     VT    + A E+   
Sbjct: 118 -QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR--WYRAPELLFG 174

Query: 259 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV-----------QNSRDFS 307
            R +    D+++ G  L EL+         S       +                S    
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234

Query: 308 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
              K           +   ++ + LI      +   R + +  
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 2e-36
 Identities = 55/290 (18%), Positives = 112/290 (38%), Gaps = 25/290 (8%)

Query: 82  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQEFIDEVCFLASIQHR 136
              +++ + IGEG +G V       + + VAIKK          Q  + E+  L   +H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 137 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 196
           N++ +    +   ++ +   Y+    +   LY    +  Q L   H         +GL +
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLY--KLLKTQHLSNDHICYFLYQILRGLKY 124

Query: 197 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT-DVAGPSSQVTADEIFLASE 255
           +HS    V+H+D K +N+L++     K+ D GL        D  G  ++  A   + A E
Sbjct: 125 IHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 256 V-KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 314
           +    + +++  D++S G  L E++S R            + +  +  S    +L  I++
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 315 ERL--------------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
            +               W+        + + L+ + L  +  +R  +   
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  132 bits (333), Expect = 2e-36
 Identities = 54/281 (19%), Positives = 97/281 (34%), Gaps = 35/281 (12%)

Query: 82  TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQEFIDEVCFLAS 132
            ++  D     +++G G F EV      +   LVAIK               +E+  L  
Sbjct: 4   AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHK 63

Query: 133 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK 192
           I+H N+V L    +     +LI + +  G +   +       +     +    +      
Sbjct: 64  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV-----EKGFYTERDASRLIFQVLD 118

Query: 193 GLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
            + +LH     +VH+D K  N+L    DED    ++D GL        V    S      
Sbjct: 119 AVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---STACGTP 173

Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL 309
            ++A EV   + +S+  D +S GV    L+ G        P   ++  +L +        
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY------PPFYDENDAKLFEQ---ILKA 224

Query: 310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
               D   W   +    +     I   ++   E+R +    
Sbjct: 225 EYEFDSPYWDDIS----DSAKDFIRHLMEKDPEKRFTCEQA 261

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  130 bits (328), Expect = 5e-36
 Identities = 54/292 (18%), Positives = 116/292 (39%), Gaps = 39/292 (13%)

Query: 83  KNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLA 131
            + SD+     ++G G   EV+    L+    VA+K       R  +    F  E    A
Sbjct: 3   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62

Query: 132 SIQHRNLVTLLGYCQENN----LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 187
           ++ H  +V +    +       L +++ EY+   ++   ++     +   +  K  + + 
Sbjct: 63  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVI 117

Query: 188 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVT 246
             A + L   H     ++H+D K AN+++      KV D G+ R      +    ++ V 
Sbjct: 118 ADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 175

Query: 247 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 306
               +L+ E         +SDVYS G  L E+++G        P +    V +       
Sbjct: 176 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQ---- 225

Query: 307 SNLLKILDERLWSTFTNEGM-EEFIQLIVRCLDPSSERRP-SMSDVVTELDR 356
                + ++ +  +  +EG+  +   ++++ L  + E R  + +++  +L R
Sbjct: 226 ----HVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 3e-35
 Identities = 61/274 (22%), Positives = 106/274 (38%), Gaps = 34/274 (12%)

Query: 84  NFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK-------RPGAPTQEFIDEVCFLASIQH 135
           +F    ++G+G FG+V+     +     AIK                 +++     + +H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 136 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 195
             L  +    Q     F + EY+  G +  H+      S  K +       A     GL 
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ-----SCHKFDLSRATFYAAEIILGLQ 117

Query: 196 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 255
            LH  S  +V++D K  N+L+D+D   K+AD G+       D    +   T D  ++A E
Sbjct: 118 FLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPD--YIAPE 173

Query: 256 VKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 315
           +   ++++   D +SFGV L E++ G+      SP   QD  EL  + R           
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ------SPFHGQDEEELFHSIR----------- 216

Query: 316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 349
                +     +E   L+V+      E+R  +  
Sbjct: 217 MDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRG 250

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (321), Expect = 8e-35
 Identities = 57/291 (19%), Positives = 99/291 (34%), Gaps = 26/291 (8%)

Query: 81  ATKNFSDKNLIGEGKFGEVYKG--LLQDGMLVAIKKRPGAPTQE--------FIDEVCFL 130
           A + +     IGEG +G+V+K   L   G  VA+K+      +E         +  +  L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 131 ASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVS-IHLYGPSQVSRQKLEFKHRLSIALG 189
            + +H N+V L   C  +         +    V         +V    +  +    +   
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 190 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 249
             +GL  LHS   RVVH+D K  N+LV      K+AD GL             + V    
Sbjct: 125 LLRGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTL 179

Query: 250 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLV----------EL 299
            + A EV     ++   D++S G    E+   +      S       +          + 
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239

Query: 300 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
            ++             +    F  +  E    L+++CL  +  +R S    
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  127 bits (320), Expect = 1e-34
 Identities = 45/291 (15%), Positives = 97/291 (33%), Gaps = 27/291 (9%)

Query: 83  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP-GAPTQEFIDEVCFLASIQHRNLVT 140
            ++     IGEG FG +++G  L +   VAIK  P  +   +  DE      +     + 
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIP 64

Query: 141 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 200
            + Y  +  L  ++   +   S+   L     +  +K   K     A      +  +H  
Sbjct: 65  NVYYFGQEGLHNVLVIDLLGPSLEDLL----DLCGRKFSVKTVAMAAKQMLARVQSIHEK 120

Query: 201 SPRVVHKDFKTANVLVDEDFI-----AKVADAGLRNFLGRTDVAGPSSQVTADEI----- 250
              +V++D K  N L+            V D G+  F                 +     
Sbjct: 121 --SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178

Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 310
           +++      R  S + D+ + G   +  + G      L   +++   E +   +  + L 
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238

Query: 311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 361
           ++     +        EEF + +    + + +  P    +     + L++ 
Sbjct: 239 ELCAG--FP-------EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 2e-34
 Identities = 58/292 (19%), Positives = 106/292 (36%), Gaps = 40/292 (13%)

Query: 73  FQMEELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK---------RPGAPTQE 122
           F+ E +      +     +G G+F  V K      G+  A K          R G   ++
Sbjct: 3   FRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 59

Query: 123 FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKH 182
              EV  L  IQH N++TL    +      LI E +  G +   L       ++ L  + 
Sbjct: 60  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA-----EKESLTEEE 114

Query: 183 RLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED----FIAKVADAGLRNFLGRTDV 238
                     G+ +LH  S ++ H D K  N+++ +        K+ D GL + +   + 
Sbjct: 115 ATEFLKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN- 171

Query: 239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVE 298
                 +     F+A E+  +     ++D++S GV    L+SG         D+ Q+ + 
Sbjct: 172 --EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG---DTKQETLA 226

Query: 299 LVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
            V             ++  +S  +          I R L    ++R ++ D 
Sbjct: 227 NVSAVN------YEFEDEYFSNTS----ALAKDFIRRLLVKDPKKRMTIQDS 268

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  126 bits (317), Expect = 5e-34
 Identities = 54/271 (19%), Positives = 106/271 (39%), Gaps = 36/271 (13%)

Query: 83  KNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 135
           ++F     +G G FG V+      +G   A+K             +   DE   L+ + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 136 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 195
             ++ + G  Q+    F+I +YI  G +   L        Q+         A      L 
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-----KSQRFPNPVAKFYAAEVCLALE 118

Query: 196 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 255
           +LH  S  ++++D K  N+L+D++   K+ D G   ++           +     ++A E
Sbjct: 119 YLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPE 171

Query: 256 VKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 315
           V   + +++  D +SFG+ + E+++G       +P    + ++  +         KIL+ 
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGY------TPFYDSNTMKTYE---------KILNA 216

Query: 316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 346
            L   F     E+   L+ R +     +R  
Sbjct: 217 EL--RFPPFFNEDVKDLLSRLITRDLSQRLG 245

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 2e-33
 Identities = 43/267 (16%), Positives = 89/267 (33%), Gaps = 22/267 (8%)

Query: 90  LIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQ- 146
           ++G G  G+V +    +     A+K     P  +   EV       Q  ++V ++   + 
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDCP--KARREVELHWRASQCPHIVRIVDVYEN 76

Query: 147 ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 203
                    ++ E +  G +   +        Q    +    I     + + +LHS+   
Sbjct: 77  LYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQYLHSI--N 131

Query: 204 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS 263
           + H+D K  N+L        +       F   T      +       ++A EV    ++ 
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 191

Query: 264 EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN 323
           +  D++S GV +  L+ G     S    +    ++       +           WS  + 
Sbjct: 192 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE-----FPNPEWSEVS- 245

Query: 324 EGMEEFIQLIVRCLDPSSERRPSMSDV 350
              EE   LI   L     +R ++++ 
Sbjct: 246 ---EEVKMLIRNLLKTEPTQRMTITEF 269

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 1e-31
 Identities = 53/294 (18%), Positives = 98/294 (33%), Gaps = 29/294 (9%)

Query: 84  NFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRN 137
            +     IG+G FGEV+K    + G  VA+KK              + E+  L  ++H N
Sbjct: 11  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70

Query: 138 LVTLLGYCQENNLQFLIYE---YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 194
           +V L+  C+     +   +   Y+        L G       K        +      GL
Sbjct: 71  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 130

Query: 195 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR---TDVAGPSSQVTADEIF 251
            ++H    +++H+D K ANVL+  D + K+AD GL         +     +++V      
Sbjct: 131 YYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188

Query: 252 LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 311
               +   R +    D++  G  + E+ +        +      L+  +  S        
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248

Query: 312 ILDERLWSTFTNEGM---------------EEFIQLIVRCLDPSSERRPSMSDV 350
           + +  L+                          + LI + L     +R    D 
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 2e-31
 Identities = 52/287 (18%), Positives = 99/287 (34%), Gaps = 27/287 (9%)

Query: 83  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHR 136
           + +     IGEG +G V+K    +   +VA+K+              + E+C L  ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 137 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 196
           N+V L      +    L++E+                    L+ +   S      KGL  
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS-----CNGDLDPEIVKSFLFQLLKGLGF 116

Query: 197 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV 256
            H  S  V+H+D K  N+L++ +   K+A+ GL    G   V   S++V          +
Sbjct: 117 CH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVVTLWYRPPDVL 173

Query: 257 KEFRRFSEKSDVYSFGVFLLELVSGR-------------EASSSLSPDSSQDLVELVQNS 303
              + +S   D++S G    EL +               +    L    +++    +   
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233

Query: 304 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
            D+                 +       L+   L  +  +R S  + 
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 8e-31
 Identities = 49/294 (16%), Positives = 111/294 (37%), Gaps = 39/294 (13%)

Query: 83  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHR 136
             + D   +G G +G V   +  + G  VAIKK     +     +    E+  L  ++H 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 137 NLVTLLGYCQENNLQ------FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 190
           N++ LL     +         +L+  ++      +          +KL       +    
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-------KHEKLGEDRIQFLVYQM 130

Query: 191 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 250
            KGL ++H+    ++H+D K  N+ V+ED   K+ D GL            +  V     
Sbjct: 131 LKGLRYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWY 184

Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE--------------ASSSLSPDSSQDL 296
                +  + R+++  D++S G  + E+++G+                  + +P +    
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244

Query: 297 VELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
                 ++++   L  L+++ +++         + L+ + L   +E+R +  + 
Sbjct: 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 1e-30
 Identities = 60/272 (22%), Positives = 96/272 (35%), Gaps = 33/272 (12%)

Query: 83  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 135
            +F    L+G+G FG+V        G   A+K                + E   L + +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 136 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 195
             L  L    Q ++    + EY   G +  HL        +    +            L 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS-----RERVFTEERARFYGAEIVSALE 119

Query: 196 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 255
           +LHS    VV++D K  N+++D+D   K+ D GL            +   T +  +LA E
Sbjct: 120 YLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE--YLAPE 175

Query: 256 VKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 315
           V E   +    D +  GV + E++ GR       P  +QD   L +          IL E
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFE---------LILME 220

Query: 316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM 347
            +   F      E   L+   L    ++R   
Sbjct: 221 EI--RFPRTLSPEAKSLLAGLLKKDPKQRLGG 250

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 2e-30
 Identities = 57/275 (20%), Positives = 96/275 (34%), Gaps = 47/275 (17%)

Query: 90  LIGEGKFGEVYKGL-LQDGMLVAIKK---------RPGAPTQEFIDEVCFLASIQ--HRN 137
           L+G G FG VY G+ + D + VAIK                     EV  L  +      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 138 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 197
           ++ LL + +  +   LI E                  R  L+ +   S      + + H 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFI----TERGALQEELARSFFWQVLEAVRHC 126

Query: 198 HSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV 256
           H+    V+H+D K  N+L+D +    K+ D G    L  T      +      ++   E 
Sbjct: 127 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEW 180

Query: 257 KEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 315
             + R+    + V+S G+ L ++V G        P               F +  +I+  
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGD------IP---------------FEHDEEIIRG 219

Query: 316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 350
           ++   F      E   LI  CL      RP+  ++
Sbjct: 220 QV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEI 252

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  109 bits (272), Expect = 1e-27
 Identities = 46/293 (15%), Positives = 108/293 (36%), Gaps = 38/293 (12%)

Query: 84  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ-HRNLVTL 141
           ++     +G GK+ EV++ + + +   V +K       ++   E+  L +++   N++TL
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 95

Query: 142 LGYCQE--NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 199
               ++  +    L++E++ N               Q L             K L + HS
Sbjct: 96  ADIVKDPVSRTPALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHS 147

Query: 200 LSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 258
           +   ++H+D K  NV++D E    ++ D GL  F         + +V +        + +
Sbjct: 148 M--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLVD 203

Query: 259 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDL----------------VELVQN 302
           ++ +    D++S G  L  ++  +E       +  Q +                   ++ 
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263

Query: 303 SRDFSNLLKILDERLWSTFTNEGM-----EEFIQLIVRCLDPSSERRPSMSDV 350
              F+++L     + W  F +         E +  + + L    + R +  + 
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  109 bits (272), Expect = 2e-27
 Identities = 57/314 (18%), Positives = 113/314 (35%), Gaps = 44/314 (14%)

Query: 39  TSETGSSEPSVQRNICIIAGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGE 98
            ++ GS + SV+  +   A  +   +         Q++        F     +G G FG 
Sbjct: 5   AAKKGSEQESVKEFL-AKAKEDFLKKWETPSQNTAQLD-------QFDRIKTLGTGSFGR 56

Query: 99  VYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ 151
           V      + G   A+K             +  ++E   L ++    LV L    ++N+  
Sbjct: 57  VMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116

Query: 152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKT 211
           +++ EY+  G +  HL         +    H    A        +LHSL   ++++D K 
Sbjct: 117 YMVMEYVAGGEMFSHLR-----RIGRFSEPHARFYAAQIVLTFEYLHSL--DLIYRDLKP 169

Query: 212 ANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSF 271
            N+L+D+    +V D G         V G +  +      LA E+   + +++  D ++ 
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKR-----VKGRTWTLCGTPEALAPEIILSKGYNKAVDWWAL 224

Query: 272 GVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQ 331
           GV + E+ +G        P  +   +++ +              R  S F+     +   
Sbjct: 225 GVLIYEMAAGY------PPFFADQPIQIYEKIVSG-------KVRFPSHFS----SDLKD 267

Query: 332 LIVRCLDPSSERRP 345
           L+   L     +R 
Sbjct: 268 LLRNLLQVDLTKRF 281

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 2e-27
 Identities = 56/308 (18%), Positives = 120/308 (38%), Gaps = 43/308 (13%)

Query: 73  FQMEELSLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQE 122
           F  +EL+       ++    + +G G +G V      + G+ VA+KK     +     + 
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63

Query: 123 FIDEVCFLASIQHRNLVTLLGYCQENN-----LQFLIYEYIPNGSVSIHLYGPSQVSRQK 177
              E+  L  ++H N++ LL                +  ++    ++      + V  QK
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN------NIVKCQK 117

Query: 178 LEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 237
           L   H   +     +GL ++H  S  ++H+D K +N+ V+ED   K+ D GL        
Sbjct: 118 LTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 175

Query: 238 VAGPSSQV-TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE------------- 283
               +++   A EI L      +  +++  D++S G  + EL++GR              
Sbjct: 176 TGYVATRWYRAPEIML-----NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230

Query: 284 -ASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSE 342
                 +P +        +++R++   L  + +  ++          + L+ + L   S+
Sbjct: 231 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD 290

Query: 343 RRPSMSDV 350
           +R + +  
Sbjct: 291 KRITAAQA 298

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (264), Expect = 1e-26
 Identities = 58/286 (20%), Positives = 98/286 (34%), Gaps = 35/286 (12%)

Query: 76  EELSLATKNFSDKNLIGEGKFGEVYKGLL----QDGMLVAIKK-------RPGAPTQEFI 124
           E++ +  +NF    ++G G +G+V+          G L A+K        +    T+   
Sbjct: 19  EKVGI--ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR 76

Query: 125 DEVCFLASIQHR-NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR 183
            E   L  I+    LVTL    Q      LI +YI  G +  HL       R++      
Sbjct: 77  TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS-----QRERFTEHEV 131

Query: 184 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 243
                     L HLH L   ++++D K  N+L+D +    + D GL       +      
Sbjct: 132 QIYVGEIVLALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD 189

Query: 244 QVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 302
                E      V+       +  D +S GV + EL++G    +     +SQ   E+ + 
Sbjct: 190 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRR 247

Query: 303 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMS 348
                      +       +         LI R L    ++R    
Sbjct: 248 ILKS-------EPPYPQEMS----ALAKDLIQRLLMKDPKKRLGCG 282

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  100 bits (249), Expect = 3e-24
 Identities = 44/307 (14%), Positives = 92/307 (29%), Gaps = 47/307 (15%)

Query: 90  LIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 146
            +G G F  V+    + +   VA+K  +     T+   DE+  L  +   +         
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79

Query: 147 ENNLQFLIYEYIPNGSVSI-----------HLYGPSQVSRQKLEFKHRLSIALGAAKGLA 195
            + L+ L +      +               L    +   + +   +   I+     GL 
Sbjct: 80  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139

Query: 196 HLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 254
           ++H     ++H D K  NVL++  D    +    + +           +       + + 
Sbjct: 140 YMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSP 198

Query: 255 EVKEFRRFSEKSDVYSFGVFLLELVSGR---EASSSLSPDSSQD---------------L 296
           EV     +   +D++S    + EL++G    E     S     D               L
Sbjct: 199 EVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYL 258

Query: 297 VELVQNSRDFSNLLKILDE-------------RLWSTFTNEGMEEFIQLIVRCLDPSSER 343
           +   + +R F N   +L                    F+ +  +E    +   L     +
Sbjct: 259 LRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 318

Query: 344 RPSMSDV 350
           R     +
Sbjct: 319 RADAGGL 325

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.9 bits (245), Expect = 9e-24
 Identities = 58/305 (19%), Positives = 105/305 (34%), Gaps = 50/305 (16%)

Query: 83  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHR 136
           K + +   IG G  G V           VAIKK     +     +    E+  +  + H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 137 NLVTLLGYC------QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 190
           N+++LL         +E    +L+ E +      +         + +L+ +    +    
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI--------QMELDHERMSYLLYQM 128

Query: 191 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 250
             G+ HLHS    ++H+D K +N++V  D   K+ D GL    G +      +       
Sbjct: 129 LCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRY 183

Query: 251 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGR----------------EASSSLSPDSSQ 294
           + A EV     + E  D++S G  + E+V  +                E   +  P+  +
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243

Query: 295 DLVELVQN---------SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP 345
            L   V+N            F  L         S        +   L+ + L     +R 
Sbjct: 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303

Query: 346 SMSDV 350
           S+ D 
Sbjct: 304 SVDDA 308

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 76.0 bits (186), Expect = 8e-17
 Identities = 34/211 (16%), Positives = 63/211 (29%), Gaps = 47/211 (22%)

Query: 89  NLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT------------QEFIDEVCFLASIQH 135
            L+GEGK   V+    +      +K  + G  +              F       A  + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 136 RNLVTLLGYCQENNLQF----LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA 191
           R L  L G        +    ++ E I    +                 ++   +     
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV------------RVENPDEVLDMIL 113

Query: 192 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF 251
           + +A  +     +VH D    NVLV E+ I  + D            +    +    E  
Sbjct: 114 EEVAKFY--HRGIVHGDLSQYNVLVSEEGI-WIIDFPQ---------SVEVGEEGWRE-I 160

Query: 252 LASEVKEF-----RRFSEKSDVYSFGVFLLE 277
           L  +V+       R +  + D+ S    +L+
Sbjct: 161 LERDVRNIITYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	386
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.41
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.31
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.59
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.07
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.9
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.69

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-57  Score=406.02  Aligned_cols=255  Identities=27%  Similarity=0.426  Sum_probs=202.5

Q ss_pred             cCCCcCCeecccCceEEEEEEeCCCcEEEEEECCC--CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecC
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPG--APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      ++|+..+.||+|+||+||+|.+.+++.||||++..  ...+++.+|+++++.++||||++++|++...+..++||||+++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~   84 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH   84 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence            57888899999999999999998888999998654  3456799999999999999999999999999999999999999


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  240 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~  240 (386)
                      |+|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus        85 g~L~~~l~~----~~~~~~~~~~~~i~~qia~gl~~lH~--~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~  157 (263)
T d1sm2a_          85 GCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T  157 (263)
T ss_dssp             CBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHhhhc--cceeecccchhheeecCCCCeEecccchheeccCCCc-e
Confidence            999998753    34568899999999999999999999  7799999999999999999999999999987754322 2


Q ss_pred             CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCC-CCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcc
Q 016588          241 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE-ASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS  319 (386)
Q Consensus       241 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (386)
                      ......+|..|+|||++.+..|+.++|||||||++|||+|+.. |+....   .......+..             ..+.
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~---~~~~~~~i~~-------------~~~~  221 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVEDIST-------------GFRL  221 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC---HHHHHHHHHH-------------TCCC
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC---HHHHHHHHHh-------------cCCC
Confidence            2334568889999999999999999999999999999999654 444322   2222222221             1122


Q ss_pred             cCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          320 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      ..+..+++++.+++.+||+.||++|||++|++++|+++++.
T Consensus       222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence            33344567799999999999999999999999999998764

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-57  Score=408.55  Aligned_cols=260  Identities=25%  Similarity=0.428  Sum_probs=204.7

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ..++|++.+.||+|+||+||+|.++.  .||||++...     ..+.|.+|+.++++++||||+++++++.. +..++||
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~   82 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT   82 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence            35689999999999999999998753  5999986432     23578899999999999999999998765 4578999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++|+|.+++..    ....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++....
T Consensus        83 Ey~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~gl~yLH~--~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~  156 (276)
T d1uwha_          83 QWCEGSSLYHHLHI----IETKFEMIKLIDIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR  156 (276)
T ss_dssp             ECCCEEEHHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred             ecCCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHhc--CCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence            99999999998853    23568999999999999999999999  7799999999999999999999999999988765


Q ss_pred             CCCCCCCccccCcccccchhhhcc---cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEF---RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      ...........||+.|+|||++.+   ..|+.++|||||||++|||+||+.||.+..+.  ......+........    
T Consensus       157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~--~~~~~~~~~~~~~p~----  230 (276)
T d1uwha_         157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIFMVGRGYLSPD----  230 (276)
T ss_dssp             ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHHTSCCCC----
T ss_pred             cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH--HHHHHHHhcCCCCCc----
Confidence            444444456678999999999864   35899999999999999999999999875542  222222222111111    


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                           ....+.++++++.+++.+||+.||++|||+.|++++|+.+.+.
T Consensus       231 -----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         231 -----LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             -----GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -----chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence                 1123344557799999999999999999999999999988753

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.9e-56  Score=408.89  Aligned_cols=261  Identities=25%  Similarity=0.461  Sum_probs=204.1

Q ss_pred             cCCCcCCeecccCceEEEEEEeCC-C---cEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQD-G---MLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      ++|+..+.||+|+||+||+|.++. +   ..||||......    .++|.+|+++|++++||||++++|++...+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            457778899999999999999653 2   368999865432    24688999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      |||+++|+|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+||||+.++++||+|||+++.+.
T Consensus       106 ~Ey~~~g~L~~~~~~----~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLAD--MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             EECCTTEEHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEecCCCcceeeecc----ccCCCCHHHHHHHHHHHHHHHHHHhh--CCCccCccccceEEECCCCcEEECCcccceEcc
Confidence            999999999988742    34568999999999999999999999  779999999999999999999999999998775


Q ss_pred             CCCCCC---CCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          235 RTDVAG---PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       235 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      ......   ......+|+.|+|||.+.+..|+.++|||||||++|||+| |..||.+...   .++...+.         
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~~~~~~i~---------  247 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---QDVINAIE---------  247 (299)
T ss_dssp             ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHH---------
T ss_pred             CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH---HHHHHHHH---------
Confidence            432221   1223457889999999999999999999999999999998 8999986543   22222221         


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhcccc
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLT  365 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~~~~  365 (386)
                          ...+...+..+++++.+|+.+||+.||++|||+.|+++.|+++++.+.++.
T Consensus       248 ----~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~slk  298 (299)
T d1jpaa_         248 ----QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLK  298 (299)
T ss_dssp             ----TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGT
T ss_pred             ----cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcChhhCC
Confidence                122233445566789999999999999999999999999999998765543

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.9e-57  Score=411.93  Aligned_cols=260  Identities=25%  Similarity=0.418  Sum_probs=215.2

Q ss_pred             HHhcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC--ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           80 LATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        80 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      ...++|++.+.||+|+||+||+|.++ +++.||||+++..  ..+++.+|+.++++++||||+++++++.+.+..++|||
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence            34567888899999999999999975 4889999986543  45679999999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      |+++|+|.+++...   ....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++.....
T Consensus        94 ~~~~g~l~~~l~~~---~~~~~~~~~~~~i~~qi~~gL~yLH~--~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          94 FMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             CCTTCBHHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred             cccCcchHHHhhhc---cccchHHHHHHHHHHHHHHHHHHHHH--CCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence            99999999888532   34678999999999999999999999  77999999999999999999999999999876542


Q ss_pred             CCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchh
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  316 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (386)
                      .. .......++..|+|||++.+..|+.++|||||||++|||++|..|+.....  .....+.             +...
T Consensus       169 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~~~~~-------------i~~~  232 (287)
T d1opja_         169 TY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYEL-------------LEKD  232 (287)
T ss_dssp             SS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHHH-------------HHTT
T ss_pred             Cc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--HHHHHHH-------------HhcC
Confidence            22 122334577889999999999999999999999999999998777654332  1222222             2222


Q ss_pred             hcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          317 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      .....+..+++++.+|+.+||+.||++|||+.|+++.|+.+.++
T Consensus       233 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            33344555667899999999999999999999999999988765

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-56  Score=403.17  Aligned_cols=250  Identities=21%  Similarity=0.296  Sum_probs=204.8

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      ++|++.+.||+|+||+||+|..+ +++.||||++...    ..+.+.+|++++++++||||+++++++.+.+..|+||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            57889999999999999999965 5899999985432    235688999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +++|+|.+++.     ....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++......
T Consensus        85 ~~gg~L~~~l~-----~~~~l~e~~~~~i~~qi~~al~ylH~--~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          85 CSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             CTTEEGGGGSB-----TTTBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCcHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHH--cCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            99999999984     34578999999999999999999999  779999999999999999999999999998875544


Q ss_pred             CCCCCccccCcccccchhhhcccCC-CcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchh
Q 016588          238 VAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  316 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (386)
                      .........||+.|+|||++.+..+ +.++||||+||++|||++|+.||........  .........            
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~~~~~~~~~------------  223 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWKEKK------------  223 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH--HHHHHHTTC------------
T ss_pred             ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH--HHHHHhcCC------------
Confidence            3344456789999999999988876 5789999999999999999999986553221  111111110            


Q ss_pred             hcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          317 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .........++++.+++.+||+.||++|||++|++++
T Consensus       224 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         224 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            0011112334668999999999999999999999764

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-55  Score=394.06  Aligned_cols=252  Identities=25%  Similarity=0.421  Sum_probs=213.4

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCCCcEEEEEECC--CCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeec
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRP--GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  159 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  159 (386)
                      .++|+..+.||+|+||+||+|.+++++.||||.++  ....+++.+|+.+++.++||||++++|++.+.+..++||||++
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            36889999999999999999999888899999854  3456789999999999999999999999999999999999999


Q ss_pred             CCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016588          160 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  239 (386)
Q Consensus       160 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~  239 (386)
                      +|+|..++..    ....+++..+.+++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+++....... 
T Consensus        83 ~g~l~~~~~~----~~~~~~~~~~~~i~~qi~~gl~~LH~--~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-  155 (258)
T d1k2pa_          83 NGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-  155 (258)
T ss_dssp             TEEHHHHHHS----GGGCCCHHHHHHHHHHHHHHHHHHHH--TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-
T ss_pred             CCcHHHhhhc----cccCCcHHHHHHHHHHHHHHHHHHhh--cCcccccccceeEEEcCCCcEEECcchhheeccCCCc-
Confidence            9999888743    34568899999999999999999999  7799999999999999999999999999987755332 


Q ss_pred             CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          240 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       240 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                      .......+|..|+|||.+.+..|+.++|||||||++|||+| |+.||.....   .+....+..             ..+
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~---~~~~~~i~~-------------~~~  219 (258)
T d1k2pa_         156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETAEHIAQ-------------GLR  219 (258)
T ss_dssp             CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHHHT-------------TCC
T ss_pred             eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH---HHHHHHHHh-------------CCC
Confidence            23345668889999999999999999999999999999998 7889987553   222222211             122


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHH
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  356 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~  356 (386)
                      ...+..+++++.+++.+||+.||++|||+++++++|.+
T Consensus       220 ~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            23344555789999999999999999999999999864

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-56  Score=403.94  Aligned_cols=257  Identities=26%  Similarity=0.428  Sum_probs=209.9

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCC--CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPG--APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      ..++|++.+.||+|+||+||+|.++++..||||++..  ...+.+.+|++++++++||||++++|++.+ +..++||||+
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            3467888899999999999999998888999998654  345679999999999999999999998865 4568999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++|+|.+++...   ....+++..++.++.|++.||.|||+  ++|+||||||+||||++++.+||+|||+++.......
T Consensus        90 ~~g~L~~~~~~~---~~~~l~~~~~~~i~~qi~~gl~~lH~--~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~  164 (272)
T d1qpca_          90 ENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (272)
T ss_dssp             TTCBHHHHTTSH---HHHTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             CCCcHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCccchhheeeecccceeeccccceEEccCCcc
Confidence            999999877432   23468999999999999999999999  7799999999999999999999999999998754322


Q ss_pred             CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                       .......+|+.|+|||++.+..|+.++|||||||++|||+||..|+.....  .......+.             ...+
T Consensus       165 -~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~~~i~-------------~~~~  228 (272)
T d1qpca_         165 -TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQNLE-------------RGYR  228 (272)
T ss_dssp             -ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHH-------------TTCC
T ss_pred             -ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHHHHHHH-------------hcCC
Confidence             223345688899999999999999999999999999999997665543322  122222221             1122


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhh
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD  359 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~  359 (386)
                      ...+..+++++.+|+.+||+.||++|||+.++++.|++...
T Consensus       229 ~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            23344556789999999999999999999999999988653

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-55  Score=398.16  Aligned_cols=262  Identities=26%  Similarity=0.452  Sum_probs=206.1

Q ss_pred             cCCCcCCeecccCceEEEEEEeCCC-----cEEEEEECCCCCh----hHHHHHHHHHHcCCCCcccccccceeeCCeEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQDG-----MLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (386)
                      +.|+..++||+|+||+||+|.++..     ..||||++.....    .+|.+|+.++++++||||++++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4677789999999999999996542     4799998654432    358899999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      ||||+.++++.+.+..    ....+++..+..++.|++.||.|||+  ++|+||||||+||||+.++.+||+|||+++..
T Consensus        87 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~~i~~gl~~lH~--~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          87 ITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEECCTTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEecccCcchhhhhc----ccccccHHHHHHHHHHHHHhhhhccc--cccccCccccceEEECCCCeEEEcccchhhcc
Confidence            9999999999887632    34568999999999999999999999  77999999999999999999999999999876


Q ss_pred             CCCCC-CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          234 GRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       234 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      ..... ........+|..|+|||++.+..|+.++|||||||++|||++|..|+.....  .......             
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~~~~~~~-------------  225 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEVMKA-------------  225 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHH-------------
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--HHHHHHH-------------
Confidence            54322 2223345678899999999999999999999999999999997666554322  1222222             


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhcccc
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLT  365 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~~~~  365 (386)
                      +....+...+..+++++.+|+.+||+.||++|||+.|+++.|+++++.+.++.
T Consensus       226 i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~~l~  278 (283)
T d1mqba_         226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK  278 (283)
T ss_dssp             HHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGG
T ss_pred             HhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCccccc
Confidence            22223334555566789999999999999999999999999999988765554

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-55  Score=394.94  Aligned_cols=243  Identities=26%  Similarity=0.380  Sum_probs=205.9

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECC------CCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ++|++.+.||+|+||+||+|..+ +++.||+|++.      ....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46888999999999999999975 58899999753      334567889999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++|+|.+++.     ....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++....
T Consensus        86 Ey~~~g~L~~~l~-----~~~~l~e~~~~~i~~qi~~al~~lH~--~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          86 EYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             ECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             eecCCCcHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeeeeccccceecCCCCEeecccceeeecCC
Confidence            9999999998883     34568999999999999999999999  7799999999999999999999999999987643


Q ss_pred             CCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      .    ......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+...   ......+.+.            
T Consensus       159 ~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~------------  219 (263)
T d2j4za1         159 S----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---QETYKRISRV------------  219 (263)
T ss_dssp             C----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTT------------
T ss_pred             C----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH---HHHHHHHHcC------------
Confidence            2    23456789999999999999999999999999999999999999976432   2222211111            


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                        ....+...++++.+++.+||+.||++|||++|+++|
T Consensus       220 --~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         220 --EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             --CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence              012333455778999999999999999999999975

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-55  Score=396.17  Aligned_cols=247  Identities=22%  Similarity=0.363  Sum_probs=205.6

Q ss_pred             cCCCcCCeecccCceEEEEEEe-CCCcEEEEEECC---CCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      ++|+..+.||+|+||+||+|.. .+++.||||++.   ....+.+.+|+.+++.++||||+++++++.+.+..|+||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            4799999999999999999995 468999999743   234567899999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++|+|.+++.      ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+++.+.... 
T Consensus       100 ~gg~L~~~~~------~~~l~~~~~~~i~~qi~~aL~yLH~--~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-  170 (293)
T d1yhwa1         100 AGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-  170 (293)
T ss_dssp             TTCBHHHHHH------HSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred             CCCcHHHHhh------ccCCCHHHHHHHHHHHHHHHHHHHH--CCCcccCCcHHHeEECCCCcEeeccchhheeecccc-
Confidence            9999988763      3468999999999999999999999  779999999999999999999999999998765422 


Q ss_pred             CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          239 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                       .......||+.|+|||++.+..|+.++|||||||++|||++|..||.+....  ..+........            ..
T Consensus       171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~~~~~~~------------~~  235 (293)
T d1yhwa1         171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYLIATNGT------------PE  235 (293)
T ss_dssp             -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHHCS------------CC
T ss_pred             -ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH--HHHHHHHhCCC------------CC
Confidence             2234567999999999999999999999999999999999999999764421  11111111100            01


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ...+...++++.+++.+||+.||++|||+.|+++|
T Consensus       236 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            12233455778999999999999999999999875

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-54  Score=394.26  Aligned_cols=255  Identities=25%  Similarity=0.403  Sum_probs=208.5

Q ss_pred             cCCCcCCe-ecccCceEEEEEEeC---CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEE
Q 016588           83 KNFSDKNL-IGEGKFGEVYKGLLQ---DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        83 ~~~~~~~~-lg~G~~g~V~~~~~~---~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      ++|...+. ||+|+||+||+|.++   ++..||||.++...    .++|.+|++++++++||||++++|++.+ +..|+|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            44555664 999999999999864   35579999865433    3468899999999999999999999865 457899


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      |||+++|+|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.+.
T Consensus        87 mE~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~gL~ylH~--~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          87 MEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             EECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEeCCCCcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCcCchhheeeccCCceeeccchhhhccc
Confidence            999999999998742    34568999999999999999999999  779999999999999999999999999998875


Q ss_pred             CCCC-CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          235 RTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       235 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      .... ........+|+.|+|||++.+..++.++|||||||++|||+| |..||.+....   +....+..          
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~~i~~----------  227 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIEQ----------  227 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHHHT----------
T ss_pred             ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHHHHHc----------
Confidence            4332 223334568889999999999999999999999999999998 89999875532   22222221          


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                         ..+...+..+++++.+|+.+||+.||++|||+.++++.|+.....
T Consensus       228 ---~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         228 ---GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             ---TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence               222344556677899999999999999999999999999877654

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-55  Score=405.25  Aligned_cols=258  Identities=25%  Similarity=0.385  Sum_probs=208.7

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeCC-C-----cEEEEEECCC----CChhHHHHHHHHHHcC-CCCcccccccceeeCC
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQD-G-----MLVAIKKRPG----APTQEFIDEVCFLASI-QHRNLVTLLGYCQENN  149 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  149 (386)
                      ..++|++.+.||+|+||+||+|.... +     ..||+|....    .....+.+|+.++.++ +||||+++++++.+.+
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            44678889999999999999999643 2     3689997543    2345688999999998 8999999999999999


Q ss_pred             eEEEEEEeecCCCccccccCCCc------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCC
Q 016588          150 LQFLIYEYIPNGSVSIHLYGPSQ------------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKT  211 (386)
Q Consensus       150 ~~~lv~e~~~~g~L~~~l~~~~~------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp  211 (386)
                      ..|+||||+++|+|.+++.....                  .....+++..++.++.|++.||+|||+  ++|+||||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~--~~IiHRDlKp  192 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAA  192 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH--TTEEETTCSG
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCch
Confidence            99999999999999999864321                  112458899999999999999999999  7799999999


Q ss_pred             CCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCC
Q 016588          212 ANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP  290 (386)
Q Consensus       212 ~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~  290 (386)
                      +|||++.++.+||+|||+|+...............+|+.|+|||++.+..|+.++|||||||++|||+| |..||.+...
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987654333323334567899999999999999999999999999999998 8999987554


Q ss_pred             CchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016588          291 DSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  355 (386)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~  355 (386)
                      ..  .+...+.             ...+...+..+++++.+|+.+||+.||++|||++||+++|.
T Consensus       273 ~~--~~~~~~~-------------~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 DA--NFYKLIQ-------------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SH--HHHHHHH-------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HH--HHHHHHh-------------cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            21  1222221             22223445556678999999999999999999999999985

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-54  Score=392.23  Aligned_cols=248  Identities=23%  Similarity=0.365  Sum_probs=200.8

Q ss_pred             CeecccCceEEEEEEeCC---CcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeecC
Q 016588           89 NLIGEGKFGEVYKGLLQD---GMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  160 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  160 (386)
                      +.||+|+||+||+|.+++   ++.||||+++...     .+++.+|++++++++||||++++|+|.++ ..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            479999999999998643   4689999865332     34689999999999999999999998654 56899999999


Q ss_pred             CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC-C
Q 016588          161 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV-A  239 (386)
Q Consensus       161 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~-~  239 (386)
                      |+|.+++.     ....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus        92 g~L~~~l~-----~~~~l~~~~~~~i~~qi~~gl~ylH~--~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          92 GPLNKYLQ-----QNRHVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EEHHHHHH-----HCTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CcHHHHHh-----hccCCCHHHHHHHHHHHHHHHhhHHh--CCcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            99999884     34568999999999999999999999  7799999999999999999999999999987654322 2


Q ss_pred             CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          240 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       240 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                      .......+|+.|+|||.+.+..|+.++|||||||++|||++ |..||.+...   .+....+.             ...+
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~~~~~i~-------------~~~~  228 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLE-------------KGER  228 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHH-------------TTCC
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---HHHHHHHH-------------cCCC
Confidence            22334568889999999999999999999999999999998 8999987542   22222222             1222


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      ...+..+++++.+|+.+||+.||++|||++++++.|+....+
T Consensus       229 ~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence            344555667899999999999999999999999988876543

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-55  Score=396.44  Aligned_cols=252  Identities=23%  Similarity=0.369  Sum_probs=192.9

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceee--CCeEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQFLI  154 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv  154 (386)
                      ++|++.+.||+|+||+||+|..+ +++.||+|.+....     .+.+.+|++++++++||||+++++++.+  ++..|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            57889999999999999999964 58999999865432     2357899999999999999999998864  4568999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC---CCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS---PRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      |||+++|+|.+++.... .....+++..++.++.|++.||.|||+.+   ++|+||||||+|||++.++.+||+|||+++
T Consensus        84 mEy~~~g~L~~~i~~~~-~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          84 MEYCEGGDLASVITKGT-KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EECCTTEEHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EecCCCCcHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            99999999999874321 12456899999999999999999999732   349999999999999999999999999998


Q ss_pred             ccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhh
Q 016588          232 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK  311 (386)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (386)
                      ......  .......||+.|+|||++.+..|+.++|||||||++|||++|..||.+...   .++...+...        
T Consensus       163 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---~~~~~~i~~~--------  229 (269)
T d2java1         163 ILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGKIREG--------  229 (269)
T ss_dssp             HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHT--------
T ss_pred             ecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH---HHHHHHHHcC--------
Confidence            875422  223346789999999999999999999999999999999999999986442   2222222111        


Q ss_pred             hcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          312 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                           .....+...++++.+++.+||+.||++|||+.|++++
T Consensus       230 -----~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         230 -----KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             -----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -----CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                 1112333455679999999999999999999999875

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-55  Score=397.66  Aligned_cols=247  Identities=17%  Similarity=0.229  Sum_probs=203.8

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECC------CCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ++|++.+.||+|+||+||+|... +++.||||++.      ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            46889999999999999999964 68999999753      344567899999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++|+|.+++.     ....+++..+..++.|++.||+|||+  ++|+||||||+|||+++++.+||+|||+++.+..
T Consensus        88 Ey~~gg~L~~~~~-----~~~~l~e~~~~~~~~qi~~al~ylH~--~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          88 SYAKNGELLKYIR-----KIGSFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             CCCTTEEHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EccCCCCHHHhhh-----ccCCCCHHHHHHHHHHHHHHHHhhcc--ccEEcCcCCccccccCCCceEEecccccceeccc
Confidence            9999999998873     34678999999999999999999999  7799999999999999999999999999998765


Q ss_pred             CCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      ...........||+.|+|||++.+..|+.++|||||||++|||++|..||.+.++   ..+...+...            
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~~~i~~~------------  225 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIFQKIIKL------------  225 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHTT------------
T ss_pred             CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH---HHHHHHHHcC------------
Confidence            4444444556799999999999999999999999999999999999999986432   1222111110            


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .  ..++...++++.+|+.+||+.||++|||++|++++
T Consensus       226 ~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         226 E--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             C--CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             C--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence            0  12333445678999999999999999999998754

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-54  Score=393.27  Aligned_cols=249  Identities=23%  Similarity=0.333  Sum_probs=202.7

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC---ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      +.|++.+.||+|+||+||+|... ++..||+|+++..   ..+.+.+|++++++++||||+++++++.+.+..|+||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46788899999999999999965 5889999985432   3457889999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++|+|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++...... 
T Consensus        92 ~~g~L~~~~~~----~~~~l~e~~~~~i~~qi~~gL~ylH~--~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-  164 (288)
T d2jfla1          92 AGGAVDAVMLE----LERPLTESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-  164 (288)
T ss_dssp             TTEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred             CCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCEEEeecChhheeECCCCCEEEEechhhhccCCCc-
Confidence            99999988732    24568999999999999999999999  779999999999999999999999999987653211 


Q ss_pred             CCCCccccCcccccchhhhc-----ccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhc
Q 016588          239 AGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  313 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (386)
                       .......||+.|+|||++.     +..|+.++|||||||++|||++|..||.+..+..   ....+....         
T Consensus       165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~~~~i~~~~---------  231 (288)
T d2jfla1         165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---VLLKIAKSE---------  231 (288)
T ss_dssp             -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHHHHHHSC---------
T ss_pred             -ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---HHHHHHcCC---------
Confidence             1123457899999999984     4568999999999999999999999998755321   111111110         


Q ss_pred             chhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                        ......+...++++.+++.+||+.||++|||++|+++|
T Consensus       232 --~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         232 --PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             --CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             --CCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              00112233455779999999999999999999999875

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=401.21  Aligned_cols=262  Identities=19%  Similarity=0.264  Sum_probs=203.3

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC----CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      .++|+..+.||+|+||+||+|... +++.||+|++..    ...+.+.+|+.+|+.++||||+++++++.+.+..|+|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            568999999999999999999964 689999998532    224568899999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      |+++|+|.+++.     ....+++..+..++.|++.||.|||+. ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus        85 y~~gg~L~~~l~-----~~~~l~~~~~~~~~~qil~aL~yLH~~-~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          85 HMDGGSLDQVLK-----KAGRIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             CCTTEEHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHH-HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             cCCCCcHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHh-CCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence            999999999884     345689999999999999999999962 37999999999999999999999999999876432


Q ss_pred             CCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhh-h-----------
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS-R-----------  304 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~-~-----------  304 (386)
                          ......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+................ .           
T Consensus       159 ----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         159 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             ----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             ----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence                123467999999999999999999999999999999999999999875532211000000000 0           


Q ss_pred             -----------cccchhhhcch---hhcccCC-HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          305 -----------DFSNLLKILDE---RLWSTFT-NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       305 -----------~~~~~~~~~~~---~~~~~~~-~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                                 ......+..+.   ......+ ...+.++.+++.+||+.||++|||++|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                       00000000000   0000111 1234678999999999999999999999986

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-54  Score=390.13  Aligned_cols=257  Identities=26%  Similarity=0.420  Sum_probs=205.4

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCC--ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEeec
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  159 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  159 (386)
                      .++|++.+.||+|+||+||+|..+++..||||++...  ..+.|.+|+.++++++||||++++|++.+ +..++||||++
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            4678899999999999999999988888999986544  34679999999999999999999999865 55789999999


Q ss_pred             CCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016588          160 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  239 (386)
Q Consensus       160 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~  239 (386)
                      +|+|..++...   ....+++..++.++.|++.||+|||+  ++|+||||||+||||+.++++||+|||+++....... 
T Consensus        95 ~g~l~~~~~~~---~~~~l~~~~~~~i~~~i~~gl~~LH~--~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-  168 (285)
T d1fmka3          95 KGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-  168 (285)
T ss_dssp             TCBHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             CCchhhhhhhc---ccccchHHHHHHHHHHHHHHHHHHhh--hheecccccceEEEECCCCcEEEcccchhhhccCCCc-
Confidence            99998887532   23568999999999999999999999  7799999999999999999999999999987654322 


Q ss_pred             CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhcc
Q 016588          240 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS  319 (386)
Q Consensus       240 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (386)
                      .......+|+.|+|||++....++.++|||||||++|||++|+.|+.....  .......+.             ...+.
T Consensus       169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~~~i~-------------~~~~~  233 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVE-------------RGYRM  233 (285)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHH-------------TTCCC
T ss_pred             eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHHHHHHH-------------hcCCC
Confidence            223345688999999999999999999999999999999997776655332  222222221             11222


Q ss_pred             cCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          320 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       320 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      +.+..+++++.+++.+||+.||++|||+++|++.|++....
T Consensus       234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence            34455667899999999999999999999999998886644

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.9e-54  Score=395.57  Aligned_cols=242  Identities=26%  Similarity=0.394  Sum_probs=198.4

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC------hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      .|+..+.||+|+||+||+|... +++.||||++....      .+.+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4888999999999999999954 68899999854332      2357899999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      ||.+|+|..++.     ....+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+++.... 
T Consensus        96 ~~~~g~l~~~~~-----~~~~l~e~~~~~i~~qi~~aL~yLH~--~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          96 YCLGSASDLLEV-----HKKPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             CCSEEHHHHHHH-----HTSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             ecCCCchHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence            999999876552     34678999999999999999999999  7799999999999999999999999999986543 


Q ss_pred             CCCCCCccccCcccccchhhhcc---cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhc
Q 016588          237 DVAGPSSQVTADEIFLASEVKEF---RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  313 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (386)
                           .....||+.|+|||++.+   ..|+.++|||||||++|||++|..||.+...  ...+......           
T Consensus       168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~--~~~~~~i~~~-----------  229 (309)
T d1u5ra_         168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQN-----------  229 (309)
T ss_dssp             -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHS-----------
T ss_pred             -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhC-----------
Confidence                 234579999999999864   4589999999999999999999999976442  1111111110           


Q ss_pred             chhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                        ......+...++++.+++.+||+.||++|||++|+++|
T Consensus       230 --~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         230 --ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             --CCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             --CCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence              01111122345679999999999999999999999874

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.9e-54  Score=393.85  Aligned_cols=265  Identities=26%  Similarity=0.398  Sum_probs=213.4

Q ss_pred             HHHHHhcCCCcCCeecccCceEEEEEEeC------CCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCccccccccee
Q 016588           77 ELSLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQ  146 (386)
Q Consensus        77 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~  146 (386)
                      +++...++|++.+.||+|+||+||+|..+      +++.||||++....    .+++.+|+.+++.++||||+++++++.
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            34445678999999999999999999864      35789999976543    345899999999999999999999999


Q ss_pred             eCCeEEEEEEeecCCCccccccCCC-------------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceec
Q 016588          147 ENNLQFLIYEYIPNGSVSIHLYGPS-------------------QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHK  207 (386)
Q Consensus       147 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~  207 (386)
                      ..+..+++|||+++|+|.+++....                   ......+++..++.++.|++.||+|||+  ++|+||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~--~~ivHr  164 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHR  164 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCS
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc--CCeEee
Confidence            9999999999999999998874321                   1123458899999999999999999999  779999


Q ss_pred             CCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCC-CCCC
Q 016588          208 DFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR-EASS  286 (386)
Q Consensus       208 dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~-~p~~  286 (386)
                      ||||+|||+|.++.+||+|||+++...............+++.|+|||.+.+..|+.++|||||||++|||++|. .||.
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence            999999999999999999999998765544444444566788899999999999999999999999999999986 5666


Q ss_pred             CCCCCchhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhh
Q 016588          287 SLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD  359 (386)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~  359 (386)
                      ...+   ......+..             ..+...+..+++++.+|+.+||+.||++||||.||++.|+++.+
T Consensus       245 ~~~~---~e~~~~v~~-------------~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         245 GMAH---EEVIYYVRD-------------GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             TSCH---HHHHHHHHT-------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CCCH---HHHHHHHHc-------------CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            5432   222222211             11223444556789999999999999999999999999998864

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-54  Score=388.69  Aligned_cols=256  Identities=26%  Similarity=0.440  Sum_probs=199.7

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCC----CcEEEEEECCCCCh----hHHHHHHHHHHcCCCCcccccccceeeCCeEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (386)
                      .++|++.+.||+|+||+||+|.+..    +..||||..+....    +.+.+|+.++++++||||++++|++.+ +..|+
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence            4678889999999999999998643    35689998654332    458899999999999999999999864 56899


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      ||||+++|+|.+++..    ....+++..++.++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||+++..
T Consensus        85 v~E~~~~g~l~~~~~~----~~~~l~~~~~~~~~~qi~~gl~ylH~--~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          85 IMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             EEECCTTEEHHHHHHH----TTTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEeccCCcHHhhhhc----cCCCCCHHHHHHHHHHHHHHhhhhcc--cCeeccccchhheeecCCCcEEEccchhheec
Confidence            9999999999887642    34568999999999999999999999  77999999999999999999999999999876


Q ss_pred             CCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          234 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       234 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      ..... .......+|+.|+|||++.+..|+.++|||||||++|||++ |..||......   .+...+...         
T Consensus       159 ~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~~i~~~---------  225 (273)
T d1mp8a_         159 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIENG---------  225 (273)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHHTT---------
T ss_pred             cCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHHHHHcC---------
Confidence            54322 22344567889999999999999999999999999999998 88888875532   222222211         


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                          .+...+..+++++.+|+.+||+.||++|||+.|++++|++++++.
T Consensus       226 ----~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  270 (273)
T d1mp8a_         226 ----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  270 (273)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence                122344456678999999999999999999999999999998763

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-53  Score=392.40  Aligned_cols=256  Identities=25%  Similarity=0.427  Sum_probs=206.4

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCc----EEEEEECCC----CChhHHHHHHHHHHcCCCCcccccccceeeCCeEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGM----LVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  153 (386)
                      .+|+..+.||+|+||+||+|.+. +++    +||+|++..    ...+++.+|++++++++||||++++|+|.+++ .++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-eeE
Confidence            46889999999999999999964 343    689997543    23567999999999999999999999998754 578


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      ++||+.+|+|.+++.    .....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++..
T Consensus        88 v~e~~~~~~l~~~~~----~~~~~~~~~~~~~i~~qi~~gl~yLH~--~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          88 ITQLMPFGCLLDYVR----EHKDNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EEECCTTCBHHHHHH----HTSSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             EEEeccCCccccccc----ccccCCCHHHHHHHHHHHHHHHHHHHH--cCcccCcchhhcceeCCCCCeEeeccccceec
Confidence            889999999988774    235678999999999999999999999  77999999999999999999999999999987


Q ss_pred             CCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          234 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       234 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      .............+|+.|+|||++.+..|+.++|||||||++|||+| |..||.+....   .+...+.           
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---~~~~~i~-----------  227 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSILE-----------  227 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---GHHHHHH-----------
T ss_pred             ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH---HHHHHHH-----------
Confidence            65444444455668999999999999999999999999999999998 78888765432   2222222           


Q ss_pred             cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          313 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                        ...+...+..+++++.+|+.+||+.||++|||+.|++++|..+.+..
T Consensus       228 --~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~  274 (317)
T d1xkka_         228 --KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  274 (317)
T ss_dssp             --HTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSH
T ss_pred             --cCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhCh
Confidence              22223444556678999999999999999999999999999987653

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-54  Score=384.91  Aligned_cols=244  Identities=25%  Similarity=0.387  Sum_probs=193.9

Q ss_pred             CcCCeecccCceEEEEEEeC-CCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceee----CCeEEEEE
Q 016588           86 SDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE----NNLQFLIY  155 (386)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~  155 (386)
                      +..+.||+|+||+||+|... ++..||+|.+...     ..+.+.+|++++++++||||+++++++.+    .+..|+||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            45568999999999999965 5889999974322     23468899999999999999999999864    45679999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC-CCCceEEcccccccccC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLG  234 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~-~~~~~kl~DFgl~~~~~  234 (386)
                      ||+++|+|.+++.     ....+++..+..++.|++.||+|||+.+.+|+||||||+|||++ +++.+||+|||+++...
T Consensus        92 E~~~~g~L~~~l~-----~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          92 ELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             ECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCcHHHHHh-----ccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            9999999999883     34568999999999999999999998434499999999999996 57899999999998653


Q ss_pred             CCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                      ..    ......||+.|+|||++.+ .|+.++|||||||++|||++|+.||.....  ...+...+......        
T Consensus       167 ~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~--~~~~~~~i~~~~~~--------  231 (270)
T d1t4ha_         167 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGVKP--------  231 (270)
T ss_dssp             TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTCCC--------
T ss_pred             CC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc--HHHHHHHHHcCCCC--------
Confidence            32    2345679999999999875 699999999999999999999999976442  22222222111110        


Q ss_pred             hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .    ..+...++++.+++.+||+.||++|||++|+++|
T Consensus       232 ~----~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         232 A----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             G----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             c----ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence            0    1112233568999999999999999999999875

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-53  Score=390.22  Aligned_cols=269  Identities=23%  Similarity=0.363  Sum_probs=204.9

Q ss_pred             HHHHHHhcCCCcCCeecccCceEEEEEEeC------CCcEEEEEECCCCC----hhHHHHHHHHHHcC-CCCcccccccc
Q 016588           76 EELSLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGY  144 (386)
Q Consensus        76 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~~~~~  144 (386)
                      ..++...++|++.+.||+|+||.||+|...      +++.||||++....    .+.+.+|..++.++ +|+||+.++++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            344445578999999999999999999853      23689999876443    23467777878776 68999999998


Q ss_pred             eee-CCeEEEEEEeecCCCccccccCCCc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCC
Q 016588          145 CQE-NNLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTA  212 (386)
Q Consensus       145 ~~~-~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~  212 (386)
                      +.. ++..++||||+++|+|.+++.....           .....+++..+..++.|++.||.|||+  ++|+||||||+
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~--~~ivHrDlKp~  163 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAAR  163 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGG
T ss_pred             eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh--CCCcCCcCCcc
Confidence            765 4568999999999999998853321           123458899999999999999999999  77999999999


Q ss_pred             CeeeCCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCC-CCCCCCCCC
Q 016588          213 NVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR-EASSSLSPD  291 (386)
Q Consensus       213 Nill~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~-~p~~~~~~~  291 (386)
                      |||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|. .||......
T Consensus       164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~  243 (299)
T d1ywna1         164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  243 (299)
T ss_dssp             GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999998776544444455667999999999999999999999999999999999975 567654432


Q ss_pred             chhhHHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          292 SSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                        ..+...+.             ...+...+..+++++.+++.+||+.||++|||+.|++++|+++++..
T Consensus       244 --~~~~~~~~-------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n  298 (299)
T d1ywna1         244 --EEFCRRLK-------------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  298 (299)
T ss_dssp             --HHHHHHHH-------------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             --HHHHHHHh-------------cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence              11222111             12222344455677999999999999999999999999999998653

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=382.16  Aligned_cols=252  Identities=29%  Similarity=0.418  Sum_probs=202.0

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCC-ChhHHHHHHHHHHcCCCCcccccccceee-CCeEEEEEEeec
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQE-NNLQFLIYEYIP  159 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~  159 (386)
                      .++|++.+.||+|+||.||+|.++ +..||||+++.. ..+.+.+|++++++++||||++++|++.+ .+..|+||||++
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~   84 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   84 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence            356778899999999999999985 778999997554 35679999999999999999999998865 456899999999


Q ss_pred             CCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016588          160 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  239 (386)
Q Consensus       160 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~~  239 (386)
                      +|+|.+++...   ....+++..+++++.|++.||.|||+  ++|+||||||+|||++.++.+|++|||+++.....   
T Consensus        85 ~g~L~~~l~~~---~~~~l~~~~~~~i~~~i~~al~ylH~--~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---  156 (262)
T d1byga_          85 KGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  156 (262)
T ss_dssp             TEEHHHHHHHH---HHHHCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCHHHHHHhc---CCCCCCHHHHHHHHHHHHhhcccccc--CceeccccchHhheecCCCCEeecccccceecCCC---
Confidence            99999998532   23458999999999999999999999  77999999999999999999999999999875432   


Q ss_pred             CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchhhc
Q 016588          240 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  318 (386)
Q Consensus       240 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (386)
                        .....++..|+|||++.+..++.++|||||||++|||+| |..||.....   .+....+             ....+
T Consensus       157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~~i-------------~~~~~  218 (262)
T d1byga_         157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRV-------------EKGYK  218 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHH-------------TTTCC
T ss_pred             --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---HHHHHHH-------------HcCCC
Confidence              223456778999999999999999999999999999998 6777765442   2223222             22233


Q ss_pred             ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          319 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       319 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      .+.+..+++++.+++.+||+.||++|||+.+++++|+++...
T Consensus       219 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence            445555667899999999999999999999999999998754

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-53  Score=390.97  Aligned_cols=249  Identities=20%  Similarity=0.274  Sum_probs=191.2

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      .+.|++.+.||+|+||+||+|..+ +++.||||.+...    ....+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            356889999999999999999965 5899999985432    23457789999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC---CCCceEEccccccccc
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFL  233 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~---~~~~~kl~DFgl~~~~  233 (386)
                      |+++|+|.+++.     ....+++..+..++.|++.||+|||+  ++|+||||||+|||+.   +++.+||+|||+++..
T Consensus        88 ~~~gg~L~~~l~-----~~~~l~e~~~~~~~~qi~~al~ylH~--~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          88 LVSGGELFDRIV-----EKGFYTERDASRLIFQVLDAVKYLHD--LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCCSCBHHHHHH-----TCSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             ccCCCcHHHhhh-----cccCCCHHHHHHHHHHHHHHHHhhhh--ceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            999999999884     34578999999999999999999999  7799999999999994   5789999999999876


Q ss_pred             CCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhc
Q 016588          234 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  313 (386)
Q Consensus       234 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (386)
                      ....   ......||+.|+|||++.+..|+.++|||||||++|||++|..||.+...   ......+....         
T Consensus       161 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~~~i~~~~---------  225 (307)
T d1a06a_         161 DPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND---AKLFEQILKAE---------  225 (307)
T ss_dssp             ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHTTC---------
T ss_pred             cCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHhccC---------
Confidence            4322   23345799999999999999999999999999999999999999986432   22222221111         


Q ss_pred             chhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          314 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       314 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                       ...........++++.+++.+||+.||++|||++|+++|
T Consensus       226 -~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         226 -YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             -CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             -CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence             011112223445678999999999999999999999986

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.4e-52  Score=390.68  Aligned_cols=249  Identities=21%  Similarity=0.280  Sum_probs=204.5

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCCh---hHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      ++|++.+.||+|+||.||+|... +|+.||||++.....   +.+.+|+.+++.++||||+++++++.+.+..|+||||+
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            47899999999999999999964 689999998755433   45789999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC--CCCceEEcccccccccCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD--EDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~--~~~~~kl~DFgl~~~~~~~  236 (386)
                      ++|+|.+++..    ....+++..+..++.||+.||.|||+  ++|+||||||+|||++  .++.+||+|||+++.+...
T Consensus       106 ~gg~L~~~l~~----~~~~l~e~~~~~i~~qi~~aL~ylH~--~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         106 SGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CSCBHHHHHTC----TTSCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHh--cCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            99999988842    34568999999999999999999999  7799999999999995  4678999999999876542


Q ss_pred             CCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchh
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  316 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (386)
                         .......||+.|+|||++.+..|+.++|||||||++|||++|..||.+...   ......+......      ... 
T Consensus       180 ---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~~~~------~~~-  246 (350)
T d1koaa2         180 ---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETLRNVKSCDWN------MDD-  246 (350)
T ss_dssp             ---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCCC------SCC-
T ss_pred             ---cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCC------CCc-
Confidence               223456789999999999999999999999999999999999999976432   2222221111100      011 


Q ss_pred             hcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          317 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                         ......++++.+++.+||+.||++|||++|+++|
T Consensus       247 ---~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         247 ---SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             ---GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ---ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               1112334678999999999999999999999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-52  Score=384.01  Aligned_cols=258  Identities=26%  Similarity=0.453  Sum_probs=207.8

Q ss_pred             cCCCcCCeecccCceEEEEEEeCC-Cc--EEEEEECCC----CChhHHHHHHHHHHcC-CCCcccccccceeeCCeEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQD-GM--LVAIKKRPG----APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  154 (386)
                      ++|++.+.||+|+||+||+|.+++ +.  .||||++..    ...+++.+|+++|+++ +||||++++|++.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            578888999999999999999653 43  577887432    2345789999999998 799999999999999999999


Q ss_pred             EEeecCCCccccccCCC-----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceE
Q 016588          155 YEYIPNGSVSIHLYGPS-----------QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAK  223 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~k  223 (386)
                      |||+++|+|.+++....           ......+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+|
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~--~~iiHrDlkp~NIL~~~~~~~k  167 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAK  167 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECGGGCEE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc--CCccccccccceEEEcCCCceE
Confidence            99999999999985431           1234678999999999999999999999  7799999999999999999999


Q ss_pred             EcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCC-CCCCCCCCchhhHHHHHHh
Q 016588          224 VADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE-ASSSLSPDSSQDLVELVQN  302 (386)
Q Consensus       224 l~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~-p~~~~~~~~~~~~~~~~~~  302 (386)
                      |+|||+++.....   .......+|..|+|||.+.+..|+.++|||||||++|||++|.. ||.....   ..+...+  
T Consensus       168 l~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---~~~~~~i--  239 (309)
T d1fvra_         168 IADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKL--  239 (309)
T ss_dssp             ECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHG--
T ss_pred             Ecccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH---HHHHHHH--
Confidence            9999999865432   22234467889999999999999999999999999999999765 5654331   2222211  


Q ss_pred             hhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          303 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                                 ....+...+..+++++.+|+.+||+.||++|||++|++++|++++++.
T Consensus       240 -----------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         240 -----------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             -----------GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             -----------HhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence                       122233444556678999999999999999999999999999998763

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-52  Score=382.01  Aligned_cols=248  Identities=21%  Similarity=0.283  Sum_probs=203.0

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC---------ChhHHHHHHHHHHcCCCCcccccccceeeCCeEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  152 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  152 (386)
                      ++|++.+.||+|+||+||+|..+ +|+.||||++...         ..+.+.+|+.+|++++||||+++++++.+.+..|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            57899999999999999999964 6899999974321         2457899999999999999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC----ceEEcccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF----IAKVADAG  228 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~----~~kl~DFg  228 (386)
                      +||||+++|+|.+++.     ....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++    .+|++|||
T Consensus        90 iv~E~~~gg~L~~~i~-----~~~~l~~~~~~~~~~qi~~al~yLH~--~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          90 LILELVAGGELFDFLA-----EKESLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEcCCCccccchhc-----cccccchhHHHHHHHHHHHHHHhhhh--cceeecccccceEEEecCCCcccceEecchh
Confidence            9999999999999883     34578999999999999999999999  7799999999999998776    59999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccc
Q 016588          229 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN  308 (386)
Q Consensus       229 l~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  308 (386)
                      +++......   ......+|+.|+|||++.+..|+.++|||||||++|||++|+.||.+...   .+....+.....  .
T Consensus       163 ~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~~~i~~~~~--~  234 (293)
T d1jksa_         163 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANVSAVNY--E  234 (293)
T ss_dssp             TCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHTTCC--C
T ss_pred             hhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH---HHHHHHHHhcCC--C
Confidence            998775432   23345688899999999999999999999999999999999999986442   222221111110  0


Q ss_pred             hhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          309 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                          .....    +...++++.+++.+||+.||++|||++|+++|
T Consensus       235 ----~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         235 ----FEDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             ----CCHHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ----CCchh----cCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                00111    11234568999999999999999999999875

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-52  Score=384.24  Aligned_cols=265  Identities=23%  Similarity=0.373  Sum_probs=214.2

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeC------CCcEEEEEECCCCC----hhHHHHHHHHHHcC-CCCcccccccceeeCC
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQENN  149 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  149 (386)
                      ..++|++.+.||+|+||.||+|++.      ++..||||++....    ..++.+|+.+++.+ +||||+++++++.+.+
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence            3467888899999999999999852      35689999876443    23578899999999 6999999999999999


Q ss_pred             eEEEEEEeecCCCccccccCCCc-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee
Q 016588          150 LQFLIYEYIPNGSVSIHLYGPSQ-------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV  216 (386)
Q Consensus       150 ~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill  216 (386)
                      ..++||||+++|+|.+++.....             .....+++..+..++.|++.||+|||+  ++++||||||+|||+
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~--~~ivHrDLKp~NIl~  178 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILL  178 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccccccccc
Confidence            99999999999999988753321             123468899999999999999999999  779999999999999


Q ss_pred             CCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcC-CCCCCCCCCCchhh
Q 016588          217 DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG-REASSSLSPDSSQD  295 (386)
Q Consensus       217 ~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg-~~p~~~~~~~~~~~  295 (386)
                      +.++.+|++|||+++...............+|+.|+|||.+.+..++.++|||||||++|||+|+ .+|+......  ..
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~--~~  256 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--SK  256 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--HH
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH--HH
Confidence            99999999999999987654444444556788999999999999999999999999999999995 5555443321  11


Q ss_pred             HHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhhc
Q 016588          296 LVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  362 (386)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~~  362 (386)
                      +..             ++....+...+...++++.+|+.+||+.||++|||++++++.|++.+.+..
T Consensus       257 ~~~-------------~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~~  310 (311)
T d1t46a_         257 FYK-------------MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST  310 (311)
T ss_dssp             HHH-------------HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             HHH-------------HHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccCC
Confidence            111             222223334444556789999999999999999999999999999887754

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.7e-52  Score=389.09  Aligned_cols=249  Identities=19%  Similarity=0.259  Sum_probs=205.0

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC---hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      ++|++.+.||+|+||+||+|... +++.||||++....   ...+.+|+.+|+.++||||+++++++.+.+..|+|||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            57899999999999999999964 68999999865443   345788999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC--CCCceEEcccccccccCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD--EDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~--~~~~~kl~DFgl~~~~~~~  236 (386)
                      ++|+|.+++.    .....+++..+..++.||+.||.|||+  +||+||||||+|||++  .++.+||+|||+++.....
T Consensus       109 ~gg~L~~~~~----~~~~~l~e~~~~~i~~qi~~aL~ylH~--~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         109 SGGELFDRIA----AEDYKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCBHHHHTT----CTTCCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCChHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence            9999988763    234568999999999999999999999  7799999999999998  6789999999999887542


Q ss_pred             CCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchh
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  316 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (386)
                         .......+|+.|+|||++.+..|+.++|||||||++|||++|..||.+...   ......+....          ..
T Consensus       183 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~i~~~~----------~~  246 (352)
T d1koba_         183 ---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQNVKRCD----------WE  246 (352)
T ss_dssp             ---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHHCC----------CC
T ss_pred             ---CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCC----------CC
Confidence               223445788999999999999999999999999999999999999986442   12222111110          01


Q ss_pred             hcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          317 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .........++++.+|+.+||+.||++|||+.|+++|
T Consensus       247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1112223345678999999999999999999999975

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-52  Score=380.94  Aligned_cols=261  Identities=27%  Similarity=0.429  Sum_probs=209.4

Q ss_pred             HhcCCCcCCeecccCceEEEEEEeCC--------CcEEEEEECCCCCh----hHHHHHHHHHHcC-CCCcccccccceee
Q 016588           81 ATKNFSDKNLIGEGKFGEVYKGLLQD--------GMLVAIKKRPGAPT----QEFIDEVCFLASI-QHRNLVTLLGYCQE  147 (386)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~----~~~~~e~~~l~~l-~h~niv~~~~~~~~  147 (386)
                      ..++|++.+.||+|+||.||+|....        +..||||++.....    .++.+|...+.++ +||||++++++|.+
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            34678888999999999999998532        24799998755443    4577888888888 79999999999999


Q ss_pred             CCeEEEEEEeecCCCccccccCCCc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeee
Q 016588          148 NNLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV  216 (386)
Q Consensus       148 ~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill  216 (386)
                      ++..++||||+++|+|.+++.....           .....+++..++.++.|++.||+|||+  ++|+||||||+|||+
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~--~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLV  168 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEE
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh--CCEEeeeecccceee
Confidence            9999999999999999999854321           123568999999999999999999999  779999999999999


Q ss_pred             CCCCceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhh
Q 016588          217 DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQD  295 (386)
Q Consensus       217 ~~~~~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~  295 (386)
                      +.++.+||+|||+++...............+++.|+|||.+.+..|+.++|||||||++|||++ |..||.....   ..
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---~~  245 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EE  245 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HH
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH---HH
Confidence            9999999999999998766555555566778889999999999999999999999999999998 6778765442   22


Q ss_pred             HHHHHHhhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhh
Q 016588          296 LVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD  359 (386)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~  359 (386)
                      +...+             ....+...+..+++++.+|+.+||+.||++|||+.||++.|++++.
T Consensus       246 ~~~~i-------------~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         246 LFKLL-------------KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             HHHHH-------------HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHH-------------HcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence            22222             1222233444556779999999999999999999999999999875

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-51  Score=377.31  Aligned_cols=252  Identities=26%  Similarity=0.452  Sum_probs=202.6

Q ss_pred             CCeecccCceEEEEEEeCC----CcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceee-CCeEEEEEEee
Q 016588           88 KNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQE-NNLQFLIYEYI  158 (386)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~  158 (386)
                      .++||+|+||+||+|.+.+    ...||||+++...    .++|.+|++++++++||||++++|++.. .+..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            4689999999999999643    2368999865432    2458999999999999999999999875 46889999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      ++|+|.+++..    .....++..++.++.|++.||.|||+  ++|+||||||+|||+++++.+||+|||+++.......
T Consensus       112 ~~g~l~~~~~~----~~~~~~~~~~~~i~~qia~gL~~lH~--~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         112 KHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             TTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             ecCchhhhhcc----ccccchHHHHHHHHHHHHHhhhhhcc--cCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            99999998853    34556788899999999999999999  7799999999999999999999999999988754332


Q ss_pred             C--CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchh
Q 016588          239 A--GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  316 (386)
Q Consensus       239 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (386)
                      .  .......+|..|+|||.+....++.++||||||+++|||++|..||......  .+....+..             .
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i~~-------------g  250 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLLQ-------------G  250 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHT-------------T
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHHHHc-------------C
Confidence            2  2233456889999999999999999999999999999999988877653321  111121111             1


Q ss_pred             hcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh
Q 016588          317 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  360 (386)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~  360 (386)
                      .+...+..+++++.+|+.+||+.||++|||+.||+++|+++++.
T Consensus       251 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         251 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            12233444567799999999999999999999999999999865

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=382.52  Aligned_cols=245  Identities=23%  Similarity=0.269  Sum_probs=206.1

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECC------CCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ++|++.+.||+|+||.||+|..+ +++.||+|++.      ....+.+.+|+.+|+.++||||+++++++.+.+..|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            57889999999999999999964 68999999854      334567889999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++|+|..++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++....
T Consensus        85 ey~~gg~L~~~~~-----~~~~~~e~~~~~~~~qil~al~ylH~--~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          85 EYANGGELFFHLS-----RERVFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             ECCTTCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eccCCCchhhhhh-----cccCCcHHHHHHHHHHHhhhhhhhhh--cCccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            9999999998883     34678899999999999999999999  7799999999999999999999999999987543


Q ss_pred             CCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      ..  .......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+.   ..+.......            
T Consensus       158 ~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~---~~~~~~i~~~------------  220 (337)
T d1o6la_         158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELILME------------  220 (337)
T ss_dssp             TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHC------------
T ss_pred             CC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH---HHHHHHHhcC------------
Confidence            22  233456799999999999999999999999999999999999999987542   2222211110            


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTE  353 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~evl~~  353 (386)
                        ...++...++++.+|+.+||+.||++||+     ++|+++|
T Consensus       221 --~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         221 --EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             --CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence              01233445677899999999999999995     8888875

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.8e-52  Score=381.62  Aligned_cols=242  Identities=22%  Similarity=0.318  Sum_probs=204.2

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECC------CCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ++|++.+.||+|+||+||+|..+ +|+.||||++.      ....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            56888999999999999999964 58999999853      334567899999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+++|+|..++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++....
T Consensus        84 E~~~gg~l~~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~--~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          84 DYIEGGELFSLLR-----KSQRFPNPVAKFYAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             CCCCSCBHHHHHH-----HTSSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eecCCcccccccc-----ccccccccHHHHHHHHHHHhhhhhcc--CcEEccccCchheeEcCCCCEEEecCccceEecc
Confidence            9999999988873     44567888889999999999999999  7799999999999999999999999999987654


Q ss_pred             CCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      .     .....||+.|+|||++.+..|+.++|||||||++|||++|..||.+...   ......+...            
T Consensus       157 ~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~i~~~------------  216 (316)
T d1fota_         157 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---MKTYEKILNA------------  216 (316)
T ss_dssp             C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHC------------
T ss_pred             c-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH---HHHHHHHHcC------------
Confidence            2     2346799999999999999999999999999999999999999986442   1122111110            


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  353 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~~  353 (386)
                      .  ...+...++++.+++.+||+.||.+|+     |++++++|
T Consensus       217 ~--~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         217 E--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             C--CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence            0  123334456789999999999999996     89999876

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=378.23  Aligned_cols=254  Identities=26%  Similarity=0.363  Sum_probs=196.9

Q ss_pred             hcCCCcCCeecccCceEEEEEEeCC--C--cEEEEEECCCC------ChhHHHHHHHHHHcCCCCcccccccceeeCCeE
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQD--G--MLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  151 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  151 (386)
                      .++|++.+.||+|+||+||+|.++.  +  ..||||++...      ..++|.+|+.++++++||||++++|++.+. ..
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-ch
Confidence            3568889999999999999998532  2  37899975432      235689999999999999999999999764 56


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      ++||||+++|++.+.+..    ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        86 ~lv~e~~~~~~l~~~~~~----~~~~l~~~~~~~~~~qi~~gl~ylH~--~~iiHrDikp~NIll~~~~~vkl~DfGl~~  159 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRK----HQGHFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMR  159 (273)
T ss_dssp             EEEEECCTTCBHHHHHHH----HGGGSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             heeeeeecCcchhhhhhc----ccCCCCHHHHHHHHHHHHHHHHHhhh--CCEeeeeecHHHhccccccceeeccchhhh
Confidence            899999999999887742    34568999999999999999999999  779999999999999999999999999999


Q ss_pred             ccCCCCCC-CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHc-CCCCCCCCCCCchhhHHHHHHhhhcccch
Q 016588          232 FLGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNL  309 (386)
Q Consensus       232 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  309 (386)
                      ........ .......+|..|+|||.+.+..++.++|||||||++|||+| |..||.+...   ......+.        
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~---~~~~~~i~--------  228 (273)
T d1u46a_         160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILHKID--------  228 (273)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHH--------
T ss_pred             hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH---HHHHHHHH--------
Confidence            87543322 22234457788999999999999999999999999999998 8999986442   22222111        


Q ss_pred             hhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHh
Q 016588          310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  357 (386)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~  357 (386)
                          ....+.+.+..+++++.+|+.+||+.||++|||+.+|++.|.+.
T Consensus       229 ----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         229 ----KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ----TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----hCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                11122233445567799999999999999999999999988764

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-52  Score=379.68  Aligned_cols=271  Identities=21%  Similarity=0.351  Sum_probs=203.0

Q ss_pred             cCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCCChhHHHHHHHHH--HcCCCCcccccccceeeCC----eEEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFL--ASIQHRNLVTLLGYCQENN----LQFLIYE  156 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l--~~l~h~niv~~~~~~~~~~----~~~lv~e  156 (386)
                      ++|...+.||+|+||+||+|++ +|+.||||+++.....++..|.+++  ..++||||+++++++.+.+    ..|+|||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E   81 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence            3566778999999999999997 5789999998766666666666555  5679999999999997643    6799999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCceecCCCCCCeeeCCCCceEEcccccc
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL------SPRVVHKDFKTANVLVDEDFIAKVADAGLR  230 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------~~~ivH~dlkp~Nill~~~~~~kl~DFgl~  230 (386)
                      |+++|+|.+++.      ...+++..++.++.|++.||.|||+.      .++|+||||||+||||+.++.+||+|||++
T Consensus        82 y~~~g~L~~~l~------~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          82 YHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             CCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             cccCCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            999999999994      24688999999999999999999973      368999999999999999999999999999


Q ss_pred             cccCCCCC--CCCCccccCcccccchhhhcccC------CCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHh
Q 016588          231 NFLGRTDV--AGPSSQVTADEIFLASEVKEFRR------FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN  302 (386)
Q Consensus       231 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~------~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~  302 (386)
                      +.......  ........||+.|+|||++.+..      ++.++|||||||++|||+||..|+........... .....
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~-~~~~~  234 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY-DLVPS  234 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT-TTSCS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh-hcccc
Confidence            87644322  12334567899999999987643      57789999999999999999888755332211000 00000


Q ss_pred             hhcccchh-hhcchhhcccC-----CHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          303 SRDFSNLL-KILDERLWSTF-----TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       303 ~~~~~~~~-~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                      ........ ...+...++..     +.+.+..+.+|+.+||+.||++|||+.||++.|+++.++.
T Consensus       235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  299 (303)
T d1vjya_         235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence            00000000 01111111111     2245677999999999999999999999999999998764

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-52  Score=382.60  Aligned_cols=266  Identities=23%  Similarity=0.368  Sum_probs=214.6

Q ss_pred             HHHHhcCCCcCCeecccCceEEEEEEeC------CCcEEEEEECCCCCh----hHHHHHHHHHHcCCCCcccccccceee
Q 016588           78 LSLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQE  147 (386)
Q Consensus        78 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~  147 (386)
                      ++...++|+..+.||+|+||+||+|.+.      ++..||||++.....    ..+.+|+.++++++||||++++|++..
T Consensus        15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            3344568888999999999999999863      257899998765432    247899999999999999999999999


Q ss_pred             CCeEEEEEEeecCCCccccccCCCc-----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCce
Q 016588          148 NNLQFLIYEYIPNGSVSIHLYGPSQ-----VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA  222 (386)
Q Consensus       148 ~~~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~  222 (386)
                      .+..++||||+++|+|.+++.....     .....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++++
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~--~~ivHrDlk~~NiLld~~~~~  172 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTV  172 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCSGGGEEECTTCCE
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh--CCeeeceEcCCceeecCCceE
Confidence            9999999999999999988753211     122457889999999999999999999  779999999999999999999


Q ss_pred             EEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCC-CCCCCCCCCchhhHHHHHH
Q 016588          223 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR-EASSSLSPDSSQDLVELVQ  301 (386)
Q Consensus       223 kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~-~p~~~~~~~~~~~~~~~~~  301 (386)
                      ||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||+||. .||.+...   ......+.
T Consensus       173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~---~~~~~~i~  249 (308)
T d1p4oa_         173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQVLRFVM  249 (308)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HHHHHHHH
T ss_pred             EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH
Confidence            999999998776544444445556889999999999999999999999999999999985 66665432   22222221


Q ss_pred             hhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          302 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                      .             ..+...+..+++.+.+++.+||+.||++|||+++|+++|++.++..
T Consensus       250 ~-------------~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~  296 (308)
T d1p4oa_         250 E-------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  296 (308)
T ss_dssp             T-------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             h-------------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence            1             1122334455677999999999999999999999999998877643

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.8e-51  Score=371.27  Aligned_cols=249  Identities=20%  Similarity=0.310  Sum_probs=203.5

Q ss_pred             hcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCCC------------hhHHHHHHHHHHcCC-CCcccccccceee
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP------------TQEFIDEVCFLASIQ-HRNLVTLLGYCQE  147 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~------------~~~~~~e~~~l~~l~-h~niv~~~~~~~~  147 (386)
                      .++|++.+.||+|+||+||+|.. .+++.||||+++...            .+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            36889999999999999999996 468999999854321            124788999999996 9999999999999


Q ss_pred             CCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccc
Q 016588          148 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA  227 (386)
Q Consensus       148 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DF  227 (386)
                      ++..|+||||+++|+|.+++.     ....+++..+..++.||+.||+|||+  ++|+||||||+|||++.++.+||+||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~-----~~~~l~e~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nill~~~~~~kl~DF  154 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLT-----EKVTLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDMNIKLTDF  154 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             CcceEEEEEcCCCchHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--cCCcccccccceEEEcCCCCeEEccc
Confidence            999999999999999999984     34578999999999999999999999  77999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCccccCcccccchhhhcc------cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHH
Q 016588          228 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEF------RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ  301 (386)
Q Consensus       228 gl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~  301 (386)
                      |+++.+....   ......||+.|+|||.+.+      ..++.++||||+||++|||++|..||.+..+   ......+.
T Consensus       155 G~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~---~~~~~~i~  228 (277)
T d1phka_         155 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---MLMLRMIM  228 (277)
T ss_dssp             TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH
T ss_pred             hheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH---HHHHHHHH
Confidence            9998875422   2345678999999999864      3468899999999999999999999987542   11222111


Q ss_pred             hhhcccchhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          302 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ....          ..........++++.+++.+||+.||++|||++|+++|
T Consensus       229 ~~~~----------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         229 SGNY----------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HTCC----------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             hCCC----------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            1110          01111223455779999999999999999999999875

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.1e-51  Score=382.96  Aligned_cols=246  Identities=21%  Similarity=0.290  Sum_probs=199.4

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC------ChhHHHHH---HHHHHcCCCCcccccccceeeCCeEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDE---VCFLASIQHRNLVTLLGYCQENNLQF  152 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~e---~~~l~~l~h~niv~~~~~~~~~~~~~  152 (386)
                      ++|++.+.||+|+||.||+|... +++.||||++...      ....+.+|   +.+++.++||||+++++++.+.+..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57899999999999999999965 5899999985422      22234444   66777889999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccc
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  232 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~  232 (386)
                      +||||+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        84 ivmE~~~gg~L~~~l~-----~~~~~~e~~~~~~~~qi~~aL~ylH~--~~iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          84 FILDLMNGGDLHYHLS-----QHGVFSEADMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             EEECCCCSCBHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             EEEEecCCCcHHHHHH-----hcccccHHHHHHHHHHHHHHHHHHHH--CCccceeeccceeEEcCCCcEEEeeeceeee
Confidence            9999999999999884     34567889999999999999999999  7799999999999999999999999999987


Q ss_pred             cCCCCCCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhh
Q 016588          233 LGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK  311 (386)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (386)
                      .....    .....||+.|+|||++.. ..|+.++|||||||++|||+||+.||...........   ......      
T Consensus       157 ~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~---~~~~~~------  223 (364)
T d1omwa3         157 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRMTLT------  223 (364)
T ss_dssp             CSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH---HHHSSS------
T ss_pred             cCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhccc------
Confidence            65432    344579999999999864 5689999999999999999999999987554322111   111100      


Q ss_pred             hcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHH
Q 016588          312 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTE  353 (386)
Q Consensus       312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~evl~~  353 (386)
                           .....+...++++.+++.+||+.||++|||     ++|+++|
T Consensus       224 -----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         224 -----MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             -----CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence                 011223344567899999999999999999     6888865

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.2e-51  Score=381.69  Aligned_cols=242  Identities=20%  Similarity=0.271  Sum_probs=204.2

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECC------CCChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  155 (386)
                      ++|++.+.||+|+||.||+|..+ +++.||||++.      ....+.+.+|+.+|+.++||||+++++++.+.+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57899999999999999999964 68999999753      234567889999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCC
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  235 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~  235 (386)
                      ||+.+|+|..++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.+..
T Consensus       121 e~~~~g~l~~~l~-----~~~~l~e~~~~~i~~qi~~aL~yLH~--~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLR-----RIGRFSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ccccccchhhhHh-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            9999999988883     34568999999999999999999999  7799999999999999999999999999987643


Q ss_pred             CCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcch
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  315 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (386)
                      .     .....||+.|+|||++.+..|+.++|||||||++|||++|..||.+...   ......+...            
T Consensus       194 ~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~i~~~------------  253 (350)
T d1rdqe_         194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSG------------  253 (350)
T ss_dssp             C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHC------------
T ss_pred             c-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH---HHHHHHHhcC------------
Confidence            2     2346789999999999999999999999999999999999999976432   1121111110            


Q ss_pred             hhcccCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016588          316 RLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  353 (386)
Q Consensus       316 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~~  353 (386)
                        ....+...++++.+++.+||+.||.+|+     |++++++|
T Consensus       254 --~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         254 --KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence              0122334556789999999999999994     89999875

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-51  Score=372.87  Aligned_cols=255  Identities=21%  Similarity=0.283  Sum_probs=194.4

Q ss_pred             CCeecccCceEEEEEEeC-CCcEEEEEECCCCC--------hhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           88 KNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP--------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      .++||+|+||+||+|..+ +++.||||+++...        .+.+.+|+.++++++||||+++++++.+.+..|+||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            578999999999999964 58999999864322        245889999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  238 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~~  238 (386)
                      .++++.....     ....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++...... 
T Consensus        83 ~~~~~~~~~~-----~~~~l~~~~~~~~~~qil~aL~~lH~--~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-  154 (299)
T d1ua2a_          83 ETDLEVIIKD-----NSLVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-  154 (299)
T ss_dssp             SEEHHHHHTT-----CCSSCCSSHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-
T ss_pred             cchHHhhhhh-----cccCCCHHHHHHHHHHHHHHHHHhhc--cceecccCCcceEEecCCCccccccCccccccCCCc-
Confidence            9887766652     34567888899999999999999999  779999999999999999999999999998765432 


Q ss_pred             CCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhh--hcccc---hhhh
Q 016588          239 AGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS--RDFSN---LLKI  312 (386)
Q Consensus       239 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~---~~~~  312 (386)
                       .......+|+.|+|||++.. ..|+.++|||||||++|||++|..||.+..+.+  .+....+..  .....   ....
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--~l~~i~~~~~~~~~~~~~~~~~~  231 (299)
T d1ua2a_         155 -RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIFETLGTPTEEQWPDMCSL  231 (299)
T ss_dssp             -CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCTTTSSSTTSS
T ss_pred             -ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH--HHHHHHHhcCCCChhhccchhcc
Confidence             22334578999999999865 467999999999999999999999998654321  111111110  00000   0000


Q ss_pred             cchhh---cc-----cCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          313 LDERL---WS-----TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       313 ~~~~~---~~-----~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .....   ..     ......++++.+|+.+||+.||++|||++|+++|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            00000   00     0011234678999999999999999999999875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.4e-51  Score=369.32  Aligned_cols=256  Identities=19%  Similarity=0.261  Sum_probs=198.6

Q ss_pred             cCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCCC------hhHHHHHHHHHHcCCCCcccccccceeeCC----eE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENN----LQ  151 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~  151 (386)
                      ++|++.+.||+|+||+||+|.. .+++.||||.++...      ...+.+|+++++.++||||+++++++...+    ..
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            5789999999999999999995 468999999865432      235789999999999999999999987643    47


Q ss_pred             EEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          152 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       152 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      |+||||+++++|..++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++..+++|||.+.
T Consensus        87 ~lvmE~~~g~~L~~~~~-----~~~~l~~~~~~~i~~qi~~al~~lH~--~~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEECCCEEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEECCCCCEehhhhc-----ccCCCCHHHHHHHHHHHHHHHHHHHh--CCccCccccCcccccCccccceeehhhhhh
Confidence            99999999999998773     34578999999999999999999999  779999999999999999999999999987


Q ss_pred             ccCCCCC-CCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchh
Q 016588          232 FLGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  310 (386)
Q Consensus       232 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (386)
                      ....... ........||+.|+|||++.+..|+.++|||||||++|||+||..||.+..+.  ...........      
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~~~~~~~~------  231 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV--SVAYQHVREDP------  231 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHCCC------
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH--HHHHHHHhcCC------
Confidence            6543222 22334567899999999999999999999999999999999999999864421  11111111100      


Q ss_pred             hhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCC-CHHHHHHHHHHhh
Q 016588          311 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-SMSDVVTELDRTL  358 (386)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-t~~evl~~L~~~~  358 (386)
                           ..........++++.+++.+||+.||++|| |++++++.|.++.
T Consensus       232 -----~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         232 -----IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             -----CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -----CCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence                 001112223456789999999999999999 8999999888764

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-51  Score=374.92  Aligned_cols=245  Identities=23%  Similarity=0.344  Sum_probs=202.8

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECC------CCChhHHHHHHHHHH-cCCCCcccccccceeeCCeEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLA-SIQHRNLVTLLGYCQENNLQFLI  154 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv  154 (386)
                      ++|.+.+.||+|+||+||+|... +++.||||++.      ....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57889999999999999999965 58999999864      334456777777765 68999999999999999999999


Q ss_pred             EEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccC
Q 016588          155 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  234 (386)
Q Consensus       155 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~  234 (386)
                      |||+++|+|.+++.     ....+++..+..++.|++.||+|||+  ++|+||||||+|||+++++.+||+|||+++...
T Consensus        82 mEy~~~g~L~~~i~-----~~~~~~e~~~~~~~~qi~~al~ylH~--~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          82 MEYLNGGDLMYHIQ-----SCHKFDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             EECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EeecCCCcHHHHhh-----ccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCcccceeecCCCceeccccchhhhcc
Confidence            99999999999884     34568899999999999999999999  779999999999999999999999999998764


Q ss_pred             CCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcc
Q 016588          235 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  314 (386)
Q Consensus       235 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (386)
                      ...  .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+..+   ..+...+...           
T Consensus       155 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~~i~~~-----------  218 (320)
T d1xjda_         155 LGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EELFHSIRMD-----------  218 (320)
T ss_dssp             CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHC-----------
T ss_pred             ccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHHcC-----------
Confidence            322  233456789999999999999999999999999999999999999986442   2222211110           


Q ss_pred             hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHH-HHHHH
Q 016588          315 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMS-DVVTE  353 (386)
Q Consensus       315 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~-evl~~  353 (386)
                         ...++...++++.+|+.+||+.||++|||+. ++++|
T Consensus       219 ---~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         219 ---NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             ---CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence               1123334557789999999999999999996 77653

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-51  Score=375.43  Aligned_cols=250  Identities=20%  Similarity=0.249  Sum_probs=203.6

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCChh--HHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEee
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQ--EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      .++|++.+.||+|+||+||+|... +++.||+|.++....+  .+.+|+++|+.++||||+++++++.+.+..|+|||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~   83 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence            357899999999999999999965 5889999987655443  4779999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC--CCceEEcccccccccCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE--DFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~--~~~~kl~DFgl~~~~~~~  236 (386)
                      ++|+|.+++..    ....+++..+..++.|++.||.|||+  .||+||||||+|||++.  ...+||+|||+++.....
T Consensus        84 ~gg~L~~~i~~----~~~~l~e~~~~~i~~qi~~al~yLH~--~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          84 SGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--cCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            99999998842    23468999999999999999999999  77999999999999985  458999999999876432


Q ss_pred             CCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhhcchh
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  316 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (386)
                      .   ......+++.|+|||...+..|+.++||||+||++|||++|..||.....   .+....+.....      .++..
T Consensus       158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~---~~~~~~i~~~~~------~~~~~  225 (321)
T d1tkia_         158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQIIENIMNAEY------TFDEE  225 (321)
T ss_dssp             C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHTCC------CCCHH
T ss_pred             C---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCC------CCChh
Confidence            2   23345678899999999999999999999999999999999999986442   222222211110      01111


Q ss_pred             hcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          317 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       317 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .+..    .++++.+++.+||+.||++|||+.|+++|
T Consensus       226 ~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         226 AFKE----ISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hccC----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1112    34568999999999999999999999985

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-51  Score=376.57  Aligned_cols=250  Identities=18%  Similarity=0.219  Sum_probs=197.9

Q ss_pred             cCCCcCC-eecccCceEEEEEEe-CCCcEEEEEECCCCChhHHHHHHHHHHcC-CCCcccccccceee----CCeEEEEE
Q 016588           83 KNFSDKN-LIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQE----NNLQFLIY  155 (386)
Q Consensus        83 ~~~~~~~-~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~~~lv~  155 (386)
                      ++|.+.+ .||+|+||+||+|.. .+++.||||++..  ...+.+|+.++.++ +||||+++++++.+    .+..|+||
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivm   88 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM   88 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC--cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEE
Confidence            4677764 699999999999996 4689999998754  46678999987654 89999999999865    46789999


Q ss_pred             EeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC---CCceEEcccccccc
Q 016588          156 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADAGLRNF  232 (386)
Q Consensus       156 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~---~~~~kl~DFgl~~~  232 (386)
                      |||++|+|.+++...   ....+++..+..++.|++.||+|||+  ++|+||||||+|||++.   ++.+||+|||+++.
T Consensus        89 Ey~~gg~L~~~i~~~---~~~~l~e~~~~~i~~qi~~al~ylH~--~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~  163 (335)
T d2ozaa1          89 ECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  163 (335)
T ss_dssp             ECCCSEEHHHHHHSC---SCCCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             ECCCCCcHHHHHHhc---CCCCcCHHHHHHHHHHHHHHHHHHHH--cCCccccccccccccccccccccccccccceeee
Confidence            999999999998532   23568999999999999999999999  77999999999999985   56799999999987


Q ss_pred             cCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhhh
Q 016588          233 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  312 (386)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (386)
                      .....   ......||+.|+|||++.+..|+.++|||||||++|||+||+.||.+..........   ..        .+
T Consensus       164 ~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~---~~--------~i  229 (335)
T d2ozaa1         164 TTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KT--------RI  229 (335)
T ss_dssp             CCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------------CC
T ss_pred             ccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH---HH--------HH
Confidence            65422   234567899999999999999999999999999999999999999875542211100   00        00


Q ss_pred             cchhh--cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          313 LDERL--WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       313 ~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      .....  ........++++.+|+.+||+.||++|||+.|+++|
T Consensus       230 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         230 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             CSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            00000  001112345679999999999999999999999986

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-50  Score=366.21  Aligned_cols=261  Identities=24%  Similarity=0.301  Sum_probs=200.0

Q ss_pred             cCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      ++|+..+.||+|+||+||+|.. .+++.||||+++..     ..+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5789999999999999999996 46899999985432     34578899999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      |+.++++.....    .....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~~~~~~~~~~~----~~~~~l~e~~~~~~~~qil~~L~yLH~--~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          82 FLHQDLKKFMDA----SALTGIPLPLIKSYLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             CCSEEHHHHHHH----TTTTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             ecCCchhhhhhh----hcccCCCHHHHHHHHHHHHHHHHHhhc--CCEEccccCchheeecccCcceeccCCcceeccCC
Confidence            997754443321    234568999999999999999999999  77999999999999999999999999999876543


Q ss_pred             CCCCCCccccCcccccchhhhcccCC-CcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccc--hhhhc
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN--LLKIL  313 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  313 (386)
                      .  .......+|+.|+|||......+ +.++||||+||++|||++|+.||.+.+.  ...+............  .....
T Consensus       156 ~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~  231 (298)
T d1gz8a_         156 V--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE--IDQLFRIFRTLGTPDEVVWPGVT  231 (298)
T ss_dssp             S--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             c--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH--HHHHHHHHHhcCCCchhhccccc
Confidence            2  22345578899999998877654 8899999999999999999999986442  1112221111111000  00000


Q ss_pred             -chhhc-----------ccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          314 -DERLW-----------STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       314 -~~~~~-----------~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                       .+...           .......++++.+++.+||+.||++|||+.|+++|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence             00000           00111234678999999999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=6.3e-50  Score=364.05  Aligned_cols=260  Identities=23%  Similarity=0.341  Sum_probs=201.1

Q ss_pred             cCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEEe
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  157 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  157 (386)
                      ++|+..+.||+|+||+||+|..++++.||||++...     ..+.+.+|+.+|++++||||+++++++...+..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            578899999999999999999988999999986443     245789999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016588          158 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  237 (386)
Q Consensus       158 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~~  237 (386)
                      +.++++....     .....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+|++|||++.......
T Consensus        82 ~~~~~~~~~~-----~~~~~l~~~~~~~i~~qi~~~L~~LH~--~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          82 LDQDLKKLLD-----VCEGGLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             CSEEHHHHHH-----TSTTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             ehhhhHHHHH-----hhcCCcchhhhHHHHHHHHHHHHHhcc--CcEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence            9887776665     345679999999999999999999999  679999999999999999999999999998765432


Q ss_pred             CCCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc-----ccchhh
Q 016588          238 VAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD-----FSNLLK  311 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~~  311 (386)
                      .  ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+..+.  +.+.........     ......
T Consensus       155 ~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         155 R--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIFRILGTPNSKNWPNVTE  230 (286)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             c--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH--HHHHHHHHhhCCCChhhccchhh
Confidence            2  22344578889999998765 4689999999999999999999999865431  111111111000     000000


Q ss_pred             ---------hcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          312 ---------ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       312 ---------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                               ...+..+.......++++.+++.+||+.||++|||++|+++|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                     001111122333445778999999999999999999999865

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-51  Score=366.57  Aligned_cols=237  Identities=23%  Similarity=0.361  Sum_probs=193.7

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCC---------ChhHHHHHHHHHHcCC--CCcccccccceeeCCe
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---------PTQEFIDEVCFLASIQ--HRNLVTLLGYCQENNL  150 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---------~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~  150 (386)
                      ++|++.+.||+|+||+||+|... +++.||||++...         ...++.+|+.++++++  ||||+++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57899999999999999999964 6899999975321         1234678999999986  8999999999999999


Q ss_pred             EEEEEEeecC-CCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-CCceEEcccc
Q 016588          151 QFLIYEYIPN-GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAG  228 (386)
Q Consensus       151 ~~lv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~-~~~~kl~DFg  228 (386)
                      .|+||||+.+ +++.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++. ++.+||+|||
T Consensus        84 ~~lv~e~~~~~~~l~~~~~-----~~~~l~e~~~~~~~~qi~~al~~lH~--~~iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFIT-----ERGALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEEEeccCcchHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCCccccCcccceEEecCCCeEEECccc
Confidence            9999999976 46666652     34578999999999999999999999  77999999999999985 4799999999


Q ss_pred             cccccCCCCCCCCCccccCcccccchhhhcccCC-CcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhccc
Q 016588          229 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS  307 (386)
Q Consensus       229 l~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  307 (386)
                      +++.....    ......||+.|+|||++.+..+ +.++||||+||++|||++|..||....     .   .....    
T Consensus       157 ~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~---i~~~~----  220 (273)
T d1xwsa_         157 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----E---IIRGQ----  220 (273)
T ss_dssp             TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H---HHHCC----
T ss_pred             cceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----H---Hhhcc----
Confidence            99875432    2345678999999999988776 577899999999999999999997421     0   00000    


Q ss_pred             chhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          308 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                                 ...+...++++.+++.+||+.||++|||++|++++
T Consensus       221 -----------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         221 -----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             -----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -----------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                       01222345678999999999999999999999875

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-49  Score=363.65  Aligned_cols=261  Identities=23%  Similarity=0.302  Sum_probs=198.0

Q ss_pred             hcCCCcCCeecccCceEEEEEEe-CC-CcEEEEEECC-----CCChhHHHHHHHHHHcC---CCCcccccccceee----
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLL-QD-GMLVAIKKRP-----GAPTQEFIDEVCFLASI---QHRNLVTLLGYCQE----  147 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~-~~-~~~vavK~~~-----~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~----  147 (386)
                      .++|++.+.||+|+||+||+|.. ++ ++.||||++.     ......+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999996 34 6679999742     22344577888877765   79999999998853    


Q ss_pred             -CCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcc
Q 016588          148 -NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVAD  226 (386)
Q Consensus       148 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D  226 (386)
                       ....+++|||+.++++.....    .....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~----~~~~~~~~~~~~~~~~qi~~aL~yLH~--~~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK----VPEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH----SCTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCceEEEEEEeccCCchhhhhh----ccCCCCCHHHHHHHHHHHHHHHHHHHh--CCEEecCCCccEEEEcCCCCeeecc
Confidence             356799999999887654432    244668899999999999999999999  7799999999999999999999999


Q ss_pred             cccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhh--
Q 016588          227 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR--  304 (386)
Q Consensus       227 Fgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~--  304 (386)
                      ||+++.....   .......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+..+..  .+........  
T Consensus       160 fg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~~i~~~~~~~  234 (305)
T d1blxa_         160 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILDVIGLP  234 (305)
T ss_dssp             CCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCC
T ss_pred             hhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH--HHHHHHHhhCCC
Confidence            9998865432   22345678999999999999999999999999999999999999998754321  1111111100  


Q ss_pred             cccchh-------h---hcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          305 DFSNLL-------K---ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       305 ~~~~~~-------~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ......       .   ..............++.+.+|+.+||+.||++|||+.|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            000000       0   000011112233445678999999999999999999999876

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-48  Score=356.66  Aligned_cols=264  Identities=19%  Similarity=0.253  Sum_probs=195.9

Q ss_pred             cCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCC-----CChhHHHHHHHHHHcCCCCcccccccceee--------C
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQE--------N  148 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------~  148 (386)
                      ++|++.+.||+|+||+||+|.. ++++.||||++..     ....++.+|+++|++++|||++++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            5788999999999999999996 4689999998532     234568899999999999999999998754        3


Q ss_pred             CeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccc
Q 016588          149 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  228 (386)
Q Consensus       149 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFg  228 (386)
                      +..|+||||+.++++....     .....++...+..++.|++.||.|||+  +||+||||||+|||++.++.+|++|||
T Consensus        90 ~~~~iv~e~~~~~~~~~~~-----~~~~~~~~~~~~~i~~qil~~l~~lH~--~~ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLS-----NVLVKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHT-----CTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             ceEEEEEeccCCCccchhh-----hcccccccHHHHHHHHHHHHHHHHhcc--CCEEecCcCchheeecCCCcEEeeecc
Confidence            4679999999887776554     234568888999999999999999999  779999999999999999999999999


Q ss_pred             cccccCCCCC--CCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc
Q 016588          229 LRNFLGRTDV--AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD  305 (386)
Q Consensus       229 l~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  305 (386)
                      +++.......  ........+|+.|+|||++.+. .|+.++||||+||++|||++|+.||.+..+...............
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  242 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  242 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9987654322  2223345689999999998765 689999999999999999999999986543222111111111110


Q ss_pred             ccchhhhcchhh-------cc-cCC-------HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          306 FSNLLKILDERL-------WS-TFT-------NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       306 ~~~~~~~~~~~~-------~~-~~~-------~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ............       .. ...       ....+++.+|+.+||+.||++|||++|+++|
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            000000000000       00 000       0113467899999999999999999999976

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=6.9e-47  Score=344.68  Aligned_cols=263  Identities=17%  Similarity=0.238  Sum_probs=210.3

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCC-CChhHHHHHHHHHHcCCC-CcccccccceeeCCeEEEEEEeec
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG-APTQEFIDEVCFLASIQH-RNLVTLLGYCQENNLQFLIYEYIP  159 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~  159 (386)
                      .+|++.+.||+|+||+||+|... +++.||||..+. .....+.+|++.++.++| +|++.+++++......++||||+ 
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-   83 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-   83 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence            57889999999999999999954 588999998543 344568899999999965 89999999999999999999998 


Q ss_pred             CCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCC-----CCceEEcccccccccC
Q 016588          160 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-----DFIAKVADAGLRNFLG  234 (386)
Q Consensus       160 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~-----~~~~kl~DFgl~~~~~  234 (386)
                      +++|.+++..    ....++...+..++.|++.||+|||+  +||+||||||+|||++.     ++.+||+|||+++...
T Consensus        84 ~~~l~~~~~~----~~~~~~~~~~~~i~~q~~~~l~~lH~--~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          84 GPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             CCCHHHHHHh----hccchhhHHHHHHHHHHHHHHHHHHH--CCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            5788877732    34568999999999999999999999  77999999999999974     5789999999998765


Q ss_pred             CCCCC-----CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccch
Q 016588          235 RTDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL  309 (386)
Q Consensus       235 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  309 (386)
                      .....     .......||+.|+|||++.+..++.++|||||||++|||++|..||.+............+.........
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL  237 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence            42211     1233457999999999999999999999999999999999999999876654443333222221111111


Q ss_pred             hhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhhh
Q 016588          310 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  361 (386)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~~  361 (386)
                           +.+    ...+++++.+++..|+..+|++||+++.+.+.|++++++.
T Consensus       238 -----~~l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         238 -----REL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             -----HHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             -----HHh----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence                 111    1223466899999999999999999999999999988763

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-48  Score=363.43  Aligned_cols=266  Identities=25%  Similarity=0.312  Sum_probs=196.6

Q ss_pred             CCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCChhHHHHHHHHHHcCCCCcccccccceee------CCeEEEEEE
Q 016588           84 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQE------NNLQFLIYE  156 (386)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~~~lv~e  156 (386)
                      +|+..++||+|+||+||+|... +++.||||++.... ....+|+++|++++||||+++++++..      ....|+|||
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E   99 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD   99 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence            5778899999999999999965 58999999865432 334579999999999999999998853      335789999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC-ceEEcccccccccCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNFLGR  235 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~-~~kl~DFgl~~~~~~  235 (386)
                      |++++++.......  .....+++..+..++.|++.||+|||+  +||+||||||+|||++.++ .+||+|||+++....
T Consensus       100 y~~~~~~~~l~~~~--~~~~~l~~~~~~~i~~qil~aL~yLH~--~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~  175 (350)
T d1q5ka_         100 YVPETVYRVARHYS--RAKQTLPVIYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR  175 (350)
T ss_dssp             CCSEEHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred             ccCCccHHHHHhhh--hccCCCCHHHHHHHHHHHHHHHHHHHh--cCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence            99876544333111  234568999999999999999999998  7799999999999999775 899999999987644


Q ss_pred             CCCCCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc--ccchhhh
Q 016588          236 TDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD--FSNLLKI  312 (386)
Q Consensus       236 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  312 (386)
                      ..   ......+++.|+|||.+.+ ..|+.++||||+||++|||++|+.||.....  .+.+....+....  .......
T Consensus       176 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~--~~~l~~i~~~~g~~~~~~~~~~  250 (350)
T d1q5ka_         176 GE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG--VDQLVEIIKVLGTPTREQIREM  250 (350)
T ss_dssp             TS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH--HHHHHHHHHHHCCCCHHHHHHH
T ss_pred             Cc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH--HHHHHHHHHHhCCChHHhhhhh
Confidence            32   2334578889999998765 5789999999999999999999999976542  1222211111000  0000000


Q ss_pred             ------------cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH--HHHhhh
Q 016588          313 ------------LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE--LDRTLD  359 (386)
Q Consensus       313 ------------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~--L~~~~~  359 (386)
                                  .............++++.+|+.+||+.||++|||+.|+++|  ++++.+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence                        00000111122345678999999999999999999999976  455443

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.8e-47  Score=348.65  Aligned_cols=270  Identities=17%  Similarity=0.202  Sum_probs=202.4

Q ss_pred             cCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCC-CChhHHHHHHHHHHcCCCCcccc-cccceeeCCeEEEEEEeec
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG-APTQEFIDEVCFLASIQHRNLVT-LLGYCQENNLQFLIYEYIP  159 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~-~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~~~~~~lv~e~~~  159 (386)
                      ++|++.+.||+|+||+||+|.. .+++.||||.... ...+++..|+++++.++|+|++. +.++....+..++||||+.
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~   86 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG   86 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC
Confidence            4688999999999999999996 4589999997433 34457889999999998766554 4555677888999999995


Q ss_pred             CCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeC---CCCceEEcccccccccCCC
Q 016588          160 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       160 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~---~~~~~kl~DFgl~~~~~~~  236 (386)
                      + ++...+.    .....+++..+..++.|++.||+|||+  ++|+||||||+|||++   .+..+||+|||+++.....
T Consensus        87 ~-~l~~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          87 P-SLEDLFN----FCSRKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             C-BHHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             C-chhhhhh----hccCCCcHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            5 5554442    234578999999999999999999999  7799999999999986   4567999999999887543


Q ss_pred             CCC-----CCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhh
Q 016588          237 DVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK  311 (386)
Q Consensus       237 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (386)
                      ...     .......||+.|+|||.+.+..++.++|||||||++|||++|..||......................    
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~----  235 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST----  235 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS----
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC----
Confidence            221     12335579999999999999999999999999999999999999998766533322221111110000    


Q ss_pred             hcchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHHhhhh-hccccccc
Q 016588          312 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK-EMNLTTVM  368 (386)
Q Consensus       312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~~~~~-~~~~~~~~  368 (386)
                       ..+.    ....+++++.+++..||+.||++||++.++.+.|+.+..+ ..+.+.+.
T Consensus       236 -~~~~----~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~  288 (299)
T d1ckia_         236 -PIEV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVF  288 (299)
T ss_dssp             -CHHH----HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCC
T ss_pred             -ChhH----hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCc
Confidence             0011    1223446789999999999999999999999999887654 34444433

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.4e-47  Score=353.73  Aligned_cols=257  Identities=19%  Similarity=0.246  Sum_probs=199.9

Q ss_pred             cCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCCChhHHHHHHHHHHcCC-CCcccccccceee--CCeEEEEEEee
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLASIQ-HRNLVTLLGYCQE--NNLQFLIYEYI  158 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~e~~  158 (386)
                      ++|++.+.||+|+||+||+|.. .+++.||||+++....+++.+|+.+|+.++ ||||+++++++..  ....++||||+
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~  114 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV  114 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence            5799999999999999999996 468999999988888889999999999995 9999999999874  45689999999


Q ss_pred             cCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC-ceEEcccccccccCCCC
Q 016588          159 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNFLGRTD  237 (386)
Q Consensus       159 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~-~~kl~DFgl~~~~~~~~  237 (386)
                      .+++|....        +.+++..+..++.|++.||.|||+  +||+||||||+|||++.++ .+||+|||+++......
T Consensus       115 ~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~--~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         115 NNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             CSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             CCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhh--cccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            999987654        358899999999999999999999  7799999999999998655 68999999998765422


Q ss_pred             CCCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhh--h---------c
Q 016588          238 VAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS--R---------D  305 (386)
Q Consensus       238 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~--~---------~  305 (386)
                         ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||......... ........  +         .
T Consensus       185 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~-~~~i~~~~g~~~~~~~~~~~~  260 (328)
T d3bqca1         185 ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLYDYIDKYN  260 (328)
T ss_dssp             ---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHHHHHHHHTT
T ss_pred             ---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHH-HHHHHHHHCCchhhhhhhhcc
Confidence               23455788899999998765 4799999999999999999999999875542111 11100000  0         0


Q ss_pred             ---ccchhhhcc--------hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          306 ---FSNLLKILD--------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       306 ---~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                         .........        ...........++++.+|+.+||+.||++|||++|+++|
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               000000000        000111122345678999999999999999999999875

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-48  Score=359.88  Aligned_cols=263  Identities=20%  Similarity=0.285  Sum_probs=193.8

Q ss_pred             cCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCCC----hhHHHHHHHHHHcCCCCcccccccceeeCC----eEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENN----LQFL  153 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~l  153 (386)
                      .+|+..+.||+|+||+||+|.. .+++.||||++....    .+.+.+|+++|+.++||||+++++++....    ..++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            4688899999999999999985 469999999876443    235788999999999999999999986543    2344


Q ss_pred             EEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccccccc
Q 016588          154 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  233 (386)
Q Consensus       154 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~  233 (386)
                      +++|+.+|+|.+++.      ...+++..+..++.|++.||+|||+  +||+||||||+|||++.++.+||+|||+++..
T Consensus        88 l~~~~~~g~L~~~l~------~~~l~~~~i~~i~~qil~al~yLH~--~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          88 LVTHLMGADLYKLLK------TQHLSNDHICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEECCCEEHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEeecCCchhhhhh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            556677899998883      2468999999999999999999999  78999999999999999999999999999876


Q ss_pred             CCCCC-CCCCccccCcccccchhhhcc-cCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccchhh
Q 016588          234 GRTDV-AGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK  311 (386)
Q Consensus       234 ~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (386)
                      ..... ........+|+.|+|||++.. ..++.++||||+||++|||++|..||..........................
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  239 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence            44322 222345678999999999854 5678999999999999999999999987543221111111111100000000


Q ss_pred             hcc--------------hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          312 ILD--------------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       312 ~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ...              ...+.......+.++.+++.+||+.||.+|||++|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000              000001111233568999999999999999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=357.97  Aligned_cols=256  Identities=20%  Similarity=0.330  Sum_probs=191.6

Q ss_pred             hcCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeCC------
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENN------  149 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  149 (386)
                      .++|+..+.||+|+||+||+|... +++.||||++....     .+.+.+|+++|+.++||||+++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            367899999999999999999964 58999999976432     235788999999999999999999987654      


Q ss_pred             eEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEccccc
Q 016588          150 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  229 (386)
Q Consensus       150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl  229 (386)
                      ..|+||||+ +.+|....      ....+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+|++|||+
T Consensus        97 ~~~lv~e~~-~~~l~~~~------~~~~l~~~~~~~~~~qi~~aL~~LH~--~~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLM------KHEKLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCEEEEECC-SEEHHHHH------HHCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecc-cccHHHHH------HhccccHHHHHHHHHHHHHHHHHHHh--CCCcccccCcchhhcccccccccccccc
Confidence            569999999 45666555      23568999999999999999999999  7799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCcccccchhhhccc-CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcc-c
Q 016588          230 RNFLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF-S  307 (386)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~  307 (386)
                      ++.....     .....+|+.|+|||++.+. .++.++||||+||++|||++|..||.+.....  .+.......... .
T Consensus       168 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~  240 (346)
T d1cm8a_         168 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD--QLKEIMKVTGTPPA  240 (346)
T ss_dssp             CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCH
T ss_pred             eeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH--HHHHHHhccCCCcH
Confidence            9876432     3456788999999998764 56899999999999999999999998754311  111111100000 0


Q ss_pred             chh------------hh---cchhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          308 NLL------------KI---LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       308 ~~~------------~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ...            ..   .....+.......++++.+|+.+||+.||++|||+.|+++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            000            00   00011112223345678999999999999999999999987

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-47  Score=351.40  Aligned_cols=250  Identities=22%  Similarity=0.267  Sum_probs=200.1

Q ss_pred             cCCCcCCeecccCceEEEEEEeC----CCcEEEEEECCC-------CChhHHHHHHHHHHcCCC-CcccccccceeeCCe
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPG-------APTQEFIDEVCFLASIQH-RNLVTLLGYCQENNL  150 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~-------~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~  150 (386)
                      ++|++.+.||+|+||+||+|...    +|+.||||.++.       ...+.+.+|++++++++| |||+++++++.+.+.
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            56899999999999999999842    478999997542       234568899999999966 899999999999999


Q ss_pred             EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  230 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~  230 (386)
                      .+++|||+.+|+|.+++.     ....+.+.....++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~v~e~~~~~~L~~~i~-----~~~~~~e~~~~~~~~Qi~~al~~lH~--~~ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLS-----QRERFTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             EEEEECCCCSCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eeeeeecccccHHHHHHH-----hcccccHHHHHHHHHHHHHHHHHhhc--CCEEeccCCccceeecCCCCEEEeeccch
Confidence            999999999999998883     34567788899999999999999999  77999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhccc--CCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhcccc
Q 016588          231 NFLGRTDVAGPSSQVTADEIFLASEVKEFR--RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN  308 (386)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  308 (386)
                      +.+...... ......+++.|++||.+.+.  .++.++|||||||++|||++|+.||............  .....    
T Consensus       177 ~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i--~~~~~----  249 (322)
T d1vzoa_         177 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRIL----  249 (322)
T ss_dssp             EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHH----
T ss_pred             hhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhcc----
Confidence            876442222 23345688899999998764  4688999999999999999999999876543221111  11110    


Q ss_pred             hhhhcchhhcccCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016588          309 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  353 (386)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~~  353 (386)
                             ......+...++++.+++.+||+.||.+||     |++|+++|
T Consensus       250 -------~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         250 -------KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             -------HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             -------cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence                   001123344567899999999999999999     47888874

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=343.17  Aligned_cols=260  Identities=20%  Similarity=0.254  Sum_probs=201.7

Q ss_pred             cCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCC-----ChhHHHHHHHHHHcCCCCcccccccceeeCCeEEEEEE
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  156 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  156 (386)
                      ++|+..+.||+|+||+||+|+. .+++.||||+++..     ....+.+|+.+++.++||||+++++++.+.+..++|++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            4788999999999999999995 46889999984322     23568899999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016588          157 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  236 (386)
Q Consensus       157 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~~~~~~  236 (386)
                      ++.++++..++.     ....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||.++.....
T Consensus        82 ~~~~~~l~~~~~-----~~~~~~~~~~~~~~~q~~~aL~~lH~--~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          82 FCDQDLKKYFDS-----CNGDLDPEIVKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSEEHHHHHHH-----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             eccccccccccc-----cccccchhHHHHHHHHHHHHHHHhhc--CCEeeecccCcccccccCCceeeeecchhhcccCC
Confidence            999988887763     34667899999999999999999999  77999999999999999999999999999877543


Q ss_pred             CCCCCCccccCcccccchhhhcccC-CCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhccc------ch
Q 016588          237 DVAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS------NL  309 (386)
Q Consensus       237 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~  309 (386)
                      ..  ......++..|+|||.+.+.. ++.++||||+||++|||++|+.||.....  ..+....+.......      ..
T Consensus       155 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  230 (292)
T d1unla_         155 VR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSM  230 (292)
T ss_dssp             CS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTG
T ss_pred             Cc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC--HHHHHHHHHhhcCCCChhhhhhh
Confidence            32  223345677899999987665 58999999999999999999999765332  222222221111100      00


Q ss_pred             hhhcc---------hhhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          310 LKILD---------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       310 ~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ....+         ...........++.+.+|+.+||+.||++|||++|+++|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00000         000111223345678999999999999999999999876

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-46  Score=350.97  Aligned_cols=256  Identities=20%  Similarity=0.286  Sum_probs=187.8

Q ss_pred             cCCCcCCeecccCceEEEEEEeC-CCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceee------CCe
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQE------NNL  150 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~  150 (386)
                      ++|++.+.||+|+||+||+|... +++.||||+++...     .+.+.+|+.+++.++||||+++++++..      .+.
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57899999999999999999965 59999999865332     2357899999999999999999999853      468


Q ss_pred             EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  230 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~  230 (386)
                      .|+||||+.++++....        ..+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+|++|||++
T Consensus        97 ~~iv~Ey~~~~l~~~~~--------~~~~~~~i~~~~~qil~gl~~LH~--~giiHrDlKP~Nil~~~~~~~kl~df~~~  166 (355)
T d2b1pa1          97 VYLVMELMDANLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_dssp             EEEEEECCSEEHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             eEEEEeccchHHHHhhh--------cCCCHHHHHHHHHHHHHHHHHhhh--cccccccCCccccccccccceeeechhhh
Confidence            89999999776554332        347899999999999999999999  77999999999999999999999999998


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhc-----
Q 016588          231 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD-----  305 (386)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-----  305 (386)
                      +.....   .......+|+.|+|||++.+..++.++||||+||++|||++|+.||.+.+....  ..........     
T Consensus       167 ~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~--~~~i~~~~~~~~~~~  241 (355)
T d2b1pa1         167 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ--WNKVIEQLGTPCPEF  241 (355)
T ss_dssp             -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHH
T ss_pred             hccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHH--HHHHHHhccCCCHHH
Confidence            876432   233455688899999999999999999999999999999999999986542111  1111100000     


Q ss_pred             -----------------c--cchhhhcchhhccc---CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          306 -----------------F--SNLLKILDERLWST---FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       306 -----------------~--~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                                       .  ..............   .....++++.+|+.+||+.||++|||++|+|+|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                             0  00011111111111   122356789999999999999999999999977

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-46  Score=346.99  Aligned_cols=256  Identities=20%  Similarity=0.306  Sum_probs=191.4

Q ss_pred             hcCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCCC-----hhHHHHHHHHHHcCCCCcccccccceeeC-----Ce
Q 016588           82 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN-----NL  150 (386)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  150 (386)
                      .++|++.+.||+|+||+||+|.. .+++.||||++....     .+.+.+|+++|+.++|||++++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            35799999999999999999995 469999999976432     23578999999999999999999988532     33


Q ss_pred             EEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEEcccccc
Q 016588          151 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  230 (386)
Q Consensus       151 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~  230 (386)
                      .+++++|+.+|+|.+++.      ...+++..+..++.|++.||+|||+  +||+||||||+|||++.++.+|++|||++
T Consensus        97 ~~~i~~~~~gg~L~~~~~------~~~l~e~~~~~i~~qil~aL~~LH~--~giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVK------CQKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCEEEEECCSEEHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             eEEEEEeecCCchhhhcc------cccccHHHHHHHHHHHHHHHHHHHh--CCCcccccCCccccccccccccccccchh
Confidence            466677888999998883      3468999999999999999999999  77999999999999999999999999998


Q ss_pred             cccCCCCCCCCCccccCcccccchhhhcccC-CCcccchhhHHHHHHHHHcCCCCCCCCCCCchhhHHHHHHhhhccc--
Q 016588          231 NFLGRTDVAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS--  307 (386)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--  307 (386)
                      ......     .....+++.|+|||...+.. ++.++||||+||++|+|++|..||.+.+....   ...+.......  
T Consensus       169 ~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~---~~~i~~~~~~~~~  240 (348)
T d2gfsa1         169 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ---LKLILRLVGTPGA  240 (348)
T ss_dssp             -CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCH
T ss_pred             cccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCh
Confidence            765432     23456788899999877654 58899999999999999999999986543211   11111110000  


Q ss_pred             chhh---------hcchhh------cccCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016588          308 NLLK---------ILDERL------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  353 (386)
Q Consensus       308 ~~~~---------~~~~~~------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~  353 (386)
                      ....         ......      ........++++.+|+.+||+.||++|||++|+++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence            0000         000000      000011234668999999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.2e-40  Score=312.60  Aligned_cols=263  Identities=17%  Similarity=0.214  Sum_probs=189.2

Q ss_pred             cCCCcCCeecccCceEEEEEEe-CCCcEEEEEECCCCC--hhHHHHHHHHHHcCC-----------CCcccccccceee-
Q 016588           83 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP--TQEFIDEVCFLASIQ-----------HRNLVTLLGYCQE-  147 (386)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~-  147 (386)
                      .+|++.+.||+|+||+||+|+. .+++.||||++....  .+.+.+|+.+++.++           |+||+++++++.. 
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            3589999999999999999996 468999999976543  356788998888774           5789999988754 


Q ss_pred             -CCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCC------
Q 016588          148 -NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF------  220 (386)
Q Consensus       148 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~------  220 (386)
                       ....+++++++..+........  ......+++..+..++.|++.||.|||+. .||+||||||+|||++.++      
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~~-~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHRR-CGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHHT-TCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             cccceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhhh-cCcccccCChhHeeeeccCcccccc
Confidence             3566677777655443222211  13456678889999999999999999962 5699999999999998655      


Q ss_pred             ceEEcccccccccCCCCCCCCCccccCcccccchhhhcccCCCcccchhhHHHHHHHHHcCCCCCCCCCCCchh----hH
Q 016588          221 IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ----DL  296 (386)
Q Consensus       221 ~~kl~DFgl~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~el~tg~~p~~~~~~~~~~----~~  296 (386)
                      .++++|||.+......     .....+|+.|+|||++....|+.++||||+||+++||++|+.||.........    .+
T Consensus       170 ~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         170 QIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             EEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             eeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence            4899999998765332     23456888999999999999999999999999999999999999865432211    11


Q ss_pred             HHHHHhhhcc--------cchhhhcch-------------------hhcccCCHHHHHHHHHHHhHccCCCCCCCCCHHH
Q 016588          297 VELVQNSRDF--------SNLLKILDE-------------------RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD  349 (386)
Q Consensus       297 ~~~~~~~~~~--------~~~~~~~~~-------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~e  349 (386)
                      ...+......        .......+.                   ..........++++.+|+.+||+.||++|||++|
T Consensus       245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence            1111100000        000000000                   0112345567788999999999999999999999


Q ss_pred             HHHH
Q 016588          350 VVTE  353 (386)
Q Consensus       350 vl~~  353 (386)
                      +|+|
T Consensus       325 ~L~H  328 (362)
T d1q8ya_         325 LVNH  328 (362)
T ss_dssp             HHTC
T ss_pred             HhcC
Confidence            9986

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=4.6e-25  Score=186.92  Aligned_cols=159  Identities=17%  Similarity=0.107  Sum_probs=115.3

Q ss_pred             CcCCeecccCceEEEEEEeCCCcEEEEEECCCCC---------------------hhHHHHHHHHHHcCCCCcccccccc
Q 016588           86 SDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP---------------------TQEFIDEVCFLASIQHRNLVTLLGY  144 (386)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---------------------~~~~~~e~~~l~~l~h~niv~~~~~  144 (386)
                      .+.+.||+|+||+||+|...+|+.||||......                     ......|...+..+.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            3467899999999999998889999999743211                     0123457888889999999888765


Q ss_pred             eeeCCeEEEEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeeeCCCCceEE
Q 016588          145 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKV  224 (386)
Q Consensus       145 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl  224 (386)
                      ..    .+++|||+++..+..+            +......++.|++.++.|||+  .||+||||||+|||++++ .++|
T Consensus        83 ~~----~~lvme~~~~~~~~~l------------~~~~~~~i~~ql~~~l~~lH~--~giiHrDiKP~NILv~~~-~~~l  143 (191)
T d1zara2          83 EG----NAVLMELIDAKELYRV------------RVENPDEVLDMILEEVAKFYH--RGIVHGDLSQYNVLVSEE-GIWI  143 (191)
T ss_dssp             ET----TEEEEECCCCEEGGGC------------CCSCHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEEETT-EEEE
T ss_pred             cC----CEEEEEeeccccccch------------hhHHHHHHHHHHHHHHHHHhh--CCEEEccCChhheeeeCC-CEEE
Confidence            32    2699999987654332            222345689999999999999  779999999999999965 4899


Q ss_pred             cccccccccCCCCCCCCCccccCcccccch------hhhcccCCCcccchhhHHHH
Q 016588          225 ADAGLRNFLGRTDVAGPSSQVTADEIFLAS------EVKEFRRFSEKSDVYSFGVF  274 (386)
Q Consensus       225 ~DFgl~~~~~~~~~~~~~~~~~~~~~y~aP------E~~~~~~~~~~~DvwSlGvi  274 (386)
                      +|||++........          ..|...      +.+ .+.|+.++|+||..--
T Consensus       144 iDFG~a~~~~~~~~----------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         144 IDFPQSVEVGEEGW----------REILERDVRNIITYF-SRTYRTEKDINSAIDR  188 (191)
T ss_dssp             CCCTTCEETTSTTH----------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred             EECCCcccCCCCCc----------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence            99999876543211          012211      222 2567899999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.41  E-value=4.8e-07  Score=78.18  Aligned_cols=144  Identities=15%  Similarity=0.092  Sum_probs=92.3

Q ss_pred             HHHHHhcCCCcCCeecccCceEEEEEEeCCCcEEEEEECCCC---ChhHHHHHHHHHHcCC-CCcccccccceeeCCeEE
Q 016588           77 ELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA---PTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQF  152 (386)
Q Consensus        77 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  152 (386)
                      ++......|+..+..+.++.+.||+...+ +..+++|+....   ....+.+|...+..+. +--+.+++.+....+..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            34444455655554444455789998754 456677874432   3446788888888774 434677788888888999


Q ss_pred             EEEEeecCCCccccccCCCcCCCCCCCHHHHHHHHHHHHHHHHHhhcC--------------------------------
Q 016588          153 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL--------------------------------  200 (386)
Q Consensus       153 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------------------------------  200 (386)
                      +||+++++.++.......       ..   ...++.+++..+..||+.                                
T Consensus        87 lv~~~l~G~~~~~~~~~~-------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDE-------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEECCSSEEHHHHTTTC-------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred             EEEEeccccccccccccc-------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence            999999987765433111       00   112333344444444421                                


Q ss_pred             -------------------------CCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          201 -------------------------SPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       201 -------------------------~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                                               ...++|+|+.|.|||+++++..-|.||+.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                     1236899999999999987777799998654

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.31  E-value=1.1e-06  Score=75.50  Aligned_cols=75  Identities=16%  Similarity=0.153  Sum_probs=57.5

Q ss_pred             ecccC-ceEEEEEEeCCCcEEEEEECCCCChhHHHHHHHHHHcCC--CCcccccccceeeCCeEEEEEEeecCCCccc
Q 016588           91 IGEGK-FGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ--HRNLVTLLGYCQENNLQFLIYEYIPNGSVSI  165 (386)
Q Consensus        91 lg~G~-~g~V~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~  165 (386)
                      +..|. .+.||+...+++..+++|..+......+..|...++.+.  .-.+.+++.+..+.+..++||+++++.++..
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~   95 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS   95 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccc
Confidence            34444 367999998878889999877777777889999888774  2336677888888888999999998866643

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.59  E-value=0.00014  Score=66.22  Aligned_cols=73  Identities=15%  Similarity=0.124  Sum_probs=47.3

Q ss_pred             CCeecccCceEEEEEEeCC-CcEEEEEECCC----------CChhHHHHHHHHHHcCC-C--CcccccccceeeCCeEEE
Q 016588           88 KNLIGEGKFGEVYKGLLQD-GMLVAIKKRPG----------APTQEFIDEVCFLASIQ-H--RNLVTLLGYCQENNLQFL  153 (386)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~----------~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~l  153 (386)
                      .+.+|.|....||+....+ ++.+++|.-.+          ...++...|.+.|+.+. +  ..+++++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            3578999999999998654 67888985221          12345567888887662 2  345566654  3444578


Q ss_pred             EEEeecCCC
Q 016588          154 IYEYIPNGS  162 (386)
Q Consensus       154 v~e~~~~g~  162 (386)
                      |||++.+..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997644

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.07  E-value=0.00086  Score=59.10  Aligned_cols=68  Identities=12%  Similarity=0.167  Sum_probs=46.3

Q ss_pred             ceEEEEEEeCCCcEEEEEECCCC--ChhHHHHHHHHHHcCCCCcc-----cccc--cceeeCCeEEEEEEeecCCCc
Q 016588           96 FGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNL-----VTLL--GYCQENNLQFLIYEYIPNGSV  163 (386)
Q Consensus        96 ~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~h~ni-----v~~~--~~~~~~~~~~lv~e~~~~g~L  163 (386)
                      --.||++..++|..+++|...+.  +.+++..|...+..|...++     +..-  ......+..+.+++++.|..+
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~  111 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF  111 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence            35899999989999999986543  45678889888877742211     1211  123455677889999877544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.90  E-value=0.006  Score=53.04  Aligned_cols=157  Identities=12%  Similarity=0.004  Sum_probs=82.8

Q ss_pred             CHHHHHHHhcCCCcCCe-----ecccCceEEEEEEeCCCcEEEEEECCCC-ChhHHHHHHHHHHcCCCCc--cccccc--
Q 016588           74 QMEELSLATKNFSDKNL-----IGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHRN--LVTLLG--  143 (386)
Q Consensus        74 ~~~~~~~~~~~~~~~~~-----lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~h~n--iv~~~~--  143 (386)
                      +.+++.....+|...+.     |..|---+.|+...++++ +++|+.... ..+++..|++++..|...+  +...+.  
T Consensus         4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~   82 (316)
T d2ppqa1           4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRK   82 (316)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBT
T ss_pred             CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCHHHHHHHHHHHHhhhhccccccccceec
Confidence            34566666667766544     335666888999887654 788886543 4556677887777764222  221111  


Q ss_pred             ----ceeeCCeEEEEEEeecCCCcccccc------------------CCCcCCCCC------------------CCHHHH
Q 016588          144 ----YCQENNLQFLIYEYIPNGSVSIHLY------------------GPSQVSRQK------------------LEFKHR  183 (386)
Q Consensus       144 ----~~~~~~~~~lv~e~~~~g~L~~~l~------------------~~~~~~~~~------------------l~~~~~  183 (386)
                          +....+....++.+..+........                  .........                  ......
T Consensus        83 ~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (316)
T d2ppqa1          83 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL  162 (316)
T ss_dssp             TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred             CCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhH
Confidence                1223445566667666543322110                  000000000                  000111


Q ss_pred             HHHHHHHHHHHHHhhc--CCCCceecCCCCCCeeeCCCCceEEccccccc
Q 016588          184 LSIALGAAKGLAHLHS--LSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  231 (386)
Q Consensus       184 ~~i~~~i~~~l~~LH~--~~~~ivH~dlkp~Nill~~~~~~kl~DFgl~~  231 (386)
                      ...+......+.-.+.  ...|+||+|+.++|++++++...-+.||+.+.
T Consensus       163 ~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         163 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            1222233333333332  23579999999999999998877899998654

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.69  E-value=0.004  Score=56.20  Aligned_cols=72  Identities=17%  Similarity=0.174  Sum_probs=49.1

Q ss_pred             CeecccCceEEEEEEeCC--------CcEEEEEECCC-CChhHHHHHHHHHHcCC-CCcccccccceeeCCeEEEEEEee
Q 016588           89 NLIGEGKFGEVYKGLLQD--------GMLVAIKKRPG-APTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEYI  158 (386)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~  158 (386)
                      +.|+.|-.-.+|++...+        ...|.+++... .......+|..+++.+. +.-..++++++.+    .+|+||+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi  123 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYI  123 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEe
Confidence            567888889999998653        24677776442 23345667888888874 4334577777654    4789999


Q ss_pred             cCCCcc
Q 016588          159 PNGSVS  164 (386)
Q Consensus       159 ~~g~L~  164 (386)
                      ++..+.
T Consensus       124 ~g~~l~  129 (395)
T d1nw1a_         124 PSRPLS  129 (395)
T ss_dssp             CEEECC
T ss_pred             ccccCC
Confidence            876554